Citrus Sinensis ID: 039471

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360---
Protein Sequence
MSLVMSLIILFLFLLYTCTLAKASAEDNKTDKYEFCQPTRCSNKSPRIRYPFRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEEEEccccEEEEcccccEEEEEEccccEEEEEHHHHHHccccccccccEEEEEccccccccEEEEEEEccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEcccccccccccccccccccccccccccccccEEEEEEccccccccccccccccccHHHHHHHHHcccccccccccccccEEHHHHHHHHHHcccEEEcccccccHHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHccccccEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccHHccccccccccEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEcccccccHHcHccHHEEccccccEEEEEEEEEccccccHccccHHHHHHHEHHHHHccccccccccccccHHHHHHHHHHHHcccccccHcHcccccHHHHHHHHHHHHHHHcccHcccccccc
Coil and Loop (DISEMBL)
MSLVMSLIILFLFLLYTCTLAKasaednktdkyefcqptrcsnksprirypfrlkaqptycglegfelsclsdktilhfpssgdyyvHKISYldssititdvnetacpfqslisfnltnskffflHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIyefmpngslqkfifsktnssshrqLSWEKLRKIAFGVARGVEYLHQGcnqrilhfdikphnilldhnfqpkisdfglaklcskdisivsrtaargtsgyiapelfsrNFCYGMMLLEMVgcrknndpaveiqsqiyfpeWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIqwnpterpsmpm
Flexible Loop (DISEMBL)
MSLVMSLIILFLFLLYTCTLAKAsaednktdkyefcqptrcsnksprirypfRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSrtaargtsgyiapELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIqwnpterpsmpm
Low Complexity Region (SEG)
MSLVMSLIILFLFLLYTCTLAKASAEDNKTDKYEFCQPTRCSNKSPRIRYPFRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM
Disordered region (IsUnstruct)
**LVMSLIILFLFLLYTCTLAKASAE**KTDKYEFCQPTRCSNKSPRIRYPFRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTN***HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN*********
Disordered Region (DISOPRED)
****MSL*ILFLFLLYTCTLAKASAEDNKTDKYEFCQPTRCSNKSPRIRYPFRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLE******QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNN*****IQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP*
Disordered Region (DISEMBL)
MSLVMSLIILFLFLLYTCTLAKASAEDNKTDKYEFCQPTRCSNKSPRIRYPFRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS*********LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM
Disordered Region (DISPRO)
*SLVMSLIILFLFLLYTCTLAKASAEDNKTDK*************************************************************DSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN*********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSLVMSLIILFLFLLYTCTLAKASAEDNKTDKYEFCQPTRCSNKSPRIRYPFRLKAQPTYCGLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	363	2.2.26 [Sep-21-2011]
Q3ECH2	892	Probable receptor-like pr	no	no	0.636	0.258	0.490	1e-61
Q9FID5	806	Probable receptor-like pr	no	no	0.661	0.297	0.442	2e-59
Q9FID6	813	Probable receptor-like pr	no	no	0.661	0.295	0.445	8e-59
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.622	0.275	0.444	3e-50
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.625	0.260	0.444	4e-48
Q39202	832	G-type lectin S-receptor-	no	no	0.603	0.263	0.418	2e-47
Q9XID3	829	G-type lectin S-receptor-	no	no	0.628	0.275	0.412	5e-46
Q39203	797	G-type lectin S-receptor-	no	no	0.622	0.283	0.430	2e-45
O64477	828	G-type lectin S-receptor-	no	no	0.636	0.278	0.426	5e-45
Q9SYS7	659	Putative cysteine-rich re	no	no	0.639	0.352	0.379	1e-40

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  237 bits (604), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 127/259 (49%), Positives = 165/259 (63%), Gaps = 28/259 (10%)

Query: 127 SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           S+ +AVK+L+  KG +G++FINEVA++ +  H +IV LLGFC EG+RR +IYEF+ NGSL
Sbjct: 578 SSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSL 637

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            KFI  K    S   L  + L  IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  
Sbjct: 638 DKFISDK----SSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLC 693

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR----------NFCYGMMLLEMV 295
           PK+SDFGLAKLC K  SI+S    RGT GYIAPE+ SR           + YGM++LEM+
Sbjct: 694 PKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMI 753

Query: 296 GCRKN---NDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG----------DEGIARK 342
           G RK    +  +    S IYFPEWIY  +       ++  E+G          +E IARK
Sbjct: 754 GARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARK 813

Query: 343 LAIVAIWCIQWNPTERPSM 361
           + +V +WCIQ +P++RP M
Sbjct: 814 MTLVGLWCIQSSPSDRPPM 832

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  229 bits (585), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 119/269 (44%), Positives = 172/269 (63%), Gaps = 29/269 (10%)

Query: 109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 168
           F ++   NL+N +       ++AVK+L+ LKG+ ++FINEVA++ +  H +IV LLGFC 
Sbjct: 509 FGTVYGGNLSNGR-------KVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCF 561

Query: 169 EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE--KLRKIAFGVARGVEYLHQGCNQ 226
           EG++R ++YEF+ NGSL +F+      S ++ L+ +   L  IA G+ARG+EYLH GC  
Sbjct: 562 EGSKRAIVYEFLENGSLDQFM------SRNKSLTQDVTTLYGIALGIARGLEYLHYGCKT 615

Query: 227 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-- 284
           RI+HFDIKP NILLD N  PK+SDFGLAKLC K  S++S    RGT GYIAPE+FSR   
Sbjct: 616 RIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYG 675

Query: 285 --------FCYGMMLLEMVGCRKNN--DPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED 334
                   + +GM++++M+G R     +      S  YFP+WIY  +  G++  +  +E 
Sbjct: 676 RVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEI 735

Query: 335 GDE--GIARKLAIVAIWCIQWNPTERPSM 361
             E   IA+K+ +V +WCIQ  P++RPSM
Sbjct: 736 TKEEKEIAKKMIVVGLWCIQPCPSDRPSM 764

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  228 bits (580), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 119/267 (44%), Positives = 167/267 (62%), Gaps = 27/267 (10%)

Query: 109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 168
           F ++   NL+N +        +AVK+L+ LKGNG +FINEV ++ +  H +IV LLGFC 
Sbjct: 507 FGTVYRGNLSNGR-------TVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCY 559

Query: 169 EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS--WEKLRKIAFGVARGVEYLHQGCNQ 226
           EG++R +I EF+ +GSL +FI      S ++ L+     L  IA G+ARG+EYLH GC  
Sbjct: 560 EGSKRAIISEFLEHGSLDQFI------SRNKSLTPNVTTLYGIALGIARGLEYLHYGCKT 613

Query: 227 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-- 284
           RI+HFDIKP NILLD NF PK++DFGLAKLC K  SI+S    RGT GYIAPE+ SR   
Sbjct: 614 RIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYG 673

Query: 285 --------FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE--D 334
                   + YGM++L+M+G R   +      S  YFP+WIY  +  G +  +  +E  +
Sbjct: 674 GISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINE 733

Query: 335 GDEGIARKLAIVAIWCIQWNPTERPSM 361
            D  I +K+ +V++WCI+  P++RP M
Sbjct: 734 EDNKIVKKMILVSLWCIRPCPSDRPPM 760

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  199 bits (505), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 111/250 (44%), Positives = 151/250 (60%), Gaps = 24/250 (9%)

Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           + +AVK LE +    +EF  EV+ IG IHH H+VRL GFC+EG  R L YEF+  GSL++
Sbjct: 516 SRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLER 575

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           +IF K +      L W+    IA G A+G+ YLH+ C+ RI+H DIKP NILLD NF  K
Sbjct: 576 WIFRKKDGDV--LLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAK 633

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK 299
           +SDFGLAKL +++ S V  T  RGT GY+APE          S  + YGM+LLE++G RK
Sbjct: 634 VSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRK 692

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG--------DEGIARKLAIVAIWCI 351
           N DP+ E   + +FP + + +M  G+ + +    DG        DE + R +   A+WCI
Sbjct: 693 NYDPS-ETSEKCHFPSFAFKKMEEGKLMDI---VDGKMKNVDVTDERVQRAMK-TALWCI 747

Query: 352 QWNPTERPSM 361
           Q +   RPSM
Sbjct: 748 QEDMQTRPSM 757

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  192 bits (487), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 109/245 (44%), Positives = 149/245 (60%), Gaps = 18/245 (7%)

Query: 130 IAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    +G+ EFI EV TIG +HH ++VRL G+CSE + R L+YE+M NGSL K+
Sbjct: 555 VAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKW 614

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           IFS   +++   L W    +IA   A+G+ Y H+ C  RI+H DIKP NILLD NF PK+
Sbjct: 615 IFSSEQTAN--LLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKV 672

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKN 300
           SDFGLAK+  ++ S V  T  RGT GY+APE  S          + YGM+LLE+VG R+N
Sbjct: 673 SDFGLAKMMGREHSHVV-TMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRN 731

Query: 301 NDPAVEIQSQIYFPEWIYNRMRLGQEL-CLDFEEDG---DEGIARKLAIVAIWCIQWNPT 356
            D + + +   ++P W Y  +  G  L  +D    G   +E + + L  VA WCIQ   +
Sbjct: 732 LDMSYDAE-DFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALK-VAFWCIQDEVS 789

Query: 357 ERPSM 361
            RPSM
Sbjct: 790 MRPSM 794

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  189 bits (481), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/246 (41%), Positives = 147/246 (59%), Gaps = 27/246 (10%)

Query: 130 IAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+ L   N +EF NEV  IG+IHH ++VRL+GFC+EG  + ++YEF+P G+L  F
Sbjct: 560 VAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANF 619

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +F +       + SWE  + IA  +ARG+ YLH+ C+++I+H DIKP NILLD  + P+I
Sbjct: 620 LFRRP------RPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRI 673

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKN 300
           SDFGLAKL   +    + T  RGT GY+APE F  +        + YG+MLLE+V C+K 
Sbjct: 674 SDFGLAKLLLMN-QTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKK- 731

Query: 301 NDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI-----ARKLAIVAIWCIQWNP 355
              AV+++  +    W Y+  R G+    D  ED  E +       +   +AIWCIQ   
Sbjct: 732 ---AVDLEDNVILINWAYDCFRQGR--LEDLTEDDSEAMNDMETVERYVKIAIWCIQEEH 786

Query: 356 TERPSM 361
             RP+M
Sbjct: 787 GMRPNM 792

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  185 bits (469), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/245 (41%), Positives = 143/245 (58%), Gaps = 17/245 (6%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVK LE ++   ++F  EVATI   HH ++VRL+GFCS+G  R L+YEFM NGSL  F+
Sbjct: 509 VAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFL 568

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           F+   + S + L+WE    IA G A+G+ YLH+ C   I+H DIKP NIL+D NF  K+S
Sbjct: 569 FT---TDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVS 625

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNN 301
           DFGLAKL +   +  + ++ RGT GY+APE          S  + YGM+LLE+V  ++N 
Sbjct: 626 DFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNF 685

Query: 302 DPAVEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDGDEGI----ARKLAIVAIWCIQWNPT 356
           D + E  +   F  W Y     G  +  LD     D+ +      ++   + WCIQ  P 
Sbjct: 686 DVS-EKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPL 744

Query: 357 ERPSM 361
           +RP+M
Sbjct: 745 QRPTM 749

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  183 bits (465), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 108/251 (43%), Positives = 147/251 (58%), Gaps = 25/251 (9%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVK LE       EF  EV TIG I H ++VRL GFCSE   R L+Y++MP GSL  ++
Sbjct: 487 VAVKRLERPGSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL 546

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
               + +S + LSWE   +IA G A+G+ YLH+GC   I+H DIKP NILLD ++  K+S
Sbjct: 547 ----SRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVS 602

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFS--------RNFCYGMMLLEMVGCRK-- 299
           DFGLAKL  +D S V  T  RGT GY+APE  S          + +GM LLE++G R+  
Sbjct: 603 DFGLAKLLGRDFSRVLAT-MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNV 661

Query: 300 --NNDPAVEIQSQ---IYFPEWIYNRMRLGQ-ELCLDFEEDGD---EGIARKLAIVAIWC 350
             N+D   E +++    +FP W    +  G  +  +D   +G+   E + R +A VAIWC
Sbjct: 662 IVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTR-MATVAIWC 720

Query: 351 IQWNPTERPSM 361
           IQ N   RP+M
Sbjct: 721 IQDNEEIRPAM 731

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  181 bits (460), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 107/251 (42%), Positives = 145/251 (57%), Gaps = 20/251 (7%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            S++IAVK LE +    ++F  EV TIG I H ++VRL GFCSEG+++ L+Y++MPNGSL
Sbjct: 514 DSSDIAVKRLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSL 573

Query: 186 QKFIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
              +F   N    +  L W+   +IA G ARG+ YLH  C   I+H DIKP NILLD  F
Sbjct: 574 DSHLF--LNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQF 631

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS--------RNFCYGMMLLEMVG 296
            PK++DFGLAKL  +D S V  T  RGT GY+APE  S          + YGMML E+V 
Sbjct: 632 CPKVADFGLAKLVGRDFSRV-LTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVS 690

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL--CLDFEEDGD----EGIARKLAIVAIWC 350
            R+N + + E +   +FP W    +    ++   +D   +GD    E + R    VA WC
Sbjct: 691 GRRNTEQS-ENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACK-VACWC 748

Query: 351 IQWNPTERPSM 361
           IQ   + RP+M
Sbjct: 749 IQDEESHRPAM 759

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYS7|CRK39_ARATH Putative cysteine-rich receptor-like protein kinase 39 OS=Arabidopsis thaliana GN=CRK39 PE=2 SV=1

 Score =  167 bits (423), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/253 (37%), Positives = 141/253 (55%), Gaps = 21/253 (8%)

Query: 121 KFFFLHSNEIAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
           K   L+  E+AVK L    G G  EF NEV+ + R+ H ++V+LLGFC+EG+ + L+YEF
Sbjct: 369 KGTLLNGQEVAVKRLTKGSGQGDIEFKNEVSLLTRLQHRNLVKLLGFCNEGDEQILVYEF 428

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           +PN SL  FIF     S    L+WE   +I  G+ARG+ YLH+    +I+H D+K  NIL
Sbjct: 429 VPNSSLDHFIFDDEKRS---LLTWEMRYRIIEGIARGLLYLHEDSQLKIIHRDLKASNIL 485

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMML 291
           LD    PK++DFG A+L   D +        GT GY+APE  +          + +G+ML
Sbjct: 486 LDAEMNPKVADFGTARLFDSDETRAETKRIAGTRGYMAPEYLNHGQISAKSDVYSFGVML 545

Query: 292 LEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD---FEEDGDEGIARKLAIVAI 348
           LEM+   +NN    E  +   +  W+  +     E+ +D    E+  +E I  KL  + +
Sbjct: 546 LEMISGERNNSFEGEGLAAFAWKRWVEGK----PEIIIDPFLIEKPRNEII--KLIQIGL 599

Query: 349 WCIQWNPTERPSM 361
            C+Q NPT+RP+M
Sbjct: 600 LCVQENPTKRPTM 612

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
359490790	390	PREDICTED: probable receptor-like protei	0.647	0.602	0.654	9e-90
125568779	581	hypothetical protein OsJ_00129 [Oryza sa	0.639	0.399	0.662	5e-89
297595951	408	Os01g0114300 [Oryza sativa Japonica Grou	0.639	0.568	0.654	5e-89
359472653	439	PREDICTED: probable receptor-like protei	0.564	0.466	0.726	9e-89
222617637	651	hypothetical protein OsJ_00156 [Oryza sa	0.639	0.356	0.650	1e-88
115434192	636	Os01g0117700 [Oryza sativa Japonica Grou	0.639	0.364	0.650	1e-88
115434156	621	Os01g0115600 [Oryza sativa Japonica Grou	0.639	0.373	0.662	1e-88
222617628	622	hypothetical protein OsJ_00139 [Oryza sa	0.639	0.372	0.654	2e-88
215767653	321	unnamed protein product [Oryza sativa Ja	0.639	0.722	0.654	2e-88
297595965	530	Os01g0115900 [Oryza sativa Japonica Grou	0.655	0.449	0.638	2e-88

>gi|359490790|ref|XP_002268734.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  336 bits (862), Expect = 9e-90,   Method: Compositional matrix adjust.
 Identities = 163/249 (65%), Positives = 194/249 (77%), Gaps = 14/249 (5%)

Query: 127 SNEI--AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           SNE+  AVK+L++ KGNG+EFINEV T+G IHH ++VRL+GFC++G RR +IYE++PN S
Sbjct: 121 SNEVFVAVKILKNFKGNGEEFINEVETMGTIHHVNVVRLVGFCADGFRRAVIYEYLPNES 180

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L+KFIFS T    +  LSWEKL+ IA GVA+G+EYLHQGC+QRILHFDIKPHNILLDHNF
Sbjct: 181 LEKFIFSTT--FKNYSLSWEKLQNIALGVAKGIEYLHQGCDQRILHFDIKPHNILLDHNF 238

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEM 294
            PKISDFGLAKLCSK+ S VS TAARGT GYIAPE+ SRNF           +GM+LLEM
Sbjct: 239 NPKISDFGLAKLCSKEQSAVSMTAARGTMGYIAPEMLSRNFGNVSYKSDVYSFGMLLLEM 298

Query: 295 VGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
           VG RKN D  VE  SQ YFPEWIYN +  G+EL +  EE+GD  IARKL IV +WCIQW 
Sbjct: 299 VGGRKNIDVTVENSSQAYFPEWIYNHLDQGEELHIRIEEEGDTHIARKLTIVGLWCIQWY 358

Query: 355 PTERPSMPM 363
           P +RPSM +
Sbjct: 359 PVDRPSMKL 367

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|125568779|gb|EAZ10294.1| hypothetical protein OsJ_00129 [Oryza sativa Japonica Group]

 Score =  334 bits (856), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 161/243 (66%), Positives = 192/243 (79%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+  G G+EFINEVATIGRIHH +IVRLLGFCSEG RR LIYEFMPN SL+K+I
Sbjct: 309 VAVKMLENSLGEGEEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYEFMPNESLEKYI 368

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS  ++ S   L  +K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD++F PKIS
Sbjct: 369 FSNGSNISREFLVPKKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYSFSPKIS 428

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SIV+ TAARGT GYIAPEL+SR+F           +GM++LEMV  R+
Sbjct: 429 DFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRSFGAISYKSDVYSFGMLVLEMVSGRR 488

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQWNPTER 358
           N DP VE Q++ YFPEWIY R+  GQEL L+ E   G++   R+LAIVA+WCIQWNPT R
Sbjct: 489 NTDPTVENQNEFYFPEWIYERVINGQELVLNMETTQGEKETVRQLAIVALWCIQWNPTNR 548

Query: 359 PSM 361
           PSM
Sbjct: 549 PSM 551

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297595951|ref|NP_001041828.2| Os01g0114300 [Oryza sativa Japonica Group] gi|255672793|dbj|BAF03742.2| Os01g0114300, partial [Oryza sativa Japonica Group]

 Score =  334 bits (856), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 159/243 (65%), Positives = 190/243 (78%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+  G GQEFINEVATIGRIHH +IVRLLGFCSEG RR LIYE MPN SL+K+I
Sbjct: 136 VAVKMLENSVGEGQEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYELMPNESLEKYI 195

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           F   ++ S   L  +K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD++F PKIS
Sbjct: 196 FPHGSNISRELLVPDKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYSFNPKIS 255

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SIV+ TAARGT GYIAPEL+SRNF           +GM++LEMV  R+
Sbjct: 256 DFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAISYKSDVYSFGMLVLEMVSGRR 315

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQWNPTER 358
           N DP VE Q++ YFPEWIY R+  GQ+L L  E   G++ + R+LAIVA+WCIQWNP +R
Sbjct: 316 NTDPTVESQNEFYFPEWIYERVINGQDLVLTMETTQGEKEMVRQLAIVALWCIQWNPKDR 375

Query: 359 PSM 361
           PSM
Sbjct: 376 PSM 378

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472653|ref|XP_002280038.2| PREDICTED: probable receptor-like protein kinase At5g39020-like [Vitis vinifera]

 Score =  333 bits (853), Expect = 9e-89,   Method: Compositional matrix adjust.
 Identities = 157/216 (72%), Positives = 182/216 (84%), Gaps = 11/216 (5%)

Query: 159 HIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSS-HRQLSWEKLRKIAFGVARGV 217
           ++VRLLGFC+EG RR L+YEFMPN SL+KFIFS  +S + +R  SWEKL++IA G+ARG+
Sbjct: 195 NVVRLLGFCAEGTRRALVYEFMPNESLEKFIFSSKDSKTRNRPFSWEKLQQIAMGIARGM 254

Query: 218 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIA 277
           EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK+ S+VS TAARGT+GYIA
Sbjct: 255 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKERSVVSMTAARGTAGYIA 314

Query: 278 PELFSRN----------FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL 327
           PELFSRN          F +GM+LLE+VGCR+N D  VE QSQIYFPEWIYNRM  G+E+
Sbjct: 315 PELFSRNFGAVSHKSDVFSFGMLLLEIVGCRRNIDVTVENQSQIYFPEWIYNRMSQGKEM 374

Query: 328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM 363
            L+ E DGDE IA+KLAIVA+WCIQWNPT+RPSM M
Sbjct: 375 GLEIEIDGDEEIAKKLAIVALWCIQWNPTDRPSMTM 410

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|222617637|gb|EEE53769.1| hypothetical protein OsJ_00156 [Oryza sativa Japonica Group]

 Score =  333 bits (853), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 158/243 (65%), Positives = 193/243 (79%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+ +G G EFINEVATIGRIHH +IVRLLGFCSEG RR LIYE+MPN SL+K+I
Sbjct: 370 VAVKMLENSEGEGDEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYEYMPNDSLEKYI 429

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS+ + +S   L   K+  IA G+ARG+EYLHQGCNQRILHFDIKP+NILLD+NF PKIS
Sbjct: 430 FSQDSDTSQELLVPSKMLDIALGIARGMEYLHQGCNQRILHFDIKPNNILLDYNFSPKIS 489

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SI++ TAARGT GYIAPEL+SRNF           +GM++LEMV  R+
Sbjct: 490 DFGLAKLCARDQSIITLTAARGTMGYIAPELYSRNFGEISYKSDVYSFGMLVLEMVSGRR 549

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE-GIARKLAIVAIWCIQWNPTER 358
           N+DP+VE Q+ +YFPEWIY ++ +GQ+L L  E   +E  I R+LAIVA+WCIQWNP  R
Sbjct: 550 NSDPSVESQNVVYFPEWIYEQVTIGQDLELGREMTEEEKAIMRQLAIVALWCIQWNPKNR 609

Query: 359 PSM 361
           PSM
Sbjct: 610 PSM 612

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434192|ref|NP_001041854.1| Os01g0117700 [Oryza sativa Japonica Group] gi|11072003|dbj|BAB17348.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|14090209|dbj|BAB55470.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531385|dbj|BAF03768.1| Os01g0117700 [Oryza sativa Japonica Group]

 Score =  333 bits (853), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 158/243 (65%), Positives = 193/243 (79%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+ +G G EFINEVATIGRIHH +IVRLLGFCSEG RR LIYE+MPN SL+K+I
Sbjct: 355 VAVKMLENSEGEGDEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYEYMPNDSLEKYI 414

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS+ + +S   L   K+  IA G+ARG+EYLHQGCNQRILHFDIKP+NILLD+NF PKIS
Sbjct: 415 FSQDSDTSQELLVPSKMLDIALGIARGMEYLHQGCNQRILHFDIKPNNILLDYNFSPKIS 474

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SI++ TAARGT GYIAPEL+SRNF           +GM++LEMV  R+
Sbjct: 475 DFGLAKLCARDQSIITLTAARGTMGYIAPELYSRNFGEISYKSDVYSFGMLVLEMVSGRR 534

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE-GIARKLAIVAIWCIQWNPTER 358
           N+DP+VE Q+ +YFPEWIY ++ +GQ+L L  E   +E  I R+LAIVA+WCIQWNP  R
Sbjct: 535 NSDPSVESQNVVYFPEWIYEQVTIGQDLELGREMTEEEKAIMRQLAIVALWCIQWNPKNR 594

Query: 359 PSM 361
           PSM
Sbjct: 595 PSM 597

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434156|ref|NP_001041836.1| Os01g0115600 [Oryza sativa Japonica Group] gi|11034602|dbj|BAB17126.1| putative receptor serine/threonine kinase PR5K [Oryza sativa Japonica Group] gi|13366230|dbj|BAB39451.1| putative receptor serine/threonine kinase PR5K [Oryza sativa Japonica Group] gi|113531367|dbj|BAF03750.1| Os01g0115600 [Oryza sativa Japonica Group]

 Score =  332 bits (852), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 161/243 (66%), Positives = 192/243 (79%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+  G G+EFINEVATIGRIHH +IVRLLGFCSEG RR LIYEFMPN SL+K+I
Sbjct: 349 VAVKMLENSLGEGEEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYEFMPNESLEKYI 408

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS  ++ S   L  +K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD++F PKIS
Sbjct: 409 FSNGSNISREFLVPKKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYSFSPKIS 468

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SIV+ TAARGT GYIAPEL+SR+F           +GM++LEMV  R+
Sbjct: 469 DFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRSFGAISYKSDVYSFGMLVLEMVSGRR 528

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQWNPTER 358
           N DP VE Q++ YFPEWIY R+  GQEL L+ E   G++   R+LAIVA+WCIQWNPT R
Sbjct: 529 NTDPTVENQNEFYFPEWIYERVINGQELVLNMETTQGEKETVRQLAIVALWCIQWNPTNR 588

Query: 359 PSM 361
           PSM
Sbjct: 589 PSM 591

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|222617628|gb|EEE53760.1| hypothetical protein OsJ_00139 [Oryza sativa Japonica Group]

 Score =  332 bits (851), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 159/243 (65%), Positives = 190/243 (78%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+  G GQEFINEVATIGRIHH +IVRLLGFCSEG RR LIYE MPN SL+K+I
Sbjct: 350 VAVKMLENSVGEGQEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYELMPNESLEKYI 409

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           F   ++ S   L  +K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD++F PKIS
Sbjct: 410 FPHGSNISRELLVPDKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYSFNPKIS 469

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SIV+ TAARGT GYIAPEL+SRNF           +GM++LEMV  R+
Sbjct: 470 DFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAISYKSDVYSFGMLVLEMVSGRR 529

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQWNPTER 358
           N DP VE Q++ YFPEWIY R+  GQ+L L  E   G++ + R+LAIVA+WCIQWNP +R
Sbjct: 530 NTDPTVESQNEFYFPEWIYERVINGQDLVLTMETTQGEKEMVRQLAIVALWCIQWNPKDR 589

Query: 359 PSM 361
           PSM
Sbjct: 590 PSM 592

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|215767653|dbj|BAG99881.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  332 bits (850), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 159/243 (65%), Positives = 190/243 (78%), Gaps = 11/243 (4%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVKMLE+  G GQEFINEVATIGRIHH +IVRLLGFCSEG RR LIYE MPN SL+K+I
Sbjct: 49  VAVKMLENSVGEGQEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYELMPNESLEKYI 108

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           F   ++ S   L  +K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD++F PKIS
Sbjct: 109 FPHGSNISRELLVPDKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYSFNPKIS 168

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
           DFGLAKLC++D SIV+ TAARGT GYIAPEL+SRNF           +GM++LEMV  R+
Sbjct: 169 DFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAISYKSDVYSFGMLVLEMVSGRR 228

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQWNPTER 358
           N DP VE Q++ YFPEWIY R+  GQ+L L  E   G++ + R+LAIVA+WCIQWNP +R
Sbjct: 229 NTDPTVESQNEFYFPEWIYERVINGQDLVLTMETTQGEKEMVRQLAIVALWCIQWNPKDR 288

Query: 359 PSM 361
           PSM
Sbjct: 289 PSM 291

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297595965|ref|NP_001041839.2| Os01g0115900 [Oryza sativa Japonica Group] gi|255672800|dbj|BAF03753.2| Os01g0115900 [Oryza sativa Japonica Group]

 Score =  332 bits (850), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 159/249 (63%), Positives = 192/249 (77%), Gaps = 11/249 (4%)

Query: 124 FLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
            L+   +AVKMLE+  G GQEFINEVATIGRIHH +IVRLLGFCSEG R+ LIYEFMPN 
Sbjct: 252 LLNGVPVAVKMLENSVGEGQEFINEVATIGRIHHANIVRLLGFCSEGTRQALIYEFMPNE 311

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL+K+IF   ++ S   L  +K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD++
Sbjct: 312 SLEKYIFPHGSNISRELLVPDKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYS 371

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLE 293
           F PKISDFGLAKLC++D SIV+ TAARGT GYIAPEL+SRNF           +GM++LE
Sbjct: 372 FNPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAISYKSDVYSFGMLVLE 431

Query: 294 MVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQ 352
           MV  R+N +P VE Q++ YFPEWIY R+  GQ+L L  E   G++ + R+LAIVA+WCIQ
Sbjct: 432 MVSGRRNTEPTVENQNEFYFPEWIYERVMNGQDLVLTMETTQGEKEMVRQLAIVALWCIQ 491

Query: 353 WNPTERPSM 361
           WNP  RPSM
Sbjct: 492 WNPKNRPSM 500

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.622	0.339	0.5	3.3e-65
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.630	0.268	0.493	1.4e-62
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.630	0.358	0.473	2e-61
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.628	0.338	0.497	1.4e-60
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.625	0.341	0.514	1.5e-60
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.614	0.379	0.485	1.3e-59
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.636	0.289	0.484	1.7e-57
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.639	0.287	0.46	3.5e-54
TAIR|locus:2176707	579	AT5G38250 [Arabidopsis thalian	0.779	0.488	0.420	1.9e-53
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.628	0.280	0.471	6e-53

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 605 (218.0 bits), Expect = 3.3e-65, Sum P(2) = 3.3e-65
 Identities = 124/248 (50%), Positives = 166/248 (66%)

Query:   130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
             +AVK+L+  +GNG++FINEVA++ +  H +IV LLGFCSEG +R +IYEFM NGSL KFI
Sbjct:   373 VAVKVLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFI 432

Query:   190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
              SK +S+    + W +L  IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  PK+S
Sbjct:   433 SSKKSST----MDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVS 488

Query:   250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
             DFGLAKLC +  SI+S    RGT GYIAPE+FSR +           YGM++L+++G R 
Sbjct:   489 DFGLAKLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARN 548

Query:   300 --NNDPAVEIQSQIYFPEWIYNRMRL---GQELCLDFEEDGDEGIARKLAIVAIWCIQ-W 353
               + +      S +YFPEWIY  +     G+ +      + DE IA+K+ +V +WCIQ W
Sbjct:   549 KTSTEDTTSSTSSMYFPEWIYRDLEKAHNGKSIETAISNEEDE-IAKKMTLVGLWCIQPW 607

Query:   354 NPTERPSM 361
              P +RP+M
Sbjct:   608 -PLDRPAM 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 614 (221.2 bits), Expect = 1.4e-62, Sum P(2) = 1.4e-62
 Identities = 123/249 (49%), Positives = 168/249 (67%)

Query:   129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
             +IA+K+L+  KGNG+EFINE+ ++ R  H +IV L GFC EG++R +IYEFMPNGSL KF
Sbjct:   545 DIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKF 604

Query:   189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
             I    N S+  ++ W+ L  IA GVARG+EYLH  C  +I+HFDIKP NIL+D +  PKI
Sbjct:   605 I--SENMST--KIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKI 660

Query:   249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCR 298
             SDFGLAKLC K  SI+S   ARGT GYIAPE+FS+N+           YGM++LEM+G  
Sbjct:   661 SDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGAT 720

Query:   299 KNNDPAVEI--QSQIYFPEWIYNRMRLGQELCL--D--FEEDGDEGIARKLAIVAIWCIQ 352
             K  +       +S +YFP+W+Y  +   + + L  D   EE+ +E I +++ +V +WCIQ
Sbjct:   721 KREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQ 780

Query:   353 WNPTERPSM 361
              NP++RP M
Sbjct:   781 TNPSDRPPM 789

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 575 (207.5 bits), Expect = 2.0e-61, Sum P(2) = 2.0e-61
 Identities = 117/247 (47%), Positives = 161/247 (65%)

Query:   129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
             ++AVK+L+  K NG++FINEVA++ +  H +IV LLGFC EG++R ++YEF+ NGSL +F
Sbjct:   345 KVAVKILKDFKSNGEDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQF 404

Query:   189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
             +  K + +    L    L +IA GVARG++YLH GC  RI+HFDIKP NILLD  F PK+
Sbjct:   405 LSEKKSLN----LDVSTLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKV 460

Query:   249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCR 298
             SDFGLAKLC K  SI+S   ARGT GYIAPE+FS  +           YGM++LEM+G +
Sbjct:   461 SDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAK 520

Query:   299 KNN--DPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG--DEGIARKLAIVAIWCIQWN 354
                  + A    S  YFP+WIY  +  G++     +E    D+ +A+K+ +V +WCIQ +
Sbjct:   521 NKEIEETAASNSSSAYFPDWIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPS 580

Query:   355 PTERPSM 361
             P  RP M
Sbjct:   581 PLNRPPM 587

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 575 (207.5 bits), Expect = 1.4e-60, Sum P(2) = 1.4e-60
 Identities = 124/249 (49%), Positives = 158/249 (63%)

Query:   130 IAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
             +AVK+L+  KGN  E FINEV+++ +  H +IV LLGFCSEG+RR +IYEF+ NGSL KF
Sbjct:   371 VAVKVLKESKGNNSEDFINEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKF 430

Query:   189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
             I  KT+      L    L  IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  PK+
Sbjct:   431 ISEKTSVI----LDLTALYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKV 486

Query:   249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCR 298
             SDFGLAKLC K  S++S    RGT GYIAPE+ SR +           YGM++ EM+G R
Sbjct:   487 SDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGAR 546

Query:   299 KNNDPAVEIQ--SQIYFPEWIYNRMRLGQELCLDFEEDG----DEGIARKLAIVAIWCIQ 352
             K           S +YFPEWIY  +       L+  E G    +E IA+K+ +V +WCIQ
Sbjct:   547 KKERFGQNSANGSSMYFPEWIYKDLEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQ 606

Query:   353 WNPTERPSM 361
              +P++RP M
Sbjct:   607 SSPSDRPPM 615

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 128/249 (51%), Positives = 167/249 (67%)

Query:   129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
             ++AVK+L+  +GNG+EFINEVA++ R  H +IV LLGFC E N+R +IYEFMPNGSL K+
Sbjct:   356 DVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKY 415

Query:   189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
             I    N S+  ++ WE+L  +A G++RG+EYLH  C  RI+HFDIKP NIL+D N  PKI
Sbjct:   416 I--SANMST--KMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKI 471

Query:   249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCR 298
             SDFGLAKLC    SI+S    RGT GYIAPE+FS+NF           YGM++LEM+G +
Sbjct:   472 SDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAK 531

Query:   299 KNNDPAVEIQSQ----IYFPEWIYNRMRLGQ--ELCLDFEEDGDEGIARKLAIVAIWCIQ 352
               N   VE        +YFPEW+Y     G+   +  D   D +E IA+KL +VA+WCIQ
Sbjct:   532 --NIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQ 589

Query:   353 WNPTERPSM 361
              NP++RP M
Sbjct:   590 MNPSDRPPM 598

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 555 (200.4 bits), Expect = 1.3e-59, Sum P(2) = 1.3e-59
 Identities = 120/247 (48%), Positives = 160/247 (64%)

Query:   129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
             ++AVK+L+   GN ++FINEVA+I +  H +IV LLGFC E ++R ++YEF+ NGSL + 
Sbjct:   305 KVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEKSKRAIVYEFLENGSLDQ- 363

Query:   189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
                    SS+  +S   L  IA GVARG+EYLH GC +RI+HFDIKP N+LLD N +PK+
Sbjct:   364 -------SSNLDVS--TLYGIALGVARGIEYLHFGCKKRIVHFDIKPQNVLLDENLKPKV 414

Query:   249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR---N-------FCYGMMLLEMVGCR 298
             +DFGLAKLC K  SI+S    RGT GYIAPELFSR   N       + YGM++LEM G R
Sbjct:   415 ADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSHKSDVYSYGMLVLEMTGAR 474

Query:   299 KNN--DPAVEIQSQIYFPEWIYNRMRLGQ--ELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
                    A    S  YFP+WI+  +  G   +L  D     +E IA+K+ +V +WCIQ+ 
Sbjct:   475 NKERVQNADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREEEDIAKKMILVGLWCIQFR 534

Query:   355 PTERPSM 361
             P++RPSM
Sbjct:   535 PSDRPSM 541

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 591 (213.1 bits), Expect = 1.7e-57, P = 1.7e-57
 Identities = 121/250 (48%), Positives = 163/250 (65%)

Query:   127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
             S ++AVK+L+    +G++FINE+A++ R  H +IV LLGFC EG ++ +IYE MPNGSL 
Sbjct:   482 SRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLD 541

Query:   187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             KFI SK  S+   ++ W+ L  IA GV+ G+EYLH  C  RI+HFDIKP NIL+D +  P
Sbjct:   542 KFI-SKNMSA---KMEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCP 597

Query:   247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVG 296
             KISDFGLAKLC  + SI+S   ARGT GYIAPE+FS+NF           YGM++LEM+G
Sbjct:   598 KISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIG 657

Query:   297 CRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCL---DFEEDGDEGIARKLAIVAIWCI 351
              R       A    + +YFP+WIY  +  G+ +        E+ DE I +K+ +V +WCI
Sbjct:   658 ARNIGRAQNAGSSNTSMYFPDWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCI 717

Query:   352 QWNPTERPSM 361
             Q NP +RP M
Sbjct:   718 QTNPYDRPPM 727

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 3.5e-54, P = 3.5e-54
 Identities = 115/250 (46%), Positives = 167/250 (66%)

Query:   126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
             +  ++AVK+L+ LKG+ ++FINEVA++ +  H +IV LLGFC EG++R ++YEF+ NGSL
Sbjct:   519 NGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSL 578

Query:   186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
              +F+ S+ N S  + ++   L  IA G+ARG+EYLH GC  RI+HFDIKP NILLD N  
Sbjct:   579 DQFM-SR-NKSLTQDVT--TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLC 634

Query:   246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMV 295
             PK+SDFGLAKLC K  S++S    RGT GYIAPE+FSR +           +GM++++M+
Sbjct:   635 PKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMI 694

Query:   296 GCRKNN--DPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE--DGDEGIARKLAIVAIWCI 351
             G R     +      S  YFP+WIY  +  G++  +  +E    ++ IA+K+ +V +WCI
Sbjct:   695 GARSKEIVETVDSAASSTYFPDWIYKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCI 754

Query:   352 QWNPTERPSM 361
             Q  P++RPSM
Sbjct:   755 QPCPSDRPSM 764

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)]

 Score = 553 (199.7 bits), Expect = 1.9e-53, P = 1.9e-53
 Identities = 137/326 (42%), Positives = 189/326 (57%)

Query:    60 YC--GLEGFELSCLSDKTILHFPSSGDYYVHKISYLDSSITITDVNET----ACPFQSLI 113
             +C   + G E+SCL+  T ++   +G Y  ++  +L +  T   +NE     A   Q L 
Sbjct:   227 FCCTNVSGPEISCLTSITTMN---NGTYSDNR-PFLVTIGTAFYLNERRIAKAARIQHLE 282

Query:   114 SFN-LTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNR 172
             +   L   +       ++AVK+L+  KGN ++FINEVA++ +  H +IV LLGFC EG++
Sbjct:   283 ALGTLRGGRL--RDGRKVAVKVLKDSKGNCEDFINEVASMSQTSHVNIVTLLGFCYEGSK 340

Query:   173 RTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFD 232
             R +IYEF+ NGSL + +           L    L  IA GVARG+EYLH GC  RI+HFD
Sbjct:   341 RAIIYEFLENGSLDQSL----------NLDVSTLYGIALGVARGLEYLHYGCKTRIVHFD 390

Query:   233 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF------- 285
             IKP N+LLD N +PK++DFGLAKLC K  SI+S    RGT GYIAPELFSR +       
Sbjct:   391 IKPQNVLLDENLRPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRMYGSVSHKS 450

Query:   286 ---CYGMMLLEMVGCR-----KNNDPAVEIQSQIYFPEWIYNRMRL--GQELCLDFEEDG 335
                 YGM++LEM+G R     +N DP     S  YFP+WIY  +       L  D     
Sbjct:   451 DVYSYGMLVLEMIGARNKERVQNADPN---NSSAYFPDWIYKDLENFDNTRLLGDGLTRE 507

Query:   336 DEGIARKLAIVAIWCIQWNPTERPSM 361
             +E  A+K+ +V +WCIQ+ P++RPSM
Sbjct:   508 EEKNAKKMILVGLWCIQFRPSDRPSM 533

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 551 (199.0 bits), Expect = 6.0e-53, P = 6.0e-53
 Identities = 115/244 (47%), Positives = 159/244 (65%)

Query:   130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
             +AVK+L+ LKGNG +FINEV ++ +  H +IV LLGFC EG++R +I EF+ +GSL +FI
Sbjct:   521 VAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI 580

Query:   190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
              S+  S +    +   L  IA G+ARG+EYLH GC  RI+HFDIKP NILLD NF PK++
Sbjct:   581 -SRNKSLTPNVTT---LYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVA 636

Query:   250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF----------CYGMMLLEMVGCRK 299
             DFGLAKLC K  SI+S    RGT GYIAPE+ SR +           YGM++L+M+G R 
Sbjct:   637 DFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARN 696

Query:   300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE--DGDEGIARKLAIVAIWCIQWNPTE 357
               +      S  YFP+WIY  +  G +  +  +E  + D  I +K+ +V++WCI+  P++
Sbjct:   697 KVETTTCNGSTAYFPDWIYKDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSD 756

Query:   358 RPSM 361
             RP M
Sbjct:   757 RPPM 760

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	363
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-32
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-19
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-13
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-13
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-11
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-06
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-06
pfam13947	106	pfam13947, GUB_WAK_bind, Wall-associated receptor	6e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.001
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.001
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	0.001
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.002
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (346), Expect = 1e-38
 Identities = 53/179 (29%), Positives = 94/179 (52%), Gaps = 22/179 (12%)

Query: 128 NEIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            ++A+K++  E      +E + E+  + +++H +IV+L G   + N   L+ E+   GSL
Sbjct: 19  KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NF 244
           +  +          +LS +++ +I   +  G+EYLH      I+H D+KP NILLD  N 
Sbjct: 79  KDLLKEN-----EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNG 130

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---------FCYGMMLLEM 294
           + K++DFGL+KL + D S++      GT  Y+APE+             +  G++L E+
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  138 bits (349), Expect = 1e-38
 Identities = 72/246 (29%), Positives = 114/246 (46%), Gaps = 31/246 (12%)

Query: 129 EIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            +AVK+L+         Q    E+  + R+ H +IVRL+    + +   L+ E+   G L
Sbjct: 26  IVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL 85

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++      S    LS ++ +KIA  + RG+EYLH   +  I+H D+KP NILLD N  
Sbjct: 86  FDYL------SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDENGV 136

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMVG 296
            KI+DFGLAK   K  S  S T   GT  Y+APE+      Y         G++L E++ 
Sbjct: 137 VKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELL- 193

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
             K       I  Q+     +  R+       L+F+E      + +   +   C+  +P+
Sbjct: 194 TGKPPFSGENILDQLQ----LIRRILGPP---LEFDEPKWSSGSEEAKDLIKKCLNKDPS 246

Query: 357 ERPSMP 362
           +RP+  
Sbjct: 247 KRPTAE 252

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (314), Expect = 1e-33
 Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 42/248 (16%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           E+AVK L  +  +   +EF+ E   + ++ H ++V+LLG C+E     ++ E+M  G L 
Sbjct: 30  EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLL 89

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++       +  +LS   L   A  +ARG+EYL     +  +H D+   N L+  N   
Sbjct: 90  SYL-----RKNRPKLSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVV 141

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYI---APELFSRNFC--------YGMMLLEMV 295
           KISDFGL    S+D+        RG    I   APE               +G++L E+ 
Sbjct: 142 KISDFGL----SRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 197

Query: 296 -GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDGDEGIARKLAIVAIWCIQW 353
               +   P   + S     E++ N  RL Q   C             +L  + + C   
Sbjct: 198 TLGEQ---PYPGM-SNEEVLEYLKNGYRLPQPPNCPP-----------ELYDLMLQCWAE 242

Query: 354 NPTERPSM 361
           +P +RP+ 
Sbjct: 243 DPEDRPTF 250

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  121 bits (305), Expect = 3e-32
 Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 35/245 (14%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           E+AVK L  +  +   +EF+ E   + ++ H +IV+LLG C+E     ++ E+MP G L 
Sbjct: 30  EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++      +  ++LS   L   A  +ARG+EYL     +  +H D+   N L+  N   
Sbjct: 90  DYL----RKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVV 142

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFC--------YGMMLLEMV-GC 297
           KISDFGL++    D         +    ++APE               +G++L E+    
Sbjct: 143 KISDFGLSRD-LYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
            +         +++   E++    RL +   C             +L  + + C   +P 
Sbjct: 202 EE--PYPGMSNAEVL--EYLKKGYRLPKPPNCPP-----------ELYKLMLQCWAEDPE 246

Query: 357 ERPSM 361
           +RP+ 
Sbjct: 247 DRPTF 251

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  119 bits (302), Expect = 8e-32
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 45/248 (18%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A+K++  + +K + +  + E+  + ++ H +IVRL     + ++  L+ E+   G L 
Sbjct: 26  LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF 85

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             +          +LS ++ R     +   +EYLH    + I+H D+KP NILLD +   
Sbjct: 86  DLL------KKRGRLSEDEARFYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHV 136

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGM---------MLLEMVGC 297
           K++DFGLA+           T   GT  Y+APE+      YG          +L E++  
Sbjct: 137 KLADFGLARQLDPG---EKLTTFVGTPEYMAPEVLLGK-GYGKAVDIWSLGVILYELLTG 192

Query: 298 R---KNNDPAVEIQSQI--YFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ 352
           +     +D  +E+  +I    P +      +  E   D        I +         + 
Sbjct: 193 KPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK-DL-------IRK--------LLV 236

Query: 353 WNPTERPS 360
            +P +R +
Sbjct: 237 KDPEKRLT 244

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 64/256 (25%), Positives = 112/256 (43%), Gaps = 43/256 (16%)

Query: 126 HSNEIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
            + E+AVK L  +  +   ++F+ E   + ++ H ++VRLLG C+E     L+ E+M  G
Sbjct: 22  KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81

Query: 184 SLQKFI---FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
            L  ++        S     LS + L   A  +A+G+EYL     ++ +H D+   N L+
Sbjct: 82  DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLV 138

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAA----RGTSGYIAPELFSRNFC--------YG 288
             +   KISDFGL++    D     +T      R    ++APE               +G
Sbjct: 139 GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WMAPESLKDGIFTSKSDVWSFG 194

Query: 289 MMLLEMV--GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDGDEGIARKLAI 345
           ++L E+   G      P   + ++    E++    RL + E C D           +L  
Sbjct: 195 VLLWEIFTLGA----TPYPGLSNE-EVLEYLRKGYRLPKPEYCPD-----------ELYE 238

Query: 346 VAIWCIQWNPTERPSM 361
           + + C Q +P +RP+ 
Sbjct: 239 LMLSCWQLDPEDRPTF 254

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  112 bits (282), Expect = 7e-29
 Identities = 62/246 (25%), Positives = 115/246 (46%), Gaps = 37/246 (15%)

Query: 129 EIAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++AVK L+      +  EF+ E + + ++ H +IVRLLG C++G    ++ E+MP G L 
Sbjct: 30  KVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLL 89

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+           L+ + L ++A  +A+G+EYL    ++  +H D+   N L+  N   
Sbjct: 90  DFLRKHGEK-----LTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVV 141

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV-GC 297
           KISDFGL++   +D     R   +    ++APE             + +G++L E+    
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201

Query: 298 RKNNDPAVEIQ-SQIYFPEWIYNRMRLGQ-ELCLDFEEDGDEGIARKLAIVAIWCIQWNP 355
            +   P   +   ++   E + +  RL + E C D           +L  + + C  ++P
Sbjct: 202 EQ---PYPGMSNEEVL--ELLEDGYRLPRPENCPD-----------ELYELMLQCWAYDP 245

Query: 356 TERPSM 361
            +RP+ 
Sbjct: 246 EDRPTF 251

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 98.8 bits (247), Expect = 6e-24
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)

Query: 129 EIAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPN 182
            +AVK +E L G+ +E +     E+  +  + H +IVR  G     E N   +  E++  
Sbjct: 27  LMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL   +  K        L    +RK    +  G+ YLH   +  I+H DIK  NIL+D 
Sbjct: 86  GSLSSLL--KKFGK----LPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDS 136

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           +   K++DFG AK      +     + RGT  ++APE+  
Sbjct: 137 DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 24/198 (12%)

Query: 129 EIAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGS 184
           ++AVK L H        +F  E+  +  + H +IV+  G C +   R+  LI E++P+GS
Sbjct: 35  QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94

Query: 185 LQKFI-FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           L+ ++   +   +  R L +      +  + +G++YL    +QR +H D+   NIL++  
Sbjct: 95  LRDYLQRHRDQINLKRLLLF------SSQICKGMDYLG---SQRYIHRDLAARNILVESE 145

Query: 244 FQPKISDFGLAKLCSKDIS-IVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
              KISDFGLAK+  +D      +        + APE    +        + +G+ L E+
Sbjct: 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205

Query: 295 VG-CRKNNDPAVEIQSQI 311
                 +  P  E    I
Sbjct: 206 FTYGDPSQSPPAEFLRMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 63/243 (25%), Positives = 117/243 (48%), Gaps = 29/243 (11%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 30  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 90  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 142

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D    +   A+    + APE  + N        + +G++L E+   
Sbjct: 143 VKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L   +  +  EG   K+  +   C QWNP++
Sbjct: 202 GMSPYPGIDL-SQVY------------ELLEKGYRMERPEGCPPKVYELMRACWQWNPSD 248

Query: 358 RPS 360
           RPS
Sbjct: 249 RPS 251

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 18/175 (10%)

Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +A+K+L+       Q+F  EV  + R+ H H++ L   CS G    +I E M  GSL  F
Sbjct: 33  VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +     S   + L    L  +A  VA G+ YL +   Q  +H D+   NIL+  +   K+
Sbjct: 93  L----RSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKV 145

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           +DFGLA+L  +D+ + S    +    + APE  S          + +G++L EM 
Sbjct: 146 ADFGLARLIKEDVYLSSDK--KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 20/178 (11%)

Query: 127 SNEIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
             E+A+K+++      +E I NE+  + +  H +IV+  G   + +   ++ EF   GSL
Sbjct: 25  GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           +  +      S+++ L+  ++  +   + +G+EYLH   +  I+H DIK  NILL  + +
Sbjct: 85  KDLL-----KSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGE 136

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFC--------YGMMLLEMV 295
            K+ DFGL+   S   +  +     GT  ++APE+ +             G+  +E+ 
Sbjct: 137 VKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 21/176 (11%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           ++AVK ++  K   +E + NEV  +    H +IV +      G+   ++ EF+  G+L  
Sbjct: 46  QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL-- 103

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +H +++ E++  +   V + + +LH    Q ++H DIK  +ILL  + + K
Sbjct: 104 -----TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVK 155

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           +SDFG     SK++    R +  GT  ++APE+ SR         +  G+M++EMV
Sbjct: 156 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 87.5 bits (215), Expect = 4e-19
 Identities = 63/257 (24%), Positives = 96/257 (37%), Gaps = 29/257 (11%)

Query: 126 HSNEIAVKML----EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFM 180
               +A+K+L    E      + F+ E+  +  + H  +IV+L  F  +     L+ E++
Sbjct: 21  DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             GSL+  +           LS  +   I   +   +EYLH    + I+H DIKP NILL
Sbjct: 81  DGGSLEDLL---KKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILL 134

Query: 241 DHN-FQPKISDFGLAKLCSKDISIVSRTAAR----GTSGYIAPELFSRNFC--------- 286
           D +    K+ DFGLAKL     S  S  A      GT GY+APE+               
Sbjct: 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI 194

Query: 287 --YGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLA 344
              G+ L E+           E  S                 L         E I++  +
Sbjct: 195 WSLGITLYEL--LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAAS 252

Query: 345 IVAIWCIQWNPTERPSM 361
            +    +  +P  R S 
Sbjct: 253 DLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 85.2 bits (211), Expect = 7e-19
 Identities = 43/142 (30%), Positives = 74/142 (52%), Gaps = 17/142 (11%)

Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK L+    N   ++F  E   +    H +IV+  G C+EG+   +++E+M +G L K
Sbjct: 38  VAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97

Query: 188 FI--------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           F+        F K+  S   +L+  +L +IA  +A G+ YL    +Q  +H D+   N L
Sbjct: 98  FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCL 154

Query: 240 LDHNFQPKISDFGLAKLCSKDI 261
           + ++   KI DFG+    S+D+
Sbjct: 155 VGYDLVVKIGDFGM----SRDV 172

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 82.5 bits (205), Expect = 6e-18
 Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 13/137 (9%)

Query: 126 HSNEI-AVKM--LEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
            + EI A+K   L++ + G     + E++ +  + H +IV+LL       +  L++E+  
Sbjct: 22  KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
              L+K++           LS   ++ I + + RG+ Y H     RILH D+KP NIL++
Sbjct: 82  M-DLKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILIN 132

Query: 242 HNFQPKISDFGLAKLCS 258
            +   K++DFGLA+   
Sbjct: 133 RDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 9e-18
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 21/178 (11%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           E+AVK L  EH+    +EF+ E + + ++ H  IVRL+G C +G    L+ E  P G L 
Sbjct: 25  EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLL 83

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           K++  +                 A  VA G+ YL     +  +H D+   N+LL +  Q 
Sbjct: 84  KYLKKRREIPVSDLKEL------AHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQA 134

Query: 247 KISDFGLAK-LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV 295
           KISDFG+++ L +      + TA R    + APE          S  + YG+ L E  
Sbjct: 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 39/129 (30%), Positives = 71/129 (55%), Gaps = 12/129 (9%)

Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+    + Q  +F+ E + +G+  H +I+RL G  ++     +I E+M NGSL K
Sbjct: 35  VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94

Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           F+        +  + +  +L  +  G+A G++YL +      +H D+   NIL++ N   
Sbjct: 95  FL------RENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC 145

Query: 247 KISDFGLAK 255
           K+SDFGL++
Sbjct: 146 KVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 18/178 (10%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           + ++AVK L+    + + F+ E   + ++ H  +V+L   CSE     ++ E+M  GSL 
Sbjct: 30  TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+     S   ++L   +L  +A  +A G+ YL     +  +H D+   NIL+  N   
Sbjct: 90  DFL----KSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVC 142

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSRNF-------CYGMMLLEMV 295
           KI+DFGLA+L   D    +R  A+    + APE   + R F        +G++L E+V
Sbjct: 143 KIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 38/128 (29%), Positives = 68/128 (53%), Gaps = 7/128 (5%)

Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            ++AVK L+      Q F+ E + +  + H ++V+LLG   +GN   ++ E+M  GSL  
Sbjct: 30  QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++ S+  +     ++  +    A  V  G+EYL +   +  +H D+   N+L+  +   K
Sbjct: 90  YLRSRGRAV----ITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAK 142

Query: 248 ISDFGLAK 255
           +SDFGLAK
Sbjct: 143 VSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 77.2 bits (191), Expect = 4e-16
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 30/166 (18%)

Query: 143 QEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
           ++ + E+ T+      ++V+  G F  EG   +++ E+M  GSL   +          ++
Sbjct: 44  KQLLRELKTLRSCESPYVVKCYGAFYKEG-EISIVLEYMDGGSLADLL------KKVGKI 96

Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
               L  IA  + +G++YLH    + I+H DIKP N+L++   + KI+DFG++K      
Sbjct: 97  PEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISK------ 148

Query: 262 SIVSRTAAR-----GTSGYIAPELF-SRNFCY-------GMMLLEM 294
            ++  T  +     GT  Y++PE     ++ Y       G+ LLE 
Sbjct: 149 -VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLEC 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 24/195 (12%)

Query: 129 EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A+K+L         +E ++E   +  + H H+VRLLG C   ++  LI + MP G L 
Sbjct: 38  PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLL 96

Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++ + K N  S   L+W         +A+G+ YL +   +R++H D+   N+L+     
Sbjct: 97  DYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQH 147

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNF-------CYGMMLLEMV-- 295
            KI+DFGLAKL   D         +    ++A E +  R +        YG+ + E++  
Sbjct: 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207

Query: 296 GCRKNND-PAVEIQS 309
           G +     PAVEI  
Sbjct: 208 GAKPYEGIPAVEIPD 222

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 52/176 (29%), Positives = 93/176 (52%), Gaps = 21/176 (11%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           ++AVK ++  K   +E + NEV  +   HH ++V +      G+   ++ EF+  G+L  
Sbjct: 49  QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL-- 106

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +H +++ E++  +   V R + YLH   NQ ++H DIK  +ILL  + + K
Sbjct: 107 -----TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIK 158

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           +SDFG     SK++    R +  GT  ++APE+ SR         +  G+M++EM+
Sbjct: 159 LSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 38/194 (19%)

Query: 130 IAVKMLEHLKGNGQE-----FINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           +AVKML   K +  E      ++E+  +  I  H +I+ LLG C++     ++ E+  +G
Sbjct: 45  VAVKML---KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG 101

Query: 184 SLQKFI---------FSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
           +L+ F+          S  +       L+ + L   A+ VARG+E+L     ++ +H D+
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDL 158

Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIV----SRTAARGTSGYIAPE-LFSRNF--- 285
              N+L+  +   KI+DFGLA    +DI  +      T  R    ++APE LF R +   
Sbjct: 159 AARNVLVTEDHVMKIADFGLA----RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ 214

Query: 286 ----CYGMMLLEMV 295
                +G++L E+ 
Sbjct: 215 SDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 23/196 (11%)

Query: 130 IAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQ 186
           +AVK L+H        F  E+  +  + H +IV+  G C    RR   L+ E++P GSL+
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        HR     KL   A  + +G+EYL     +R +H D+   NIL++   + 
Sbjct: 96  DYLQKHRERLDHR-----KLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRV 147

Query: 247 KISDFGLAKL--CSKDISIVSRTAARGTSGYIAPE-----LFSRN---FCYGMMLLEMVG 296
           KI DFGL K+    K+   V          Y APE      FS     + +G++L E+  
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    +
Sbjct: 207 YSDKSCSPPAEFMRMM 222

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 22/180 (12%)

Query: 126 HSN-EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           HS  ++AVKM++  K   +E + NEV  +    H ++V +      G    ++ EF+  G
Sbjct: 44  HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           +L       T+  S  +L+ E++  +   V + + YLH   +Q ++H DIK  +ILL  +
Sbjct: 104 AL-------TDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLD 153

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
            + K+SDFG     SKD+    R +  GT  ++APE+ SR         +  G+M++EMV
Sbjct: 154 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 51/263 (19%)

Query: 115 FNLTNSKFFFLHSNEIAVK--MLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCS 168
            NL +  FF       AVK   L      GQE +     E+A + ++ H +IV+ LG   
Sbjct: 20  LNLDDGDFF-------AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER 72

Query: 169 EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRI 228
           E +   +  E +P GSL K +  K  S          +R     +  G+EYLH   ++  
Sbjct: 73  EEDNLYIFLELVPGGSLAK-LLKKYGS-----FPEPVIRLYTRQILLGLEYLH---DRNT 123

Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY- 287
           +H DIK  NIL+D N   K++DFG+AK   +     S    +G+  ++APE+ ++   Y 
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS---FKGSPYWMAPEVIAQQGGYG 180

Query: 288 --------GMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ--ELCLDFEEDGDE 337
                   G  +LEM        P     SQ+     ++   R  +   +     ++  +
Sbjct: 181 LAADIWSLGCTVLEMA----TGKPP---WSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233

Query: 338 GIARKLAIVAIWCIQWNPTERPS 360
            I +        C+Q +P+ RP+
Sbjct: 234 FILK--------CLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 51/175 (29%), Positives = 90/175 (51%), Gaps = 21/175 (12%)

Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 104

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 105 ----TDIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 157

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R +  GT  ++APEL SR         +  G+M++EMV
Sbjct: 158 SDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 18/175 (10%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           E+A+K +   K N +  INE+  +    H +IV        G+   ++ E+M  GSL   
Sbjct: 46  EVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI 105

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           I       +  Q+++     +   V +G+EYLH    Q ++H DIK  NILL  +   K+
Sbjct: 106 ITQNFVRMNEPQIAY-----VCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKL 157

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           +DFG A   +K+ S   R +  GT  ++APE+  R         +  G+M +EM 
Sbjct: 158 ADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.6 bits (183), Expect = 3e-15
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 9/160 (5%)

Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L   ++A+K +     + ++FI E   + ++ H  +V+L G C+E +   L++EFM +
Sbjct: 24  YWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         S E L  +   V  G+ YL       ++H D+   N L+  
Sbjct: 84  GCLSDYLRAQRGK-----FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGE 135

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 136 NQVVKVSDFGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFS 174

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.1 bits (183), Expect = 4e-15
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 7/138 (5%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           +NEV  + +++H +I++      E  +  ++ E+   G L + I  K      +    E+
Sbjct: 47  LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQ 104

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           +      +   ++YLH    ++ILH DIKP NI L  N   K+ DFG++K+ S     ++
Sbjct: 105 ILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLA 160

Query: 266 RTAARGTSGYIAPELFSR 283
           +T   GT  Y++PEL   
Sbjct: 161 KTVV-GTPYYLSPELCQN 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 63/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)

Query: 130 IAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR------TLIYEFM 180
           +AVK ++   H     +EF++E A +    H ++++L+G C E +         +I  FM
Sbjct: 30  VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
            +G L  F+          +L  + L K    +A G+EYL    N+  +H D+   N +L
Sbjct: 90  KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCML 146

Query: 241 DHNFQPKISDFGLA-KLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMML 291
             +    ++DFGL+ K+ S D     R  A+    +IA E  +          + +G+ +
Sbjct: 147 REDMTVCVADFGLSKKIYSGDYYRQGR-IAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 205

Query: 292 LEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDGDEGIARKLAIVAIWC 350
            E+    +   P VE   +IY  +++ +  RL Q E CLD           +L  +   C
Sbjct: 206 WEIATRGQTPYPGVE-NHEIY--DYLRHGNRLKQPEDCLD-----------ELYDLMYSC 251

Query: 351 IQWNPTERPS 360
            + +P +RP+
Sbjct: 252 WRADPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 35/229 (15%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++ +NE+  +  ++H +I+       +GN+  ++ E+ P G L K I         + + 
Sbjct: 44  EDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIP 101

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            +++ +I   + RG++ LH+   Q+ILH D+K  NILL  N   KI D G++K+  K++ 
Sbjct: 102 EQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157

Query: 263 IVSRTAARGTSGYIAPELF-SRNFCY-------GMMLLEMVGCRKNNDPAVEIQSQIYFP 314
             ++T   GT  Y+APE++  R + Y       G +L EM        P  E +S     
Sbjct: 158 --AKTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA----PPFEARSM---- 206

Query: 315 EWIYNRMRLGQ--ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM 361
           + +  +++ G+   +   + +D        L       +Q  P  RP+ 
Sbjct: 207 QDLRYKVQRGKYPPIPPIYSQD--------LQNFIRSMLQVKPKLRPNC 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 14/143 (9%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV  + ++ H +IV L        R  L++E++    L+         +S   L  + +R
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELL------EASPGGLPPDAVR 103

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL--CSKDISIVS 265
              + + + + Y H      I+H DIKP NIL+  +   K+ DFG A+         +  
Sbjct: 104 SYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 266 RTAARGTSGYIAPELFSRNFCYG 288
             A R    Y APEL   +  YG
Sbjct: 161 YVATR---WYRAPELLVGDTNYG 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 65/261 (24%), Positives = 123/261 (47%), Gaps = 48/261 (18%)

Query: 130 IAVKMLEHLKGNGQ----EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVKML+  +        + ++E   + +++H H+++L G CS+     LI E+   GSL
Sbjct: 33  VAVKMLK--ENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90

Query: 186 QKFI-------------FSKTNSSS-----HRQLSWEKLRKIAFGVARGVEYLHQGCNQR 227
           + F+                 NSS       R L+   L   A+ ++RG++YL +    +
Sbjct: 91  RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MK 147

Query: 228 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LF----- 281
           ++H D+   N+L+    + KISDFGL++   ++ S V R+  R    ++A E LF     
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207

Query: 282 --SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI 339
             S  + +G++L E+V    N  P +        PE ++N ++ G  +      +  E  
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNPYPGIA-------PERLFNLLKTGYRM------ERPENC 254

Query: 340 ARKLAIVAIWCIQWNPTERPS 360
           + ++  + + C +  P +RP+
Sbjct: 255 SEEMYNLMLTCWKQEPDKRPT 275

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 23/177 (12%)

Query: 130 IAVKMLEHLKGNGQEF---INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVK +  L+ N       + E+  + + +  +IV   G        ++  E+M  GSL 
Sbjct: 29  MAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           K +          ++    L KIA  V +G+ YLH+    +I+H D+KP NIL++   Q 
Sbjct: 88  KIL-----KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQI 140

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           K+ DFG++    + ++ +++T   GTS Y+APE    N        +  G+ L+E+ 
Sbjct: 141 KLCDFGVSG---QLVNSLAKTFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 29/158 (18%)

Query: 156 HHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ---KFIFSKTNSSSHRQLSWEKLRKIA 210
              +IV+  G   + +  ++    E+   GSL    K +  +      + L      KIA
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIA 111

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
             V +G+ YLH    ++I+H DIKP NILL    Q K+ DFG++        +V+  A  
Sbjct: 112 ESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG------ELVNSLAGT 162

Query: 271 --GTSGYIAPE--------LFSRNFCYGMMLLEMVGCR 298
             GTS Y+APE        + S  +  G+ LLE+   R
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 20/152 (13%)

Query: 133 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSK 192
            ML+ L         E+A +  + H +IV+ LG   + +   +  E++P GS+   +   
Sbjct: 48  SMLDALAR-------EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--- 97

Query: 193 TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 252
              +++       +R     + +G+ YLH   N+ I+H DIK  NIL+D+    KISDFG
Sbjct: 98  ---NNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFG 151

Query: 253 LAKLCSKDISIVSRTAAR----GTSGYIAPEL 280
           ++K    +        AR    G+  ++APE+
Sbjct: 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 22/164 (13%)

Query: 129 EIAVKMLE------HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           E+AVK +         K        E+  +  + H  IV+  G   +    ++  E+MP 
Sbjct: 29  ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GS++  +       ++  L+    RK    +  GVEYLH   +  I+H DIK  NIL D 
Sbjct: 89  GSVKDQL------KAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDS 139

Query: 243 NFQPKISDFGLAK----LCSKDISIVSRTAARGTSGYIAPELFS 282
               K+ DFG +K    +CS    + S T   GT  +++PE+ S
Sbjct: 140 AGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMSPEVIS 180

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 48/177 (27%), Positives = 90/177 (50%), Gaps = 16/177 (9%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +AVK L+    + ++F+ E   + ++ H  +++L   C+      ++ E M  GSL 
Sbjct: 30  TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           +++       + R L   +L  +A  VA G+ YL     Q  +H D+   N+L+  N   
Sbjct: 90  EYL----QGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNIC 142

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA++  +DI   +R  A+    + APE  L++R       + +G++L E+V
Sbjct: 143 KVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 31/226 (13%)

Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
           +E+A +G++ H +IV+L+G C       LI+E++   +L + +         R LSWE+ 
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---------RNLSWERR 782

Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
           RKIA G+A+ + +LH  C+  ++  ++ P  I++D   +P +       LC+     +S 
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFIS- 841

Query: 267 TAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI- 317
                 S Y+APE             + +G++L+E++  +   D    +   I   EW  
Sbjct: 842 ------SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EWAR 893

Query: 318 YNRMRLGQELCLDFEEDGDEGIARKLAI----VAIWCIQWNPTERP 359
           Y       ++ +D    GD  + +   +    +A+ C   +PT RP
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Length = 968

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 5e-14
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 36/214 (16%)

Query: 131 AVKMLE--HLKGNGQE--FINEVATIGRIHHFHIVRLLGFCS--EGNRRTLIYEFMPNGS 184
           A+K+L+   +    +    + E   + RI+H  IV+L    +     +  L+ E+ P G 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGE 79

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +      S   + S E+ R  A  +   +EYLH   +  I++ D+KP NILLD + 
Sbjct: 80  LFSHL------SKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADG 130

Query: 245 QPKISDFGLAK-LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM- 294
             K++DFGLAK L S+     +     GT  Y+APE+            +  G++L EM 
Sbjct: 131 HIKLTDFGLAKELSSEGSRTNTFC---GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187

Query: 295 VGC---RKNNDPAVE---IQSQIYFPEWIYNRMR 322
            G       +   +    ++  + FPE++    R
Sbjct: 188 TGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEAR 221

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 18/195 (9%)

Query: 129 EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 67  KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             F+  K        L+ E L   ++ VA+G+ +L    ++  +H D+   N+LL H   
Sbjct: 127 LNFLRRK----RESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKI 179

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LF-------SRNFCYGMMLLEMVGC 297
            KI DFGLA+    D + V +  AR    ++APE +F       S  + YG++L E+   
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239

Query: 298 RKNNDPAVEIQSQIY 312
             N  P + + S+ Y
Sbjct: 240 GSNPYPGMPVDSKFY 254

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 11/157 (7%)

Query: 107 CPFQSLISFNLTNSKFFFLHSNEIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLL 164
           C  + L  F    +  F      +AVKML  +  K    +F+ E+  + R+ + +I+RLL
Sbjct: 24  CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83

Query: 165 GFCSEGNRRTLIYEFMPNGSLQKF-----IFSK-TNSSSHRQLSWEKLRKIAFGVARGVE 218
           G C   +   +I E+M NG L +F     I S  T++++   +S   L  +A  +A G++
Sbjct: 84  GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143

Query: 219 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           YL    +   +H D+   N L+ +++  KI+DFG+++
Sbjct: 144 YL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 43/132 (32%), Positives = 71/132 (53%), Gaps = 18/132 (13%)

Query: 130 IAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNG 183
           +AVK L+  +  GQ+    +  E+  +  ++H +IV+  G CSE   +   LI E++P G
Sbjct: 36  VAVKTLK--RECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL+ ++          +L+  +L   A  +  G+ YLH   +Q  +H D+   N+LLD++
Sbjct: 94  SLRDYL-------PKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDND 143

Query: 244 FQPKISDFGLAK 255
              KI DFGLAK
Sbjct: 144 RLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 52/182 (28%), Positives = 93/182 (51%), Gaps = 29/182 (15%)

Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   Q+F++E + +G+  H +I+RL G  ++     +I E+M NG+L K
Sbjct: 36  VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++       S  QL    LR    G+A G++YL    +   +H D+   NIL++ N + K
Sbjct: 96  YLRDHDGEFSSYQLV-GMLR----GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECK 147

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D           TSG      + APE  + R F        +G+++ E
Sbjct: 148 VSDFGLSRVLEDDPE-----GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 202

Query: 294 MV 295
           ++
Sbjct: 203 VM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 9/138 (6%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E I+E   + ++   +I+R      +  +  ++ E+  NG L K +         R L 
Sbjct: 44  EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL----KMQRGRPLP 99

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            +++ +    +  G+ +LH   +++ILH DIK  N+ LD     KI D G+AKL S D +
Sbjct: 100 EDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNT 155

Query: 263 IVSRTAARGTSGYIAPEL 280
             + T   GT  Y++PEL
Sbjct: 156 NFANTIV-GTPYYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 29/71 (40%), Positives = 40/71 (56%), Gaps = 6/71 (8%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +   +EYLH   ++ I+H DIKP NILLD      I+DF +A   + D    S +   GT
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GT 162

Query: 273 SGYIAPELFSR 283
            GY+APE+  R
Sbjct: 163 PGYMAPEVLCR 173

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 38/144 (26%), Positives = 63/144 (43%), Gaps = 19/144 (13%)

Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
           +E+  +  + H ++V+  G      +  +  E+   G+L++ +         R L    +
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG------RILDEHVI 101

Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
           R     +  G+ YLH      I+H DIKP NI LDHN   K+ DFG    C+  +   + 
Sbjct: 102 RVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFG----CAVKLKNNTT 154

Query: 267 TAAR------GTSGYIAPELFSRN 284
           T         GT  Y+APE+ +  
Sbjct: 155 TMGEEVQSLAGTPAYMAPEVITGG 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 15/144 (10%)

Query: 125 LHSNEIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           L +  +A+K L         QEF  E   +  + H +IV LLG C++     +++E++ +
Sbjct: 33  LSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH 92

Query: 183 GSLQKFI----------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFD 232
           G L +F+              + +    L       IA  +A G+EYL    +   +H D
Sbjct: 93  GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRD 149

Query: 233 IKPHNILLDHNFQPKISDFGLAKL 256
           +   N L+      KISDFGL++ 
Sbjct: 150 LAARNCLVGEGLTVKISDFGLSRD 173

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 34/182 (18%)

Query: 129 EIAVKMLE--HL-KGNGQEFIN-EVATIGRIHHF-HIVRLLG-FCSEGNRRTLIYEFMPN 182
           E A+K+L+   L K    +++  E   + R++    I++L   F  E N    + E+ PN
Sbjct: 28  EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL-YFVLEYAPN 86

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L ++I  +   S    L  +  R  A  +   +EYLH   ++ I+H D+KP NILLD 
Sbjct: 87  GELLQYI--RKYGS----LDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDK 137

Query: 243 NFQPKISDFGLAK-LCSKDISIVSRTAAR-----------------GTSGYIAPELFSRN 284
           +   KI+DFG AK L        ++  A                  GT+ Y++PEL +  
Sbjct: 138 DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK 197

Query: 285 FC 286
             
Sbjct: 198 PA 199

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 30/190 (15%)

Query: 125 LHSNEI-AVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
             + E  A+K +  L+    G   + + E+  +    H ++V+LL     G+   L+ E+
Sbjct: 22  RETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           MP   L + +         R L   +++     + +GV Y+H      I+H D+KP N+L
Sbjct: 81  MP-SDLSEVL-----RDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLL 131

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRK 299
           +  +   KI+DFGLA+L S++      +    T  Y APEL             + G RK
Sbjct: 132 ISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPEL-------------LYGARK 177

Query: 300 NNDPAVEIQS 309
             DP V++ +
Sbjct: 178 -YDPGVDLWA 186

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 50/174 (28%), Positives = 90/174 (51%), Gaps = 22/174 (12%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++AVK ++      Q F+ E A + ++HH ++VRLLG     N   ++ E M  G+L  F
Sbjct: 31  KVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNF 88

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           + ++  +     +S  +L + +  VA G+EYL    +++++H D+   NIL+  +   K+
Sbjct: 89  LRTRGRAL----VSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKV 141

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
           SDFGLA++ S  +   S+   + T    APE             + YG++L E+
Sbjct: 142 SDFGLARVGSMGVD-NSKLPVKWT----APEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   + ++ H  +V+L G C++     ++ E+M NG L  +
Sbjct: 30  DVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +         ++    +L ++   V  G+ YL    +++ +H D+   N L+D     K+
Sbjct: 90  L-----REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKV 141

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK- 299
           SDFGL++    D    S   ++    +  PE+         S  + +G+++ E+    K 
Sbjct: 142 SDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200

Query: 300 -----NNDPAVEIQSQ---IYFP----EWIYNRM 321
                NN   VE  SQ   +Y P    E +Y  M
Sbjct: 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM 234

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 25/176 (14%)

Query: 126 HSNEIAVKMLEHLKGNGQE-----FINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEF 179
            +  +AVKML   K N  +      I+E+  +  I  H +I+ LLG C++     +I E+
Sbjct: 43  QTVTVAVKML---KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEY 99

Query: 180 MPNGSLQKFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
              G+L++F+ ++                 QLS++ L   A+ VARG+EYL    ++R +
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCI 156

Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA-ARGTSGYIAPE-LFSR 283
           H D+   N+L+  +   KI+DFGLA+    DI    +T+  R    ++APE LF R
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLAR-GVHDIDYYKKTSNGRLPVKWMAPEALFDR 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 13/134 (9%)

Query: 130 IAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K+L    G     EF++E   +  + H H+VRLLG C     + L+ + MP+G L  
Sbjct: 39  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLD 97

Query: 188 FIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           ++   K N  S   L+W         +A+G+ YL +   +R++H D+   N+L+      
Sbjct: 98  YVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHV 148

Query: 247 KISDFGLAKLCSKD 260
           KI+DFGLA+L   D
Sbjct: 149 KITDFGLARLLEGD 162

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 53/177 (29%), Positives = 95/177 (53%), Gaps = 27/177 (15%)

Query: 139 KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI-------- 189
           K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L  F+        
Sbjct: 48  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 107

Query: 190 ---FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
              F+  NS++   LS ++L   A  VARG++YL Q   ++ +H D+   NIL+  N+  
Sbjct: 108 DPAFAIANSTA-STLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-----LFSRN---FCYGMMLLEMV 295
           KI+DFGL++   +++  V +T  R    ++A E     +++ N   + YG++L E+V
Sbjct: 164 KIADFGLSR--GQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 42/179 (23%), Positives = 80/179 (44%), Gaps = 17/179 (9%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM+     +  +FI E   + ++ H ++V+L G C++     ++ E+M NG L  +
Sbjct: 30  DVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +          +L  E L  +   V   +EYL        +H D+   N L+  +   K+
Sbjct: 90  L-----RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKV 141

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRK 299
           SDFGLA+    D    S    +    +  PE+F  +        + +G+++ E+    K
Sbjct: 142 SDFGLARYVLDD-QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K ++   G    QE  + +  +G + H +IVRLLG C  G    L+ +  P GSL  
Sbjct: 39  VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLD 97

Query: 188 FIFSKTNS-SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            +    +S    R L+W         +A+G+ YL +    R++H ++   NILL  +   
Sbjct: 98  HVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIV 148

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSRN------FCYGMMLLEMV 295
           +I+DFG+A L   D      +  +    ++A E  LF R       + YG+ + EM+
Sbjct: 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 16/181 (8%)

Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++ +S ++AVK L+    + Q F+ E   +  + H  +VRL    ++     +I E+M  
Sbjct: 26  YYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+  K++      L   KL   +  +A G+ Y+ +   +  +H D++  N+L+  
Sbjct: 86  GSLLDFL--KSDEGGKVLLP--KLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSE 138

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGMMLLEM 294
           +   KI+DFGLA++  +D    +R  A+    + APE        + S  + +G++L E+
Sbjct: 139 SLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197

Query: 295 V 295
           V
Sbjct: 198 V 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 47/172 (27%), Positives = 88/172 (51%), Gaps = 17/172 (9%)

Query: 130 IAVKMLEH--LKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML+    + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++                 Q++++ L    + VARG+EYL    +Q+ +H D+   
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166

Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 60/252 (23%), Positives = 117/252 (46%), Gaps = 37/252 (14%)

Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +    +  + ++E+  +  I  H +I+ LLG C++     ++ E+   G+L+
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106

Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++          T      QL+++ L   A+ VARG+EYL    +Q+ +H D+   
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163

Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        +G
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223

Query: 289 MMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI 348
           ++L E+     +  P + +       E ++  ++ G  +      D       +L ++  
Sbjct: 224 VLLWEIFTLGGSPYPGIPV-------EELFKLLKEGHRM------DKPANCTHELYMIMR 270

Query: 349 WCIQWNPTERPS 360
            C    P++RP+
Sbjct: 271 ECWHAVPSQRPT 282

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 35/110 (31%), Positives = 63/110 (57%), Gaps = 8/110 (7%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  ++H +IVRLL      N+  L++EF+ +  L+K++    +SS    L    
Sbjct: 46  IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM----DSSPLTGLDPPL 100

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++   + + +G+ Y H     R+LH D+KP N+L+D     K++DFGLA+
Sbjct: 101 IKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 18/154 (11%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN---GSLQKFIFSKTNSSSHRQLSWE 204
           E+  + ++ H ++V L+       R  L++EF+ +     L+K+            L   
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY---------PNGLDES 100

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
           ++RK  F + RG+E+ H   +  I+H DIKP NIL+  +   K+ DFG A+  +    + 
Sbjct: 101 RVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157

Query: 265 SRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
           +   A  T  Y APEL   +  YG  + +  VGC
Sbjct: 158 TDYVA--TRWYRAPELLVGDTKYGRAVDIWAVGC 189

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 50/181 (27%), Positives = 94/181 (51%), Gaps = 21/181 (11%)

Query: 128 NEIAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
             +A+K L+  + +   ++F++E + +G+  H +I+ L G  ++     +I EFM NG+L
Sbjct: 33  IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL 92

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             F+  + N     Q +  +L  +  G+A G++YL +      +H D+   NIL++ N  
Sbjct: 93  DSFL--RQNDG---QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLV 144

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTS---GYIAPELFS-RNFC-------YGMMLLEM 294
            K+SDFGL++    D S  + T++ G      + APE  + R F        YG+++ E+
Sbjct: 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204

Query: 295 V 295
           +
Sbjct: 205 M 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 49/182 (26%), Positives = 93/182 (51%), Gaps = 29/182 (15%)

Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F++E + +G+  H +I+ L G  ++     ++ E+M NGSL  
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  + +     Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 95  FL--RKHDG---QFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCK 146

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNF-------CYGMMLLE 293
           +SDFGL+++   D       AA  T G      + APE  + R F        YG+++ E
Sbjct: 147 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201

Query: 294 MV 295
           ++
Sbjct: 202 VM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 11/136 (8%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+ T+  + H +IV+ LGF +     ++  E++P GS+   +  +T      QL      
Sbjct: 58  EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTE 115

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-SIVSR 266
           ++  G+A    YLH   ++ ILH D+K  N+L+D +   KISDFG++K  S DI      
Sbjct: 116 QVLEGLA----YLH---SKGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQN 167

Query: 267 TAARGTSGYIAPELFS 282
            + +G+  ++APE+  
Sbjct: 168 MSMQGSVFWMAPEVIH 183

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 39/134 (29%), Positives = 68/134 (50%), Gaps = 11/134 (8%)

Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    N  ++F  E   +  + H HIV+  G C EG+   +++E+M +G L KF
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 189 IFSK-------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           + +           +   +L+  ++  IA  +A G+ YL    +Q  +H D+   N L+ 
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 154

Query: 242 HNFQPKISDFGLAK 255
            N   KI DFG+++
Sbjct: 155 ENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 48/143 (33%), Positives = 78/143 (54%), Gaps = 21/143 (14%)

Query: 146 INEVATIGRIHHF---HIVRLLGFCSEGNRR------TLIYEFMPNGSLQKFIFSKTNSS 196
           + E+A + ++  F   +IVRLL  C  G R       TL++E + +  L  ++ SK    
Sbjct: 46  LREIALLKQLESFEHPNIVRLLDVC-HGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKP 102

Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
               L  E ++ +   + RGV++LH   + RI+H D+KP NIL+  + Q KI+DFGLA++
Sbjct: 103 G---LPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156

Query: 257 CSKDISIVSRTAARGTSGYIAPE 279
            S ++++ S      T  Y APE
Sbjct: 157 YSFEMALTSVVV---TLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 42/142 (29%), Positives = 68/142 (47%), Gaps = 17/142 (11%)

Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    +  Q+F  E   +  + H HIVR  G C+EG    +++E+M +G L +F
Sbjct: 38  VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97

Query: 189 ---------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
                    I +     +  QL+  ++  IA  +A G+ YL    +   +H D+   N L
Sbjct: 98  LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCL 154

Query: 240 LDHNFQPKISDFGLAKLCSKDI 261
           +      KI DFG+    S+DI
Sbjct: 155 VGQGLVVKIGDFGM----SRDI 172

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 21/144 (14%)

Query: 130 IAVKML-EHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVKML E    + Q +F  E A +    H +IV+LLG C+ G    L++E+M  G L +
Sbjct: 38  VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97

Query: 188 FIFSK----TNSSSHR------------QLSWEKLRKIAFGVARGVEYLHQGCNQRILHF 231
           F+  +      S SH              LS  +   IA  VA G+ YL +   ++ +H 
Sbjct: 98  FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHR 154

Query: 232 DIKPHNILLDHNFQPKISDFGLAK 255
           D+   N L+  N   KI+DFGL++
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 7e-12
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 10/133 (7%)

Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVKML  +  K    +F+ E+  + R+   +I+RLL  C   +   +I E+M NG L +
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 188 FIF-----SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           F+           +    +S+  L  +A  +A G++YL    +   +H D+   N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 243 NFQPKISDFGLAK 255
           N+  KI+DFG+++
Sbjct: 166 NYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 41/133 (30%), Positives = 61/133 (45%), Gaps = 11/133 (8%)

Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK L        E  F+ E   + + +H +IVRL+G   E   R ++ E M  G L+ 
Sbjct: 39  VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98

Query: 188 FIFSKTNSSSH-RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           F+            L+ + L   A  VA+G +YL +      +H DI   N LL     P
Sbjct: 99  FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCK-GP 154

Query: 247 ----KISDFGLAK 255
               KI+DFG+A+
Sbjct: 155 GRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+  +  ++H +I++LL          L++EFM +  L K I  K      R L    
Sbjct: 46  LREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQ---RGLPESL 99

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           ++   + + +G+ + H      ILH D+KP N+L++     K++DFGLA+     +   +
Sbjct: 100 IKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156

Query: 266 RTAARGTSGYIAPELFSRNFCYGM-MLLEMVGC 297
                 T  Y APEL   +  Y   + +  VGC
Sbjct: 157 HYVV--TRWYRAPELLLGDKGYSTPVDIWSVGC 187

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 22/176 (12%)

Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIY-EFMPNGSLQ 186
           N++AVK +++     Q F+ E + + ++ H ++V+LLG   E      I  E+M  GSL 
Sbjct: 30  NKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++ S+  S     L  + L K +  V   +EYL        +H D+   N+L+  +   
Sbjct: 89  DYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVA 141

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-----LFSRN---FCYGMMLLEM 294
           K+SDFGL K  S      ++   +    + APE      FS     + +G++L E+
Sbjct: 142 KVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 130 IAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K +   K      +  + E+  +  + H +IV+ +G     +   +I E+  NGSL+
Sbjct: 28  VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           + I  K        ++        + V +G+ YLH+   Q ++H DIK  NIL   +   
Sbjct: 88  Q-IIKKFGPFPESLVA-----VYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVV 138

Query: 247 KISDFGLA-KLCSKDISIVSRTAARGTSGYIAPE 279
           K++DFG+A KL           +  GT  ++APE
Sbjct: 139 KLADFGVATKLNDVSK---DDASVVGTPYWMAPE 169

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 36/133 (27%), Positives = 63/133 (47%), Gaps = 22/133 (16%)

Query: 155 IHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFG 212
           + H +IVRL    +   + +  +++E+M +  L   + S     +  Q+     +     
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQI-----KCYMKQ 108

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +  G++YLH   +  ILH DIK  NIL++++   K++DFGLA+          R +A  T
Sbjct: 109 LLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR------PYTKRNSADYT 159

Query: 273 SG-----YIAPEL 280
           +      Y  PEL
Sbjct: 160 NRVITLWYRPPEL 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 43/131 (32%), Positives = 74/131 (56%), Gaps = 17/131 (12%)

Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +    +  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 27  AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL-PYMKHGDLR 85

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI S+T++ + + L       I FG  VA+G+EYL    +++ +H D+   N +LD +F
Sbjct: 86  NFIRSETHNPTVKDL-------IGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESF 135

Query: 245 QPKISDFGLAK 255
             K++DFGLA+
Sbjct: 136 TVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 63.7 bits (156), Expect = 1e-11
 Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 18/145 (12%)

Query: 147 NEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
            EV ++ ++  H +IV+L     E +    ++E+M  G+L + +  +      +  S   
Sbjct: 46  REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK----GKPFSESV 100

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           +R I + + +G+ ++H+       H D+KP N+L+      KI+DFGLA+       I S
Sbjct: 101 IRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR------EIRS 151

Query: 266 R---TAARGTSGYIAPELFSRNFCY 287
           R   T    T  Y APE+  R+  Y
Sbjct: 152 RPPYTDYVSTRWYRAPEILLRSTSY 176

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 62/246 (25%), Positives = 112/246 (45%), Gaps = 30/246 (12%)

Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++A+K L+    + + F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 26  YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMEN 84

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+  KT      +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 85  GSLVDFL--KTPEGI--KLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSE 137

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE        + S  + +G++L E+
Sbjct: 138 TLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196

Query: 295 VGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
           V   +   P +        PE I N  R  +    D           +L  +   C +  
Sbjct: 197 VTYGRIPYPGMT------NPEVIQNLERGYRMPRPD-------NCPEELYELMRLCWKEK 243

Query: 355 PTERPS 360
           P ERP+
Sbjct: 244 PEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 17/177 (9%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           + ++AVK L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 30  NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLL 88

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         R L    L  +A  VA G+ Y+ +      +H D++  NIL+      
Sbjct: 89  DFL----KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVC 141

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           KI+DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+V
Sbjct: 142 KIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 44/137 (32%), Positives = 74/137 (54%), Gaps = 16/137 (11%)

Query: 130 IAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPNG 183
           +AVK L+    +G   I     E+  +  ++H +IV+  G C+E  GN   LI EF+P+G
Sbjct: 36  VAVKSLK--PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL++++    N     +++ ++  K A  + +G++YL  G  Q + H D+   N+L++  
Sbjct: 94  SLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESE 145

Query: 244 FQPKISDFGLAKLCSKD 260
            Q KI DFGL K    D
Sbjct: 146 HQVKIGDFGLTKAIETD 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 7/116 (6%)

Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S +K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 38/135 (28%), Positives = 75/135 (55%), Gaps = 10/135 (7%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+    ++S    +    
Sbjct: 47  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM----DASPLSGIPLPL 101

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           ++   F + +G+ + H   + R+LH D+KP N+L++     K++DFGLA+  +  + + +
Sbjct: 102 IKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRT 156

Query: 266 RTAARGTSGYIAPEL 280
            T    T  Y APE+
Sbjct: 157 YTHEVVTLWYRAPEI 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 33/206 (16%)

Query: 170 GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
           G    L   F P+ S       +T+      L+ E L   +F VARG+E+L    +++ +
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196

Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-- 286
           H D+   NILL  N   KI DFGLA+   KD   V + +AR    ++APE +F + +   
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256

Query: 287 -----YGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR 341
                +G++L E+     +  P V+I                 +E C    +DG    A 
Sbjct: 257 SDVWSFGVLLWEIFSLGASPYPGVQIN----------------EEFCQRL-KDGTRMRAP 299

Query: 342 KLAIVAIW-----CIQWNPTERPSMP 362
           + A   I+     C Q +P ERP+  
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFS 325

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 42/138 (30%), Positives = 62/138 (44%), Gaps = 33/138 (23%)

Query: 155 IHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
           + H +I+ LL  F  + N   L++EFM    L+K I               K + I    
Sbjct: 59  LKHPNIIGLLDVFGHKSNI-NLVFEFME-TDLEKVI---------------KDKSIVLTP 101

Query: 214 A----------RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           A          RG+EYLH   +  ILH D+KP+N+L+  +   K++DFGLA+        
Sbjct: 102 ADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 264 VSRTAARGTSGYIAPELF 281
           ++      T  Y APEL 
Sbjct: 159 MTHQVV--TRWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 8/131 (6%)

Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           + VK L+  K      EF  E+    ++ H ++VRLLG C E     +I E+   G L++
Sbjct: 38  VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97

Query: 188 FIF---SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           F+    SK        LS ++   +   +A G+++L    N R +H D+   N L+    
Sbjct: 98  FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQR 154

Query: 245 QPKISDFGLAK 255
           + K+S   L+K
Sbjct: 155 EVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 10/128 (7%)

Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK L  + L     +F+ E A +  + H +++RL G     +   ++ E  P GSL  
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +  + ++  H  +S   L   A  +A G+ YL     +R +H D+   NILL  + + K
Sbjct: 85  RL--RKDALGHFLIS--TLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVK 137

Query: 248 ISDFGLAK 255
           I DFGL +
Sbjct: 138 IGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)

Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 39  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 96

Query: 187 KFIF-SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL +   +R++H D+   N+L+     
Sbjct: 97  DYVREHKDNIGSQYLLNW------CVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQH 147

Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   D
Sbjct: 148 VKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 44/158 (27%), Positives = 64/158 (40%), Gaps = 15/158 (9%)

Query: 133 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIY-EFMPNGSLQKFI- 189
            M E  K   Q+ ++EV  +  + H +IVR         N+   I  E+   G L + I 
Sbjct: 37  NMTEKEK---QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ 93

Query: 190 -FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC--NQRILHFDIKPHNILLDHNFQP 246
              K       +  W    +I   +   +   H        +LH D+KP NI LD N   
Sbjct: 94  KCKKERKYIEEEFIW----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           K+ DFGLAK+   D S        GT  Y++PE  +  
Sbjct: 150 KLGDFGLAKILGHDSSFAKTYV--GTPYYMSPEQLNHM 185

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 18/158 (11%)

Query: 107 CPFQSLISFNLTNSKFFF--LHSNEIAVKML-----EHLKGNGQEFINEVATIGRIHHFH 159
           C    L  F+               +AVK+L     ++ +   ++F+ EV  + R+   +
Sbjct: 24  CEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR---EDFLKEVKILSRLSDPN 80

Query: 160 IVRLLGFCSEGNRRTLIYEFMPNGSLQKF-----IFSKTNSSSHRQLSWEKLRKIAFGVA 214
           I RLLG C+      +I E+M NG L +F       +   + + + LS+  L  +A  +A
Sbjct: 81  IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140

Query: 215 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 252
            G+ YL        +H D+   N L+  N+  KI+DFG
Sbjct: 141 SGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 62.2 bits (151), Expect = 5e-11
 Identities = 62/248 (25%), Positives = 106/248 (42%), Gaps = 37/248 (14%)

Query: 130 IAVKMLEHLKGNG-------QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           +AVK + +++          +    E+  + R++H HI+R+LG   E +   L  E+M  
Sbjct: 28  MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG 87

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GS+   +      S +       +      + RG+ YLH+    +I+H D+K  N+L+D 
Sbjct: 88  GSVSHLL------SKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDS 138

Query: 243 NFQP-KISDFGLAKLCSKDISIVSRTAAR--GTSGYIAPELFSRNFCYGMML-LEMVGCR 298
             Q  +I+DFG A   +   +       +  GT  ++APE+  R   YG    +  VGC 
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGC- 196

Query: 299 KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE-------EDGDEGIARKLAIVAIWCI 351
                 V I+     P W  N  +    L L F+           E ++  L  V + C+
Sbjct: 197 ------VIIEMATAKPPW--NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCL 248

Query: 352 QWNPTERP 359
           +  P +RP
Sbjct: 249 ELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 62.6 bits (153), Expect = 5e-11
 Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 29/174 (16%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH+       +NE   +  I H  +V L G   + +   L+ E++P G L    
Sbjct: 40  VKLKQVEHV-------LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL---- 88

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS    S   +      R  A  V   +EYLH   +  I++ D+KP N+LLD +   KI+
Sbjct: 89  FSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKIT 143

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           DFG AK        +      GT  Y+APE+            +  G+++ EM+
Sbjct: 144 DFGFAKRVKGRTYTLC-----GTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 46/238 (19%)

Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL-- 201
           EF+NE + +   +  H+VRLLG  S G    ++ E M  G L+ ++ S+   + +     
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114

Query: 202 --SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +K  ++A  +A G+ YL     ++ +H D+   N ++  +   KI DFG+     +
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMT----R 167

Query: 260 DI--SIVSRTAARGT--SGYIAPE-----LF---SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE     +F   S  + +G++L EM            +
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM----------ATL 217

Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      E    KL  +   C Q+NP  RP+
Sbjct: 218 AEQPY--------QGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 24/201 (11%)

Query: 129 EIAVKMLEH--LKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+    + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L
Sbjct: 52  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111

Query: 186 QKFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           ++++ ++                 QLS++ L   A+ VARG+EYL    +++ +H D+  
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168

Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        +
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228

Query: 288 GMMLLEMVGCRKNNDPAVEIQ 308
           G++L E+     +  P V ++
Sbjct: 229 GVLLWEIFTLGGSPYPGVPVE 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 37/134 (27%), Positives = 72/134 (53%), Gaps = 12/134 (8%)

Query: 126 HSNEI-AVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
            + EI A+K + HL   +G     I E++ +  + H +IVRL       N+  L++E+M 
Sbjct: 23  TTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM- 80

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           +  L+K++ +         L    ++   + + +G+ + H+    R+LH D+KP N+L++
Sbjct: 81  DKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLIN 134

Query: 242 HNFQPKISDFGLAK 255
              + K++DFGLA+
Sbjct: 135 KRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 12/126 (9%)

Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+  L     + Q   F+ E  T+G+  H +IVRL G  + GN   ++ E+M NG+L  
Sbjct: 36  VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95

Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           F+        H  QL   +L  +  G+A G++YL +      +H  +  H +L++ +   
Sbjct: 96  FL------RKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVC 146

Query: 247 KISDFG 252
           KIS F 
Sbjct: 147 KISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 12/154 (7%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++A+K+L  E+ K    E + E   + ++ + +IVR++G C E     L+ E    G L 
Sbjct: 24  DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLN 82

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+  K +     +++   + ++   V+ G++YL     +  +H D+   N+LL +    
Sbjct: 83  KFLSGKKD-----EITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYA 134

Query: 247 KISDFGLAK-LCSKDISIVSRTAARGTSGYIAPE 279
           KISDFGL+K L + D    +R+A +    + APE
Sbjct: 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 32/152 (21%)

Query: 126 HSNEIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
               +AVK+L  +  K    +F+ EV  + R+   +I+RLLG C + +   +I E+M NG
Sbjct: 45  RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104

Query: 184 SLQKFIFSKTNSSSHRQL--------------------SWEKLRKIAFGVARGVEYLHQG 223
            L +F+       S   L                    S+  L  +A  +A G++YL   
Sbjct: 105 DLNQFL-------SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--- 154

Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
            +   +H D+   N L+  N   KI+DFG+++
Sbjct: 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 60.9 bits (148), Expect = 9e-11
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 16/156 (10%)

Query: 129 EIAVK-----MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           E+AVK     +   LK   ++F+ E   + +  H +IV+L+G C +     ++ E +P G
Sbjct: 21  EVAVKTCRSTLPPDLK---RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL  F+  K N     +L+ +KL +++   A G+EYL        +H D+   N L+  N
Sbjct: 78  SLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGEN 129

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
              KISDFG+++     I  VS    +    + APE
Sbjct: 130 NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 46/176 (26%), Positives = 87/176 (49%), Gaps = 17/176 (9%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 30  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 88

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +      + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 89  DFLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 141

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEM 294
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+
Sbjct: 142 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 32/233 (13%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRR------TLIYEFMPNGSLQKFIFSKTNSS 196
           ++F++E   +    H +++RL+G C +           +I  FM +G L  F+       
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L  + L K    +A G+EYL    ++  +H D+   N +L+ N    ++DFGL+K 
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161

Query: 257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQ 308
                       A+    +IA E          S  + +G+ + E+    +   P VE  
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-N 220

Query: 309 SQIYFPEWIYNRMRLGQEL-CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
           S+IY  +++    RL Q   CLD            L  +   C   NP +RPS
Sbjct: 221 SEIY--DYLRQGNRLKQPPDCLD-----------GLYSLMSSCWLLNPKDRPS 260

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 35/177 (19%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQK 187
           I +K  +H+        NE   +  + H  I+RL  F +E ++R L  + E++P G L  
Sbjct: 40  IRLKQEQHVH-------NEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGEL-- 88

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
             FS   +S   + S       A  +   +EYLH   ++ I++ D+KP NILLD     K
Sbjct: 89  --FSYLRNS--GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIK 141

Query: 248 ISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG AK       +  RT    GT  Y+APE+            +  G+++ EM+
Sbjct: 142 LTDFGFAK------KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 12/157 (7%)

Query: 125 LHSNEI-AVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           + + E+ A+K+++   G+  E I  E++ +    H +IV   G     ++  ++ E+   
Sbjct: 25  IATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSLQ  I+  T       LS  ++  +     +G+ YLH+      +H DIK  NILL  
Sbjct: 85  GSLQD-IYQVTR----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTE 136

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           +   K++DFG++   +  I+   R +  GT  ++APE
Sbjct: 137 DGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPE 171

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 16/169 (9%)

Query: 127 SNEIAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           + ++A+K   LE  + +  E   EV  + + +H ++V+       G+   L+  ++  GS
Sbjct: 26  NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAF---GVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           L   + S        +        IA     V +G+EYLH   N +I H DIK  NILL 
Sbjct: 86  LLDIMKSSYPRGGLDEAI------IATVLKEVLKGLEYLHS--NGQI-HRDIKAGNILLG 136

Query: 242 HNFQPKISDFGLAKLCSK--DISIVSRTAARGTSGYIAPELFSRNFCYG 288
            +   KI+DFG++   +   D +   R    GT  ++APE+  +   Y 
Sbjct: 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 17/177 (9%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           + ++A+K L+      + F+ E   + ++ H  +V L    SE     ++ EFM  GSL 
Sbjct: 30  TTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLL 88

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  K     + +L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 89  DFL--KEGDGKYLKLP--QLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVC 141

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           KI+DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+V
Sbjct: 142 KIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 21/146 (14%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++   EV  +  + H +IV+ LG C + N  ++  EF+P GS+   +      +    L 
Sbjct: 47  EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL------NRFGPLP 100

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
                K    +  GV YLH  C   ++H DIK +N++L  N   K+ DFG    C++ ++
Sbjct: 101 EPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFG----CARRLA 153

Query: 263 IVSRTAA--------RGTSGYIAPEL 280
            V              GT  ++APE+
Sbjct: 154 WVGLHGTHSNMLKSMHGTPYWMAPEV 179

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 23/146 (15%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q    E+A    + H +IV+ LG  SE     +  E +P GSL   + SK          
Sbjct: 50  QPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---------- 99

Query: 203 WEKLRK----IAF---GVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLA 254
           W  L+     I F    +  G++YLH     +I+H DIK  N+L++ ++   KISDFG +
Sbjct: 100 WGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156

Query: 255 KLCSKDISIVSRTAARGTSGYIAPEL 280
           K  +  I+  + T   GT  Y+APE+
Sbjct: 157 KRLAG-INPCTETFT-GTLQYMAPEV 180

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 34/132 (25%), Positives = 69/132 (52%), Gaps = 15/132 (11%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  ++H ++V+            ++ EFM  GSL+      T+ +  + L+     
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-----THIADEQFLA----- 171

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            +A  +  G+ YLH+   + I+H DIKP N+L++     KI+DFG++++ ++ +   + +
Sbjct: 172 DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 268 AARGTSGYIAPE 279
              GT  Y++PE
Sbjct: 229 V--GTIAYMSPE 238

Length = 353

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 33/123 (26%), Positives = 61/123 (49%), Gaps = 13/123 (10%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS------ 196
           ++F  E   +  + H HIV+  G C +G+   +++E+M +G L KF+ +    +      
Sbjct: 52  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111

Query: 197 ----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 252
               +  +L   ++  IA  +A G+ YL    +Q  +H D+   N L+  N   KI DFG
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFG 168

Query: 253 LAK 255
           +++
Sbjct: 169 MSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 38/231 (16%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q+ + E+  + ++ H ++++ L    E N   ++ E    G L + I  K      R + 
Sbjct: 47  QDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMI--KHFKKQKRLIP 104

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              + K    +   +E++H    +RI+H DIKP N+ +      K+ D GL +  S    
Sbjct: 105 ERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---- 157

Query: 263 IVSRTAAR----GTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQSQ 310
             S+T A     GT  Y++PE    N        +  G +L EM            +QS 
Sbjct: 158 --SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM----------AALQSP 205

Query: 311 IYFPEWIYNRMRLGQ--ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
            Y  +   N   L +  E C D+     +  + +L  +   CI  +P +RP
Sbjct: 206 FYGDK--MNLYSLCKKIEKC-DYPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 39/135 (28%), Positives = 73/135 (54%), Gaps = 9/135 (6%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  + H +IV L     + +R  LI+EF+ +  L+K++ S       + +  E 
Sbjct: 47  IREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDS---LPKGQYMDAEL 102

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           ++   + + +G+ + H    +R+LH D+KP N+L+D+    K++DFGLA+  +  I +  
Sbjct: 103 VKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRV 157

Query: 266 RTAARGTSGYIAPEL 280
            T    T  Y APE+
Sbjct: 158 YTHEVVTLWYRAPEV 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 15/136 (11%)

Query: 130 IAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVK L   KG      +EF+ E   +   +H +IV+LLG C     + +I E M  G L
Sbjct: 29  VAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86

Query: 186 QKFIF-SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---- 240
             ++  ++        L+ ++L  I   VA+G  YL Q      +H D+   N L+    
Sbjct: 87  LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKG 143

Query: 241 -DHNFQPKISDFGLAK 255
            D +   KI DFGLA+
Sbjct: 144 YDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 4/84 (4%)

Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
           S + LS + ++   + + RG++YLH      ILH DIKP N+L++ N   KI DFGLA++
Sbjct: 96  SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Query: 257 CSKDISIVSRTAARGTSGYIAPEL 280
              D S    T    T  Y APE+
Sbjct: 153 EEPDES-KHMTQEVVTQYYRAPEI 175

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 44/144 (30%), Positives = 75/144 (52%), Gaps = 19/144 (13%)

Query: 146 INEVATIGRIHHF---HIVRLLGFCSEGN-----RRTLIYEFMPNGSLQKFIFSKTNSSS 197
           + EVA + R+  F   +IVRL+  C+        + TL++E + +  L+ ++  K     
Sbjct: 47  VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPG 104

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              L  E ++ +     RG+++LH  C   I+H D+KP NIL+    Q K++DFGLA++ 
Sbjct: 105 ---LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY 158

Query: 258 SKDISIVSRTAARGTSGYIAPELF 281
           S  +++   T    T  Y APE+ 
Sbjct: 159 SCQMAL---TPVVVTLWYRAPEVL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 16/95 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +  G+E+LHQ   +RI++ D+KP N+LLD +   +ISD GLA     ++    +   R G
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAG 156

Query: 272 TSGYIAPEL-------FSRN-FCYGMMLLEMVGCR 298
           T GY+APE+       FS + F  G  L EM+  R
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)

Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 55  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 167

Query: 260 DI--SIVSRTAARG--TSGYIAPE--------LFSRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT----------SL 217

Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 218 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 12/136 (8%)

Query: 129 EIAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLGFC--SEGNRR----TLIYEF 179
           ++AVKML+       + +EF+ E A +    H ++++L+G    S    R     +I  F
Sbjct: 29  KVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPF 88

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           M +G L  F+           L  + L +    +A G+EYL    ++  +H D+   N +
Sbjct: 89  MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCM 145

Query: 240 LDHNFQPKISDFGLAK 255
           L+ N    ++DFGL+K
Sbjct: 146 LNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 27/74 (36%), Positives = 43/74 (58%), Gaps = 5/74 (6%)

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           L KIA  + + +EYLH      ++H D+KP N+L++ N Q K+ DFG++      +  V+
Sbjct: 105 LGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVA 159

Query: 266 RTAARGTSGYIAPE 279
           +T   G   Y+APE
Sbjct: 160 KTIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.5 bits (141), Expect = 7e-10
 Identities = 59/240 (24%), Positives = 109/240 (45%), Gaps = 30/240 (12%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++AVK ++    + + F+ E   +  + H  +V+L    ++     +I EFM  GSL  F
Sbjct: 32  KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +  K++  S + L   KL   +  +A G+ ++ Q   +  +H D++  NIL+  +   KI
Sbjct: 91  L--KSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKI 143

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGMMLLEMVGCRKN 300
           +DFGLA++  +D    +R  A+    + APE        + S  + +G++L+E+V   + 
Sbjct: 144 ADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 202

Query: 301 NDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
             P +     I   E  Y   R              E    +L  + + C +  P ERP+
Sbjct: 203 PYPGMSNPEVIRALERGYRMPR-------------PENCPEELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 19/159 (11%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +A+K++  ++ + QE I E++ + +    +IV+  G   +     ++ E+   GS+   +
Sbjct: 31  VAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM 89

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
                  +++ L+ E++  I +   +G+EYLH   + + +H DIK  NILL+   Q K++
Sbjct: 90  -----KITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLA 141

Query: 250 DFGLAKLCSKDISIVSRTAAR----GTSGYIAPELFSRN 284
           DFG++        +    A R    GT  ++APE+    
Sbjct: 142 DFGVSG------QLTDTMAKRNTVIGTPFWMAPEVIQEI 174

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 75/305 (24%), Positives = 117/305 (38%), Gaps = 96/305 (31%)

Query: 130 IAVKML-------EHLKGNGQEFINEVATIGRI-HHFHIVRLLG--------------FC 167
           +AVKML       E+     +  + E+  +  I HH ++V LLG              +C
Sbjct: 40  VAVKMLKEGATASEY-----KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYC 94

Query: 168 SEGNR----RTLIYEFMPN-----------------GSLQKFIFSKTNSSS--------- 197
             GN     R+    F P                    L     S++++SS         
Sbjct: 95  KFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154

Query: 198 ------------HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                          L+ E L   +F VARG+E+L    +++ +H D+   NILL  N  
Sbjct: 155 DVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNV 211

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNF-------CYGMMLLEMVGC 297
            KI DFGLA+   KD   V +  AR    ++APE +F + +        +G++L E+   
Sbjct: 212 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW--NP 355
             +  P V+I       E    R++ G  +    E    E       I +I    W  NP
Sbjct: 272 GASPYPGVQID------EEFCRRLKEGTRMRAP-EYATPE-------IYSIMLDCWHNNP 317

Query: 356 TERPS 360
            +RP+
Sbjct: 318 EDRPT 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 9/156 (5%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+K +     + ++FI E   + ++ H  +V+L G C++     ++ EFM NG L  +
Sbjct: 30  KVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +  +       +LS + L  +   V  G+EYL +      +H D+   N L+      K+
Sbjct: 90  LRQRQG-----KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKV 141

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           SDFG+ +    D    S + A+    +  PE+F+ +
Sbjct: 142 SDFGMTRYVLDD-EYTSSSGAKFPVKWSPPEVFNFS 176

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 34/185 (18%)

Query: 154 RIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAF 211
           +    ++V+L  + S   ++ L  + E++P G L   +       +   L  +  R    
Sbjct: 49  QAQSPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLL------ENVGSLDEDVARIYIA 100

Query: 212 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL------CSKDISIVS 265
            +   +EYLH      I+H D+KP NIL+D N   K++DFGL+K+       + +     
Sbjct: 101 EIVLALEYLHS-NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157

Query: 266 RTAARGTSGYIAPEL---FSRNFC-----YGMMLLE-MVGCRKNNDPAVE------IQSQ 310
                GT  YIAPE+      +        G +L E +VG    +    E      +  +
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217

Query: 311 IYFPE 315
           I +PE
Sbjct: 218 IEWPE 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 13/117 (11%)

Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           ++ + I + M  G L   +      S H   S  ++R  A  +  G+E++H   N+ +++
Sbjct: 70  DKLSFILDLMNGGDLHYHL------SQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVY 120

Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
            D+KP NILLD +   +ISD GLA  C  D S     A+ GT GY+APE+  +   Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTHGYMAPEVLQKGVAY 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 21/176 (11%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A+K +   +   +E I NE+  +    H +IV  L     G+   ++ E++  GSL  
Sbjct: 46  EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 103

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   NQ ++H DIK  NILL  +   K
Sbjct: 104 -----TDVVTETCMDEGQIAAVCRECLQALEFLHS--NQ-VIHRDIKSDNILLGMDGSVK 155

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EMV
Sbjct: 156 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 44/139 (31%), Positives = 76/139 (54%), Gaps = 18/139 (12%)

Query: 131 AVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           A+K ++    K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L  
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85

Query: 188 FI-----------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           F+           F+  NS++   LS ++L   A  VARG++YL Q   ++ +H D+   
Sbjct: 86  FLRKSRVLETDPAFAIANSTA-STLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAAR 141

Query: 237 NILLDHNFQPKISDFGLAK 255
           NIL+  N+  KI+DFGL++
Sbjct: 142 NILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 40/133 (30%), Positives = 73/133 (54%), Gaps = 11/133 (8%)

Query: 125 LHSNEIAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           L  N +A+K   LEH +G     I EV+ +  + H +IV L          TL++E++ +
Sbjct: 28  LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
             L++++ +  N      +S   ++   F + RG+ Y H+   ++ILH D+KP N+L++ 
Sbjct: 88  -DLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINE 138

Query: 243 NFQPKISDFGLAK 255
             + K++DFGLA+
Sbjct: 139 KGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 28/200 (14%)

Query: 126 HSNE-IAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
            +NE IA+K +   +  +G     I E++ +  + H +IVRL        R  L++E++ 
Sbjct: 25  VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL- 83

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           +  L+K + S  + + + +L    ++   + + RG+ Y H   + R+LH D+KP N+L+D
Sbjct: 84  DLDLKKHMDSSPDFAKNPRL----IKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLID 136

Query: 242 H-NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--SRNF-------CYGMML 291
                 K++DFGLA+  +  I + + T    T  Y APE+   SR++         G + 
Sbjct: 137 RRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIF 194

Query: 292 LEMVGCRKNNDPAVEIQSQI 311
            EMV    N  P     S+I
Sbjct: 195 AEMV----NQKPLFPGDSEI 210

Length = 294

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 17/138 (12%)

Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
           NE   +  + H +I+       E     ++ E+ P G+L ++I  + NS           
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107

Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVS 265
            +I          LH    + ILH D+K  NILLD H    KI DFG++K+      + S
Sbjct: 108 VQILLA-------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI------LSS 154

Query: 266 RTAAR---GTSGYIAPEL 280
           ++ A    GT  YI+PEL
Sbjct: 155 KSKAYTVVGTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 39/139 (28%), Positives = 75/139 (53%), Gaps = 18/139 (12%)

Query: 131 AVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           A+KML+    + + ++F  E+  + ++ HH +I+ LLG C       +  E+ P G+L  
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92

Query: 188 FI-----------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           F+           F+K + ++   L+ ++L + A  VA G++YL +   ++ +H D+   
Sbjct: 93  FLRKSRVLETDPAFAKEHGTA-STLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAAR 148

Query: 237 NILLDHNFQPKISDFGLAK 255
           N+L+  N   KI+DFGL++
Sbjct: 149 NVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 16/143 (11%)

Query: 126 HSNEIAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           H+  +A+K L+ +    Q  EF  E + +  +HH +IV LLG  ++     +++E++  G
Sbjct: 33  HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG 92

Query: 184 SLQKFIF-----------SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFD 232
            L +F+            S  + +    L       IA  +A G+EYL    +   +H D
Sbjct: 93  DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKD 149

Query: 233 IKPHNILLDHNFQPKISDFGLAK 255
           +   NIL+      KISD GL++
Sbjct: 150 LAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 13/117 (11%)

Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           ++   I + M  G L   +      S H   S +++R  A  +  G+E++H   N+ +++
Sbjct: 70  DKLCFILDLMNGGDLHYHL------SQHGVFSEKEMRFYATEIILGLEHMH---NRFVVY 120

Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
            D+KP NILLD +   +ISD GLA  C  D S     A+ GT GY+APE+  +   Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTHGYMAPEVLQKGTAY 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 9/108 (8%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  + H +IVRL        + TL++E+  +  L+K+ F   N     ++    ++
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEI----VK 102

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
              F + +G+ + H      +LH D+KP N+L++ N + K++DFGLA+
Sbjct: 103 SFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 9/144 (6%)

Query: 146 INEVATIG-RIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE 204
           ++EV  I  ++ H +IVR      E +R  ++ + +    L +   S       ++ + E
Sbjct: 56  VSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL--KEKKQRFTEE 113

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
           ++  I   +   + YLH+   +RI+H D+ P+NI+L  + +  I+DFGLAK    +  + 
Sbjct: 114 RIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL- 170

Query: 265 SRTAARGTSGYIAPELFSRNFCYG 288
             T+  GT  Y  PE+  +N  YG
Sbjct: 171 --TSVVGTILYSCPEIV-KNEPYG 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 39/133 (29%), Positives = 73/133 (54%), Gaps = 11/133 (8%)

Query: 125 LHSNEIAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           L  N +A+K   LEH +G     I EV+ +  + H +IV L          TL++E++ +
Sbjct: 29  LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-D 87

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
             L++++    NS     ++   ++   F + RG+ Y H+   +++LH D+KP N+L++ 
Sbjct: 88  KDLKQYLDDCGNS-----INMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINE 139

Query: 243 NFQPKISDFGLAK 255
             + K++DFGLA+
Sbjct: 140 RGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 46/122 (37%), Positives = 66/122 (54%), Gaps = 14/122 (11%)

Query: 159 HIVRLLG-FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGV 217
           +IV   G F +E N   +  EFM  GSL + I+ K        +  E L KIA  V  G+
Sbjct: 64  YIVSFYGAFLNENNI-CMCMEFMDCGSLDR-IYKKGGP-----IPVEILGKIAVAVVEGL 116

Query: 218 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIA 277
            YL+     RI+H DIKP NIL++   Q K+ DFG++    + I+ ++ T   GTS Y++
Sbjct: 117 TYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFV-GTSTYMS 170

Query: 278 PE 279
           PE
Sbjct: 171 PE 172

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 36/136 (26%), Positives = 59/136 (43%), Gaps = 11/136 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL-QKFIFSKTNSSSHRQLSWE 204
           +NE+  +  + H +I+       + N   +  E+   G+L  K +  K        + W 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW- 105

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
                 F +   V Y+H+     ILH DIK  NI L      K+ DFG++K+   + S+ 
Sbjct: 106 ----YLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 265 SRTAARGTSGYIAPEL 280
                 GT  Y++PEL
Sbjct: 159 ETVV--GTPYYMSPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 64/254 (25%), Positives = 104/254 (40%), Gaps = 76/254 (29%)

Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 40  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99

Query: 186 QKFIFS--------KTNSSSHRQ------------------------------------- 200
             ++ S        KT  +  RQ                                     
Sbjct: 100 SNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159

Query: 201 ----------------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
                           L+ E L   +F VA+G+E+L    +++ +H D+   NILL  N 
Sbjct: 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENN 216

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVG 296
             KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L E+  
Sbjct: 217 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Query: 297 CRKNNDPAVEIQSQ 310
              +  P V+I  +
Sbjct: 277 LGASPYPGVKIDEE 290

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 22/160 (13%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           +NE   + +++   +V L       +   L+   M  G L+  I+         +  +E+
Sbjct: 48  LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG------EAGFEE 101

Query: 206 LRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
            R + +   +  G+E LHQ   +RI++ D+KP NILLD +   +ISD GLA    +  +I
Sbjct: 102 GRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158

Query: 264 VSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMV 295
             R    GT GY+APE+       FS + +  G +L EM+
Sbjct: 159 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 38/133 (28%), Positives = 72/133 (54%), Gaps = 11/133 (8%)

Query: 125 LHSNEIAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           L  N +A+K   LEH +G     I EV+ +  + H +IV L          TL++E++ +
Sbjct: 29  LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-D 87

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
             L++++    N      +S   ++   + + RG+ Y H+   +++LH D+KP N+L++ 
Sbjct: 88  KDLKQYMDDCGNI-----MSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINE 139

Query: 243 NFQPKISDFGLAK 255
             + K++DFGLA+
Sbjct: 140 RGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 45/141 (31%), Positives = 64/141 (45%), Gaps = 18/141 (12%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           E+  +  + H  IV+  G   +   RTL    E MP GS+      K    S+  L+   
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENV 107

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDI 261
            RK    +  GV YLH   +  I+H DIK  NIL D     K+ DFG +K    +C    
Sbjct: 108 TRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT 164

Query: 262 SIVSRTAARGTSGYIAPELFS 282
            + S T   GT  +++PE+ S
Sbjct: 165 GMKSVT---GTPYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 13/91 (14%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
           G+E+LHQ   +RI++ D+KP N+LLD++   +ISD GLA +  KD    ++  A GT G+
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYA-GTPGF 163

Query: 276 IAPEL-------FSRN-FCYGMMLLEMVGCR 298
           +APEL       FS + F  G+ L EM+  R
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 37/112 (33%), Positives = 57/112 (50%), Gaps = 17/112 (15%)

Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           NR ++  EFM  GSL  +          R++    L +IA  V +G+ YL    + +ILH
Sbjct: 72  NRISICTEFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYL---WSLKILH 118

Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
            D+KP N+L++   Q K+ DFG++      I+        GT+ Y+APE  S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGTNAYMAPERIS 166

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 19/107 (17%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ E++  G     I  KT       L  +  ++    V  GVE LHQ   + I+H DIK
Sbjct: 74  LVMEYLNGGDCASLI--KTLGG----LPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIK 124

Query: 235 PHNILLDHNFQPKISDFGLAK--LCSKDISIVSRTAARGTSGYIAPE 279
           P N+L+D     K++DFGL++  L +K           GT  Y+APE
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENKKFV--------GTPDYLAPE 163

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 35/138 (25%), Positives = 73/138 (52%), Gaps = 10/138 (7%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++++ E+  +   +H +IV+LLG      +  ++ EF P G++   +         R L+
Sbjct: 54  EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-----RGLT 108

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             +++ I   +   ++YLH   + +I+H D+K  N+LL  +   K++DFG++    K  +
Sbjct: 109 EPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--T 163

Query: 263 IVSRTAARGTSGYIAPEL 280
           +  R +  GT  ++APE+
Sbjct: 164 LQRRDSFIGTPYWMAPEV 181

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 36/134 (26%), Positives = 67/134 (50%), Gaps = 13/134 (9%)

Query: 130 IAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVK+L++   +     E + E   + ++ + +IVR++G C E     L+ E    G L 
Sbjct: 25  VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLN 83

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+        ++ ++ + + ++   V+ G++YL +      +H D+   N+LL      
Sbjct: 84  KFL------QKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYA 134

Query: 247 KISDFGLAKLCSKD 260
           KISDFGL+K    D
Sbjct: 135 KISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 21/176 (11%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A+K +   K   +E I NE+  +  + + +IV  L     G+   ++ E++  GSL  
Sbjct: 46  EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL-- 103

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   NQ ++H DIK  N+LL  +   K
Sbjct: 104 -----TDVVTETCMDEAQIAAVCRECLQALEFLH--ANQ-VIHRDIKSDNVLLGMDGSVK 155

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EMV
Sbjct: 156 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 49/235 (20%)

Query: 127 SNEIAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLL--GFCSEGNRRTLIYEFM 180
            +E+A+K+L       +     F  E A   R++H +IV LL  G    G     ++E++
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           P  +L++ +      ++   L   +  ++   V   +   H   NQ I+H D+KP NI++
Sbjct: 62  PGRTLREVL------AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112

Query: 241 ---DHNFQPKISDFGLAKLCS--KDISIVSRTAAR---GTSGYIAPELF--------SRN 284
                    K+ DFG+  L    +D  + + T      GT  Y APE          S  
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 285 FCYGMMLLEMVGCRKNNDPAVEIQS--QIYF----------PEWIYNRMRLGQEL 327
           + +G++ LE +         V+  S  +I +          P WI     LGQ L
Sbjct: 173 YAWGLIFLECL----TGQRVVQGASVAEILYQQLSPVDVSLPPWIAG-HPLGQVL 222

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 19/160 (11%)

Query: 146 INEVATIGRIHHF---HIVRLLGFC--SEGNRRT---LIYEFMPNGSLQKFIFSKTNSSS 197
           I EVA +  +  F   ++VRL   C  S  +R T   L++E + +  L  ++    +   
Sbjct: 49  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVP 103

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              +  E ++ + F + RG+++LH   + R++H D+KP NIL+  + Q K++DFGLA++ 
Sbjct: 104 EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Query: 258 SKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           S  +++ S      T  Y APE+  ++     + L  VGC
Sbjct: 161 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGC 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 18/132 (13%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+   M  G L+  I++       R L  E++   +  +  G+ +LH      I++ D+K
Sbjct: 70  LVMSLMNGGDLKYHIYN----VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMK 122

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FC 286
           P N+LLD     ++SD GLA       +I  R    GT+GY+APE+            F 
Sbjct: 123 PENVLLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPEILKEEPYSYPVDWFA 179

Query: 287 YGMMLLEMVGCR 298
            G  + EMV  R
Sbjct: 180 MGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           G+ YLH+     ILH DIK  NIL+D+    KI+DFGLA+
Sbjct: 127 GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)

Query: 155 IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL-----QKFIFSKTNSSSHRQLSWEKLRKI 209
           + H  IV L+     G +  LI E++  G L     ++ IF +  +  +       L +I
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY-------LSEI 109

Query: 210 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA 269
           +  +    E+LHQ   Q I++ D+KP NILLD     K++DFG   LC + I   + T  
Sbjct: 110 SLAL----EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFG---LCKESIHEGTVTHT 159

Query: 270 R-GTSGYIAPELFSR 283
             GT  Y+APE+  R
Sbjct: 160 FCGTIEYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 18/141 (12%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRR--TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           E+  +  + H  IV+  G   +   +  ++  E+MP GS+      K    ++  L+   
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENV 107

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDI 261
            R+    + +GV YLH   +  I+H DIK  NIL D     K+ DFG +K    +C    
Sbjct: 108 TRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164

Query: 262 SIVSRTAARGTSGYIAPELFS 282
            I S T   GT  +++PE+ S
Sbjct: 165 GIKSVT---GTPYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 8/63 (12%)

Query: 218 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYI 276
           EYLH   N+ I++ D+KP N+LLD N   K+ DFG     +K +    +T    GT  Y+
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFG----FAKKLKSGQKTWTFCGTPEYV 159

Query: 277 APE 279
           APE
Sbjct: 160 APE 162

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 16/133 (12%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLI-YEFMPNGS 184
           H++EI V +L          + E   +  + H +I+ +L  C E      + Y +M  G+
Sbjct: 46  HASEIQVTLL----------LQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGN 95

Query: 185 LQKFIFSKTNSS--SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           L+ F+         + + LS ++L  +A  +A G+ YLH    + ++H DI   N ++D 
Sbjct: 96  LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDE 152

Query: 243 NFQPKISDFGLAK 255
             Q KI+D  L++
Sbjct: 153 ELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 19/159 (11%)

Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +F++E   + +  H +IV+L+G C++     ++ E +P G    F+  K +     +L  
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD-----ELKT 92

Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           ++L K A   A G+ YL    ++  +H D+   N L+  N   KISDFG+++   +D  I
Sbjct: 93  KQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGI 147

Query: 264 VSRTAARGTS-GYIAPELF--------SRNFCYGMMLLE 293
            S +  +     + APE          S  + YG++L E
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 18/141 (12%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           E+  +  + H  IV+  G   +   +TL    E+MP GS+      K    ++  L+   
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESV 107

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDI 261
            RK    +  G+ YLH   +  I+H DIK  NIL D     K+ DFG +K    +C    
Sbjct: 108 TRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164

Query: 262 SIVSRTAARGTSGYIAPELFS 282
            I S T   GT  +++PE+ S
Sbjct: 165 GIRSVT---GTPYWMSPEVIS 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
             K+++    S     +  E L KIA    + + YL +    +I+H D+KP NILLD N 
Sbjct: 92  FYKYVYEVLKS----VIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNG 145

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
             K+ DFG   +  + +  +++T   G   Y+APE
Sbjct: 146 NIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPE 177

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 15/145 (10%)

Query: 125 LHSNEIAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           L    +A+K   LEH +G     I E + +  + H +IV L          TL++E++ +
Sbjct: 28  LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-D 86

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
             L++++           LS   +R   F + RG+ Y HQ   +R+LH D+KP N+L+  
Sbjct: 87  TDLKQYM-----DDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISE 138

Query: 243 NFQPKISDFGLAKLCSKDISIVSRT 267
             + K++DFGLA+  +K  S+ S+T
Sbjct: 139 RGELKLADFGLAR--AK--SVPSKT 159

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 13/154 (8%)

Query: 130 IAVKMLEHLKGNGQEF--INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K++      G  F  I E + +  + H +IV L          T ++E+M     Q 
Sbjct: 33  VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQY 92

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I        +       +R   F + RG+ Y+H    Q ILH D+KP N+L+ +  + K
Sbjct: 93  MIQHPGGLHPY------NVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELK 143

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           ++DFGLA+  +K I   + ++   T  Y  P++ 
Sbjct: 144 LADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVL 175

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 23/151 (15%)

Query: 155 IHHFHIVRL-LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
           ++H  IV+L   F +EG +  LI +F+  G L    F  T  S     + E ++     +
Sbjct: 55  VNHPFIVKLHYAFQTEG-KLYLILDFLRGGDL----F--TRLSKEVMFTEEDVKFYLAEL 107

Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GT 272
           A  +++LH   +  I++ D+KP NILLD     K++DFGL+K   + I    +  +  GT
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGT 161

Query: 273 SGYIAPELFSRN--------FCYGMMLLEMV 295
             Y+APE+ +R         + +G+++ EM+
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 36/232 (15%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q+ + E+  + +++H ++++ L    E N   ++ E    G L + I  K      R + 
Sbjct: 47  QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMI--KYFKKQKRLIP 104

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              + K    +   VE++H   ++R++H DIKP N+ +      K+ D GL +  S    
Sbjct: 105 ERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160

Query: 263 IVSRTAAR---GTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQSQI 311
               TAA    GT  Y++PE    N        +  G +L EM            +QS  
Sbjct: 161 ----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA----------LQSPF 206

Query: 312 YFPEWIYNRMRLGQ--ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM 361
           Y  +   N   L Q  E C D+     E  + KL  +   CI  +P +RP +
Sbjct: 207 YGDK--MNLFSLCQKIEQC-DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 26/82 (31%), Positives = 46/82 (56%), Gaps = 8/82 (9%)

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
            ++LS + ++ + + + RG++Y+H      I+H D+KP NI ++ + + KI DFGLA+  
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168

Query: 258 SKDISIVSRTAARGTSGYIAPE 279
             ++     T    T  Y APE
Sbjct: 169 DDEM-----TGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 9e-08
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 10/160 (6%)

Query: 125 LHSNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
               ++ VK L          +F+ E      + H ++++ LG C+E     L+ EF P 
Sbjct: 20  YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79

Query: 183 GSLQKFIFSKTNSSSHRQLSWE--KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L+ ++ S   +     ++ +   L+++A  +A G+ +LH+      +H D+   N LL
Sbjct: 80  GDLKGYLRSCRKAEL---MTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLL 133

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
             +   KI D+GL+    K+   V+         +IAPEL
Sbjct: 134 TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 30/189 (15%)

Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGN------RRTLIYEFMPNG 183
           A+K+++      +E   E+  + +  HH +I    G   + N      +  L+ EF   G
Sbjct: 35  AIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 94

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           S+   I     ++    L  E +  I   + RG+ +LHQ    +++H DIK  N+LL  N
Sbjct: 95  SVTDLI----KNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN 147

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDP 303
            + K+ DFG++     D ++  R    GT  ++APE+              + C +N D 
Sbjct: 148 AEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEV--------------IACDENPDA 191

Query: 304 AVEIQSQIY 312
             + +S ++
Sbjct: 192 TYDFKSDLW 200

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 15/92 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC + I     T+   G
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCG 158

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEMV 295
           T  Y+APE+  +         +C G +L EM+
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 29/65 (44%), Positives = 40/65 (61%), Gaps = 6/65 (9%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
           G+E LH+   +RI++ D+KP NILLD     +ISD GLA    +  +I  R    GT GY
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVGY 167

Query: 276 IAPEL 280
           +APE+
Sbjct: 168 MAPEV 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 39/128 (30%), Positives = 64/128 (50%), Gaps = 13/128 (10%)

Query: 159 HIVRLLGFCS--EGNRRTLIY---EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
           +IVRLL      E N +  +Y   E++ +  L+KF+ S       R L  + ++   + +
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQL 119

Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGT 272
            +GV + H+     ++H D+KP N+L+D      KI+D GL +  S  I + S T    T
Sbjct: 120 LKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--IPVKSYTHEIVT 174

Query: 273 SGYIAPEL 280
             Y APE+
Sbjct: 175 LWYRAPEV 182

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 30/171 (17%)

Query: 128 NEIAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMP 181
            E A+K  +       G  Q    E+A +  + H ++V L+    E   ++  L++++  
Sbjct: 28  KEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE 87

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL- 240
           +   Q   F +        +    ++ + + +  GV YLH      +LH D+KP NIL+ 
Sbjct: 88  HDLWQIIKFHRQAKR--VSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVM 142

Query: 241 -DHNFQP--KISDFGLAKLC--------SKDISIVSRTAARGTSGYIAPEL 280
            +   +   KI D GLA+L           D  +V       T  Y APEL
Sbjct: 143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV-------TIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 38/137 (27%), Positives = 69/137 (50%), Gaps = 14/137 (10%)

Query: 144 EFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           + I E+  +   +  +IV   G F S+G   ++  E M  GSL + +         +++ 
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL------KEAKRIP 101

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            E L K++  V RG+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++
Sbjct: 102 EEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159

Query: 263 IVSRTAARGTSGYIAPE 279
                +  GT  Y++PE
Sbjct: 160 ----NSFVGTRSYMSPE 172

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 14/137 (10%)

Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS--SSHRQLSWE 204
            EV  + ++ H +IV       E  R  ++ E+   G L K I  +     S  + LSW 
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW- 106

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-PKISDFGLAKLCSKDISI 263
                   ++ G++++H   +++ILH DIK  NI L  N    K+ DFG+A+  + D   
Sbjct: 107 -----FVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSME 157

Query: 264 VSRTAARGTSGYIAPEL 280
           ++ T   GT  Y++PE+
Sbjct: 158 LAYTCV-GTPYYLSPEI 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 12/106 (11%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++YE M +  L + I       S + LS +  +   + + RG++Y+H      +LH D+K
Sbjct: 86  IVYELM-DTDLHQII------RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLK 135

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P N+LL+ N   KI DFGLA+  S+    ++      T  Y APEL
Sbjct: 136 PSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPEL 179

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 11/144 (7%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           +NE   + +++   +V L       +   L+   M  G L+  I++  N         E+
Sbjct: 48  LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEER 103

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
               A  +  G+E LH+   +  ++ D+KP NILLD     +ISD GLA    +  SI  
Sbjct: 104 ALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160

Query: 266 RTAARGTSGYIAPELFSRNFCYGM 289
           R    GT GY+APE+   N  Y +
Sbjct: 161 RV---GTVGYMAPEVL-NNQRYTL 180

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 12/145 (8%)

Query: 141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ 200
             ++F+ E   + +  H HIV+L+G  +E N   ++ E  P G L+ ++  + N  S   
Sbjct: 50  VREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYS--- 103

Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           L    L   ++ ++  + YL    ++R +H DI   N+L+      K+ DFGL++    D
Sbjct: 104 LDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-D 159

Query: 261 ISIVSRTAARGTSGYIAPELFSRNF 285
            S    +  +    ++APE  S NF
Sbjct: 160 ESYYKASKGKLPIKWMAPE--SINF 182

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 24/153 (15%)

Query: 179 FMPNGSLQK---FIFSKTNSSSHR------QLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
             P G+  K    +     S  H        L+ E +R   + + RG++Y+H      ++
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VI 129

Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR--TAARGTSGYIAPEL-FSRN-- 284
           H D+KP N+L++ + + +I DFG+A+  S   +      T    T  Y APEL  S    
Sbjct: 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEY 189

Query: 285 ------FCYGMMLLEMVGCRKNNDPAVEIQSQI 311
                 +  G +  EM+G R+   P      Q+
Sbjct: 190 TTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQL 221

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 37/163 (22%)

Query: 156 HHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
            H +IV+LL      N +   L++E+M    L   I +      H++        I + +
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRY-------IMYQL 116

Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARG-- 271
            + ++Y+H G    ++H D+KP NILL+ + + K++DFGLA+      S+          
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENP 167

Query: 272 -------TSGYIAPE--LFSRNFCYGM-------MLLEMVGCR 298
                  T  Y APE  L S  +  G+       +L EM+  +
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 130 IAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K+L      K N +E ++E   +  +   ++ RLLG C     + L+ + MP G L 
Sbjct: 39  VAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLL 96

Query: 187 KFIF-SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++  +K    S   L+W         +A+G+ YL +    R++H D+   N+L+     
Sbjct: 97  DYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNH 147

Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLA+L   D
Sbjct: 148 VKITDFGLARLLDID 162

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 17/110 (15%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ E    GS+   +  K      ++L  E +  I     RG+ YLH     +++H DIK
Sbjct: 86  LVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIK 140

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-----GTSGYIAPE 279
             NILL  N + K+ DFG++       + +  T  R     GT  ++APE
Sbjct: 141 GQNILLTKNAEVKLVDFGVS-------AQLDSTLGRRNTFIGTPYWMAPE 183

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 23/59 (38%), Positives = 38/59 (64%), Gaps = 3/59 (5%)

Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S + L+ + ++   + + RG++YLH   N  ++H D+KP NIL++ N   KI DFGLA+
Sbjct: 96  SPQPLTDDHIQYFLYQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 9/102 (8%)

Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           E+M  GSL K         +   +  + LR+I + V +G+++L +  N  I+H D+KP N
Sbjct: 79  EYMDAGSLDKLY---AGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTN 133

Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           +L++ N Q K+ DFG++      +   ++T   G   Y+APE
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASL---AKTNI-GCQSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 29/112 (25%), Positives = 54/112 (48%), Gaps = 8/112 (7%)

Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +F+ E   + +  H +IVRL+G C++     ++ E +  G    F+      +   +L  
Sbjct: 39  KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-----RTEGPRLKV 93

Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++L ++    A G+EYL        +H D+   N L+      KISDFG+++
Sbjct: 94  KELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 38/137 (27%), Positives = 69/137 (50%), Gaps = 6/137 (4%)

Query: 145 FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE 204
           F+ EV     ++H ++++ LG C E     L+ EF P G L+ ++  ++N     Q++ +
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQK 99

Query: 205 K-LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
             L+++A  VA G+ +LHQ      +H D+   N  L  +   KI D+GLA     +   
Sbjct: 100 DVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156

Query: 264 VSRTAARGTSGYIAPEL 280
           +++        ++APEL
Sbjct: 157 ITKDCHAVPLRWLAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 29/176 (16%)

Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
             L  + L + +  VA+G+++L    ++  +H D+   N+LL      KI DFGLA+   
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM 263

Query: 259 KDISIVSRTAARGTSGYIAPE-LF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ 310
            D + V +  AR    ++APE +F       S  + YG++L E+    K+  P + + S+
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK 323

Query: 311 IYFPEWIYNRMRLGQEL-CLDFEEDGDEGIARKLAIVAIWCIQWN--PTERPSMPM 363
                  Y  ++ G ++   DF             I +I  + WN  PTERP+   
Sbjct: 324 ------FYKMVKRGYQMSRPDFA---------PPEIYSIMKMCWNLEPTERPTFSQ 364

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 11/120 (9%)

Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           L  E L   ++ VA+G+ +L    ++  +H D+   NILL H    KI DFGLA+    D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 261 ISIVSRTAARGTSGYIAPE-LF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            + V +  AR    ++APE +F       S  + YG++L E+     +  P + + S+ Y
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.5 bits (120), Expect = 5e-07
 Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 21/176 (11%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A+K +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 46  EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 103

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +++LH   + +++H DIK  NILL  +   K
Sbjct: 104 -----TDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVK 155

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EMV
Sbjct: 156 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 12/139 (8%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E+  +    H +IV L       N+  ++ EF   G+L   +         R L+
Sbjct: 47  EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE-----LERGLT 101

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL-AKLCSKDI 261
             ++R +   +   + +LH   + +++H D+K  NILL  +   K++DFG+ AK  S   
Sbjct: 102 EPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157

Query: 262 SIVSRTAARGTSGYIAPEL 280
               R    GT  ++APE+
Sbjct: 158 --QKRDTFIGTPYWMAPEV 174

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 14/108 (12%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFD 232
           L+   M  G L+  I++  N     Q      R I +   +  G+E L +   +RI++ D
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFDEQ------RAIFYAAELCCGLEDLQR---ERIVYRD 127

Query: 233 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           +KP NILLD     +ISD GLA    +  ++  R    GT GY+APE+
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEV 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.7 bits (118), Expect = 7e-07
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 21/176 (11%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 104

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 105 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+
Sbjct: 157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 8e-07
 Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 24/163 (14%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC-SEGNRRTLIYEFMPNG 183
                + +K+L     +   F    + + ++ H H+V+L G C  + N   ++ E++  G
Sbjct: 28  GQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN--IMVEEYVKFG 85

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--- 240
            L  F+  + N+ S   L W KL  +A  +A  + YL    +++++H ++   NIL+   
Sbjct: 86  PLDVFLHREKNNVS---LHW-KL-DVAKQLASALHYLE---DKKLVHGNVCGKNILVARY 137

Query: 241 --DHNFQP--KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
             +  + P  K+SD G+       I+++SR        +IAPE
Sbjct: 138 GLNEGYVPFIKLSDPGIP------ITVLSREERVERIPWIAPE 174

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 44/147 (29%), Positives = 70/147 (47%), Gaps = 26/147 (17%)

Query: 159 HIVRLLG-FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGV 217
           +IV   G F S+G     + E M  GSL + +          ++    L KI+  V RG+
Sbjct: 60  YIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KKAGRIPENILGKISIAVLRGL 112

Query: 218 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSRTAARGTSGY 275
            YL +    +I+H D+KP NIL++   + K+ DFG++   + S   S V      GT  Y
Sbjct: 113 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSY 164

Query: 276 IAPE--------LFSRNFCYGMMLLEM 294
           ++PE        + S  +  G+ L+EM
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 25/121 (20%)

Query: 218 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYI 276
           EYLH   ++ I++ D+KP N+LLD+    K++DFG AK       +  RT    GT  Y+
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYL 182

Query: 277 APELFSRN--------FCYGMMLLEMVGCRKN--NDPAVEIQSQIY-----FPEWIYNRM 321
           APE+            +  G++L E +       +D    I  +I      FP W   R 
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA 242

Query: 322 R 322
           R
Sbjct: 243 R 243

Length = 329

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 5/85 (5%)

Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
             ++KI +   + V + H+      +H D+KP NIL+    Q K+ DFG A++ +     
Sbjct: 100 HLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156

Query: 264 VSRTAARGTSGYIAPELFSRNFCYG 288
            +   A  T  Y APEL   +  YG
Sbjct: 157 YTDYVA--TRWYRAPELLVGDTQYG 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 23/74 (31%), Positives = 42/74 (56%), Gaps = 5/74 (6%)

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           L K+   + + + YL +     ++H D+KP NILLD +   K+ DFG++    + +   +
Sbjct: 116 LGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKA 170

Query: 266 RTAARGTSGYIAPE 279
           +T + G + Y+APE
Sbjct: 171 KTRSAGCAAYMAPE 184

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 11/133 (8%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +    H +IV   G     ++  +  EF   GSLQ  I+  T   S  Q+++    
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAY---- 110

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            ++    +G+ YLH   ++  +H DIK  NILL  N   K++DFG++   +   +I  R 
Sbjct: 111 -VSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRK 164

Query: 268 AARGTSGYIAPEL 280
           +  GT  ++APE+
Sbjct: 165 SFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 32/182 (17%)

Query: 133 KMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           K  EH+    G       E   +  I+H  I++L G        T  Y       L ++ 
Sbjct: 115 KTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKG--------TFTYNKFTCLILPRY- 165

Query: 190 FSKTNS----SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             KT+     ++ R ++   +  I   V R ++YLH     RI+H DIK  NI ++H   
Sbjct: 166 --KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGD 220

Query: 246 PKISDFGLAKLCSK-DISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             + DFG A  C   DI+        GT    APEL +R+        +  G++L EM  
Sbjct: 221 VCLGDFGAA--CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Query: 297 CR 298
           C 
Sbjct: 279 CH 280

Length = 391

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 13/158 (8%)

Query: 125 LHSNEIA-VKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           LH+ E+A VK+++   G+    I  E+  +    H +IV   G      +  +  E+   
Sbjct: 31  LHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSLQ  I+  T   S  Q+++     +     +G+ YLH   ++  +H DIK  NILL  
Sbjct: 91  GSLQD-IYHVTGPLSELQIAY-----VCRETLQGLAYLH---SKGKMHRDIKGANILLTD 141

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           N   K++DFG+A   +   +I  R +  GT  ++APE+
Sbjct: 142 NGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEV 177

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 22/148 (14%)

Query: 156 HHFHIVRLLG--FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
            H +I+RL+   F  +  R  L++E M + +L + I  +      R L  ++++   + +
Sbjct: 56  PHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGR-----KRPLPEKRVKSYMYQL 109

Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR---TAAR 270
            + ++++H+     I H DIKP NIL+  +   K++DFG  +       I S+   T   
Sbjct: 110 LKSLDHMHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR------GIYSKPPYTEYI 159

Query: 271 GTSGYIAPELFSRNFCYG-MMLLEMVGC 297
            T  Y APE    +  YG  M +  VGC
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGC 187

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 26/71 (36%), Positives = 39/71 (54%), Gaps = 1/71 (1%)

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           F +A  V  +H       +H DIKP N+LLD N   +++DFG     ++D ++ S  A  
Sbjct: 106 FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV- 164

Query: 271 GTSGYIAPELF 281
           GT  YI+PE+ 
Sbjct: 165 GTPDYISPEIL 175

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 11/128 (8%)

Query: 130 IAVKMLEHLKGNGQEF--INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K++   +  G  F  I E + +  + H +IV L          TL++E++     Q 
Sbjct: 33  VALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQ- 91

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
               K     H     E ++   F + RG+ Y+HQ   + ILH D+KP N+L+    + K
Sbjct: 92  -YMDKHPGGLHP----ENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELK 143

Query: 248 ISDFGLAK 255
           ++DFGLA+
Sbjct: 144 LADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 10/92 (10%)

Query: 220 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-IVSRTAARGTSGYIAP 278
           +H   ++ ++H DIK  NILL  N   K+ DFG +K+ +  +S  V RT   GT  Y+AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTPYYVAP 214

Query: 279 ELFSRN--------FCYGMMLLEMVGCRKNND 302
           E++ R         F  G++L E++  ++  D
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 12/139 (8%)

Query: 143 QEFINEVATIGRIHHFHIVRLL-GFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
           ++++ E+  +    H +IV+LL  F  E N   LI EF   G++   +         R L
Sbjct: 47  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLEL-----ERPL 100

Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +  ++R +       + YLH+    +I+H D+K  NIL   +   K++DFG++   ++  
Sbjct: 101 TEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-- 155

Query: 262 SIVSRTAARGTSGYIAPEL 280
           +I  R +  GT  ++APE+
Sbjct: 156 TIQRRDSFIGTPYWMAPEV 174

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 25/67 (37%), Positives = 34/67 (50%), Gaps = 5/67 (7%)

Query: 215 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSG 274
            GV +LH      ILH D+K  N+LL++    KI DFGLA+     +   ++     T  
Sbjct: 117 SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171

Query: 275 YIAPELF 281
           Y APEL 
Sbjct: 172 YRAPELL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 9/108 (8%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ E+ P G L   +      + +     E +    F +A  V  +H       +H DIK
Sbjct: 78  LVMEYQPGGDLLSLL------NRYEDQFDEDM--AQFYLAELVLAIHSVHQMGYVHRDIK 129

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           P N+L+D     K++DFG A   + +  + S+    GT  YIAPE+ +
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLT 176

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 28/72 (38%), Positives = 37/72 (51%), Gaps = 9/72 (12%)

Query: 209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA 268
           I  G  +G+ YLH   +   +H DIK  NILL      K++DFG A L S   S V    
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---- 172

Query: 269 ARGTSGYIAPEL 280
             GT  ++APE+
Sbjct: 173 --GTPYWMAPEV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 15/92 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC + I+    T    G
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTTFCG 158

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEMV 295
           T  Y+APE+  +         +C G +L EM+
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 11/82 (13%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ E M    L K I ++  S+ H Q          + + RG++Y+H   N  +LH D+K
Sbjct: 85  IVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQILRGLKYIH-SAN--VLHRDLK 133

Query: 235 PHNILLDHNFQPKISDFGLAKL 256
           P N+LL+ N   KI DFGLA++
Sbjct: 134 PSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 15/106 (14%)

Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
           R     + R  A  VA  + YLH   +  I++ D+KP NILLD      ++DFG   LC 
Sbjct: 91  RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG---LCK 144

Query: 259 KDISIVSRTAAR-GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           + +     T+   GT  Y+APE+  +         +C G +L EM+
Sbjct: 145 EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 15/162 (9%)

Query: 126 HSNEI-AVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
            + E+ A+K+  LE  +   ++   E+  + +    +I R  G   +G +  +I E++  
Sbjct: 27  RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GS    +       ++       +  I   + +G++YLH   ++R +H DIK  N+LL  
Sbjct: 87  GSALDLLKPGPLEETY-------IATILREILKGLDYLH---SERKIHRDIKAANVLLSE 136

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
               K++DFG+A   +   + + R    GT  ++APE+  ++
Sbjct: 137 QGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 51/233 (21%), Positives = 95/233 (40%), Gaps = 38/233 (16%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI--FSKTNSSSHRQ 200
            + I E+  + +++H ++++      E N   ++ E    G L + I  F K       +
Sbjct: 47  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK 106

Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
             W+   ++       +E++H   ++R++H DIKP N+ +      K+ D GL +  S  
Sbjct: 107 TVWKYFVQLC----SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-- 157

Query: 261 ISIVSRTAAR----GTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQ 308
               S+T A     GT  Y++PE    N        +  G +L EM            +Q
Sbjct: 158 ----SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA----------LQ 203

Query: 309 SQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM 361
           S  Y  +     +    E C D+     +  + +L  +   CI  +P +RP +
Sbjct: 204 SPFYGDKMNLYSLCKKIEQC-DYPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 13/88 (14%)

Query: 198 HRQLSWEKLRK-----IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 252
           HR L+   L K       + + RG++Y+H      ++H D+KP NIL++ N   KI DFG
Sbjct: 97  HRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFG 153

Query: 253 LAKLCSKDISIVSRTAARGTSGYIAPEL 280
           LA+     I     T    T  Y APE+
Sbjct: 154 LAR-----IQDPQMTGYVSTRYYRAPEI 176

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 37/132 (28%), Positives = 68/132 (51%), Gaps = 22/132 (16%)

Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKFI-------FSKTNSSS---HRQLSWEKLRKIA 210
           +RLL      N   L+  F P+ SL +F        F  T+      H +LS ++++ + 
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS--IVSRTA 268
           + + +G++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +++  +V+R  
Sbjct: 125 YQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW- 180

Query: 269 ARGTSGYIAPEL 280
                 Y APE+
Sbjct: 181 ------YRAPEV 186

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 5/89 (5%)

Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH G   +I++ D+K  N++LD +   KI+DFGL K
Sbjct: 87  SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN 284
               D + +      GT  Y+APE+   N
Sbjct: 144 EGITDAATMKTFC--GTPEYLAPEVLEDN 170

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding

 Score = 44.2 bits (105), Expect = 6e-06
 Identities = 21/66 (31%), Positives = 30/66 (45%), Gaps = 7/66 (10%)

Query: 38  PTRCSNKSPRIRYPFRLKAQPTYCGL-EGFELSCL-SDKTILHFPSSGDYYVHKISYLDS 95
           P RC N S  I YPF +      C    GFEL+C  +         +G+Y V  IS  + 
Sbjct: 5   PDRCGNVS--IPYPFGIGPG---CARDPGFELTCNNTTSPPRLLLGNGNYEVLSISLANG 59

Query: 96  SITITD 101
           ++ + D
Sbjct: 60  TVRVLD 65

This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 15/159 (9%)

Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE-----GNRRTLIYEFMPNGS 184
           AVK+L+ +    +E   E   +  + +H ++V+  G   +     G +  L+ E    GS
Sbjct: 51  AVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS 110

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           + + +  K      ++L    +  I +G   G+++LH   N RI+H D+K +NILL    
Sbjct: 111 VTELV--KGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165

Query: 245 QPKISDFGL-AKLCSKDISIVSRTAARGTSGYIAPELFS 282
             K+ DFG+ A+L S  +    R  + GT  ++APE+ +
Sbjct: 166 GVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIA 201

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 7/90 (7%)

Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   + YLH      +++ D+K  N++LD +   KI+DFG   
Sbjct: 87  SRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFG--- 140

Query: 256 LCSKDISIVSRTAAR-GTSGYIAPELFSRN 284
           LC + IS  +      GT  Y+APE+   N
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDN 170

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 20/160 (12%)

Query: 126 HSNEI-AVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           H+NE+ AVK + +         Q+ I EV  + ++ H + +   G   + +   L+ E+ 
Sbjct: 44  HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC 103

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
              +      S       + L   ++  I  G  +G+ YLH      ++H DIK  NILL
Sbjct: 104 LGSA------SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILL 154

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
               Q K++DFG A   S   S V      GT  ++APE+
Sbjct: 155 TEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEV 188

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 23/138 (16%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ EF   GS+   +   T  ++ ++  W  +  I   + RG+ +LH     +++H DIK
Sbjct: 96  LVMEFCGAGSVTDLV-KNTKGNALKE-DW--IAYICREILRGLAHLHA---HKVIHRDIK 148

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEM 294
             N+LL  N + K+ DFG++     D ++  R    GT  ++APE+              
Sbjct: 149 GQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEV-------------- 192

Query: 295 VGCRKNNDPAVEIQSQIY 312
           + C +N D   + +S I+
Sbjct: 193 IACDENPDATYDYRSDIW 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 35/108 (32%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA-------- 268
           +EYLH   N  I+H D+KP N+L+      K++DFGL+K     I ++S T         
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSK-----IGLMSLTTNLYEGHIE 165

Query: 269 --AR--------GTSGYIAPELFSRN--------FCYGMMLLE-MVGC 297
              R        GT  YIAPE+  R         +  G++L E +VGC
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 23/163 (14%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  I H +I+ L+    EG+   L+ + M    L+K +  K       +L+  +++
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI------RLTESQVK 122

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK---------LCS 258
            I   +  G+  LH       +H D+ P NI ++     KI+DFGLA+           S
Sbjct: 123 CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 259 KDISIVSR---TAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
           KD ++  R   T+   T  Y APEL      Y   + +  VGC
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222

Length = 335

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 38/165 (23%)

Query: 129 EIAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS-- 184
            +A+K+  LE  +   ++   E+  + +    +I +  G   +G++  +I E+   GS  
Sbjct: 28  VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL 87

Query: 185 --LQKFIFSKTNSSSHRQLSWEKLRKIAF---GVARGVEYLHQGCNQRILHFDIKPHNIL 239
             L+     +T               IAF    V  G+EYLH    +  +H DIK  NIL
Sbjct: 88  DLLKPGKLDET--------------YIAFILREVLLGLEYLH---EEGKIHRDIKAANIL 130

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAAR-----GTSGYIAPE 279
           L      K++DFG++         ++ T ++     GT  ++APE
Sbjct: 131 LSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPE 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 15/100 (15%)

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
           + R  A  +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC ++I   
Sbjct: 97  RARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHN 150

Query: 265 SRTAAR-GTSGYIAPELFSRN--------FCYGMMLLEMV 295
             T+   GT  Y+APE+  +         +C G +L EM+
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 41/138 (29%), Positives = 63/138 (45%), Gaps = 15/138 (10%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q+ I EV  + RI H + +   G     +   L+ E+   GS    +         + L 
Sbjct: 70  QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL-----EVHKKPLQ 123

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             ++  I  G  +G+ YLH   +  ++H DIK  NILL    Q K++DFG A + S   S
Sbjct: 124 EVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180

Query: 263 IVSRTAARGTSGYIAPEL 280
            V      GT  ++APE+
Sbjct: 181 FV------GTPYWMAPEV 192

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 17/93 (18%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI--SIVSRTAAR 270
           +A G+ +LH   ++ I++ D+K  N++LD     KI+DFG   +C ++I     +RT   
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFC- 162

Query: 271 GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           GT  YIAPE+ +          + +G++L EM+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ E+MP G L        N  S+  +  EK  +  F  A  V  L    +   +H D+K
Sbjct: 120 MVMEYMPGGDL-------VNLMSNYDIP-EKWAR--FYTAEVVLALDAIHSMGFIHRDVK 169

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P N+LLD +   K++DFG       +  +   TA  GT  YI+PE+
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEV 214

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 14/133 (10%)

Query: 151 TIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIA 210
           T     H  +V L       +    + E+   G L   I +          S  +    A
Sbjct: 55  TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYA 107

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
             V  G++YLH+    +I++ D+K  N+LLD     KI+DFG   LC + +    RT+  
Sbjct: 108 ACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTF 161

Query: 271 -GTSGYIAPELFS 282
            GT  ++APE+ +
Sbjct: 162 CGTPEFLAPEVLT 174

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 41/216 (18%)

Query: 130 IAVKMLEHLKGNGQEFINEVAT----IGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +A+K  E  K   Q+ ++ V +    +  I+H   V L G   + +   L+ EF+  G  
Sbjct: 59  VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGV---EYLHQGCNQRILHFDIKPHNILLDH 242
             F F + N      +         F  A+ V   EYL Q  N  I++ D+KP N+LLD 
Sbjct: 119 --FTFLRRNKRFPNDVG-------CFYAAQIVLIFEYL-QSLN--IVYRDLKPENLLLDK 166

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELF--------SRNFCYGMMLLE 293
           +   K++DFG AK+      + +RT    GT  YIAPE+         +  +  G+ + E
Sbjct: 167 DGFIKMTDFGFAKV------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220

Query: 294 M-VGCRK--NNDPAVEIQS----QIYFPEWIYNRMR 322
           + VGC     N+P +  Q      IYFP+++ N  +
Sbjct: 221 ILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256

Length = 340

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 36/137 (26%), Positives = 65/137 (47%), Gaps = 5/137 (3%)

Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
           +E+  +    HF IV+        ++  LI E+   G L K I  K     H      ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYEV 171

Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             + + +   ++ +H   +++++H D+K  NI L      K+ DFG +K  S  +S+   
Sbjct: 172 GLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 267 TAARGTSGYIAPELFSR 283
           ++  GT  Y+APEL+ R
Sbjct: 229 SSFCGTPYYLAPELWER 245

Length = 478

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 13/137 (9%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP--NGSLQKFIFSKTNSSSHRQLSW 203
           + E+  +  + H +IV L      G     I+  M      L   + +     S  Q+  
Sbjct: 54  LREITLLLNLRHPNIVELKEVVV-GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQV-- 110

Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
              + +   + RG++YLH+     I+H D+K  N+LL      KI+DFGLA+     +  
Sbjct: 111 ---KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPA 162

Query: 264 VSRTAARGTSGYIAPEL 280
              T    T  Y APEL
Sbjct: 163 KPMTPKVVTLWYRAPEL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH    + +++ D+K  N++LD +   KI+DFGL K
Sbjct: 87  SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN 284
              KD + +      GT  Y+APE+   N
Sbjct: 145 EGIKDGATMKTFC--GTPEYLAPEVLEDN 171

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 4/67 (5%)

Query: 215 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-SIVSRTAARGTS 273
           R ++Y+H      + H D+KP NIL + + + KI DFGLA++   D  + +  T    T 
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 274 GYIAPEL 280
            Y APEL
Sbjct: 171 WYRAPEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +  G+++LH+   + I++ D+K  N+LLD     KI+DFG   +C + I     T+   G
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFG---MCKEGILGGVTTSTFCG 158

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  YIAPE+ S          +  G++L EM
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 37/135 (27%), Positives = 53/135 (39%), Gaps = 34/135 (25%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ ++ P G L    F        + LS E  R  A  V   +EYLH      I++ D+K
Sbjct: 78  LVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLK 130

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSG-------------------- 274
           P NILL  +    +SDF L+K    +   VS+   +G+                      
Sbjct: 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSN 190

Query: 275 -------YIAPELFS 282
                  YIAPE+ S
Sbjct: 191 SFVGTEEYIAPEVIS 205

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 29/69 (42%), Positives = 40/69 (57%), Gaps = 10/69 (14%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC--SKDISIVSRTAARGTS 273
           GV Y+HQ   +RILH D+K  NI L +N   KI DFG+++L   S D++    T   GT 
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA----TTFTGTP 169

Query: 274 GYIAPELFS 282
            Y++PE   
Sbjct: 170 YYMSPEALK 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 23/168 (13%)

Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           L+   L    + VARG+E+L    ++  +H D+   N+LL      KI DFGLA+    D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 261 ISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            + VS+ +      ++APE    N        + YG++L E+        P + + S   
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-- 348

Query: 313 FPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
                YN+++ G  +         +   +++  + + C    P +RPS
Sbjct: 349 ----FYNKIKSGYRMA------KPDHATQEVYDIMVKCWNSEPEKRPS 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 36/157 (22%), Positives = 78/157 (49%), Gaps = 14/157 (8%)

Query: 130 IAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K+  LE  +   ++   E+  + +    ++ +  G   +G +  +I E++  GS   
Sbjct: 32  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD 91

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +  +       Q++   L++I     +G++YLH   +++ +H DIK  N+LL      K
Sbjct: 92  LL--RAGPFDEFQIA-TMLKEIL----KGLDYLH---SEKKIHRDIKAANVLLSEQGDVK 141

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           ++DFG+A   +   + + R    GT  ++APE+  ++
Sbjct: 142 LADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 22/160 (13%)

Query: 144 EFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           + I E+  +   +  +IV   G F S+G   ++  E M  GSL + +  K       ++ 
Sbjct: 49  QIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAG-----RIP 101

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++
Sbjct: 102 EQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159

Query: 263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
                +  GT  Y++PE          S  +  G+ L+EM
Sbjct: 160 ----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 34/125 (27%), Positives = 59/125 (47%), Gaps = 19/125 (15%)

Query: 146 INEVATIGRIHHFHIVRL----------LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS 195
           I E+  + +++H +IV L          L F  +     L++E+M +  L   + S    
Sbjct: 54  IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVH 112

Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
            S      + ++     +  G+ Y H    +  LH DIK  NILL++  Q K++DFGLA+
Sbjct: 113 FSE-----DHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 256 LCSKD 260
           L + +
Sbjct: 165 LYNSE 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 31/121 (25%), Positives = 56/121 (46%), Gaps = 13/121 (10%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +EF +E     R+ H +IV LLG  ++    ++I+ +  +  L +F+  ++  S      
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 203 WEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 252
            +K  K          I   +A G+E+L    +  ++H D+   N+L+      KISD G
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLG 169

Query: 253 L 253
           L
Sbjct: 170 L 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 13/92 (14%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           ++ G+ +LH+   + I++ D+K  N++LD     KI+DFG+ K    D  + +RT   GT
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFC-GT 164

Query: 273 SGYIAPELFSRN--------FCYGMMLLEMVG 296
             YIAPE+ +          + YG++L EM+ 
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 87  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN 284
               D + + +T   GT  Y+APE+   N
Sbjct: 144 EGISDGATM-KTFC-GTPEYLAPEVLEDN 170

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 5/66 (7%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
           GV+++H+   +R+LH DIK  NI L  N + K+ DFG A+L +   +        GT  Y
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYY 166

Query: 276 IAPELF 281
           + PE++
Sbjct: 167 VPPEIW 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 19/135 (14%)

Query: 172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHF 231
           R   + EF+  G L   +F   +    R+L  E  R  +  ++  + +LH+     I++ 
Sbjct: 70  RLFFVIEFVSGGDL---MF---HMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYR 120

Query: 232 DIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL-------FSRN 284
           D+K  N+LLD     K++D+G+ K   +     S     GT  YIAPE+       FS +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEILRGEDYGFSVD 178

Query: 285 -FCYGMMLLEMVGCR 298
            +  G+++ EM+  R
Sbjct: 179 WWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 30/118 (25%), Positives = 61/118 (51%), Gaps = 17/118 (14%)

Query: 146 INEVATIGRIHHFHIVRLLGFC----SEGNRRT----LIYEFMPNGSLQKFIFSKTNSSS 197
           + E+  +  + H ++V L+  C    +  NR      L++EF  +  L   +     S+ 
Sbjct: 59  LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-----SNK 112

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           + + +  +++K+   +  G+ Y+H+    +ILH D+K  NIL+  +   K++DFGLA+
Sbjct: 113 NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)

Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 67  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 127 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 178

Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 206

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 27/143 (18%)

Query: 166 FCSEGNRRTLIY--EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG 223
           FC+   +  L +  E++  G L   I      SS R     + R  A  +  G+++LH+ 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGR-FDEARARFYAAEIICGLQFLHK- 114

Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR---GTSGYIAPEL 280
             + I++ D+K  N+LLD +   KI+DFG+ K      ++     A    GT  YIAPE+
Sbjct: 115 --KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-----NMNGEGKASTFCGTPDYIAPEI 167

Query: 281 -------FSRNF-CYGMMLLEMV 295
                   S ++  +G++L EM+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 5/70 (7%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +A  ++YLH+   + ILH D+K  N+ L      K+ D G+A++      + S     GT
Sbjct: 111 IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GT 165

Query: 273 SGYIAPELFS 282
             Y++PELFS
Sbjct: 166 PYYMSPELFS 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 4/64 (6%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI 276
           ++ +HQ      +H DIKP N+LLD N   +++DFG       D ++ S  A  GT  YI
Sbjct: 115 IDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYI 170

Query: 277 APEL 280
           +PE+
Sbjct: 171 SPEI 174

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ E+MP G L        N  S+  +  +  R     V   ++ +H   +   +H D+K
Sbjct: 120 MVMEYMPGGDL-------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVK 169

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           P N+LLD +   K++DFG     +K+  +V    A GT  YI+PE+ 
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISPEVL 215

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 36/130 (27%), Positives = 64/130 (49%), Gaps = 18/130 (13%)

Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKTNSSSH--------RQLSWEKLRKIA 210
           +RLL      N   L+  F P  S++ F  ++  TN            ++LS E ++ + 
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI 124

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+    ++     T   
Sbjct: 125 YQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYV 176

Query: 271 GTSGYIAPEL 280
            T  Y APE+
Sbjct: 177 ATRWYRAPEI 186

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 15/127 (11%)

Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           LL   +  N  +L+  F P  SL++F         + +      H +L  E++  + + +
Sbjct: 73  LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132

Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA+    +  +      R   
Sbjct: 133 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR--- 186

Query: 274 GYIAPEL 280
            Y APE+
Sbjct: 187 YYRAPEV 193

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 20/94 (21%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +  G+ YLH    QRI+H D+K  NI ++   Q  I D G A+        V   A  G 
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP------VVAPAFLGL 216

Query: 273 SGYI---APELFSRN--------FCYGMMLLEMV 295
           +G +   APE+ +R+        +  G++L EM+
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 29/185 (15%)

Query: 149 VATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK 208
           + ++ R H F + +L       +R   + EF+  G L  F   K+     R+    + R 
Sbjct: 48  ILSLARNHPF-LTQLYCCFQTPDRLFFVMEFVNGGDLM-FHIQKS-----RRFDEARARF 100

Query: 209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA 268
            A  +   + +LH   ++ I++ D+K  N+LLDH    K++DFG   +C + I     T+
Sbjct: 101 YAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTS 154

Query: 269 AR-GTSGYIAPELFSRN--------FCYGMMLLEMVGCR-----KNNDPAVE--IQSQIY 312
              GT  YIAPE+            +  G++L EM+        +N D   E  +  ++ 
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 214

Query: 313 FPEWI 317
           +P W+
Sbjct: 215 YPTWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 24/92 (26%), Positives = 35/92 (38%), Gaps = 30/92 (32%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--------------------- 255
           ++ +H+      +H DIKP NIL+D +   K++DFGL K                     
Sbjct: 114 LDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 256 ------LCSKDISIVSRTAARGTSGYIAPELF 281
                         V   +  GT  YIAPE+ 
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 17/120 (14%)

Query: 166 FCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG 223
           FC+  + + L  + E+MP G L   +     S+      W K     F  A  V  L   
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDVPEKWAK-----FYTAEVVLALDAI 158

Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSRTAARGTSGYIAPELF 281
            +  ++H D+KP N+LLD +   K++DFG    C K  +  +V    A GT  YI+PE+ 
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISPEVL 215

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 4/66 (6%)

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKL 256
              LS E  R   + + RG++Y+H      +LH D+KP N+ ++  +   KI DFGLA++
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Query: 257 CSKDIS 262
                S
Sbjct: 165 VDPHYS 170

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 34/157 (21%), Positives = 76/157 (48%), Gaps = 14/157 (8%)

Query: 130 IAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K+  LE  +   ++   E+  + +    ++ +  G   +  +  +I E++  GS   
Sbjct: 32  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 91

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +           L   ++  I   + +G++YLH   +++ +H DIK  N+LL  + + K
Sbjct: 92  LL-------EPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVK 141

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           ++DFG+A   +   + + R    GT  ++APE+  ++
Sbjct: 142 LADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 15/138 (10%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q+ I EV  + ++ H + ++  G     +   L+ E+   GS    +         + L 
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL-----EVHKKPLQ 113

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             ++  +  G  +G+ YLH   +  ++H D+K  NILL      K+ DFG A + +    
Sbjct: 114 EVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170

Query: 263 IVSRTAARGTSGYIAPEL 280
            V      GT  ++APE+
Sbjct: 171 FV------GTPYWMAPEV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 43.3 bits (102), Expect = 8e-05
 Identities = 34/138 (24%), Positives = 68/138 (49%), Gaps = 9/138 (6%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EVA +  + H +IV+      E     ++ ++   G L    + K N+       
Sbjct: 44  EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFP 99

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            +++      +   ++++H   +++ILH DIK  NI L  +   K+ DFG+A++ +  + 
Sbjct: 100 EDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156

Query: 263 IVSRTAARGTSGYIAPEL 280
           + +RT   GT  Y++PE+
Sbjct: 157 L-ARTCI-GTPYYLSPEI 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 36/165 (21%)

Query: 144 EFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLI-YEFMPNGSLQKFI------FSKTNS 195
           + + EV  +  + H +IVR +  F ++ N++  I  EF   G L + I      F K   
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCN-QRILHFDIKPHNILL-------------- 240
            +   ++ + L  +A+        L  G N +R+LH D+KP NI L              
Sbjct: 118 HAIVDITRQLLHALAY-----CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 241 -DHNFQP--KISDFGLAKLCSKDISIVSRT-AARGTSGYIAPELF 281
            + N +P  KI DFGL    SK+I I S   +  GT  Y +PEL 
Sbjct: 173 NNLNGRPIAKIGDFGL----SKNIGIESMAHSCVGTPYYWSPELL 213

Length = 1021

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 4/78 (5%)

Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           EK+R   + + + + + H+     I+H DIKP N+L+ HN   K+ DFG A+  S+  S 
Sbjct: 100 EKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SN 155

Query: 264 VSRTAARGTSGYIAPELF 281
            + T    T  Y +PEL 
Sbjct: 156 ANYTEYVATRWYRSPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 5/68 (7%)

Query: 215 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR--TAARGT 272
            G++Y+H      +LH D+KP N+L++ + + KI DFGLA+  S++    +   T    T
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 273 SGYIAPEL 280
             Y APE+
Sbjct: 173 RWYRAPEI 180

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 13/150 (8%)

Query: 110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGF 166
           Q      + N     + + E    ++E L  N    I+++A    IH   H  I +  G 
Sbjct: 32  QCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG- 90

Query: 167 CSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK--LRKIAFGVARGVEYLHQGC 224
           C    R  + Y F+    L + +   T     R     K  ++ I   +   +EY+H+  
Sbjct: 91  CGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-- 144

Query: 225 NQRILHFDIKPHNILLDHNFQPKISDFGLA 254
              I H DIKP NI++D N +  I D+G+A
Sbjct: 145 -HGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 21/141 (14%)

Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           +R  L+ E++  G L        +    R+L  E  R  A  +   + +LH+   + I++
Sbjct: 69  SRLFLVIEYVNGGDLM------FHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119

Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPEL-------FS 282
            D+K  N+LLD +   K++D+G   +C + +     T+   GT  YIAPE+       FS
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYG---MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176

Query: 283 RN-FCYGMMLLEMVGCRKNND 302
            + +  G+++ EM+  R   D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 13/87 (14%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI 276
           +E LH+     +++ D+KP NILLD+     + DFGL KL  KD    +     GT  Y+
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYL 160

Query: 277 APELFSRN--------FCYGMMLLEMV 295
           APEL   +        +  G++L EM+
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 7/76 (9%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGY 275
           +E+LH+     I++ D+KP NILLD      + DFGL+K    +++    T    GT+ Y
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEY 162

Query: 276 IAPELFSRNFCYGMML 291
           +APE+      Y   +
Sbjct: 163 LAPEVLLDEKGYTKHV 178

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 34/138 (24%), Positives = 67/138 (48%), Gaps = 21/138 (15%)

Query: 148 EVATIGRIHHFHIVRLLG-FCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWE 204
           E+  +  + H +++ LL  F S  +       Y  MP      ++ +         LS +
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSED 117

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-- 262
           K++ + + +  G++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +++  
Sbjct: 118 KVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 174

Query: 263 IVSRTAARGTSGYIAPEL 280
           +V+R        Y APE+
Sbjct: 175 VVTRW-------YRAPEV 185

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 39/140 (27%), Positives = 52/140 (37%), Gaps = 42/140 (30%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           LI EF+P G +   +  K        LS E  +         ++ +HQ      +H DIK
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT------LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIK 128

Query: 235 PHNILLDHNFQPKISDFGLAKLCSK----------------DISIVSRTAAR-------- 270
           P N+LLD     K+SDFGL     K                D S  +  + R        
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 271 ---------GTSGYIAPELF 281
                    GT  YIAPE+F
Sbjct: 189 RRQLAYSTVGTPDYIAPEVF 208

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)

Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA----- 173

Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 34/181 (18%)

Query: 127 SNEIAVKML-EHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP- 181
           S  +A+K + E L  N    + F+ E      + H  IV +   CS+G+    +Y  MP 
Sbjct: 27  SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPY 83

Query: 182 -NG----SLQKFIFSKTNSSS--HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
             G    SL K ++ K + S     + S      I   +   +EY+H   ++ +LH D+K
Sbjct: 84  IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLK 140

Query: 235 PHNILLDHNFQPKISDFGLAKLCSK------DISIVSRTAAR----------GTSGYIAP 278
           P NILL    +  I D+G A           DI +  R              GT  Y+AP
Sbjct: 141 PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200

Query: 279 E 279
           E
Sbjct: 201 E 201

Length = 932

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 35/118 (29%), Positives = 65/118 (55%), Gaps = 22/118 (18%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSG 274
           G+++LH   ++ I++ D+K  N++LD +   KI+DFG   +C +++   +R +   GT  
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFG---MCKENVFGDNRASTFCGTPD 161

Query: 275 YIAPEL-------FSRN-FCYGMMLLEMVGCRK--NNDPAVEIQSQI-----YFPEWI 317
           YIAPE+       FS + + +G++L EM+  +   + D   E+   I     ++P WI
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 1/53 (1%)

Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +H DIKP NIL+D N   +++DFG      +D ++ S  A  GT  YI+PE+ 
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 175

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 31/122 (25%), Positives = 57/122 (46%), Gaps = 11/122 (9%)

Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           LS+  L   ++ VA G+E+L    ++  +H D+   N+L+      KI DFGLA+   +D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 261 ISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            + +S+ +      ++APE    N        + +G++L E+        P + +  Q Y
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 313 FP 314
             
Sbjct: 353 NA 354

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 29/89 (32%), Positives = 51/89 (57%), Gaps = 15/89 (16%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSG 274
           G+++LH   ++ I++ D+K  NILLD +   KI+DFG   +C +++   ++T    GT  
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFG---MCKENMLGDAKTCTFCGTPD 161

Query: 275 YIAPELFSRN--------FCYGMMLLEMV 295
           YIAPE+            + +G++L EM+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 40/162 (24%), Positives = 62/162 (38%), Gaps = 50/162 (30%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           LI EF+P G +   +  K        L+ E+ +         ++ +HQ      +H DIK
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT------LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIK 128

Query: 235 PHNILLDHNFQPKISDFGLAKLCSK----------------DISIVSRTAAR-------- 270
           P N+LLD     K+SDFGL     K                D +  +  + R        
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188

Query: 271 ---------GTSGYIAPELFSRN--------FCYGMMLLEMV 295
                    GT  YIAPE+F +         +  G+++ EM+
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 31/125 (24%), Positives = 54/125 (43%), Gaps = 16/125 (12%)

Query: 156 HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR 215
            + + ++L    +      LI +++ +G L  F   K       +LS  +++KI   +  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL--FDLLKKE----GKLSEAEVKKIIRQLVE 120

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSRTAARGTSG 274
            +  LH      I+H DIK  N+L D    +  + D+GL K       I + +   GT  
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLD 171

Query: 275 YIAPE 279
           Y +PE
Sbjct: 172 YFSPE 176

Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 26/146 (17%)

Query: 160 IVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEY 219
           +V+LL    +     L  E++P G  +  +      ++   LS +  R     +   V+ 
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL------NNLGVLSEDHARFYMAEMFEAVDA 116

Query: 220 LHQ-GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSRTAARGTSGYIA 277
           LH+ G     +H D+KP N L+D +   K++DFGL+K + +   S+V      G+  Y+A
Sbjct: 117 LHELG----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMA 166

Query: 278 PE-LFSRNFCY-------GMMLLEMV 295
           PE L  + + +       G ML E +
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFL 192

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 13/113 (11%)

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
            R+L  E  R  +  ++  + YLH+   + I++ D+K  N+LLD     K++D+G+ K  
Sbjct: 90  QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146

Query: 258 SKDISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGCRKNND 302
            +     S     GT  YIAPE+       FS + +  G+++ EM+  R   D
Sbjct: 147 LRPGDTTSTFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 6/82 (7%)

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              L  E++  + + +  G+++LH   +  I+H D+KP NI++  +   KI DFGLA+  
Sbjct: 112 QMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168

Query: 258 SKDISIVSRTAARGTSGYIAPE 279
                +      R    Y APE
Sbjct: 169 GTSFMMTPYVVTR---YYRAPE 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 24/72 (33%), Positives = 36/72 (50%), Gaps = 14/72 (19%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-----G 271
           +++LHQ     I++ DIK  NILLD      ++DFGL+K        ++    R     G
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE------FLAEEEERAYSFCG 168

Query: 272 TSGYIAPELFSR 283
           T  Y+APE+   
Sbjct: 169 TIEYMAPEVIRG 180

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 5/126 (3%)

Query: 155 IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVA 214
           + H +I++ LG C E     L++E+   G L+ ++  +     + QL    L+++A  +A
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL--LLQRMACEIA 109

Query: 215 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSG 274
            GV ++H+      LH D+   N  L  +   K+ D+G+     K+  I +         
Sbjct: 110 AGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 275 YIAPEL 280
           ++APEL
Sbjct: 167 WLAPEL 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 18/44 (40%), Positives = 30/44 (68%), Gaps = 3/44 (6%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
           VA  ++YLH+     I+H D+KP N+L+ +    K++DFGL+K+
Sbjct: 113 VALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 28/94 (29%), Positives = 53/94 (56%), Gaps = 17/94 (18%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI--SIVSRTAAR 270
           +A G+ +LH   ++ I++ D+K  N++LD     KI+DFG   +C +++   + ++T   
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFC- 162

Query: 271 GTSGYIAPELFSRN--------FCYGMMLLEMVG 296
           GT  YIAPE+ +          + +G++L EM+ 
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 13/162 (8%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRT-LIYEFMPNGSLQ 186
           E A+K +E   G       E+A +  + H +++ L   F S  +R+  L++++  +    
Sbjct: 30  EYALKQIEG-TGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWH 88

Query: 187 KFIFSKTNSSSHR--QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---- 240
              F + + ++ +  QL    ++ + + +  G+ YLH      +LH D+KP NIL+    
Sbjct: 89  IIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEG 145

Query: 241 DHNFQPKISDFGLAKLCSKDIS-IVSRTAARGTSGYIAPELF 281
               + KI+D G A+L +  +  +        T  Y APEL 
Sbjct: 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)

Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA----- 166

Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 167 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 200

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 15/84 (17%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR---GVEYLHQGCNQRILHF 231
           LI E++P G +   +  K         + E+ R   F +A     ++ +H+      +H 
Sbjct: 78  LIMEYLPGGDMMTLLMKKDT------FTEEETR---FYIAETILAIDSIHK---LGYIHR 125

Query: 232 DIKPHNILLDHNFQPKISDFGLAK 255
           DIKP N+LLD     K+SDFGL  
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 26/167 (15%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFIN----EVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEF 179
            +S E  +K++  +       I+    E A++ R + H HIV L G C       ++ EF
Sbjct: 26  GYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEF 85

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           +  G L  F+  K++  +     W+   K+A  +A  + YL    ++ ++H ++   NIL
Sbjct: 86  VEFGPLDLFMHRKSDVLT---TPWK--FKVAKQLASALSYLE---DKDLVHGNVCTKNIL 137

Query: 240 L-----DHNFQP--KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           L     D    P  K+SD G+       I+++SR        +IAPE
Sbjct: 138 LAREGIDGECGPFIKLSDPGIP------ITVLSRQECVERIPWIAPE 178

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 14/158 (8%)

Query: 135 LEHLKGNG--QEFINEVATIGRIHHFHIVRLLG-FCSEGNRRT-LIYEFMPNGSLQKFIF 190
           L+ ++G G       E+A +  + H +++ L   F S  +R+  L++++  +       F
Sbjct: 33  LKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF 92

Query: 191 SKTNSSSHR--QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNF 244
            + + ++ +  QL    ++ + + +  G+ YLH      +LH D+KP NIL+        
Sbjct: 93  HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 149

Query: 245 QPKISDFGLAKLCSKDIS-IVSRTAARGTSGYIAPELF 281
           + KI+D G A+L +  +  +        T  Y APEL 
Sbjct: 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 14/86 (16%)

Query: 219 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAP 278
           Y+H+     ++H DIK  NIL+ +    K+ DFG+A L +++ S   R+   GT  ++AP
Sbjct: 116 YIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAP 170

Query: 279 ELFSRNFCY---------GMMLLEMV 295
           E+ +    Y         G+ + EM 
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 7/83 (8%)

Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
           R+    + R  A  V   + +LH+     +++ D+K  NILLD     K++DFG   +C 
Sbjct: 91  RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFG---MCK 144

Query: 259 KDISI-VSRTAARGTSGYIAPEL 280
           + I   V+ T   GT  YIAPE+
Sbjct: 145 EGILNGVTTTTFCGTPDYIAPEI 167

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 30/165 (18%)

Query: 147 NEVATIGRIHHFHIVRLLGFC-SEGNRRTL-------IYEFMPNGSLQKFIFSKTNSSSH 198
           NE+  +GR++H +I+++     SE N   +       +Y FM + +              
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---------WKD 262

Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
           R L  +  R I   +   VEY+H   +++++H DIK  NI L+ + +  + DFG A    
Sbjct: 263 RPLLKQT-RAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318

Query: 259 KDISIVSRTAARGTSGYIAPELFSRN-FCY-------GMMLLEMV 295
           K+          GT    +PE+ + + +C        G++LL+M+
Sbjct: 319 KE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 30/128 (23%), Positives = 47/128 (36%), Gaps = 52/128 (40%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL----------------------- 253
           +E +H       +H DIKP NIL+D +   K++DFGL                       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 254 -------AKLCSKDISIVSRTAAR-----------GTSGYIAPELFSRN--------FCY 287
                  +++    +  + R   R           GT  YIAPE+  R         +  
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 288 GMMLLEMV 295
           G++L EM+
Sbjct: 231 GVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 9/140 (6%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATI-GRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           LH  E+ +K+L+    N  E   E A++  ++ H H+V   G C  G+   ++ E++  G
Sbjct: 25  LHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFG 84

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL  ++    N  +   +SW KL ++A  +A  + +L    ++ + H ++   N+LL   
Sbjct: 85  SLDTYLKKNKNLIN---ISW-KL-EVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIRE 136

Query: 244 FQPKISDFGLAKLCSKDISI 263
              K  +    KL    ISI
Sbjct: 137 EDRKTGNPPFIKLSDPGISI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 25/88 (28%)

Query: 175 LIYEFMPNGSLQKF-----IFSKTNSSSHRQ---LSWEKLRKIAFGVARGVEYLHQGCNQ 226
           LI EF+P G L         FS+  +  +     L+ E + K+ F               
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF--------------- 122

Query: 227 RILHFDIKPHNILLDHNFQPKISDFGLA 254
             +H DIKP NIL+D     K+SDFGL+
Sbjct: 123 --IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	363
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
smart00090	237	RIO RIO-like kinase.	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.51
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.3
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.12
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.09
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.92
KOG3087	229	consensus Serine/threonine protein kinase [General	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.87
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.79
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.68
PRK09902	216	hypothetical protein; Provisional	98.63
COG4248	637	Uncharacterized protein with protein kinase and he	98.54
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.49
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.34
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.24
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.0
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.88
PF01636	239	APH: Phosphotransferase enzyme family This family	97.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.8
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.76
PLN02876	822	acyl-CoA dehydrogenase	97.63
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.56
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.42
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.41
PRK10593	297	hypothetical protein; Provisional	97.39
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.36
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.32
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.21
PRK05231	319	homoserine kinase; Provisional	96.94
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.94
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.83
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.75
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.73
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.62
PLN02236	344	choline kinase	96.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.18
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.13
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.07
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.99
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.87
COG2334	331	Putative homoserine kinase type II (protein kinase	95.84
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.79
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.44
PLN02756	418	S-methyl-5-thioribose kinase	94.9
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.88
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.49
PRK11768	325	serine/threonine protein kinase; Provisional	94.4
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.1
PHA03111	444	Ser/Thr kinase; Provisional	94.07
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.43
KOG2270	520	consensus Serine/threonine protein kinase involved	92.93
PTZ00384	383	choline kinase; Provisional	92.69
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.14
PRK10271	188	thiK thiamine kinase; Provisional	91.83

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-48  Score=339.40  Aligned_cols=234  Identities=24%  Similarity=0.364  Sum_probs=192.0

Q ss_pred             CcccccccccCCcceeecc-----CCeeEEEEcccCCc--------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCcee
Q 039471          108 PFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKG--------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT  174 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  174 (363)
                      .|.....+|.|+.+.|.+.     ++.||||+++....        ......+|+++|++|+|||||+++++|......|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            3444455666666665442     33499999974221        2234579999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC---CCeeEecc
Q 039471          175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDF  251 (363)
Q Consensus       175 lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Df  251 (363)
                      +||||++||.|.+.+-      .++.+.+..-+.++.|++.|+.|||+   +||+||||||+|||++.+   ..+||+||
T Consensus       253 mVlE~v~GGeLfd~vv------~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVV------ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             EEEEEecCccHHHHHH------hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999994      44678888889999999999999999   999999999999999866   67999999


Q ss_pred             ccceeccCCccccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHH
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      |+|+........   .+..||+.|.|||++           .|+||+||++|-+++|.+||.......+       ++++
T Consensus       324 GlAK~~g~~sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~eQ  393 (475)
T KOG0615|consen  324 GLAKVSGEGSFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LKEQ  393 (475)
T ss_pred             chhhccccceeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HHHH
Confidence            999998755432   567799999999999           5999999999999999999987655443       4555


Q ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..|..   .+.+..+.+.+.+..++|.|||+.||++|||++|
T Consensus       394 I~~G~y---~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~e  433 (475)
T KOG0615|consen  394 ILKGRY---AFGPLQWDRISEEALDLINWMLVVDPENRPSADE  433 (475)
T ss_pred             HhcCcc---cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence            555433   2334567788999999999999999999999875

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-48  Score=335.38  Aligned_cols=232  Identities=25%  Similarity=0.316  Sum_probs=185.2

Q ss_pred             cccccccCCcceeeccCCe--eEEEEcc--cCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC-ceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLHSNE--IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN-RRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~--vAvK~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL  185 (363)
                      .+|.++.|.+..+..+...  +|+|++.  ......+++.+|++++++.+|||||.+||.|..++ ...|+||||.+|||
T Consensus        86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSL  165 (364)
T KOG0581|consen   86 VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSL  165 (364)
T ss_pred             hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCH
Confidence            3444444555555555443  9999994  33445578999999999999999999999999998 49999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ++++..      .+.++|..+..++.++++||.|||.  ..+|+||||||+|||+++.|.+||+|||.++.+...    .
T Consensus       166 d~~~k~------~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~  233 (364)
T KOG0581|consen  166 DDILKR------VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I  233 (364)
T ss_pred             HHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence            999932      2569999999999999999999995  389999999999999999999999999999887654    2


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      ..+..||..|||||.+        +||||||+.++|+++|+.|+.......  ....+ +...+..      ...+..+.
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~~~~-Ll~~Iv~------~ppP~lP~  304 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LDIFE-LLCAIVD------EPPPRLPE  304 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--CCHHH-HHHHHhc------CCCCCCCc
Confidence            3677899999999999        899999999999999999987761111  11111 1122221      12233344


Q ss_pred             -HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 -GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 -~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .+++++++|+..||+.||.+|||++|
T Consensus       305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~q  331 (364)
T KOG0581|consen  305 GEFSPEFRSFVSCCLRKDPSERPSAKQ  331 (364)
T ss_pred             ccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence             48999999999999999999999864

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=343.13  Aligned_cols=248  Identities=39%  Similarity=0.666  Sum_probs=202.9

Q ss_pred             CcccccccccCCcceeeccC-CeeEEEEcccCCcC-hhHHHHHHHHHhccCCCceeeeeeeeeeCC-ceeEEEeccCCCC
Q 039471          108 PFQSLISFNLTNSKFFFLHS-NEIAVKMLEHLKGN-GQEFINEVATIGRIHHFHIVRLLGFCSEGN-RRTLIYEFMPNGS  184 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~s  184 (363)
                      .-..++.+|+|.++...+.+ ..||||++...... .++|.+|+.++.+++|+|+|+++|||.+.+ +.+||||||++||
T Consensus        79 ~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGs  158 (361)
T KOG1187|consen   79 ESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGS  158 (361)
T ss_pred             hhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCC
Confidence            33567888888888888877 56999988866554 677999999999999999999999999988 5999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC-Cccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK-DISI  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~-~~~~  263 (363)
                      |.++++.....    .++|..+.+|+.++|+||+|||.++...|+||||||+|||+|+++++||+|||+|+..+. ....
T Consensus       159 L~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~  234 (361)
T KOG1187|consen  159 LEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV  234 (361)
T ss_pred             HHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce
Confidence            99999765421    789999999999999999999998877899999999999999999999999999977665 3322


Q ss_pred             cccccc-cccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc---cccccc
Q 039471          264 VSRTAA-RGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ---ELCLDF  331 (363)
Q Consensus       264 ~~~~~~-~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  331 (363)
                         ... .||.+|+|||.+        +||||||++++|++||+++.+.... .....+.+|....+..+.   ..+...
T Consensus       235 ---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  235 ---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHHHHHHHHCcchhheeCCCc
Confidence               112 699999999987        8999999999999999998876542 222236777766665542   122222


Q ss_pred             C-CCCcH-HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 E-EDGDE-GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      . ..... .....+..++.+|++.+|++||+|.|
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~  344 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ  344 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence            2 22332 56777999999999999999999975

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-45  Score=337.83  Aligned_cols=229  Identities=23%  Similarity=0.358  Sum_probs=191.6

Q ss_pred             cccccccccCCcceeec-----cCCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          109 FQSLISFNLTNSKFFFL-----HSNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~-----~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      |.+-.-+|.|+...++.     .++.||+|++.+    .....+...+||++.++|+|||||+++++|++.+..|||+|+
T Consensus        20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL   99 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL   99 (592)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence            33333344455544443     244499999975    556677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |++++|..++.      ..+.++|.+++.+++||+.||.|||+   .+|+|||||..|++++++.++||+|||+|..+..
T Consensus       100 C~~~sL~el~K------rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen  100 CHRGSLMELLK------RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             cCCccHHHHHH------hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999994      34789999999999999999999999   9999999999999999999999999999999875


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      +...  ..+..||+.|+|||++        +||||+||++|-|+.|++||+...-..        .|+++.....     
T Consensus       171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~Y-----  235 (592)
T KOG0575|consen  171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNEY-----  235 (592)
T ss_pred             cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcCc-----
Confidence            5321  2567799999999999        899999999999999999998764332        5666554332     


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ..+..++.+..++|.++|+.||.+|||+++
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~  265 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDE  265 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHH
Confidence              234577888999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=333.76  Aligned_cols=231  Identities=25%  Similarity=0.422  Sum_probs=195.7

Q ss_pred             ccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+.||.+....+.++ +||+|.++...-..+.|.+|+.+|++|+|+|||+++|+|..+..++||||||+.|||.++
T Consensus       212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y  291 (468)
T KOG0197|consen  212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY  291 (468)
T ss_pred             HHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence            3466777777777777777 699999997776778999999999999999999999999998899999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +...    .+..+...+++.++.|||.||+||++   +++|||||..+|||++++..+||+|||+|+...++.. .....
T Consensus       292 Lr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~~~  363 (468)
T KOG0197|consen  292 LRTR----EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TASEG  363 (468)
T ss_pred             hhhc----CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCce-eecCC
Confidence            9652    23679999999999999999999999   9999999999999999999999999999995554443 33455


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..-++.|.|||.+        |||||||++||||+| |+.|+.+... .+       +.+.++.|.++      ..+..+
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~e-------v~~~le~GyRl------p~P~~C  429 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-EE-------VLELLERGYRL------PRPEGC  429 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-HH-------HHHHHhccCcC------CCCCCC
Confidence            5567899999998        999999999999998 4555444332 22       45566666554      557778


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      +..+.+++..||+.+|++|||++
T Consensus       430 P~~vY~lM~~CW~~~P~~RPtF~  452 (468)
T KOG0197|consen  430 PDEVYELMKSCWHEDPEDRPTFE  452 (468)
T ss_pred             CHHHHHHHHHHhhCCcccCCCHH
Confidence            99999999999999999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-45  Score=330.96  Aligned_cols=234  Identities=27%  Similarity=0.397  Sum_probs=193.6

Q ss_pred             CcccccccccCCcceeeccCCe-eEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCC-ceeEEEeccCC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNE-IAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGN-RRTLIYEFMPN  182 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~-vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~  182 (363)
                      ..+.++.+++|.++...+.+.. ||||++......   .++|.+|+.+|.+++|||||+++|+|.+.. ...+||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3344788888888888888888 999999754433   458999999999999999999999999887 79999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-ceecCCCCCceEEcCCC-CeeEeccccceeccCC
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR-ILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD  260 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~  260 (363)
                      |+|.++++..    ....+++..+..++.||++||+|||+   .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       125 GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  125 GSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999764    23789999999999999999999999   88 99999999999999997 9999999999887653


Q ss_pred             ccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          261 ISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .  ...+...||..|||||++          +||||||+++|||+||+.||........       .+.....+.     
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-------~~~v~~~~~-----  263 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-------ASAVVVGGL-----  263 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcCC-----
Confidence            2  122446799999999998          6999999999999999999987654211       122221222     


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .+..+...++.+..++.+||+.||+.||++.|
T Consensus       264 -Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e  295 (362)
T KOG0192|consen  264 -RPPIPKECPPHLSSLMERCWLVDPSRRPSFLE  295 (362)
T ss_pred             -CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence             22334447888999999999999999999864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=309.92  Aligned_cols=226  Identities=24%  Similarity=0.343  Sum_probs=173.8

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+.++.++....+.  ..||||.+...   ++..+....|+++|+.++|+|||++++++..++..|+|||||.||+|.
T Consensus        18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs   97 (429)
T KOG0595|consen   18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLS   97 (429)
T ss_pred             ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHH
Confidence            4555555555444433  34999998644   334456789999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC------CCeeEeccccceeccCC
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN------FQPKISDFGLAKLCSKD  260 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~------~~~kl~Dfg~a~~~~~~  260 (363)
                      +|++.      .+.+++..++.++.||+.||++||+   ++|+||||||+|||++..      -.+||+|||+|+.+...
T Consensus        98 ~yi~~------~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   98 DYIRR------RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             HHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            99953      3579999999999999999999999   999999999999999864      45899999999999865


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...   ....|++.|||||++        .|+||+|+++|+|++|+.||+.....+        +...++++....    
T Consensus       169 ~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~~~~----  233 (429)
T KOG0595|consen  169 SMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGNEIV----  233 (429)
T ss_pred             hHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhcccccc----
Confidence            543   556799999999999        899999999999999999998654322        222333332221    


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +..+...+..+.+++...++.+|.+|-+.
T Consensus       234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~  262 (429)
T KOG0595|consen  234 PVLPAELSNPLRELLISLLQRNPKDRISF  262 (429)
T ss_pred             CchhhhccCchhhhhhHHHhcCccccCch
Confidence            12233344444455555566666655543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-44  Score=298.48  Aligned_cols=236  Identities=22%  Similarity=0.301  Sum_probs=190.9

Q ss_pred             cccccccccCCcceeeccC--CeeEEEEccc---CCcChhHHHHHHHHHhccCCCceeeeee-eeeeCCc-eeEEEeccC
Q 039471          109 FQSLISFNLTNSKFFFLHS--NEIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNR-RTLIYEFMP  181 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~--~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~  181 (363)
                      +.++|.++||.++.+....  ..||.|.+.-   ..+..+....|+.+|++|+|||||++++ .+.+++. ++||||+|.
T Consensus        24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~  103 (375)
T KOG0591|consen   24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD  103 (375)
T ss_pred             HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence            3456777777777665443  3499998862   3344578899999999999999999999 4555554 899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN-QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      +|+|..++..-+  .+++.+++..++.++.|++.||..+|+... .-++||||||.||+++.+|.+||+|||+++.+...
T Consensus       104 ~GDLsqmIk~~K--~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~  181 (375)
T KOG0591|consen  104 AGDLSQMIKHFK--KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK  181 (375)
T ss_pred             ccCHHHHHHHHH--hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence            999999997655  456889999999999999999999998332 34899999999999999999999999999999876


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...  ....+||+.||+||.+        |||||+||++|||..-.+||.+..-.+        +..++..+..     .
T Consensus       182 ~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~--------L~~KI~qgd~-----~  246 (375)
T KOG0591|consen  182 TTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS--------LCKKIEQGDY-----P  246 (375)
T ss_pred             hHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH--------HHHHHHcCCC-----C
Confidence            543  3567899999999999        999999999999999999998862111        3344544422     1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +-....++.++..++..|+..||+.||+.
T Consensus       247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            12237889999999999999999999973

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=299.00  Aligned_cols=243  Identities=19%  Similarity=0.274  Sum_probs=186.8

Q ss_pred             cccccccccCCcceeeccCCe-----eEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          109 FQSLISFNLTNSKFFFLHSNE-----IAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~-----vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      |++++..|.|+.|.|+...+.     ||||++..++.+   .+-..+|++.|++++|+|+|.++.+|.....++||+|||
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            556677777777776654332     999999866543   246789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      +. ++.+-+...     ...++...+..++.|++.|+.|+|+   ++++||||||+|||++.+|.+||||||+|+.+...
T Consensus        84 dh-TvL~eLe~~-----p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   84 DH-TVLHELERY-----PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ch-HHHHHHHhc-----cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            87 555555332     2568999999999999999999999   99999999999999999999999999999998843


Q ss_pred             ccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc----
Q 039471          261 ISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL----  327 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  327 (363)
                      ....  +..+.|.+|+|||++         .|||++||++.||++|.+.|.+..+.++...+...+.+.+...+..    
T Consensus       155 gd~Y--TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  155 GDNY--TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             cchh--hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            3222  456789999999999         7999999999999999999988877665333222221111111000    


Q ss_pred             ----cccc--------CCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          328 ----CLDF--------EEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       328 ----~~~~--------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                          ....        .+......+.-+.+++..||++||.+|+|-+
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~  279 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCE  279 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHH
Confidence                0000        0112234456789999999999999999854

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=317.43  Aligned_cols=245  Identities=22%  Similarity=0.321  Sum_probs=192.2

Q ss_pred             CCcccccccccCCcceeecc-----CCeeEEEEcccCCcChhHH--HHHHHHHhccC-CCceeeeeeeeeeCC-ceeEEE
Q 039471          107 CPFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNGQEF--INEVATIGRIH-HFHIVRLLGFCSEGN-RRTLIY  177 (363)
Q Consensus       107 c~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~  177 (363)
                      +.|..++.+|-|+.|-|++.     ++.||||.++..-..+++.  ++|++.|++++ |+|||++.+.+.++. .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            44555566666666666553     3339999998766667665  47999999999 999999999998887 999999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |||+ .+|++++..+     ++.|++..++.|+.||++||+|+|+   +|+.|||+||+|||+..+..+||+|||+|+..
T Consensus        90 E~Md-~NLYqLmK~R-----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   90 EFMD-CNLYQLMKDR-----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             Hhhh-hhHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence            9996 5999999654     3789999999999999999999999   99999999999999998889999999999988


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH---------H-
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI---------Y-  318 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~---------~-  318 (363)
                      ......   +..+.|.+|+|||++         .|+|++|||++|+.+-++.|.+..+.++...+.+.+         . 
T Consensus       161 ~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            765544   567789999999999         799999999999999999999887776543332221         1 


Q ss_pred             HHhhhcccccccc-----CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          319 NRMRLGQELCLDF-----EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       319 ~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++..........     ........+.+..+++.+|++|||.+|||++|
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~  287 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ  287 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence            0111000000000     01112236788999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=314.87  Aligned_cols=233  Identities=23%  Similarity=0.367  Sum_probs=191.4

Q ss_pred             CCcccccccccCCcceeecc-----CCeeEEEEcccCCcCh-hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          107 CPFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       107 c~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..|.....+|.|..+.++..     ++.||||.+....... +-+++|+.+|+..+|+|||++++.|..++.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            34444455566666655543     4449999998655444 55779999999999999999999998889999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      +||+|.+.+..       ..++|.++..|++++++||+|||.   ++|+|||||.+|||++.+|.+||+|||+|..+...
T Consensus       353 ~ggsLTDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  353 EGGSLTDVVTK-------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             CCCchhhhhhc-------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999999832       459999999999999999999999   99999999999999999999999999999988776


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  .+...+||+.|||||++        .||||||++++||+-|.+||-.......       +| .+....    ...
T Consensus       423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-------ly-LIa~ng----~P~  488 (550)
T KOG0578|consen  423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LY-LIATNG----TPK  488 (550)
T ss_pred             cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-------HH-HHhhcC----CCC
Confidence            64  45788999999999999        8999999999999999999976443321       11 111111    122


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...++.+++.|.+|+.+||+.|+++|||++|
T Consensus       489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~e  519 (550)
T KOG0578|consen  489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKE  519 (550)
T ss_pred             cCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence            3456788999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=297.20  Aligned_cols=226  Identities=22%  Similarity=0.279  Sum_probs=184.7

Q ss_pred             cccccccccCCcceeeccCCe--eEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          109 FQSLISFNLTNSKFFFLHSNE--IAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      +..++.+++|-+..|...+.+  +|+|++++..    +..+....|..+|.+++||.||+++-.|++...+|+|+||+.|
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            344555555555555544333  9999997532    2345678999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |.|..+|.      +.+.+++..++-++.+|+.||.|||+   ++|+|||+||+|||+|.+|.++|+|||+|+..-.+..
T Consensus       110 GeLf~hL~------~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  110 GELFYHLQ------REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             ccHHHHHH------hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999993      44679999999999999999999999   9999999999999999999999999999996544432


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....||+.|||||++        +|-||+|+++|||++|.+||.......        +++.+..+..      ..
T Consensus       181 ~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~------~~  244 (357)
T KOG0598|consen  181 A--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKL------PL  244 (357)
T ss_pred             c--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcC------CC
Confidence            2  2457899999999999        899999999999999999998765432        4455554431      12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      .+.-++.+.++++.+.|+.+|++|.
T Consensus       245 ~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCccCCHHHHHHHHHHhccCHHHhc
Confidence            2334677899999999999999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=301.81  Aligned_cols=234  Identities=26%  Similarity=0.346  Sum_probs=183.4

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--ceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--RRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~s  184 (363)
                      +.++.+.+|.++.....+  ...|||.+.... ...+.+.+|+.+|.+++|+|||+++|......  .++++|||+++||
T Consensus        23 ~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~Gs  102 (313)
T KOG0198|consen   23 KLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGS  102 (313)
T ss_pred             ccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCc
Confidence            445566666666666554  459999987441 11456889999999999999999999754433  6999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccCCccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      |.+++....     ..+++..++.+.+||++||+|||+   ++|+||||||+|||++. ++.+||+|||+++........
T Consensus       103 L~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen  103 LSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             HHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            999995432     269999999999999999999999   99999999999999999 799999999999877641111


Q ss_pred             -cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          264 -VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       264 -~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                       .......||+.|||||++         +|||||||++.||+||++||.....      ..+++.....   ..   ..+
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~------~~~~~~~ig~---~~---~~P  242 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE------EAEALLLIGR---ED---SLP  242 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc------hHHHHHHHhc---cC---CCC
Confidence             122457799999999998         7999999999999999999976411      1122222211   11   122


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..++.+..+++.+|++.+|++|||++|
T Consensus       243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e  272 (313)
T KOG0198|consen  243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEE  272 (313)
T ss_pred             CCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence            456668889999999999999999999864

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=312.53  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             CCceEEEeEEeeecceecccCCCCCCCcccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCcee
Q 039471           82 SGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIV  161 (363)
Q Consensus        82 ~g~y~v~~I~y~~~~~~v~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv  161 (363)
                      .|+.+++++.......+-++.+. -.-++.++.+..|.+....++++.||||+++..+      ..+++-|++|+|+||+
T Consensus       103 iGk~~s~e~k~qq~e~WeiPFe~-IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk------ETdIKHLRkLkH~NII  175 (904)
T KOG4721|consen  103 IGKAYSTEHKQQQEELWEIPFEE-ISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK------ETDIKHLRKLKHPNII  175 (904)
T ss_pred             hccceeeehhhhhhhhccCCHHH-hhhhhhhccCcccceeeeeccCceehhHHHhhhh------hhhHHHHHhccCccee
Confidence            45566666655555555555442 2345667888888888888899999999987433      2678889999999999


Q ss_pred             eeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc
Q 039471          162 RLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       162 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~  241 (363)
                      .|.|+|.....++||||||+.|-|+..++.      ...+....+..|..+||.||.|||.   +.|||||+|.-||||+
T Consensus       176 ~FkGVCtqsPcyCIiMEfCa~GqL~~VLka------~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs  246 (904)
T KOG4721|consen  176 TFKGVCTQSPCYCIIMEFCAQGQLYEVLKA------GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILIS  246 (904)
T ss_pred             eEeeeecCCceeEEeeeccccccHHHHHhc------cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEee
Confidence            999999999999999999999999999943      3668999999999999999999999   9999999999999999


Q ss_pred             CCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccch
Q 039471          242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF  313 (363)
Q Consensus       242 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~  313 (363)
                      .+..+||+|||.++......   +...+.||..|||||++        .||||||||||||+||..|+...+...-    
T Consensus       247 ~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----  319 (904)
T KOG4721|consen  247 YDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----  319 (904)
T ss_pred             ccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----
Confidence            99999999999998876542   23567799999999999        8999999999999999999876443221    


Q ss_pred             HHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 PEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ++..   |   .-.+....+..+++-|..|++.||+-+|.+|||+.+
T Consensus       320 ---IwGV---G---sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrq  360 (904)
T KOG4721|consen  320 ---IWGV---G---SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQ  360 (904)
T ss_pred             ---EEec---c---CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHH
Confidence               1110   1   111223456677888999999999999999999853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-41  Score=279.96  Aligned_cols=243  Identities=22%  Similarity=0.308  Sum_probs=187.2

Q ss_pred             cccccccccCCcceeecc-----CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          109 FQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      |.++...|.|..+.|+..     ++.||||+++...   +.....++|++.|+.++|+||+.++++|...+...||+|||
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence            444555666666666653     3449999997443   22467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      +. +|+..++..     ...++...++.++.++++||+|||+   +.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus        84 ~t-dLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   84 PT-DLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             cc-cHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            75 999999544     3679999999999999999999999   99999999999999999999999999999998765


Q ss_pred             ccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch------------HHHH--
Q 039471          261 ISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF------------PEWI--  317 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~------------~~~~--  317 (363)
                      ....  ...+.|.+|+|||++         .|+||.|||+.||+-|.+.|.+..+.++...+            |++.  
T Consensus       155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            4322  233679999999988         79999999999999999988887665543221            1110  


Q ss_pred             HHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 YNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      -+..+..+..... ........+.+..+++.+|+.+||.+|+|++|
T Consensus       233 pdY~~~~~~P~~~-~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q  277 (318)
T KOG0659|consen  233 PDYVKIQQFPKPP-LNNLFPAASSDALDLLSKMLTYNPKKRITASQ  277 (318)
T ss_pred             ccHHHHhcCCCCc-cccccccccHHHHHHHHhhhccCchhcccHHH
Confidence            0000000011111 11123345667799999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-41  Score=301.60  Aligned_cols=246  Identities=20%  Similarity=0.262  Sum_probs=189.3

Q ss_pred             CcccccccccCCcceeeccCC-----eeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEE
Q 039471          108 PFQSLISFNLTNSKFFFLHSN-----EIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIY  177 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  177 (363)
                      .|+++..+|.|+.+-|+...+     -||+|++.-..   +...-.++||.+|++|+||||+++.+...+.  +.+|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            566777778888777765433     39999997432   3335668999999999999999999998776  6899999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |||++ +|..++..     ..-.|++.+++.+++||+.||+|+|+   .+|+|||||.+|||||++|.+||+|||+|+++
T Consensus       198 eYMdh-DL~GLl~~-----p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSS-----PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             ecccc-hhhhhhcC-----CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            99987 89888843     33679999999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH---------HHHH
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE---------WIYN  319 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~---------~~~~  319 (363)
                      ...... ..+..+.|.+|+|||++         .|+||.|||+.||+.|++.+.+..+..+...+.+         |...
T Consensus       269 ~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            765532 23556689999999999         7999999999999999999998776654322211         1101


Q ss_pred             Hhhhccccc-----cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELC-----LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.......     .+...+....++....+|+..+|..||.+|.|+.+
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~  396 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS  396 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence            111000000     00001112345667889999999999999999853

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=293.25  Aligned_cols=224  Identities=22%  Similarity=0.328  Sum_probs=180.5

Q ss_pred             cCCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCH
Q 039471          126 HSNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW  203 (363)
Q Consensus       126 ~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~  203 (363)
                      .++.||||++.-.+.  ....+.+|+..++.++||||++++..|..+..+|+||.||.+||+.++++....    ..++|
T Consensus        50 ~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~----~Gl~E  125 (516)
T KOG0582|consen   50 TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP----DGLEE  125 (516)
T ss_pred             cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc----ccccH
Confidence            345599999974432  346888999999999999999999999999999999999999999999977654    56999


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC-Ccccccc-ccccccccccCCccc
Q 039471          204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK-DISIVSR-TAARGTSGYIAPELF  281 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~-~~~~~~~-~~~~gt~~y~aPE~~  281 (363)
                      ..+..|++++++||.|||+   +|.||||||+.||||+++|.+||+|||.+..+-. +.....+ ....||+.|||||++
T Consensus       126 ~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl  202 (516)
T KOG0582|consen  126 ASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL  202 (516)
T ss_pred             HHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence            9999999999999999999   9999999999999999999999999997655433 3222233 566799999999995


Q ss_pred             ----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc--ccccCCCCcHHHHHHHHHHHHH
Q 039471          282 ----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL--CLDFEEDGDEGIARKLAIVAIW  349 (363)
Q Consensus       282 ----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~  349 (363)
                                +||||||++..||++|..||........       +...+......  ......+....+++.+..++..
T Consensus       203 ~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-------Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~  275 (516)
T KOG0582|consen  203 MQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-------LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIAL  275 (516)
T ss_pred             hhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-------HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHH
Confidence                      8999999999999999999976543321       22222211110  1122333456677899999999


Q ss_pred             hccCCCCCCCCCCC
Q 039471          350 CIQWNPTERPSMPM  363 (363)
Q Consensus       350 cl~~~p~~RPs~~e  363 (363)
                      ||+.||.+|||+++
T Consensus       276 CL~kDP~kRptAsk  289 (516)
T KOG0582|consen  276 CLVKDPSKRPTASK  289 (516)
T ss_pred             HhhcCcccCCCHHH
Confidence            99999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.8e-41  Score=321.00  Aligned_cols=217  Identities=28%  Similarity=0.459  Sum_probs=183.1

Q ss_pred             eEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCC--------CCC
Q 039471          130 IAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS--------SHR  199 (363)
Q Consensus       130 vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~--------~~~  199 (363)
                      ||||.+++...  ..++|.+|++.++.++|+|||+++|.|.+++..++|+|||..|+|.++|.......        ...
T Consensus       519 VAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~  598 (774)
T KOG1026|consen  519 VAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPP  598 (774)
T ss_pred             hhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCC
Confidence            99999986544  35799999999999999999999999999999999999999999999997654311        134


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCc
Q 039471          200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE  279 (363)
Q Consensus       200 ~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  279 (363)
                      +++..+.+.|+.|||.||+||-+   +.++||||..+|+||.++..|||+|||+++..-....+.......-.++||+||
T Consensus       599 ~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  599 PLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            59999999999999999999999   999999999999999999999999999998765444333333334578999999


Q ss_pred             cc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHh
Q 039471          280 LF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWC  350 (363)
Q Consensus       280 ~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  350 (363)
                      .+        ||||||||+|||+++ |+.|+.+....+        +.+.+..++.+      ..++.++.++..|++.|
T Consensus       676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------VIe~i~~g~lL------~~Pe~CP~~vY~LM~~C  741 (774)
T KOG1026|consen  676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------VIECIRAGQLL------SCPENCPTEVYSLMLEC  741 (774)
T ss_pred             HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--------HHHHHHcCCcc------cCCCCCCHHHHHHHHHH
Confidence            98        999999999999996 777877665443        45556555543      45678889999999999


Q ss_pred             ccCCCCCCCCCCC
Q 039471          351 IQWNPTERPSMPM  363 (363)
Q Consensus       351 l~~~p~~RPs~~e  363 (363)
                      |+.+|++|||++|
T Consensus       742 W~~~P~~RPsF~e  754 (774)
T KOG1026|consen  742 WNENPKRRPSFKE  754 (774)
T ss_pred             hhcCcccCCCHHH
Confidence            9999999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=302.09  Aligned_cols=224  Identities=26%  Similarity=0.364  Sum_probs=181.1

Q ss_pred             ccCCcceeecc-----CCeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          116 NLTNSKFFFLH-----SNEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       116 ~~~~~~~~~~~-----~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      |.|+...|++.     ++.+|||++.+.    +...+-...|-.+|.+| .||.|++|+-.|.+...+|+|+||+++|.|
T Consensus        82 GeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdl  161 (604)
T KOG0592|consen   82 GEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDL  161 (604)
T ss_pred             ccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcH
Confidence            44444444442     344999999642    22334566788899999 799999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc--
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI--  263 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--  263 (363)
                      .++|.      +.+.|++...+.++.+|+.||+|||+   +|||||||||+|||+|.++.+||+|||.|+.+++....  
T Consensus       162 l~~i~------K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~  232 (604)
T KOG0592|consen  162 LDLIK------KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE  232 (604)
T ss_pred             HHHHH------HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence            99994      33679999999999999999999999   99999999999999999999999999999998754322  


Q ss_pred             ---------cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          264 ---------VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       264 ---------~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                               ..+...+||..|.+||++        +|+|+|||++|.|+.|.+||....+-.        +.+++..   
T Consensus       233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--------iFqkI~~---  301 (604)
T KOG0592|consen  233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--------IFQKIQA---  301 (604)
T ss_pred             CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------HHHHHHH---
Confidence                     112557899999999999        899999999999999999998765422        1222211   


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ..-+.+..+++...+|+.+.|..||.+|+|.+|
T Consensus       302 ----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~q  334 (604)
T KOG0592|consen  302 ----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQ  334 (604)
T ss_pred             ----hcccCCCCCCHHHHHHHHHHHccCccccccHHH
Confidence                112345556688999999999999999999754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=300.92  Aligned_cols=224  Identities=24%  Similarity=0.346  Sum_probs=180.3

Q ss_pred             cccccCCcceeec--cCCeeEEEEcccC----C--cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          113 ISFNLTNSKFFFL--HSNEIAVKMLEHL----K--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       113 ~~~~~~~~~~~~~--~~~~vAvK~~~~~----~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      +.+++|.+.....  .+..||+|+++..    .  ...+.+.+|+.++++++ ||||++++.++......++||||+.||
T Consensus        26 G~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gG  105 (370)
T KOG0583|consen   26 GSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGG  105 (370)
T ss_pred             cCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCc
Confidence            4444444443332  2455999977643    1  22346668999999999 999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceecc-CCc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCS-KDI  261 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~-~~~  261 (363)
                      .|.+++..      ...+.+.....+++|++.|++|+|+   .+|+||||||+|||++.+ +++||+|||++.... .+.
T Consensus       106 dL~~~i~~------~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~  176 (370)
T KOG0583|consen  106 DLFDYIVN------KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG  176 (370)
T ss_pred             cHHHHHHH------cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC
Confidence            99999954      3679999999999999999999999   999999999999999999 999999999999884 333


Q ss_pred             cccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          262 SIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      .   .....||+.|+|||++          .||||+|++||.|++|+.||+.....        .++..+..++..    
T Consensus       177 ~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------~l~~ki~~~~~~----  241 (370)
T KOG0583|consen  177 L---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------NLYRKIRKGEFK----  241 (370)
T ss_pred             c---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--------HHHHHHhcCCcc----
Confidence            3   2567799999999999          79999999999999999999873321        133334333222    


Q ss_pred             CCCCcHHH-HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGI-ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         .+..+ ++++..++.+|++.||.+|+|+.|
T Consensus       242 ---~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~  271 (370)
T KOG0583|consen  242 ---IPSYLLSPEARSLIEKMLVPDPSTRITLLE  271 (370)
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCCcccCCCHHH
Confidence               22233 888999999999999999999754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-40  Score=304.08  Aligned_cols=224  Identities=21%  Similarity=0.310  Sum_probs=189.1

Q ss_pred             cccccCCcceeecc-----CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          113 ISFNLTNSKFFFLH-----SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       113 ~~~~~~~~~~~~~~-----~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..+|.|+.+.+.+.     ++.+|||++...    ......+.+|+.+|+-+.||||+++|+.++++.++|+|.||+++|
T Consensus        18 kTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gG   97 (786)
T KOG0588|consen   18 KTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGG   97 (786)
T ss_pred             ccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCc
Confidence            35666666666553     445999999643    233457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      -|.+++      ..++.+++.+..++++||+.|+.|+|.   .+|+|||+||+|+|+|.++++||+|||+|.+..++...
T Consensus        98 ELFdyl------v~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   98 ELFDYL------VRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             hhHHHH------HhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            999999      455789999999999999999999999   99999999999999999999999999999988776554


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                         .+..|+++|+|||++         +||||-|+|||.|++|+.||+...-.        .++.++..|..       +
T Consensus       169 ---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--------~LLlKV~~G~f-------~  230 (786)
T KOG0588|consen  169 ---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--------VLLLKVQRGVF-------E  230 (786)
T ss_pred             ---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCcc-------c
Confidence               556799999999999         89999999999999999999843321        13344443332       3


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..++.+.++|+.+|+..||+.|.|++|
T Consensus       231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~e  259 (786)
T KOG0588|consen  231 MPSNISSEAQDLLRRMLDVDPSTRITTEE  259 (786)
T ss_pred             CCCcCCHHHHHHHHHHhccCccccccHHH
Confidence            45778889999999999999999999864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=277.81  Aligned_cols=218  Identities=26%  Similarity=0.338  Sum_probs=184.4

Q ss_pred             ccccccCCcceeeccCCe--eEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLHSNE--IAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~--vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.++||.+..+..+..+  +|+|+++...    ++.+...+|..+|+.+.||.++++++.|.+.+..++||||.+||-|
T Consensus        52 lGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGEl  131 (355)
T KOG0616|consen   52 LGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGEL  131 (355)
T ss_pred             eccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccH
Confidence            344445555555444444  9999997543    3345677999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..+++..      +.+++...+-++.||+.||+|||+   ++|++||+||+|||+|++|.+||+|||.|+.+....    
T Consensus       132 FS~Lrk~------~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT----  198 (355)
T KOG0616|consen  132 FSYLRKS------GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT----  198 (355)
T ss_pred             HHHHHhc------CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCcE----
Confidence            9999543      579999999999999999999999   999999999999999999999999999999987653    


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                       -+..||+.|+|||++        +|-|+||+++|||+.|.+||.......        +|+++..++.       ..+.
T Consensus       199 -~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--------iY~KI~~~~v-------~fP~  262 (355)
T KOG0616|consen  199 -WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--------IYEKILEGKV-------KFPS  262 (355)
T ss_pred             -EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--------HHHHHHhCcc-------cCCc
Confidence             345699999999999        799999999999999999998765522        6777766543       3456


Q ss_pred             HHHHHHHHHHHHhccCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTER  358 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~R  358 (363)
                      -++.++.+++.+.|+.|-.+|
T Consensus       263 ~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  263 YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCHHHHHHHHHHHhhhhHhh
Confidence            778889999999999998888

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=304.09  Aligned_cols=235  Identities=24%  Similarity=0.354  Sum_probs=184.2

Q ss_pred             CcccccccccCCcceeeccCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..+++|.+.||+++...+.+ +||||+++...   ...+.|.+|+..+++-+|.||+-+.|+|..... .||..+|+|-|
T Consensus       396 l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS  473 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS  473 (678)
T ss_pred             ccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence            33446666666666655554 49999997433   345789999999999999999999999999877 99999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |+.+++-.+     ..|.......|++||++||.|||.   ++|||||+|..||++.++++|||+|||++..-..-....
T Consensus       474 LY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  474 LYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            999996433     679999999999999999999999   999999999999999999999999999987644322112


Q ss_pred             ccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          265 SRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .....-|...|||||++           +||||||+|+|||++|..|+..  ....++-+      .+..|.  ......
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi--~~~dqIif------mVGrG~--l~pd~s  615 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI--QNRDQIIF------MVGRGY--LMPDLS  615 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC--CChhheEE------Eecccc--cCccch
Confidence            22344578889999998           9999999999999999999983  22222211      111111  111112


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .......+++.+|+..||..++++||++.
T Consensus       616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  616 KIRSNCPKAMKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             hhhccCHHHHHHHHHHHHhcCcccCccHH
Confidence            23456778999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-39  Score=292.01  Aligned_cols=227  Identities=16%  Similarity=0.238  Sum_probs=179.9

Q ss_pred             cccccccCCcceeeccCCeeEEEEcccCCcCh----hHHHHHHHHHhccCCCceeeeeeeeee----CCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHSNEIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSE----GNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~  182 (363)
                      .++.++++.++.....++.||||+++......    +.|.+|+.++++++|+||++++|++.+    ....++||||+++
T Consensus        27 ~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~  106 (283)
T PHA02988         27 LIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTR  106 (283)
T ss_pred             EEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCC
Confidence            34566677777777777789999997554333    567799999999999999999999876    3578999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++..      ...+++.....++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++...... 
T Consensus       107 g~L~~~l~~------~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        107 GYLREVLDK------EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CcHHHHHhh------CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999943      2468899999999999999999997  2488999999999999999999999999988664322 


Q ss_pred             ccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          263 IVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                          ....++..|+|||++          +|+||||+++|||++|+.||.......        ++..+..... .    
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--------~~~~i~~~~~-~----  240 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--------IYDLIINKNN-S----  240 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcCC-C----
Confidence                234578899999987          799999999999999999997543211        2222211110 1    


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...++.+.+++.+||+.||++|||++|
T Consensus       241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  271 (283)
T PHA02988        241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKE  271 (283)
T ss_pred             CCCCCcCcHHHHHHHHHHhcCCcccCcCHHH
Confidence            1122345678999999999999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=289.42  Aligned_cols=228  Identities=21%  Similarity=0.341  Sum_probs=188.9

Q ss_pred             CcccccccccCCcceeecc-----CCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEe
Q 039471          108 PFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      .|+....+|.|+.+.+.+.     ++.||||.++++.-.    .-.+.+|++++..|+||||+.+|.+|++.+..+||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            3444456677777766553     445999999755432    2367899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |..+|.|++|+..      .+.+++.+.+.+++||..|+.|+|+   ++++|||+|.+|||+|.|+++||+|||++..+.
T Consensus       134 YaS~GeLYDYiSe------r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  134 YASGGELYDYISE------RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             ecCCccHHHHHHH------hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999943      4679999999999999999999999   999999999999999999999999999998887


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      .+...   .+..|++.|.+||++         .|.||||++||.|+.|..||++.+...        +.+++..|...  
T Consensus       205 ~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------lvrQIs~GaYr--  271 (668)
T KOG0611|consen  205 DKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------LVRQISRGAYR--  271 (668)
T ss_pred             cccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--------HHHHhhccccc--
Confidence            66543   567799999999999         799999999999999999999876533        34455544332  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            .++.+....-+|+|||-.||++|.|+.+
T Consensus       272 ------EP~~PSdA~gLIRwmLmVNP~RRATieD  299 (668)
T KOG0611|consen  272 ------EPETPSDASGLIRWMLMVNPERRATIED  299 (668)
T ss_pred             ------CCCCCchHHHHHHHHHhcCcccchhHHH
Confidence                  1223345677999999999999999753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=288.78  Aligned_cols=234  Identities=23%  Similarity=0.333  Sum_probs=182.1

Q ss_pred             CcccccccccCCcceeeccC-----CeeEEEEcccCCc---------------ChhHHHHHHHHHhccCCCceeeeeeee
Q 039471          108 PFQSLISFNLTNSKFFFLHS-----NEIAVKMLEHLKG---------------NGQEFINEVATIGRIHHFHIVRLLGFC  167 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~~~~~  167 (363)
                      .|.....+|.|..|+|.+..     +-||||++.+.+.               ..+...+|+.+|++++|+|||+++.+.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            45556677777777776643     3399999964221               124778999999999999999999998


Q ss_pred             ee--CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC
Q 039471          168 SE--GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ  245 (363)
Q Consensus       168 ~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~  245 (363)
                      .+  ...+|||+|||..|.+...-      .....+++.+.+.++++++.||+|||.   ++|+||||||+|+|++++|.
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p------~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCP------PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCC------CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            65  46899999999988875432      222339999999999999999999999   99999999999999999999


Q ss_pred             eeEeccccceeccCCcc---ccccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccc
Q 039471          246 PKISDFGLAKLCSKDIS---IVSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ  310 (363)
Q Consensus       246 ~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~  310 (363)
                      +||+|||.+...+....   ........||+.|+|||..            .||||+|++||.|+.|+-||.......  
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~--  326 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE--  326 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--
Confidence            99999999987633211   1112336799999999988            589999999999999999998776543  


Q ss_pred             cchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          311 IYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            +++++....     .......++...+.+||+++|+.||+.|.+..+
T Consensus       327 ------l~~KIvn~p-----L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~  368 (576)
T KOG0585|consen  327 ------LFDKIVNDP-----LEFPENPEINEDLKDLIKRLLEKDPEQRITLPD  368 (576)
T ss_pred             ------HHHHHhcCc-----ccCCCcccccHHHHHHHHHHhhcChhheeehhh
Confidence                  344433211     112223356778999999999999999998753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=296.85  Aligned_cols=227  Identities=23%  Similarity=0.297  Sum_probs=188.4

Q ss_pred             cccccccccCCcceeeccCCe--eEEEEcccCCcCh---hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          109 FQSLISFNLTNSKFFFLHSNE--IAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ++.+|.+++|.+++...+.+.  ||+|.+.+.....   +...+|++++++++|||||.++++|+...+.|+|.||+.| 
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-   85 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-   85 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence            455667777777666555444  9999997655444   4577899999999999999999999999999999999976 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++      .+...++|+.+..++.+++.||.|||+   ++|+|||+||.|||++.++.+|++|||+|+.++.+.. 
T Consensus        86 ~L~~il------~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   86 DLFTIL------EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             hHHHHH------HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence            999999      455789999999999999999999999   9999999999999999999999999999999877543 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                       ..+...||+.|||||++        +|.||+||++||++.|++||....-..        +.+.+..       .+...
T Consensus       156 -vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~--------Lv~~I~~-------d~v~~  219 (808)
T KOG0597|consen  156 -VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ--------LVKSILK-------DPVKP  219 (808)
T ss_pred             -eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH--------HHHHHhc-------CCCCC
Confidence             33566799999999998        899999999999999999997643211        1112211       11234


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      +...+..+..++...|+.||..|.|..
T Consensus       220 p~~~S~~f~nfl~gLL~kdP~~RltW~  246 (808)
T KOG0597|consen  220 PSTASSSFVNFLQGLLIKDPAQRLTWT  246 (808)
T ss_pred             cccccHHHHHHHHHHhhcChhhcccHH
Confidence            457889999999999999999998853

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.3e-39  Score=289.18  Aligned_cols=231  Identities=23%  Similarity=0.276  Sum_probs=179.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  +..||+|.+....    .....+.+|+.++++++|+||+++++.+.+++..++||||+++|
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g   85 (285)
T cd05631           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence            44566666666554443  4459999886322    22346789999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++....    ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++.........
T Consensus        86 ~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          86 DLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             cHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            9998885432    2468999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||..|+|||++        +|+|||||++|||++|+.||.........    +.+...+..       .....
T Consensus       159 ---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~----~~~~~~~~~-------~~~~~  224 (285)
T cd05631         159 ---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR----EEVDRRVKE-------DQEEY  224 (285)
T ss_pred             ---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH----HHHHHHhhc-------ccccC
Confidence               334689999999987        79999999999999999999765432111    111111111       11123


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ....+..+.+++.+||+.||++|||+
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGC  250 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCC
Confidence            34467789999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=301.80  Aligned_cols=231  Identities=26%  Similarity=0.431  Sum_probs=195.2

Q ss_pred             ccccccCCcceeeccCCe--eEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          112 LISFNLTNSKFFFLHSNE--IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ++.+.+|.++..+++.-.  ||||.++......++|+.|.++++.++|+|+|+++|+|..+..+|||.|||.+|+|.+|+
T Consensus       275 LGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYL  354 (1157)
T KOG4278|consen  275 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYL  354 (1157)
T ss_pred             cCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHH
Confidence            445556666655555444  999999988888899999999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      +..+.    ..++.-.++.++-||..||+||..   +++||||+..+|+|+.++..+|++|||+++++..+..+. ....
T Consensus       355 Recnr----~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAGA  426 (1157)
T KOG4278|consen  355 RECNR----SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAGA  426 (1157)
T ss_pred             HHhch----hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccCc
Confidence            87664    557778889999999999999999   999999999999999999999999999999998775432 2334


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      .-.+.|.|||-+        +|||+||++|||++|.....++..+..+       +|..++++.+      ++.+..+++
T Consensus       427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkgyR------M~~PeGCPp  493 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKGYR------MDGPEGCPP  493 (1157)
T ss_pred             cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcccc------ccCCCCCCH
Confidence            457889999988        8999999999999985544444333322       6777776654      466788999


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.++++.||+|+|.+||++.|
T Consensus       494 kVYeLMraCW~WsPsDRPsFae  515 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAE  515 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHH
Confidence            9999999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.5e-39  Score=296.10  Aligned_cols=238  Identities=28%  Similarity=0.403  Sum_probs=177.8

Q ss_pred             ccccccccCCcceeec-------cCCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeC-CceeEEEe
Q 039471          110 QSLISFNLTNSKFFFL-------HSNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEG-NRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e  178 (363)
                      ..++.+++|.++.+..       ....||||++.....  ..+.+.+|+.++.++ +|+||+++++++... ...+++||
T Consensus        13 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~e   92 (338)
T cd05102          13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVE   92 (338)
T ss_pred             eEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEe
Confidence            3455666666555432       123499999974332  235788999999999 899999999988754 46889999


Q ss_pred             ccCCCCHHHHhhhcCCC--------------------------------------------------------CCCCCCC
Q 039471          179 FMPNGSLQKFIFSKTNS--------------------------------------------------------SSHRQLS  202 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~--------------------------------------------------------~~~~~l~  202 (363)
                      |+++|+|.+++......                                                        .....++
T Consensus        93 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  172 (338)
T cd05102          93 FCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLT  172 (338)
T ss_pred             cCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCC
Confidence            99999999999653210                                                        0023588


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-
Q 039471          203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-  281 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-  281 (363)
                      +..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....+..........++..|+|||++ 
T Consensus       173 ~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  249 (338)
T cd05102         173 MEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIF  249 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhh
Confidence            89999999999999999999   99999999999999999999999999999876544332222344567889999987 


Q ss_pred             -------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccC
Q 039471          282 -------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW  353 (363)
Q Consensus       282 -------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  353 (363)
                             +||||||+++|||++ |..||........       ....+..+..      ...+...++.+.+++.+||+.
T Consensus       250 ~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~  316 (338)
T cd05102         250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRLKDGTR------MRAPENATPEIYRIMLACWQG  316 (338)
T ss_pred             cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------HHHHHhcCCC------CCCCCCCCHHHHHHHHHHccC
Confidence                   799999999999996 9999865432111       1222222211      112334567799999999999


Q ss_pred             CCCCCCCCCC
Q 039471          354 NPTERPSMPM  363 (363)
Q Consensus       354 ~p~~RPs~~e  363 (363)
                      ||++|||++|
T Consensus       317 dp~~RPs~~e  326 (338)
T cd05102         317 DPKERPTFSA  326 (338)
T ss_pred             ChhhCcCHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-39  Score=278.10  Aligned_cols=245  Identities=19%  Similarity=0.261  Sum_probs=186.9

Q ss_pred             CcccccccccCCcceeeccCCe-----eEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEE
Q 039471          108 PFQSLISFNLTNSKFFFLHSNE-----IAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIY  177 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~-----vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  177 (363)
                      -|+++..++.|+.|.|+...+.     ||+|+++.....   --..++|+.+|.+++|+|||.+-.+....  +..|+||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            4667777788888888775444     999999854422   13568999999999999999999887543  5799999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |||++ +|...+....     ..|...+++.+..|+++|++|||+   +.|+|||+||+|+|++..|.+||+|||+|+.+
T Consensus       157 e~~Eh-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             HHHHh-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            99986 8999995443     679999999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH-------HH--
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI-------YN--  319 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~-------~~--  319 (363)
                      +.....  .+..+.|.+|+|||++         .|+||+|||+.||+++++.|.+..+..+...+...+       +.  
T Consensus       228 gsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  228 GSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             cCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            776432  2556689999999998         799999999999999999998877655422111110       00  


Q ss_pred             -------HhhhccccccccCCCCcH-HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 -------RMRLGQELCLDFEEDGDE-GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 -------~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                             ++...+..--........ .++..-.+++...|..||.+|.|++|
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence                   000000000000001111 14567789999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=289.57  Aligned_cols=223  Identities=22%  Similarity=0.252  Sum_probs=176.6

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.++.+...  +..||+|++...    ......+.+|+.++++++|+||+++++++.+++..++||||+++++|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~   81 (312)
T cd05585           2 GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF   81 (312)
T ss_pred             CcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHH
Confidence            45566665555443  334999998642    223457789999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..      ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        82 ~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~  150 (312)
T cd05585          82 HHLQR------EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KT  150 (312)
T ss_pred             HHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cc
Confidence            99943      2568999999999999999999999   9999999999999999999999999999886433221  11


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....||..|+|||++        +|+|||||++|||++|+.||.......        ....+..+       ....+..
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--------~~~~~~~~-------~~~~~~~  215 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--------MYRKILQE-------PLRFPDG  215 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcC-------CCCCCCc
Confidence            345689999999987        899999999999999999997543211        12222111       1122345


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .++.+.+++.+||+.||++||++
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~  238 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGY  238 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCC
Confidence            66789999999999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=282.42  Aligned_cols=241  Identities=21%  Similarity=0.260  Sum_probs=181.5

Q ss_pred             ccccccCCcceeec-----cCCeeEEEEccc---CCcChhHHHHHHHHHhccCCCceeeeeeeeee-----CCceeEEEe
Q 039471          112 LISFNLTNSKFFFL-----HSNEIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSE-----GNRRTLIYE  178 (363)
Q Consensus       112 ~~~~~~~~~~~~~~-----~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e  178 (363)
                      +...|.|..|+++-     .+..||||++.+   .....++..+|++.|++++|+||+.+.+.+..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            44555666665543     345599999973   33345788999999999999999999998854     357899999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      +|+ -+|.+.+++      +..++...+..++.|+++||+|+|+   .+++|||+||.|+|++.+..+||+|||+|+...
T Consensus       107 lMe-tDL~~iik~------~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  107 LME-TDLHQIIKS------QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             HHh-hHHHHHHHc------CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence            995 599999943      3459999999999999999999999   999999999999999999999999999999986


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch-------HHHHHHHhh
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF-------PEWIYNRMR  322 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~-------~~~~~~~~~  322 (363)
                      ........+..+.|.+|+|||++         .||||.|||+.||++|++.|.+.....+...+       .+.....+.
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            54222223667789999999998         79999999999999999999876554332111       011111111


Q ss_pred             h----------ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 L----------GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .          .+.....+ ....+...+...+++.+||..||.+|+|++|
T Consensus       257 s~~ar~yi~slp~~p~~~f-~~~fp~a~p~AidLlekmL~fdP~kRita~e  306 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPF-SSIFPNANPLAIDLLEKMLVFDPKKRITAEE  306 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCH-HHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence            0          00000000 0112255677899999999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-38  Score=288.68  Aligned_cols=225  Identities=24%  Similarity=0.331  Sum_probs=168.3

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC-----------
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS-----------  195 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------  195 (363)
                      .||+|.+....  ....+|.+|++++.+++|+||+++++++.+.+..+++|||+++++|.+++......           
T Consensus        48 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  127 (304)
T cd05096          48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP  127 (304)
T ss_pred             EEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccc
Confidence            39999987532  22357899999999999999999999999999999999999999999998553211           


Q ss_pred             --CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccc
Q 039471          196 --SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS  273 (363)
Q Consensus       196 --~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  273 (363)
                        .....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...............++.
T Consensus       128 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~  204 (304)
T cd05096         128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI  204 (304)
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCc
Confidence              112357889999999999999999999   999999999999999999999999999998764433222223344678


Q ss_pred             cccCCccc--------cCceehhHHHHHHhc--CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHH
Q 039471          274 GYIAPELF--------SRNFCYGMMLLEMVG--CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKL  343 (363)
Q Consensus       274 ~y~aPE~~--------~Di~slG~il~el~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  343 (363)
                      .|+|||.+        +|+||||+++|||++  +..|+.......    ...............   .....+..++..+
T Consensus       205 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  277 (304)
T cd05096         205 RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ----VIENAGEFFRDQGRQ---VYLFRPPPCPQGL  277 (304)
T ss_pred             cccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHH----HHHHHHHHhhhcccc---ccccCCCCCCHHH
Confidence            89999986        799999999999986  455665432211    111111111111000   0011223456779


Q ss_pred             HHHHHHhccCCCCCCCCCCC
Q 039471          344 AIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       344 ~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+++.+||+.+|++|||++|
T Consensus       278 ~~li~~cl~~~p~~RPs~~~  297 (304)
T cd05096         278 YELMLQCWSRDCRERPSFSD  297 (304)
T ss_pred             HHHHHHHccCCchhCcCHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.9e-39  Score=292.77  Aligned_cols=223  Identities=19%  Similarity=0.230  Sum_probs=175.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  ++.||||++...    ......+.+|+.++++++|+||+++++++..++..++||||+++++|
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L   82 (323)
T cd05571           3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL   82 (323)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcH
Confidence            455566655544433  344999998742    22335678899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        83 ~~~l~~------~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  151 (323)
T cd05571          83 FFHLSR------ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             HHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence            999843      3568999999999999999999999   9999999999999999999999999999875432221  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||+.|+|||++        +|+|||||++|||++|+.||.......        ....+..+.       ...+.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~-------~~~p~  216 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEE-------IRFPR  216 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCC-------CCCCC
Confidence            1345689999999988        899999999999999999996543211        112221111       12234


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ..+.++.+++.+||+.||++||+
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCC
Confidence            46778999999999999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=289.01  Aligned_cols=232  Identities=19%  Similarity=0.258  Sum_probs=180.2

Q ss_pred             CcccccccccCCcceeeccCCe--eEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNE--IAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .+..++.|++|.|..+..++.+  +|+|+++++.    ++.+....|-.+|....+++||++|-.|.+...+||||||++
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            3344455555555555444444  9999998653    344567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      ||++..+|      .....|+++..+.++.+++.||+-||+   .|+|||||||+|+|||..|.+||+|||++.-+....
T Consensus       225 GGD~mTLL------~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  225 GGDMMTLL------MRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             CccHHHHH------HhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            99999999      445789999999999999999999999   999999999999999999999999999986432100


Q ss_pred             ---------------------ccc-----c-------------------cccccccccccCCccc--------cCceehh
Q 039471          262 ---------------------SIV-----S-------------------RTAARGTSGYIAPELF--------SRNFCYG  288 (363)
Q Consensus       262 ---------------------~~~-----~-------------------~~~~~gt~~y~aPE~~--------~Di~slG  288 (363)
                                           ...     .                   ....+||+.|+|||++        +|.||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                 000     0                   1123699999999999        8999999


Q ss_pred             HHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          289 MMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       289 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ||+|||+.|-+||.......        .++++..-...   +........+.+..++|.+|+. ||++|.-
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~---l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQE--------TYRKIVNWRET---LKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhh---ccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999998876554        33333221111   1112223445788999999999 9999964

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=289.02  Aligned_cols=233  Identities=20%  Similarity=0.278  Sum_probs=190.5

Q ss_pred             CCCcccccccccCCcceeecc--CCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          106 ACPFQSLISFNLTNSKFFFLH--SNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      +..++.++.+.||.++.....  ++.||+|++.-.  +...+++.+|+.+|.+++++||.++||.+..+..+|++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            334455666666666554433  344999999743  3445788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      ||++.+.+..      ...+.+..+.-++++++.|+.|||+   .+.+|||||+.|||+..+|.+|++|||.+..+..+.
T Consensus        95 gGsv~~lL~~------~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   95 GGSVLDLLKS------GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             Ccchhhhhcc------CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999999943      3445889999999999999999999   999999999999999999999999999999887765


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..  +...+||+.|||||++        .||||||++.+||++|.+|+.......-...              ......+
T Consensus       166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl--------------Ipk~~PP  229 (467)
T KOG0201|consen  166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL--------------IPKSAPP  229 (467)
T ss_pred             hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe--------------ccCCCCC
Confidence            43  3678899999999999        8999999999999999999876544322111              1112223


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+++.+++|+..||+.||++|||+++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~  259 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKE  259 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHH
Confidence            344578889999999999999999999874

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-39  Score=290.10  Aligned_cols=235  Identities=22%  Similarity=0.296  Sum_probs=194.7

Q ss_pred             CCCcccccccccCCcceeeccCCe--eEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCc-eeEEEec
Q 039471          106 ACPFQSLISFNLTNSKFFFLHSNE--IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNR-RTLIYEF  179 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~  179 (363)
                      +.....+|.+.||....+..+.+.  +++|.+.-.   ....+..++|+.++++++|||||.+.+.|.+++. .+|+|+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            444556677777776666655544  999998633   3344578899999999999999999999998887 9999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++||+|.+.+...+    +..++++.+..|+.|++.|+.|||+   ++|+|||||+.||+++.++.+||.|||+|+.+..
T Consensus        86 ~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             cCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999996654    3679999999999999999999999   9999999999999999999999999999999987


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ....  .....||+.|+.||++        +|||||||++|||++-+++|...+...        +..++..+.      
T Consensus       159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--------Li~ki~~~~------  222 (426)
T KOG0589|consen  159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--------LILKINRGL------  222 (426)
T ss_pred             chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--------HHHHHhhcc------
Confidence            6532  2567799999999999        899999999999999999998765432        222222121      


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      -...+..++.++..++..|++.+|+.||++.|
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~  254 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALE  254 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHH
Confidence            23456778899999999999999999999853

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-38  Score=290.28  Aligned_cols=222  Identities=22%  Similarity=0.280  Sum_probs=177.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||+|++....    ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        25 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  104 (329)
T PTZ00263         25 TLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGE  104 (329)
T ss_pred             EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCCh
Confidence            3455556655555443  3449999986432    234578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......   
T Consensus       105 L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---  172 (329)
T PTZ00263        105 LFTHLRK------AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---  172 (329)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence            9999943      2568999999999999999999999   999999999999999999999999999998765432   


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....||+.|+|||++        +|+|||||++|||++|+.||.......        .+..+..+..       ..+
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~~~-------~~p  235 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--------IYEKILAGRL-------KFP  235 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCCc-------CCC
Confidence              234589999999987        899999999999999999996543211        2233322211       112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ...+..+.+++.+||+.||++||+.
T Consensus       236 ~~~~~~~~~li~~~L~~dP~~R~~~  260 (329)
T PTZ00263        236 NWFDGRARDLVKGLLQTDHTKRLGT  260 (329)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2345678999999999999999973

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=287.38  Aligned_cols=238  Identities=22%  Similarity=0.300  Sum_probs=183.9

Q ss_pred             ccccccCCcceeeccC-CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLHS-NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+.||-+......+ ..||||+++....  .+.+|.+|+++|.+++||||++++|+|..+..+++|+|||++|+|..+
T Consensus       546 iGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqF  625 (807)
T KOG1094|consen  546 IGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQF  625 (807)
T ss_pred             hcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHH
Confidence            4455555555544444 5599999985432  347899999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +..+..    ..+......+|+.||+.||+||.+   .+++|||+.+.|||++.++++||+|||.++.+-.+..+.....
T Consensus       626 l~ahea----pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr  698 (807)
T KOG1094|consen  626 LSAHEL----PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR  698 (807)
T ss_pred             HHhccC----cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence            966543    224556677799999999999999   9999999999999999999999999999997766665555566


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHh--cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMV--GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      .+-++.|||+|.+        ||+|+||+++||++  +...|+....+.+-.    +.....+.   ......-...+.-
T Consensus       699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~---~~~~~~~l~~P~~  771 (807)
T KOG1094|consen  699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFR---DQGRQVVLSRPPA  771 (807)
T ss_pred             eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcC---CCCcceeccCCCc
Confidence            6778999999988        99999999999987  466777654433210    00111111   0111112234556


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.++.+++++||..+.++|||+++
T Consensus       772 cp~~lyelml~Cw~~es~~RPsFe~  796 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRPSFEQ  796 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCCCHHH
Confidence            6778999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=288.02  Aligned_cols=222  Identities=22%  Similarity=0.262  Sum_probs=177.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||+|++....    ...+.+.+|+.++++++|+||+++++++.++...++||||++++
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   86 (291)
T cd05612           7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG   86 (291)
T ss_pred             eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence            34556666666555544  4459999986322    23456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......  
T Consensus        87 ~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          87 ELFSYLRN------SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             CHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            99999943      2568999999999999999999999   999999999999999999999999999988764322  


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....|+..|+|||++        +|+|||||++|||++|+.||.......        ++..+..+.       ...
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~-------~~~  217 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILAGK-------LEF  217 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------cCC
Confidence               234589999999987        799999999999999999997643211        223322221       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      +...+..+.+++.+||+.||.+||+
T Consensus       218 ~~~~~~~~~~li~~~l~~dp~~R~~  242 (291)
T cd05612         218 PRHLDLYAKDLIKKLLVVDRTRRLG  242 (291)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHccC
Confidence            2334677999999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-39  Score=267.42  Aligned_cols=215  Identities=27%  Similarity=0.411  Sum_probs=179.6

Q ss_pred             cCCeeEEEEcccCC-----cCh----hHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC
Q 039471          126 HSNEIAVKMLEHLK-----GNG----QEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS  195 (363)
Q Consensus       126 ~~~~vAvK~~~~~~-----~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~  195 (363)
                      .+.+.|+|++....     .+.    +.-.+|+.+|+++. ||||+++.++++.+...++|+|.|+.|-|.+|+      
T Consensus        41 t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL------  114 (411)
T KOG0599|consen   41 TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL------  114 (411)
T ss_pred             cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh------
Confidence            35558999885321     112    34568999999996 999999999999999999999999999999999      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccc
Q 039471          196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY  275 (363)
Q Consensus       196 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  275 (363)
                      +..-.+++...++|++|+..|++|||.   .+|+|||+||+|||++++.++||+|||.|+.+.++...   ....||++|
T Consensus       115 ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL---relCGTPgY  188 (411)
T KOG0599|consen  115 TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL---RELCGTPGY  188 (411)
T ss_pred             hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCchhH---HHhcCCCcc
Confidence            344679999999999999999999999   99999999999999999999999999999999888765   456699999


Q ss_pred             cCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          276 IAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       276 ~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      +|||.+              .|+|+.|+++|.|+.|.+||.-.....        +.+.+..|+   ..+..+...+.+.
T Consensus       189 LAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml--------MLR~ImeGk---yqF~speWadis~  257 (411)
T KOG0599|consen  189 LAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML--------MLRMIMEGK---YQFRSPEWADISA  257 (411)
T ss_pred             cChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH--------HHHHHHhcc---cccCCcchhhccc
Confidence            999998              799999999999999999986543322        122222222   2333456678888


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++++.+||+.||.+|.|++|
T Consensus       258 ~~KdLIsrlLqVdp~~Ritake  279 (411)
T KOG0599|consen  258 TVKDLISRLLQVDPTKRITAKE  279 (411)
T ss_pred             cHHHHHHHHHeeCchhcccHHH
Confidence            9999999999999999999865

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.5e-39  Score=280.81  Aligned_cols=241  Identities=23%  Similarity=0.274  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeeccCC--eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC-----ceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHSN--EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN-----RRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~--~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~  182 (363)
                      ..++.|.||.+........  .||||+.-..+...   -+|+.+|+++.|||||++.-+|....     ...+|||||+.
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~  106 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE  106 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence            3456777777776665544  49999886544322   27999999999999999999885332     45689999985


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceeccCCc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~  261 (363)
                       +|+++++...  ..+..++.-.++-+..||++||.|||+   .+|+||||||.|+|+|.+ |.+||+|||.|+.+..+.
T Consensus       107 -tL~~~~r~~~--~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  107 -TLYRVIRHYT--RANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             -HHHHHHHHHh--hcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence             9999997543  234678888999999999999999999   999999999999999955 999999999999988776


Q ss_pred             cccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHH----HHhhhc--c-
Q 039471          262 SIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY----NRMRLG--Q-  325 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~--~-  325 (363)
                      ..   .....|..|+|||++         .||||.|||+.||+-|++.|.+.....+...+.+.+.    +.+..-  . 
T Consensus       181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            54   456689999999999         7999999999999999999988766554333222110    000000  0 


Q ss_pred             ------ccc-cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          326 ------ELC-LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       326 ------~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                            ... ...........+++..+++.++|+.+|.+|.|+.
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~  301 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL  301 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence                  000 0000113345677899999999999999999864

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-38  Score=301.44  Aligned_cols=233  Identities=20%  Similarity=0.268  Sum_probs=180.1

Q ss_pred             ccccccCCcceeeccC---CeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLHS---NEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~---~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++......   ..||+|.+.... .....+.+|+.+++.++|+||+++++++..++..++||||+++|+|.+
T Consensus        75 lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~  154 (478)
T PTZ00267         75 VGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK  154 (478)
T ss_pred             EEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHH
Confidence            3555666555444332   348888765332 233567789999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....  .....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++............
T Consensus       155 ~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~  229 (478)
T PTZ00267        155 QIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS  229 (478)
T ss_pred             HHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccccc
Confidence            885432  123568999999999999999999999   999999999999999999999999999998765443222224


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...||+.|+|||++        +|+|||||++|||++|+.||.......        +...+..+..      ...+..+
T Consensus       230 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--------~~~~~~~~~~------~~~~~~~  295 (478)
T PTZ00267        230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--------IMQQVLYGKY------DPFPCPV  295 (478)
T ss_pred             ccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC------CCCCccC
Confidence            45689999999987        799999999999999999986543211        1222221211      1122345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++|||++|
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~  319 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQ  319 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHH
Confidence            678999999999999999999753

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-38  Score=280.36  Aligned_cols=232  Identities=28%  Similarity=0.464  Sum_probs=176.4

Q ss_pred             cccccccCCcceeecc------CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH------SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+.+|.+..+.+.      +..|+||+++....  ..+.|.+|++.+++++|+||++++|++......++|+||+++
T Consensus         6 ~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~   85 (259)
T PF07714_consen    6 QIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPG   85 (259)
T ss_dssp             EEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TT
T ss_pred             EEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccc
Confidence            3566666666665555      33499999965332  257899999999999999999999999988889999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++....    ...+++..+..|+.|++.||.|||+   .+++|+||+++||++++++.+||+|||++........
T Consensus        86 g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   86 GSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             EBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccc----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            99999997652    2568999999999999999999999   9999999999999999999999999999988743333


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ............|+|||.+        +||||||+++|||++ |+.|+.......        +...+..+..      .
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--------~~~~~~~~~~------~  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--------IIEKLKQGQR------L  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--------HHHHHHTTEE------T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccc------c
Confidence            2233444577889999998        899999999999999 677765542211        2233332322      1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..++..+.+++..||+.+|++||||+|
T Consensus       225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~  254 (259)
T PF07714_consen  225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQE  254 (259)
T ss_dssp             TSBTTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred             eeccchhHHHHHHHHHHcCCChhhCcCHHH
Confidence            233445777999999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=289.02  Aligned_cols=232  Identities=19%  Similarity=0.207  Sum_probs=179.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||||++....    ...+.+.+|+.++..++|+||+++++++.++...++||||++++
T Consensus         7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~   86 (333)
T cd05600           7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG   86 (333)
T ss_pred             EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence            34555566665555443  3459999987432    23457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++......   
T Consensus        87 ~L~~~l~~------~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~---  154 (333)
T cd05600          87 DFRTLLNN------LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY---  154 (333)
T ss_pred             CHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc---
Confidence            99999943      2568999999999999999999999   99999999999999999999999999998765431   


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc-cccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE-LCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  334 (363)
                        .....||..|+|||++        +|+|||||++|||++|..||.......        ....+..... ........
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~  224 (333)
T cd05600         155 --ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQRPVYDD  224 (333)
T ss_pred             --cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccCCCCCc
Confidence              1345689999999987        899999999999999999997643322        1111111111 10011111


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+.++.+++.+||+.+|++|||++|
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~  253 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLED  253 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence            11245778999999999999999999764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=263.12  Aligned_cols=235  Identities=22%  Similarity=0.262  Sum_probs=179.7

Q ss_pred             cccccCCcceeeccC--CeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEeccCCCC
Q 039471          113 ISFNLTNSKFFFLHS--NEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFMPNGS  184 (363)
Q Consensus       113 ~~~~~~~~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~s  184 (363)
                      +.+|++-+..+.--.  ..+|+|++.-+. +..+...+|++..++++|||+++++++...+     ...||+++|...||
T Consensus        30 geGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gs  109 (302)
T KOG2345|consen   30 GEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGS  109 (302)
T ss_pred             cCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcccc
Confidence            444444444443222  239999987554 5567889999999999999999999987432     35899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |.+.+....  .++..+++.+++.|+.++++||++||+   ..  +.||||||.|||+++.+.++|.|||.+...+-...
T Consensus       110 l~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~  184 (302)
T KOG2345|consen  110 LLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE  184 (302)
T ss_pred             HHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence            999996654  344689999999999999999999999   66  99999999999999999999999999876542211


Q ss_pred             -------ccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          263 -------IVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       263 -------~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                             .......+.|..|+|||++           .|||||||++|+|+.|..||+..........+.      +..+
T Consensus       185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA------v~n~  258 (302)
T KOG2345|consen  185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA------VQNA  258 (302)
T ss_pred             chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe------eecc
Confidence                   1112334578999999998           799999999999999999998766533221110      0000


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           .........++..+.+++.+||+.||.+||++.|
T Consensus       259 -----q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~  292 (302)
T KOG2345|consen  259 -----QISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE  292 (302)
T ss_pred             -----ccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence                 1111223348889999999999999999999753

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.7e-38  Score=280.22  Aligned_cols=232  Identities=22%  Similarity=0.249  Sum_probs=178.4

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.++.+...  ++.||+|.+....    ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~   81 (280)
T cd05608           2 GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR   81 (280)
T ss_pred             CCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHH
Confidence            44556655544433  3459999986432    22356788999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      .++....  .....+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||++.........  .
T Consensus        82 ~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~  154 (280)
T cd05608          82 YHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T  154 (280)
T ss_pred             HHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence            8885432  223578999999999999999999999   99999999999999999999999999999876543321  1


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....||..|+|||++        +|+||||+++|||++|+.||.........    .........       .....+..
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~-------~~~~~~~~  223 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILN-------DSVTYPDK  223 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcc-------cCCCCccc
Confidence            345689999999987        89999999999999999999754322110    001111110       01122345


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ++..+.+++.+||+.||++||+++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCC
Confidence            677899999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.8e-38  Score=286.92  Aligned_cols=224  Identities=21%  Similarity=0.237  Sum_probs=176.2

Q ss_pred             cccccccCCcceeec-----cCCeeEEEEcccC-----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFL-----HSNEIAVKMLEHL-----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++.+++|.++.+..     .++.||||+++..     ......+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~   82 (323)
T cd05584           3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL   82 (323)
T ss_pred             eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence            456666666665543     2344999998642     223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          83 SGGELFMHLER------EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCchHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            99999999843      3568899999999999999999999   99999999999999999999999999998754332


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...  .....||..|+|||++        +|+||||+++|||++|+.||.......        ....+..+.       
T Consensus       154 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--------~~~~~~~~~-------  216 (323)
T cd05584         154 GTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--------TIDKILKGK-------  216 (323)
T ss_pred             CCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCC-------
Confidence            221  1334689999999987        899999999999999999997643221        122222111       


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ...+...++.+.+++.+||+.+|++||+
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~  244 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLG  244 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCC
Confidence            1123345677899999999999999994

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.3e-38  Score=288.73  Aligned_cols=223  Identities=20%  Similarity=0.246  Sum_probs=175.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  +..||+|++...    ......+.+|+.+++.++|+||+++++++..+...++||||+++++|
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L   82 (328)
T cd05593           3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL   82 (328)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCH
Confidence            455566655554433  344999999643    22345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        83 ~~~l~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  151 (328)
T cd05593          83 FFHLSR------ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T  151 (328)
T ss_pred             HHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence            998843      3568999999999999999999999   9999999999999999999999999999876432221  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||..|+|||++        +|+|||||++|||++|+.||.......        ....+....       ...+.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~~-------~~~p~  216 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMED-------IKFPR  216 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccCC-------ccCCC
Confidence            1334689999999987        799999999999999999996543211        111111111       12233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      .++.++.+++.+||+.||++||+
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCC
Confidence            45678999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-38  Score=289.49  Aligned_cols=221  Identities=21%  Similarity=0.260  Sum_probs=176.8

Q ss_pred             ccccccccCCcceeeccC---CeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS---NEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~---~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+...+   ..||+|++...    ....+.+.+|+.+++.++|+||+++++++.+++..++||||+++
T Consensus        36 ~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~  115 (340)
T PTZ00426         36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIG  115 (340)
T ss_pred             EEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCC
Confidence            334556666655554333   24999988632    23346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       116 g~L~~~i~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-  185 (340)
T PTZ00426        116 GEFFTFLRR------NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-  185 (340)
T ss_pred             CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence            999999943      2568999999999999999999999   999999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                          ....||+.|+|||++        +|+|||||++|||++|+.||......        ..+..+..+..       .
T Consensus       186 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~-------~  246 (340)
T PTZ00426        186 ----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGII-------Y  246 (340)
T ss_pred             ----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCC-------C
Confidence                234589999999987        89999999999999999999764321        13333332211       1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      .+...++.+.+++.+||+.+|++|+
T Consensus       247 ~p~~~~~~~~~li~~~l~~dp~~R~  271 (340)
T PTZ00426        247 FPKFLDNNCKHLMKKLLSHDLTKRY  271 (340)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHcC
Confidence            2233556789999999999999996

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.7e-38  Score=288.12  Aligned_cols=227  Identities=20%  Similarity=0.208  Sum_probs=178.2

Q ss_pred             cccccccCCcceeec-----cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFL-----HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+..     .++.||+|++....   .....+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus         3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~   82 (318)
T cd05582           3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG   82 (318)
T ss_pred             eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence            345556665554432     23459999987432   2335677899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~L~~~l~~------~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          83 GDLFTRLSK------EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            999999843      2568999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....|+..|+|||++        +|+||||+++|||++|+.||.......        ....+....       ..
T Consensus       154 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--------~~~~i~~~~-------~~  216 (318)
T cd05582         154 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--------TMTMILKAK-------LG  216 (318)
T ss_pred             c--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--------HHHHHHcCC-------CC
Confidence            1  1334689999999987        899999999999999999997543221        112221111       11


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+++.+.+++.+||+.||++|||+.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            23345677899999999999999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.5e-38  Score=288.73  Aligned_cols=223  Identities=20%  Similarity=0.244  Sum_probs=175.5

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  ++.||+|++...    ......+.+|+.++++++|+||+++++++..+...++||||+++++|
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L   82 (323)
T cd05595           3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL   82 (323)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcH
Confidence            455666666555433  345999998642    22335677899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..++..      ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        83 ~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  151 (323)
T cd05595          83 FFHLSR------ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             HHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence            988843      3568999999999999999999999   9999999999999999999999999999875432221  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||..|+|||++        +|+|||||++|||++|+.||.......        ....+....       ...+.
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~-------~~~p~  216 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-------IRFPR  216 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC-------CCCCC
Confidence            1335689999999987        799999999999999999997543221        111111111       11233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      .+++.+.+++.+||+.||++||+
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCC
Confidence            45678999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.4e-37  Score=273.88  Aligned_cols=230  Identities=22%  Similarity=0.362  Sum_probs=179.4

Q ss_pred             cccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++.+++|.++.+..... .+|+|.+.......++|.+|+.++++++|+||+++++++.++...+++|||+++++|.+++
T Consensus        11 ~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~   90 (256)
T cd05114          11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL   90 (256)
T ss_pred             EecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence            355666666655544433 4999998765555678999999999999999999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.++........ .....
T Consensus        91 ~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~  161 (256)
T cd05114          91 RQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGA  161 (256)
T ss_pred             HhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCC
Confidence            5322     358999999999999999999999   99999999999999999999999999998865433221 11233


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+...      ..+...+
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--------~~~~i~~~~~~------~~~~~~~  227 (256)
T cd05114         162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--------VVEMISRGFRL------YRPKLAS  227 (256)
T ss_pred             CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCCC------CCCCCCC
Confidence            356689999987        899999999999999 888886543211        11222222111      1122345


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.+|++|||++|
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~~~  250 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTFAE  250 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHH
Confidence            67899999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.9e-38  Score=291.30  Aligned_cols=185  Identities=24%  Similarity=0.331  Sum_probs=155.1

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccC-C-----CceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIH-H-----FHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      +|.+.||.+...+-.  ++.||||++++......+...|+.+|..|+ |     -|+|+++++|...++.+||+|.++ .
T Consensus       194 LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~  272 (586)
T KOG0667|consen  194 LGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-T  272 (586)
T ss_pred             ecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-h
Confidence            344444444444433  344999999988877788889999999997 4     399999999999999999999995 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC--CCCeeEeccccceeccCCc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|++++..++.    ..++...++.++.||+.||.+||+   .+|||+||||+|||+.+  ...+||+|||.|.......
T Consensus       273 NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v  345 (586)
T KOG0667|consen  273 NLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV  345 (586)
T ss_pred             hHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence            99999976554    679999999999999999999999   99999999999999964  3479999999999876543


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS  309 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~  309 (363)
                           .....+..|+|||++        .||||||||+.||.+|.+.|.+..+.+.
T Consensus       346 -----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ  396 (586)
T KOG0667|consen  346 -----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ  396 (586)
T ss_pred             -----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence                 245678899999999        8999999999999999888877665543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.2e-37  Score=287.91  Aligned_cols=238  Identities=26%  Similarity=0.393  Sum_probs=177.3

Q ss_pred             ccccccccCCcceeec-------cCCeeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFL-------HSNEIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ..++.+++|.+..+..       ....||||+++...  ...+.+.+|+.++..+ +|+||+++++++..+...++||||
T Consensus        41 ~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~  120 (375)
T cd05104          41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEY  120 (375)
T ss_pred             heecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehh
Confidence            3345555555543321       12249999997433  2345788999999999 899999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCC----------------------------------------------------------------
Q 039471          180 MPNGSLQKFIFSKTNS----------------------------------------------------------------  195 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~----------------------------------------------------------------  195 (363)
                      +++|+|.+++......                                                                
T Consensus       121 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (375)
T cd05104         121 CCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVT  200 (375)
T ss_pred             ccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccH
Confidence            9999999999653210                                                                


Q ss_pred             -----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccc
Q 039471          196 -----SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR  270 (363)
Q Consensus       196 -----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  270 (363)
                           .....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++...............
T Consensus       201 ~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  277 (375)
T cd05104         201 SEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR  277 (375)
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCC
Confidence                 012357899999999999999999999   999999999999999999999999999998765443322223334


Q ss_pred             ccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          271 GTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       271 gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      ++..|+|||.+        +|+||||+++|||++ |..||........       ....+..+...      ..+...+.
T Consensus       278 ~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~~  344 (375)
T cd05104         278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-------FYKMIKEGYRM------LSPECAPS  344 (375)
T ss_pred             CCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-------HHHHHHhCccC------CCCCCCCH
Confidence            56789999987        899999999999997 7888765322111       11222211111      11223356


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+++.+||+.||++||||+|
T Consensus       345 ~l~~li~~cl~~dP~~RPs~~e  366 (375)
T cd05104         345 EMYDIMKSCWDADPLKRPTFKQ  366 (375)
T ss_pred             HHHHHHHHHccCChhHCcCHHH
Confidence            7999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-37  Score=285.80  Aligned_cols=181  Identities=25%  Similarity=0.345  Sum_probs=149.3

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.+..+...  +..||+|++....  ...+++.+|++++++++|+||+++++++..++..++||||+++++|.+
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (331)
T cd06649          13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   92 (331)
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHH
Confidence            444555544444433  2339999886432  223578999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++..      ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++........    .
T Consensus        93 ~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~  160 (331)
T cd06649          93 VLKE------AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N  160 (331)
T ss_pred             HHHH------cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc----c
Confidence            9943      2468999999999999999999998  23699999999999999999999999999876543221    3


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcc
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPA  304 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~  304 (363)
                      ...|+..|+|||++        +|+||||+++|||++|+.||...
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            34689999999987        89999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-37  Score=282.72  Aligned_cols=243  Identities=21%  Similarity=0.237  Sum_probs=173.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  +..||||++....  .....+.+|+.++++++|+||+++++++.++...++||||++ ++|
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l   89 (303)
T cd07869          11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL   89 (303)
T ss_pred             eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence            33455555555544433  3459999987433  233467899999999999999999999999999999999996 588


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        90 ~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  159 (303)
T cd07869          90 CQYMDKH-----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--T  159 (303)
T ss_pred             HHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--c
Confidence            8887432     2458899999999999999999999   9999999999999999999999999999876533221  1


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhh--------h-cccc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMR--------L-GQEL  327 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~~  327 (363)
                      .....++..|+|||++         +|+||+||++|||++|..||.....................        . ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            1334578999999976         69999999999999999999764332211100000000000        0 0000


Q ss_pred             cccc---CCCC------cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDF---EEDG------DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~---~~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....   ....      ....+..+.+++.+||+.||++|||++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~  284 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA  284 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence            0000   0000      0012356889999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.5e-37  Score=275.49  Aligned_cols=231  Identities=22%  Similarity=0.278  Sum_probs=177.2

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.++.+...  ++.||+|.+....    .....+..|++++++++|+||+++++++..+...++||||+++++|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~   81 (277)
T cd05607           2 GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK   81 (277)
T ss_pred             CCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHH
Confidence            45666666655443  4459999886321    12235567999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....    ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.........   
T Consensus        82 ~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---  151 (277)
T cd05607          82 YHIYNVG----ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---  151 (277)
T ss_pred             HHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---
Confidence            8885432    2458999999999999999999999   99999999999999999999999999998876543221   


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....|+..|+|||++        +|+||+||++|||++|+.||.........   .+ +........ .     ......
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~-~~~~~~~~~-~-----~~~~~~  221 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EE-LKRRTLEDE-V-----KFEHQN  221 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HH-HHHHhhccc-c-----cccccc
Confidence            334588999999987        89999999999999999998654321110   01 111111110 0     011124


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.++.+++.+||+.||++|||++|
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~  246 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSRE  246 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCcc
Confidence            5678999999999999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-37  Score=289.19  Aligned_cols=228  Identities=20%  Similarity=0.303  Sum_probs=174.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  ++.||||++.....  ..+.+.+|++++++++|+||+++++++..++..++||||+++++|
T Consensus        80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  159 (353)
T PLN00034         80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL  159 (353)
T ss_pred             hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence            34555566655554443  44599999864332  235788999999999999999999999999999999999999998


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+.          ...++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       160 ~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  224 (353)
T PLN00034        160 EGT----------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P  224 (353)
T ss_pred             ccc----------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence            653          235678889999999999999999   9999999999999999999999999999987654321  1


Q ss_pred             cccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          266 RTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .....||..|+|||++             +|||||||++|||++|+.||.......    +... .......      ..
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~-~~~~~~~------~~  293 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASL-MCAICMS------QP  293 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHH-HHHHhcc------CC
Confidence            1345689999999975             699999999999999999997322111    1111 1111101      11


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......+.++.+++.+||+.||++|||++|
T Consensus       294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  324 (353)
T PLN00034        294 PEAPATASREFRHFISCCLQREPAKRWSAMQ  324 (353)
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence            1233456678999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-38  Score=260.72  Aligned_cols=225  Identities=24%  Similarity=0.321  Sum_probs=188.4

Q ss_pred             ccccccCCcceeeccCCe--eEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLHSNE--IAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~--vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+.||.++....+.+.  ||+|++.++.    +-.+++.+|+++-..|+||||.++|++|-+....||++||.++|+|
T Consensus        30 LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel  109 (281)
T KOG0580|consen   30 LGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGEL  109 (281)
T ss_pred             ccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchH
Confidence            344566676666666555  9999996443    2335788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+.+.+...    ..+++.....++.|++.||.|+|.   .+++||||||+|+|++..+.+||+|||.+...+.+    .
T Consensus       110 ~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----k  178 (281)
T KOG0580|consen  110 YKDLQEGRM----KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----K  178 (281)
T ss_pred             HHHHHhccc----ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC----C
Confidence            999965443    679999999999999999999999   99999999999999999999999999999876533    2


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      +....||..|.+||+.        .|+|++|++.||++.|.+||.......        .|+++.+-..       ..+.
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--------tYkrI~k~~~-------~~p~  243 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--------TYKRIRKVDL-------KFPS  243 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--------HHHHHHHccc-------cCCc
Confidence            3667799999999998        799999999999999999998765322        5555553322       2345


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..+....++|.+|+..+|.+|.+..
T Consensus       244 ~is~~a~dlI~~ll~~~p~~r~~l~  268 (281)
T KOG0580|consen  244 TISGGAADLISRLLVKNPIERLALT  268 (281)
T ss_pred             ccChhHHHHHHHHhccCccccccHH
Confidence            6778899999999999999998754

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=270.34  Aligned_cols=245  Identities=22%  Similarity=0.264  Sum_probs=179.6

Q ss_pred             ccccccccCCcceeec-----cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCc-eeeeeeeeeeCC------cee
Q 039471          110 QSLISFNLTNSKFFFL-----HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFH-IVRLLGFCSEGN------RRT  174 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~  174 (363)
                      .++...|.|+.+.|+.     .++.||+|++.-..+   --...++|+.++++++|+| |+++++++...+      ..+
T Consensus        14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~   93 (323)
T KOG0594|consen   14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY   93 (323)
T ss_pred             HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence            3344445555555443     244599999975433   3356789999999999999 999999997766      889


Q ss_pred             EEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       175 lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      +|+||+. .+|.+++.......  ..++...++.++.||+.||+|||+   ++|+||||||+|||++++|.+||+|||+|
T Consensus        94 lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   94 LVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence            9999996 59999996654311  467779999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHH------
Q 039471          255 KLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYN------  319 (363)
Q Consensus       255 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~------  319 (363)
                      +...-....  ....++|.+|+|||++         .||||+||++.||+++++.|.+..+..+...+...+..      
T Consensus       168 ra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            976533221  2456689999999999         79999999999999999999887764432221111100      


Q ss_pred             -HhhhccccccccCCC--------CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          320 -RMRLGQELCLDFEED--------GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       320 -~~~~~~~~~~~~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                       ......+....+...        ..........+++.+||+.+|.+|.|++
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~  297 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK  297 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence             000000000000000        0111224788999999999999999975

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.9e-37  Score=283.56  Aligned_cols=224  Identities=22%  Similarity=0.256  Sum_probs=176.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  ++.||||++...    ....+.+.+|..++..+ +|+||+++++++...+..++||||+++++
T Consensus         3 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~   82 (320)
T cd05590           3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGD   82 (320)
T ss_pred             eeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCch
Confidence            456666666655544  334999998642    23345677898888876 69999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........ 
T Consensus        83 L~~~i~~------~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-  152 (320)
T cd05590          83 LMFHIQK------SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-  152 (320)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-
Confidence            9998843      2568999999999999999999999   99999999999999999999999999998764322211 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||..|+|||++        +|+||||+++|||++|+.||.......        +...+..+.       ...+
T Consensus       153 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~-------~~~~  216 (320)
T cd05590         153 -TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDE-------VVYP  216 (320)
T ss_pred             -ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCC-------CCCC
Confidence             1344689999999987        799999999999999999997643321        222222111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ...+.++.+++.+||+.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            3356788999999999999999997

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-37  Score=275.70  Aligned_cols=230  Identities=27%  Similarity=0.401  Sum_probs=178.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ++.+++|.+..+...  +..||+|++........++.+|++++++++|+||+++++++..+...+++|||+++++|.+++
T Consensus        14 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (263)
T cd05052          14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL   93 (263)
T ss_pred             cCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHH
Confidence            344455544443333  344999998765555678999999999999999999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++......... .....
T Consensus        94 ~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~  165 (263)
T cd05052          94 RECN----RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGA  165 (263)
T ss_pred             HhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCC
Confidence            5432    2568999999999999999999999   99999999999999999999999999999876543221 11222


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||.+        +|+||||+++|||++ |..|+.......        ....+..+.      ....+...+
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~  231 (263)
T cd05052         166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKGY------RMERPEGCP  231 (263)
T ss_pred             CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCC------CCCCCCCCC
Confidence            346689999976        899999999999998 888876532211        122222111      112234456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+++.+||+.+|++|||++|
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~  254 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAE  254 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHH
Confidence            78999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-37  Score=282.13  Aligned_cols=225  Identities=21%  Similarity=0.260  Sum_probs=175.5

Q ss_pred             ccccccCCcceeeccCC--eeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHSN--EIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~--~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...++  .||||+++..    ....+.+..|..++... +|+||+++++++..+...++||||+++++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~   82 (316)
T cd05592           3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGD   82 (316)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCc
Confidence            55666666666555433  4999998643    22334566777777654 79999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--  151 (316)
T cd05592          83 LMFHIQS------SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--  151 (316)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence            9999843      2468999999999999999999999   9999999999999999999999999999986533221  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+|||||++|||++|+.||.......        +...+...       ....+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~-------~~~~~  216 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILND-------RPHFP  216 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcC-------CCCCC
Confidence            12345689999999987        899999999999999999997643321        22222111       11223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+.++.+++.+||+.+|++||++.
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence            34567789999999999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-37  Score=278.54  Aligned_cols=242  Identities=20%  Similarity=0.253  Sum_probs=174.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.....  +..||+|.++...  .....+.+|+.++++++|+||+++++++..+...++||||+++ +|.
T Consensus        12 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~   90 (288)
T cd07871          12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLK   90 (288)
T ss_pred             EEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHH
Confidence            3445555555444332  3449999986432  2345788999999999999999999999999999999999975 999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        91 ~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~  160 (288)
T cd07871          91 QYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY  160 (288)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cc
Confidence            9885332     457899999999999999999999   9999999999999999999999999999976543221  11


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHhhhcccc---
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRMRLGQEL---  327 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~---  327 (363)
                      ....++..|+|||++         +|+||+|+++|||++|+.||...............       .+..+......   
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            334578999999976         79999999999999999999764332211000000       00000000000   


Q ss_pred             -ccccC----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 -CLDFE----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 -~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .....    .......+.++.+++.+||++||.+|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~  281 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA  281 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence             00000    0011134567899999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.7e-37  Score=283.68  Aligned_cols=232  Identities=20%  Similarity=0.256  Sum_probs=177.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  +..||||+++...    ...+.+.+|..++.++ +|+||+++++++.+.+..++||||+++++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~   82 (329)
T cd05588           3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGD   82 (329)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCC
Confidence            455666666555443  3449999997432    2234577899999888 69999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          83 LMFHMQR------QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            9988842      2569999999999999999999999   9999999999999999999999999999875322111  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc-ccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS-QIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ......||..|+|||++        +|+||||+++|||++|+.||+....... .....++..+.+.....       ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~  224 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-------RI  224 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-------CC
Confidence            11345689999999987        7999999999999999999964322111 11122333333322211       12


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +..++.++.+++.+||+.||++|||+
T Consensus       225 p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         225 PRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            23456779999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-37  Score=284.97  Aligned_cols=230  Identities=19%  Similarity=0.193  Sum_probs=176.1

Q ss_pred             cccccccCCcceeec-----cCCeeEEEEcccC-----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEec
Q 039471          111 SLISFNLTNSKFFFL-----HSNEIAVKMLEHL-----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .++.+++|.++.+..     .+..||+|++...     ....+.+.+|+.++.++ +|+||+++++++..++..++||||
T Consensus         7 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (332)
T cd05614           7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDY   86 (332)
T ss_pred             EEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeC
Confidence            345555555544433     2344999998632     22335678899999999 499999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++|+|.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~~~g~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          87 VSGGEMFTHLYQ------RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             CCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            999999999843      2568999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .... ......||..|+|||++         +|+|||||++|||++|+.||.........    ..+...+...      
T Consensus       158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~------  226 (332)
T cd05614         158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILKC------  226 (332)
T ss_pred             cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhcC------
Confidence            3221 11234689999999986         79999999999999999999754322211    1122222111      


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                       ....+...++.+.+++.+||+.||++||++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  256 (332)
T cd05614         227 -DPPFPSFIGPEAQDLLHKLLRKDPKKRLGA  256 (332)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence             112233456778999999999999999965

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-37  Score=280.61  Aligned_cols=242  Identities=20%  Similarity=0.213  Sum_probs=175.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+...  +..||+|++....   ...+.+.+|+.++++++|+||+++++++..++..++||||++++++.
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~   88 (287)
T cd07848           9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE   88 (287)
T ss_pred             ecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHH
Confidence            445555555444443  3349999987432   23457889999999999999999999999999999999999987776


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      .+..      ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......... ..
T Consensus        89 ~~~~------~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~  158 (287)
T cd07848          89 LLEE------MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NY  158 (287)
T ss_pred             HHHh------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cc
Confidence            5542      12468999999999999999999999   99999999999999999999999999999876543221 11


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccch-------H-HHHHHHhhhcc--ccc
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF-------P-EWIYNRMRLGQ--ELC  328 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~-------~-~~~~~~~~~~~--~~~  328 (363)
                      ....|+..|+|||++        +|+||||+++|||++|+.||............       + ++.........  ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            334589999999987        89999999999999999999764332110000       0 00000000000  000


Q ss_pred             c-cc------CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 L-DF------EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~-~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      . ..      ........+..+.+++.+||+.||++|||++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~  280 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ  280 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence            0 00      00011235677999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.8e-37  Score=275.99  Aligned_cols=237  Identities=22%  Similarity=0.339  Sum_probs=181.8

Q ss_pred             ccccccccCCcceeeccC-------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHS-------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+....       ..||+|.+.....  ..++|.+|+.++++++|+||+++++++......+++|||+
T Consensus        11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   90 (283)
T cd05048          11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL   90 (283)
T ss_pred             hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence            445555566555443322       2399999864332  2357899999999999999999999999888999999999


Q ss_pred             CCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEec
Q 039471          181 PNGSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  250 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D  250 (363)
                      ++++|.+++......          .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|
T Consensus        91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~d  167 (283)
T cd05048          91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISD  167 (283)
T ss_pred             CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEECC
Confidence            999999999654321          112568999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHh
Q 039471          251 FGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRM  321 (363)
Q Consensus       251 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ||+++...............++..|+|||.+        +|+||||+++|||++ |..||.......        +...+
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--------~~~~i  239 (283)
T cd05048         168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--------VIEMI  239 (283)
T ss_pred             CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHH
Confidence            9999866443322222334567889999986        799999999999998 999987543211        22222


Q ss_pred             hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..      ...+..++.++.+++.+||+.||++|||++|
T Consensus       240 ~~~~~------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~  275 (283)
T cd05048         240 RSRQL------LPCPEDCPARVYALMIECWNEIPARRPRFKD  275 (283)
T ss_pred             HcCCc------CCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            22211      1234456788999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-37  Score=290.59  Aligned_cols=219  Identities=26%  Similarity=0.454  Sum_probs=169.4

Q ss_pred             eeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCC-----------
Q 039471          129 EIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTN-----------  194 (363)
Q Consensus       129 ~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------  194 (363)
                      .||||++.....  ..+.+.+|+++++.+ +|+||+++++++...+..++||||+++|+|.+++.....           
T Consensus        70 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~  149 (374)
T cd05106          70 RVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPE  149 (374)
T ss_pred             eeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccc
Confidence            499999974332  235688999999999 899999999999999999999999999999999864321           


Q ss_pred             -----------------------------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 039471          195 -----------------------------------------------------SSSHRQLSWEKLRKIAFGVARGVEYLH  221 (363)
Q Consensus       195 -----------------------------------------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH  221 (363)
                                                                           ......+++..+..++.||+.||+|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH  229 (374)
T cd05106         150 ISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA  229 (374)
T ss_pred             cccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence                                                                 011235888999999999999999999


Q ss_pred             cCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHH
Q 039471          222 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLE  293 (363)
Q Consensus       222 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~e  293 (363)
                      +   .+++||||||+|||+++++.+||+|||+++...............++..|+|||++        +|+||||+++||
T Consensus       230 ~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~e  306 (374)
T cd05106         230 S---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE  306 (374)
T ss_pred             H---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHH
Confidence            9   99999999999999999999999999999876543322222333456789999987        799999999999


Q ss_pred             Hhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          294 MVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       294 l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      |++ |+.||........       .......+.      ....+...++++.+++.+||+.+|++|||++|
T Consensus       307 llt~G~~Pf~~~~~~~~-------~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~  364 (374)
T cd05106         307 IFSLGKSPYPGILVNSK-------FYKMVKRGY------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQ  364 (374)
T ss_pred             HHhCCCCCCccccccHH-------HHHHHHccc------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            997 9999875432211       111111111      11112234578999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=289.48  Aligned_cols=227  Identities=21%  Similarity=0.290  Sum_probs=186.7

Q ss_pred             CcccccccccCCcceeeccCCe--eEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNE--IAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .+..+|.++||.++|..-..+.  ||||++.-    +...+++++.|++.|++++|||+|.+-|+|......|||||||-
T Consensus        30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl  109 (948)
T KOG0577|consen   30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL  109 (948)
T ss_pred             HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh
Confidence            3445666777777665543333  99999963    33456899999999999999999999999999999999999995


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ||-.+++.-.     .+++.+..+..|+++.+.||.|||+   .+.||||||..|||+++.|.|||+|||.|....+..
T Consensus       110 -GSAsDlleVh-----kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  110 -GSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             -ccHHHHHHHH-----hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence             5888888533     3789999999999999999999999   999999999999999999999999999999887654


Q ss_pred             cccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          262 SIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                            .++||+.|||||++           .||||||++..||+-.++|.........       +|. +....     
T Consensus       181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------LYH-IAQNe-----  241 (948)
T KOG0577|consen  181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYH-IAQNE-----  241 (948)
T ss_pred             ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------HHH-HHhcC-----
Confidence                  45699999999999           7999999999999999999776544332       222 11111     


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...-...+++..++.|+..||+.-|.+|||.+
T Consensus       242 sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse  273 (948)
T KOG0577|consen  242 SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSE  273 (948)
T ss_pred             CCCCCCchhHHHHHHHHHHHHhhCcccCCcHH
Confidence            11124678899999999999999999999964

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.3e-37  Score=282.95  Aligned_cols=232  Identities=21%  Similarity=0.264  Sum_probs=176.6

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCC----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....  ..||+|+++...    ...+.+.+|+.++.++ +|+||+++++++..++..++||||+++++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~   82 (329)
T cd05618           3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD   82 (329)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCC
Confidence            4566666666555433  349999987432    2234577888888776 79999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        83 L~~~~~~------~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          83 LMFHMQR------QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            9988843      2568999999999999999999999   9999999999999999999999999999875332211  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc-ccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS-QIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ......||..|+|||++        +|+||||+++|||++|+.||........ ......++.+.+....       ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------~~~  224 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI  224 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------CCC
Confidence            11345689999999987        8999999999999999999964221111 1111223333322111       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +...+.++.+++.+||+.||++|||+
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            33456778999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.6e-37  Score=273.50  Aligned_cols=232  Identities=23%  Similarity=0.358  Sum_probs=181.1

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      .+++.+++|.++..... +..||+|.+.......+.+.+|+.++++++|+||+++++.+.+....+++|||+++++|.++
T Consensus        12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   91 (261)
T cd05072          12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF   91 (261)
T ss_pred             eecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence            44566666666554433 33499999876555567899999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......... ....
T Consensus        92 l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~  163 (261)
T cd05072          92 LKSDE----GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREG  163 (261)
T ss_pred             HHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCC
Confidence            96432    2568899999999999999999999   99999999999999999999999999999876543221 1123


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+..      .......
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  229 (261)
T cd05072         164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYR------MPRMENC  229 (261)
T ss_pred             CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCCC
Confidence            3456789999986        799999999999998 888886533211        1122211111      1122235


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +.++.+++.+|++.+|++|||+++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~  253 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDY  253 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHH
Confidence            667999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=306.66  Aligned_cols=217  Identities=26%  Similarity=0.418  Sum_probs=176.9

Q ss_pred             eEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCC-CCCCCCCCHHHH
Q 039471          130 IAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTN-SSSHRQLSWEKL  206 (363)
Q Consensus       130 vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~l~~~~~  206 (363)
                      ||||.++..  .....+|.+|..+|++++|||||+++|++.+....+|++|||++|+|..+|++.+. ..+...++...+
T Consensus       725 vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dL  804 (1025)
T KOG1095|consen  725 VAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDL  804 (1025)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHH
Confidence            999999855  34456999999999999999999999999999999999999999999999987643 223467899999


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-----
Q 039471          207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----  281 (363)
Q Consensus       207 ~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----  281 (363)
                      ..++.|||+|++||++   +++|||||..+|+|++....+||+|||+|+.+.............-+..|||||.+     
T Consensus       805 l~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF  881 (1025)
T KOG1095|consen  805 LAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF  881 (1025)
T ss_pred             HHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccc
Confidence            9999999999999999   99999999999999999999999999999955444333322333456789999998     


Q ss_pred             ---cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 039471          282 ---SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTER  358 (363)
Q Consensus       282 ---~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (363)
                         +|||||||++||++|...+.++...+.+       +......+.+      .+.+..++..+.+|++.||+.+|++|
T Consensus       882 tskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~ggR------L~~P~~CP~~ly~lM~~CW~~~pe~R  948 (1025)
T KOG1095|consen  882 TSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEGGR------LDPPSYCPEKLYQLMLQCWKHDPEDR  948 (1025)
T ss_pred             ccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhCCc------cCCCCCCChHHHHHHHHHccCChhhC
Confidence               8999999999999985555444443332       2222222222      34567788899999999999999999


Q ss_pred             CCCC
Q 039471          359 PSMP  362 (363)
Q Consensus       359 Ps~~  362 (363)
                      |++.
T Consensus       949 P~F~  952 (1025)
T KOG1095|consen  949 PSFR  952 (1025)
T ss_pred             ccHH
Confidence            9974

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7e-37  Score=271.02  Aligned_cols=231  Identities=21%  Similarity=0.368  Sum_probs=179.5

Q ss_pred             ccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.....+. .+|+|.+.......++|.+|+.++++++|+||+++++++.+....+++|||+++++|.++
T Consensus        10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~   89 (256)
T cd05113          10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY   89 (256)
T ss_pred             eEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHH
Confidence            3455556665554443333 399999876555567899999999999999999999999988899999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.++........ ....
T Consensus        90 i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05113          90 LREHG-----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVG  160 (256)
T ss_pred             HHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCC
Confidence            85432     368999999999999999999999   99999999999999999999999999998866443221 1122


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||.+        +|+||||+++|||++ |..||.......        ....+..+...      ..+...
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~  226 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRL------YRPHLA  226 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCC------CCCCCC
Confidence            3456789999987        899999999999998 888886533211        12222222111      112234


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++|||+.+
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~  250 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQ  250 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHH
Confidence            678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.9e-37  Score=280.33  Aligned_cols=225  Identities=20%  Similarity=0.253  Sum_probs=175.4

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....  ..||+|+++..    ....+.+..|..++... +|+||+++++++.+++..++||||+++++
T Consensus         3 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~   82 (316)
T cd05620           3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGD   82 (316)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCc
Confidence            4566666666555543  34999998743    23345667788888754 89999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~i~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          83 LMFHIQD------KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            9999843      2468999999999999999999999   9999999999999999999999999999875322111  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+||||+++|||++|+.||.......        +.+.+....       ...+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--------~~~~~~~~~-------~~~~  216 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--------LFESIRVDT-------PHYP  216 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CCCC
Confidence            12345689999999987        899999999999999999997543221        222222111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+.++.+++.+||+.||++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~  242 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVV  242 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence            23567789999999999999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.6e-37  Score=280.19  Aligned_cols=224  Identities=21%  Similarity=0.237  Sum_probs=175.3

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...+  ..||||++...    ....+.+..|.+++..+ +|+||+++++++..++..++||||+++++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   82 (321)
T cd05591           3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGD   82 (321)
T ss_pred             cccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCc
Confidence            4566666666554443  34999998642    22345677899988866 79999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus        83 L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-  152 (321)
T cd05591          83 LMFQIQR------SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-  152 (321)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-
Confidence            9998843      2568999999999999999999999   99999999999999999999999999998764332221 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||..|+|||++        +|+||||+++|||++|+.||.......        ....+..+..       ..+
T Consensus       153 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~~~-------~~p  216 (321)
T cd05591         153 -TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHDDV-------LYP  216 (321)
T ss_pred             -ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC-------CCC
Confidence             2345689999999987        799999999999999999997654321        2222221111       122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ...++++.+++.+||+.+|++||+.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~  241 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGC  241 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2346778999999999999999943

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=290.63  Aligned_cols=228  Identities=25%  Similarity=0.304  Sum_probs=188.2

Q ss_pred             ccccCCcceeeccCCe-----eEEEEccc-CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          114 SFNLTNSKFFFLHSNE-----IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       114 ~~~~~~~~~~~~~~~~-----vAvK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .+|.|+.|.++-..+.     +|||.+.. .....+-..+|++.-++|+|.|||+++|.+.+++.+-|.||-.+||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            3577777777765443     89998863 34455778899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEeccccceeccCCcccc
Q 039471          188 FIFSKTNSSSHRQL--SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       188 ~l~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ++.+..     +++  ++..+..+.+||+.||+|||+   +.|+|||||-+|+|++ -.|.+||+|||.++.+..-..  
T Consensus       662 LLrskW-----GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--  731 (1226)
T KOG4279|consen  662 LLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--  731 (1226)
T ss_pred             HHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence            996543     566  899999999999999999999   9999999999999997 578999999999988754332  


Q ss_pred             ccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 SRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ...+..||..|||||++          .|||||||++.||+||++||......+..         .   -+.......++
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------M---FkVGmyKvHP~  799 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------M---FKVGMYKVHPP  799 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------h---hhhcceecCCC
Confidence            12456699999999999          89999999999999999999754332210         0   01122334567


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++.+.+.+|++|+.++|.+|||+++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~  828 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKD  828 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHH
Confidence            88899999999999999999999999864

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=270.09  Aligned_cols=231  Identities=24%  Similarity=0.383  Sum_probs=179.4

Q ss_pred             cccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++.+++|.++.+...+ ..||+|.+.......+++.+|+.++++++|+||+++++++...+..+++|||+++++|.+++
T Consensus        13 ~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   92 (261)
T cd05068          13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL   92 (261)
T ss_pred             EecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHH
Confidence            34555666555544333 34999999766555678999999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..+..++.|++.||.+||+   .+++|+||||+||+++.++.+||+|||+++........ .....
T Consensus        93 ~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~  164 (261)
T cd05068          93 QGGA----GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGA  164 (261)
T ss_pred             hccC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCC
Confidence            5432    2468999999999999999999999   99999999999999999999999999999877533221 11222


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..+..|+|||.+        +|+||||++++||++ |+.||.......        ....+.....      ...+...+
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~  230 (261)
T cd05068         165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYR------MPCPPGCP  230 (261)
T ss_pred             cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCcCC
Confidence            234679999986        899999999999998 888886543211        1222221111      11223456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+|++.+|++||++++
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~  253 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFET  253 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHH
Confidence            78999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.6e-37  Score=281.48  Aligned_cols=225  Identities=21%  Similarity=0.248  Sum_probs=173.8

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHH-HHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  ++.||||++....    ...+++.+|.. +++.++|+||+++++.+.++...++||||+++++
T Consensus         3 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~   82 (323)
T cd05575           3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGE   82 (323)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCC
Confidence            455666666555543  3449999986421    22245556655 4577899999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          83 LFFHLQR------ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            9999843      3568999999999999999999999   9999999999999999999999999999875432221  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+|||||++|||++|+.||.......        .+..+..+.       ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~-------~~~~  216 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--------MYDNILNKP-------LRLK  216 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCC-------CCCC
Confidence            12344689999999987        899999999999999999997543211        222222111       1112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+..+.+++.+||+.||++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23467899999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.6e-37  Score=281.03  Aligned_cols=225  Identities=20%  Similarity=0.239  Sum_probs=172.6

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHH---hccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATI---GRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+...  ++.||||+++..    ....+.+.+|++++   ++++|+||+++++++..++..++||||++
T Consensus         6 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~   85 (324)
T cd05589           6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA   85 (324)
T ss_pred             EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC
Confidence            3455555555544433  344999999643    22334566776655   56679999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|..++..       ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        86 ~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          86 GGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             CCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999988732       468999999999999999999999   999999999999999999999999999987543222


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .  ......|+..|+|||++        +|+||||+++|||++|+.||.......        ....+..+..       
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~-------  218 (324)
T cd05589         156 D--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVNDEV-------  218 (324)
T ss_pred             C--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC-------
Confidence            1  12345689999999987        799999999999999999997643321        1222221111       


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..+..++..+.+++.+||+.||.+||+++
T Consensus       219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         219 RYPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence            12234567789999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-37  Score=286.21  Aligned_cols=239  Identities=22%  Similarity=0.260  Sum_probs=172.3

Q ss_pred             cccccccccCCcceeecc-----CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          109 FQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      |..+..+|.|+.+.++..     ++.||+|...     .+.+.+|+.++++++|+||+++++++..+...++++|++. +
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~  167 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T  167 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence            444445555555555442     3449999753     3457899999999999999999999999999999999995 6


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++..      ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       168 ~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        168 DLYCYLAA------KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            89888843      2468999999999999999999999   99999999999999999999999999999754322111


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc---hHHHH---------------
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY---FPEWI---------------  317 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~---~~~~~---------------  317 (363)
                       ......||+.|+|||++        +|+|||||++|||++|+.|+...........   ....+               
T Consensus       239 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 -KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             -ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence             11345689999999987        7999999999999999988754321110000   00000               


Q ss_pred             -------HHHhhhccccccccCC--CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 -------YNRMRLGQELCLDFEE--DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 -------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                             +...............  ......+.++.+++.+||++||++|||++|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e  372 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA  372 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence                   0000000000000000  011245678999999999999999999865

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.4e-37  Score=272.43  Aligned_cols=230  Identities=22%  Similarity=0.307  Sum_probs=177.1

Q ss_pred             cccccccCCcceeecc-----CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH-----SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.....     ...||+|+++...  .....|.+|+..+++++|+||+++++++..+...++||||++++
T Consensus        12 ~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   91 (266)
T cd05064          12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG   91 (266)
T ss_pred             eecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCC
Confidence            3566667666554332     2349999987543  22357889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+.........
T Consensus        92 ~L~~~l~~~-----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          92 ALDSFLRKH-----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             cHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            999998532     2468999999999999999999999   99999999999999999999999999987654322111


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......++..|+|||.+        +|+||||+++||+++ |..||.......        ....+..+..      ..
T Consensus       164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~------~~  228 (266)
T cd05064         164 -TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFR------LP  228 (266)
T ss_pred             -cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCC------CC
Confidence             11223356789999987        799999999999775 999986543221        1222222211      12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..++..+.+++..||+.+|++|||++|
T Consensus       229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~~  257 (266)
T cd05064         229 APRNCPNLLHQLMLDCWQKERGERPRFSQ  257 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            23456778999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.5e-37  Score=280.44  Aligned_cols=232  Identities=20%  Similarity=0.243  Sum_probs=178.1

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCC----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.+..+....  ..||+|++....    ...+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (327)
T cd05617           3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGD   82 (327)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCc
Confidence            4566666666555433  349999997432    2234678899999888 59999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          83 LMFHMQR------QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            9998843      2569999999999999999999999   9999999999999999999999999999875322211  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+||||+++|||++|+.||........ ....+++...+....       ...+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~-------~~~p  223 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKP-------IRIP  223 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCC-------CCCC
Confidence            11345689999999987        8999999999999999999965432211 111222333222111       1123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+..+.+++.+||+.||++||++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            34567789999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-37  Score=271.06  Aligned_cols=230  Identities=21%  Similarity=0.356  Sum_probs=178.1

Q ss_pred             cccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++.+++|.++.+.... ..+|+|++........+|.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus        11 ~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   90 (256)
T cd05059          11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL   90 (256)
T ss_pred             hhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence            34555555554443333 34999998765556678999999999999999999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....     ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.++........ .....
T Consensus        91 ~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~  161 (256)
T cd05059          91 RERK-----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGT  161 (256)
T ss_pred             Hhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCC
Confidence            5332     368999999999999999999999   99999999999999999999999999998866433221 11222


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+.      ....+...+
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~  227 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAGY------RLYRPKLAP  227 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcCC------cCCCCCCCC
Confidence            345679999986        899999999999998 788886543221        112222111      112223457


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+++.+||+.+|++|||++|
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~  250 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKK  250 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHH
Confidence            78999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=270.95  Aligned_cols=237  Identities=23%  Similarity=0.345  Sum_probs=179.6

Q ss_pred             ccccccccCCcceeeccC-----CeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCc------eeE
Q 039471          110 QSLISFNLTNSKFFFLHS-----NEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNR------RTL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~l  175 (363)
                      ..++.+++|.+..+....     ..||+|+++.....   ...+.+|+..++.++|+||+++++++.....      .++
T Consensus         5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05035           5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV   84 (273)
T ss_pred             cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence            345666666665554432     34999998754322   3578899999999999999999998865443      799


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ++||+++++|..++...........+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++
T Consensus        85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  161 (273)
T cd05035          85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK  161 (273)
T ss_pred             EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcccee
Confidence            99999999999998665433334578999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ...............++..|+|||.+        +|+||||+++|||++ |..||.......        +.+.+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~  233 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDYLRHGNR  233 (273)
T ss_pred             eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            76544322222223356789999987        899999999999998 888875432211        2222221211


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ...+...+.++.+++.+||+.||++|||+.|
T Consensus       234 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  264 (273)
T cd05035         234 ------LKQPEDCLDELYDLMYSCWRADPKDRPTFTK  264 (273)
T ss_pred             ------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence                  1223345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.8e-37  Score=279.32  Aligned_cols=225  Identities=21%  Similarity=0.257  Sum_probs=175.6

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...+  ..||||+++..    ....+.+..|..++... +|+||+++++++.++...++||||+++|+
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~   82 (316)
T cd05619           3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGD   82 (316)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCc
Confidence            4566666666555443  34999998743    23345667788888764 89999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~l~~------~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          83 LMFHIQS------CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            9999843      2468899999999999999999999   9999999999999999999999999999875432211  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+|||||++|||++|+.||.......        +...+....       ...+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~-------~~~~  216 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--------LFQSIRMDN-------PCYP  216 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CCCC
Confidence            11334589999999987        799999999999999999997543211        222222111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+.++.+++.+||+.||++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~  242 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVK  242 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCCh
Confidence            34567789999999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-37  Score=285.55  Aligned_cols=224  Identities=20%  Similarity=0.237  Sum_probs=174.2

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+..  .+..||+|++...    .....++.+|++++..++|+||+++++++..+...++||||+++++|
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L   82 (325)
T cd05594           3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL   82 (325)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcH
Confidence            45566666655443  2344999998742    22335678899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..++..      ...+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++........  
T Consensus        83 ~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--  152 (325)
T cd05594          83 FFHLSR------ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--  152 (325)
T ss_pred             HHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence            998842      3568999999999999999999996  269999999999999999999999999998754332211  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||..|+|||++        +|+||||+++|||++|+.||.......        ....+....       ...+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i~~~~-------~~~p~  217 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEE-------IRFPR  217 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHHhcCC-------CCCCC
Confidence            1334589999999987        899999999999999999996543211        111111111       11223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ..++++.+++.+||+.||++|++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCC
Confidence            45678999999999999999973

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=286.46  Aligned_cols=231  Identities=22%  Similarity=0.273  Sum_probs=179.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||||++...    ......+.+|+.++..++|+||+++++++.+++..++||||++++
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (350)
T cd05573           7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG   86 (350)
T ss_pred             EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence            34556666666555544  455999998643    233457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc--
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI--  261 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~--  261 (363)
                      +|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.......  
T Consensus        87 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          87 DLMNLLIRK------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            999999432      568999999999999999999999   999999999999999999999999999998765433  


Q ss_pred             -------------------------cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcc
Q 039471          262 -------------------------SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQ  308 (363)
Q Consensus       262 -------------------------~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~  308 (363)
                                               .........||..|+|||++        +|+|||||++|||++|+.||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                     00112345689999999987        899999999999999999997654321


Q ss_pred             cccchHHHHHHHhhh-ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC-CC
Q 039471          309 SQIYFPEWIYNRMRL-GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS-MP  362 (363)
Q Consensus       309 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~  362 (363)
                              .+..+.. .....    ......+++.+.+++.+|++ +|++||+ ++
T Consensus       238 --------~~~~i~~~~~~~~----~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         238 --------TYNKIINWKESLR----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             --------HHHHHhccCCccc----CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence                    1122211 01111    11112257889999999998 9999999 64

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=260.19  Aligned_cols=231  Identities=20%  Similarity=0.284  Sum_probs=186.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc---CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+.|+.+......  +.++|+|+++.   +....+++.+|+++.+.|+||||+++.+...+.+..|+|+|+|.|+.
T Consensus        17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d   96 (355)
T KOG0033|consen   17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   96 (355)
T ss_pred             HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence            34455555444433333  33478887752   23356888999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |..-|-      .+..+++..+-..++||+.+|+|+|.   ++|+|||+||+|+|+-+   ..-+||+|||+|..++.+.
T Consensus        97 l~~eIV------~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   97 LFEDIV------AREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             HHHHHH------HHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            976662      23568899999999999999999999   99999999999999953   3458999999999988433


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .   .....||++|+|||++        +|||+-|++||-|+.|.+||.+.....        +++++..+..   ..+.
T Consensus       168 ~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~y---d~~~  233 (355)
T KOG0033|consen  168 A---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGAY---DYPS  233 (355)
T ss_pred             c---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhcccc---CCCC
Confidence            2   3667799999999999        899999999999999999998754432        6666665432   3334


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...+++.++++++||..||.+|.|++|
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHH
Confidence            456778889999999999999999999875

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=267.58  Aligned_cols=231  Identities=20%  Similarity=0.282  Sum_probs=191.0

Q ss_pred             CcccccccccCCcceeeccCCe--eEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          108 PFQSLISFNLTNSKFFFLHSNE--IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .+.+++.+++|++.....+..+  ||||.+.. ....++++.|+.++++.+.+++|++||.+.....+|+|||||..||+
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi  115 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI  115 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence            3456667777776665554444  99999864 34678999999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .++++..     ++++++.++..+++..++||+|||.   ..-+|||||..|||++.+|..||+|||.|-.+...-.  .
T Consensus       116 SDI~R~R-----~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K  185 (502)
T KOG0574|consen  116 SDIMRAR-----RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K  185 (502)
T ss_pred             HHHHHHh-----cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence            9999644     3789999999999999999999999   9999999999999999999999999999987765322  3


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      +....||+.|||||++        .||||||+...||+.|++|+...-.......+            ...+......++
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------PT~PPPTF~KPE  253 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------PTKPPPTFKKPE  253 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------cCCCCCCCCChH
Confidence            4677899999999999        89999999999999999998765443221100            011112223567


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ..+.++-++++.||..+|++|-|+
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA  277 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTA  277 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHH
Confidence            889999999999999999999875

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-37  Score=274.92  Aligned_cols=230  Identities=23%  Similarity=0.272  Sum_probs=177.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||+|++....    .....+.+|+.++++++|+||+++++.+.++...++||||+++++
T Consensus         7 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   86 (285)
T cd05605           7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD   86 (285)
T ss_pred             EEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCc
Confidence            3455555555444432  3459999986432    123457889999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....    ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++......... 
T Consensus        87 L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  158 (285)
T cd05605          87 LKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-  158 (285)
T ss_pred             HHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc-
Confidence            998885432    2468999999999999999999999   99999999999999999999999999999876443221 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....|+..|+|||++        +|+||+|+++|||++|+.||........    .+.+...+...       ....+
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~----~~~~~~~~~~~-------~~~~~  225 (285)
T cd05605         159 --RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRVKED-------QEEYS  225 (285)
T ss_pred             --ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH----HHHHHHHhhhc-------ccccC
Confidence              234688999999987        7999999999999999999976432211    01111111111       11223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ..++..+.+++.+||+.||++||+.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGC  250 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCC
Confidence            4567789999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7e-37  Score=279.61  Aligned_cols=224  Identities=21%  Similarity=0.262  Sum_probs=176.4

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....  ..||||++...    ......+.+|.+++..+ +|+||+++++++...+..++||||+++++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (318)
T cd05570           3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGD   82 (318)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence            4566676666655543  34999998743    23345677899998877 69999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++........ 
T Consensus        83 L~~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  152 (318)
T cd05570          83 LMFHIQR------SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-  152 (318)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-
Confidence            9998843      2468999999999999999999999   99999999999999999999999999998753222211 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....|+..|+|||++        +|+|||||++|||++|+.||.......        ....+....       ...+
T Consensus       153 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--------~~~~i~~~~-------~~~~  216 (318)
T cd05570         153 -TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--------LFQSILEDE-------VRYP  216 (318)
T ss_pred             -ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCC-------CCCC
Confidence             1334589999999987        799999999999999999997543221        122222111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ...+..+.+++.+||+.||++|||+
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCC
Confidence            3456789999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-36  Score=284.74  Aligned_cols=219  Identities=26%  Similarity=0.435  Sum_probs=170.5

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC----------
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS----------  195 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------  195 (363)
                      .||||++....  ...+.+.+|+++++++. ||||+++++++.+....++||||+++|+|.+++......          
T Consensus        69 ~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~  148 (400)
T cd05105          69 KVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPK  148 (400)
T ss_pred             EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccccc
Confidence            49999996432  23467899999999996 999999999999999999999999999999998653210          


Q ss_pred             --------------------------------------------------------------------------------
Q 039471          196 --------------------------------------------------------------------------------  195 (363)
Q Consensus       196 --------------------------------------------------------------------------------  195 (363)
                                                                                                      
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  228 (400)
T cd05105         149 KDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSD  228 (400)
T ss_pred             ccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHh
Confidence                                                                                            


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccc
Q 039471          196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY  275 (363)
Q Consensus       196 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  275 (363)
                      .....+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++...............++..|
T Consensus       229 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y  305 (400)
T cd05105         229 DGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW  305 (400)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcce
Confidence            012358888999999999999999999   99999999999999999999999999999876543322222334467789


Q ss_pred             cCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          276 IAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       276 ~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      +|||.+        +|+||||+++|||++ |..||.......       ..+..+..+.      ....+...+..+.++
T Consensus       306 ~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~l~~l  372 (400)
T cd05105         306 MAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-------TFYNKIKSGY------RMAKPDHATQEVYDI  372 (400)
T ss_pred             EChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-------HHHHHHhcCC------CCCCCccCCHHHHHH
Confidence            999987        899999999999996 888886542211       1222222211      112234566789999


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      +.+||+.+|++|||+.+
T Consensus       373 i~~cl~~dP~~RPt~~~  389 (400)
T cd05105         373 MVKCWNSEPEKRPSFLH  389 (400)
T ss_pred             HHHHCccCHhHCcCHHH
Confidence            99999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.5e-37  Score=279.95  Aligned_cols=226  Identities=21%  Similarity=0.242  Sum_probs=174.0

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCC----cChhHHHHHHH-HHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....  ..||+|++....    .....+..|.. .++.++|+||+++++++.+.+..++||||+++++
T Consensus         3 lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~   82 (325)
T cd05602           3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE   82 (325)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCc
Confidence            5666677666655443  349999986422    22234455554 4677899999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          83 LFYHLQR------ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            9999943      2568899999999999999999999   9999999999999999999999999999875432221  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+|||||++|||++|+.||.......        .+..+....       ....
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~-------~~~~  216 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKP-------LQLK  216 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCC-------cCCC
Confidence            12345689999999987        899999999999999999997543221        122221111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...++.+.+++.+||+.+|.+||++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            345678999999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-36  Score=272.14  Aligned_cols=237  Identities=23%  Similarity=0.358  Sum_probs=177.2

Q ss_pred             ccccccccCCcceeeccCC----eeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEE
Q 039471          110 QSLISFNLTNSKFFFLHSN----EIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLI  176 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~----~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv  176 (363)
                      ..++.+++|.++.+.....    .||+|.++...   ...+.+.+|+.+++.++|+||+++++.+...      ...+++
T Consensus         5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v   84 (272)
T cd05075           5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI   84 (272)
T ss_pred             cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence            3456666666655544332    38999886432   2346788999999999999999999987432      256899


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      |||+++++|.+++...........+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.
T Consensus        85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            9999999999988544332334568999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ..............++..|+|||.+        +|+||||+++|||++ |..||......        .++..+..+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~  233 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLRQGNRL  233 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            6543322112233456789999987        899999999999998 78887653221        123333322211


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ......+..+.+++.+||+.+|++|||++|
T Consensus       234 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  263 (272)
T cd05075         234 ------KQPPDCLDGLYSLMSSCWLLNPKDRPSFET  263 (272)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence                  112245567999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.8e-37  Score=281.83  Aligned_cols=182  Identities=24%  Similarity=0.329  Sum_probs=149.0

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.....  +..+|+|.+....  ...+.+.+|++++++++|+||+++++++.+++..++||||+++++|.
T Consensus        12 ~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   91 (333)
T cd06650          12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD   91 (333)
T ss_pred             cccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Confidence            3444455544443333  3338999876432  22357889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..      ...+++..+..++.|++.||.|||+  ..+++|+||||+|||+++++.+||+|||++........    
T Consensus        92 ~~l~~------~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~----  159 (333)
T cd06650          92 QVLKK------AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----  159 (333)
T ss_pred             HHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc----
Confidence            99943      2458899999999999999999997  24799999999999999999999999999876543211    


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcc
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPA  304 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~  304 (363)
                      ....|+..|+|||++        +|+|||||++|||++|+.||...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            334588999999997        79999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.5e-37  Score=269.70  Aligned_cols=231  Identities=21%  Similarity=0.311  Sum_probs=175.7

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.+..  .++.||+|......  .....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            355666666655544  34449999876432  22357899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...     ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++............
T Consensus        82 ~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          82 TFLRTE-----GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            998432     2458999999999999999999999   99999999999999999999999999998765432211111


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....+..|+|||.+        +|+||||+++|||++ |..|+.......        ....+....      ....+.
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------~~~~~~~~~------~~~~~~  219 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------TREAIEQGV------RLPCPE  219 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCC------CCCCcc
Confidence            112234579999987        799999999999997 888775432211        111121111      112233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++|||++|
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~  245 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFST  245 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            45678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-36  Score=272.96  Aligned_cols=237  Identities=22%  Similarity=0.332  Sum_probs=180.7

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...       ...||||.+......  .+.+.+|++++++++|+||+++++++..+...+++|||+
T Consensus        11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   90 (280)
T cd05049          11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM   90 (280)
T ss_pred             hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence            33455555554443322       234999998754433  468999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          181 PNGSLQKFIFSKTN--------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       181 ~~~sL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      ++++|.+++.....        ......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d~g  167 (280)
T cd05049          91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFG  167 (280)
T ss_pred             CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECCcc
Confidence            99999999965432        1223568999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ++................++..|+|||++        +|+||||+++|||++ |..||.......        ....+..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--------~~~~~~~  239 (280)
T cd05049         168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------VIECITQ  239 (280)
T ss_pred             cceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHc
Confidence            99865433222112333457789999987        899999999999998 999986543221        1112221


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..      ...+...+..+.+++.+||+.||++|||++|
T Consensus       240 ~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  273 (280)
T cd05049         240 GRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKD  273 (280)
T ss_pred             CCc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence            111      1122345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=286.71  Aligned_cols=230  Identities=23%  Similarity=0.342  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeeccC-----Ce-eEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLHS-----NE-IAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-----~~-vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .++|.|.||.+....+..     .. ||||..+..    .....+|.+|.+++++++|+|||++||++.....+++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            456666666666554432     23 899998742    33446899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |+||+|.+++....     ..++..+...++.+.+.||+|||+   ++++||||..+|+|++.++.+||+|||+++....
T Consensus       243 ~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~  314 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ  314 (474)
T ss_pred             cCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence            99999999995433     369999999999999999999999   9999999999999999999999999999886542


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHh-hhcccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRM-RLGQELCL  329 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  329 (363)
                      ....  .....-+..|+|||.+        +||||||+++||+.+ |..|+.+.....        +..++ ..+.    
T Consensus       315 ~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--------v~~kI~~~~~----  380 (474)
T KOG0194|consen  315 YVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--------VKAKIVKNGY----  380 (474)
T ss_pred             eeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--------HHHHHHhcCc----
Confidence            2111  1123457889999998        899999999999998 788877654332        23333 2122    


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ....+...+..+..++.+|+..+|++||||.+
T Consensus       381 --r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~  412 (474)
T KOG0194|consen  381 --RMPIPSKTPKELAKVMKQCWKKDPEDRPTMST  412 (474)
T ss_pred             --cCCCCCCCHHHHHHHHHHhccCChhhccCHHH
Confidence              22333456777889999999999999999963

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.1e-37  Score=285.03  Aligned_cols=231  Identities=19%  Similarity=0.245  Sum_probs=177.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  +..||+|++...    ....+.+.+|+.+++.++|+||+++++++.+++..++||||+++|+
T Consensus        50 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~  129 (370)
T cd05596          50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD  129 (370)
T ss_pred             EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCc
Confidence            3455555555544333  344999998632    2233457789999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus       130 L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-  198 (370)
T cd05596         130 LVNLMSN-------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-  198 (370)
T ss_pred             HHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-
Confidence            9999842       347889999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             ccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          265 SRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ......||+.|+|||++            +|+|||||++|||++|+.||.......        .+..+......   ..
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~---~~  267 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDHKNS---LT  267 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcCCCc---CC
Confidence            12345689999999975            699999999999999999997643321        22222221110   11


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCC--CCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTE--RPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~e  363 (363)
                      .......+.++.+++.+||+.+|.+  |||++|
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~e  300 (370)
T cd05596         268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDE  300 (370)
T ss_pred             CCCcCCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence            1112245678999999999999987  998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-36  Score=273.59  Aligned_cols=235  Identities=22%  Similarity=0.327  Sum_probs=178.7

Q ss_pred             ccccccCCcceeecc-------CCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFLH-------SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ++.+++|.++.+...       +..+|+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||++++
T Consensus        13 lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   92 (288)
T cd05093          13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG   92 (288)
T ss_pred             cCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCC
Confidence            455556655554321       12289998875432 3457899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          184 SLQKFIFSKTN-------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       184 sL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      +|.+++.....       ......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.
T Consensus        93 ~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  169 (288)
T cd05093          93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRD  169 (288)
T ss_pred             CHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCCcccc
Confidence            99999965431       1122459999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ..............++..|+|||++        +|+||||++++||++ |..||.......        ....+..+...
T Consensus       170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------~~~~i~~~~~~  241 (288)
T cd05093         170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIECITQGRVL  241 (288)
T ss_pred             ccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCcC
Confidence            6443322222333457789999987        899999999999998 888886543211        12222222211


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ..+...+.++.+++.+||+.||.+|||++|
T Consensus       242 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  271 (288)
T cd05093         242 ------QRPRTCPKEVYDLMLGCWQREPHMRLNIKE  271 (288)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence                  112234567999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.7e-37  Score=286.16  Aligned_cols=233  Identities=18%  Similarity=0.202  Sum_probs=171.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  +..||||++....    ...+.+.+|+.++++++|+||+++++++.++...++||||+++|+
T Consensus         8 ~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~   87 (381)
T cd05626           8 TLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD   87 (381)
T ss_pred             EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence            3445555555444333  3349999996432    233578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc-
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  263 (363)
                      |.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        88 L~~~l~~------~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          88 MMSLLIR------MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999843      2568999999999999999999999   99999999999999999999999999997643210000 


Q ss_pred             --------------------------------------------cccccccccccccCCccc--------cCceehhHHH
Q 039471          264 --------------------------------------------VSRTAARGTSGYIAPELF--------SRNFCYGMML  291 (363)
Q Consensus       264 --------------------------------------------~~~~~~~gt~~y~aPE~~--------~Di~slG~il  291 (363)
                                                                  .......||..|+|||++        +|+|||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        000124689999999987        8999999999


Q ss_pred             HHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHH--hccCCCCCCCCCCC
Q 039471          292 LEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIW--CIQWNPTERPSMPM  363 (363)
Q Consensus       292 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~e  363 (363)
                      |||++|+.||.........       ..........    .......+++++.+++.+  |+..+|..|||++|
T Consensus       239 ~elltG~~Pf~~~~~~~~~-------~~i~~~~~~~----~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQ-------LKVINWENTL----HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHH-------HHHHcccccc----CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999765432211       1111100111    111122356778888888  44556666999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.7e-37  Score=282.55  Aligned_cols=242  Identities=19%  Similarity=0.261  Sum_probs=171.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEecc
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~  180 (363)
                      .++.+++|.+..+...  +..||||++...   .....++.+|++++++++|+||+++++++...     ...++||||+
T Consensus         7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~   86 (338)
T cd07859           7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM   86 (338)
T ss_pred             EEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC
Confidence            3455555555544432  345999998642   22335688999999999999999999987543     2579999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      + ++|.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~-~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          87 E-SDLHQVIKA------NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             C-CCHHHHHHh------cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            5 689998842      2468999999999999999999999   99999999999999999999999999999865332


Q ss_pred             ccc-cccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHHHHHh
Q 039471          261 ISI-VSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWIYNRM  321 (363)
Q Consensus       261 ~~~-~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~~~~~  321 (363)
                      ... .......||..|+|||++          +|+|||||++|||++|+.||..........        ..+.+. ..+
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~i  235 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI-SRV  235 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH-HHh
Confidence            211 111334689999999975          799999999999999999996543211100        000000 000


Q ss_pred             hhcc------ccccccCC---CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQ------ELCLDFEE---DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~------~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....      ........   ......++.+.+++.+||+.||++|||++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e  286 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE  286 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHH
Confidence            0000      00000000   001123567889999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.7e-37  Score=283.87  Aligned_cols=232  Identities=19%  Similarity=0.216  Sum_probs=178.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||+|+++...    ...+.+.+|+.+++.++|+||+++++++.+++..++||||+++++
T Consensus         8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (330)
T cd05601           8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD   87 (330)
T ss_pred             EEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCC
Confidence            3455555555544432  4449999997432    234567889999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus        88 L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          88 LLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-  158 (330)
T ss_pred             HHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence            999995432     468999999999999999999999   99999999999999999999999999999876544322 


Q ss_pred             ccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          265 SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      ......||..|+|||++              +|+||||+++|||++|+.||.......        .+..+......   
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~---  227 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQRF---  227 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCCc---
Confidence            12334689999999975              699999999999999999997543321        11222111111   


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .........+..+.+++.+|++ +|.+|||+++
T Consensus       228 ~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~  259 (330)
T cd05601         228 LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEG  259 (330)
T ss_pred             cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence            0111122456778999999998 9999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=286.05  Aligned_cols=230  Identities=20%  Similarity=0.241  Sum_probs=174.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  +..||||++...    ......+.+|+.++..++|+||+++++++.++...++||||+++|
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g   86 (364)
T cd05599           7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG   86 (364)
T ss_pred             EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence            34555555555444332  345999999643    223356788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        87 ~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          87 DMMTLLMK------KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             HHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            99999843      2468999999999999999999999   99999999999999999999999999998765322110


Q ss_pred             c------------------------------------ccccccccccccCCccc--------cCceehhHHHHHHhcCCC
Q 039471          264 V------------------------------------SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK  299 (363)
Q Consensus       264 ~------------------------------------~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~  299 (363)
                      .                                    ......||+.|+|||++        +|+|||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence            0                                    00123589999999987        899999999999999999


Q ss_pred             CCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ||.......        ....+.....   ..........++.+.+++.+|+. +|.+|++
T Consensus       238 Pf~~~~~~~--------~~~~i~~~~~---~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         238 PFCSDNPQE--------TYRKIINWKE---TLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCHHH--------HHHHHHcCCC---ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            997654321        1111111110   01111112346778899999997 9999997

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-36  Score=274.08  Aligned_cols=243  Identities=22%  Similarity=0.296  Sum_probs=171.7

Q ss_pred             ccccccccCCcceeecc---CCeeEEEEcccCC---cChhHHHHHHHHHhcc---CCCceeeeeeeee-----eCCceeE
Q 039471          110 QSLISFNLTNSKFFFLH---SNEIAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCS-----EGNRRTL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~---~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~~~l  175 (363)
                      ..++.+++|.++.+...   +..||+|++....   .....+.+|+.+++++   +|+||+++++++.     .....++
T Consensus         7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l   86 (290)
T cd07862           7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   86 (290)
T ss_pred             eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence            33455556555554332   2349999886432   2234667788877766   6999999999885     3456899


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ||||++ ++|.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        87 v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          87 VFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             EEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            999996 59999985432    2458999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH--------HHH
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW--------IYN  319 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~--------~~~  319 (363)
                      .......   .....|+..|+|||++        +|+||||+++|||++|++||...........+.+.        ...
T Consensus       159 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         159 IYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            7654321   2345589999999987        79999999999999999999765432211000000        000


Q ss_pred             HhhhccccccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..............    ......+..+.+++.+||+.||++|||+.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  283 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  283 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence            00000000000000    011234567889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-36  Score=278.12  Aligned_cols=225  Identities=21%  Similarity=0.237  Sum_probs=172.9

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHH-HHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  +..||+|++....    ....++.+|.. +++.++|+||+++++++.+.+..++||||+++++
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   82 (321)
T cd05603           3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGE   82 (321)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence            455666666555543  3349999986321    22345556654 5778899999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        83 L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          83 LFFHLQR------ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            9988843      2568899999999999999999999   9999999999999999999999999999875322211  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+|||||++|||++|..||.......        .+..+....       ...+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~-------~~~~  216 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKP-------LQLP  216 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--------HHHHHhcCC-------CCCC
Confidence            12344689999999987        899999999999999999997643211        222222111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+..+.+++.+||+.+|++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34456789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.8e-36  Score=276.66  Aligned_cols=231  Identities=23%  Similarity=0.357  Sum_probs=174.7

Q ss_pred             ccccccccCCcceeecc--CC----eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SN----EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~----~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+...  +.    .||+|+++...  ...+++.+|+.+++.++|+||++++|++... ..++++||++
T Consensus        13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~   91 (316)
T cd05108          13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP   91 (316)
T ss_pred             eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCC
Confidence            34555555555544321  22    28999986432  2346889999999999999999999998765 4679999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++......
T Consensus        92 ~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          92 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             CCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            999999995432     458899999999999999999999   999999999999999999999999999998776543


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........++..|+|||.+        +|+||||+++|||++ |+.|+.......        +......+...     
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-----  230 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL-----  230 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhCCCCC-----
Confidence            32222333356789999987        799999999999997 899886532211        11122211111     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+...+.++.+++.+||+.+|++|||+.|
T Consensus       231 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~~  260 (316)
T cd05108         231 -PQPPICTIDVYMIMVKCWMIDADSRPKFRE  260 (316)
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence             112234567899999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.8e-36  Score=267.27  Aligned_cols=227  Identities=23%  Similarity=0.387  Sum_probs=173.9

Q ss_pred             ccccccCCcceeec----cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFL----HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~----~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+..    .+..+|+|+++....   ..+++.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~   81 (257)
T cd05116           3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGP   81 (257)
T ss_pred             CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCc
Confidence            45566666554322    234499999864432   23578999999999999999999998764 56789999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........
T Consensus        82 L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          82 LNKFLQK------NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999942      2468999999999999999999999   999999999999999999999999999998765443211


Q ss_pred             -ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 -SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 -~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......++..|+|||.+        +|+||||+++|||++ |..||.......        +...+..+..      ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~i~~~~~------~~  218 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQMIESGER------ME  218 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCC------CC
Confidence             11222345789999976        899999999999997 899987543321        1222222221      11


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+...++++.+++.+||+.||++|||++
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~  246 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFA  246 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHH
Confidence            2334567899999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.2e-36  Score=266.38  Aligned_cols=230  Identities=23%  Similarity=0.359  Sum_probs=177.6

Q ss_pred             cccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      +++.+++|.++.+...+ ..||+|++.......++|.+|+.++++++|+||+++++.+.+ ...+++|||+++++|.+++
T Consensus        13 ~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   91 (262)
T cd05071          13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL   91 (262)
T ss_pred             ecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHH
Confidence            34555666555543333 349999998655556789999999999999999999998754 5678999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+......... .....
T Consensus        92 ~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~  163 (262)
T cd05071          92 KGEM----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGA  163 (262)
T ss_pred             hhcc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCC
Confidence            5432    2457899999999999999999999   99999999999999999999999999999876543321 11233


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||..        +|+||||+++|||++ |..||.......        ....+..+..      .......+
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~  229 (262)
T cd05071         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYR------MPCPPECP  229 (262)
T ss_pred             cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------HHHHHhcCCC------CCCccccC
Confidence            466789999987        899999999999999 777776543211        2222221111      12234567


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+|++.+|++|||+++
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~  252 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEY  252 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHH
Confidence            78999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-36  Score=271.54  Aligned_cols=218  Identities=24%  Similarity=0.391  Sum_probs=167.9

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCC----CCCCCC
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS----SHRQLS  202 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~----~~~~l~  202 (363)
                      .||||++....  ....+|.+|+.+++.++|+||+++++++.++...++||||+++++|.+++.......    ....++
T Consensus        38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  117 (277)
T cd05062          38 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS  117 (277)
T ss_pred             EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCC
Confidence            49999986432  233578899999999999999999999999999999999999999999996533211    123467


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-
Q 039471          203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-  281 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-  281 (363)
                      +..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++...............++..|+|||.+ 
T Consensus       118 ~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  194 (277)
T cd05062         118 LKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK  194 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence            88999999999999999999   99999999999999999999999999998765443322222233457789999987 


Q ss_pred             -------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccC
Q 039471          282 -------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW  353 (363)
Q Consensus       282 -------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  353 (363)
                             +|+||||+++|||++ |..||.......        ..........      ...+...+..+.+++.+||+.
T Consensus       195 ~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~  260 (277)
T cd05062         195 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--------VLRFVMEGGL------LDKPDNCPDMLFELMRMCWQY  260 (277)
T ss_pred             cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCC
Confidence                   799999999999998 677876543211        1111111111      111223456799999999999


Q ss_pred             CCCCCCCCCC
Q 039471          354 NPTERPSMPM  363 (363)
Q Consensus       354 ~p~~RPs~~e  363 (363)
                      +|++|||+.|
T Consensus       261 ~p~~Rps~~e  270 (277)
T cd05062         261 NPKMRPSFLE  270 (277)
T ss_pred             ChhhCcCHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.6e-36  Score=276.56  Aligned_cols=226  Identities=19%  Similarity=0.218  Sum_probs=174.8

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhccCC-CceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+...+  +.||||++...    ....+.+..|.+++..++| ++|+++++++.+.+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   85 (324)
T cd05587           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG   85 (324)
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence            345556666665554443  34999998642    2334577889999998875 5688899999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 g~L~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          86 GDLMYHIQQ------VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            999999843      2468999999999999999999999   9999999999999999999999999999875322111


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ......||..|+|||++        +|+||+|+++|||++|+.||.......        ....+....       ..
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~-------~~  219 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHN-------VS  219 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC-------CC
Confidence              11345689999999987        799999999999999999997543221        122222111       11


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+...++++.+++.+||+.||++||+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            233456788999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-36  Score=271.92  Aligned_cols=220  Identities=25%  Similarity=0.377  Sum_probs=166.1

Q ss_pred             CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCH
Q 039471          128 NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW  203 (363)
Q Consensus       128 ~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~  203 (363)
                      ..||+|++.....  ....|.+|++++++++|+||+++++++...  ...+++|||+++++|.+++..       ..+++
T Consensus        34 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~l~~  106 (283)
T cd05080          34 EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-------HKLNL  106 (283)
T ss_pred             ceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-------cCCCH
Confidence            3499999875432  446788999999999999999999988653  468899999999999999842       34899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc-cccccccccccCCccc-
Q 039471          204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAARGTSGYIAPELF-  281 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~-  281 (363)
                      ..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.......... .....++..|+|||.+ 
T Consensus       107 ~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         107 AQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            9999999999999999999   9999999999999999999999999999987654332111 1223356679999987 


Q ss_pred             -------cCceehhHHHHHHhcCCCCCCcchhcccccc-------hHHHHHHHhhhccccccccCCCCcHHHHHHHHHHH
Q 039471          282 -------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY-------FPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA  347 (363)
Q Consensus       282 -------~Di~slG~il~el~~g~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  347 (363)
                             +|+||||++++||++|..|+...........       ......+....      ......+...+.++.+++
T Consensus       184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li  257 (283)
T cd05080         184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER------GMRLPCPKNCPQEVYILM  257 (283)
T ss_pred             ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc------CCCCCCCCCCCHHHHHHH
Confidence                   7999999999999999998754322110000       00000000000      111122334567899999


Q ss_pred             HHhccCCCCCCCCCCC
Q 039471          348 IWCIQWNPTERPSMPM  363 (363)
Q Consensus       348 ~~cl~~~p~~RPs~~e  363 (363)
                      .+||+.+|++|||+++
T Consensus       258 ~~cl~~~p~~Rps~~~  273 (283)
T cd05080         258 KNCWETEAKFRPTFRS  273 (283)
T ss_pred             HHHhccChhhCCCHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-36  Score=268.96  Aligned_cols=238  Identities=22%  Similarity=0.303  Sum_probs=173.3

Q ss_pred             ccccccCCcceeecc----CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH----SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~----~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.+..+...    ...+|+|.+.....  ....|.+|+..++.++|+||+++++.+......++||||+++|+|
T Consensus         3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L   82 (269)
T cd05042           3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL   82 (269)
T ss_pred             CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcH
Confidence            455666666544322    12388887764322  234688999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..... ......++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++...........
T Consensus        83 ~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          83 KNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHhccc-cccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999965442 122345788899999999999999999   9999999999999999999999999999876443322222


Q ss_pred             cccccccccccCCccc---------------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          266 RTAARGTSGYIAPELF---------------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      .....++..|+|||++               +|+||||+++|||++ |..||.......       ....... ..... 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~-~~~~~-  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVR-EQDIK-  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhh-ccCcc-
Confidence            2333456789999973               799999999999998 677775432211       0111111 11111 


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+......++.+.+++..|+ .||++|||++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~  262 (269)
T cd05042         230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE  262 (269)
T ss_pred             CCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence            1112233456677888999998 49999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=285.88  Aligned_cols=229  Identities=21%  Similarity=0.229  Sum_probs=170.5

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+..  .++.||||++....    ...+.+.+|++++++++|+||+++++++.++...++||||+++|
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg   86 (377)
T cd05629           7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG   86 (377)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence            3455555655554433  23449999886422    22356788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        87 ~L~~~l~~------~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          87 DLMTMLIK------YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999943      3568999999999999999999999   99999999999999999999999999998643211000


Q ss_pred             ------------c---------------------------------ccccccccccccCCccc--------cCceehhHH
Q 039471          264 ------------V---------------------------------SRTAARGTSGYIAPELF--------SRNFCYGMM  290 (363)
Q Consensus       264 ------------~---------------------------------~~~~~~gt~~y~aPE~~--------~Di~slG~i  290 (363)
                                  .                                 ......||+.|+|||++        +|+|||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                        0                                 00123589999999987        899999999


Q ss_pred             HHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          291 LLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       291 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +|||++|..||.......        .+..+.....   ..........+.++.+++.+||+ +|.+|+
T Consensus       238 l~elltG~~Pf~~~~~~~--------~~~~i~~~~~---~~~~p~~~~~s~~~~dli~~lL~-~~~~r~  294 (377)
T cd05629         238 MFECLIGWPPFCSENSHE--------TYRKIINWRE---TLYFPDDIHLSVEAEDLIRRLIT-NAENRL  294 (377)
T ss_pred             hhhhhcCCCCCCCCCHHH--------HHHHHHccCC---ccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence            999999999997543321        1111111100   01111122356778999999998 788765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-36  Score=278.61  Aligned_cols=225  Identities=21%  Similarity=0.243  Sum_probs=172.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHH-HhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVAT-IGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  ++.||+|++...    .....++.+|... ++.++|+||+++++.+..++..++||||+++++
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~   82 (325)
T cd05604           3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE   82 (325)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCC
Confidence            455566655544433  445999998642    1223455666654 677899999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |..++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 L~~~l~~------~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          83 LFFHLQR------ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             HHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            9988842      3568999999999999999999999   9999999999999999999999999999875432211  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||..|+|||++        +|+|||||++|||++|..||.......        +.+.+.... .      ...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~-~------~~~  216 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKP-L------VLR  216 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCC-c------cCC
Confidence            11345689999999987        899999999999999999997543221        222222111 1      112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+..+.+++.+|++.+|++||++.
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            23556788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-36  Score=282.03  Aligned_cols=232  Identities=18%  Similarity=0.254  Sum_probs=175.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.+..+...  ++.+|+|++...    ....+.+.+|+.+++.++|+||+++++++.++...++||||+++|
T Consensus        49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg  128 (370)
T cd05621          49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG  128 (370)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCC
Confidence            34455555555544443  334999998632    223356789999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..       ..+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||++.........
T Consensus       129 ~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         129 DLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             cHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            99999832       347899999999999999999999   99999999999999999999999999999876533221


Q ss_pred             cccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          264 VSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                       ......||+.|+|||++            +|+||+||++|||++|+.||.......        .+..+.....   ..
T Consensus       199 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------~~~~i~~~~~---~~  266 (370)
T cd05621         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------TYSKIMDHKN---SL  266 (370)
T ss_pred             -ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCc---cc
Confidence             12345699999999975            899999999999999999997653321        1222221111   01


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCC--CCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTE--RPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~e  363 (363)
                      ........+..+.+++.+|++.++.+  |||++|
T Consensus       267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e  300 (370)
T cd05621         267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE  300 (370)
T ss_pred             CCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence            11122345777889999999854433  777653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=293.85  Aligned_cols=230  Identities=23%  Similarity=0.371  Sum_probs=186.6

Q ss_pred             ccccccCCcceeecc--CC---eeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SN---EIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~---~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+-||.+....++  ++   .||||.++..  ++.+.+|+.|..++.+++||||++|.|+........||.|||++|+
T Consensus       637 IGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGs  716 (996)
T KOG0196|consen  637 IGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGS  716 (996)
T ss_pred             EecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCc
Confidence            455555555554443  22   2999999854  4566799999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc-c
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-I  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~  263 (363)
                      |+.+|+.+.     .+|+.-++..++++|+.||+||-+   .+++||||..+|||++++-..|++|||+++.+.++.. .
T Consensus       717 LDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  717 LDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             HHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            999996543     679999999999999999999999   9999999999999999999999999999998866542 1


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHh-cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .+.....-++.|.|||.+        |||||||+++||.+ .|.+|+-.....+        +.+.++.+.++      .
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------VIkaIe~gyRL------P  854 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIEQGYRL------P  854 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--------HHHHHHhccCC------C
Confidence            111222235789999999        99999999999988 4777765543322        44555555443      3


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++..|..|+++|||+|-.+||+++|
T Consensus       855 pPmDCP~aL~qLMldCWqkdR~~RP~F~q  883 (996)
T KOG0196|consen  855 PPMDCPAALYQLMLDCWQKDRNRRPKFAQ  883 (996)
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhcCCCHHH
Confidence            45678888999999999999999999864

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-36  Score=275.97  Aligned_cols=226  Identities=19%  Similarity=0.211  Sum_probs=175.1

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccCC----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+...+  ..||||++....    ...+.+..|..++..+ +|++|+++++++...+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   85 (323)
T cd05616           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG   85 (323)
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence            345566666655554433  349999987432    2234567788888777 589999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 g~L~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          86 GDLMYQIQQ------VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             CCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            999999843      2468999999999999999999999   9999999999999999999999999999876432221


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....||+.|+|||++        +|+|||||++|||++|+.||.......        +...+....       ..
T Consensus       157 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~i~~~~-------~~  219 (323)
T cd05616         157 T--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHN-------VA  219 (323)
T ss_pred             c--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CC
Confidence            1  1345689999999987        799999999999999999997643321        222222111       11


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+...+.++.+++.+||+.+|++|++.
T Consensus       220 ~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            233456788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.7e-36  Score=271.94  Aligned_cols=224  Identities=22%  Similarity=0.356  Sum_probs=170.2

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC-----CCCCCC
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS-----SSHRQL  201 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~l  201 (363)
                      .||+|.+....  ...+++.+|++++++++|+||+++++++..+...++++||+++++|.+++......     .....+
T Consensus        48 ~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  127 (296)
T cd05051          48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL  127 (296)
T ss_pred             eEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCC
Confidence            38999987443  23467889999999999999999999999999999999999999999999654321     112368


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc
Q 039471          202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF  281 (363)
Q Consensus       202 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  281 (363)
                      ++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++...............++..|+|||.+
T Consensus       128 ~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (296)
T cd05051         128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV  204 (296)
T ss_pred             CHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence            999999999999999999999   99999999999999999999999999998865443322222344567889999986


Q ss_pred             --------cCceehhHHHHHHhc--CCCCCCcchhcccccchHHHHHHHhhhc-cccccccCCCCcHHHHHHHHHHHHHh
Q 039471          282 --------SRNFCYGMMLLEMVG--CRKNNDPAVEIQSQIYFPEWIYNRMRLG-QELCLDFEEDGDEGIARKLAIVAIWC  350 (363)
Q Consensus       282 --------~Di~slG~il~el~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~c  350 (363)
                              +||||||+++|||++  |..|+.......        ........ ...........+...+.++.+++.+|
T Consensus       205 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  276 (296)
T cd05051         205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ--------VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLEC  276 (296)
T ss_pred             hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH--------HHHHHHhccccccccccCCCccCCCHHHHHHHHHH
Confidence                    899999999999997  566665432211        11111110 00001111112234557899999999


Q ss_pred             ccCCCCCCCCCCC
Q 039471          351 IQWNPTERPSMPM  363 (363)
Q Consensus       351 l~~~p~~RPs~~e  363 (363)
                      |+.+|++|||++|
T Consensus       277 l~~~p~~Rpt~~e  289 (296)
T cd05051         277 WRRDEEDRPTFRE  289 (296)
T ss_pred             hccChhcCCCHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.2e-36  Score=270.03  Aligned_cols=233  Identities=21%  Similarity=0.272  Sum_probs=178.8

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeC------CceeEEEec
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG------NRRTLIYEF  179 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv~e~  179 (363)
                      ...++.+++|.++.+...  +..||+|..........++.+|+.++.++ +|+||+++++++...      ...+++|||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            344556666665554443  33499999976666667889999999998 699999999998653      468999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.....
T Consensus        91 ~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          91 CGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             CCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            99999999985432    2568999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CccccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ...  ......|+..|+|||++             +|+||||+++|||++|+.|+........        ........ 
T Consensus       164 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~--------~~~~~~~~-  232 (272)
T cd06637         164 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LFLIPRNP-  232 (272)
T ss_pred             ccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH--------HHHHhcCC-
Confidence            322  12345688899999975             8999999999999999999865432211        01111000 


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .........+.++.+++.+||+.+|.+|||++|
T Consensus       233 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  265 (272)
T cd06637         233 ----APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ  265 (272)
T ss_pred             ----CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence                011112245667999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-36  Score=266.60  Aligned_cols=232  Identities=23%  Similarity=0.363  Sum_probs=178.6

Q ss_pred             ccccccccCCcceeecc-----CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+...     ...||||++.....  ...+|.+|+.++++++|+||+++++++.++...+++|||+++
T Consensus        10 ~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   89 (266)
T cd05033          10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMEN   89 (266)
T ss_pred             eEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCC
Confidence            34556666666554432     22499999864332  235789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.++|+|||+++.......
T Consensus        90 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          90 GSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             CCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            99999995432     468999999999999999999999   9999999999999999999999999999988753222


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ........++..|+|||.+        +|+||||+++|||++ |..||.......        ....+..+...      
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~------  227 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAVEDGYRL------  227 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCC------
Confidence            2122233456789999987        799999999999997 888885432211        12222211111      


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...+..+.+++.+||+.+|++|||++|
T Consensus       228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e  257 (266)
T cd05033         228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQ  257 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            122345677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.3e-36  Score=271.04  Aligned_cols=236  Identities=21%  Similarity=0.329  Sum_probs=178.9

Q ss_pred             cccccccCCcceeecc-------CCeeEEEEcccCCcC-hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH-------SNEIAVKMLEHLKGN-GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+...       ...+++|.+...... .+.+.+|+.++++++|+||+++++++......++||||+++
T Consensus        12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   91 (291)
T cd05094          12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH   91 (291)
T ss_pred             eecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCC
Confidence            3455555555544321       123889988754432 35789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          183 GSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       183 ~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      ++|.+++......          .....+++..++.++.||+.||+|||+   .+++||||||+||+++.++.++|+|||
T Consensus        92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~dfg  168 (291)
T cd05094          92 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFG  168 (291)
T ss_pred             CcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEECCCC
Confidence            9999999654310          122458999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ++................++..|+|||.+        +|+||||+++|||++ |+.||.......        ..+.+..
T Consensus       169 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~  240 (291)
T cd05094         169 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------VIECITQ  240 (291)
T ss_pred             cccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhC
Confidence            99766543322222334467889999976        899999999999998 999876543221        1122221


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..      .......+..+.+++.+||+.+|++|||++|
T Consensus       241 ~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  274 (291)
T cd05094         241 GRV------LERPRVCPKEVYDIMLGCWQREPQQRLNIKE  274 (291)
T ss_pred             CCC------CCCCccCCHHHHHHHHHHcccChhhCcCHHH
Confidence            111      1122335677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.7e-36  Score=267.09  Aligned_cols=238  Identities=23%  Similarity=0.291  Sum_probs=174.3

Q ss_pred             ccccccCCcceeeccC----CeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLHS----NEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~----~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...+    ..+|+|.++.....  ...+.+|+.++++++|+||+++++++.+....++||||+++++|
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   82 (269)
T cd05087           3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL   82 (269)
T ss_pred             ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcH
Confidence            4556666665543322    23899988754322  24788999999999999999999999998899999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..... ......++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++..........
T Consensus        83 ~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          83 KGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999965432 122456788889999999999999999   9999999999999999999999999999876543332222


Q ss_pred             cccccccccccCCccc---------------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          266 RTAARGTSGYIAPELF---------------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      .....++..|+|||++               +|+||||+++|||++ |+.||........       ...... +.... 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~-~~~~~-  229 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-------LTYTVR-EQQLK-  229 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHhh-cccCC-
Confidence            2334467889999974               699999999999996 9989865432211       000111 11110 


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+......++.+.+++..|+ .+|++|||++|
T Consensus       230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~  262 (269)
T cd05087         230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE  262 (269)
T ss_pred             CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHH
Confidence            0111112234556888999998 58999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=292.02  Aligned_cols=233  Identities=22%  Similarity=0.282  Sum_probs=177.9

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--------ceeEEEe
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--------RRTLIYE  178 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e  178 (363)
                      ++.+++|.++.+..  .+..||||++....   .....+.+|+.++..++|+||+++++.+....        ..++|||
T Consensus        40 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~E  119 (496)
T PTZ00283         40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLD  119 (496)
T ss_pred             EecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEe
Confidence            45555655554433  24459999986432   22356789999999999999999988764332        3689999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+++|+|.+++.....  ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       120 y~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~  194 (496)
T PTZ00283        120 YANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA  194 (496)
T ss_pred             CCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence            9999999999965432  23579999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      ............||+.|+|||++        +||||||+++|||++|+.||.......        +......+..    
T Consensus       195 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--------~~~~~~~~~~----  262 (496)
T PTZ00283        195 ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--------VMHKTLAGRY----  262 (496)
T ss_pred             ccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHhcCCC----
Confidence            43322222445689999999987        899999999999999999997543211        1222211111    


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...+...++++.+++.+||+.+|++|||++|
T Consensus       263 --~~~~~~~~~~l~~li~~~L~~dP~~RPs~~e  293 (496)
T PTZ00283        263 --DPLPPSISPEMQEIVTALLSSDPKRRPSSSK  293 (496)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence              1123345678999999999999999999853

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.8e-36  Score=271.24  Aligned_cols=235  Identities=24%  Similarity=0.406  Sum_probs=177.8

Q ss_pred             ccccccCCcceeecc-------CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH-------SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+...       ...+|+|.+.....  ..+++.+|+.+++.++|+||+++++.+..++..++++||+.+
T Consensus         8 lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (290)
T cd05045           8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY   87 (290)
T ss_pred             ccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCC
Confidence            455555555443321       13489998864432  235788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC
Q 039471          183 GSLQKFIFSKTNS------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF  244 (363)
Q Consensus       183 ~sL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~  244 (363)
                      ++|.+++......                  .....+++..++.++.|++.||+|||+   .+++||||||+||++++++
T Consensus        88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~~~~  164 (290)
T cd05045          88 GSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGR  164 (290)
T ss_pred             CCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEcCCC
Confidence            9999998653211                  112458899999999999999999999   9999999999999999999


Q ss_pred             CeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHH
Q 039471          245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       245 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~  315 (363)
                      .+||+|||+++...............++..|+|||.+        +|+||||++++||++ |..||......        
T Consensus       165 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------  236 (290)
T cd05045         165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--------  236 (290)
T ss_pred             cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence            9999999999865443322222334456789999986        799999999999998 88888653221        


Q ss_pred             HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+......+..      ...+...+.++.+++.+||+.+|++|||++|
T Consensus       237 ~~~~~~~~~~~------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         237 RLFNLLKTGYR------MERPENCSEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HHHHHHhCCCC------CCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            12222221111      1223345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.7e-36  Score=266.92  Aligned_cols=229  Identities=22%  Similarity=0.304  Sum_probs=180.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.++++.++.+...  +..|++|.+...   ....+++.+|++++++++|+||+++++++.+++..+++|||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd08529           8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLH   87 (256)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHH
Confidence            445555555544443  344999988632   234568889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....    ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++........  .
T Consensus        88 ~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~  158 (256)
T cd08529          88 KLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--A  158 (256)
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--h
Confidence            9996542    2568999999999999999999999   99999999999999999999999999998876544322  1


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||++        +|+||||++++||++|+.||.......        .......+.      .......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~  224 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKIIRGV------FPPVSQM  224 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC------CCCCccc
Confidence            334578899999986        899999999999999999987554211        112221111      1122235


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++..+.+++.+||+.+|++||++.|
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~  249 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQ  249 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHH
Confidence            6778999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.8e-36  Score=269.06  Aligned_cols=237  Identities=22%  Similarity=0.344  Sum_probs=178.1

Q ss_pred             ccccccccCCcceeec------cCCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFL------HSNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+..      ....||+|.+.....  ...++.+|++++++++|+||+++++++..+...+++|||++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   90 (283)
T cd05090          11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN   90 (283)
T ss_pred             eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence            3455566665554432      223499999874332  22578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEec
Q 039471          182 NGSLQKFIFSKTN-----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  250 (363)
Q Consensus       182 ~~sL~~~l~~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D  250 (363)
                      +++|.+++.....           ......+++..+..++.|++.||+|||+   .+++|+||||+|||+++++.+||+|
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl~d  167 (283)
T cd05090          91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISD  167 (283)
T ss_pred             CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEecc
Confidence            9999999853321           0112458899999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHh
Q 039471          251 FGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRM  321 (363)
Q Consensus       251 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ||+++...............++..|+|||.+        +|+||||+++|||++ |..||......        .+....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------~~~~~~  239 (283)
T cd05090         168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------EVIEMV  239 (283)
T ss_pred             ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHH
Confidence            9999876443222122333456789999987        899999999999998 88887653221        122222


Q ss_pred             hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....      ...+..++..+.+++.+||+.+|++||++.+
T Consensus       240 ~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  275 (283)
T cd05090         240 RKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKD  275 (283)
T ss_pred             HcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence            21111      1123345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-36  Score=265.39  Aligned_cols=235  Identities=26%  Similarity=0.398  Sum_probs=184.9

Q ss_pred             ccccccCCcceeecc-----CCeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH-----SNEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.+..+...     +..||+|.+......  .+.+.+|++.++.++|+||+++++++..+...+++|||+++++
T Consensus         3 ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (262)
T cd00192           3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGD   82 (262)
T ss_pred             cccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCc
Confidence            455666666555444     445999999755433  5788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNS---SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++......   .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.+.......
T Consensus        83 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          83 LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             HHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999543210   013679999999999999999999999   999999999999999999999999999998876544


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........++..|+|||.+        +|+||+|+++|||++ |..||......        .+.+.+..+.      .
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~------~  225 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRKGY------R  225 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC------C
Confidence            32223445578899999987        799999999999998 58888765221        1222222211      1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...+.++.+++.+||+.+|++|||++|
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  256 (262)
T cd00192         226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSE  256 (262)
T ss_pred             CCCCccCChHHHHHHHHHccCCcccCcCHHH
Confidence            2233445788999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5e-36  Score=266.10  Aligned_cols=231  Identities=25%  Similarity=0.372  Sum_probs=177.9

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+... +..||+|.+.......+.+.+|+.++++++|+|++++++++.+ ...+++|||+++++|.++
T Consensus        12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~   90 (260)
T cd05070          12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF   90 (260)
T ss_pred             heeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHH
Confidence            34556666655554433 3349999998665566789999999999999999999998754 567899999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||.+......... ....
T Consensus        91 ~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~  162 (260)
T cd05070          91 LKDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQG  162 (260)
T ss_pred             HHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccC
Confidence            96432    2458999999999999999999999   99999999999999999999999999999876543321 1122


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||.+        +|+||||+++|||++ |..||.......        ....+..+.      ....+...
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~  228 (260)
T cd05070         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------VLEQVERGY------RMPCPQDC  228 (260)
T ss_pred             CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCC------CCCCCCcC
Confidence            3356789999986        899999999999998 888886532211        112222111      11223455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+|++.+|++|||+.+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~  252 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEY  252 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHH
Confidence            678999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.4e-36  Score=265.04  Aligned_cols=229  Identities=24%  Similarity=0.370  Sum_probs=174.4

Q ss_pred             ccccccCCcceeecc----CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH----SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~----~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...    +..||+|++.....  ..+++.+|+.++++++|+||+++++++.. ...++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            455666665543322    22399999875432  23578999999999999999999998754 578999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...     ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.....+.....
T Consensus        82 ~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          82 NKFLSGK-----KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            9998532     2568999999999999999999999   9999999999999999999999999999986654432211


Q ss_pred             -cccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          266 -RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       266 -~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                       .....++..|+|||.+        +|+||||+++||+++ |..||.......        +...+..+..      ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~  219 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKR------LDC  219 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCC------CCC
Confidence             1222345789999986        799999999999996 999986543221        1222222221      122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...++++.+++.+||+.+|++||++.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~  247 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAK  247 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            3345678999999999999999999863

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-36  Score=284.11  Aligned_cols=238  Identities=18%  Similarity=0.186  Sum_probs=170.9

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ++.+++|.++.....  +..||||...     ...+.+|++++++++|+||+++++++..++..+++||++. ++|.+++
T Consensus       177 Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l  250 (461)
T PHA03211        177 LTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYL  250 (461)
T ss_pred             EccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHH
Confidence            444445444444333  2349999642     3356799999999999999999999999999999999995 6898888


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ...     ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..............
T Consensus       251 ~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  322 (461)
T PHA03211        251 GAR-----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI  322 (461)
T ss_pred             Hhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccccc
Confidence            432     2469999999999999999999999   99999999999999999999999999999876543222122345


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc-----------
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD-----------  330 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  330 (363)
                      .||..|+|||++        +|+|||||++|||++|..++...........+...+.+.+...+.....           
T Consensus       323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~  402 (461)
T PHA03211        323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS  402 (461)
T ss_pred             CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence            689999999987        7999999999999998866543322211111212122222111100000           


Q ss_pred             -------------cCCCCc---HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 -------------FEEDGD---EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 -------------~~~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                   ......   ...+..+.+|+.+||+.||++|||++|
T Consensus       403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~e  451 (461)
T PHA03211        403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAE  451 (461)
T ss_pred             HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHH
Confidence                         000000   123457889999999999999999865

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-36  Score=269.95  Aligned_cols=235  Identities=20%  Similarity=0.289  Sum_probs=177.5

Q ss_pred             ccccccCCcceeecc-------CCeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH-------SNEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+...       +..||||++......  .+.+.+|+.++..++|+||+++++++......++++||+++
T Consensus        13 lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~   92 (283)
T cd05091          13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSH   92 (283)
T ss_pred             hCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCC
Confidence            445555555444322       234999999754322  35688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          183 GSLQKFIFSKTN----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       183 ~sL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      ++|.+++.....          ......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        93 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~Dfg  169 (283)
T cd05091          93 SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLG  169 (283)
T ss_pred             CcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEecccc
Confidence            999999853211          1112458899999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      +++...............+++.|+|||.+        +|+||||+++|||++ |..|+.......        +...+..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~i~~  241 (283)
T cd05091         170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--------VIEMIRN  241 (283)
T ss_pred             cccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHc
Confidence            98876443322222334467789999987        799999999999998 777776532211        2222222


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...      ..+...+..+.+++.+||+.+|++|||++|
T Consensus       242 ~~~~------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~  275 (283)
T cd05091         242 RQVL------PCPDDCPAWVYTLMLECWNEFPSRRPRFKD  275 (283)
T ss_pred             CCcC------CCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence            2211      123345677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=256.97  Aligned_cols=216  Identities=23%  Similarity=0.276  Sum_probs=175.9

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeee----CCceeEEEeccCCCCHHHHhhhcCCCCCCCCC
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE----GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL  201 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l  201 (363)
                      ++.+|+|++.++    +...+|++.--.. .|+|||.+++++.+    ...+.+|||.|+||.|.+.+.....    ..+
T Consensus        87 ~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~----~af  158 (400)
T KOG0604|consen   87 QEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD----QAF  158 (400)
T ss_pred             hhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc----ccc
Confidence            444999999844    3455777765444 49999999998853    3578899999999999999965543    679


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCccccccccccccccccCC
Q 039471          202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAP  278 (363)
Q Consensus       202 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  278 (363)
                      +|.+...|++||+.|+.|||+   .+|.||||||+|+|...   |..+||+|||+|+...+...   .....-|+.|.||
T Consensus       159 TErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  159 TEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAP  232 (400)
T ss_pred             hHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCcccccccCH
Confidence            999999999999999999999   99999999999999974   45689999999998665433   3556689999999


Q ss_pred             ccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHh
Q 039471          279 ELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWC  350 (363)
Q Consensus       279 E~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  350 (363)
                      |++        .|+||+|+++|-|++|.+||+..-..    .++.-...++..++.   .+..+.....++..+++|+.+
T Consensus       233 evlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~gqy---~FP~pEWs~VSe~aKdlIR~L  305 (400)
T KOG0604|consen  233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTGQY---EFPEPEWSCVSEAAKDLIRKL  305 (400)
T ss_pred             HHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhccCc---cCCChhHhHHHHHHHHHHHHH
Confidence            999        79999999999999999999876442    233345556655543   344566788999999999999


Q ss_pred             ccCCCCCCCCCCC
Q 039471          351 IQWNPTERPSMPM  363 (363)
Q Consensus       351 l~~~p~~RPs~~e  363 (363)
                      |..+|.+|.|+.|
T Consensus       306 Lkt~PteRlTI~~  318 (400)
T KOG0604|consen  306 LKTEPTERLTIEE  318 (400)
T ss_pred             hcCCchhheeHHH
Confidence            9999999999864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.4e-36  Score=284.56  Aligned_cols=229  Identities=19%  Similarity=0.215  Sum_probs=169.5

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  +..||+|++....    ...+.+.+|+.++++++|+||+++++.+.++...++||||+++|+
T Consensus         8 ~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~   87 (382)
T cd05625           8 TLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD   87 (382)
T ss_pred             EEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCc
Confidence            3444455444443332  3349999986432    233578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc--
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS--  262 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--  262 (363)
                      |.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........  
T Consensus        88 L~~~l~~------~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          88 MMSLLIR------MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999843      2468999999999999999999999   9999999999999999999999999999753211000  


Q ss_pred             -------------------------------------------ccccccccccccccCCccc--------cCceehhHHH
Q 039471          263 -------------------------------------------IVSRTAARGTSGYIAPELF--------SRNFCYGMML  291 (363)
Q Consensus       263 -------------------------------------------~~~~~~~~gt~~y~aPE~~--------~Di~slG~il  291 (363)
                                                                 ........||+.|+|||++        +|+|||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       0001124589999999987        8999999999


Q ss_pred             HHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          292 LEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       292 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      |||++|+.||........        ...+....   ...........+++..+++.+++ .+|++|++
T Consensus       239 ~elltG~~Pf~~~~~~~~--------~~~i~~~~---~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         239 YEMLVGQPPFLAQTPLET--------QMKVINWQ---TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             HHHHhCCCCCCCCCHHHH--------HHHHHccC---CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            999999999976543221        11111100   01111122345667888888876 59999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.5e-36  Score=265.83  Aligned_cols=231  Identities=24%  Similarity=0.386  Sum_probs=179.7

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      .+++.+++|.++.+... ++.||+|.+.......+++.+|+.++++++|+||+++++++. ....+++|||+++++|.++
T Consensus        12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~   90 (260)
T cd05067          12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDF   90 (260)
T ss_pred             eeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHH
Confidence            34566666666555543 345999999876666788999999999999999999999874 4568999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++......... ....
T Consensus        91 ~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~  162 (260)
T cd05067          91 LKTPE----GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREG  162 (260)
T ss_pred             HHhcC----CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccC
Confidence            85433    2568999999999999999999999   99999999999999999999999999999876533221 1123


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+..      .......
T Consensus       163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  228 (260)
T cd05067         163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------VIQNLERGYR------MPRPDNC  228 (260)
T ss_pred             CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHHcCCC------CCCCCCC
Confidence            3456789999987        799999999999998 999986543211        1222221111      1122334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +.++.+++.+||+.+|++|||+++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEY  252 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHH
Confidence            567999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.6e-36  Score=269.60  Aligned_cols=235  Identities=23%  Similarity=0.364  Sum_probs=177.6

Q ss_pred             ccccccCCcceeecc-------CCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccC
Q 039471          112 LISFNLTNSKFFFLH-------SNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ++.+++|.++.....       ...+|+|++.....  ...++.+|+.++.++ +|+||+++++++..++..+++|||++
T Consensus        20 ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~   99 (293)
T cd05053          20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAA   99 (293)
T ss_pred             ecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCC
Confidence            445555555444322       13499999874322  235688999999999 79999999999999999999999999


Q ss_pred             CCCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          182 NGSLQKFIFSKTN----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       182 ~~sL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      +++|.+++.....          ......+++..++.++.|++.||+|||+   .+|+|+||||+||+++.++.+||+||
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL~Df  176 (293)
T cd05053         100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADF  176 (293)
T ss_pred             CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEeCcc
Confidence            9999999965321          0223578999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhh
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMR  322 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      |+++...............++..|+|||.+        +|+||||+++|||++ |..|+.......        ..+.+.
T Consensus       177 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~  248 (293)
T cd05053         177 GLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------LFKLLK  248 (293)
T ss_pred             ccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--------HHHHHH
Confidence            999876543322222333456789999986        799999999999997 888875432211        122222


Q ss_pred             hccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 LGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..      ...+...+..+.+++.+|++.+|++|||++|
T Consensus       249 ~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  283 (293)
T cd05053         249 EGYR------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ  283 (293)
T ss_pred             cCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence            2211      1122344667999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=279.49  Aligned_cols=224  Identities=21%  Similarity=0.228  Sum_probs=171.0

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhcc---CCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRI---HHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      +.+++|.++.+...  +..||||++....    .....+..|..++.+.   +|+||+++++.+.++...++||||++++
T Consensus         2 G~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g   81 (330)
T cd05586           2 GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG   81 (330)
T ss_pred             CCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCC
Confidence            45556655554433  3459999986321    1223455677777655   6999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~L~~~l~~------~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          82 ELFWHLQK------EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             hHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            99998842      3568999999999999999999999   99999999999999999999999999998754332211


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        .....||..|+|||++         +|+|||||++|||++|+.||.......        .+..+..+...   .   
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~---~---  216 (330)
T cd05586         153 --TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVR---F---  216 (330)
T ss_pred             --ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHcCCCC---C---
Confidence              2345689999999976         799999999999999999997643211        22222222111   0   


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ....++..+.+++.+||+.||++||++
T Consensus       217 ~~~~~~~~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         217 PKNVLSDEGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHCCCC
Confidence            112356778999999999999999965

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-36  Score=267.19  Aligned_cols=236  Identities=22%  Similarity=0.346  Sum_probs=178.6

Q ss_pred             cccccccCCcceeecc-------CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLH-------SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .++.+++|.+..+...       ...||+|.+.....  ....+.+|+.+++.++|+||+++++++..+...+++|||++
T Consensus        13 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   92 (277)
T cd05032          13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA   92 (277)
T ss_pred             EecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCC
Confidence            3445555555443332       23499999864432  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          182 NGSLQKFIFSKTNSS----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      +++|.+++.......    ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        93 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~~~  169 (277)
T cd05032          93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI  169 (277)
T ss_pred             CCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccchhh
Confidence            999999996543211    22457899999999999999999999   99999999999999999999999999998866


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .............++..|+|||.+        +|+||||+++||+++ |..|+.......        ..+....+..  
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~--  239 (277)
T cd05032         170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------VLKFVIDGGH--  239 (277)
T ss_pred             ccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------HHHHHhcCCC--
Confidence            544322222334467889999987        899999999999998 888876433211        1122221111  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ...+...+..+.+++.+||+.+|++|||+.|
T Consensus       240 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  270 (277)
T cd05032         240 ----LDLPENCPDKLLELMRMCWQYNPKMRPTFLE  270 (277)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence                1122334678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-36  Score=284.64  Aligned_cols=228  Identities=17%  Similarity=0.219  Sum_probs=169.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++...    ....+.+.+|++++++++|+||+++++.+.+++..++||||+++|+
T Consensus         8 ~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~   87 (376)
T cd05598           8 TIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD   87 (376)
T ss_pred             EEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCc
Confidence            3444455544443332  344999998632    2234578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc--
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS--  262 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--  262 (363)
                      |.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|..+.....  
T Consensus        88 L~~~i~~------~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          88 MMSLLIR------LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999943      3568999999999999999999999   9999999999999999999999999999753310000  


Q ss_pred             ---------------------------------------ccccccccccccccCCccc--------cCceehhHHHHHHh
Q 039471          263 ---------------------------------------IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV  295 (363)
Q Consensus       263 ---------------------------------------~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~  295 (363)
                                                             ........||..|+|||++        +|+|||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                   0001124689999999987        79999999999999


Q ss_pred             cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          296 GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       296 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +|+.||........        ...+.....   .........+++.+.+++.+|+ .+|++|+
T Consensus       239 ~G~~Pf~~~~~~~~--------~~~i~~~~~---~~~~~~~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         239 VGQPPFLADTPAET--------QLKVINWET---TLHIPSQAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             hCCCCCCCCCHHHH--------HHHHhccCc---cccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence            99999976543221        111111000   0111112235667888888876 4999999

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.8e-36  Score=270.58  Aligned_cols=231  Identities=23%  Similarity=0.276  Sum_probs=177.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||+|.+.....    ....+.+|+.++++++|+||+++++.+.+++..++||||++++
T Consensus         6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~   85 (285)
T cd05630           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG   85 (285)
T ss_pred             EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence            34566666665544443  34599998864321    2245778999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....    ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++.........
T Consensus        86 ~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          86 DLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             cHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            9999885432    2458999999999999999999999   99999999999999999999999999998765543321


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....|+..|+|||++        +|+||||+++|||++|+.||.........    .........       .....
T Consensus       159 ---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~-------~~~~~  224 (285)
T cd05630         159 ---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKE-------VQEEY  224 (285)
T ss_pred             ---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhh-------hhhhc
Confidence               234589999999998        79999999999999999999764321110    000110000       00112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ....++.+.+++.+||+.||++|||+
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~  250 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGC  250 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCC
Confidence            23456778999999999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.3e-36  Score=269.13  Aligned_cols=232  Identities=23%  Similarity=0.256  Sum_probs=178.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||+|.+....    .....+.+|++++++++|+||+++.+.+..++..+++|||++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence            34556666655444433  3459999986432    12245788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....    ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++.........
T Consensus        86 ~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          86 DLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             cHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            9998885432    2469999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....|+..|+|||.+        +|+||||+++|||++|..||........    .+.+.......       ....
T Consensus       159 ---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~-------~~~~  224 (285)
T cd05632         159 ---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLET-------EEVY  224 (285)
T ss_pred             ---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhcc-------cccc
Confidence               234589999999997        7999999999999999999975432211    01111111111       1112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ....+..+.+++.+|++.+|++|||+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            334566789999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.2e-36  Score=264.74  Aligned_cols=230  Identities=25%  Similarity=0.374  Sum_probs=177.3

Q ss_pred             cccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++.+++|.++.+...+ ..+|+|.+.......+.+.+|+.++++++|+|++++++++.. +..+++|||+++++|.+++
T Consensus        13 ~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05069          13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFL   91 (260)
T ss_pred             eecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHH
Confidence            34555666555544333 349999987655556789999999999999999999998754 5678999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||.+......... .....
T Consensus        92 ~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~  163 (260)
T cd05069          92 KEGD----GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGA  163 (260)
T ss_pred             hhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCC
Confidence            6432    2458999999999999999999999   99999999999999999999999999999876443221 11233


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||..        +|+||||+++|||++ |+.||.......        ....+..+.      ....+...+
T Consensus       164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~  229 (260)
T cd05069         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERGY------RMPCPQGCP  229 (260)
T ss_pred             ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCC------CCCCCcccC
Confidence            466789999986        799999999999998 888886543211        112222111      112234567


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.+|++|||+++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~  252 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEY  252 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHH
Confidence            78999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.6e-36  Score=269.74  Aligned_cols=224  Identities=24%  Similarity=0.335  Sum_probs=167.7

Q ss_pred             eEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC-----CCCCCCC
Q 039471          130 IAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS-----SSHRQLS  202 (363)
Q Consensus       130 vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~l~  202 (363)
                      ||+|++.....  ..++|.+|++++++++|+||+++++++..+...+++|||+++++|.+++......     .....++
T Consensus        49 ~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  128 (296)
T cd05095          49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS  128 (296)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccC
Confidence            89999975432  2357899999999999999999999999999999999999999999999654321     1124588


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-
Q 039471          203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-  281 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-  281 (363)
                      +..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++.+.............++..|+|||.. 
T Consensus       129 ~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  205 (296)
T cd05095         129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL  205 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence            89999999999999999999   99999999999999999999999999999866443322112233346789999965 


Q ss_pred             -------cCceehhHHHHHHhc--CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhcc
Q 039471          282 -------SRNFCYGMMLLEMVG--CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ  352 (363)
Q Consensus       282 -------~Di~slG~il~el~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  352 (363)
                             +|+||||+++|||++  |..|+........    .............   ......+..+++.+.+++.+||+
T Consensus       206 ~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~  278 (296)
T cd05095         206 LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV----IENTGEFFRDQGR---QVYLPKPALCPDSLYKLMLSCWR  278 (296)
T ss_pred             cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH----HHHHHHHHhhccc---cccCCCCCCCCHHHHHHHHHHcC
Confidence                   899999999999998  6677754322111    0000000000000   00011123345789999999999


Q ss_pred             CCCCCCCCCCC
Q 039471          353 WNPTERPSMPM  363 (363)
Q Consensus       353 ~~p~~RPs~~e  363 (363)
                      .||++|||++|
T Consensus       279 ~~p~~Rp~~~~  289 (296)
T cd05095         279 RNAKERPSFQE  289 (296)
T ss_pred             CCcccCCCHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=270.42  Aligned_cols=224  Identities=23%  Similarity=0.326  Sum_probs=166.3

Q ss_pred             eEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC------CCCCCC
Q 039471          130 IAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS------SSHRQL  201 (363)
Q Consensus       130 vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~l  201 (363)
                      ||+|.+....  ...+.|.+|++++++++|+|++++++++......++||||+++++|.+++......      .....+
T Consensus        47 vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  126 (295)
T cd05097          47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV  126 (295)
T ss_pred             EEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcc
Confidence            8999987432  22357889999999999999999999999999999999999999999998543210      111347


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc
Q 039471          202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF  281 (363)
Q Consensus       202 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  281 (363)
                      ++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++................++..|+|||.+
T Consensus       127 ~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  203 (295)
T cd05097         127 SIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI  203 (295)
T ss_pred             cHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence            889999999999999999999   99999999999999999999999999998765443322222333457789999976


Q ss_pred             --------cCceehhHHHHHHhc--CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhc
Q 039471          282 --------SRNFCYGMMLLEMVG--CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI  351 (363)
Q Consensus       282 --------~Di~slG~il~el~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (363)
                              +|+||||++++||++  +..||........    .............   ......+...+..+.+++.+||
T Consensus       204 ~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l  276 (295)
T cd05097         204 LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV----IENTGEFFRNQGR---QIYLSQTPLCPSPVFKLMMRCW  276 (295)
T ss_pred             ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH----HHHHHHhhhhccc---cccCCCCCCCCHHHHHHHHHHc
Confidence                    899999999999988  5556654322110    0001110000000   0001122234578999999999


Q ss_pred             cCCCCCCCCCCC
Q 039471          352 QWNPTERPSMPM  363 (363)
Q Consensus       352 ~~~p~~RPs~~e  363 (363)
                      +.+|++||||++
T Consensus       277 ~~~p~~RPs~~~  288 (295)
T cd05097         277 SRDIKDRPTFNK  288 (295)
T ss_pred             CCCchhCcCHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-36  Score=265.16  Aligned_cols=228  Identities=24%  Similarity=0.408  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ..++.+++|.+..+...++.||+|.+.......+++.+|+.++++++|+||+++++++.+....++||||+++++|.+++
T Consensus        12 ~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~   91 (256)
T cd05039          12 ATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL   91 (256)
T ss_pred             eeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHH
Confidence            34566666666666666777999999866555678999999999999999999999999889999999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      .....    ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.++.......     ..
T Consensus        92 ~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~  159 (256)
T cd05039          92 RSRGR----AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SG  159 (256)
T ss_pred             HhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-----cC
Confidence            54321    368999999999999999999999   9999999999999999999999999999987643221     22


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..+..|+|||.+        +|+||||++++||++ |..||.......        +...+..+..      ...+...+
T Consensus       160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~  225 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPHVEKGYR------MEAPEGCP  225 (256)
T ss_pred             CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCC------CCCccCCC
Confidence            346679999986        799999999999997 888876542211        2222221111      12223456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +.+.+++.+||+.+|++|||++|
T Consensus       226 ~~~~~li~~~l~~~p~~Rp~~~~  248 (256)
T cd05039         226 PEVYKVMKDCWELDPAKRPTFKQ  248 (256)
T ss_pred             HHHHHHHHHHhccChhhCcCHHH
Confidence            78999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.4e-36  Score=271.02  Aligned_cols=234  Identities=20%  Similarity=0.287  Sum_probs=180.2

Q ss_pred             CCCcccccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          106 ACPFQSLISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      +.....++.+++|.++.+..  .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            33444455555555544432  23459999886433 3456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..       ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       102 ~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999832       347899999999999999999999   9999999999999999999999999999876543322


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....++..|+|||.+        +|+||||+++|||++|+.||........       .......+     .....
T Consensus       172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-------~~~~~~~~-----~~~~~  237 (296)
T cd06654         172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNG-----TPELQ  237 (296)
T ss_pred             c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-------HHHHhcCC-----CCCCC
Confidence            1  1234578899999977        8999999999999999999965433211       11111101     01112


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+..+.+++.+||+.+|++|||++|
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  266 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKE  266 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHH
Confidence            23456678999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.7e-36  Score=266.93  Aligned_cols=231  Identities=26%  Similarity=0.412  Sum_probs=181.0

Q ss_pred             ccccccccCCcceeeccC-CeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLHS-NEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.++.+...+ ..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....+++|||+++++|.+
T Consensus        12 ~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (261)
T cd05148          12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA   91 (261)
T ss_pred             hhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHH
Confidence            345566666665544433 4499999875544 45688999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....    ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||.+.........  ..
T Consensus        92 ~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~  162 (261)
T cd05148          92 FLRSPE----GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SS  162 (261)
T ss_pred             HHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--cc
Confidence            996432    2568999999999999999999999   99999999999999999999999999999876543221  12


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ...++..|+|||.+        +|+||||+++|+|++ |+.||.......        ....+..+.      ....+..
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~  228 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------VYDQITAGY------RMPCPAK  228 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHHhCC------cCCCCCC
Confidence            33467789999987        799999999999998 788886543211        112221111      1122345


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+.+++.+||+.+|++|||++|
T Consensus       229 ~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (261)
T cd05148         229 CPQEIYKIMLECWAAEPEDRPSFKA  253 (261)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHH
Confidence            5678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-36  Score=281.63  Aligned_cols=240  Identities=19%  Similarity=0.188  Sum_probs=174.1

Q ss_pred             cccccccccCCcceeec---c----CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          109 FQSLISFNLTNSKFFFL---H----SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~---~----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      |..+..+|.|+.+.++.   .    +..||+|.+...    ....+|++++++++|+||+++++++......+++||++.
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  169 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK  169 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence            44444455555555443   2    233899988632    345689999999999999999999999999999999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ++|.+++.      ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       170 -~~l~~~l~------~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        170 -CDLFTYVD------RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             -CCHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence             68888882      22568999999999999999999999   999999999999999999999999999997765433


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHh------------
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRM------------  321 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~------------  321 (363)
                      .........||..|+|||++        +|+|||||++|||++|+.||...........+.. +.+.+            
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCccc
Confidence            32222345689999999987        7999999999999999999976433221100000 00000            


Q ss_pred             ----------hhccccccccCC-CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 ----------RLGQELCLDFEE-DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ----------~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                ............ ......+.++.+++.+||+.||++|||+.|
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e  371 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD  371 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHH
Confidence                      000000000000 001123457889999999999999999864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-36  Score=278.52  Aligned_cols=186  Identities=23%  Similarity=0.307  Sum_probs=151.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.+..+...  ++.||||++...    ......+.+|+.++.+++|+||+++++.+.++...++||||+++|+
T Consensus         8 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~   87 (363)
T cd05628           8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGD   87 (363)
T ss_pred             EEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCc
Confidence            3455555555544333  344999999642    2233567889999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc-
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  263 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        88 L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          88 MMTLLMK------KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999943      3568999999999999999999999   99999999999999999999999999998765321100 


Q ss_pred             --------------------------------cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCc
Q 039471          264 --------------------------------VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDP  303 (363)
Q Consensus       264 --------------------------------~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~  303 (363)
                                                      .......||..|+|||++        +|+|||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001234689999999997        7999999999999999999975


Q ss_pred             ch
Q 039471          304 AV  305 (363)
Q Consensus       304 ~~  305 (363)
                      ..
T Consensus       239 ~~  240 (363)
T cd05628         239 ET  240 (363)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.5e-36  Score=273.76  Aligned_cols=226  Identities=19%  Similarity=0.236  Sum_probs=174.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+...  ++.||+|++...    ....+.+..|..++..+. |++|+++++++.+.+..++||||+++|
T Consensus         7 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g   86 (323)
T cd05615           7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG   86 (323)
T ss_pred             EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCC
Confidence            3455555555554433  334999998642    223356778999988875 577888999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++....... 
T Consensus        87 ~L~~~i~~------~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-  156 (323)
T cd05615          87 DLMYHIQQ------VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-  156 (323)
T ss_pred             cHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence            99999843      2568999999999999999999999   9999999999999999999999999999875432221 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                       ......||..|+|||++        +|+||||+++|||++|+.||.......        +...+....       ...
T Consensus       157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~-------~~~  220 (323)
T cd05615         157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHN-------VSY  220 (323)
T ss_pred             -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CCC
Confidence             11334589999999987        799999999999999999997653321        222222111       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      +...+.++.+++.+||+.+|.+|++..
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            234567789999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-36  Score=264.13  Aligned_cols=228  Identities=27%  Similarity=0.427  Sum_probs=174.9

Q ss_pred             ccccccCCcceeeccC-----CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS-----NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.+.......     ..+|+|.+.....  ..+++.+|+.++++++|+||+++++++.. ...+++|||+++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~   81 (257)
T cd05060           3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGP   81 (257)
T ss_pred             cCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCc
Confidence            4556666555443321     3499999875544  44678999999999999999999998764 56899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        82 L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          82 LLKYLKKR------REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             HHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999432      368999999999999999999999   999999999999999999999999999998765443221


Q ss_pred             c-cccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 S-RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 ~-~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . .....++..|+|||.+        +|+||||+++|||++ |..||.......        +...+.....      ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGER------LP  218 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCc------CC
Confidence            1 1222345679999986        899999999999997 899986543211        1122221111      12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+..+.+++.+|++.+|++|||+.|
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~  247 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSE  247 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            23345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5e-36  Score=272.03  Aligned_cols=215  Identities=27%  Similarity=0.437  Sum_probs=168.9

Q ss_pred             eeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHH
Q 039471          129 EIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK  205 (363)
Q Consensus       129 ~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~  205 (363)
                      .||||+++....  ..+.+.+|+++++++ +|+||+++++++...+..+++|||+++++|.+++.....    ..+++..
T Consensus        67 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~  142 (302)
T cd05055          67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE----SFLTLED  142 (302)
T ss_pred             EEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHH
Confidence            499998875432  235788999999999 799999999999999999999999999999999954321    3489999


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc----
Q 039471          206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----  281 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----  281 (363)
                      +..++.|++.||+|||+   .+++|+||||+|||++.++.++++|||+++...............++..|+|||.+    
T Consensus       143 ~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  219 (302)
T cd05055         143 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV  219 (302)
T ss_pred             HHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence            99999999999999999   99999999999999999999999999999876544322222334467789999986    


Q ss_pred             ----cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCC
Q 039471          282 ----SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT  356 (363)
Q Consensus       282 ----~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~  356 (363)
                          +|+||||+++|||++ |..|+........       .......+..      ...+...++.+.+++.+||+.+|+
T Consensus       220 ~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~  286 (302)
T cd05055         220 YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-------FYKLIKEGYR------MAQPEHAPAEIYDIMKTCWDADPL  286 (302)
T ss_pred             CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-------HHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCCch
Confidence                799999999999998 8888765432211       1111111111      111223456799999999999999


Q ss_pred             CCCCCCC
Q 039471          357 ERPSMPM  363 (363)
Q Consensus       357 ~RPs~~e  363 (363)
                      +|||++|
T Consensus       287 ~Rpt~~e  293 (302)
T cd05055         287 KRPTFKQ  293 (302)
T ss_pred             hCcCHHH
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.1e-36  Score=265.71  Aligned_cols=231  Identities=21%  Similarity=0.227  Sum_probs=175.5

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.++.+..  .+..||+|++.... .....+.+|+.++++++|+||+++++++..+...++||||+++++|.++
T Consensus        17 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~   96 (267)
T cd06646          17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDI   96 (267)
T ss_pred             eecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHH
Confidence            34444554444433  23349999987443 2345678899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +..      ...+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.++|+|||++........  ....
T Consensus        97 ~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~  165 (267)
T cd06646          97 YHV------TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKS  165 (267)
T ss_pred             HHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCc
Confidence            843      2468999999999999999999999   9999999999999999999999999999987643221  1233


Q ss_pred             ccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          269 ARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       269 ~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      ..++..|+|||.+           +|+||||+++|||++|+.|+..........        .+... ... ........
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------~~~~~-~~~-~~~~~~~~  235 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------LMSKS-NFQ-PPKLKDKT  235 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--------eeecC-CCC-CCCCcccc
Confidence            4578899999975           799999999999999999985433221100        00000 000 00111223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++..+.+++.+||+.+|++|||++|
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~  261 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAER  261 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHH
Confidence            45678999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-35  Score=266.23  Aligned_cols=230  Identities=23%  Similarity=0.336  Sum_probs=172.4

Q ss_pred             cccccccCCcceeecc--CC----eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SN----EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~----~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+...  ++    .+++|.......  ...++..|+..+++++|+||+++++++.. ...++++||+++
T Consensus        14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~   92 (279)
T cd05111          14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPL   92 (279)
T ss_pred             ccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCC
Confidence            3555566555444332  22    278888754322  23567788889999999999999998764 457889999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......
T Consensus        93 gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          93 GSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             CcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            99999995432     468999999999999999999999   9999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ........++..|+|||.+        +|+||||+++|||++ |+.|+.......        ..+.+..+....     
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~-----  231 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------VPDLLEKGERLA-----  231 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCcCC-----
Confidence            2222344567789999987        799999999999998 998886543211        111122222111     


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .+...+..+.+++.+||+.+|++|||+.|
T Consensus       232 -~~~~~~~~~~~li~~c~~~~p~~Rps~~e  260 (279)
T cd05111         232 -QPQICTIDVYMVMVKCWMIDENVRPTFKE  260 (279)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence             11223456888999999999999999864

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.7e-36  Score=264.94  Aligned_cols=205  Identities=23%  Similarity=0.341  Sum_probs=160.2

Q ss_pred             eeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHH
Q 039471          129 EIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR  207 (363)
Q Consensus       129 ~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~  207 (363)
                      .||+|.+..... ....|.+|+.+++.++||||+++++++..+...+++|||+++++|..++...     ...+++..+.
T Consensus        34 ~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~  108 (262)
T cd05077          34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK-----SDVLTTPWKF  108 (262)
T ss_pred             eEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhc-----CCCCCHHHHH
Confidence            389998865432 3357889999999999999999999999999999999999999999888432     2468999999


Q ss_pred             HHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC-------eeEeccccceeccCCccccccccccccccccCCcc
Q 039471          208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-------PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL  280 (363)
Q Consensus       208 ~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  280 (363)
                      .++.||+.||+|||+   .+++||||||+|||++.++.       ++++|||++......      ....++..|+|||.
T Consensus       109 ~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~  179 (262)
T cd05077         109 KVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPEC  179 (262)
T ss_pred             HHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhh
Confidence            999999999999999   99999999999999987664       899999998655322      23457888999997


Q ss_pred             c---------cCceehhHHHHHHh-cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHh
Q 039471          281 F---------SRNFCYGMMLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWC  350 (363)
Q Consensus       281 ~---------~Di~slG~il~el~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  350 (363)
                      +         +||||||+++|||+ +|+.|+........         .....+..   .    .......++.+++.+|
T Consensus       180 ~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---------~~~~~~~~---~----~~~~~~~~~~~li~~c  243 (262)
T cd05077         180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---------ERFYEGQC---M----LVTPSCKELADLMTHC  243 (262)
T ss_pred             hcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---------HHHHhcCc---c----CCCCChHHHHHHHHHH
Confidence            6         69999999999998 57777654321110         01111110   0    1112246789999999


Q ss_pred             ccCCCCCCCCCCC
Q 039471          351 IQWNPTERPSMPM  363 (363)
Q Consensus       351 l~~~p~~RPs~~e  363 (363)
                      |+.||++||+++|
T Consensus       244 l~~dp~~Rp~~~~  256 (262)
T cd05077         244 MNYDPNQRPFFRA  256 (262)
T ss_pred             cCCChhhCcCHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.2e-36  Score=267.21  Aligned_cols=218  Identities=25%  Similarity=0.392  Sum_probs=170.7

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCC-CCCCCCHHH
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS-SHRQLSWEK  205 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~l~~~~  205 (363)
                      .+|+|.+....  ....++.+|+.+++.++|+||+++++++......+++|||+++++|.+++....... ....+++..
T Consensus        28 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  107 (269)
T cd05044          28 RVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE  107 (269)
T ss_pred             eehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHH
Confidence            48999886433  345688999999999999999999999999899999999999999999996543211 234588999


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-----CeeEeccccceeccCCccccccccccccccccCCcc
Q 039471          206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-----QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL  280 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  280 (363)
                      +..++.|++.||+|||+   .+++|+||||+||+++.++     .++++|||+++...............++..|+|||.
T Consensus       108 ~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (269)
T cd05044         108 LLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPES  184 (269)
T ss_pred             HHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHH
Confidence            99999999999999999   9999999999999999877     899999999876644332222233345678999998


Q ss_pred             c--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhc
Q 039471          281 F--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI  351 (363)
Q Consensus       281 ~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (363)
                      +        +|+||||+++|||++ |..||.......        ....+..+.      ........+..+.+++.+||
T Consensus       185 ~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~~~~~~li~~~l  250 (269)
T cd05044         185 LLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVTAGG------RLQKPENCPDKIYQLMTNCW  250 (269)
T ss_pred             HccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHhcCC------ccCCcccchHHHHHHHHHHc
Confidence            7        799999999999998 898886433211        111111111      11223445778999999999


Q ss_pred             cCCCCCCCCCCC
Q 039471          352 QWNPTERPSMPM  363 (363)
Q Consensus       352 ~~~p~~RPs~~e  363 (363)
                      +.+|.+|||++|
T Consensus       251 ~~~p~~Rp~~~~  262 (269)
T cd05044         251 AQDPSERPTFDR  262 (269)
T ss_pred             CCCcccCCCHHH
Confidence            999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.4e-36  Score=271.95  Aligned_cols=232  Identities=26%  Similarity=0.410  Sum_probs=173.8

Q ss_pred             ccccccCCcceeeccCC----eeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHSN----EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~----~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....+    .+|+|.+....  ...+++.+|++++.++ +|+||+++++++..++..+++|||+++++
T Consensus        15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   94 (303)
T cd05088          15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN   94 (303)
T ss_pred             ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCc
Confidence            45556665555543332    26888776422  2335788999999999 89999999999999999999999999999


Q ss_pred             HHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          185 LQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       185 L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      |.+++......          .....+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~dfg~~  171 (303)
T cd05088          95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS  171 (303)
T ss_pred             HHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCccccC
Confidence            99999654321          112468999999999999999999999   99999999999999999999999999998


Q ss_pred             eeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          255 KLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       255 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ........   .....++..|+|||.+        +|+||||+++|||+| |..||.......        ....+..+.
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~  240 (303)
T cd05088         172 RGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGY  240 (303)
T ss_pred             cccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------HHHHHhcCC
Confidence            64322111   1222346679999986        899999999999998 999886433211        112221111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ....+...+..+.+++.+||+.+|++|||+++
T Consensus       241 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  272 (303)
T cd05088         241 ------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  272 (303)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence                  11122234567899999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.3e-36  Score=287.30  Aligned_cols=242  Identities=18%  Similarity=0.220  Sum_probs=169.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeC--------CceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG--------NRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~  179 (363)
                      ..++.+++|.++.+...  +..||||++....   ....+|+.++++++|+||+++++++...        ...++||||
T Consensus        72 ~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~  148 (440)
T PTZ00036         72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF  148 (440)
T ss_pred             EEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEec
Confidence            44556666655554442  3459999885432   3345799999999999999999876432        246789999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceecc
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCS  258 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~  258 (363)
                      +++ +|.+++....  .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|||+|+...
T Consensus       149 ~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        149 IPQ-TVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             CCc-cHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            975 7877775432  123678999999999999999999999   9999999999999999654 79999999998765


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH----HHHhhh--
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI----YNRMRL--  323 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~--  323 (363)
                      .....   ....||+.|+|||++         +|+|||||++|||++|.+||................    .+.+..  
T Consensus       223 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        223 AGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             CCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence            43322   334679999999986         799999999999999999997654322111000000    000000  


Q ss_pred             ccccccccC--------CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFE--------EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .........        ...+...+.++.+++.+||+.+|.+|||+.|
T Consensus       300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e  347 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIE  347 (440)
T ss_pred             hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            000000000        0011224567999999999999999999864

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-35  Score=266.24  Aligned_cols=229  Identities=24%  Similarity=0.290  Sum_probs=173.1

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+..  .+..||+|++....  ...+++.+|++++++++|+||+++++.+...+..++||||+++++|..
T Consensus         9 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (279)
T cd06619           9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDV   88 (279)
T ss_pred             eccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHH
Confidence            44445554444432  23449999986432  233578899999999999999999999999999999999999999965


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      +.          .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........    .
T Consensus        89 ~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~----~  151 (279)
T cd06619          89 YR----------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----K  151 (279)
T ss_pred             hh----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----c
Confidence            43          47889999999999999999999   9999999999999999999999999999986643321    3


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||.+        +|+||||+++|||++|+.||..............+ ...+....     .........
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~  225 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDED-----PPVLPVGQF  225 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccC-----CCCCCCCcC
Confidence            45689999999987        79999999999999999999764332221111111 11111000     000112234


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++++.+++.+||+.+|++||+++|
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~e  249 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPEN  249 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHH
Confidence            567899999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-35  Score=273.64  Aligned_cols=220  Identities=30%  Similarity=0.463  Sum_probs=168.4

Q ss_pred             CeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeee-CCceeEEEeccCCCCHHHHhhhcCCC--------
Q 039471          128 NEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSLQKFIFSKTNS--------  195 (363)
Q Consensus       128 ~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~--------  195 (363)
                      +.||+|++.....  ..+.+.+|+.++.++ +|+||+++++++.. +...+++|||+++++|.+++......        
T Consensus        38 ~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~  117 (337)
T cd05054          38 RTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKS  117 (337)
T ss_pred             ceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccc
Confidence            3499999874332  234678899999999 79999999998864 45788999999999999998643210        


Q ss_pred             -----------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 039471          196 -----------------------------------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRI  228 (363)
Q Consensus       196 -----------------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  228 (363)
                                                                     .....+++..+..++.||+.||+|||+   .+|
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i  194 (337)
T cd05054         118 TRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKC  194 (337)
T ss_pred             ccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence                                                           001368999999999999999999999   999


Q ss_pred             eecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCC
Q 039471          229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRK  299 (363)
Q Consensus       229 ~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~  299 (363)
                      +||||||+|||++.++.+||+|||+++.+.............++..|+|||++        +|+|||||++|||++ |..
T Consensus       195 vHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~  274 (337)
T cd05054         195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS  274 (337)
T ss_pred             ecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999876544333223344567789999977        799999999999997 998


Q ss_pred             CCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ||........       ....+..+..      ...+...++++.+++.+||+.+|++|||++|
T Consensus       275 p~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e  325 (337)
T cd05054         275 PYPGVQIDEE-------FCRRLKEGTR------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSE  325 (337)
T ss_pred             CCCCCCccHH-------HHHHHhccCC------CCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            8865322110       1112211111      1122345677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.1e-36  Score=280.44  Aligned_cols=243  Identities=22%  Similarity=0.254  Sum_probs=174.7

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCC-----ceeEEEec
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN-----RRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~  179 (363)
                      ..++.+++|.++.+..  .++.||||++....   ...+++.+|+++++.++|+||+++++++....     ..++|+||
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   85 (372)
T cd07853           6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL   85 (372)
T ss_pred             ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence            3445555555554442  34559999986432   23357889999999999999999999998766     78999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +. ++|.+++.      ....+++..+..++.||+.||+|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~-~~l~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          86 MQ-SDLHKIIV------SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             cc-cCHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            96 58888873      23568999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch---------HHH-----
Q 039471          260 DISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF---------PEW-----  316 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~---------~~~-----  316 (363)
                      .... ......++..|+|||++         +|+||+||++|||++|+.||...........+         .++     
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             Cccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            3221 11334578899999976         69999999999999999999764432211000         000     


Q ss_pred             -HHHHhhhccccccc--cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          317 -IYNRMRLGQELCLD--FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       317 -~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ....+.........  .........+.++.+++.+||+.||++|||++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e  284 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD  284 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH
Confidence             00000000000000  000111223567899999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-35  Score=262.13  Aligned_cols=229  Identities=24%  Similarity=0.341  Sum_probs=176.1

Q ss_pred             ccccccCCcceeecc-CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLH-SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.++.+... +..+|+|.+.....  ....+.+|+.++++++|+||+++++++...+..++||||+++++|.++
T Consensus         3 ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   82 (250)
T cd05085           3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSF   82 (250)
T ss_pred             cCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHH
Confidence            455666666555433 33499999864432  234788999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..+..++.|++.+|.|||+   .+++|+||||+||+++.++.+||+|||++......... ....
T Consensus        83 ~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~  153 (250)
T cd05085          83 LRKKK-----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL  153 (250)
T ss_pred             HHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence            85322     458899999999999999999999   99999999999999999999999999998765433221 1122


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||.+        +|+||||+++||+++ |..||.......        ....+..+..      ...+...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  219 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------AREQVEKGYR------MSCPQKC  219 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCCC
Confidence            2346679999987        799999999999998 888886543211        1122221111      1122345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+|++.+|++|||+.|
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~  243 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSE  243 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHH
Confidence            678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=264.28  Aligned_cols=230  Identities=22%  Similarity=0.267  Sum_probs=175.2

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ++.+++|.++.+..  .+..||+|.+.....      ..+.+.+|++++++++|+||+++++++.++...++++||++++
T Consensus        10 lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   89 (263)
T cd06625          10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGG   89 (263)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCC
Confidence            34444444444432  245599998863321      2246888999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++........
T Consensus        90 ~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          90 SVKDQLKAY------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             cHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            999998432      458899999999999999999999   99999999999999999999999999998866432211


Q ss_pred             cc-cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VS-RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~-~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .. .....++..|+|||++        +|+||||+++|||++|+.||........       ...... .     .....
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~-~-----~~~~~  227 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-------IFKIAT-Q-----PTNPQ  227 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-------HHHHhc-c-----CCCCC
Confidence            11 0234477889999987        7999999999999999999865322110       111111 0     11122


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+..+.+++.+||+.+|++|||+.|
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  256 (263)
T cd06625         228 LPSHVSPDARNFLRRTFVENAKKRPSAEE  256 (263)
T ss_pred             CCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence            33456678999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.1e-36  Score=263.92  Aligned_cols=229  Identities=20%  Similarity=0.261  Sum_probs=177.4

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.+..+..  .+..+|+|.++..  ....+.+.+|+.+++.++|+||+++++.+.+++..+++|||+++++|.+
T Consensus         8 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   87 (255)
T cd08219           8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ   87 (255)
T ss_pred             eeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHH
Confidence            34444444443332  2344999988532  2344678899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....    ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++++|||.+.........  ..
T Consensus        88 ~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~  158 (255)
T cd08219          88 KIKLQR----GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--AC  158 (255)
T ss_pred             HHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--cc
Confidence            885432    2468999999999999999999999   99999999999999999999999999998876543221  12


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||++        +|+||||+++|+|++|..||.......        ....+..+..      ...+...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  224 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--------LILKVCQGSY------KPLPSHY  224 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--------HHHHHhcCCC------CCCCccc
Confidence            34578899999987        899999999999999999997543211        1112211111      1123345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++|||++|
T Consensus       225 ~~~~~~li~~~l~~~P~~Rp~~~~  248 (255)
T cd08219         225 SYELRSLIKQMFKRNPRSRPSATT  248 (255)
T ss_pred             CHHHHHHHHHHHhCCcccCCCHHH
Confidence            677999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-36  Score=265.86  Aligned_cols=232  Identities=26%  Similarity=0.410  Sum_probs=175.1

Q ss_pred             ccccccCCcceeeccCC----eeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHSN----EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~----~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...++    .+|+|.++...  ...+.+.+|+.++.++ +|+||+++++++...+..+++|||+++++
T Consensus         3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   82 (270)
T cd05047           3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN   82 (270)
T ss_pred             CCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCc
Confidence            45666776666555433    27888887432  2346788999999999 79999999999999999999999999999


Q ss_pred             HHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          185 LQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       185 L~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      |.+++......          .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++
T Consensus        83 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          83 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             HHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCCc
Confidence            99999654310          112358899999999999999999999   99999999999999999999999999998


Q ss_pred             eeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          255 KLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       255 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .......   .......+..|+|||.+        +|+||||+++|||++ |..||.......        ..+.+..+.
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~  228 (270)
T cd05047         160 RGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQGY  228 (270)
T ss_pred             cccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhCCC
Confidence            6432211   11222345679999986        799999999999996 999886532211        112221111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .      ...+...+.++.+++.+||+.+|.+|||++|
T Consensus       229 ~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (270)
T cd05047         229 R------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  260 (270)
T ss_pred             C------CCCCCcCCHHHHHHHHHHcccChhhCCCHHH
Confidence            1      1122235567899999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-35  Score=265.29  Aligned_cols=230  Identities=22%  Similarity=0.336  Sum_probs=173.3

Q ss_pred             cccccccCCcceeeccCC------eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHSN------EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~------~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+....+      .||+|+++...  ...+++.+|+.+++.++|+||+++++++... ..++++||+++
T Consensus        14 ~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~   92 (279)
T cd05109          14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPY   92 (279)
T ss_pred             ecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCC
Confidence            345555555544432222      27999986432  2345788999999999999999999998754 56799999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.......
T Consensus        93 g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          93 GCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             CCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            99999985432     468999999999999999999999   9999999999999999999999999999987754333


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ........++..|+|||.+        +|+||||+++|||++ |..|+.......        +...+..+...      
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~------  230 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGERL------  230 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCcC------
Confidence            2222223356789999987        699999999999998 888876432211        11222222111      


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...+.++.+++.+||+.||++|||+.|
T Consensus       231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  260 (279)
T cd05109         231 PQPPICTIDVYMIMVKCWMIDSECRPRFRE  260 (279)
T ss_pred             CCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            122345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.9e-36  Score=272.03  Aligned_cols=241  Identities=19%  Similarity=0.256  Sum_probs=173.5

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+..  .++.||+|.++...  .....+.+|+.++++++|+||+++++++..++..++||||+++ +|.+
T Consensus        14 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~   92 (309)
T cd07872          14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQ   92 (309)
T ss_pred             ecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHH
Confidence            44555555444433  23449999986432  2335678999999999999999999999999999999999975 8888


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++...     ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++........  ..
T Consensus        93 ~~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~  162 (309)
T cd07872          93 YMDDC-----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YS  162 (309)
T ss_pred             HHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc--cc
Confidence            87433     2458899999999999999999999   99999999999999999999999999998765433221  12


Q ss_pred             cccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchH-------HHHHHHhhhcc---ccc
Q 039471          268 AARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFP-------EWIYNRMRLGQ---ELC  328 (363)
Q Consensus       268 ~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~---~~~  328 (363)
                      ...++..|+|||++         +|+||||+++|||++|+.||.............       ...+..+....   ...
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            34578899999976         799999999999999999997543321100000       00000000000   000


Q ss_pred             c-ccC----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 L-DFE----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~-~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      . ...    .......+.++.+++.+||+.||++|||++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  282 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE  282 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence            0 000    0011235667899999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-35  Score=266.45  Aligned_cols=237  Identities=22%  Similarity=0.319  Sum_probs=178.4

Q ss_pred             ccccccccCCcceeec-------cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFL-------HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+|+|.++.+..       .+..+|+|.+.... ...+.+.+|+++++.++|+||+++++++..+...+++|||++
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   90 (280)
T cd05092          11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMR   90 (280)
T ss_pred             cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCC
Confidence            3455566665554421       12238999886433 234679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          182 NGSLQKFIFSKTNS---------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       182 ~~sL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      +++|.+++......         .....+++..+..++.|++.||+|||+   .+++|+||||+|||+++++.+||+|||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~dfg  167 (280)
T cd05092          91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFG  167 (280)
T ss_pred             CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECCCC
Confidence            99999999654310         111358999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ++................++..|+|||.+        +|+||||+++|||++ |..||.......        .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~  239 (280)
T cd05092         168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------AIECITQ  239 (280)
T ss_pred             ceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--------HHHHHHc
Confidence            99866443322222233356789999976        799999999999998 888875433221        1111211


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..      ...+...++.+.+++.+||+.+|++|||++|
T Consensus       240 ~~~------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  273 (280)
T cd05092         240 GRE------LERPRTCPPEVYAIMQGCWQREPQQRMVIKD  273 (280)
T ss_pred             Ccc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            111      1222345677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-35  Score=278.44  Aligned_cols=238  Identities=24%  Similarity=0.363  Sum_probs=179.5

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCCcC--hhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLKGN--GQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ..++.+++|.++.+...       +..||||+++.....  .+.+.+|++++.++. |+||+++++++..++..++||||
T Consensus        43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~  122 (401)
T cd05107          43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEY  122 (401)
T ss_pred             hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEec
Confidence            45566666666555432       234999999754322  357889999999997 99999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCC----------------------------------------------------------------
Q 039471          180 MPNGSLQKFIFSKTNS----------------------------------------------------------------  195 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~----------------------------------------------------------------  195 (363)
                      +++|+|.++++.....                                                                
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (401)
T cd05107         123 CRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYA  202 (401)
T ss_pred             cCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhh
Confidence            9999999999754210                                                                


Q ss_pred             ----------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCee
Q 039471          196 ----------------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK  247 (363)
Q Consensus       196 ----------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~k  247 (363)
                                                  .....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~k  279 (401)
T cd05107         203 DIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVK  279 (401)
T ss_pred             hhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCEEE
Confidence                                        111347888899999999999999999   9999999999999999999999


Q ss_pred             EeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHH
Q 039471          248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIY  318 (363)
Q Consensus       248 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      |+|||+++...............++..|+|||.+        +|+||||+++|||++ |..|+.......       ...
T Consensus       280 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-------~~~  352 (401)
T cd05107         280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-------QFY  352 (401)
T ss_pred             EEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-------HHH
Confidence            9999999875433222222334467889999987        799999999999998 888875432211       112


Q ss_pred             HHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          319 NRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+..      ...+...+.++.+++.+||+.+|++|||++|
T Consensus       353 ~~~~~~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~e  391 (401)
T cd05107         353 NAIKRGYR------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ  391 (401)
T ss_pred             HHHHcCCC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            22221211      1122335678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=262.16  Aligned_cols=233  Identities=21%  Similarity=0.279  Sum_probs=184.7

Q ss_pred             CcccccccccCCcceeecc---C--CeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEe
Q 039471          108 PFQSLISFNLTNSKFFFLH---S--NEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~---~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      .|..+..+|.|..|.|++.   +  ...|+|++.+.    .+...+...|-+||+.+.||-++.+|+.|+.+...+++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            3455566677777766654   3  23999999753    2334577889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ||+||+|....+.+.    .+.|++..++-++.+++.||+|||-   .|||.||+||+||||-++|.+.|+||.++..+.
T Consensus       158 yCpGGdL~~LrqkQp----~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQP----GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             cCCCccHHHHHhhCC----CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999886544    3789999999999999999999999   999999999999999999999999999876542


Q ss_pred             CCcc--------------------------------c----------------------cccccccccccccCCccc---
Q 039471          259 KDIS--------------------------------I----------------------VSRTAARGTSGYIAPELF---  281 (363)
Q Consensus       259 ~~~~--------------------------------~----------------------~~~~~~~gt~~y~aPE~~---  281 (363)
                      ....                                .                      ......+||..|+|||++   
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            1000                                0                      001234699999999999   


Q ss_pred             -----cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCC
Q 039471          282 -----SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT  356 (363)
Q Consensus       282 -----~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~  356 (363)
                           .|-|+||+++|||+.|.-||.+......       +.+-+.  +...+    ......+..+.+||++.|..||+
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv~--~~l~F----p~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIVG--QPLKF----PEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHhc--CCCcC----CCCCcchhHHHHHHHHHhccChh
Confidence                 7999999999999999999998766543       222221  22211    22336778899999999999999


Q ss_pred             CCCC
Q 039471          357 ERPS  360 (363)
Q Consensus       357 ~RPs  360 (363)
                      +|.-
T Consensus       378 kRlg  381 (459)
T KOG0610|consen  378 KRLG  381 (459)
T ss_pred             hhhc
Confidence            9975

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2e-35  Score=261.58  Aligned_cols=227  Identities=25%  Similarity=0.381  Sum_probs=176.4

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeee-eCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS-EGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+...+..||+|...... ..+.+.+|+.++++++|+|++++++++. +++..++++||+++++|.++
T Consensus        12 ~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   90 (256)
T cd05082          12 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY   90 (256)
T ss_pred             eeecccCCCeEEEEEEcCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHH
Confidence            335566666666555566679999986443 4567999999999999999999999764 55678999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....    ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++......     ..
T Consensus        91 ~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~  158 (256)
T cd05082          91 LRSRG----RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  158 (256)
T ss_pred             HHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-----CC
Confidence            85432    2458999999999999999999999   999999999999999999999999999987654322     22


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||++        +|+||||+++|||++ |+.|+.......        +...+..+.      ........
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~  224 (256)
T cd05082         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGY------KMDAPDGC  224 (256)
T ss_pred             CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCC------CCCCCCCC
Confidence            3346689999986        899999999999997 888875432111        112222111      11223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+.+++.+|++.+|++|||++|
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~  248 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQ  248 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHH
Confidence            678999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-35  Score=271.30  Aligned_cols=190  Identities=20%  Similarity=0.261  Sum_probs=148.4

Q ss_pred             cccccccCCcceeecc----CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH----SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~s  184 (363)
                      +++.+++|.++.+...    +..||+|.+.... ....+.+|+.++++++|+||+++++++..  +...+++|||+. ++
T Consensus         8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~   85 (317)
T cd07868           8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD   85 (317)
T ss_pred             ccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CC
Confidence            4566666666555432    2349999986443 34567899999999999999999998854  456889999996 58


Q ss_pred             HHHHhhhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE----cCCCCeeEeccccceec
Q 039471          185 LQKFIFSKTN---SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLC  257 (363)
Q Consensus       185 L~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~  257 (363)
                      |.+++.....   ......+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence            8888753321   1122468999999999999999999999   999999999999999    45678999999999876


Q ss_pred             cCCccc-cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcch
Q 039471          258 SKDISI-VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       258 ~~~~~~-~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                      ...... .......+|..|+|||++         +|+||+||++|||++|++||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            543221 112345689999999976         799999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-35  Score=263.98  Aligned_cols=234  Identities=20%  Similarity=0.308  Sum_probs=178.5

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+..  .+..||||.+....    .....+.+|++++++++|+||+++++++.+.+..++++||+++++|
T Consensus        10 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   89 (267)
T cd08228          10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDL   89 (267)
T ss_pred             eccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcH
Confidence            44555555544433  34559999875322    2234688999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.....  ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.........  
T Consensus        90 ~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--  162 (267)
T cd08228          90 SQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--  162 (267)
T ss_pred             HHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--
Confidence            998854321  23568999999999999999999999   99999999999999999999999999998876543221  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||.+        +|+||||+++|||++|+.|+........     . ....+....     .......
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-----~-~~~~~~~~~-----~~~~~~~  231 (267)
T cd08228         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-----S-LCQKIEQCD-----YPPLPTE  231 (267)
T ss_pred             HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-----H-HHHHHhcCC-----CCCCChh
Confidence            1334578899999987        7999999999999999999865432110     1 111111111     1112233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++|||++|
T Consensus       232 ~~~~~~~~li~~cl~~~p~~Rp~~~~  257 (267)
T cd08228         232 HYSEKLRELVSMCIYPDPDQRPDIGY  257 (267)
T ss_pred             hcCHHHHHHHHHHCCCCcccCcCHHH
Confidence            56678999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-35  Score=265.57  Aligned_cols=236  Identities=23%  Similarity=0.329  Sum_probs=176.3

Q ss_pred             cccccccCCcceeeccC-------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLHS-------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+...+       ..||+|.......  ....|.+|+.++++++|+||+++++++.+....+++|||++
T Consensus        13 ~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   92 (277)
T cd05036          13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMA   92 (277)
T ss_pred             ECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCC
Confidence            34555666655554433       3389998864332  23468999999999999999999999998889999999999


Q ss_pred             CCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEeccccceec
Q 039471          182 NGSLQKFIFSKTNS-SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLC  257 (363)
Q Consensus       182 ~~sL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~  257 (363)
                      +++|.+++...... .....+++..+..++.||+.||+|||+   .+++|+||||+||+++.++   .+||+|||+++..
T Consensus        93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036          93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcccccc
Confidence            99999999665421 122468999999999999999999999   9999999999999998654   5899999999876


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ..............+..|+|||++        +|+|||||++|||++ |..||.......        +...+.....  
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~--  239 (277)
T cd05036         170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------VMEFVTGGGR--  239 (277)
T ss_pred             CCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCCc--
Confidence            433221111222345679999986        899999999999996 888886543211        1111111111  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ...+...+..+.+++.+|++.+|++|||+.|
T Consensus       240 ----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~  270 (277)
T cd05036         240 ----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT  270 (277)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence                1123345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-35  Score=272.38  Aligned_cols=170  Identities=16%  Similarity=0.160  Sum_probs=139.0

Q ss_pred             CeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHH
Q 039471          128 NEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE  204 (363)
Q Consensus       128 ~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~  204 (363)
                      ..||+|++.....   ..+.+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++.....    ..+++.
T Consensus        26 ~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~----~~l~~~  101 (327)
T cd08227          26 EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM----DGMSEL  101 (327)
T ss_pred             cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc----CCCCHH
Confidence            3499999874322   224567899999999999999999999999999999999999999999954322    458999


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc-----ccccccccccccCCc
Q 039471          205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-----SRTAARGTSGYIAPE  279 (363)
Q Consensus       205 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE  279 (363)
                      .++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+.+..........     ......++..|+|||
T Consensus       102 ~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (327)
T cd08227         102 AIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE  178 (327)
T ss_pred             HHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChH
Confidence            999999999999999999   999999999999999999999999998654432111100     012234667899999


Q ss_pred             cc----------cCceehhHHHHHHhcCCCCCCcc
Q 039471          280 LF----------SRNFCYGMMLLEMVGCRKNNDPA  304 (363)
Q Consensus       280 ~~----------~Di~slG~il~el~~g~~~~~~~  304 (363)
                      ++          +|+|||||++|||++|+.||...
T Consensus       179 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         179 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             HhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            76          79999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-35  Score=261.57  Aligned_cols=231  Identities=23%  Similarity=0.311  Sum_probs=177.8

Q ss_pred             ccccccCCcceeeccC---C--eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS---N--EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~---~--~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....   +  .||||.+.....  ..+++.+|+.++++++|+||+++++.+.+ ...++++||+++++
T Consensus         3 ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~   81 (257)
T cd05040           3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGS   81 (257)
T ss_pred             CCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCc
Confidence            4555666555544322   2  389999975443  34688999999999999999999999988 88999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        82 L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          82 LLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             HHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            9999964321    468999999999999999999999   999999999999999999999999999998775532211


Q ss_pred             -ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 -SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 -~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......++..|+|||.+        +|+||||+++|||++ |..|+.......        +...+....     ....
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~-----~~~~  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------ILKKIDKEG-----ERLE  221 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHhcC-----CcCC
Confidence             11234467889999976        899999999999998 999986432211        111111100     0111


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+..+.+++.+|++.+|++|||+.|
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~  250 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAA  250 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence            22345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=277.46  Aligned_cols=228  Identities=21%  Similarity=0.367  Sum_probs=189.0

Q ss_pred             ccccccCCcceeeccCC----e--eEEEEccc--CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFLHSN----E--IAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~----~--vAvK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      +|.+.||.++...+..-    .  ||||+.+.  ...+.+.|..|..++++++|||||+++|.|.+. ..|||||.++-|
T Consensus       397 iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~G  475 (974)
T KOG4257|consen  397 IGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLG  475 (974)
T ss_pred             hcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccch
Confidence            45666777766554322    1  99999985  345678999999999999999999999999884 689999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      -|..|+..++     ..++...+..++.||+.||.|||+   .+++||||..+|||+.+...+||+|||+++.+..+...
T Consensus       476 ELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  476 ELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             hHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            9999996554     568999999999999999999999   99999999999999999999999999999988776554


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHh-cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .. ....-++.|||||.+        ||||.||+++||++ .|..||.+-...+        +...++.|.+.      .
T Consensus       548 ka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeRl------P  612 (974)
T KOG4257|consen  548 KA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGERL------P  612 (974)
T ss_pred             hc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCCC------C
Confidence            33 344457889999998        99999999999988 5889997754433        22344545443      4


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+++.|..++.+||.++|.+||++.|
T Consensus       613 ~P~nCPp~LYslmskcWayeP~kRPrfte  641 (974)
T KOG4257|consen  613 CPPNCPPALYSLMSKCWAYEPSKRPRFTE  641 (974)
T ss_pred             CCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence            56788899999999999999999999864

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-35  Score=263.57  Aligned_cols=231  Identities=20%  Similarity=0.230  Sum_probs=175.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.+..+...  +..||+|.++... .....+.+|+.+++.++|+||+++++.+..+...+++|||+++++|.++
T Consensus        17 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~   96 (267)
T cd06645          17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI   96 (267)
T ss_pred             hCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHH
Confidence            445555555444332  3449999987443 2335678899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +..      ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........  ....
T Consensus        97 ~~~------~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~  165 (267)
T cd06645          97 YHV------TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKS  165 (267)
T ss_pred             HHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--cccc
Confidence            843      2568999999999999999999999   9999999999999999999999999999876643221  1234


Q ss_pred             ccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          269 ARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       269 ~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      ..|+..|+|||.+           +|+|||||++|||++|..|+........       .. ..........  ......
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~-~~~~~~~~~~--~~~~~~  235 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LF-LMTKSNFQPP--KLKDKM  235 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HH-hhhccCCCCC--cccccC
Confidence            5688999999975           7999999999999999999864332111       00 0110110000  001112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++..+.+++.+||+.+|++|||++|
T Consensus       236 ~~~~~~~~li~~~l~~~P~~R~~~~~  261 (267)
T cd06645         236 KWSNSFHHFVKMALTKNPKKRPTAEK  261 (267)
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHH
Confidence            34567899999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=269.77  Aligned_cols=223  Identities=20%  Similarity=0.323  Sum_probs=185.8

Q ss_pred             cccCCcceee-----ccCCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          115 FNLTNSKFFF-----LHSNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       115 ~~~~~~~~~~-----~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +|.|....+.     +.+..||||++.+.+-.   ...+.+|++.++-++|||||++|.+......+|||+|.=.+|+|.
T Consensus        26 lG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~  105 (864)
T KOG4717|consen   26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLF  105 (864)
T ss_pred             hcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHH
Confidence            4444444443     34677999999865433   356789999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE-cCCCCeeEeccccceeccCCccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-DHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      +||-...     ..+.+....+++.||+.|+.|+|+   ..++|||+||+|+.+ .+-|-+||.|||++..+.++...  
T Consensus       106 DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL--  175 (864)
T KOG4717|consen  106 DYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL--  175 (864)
T ss_pred             HHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh--
Confidence            9995443     679999999999999999999999   999999999999976 56789999999999888777655  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       ....|+..|.|||++         .||||||+|||.|++|+.||....+.+....+               .+-.-..+
T Consensus       176 -~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDCKYtvP  239 (864)
T KOG4717|consen  176 -TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDCKYTVP  239 (864)
T ss_pred             -hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcccccCc
Confidence             556799999999999         79999999999999999999887665432111               11122356


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+.+..++|..||+.||.+|.|.+|
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEe  266 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEE  266 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHH
Confidence            788999999999999999999998754

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=263.18  Aligned_cols=231  Identities=26%  Similarity=0.399  Sum_probs=179.1

Q ss_pred             cccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++.+++|.++.....+ ..||||.+.......+++.+|+.++++++|+||+++++++......+++|||+++++|.+++
T Consensus        13 ~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i   92 (261)
T cd05034          13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL   92 (261)
T ss_pred             eeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHH
Confidence            34555666555544332 34999999866666788999999999999999999999999888999999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||.+.....+... .....
T Consensus        93 ~~~~----~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  164 (261)
T cd05034          93 KSGE----GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGA  164 (261)
T ss_pred             hccc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhcc
Confidence            5432    2468999999999999999999999   99999999999999999999999999999876543211 11222


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||.+        +|+||||++++||++ |+.||.......        ....+..+.      ....+...+
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~  230 (261)
T cd05034         165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--------VLEQVERGY------RMPRPPNCP  230 (261)
T ss_pred             CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCC------CCCCCCCCC
Confidence            345689999986        799999999999998 898885432211        122222111      111122336


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.+|++|||++|
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~  253 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEY  253 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHH
Confidence            67999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.8e-36  Score=277.35  Aligned_cols=230  Identities=19%  Similarity=0.270  Sum_probs=173.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  +..+|+|++...    ....+.+.+|+.+++.++|+||+++++.+.++...++||||+++|
T Consensus        49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg  128 (371)
T cd05622          49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG  128 (371)
T ss_pred             EEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence            33455555555444433  334999998632    223346788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..       ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus       129 ~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         129 DLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             cHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            99999842       347899999999999999999999   99999999999999999999999999999876543221


Q ss_pred             cccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          264 VSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                       ......||+.|+|||++            +|+|||||++|||++|+.||.......        .+..+......   .
T Consensus       199 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~---~  266 (371)
T cd05622         199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHKNS---L  266 (371)
T ss_pred             -cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCc---c
Confidence             12345699999999975            799999999999999999997643321        22222211110   1


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCC---CCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTE---RPSMP  362 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~---RPs~~  362 (363)
                      .......++..+.+++.+||+ +|..   ||+++
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~  299 (371)
T cd05622         267 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGVE  299 (371)
T ss_pred             cCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHH
Confidence            111223567788999999998 5555   45543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=270.13  Aligned_cols=229  Identities=23%  Similarity=0.300  Sum_probs=187.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+.+|.+......  ++.+|+|.+.+...    ..+...+|+++|+++. |+|||.+++.+++....++|||++.||
T Consensus        42 ~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GG  121 (382)
T KOG0032|consen   42 ELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGG  121 (382)
T ss_pred             hhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCc
Confidence            3455555555544443  34499999975433    2358899999999998 999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC----CCeeEeccccceeccC
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN----FQPKISDFGLAKLCSK  259 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~~~~  259 (363)
                      .|.+.+...       .+++.....++.|++.+++|||+   .+++|||+||+|+|+...    +.+|++|||++.....
T Consensus       122 eLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  122 ELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             hHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999433       29999999999999999999999   999999999999999633    5799999999999877


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      +..   .....||+.|+|||++        .|+||+|+++|.|++|.+||....+...        ...+..+   ...+
T Consensus       192 ~~~---~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~~i~~~---~~~f  257 (382)
T KOG0032|consen  192 GER---LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FLAILRG---DFDF  257 (382)
T ss_pred             Cce---EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HHHHHcC---CCCC
Confidence            333   2667799999999999        7999999999999999999988765432        1122222   2244


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+....++..+.++++.++..||..|+|+.+
T Consensus       258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~  289 (382)
T KOG0032|consen  258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQ  289 (382)
T ss_pred             CCCCccccCHHHHHHHHHhcccCcccCCCHHH
Confidence            55566778999999999999999999999753

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.8e-36  Score=277.79  Aligned_cols=230  Identities=21%  Similarity=0.267  Sum_probs=172.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.+..+...  ++.||||++...    ......+.+|+.++.+++|+||+++++.+.++...++||||+++|
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg   86 (360)
T cd05627           7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG   86 (360)
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence            34455555555544443  344999998632    233457788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        87 ~L~~~l~~------~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          87 DMMTLLMK------KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            99999943      3568999999999999999999999   99999999999999999999999999998754321100


Q ss_pred             ---------------------------------cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCC
Q 039471          264 ---------------------------------VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNND  302 (363)
Q Consensus       264 ---------------------------------~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~  302 (363)
                                                       .......||+.|+|||++        +|+|||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             001134689999999987        899999999999999999997


Q ss_pred             cchhcccccchHHHHHHHhhhc-cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          303 PAVEIQSQIYFPEWIYNRMRLG-QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ......        .+..+... .....    ......+.++.+++.+++. +|++|++.
T Consensus       238 ~~~~~~--------~~~~i~~~~~~~~~----p~~~~~s~~~~~li~~l~~-~p~~R~~~  284 (360)
T cd05627         238 SETPQE--------TYRKVMNWKETLVF----PPEVPISEKAKDLILRFCT-DSENRIGS  284 (360)
T ss_pred             CCCHHH--------HHHHHHcCCCceec----CCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence            643321        12222111 11111    1111245678888888775 99999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.3e-35  Score=265.02  Aligned_cols=230  Identities=19%  Similarity=0.276  Sum_probs=175.4

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.++.+....  ..+++|.+.... ...+.+.+|+++++.++|+||+++++++..++..++|+||+++++|..+
T Consensus        13 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~   92 (282)
T cd06643          13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV   92 (282)
T ss_pred             cccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHH
Confidence            3444444444433332  237888886432 3346788999999999999999999999999999999999999999988


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +...     ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........  ....
T Consensus        93 ~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~  162 (282)
T cd06643          93 MLEL-----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDS  162 (282)
T ss_pred             HHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--cccc
Confidence            7532     2568999999999999999999999   9999999999999999999999999999876543221  1133


Q ss_pred             ccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          269 ARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       269 ~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ..++..|+|||++             +|+||||+++|||++|++||........       ... ......    .....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~-~~~~~~----~~~~~  230 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-------LLK-IAKSEP----PTLAQ  230 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-------HHH-HhhcCC----CCCCC
Confidence            4588899999975             8999999999999999999865432111       111 111110    01122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..++.++.+++.+||+.+|++|||++|
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQ  258 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            3345678999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2e-35  Score=268.66  Aligned_cols=218  Identities=26%  Similarity=0.432  Sum_probs=168.5

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC----------
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS----------  195 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------  195 (363)
                      .+|+|.+....  ...+++.+|+++++++ +|+||+++++++..++..++||||+++++|.+++......          
T Consensus        52 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~  131 (307)
T cd05098          52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ  131 (307)
T ss_pred             eEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence            49999997532  2235788999999999 7999999999999999999999999999999999654321          


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccc
Q 039471          196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY  275 (363)
Q Consensus       196 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  275 (363)
                      .....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+................++..|
T Consensus       132 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y  208 (307)
T cd05098         132 VPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW  208 (307)
T ss_pred             CccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccce
Confidence            112458999999999999999999999   99999999999999999999999999998766432221111222345689


Q ss_pred             cCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          276 IAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       276 ~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      +|||.+        +|+||||+++|||++ |..|+......        -+...+..+..      .+.+...+.++.++
T Consensus       209 ~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~~l  274 (307)
T cd05098         209 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--------ELFKLLKEGHR------MDKPSNCTNELYMM  274 (307)
T ss_pred             eChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHcCCC------CCCCCcCCHHHHHH
Confidence            999976        899999999999998 77887543211        12222221111      12233456789999


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      +.+||+.+|++||||.|
T Consensus       275 i~~~l~~~p~~Rps~~e  291 (307)
T cd05098         275 MRDCWHAVPSQRPTFKQ  291 (307)
T ss_pred             HHHHcccChhhCcCHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.2e-35  Score=262.21  Aligned_cols=237  Identities=20%  Similarity=0.302  Sum_probs=170.1

Q ss_pred             ccccccCCcceeeccCC----eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLHSN----EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~----~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.......    .+++|.+....  ...+.|.+|+.+++.++|+||+++++.+.+....++||||+++++|
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   82 (268)
T cd05086           3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDL   82 (268)
T ss_pred             CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcH
Confidence            45566666554432222    25666665332  2346899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.....  ....+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||++...........
T Consensus        83 ~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          83 KSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             HHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            999965432  12456778889999999999999999   9999999999999999999999999999764322211111


Q ss_pred             cccccccccccCCccc---------------cCceehhHHHHHHhcC-CCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          266 RTAARGTSGYIAPELF---------------SRNFCYGMMLLEMVGC-RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      .....++..|+|||++               +|+||||+++|||+++ ..|+......       + .......+.... 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~-~~~~~~~~~~~~-  228 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------E-VLNHVIKDQQVK-  228 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHhhcccc-
Confidence            1334578899999974               7999999999999964 5566433221       1 111111111111 


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+.....++..+.+++..|| .+|++|||++|
T Consensus       229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~  261 (268)
T cd05086         229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE  261 (268)
T ss_pred             cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence            1112222335677888999999 68999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.5e-35  Score=260.82  Aligned_cols=231  Identities=23%  Similarity=0.416  Sum_probs=179.4

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+... +..+|+|.+........+|.+|++++++++|+|++++++++......+++|||+++++|.++
T Consensus        10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   89 (256)
T cd05112          10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY   89 (256)
T ss_pred             eeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHH
Confidence            34556666665554433 45599999876655667899999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..++++.+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+......... ....
T Consensus        90 ~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05112          90 LRAQR-----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTG  160 (256)
T ss_pred             HHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCC
Confidence            85332     458899999999999999999999   99999999999999999999999999998866433221 1122


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||.+        +|+||||+++|||++ |+.||.......        ..+.+..+...      ..+...
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~  226 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--------VVETINAGFRL------YKPRLA  226 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHhCCCCC------CCCCCC
Confidence            3356789999987        899999999999998 888886533211        12222211111      111224


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++|||++|
T Consensus       227 ~~~~~~l~~~~l~~~p~~Rp~~~~  250 (256)
T cd05112         227 SQSVYELMQHCWKERPEDRPSFSL  250 (256)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHH
Confidence            567999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.3e-35  Score=268.62  Aligned_cols=233  Identities=23%  Similarity=0.402  Sum_probs=174.8

Q ss_pred             cccccccCCcceeeccCC----eeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHSN----EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~----~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.+..+....+    .+++|.++...  ...+.+.+|+.++.++ +|+||+++++++.+.+..++++||++++
T Consensus         9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   88 (297)
T cd05089           9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG   88 (297)
T ss_pred             eecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCC
Confidence            345666666655544332    27888887422  2335789999999999 7999999999999999999999999999


Q ss_pred             CHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccc
Q 039471          184 SLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       184 sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      +|.+++......          .....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~  165 (297)
T cd05089          89 NLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGL  165 (297)
T ss_pred             cHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECCcCC
Confidence            999999653211          112358999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          254 AKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       254 a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      +........   ......+..|+|||.+        +|+||||+++|||++ |..||.......        ....+..+
T Consensus       166 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~~~~~~~~  234 (297)
T cd05089         166 SRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQG  234 (297)
T ss_pred             Cccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcC
Confidence            864322111   1112235579999987        899999999999997 999986543211        11222111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .      ....+..++..+.+++.+||+.+|.+|||++|
T Consensus       235 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  267 (297)
T cd05089         235 Y------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ  267 (297)
T ss_pred             C------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            1      11122345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-35  Score=270.18  Aligned_cols=234  Identities=22%  Similarity=0.277  Sum_probs=177.4

Q ss_pred             CcccccccccCCccee---eccCCe-eEEEEcccCCc---ChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEec
Q 039471          108 PFQSLISFNLTNSKFF---FLHSNE-IAVKMLEHLKG---NGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~---~~~~~~-vAvK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .|+.++.+|.|++..|   ...++. +|+|++.....   ....|.+|++.|.+|+ |.+||++|+|-..++.+|+|||+
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            3444444555555444   333333 88888764333   3368999999999996 99999999999999999999997


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      = ..+|.++|....     ..++.-.++.+-.|++.+++++|+   .||||.|+||.|+|+-. |.+||+|||+|..+..
T Consensus       442 G-d~DL~kiL~k~~-----~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  442 G-DIDLNKILKKKK-----SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             c-cccHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            6 469999996543     334434888999999999999999   99999999999999865 5899999999999988


Q ss_pred             CccccccccccccccccCCccc-------------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHH
Q 039471          260 DISIVSRTAARGTSGYIAPELF-------------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~-------------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      +.....+....||..||+||.+                   |||||+|||||+|+.|+.||......          +.+
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----------~aK  581 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----------IAK  581 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----------HHH
Confidence            8776666788899999999998                   89999999999999999999764321          122


Q ss_pred             hhhccccccccCCCCcHHHH-HHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIA-RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..-..  +..+.+.+..-. .++.+++..||++||.+|||+.|
T Consensus       582 l~aI~~--P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e  623 (677)
T KOG0596|consen  582 LHAITD--PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE  623 (677)
T ss_pred             HHhhcC--CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence            221111  111111111111 12999999999999999999864

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-35  Score=273.11  Aligned_cols=238  Identities=22%  Similarity=0.244  Sum_probs=169.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCC------ceeEEEec
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN------RRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~  179 (363)
                      .++.+++|.+..+...  +..||||++...   .....++.+|+.+++.++|+||+++++++....      ..++||||
T Consensus        28 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~  107 (359)
T cd07876          28 PIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL  107 (359)
T ss_pred             EeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeC
Confidence            3445555544444322  345999998643   233457889999999999999999999986443      57999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++ +|.+.+.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       108 ~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         108 MDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             CCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            975 6766662        347889999999999999999999   9999999999999999999999999999976543


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHH---HH--
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEW---IY--  318 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~---~~--  318 (363)
                      ...   .....||..|+|||++        +|+||||+++|||++|+.||..........        ...++   ..  
T Consensus       176 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         176 NFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             Ccc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            322   1344689999999987        899999999999999999997653221100        00000   00  


Q ss_pred             --HHhhhcccc-c-----------cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          319 --NRMRLGQEL-C-----------LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       319 --~~~~~~~~~-~-----------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ......... .           ...........++.+.+++.+||++||++|||++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e  311 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE  311 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence              000000000 0           00001111223567899999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=270.42  Aligned_cols=234  Identities=19%  Similarity=0.237  Sum_probs=173.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||+|++...    ....+.+.+|+.++..++|+||+++++++.+++..++||||++++
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~   86 (331)
T cd05597           7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG   86 (331)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence            34556666665554443  344999998632    223456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        87 ~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          87 DLLTLLSKF-----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            999999532     2468999999999999999999999   99999999999999999999999999998766543321


Q ss_pred             cccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 VSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                       ......||+.|+|||++             +|+|||||++|||++|+.||.......        .+..+..... ...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--------~~~~i~~~~~-~~~  228 (331)
T cd05597         159 -QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKE-HFQ  228 (331)
T ss_pred             -cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCC-ccc
Confidence             11234589999999975             699999999999999999996543211        1122211111 011


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCC--CCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPT--ERPSMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~  362 (363)
                      . .......+..+.+++.+|+..+++  .||+++
T Consensus       229 ~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~  261 (331)
T cd05597         229 F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQ  261 (331)
T ss_pred             C-CCccCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            1 111223567788999998864332  356654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-35  Score=259.76  Aligned_cols=230  Identities=26%  Similarity=0.390  Sum_probs=177.6

Q ss_pred             ccccccCCcceeecc-CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLH-SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.++.+... ++.||+|.+.....  ..+.+.+|++++++++|+||+++++++.+....+++|||+++++|.++
T Consensus         3 lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~   82 (251)
T cd05041           3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTF   82 (251)
T ss_pred             cccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHH
Confidence            456666666655544 45599998875433  346889999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..+..++.+++.||+|||+   ++++|+||||+||+++.++.+||+|||.+..............
T Consensus        83 l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          83 LRKKK-----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            85432     457899999999999999999999   9999999999999999999999999999986653222111122


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...+..|+|||.+        +|+||||+++|||++ |..||.......        ....+....      ....+...
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~  220 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------TRERIESGY------RMPAPQLC  220 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------HHHHHhcCC------CCCCCccC
Confidence            2345679999986        799999999999998 777775443211        111121111      11223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+|++.+|.+|||++|
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~e  244 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSE  244 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHH
Confidence            678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-35  Score=265.83  Aligned_cols=243  Identities=20%  Similarity=0.231  Sum_probs=175.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+...  +..||||++....   ...+.+.+|+.++++++|+||+++++++.++...++||||++ ++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~   86 (285)
T cd07861           8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLK   86 (285)
T ss_pred             ecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHH
Confidence            445555555554433  3449999886432   234678899999999999999999999999999999999997 5898


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....   ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++........  ..
T Consensus        87 ~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  158 (285)
T cd07861          87 KYLDSLP---KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VY  158 (285)
T ss_pred             HHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cc
Confidence            8885432   22568999999999999999999999   9999999999999999999999999999876543321  11


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH-------HHHhhhccc----
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI-------YNRMRLGQE----  326 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----  326 (363)
                      ....++..|+|||.+         +|+||||++++||++|+.||................       +........    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            233568889999976         799999999999999999997543321110000000       000000000    


Q ss_pred             ---cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 ---LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ---~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         .............++++.+++.+||+.||++|||++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  278 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK  278 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence               0000000011235677899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-35  Score=258.68  Aligned_cols=232  Identities=19%  Similarity=0.255  Sum_probs=178.9

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.++++.+..+...  ++.+|+|++.... ...+.+.+|+.++++++|+||+++++.+.++...+++|||+++++|.++
T Consensus        11 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~   90 (262)
T cd06613          11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI   90 (262)
T ss_pred             ecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence            444455554444332  3449999987443 2456889999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.+........  ....
T Consensus        91 ~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~  160 (262)
T cd06613          91 YQVTR-----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKS  160 (262)
T ss_pred             HHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--cccc
Confidence            85432     568999999999999999999999   9999999999999999999999999999876654321  1133


Q ss_pred             ccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          269 ARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       269 ~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      ..++..|+|||.+           +|+||||+++|||++|+.|+........       .. ...... . .........
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~-~~~~~~-~-~~~~~~~~~  230 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LF-LISKSN-F-PPPKLKDKE  230 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HH-HHHhcc-C-CCccccchh
Confidence            4578889999986           6999999999999999999876432221       00 111110 0 011112334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.++.+++.+||+.+|.+|||++|
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~  256 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATK  256 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHH
Confidence            56778999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.7e-35  Score=269.03  Aligned_cols=190  Identities=21%  Similarity=0.269  Sum_probs=148.8

Q ss_pred             cccccccCCcceeeccC----CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeee--eCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLHS----NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS--EGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~----~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~s  184 (363)
                      +++.+++|.++.+...+    ..||+|.+.... ....+.+|++++++++|+||+++++++.  .+...++++||+++ +
T Consensus         8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~   85 (317)
T cd07867           8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-D   85 (317)
T ss_pred             EeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-c
Confidence            45666777666655432    349999886443 3456789999999999999999999885  35678999999964 8


Q ss_pred             HHHHhhhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE----cCCCCeeEeccccceec
Q 039471          185 LQKFIFSKTN---SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLC  257 (363)
Q Consensus       185 L~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~  257 (363)
                      |.+++.....   ......+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++..
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence            8887743221   1223468999999999999999999999   999999999999999    56678999999999876


Q ss_pred             cCCccc-cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcch
Q 039471          258 SKDISI-VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       258 ~~~~~~-~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                      ...... .......+|..|+|||++         +|+||||+++|||++|++||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            543221 112344678999999976         799999999999999999987543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2e-35  Score=266.10  Aligned_cols=242  Identities=24%  Similarity=0.273  Sum_probs=169.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhcc---CCCceeeeeeeeee-----CCceeEEE
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCSE-----GNRRTLIY  177 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~lv~  177 (363)
                      .++.+++|.++.+...  ++.||+|.++...   .....+.+|+.+++++   +|+||+++++++..     ....+++|
T Consensus         7 ~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~   86 (288)
T cd07863           7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVF   86 (288)
T ss_pred             EEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEE
Confidence            3455555555444433  3349999886432   2234566788777765   69999999998754     34579999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||+++ +|.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        87 e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          87 EHVDQ-DLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ccccc-CHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            99974 8988885432    2458999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHH--------HHh
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY--------NRM  321 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~--------~~~  321 (363)
                      ......   ....++..|+|||++        +|+||+||++|||++|++||.................        ...
T Consensus       159 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         159 SCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            543221   334578899999987        7999999999999999999865433221100000000        000


Q ss_pred             hhccccccccC----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQELCLDFE----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...........    .......+..+.+++.+||+.||++|||++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~  281 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR  281 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence            00000000000    0111235667899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-35  Score=267.04  Aligned_cols=218  Identities=25%  Similarity=0.433  Sum_probs=169.9

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC----------
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS----------  195 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------  195 (363)
                      .||+|......  ...+++.+|+.+++.+ +|+||+++++++......+++|||+++++|.+++......          
T Consensus        49 ~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  128 (304)
T cd05101          49 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR  128 (304)
T ss_pred             eEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence            39999986432  3346789999999999 7999999999999999999999999999999999754321          


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccc
Q 039471          196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY  275 (363)
Q Consensus       196 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  275 (363)
                      .....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.++...............++..|
T Consensus       129 ~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y  205 (304)
T cd05101         129 VPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW  205 (304)
T ss_pred             CCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCcee
Confidence            112468889999999999999999999   99999999999999999999999999999877543322222333456789


Q ss_pred             cCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          276 IAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       276 ~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      +|||++        +|+||||+++|||++ |..|+......        .+.+.+..+...      ..+...+..+.++
T Consensus       206 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~------~~~~~~~~~~~~l  271 (304)
T cd05101         206 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--------ELFKLLKEGHRM------DKPANCTNELYMM  271 (304)
T ss_pred             eCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcC------CCCCCCCHHHHHH
Confidence            999976        899999999999998 67776543211        122222222111      1223456789999


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      +.+||+.+|++|||+.|
T Consensus       272 i~~cl~~~p~~Rps~~e  288 (304)
T cd05101         272 MRDCWHAIPSHRPTFKQ  288 (304)
T ss_pred             HHHHcccChhhCCCHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-35  Score=258.95  Aligned_cols=214  Identities=22%  Similarity=0.331  Sum_probs=172.6

Q ss_pred             CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCH
Q 039471          127 SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW  203 (363)
Q Consensus       127 ~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~  203 (363)
                      +..+++|.+...   ....+++.+|++++++++|+||+++++++.+....+++|||+++++|.+++....    ...+++
T Consensus        25 ~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~----~~~~~~  100 (256)
T cd08221          25 DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK----GQLFEE  100 (256)
T ss_pred             CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc----ccCCCH
Confidence            344999987643   3344678899999999999999999999999999999999999999999995432    256899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--
Q 039471          204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--  281 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--  281 (363)
                      ..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||.+........  ......++..|+|||.+  
T Consensus       101 ~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~  175 (256)
T cd08221         101 EMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQG  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCC
Confidence            9999999999999999999   9999999999999999999999999999987655432  12345588999999987  


Q ss_pred             ------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCC
Q 039471          282 ------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP  355 (363)
Q Consensus       282 ------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  355 (363)
                            +|+||||++++||++|..||.......        ....+..+..      .......+.++.+++.+||+.+|
T Consensus       176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p  241 (256)
T cd08221         176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLN--------LVVKIVQGNY------TPVVSVYSSELISLVHSLLQQDP  241 (256)
T ss_pred             CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCC------CCCccccCHHHHHHHHHHcccCc
Confidence                  799999999999999999986533211        1112211111      11224556789999999999999


Q ss_pred             CCCCCCCC
Q 039471          356 TERPSMPM  363 (363)
Q Consensus       356 ~~RPs~~e  363 (363)
                      ++|||++|
T Consensus       242 ~~R~s~~~  249 (256)
T cd08221         242 EKRPTADE  249 (256)
T ss_pred             ccCCCHHH
Confidence            99999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-35  Score=262.26  Aligned_cols=230  Identities=23%  Similarity=0.343  Sum_probs=174.7

Q ss_pred             ccccccCCcceeeccC-----CeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS-----NEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....     ..||||++....  ...++|.+|+.++++++|+||+++++++.++...+++|||+++++
T Consensus        12 lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~   91 (269)
T cd05065          12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGA   91 (269)
T ss_pred             ecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCc
Confidence            4556666555544332     139999987432  234689999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...     ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........
T Consensus        92 L~~~l~~~-----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          92 LDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             HHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence            99998533     2468999999999999999999999   999999999999999999999999999987665432211


Q ss_pred             cccc---ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          265 SRTA---ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       265 ~~~~---~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ....   ...+..|+|||.+        +|+||||+++|||++ |..||.......        ....+....      .
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~~------~  229 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQDY------R  229 (269)
T ss_pred             ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCC------c
Confidence            1111   1124579999987        799999999999886 998886543221        112221111      1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+.+.+..+.+++.+||+.+|.+|||+++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (269)
T cd05065         230 LPPPMDCPTALHQLMLDCWQKDRNARPKFGQ  260 (269)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            1122345677899999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.8e-35  Score=264.43  Aligned_cols=218  Identities=24%  Similarity=0.420  Sum_probs=166.8

Q ss_pred             eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC----CCCCCCC
Q 039471          129 EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS----SSHRQLS  202 (363)
Q Consensus       129 ~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~l~  202 (363)
                      .||+|.+.....  ...++.+|+.++++++|+||+++++++.++...+++|||+++|+|.+++......    .....++
T Consensus        38 ~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  117 (288)
T cd05061          38 RVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT  117 (288)
T ss_pred             EEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCC
Confidence            499998864432  2346889999999999999999999999999999999999999999999653211    1124467


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-
Q 039471          203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-  281 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-  281 (363)
                      ...+..++.|++.||.|||+   ++++||||||+||++++++.++|+|||+++...............++..|+|||.+ 
T Consensus       118 ~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  194 (288)
T cd05061         118 LQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK  194 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhc
Confidence            78899999999999999999   99999999999999999999999999998865443222112223356789999987 


Q ss_pred             -------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccC
Q 039471          282 -------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW  353 (363)
Q Consensus       282 -------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  353 (363)
                             +|+||||+++|||++ |..||.......        ....+..+...      ..+...+..+.+++.+||+.
T Consensus       195 ~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~  260 (288)
T cd05061         195 DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--------VLKFVMDGGYL------DQPDNCPERVTDLMRMCWQF  260 (288)
T ss_pred             cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CCCCCCCHHHHHHHHHHcCC
Confidence                   799999999999998 677776432211        11111111111      11223457899999999999


Q ss_pred             CCCCCCCCCC
Q 039471          354 NPTERPSMPM  363 (363)
Q Consensus       354 ~p~~RPs~~e  363 (363)
                      +|++|||+.|
T Consensus       261 ~p~~Rps~~~  270 (288)
T cd05061         261 NPKMRPTFLE  270 (288)
T ss_pred             ChhHCcCHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.4e-35  Score=259.85  Aligned_cols=231  Identities=22%  Similarity=0.319  Sum_probs=181.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.++++.+..+...  +..+|+|.+..... .+++.+|++++++++|+||+++++++.++...++++||+++++|.+
T Consensus         9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   87 (256)
T cd06612           9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD   87 (256)
T ss_pred             hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHH
Confidence            44555556655555443  34599999875443 6789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++...     ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........  ...
T Consensus        88 ~l~~~-----~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~  157 (256)
T cd06612          88 IMKIT-----NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN  157 (256)
T ss_pred             HHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence            98532     2568999999999999999999999   9999999999999999999999999999887654332  113


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||++        +|+||||+++|+|++|+.|+.........       . ...  .  ........+..+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~-~~~--~--~~~~~~~~~~~~  225 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------F-MIP--N--KPPPTLSDPEKW  225 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------h-hhc--c--CCCCCCCchhhc
Confidence            34478899999986        89999999999999999998754332210       0 000  0  000111223456


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++|||++|
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~  249 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQ  249 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHH
Confidence            678999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.4e-35  Score=264.72  Aligned_cols=236  Identities=25%  Similarity=0.340  Sum_probs=176.4

Q ss_pred             cccccccCCcceeec-------cCCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFL-------HSNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .++.+++|.+..+..       ....||+|++.....  ..++|.+|+.++++++|+||+++++++..+...++++||++
T Consensus        12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (288)
T cd05050          12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMA   91 (288)
T ss_pred             cccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCC
Confidence            344555555554432       233499999874322  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCC----------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC
Q 039471          182 NGSLQKFIFSKTN----------------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ  245 (363)
Q Consensus       182 ~~sL~~~l~~~~~----------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~  245 (363)
                      +++|.+++.....                ......+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~~~  168 (288)
T cd05050          92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMV  168 (288)
T ss_pred             CCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCCCc
Confidence            9999999964321                0112358899999999999999999999   99999999999999999999


Q ss_pred             eeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHH
Q 039471          246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEW  316 (363)
Q Consensus       246 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~  316 (363)
                      ++|+|||.+.................+..|+|||.+        +|+||||+++|||++ |..||.......        
T Consensus       169 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~--------  240 (288)
T cd05050         169 VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--------  240 (288)
T ss_pred             eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            999999998865443222111223346679999976        799999999999997 777875432211        


Q ss_pred             HHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          317 IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+..+...      ..+...+.++.+++.+||+.+|++|||++|
T Consensus       241 ~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e  281 (288)
T cd05050         241 VIYYVRDGNVL------SCPDNCPLELYNLMRLCWSKLPSDRPSFAS  281 (288)
T ss_pred             HHHHHhcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence            11222222111      112245678999999999999999999865

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-36  Score=277.12  Aligned_cols=202  Identities=24%  Similarity=0.395  Sum_probs=168.8

Q ss_pred             CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC--ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 039471          138 LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR  215 (363)
Q Consensus       138 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~  215 (363)
                      .....++|..|+.+|+.|+|+||+++|.+|.+..  ...+|+|.|..|+|..|..      +.+.++...++.|++||++
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k------k~~~vn~kaik~W~RQILk  154 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK------KHRRVNIKAIKSWCRQILK  154 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH------HhccCCHHHHHHHHHHHHH
Confidence            3445589999999999999999999999997655  4889999999999999994      3466889999999999999


Q ss_pred             HHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEeccccceeccCCccccccccccccccccCCccc-------cCceeh
Q 039471          216 GVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-------SRNFCY  287 (363)
Q Consensus       216 ~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~Di~sl  287 (363)
                      ||.|||+. ..+|+|||||-+||+|+ ..|.|||+|+|+|........    ....||+.|||||++       .|||||
T Consensus       155 GL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYEE~YnE~VDVYaF  229 (632)
T KOG0584|consen  155 GLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYEENYNELVDVYAF  229 (632)
T ss_pred             HhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHhhhcchhhhhhhh
Confidence            99999983 45899999999999998 468999999999998765443    346899999999999       899999


Q ss_pred             hHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          288 GMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       288 G~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ||+++||+|+..|+.....       +..+|+++..|.....-     ..--.++++++|.+||.. .++|||+.|
T Consensus       230 GMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~sl-----~kV~dPevr~fIekCl~~-~~~R~sa~e  292 (632)
T KOG0584|consen  230 GMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAAL-----SKVKDPEVREFIEKCLAT-KSERLSAKE  292 (632)
T ss_pred             hHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHHh-----hccCCHHHHHHHHHHhcC-chhccCHHH
Confidence            9999999999999876543       34488888766543221     111246799999999999 999999864

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.3e-35  Score=260.88  Aligned_cols=230  Identities=23%  Similarity=0.371  Sum_probs=176.7

Q ss_pred             cccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          111 SLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++.+++|.++.+... +..+|+|.+.......+.+.+|+.++++++|+||+++++.+.+ ...+++|||+++++|.+++
T Consensus        13 ~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~   91 (260)
T cd05073          13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL   91 (260)
T ss_pred             EecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHH
Confidence            3455555555544432 2349999887655556789999999999999999999999887 7789999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+......... .....
T Consensus        92 ~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~  163 (260)
T cd05073          92 KSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGA  163 (260)
T ss_pred             HhCC----ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCC
Confidence            5432    2568889999999999999999999   99999999999999999999999999999876543221 11233


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||.+        +|+||||+++|++++ |+.||.......        ....+..+.      ........+
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~~  229 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGY------RMPRPENCP  229 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCC------CCCCcccCC
Confidence            456779999987        799999999999998 888886543211        111122111      111223456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+++.+|++.+|++|||+.+
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~  252 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEY  252 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHH
Confidence            77999999999999999999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.4e-35  Score=267.33  Aligned_cols=218  Identities=27%  Similarity=0.444  Sum_probs=168.0

Q ss_pred             eeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCC----------C
Q 039471          129 EIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTN----------S  195 (363)
Q Consensus       129 ~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------~  195 (363)
                      .+|+|++.....  ...++.+|+.+++++ +|+||+++++++..++..+++|||+++++|.+++.....          .
T Consensus        46 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~  125 (314)
T cd05099          46 TVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK  125 (314)
T ss_pred             EEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccC
Confidence            399999874332  235788999999999 599999999999998999999999999999999965431          1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccc
Q 039471          196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY  275 (363)
Q Consensus       196 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  275 (363)
                      .....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++...............++..|
T Consensus       126 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y  202 (314)
T cd05099         126 VPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKW  202 (314)
T ss_pred             CcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccc
Confidence            122468999999999999999999999   99999999999999999999999999999876533221111222345679


Q ss_pred             cCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          276 IAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       276 ~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      +|||.+        +|+||||+++|||++ |..||......        .....+..+..      ...+...+.++.++
T Consensus       203 ~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~l~~l  268 (314)
T cd05099         203 MAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--------ELFKLLREGHR------MDKPSNCTHELYML  268 (314)
T ss_pred             cCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC------CCCCCCCCHHHHHH
Confidence            999986        899999999999998 78887543221        12222222211      11223445678899


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      +.+||+.+|++|||+.|
T Consensus       269 i~~cl~~~p~~Rps~~~  285 (314)
T cd05099         269 MRECWHAVPTQRPTFKQ  285 (314)
T ss_pred             HHHHcCCCcccCcCHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-35  Score=263.36  Aligned_cols=234  Identities=18%  Similarity=0.258  Sum_probs=175.0

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeee-----eCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCS-----EGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+..  .++.+|+|++........++.+|+.+++++ +|+||+++++++.     .+...++||||+++
T Consensus        25 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~  104 (286)
T cd06638          25 TIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNG  104 (286)
T ss_pred             eeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCC
Confidence            344555554443333  234599998875544456788999999999 6999999999874     34578999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++....  .....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       105 ~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (286)
T cd06638         105 GSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  179 (286)
T ss_pred             CCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence            99999885432  123568999999999999999999999   9999999999999999999999999999887643321


Q ss_pred             ccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          263 IVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                        ......|+..|+|||.+             +|+||+|+++|||++|+.|+........       +. ........  
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~-~~~~~~~~--  247 (286)
T cd06638         180 --RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LF-KIPRNPPP--  247 (286)
T ss_pred             --ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hh-hccccCCC--
Confidence              12344688999999964             7999999999999999999865432111       00 11111000  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ....+...+..+.+++.+||+.+|++|||++|
T Consensus       248 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  279 (286)
T cd06638         248 --TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSD  279 (286)
T ss_pred             --cccCCCCcCHHHHHHHHHHccCCcccCCCHHH
Confidence              01122234567999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-35  Score=262.81  Aligned_cols=233  Identities=19%  Similarity=0.307  Sum_probs=179.0

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+..  .++.+|||.+....    ...+++.+|+.+++.++|+||+++++++.+++..+++|||+++++|
T Consensus        10 ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   89 (267)
T cd08229          10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL   89 (267)
T ss_pred             hcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCH
Confidence            44555555554442  34559999876422    2335788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....  .....+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+.........  
T Consensus        90 ~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--  162 (267)
T cd08229          90 SRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--  162 (267)
T ss_pred             HHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--
Confidence            99986432  123568999999999999999999999   99999999999999999999999999998776543321  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||.+        +|+||||+++|||++|..||........     . ....+...     ........
T Consensus       163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~-----~~~~~~~~  231 (267)
T cd08229         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----S-LCKKIEQC-----DYPPLPSD  231 (267)
T ss_pred             cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-----H-HhhhhhcC-----CCCCCCcc
Confidence            1234578899999987        7999999999999999999864322110     1 11111111     11111233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..+..+.+++.+||+.+|++||||+
T Consensus       232 ~~~~~~~~li~~~l~~~p~~Rpt~~  256 (267)
T cd08229         232 HYSEELRQLVNMCINPDPEKRPDIT  256 (267)
T ss_pred             cccHHHHHHHHHhcCCCcccCCCHH
Confidence            5677899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=274.87  Aligned_cols=222  Identities=21%  Similarity=0.269  Sum_probs=180.1

Q ss_pred             cccccCCcceeec---cCC--eeEEEEcccC----CcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCC
Q 039471          113 ISFNLTNSKFFFL---HSN--EIAVKMLEHL----KGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       113 ~~~~~~~~~~~~~---~~~--~vAvK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..+|.|+.|.|.+   +++  -+|||++++.    ....+....|.+++.... ||.+++++.+|..+.+.++||||+.|
T Consensus       374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~G  453 (694)
T KOG0694|consen  374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAG  453 (694)
T ss_pred             EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCC
Confidence            3455555555544   333  3999999864    334567778888887775 99999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |++..++       ....|++..+.-++..++.||+|||+   ++||+||||.+|||+|.+|.+||+|||+++..-....
T Consensus       454 gdm~~~~-------~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  454 GDLMHHI-------HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             CcEEEEE-------ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            9955544       22679999999999999999999999   9999999999999999999999999999997653222


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ...+..||+.|+|||++        .|-|||||+||||+.|..||.+.++.+        +.+.+..       .+..
T Consensus       524 --~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~-------d~~~  586 (694)
T KOG0694|consen  524 --RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVN-------DEVR  586 (694)
T ss_pred             --ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhc-------CCCC
Confidence              23677899999999999        789999999999999999999876543        2222221       1223


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+..++.+...+++++|..+|++|.-+
T Consensus       587 yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCcccHHHHHHHHHHhccCcccccCC
Confidence            566778889999999999999999866

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.2e-35  Score=263.59  Aligned_cols=231  Identities=20%  Similarity=0.294  Sum_probs=176.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+...  +..||+|++.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++++|..
T Consensus        19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   98 (292)
T cd06644          19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA   98 (292)
T ss_pred             eecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence            4455555555444433  3449999986443 234678899999999999999999999999999999999999999988


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..+..++.|++.+|.|||+   .+++|+||||+||+++.++.++|+|||++........  ...
T Consensus        99 ~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~  168 (292)
T cd06644          99 IMLELD-----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRD  168 (292)
T ss_pred             HHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc--ccc
Confidence            874322     468999999999999999999999   9999999999999999999999999999876433211  113


Q ss_pred             cccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          268 AARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       268 ~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ...++..|+|||++             +|+||||+++|||++|+.|+.......        ..........    ....
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~----~~~~  236 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEP----PTLS  236 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--------HHHHHhcCCC----ccCC
Confidence            34578899999976             699999999999999999986543211        1111111111    1112


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..++.++.+++.+||+.+|++||+++|
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  265 (292)
T cd06644         237 QPSKWSMEFRDFLKTALDKHPETRPSAAQ  265 (292)
T ss_pred             CCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence            23456678999999999999999999764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-35  Score=269.14  Aligned_cols=236  Identities=22%  Similarity=0.296  Sum_probs=172.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.+..+...  +..+|+|.+....  ....++.+|++++++++|+||+++++.+.+++..+++|||+++++|.+
T Consensus         9 lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~   88 (308)
T cd06615           9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ   88 (308)
T ss_pred             ccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHH
Confidence            344444444433332  2338888876432  223568899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++...      ..+++..+..++.|++.||+|||+  ..+++|+||||+|||++.++.+||+|||++........    .
T Consensus        89 ~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~  156 (308)
T cd06615          89 VLKKA------GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N  156 (308)
T ss_pred             HHHhc------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccccc----c
Confidence            99432      568999999999999999999997  25899999999999999999999999999876533221    3


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc--------------
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ--------------  325 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------  325 (363)
                      ...++..|+|||.+        +|+||||+++|||++|+.|+.........    .+.........              
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE----AMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH----HhhcCccccccccCCcccccCCCCC
Confidence            34578899999987        79999999999999999998643321110    00000000000              


Q ss_pred             ------------ccccccCCC-CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ------------ELCLDFEED-GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ------------~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                  .......+. ....++.++.+++.+||+.+|++|||++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  283 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE  283 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence                        000000000 11125667999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-35  Score=262.14  Aligned_cols=228  Identities=22%  Similarity=0.332  Sum_probs=174.7

Q ss_pred             cccccCCcceeec--cCCeeEEEEcccCCcC----------hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          113 ISFNLTNSKFFFL--HSNEIAVKMLEHLKGN----------GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       113 ~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      +.+++|.+..+..  .+..+|+|.+......          .+.+.+|+.++++++|+||+++++++.+....++++||+
T Consensus         9 g~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06628           9 GSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYV   88 (267)
T ss_pred             ecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEec
Confidence            4444444444332  2345999988643221          146788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.++.....
T Consensus        89 ~~~~L~~~l~~------~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          89 PGGSVAALLNN------YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             CCCCHHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999943      2568899999999999999999999   99999999999999999999999999998877532


Q ss_pred             cccc----ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          261 ISIV----SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       261 ~~~~----~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ....    ......|+..|+|||.+        +|+||||+++|+|++|+.||........       +. ....     
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~-~~~~-----  226 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------IF-KIGE-----  226 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------HH-HHhc-----
Confidence            2110    11223478899999976        8999999999999999999975432111       11 1111     


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ......+...+..+.+++.+||+.+|.+|||++|
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06628         227 -NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAE  260 (267)
T ss_pred             -cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence             1111233446678999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-35  Score=265.92  Aligned_cols=234  Identities=20%  Similarity=0.280  Sum_probs=179.6

Q ss_pred             CCCcccccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          106 ACPFQSLISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      +.....++.+++|.++.+..  .++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            33334455555554444432  34559999986433 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..       ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus       101 ~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656         101 GSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999832       357899999999999999999999   9999999999999999999999999999887654332


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....++..|+|||.+        +|+||||+++|+|++|+.||.........       .. .....    .....
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~~-~~~~~----~~~~~  236 (297)
T cd06656         171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YL-IATNG----TPELQ  236 (297)
T ss_pred             C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------ee-eccCC----CCCCC
Confidence            1  1334578899999987        79999999999999999999654332110       00 00000    11112


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+..+.+++.+||+.+|++|||++|
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~  265 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKE  265 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            23456677899999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-36  Score=285.31  Aligned_cols=229  Identities=20%  Similarity=0.234  Sum_probs=176.8

Q ss_pred             ccccccCCcceeeccC--CeeEEEEccc-CCcChhHHHHHHHHHhccC-CCceeeeeeee-e----e--CCceeEEEecc
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEH-LKGNGQEFINEVATIGRIH-HFHIVRLLGFC-S----E--GNRRTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~----~--~~~~~lv~e~~  180 (363)
                      +..|||+.++.+...+  .++|+|++-. .+...+...+|+.++++|+ |+|||.+++.. .    .  .-+.+|.||||
T Consensus        45 LAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC  124 (738)
T KOG1989|consen   45 LAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYC  124 (738)
T ss_pred             EccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhc
Confidence            4567777777665544  4599998753 4444567889999999998 99999999942 1    1  13678999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      +||+|-+++.....    ..|++.++++|+.|+++|+.+||. +...|||||||-+|+||+.++..||||||.|......
T Consensus       125 ~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~  199 (738)
T KOG1989|consen  125 KGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS  199 (738)
T ss_pred             cCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence            99999999965443    449999999999999999999998 2345999999999999999999999999998754332


Q ss_pred             cccc-------ccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhh
Q 039471          261 ISIV-------SRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMR  322 (363)
Q Consensus       261 ~~~~-------~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ....       ..-...-|+.|+|||++           +|||+|||+||-|+....||+......            +.
T Consensus       200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------------Il  267 (738)
T KOG1989|consen  200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------------IL  267 (738)
T ss_pred             CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------------EE
Confidence            2100       01122368899999999           899999999999999999998653221            11


Q ss_pred             hccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          323 LGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+     .........++..|.+||+.||+.||.+||++-
T Consensus       268 ng-----~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~  302 (738)
T KOG1989|consen  268 NG-----NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIY  302 (738)
T ss_pred             ec-----cccCCCCccHHHHHHHHHHHHhccCcccCCCHH
Confidence            11     111223467899999999999999999999864

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.6e-35  Score=269.19  Aligned_cols=234  Identities=18%  Similarity=0.222  Sum_probs=174.6

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+....  ..+|+|++...    ....+.+.+|+.++..++|+||+++++.+.+....++||||+++|
T Consensus         7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g   86 (332)
T cd05623           7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG   86 (332)
T ss_pred             EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence            345666666665554443  34999998632    222345788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          87 DLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999995432     468999999999999999999999   99999999999999999999999999998765433221


Q ss_pred             cccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 VSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                       ......||+.|+|||++             +|+||||+++|||++|+.||.......        .+..+...... ..
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~-~~  228 (332)
T cd05623         159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKER-FQ  228 (332)
T ss_pred             -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCcc-cc
Confidence             11334689999999974             799999999999999999997543211        12222211110 00


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCC--CCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTE--RPSMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~  362 (363)
                       .+......++.+.+++.+|+..++.+  |+|++
T Consensus       229 -~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~  261 (332)
T cd05623         229 -FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIE  261 (332)
T ss_pred             -CCCccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence             11122345778899999998754443  45553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.6e-35  Score=257.97  Aligned_cols=226  Identities=25%  Similarity=0.401  Sum_probs=176.5

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ..++.+++|.+..+...++.||+|...... ..+.+.+|+.++++++|+|++++++++..+ ..+++|||+++++|.+++
T Consensus        12 ~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l   89 (254)
T cd05083          12 EIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFL   89 (254)
T ss_pred             eeeccCCCCceEecccCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHH
Confidence            345666777666666666679999986433 456889999999999999999999998765 478999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      ....    ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||.+.......     ...
T Consensus        90 ~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~  157 (254)
T cd05083          90 RTRG----RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNS  157 (254)
T ss_pred             HhcC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCC
Confidence            6432    2468999999999999999999999   999999999999999999999999999987654321     222


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..+..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+..      .......+
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~  223 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VKECVEKGYR------MEPPEGCP  223 (254)
T ss_pred             CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhCCCC------CCCCCcCC
Confidence            345679999987        799999999999997 888886543211        1222222211      11223456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.+|++|||++|
T Consensus       224 ~~~~~li~~~l~~~p~~Rp~~~~  246 (254)
T cd05083         224 ADVYVLMTSCWETEPKKRPSFHK  246 (254)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHH
Confidence            78899999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-35  Score=263.70  Aligned_cols=204  Identities=21%  Similarity=0.334  Sum_probs=159.3

Q ss_pred             eEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHH
Q 039471          130 IAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK  208 (363)
Q Consensus       130 vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~  208 (363)
                      ||+|++..... ..++|.+|+.+++.++|+||+++++++.++...++||||+++++|..++...     ...+++..+..
T Consensus        47 v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~  121 (274)
T cd05076          47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-----KGRVPVAWKIT  121 (274)
T ss_pred             EEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-----CCCCCHHHHHH
Confidence            89999864332 2357889999999999999999999999999999999999999999998532     24688999999


Q ss_pred             HHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-------CeeEeccccceeccCCccccccccccccccccCCccc
Q 039471          209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-------QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF  281 (363)
Q Consensus       209 i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  281 (363)
                      ++.|+++||+|||+   .+|+||||||+|||++..+       .+|++|||.+......      ....++..|+|||.+
T Consensus       122 i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~  192 (274)
T cd05076         122 VAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECV  192 (274)
T ss_pred             HHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhh
Confidence            99999999999999   9999999999999997643       3799999987654322      223467789999966


Q ss_pred             ---------cCceehhHHHHHHh-cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhc
Q 039471          282 ---------SRNFCYGMMLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI  351 (363)
Q Consensus       282 ---------~Di~slG~il~el~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (363)
                               +|+||||+++|||+ +|..|+........        ........        ..+....+.+.+++.+||
T Consensus       193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~--------~~~~~~~~~~~~li~~cl  256 (274)
T cd05076         193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--------ERFYEKKH--------RLPEPSCKELATLISQCL  256 (274)
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--------HHHHHhcc--------CCCCCCChHHHHHHHHHc
Confidence                     79999999999985 78888865432211        01111000        011122356899999999


Q ss_pred             cCCCCCCCCCCC
Q 039471          352 QWNPTERPSMPM  363 (363)
Q Consensus       352 ~~~p~~RPs~~e  363 (363)
                      +.+|++|||++|
T Consensus       257 ~~~p~~Rps~~~  268 (274)
T cd05076         257 TYEPTQRPSFRT  268 (274)
T ss_pred             ccChhhCcCHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.7e-35  Score=261.68  Aligned_cols=237  Identities=22%  Similarity=0.314  Sum_probs=179.7

Q ss_pred             ccccccccCCcceeeccC------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeee-CCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHS------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSE-GNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+....      ..||+|++.....  ..+.+.+|+.++++++|+||+++++++.. +...++++||+
T Consensus        12 ~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~   91 (280)
T cd05043          12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYM   91 (280)
T ss_pred             eeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcC
Confidence            345666777766665543      4499998874322  23578899999999999999999998765 56789999999


Q ss_pred             CCCCHHHHhhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          181 PNGSLQKFIFSKTNS--SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ++++|.+++......  .....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.+.
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~  168 (280)
T cd05043          92 NWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLF  168 (280)
T ss_pred             CCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCccccc
Confidence            999999998654321  122568999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ............++..|+|||.+        +|+||||+++||+++ |+.||.......        +...+..+...  
T Consensus       169 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~--  238 (280)
T cd05043         169 PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--------MAAYLKDGYRL--  238 (280)
T ss_pred             CCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHcCCCC--
Confidence            43322112233457789999987        899999999999998 999986543211        12222222111  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .....++..+.+++.+||+.+|++|||+.|
T Consensus       239 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  268 (280)
T cd05043         239 ----AQPINCPDELFAVMACCWALDPEERPSFSQ  268 (280)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence                112234567999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=264.14  Aligned_cols=232  Identities=19%  Similarity=0.283  Sum_probs=179.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.+..+...  +..||+|...... ...+.|.+|++++++++|+||+++++.+..+...++||||+++++|.
T Consensus        11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (280)
T cd06611          11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALD   90 (280)
T ss_pred             HHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHH
Confidence            44556666666555443  3449999986433 23467889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........  ..
T Consensus        91 ~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~  160 (280)
T cd06611          91 SIMLELE-----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KR  160 (280)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc--cc
Confidence            9985432     468999999999999999999999   9999999999999999999999999998876543221  11


Q ss_pred             ccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          267 TAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ....++..|+|||.+             +|+||||+++|||++|+.||.......        ....+..+..    ...
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~----~~~  228 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEP----PTL  228 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCC----CCc
Confidence            334578899999974             799999999999999999987543211        1111111111    111


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..++..+.+++.+||+.+|.+|||++|
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  258 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAE  258 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence            123345678999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.2e-35  Score=267.68  Aligned_cols=241  Identities=20%  Similarity=0.263  Sum_probs=173.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+...  ++.||+|.+....  .....+.+|+.++++++|+||+++++++..++..++||||++ ++|.+
T Consensus        14 lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (301)
T cd07873          14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQ   92 (301)
T ss_pred             eccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHH
Confidence            444455544444332  3449999886432  233567899999999999999999999999999999999997 58998


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.........  ..
T Consensus        93 ~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~  162 (301)
T cd07873          93 YLDDCG-----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YS  162 (301)
T ss_pred             HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--cc
Confidence            885432     458899999999999999999999   99999999999999999999999999998765432211  12


Q ss_pred             cccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH-------HHHHHhhhcccc-ccc
Q 039471          268 AARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE-------WIYNRMRLGQEL-CLD  330 (363)
Q Consensus       268 ~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~  330 (363)
                      ...++..|+|||++         +|+||||+++|||++|+.||..............       ..+..+...... ...
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            34568899999976         6999999999999999999975433211000000       000000000000 000


Q ss_pred             c---C----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 F---E----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~---~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .   .    .......++.+.+++.+||+.||++|||++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~e  282 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE  282 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence            0   0    0011234667899999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.6e-35  Score=259.99  Aligned_cols=232  Identities=22%  Similarity=0.357  Sum_probs=176.8

Q ss_pred             ccccccccCCcceeeccC--C---eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS--N---EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~---~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+....  .   .+|+|.+....  ...+++.+|++++++++|+||+++.+++......+++|||+++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (268)
T cd05063          11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN   90 (268)
T ss_pred             eEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCC
Confidence            345666666665554432  1   39999986442  2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++...     ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        91 ~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          91 GALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            9999998532     2468999999999999999999999   9999999999999999999999999999887654322


Q ss_pred             cc-ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          263 IV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       263 ~~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .. .......+..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+.      .
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--------~~~~i~~~~------~  228 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------VMKAINDGF------R  228 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------HHHHHhcCC------C
Confidence            11 11112234579999986        799999999999997 999986533211        222222111      1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......+.++.+++.+||+.+|++||++.+
T Consensus       229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~  259 (268)
T cd05063         229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVD  259 (268)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            1122345677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-35  Score=260.94  Aligned_cols=236  Identities=21%  Similarity=0.306  Sum_probs=180.0

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCC------ceeEEEec
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGN------RRTLIYEF  179 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~lv~e~  179 (363)
                      ...++.++++.+..+...  +..+++|++.......+++.+|+.+++++ +|+||+++++++.+..      ..+++|||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~   90 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL   90 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence            344455555555544433  34499999886665667899999999999 6999999999996644      48999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++++|.+++....  ..+..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+.....
T Consensus        91 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  165 (275)
T cd06608          91 CGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS  165 (275)
T ss_pred             CCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence            99999999985432  123578999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ...  ......++..|+|||++             +|+||||++++||++|..||........       .. .+.... 
T Consensus       166 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~-~~~~~~-  234 (275)
T cd06608         166 TLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-------LF-KIPRNP-  234 (275)
T ss_pred             chh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-------HH-HhhccC-
Confidence            322  12345588899999975             7999999999999999999864322111       11 111111 


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         .........++..+.+++.+||+.||++|||++|
T Consensus       235 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  268 (275)
T cd06608         235 ---PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE  268 (275)
T ss_pred             ---CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence               1111223346778999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-35  Score=266.33  Aligned_cols=231  Identities=16%  Similarity=0.173  Sum_probs=171.8

Q ss_pred             cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCC
Q 039471          126 HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS  202 (363)
Q Consensus       126 ~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~  202 (363)
                      .+..||||++...   ....+.+.+|+.++++++|+||+++++++.++...+++|||+++++|.+++.....    ..++
T Consensus        24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~----~~~~   99 (314)
T cd08216          24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLP   99 (314)
T ss_pred             CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc----cCCC
Confidence            4555999998643   23446889999999999999999999999999999999999999999999965432    4588


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc-----cccccccccccccC
Q 039471          203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-----VSRTAARGTSGYIA  277 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~a  277 (363)
                      +..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||.+.........     .......++..|+|
T Consensus       100 ~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a  176 (314)
T cd08216         100 ELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS  176 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccC
Confidence            99999999999999999999   99999999999999999999999999988765432110     01123346778999


Q ss_pred             Cccc----------cCceehhHHHHHHhcCCCCCCcchhcccccc-----hHHHHH----HH----hh------hccccc
Q 039471          278 PELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY-----FPEWIY----NR----MR------LGQELC  328 (363)
Q Consensus       278 PE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~-----~~~~~~----~~----~~------~~~~~~  328 (363)
                      ||++          +|+||||+++|||++|+.||...........     .+.++.    ..    ..      ......
T Consensus       177 PE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (314)
T cd08216         177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR  256 (314)
T ss_pred             HHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchh
Confidence            9975          7999999999999999999975432211000     000000    00    00      000000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..........++.++.+++.+||++||++|||++|
T Consensus       257 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence            01112233456678999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.5e-35  Score=265.03  Aligned_cols=228  Identities=21%  Similarity=0.304  Sum_probs=176.6

Q ss_pred             ccccccCCcceee--ccCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFF--LHSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~--~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.++.+.  ..++.||+|.+.... ...+.+.+|+++++.++|+||+++++++..+...++|+||+++++|.++
T Consensus        27 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  106 (296)
T cd06655          27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV  106 (296)
T ss_pred             EecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHH
Confidence            3444444443332  234559999886433 3456788999999999999999999999999999999999999999998


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +..       ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.........  ...
T Consensus       107 ~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~  174 (296)
T cd06655         107 VTE-------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RST  174 (296)
T ss_pred             HHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCC
Confidence            832       358999999999999999999999   99999999999999999999999999998866543321  133


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..++..|+|||.+        +|+||||+++|+|++|+.||........       ... +.....    .....+...+
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-------~~~-~~~~~~----~~~~~~~~~~  242 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYL-IATNGT----PELQNPEKLS  242 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH-HHhcCC----cccCCcccCC
Confidence            4578899999987        8999999999999999999976543221       100 110100    0111233456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.+|++|||++|
T Consensus       243 ~~~~~li~~~l~~dp~~Rpt~~~  265 (296)
T cd06655         243 PIFRDFLNRCLEMDVEKRGSAKE  265 (296)
T ss_pred             HHHHHHHHHHhhcChhhCCCHHH
Confidence            77999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.7e-35  Score=268.39  Aligned_cols=236  Identities=24%  Similarity=0.382  Sum_probs=176.6

Q ss_pred             cccccccCCcceeecc---------CCeeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEe
Q 039471          111 SLISFNLTNSKFFFLH---------SNEIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~---------~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      .++.+++|.++.+...         ...||+|+++...  ...+++.+|+.+++++ +|+||+++++++..++..++++|
T Consensus        19 ~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   98 (334)
T cd05100          19 PLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVE   98 (334)
T ss_pred             eeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEe
Confidence            3455566655544321         1248999887432  2346789999999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          179 FMPNGSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                      |+++++|.+++......          .....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||
T Consensus        99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~~~~kL  175 (334)
T cd05100          99 YASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKI  175 (334)
T ss_pred             cCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEE
Confidence            99999999999653210          123458889999999999999999999   99999999999999999999999


Q ss_pred             eccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHH
Q 039471          249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYN  319 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      +|||+++...............++..|+|||++        +|+||||+++|||++ |..||.......        ...
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~  247 (334)
T cd05100         176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------LFK  247 (334)
T ss_pred             CCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------HHH
Confidence            999999876543222222223345679999987        899999999999998 778775432111        122


Q ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+..      ...+...+.++.+++.+||+.+|++|||+.|
T Consensus       248 ~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e  285 (334)
T cd05100         248 LLKEGHR------MDKPANCTHELYMIMRECWHAVPSQRPTFKQ  285 (334)
T ss_pred             HHHcCCC------CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            2221111      1122344567999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8e-35  Score=260.86  Aligned_cols=227  Identities=17%  Similarity=0.261  Sum_probs=177.9

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.+...  +..||+|.+....  ...+.+.+|+.+++++.|+||+++++.+.+++..++||||+++++|.
T Consensus        11 ~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (277)
T cd06640          11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL   90 (277)
T ss_pred             hcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHH
Confidence            3444555544444332  3449999886432  23467889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..       ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        91 ~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~  158 (277)
T cd06640          91 DLLRA-------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--R  158 (277)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc--c
Confidence            99832       358899999999999999999999   99999999999999999999999999999776543221  1


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||.+        +|+||||+++|||++|..|+........        .....      ....+.....
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~~~------~~~~~~~~~~  224 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LFLIP------KNNPPTLTGE  224 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hhhhh------cCCCCCCchh
Confidence            334578889999986        8999999999999999999875432211        01111      0111234456


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+.+++.+||+.+|++|||++|
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~  249 (277)
T cd06640         225 FSKPFKEFIDACLNKDPSFRPTAKE  249 (277)
T ss_pred             hhHHHHHHHHHHcccCcccCcCHHH
Confidence            7888999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-35  Score=273.96  Aligned_cols=238  Identities=22%  Similarity=0.246  Sum_probs=169.7

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEec
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~  179 (363)
                      .++.+++|.+..+..  .++.||||++....   ...+.+.+|+.+++.++|+||+++++++...      ...+++|||
T Consensus        24 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~  103 (355)
T cd07874          24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL  103 (355)
T ss_pred             EeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhh
Confidence            345555555444332  24459999986432   2335778999999999999999999988543      357999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++ +|.+.+.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       104 ~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         104 MDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             hcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            975 6777662        348899999999999999999999   9999999999999999999999999999986543


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHH------
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWI------  317 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~------  317 (363)
                      ...   .....||..|+|||++        +|+|||||++|||++|+.||..........        ..+++.      
T Consensus       172 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         172 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             ccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            322   1345689999999987        899999999999999999997543221100        001100      


Q ss_pred             -HHHhhhccc---c---------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 -YNRMRLGQE---L---------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 -~~~~~~~~~---~---------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .........   .         ............+..+.+++.+||+.||++|||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~e  307 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE  307 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHH
Confidence             000000000   0         000011112234567899999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.1e-35  Score=272.99  Aligned_cols=238  Identities=20%  Similarity=0.227  Sum_probs=169.9

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEec
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~  179 (363)
                      .++.+++|.+..+..  .++.||||++...   ....+.+.+|+.+++.++|+||+++++++...      ...++||||
T Consensus        31 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~  110 (364)
T cd07875          31 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL  110 (364)
T ss_pred             EeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeC
Confidence            345555555544432  2445999998643   23345788999999999999999999987543      357999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++ +|.+.+.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       111 ~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         111 MDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CCC-CHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            975 7777772        347889999999999999999999   9999999999999999999999999999986544


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHHHH----
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWIYN----  319 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~~~----  319 (363)
                      ...   .....+|..|+|||++        +|+|||||++|||++|+.||..........        ..+++...    
T Consensus       179 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         179 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            322   1344689999999987        899999999999999999997543221100        00111000    


Q ss_pred             ---Hhhhcc-c-----------cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 ---RMRLGQ-E-----------LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ---~~~~~~-~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ...... .           .............+.++.+++.+||+.||++|||++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e  314 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE  314 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence               000000 0           0000001111223457899999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=293.21  Aligned_cols=235  Identities=21%  Similarity=0.299  Sum_probs=173.7

Q ss_pred             ccccccccCCcceeeccCC--eeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHSN--EIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~--~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+.....  .||+|.+....   .....|..|+.++++++|+||++++++|..  ...++|||||+++
T Consensus        19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g   98 (1021)
T PTZ00266         19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA   98 (1021)
T ss_pred             EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence            3445555555554443332  38999886432   234578899999999999999999998854  4568999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCceecCCCCCceEEcC----------------
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC----NQRILHFDIKPHNILLDH----------------  242 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~i~H~dikp~Nill~~----------------  242 (363)
                      ++|.++|.....  ....+++..++.|+.||+.||.|||+..    ..+|+||||||+|||++.                
T Consensus        99 GSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n  176 (1021)
T PTZ00266         99 GDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN  176 (1021)
T ss_pred             CcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence            999999964321  2256999999999999999999999821    134999999999999964                


Q ss_pred             -CCCeeEeccccceeccCCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhccccc
Q 039471          243 -NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI  311 (363)
Q Consensus       243 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~  311 (363)
                       .+.+||+|||++.........   ....||+.|+|||++          +|||||||++|||++|+.||.......   
T Consensus       177 g~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~---  250 (1021)
T PTZ00266        177 GRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS---  250 (1021)
T ss_pred             CCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH---
Confidence             335899999999876443221   345689999999986          699999999999999999996543211   


Q ss_pred             chHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          312 YFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .+...+..+...       .....+.++.+|+.+||+.+|.+|||+.|
T Consensus       251 ----qli~~lk~~p~l-------pi~~~S~eL~dLI~~~L~~dPeeRPSa~Q  291 (1021)
T PTZ00266        251 ----QLISELKRGPDL-------PIKGKSKELNILIKNLLNLSAKERPSALQ  291 (1021)
T ss_pred             ----HHHHHHhcCCCC-------CcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence                122222211110       11234677999999999999999999753

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-35  Score=263.90  Aligned_cols=233  Identities=22%  Similarity=0.308  Sum_probs=178.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.+...  +..||+|.+....  .....+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus         8 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~   87 (286)
T cd06622           8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD   87 (286)
T ss_pred             hhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHH
Confidence            3455555555544443  4459999886432  22357889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      .++....   ....+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||.+........    
T Consensus        88 ~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----  158 (286)
T cd06622          88 KLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----  158 (286)
T ss_pred             HHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----
Confidence            9885431   12478999999999999999999996  25999999999999999999999999999876543322    


Q ss_pred             ccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          267 TAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ....++..|+|||.+              +|+||||+++|||++|+.||.......        ....+....   ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~---~~~~  227 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------IFAQLSAIV---DGDP  227 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------HHHHHHHHh---hcCC
Confidence            334578889999975              699999999999999999986532211        111111100   0111


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..++.++.+++.+||+.+|++||+++|
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (286)
T cd06622         228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ  258 (286)
T ss_pred             CCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence            2234457888999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-34  Score=260.78  Aligned_cols=240  Identities=25%  Similarity=0.270  Sum_probs=176.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.+..+...  +..+|+|.+.....  ...++.+|++++++++|+||+++++++.+  .+..++||||+++++
T Consensus         8 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~   87 (287)
T cd06621           8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS   87 (287)
T ss_pred             EeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCC
Confidence            3445555555544443  34499999874432  34678999999999999999999998854  347899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++.....  ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        88 L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  160 (287)
T cd06621          88 LDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--  160 (287)
T ss_pred             HHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc--
Confidence            9998754321  23568999999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcc-cccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQ-SQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        ....++..|+|||.+        +|+||||+++|||++|..|+....... .......+    +..............
T Consensus       161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  234 (287)
T cd06621         161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELKDEPGN  234 (287)
T ss_pred             --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhccCCCC
Confidence              223467889999976        899999999999999999997653211 11111111    111111111111111


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....++.+.+++.+||+.+|++|||+.|
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e  262 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWD  262 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHH
Confidence            2235678999999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-35  Score=262.15  Aligned_cols=234  Identities=24%  Similarity=0.260  Sum_probs=176.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.+..+...  +..||+|++....  ...+.+.+|+++++.++|+||+++++.+......++||||+++++|.+
T Consensus        13 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (284)
T cd06620          13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR   92 (284)
T ss_pred             cCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHH
Confidence            444455544444433  3449999876432  234688999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++..      ...+++..+..++.+++.||.|||+  ..+++|+||||+||++++++.++|+|||++........    .
T Consensus        93 ~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~  160 (284)
T cd06620          93 IYKK------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----D  160 (284)
T ss_pred             HHHh------ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----C
Confidence            8843      2468999999999999999999996  25899999999999999999999999999865533211    2


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc----chHHHHHHHhhhccccccccCCCC
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI----YFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ...|+..|+|||++        +|+||||+++|||++|+.||..........    ...++... +.....     ....
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~  234 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-IVQEPP-----PRLP  234 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-HhhccC-----CCCC
Confidence            34588999999986        899999999999999999998654321110    01111111 111110     0111


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+..+.+++.+||+.||++|||++|
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e  262 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQ  262 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence            2236678999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-35  Score=262.92  Aligned_cols=224  Identities=19%  Similarity=0.272  Sum_probs=168.7

Q ss_pred             cccccccCCcceeecc---------CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFLH---------SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~---------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++.+++|.++.+...         ...||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            3456666666554432         2238888886433 23467889999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC--------eeEeccc
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--------PKISDFG  252 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~--------~kl~Dfg  252 (363)
                      ++|+|.+++....     ..+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.        ++++|||
T Consensus        82 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          82 KFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999995432     368999999999999999999999   99999999999999987765        5999999


Q ss_pred             cceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      .+......      ....++..|+|||.+         +|+||||+++|||++|..++........       .......
T Consensus       154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~  220 (258)
T cd05078         154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYED  220 (258)
T ss_pred             cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHHHHc
Confidence            88654332      223477889999976         6999999999999999644332221111       0000110


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        .      ...+.....++.+++.+||+.+|++|||++|
T Consensus       221 --~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  252 (258)
T cd05078         221 --R------HQLPAPKWTELANLINQCMDYEPDFRPSFRA  252 (258)
T ss_pred             --c------ccCCCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence              0      1112223467899999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-35  Score=262.60  Aligned_cols=234  Identities=26%  Similarity=0.376  Sum_probs=178.8

Q ss_pred             cccccccCCcceeeccCCe--eEEEEcccCCcChh---HHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLHSNE--IAVKMLEHLKGNGQ---EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.|++|.+..+...++.  +|+|.+........   ...+|+..+++++|+||+++++++......+++||++++++|
T Consensus         6 ~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L   85 (260)
T PF00069_consen    6 KLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSL   85 (260)
T ss_dssp             EEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBH
T ss_pred             EEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccc
Confidence            3566666666666555544  99999986543333   335699999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.      ....+++..+..++.|++.||++||+   .+++|+||||+||++++++.++|+|||.+........  .
T Consensus        86 ~~~l~------~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~--~  154 (260)
T PF00069_consen   86 QDYLQ------KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE--N  154 (260)
T ss_dssp             HHHHH------HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS--E
T ss_pred             ccccc------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--c
Confidence            99995      23568999999999999999999999   9999999999999999999999999999986422211  2


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      .....++..|+|||++         +|+||+|+++++|++|..|+...........+..........        .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~  226 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------SSQQS  226 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------HTTSH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------ccccc
Confidence            2455688999999996         799999999999999999998762111111111111111100        00111


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......+.+++.+||+.||++|||++|
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~  253 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEE  253 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHH
Confidence            111378999999999999999999853

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.1e-35  Score=257.33  Aligned_cols=229  Identities=19%  Similarity=0.274  Sum_probs=175.9

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeee-CCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL  185 (363)
                      ++.++++.++.+...  ++.||+|.+....   ...+.+.+|++++++++|+|++++++.+.. +...+++|||+++++|
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l   87 (257)
T cd08223           8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL   87 (257)
T ss_pred             ecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcH
Confidence            444555555444332  3449999986432   233578899999999999999999998764 4467899999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....    ...+++.++..++.|++.||++||+   .+++|+||||+||+++.++.++|+|||++........  .
T Consensus        88 ~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~  158 (257)
T cd08223          88 YHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--M  158 (257)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC--c
Confidence            99996432    2468999999999999999999999   9999999999999999999999999999987644322  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||++        +|+||||++++||++|+.||.......       ... .+..+..      ...+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-------~~~-~~~~~~~------~~~~~  224 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------LVY-RIIEGKL------PPMPK  224 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHH-HHHhcCC------CCCcc
Confidence            2334578899999987        799999999999999999987543211       111 1111111      12234


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++.+.+++.+|++.+|++|||+.|
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rp~~~~  250 (257)
T cd08223         225 DYSPELGELIATMLSKRPEKRPSVKS  250 (257)
T ss_pred             ccCHHHHHHHHHHhccCcccCCCHHH
Confidence            56778999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.9e-35  Score=262.84  Aligned_cols=232  Identities=20%  Similarity=0.273  Sum_probs=176.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeee------CCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE------GNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...  +..+|+|..........++..|+.++.++ +|+||+++++++..      ....+++|||+
T Consensus        22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~  101 (282)
T cd06636          22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC  101 (282)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeC
Confidence            34455555555544432  34499999876555556788999999998 69999999999853      45789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus       102 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636         102 GAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             CCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            9999999986433    2458899999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          261 ISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ..  ......|+..|+|||.+             +|+||||+++|||++|+.||........       .. ...  ...
T Consensus       175 ~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------~~-~~~--~~~  242 (282)
T cd06636         175 VG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------LF-LIP--RNP  242 (282)
T ss_pred             cc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------hh-hHh--hCC
Confidence            21  12335588899999975             7999999999999999999865432211       00 000  000


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ........++..+.+++.+||+.||.+|||+.|
T Consensus       243 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e  275 (282)
T cd06636         243 ---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ  275 (282)
T ss_pred             ---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence               001122345678999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-34  Score=257.49  Aligned_cols=230  Identities=24%  Similarity=0.350  Sum_probs=168.9

Q ss_pred             ccccccCCcceeecc-----CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeee-eCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFLH-----SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCS-EGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~  183 (363)
                      ++.+++|.++.+...     ...||+|.+....  ...+.+.+|+.+++.++|+||+++++++. .++..++++||++++
T Consensus         3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~   82 (262)
T cd05058           3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHG   82 (262)
T ss_pred             ccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCC
Confidence            455666665544432     1239999885432  23467889999999999999999999765 456688999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++........
T Consensus        83 ~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          83 DLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999995332     346778889999999999999999   99999999999999999999999999998765432211


Q ss_pred             --cccccccccccccCCccc--------cCceehhHHHHHHhcCC-CCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 --VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR-KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 --~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                        .......++..|+|||.+        +|+||||+++|||++|. +|+......       + ....+..+...     
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~-~~~~~~~~~~~-----  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------D-ITVYLLQGRRL-----  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhcCCCC-----
Confidence              111233456789999987        89999999999999965 444332111       1 11122212111     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+...+..+.+++.+||+.+|++|||+.|
T Consensus       222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  251 (262)
T cd05058         222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSE  251 (262)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence             112234567999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-35  Score=289.34  Aligned_cols=236  Identities=21%  Similarity=0.260  Sum_probs=175.5

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++.....    ..++|.+|++++++++||||+++++++.+++..+++|||++|++
T Consensus         9 ~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGS   88 (932)
T PRK13184          9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT   88 (932)
T ss_pred             EEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCC
Confidence            3455555555554432  44599999864322    23578999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          185 LQKFIFSKTN-----SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       185 L~~~l~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |.+++.....     ......+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        89 L~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~  165 (932)
T PRK13184         89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL  165 (932)
T ss_pred             HHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence            9999864321     0112456778889999999999999999   9999999999999999999999999999987621


Q ss_pred             Ccc----------------ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHH
Q 039471          260 DIS----------------IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       260 ~~~----------------~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~  315 (363)
                      ...                ........||+.|+|||++        +|+|||||++|||++|+.||........      
T Consensus       166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki------  239 (932)
T PRK13184        166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI------  239 (932)
T ss_pred             ccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh------
Confidence            110                0011224589999999987        7999999999999999999975322110      


Q ss_pred             HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          316 WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                       ....     ..............++.+.+++.+||+.||++||+.
T Consensus       240 -~~~~-----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss  279 (932)
T PRK13184        240 -SYRD-----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS  279 (932)
T ss_pred             -hhhh-----hccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence             0000     000000011123456779999999999999999864

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-34  Score=255.90  Aligned_cols=232  Identities=25%  Similarity=0.404  Sum_probs=180.7

Q ss_pred             ccccccccCCcceeeccC------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHS------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++......      ..||+|++.....  ..+.+.+|+..+.+++|+||+++++++.+.+..+++|||++
T Consensus         5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~   84 (258)
T smart00219        5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME   84 (258)
T ss_pred             ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence            345566666666555443      4599999975543  45688999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++.....    ..+++..+..++.|++.||++||+   .+++|+||||+||++++++.++|+|||.+.......
T Consensus        85 ~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       85 GGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             CCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9999999954321    228999999999999999999999   999999999999999999999999999998776543


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .... ....++..|+|||.+        +|+||+|++++||++ |..|+.......        ....+..+..      
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~------  222 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--------VLEYLKKGYR------  222 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCC------
Confidence            2211 123367889999977        899999999999998 777776522111        2222222211      


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...+.++.+++.+|++.+|++|||++|
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~  253 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSE  253 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence            1222336778999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-34  Score=260.95  Aligned_cols=233  Identities=20%  Similarity=0.256  Sum_probs=175.2

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeC-----CceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG-----NRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~~  183 (363)
                      ++.+++|.++.+..  .++.+|+|.+.........+.+|+.+++++ +|+|++++++++...     ...++|+||++++
T Consensus        30 l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~  109 (291)
T cd06639          30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGG  109 (291)
T ss_pred             eecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCC
Confidence            34444544444333  234499999876554556788999999999 799999999998643     3689999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....  .....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus       110 sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  184 (291)
T cd06639         110 SVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR  184 (291)
T ss_pred             cHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc
Confidence            9999885432  123568999999999999999999999   99999999999999999999999999998865433211


Q ss_pred             cccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 VSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                        .....++..|+|||.+             +|+||||+++|||++|+.|+........       + ..+.....    
T Consensus       185 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-------~-~~~~~~~~----  250 (291)
T cd06639         185 --RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-------L-FKIPRNPP----  250 (291)
T ss_pred             --ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-------H-HHHhcCCC----
Confidence              1234578899999964             7999999999999999999865432111       1 11111111    


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ............+.+++.+||+.+|++|||+.|
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  283 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH  283 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence            011122345567999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-34  Score=257.91  Aligned_cols=234  Identities=19%  Similarity=0.291  Sum_probs=179.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  ++.||+|.++..    ....+++.+|++++++++|+|++++++.+.+++..+++|||+++++|
T Consensus        10 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   89 (267)
T cd08224          10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL   89 (267)
T ss_pred             eccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCH
Confidence            455555555555443  455999988532    22356889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....  .....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........  
T Consensus        90 ~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--  162 (267)
T cd08224          90 SRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--  162 (267)
T ss_pred             HHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--
Confidence            99986532  223568999999999999999999999   99999999999999999999999999998765443211  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||.+        +|+||||+++|+|++|+.|+.......     .+ ..+.+..+..     .+....
T Consensus       163 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~-----~~~~~~  231 (267)
T cd08224         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEKCDY-----PPLPAD  231 (267)
T ss_pred             cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HH-HHhhhhcCCC-----CCCChh
Confidence            1334578899999986        799999999999999999986543211     01 1111211111     111122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++|||+.|
T Consensus       232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~  257 (267)
T cd08224         232 HYSEELRDLVSRCINPDPEKRPDISY  257 (267)
T ss_pred             hcCHHHHHHHHHHcCCCcccCCCHHH
Confidence            56678999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-34  Score=259.91  Aligned_cols=230  Identities=24%  Similarity=0.268  Sum_probs=176.9

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.++.+...  ++.||+|.+...    ....+.+.+|++++++++|+||+++++.+...+..++||||+++++|.
T Consensus         2 g~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (277)
T cd05577           2 GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK   81 (277)
T ss_pred             CCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHH
Confidence            34555555544333  445999988642    223456778999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++.....    ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||.+.....+...   
T Consensus        82 ~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---  151 (277)
T cd05577          82 YHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---  151 (277)
T ss_pred             HHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---
Confidence            99964332    468999999999999999999999   99999999999999999999999999998766543221   


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||.+        +|+||||+++++|++|+.||.........    ..+.....       ......+..
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~-------~~~~~~~~~  220 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EELKRRTL-------EMAVEYPDK  220 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH----HHHHhccc-------cccccCCcc
Confidence            334578889999986        79999999999999999998664432111    01111110       111123344


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+.+++.+||+.+|++||+..|
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCc
Confidence            5778999999999999999996653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.1e-35  Score=259.46  Aligned_cols=231  Identities=25%  Similarity=0.264  Sum_probs=175.9

Q ss_pred             cccccccCCcceeeccC--CeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLHS--NEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+...+  ..||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++++||+++++|.+
T Consensus        15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (268)
T cd06624          15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA   94 (268)
T ss_pred             EEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHH
Confidence            34555666655554333  339999886443 234678999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccCCcccc
Q 039471          188 FIFSKTNSSSHRQL--SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       188 ~l~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ++....     ..+  ++..+..++.|++.||+|||+   .+|+|+||||+||+++. ++.++|+|||.+......... 
T Consensus        95 ~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-  165 (268)
T cd06624          95 LLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-  165 (268)
T ss_pred             HHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-
Confidence            996432     234  788899999999999999999   99999999999999986 678999999998766433221 


Q ss_pred             ccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 SRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       .....++..|+|||.+          +|+||||+++|+|++|+.|+.........      .....      .......
T Consensus       166 -~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~------~~~~~~~  232 (268)
T cd06624         166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVG------MFKIHPE  232 (268)
T ss_pred             -cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------Hhhhh------hhccCCC
Confidence             1234578899999975          79999999999999999998653221110      00000      0011122


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+.++.+++.+||+.+|.+|||++|
T Consensus       233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  261 (268)
T cd06624         233 IPESLSAEAKNFILRCFEPDPDKRASAHD  261 (268)
T ss_pred             CCcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence            33456678999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.4e-35  Score=262.49  Aligned_cols=226  Identities=19%  Similarity=0.284  Sum_probs=175.1

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+...  +..||+|.+....  ...+.+.+|+.++++++|+||+++++++..++..++||||+++++|.+
T Consensus        12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   91 (277)
T cd06642          12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD   91 (277)
T ss_pred             hcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHH
Confidence            344445544444332  3349999886432  233578899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++..       ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........  ...
T Consensus        92 ~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06642          92 LLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             Hhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence            8832       458899999999999999999999   9999999999999999999999999999877654322  113


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||.+        +|+||||+++|||++|+.|+.......        ....+...      .........
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~------~~~~~~~~~  225 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKN------SPPTLEGQY  225 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcC------CCCCCCccc
Confidence            34578899999987        899999999999999999986433211        11111111      111223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++||||.|
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~  249 (277)
T cd06642         226 SKPFKEFVEACLNKDPRFRPTAKE  249 (277)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHH
Confidence            677999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-34  Score=256.59  Aligned_cols=203  Identities=21%  Similarity=0.350  Sum_probs=159.9

Q ss_pred             eEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHH
Q 039471          130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKI  209 (363)
Q Consensus       130 vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i  209 (363)
                      |++|.+.........|.+|+.++++++|+||+++++++.. ...++||||+++++|.+++....     ..+++..+..+
T Consensus        33 v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~  106 (259)
T cd05037          33 VVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREK-----NNVSLHWKLDV  106 (259)
T ss_pred             eeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhc-----cCCCHHHHHHH
Confidence            7888876554446789999999999999999999999888 77899999999999999995432     26899999999


Q ss_pred             HHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-------CeeEeccccceeccCCccccccccccccccccCCccc-
Q 039471          210 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-------QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-  281 (363)
Q Consensus       210 ~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-  281 (363)
                      +.||+.||+|||+   .+++|+||||+||+++.++       .+||+|||++......      ....++..|+|||++ 
T Consensus       107 ~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~  177 (259)
T cd05037         107 AKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIR  177 (259)
T ss_pred             HHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhc
Confidence            9999999999999   9999999999999999887       7999999998865431      223466789999985 


Q ss_pred             ---------cCceehhHHHHHHhcC-CCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhc
Q 039471          282 ---------SRNFCYGMMLLEMVGC-RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI  351 (363)
Q Consensus       282 ---------~Di~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (363)
                               +|+||||+++|||++| ..|+........        ..........    ...    ....+.+++.+||
T Consensus       178 ~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--------~~~~~~~~~~----~~~----~~~~~~~li~~~l  241 (259)
T cd05037         178 NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--------ERFYQDQHRL----PMP----DCAELANLINQCW  241 (259)
T ss_pred             CCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--------HHHHhcCCCC----CCC----CchHHHHHHHHHh
Confidence                     8999999999999984 666654321110        0011101000    001    1167899999999


Q ss_pred             cCCCCCCCCCCC
Q 039471          352 QWNPTERPSMPM  363 (363)
Q Consensus       352 ~~~p~~RPs~~e  363 (363)
                      +.+|.+|||+.|
T Consensus       242 ~~~p~~Rpt~~~  253 (259)
T cd05037         242 TYDPTKRPSFRA  253 (259)
T ss_pred             ccChhhCCCHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.1e-35  Score=282.33  Aligned_cols=181  Identities=19%  Similarity=0.310  Sum_probs=140.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCC------CceeeeeeeeeeC-CceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHH------FHIVRLLGFCSEG-NRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~-~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+...  +..||||+++......+++..|+.+++.++|      .+++++++++... .+.++|||++ 
T Consensus       136 ~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-  214 (467)
T PTZ00284        136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-  214 (467)
T ss_pred             EEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-
Confidence            3455555555444332  3349999997554445566778887777754      4588999988654 5789999988 


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----------------C
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----------------Q  245 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----------------~  245 (363)
                      +++|.+++..      ...+++..+..++.||+.||+|||+  +.+|+||||||+|||++.++                .
T Consensus       215 g~~l~~~l~~------~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        215 GPCLLDWIMK------HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             CCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            6789988843      2568999999999999999999997  14999999999999998765                4


Q ss_pred             eeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcch
Q 039471          246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       246 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                      +||+|||.+......     .....||..|+|||++        +|||||||++|||++|+.||....
T Consensus       287 vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        287 VRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             EEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999987643221     1345689999999997        799999999999999999997644

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-35  Score=262.49  Aligned_cols=221  Identities=23%  Similarity=0.427  Sum_probs=166.2

Q ss_pred             CeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCH
Q 039471          128 NEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW  203 (363)
Q Consensus       128 ~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~  203 (363)
                      ..||+|.+....  ...+.+.+|+.++++++|+||+++++++...  ...+++|||+++++|.+++....     ..+++
T Consensus        34 ~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~  108 (284)
T cd05079          34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-----NKINL  108 (284)
T ss_pred             ceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-----CCCCH
Confidence            349999986432  2335789999999999999999999998765  56889999999999999984322     35899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc-ccccccccccccCCccc-
Q 039471          204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SRTAARGTSGYIAPELF-  281 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~-  281 (363)
                      ..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++......... ......++..|+|||.+ 
T Consensus       109 ~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         109 KQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            9999999999999999999   999999999999999999999999999998765432211 11234467789999986 


Q ss_pred             -------cCceehhHHHHHHhcCCCCCCcchhcc--------cccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          282 -------SRNFCYGMMLLEMVGCRKNNDPAVEIQ--------SQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       282 -------~Di~slG~il~el~~g~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                             +|+||||+++|||++++.|........        ..... ......+..+.      ....+..++..+.++
T Consensus       186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~l  258 (284)
T cd05079         186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TRLVRVLEEGK------RLPRPPNCPEEVYQL  258 (284)
T ss_pred             cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HHHHHHHHcCc------cCCCCCCCCHHHHHH
Confidence                   899999999999999876643321110        00000 11111111111      111223456789999


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      +.+||+.+|++|||++|
T Consensus       259 i~~~l~~~p~~Rpt~~~  275 (284)
T cd05079         259 MRKCWEFQPSKRTTFQN  275 (284)
T ss_pred             HHHHccCCcccCcCHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.9e-35  Score=266.86  Aligned_cols=228  Identities=19%  Similarity=0.230  Sum_probs=172.1

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+....  +.||+|++...    ....+.+.+|..++..++|+||+++++++.+++..++||||+++|
T Consensus         7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg   86 (331)
T cd05624           7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG   86 (331)
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence            445666666665554433  34999998642    222345788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          87 DLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999995422     468999999999999999999999   99999999999999999999999999999876544322


Q ss_pred             cccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 VSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                       ......||..|+|||++             +|+||||+++|||++|+.||.......        .+..+..... ...
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~-~~~  228 (331)
T cd05624         159 -QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEE-RFQ  228 (331)
T ss_pred             -eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCC-ccc
Confidence             11335689999999964             699999999999999999997543211        1122211110 000


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPT  356 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~  356 (363)
                      . +......+..+.+++.+|+..+++
T Consensus       229 ~-p~~~~~~~~~~~~li~~ll~~~~~  253 (331)
T cd05624         229 F-PSHITDVSEEAKDLIQRLICSRER  253 (331)
T ss_pred             C-CCccccCCHHHHHHHHHHccCchh
Confidence            1 111223567889999999986543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.3e-35  Score=261.03  Aligned_cols=239  Identities=23%  Similarity=0.409  Sum_probs=178.5

Q ss_pred             ccccccccCCcceeecc------CCeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH------SNEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~------~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  179 (363)
                      ..++.+++|.++.+...      +..||||.+......  .+.|.+|++++++++|+||+++++++..  +...+++|||
T Consensus        10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   89 (284)
T cd05038          10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY   89 (284)
T ss_pred             eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence            33455566655554433      234999999765543  5689999999999999999999999877  5678999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.....
T Consensus        90 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          90 LPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             CCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            99999999995432     358999999999999999999999   9999999999999999999999999999987764


Q ss_pred             Cccccc-cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccc--------cchHHHHHHHhh
Q 039471          260 DISIVS-RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ--------IYFPEWIYNRMR  322 (363)
Q Consensus       260 ~~~~~~-~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~--------~~~~~~~~~~~~  322 (363)
                      ...... .....++..|+|||.+        +|+||||++++||++|..|+.........        ..... +...+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-LLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH-HHHHHH
Confidence            322211 1123345679999976        89999999999999999887654322111        00111 111111


Q ss_pred             hccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 LGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.      ....+...+.++.+++.+||+.+|++||||.|
T Consensus       241 ~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  275 (284)
T cd05038         241 EGE------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFAD  275 (284)
T ss_pred             cCC------cCCCCccCCHHHHHHHHHHhccChhhCCCHHH
Confidence            111      11122344577999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-34  Score=269.01  Aligned_cols=175  Identities=21%  Similarity=0.287  Sum_probs=141.6

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.++.+...+  +.||+|+....     ....|+.++++++|+||+++++++..+...++|+|++. ++|.+
T Consensus        72 ~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~  145 (357)
T PHA03209         72 KTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYT  145 (357)
T ss_pred             EEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHH
Confidence            344555555555444433  34999975422     34579999999999999999999999999999999995 58888


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++...     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......   ..
T Consensus       146 ~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~  214 (357)
T PHA03209        146 YLTKR-----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FL  214 (357)
T ss_pred             HHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc---cc
Confidence            88532     2568999999999999999999999   9999999999999999999999999999875432221   13


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCC
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNN  301 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~  301 (363)
                      ...||..|+|||++        +|+|||||++|||+++..++
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            34589999999987        89999999999999866554

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=247.23  Aligned_cols=229  Identities=20%  Similarity=0.283  Sum_probs=175.0

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCC--cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+.-|.+......+  .-+|||.+..+.  .+.++++..+.++.+-+ .|+||+.+|+|..+...++.||.|. ..++
T Consensus       100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~e  178 (391)
T KOG0983|consen  100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAE  178 (391)
T ss_pred             hcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHH
Confidence            3444444444444455  339999987443  34467788888877665 8999999999999999999999994 4677


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..-     .++++|..+.++...+.+||.||..  +++|+|||+||+|||+|+.|++|++|||++-.+-+....   
T Consensus       179 kLlkri-----k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---  248 (391)
T KOG0983|consen  179 KLLKRI-----KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---  248 (391)
T ss_pred             HHHHHh-----cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc---
Confidence            777433     2679999999999999999999988  589999999999999999999999999998776554332   


Q ss_pred             ccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          267 TAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      +...|.+.|||||.+           +||||||+.++||+||..||......-+       +...+...+...    ...
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------~ltkvln~ePP~----L~~  317 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------VLTKVLNEEPPL----LPG  317 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-------HHHHHHhcCCCC----CCc
Confidence            344588999999998           8999999999999999999987543221       112222111111    112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+++.+++++..||+.|+.+||...
T Consensus       318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~  344 (391)
T KOG0983|consen  318 HMGFSPDFQSFVKDCLTKDHRKRPKYN  344 (391)
T ss_pred             ccCcCHHHHHHHHHHhhcCcccCcchH
Confidence            223889999999999999999999753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.3e-36  Score=253.81  Aligned_cols=195  Identities=24%  Similarity=0.343  Sum_probs=163.7

Q ss_pred             CCcccccccccCCcceeecc---------CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeee-CCce
Q 039471          107 CPFQSLISFNLTNSKFFFLH---------SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GNRR  173 (363)
Q Consensus       107 c~~~~~~~~~~~~~~~~~~~---------~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  173 (363)
                      ..|+.++.+|.|+.+.|+..         ...+|||+++..+   +-.....+|+..++.++|+|++.+..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            34566677777777777654         2248999997543   334688899999999999999999999866 7889


Q ss_pred             eEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC----CCeeEe
Q 039471          174 TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN----FQPKIS  249 (363)
Q Consensus       174 ~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~----~~~kl~  249 (363)
                      ++++||.++ +|..+|+..+... .+.++...++.|+.||+.|+.|||+   +.|+|||+||.|||+..+    |.+||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~-~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASK-AKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccch-hccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence            999999987 8999997766543 3789999999999999999999999   999999999999999866    999999


Q ss_pred             ccccceeccCCcccc-ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          250 DFGLAKLCSKDISIV-SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      |||+++.+....... +....+.|.+|+|||++         .|+|+.|||+.||+|-.+.|.+...
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            999999987654332 44566789999999998         7999999999999999998876543

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.9e-35  Score=261.83  Aligned_cols=241  Identities=19%  Similarity=0.220  Sum_probs=174.4

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+...  ++.||+|++....   ...+.+.+|+.++++++|+|++++++++..+...++||||+++++|.
T Consensus         9 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   88 (286)
T cd07847           9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLN   88 (286)
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHH
Confidence            344445544444333  3459999886432   23356889999999999999999999999999999999999998888


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      .++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.........  .
T Consensus        89 ~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~  157 (286)
T cd07847          89 ELEKN------PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--Y  157 (286)
T ss_pred             HHHhC------CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc--c
Confidence            77632      2458999999999999999999999   99999999999999999999999999999876554321  1


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHH-------hhhccc----
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNR-------MRLGQE----  326 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----  326 (363)
                      ....++..|+|||.+         +|+||||+++|||++|+.||...................       ......    
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            233477889999975         799999999999999999997544322110000000000       000000    


Q ss_pred             cccccCC-----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEE-----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......     ......+..+.+++.+||+.+|++|||+.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  279 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE  279 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence            0000000     001234677999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-34  Score=258.69  Aligned_cols=229  Identities=21%  Similarity=0.343  Sum_probs=174.8

Q ss_pred             cccccccCCcceeeccCC-----eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHSN-----EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.+........     .||||......  ...+.+.+|+.++++++|+||+++++++.+ ...+++|||++++
T Consensus        13 ~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~   91 (270)
T cd05056          13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLG   91 (270)
T ss_pred             eeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCC
Confidence            345556665554443222     38999886443  234689999999999999999999998876 4578999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        92 ~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          92 ELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             cHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            9999995432     458999999999999999999999   99999999999999999999999999999876554222


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......++..|+|||.+        +|+||||++++|+++ |..||.......        ....+..+...      .
T Consensus       164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~------~  228 (270)
T cd05056         164 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGERL------P  228 (270)
T ss_pred             -ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCcC------C
Confidence             11223345689999987        799999999999885 999986554321        11122222111      1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...+..+.+++.+|+..+|.+|||+.|
T Consensus       229 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  257 (270)
T cd05056         229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTE  257 (270)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            22345678999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-34  Score=257.50  Aligned_cols=231  Identities=23%  Similarity=0.290  Sum_probs=175.6

Q ss_pred             ccccccCCcceeec-cCCeeEEEEcccCCc-------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFL-HSNEIAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ++.+++|.++.+.. .++.+|+|.+.....       ..+.+.+|+.++++++|+||+++++++.+....++++||++++
T Consensus         8 ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (265)
T cd06631           8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGG   87 (265)
T ss_pred             EeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCC
Confidence            44555555544433 334499998864321       1246888999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc-
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-  262 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-  262 (363)
                      +|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        88 ~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          88 SISSILNR------FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999943      2458899999999999999999999   9999999999999999999999999999876532111 


Q ss_pred             ---ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          263 ---IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       263 ---~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                         ........++..|+|||.+        +|+||||++++||++|..||........       .. .......    .
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~-~~~~~~~----~  226 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-------MF-YIGAHRG----L  226 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-------HH-HhhhccC----C
Confidence               0111234578899999987        8999999999999999999965322111       11 1111101    1


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+...+..+.+++++||+.+|++|||+.|
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  258 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ  258 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence            11223346678999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-35  Score=269.14  Aligned_cols=239  Identities=19%  Similarity=0.253  Sum_probs=169.4

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEE
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIY  177 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~  177 (363)
                      ...++.+++|.++.+...  +..||||++....   ...+.+.+|+.++++++|+||+++++++...      ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            344555555555444332  3349999986432   2335678999999999999999999987533      3578999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |++ +++|.+++.       ...+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++..
T Consensus       100 ~~~-~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878         100 NLM-GADLNNIVK-------CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ecC-CCCHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence            988 679988873       2458999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH-------HHHHHh
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE-------WIYNRM  321 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~-------~~~~~~  321 (363)
                      ....     ....||..|+|||++         +|+||||+++|||++|+.||.............+       .....+
T Consensus       169 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         169 DDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             CCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            4432     334589999999986         7999999999999999999865432111000000       000000


Q ss_pred             hhcc--ccccc---cCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQ--ELCLD---FEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~--~~~~~---~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....  .....   ....    ......+.+.+++.+||+.||++|||++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e  294 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE  294 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            0000  00000   0000    00122446789999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-34  Score=258.21  Aligned_cols=231  Identities=24%  Similarity=0.374  Sum_probs=175.4

Q ss_pred             ccccccccCCcceeeccC------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHS------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.+..+....      ..+|+|.......  ...++.+|+.++++++|+||+++++++.. ...++++||++
T Consensus        13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   91 (279)
T cd05057          13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP   91 (279)
T ss_pred             ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence            344555565554443221      1389998875432  33578899999999999999999999887 78899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.++......
T Consensus        92 ~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          92 LGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            999999995432     458999999999999999999999   999999999999999999999999999998776443


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........++..|+|||.+        +|+||||+++||+++ |+.||.......        +...+..+...     
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----  230 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGERL-----  230 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCCCC-----
Confidence            32222223345689999976        899999999999998 999987643211        22222222111     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+...+..+.+++.+||..+|.+|||+.+
T Consensus       231 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~  260 (279)
T cd05057         231 -PQPPICTIDVYMVLVKCWMIDAESRPTFKE  260 (279)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence             112234467889999999999999999853

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-34  Score=256.52  Aligned_cols=231  Identities=23%  Similarity=0.349  Sum_probs=175.7

Q ss_pred             cccccccCCcceeecc--C---CeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--S---NEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~---~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+...  +   ..+|+|.++...  ...+.+.+|+.++++++|+||+++++++..++..+++|||++++
T Consensus        11 ~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (267)
T cd05066          11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENG   90 (267)
T ss_pred             eecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCC
Confidence            3455566655544332  1   139999986433  23357899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        91 ~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          91 SLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            9999995432     468999999999999999999999   99999999999999999999999999999876543221


Q ss_pred             cc-cccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          264 VS-RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       264 ~~-~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. .....++..|+|||.+        +|+||||+++||+++ |..||.......        ....+..+..      .
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~------~  228 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR------L  228 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc------C
Confidence            11 1112235679999987        799999999999886 999986543211        1122221111      1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......+..+.+++.+|++.+|++||||.|
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (267)
T cd05066         229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQ  258 (267)
T ss_pred             CCCCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence            122345678899999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-34  Score=257.92  Aligned_cols=237  Identities=22%  Similarity=0.341  Sum_probs=176.2

Q ss_pred             ccccccccCCcceeecc-----CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCC------ceeE
Q 039471          110 QSLISFNLTNSKFFFLH-----SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN------RRTL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  175 (363)
                      ..++.+++|.++.+...     +..||||++....   ...+++.+|+.++++++|+||+++++++....      ..++
T Consensus         5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05074           5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV   84 (273)
T ss_pred             hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence            34566777766666543     2349999987432   23457889999999999999999999885432      2478


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ++||+++++|.+++...........+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||+++
T Consensus        85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccccc
Confidence            89999999999988544322223468999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ...............++..|++||.+        +|+||||+++|||++ |+.|+.......        +...+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~  233 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IYNYLIKGNR  233 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HHHHHHcCCc
Confidence            76543322122233356779999986        899999999999998 778876443211        1222221111


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .      ..+...+..+.+++.+||+.+|++|||++|
T Consensus       234 ~------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~  264 (273)
T cd05074         234 L------KQPPDCLEDVYELMCQCWSPEPKCRPSFQH  264 (273)
T ss_pred             C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            1      112234578999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-34  Score=258.54  Aligned_cols=240  Identities=24%  Similarity=0.385  Sum_probs=173.3

Q ss_pred             ccccccccCCcceeec------cCCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFL------HSNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+..      .+..||+|.+..... ..+.+.+|++++++++|+||+++++++..  ....++|+||+
T Consensus        10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   89 (284)
T cd05081          10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL   89 (284)
T ss_pred             eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence            4455666666555432      234599999875432 34578899999999999999999998743  34689999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          90 PYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             CCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999985332     458999999999999999999999   99999999999999999999999999999877544


Q ss_pred             ccccc-cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc-----cc---chHHHHHHHhhh
Q 039471          261 ISIVS-RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS-----QI---YFPEWIYNRMRL  323 (363)
Q Consensus       261 ~~~~~-~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~-----~~---~~~~~~~~~~~~  323 (363)
                      ..... .....++..|+|||.+        +|+||||++++||++|..++........     ..   .....+.+.+..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            32211 1122234569999987        7999999999999998766543221100     00   000011111111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..      ........+..+.+++.+||+.+|++||||+|
T Consensus       242 ~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  275 (284)
T cd05081         242 NG------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSE  275 (284)
T ss_pred             CC------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            11      11122345677999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=273.87  Aligned_cols=238  Identities=20%  Similarity=0.311  Sum_probs=191.2

Q ss_pred             CCCCCcccccccccCCcceeeccCCe-----eEEEEcc-cCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEE
Q 039471          104 ETACPFQSLISFNLTNSKFFFLHSNE-----IAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIY  177 (363)
Q Consensus       104 ~~~c~~~~~~~~~~~~~~~~~~~~~~-----vAvK~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  177 (363)
                      .....+..+|.+|-|..|.|+...+.     .|-|++. .+....++|+-|+++|..+.||+||++++.|...+.+|+..
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            34455667778888888777654332     5667775 34455678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |||.||.++.++-...     ..+.+.++.-++.|++.||.|||+   ++|||||+|..|||++.+|.++|+|||.+...
T Consensus       109 EFC~GGAVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn  180 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKN  180 (1187)
T ss_pred             eecCCchHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccc
Confidence            9999999999885443     789999999999999999999999   99999999999999999999999999987654


Q ss_pred             cCCccccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ...  ...+....||+.|||||+.             +||||||++|.||+-+.+|-..-....        +.-++.+.
T Consensus       181 ~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--------VllKiaKS  250 (1187)
T KOG0579|consen  181 KST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKS  250 (1187)
T ss_pred             hhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--------HHHHHhhc
Confidence            332  2234678899999999998             899999999999999998864433222        11122211


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .    ....-.+..++..+.+++.+||..||..||+++|
T Consensus       251 e----PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq  285 (1187)
T KOG0579|consen  251 E----PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQ  285 (1187)
T ss_pred             C----CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHH
Confidence            1    1122367788999999999999999999999764

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.7e-35  Score=261.13  Aligned_cols=241  Identities=19%  Similarity=0.252  Sum_probs=172.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+...  +..||+|.+....   .....+.+|+.++++++|+||+++++++.+....++++||++ ++|.
T Consensus         8 l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~   86 (284)
T cd07839           8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLK   86 (284)
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHH
Confidence            444555555444432  3459999986432   223567889999999999999999999999999999999997 5888


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..++.++.||++||.|||+   .+++|+||||+||+++.++.+||+|||+++........  .
T Consensus        87 ~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~  156 (284)
T cd07839          87 KYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--Y  156 (284)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--c
Confidence            8875332     458999999999999999999999   99999999999999999999999999998865433221  1


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHHHHHhhhcccc--
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWIYNRMRLGQEL--  327 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~--  327 (363)
                      ....++..|+|||.+         +|+||||+++|||++|..|+............        ....+..+......  
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            334578899999976         79999999999999999886543322110000        00000000000000  


Q ss_pred             ccccC-----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFE-----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....     .......++++.+++.+||+.||.+|||++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~  277 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE  277 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence            00000     0011235678899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-34  Score=268.13  Aligned_cols=220  Identities=29%  Similarity=0.454  Sum_probs=164.8

Q ss_pred             CeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeee-CCceeEEEeccCCCCHHHHhhhcCCCC-------
Q 039471          128 NEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSLQKFIFSKTNSS-------  196 (363)
Q Consensus       128 ~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~-------  196 (363)
                      +.||||+++....  ....+.+|+.++.++ +|+||+++++++.. +...+++|||+++|+|.+++.......       
T Consensus        38 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~  117 (343)
T cd05103          38 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKD  117 (343)
T ss_pred             eeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccc
Confidence            3499999975332  235688999999999 68999999998865 456789999999999999986532100       


Q ss_pred             ------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 039471          197 ------------------------------------------------------SHRQLSWEKLRKIAFGVARGVEYLHQ  222 (363)
Q Consensus       197 ------------------------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~  222 (363)
                                                                            ....+++..+..++.|++.||+|||+
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  197 (343)
T cd05103         118 ARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS  197 (343)
T ss_pred             cccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh
Confidence                                                                  01347888899999999999999999


Q ss_pred             CCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHH
Q 039471          223 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM  294 (363)
Q Consensus       223 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el  294 (363)
                         .+|+||||||+||+++.++.+||+|||++................++..|+|||.+        +|+||||+++|||
T Consensus       198 ---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  274 (343)
T cd05103         198 ---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI  274 (343)
T ss_pred             ---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHH
Confidence               99999999999999999999999999999876443322222334456789999986        7999999999999


Q ss_pred             hc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          295 VG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       295 ~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++ |..|+.......       .....+..+...      ..+...++++.+++.+||+.+|++|||+.|
T Consensus       275 ~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~e  331 (343)
T cd05103         275 FSLGASPYPGVKIDE-------EFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  331 (343)
T ss_pred             HHCCCCCCCCccccH-------HHHHHHhccCCC------CCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            96 888875432111       111222212111      111223567899999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.8e-34  Score=255.10  Aligned_cols=226  Identities=23%  Similarity=0.281  Sum_probs=177.4

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.+..+...  +..||+|++....    ...+.+.+|+.++++++|+||+++++.+.++...++++||+++++|.
T Consensus         2 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (262)
T cd05572           2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW   81 (262)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHH
Confidence            44556665555554  4559999986432    23357889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..      ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+........   .
T Consensus        82 ~~l~~------~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~  149 (262)
T cd05572          82 TILRD------RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---T  149 (262)
T ss_pred             HHHhh------cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---c
Confidence            99943      2458999999999999999999999   9999999999999999999999999999987754321   1


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|++||.+        +|+||+|+++|||++|..|+.......     .+ .......+.     .....+..
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~-----~~~~~~~~  218 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----ME-IYNDILKGN-----GKLEFPNY  218 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HH-HHHHHhccC-----CCCCCCcc
Confidence            234578899999987        799999999999999999997654311     11 111111111     11122223


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+..+.+++.+||+.+|++|||+
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCC
Confidence            36789999999999999999994

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=258.12  Aligned_cols=227  Identities=20%  Similarity=0.287  Sum_probs=177.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.++++.++.+...  ++.||+|++....  .....+.+|+.++++++|+||+++++++.++...++|+||+++++|.
T Consensus         8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (274)
T cd06609           8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL   87 (274)
T ss_pred             hhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence            3445555555444432  3449999986432  23457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..       ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.......  ..
T Consensus        88 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~  155 (274)
T cd06609          88 DLLKP-------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KR  155 (274)
T ss_pred             HHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--cc
Confidence            99842       268999999999999999999999   9999999999999999999999999999988764421  12


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||.+        +|+||||+++|||++|+.||.......        ....+....      .......
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~  221 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNN------PPSLEGN  221 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhcC------CCCCccc
Confidence            344578889999987        899999999999999999986543211        111111111      1111111


Q ss_pred             -HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 -IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 -~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ++..+.+++.+||+.+|++|||++|
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~  247 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKE  247 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHH
Confidence             6678999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-34  Score=256.14  Aligned_cols=230  Identities=20%  Similarity=0.286  Sum_probs=178.1

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.+.++..  .+..||+|.+...   ....+++.+|+.++++++|+||+++++++.+.+..++|+||+++++|
T Consensus         7 ~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (256)
T cd08218           7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL   86 (256)
T ss_pred             EeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcH
Confidence            344455554444333  2345999988643   22345789999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....    ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        87 ~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--  157 (256)
T cd08218          87 YKKINAQR----GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--  157 (256)
T ss_pred             HHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--
Confidence            99985432    2457899999999999999999999   99999999999999999999999999999876543221  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....|+..|+|||.+        +|+||||+++++|++|+.|+......       + .......+..      ...+.
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~------~~~~~  223 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------N-LVLKIIRGSY------PPVSS  223 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------H-HHHHHhcCCC------CCCcc
Confidence            1234578889999986        79999999999999999998653221       1 1111111111      12234


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.++.+++.+||+.+|.+||+++|
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNS  249 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHH
Confidence            55778999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-34  Score=257.04  Aligned_cols=234  Identities=23%  Similarity=0.323  Sum_probs=175.7

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc-----------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEe
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG-----------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      ++.+++|.++.+..  .++.||+|.+.....           ..+.+.+|+.++++++|+|++++++++......++|||
T Consensus         9 lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   88 (272)
T cd06629           9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLE   88 (272)
T ss_pred             ecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEe
Confidence            44555555544433  244599998753211           11357789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+++++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+++...
T Consensus        89 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          89 YVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             cCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            99999999999432      468999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ............++..|+|||.+          +|+||||++++|+++|..|+........       ..+...  ....
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~--~~~~  230 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-------MFKLGN--KRSA  230 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-------HHHhhc--cccC
Confidence            33222112334578899999965          6999999999999999999864322111       111111  1111


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..........++..+.+++.+||+.+|++|||++|
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  265 (272)
T cd06629         231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE  265 (272)
T ss_pred             CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            11122223346788999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.5e-35  Score=264.49  Aligned_cols=231  Identities=23%  Similarity=0.341  Sum_probs=177.5

Q ss_pred             cccccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          109 FQSLISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      +..++.+++|.+..+..  .+..||||.+.... ...+.+.+|+..+++++|+||+++++.+..++..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            44555666655554433  34459999986433 2345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..       ..+++..+..++.||+.||+|||+   .+++|+||||+||++++++.++|+|||++........  .
T Consensus       107 ~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         107 TDIVTH-------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            998832       358899999999999999999999   9999999999999999999999999999876543322  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||.+        +|+||||+++|||++|+.||.......        ....+....    ........
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~----~~~~~~~~  242 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNL----PPRVKDSH  242 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcC----CCcccccc
Confidence            1334578899999987        899999999999999999986533211        111111100    00111222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+|++.+|++|||++|
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~  268 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQE  268 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHH
Confidence            45667899999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=296.85  Aligned_cols=233  Identities=22%  Similarity=0.268  Sum_probs=186.3

Q ss_pred             CcccccccccCCcceeecc-----CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          108 PFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .+++-..+|.|..|.++..     ++..|+|-++-.   .+....+.+|..++..++|||+|++||+-......+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            3344444555555555543     223899977532   23345778999999999999999999998888899999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |++|+|.+.+...      +..++.....+..|++.|+.|||+   .|||||||||.||+++.+|.+|++|||.|..+..
T Consensus      1316 C~~GsLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             hccCcHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999433      457778888899999999999999   9999999999999999999999999999998876


Q ss_pred             Ccccc--ccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          260 DISIV--SRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       260 ~~~~~--~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .....  ......||+-|||||++           .||||+|||+.||+||++||...+.+..       +..++..|. 
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-------IMy~V~~gh- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-------IMYHVAAGH- 1458 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-------HHhHHhccC-
Confidence            53221  12456799999999999           7999999999999999999987765543       222333333 


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                           .+..+..++.+-.+++..||+.||++|+++.
T Consensus      1459 -----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1459 -----KPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred             -----CCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence                 2345666899999999999999999999874

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-34  Score=261.00  Aligned_cols=229  Identities=24%  Similarity=0.325  Sum_probs=176.5

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+..  .+..||+|.+... ....+.+.+|+.+++.++|+||+++++.+..++..++++||+++++|.+
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  107 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD  107 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence            345555555544433  3455999998643 2334678899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++..       ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.....+...  ..
T Consensus       108 ~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~  175 (297)
T cd06659         108 IVSQ-------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RK  175 (297)
T ss_pred             HHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--cc
Confidence            8732       458999999999999999999999   99999999999999999999999999998765443221  13


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||.+        +|+||||++++||++|+.||........        ...+.....    .........
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~----~~~~~~~~~  243 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--------MKRLRDSPP----PKLKNAHKI  243 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHhccCC----CCccccCCC
Confidence            34588999999987        7999999999999999999875432111        111111110    011122234


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++|||++|
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~  267 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQE  267 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHH
Confidence            567899999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-34  Score=255.60  Aligned_cols=228  Identities=21%  Similarity=0.316  Sum_probs=175.3

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+..  .+..+|+|.+....   ...+.+.+|++++++++|+|++++++.+..++..++||||+++++|.
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd08220           8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA   87 (256)
T ss_pred             ecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHH
Confidence            34444444433332  34449999986432   23467889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceeccCCccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      +++....    ...+++..+..++.|++.||+|||+   ++++|+||||+||+++.+ +.+||+|||.+.........  
T Consensus        88 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--  158 (256)
T cd08220          88 EYIQKRC----NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA--  158 (256)
T ss_pred             HHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc--
Confidence            9996433    2458999999999999999999999   999999999999999855 45799999999877544321  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                       ....++..|+|||.+        +|+||||+++|+|++|+.|+......       .... ....+.      ....+.
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~-~~~~~~------~~~~~~  223 (256)
T cd08220         159 -YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVL-KIMSGT------FAPISD  223 (256)
T ss_pred             -cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHH-HHHhcC------CCCCCC
Confidence             234578899999987        89999999999999999998654321       1111 111111      111233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++|||++|
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~  249 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQ  249 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHH
Confidence            46778999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.8e-35  Score=263.34  Aligned_cols=242  Identities=21%  Similarity=0.271  Sum_probs=176.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+...  ++.||+|.+.....   ..+.+.+|++++++++|+||+++++++..+...++|+||+++++|
T Consensus         8 ~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   87 (286)
T cd07846           8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL   87 (286)
T ss_pred             eeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHH
Confidence            3455555555554443  34599998864322   345788999999999999999999999999999999999999988


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..+...      ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........  
T Consensus        88 ~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--  156 (286)
T cd07846          88 DDLEKY------PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--  156 (286)
T ss_pred             HHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc--
Confidence            887632      2358999999999999999999999   99999999999999999999999999998876543321  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHH-------HHhhhcc----
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY-------NRMRLGQ----  325 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~----  325 (363)
                      .....++..|+|||.+         +|+||||+++|||++|++||..............+..       .......    
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            1334578899999975         8999999999999999988865432211100100000       0000000    


Q ss_pred             ccccccCC-----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEE-----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ........     .....++..+.+++.+||+.+|++|||++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  279 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ  279 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence            00000000     011244678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-34  Score=261.29  Aligned_cols=231  Identities=24%  Similarity=0.390  Sum_probs=172.7

Q ss_pred             ccccccccCCcceeecc--CC----eeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SN----EIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~----~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+...  +.    .||+|.+......  ..++.+|+.++++++|+||+++++++... ..++++||++
T Consensus        13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~   91 (303)
T cd05110          13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP   91 (303)
T ss_pred             cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence            34555666655544332  22    2789988644322  24788999999999999999999998754 4678999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|+|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        92 ~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          92 HGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             CCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            999999985432     458899999999999999999999   999999999999999999999999999998765443


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........++..|+|||.+        +|+||||+++|||++ |..||.......        ..+.+..+...     
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-----  230 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERL-----  230 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCCC-----
Confidence            32222334457789999987        799999999999997 888886542211        11112211111     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+...+..+.+++.+||..+|++|||++|
T Consensus       231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~  260 (303)
T cd05110         231 -PQPPICTIDVYMVMVKCWMIDADSRPKFKE  260 (303)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence             112234567899999999999999999864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.6e-34  Score=260.26  Aligned_cols=230  Identities=19%  Similarity=0.244  Sum_probs=172.5

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.++++.++.....  +..||+|.+....    ...+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus         9 l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L   88 (305)
T cd05609           9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC   88 (305)
T ss_pred             eecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcH
Confidence            344455544433332  3449999886432    2335788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc---
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS---  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---  262 (363)
                      .+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......   
T Consensus        89 ~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          89 ATLLKNI------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999432      468999999999999999999999   9999999999999999999999999999874211100   


Q ss_pred             ----------ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          263 ----------IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       263 ----------~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                                ........++..|+|||.+        +|+||||+++|||++|..||......       + +......+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------~-~~~~~~~~  231 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------E-LFGQVISD  231 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhc
Confidence                      0001123467889999987        89999999999999999998643221       1 12221111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ....    .......+..+.+++.+||+.+|++|||+.
T Consensus       232 ~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         232 DIEW----PEGDEALPADAQDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             ccCC----CCccccCCHHHHHHHHHHhccChhhccCcc
Confidence            1110    111224667799999999999999999853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-34  Score=255.02  Aligned_cols=228  Identities=24%  Similarity=0.315  Sum_probs=178.1

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+...  ++.|++|.+....      ...+.+.+|+.++++++|+||+++++++.++...++++||+++
T Consensus         7 ~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (258)
T cd06632           7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG   86 (258)
T ss_pred             eeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCC
Confidence            3455566655554443  4559999886432      1335788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+........
T Consensus        87 ~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          87 GSLAKLLKK------YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             CcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence            999999943      2458899999999999999999999   9999999999999999999999999999887654331


Q ss_pred             ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                         .....++..|+|||.+         +|+||||+++|+|++|+.||.......       .... ......     ..
T Consensus       158 ---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-------~~~~-~~~~~~-----~~  221 (258)
T cd06632         158 ---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-------AVFK-IGRSKE-----LP  221 (258)
T ss_pred             ---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-------HHHH-HHhccc-----CC
Confidence               1344578889999965         799999999999999999986643211       1111 111000     11


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...++.+.+++.+||+.+|.+|||++|
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  251 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAE  251 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence            223345678999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-34  Score=255.70  Aligned_cols=234  Identities=21%  Similarity=0.290  Sum_probs=177.2

Q ss_pred             ccccccccCCcceeeccC---CeeEEEEcccCC-----------cChhHHHHHHHHHhc-cCCCceeeeeeeeeeCCcee
Q 039471          110 QSLISFNLTNSKFFFLHS---NEIAVKMLEHLK-----------GNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRT  174 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~---~~vAvK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~  174 (363)
                      ..++.+++|.++.+....   +.+|+|.+....           ....++.+|+.++.+ ++|+||+++++++.+++..+
T Consensus         6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   85 (269)
T cd08528           6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY   85 (269)
T ss_pred             hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence            345566666666655543   449999875221           122457788888875 78999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       175 lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      ++|||+++++|.+++.....  ....+++..++.++.|++.||.|||+  ..+++|+||+|+||++++++.+||+|||.+
T Consensus        86 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          86 IVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence            99999999999998854321  23568999999999999999999995  267999999999999999999999999999


Q ss_pred             eeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          255 KLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       255 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ........   .....++..|+|||.+        +|+||||+++|||++|+.|+.......        ....+..+..
T Consensus       162 ~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--------~~~~~~~~~~  230 (269)
T cd08528         162 KQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--------LATKIVEAVY  230 (269)
T ss_pred             eecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------HHHHHhhccC
Confidence            87655431   2345588899999987        799999999999999999986543221        1111111111


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .     +......+..+.+++.+||+.||++|||+.|
T Consensus       231 ~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e  262 (269)
T cd08528         231 E-----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQ  262 (269)
T ss_pred             C-----cCCcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence            0     1112235678999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-34  Score=255.96  Aligned_cols=229  Identities=22%  Similarity=0.266  Sum_probs=169.8

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC------cChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  181 (363)
                      ++.+++|.++.+..  .+..||+|++....      ...+.+.+|+.++++++|+||+++++++.+  +...++++||++
T Consensus        10 lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~   89 (266)
T cd06651          10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMP   89 (266)
T ss_pred             ecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCC
Confidence            44455554444433  23459999886322      122467889999999999999999998865  357889999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++...      ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          90 GGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            99999999432      458899999999999999999999   999999999999999999999999999987654321


Q ss_pred             cc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .. .......++..|+|||.+        +|+||||+++|||++|+.||.......       .+.....      ....
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-------~~~~~~~------~~~~  227 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-------AIFKIAT------QPTN  227 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-------HHHHHhc------CCCC
Confidence            11 111234478899999987        799999999999999999987542211       1111111      0111


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...++.+.+++ +||..+|++||||+|
T Consensus       228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e  257 (266)
T cd06651         228 PQLPSHISEHARDFL-GCIFVEARHRPSAEE  257 (266)
T ss_pred             CCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence            223445566777777 688899999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.2e-34  Score=259.40  Aligned_cols=226  Identities=22%  Similarity=0.293  Sum_probs=173.4

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+..  .++.||+|.+....    ...+++.+|++++++++|+||+++++++.++...++|+||++ |
T Consensus        21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g   99 (307)
T cd06607          21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G   99 (307)
T ss_pred             eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence            3345555555544443  24459999886332    223568899999999999999999999999999999999997 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......   
T Consensus       100 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607         100 SASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             CHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            7877774322     458999999999999999999999   99999999999999999999999999998765433   


Q ss_pred             cccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                         ....++..|+|||++           +|+||||+++|||++|..|+........       .+. +....     ..
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-------~~~-~~~~~-----~~  232 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYH-IAQND-----SP  232 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-------HHH-HhcCC-----CC
Confidence               223478889999975           7999999999999999999865432211       111 11110     01


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......++..+.+++.+||+.+|++|||+++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  263 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEE  263 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHH
Confidence            1123346778999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.2e-34  Score=252.48  Aligned_cols=238  Identities=20%  Similarity=0.280  Sum_probs=180.6

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.+..  .+..+|+|++....  ...+.+.+|+++++.++|+||+++++.+..+...++++|++++++|.
T Consensus         8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~   87 (267)
T cd06610           8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL   87 (267)
T ss_pred             eecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHH
Confidence            345555555554443  23449999986432  24467899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc--
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV--  264 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  264 (363)
                      +++.....   ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..........  
T Consensus        88 ~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  161 (267)
T cd06610          88 DIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK  161 (267)
T ss_pred             HHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence            99964321   2468999999999999999999999   999999999999999999999999999987765433221  


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ......++..|+|||.+         +|+||||++++||++|+.||.......        ............. .....
T Consensus       162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-~~~~~  232 (267)
T cd06610         162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQNDPPSL-ETGAD  232 (267)
T ss_pred             ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCCCCCc-CCccc
Confidence            12334578899999986         799999999999999999986543221        1111111111000 00111


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+++.+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEE  260 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHH
Confidence            2356788999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-34  Score=258.95  Aligned_cols=242  Identities=21%  Similarity=0.268  Sum_probs=173.5

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+...  +..||||.+....   .....+.+|++++++++|+||+++++++.++...+++|||+. ++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~   86 (284)
T cd07860           8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK   86 (284)
T ss_pred             ecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHH
Confidence            344445544444332  3449999886432   233578899999999999999999999999999999999996 5899


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.........  .
T Consensus        87 ~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~  157 (284)
T cd07860          87 KFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--Y  157 (284)
T ss_pred             HHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--c
Confidence            9885432    2568999999999999999999999   99999999999999999999999999998765433211  1


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHH---hhhcccc
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNR---MRLGQEL  327 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~~~  327 (363)
                      ....++..|+|||.+         +|+||||+++|||+||+.||.............++       .+..   +......
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            233467889999965         79999999999999999998654332211000000       0000   0000000


Q ss_pred             ccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......    ......+..+.+++.+||+.||++|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  277 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA  277 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence            000000    011234567889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-34  Score=257.40  Aligned_cols=238  Identities=20%  Similarity=0.260  Sum_probs=176.0

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.+..+..  .++.||+|++....   ...+.+.+|+.++++++|+||+++++++..+...++|+||+ +++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~   86 (286)
T cd07832           8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLS   86 (286)
T ss_pred             cccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHH
Confidence            34444554444433  24459999987433   23467899999999999999999999999999999999999 99999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+......... ..
T Consensus        87 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~  157 (286)
T cd07832          87 EVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LY  157 (286)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-cc
Confidence            9985432     569999999999999999999999   99999999999999999999999999998876544321 11


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc-------------
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG-------------  324 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------  324 (363)
                      ....++..|+|||.+         +|+||+|++++||++|.+++.........    .+....+...             
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL----AIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH----HHHHHHcCCCChHHHhhccCcch
Confidence            334688899999986         89999999999999998777654322110    0010000000             


Q ss_pred             -cccccccCC-----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 -QELCLDFEE-----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 -~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .........     ....+.+..+.+++.+||+.+|++|||++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  278 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE  278 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence             000000000     011234578999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-34  Score=259.09  Aligned_cols=222  Identities=25%  Similarity=0.300  Sum_probs=176.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||+|++....    ...+.+.+|++++++++|+||+++++++.++...++||||++++
T Consensus         7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   86 (290)
T cd05580           7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG   86 (290)
T ss_pred             EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence            34455566655544443  3459999986432    33467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.......  
T Consensus        87 ~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--  155 (290)
T cd05580          87 ELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--  155 (290)
T ss_pred             CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence            999999432      568999999999999999999999   999999999999999999999999999988765441  


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....++..|+|||.+        +|+||||+++|+|++|+.||......        .....+..+.       ...
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~-------~~~  217 (290)
T cd05580         156 ---YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKILEGK-------VRF  217 (290)
T ss_pred             ---CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC-------ccC
Confidence               334578899999987        79999999999999999998754421        1222222111       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      +...+..+.+++.+||+.+|.+||+
T Consensus       218 ~~~~~~~l~~li~~~l~~~p~~R~~  242 (290)
T cd05580         218 PSFFSPDAKDLIRNLLQVDLTKRLG  242 (290)
T ss_pred             CccCCHHHHHHHHHHccCCHHHccC
Confidence            2334678999999999999999993

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=249.75  Aligned_cols=239  Identities=21%  Similarity=0.282  Sum_probs=185.3

Q ss_pred             ccccccCCccee--eccCCeeEEEEcccCCcC-hhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFF--FLHSNEIAVKMLEHLKGN-GQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~--~~~~~~vAvK~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+.++.+...  ...+.++|||++.+..+. +.+..+|++++.+.+ |+||++++++|+++..+|||||-|.||+|..
T Consensus        86 LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLs  165 (463)
T KOG0607|consen   86 LGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLS  165 (463)
T ss_pred             hcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHH
Confidence            344444444332  234556999999876554 468889999999996 9999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEeccccceeccCCcc--
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCSKDIS--  262 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~--  262 (363)
                      +|.      +++.|++.+..++.++|+.||+|||.   ++|.|||+||+|||-.+..   -+||+||.+......+..  
T Consensus       166 hI~------~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  166 HIQ------KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHH------HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            994      44679999999999999999999999   9999999999999987543   379999998765433221  


Q ss_pred             ---ccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccc-------hHHHHHH
Q 039471          263 ---IVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY-------FPEWIYN  319 (363)
Q Consensus       263 ---~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~-------~~~~~~~  319 (363)
                         .....+..|+..|||||+.             .|.||||||+|-|+.|.+||.+.........       ..+.+.+
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence               2223456788999999988             7999999999999999999987554332211       1111222


Q ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+   ++....+..+....++.+..+++...+..++.+|-++.
T Consensus       317 sI---QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~  356 (463)
T KOG0607|consen  317 SI---QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAA  356 (463)
T ss_pred             HH---hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhh
Confidence            22   23334455667788999999999999999999998764

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-34  Score=260.64  Aligned_cols=241  Identities=22%  Similarity=0.209  Sum_probs=173.9

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcC------hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGN------GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ++.++++.++.+...  +..||||.+......      ...+.+|++++++++|+||+++++++.+++..++||||+ ++
T Consensus         8 lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   86 (298)
T cd07841           8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ET   86 (298)
T ss_pred             eeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CC
Confidence            445555555554433  345999999754322      346778999999999999999999999999999999999 88


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.||++||.|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        87 ~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          87 DLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             CHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            9999994321     369999999999999999999999   99999999999999999999999999999876543221


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHHHHHhhhccc
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWIYNRMRLGQE  326 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  326 (363)
                        .....++..|+|||.+         +|+||||++++||++|.++|............        ..+..........
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         159 --MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             --ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence              1233467789999975         89999999999999998777543321110000        0000000000000


Q ss_pred             cccc-----cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLD-----FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....     .........+..+.+++.+||+++|++|||++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e  278 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ  278 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence            0000     000111234678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.1e-34  Score=256.76  Aligned_cols=231  Identities=23%  Similarity=0.332  Sum_probs=177.0

Q ss_pred             cccccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          109 FQSLISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      +..++.+++|.+.....  .+..+++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            34455555555444432  23449999886433 2345688999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..       ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||.+........  .
T Consensus       104 ~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         104 TDIVTH-------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             HHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999842       458899999999999999999999   9999999999999999999999999998876544322  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....|+..|+|||.+        +|+||||++++||++|+.||.......        ....+.....    .......
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--------~~~~~~~~~~----~~~~~~~  239 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--------AMKRIRDNLP----PKLKNLH  239 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--------HHHHHHhcCC----CCCcccc
Confidence            1334588899999987        799999999999999999986532211        1112221111    0111122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++|||++|
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~  265 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAE  265 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHH
Confidence            35678999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3e-34  Score=256.76  Aligned_cols=218  Identities=25%  Similarity=0.382  Sum_probs=167.9

Q ss_pred             eeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCC---CCCCCCH
Q 039471          129 EIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS---SHRQLSW  203 (363)
Q Consensus       129 ~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~---~~~~l~~  203 (363)
                      .||+|.+......  .+++.+|++++++++|+||+++++++.+....++||||+++++|.+++.......   ....+++
T Consensus        37 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~  116 (275)
T cd05046          37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST  116 (275)
T ss_pred             eEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCH
Confidence            3999988754433  4689999999999999999999999999899999999999999999996543210   1236899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--
Q 039471          204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--  281 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--  281 (363)
                      ..+..++.|++.||+|||+   .+++|+||||+||+++.++.++++|||++......... ......++..|+|||.+  
T Consensus       117 ~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~  192 (275)
T cd05046         117 KQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQE  192 (275)
T ss_pred             HHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhcc
Confidence            9999999999999999999   99999999999999999999999999998754322211 12333467789999986  


Q ss_pred             ------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCC
Q 039471          282 ------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN  354 (363)
Q Consensus       282 ------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~  354 (363)
                            +|+||||+++|+|++ |..||.......        .......+ ....    .....++..+.+++.+||+.+
T Consensus       193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~~~~~-~~~~----~~~~~~~~~l~~~i~~~l~~~  259 (275)
T cd05046         193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNRLQAG-KLEL----PVPEGCPSRLYKLMTRCWAVN  259 (275)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHHHHcC-CcCC----CCCCCCCHHHHHHHHHHcCCC
Confidence                  799999999999998 777775432211        11111111 1111    112235568999999999999


Q ss_pred             CCCCCCCCC
Q 039471          355 PTERPSMPM  363 (363)
Q Consensus       355 p~~RPs~~e  363 (363)
                      |++|||+.|
T Consensus       260 p~~Rp~~~~  268 (275)
T cd05046         260 PKDRPSFSE  268 (275)
T ss_pred             cccCCCHHH
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.6e-34  Score=255.24  Aligned_cols=231  Identities=22%  Similarity=0.296  Sum_probs=178.5

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  +..||+|++....   ...+++.+|+.++++++|+||+++++++..  +...+++|||+++++
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~   87 (265)
T cd08217           8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD   87 (265)
T ss_pred             eccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCC
Confidence            445555555544432  3449999886432   233578899999999999999999998753  456899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH-----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |.+++....  .....+++..++.++.|++.||+|||     +   .+++|+||||+||++++++.+||+|||++.....
T Consensus        88 L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          88 LAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             HHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            999996543  22367899999999999999999999     7   8999999999999999999999999999987765


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ....  .....++..|+|||.+        +|+||||+++++|++|+.|+.......        ..+.+..+.      
T Consensus       163 ~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~------  226 (265)
T cd08217         163 DSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGK------  226 (265)
T ss_pred             Cccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--------HHHHHhcCC------
Confidence            4321  1334588999999987        799999999999999999987643211        222222211      


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+...+..+.+++.+|++.+|++|||++|
T Consensus       227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~  258 (265)
T cd08217         227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE  258 (265)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            11233456788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.8e-34  Score=254.47  Aligned_cols=226  Identities=21%  Similarity=0.275  Sum_probs=179.3

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.++++.++.+...  +..||+|.+....    ...+.+.+|++++++++|+||+++++.+.++...++|+||+++++|
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   87 (258)
T cd05578           8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL   87 (258)
T ss_pred             eccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCH
Confidence            445555555555443  4459999986432    2346889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..      ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||.+........   
T Consensus        88 ~~~l~~------~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---  155 (258)
T cd05578          88 RYHLSQ------KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---  155 (258)
T ss_pred             HHHHHh------cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---
Confidence            999943      2468999999999999999999999   9999999999999999999999999999887654422   


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||.+        +|+||||+++|+|++|..|+.......     ..+.......       .....+.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-------~~~~~~~  223 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-------ADVLYPA  223 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-------ccccCcc
Confidence            1344578899999987        899999999999999999987654321     1112111110       1122334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ..+..+.+++.+||+.+|.+||++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~  247 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGD  247 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCc
Confidence            456889999999999999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.7e-34  Score=255.85  Aligned_cols=228  Identities=17%  Similarity=0.277  Sum_probs=177.6

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+..  .+..||+|......  ...+.+.+|+.++++++|+||+++++++.++...++||||+++++|
T Consensus        10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l   89 (277)
T cd06641          10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA   89 (277)
T ss_pred             eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence            3455666666655433  23459999876432  2335788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..       ..+++..+..++.|++.|+.+||+   .+++|+||+|+||+++.++.++|+|||++........  .
T Consensus        90 ~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          90 LDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            999832       358899999999999999999999   9999999999999999999999999999876644321  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||.+        +|+||||+++|+|++|..|+.......        ....+....      ......
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~  223 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNN------PPTLEG  223 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCC------CCCCCc
Confidence            1234578889999987        799999999999999999986532211        111111111      112233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++||+++|
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~  249 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKE  249 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHH
Confidence            45677999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=270.06  Aligned_cols=234  Identities=23%  Similarity=0.343  Sum_probs=188.3

Q ss_pred             CCcccccccccCCcceeecc---CCe--eEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          107 CPFQSLISFNLTNSKFFFLH---SNE--IAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       107 c~~~~~~~~~~~~~~~~~~~---~~~--vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      |.++.++.+.||.+....+.   ++.  ||||.+.....  ...+|++|+.+|.+|+|+|++++||...+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            45566666666665443332   222  99999986543  35799999999999999999999999887 667899999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++.|||.+.++..    ....|....+..++.||+.||.||.+   +++||||+..+|+|+-....+||+|||+.+-+..
T Consensus       192 aplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             cccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            9999999999652    23678889999999999999999999   9999999999999999999999999999998887


Q ss_pred             Ccccccc-ccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          260 DISIVSR-TAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       260 ~~~~~~~-~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      +...... ....-...|+|||.+        ||+|+|||++|||++ |..||.+....+        +.+++..++++  
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------IL~~iD~~erL--  334 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------ILKNIDAGERL--  334 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------HHHhccccccC--
Confidence            6554332 222345679999998        999999999999996 667887654322        44555544433  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                          ..++.+++.+.++++.||..+|+||||+.
T Consensus       335 ----pRPk~csedIY~imk~cWah~paDRptFs  363 (1039)
T KOG0199|consen  335 ----PRPKYCSEDIYQIMKNCWAHNPADRPTFS  363 (1039)
T ss_pred             ----CCCCCChHHHHHHHHHhccCCccccccHH
Confidence                45677889999999999999999999985

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=255.01  Aligned_cols=228  Identities=21%  Similarity=0.281  Sum_probs=175.8

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccC--CcChhHHHHHHHHHhccC---CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHL--KGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.+..+..  .+..||+|.+...  ....+++.+|+.++++++   |+|++++++++.++...+++|||++++
T Consensus         8 ~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06917           8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG   87 (277)
T ss_pred             heeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCC
Confidence            345555555554443  2344999988643  334467889999999987   999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..       ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        88 ~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          88 SVRTLMKA-------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             cHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            99999832       368999999999999999999999   99999999999999999999999999999877554321


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        .....|+..|+|||.+         +|+||||+++|+|++|..||........       . ..+.....  ..   .
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~-~~~~~~~~--~~---~  222 (277)
T cd06917         158 --RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------M-MLIPKSKP--PR---L  222 (277)
T ss_pred             --cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------h-hccccCCC--CC---C
Confidence              2334588899999975         8999999999999999999875432111       1 11110000  00   0


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+.++.+++.+||+.||++|||+.|
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  251 (277)
T cd06917         223 EDNGYSKLLREFVAACLDEEPKERLSAEE  251 (277)
T ss_pred             CcccCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            11125678999999999999999999754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-34  Score=256.66  Aligned_cols=224  Identities=23%  Similarity=0.235  Sum_probs=168.5

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhc---cCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGR---IHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+...  +..+|+|.+.....    ....+.+|..+++.   .+|+||+.+++.+..++..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            345566665554443  34499998864321    12334455544443   3699999999999998999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++........
T Consensus        82 ~~L~~~i~~------~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          82 GDLHYHLSQ------HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            999998842      3569999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                          ....|+..|+|||.+         +|+||+|+++|||++|..||........     ..+... .      .....
T Consensus       153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~-~------~~~~~  216 (279)
T cd05633         153 ----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM-T------LTVNV  216 (279)
T ss_pred             ----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHH-h------hcCCc
Confidence                234589999999976         6999999999999999999975432211     111110 0      01112


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ..+...+.++.+++.+||+.||++||+
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~  243 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLG  243 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcC
Confidence            234456778999999999999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=257.58  Aligned_cols=238  Identities=22%  Similarity=0.291  Sum_probs=170.3

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+...  +..||||.+....  .....+.+|++++++++|+||+++++++.++...++||||+++ +|.+
T Consensus        13 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~   91 (291)
T cd07844          13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQ   91 (291)
T ss_pred             EeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHH
Confidence            344445544444332  3449999986432  2235678999999999999999999999999999999999975 9999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++.......  ...
T Consensus        92 ~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~  161 (291)
T cd07844          92 YMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYS  161 (291)
T ss_pred             HHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--ccc
Confidence            885332     468999999999999999999999   9999999999999999999999999999875432211  112


Q ss_pred             cccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc------------cc
Q 039471          268 AARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG------------QE  326 (363)
Q Consensus       268 ~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~  326 (363)
                      ...++..|+|||++         +|+||+|+++|||++|+.||........+..   .+++.+...            ..
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH---KIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH---HHHHhcCCCChhhhhhhhhcccc
Confidence            23467889999976         6999999999999999999865432211110   011100000            00


Q ss_pred             cccccCC-------CCcHHHH--HHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEE-------DGDEGIA--RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~-------~~~~~~~--~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......       .......  ..+.+++.+||+++|++|||++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e  284 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE  284 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence            0000000       0000112  67789999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=270.06  Aligned_cols=244  Identities=21%  Similarity=0.254  Sum_probs=183.8

Q ss_pred             CCCCCcccccccccCCcceeeccC--CeeEEEEccc--CCcChhHHHHHHHHHhccCCCceeeeeeeeeeC------Cce
Q 039471          104 ETACPFQSLISFNLTNSKFFFLHS--NEIAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRR  173 (363)
Q Consensus       104 ~~~c~~~~~~~~~~~~~~~~~~~~--~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~  173 (363)
                      ..++.-..+|.|++|++..+..+.  +.||||.++.  .....+..-+|++++++++|+|||++++.=.+.      ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            334444667777777776665443  3399999975  345567888999999999999999999985443      367


Q ss_pred             eEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc--CCC--CeeEe
Q 039471          174 TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNF--QPKIS  249 (363)
Q Consensus       174 ~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~--~~~--~~kl~  249 (363)
                      .++||||.+|||..++.+..+   ...+++.+++.++.++..||.|||+   ++|+||||||.||++-  .+|  ..||+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             eEEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeee
Confidence            899999999999999965443   4789999999999999999999999   9999999999999983  323  47999


Q ss_pred             ccccceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHH
Q 039471          250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      |||.|+.++++...   ....||..|.+||++         .|.|||||++|+++||..||.+.....+...   ..+..
T Consensus       167 DfG~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~---~~~~~  240 (732)
T KOG4250|consen  167 DFGAARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE---IMWHI  240 (732)
T ss_pred             cccccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch---hhhhh
Confidence            99999999887744   667799999999988         7999999999999999999977554322111   11111


Q ss_pred             hhhcc-------------cccc----ccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          321 MRLGQ-------------ELCL----DFEEDGDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       321 ~~~~~-------------~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +.+..             ....    +........+...+-..+..+|.++|++|.
T Consensus       241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            11110             0111    111123344555677788889999999987

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-34  Score=253.53  Aligned_cols=233  Identities=22%  Similarity=0.330  Sum_probs=176.5

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc-------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+..  .++.||+|++.....       ..+.+.+|++.+++++|+||+++++++.+++..++|+||+++
T Consensus         8 lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~   87 (268)
T cd06630           8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG   87 (268)
T ss_pred             ecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCC
Confidence            34444444443332  344599999863321       235788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDI  261 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~  261 (363)
                      ++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++ .+||+|||.+.......
T Consensus        88 ~~L~~~l~~------~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          88 GSVSHLLSK------YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             CcHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            999999843      2468999999999999999999999   9999999999999998775 59999999988765432


Q ss_pred             ccc--ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          262 SIV--SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       262 ~~~--~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ...  ......++..|+|||.+        +|+||+|+++++|++|..||........    ...+.....      ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~------~~~  228 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIAS------ATT  228 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhc------cCC
Confidence            111  11234578899999986        7999999999999999999864322111    111111100      111


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+...++++.+++.+|++.+|.+|||+.|
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  260 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRE  260 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence            22345567788999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.6e-34  Score=252.38  Aligned_cols=233  Identities=21%  Similarity=0.331  Sum_probs=178.2

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.++++.+..+..  .+..||+|.+.....   ..+.+.+|+.++++++|+||+++++.+......++++||+++++|
T Consensus         7 ~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (264)
T cd06626           7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL   86 (264)
T ss_pred             EeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcH
Confidence            345555555544443  244599999875544   346889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..      ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.+...........
T Consensus        87 ~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          87 EELLEH------GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             HHHHhh------cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            999843      2457899999999999999999999   9999999999999999999999999999887654332111


Q ss_pred             --cccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          266 --RTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       266 --~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                        .....++..|+|||.+           +|+||||++++|+++|+.||........      ..+. ...+...    .
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~------~~~~-~~~~~~~----~  226 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ------IMFH-VGAGHKP----P  226 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH------HHHH-HhcCCCC----C
Confidence              1134578899999976           6999999999999999999975432111      0111 1111110    1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......+..+.+++.+||+.+|++|||++|
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  257 (264)
T cd06626         227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASE  257 (264)
T ss_pred             CCcccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            1112234677889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.6e-34  Score=260.07  Aligned_cols=230  Identities=19%  Similarity=0.246  Sum_probs=167.0

Q ss_pred             CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCH
Q 039471          127 SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW  203 (363)
Q Consensus       127 ~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~  203 (363)
                      ++.||+|+......   ..+.+.+|+.+++.++|+||+++++++..+...++++||+.+++|.+++.....    ..+++
T Consensus        25 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~----~~~~~  100 (328)
T cd08226          25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP----EGMSE  100 (328)
T ss_pred             CcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc----cCCCH
Confidence            44599999864332   235778899999999999999999999999999999999999999999855432    45899


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc-----cccccccccccCC
Q 039471          204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-----RTAARGTSGYIAP  278 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-----~~~~~gt~~y~aP  278 (363)
                      ..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+...........     .....++..|+||
T Consensus       101 ~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (328)
T cd08226         101 ALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP  177 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence            9999999999999999999   9999999999999999999999999986543322111100     0112245679999


Q ss_pred             ccc----------cCceehhHHHHHHhcCCCCCCcchhcccccc------hHHHH-------HHH-------hh------
Q 039471          279 ELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY------FPEWI-------YNR-------MR------  322 (363)
Q Consensus       279 E~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~------~~~~~-------~~~-------~~------  322 (363)
                      |++          +|+||||+++|||++|+.||...........      +..+.       ...       ..      
T Consensus       178 E~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (328)
T cd08226         178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGES  257 (328)
T ss_pred             hhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccc
Confidence            986          5999999999999999999975432211000      00000       000       00      


Q ss_pred             --h----ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 --L----GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 --~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        .    ...............++..+.+++++||++||++|||++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e  304 (328)
T cd08226         258 VVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS  304 (328)
T ss_pred             hhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence              0    0000001112223457788999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=260.95  Aligned_cols=230  Identities=22%  Similarity=0.267  Sum_probs=176.5

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||+|.+.....    ..+.+.+|++++++++|+||+++++.+..+...+++|||+.+++
T Consensus         8 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (316)
T cd05574           8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGE   87 (316)
T ss_pred             eecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCC
Confidence            3455555555554443  34599999875432    33578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++..........
T Consensus        88 L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          88 LFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             HHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999985332    2568999999999999999999999   999999999999999999999999999987654321110


Q ss_pred             ---------------------------ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc
Q 039471          265 ---------------------------SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS  309 (363)
Q Consensus       265 ---------------------------~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~  309 (363)
                                                 ......|+..|+|||++        +|+||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       01223578899999987        7999999999999999999975543211


Q ss_pred             ccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          310 QIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                             . ..+.. ...    ........+..+.+++.+||+.+|++|||
T Consensus       241 -------~-~~~~~-~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         241 -------F-SNILK-KEV----TFPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             -------H-HHHhc-CCc----cCCCccccCHHHHHHHHHHccCCHhHCCC
Confidence                   1 11110 011    11112226788999999999999999999

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-34  Score=259.65  Aligned_cols=191  Identities=23%  Similarity=0.287  Sum_probs=151.5

Q ss_pred             cccccccCCcceeecc----CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEecc
Q 039471          111 SLISFNLTNSKFFFLH----SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~----~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  180 (363)
                      .++.+++|.+..+...    +..||+|.+....    ...+.+.+|+.++++++|+||+++++++.+.  ...++||||+
T Consensus         7 ~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   86 (316)
T cd07842           7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA   86 (316)
T ss_pred             EeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence            3455556655555543    3459999987532    3346778999999999999999999999887  7899999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC----CCCeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH----NFQPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~----~~~~kl~Dfg~a~~  256 (363)
                      ++ +|.+++..... .....+++..++.++.|++.||+|||+   .+++||||||+||+++.    ++.+||+|||++..
T Consensus        87 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          87 EH-DLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             Cc-CHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            75 77777643322 122478999999999999999999999   99999999999999999    99999999999887


Q ss_pred             ccCCcc-ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          257 CSKDIS-IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       257 ~~~~~~-~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      ...... ........++..|+|||.+         +|+||||++++||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            644322 1122334578889999965         7999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=257.68  Aligned_cols=245  Identities=23%  Similarity=0.308  Sum_probs=186.8

Q ss_pred             CcccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhcc--CCCceeeeeeeeeeCC----ceeEEEeccC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRI--HHFHIVRLLGFCSEGN----RRTLIYEFMP  181 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~e~~~  181 (363)
                      .++.++.+++|.+....+.++.||||++.  ..+.+.|.+|-++.+..  +|+||+++++.-....    .++||+||.+
T Consensus       214 l~eli~~Grfg~V~KaqL~~~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLDNRLVAVKIFP--EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             hHHHhhcCccceeehhhccCceeEEEecC--HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            44556778888888888999999999997  33567888888887754  7999999999865444    8999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc------CCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ------GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      .|||.+|+..       ..++|....+++..+++||+|||+      +.+..|+|||||..|||+.++++..|+|||+|.
T Consensus       292 kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  292 KGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             CCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            9999999953       458999999999999999999997      446789999999999999999999999999999


Q ss_pred             eccCCccccccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-----
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-----  316 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-----  316 (363)
                      .+..+.........+||.+|||||++              .||||+|.|+|||+++-.-.+......-+..|.+.     
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            99877655555567899999999998              79999999999999866544321111111122111     


Q ss_pred             ----HHHHhhhccccccccCCC-CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          317 ----IYNRMRLGQELCLDFEED-GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       317 ----~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                          +...... +...+.+... ..+.....+++.+.-||..||+-|.|+.
T Consensus       445 t~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  445 TLEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CHHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                1111111 1111111111 2234566799999999999999999863

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-33  Score=254.01  Aligned_cols=232  Identities=22%  Similarity=0.278  Sum_probs=171.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHH-HhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVAT-IGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+...  +..||+|.++....  ...++..|+.. ++.++|+||+++++++..++..+++|||++ ++|
T Consensus         8 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l   86 (283)
T cd06617           8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSL   86 (283)
T ss_pred             EecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccH
Confidence            3455555555544433  34499999875432  23456667765 556689999999999999999999999996 689


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      .+++.....  ....+++..++.++.|++.||+|||+   . +++||||||+||+++.++.+||+|||++........  
T Consensus        87 ~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (283)
T cd06617          87 DKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--  159 (283)
T ss_pred             HHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--
Confidence            888865332  23579999999999999999999998   6 999999999999999999999999999886543221  


Q ss_pred             ccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          265 SRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                       .....++..|+|||.+            +|+||||+++|||++|+.|+........      .+.... .+..  .   
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~--~---  226 (283)
T cd06617         160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ------QLKQVV-EEPS--P---  226 (283)
T ss_pred             -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH------HHHHHH-hcCC--C---
Confidence             1224578889999975            6999999999999999999864322111      011111 1100  0   


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......++.++.+++.+||+.+|++|||++|
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~  257 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPE  257 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            0112235678999999999999999999864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.3e-34  Score=252.91  Aligned_cols=229  Identities=21%  Similarity=0.242  Sum_probs=171.3

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC------cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  181 (363)
                      ++.+++|.++.+...  +..||||.+....      ...+.+.+|+.++++++|+||+++++++.+.  ...+++|||++
T Consensus        10 l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~   89 (265)
T cd06652          10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP   89 (265)
T ss_pred             EecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecC
Confidence            445555555444433  3449999875321      1124678899999999999999999988653  46789999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        90 ~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          90 GGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            99999998432      457899999999999999999999   999999999999999999999999999987654321


Q ss_pred             cc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .. .......++..|+|||.+        +|+||||+++|||++|+.||........       .. ....     ....
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~-~~~~-----~~~~  227 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-------IF-KIAT-----QPTN  227 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-------HH-HHhc-----CCCC
Confidence            11 011234578899999987        7999999999999999999865322111       11 1110     0112


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...+..+.+++.+|+. +|++|||++|
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~  257 (265)
T cd06652         228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADE  257 (265)
T ss_pred             CCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence            23445667788999999995 9999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-33  Score=255.22  Aligned_cols=240  Identities=21%  Similarity=0.239  Sum_probs=169.8

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+..  .+..||+|++.....  ....+.+|+.+++.++|+||+++++++..+...++|+||+. ++|.+
T Consensus        13 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~   91 (291)
T cd07870          13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQ   91 (291)
T ss_pred             EEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHH
Confidence            44455555444433  245599999864332  23467899999999999999999999999999999999996 67877


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++...     ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........  ..
T Consensus        92 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~  161 (291)
T cd07870          92 YMIQH-----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YS  161 (291)
T ss_pred             HHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CC
Confidence            76432     2457888899999999999999999   99999999999999999999999999998764332211  13


Q ss_pred             cccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc---------hHHHHHHHhhhc----c
Q 039471          268 AARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY---------FPEWIYNRMRLG----Q  325 (363)
Q Consensus       268 ~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~---------~~~~~~~~~~~~----~  325 (363)
                      ...++..|+|||.+         +|+||||+++|||++|..||...........         ... ....+...    .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  240 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED-TWPGVSKLPNYKP  240 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh-hhhhhhhcccccc
Confidence            34468899999976         6999999999999999999975433211000         000 00000000    0


Q ss_pred             ccccccCCC------CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEED------GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .........      .....+..+.+++.+|++.||++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~  284 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD  284 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH
Confidence            000000000      00012467889999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=254.66  Aligned_cols=232  Identities=24%  Similarity=0.307  Sum_probs=180.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.++++.+..+...  +..||+|++.......+.+.+|++.+++++|+|++++++.+......++++||+++++|.+
T Consensus        25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  104 (286)
T cd06614          25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD  104 (286)
T ss_pred             HhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence            33455555555554444  4459999997655456788999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........  ...
T Consensus       105 ~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~  174 (286)
T cd06614         105 IITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRN  174 (286)
T ss_pred             HHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhc
Confidence            995432     368999999999999999999999   9999999999999999999999999999876544322  112


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|++||.+        +|+||||+++|+|++|+.|+........       . ..+.....    ........+
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-------~-~~~~~~~~----~~~~~~~~~  242 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-------L-FLITTKGI----PPLKNPEKW  242 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-------H-HHHHhcCC----CCCcchhhC
Confidence            33477889999986        8999999999999999999865332211       1 11111100    011122335


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|.+|||++|
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~  266 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEE  266 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHH
Confidence            678999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=254.99  Aligned_cols=229  Identities=21%  Similarity=0.275  Sum_probs=176.6

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+..  .++.||+|.+... ....+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|.+
T Consensus        26 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  105 (293)
T cd06647          26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD  105 (293)
T ss_pred             EecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHH
Confidence            344555554444432  3445999998643 3344678999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++..       ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.........  ..
T Consensus       106 ~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~  173 (293)
T cd06647         106 VVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RS  173 (293)
T ss_pred             HHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cc
Confidence            9842       357899999999999999999999   99999999999999999999999999998765543321  23


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||.+        +|+||||+++|++++|+.||..........       . .....    ..........
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~-~~~~~----~~~~~~~~~~  241 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------L-IATNG----TPELQNPEKL  241 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------e-hhcCC----CCCCCCcccc
Confidence            34578899999987        799999999999999999997543322110       0 00000    0011123345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.+|++||+++|
T Consensus       242 ~~~l~~li~~~l~~~p~~Rp~~~~  265 (293)
T cd06647         242 SAIFRDFLNRCLEMDVEKRGSAKE  265 (293)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHH
Confidence            677999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.2e-34  Score=253.03  Aligned_cols=230  Identities=20%  Similarity=0.300  Sum_probs=177.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.++++.++.+...  +..+|+|.+...   ....+.+.+|+.++++++|+||+++++.+..+...++++||+++++|
T Consensus         7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (257)
T cd08225           7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDL   86 (257)
T ss_pred             EecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcH
Confidence            3455556665555543  344999998643   23446788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCcccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      .+++....    ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++ .+||+|||.+......... 
T Consensus        87 ~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~-  158 (257)
T cd08225          87 MKRINRQR----GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL-  158 (257)
T ss_pred             HHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence            99995432    2357999999999999999999999   9999999999999999875 4699999998876543221 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....|+..|+|||.+        +|+||||++++||++|..|+......       ++...... +.      .....
T Consensus       159 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~------~~~~~  223 (257)
T cd08225         159 -AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKICQ-GY------FAPIS  223 (257)
T ss_pred             -ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhc-cc------CCCCC
Confidence             1234588899999976        79999999999999999998653221       11211111 11      11122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+.++.+++.+|++.+|++|||+.|
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~  250 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITS  250 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            345567999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=256.26  Aligned_cols=242  Identities=22%  Similarity=0.257  Sum_probs=173.7

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.+..  .+..||+|++....   ...+.+.+|++++++++|+|++++++++.+++..+++|||++ ++|.
T Consensus         7 l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~   85 (283)
T cd07835           7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLK   85 (283)
T ss_pred             ecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHH
Confidence            34444444444333  24459999886432   233578899999999999999999999999999999999995 6999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++.....    ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        86 ~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~  156 (283)
T cd07835          86 KYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--Y  156 (283)
T ss_pred             HHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--c
Confidence            99854321    468999999999999999999999   99999999999999999999999999998765432211  1


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHhhh---c---
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRMRL---G---  324 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~---~---  324 (363)
                      ....++..|+|||.+         +|+||||+++|||++|+.||.............++       .+.....   .   
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            223467889999975         89999999999999999998654332211100000       0000000   0   


Q ss_pred             -cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 -QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 -~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...............+..+.+++.+|++.+|++|||++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  276 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA  276 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence             000000000112234567899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5e-34  Score=253.78  Aligned_cols=233  Identities=24%  Similarity=0.337  Sum_probs=180.0

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.+++|.++.+...  ++.||+|.+....  ...+++.+|++.+++++|+||+++++.+..++..++++||+++++|.
T Consensus         8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (265)
T cd06605           8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD   87 (265)
T ss_pred             HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence            4556666666665554  4459999887543  33457899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..+..++.|++.||+|||+  ..+++|+||||+||++++++.++|+|||.+........    
T Consensus        88 ~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----  156 (265)
T cd06605          88 KILKEVQ-----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----  156 (265)
T ss_pred             HHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----
Confidence            9995432     568999999999999999999998  37999999999999999999999999999876543221    


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH-
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE-  337 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  337 (363)
                      ....++..|+|||.+        +|+||||+++++|++|+.|+.........  ..+ .........      ....+. 
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~-~~~~~~~~~------~~~~~~~  227 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFE-LLQYIVNEP------PPRLPSG  227 (265)
T ss_pred             hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHH-HHHHHhcCC------CCCCChh
Confidence            125578899999986        89999999999999999998765321111  011 111111111      111122 


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++..+.+++.+||+.+|++|||+.|
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~  253 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKE  253 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHH
Confidence            27788999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-36  Score=248.85  Aligned_cols=243  Identities=21%  Similarity=0.267  Sum_probs=180.2

Q ss_pred             CCCcccccccccCCccee---ecc--CCeeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEE
Q 039471          106 ACPFQSLISFNLTNSKFF---FLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIY  177 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~---~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  177 (363)
                      ...++.++.+|.|+.|.+   ..+  ++..|||.+....  ...+++..|.++..+- +.+|||++||.+..++..|+.|
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            344556666665555544   223  3449999997433  3446888898876655 5899999999999999999999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |.|. .||+.+...-. ..++..++|..+..|..-...||+||-.  ...|+||||||+|||++..|.+||+|||.+-.+
T Consensus       143 ELMd-~SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHh-hhHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9995 57765432111 1334679999999999999999999998  489999999999999999999999999998766


Q ss_pred             cCCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      .....   .+...|...|||||.+          ||+||||++|+|++||+.|+......-++      + .++..+...
T Consensus       219 v~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq------l-~~Vv~gdpp  288 (361)
T KOG1006|consen  219 VDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ------L-CQVVIGDPP  288 (361)
T ss_pred             HHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH------H-HHHHcCCCC
Confidence            54332   2445588899999998          89999999999999999998765542221      1 112222222


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .... .....+.+..+..++.-|+..|-.+||+.++
T Consensus       289 ~l~~-~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~  323 (361)
T KOG1006|consen  289 ILLF-DKECVHYSFSMVRFINTCLIKDRSDRPKYDD  323 (361)
T ss_pred             eecC-cccccccCHHHHHHHHHHhhcccccCcchhh
Confidence            1111 1122457889999999999999999998753

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-34  Score=263.75  Aligned_cols=224  Identities=24%  Similarity=0.330  Sum_probs=181.1

Q ss_pred             cccccCCcceeec-----cCCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          113 ISFNLTNSKFFFL-----HSNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       113 ~~~~~~~~~~~~~-----~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      +.+|.|..+.|.+     .+.+||||.+.++..+   .+.+.+|++++..++|||||+++.+......+|+||||+.+|.
T Consensus        62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge  141 (596)
T KOG0586|consen   62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE  141 (596)
T ss_pred             eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence            4445555554443     3555999999865433   3457899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      +.+|+.      .+..+.+.....++.|+.+|++|||+   +.|+|||||++|||++.+.++||+|||++..+...... 
T Consensus       142 ~~~yl~------~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l-  211 (596)
T KOG0586|consen  142 LFDYLV------KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML-  211 (596)
T ss_pred             hHHHHH------hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccccc-
Confidence            999994      34567789999999999999999999   99999999999999999999999999999998765543 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        ....|++.|.|||++         .|+||+|+++|-|+.|..||++..-...        ..+...+.       ...
T Consensus       212 --qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L--------r~rvl~gk-------~rI  274 (596)
T KOG0586|consen  212 --QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL--------RPRVLRGK-------YRI  274 (596)
T ss_pred             --cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc--------cchheeee-------ecc
Confidence              567799999999999         8999999999999999999987543221        11111111       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +.-.+.+..++++++|..+|.+|+++++
T Consensus       275 p~~ms~dce~lLrk~lvl~Pskr~~~dq  302 (596)
T KOG0586|consen  275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQ  302 (596)
T ss_pred             cceeechhHHHHHHhhccCccccCCHHH
Confidence            2334556788999999999999999864

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-34  Score=276.55  Aligned_cols=154  Identities=23%  Similarity=0.343  Sum_probs=128.3

Q ss_pred             hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 039471          142 GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH  221 (363)
Q Consensus       142 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  221 (363)
                      ...+.+|+.++++++|+||+++++++...+..++++|++. ++|.+++...... .........+..++.||+.||+|||
T Consensus       207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD-WKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc-ccccccHHHHHHHHHHHHHHHHHHH
Confidence            4568899999999999999999999999999999999995 5788877543321 1123446778899999999999999


Q ss_pred             cCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHH
Q 039471          222 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLE  293 (363)
Q Consensus       222 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~e  293 (363)
                      +   .+|+||||||+|||++.++.+||+|||+++.+...... ......||..|+|||++        +|||||||++||
T Consensus       285 ~---~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  360 (501)
T PHA03210        285 D---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD  360 (501)
T ss_pred             h---CCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence            9   99999999999999999999999999999876543221 11335689999999997        799999999999


Q ss_pred             HhcCCCCC
Q 039471          294 MVGCRKNN  301 (363)
Q Consensus       294 l~~g~~~~  301 (363)
                      |++|..++
T Consensus       361 ll~~~~~p  368 (501)
T PHA03210        361 MLSHDFCP  368 (501)
T ss_pred             HHHCCCCC
Confidence            99987544

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.8e-34  Score=255.83  Aligned_cols=237  Identities=21%  Similarity=0.270  Sum_probs=171.9

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+...  +..||+|.+....  .....+.+|+.++.++. |+||+++++++..++..+++|||+. ++|
T Consensus        11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l   89 (288)
T cd06616          11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISL   89 (288)
T ss_pred             HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCH
Confidence            4455555555444433  3449999886432  23457889999999996 9999999999999899999999986 466


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .++...... .....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||++.........  
T Consensus        90 ~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  164 (288)
T cd06616          90 DKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--  164 (288)
T ss_pred             HHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc--
Confidence            554321110 122569999999999999999999997  259999999999999999999999999998765433221  


Q ss_pred             cccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          266 RTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ....++..|+|||++           +|+||||+++|||++|+.||.......      +.+. ....+...  .....
T Consensus       165 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~~--~~~~~  234 (288)
T cd06616         165 -TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF------DQLT-QVVKGDPP--ILSNS  234 (288)
T ss_pred             -ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH------HHHh-hhcCCCCC--cCCCc
Confidence             233578899999974           799999999999999999986543110      0011 11111111  11112


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....++.++.+++.+||+.+|++|||++|
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  263 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKE  263 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence            22346778999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.6e-33  Score=251.43  Aligned_cols=238  Identities=19%  Similarity=0.246  Sum_probs=171.6

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc--ChhHHHHHHHHHhccC-CCceeeeeeeeeeC--CceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG--NGQEFINEVATIGRIH-HFHIVRLLGFCSEG--NRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+..  .++.||+|.++....  ......+|+.++.++. |+|++++++++.++  +..++|+||++ ++
T Consensus         7 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~   85 (282)
T cd07831           7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MN   85 (282)
T ss_pred             ccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-cc
Confidence            44555555544433  244599999875322  2234567999999885 99999999999877  88999999997 58


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+.+...     ...+++..+..++.|++.||+|||+   .+++|+||||+||+++. +.+||+|||+++........ 
T Consensus        86 l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          86 LYELIKGR-----KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             HHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence            88887432     2468999999999999999999999   99999999999999999 99999999999876543322 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHHHHHhhhcccc
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWIYNRMRLGQEL  327 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~  327 (363)
                        ....++..|+|||.+         +|+|||||++|||++|..||...........        ..+| ..........
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  232 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHM  232 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccc
Confidence              234578899999965         8999999999999999999965433211000        1111 1111111000


Q ss_pred             ccccCCC-------CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEED-------GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......       .....+..+.+++.+||+.+|++|||++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  275 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ  275 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence            0000000       11245688999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-33  Score=254.53  Aligned_cols=242  Identities=18%  Similarity=0.184  Sum_probs=173.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+...  +..+|+|.++....   ....+.+|+.++++++|+||+++++++...  ...++|+||+++ 
T Consensus        12 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-   90 (293)
T cd07843          12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-   90 (293)
T ss_pred             hhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-
Confidence            3445555555444433  34499999864332   224577899999999999999999998777  899999999974 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus        91 ~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  161 (293)
T cd07843          91 DLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-  161 (293)
T ss_pred             CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence            9999885322     368999999999999999999999   9999999999999999999999999999887654321 


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHH---Hhhhc
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYN---RMRLG  324 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~---~~~~~  324 (363)
                       ......++..|+|||.+         +|+||||++++||++|+.||...............       .+.   .+...
T Consensus       162 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         162 -PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             -ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence             11334578889999976         79999999999999999998754322110000000       000   00000


Q ss_pred             c------ccccccCCCCcHH-HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 Q------ELCLDFEEDGDEG-IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~------~~~~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .      ..........+.. .++.+.+++.+||+.+|++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~e  286 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED  286 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHH
Confidence            0      0000001111111 4677899999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=254.53  Aligned_cols=242  Identities=19%  Similarity=0.242  Sum_probs=174.4

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.++++.+..+...  ++.||+|.++..   ....+.+.+|++++++++|+||+++++++..++..+++|||++++.+.
T Consensus         9 i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~   88 (288)
T cd07833           9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE   88 (288)
T ss_pred             ecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHH
Confidence            344455554444333  345999988643   233467899999999999999999999999999999999999987676


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      .+..      ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||.+......... ..
T Consensus        89 ~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~  158 (288)
T cd07833          89 LLEA------SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PL  158 (288)
T ss_pred             HHHh------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cc
Confidence            6552      22458999999999999999999999   99999999999999999999999999998876554321 11


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH-------HHHhhhcccc-cc
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI-------YNRMRLGQEL-CL  329 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~~  329 (363)
                      ....++..|+|||++         +|+||||+++|+|++|+.||................       .......... ..
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            334578889999976         799999999999999999987543221100000000       0000000000 00


Q ss_pred             cc---------CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DF---------EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~---------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..         ....+..++.++.+++++||+.+|++|||++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  281 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE  281 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence            00         00112234678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-33  Score=250.39  Aligned_cols=227  Identities=21%  Similarity=0.275  Sum_probs=175.6

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.++.+...  ++.+|+|.+....    ...+.+.+|+.++++++|+||+++++.+..+...++++||+++++|.
T Consensus         2 g~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (265)
T cd05579           2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLA   81 (265)
T ss_pred             CCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHH
Confidence            34455555555443  4459999986433    23467889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc---
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI---  263 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---  263 (363)
                      +++.+.      ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.........   
T Consensus        82 ~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          82 SLLENV------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            999532      368999999999999999999999   99999999999999999999999999998765433110   


Q ss_pred             ---cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 ---VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 ---~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                         .......++..|+|||..        +|+||||++++|+++|..||.......        ....+..+..   .  
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~---~--  219 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILNGKI---E--  219 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCc---C--
Confidence               012334577889999976        899999999999999999986543211        1222221111   0  


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .......+..+.+++.+||+.+|.+|||+
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~  248 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGA  248 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCC
Confidence            01111136789999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-33  Score=253.58  Aligned_cols=229  Identities=20%  Similarity=0.210  Sum_probs=174.2

Q ss_pred             cccccccCCcceeec-----cCCeeEEEEcccCC-----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEec
Q 039471          111 SLISFNLTNSKFFFL-----HSNEIAVKMLEHLK-----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .++.+++|.++.+..     .+..||+|++....     ...+.+.+|+.++.++ +|+||+++++++..+...++|+||
T Consensus         7 ~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (290)
T cd05613           7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY   86 (290)
T ss_pred             eeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEec
Confidence            345555555554433     34559999986422     2336788999999999 599999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++++|.+++..      ...+++..+..++.|++.||.|||+   .+++|+||+|+|||+++++.+||+|||++.....
T Consensus        87 ~~~~~L~~~l~~------~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          87 INGGELFTHLSQ------RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             CCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            999999999943      2458899999999999999999999   9999999999999999999999999999987644


Q ss_pred             CccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      .... ......|+..|+|||.+          +|+||||+++|+|++|..|+........   ..+ +.......     
T Consensus       158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~-~~~~~~~~-----  227 (290)
T cd05613         158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAE-ISRRILKS-----  227 (290)
T ss_pred             cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHH-HHHHhhcc-----
Confidence            3221 11234578899999976          7999999999999999999864322111   111 11111111     


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                        ....+...+..+.+++.+||+.+|++||+
T Consensus       228 --~~~~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         228 --EPPYPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             --CCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence              11123345678899999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=248.91  Aligned_cols=225  Identities=20%  Similarity=0.240  Sum_probs=170.1

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc----ChhHHHHHHHHH-hccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG----NGQEFINEVATI-GRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~----~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+..  .++.||+|++.....    ....+..|...+ ...+|+|++++++++..+...++++||+++++
T Consensus         4 l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   83 (260)
T cd05611           4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD   83 (260)
T ss_pred             CCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCC
Confidence            44555555555443  234599999864321    112344555444 44579999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+++.....    
T Consensus        84 L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  150 (260)
T cd05611          84 CASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----  150 (260)
T ss_pred             HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence            99998432      468999999999999999999999   99999999999999999999999999998765431    


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....++..|+|||.+        +|+||||+++|||++|..||.......        ....+..+.   ........
T Consensus       151 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~---~~~~~~~~  217 (260)
T cd05611         151 --KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------VFDNILSRR---INWPEEVK  217 (260)
T ss_pred             --ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcc---cCCCCccc
Confidence              234578899999986        899999999999999999996543211        112221111   11111222


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..+++.+.+++.+||+.+|++|||+.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCC
Confidence            34678899999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.3e-33  Score=255.32  Aligned_cols=225  Identities=21%  Similarity=0.280  Sum_probs=172.0

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+..  .+..||+|.+.....    ..+++.+|++++++++|+|++++++++.++...++||||+++ +
T Consensus        32 ~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~  110 (317)
T cd06635          32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-S  110 (317)
T ss_pred             eeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-C
Confidence            344555555444433  234499999864322    234788999999999999999999999999999999999974 8


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+.+...     ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......    
T Consensus       111 l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----  178 (317)
T cd06635         111 ASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----  178 (317)
T ss_pred             HHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence            87777432     2458999999999999999999999   99999999999999999999999999998754432    


Q ss_pred             ccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          265 SRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ....++..|+|||.+           +|+||||+++|||++|+.|+.......        ....+.....     ..
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~-----~~  243 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNES-----PT  243 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhccC-----CC
Confidence              234578899999985           699999999999999999986542211        1111111111     11


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......++.+.+++.+||+.+|++|||+.|
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  273 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEE  273 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHH
Confidence            123345677999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.9e-33  Score=246.55  Aligned_cols=232  Identities=23%  Similarity=0.296  Sum_probs=182.1

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~  183 (363)
                      .++.+++|.+..+...  ++.|++|+.....   ...+.+.+|+..+++++|+||+++++.+...  ...++++||++++
T Consensus         7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~   86 (260)
T cd06606           7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG   86 (260)
T ss_pred             EeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCC
Confidence            3455566665555544  4459999987544   3457889999999999999999999999888  8899999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        87 ~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          87 SLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            999999432      378999999999999999999999   99999999999999999999999999999887655421


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      .......++..|+|||.+        +|+||||+++++|++|..||........      ... .+..     .......
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~-----~~~~~~~  225 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA------ALY-KIGS-----SGEPPEI  225 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHH-hccc-----cCCCcCC
Confidence            112344578899999987        8999999999999999999876541111      011 1110     0111223


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...+..+.+++.+|++.+|++|||+.|
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~  253 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADE  253 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence            3445788999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.5e-33  Score=244.13  Aligned_cols=230  Identities=23%  Similarity=0.348  Sum_probs=180.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+...  +..+++|++..... ..+.+.+|++.+++++|+|++++++++..+...++++||+++++|.+
T Consensus         7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~   86 (253)
T cd05122           7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD   86 (253)
T ss_pred             eeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHH
Confidence            3455556655555544  44599999975543 55789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..+..++.|++.||++||+   .+++|+||+|+||+++.++.++|+|||.+........   ..
T Consensus        87 ~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~  155 (253)
T cd05122          87 LLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN  155 (253)
T ss_pred             HHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence            985332     568999999999999999999999   9999999999999999999999999999887765432   13


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|++||.+        +|+||||+++++|++|+.|+........       ...... ...    ........+
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~-~~~----~~~~~~~~~  223 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIAT-NGP----PGLRNPEKW  223 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHh-cCC----CCcCccccc
Confidence            34578899999987        8999999999999999999875432111       111110 000    001112223


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.||++|||+.|
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~  247 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQ  247 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHH
Confidence            677999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=252.71  Aligned_cols=239  Identities=22%  Similarity=0.232  Sum_probs=174.8

Q ss_pred             cccccccCCcceeeccC--CeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHS--NEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+....  +.+|+|++....   ...+.+.+|+.++++++|+|++++++++...  ...++|+||+++ 
T Consensus         6 ~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-   84 (287)
T cd07840           6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-   84 (287)
T ss_pred             EeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-
Confidence            34555555555554433  459999997542   3345788999999999999999999999887  899999999975 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.+.........
T Consensus        85 ~l~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          85 DLTGLLDSP-----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             cHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            898888432     1468999999999999999999999   99999999999999999999999999999876554311


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc----------
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG----------  324 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  324 (363)
                       ......++..|+|||.+         +|+||||+++|||++|+.||.........    ..+.+.....          
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL----EKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHhCCCchhhcccccc
Confidence             11233467889999965         79999999999999999998754432110    0010000000          


Q ss_pred             ----ccccc------ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 ----QELCL------DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ----~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .....      .........+++.+.+++.+||+.+|++|||++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~  280 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ  280 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence                00000      0000001112678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-33  Score=251.11  Aligned_cols=222  Identities=23%  Similarity=0.222  Sum_probs=166.2

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHH---HhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVAT---IGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      +.+++|.++.+...  ++.||+|.+.....    ....+.+|..+   ++...|+||+++++.+.+....++||||++++
T Consensus         3 g~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~   82 (278)
T cd05606           3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG   82 (278)
T ss_pred             ccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCC
Confidence            44555555544332  34599998864321    11234445443   34457999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........ 
T Consensus        83 ~L~~~l~~------~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-  152 (278)
T cd05606          83 DLHYHLSQ------HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (278)
T ss_pred             cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence            99998842      2569999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                         ....|+..|+|||.+         +|+||+|+++|||++|+.||........     ........ .      ....
T Consensus       153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~-~------~~~~  217 (278)
T cd05606         153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-T------MAVE  217 (278)
T ss_pred             ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHhh-c------cCCC
Confidence               334589999999986         6999999999999999999976432211     00111110 0      1112


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      .+...+.++.+++.+|++.+|.+||
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~  242 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRL  242 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhcc
Confidence            2334578899999999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-33  Score=247.94  Aligned_cols=232  Identities=22%  Similarity=0.295  Sum_probs=180.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++.++++.+..+...  ++.||||++....  ...+.+.+|+..+.+++|+||+++++++..+...++++||+++++|.
T Consensus         8 ~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (264)
T cd06623           8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLA   87 (264)
T ss_pred             eeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHH
Confidence            3445555555444443  4449999987543  24578999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...      ..+++..+..++.|++.||+|||+  ..+++|+||+|+||+++.++.++|+|||.+..........  
T Consensus        88 ~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--  157 (264)
T cd06623          88 DLLKKV------GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--  157 (264)
T ss_pred             HHHHHc------CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--
Confidence            999432      568999999999999999999997  2799999999999999999999999999998765443321  


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||.+        +|+||||+++|+|++|+.|+......    ...+ ....+...      ........
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~-~~~~~~~~------~~~~~~~~  226 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFE-LMQAICDG------PPPSLPAE  226 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHH-HHHHHhcC------CCCCCCcc
Confidence            234578899999987        89999999999999999998765421    0111 11111111      11112223


Q ss_pred             -HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 -IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 -~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .+..+.+++.+||+.+|++|||+.|
T Consensus       227 ~~~~~l~~li~~~l~~~p~~R~~~~~  252 (264)
T cd06623         227 EFSPEFRDFISACLQKDPKKRPSAAE  252 (264)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHH
Confidence             6788999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-33  Score=253.20  Aligned_cols=230  Identities=22%  Similarity=0.311  Sum_probs=175.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+...  +..||||.+.... .....+.+|+.++++++|+||+++++.+..+...+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            34555555555444443  3449999886433 23457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..       ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus       106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~  173 (292)
T cd06657         106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR  173 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cc
Confidence            98732       357899999999999999999999   9999999999999999999999999999876654321  11


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||.+        +|+||+|+++|||++|..||........        ...+.....    ........
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--------~~~~~~~~~----~~~~~~~~  241 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------MKMIRDNLP----PKLKNLHK  241 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhhCC----cccCCccc
Confidence            334578899999987        7999999999999999999875432211        111110000    00111233


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+.+++.+||+.+|.+|||+.|
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~  266 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAE  266 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHH
Confidence            5667889999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.9e-33  Score=252.09  Aligned_cols=230  Identities=19%  Similarity=0.193  Sum_probs=174.4

Q ss_pred             ccccccCCcceeec-----cCCeeEEEEcccCC-----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEecc
Q 039471          112 LISFNLTNSKFFFL-----HSNEIAVKMLEHLK-----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ++.+++|.++.+..     .+..||||+++...     ...+.+.+|+.++.++ +|+||+++++.+..+...++||||+
T Consensus         8 ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (288)
T cd05583           8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV   87 (288)
T ss_pred             eccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecC
Confidence            45555555544332     23449999986422     2335688999999999 5999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++..      ...+++..+..++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||+++.....
T Consensus        88 ~~~~L~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          88 NGGELFTHLYQ------REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             CCCcHHHHHhh------cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            99999999843      2468999999999999999999999   99999999999999999999999999998765443


Q ss_pred             ccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          261 ISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .... .....++..|+|||.+          +|+||||++++||++|..|+........    ...+.......      
T Consensus       159 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~------  227 (288)
T cd05583         159 EEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKS------  227 (288)
T ss_pred             cccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHcc------
Confidence            2211 1234578899999975          7999999999999999999864322111    01111111111      


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                       ....+..++..+.+++.+||+.+|++|||++
T Consensus       228 -~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~  258 (288)
T cd05583         228 -KPPFPKTMSAEARDFIQKLLEKDPKKRLGAN  258 (288)
T ss_pred             -CCCCCcccCHHHHHHHHHHhcCCHhhccCcc
Confidence             1122334567789999999999999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-33  Score=253.50  Aligned_cols=241  Identities=20%  Similarity=0.256  Sum_probs=171.8

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCc-----eeEEEecc
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNR-----RTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~lv~e~~  180 (363)
                      ++.+++|.++.+...  ++.||+|......   .....+.+|+.++++++ |+||+++++++.....     .+++|||+
T Consensus         9 lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~   88 (295)
T cd07837           9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL   88 (295)
T ss_pred             ecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeecc
Confidence            344555555444433  3449999876432   23357889999999995 6999999999876655     89999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSK  259 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~  259 (363)
                      ++ +|.+++..... .....+++..++.++.||+.||.|||+   .+++||||||+||+++. ++.+||+|||.+.....
T Consensus        89 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~  163 (295)
T cd07837          89 DS-DLKKFMDSNGR-GPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI  163 (295)
T ss_pred             Cc-CHHHHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence            85 89998865432 123568999999999999999999999   99999999999999998 88999999999886543


Q ss_pred             CccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc-c--
Q 039471          260 DISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE-L--  327 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--  327 (363)
                      ....  .....+++.|+|||.+         +|+||||+++|||++|..||...........+    ...+..... .  
T Consensus       164 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  237 (295)
T cd07837         164 PVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI----FKLLGTPTEQVWP  237 (295)
T ss_pred             Cccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HHHhCCCChhhCc
Confidence            2111  1223467889999976         79999999999999999998754332211000    000000000 0  


Q ss_pred             -----c-----cccC----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 -----C-----LDFE----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 -----~-----~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           .     ....    .......+.++.+++.+||+.||.+|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e  287 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA  287 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence                 0     0000    0011235677999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=249.77  Aligned_cols=241  Identities=19%  Similarity=0.216  Sum_probs=175.9

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.++++.+..+..  .++.+|+|.+.....   ....+.+|+.++++++|+||+++++++..+...++++||+++ +|.
T Consensus         7 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~   85 (283)
T cd05118           7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLY   85 (283)
T ss_pred             eecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHH
Confidence            44455555544443  244499998864332   346788999999999999999999999999999999999975 888


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...     ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        86 ~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~  155 (283)
T cd05118          86 KLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PY  155 (283)
T ss_pred             HHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cc
Confidence            887432     2578999999999999999999999   9999999999999999999999999999987765431  11


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH-------HHHHHhhh----ccc
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE-------WIYNRMRL----GQE  326 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~----~~~  326 (363)
                      ....++..|+|||.+         +|+||||+++|+|++|+.||.............+       ..+.....    ...
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            234577889999976         7999999999999999998865443211000000       00000000    000


Q ss_pred             cc----cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LC----LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..    ...........+.++.+++.+||+.+|.+||+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~  276 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ  276 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence            00    00001122356788999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.3e-33  Score=248.00  Aligned_cols=229  Identities=24%  Similarity=0.316  Sum_probs=179.4

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.++++.+..+...  +..+|+|.+....   ....++.+|++++++++|+||+++++++.++...++|+||+++++|.
T Consensus         8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (256)
T cd08530           8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS   87 (256)
T ss_pred             ecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHH
Confidence            344455554443332  3449999986432   33457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....  .....+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++........    
T Consensus        88 ~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----  158 (256)
T cd08530          88 KAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----  158 (256)
T ss_pred             HHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc----
Confidence            9986532  223568999999999999999999999   9999999999999999999999999999987765421    


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|++||.+        +|+||||++++||++|+.||.......        .......+      .....+..
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~------~~~~~~~~  224 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRG------KYPPIPPI  224 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcC------CCCCCchh
Confidence            234578899999987        899999999999999999986543211        11111111      11223346


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.++.+++.+|++.+|++|||+.|
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08530         225 YSQDLQNFIRSMLQVKPKLRPNCDK  249 (256)
T ss_pred             hCHHHHHHHHHHcCCCcccCCCHHH
Confidence            7788999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-33  Score=254.30  Aligned_cols=244  Identities=18%  Similarity=0.202  Sum_probs=168.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--------ceeEE
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--------RRTLI  176 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~lv  176 (363)
                      ..++.+++|.++.....  ++.||||.+....   .....+.+|++++++++|+||+++++++....        ..++|
T Consensus        18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv   97 (310)
T cd07865          18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV   97 (310)
T ss_pred             EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence            33445555555444332  3449999886332   22345678999999999999999999986543        45999


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      |||+. ++|.+++...     ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        98 ~e~~~-~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          98 FEFCE-HDLAGLLSNK-----NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             EcCCC-cCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            99996 4888887432     2468999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccc--cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc-
Q 039471          257 CSKDISI--VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG-  324 (363)
Q Consensus       257 ~~~~~~~--~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-  324 (363)
                      .......  .......++..|+|||.+         +|+||||+++|||++|+.|+.......... ....+....... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  247 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPEV  247 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhh
Confidence            6443221  111233467889999975         799999999999999999986543321100 000000000000 


Q ss_pred             -------ccc-ccccCCCC---------cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 -------QEL-CLDFEEDG---------DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 -------~~~-~~~~~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                             ... ........         ....+..+.+++.+||+.||++|||++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e  303 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT  303 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence                   000 00000000         0112356789999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.5e-33  Score=255.14  Aligned_cols=241  Identities=19%  Similarity=0.185  Sum_probs=170.4

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.+..+...  +..||+|.+.....   ....+.+|+.++++++|+||+++++++.+.  +..++||||+.+ +
T Consensus        15 ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~   93 (309)
T cd07845          15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-D   93 (309)
T ss_pred             eeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-C
Confidence            344444444444332  34599999863321   223567899999999999999999998754  468999999964 8


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+......... 
T Consensus        94 l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~-  164 (309)
T cd07845          94 LASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-  164 (309)
T ss_pred             HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC-
Confidence            988885322     568999999999999999999999   99999999999999999999999999999876543211 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHhhhc---c
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRMRLG---Q  325 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---~  325 (363)
                       .....++..|+|||.+         +|+||+|+++|||++|+.||...............       .+......   .
T Consensus       165 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         165 -MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             -CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence             1233457789999976         79999999999999999999754332211000000       00000000   0


Q ss_pred             ccccc-cCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLD-FEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~-~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..... ...    ......++++.+++.+||++||++|||++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~  286 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE  286 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            00000 000    001224677899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.9e-33  Score=287.29  Aligned_cols=232  Identities=24%  Similarity=0.405  Sum_probs=173.2

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      .++.+++|.++.+..  .+..||||++......   ..+|++.+++++|||||+++|+|.++...++||||+++|+|.++
T Consensus       697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~  773 (968)
T PLN00113        697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV  773 (968)
T ss_pred             EEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHH
Confidence            355666666665553  3445999998744322   23568899999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +         ..+++..+..++.|+++||+|||..+..+++||||||+||+++.++.+++. ||.......+      ..
T Consensus       774 l---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~  837 (968)
T PLN00113        774 L---------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TK  837 (968)
T ss_pred             H---------hcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CC
Confidence            9         348899999999999999999996444899999999999999998888875 6655433221      22


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc---ccccc--cCCCC
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ---ELCLD--FEEDG  335 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~  335 (363)
                      ..++..|+|||++        +||||||+++|||++|+.|++.....  .....+|.........   .....  .....
T Consensus       838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            3578999999987        89999999999999999998654322  2223344332221110   00111  11223


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...++.+++.+||+.+|++||||+|
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~e  943 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCAND  943 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence            4456667889999999999999999875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=252.37  Aligned_cols=236  Identities=24%  Similarity=0.288  Sum_probs=192.5

Q ss_pred             CCCCCcccccccccCCcceeeccCCe--eEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEE
Q 039471          104 ETACPFQSLISFNLTNSKFFFLHSNE--IAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIY  177 (363)
Q Consensus       104 ~~~c~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  177 (363)
                      .+...+..++.+|+|.+.-......+  +|.|.+.+.    +....-.++|-.+|.+++.+-||.+--.|+..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            34456777888888888765554444  888888532    222345679999999999999999999999999999999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ..|.||+|.-+|+....    ..|++..+..++.+|+.||++||+   .+|+.||+||+|||+|+.|.++|+|+|+|..+
T Consensus       265 tlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999988865432    689999999999999999999999   99999999999999999999999999999999


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      +.+...   ....||.+|||||++        .|-||+||++|||+.|+.||....+..+...    +-       +...
T Consensus       338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE----vd-------rr~~  403 (591)
T KOG0986|consen  338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE----VD-------RRTL  403 (591)
T ss_pred             CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH----HH-------HHHh
Confidence            887765   444799999999999        6899999999999999999987655432111    11       1112


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ....+.+..++++..++....|+.||++|.-
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            2233456788889999999999999999963

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.3e-33  Score=254.28  Aligned_cols=226  Identities=20%  Similarity=0.298  Sum_probs=172.1

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+..  .+..+|+|.+...    ....+++.+|+++++.++|+|++++++++..+...++||||+. +
T Consensus        21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~   99 (308)
T cd06634          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G   99 (308)
T ss_pred             HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence            3445555555444433  2344999988632    1223578899999999999999999999999999999999996 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......   
T Consensus       100 ~l~~~~~~~-----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634         100 SASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            888877432     2458999999999999999999999   99999999999999999999999999998765432   


Q ss_pred             cccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                         ....++..|+|||.+           +|+||||+++|||++|..|+.......       .... ...+..     .
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~-~~~~~~-----~  232 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNES-----P  232 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHHH-HhhcCC-----C
Confidence               233478899999974           699999999999999999986532211       1111 111110     1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......+..+.+++.+||+.+|++|||++|
T Consensus       233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  263 (308)
T cd06634         233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (308)
T ss_pred             CcCcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence            1122356678999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-33  Score=244.94  Aligned_cols=227  Identities=22%  Similarity=0.313  Sum_probs=177.6

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.+..+..  .++.||+|.......   ..+.+.+|++++++++|+|++++++++.+++..++++||+++++|.
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   87 (254)
T cd06627           8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR   87 (254)
T ss_pred             EcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHH
Confidence            34444444443332  234599999975542   4467899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...      ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+.........  .
T Consensus        88 ~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~  156 (254)
T cd06627          88 QIIKKF------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--D  156 (254)
T ss_pred             HHHHhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--c
Confidence            998432      568999999999999999999999   99999999999999999999999999999877654321  1


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||..        +|+||+|+++++|++|..|+........       .. ......      ....+..
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-------~~-~~~~~~------~~~~~~~  222 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-------LF-RIVQDD------HPPLPEG  222 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-------HH-HHhccC------CCCCCCC
Confidence            334578899999976        8999999999999999999865432111       11 111111      1122334


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+.+++.+||+.+|++|||+.|
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~~~~~  247 (254)
T cd06627         223 ISPELKDFLMQCFQKDPNLRPTAKQ  247 (254)
T ss_pred             CCHHHHHHHHHHHhCChhhCcCHHH
Confidence            5678999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.6e-33  Score=257.86  Aligned_cols=241  Identities=21%  Similarity=0.265  Sum_probs=171.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeee----eCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCS----EGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+...  +..||+|++....   ...+.+.+|+.++++++|+||+++++++.    .....++||||+. 
T Consensus        13 lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-   91 (334)
T cd07855          13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-   91 (334)
T ss_pred             eecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-
Confidence            444555544443332  4459999986432   23457788999999999999999999875    3356899999996 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..      ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        92 ~~l~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          92 SDLHHIIHS------DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             hhHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            589988832      3559999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             cc--ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHH---H-H
Q 039471          263 IV--SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWI---Y-N  319 (363)
Q Consensus       263 ~~--~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~---~-~  319 (363)
                      ..  ......++..|+|||.+         +|+||||+++|||++|+.||...........        .+...   . +
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            11  11234688899999975         8999999999999999999965432211000        00000   0 0


Q ss_pred             HhhhccccccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..... .......     .....+.++.+++.+||+.+|++|||++|
T Consensus       243 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  290 (334)
T cd07855         243 RVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ  290 (334)
T ss_pred             hHHHHHh-hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            0000000 0000000     11235778999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-33  Score=257.64  Aligned_cols=240  Identities=20%  Similarity=0.231  Sum_probs=170.2

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEeccC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~  181 (363)
                      ++.+++|.++.+..  .+..||||.+...   .....++.+|+.++++++|+||+++++++...     ...++++||+.
T Consensus        13 lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~   92 (337)
T cd07858          13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD   92 (337)
T ss_pred             eccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC
Confidence            34444444443332  2344999988642   22345678899999999999999999988644     35799999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ++|.+++.      ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        93 -~~L~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          93 -TDLHQIIR------SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             -CCHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence             68988883      23569999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchH--------HHH-------
Q 039471          262 SIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFP--------EWI-------  317 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~--------~~~-------  317 (363)
                      ..  .....++..|+|||.+         +|+||||+++|+|++|+.||.............        +..       
T Consensus       163 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         163 DF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             cc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            11  1334578899999975         899999999999999999986542211000000        000       


Q ss_pred             -HHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 -YNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .+....................+.++.+++.+||+.+|++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~e  287 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEE  287 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHH
Confidence             0000000000000000011245678999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=247.65  Aligned_cols=241  Identities=21%  Similarity=0.330  Sum_probs=175.0

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcC--hhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN--GQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.....  +..||||.+......  .....+|+..+++++ |+|++++++++..+...++||||+ +++|
T Consensus         6 ~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l   84 (283)
T cd07830           6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNL   84 (283)
T ss_pred             eeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCH
Confidence            3455566665555543  344999998654332  234567999999999 999999999999999999999999 7899


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....    ...+++..+..++.|++.+|.|||+   ++++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        85 ~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (283)
T cd07830          85 YQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--  155 (283)
T ss_pred             HHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence            99885432    2468999999999999999999999   99999999999999999999999999999876543222  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch---------HHHHHHHhhhcccc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF---------PEWIYNRMRLGQEL  327 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~  327 (363)
                       ....++..|+|||++         +|+||||++++||++|+.||............         ..|... .......
T Consensus       156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  233 (283)
T cd07830         156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG-YKLASKL  233 (283)
T ss_pred             -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH-hhhhccc
Confidence             234578889999976         79999999999999999988654322110000         001000 0000000


Q ss_pred             cccc---CCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDF---EED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~---~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....   ...    .....+..+.+++.+||+.+|++|||++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  276 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ  276 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence            0000   000    00112467999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.5e-33  Score=249.68  Aligned_cols=243  Identities=20%  Similarity=0.245  Sum_probs=173.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.....  +..||||.+....  ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++ +|.+
T Consensus         8 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~   86 (284)
T cd07836           8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKK   86 (284)
T ss_pred             eccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHH
Confidence            344444444433332  3349999887432  2346778999999999999999999999999999999999985 8988


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++.....   ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++........  ...
T Consensus        87 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~  158 (284)
T cd07836          87 YMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFS  158 (284)
T ss_pred             HHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccc
Confidence            8854331   2468999999999999999999999   9999999999999999999999999999876543221  112


Q ss_pred             cccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHhhhcccccccc
Q 039471          268 AARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRMRLGQELCLDF  331 (363)
Q Consensus       268 ~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  331 (363)
                      ...++..|++||.+         +|+||||+++|||++|+.||...............       .++.+..........
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            34468889999975         79999999999999999998754322110000000       000010000000000


Q ss_pred             C-------CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 E-------EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .       .......+..+.+++.+|++.||.+|||++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  277 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD  277 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence            0       0011234677899999999999999999764

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-33  Score=277.12  Aligned_cols=235  Identities=24%  Similarity=0.305  Sum_probs=174.5

Q ss_pred             CcccccccccCCcceeec--cCCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeC-------------
Q 039471          108 PFQSLISFNLTNSKFFFL--HSNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-------------  170 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------------  170 (363)
                      -+..+|.||||.+..+..  ++..+|||++...  ......+.+|+++|++|+|||||+++..+.+.             
T Consensus       483 EL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~  562 (1351)
T KOG1035|consen  483 ELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD  562 (1351)
T ss_pred             HHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence            345578888888888754  4556999999754  33345788999999999999999997543110             


Q ss_pred             --------------------------------------------------------------------------------
Q 039471          171 --------------------------------------------------------------------------------  170 (363)
Q Consensus       171 --------------------------------------------------------------------------------  170 (363)
                                                                                                      
T Consensus       563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~  642 (1351)
T KOG1035|consen  563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL  642 (1351)
T ss_pred             hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence                                                                                            


Q ss_pred             --------------------------CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 039471          171 --------------------------NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC  224 (363)
Q Consensus       171 --------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  224 (363)
                                                ..+||-||||+..+|.+++..+...     -.....++++++|+.||.|+|+  
T Consensus       643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLaYIH~--  715 (1351)
T KOG1035|consen  643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLAYIHD--  715 (1351)
T ss_pred             CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHHHHHh--
Confidence                                      0157889999987777777543321     1467899999999999999999  


Q ss_pred             CCCceecCCCCCceEEcCCCCeeEeccccceecc---C-------------CccccccccccccccccCCccc-------
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS---K-------------DISIVSRTAARGTSGYIAPELF-------  281 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~-------  281 (363)
                       .+||||||||.||+++++..|||+|||+|....   .             .......+..+||..|+|||++       
T Consensus       716 -~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  716 -QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             -CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence             999999999999999999999999999998721   0             0111124567899999999998       


Q ss_pred             ----cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 039471          282 ----SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE  357 (363)
Q Consensus       282 ----~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  357 (363)
                          .|+||+|+|++||+.   ||....+...       +..+++.+....   .........+.=..+|+|+++.||.+
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-------iL~~LR~g~iP~---~~~f~~~~~~~e~slI~~Ll~hdP~k  861 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERAS-------ILTNLRKGSIPE---PADFFDPEHPEEASLIRWLLSHDPSK  861 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHH-------HHHhcccCCCCC---CcccccccchHHHHHHHHHhcCCCcc
Confidence                699999999999984   4555444322       444454333221   12233444555678999999999999


Q ss_pred             CCCCCC
Q 039471          358 RPSMPM  363 (363)
Q Consensus       358 RPs~~e  363 (363)
                      |||+.|
T Consensus       862 RPtA~e  867 (1351)
T KOG1035|consen  862 RPTATE  867 (1351)
T ss_pred             CCCHHH
Confidence            999864

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.5e-33  Score=250.59  Aligned_cols=241  Identities=21%  Similarity=0.246  Sum_probs=169.0

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      +.+++|.++.+...  ++.||+|.+....   ...+.+.+|++++++++|+||+++++++.++...++||||++ ++|.+
T Consensus        11 ~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~   89 (294)
T PLN00009         11 GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKK   89 (294)
T ss_pred             cCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHH
Confidence            33444444333332  3459999986432   233578899999999999999999999999999999999996 58888


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccCCcccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      ++....    ...+++..+..++.||+.||+|||+   .+++|+||+|+||+++. ++.+||+|||++.........  .
T Consensus        90 ~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~  160 (294)
T PLN00009         90 HMDSSP----DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--F  160 (294)
T ss_pred             HHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--c
Confidence            874332    2346889999999999999999999   99999999999999985 557999999999765433211  1


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh---c-------ccc
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL---G-------QEL  327 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~-------~~~  327 (363)
                      ....++..|+|||.+         +|+||+|+++|+|++|+.||..............+.......   +       ...
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            233568899999975         799999999999999999987543321100000000000000   0       000


Q ss_pred             ccccCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......    .....+.++.+++.+|++.+|++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~  280 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA  280 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence            0000000    11234567899999999999999999864

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.7e-33  Score=256.26  Aligned_cols=237  Identities=21%  Similarity=0.219  Sum_probs=168.5

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEecc
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~  180 (363)
                      ++.+++|.+..+..  .++.||||.+...   .....++.+|+.++++++|+||+++++++...      ...++||||+
T Consensus        24 lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  103 (353)
T cd07850          24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM  103 (353)
T ss_pred             eccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEecc
Confidence            34444444433332  3445999998643   22335778899999999999999999988543      3579999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      . ++|.+.+.        ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus       104 ~-~~l~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850         104 D-ANLCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             C-CCHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            6 58888873        238899999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHH-------
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWI-------  317 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~-------  317 (363)
                      ..   .....++..|+|||.+        +|+||||+++|+|++|+.||..........        ...++.       
T Consensus       172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         172 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            22   1334578899999987        799999999999999999986543211100        000000       


Q ss_pred             HHHhhhcccc-------------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 YNRMRLGQEL-------------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..........             ............+..+.+++.+||++||++|||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  307 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD  307 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence            0000000000             000000012245667899999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.5e-33  Score=242.78  Aligned_cols=199  Identities=20%  Similarity=0.186  Sum_probs=157.4

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHH
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL  206 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~  206 (363)
                      ++.+|+|.+....    .+.+|...+....|+||+++++++.+....+++|||+++++|.+++...      ..+++..+
T Consensus        18 ~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~   87 (237)
T cd05576          18 QQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF------LNIPEECV   87 (237)
T ss_pred             CcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh------cCCCHHHH
Confidence            4459999987443    2334555555667999999999999999999999999999999998432      45899999


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-----
Q 039471          207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----  281 (363)
Q Consensus       207 ~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----  281 (363)
                      ..++.|++.||+|||+   .+++|+||||+||+++.++.++++|||.+.......     ....++..|+|||.+     
T Consensus        88 ~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~  159 (237)
T cd05576          88 KRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEE  159 (237)
T ss_pred             HHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCC
Confidence            9999999999999999   999999999999999999999999999876654321     223356779999987     


Q ss_pred             ---cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 039471          282 ---SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTER  358 (363)
Q Consensus       282 ---~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (363)
                         +|+||+|+++|||++|+.++........             ..      .....+..+++.+.+++.+||+.||++|
T Consensus       160 ~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~------~~~~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         160 TEACDWWSLGAILFELLTGKTLVECHPSGIN-------------TH------TTLNIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             CchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cc------cccCCcccCCHHHHHHHHHHccCCHHHh
Confidence               7999999999999999987643211100             00      0011223456789999999999999999


Q ss_pred             CCCC
Q 039471          359 PSMP  362 (363)
Q Consensus       359 Ps~~  362 (363)
                      ||+.
T Consensus       221 ~~~~  224 (237)
T cd05576         221 LGAG  224 (237)
T ss_pred             cCCC
Confidence            9973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-33  Score=257.27  Aligned_cols=241  Identities=23%  Similarity=0.287  Sum_probs=168.8

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+..  .+..||||.+...  .....++.+|+.++++++|+||+++++++...     ...++++||+++
T Consensus        13 lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~   92 (336)
T cd07849          13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET   92 (336)
T ss_pred             EEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc
Confidence            44455554444432  2445999998632  22345788999999999999999999987543     357999999964


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                       +|.+++.       ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        93 -~l~~~~~-------~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          93 -DLYKLIK-------TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             -CHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence             8888773       1468999999999999999999999   9999999999999999999999999999887644322


Q ss_pred             cc-ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHHHHHhhhc
Q 039471          263 IV-SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWIYNRMRLG  324 (363)
Q Consensus       263 ~~-~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  324 (363)
                      .. ......|+..|+|||.+         +|+||||+++|||++|+.||............        ++.........
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR  241 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence            11 11234578899999975         79999999999999999998654321110000        00000000000


Q ss_pred             -c-cc-ccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 -Q-EL-CLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 -~-~~-~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       . .. .......     .....+.++.+++.+||+.+|++|||++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e  288 (336)
T cd07849         242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE  288 (336)
T ss_pred             hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence             0 00 0000000     01123567999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.7e-33  Score=255.44  Aligned_cols=242  Identities=20%  Similarity=0.191  Sum_probs=170.9

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeC--CceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG--NRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+...  ++.+|+|++...   ......+.+|+.+++++ +|+||+++++++...  ...++||||++ 
T Consensus        14 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-   92 (337)
T cd07852          14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-   92 (337)
T ss_pred             hhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-
Confidence            3455555555444432  345999988532   22345677899999999 999999999998643  46899999997 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..       ..+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++........
T Consensus        93 ~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          93 TDLHAVIRA-------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            599988832       267889999999999999999999   9999999999999999999999999999987654322


Q ss_pred             c---cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHh--
Q 039471          263 I---VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRM--  321 (363)
Q Consensus       263 ~---~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~--  321 (363)
                      .   .......++..|+|||.+         +|+||||+++|||++|+.||...............       ....+  
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence            1   111334578899999976         79999999999999999998654322110000000       00000  


Q ss_pred             -------hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 -------RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 -------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                             ..-...............+.++.+++.+||+.+|++|||+.|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~  291 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE  291 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHH
Confidence                   000000000001111225678999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-32  Score=244.85  Aligned_cols=219  Identities=17%  Similarity=0.241  Sum_probs=164.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.+..+...  +..+|+|.........  .  |+.....+ +|+||+++++.+..++..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            355556655554433  3348999886432221  1  22222212 699999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      +...      ..+++..+..++.|+++||+|||+   .+++|+||||+||+++.++ .++|+|||++......      .
T Consensus       100 l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~  164 (267)
T PHA03390        100 LKKE------GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------S  164 (267)
T ss_pred             HHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------c
Confidence            9432      478999999999999999999999   9999999999999999988 9999999998766432      2


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...++..|+|||.+        +|+||||+++|||++|+.||.......  .....+....         ..........
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~---------~~~~~~~~~~  233 (267)
T PHA03390        165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ---------QKKLPFIKNV  233 (267)
T ss_pred             cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh---------cccCCccccc
Confidence            23478899999987        799999999999999999997443221  1111221111         0111223367


Q ss_pred             HHHHHHHHHHhccCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ++.+.+++.+||+.+|.+||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~  254 (267)
T PHA03390        234 SKNANDFVQSMLKYNINYRLT  254 (267)
T ss_pred             CHHHHHHHHHHhccChhhCCc
Confidence            788999999999999999996

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-32  Score=250.13  Aligned_cols=226  Identities=22%  Similarity=0.307  Sum_probs=172.5

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .+++.+++|.++.+..  .+..||+|.+.....    ..+.+.+|+.+++.++|+|++++++++.++...+++|||+. +
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            3455555655555443  234499999864322    22568899999999999999999999999999999999996 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......   
T Consensus       106 ~l~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---  174 (313)
T cd06633         106 SASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---  174 (313)
T ss_pred             CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence            788877432     2468999999999999999999999   99999999999999999999999999998643221   


Q ss_pred             cccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                         ....|+..|+|||.+           +|+||||+++|||++|..|+........       ...... ..     ..
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~-~~-----~~  238 (313)
T cd06633         175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQ-ND-----SP  238 (313)
T ss_pred             ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHh-cC-----CC
Confidence               234578899999985           5999999999999999999865432211       111111 10     01


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......+..+.+++.+||+.+|++|||++|
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~  269 (313)
T cd06633         239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAE  269 (313)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence            1122334567999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.8e-33  Score=251.82  Aligned_cols=242  Identities=20%  Similarity=0.193  Sum_probs=171.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCC----------ceeEE
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN----------RRTLI  176 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------~~~lv  176 (363)
                      ++.+++|.++.+...  +..||+|.++...   .....+.+|+.++++++|+||+++++++.+..          ..+++
T Consensus        15 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv   94 (302)
T cd07864          15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLV   94 (302)
T ss_pred             ecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEE
Confidence            445555555554443  3459999986432   23356788999999999999999999986544          78999


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      +||+++ +|.+.+...     ...+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.+||+|||.+..
T Consensus        95 ~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          95 FEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             EcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence            999976 777777432     2468999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHH-------H
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYN-------R  320 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~-------~  320 (363)
                      ....... ......++..|+|||.+         +|+||||++++||++|++||...........+.+....       .
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T cd07864         166 YNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD  244 (302)
T ss_pred             ccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            6543321 11223457789999976         79999999999999999998754322111000000000       0


Q ss_pred             hhhc--------cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLG--------QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...        ...............+..+.+++.+||+.+|.+|||++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  295 (302)
T cd07864         245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE  295 (302)
T ss_pred             ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            0000        000000000011134678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-32  Score=243.38  Aligned_cols=232  Identities=22%  Similarity=0.332  Sum_probs=181.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.+..+...  +..+|+|++....   ...+++.+|++++++++|+|++++++.+..+...++++||+++++|
T Consensus         7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L   86 (258)
T cd08215           7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDL   86 (258)
T ss_pred             eeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcH
Confidence            3455556655555544  4559999987543   3446788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.....  ....+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        87 ~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~  159 (258)
T cd08215          87 SQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--L  159 (258)
T ss_pred             HHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc--e
Confidence            999965431  23679999999999999999999999   9999999999999999999999999999987655431  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....++..|+|||..        +|+||+|+++++|++|..|+.......        +........      ....+.
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~  225 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--------LALKILKGQ------YPPIPS  225 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--------HHHHHhcCC------CCCCCC
Confidence            2334578889999976        899999999999999999986543211        112211111      111222


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.+|++|||+.|
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~  251 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQ  251 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            45678999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.2e-33  Score=255.01  Aligned_cols=238  Identities=21%  Similarity=0.217  Sum_probs=172.3

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCcCh---------------hHHHHHHHHHhccCCCceeeeeeeeeeCCcee
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKGNG---------------QEFINEVATIGRIHHFHIVRLLGFCSEGNRRT  174 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  174 (363)
                      ++.+++|.++.+..  .++.||||++.......               ..+.+|++++++++|+||+++++++..+...+
T Consensus        17 ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   96 (335)
T PTZ00024         17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN   96 (335)
T ss_pred             ccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEE
Confidence            45555555554442  24459999886432211               24779999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       175 lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      ++|||++ ++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+
T Consensus        97 lv~e~~~-~~l~~~l~~------~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         97 LVMDIMA-SDLKKVVDR------KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEEeccc-cCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccce
Confidence            9999997 599998842      2468999999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCcc------------ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch
Q 039471          255 KLCSKDIS------------IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF  313 (363)
Q Consensus       255 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~  313 (363)
                      ........            ........++..|+|||.+         +|+||||+++|||++|..||.........   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---  243 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---  243 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence            87651110            0011223467789999976         79999999999999999998765432211   


Q ss_pred             HHHHHHHhhhcccc--------------ccccC---CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 PEWIYNRMRLGQEL--------------CLDFE---EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+..........              .....   .......+.++.+++.+||+.+|++|||++|
T Consensus       244 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        244 -GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             -HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence             1111111000000              00000   0011123567899999999999999999864

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-32  Score=248.62  Aligned_cols=231  Identities=19%  Similarity=0.302  Sum_probs=170.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.+..+...  ++.||||.++...  ....++.+|+.++.+.+ |+||+++++++.++...+++|||++ ++|
T Consensus        22 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l  100 (296)
T cd06618          22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCL  100 (296)
T ss_pred             EeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCH
Confidence            3445555555554444  4559999987433  23356777887777775 9999999999999999999999985 478


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....     ..+++..+..++.|++.||.|||+  ..+++|+||+|+||++++++.+||+|||++.........  
T Consensus       101 ~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~--  171 (296)
T cd06618         101 DKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--  171 (296)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--
Confidence            77764322     468999999999999999999996  258999999999999999999999999998765433221  


Q ss_pred             cccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          266 RTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                       ....++..|+|||.+            +|+||||+++|||++|+.||.......      + ............    .
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~~----~  239 (296)
T cd06618         172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------E-VLTKILQEEPPS----L  239 (296)
T ss_pred             -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------H-HHHHHhcCCCCC----C
Confidence             223477889999976            699999999999999999986532211      0 111111111110    1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....++.++.+++.+||+.+|++|||++|
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~  269 (296)
T cd06618         240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRE  269 (296)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            111135667999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=258.42  Aligned_cols=220  Identities=23%  Similarity=0.281  Sum_probs=173.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+.++.+.+....  +...++|++.....+   -.+|+.++... +|+||+++.+.+.++.+.|+|||.+.++-|.
T Consensus       328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell  404 (612)
T KOG0603|consen  328 EELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL  404 (612)
T ss_pred             cccCCCCccceeeeeccccccchhheeccccccc---cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence            33455555555555443  334899999765322   23677666655 6999999999999999999999999998888


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE-cCCCCeeEeccccceeccCCccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-DHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      +.+...      ..+. .++..|+.+|+.|+.|||+   ++++|||+||+|||+ ++.++++|+|||.++...++     
T Consensus       405 ~ri~~~------~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----  469 (612)
T KOG0603|consen  405 RRIRSK------PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----  469 (612)
T ss_pred             HHHHhc------chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence            877432      2233 7788899999999999999   999999999999999 58999999999999987765     


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....-|..|.|||+.        +|+||||++||+|++|+.|+.......       .+..++..+         ....
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------ei~~~i~~~---------~~s~  533 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------EIHTRIQMP---------KFSE  533 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-------HHHHhhcCC---------cccc
Confidence            2344578899999998        899999999999999999998765441       133333322         1236


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...++++.+||+.||.+||+|+|
T Consensus       534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~  559 (612)
T KOG0603|consen  534 CVSDEAKDLLQQLLQVDPALRLGADE  559 (612)
T ss_pred             ccCHHHHHHHHHhccCChhhCcChhh
Confidence            67888999999999999999999975

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-32  Score=247.41  Aligned_cols=236  Identities=17%  Similarity=0.126  Sum_probs=162.6

Q ss_pred             ccccccccCCcceeeccCC-----eeEEEEcccCCcCh------------hHHHHHHHHHhccCCCceeeeeeeeeeCC-
Q 039471          110 QSLISFNLTNSKFFFLHSN-----EIAVKMLEHLKGNG------------QEFINEVATIGRIHHFHIVRLLGFCSEGN-  171 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  171 (363)
                      ..++.+++|.++.+...++     .+|+|+........            .....+...+..+.|+|++++++++.... 
T Consensus        18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   97 (294)
T PHA02882         18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC   97 (294)
T ss_pred             eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence            3457777777766655443     36666543222111            12233445566778999999999765443 


Q ss_pred             ---ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          172 ---RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       172 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                         ..++++|++. .++.+.+..      ....++..+..++.|++.||+|||+   .+++||||||+|||++.++.++|
T Consensus        98 ~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         98 RMYYRFILLEKLV-ENTKEIFKR------IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             CceEEEEEEehhc-cCHHHHHHh------hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEE
Confidence               3467788774 467666632      1346788899999999999999999   99999999999999999999999


Q ss_pred             eccccceeccCCccc-----cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHH
Q 039471          249 SDFGLAKLCSKDISI-----VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~  315 (363)
                      +|||+|+....+...     .......||+.|+|||+.        +|+||||++++||++|+.||..............
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999999876432211     111334689999999987        7999999999999999999976533222111000


Q ss_pred             -HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 -WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       -...++..+..        .....++.+.+++..|++++|++||++++
T Consensus       248 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~  288 (294)
T PHA02882        248 CDFIKRLHEGKI--------KIKNANKFIYDFIECVTKLSYEEKPDYDA  288 (294)
T ss_pred             HHHHHHhhhhhh--------ccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence             01112221111        11223577999999999999999999864

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=241.53  Aligned_cols=224  Identities=26%  Similarity=0.303  Sum_probs=176.7

Q ss_pred             cccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          113 ISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       113 ~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+++|.+..+...  ++.+|+|.+.....    ....+.+|+.++++++|+||+++++.+..+...+++|||+++++|.
T Consensus         2 g~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   81 (250)
T cd05123           2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF   81 (250)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHH
Confidence            34555555554443  34599999864432    3357889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        82 ~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (250)
T cd05123          82 SHLSKE------GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RT  150 (250)
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cc
Confidence            999432      468999999999999999999999   9999999999999999999999999999887654321  12


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....++..|+|||..        +|+||||+++||+++|..||.......        ....+...       ....+..
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~-------~~~~~~~  215 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--------IYEKILKD-------PLRFPEF  215 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHhcC-------CCCCCCC
Confidence            344578899999986        899999999999999999986543211        12222211       1122333


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+..+.+++.+||+.+|++|||++
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCcc
Confidence            467789999999999999999983

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=243.40  Aligned_cols=228  Identities=20%  Similarity=0.261  Sum_probs=170.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC------CcChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  181 (363)
                      ++.+++|.++.....  +..||+|.+...      ......+.+|++++++++|+||+++++++.+.  ...++++||++
T Consensus        10 lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~   89 (264)
T cd06653          10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMP   89 (264)
T ss_pred             EccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCC
Confidence            344455544444332  344999987422      12224788999999999999999999998654  46889999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++......
T Consensus        90 ~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          90 GGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            99999998432      458899999999999999999999   999999999999999999999999999988653211


Q ss_pred             cc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .. .......++..|+|||.+        +|+||||++++||++|+.||........       +.+...      ....
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~------~~~~  227 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-------IFKIAT------QPTK  227 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-------HHHHHc------CCCC
Confidence            10 011234578899999987        7999999999999999999865322110       111111      1111


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+...++.+.+++.+|++ +|..|||+.
T Consensus       228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~  256 (264)
T cd06653         228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAE  256 (264)
T ss_pred             CCCCcccCHHHHHHHHHHhc-CcccCccHH
Confidence            23455677889999999999 579999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=243.62  Aligned_cols=244  Identities=16%  Similarity=0.247  Sum_probs=182.1

Q ss_pred             CCcccccccccCCcceeec---c--CCeeEEEEcccCCcChhHHHHHHHHHhccCC-C-----ceeeeeeeeeeCCceeE
Q 039471          107 CPFQSLISFNLTNSKFFFL---H--SNEIAVKMLEHLKGNGQEFINEVATIGRIHH-F-----HIVRLLGFCSEGNRRTL  175 (363)
Q Consensus       107 c~~~~~~~~~~~~~~~~~~---~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h-~-----niv~~~~~~~~~~~~~l  175 (363)
                      -.|.....+|.|+.+.+.-   .  +..||||++++..+..+...-|+++|.++.+ .     -+|++.+||.-.++.+|
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            3444555566666665532   2  3349999999888888888999999999942 1     47888899999999999


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-------------
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-------------  242 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-------------  242 (363)
                      |+|.+ |.|+.+++..++    ..+++...++.++.|++++++|||+   ++++|.|+||+|||+.+             
T Consensus       169 vfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence            99999 669999995543    3779999999999999999999999   99999999999999831             


Q ss_pred             -------CCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhc
Q 039471          243 -------NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI  307 (363)
Q Consensus       243 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~  307 (363)
                             +..++++|||.|....+..     ...+.|..|+|||++        +||||+||||.|+.+|...|+...+.
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   3458999999998876654     345579999999999        89999999999999999998876532


Q ss_pred             cc-------ccchHHHHHHHhhhc-----cccc-------------------cccCCCCcHHHHHHHHHHHHHhccCCCC
Q 039471          308 QS-------QIYFPEWIYNRMRLG-----QELC-------------------LDFEEDGDEGIARKLAIVAIWCIQWNPT  356 (363)
Q Consensus       308 ~~-------~~~~~~~~~~~~~~~-----~~~~-------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~  356 (363)
                      +.       ..++|..+..+..+.     ..++                   +............+|.+++.+||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            21       112233222222000     0000                   0000112234455699999999999999


Q ss_pred             CCCCCCC
Q 039471          357 ERPSMPM  363 (363)
Q Consensus       357 ~RPs~~e  363 (363)
                      +|+|+.|
T Consensus       396 ~RiTl~E  402 (415)
T KOG0671|consen  396 RRITLRE  402 (415)
T ss_pred             ccccHHH
Confidence            9999875

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-32  Score=246.92  Aligned_cols=227  Identities=23%  Similarity=0.322  Sum_probs=177.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+...  +..||+|++....    ...+.+.+|+.++++++ |+||+++++++..++..+++|||++++
T Consensus         8 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (280)
T cd05581           8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG   87 (280)
T ss_pred             eecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence            3455666665555443  4459999986422    22357889999999998 999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.|++.||.+||+   .+++|+||+|+||+++.++.++++|||++.........
T Consensus        88 ~L~~~l~~------~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          88 ELLQYIRK------YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            99999943      2469999999999999999999999   99999999999999999999999999998876543211


Q ss_pred             ------------------cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH
Q 039471          264 ------------------VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI  317 (363)
Q Consensus       264 ------------------~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  317 (363)
                                        .......++..|+|||.+        +|+||||++++++++|+.|+.......        .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~  230 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--------T  230 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--------H
Confidence                              111233567889999976        899999999999999999987654211        1


Q ss_pred             HHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          318 YNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ......       .....+...++.+.+++.+||+.+|++|||+
T Consensus       231 ~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         231 FQKILK-------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             HHHHHh-------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence            111111       1112233447789999999999999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-32  Score=242.02  Aligned_cols=237  Identities=24%  Similarity=0.289  Sum_probs=171.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhcc---CCCceeeeeeeeeeCCc-----eeEEEe
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRI---HHFHIVRLLGFCSEGNR-----RTLIYE  178 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~~lv~e  178 (363)
                      ++.+++|.++.+...  +..||+|++.....   ....+.+|+.+++++   +|+|++++++++.....     .+++||
T Consensus         7 l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e   86 (287)
T cd07838           7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFE   86 (287)
T ss_pred             ecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEeh
Confidence            445555655555543  34599999964322   234566788777666   59999999999987766     999999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+.+ +|.+++.....    ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+....
T Consensus        87 ~~~~-~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          87 HVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             hccc-CHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9974 89988854321    358999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc-----
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-----  325 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  325 (363)
                      .....   ....++..|+|||.+        +|+||||+++|||++|.+||.........   .. +........     
T Consensus       159 ~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~  231 (287)
T cd07838         159 FEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DK-IFDVIGLPSEEEWP  231 (287)
T ss_pred             CCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HH-HHHHcCCCChHhcC
Confidence            44322   233478889999987        89999999999999999988754332110   00 111000000     


Q ss_pred             --------cccc---ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 --------ELCL---DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 --------~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                              ....   ..........+..+.+++.+||+.||.+|||++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~  280 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE  280 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence                    0000   0001112345678899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-32  Score=267.26  Aligned_cols=219  Identities=25%  Similarity=0.421  Sum_probs=175.2

Q ss_pred             eeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcC---CCCC-----
Q 039471          129 EIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKT---NSSS-----  197 (363)
Q Consensus       129 ~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~-----  197 (363)
                      .||||+++....  ..+.+..|++++..+ +|+||+.++|+|.+++..++|+||++.|+|.++++..+   ....     
T Consensus       330 ~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~  409 (609)
T KOG0200|consen  330 TVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFP  409 (609)
T ss_pred             EEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCc
Confidence            399999985543  357899999999998 59999999999999999999999999999999998776   1110     


Q ss_pred             C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc-ccccc
Q 039471          198 H--RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA-RGTSG  274 (363)
Q Consensus       198 ~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~  274 (363)
                      .  ..++...+..++.||+.|++||++   .+++|||+..+|||+..+..+||+|||+|+.............. .-+..
T Consensus       410 ~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~k  486 (609)
T KOG0200|consen  410 NERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVK  486 (609)
T ss_pred             cccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCcccee
Confidence            1  248999999999999999999999   99999999999999999999999999999976655444322111 13556


Q ss_pred             ccCCccc--------cCceehhHHHHHHhcCC-CCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHH
Q 039471          275 YIAPELF--------SRNFCYGMMLLEMVGCR-KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAI  345 (363)
Q Consensus       275 y~aPE~~--------~Di~slG~il~el~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  345 (363)
                      |||||.+        +||||||+++|||++.. .|+.+ ..      ...-+++.+..|.++      +.+..+..++.+
T Consensus       487 WmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~------~~~~l~~~l~~G~r~------~~P~~c~~eiY~  553 (609)
T KOG0200|consen  487 WMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IP------PTEELLEFLKEGNRM------EQPEHCSDEIYD  553 (609)
T ss_pred             ecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CC------cHHHHHHHHhcCCCC------CCCCCCCHHHHH
Confidence            9999988        89999999999999755 45433 11      111134455555543      446667888999


Q ss_pred             HHHHhccCCCCCCCCCCC
Q 039471          346 VAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       346 l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.||+.+|++||+++|
T Consensus       554 iM~~CW~~~p~~RP~F~~  571 (609)
T KOG0200|consen  554 LMKSCWNADPEDRPTFSE  571 (609)
T ss_pred             HHHHHhCCCcccCCCHHH
Confidence            999999999999999864

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=1.9e-32  Score=243.02  Aligned_cols=232  Identities=24%  Similarity=0.292  Sum_probs=174.1

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccC------CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.+..+....  ..+++|+++..      .....++..|+.++++++|+||+++++++.+....++++||++
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (260)
T cd08222           6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE   85 (260)
T ss_pred             eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence            345555555555443322  23666666431      1223467789999999999999999999999899999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++.....  ....+++..++.++.|++.||+|||+   .+++|+||||+||++++ +.++|+|||.+.......
T Consensus        86 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          86 GRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             CCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            9999998865322  23579999999999999999999999   99999999999999986 569999999988764432


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..  .....++..|+|||.+        +|+||||+++|+|++|..|+.......        .......+      ...
T Consensus       160 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~--------~~~~~~~~------~~~  223 (260)
T cd08222         160 DL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--------VVLRIVEG------PTP  223 (260)
T ss_pred             cc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHcC------CCC
Confidence            21  1334578889999976        799999999999999999986432211        11111111      111


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...+.++.+++.+|++.+|++||++.|
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  253 (260)
T cd08222         224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAE  253 (260)
T ss_pred             CCcchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence            234566788999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.5e-33  Score=271.19  Aligned_cols=233  Identities=21%  Similarity=0.256  Sum_probs=189.5

Q ss_pred             CCCcccccccccCCcceeeccCCe--eEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          106 ACPFQSLISFNLTNSKFFFLHSNE--IAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      +-.+..+|.|.||.+..|..++.+  +|+|++++    ......-|..|-.+|..-+.+-|+++.-.|.++.++|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            334555778888888888776655  99999975    234456788899999888899999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |+||+|..++.      +...+++...+.++..|+.||+-||+   .|+|||||||+|||+|..|.+||+|||.|-.+..
T Consensus       157 ~pGGDlltLlS------k~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  157 MPGGDLLTLLS------KFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ccCchHHHHHh------hcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99999999993      22469999999999999999999999   9999999999999999999999999999988887


Q ss_pred             CccccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      +..- .....+|||.|++||++             +|-||+|+++|||+.|..||+...-..        .|.++-..+.
T Consensus       228 dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--------TY~KIm~hk~  298 (1317)
T KOG0612|consen  228 DGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--------TYGKIMNHKE  298 (1317)
T ss_pred             CCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH--------HHHHHhchhh
Confidence            6543 34678899999999999             789999999999999999998764333        3444443322


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      . +.++  ...+.+.+..++|.+.+. +|+.|..
T Consensus       299 ~-l~FP--~~~~VSeeakdLI~~ll~-~~e~RLg  328 (1317)
T KOG0612|consen  299 S-LSFP--DETDVSEEAKDLIEALLC-DREVRLG  328 (1317)
T ss_pred             h-cCCC--cccccCHHHHHHHHHHhc-Chhhhcc
Confidence            1 1121  233478888888888776 7777754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5.6e-32  Score=257.81  Aligned_cols=216  Identities=22%  Similarity=0.319  Sum_probs=180.7

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeee-----eCCceeEEEeccCCCCHHHHhhhcCCCCCCCC
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCS-----EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ  200 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~  200 (363)
                      ++.+|+|++.......+++..|.++++.. +|+|++.+||++.     .++.+|||||||.+||..+++....    +..
T Consensus        44 ~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~----g~r  119 (953)
T KOG0587|consen   44 GQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK----GNR  119 (953)
T ss_pred             CceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc----ccc
Confidence            34499999988888888999999999987 5999999999984     3468999999999999999996554    478


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCcc
Q 039471          201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL  280 (363)
Q Consensus       201 l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  280 (363)
                      +.|..+..|++.++.|+.+||.   +.++|||||-.|||++.++.+||.|||.+..+.....  .+.+..||+.|||||+
T Consensus       120 l~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEV  194 (953)
T KOG0587|consen  120 LKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEV  194 (953)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecccc--cccCcCCCccccccee
Confidence            9999999999999999999999   9999999999999999999999999999988765432  3467789999999999


Q ss_pred             c-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHH
Q 039471          281 F-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA  347 (363)
Q Consensus       281 ~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  347 (363)
                      +             +|+||||++-.||.-|.+|+...-.....+.          ..  ..+......+...++++.++|
T Consensus       195 iac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----------Ip--RNPPPkLkrp~kWs~~FndFI  262 (953)
T KOG0587|consen  195 IACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----------IP--RNPPPKLKRPKKWSKKFNDFI  262 (953)
T ss_pred             eecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----------CC--CCCCccccchhhHHHHHHHHH
Confidence            9             7999999999999999999865433322111          00  111222335678899999999


Q ss_pred             HHhccCCCCCCCCCCC
Q 039471          348 IWCIQWNPTERPSMPM  363 (363)
Q Consensus       348 ~~cl~~~p~~RPs~~e  363 (363)
                      ..||..|-+.||++.+
T Consensus       263 s~cL~Kd~e~RP~~~~  278 (953)
T KOG0587|consen  263 STCLVKDYEQRPSTEE  278 (953)
T ss_pred             HHHHhhccccCcchhh
Confidence            9999999999999864

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-33  Score=251.80  Aligned_cols=227  Identities=23%  Similarity=0.300  Sum_probs=184.4

Q ss_pred             ccccccCCccee--eccCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFF--FLHSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~--~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++++.||.++-.  ...+++||||++.+.   .+......+|+++|++++||.||.+.-.|+.....++|||-+.| +..
T Consensus       572 LGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DML  650 (888)
T KOG4236|consen  572 LGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DML  650 (888)
T ss_pred             ccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHH
Confidence            455555555433  334566999999753   34446788999999999999999999999999999999999965 555


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC---CCeeEeccccceeccCCccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +.|-+..    ...+++..-+.+..||+.||.|||-   ++|+|+|+||+|+|+.+.   ..+||+|||.|++.++... 
T Consensus       651 EMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  651 EMILSSE----KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHhh----cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            5554333    3779999999999999999999999   999999999999999754   3589999999999876543 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        +...+||+.|+|||++        -|+||.|+|+|--++|-.||+...+...+          +   +...+...+..
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----------I---QNAaFMyPp~P  787 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----------I---QNAAFMYPPNP  787 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH----------h---hccccccCCCc
Confidence              4677899999999999        69999999999999999999877654432          2   23334455667


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..+++....++|...||.+-++|-|.+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvd  814 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVD  814 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence            788899999999999999999988764

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=1.5e-32  Score=249.97  Aligned_cols=244  Identities=19%  Similarity=0.200  Sum_probs=168.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC--------CceeEEE
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--------NRRTLIY  177 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~  177 (363)
                      .++.+++|.++.+...  ++.+|||++....   .....+.+|++++++++|+||+++++++.+.        ...++++
T Consensus        15 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~   94 (311)
T cd07866          15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT   94 (311)
T ss_pred             EeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEE
Confidence            3455555555544433  3449999886332   1234678999999999999999999987543        3469999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||+.+ +|...+...     ...+++..+..++.|+++||+|||+   .+++|+||||+||++++++.++|+|||++...
T Consensus        95 ~~~~~-~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          95 PYMDH-DLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             ecCCc-CHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            99965 777776432     2569999999999999999999999   99999999999999999999999999999866


Q ss_pred             cCCccccc---------cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH----
Q 039471          258 SKDISIVS---------RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE----  315 (363)
Q Consensus       258 ~~~~~~~~---------~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~----  315 (363)
                      ........         .....++..|+|||.+         +|+||||+++|||++|++||..............    
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            54322111         1223467889999975         7999999999999999999875443221000000    


Q ss_pred             ---HHHH---Hhhhcc--ccccccCCC---CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 ---WIYN---RMRLGQ--ELCLDFEED---GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 ---~~~~---~~~~~~--~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         +.+.   .+....  .........   ......+.+.+++.+||+.+|++|||+.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e  304 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD  304 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence               0000   000000  000000000   01123367889999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=1.8e-32  Score=253.08  Aligned_cols=241  Identities=22%  Similarity=0.250  Sum_probs=166.6

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeC--------------Ccee
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--------------NRRT  174 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------------~~~~  174 (363)
                      ++.+++|.++.+...  +..||+|.+.... ...+.+.+|++++++++|+||+++++.+...              ...+
T Consensus        13 Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (342)
T cd07854          13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY   92 (342)
T ss_pred             ecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEE
Confidence            444455444433332  3449999886433 3446788999999999999999999876543              3578


Q ss_pred             EEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEecccc
Q 039471          175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGL  253 (363)
Q Consensus       175 lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~  253 (363)
                      +++||++ ++|.+++..       ..+++..++.++.||+.||+|||+   .+++||||||+||+++ .++.+||+|||.
T Consensus        93 lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          93 IVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             EEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCccc
Confidence            9999997 589888731       358999999999999999999999   9999999999999998 456789999999


Q ss_pred             ceeccCCcccc-ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch--------H-
Q 039471          254 AKLCSKDISIV-SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------P-  314 (363)
Q Consensus       254 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~-  314 (363)
                      ++......... ......++..|+|||.+         +|+||||+++|||++|+.||............        . 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            98654322111 11223478889999975         79999999999999999999754332211000        0 


Q ss_pred             ---HH---HHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          315 ---EW---IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       315 ---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ..   .......................+.++.+++.+||+.||++|||++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  296 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE  296 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence               00   00000000000000000011234567889999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.1e-32  Score=251.39  Aligned_cols=242  Identities=21%  Similarity=0.229  Sum_probs=174.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCC-----ceeEEEeccC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN-----RRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~  181 (363)
                      ++.+++|.+..+...  +..||||++...   ....+.+.+|+.++++++|+||+++++++....     ..+++|||++
T Consensus         8 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   87 (330)
T cd07834           8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME   87 (330)
T ss_pred             ecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh
Confidence            445555555555433  345999988743   234468899999999999999999999987764     7899999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||.+.......
T Consensus        88 -~~l~~~l~~------~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          88 -TDLHKVIKS------PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             -hhHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence             489888832      2479999999999999999999999   999999999999999999999999999998776543


Q ss_pred             cc-cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHH------
Q 039471          262 SI-VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWI------  317 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~------  317 (363)
                      .. .......++..|+|||.+         +|+||||+++++|++|+.||............        ++..      
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence            10 011334578889999986         89999999999999999999765432110000        0000      


Q ss_pred             --HHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 --YNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...+..................+..+.+++.+||+++|++|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  285 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE  285 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence              0000000000000000011225678999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.2e-32  Score=251.40  Aligned_cols=237  Identities=19%  Similarity=0.246  Sum_probs=169.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCC------ceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGN------RRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e  178 (363)
                      ..++.+++|.++.+...  +..||||++.....   ..+.+.+|+.++++++|+||+++++++....      ..++|||
T Consensus        21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  100 (343)
T cd07880          21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP  100 (343)
T ss_pred             EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence            33455555555444332  34499998854221   2356889999999999999999999986543      4589999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+ +++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++|+|||++....
T Consensus       101 ~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880         101 FM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            99 6799888732       458999999999999999999999   999999999999999999999999999988654


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHHHHHh
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWIYNRM  321 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~~~~~  321 (363)
                      ...     ....++..|+|||.+         +|+||||+++|++++|+.||...........        ..++. ..+
T Consensus       170 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~  243 (343)
T cd07880         170 SEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV-QKL  243 (343)
T ss_pred             cCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH-Hhh
Confidence            322     234578889999975         7999999999999999999975432211000        00000 000


Q ss_pred             hhcc--cc---ccccC----CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQ--EL---CLDFE----EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~--~~---~~~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....  ..   .....    .......+..+.+++.+|++.||++|||+.|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~  294 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE  294 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence            0000  00   00000    0011234567899999999999999999753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=7.3e-32  Score=248.02  Aligned_cols=241  Identities=21%  Similarity=0.187  Sum_probs=169.8

Q ss_pred             ccccccCCcceeeccCC----eeEEEEcccCC---cChhHHHHHHHHHhcc-CCCceeeeeeeeee----CCceeEEEec
Q 039471          112 LISFNLTNSKFFFLHSN----EIAVKMLEHLK---GNGQEFINEVATIGRI-HHFHIVRLLGFCSE----GNRRTLIYEF  179 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~----~vAvK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~  179 (363)
                      ++.+++|.++.+...+.    .||+|.+....   ...+.+.+|+.+++++ +|+||+++++.+..    ....++++||
T Consensus         8 lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~   87 (332)
T cd07857           8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEEL   87 (332)
T ss_pred             ccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEec
Confidence            45556666655554433    59999886422   2245788999999999 59999999987532    2457888998


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +. ++|.+++.      ....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        88 ~~-~~L~~~l~------~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          88 ME-ADLHQIIR------SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             cc-CCHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            86 68999883      23568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             Ccccc--ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHHHHH
Q 039471          260 DISIV--SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWIYNR  320 (363)
Q Consensus       260 ~~~~~--~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~~~~  320 (363)
                      .....  ......|+..|+|||.+         +|+||+|+++|+|++|..||..........        ...++. ..
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  236 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL-SR  236 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH-Hh
Confidence            32211  11234688999999975         699999999999999999987543211000        000010 00


Q ss_pred             hhhcc---------ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQ---------ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~---------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +....         ..............+..+.+++.+||+.+|++|||++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~  288 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE  288 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            00000         00000000011123567999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-32  Score=239.31  Aligned_cols=237  Identities=22%  Similarity=0.308  Sum_probs=178.9

Q ss_pred             ccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhc--cCCCceeeeeeeeeeC----CceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGR--IHHFHIVRLLGFCSEG----NRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~e~~~~~sL  185 (363)
                      +|.+.||.+....++++.||||++...  ..+.+.+|.++++.  |+|+||+.+++.-..+    .++|||.+|.++|||
T Consensus       219 IGkGRyGEVwrG~wrGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL  296 (513)
T KOG2052|consen  219 IGKGRFGEVWRGRWRGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSL  296 (513)
T ss_pred             ecCccccceeeccccCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcH
Confidence            566777777777888999999999732  34567788887775  5999999999886433    278999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ-----GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++|+..       ..++.+.+.+++..++.||++||.     +-+..|.|||||..|||+.+++..-|+|+|+|...+.+
T Consensus       297 ~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~  369 (513)
T KOG2052|consen  297 YDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD  369 (513)
T ss_pred             HHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence            999932       568999999999999999999995     11357999999999999999999999999999887766


Q ss_pred             cccc--ccccccccccccCCccc--------------cCceehhHHHHHHhcC----------CCCCCcchhcccccchH
Q 039471          261 ISIV--SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGC----------RKNNDPAVEIQSQIYFP  314 (363)
Q Consensus       261 ~~~~--~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g----------~~~~~~~~~~~~~~~~~  314 (363)
                      ....  ..+..+||..|||||++              .||||||.|+||++-+          ..||+.-...+-.  +.
T Consensus       370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs--~e  447 (513)
T KOG2052|consen  370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS--FE  447 (513)
T ss_pred             CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC--HH
Confidence            4332  23556799999999999              7999999999999742          2444433222211  11


Q ss_pred             HHHHHHhhhccccccccCCC-CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          315 EWIYNRMRLGQELCLDFEED-GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +  ...+.-.+...+..+.. ...+....+.++++-||..||.-|-|+
T Consensus       448 e--MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  448 E--MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             H--HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence            1  01111122233333333 455778889999999999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.8e-32  Score=250.85  Aligned_cols=236  Identities=19%  Similarity=0.250  Sum_probs=166.9

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEe
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  178 (363)
                      ..++.+++|.++.+..  .+..||||++...   ......+.+|+.++++++|+||+++++++...      ...++++|
T Consensus        21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e  100 (342)
T cd07879          21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP  100 (342)
T ss_pred             EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence            3445555555544432  3455999988642   22235688999999999999999999998654      34689999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+.. +|..+..        ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus       101 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879         101 YMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             cccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            9964 7777651        358999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHHHHHh
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWIYNRM  321 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~~~~~  321 (363)
                      ...     ....++..|+|||.+         +|+||||+++|||++|+.||...........        .+.+. +.+
T Consensus       169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~  242 (342)
T cd07879         169 AEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV-QKL  242 (342)
T ss_pred             CCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH-HHh
Confidence            321     234578889999975         7999999999999999999975432111000        00000 000


Q ss_pred             hhc--cc---cccccCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLG--QE---LCLDFEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~--~~---~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...  ..   ........    .....+..+.+++.+||+.||++|||++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e  293 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATE  293 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            000  00   00000000    01124567899999999999999999764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=8.6e-32  Score=246.98  Aligned_cols=235  Identities=20%  Similarity=0.234  Sum_probs=167.7

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeee-CCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.+..+..  .++.||+|++...   ....+.+.+|+.++++++|+||+++++++.. +...++++||+ +++|
T Consensus        18 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L   96 (328)
T cd07856          18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDL   96 (328)
T ss_pred             ecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCH
Confidence            34444444444332  3444999987532   2334678899999999999999999999865 56789999999 5689


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..       ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+.......    
T Consensus        97 ~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~----  162 (328)
T cd07856          97 HRLLTS-------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM----  162 (328)
T ss_pred             HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc----
Confidence            888731       357888999999999999999999   999999999999999999999999999987543321    


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHHHHHhhhcccc-
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWIYNRMRLGQEL-  327 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-  327 (363)
                       ....++..|+|||.+         +|+||||+++|||++|+.||...........        ..++... ...+... 
T Consensus       163 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  240 (328)
T cd07856         163 -TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT-ICSENTLR  240 (328)
T ss_pred             -CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh-ccchhhHH
Confidence             233467889999975         7999999999999999999865432111000        0111100 0000000 


Q ss_pred             ---ccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 ---CLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ---~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         .......     .....+..+.+++.+||+.+|++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e  284 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE  284 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence               0000000     11124578999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-33  Score=261.12  Aligned_cols=211  Identities=25%  Similarity=0.431  Sum_probs=179.7

Q ss_pred             eEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHH
Q 039471          130 IAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR  207 (363)
Q Consensus       130 vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~  207 (363)
                      ||||++....  +..+++.+|.-+|.++.|+|+++++|+|.... .-||++||+.|+|.+|++.++     ..+..+.++
T Consensus       728 VaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-----~~igsq~lL  801 (1177)
T KOG1025|consen  728 VAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-----DNIGSQDLL  801 (1177)
T ss_pred             eEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh-----ccccHHHHH
Confidence            9999997544  34689999999999999999999999997765 778999999999999997654     568889999


Q ss_pred             HHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc------
Q 039471          208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF------  281 (363)
Q Consensus       208 ~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~------  281 (363)
                      .|+.||++||.|||.   ++++||||..+|+|+.+-..+||.|||+++....+..........-.+.|+|-|.+      
T Consensus       802 nw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~t  878 (1177)
T KOG1025|consen  802 NWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYT  878 (1177)
T ss_pred             HHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCC
Confidence            999999999999999   99999999999999999999999999999999887765554545556789999988      


Q ss_pred             --cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 039471          282 --SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTER  358 (363)
Q Consensus       282 --~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (363)
                        +|||||||.+||++| |..|++.....+        +.+.++.+.++      ..++.++-++.-++.+||..|+..|
T Consensus       879 hqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geRL------sqPpiCtiDVy~~mvkCwmid~~~r  944 (1177)
T KOG1025|consen  879 HQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGERL------SQPPICTIDVYMVMVKCWMIDADSR  944 (1177)
T ss_pred             chhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhccccC------CCCCCccHHHHHHHHHHhccCcccC
Confidence              999999999999996 778877654332        44455555553      4567788889999999999999999


Q ss_pred             CCCCC
Q 039471          359 PSMPM  363 (363)
Q Consensus       359 Ps~~e  363 (363)
                      |+++|
T Consensus       945 p~fke  949 (1177)
T KOG1025|consen  945 PTFKE  949 (1177)
T ss_pred             ccHHH
Confidence            99864

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7.7e-32  Score=241.81  Aligned_cols=241  Identities=23%  Similarity=0.266  Sum_probs=174.8

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.++.....  ++.+|+|++...   ....+.+.+|+.++++++|+|++++++++.+....++|+||++ ++|.
T Consensus         7 ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~   85 (282)
T cd07829           7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLK   85 (282)
T ss_pred             ccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHH
Confidence            344455555444433  445999998754   3334678899999999999999999999999999999999997 5999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+.........  .
T Consensus        86 ~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~  155 (282)
T cd07829          86 KYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--Y  155 (282)
T ss_pred             HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--c
Confidence            9995432     468999999999999999999999   99999999999999999999999999998876543321  1


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchH-------HHHHHHhhhc---ccc
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFP-------EWIYNRMRLG---QEL  327 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~~---~~~  327 (363)
                      ....++..|+|||.+         +|+||||++++||++|+.||.............       +..+..+..-   ...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            233456789999976         799999999999999999986644221100000       0000000000   000


Q ss_pred             ccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......    ......+..+.+++.+||+.+|++||+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~  275 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE  275 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence            000000    011123678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-33  Score=251.81  Aligned_cols=224  Identities=22%  Similarity=0.264  Sum_probs=191.8

Q ss_pred             ccccccCCcceeeccCCe--eEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLHSNE--IAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~--vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+|||.+-.|...++.  +|+|++++.    ..+.+....|-.+|...+.+.||++|..|.++...|+.||-|-||.|
T Consensus       428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl  507 (732)
T KOG0614|consen  428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL  507 (732)
T ss_pred             cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchh
Confidence            456777777788887777  799988642    33445677899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ...++      +++.|.+...+.++..++.|++|||+   ++||.||+||+|++++.+|-+||.|||+|+.+..+..++ 
T Consensus       508 WTiLr------dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw-  577 (732)
T KOG0614|consen  508 WTILR------DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW-  577 (732)
T ss_pred             hhhhh------hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCcee-
Confidence            99993      44679999999999999999999999   999999999999999999999999999999998877653 


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                        +..||+.|.|||++        .|.||||+++|||++|.+||...+...        .|+.+.+|-+..     ..+.
T Consensus       578 --TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------tYn~ILkGid~i-----~~Pr  642 (732)
T KOG0614|consen  578 --TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------TYNLILKGIDKI-----EFPR  642 (732)
T ss_pred             --eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--------HHHHHHhhhhhh-----hccc
Confidence              46699999999999        799999999999999999998876543        566666654432     3456


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      .+.+...+++++....+|.+|.-
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhc
Confidence            67778889999999999999963

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=246.51  Aligned_cols=237  Identities=19%  Similarity=0.255  Sum_probs=167.0

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEec
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~  179 (363)
                      .++.+++|.+..+..  .+..||+|++....   ...+.+.+|+.++++++|+||+++++++...      ...++++++
T Consensus        24 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~  103 (345)
T cd07877          24 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL  103 (345)
T ss_pred             EeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehh
Confidence            345555555544432  23449999986432   2245788999999999999999999987543      346788887


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      + +++|.+++..       ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.....
T Consensus       104 ~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877         104 M-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             c-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            7 7799888731       358999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch-------HHHHHHHhhh
Q 039471          260 DISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF-------PEWIYNRMRL  323 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~-------~~~~~~~~~~  323 (363)
                      ..     ....++..|+|||.+         +|+||||+++|||++|+.||...........+       +......+..
T Consensus       173 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 EM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             cc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            21     234578899999975         79999999999999999998643321110000       0001100000


Q ss_pred             cc--cc---ccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQ--EL---CLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~--~~---~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..  ..   ......    ......++.+.+++.+|++.+|.+|||++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  296 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ  296 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence            00  00   000000    001123567899999999999999999753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5e-32  Score=250.19  Aligned_cols=235  Identities=20%  Similarity=0.271  Sum_probs=169.1

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCc------eeEEEecc
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNR------RTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~  180 (363)
                      ++.+++|.++.+...  +..||||++...   ....+.+.+|+.++++++|+|++++++++.....      .++|+||+
T Consensus        23 ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~  102 (343)
T cd07851          23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM  102 (343)
T ss_pred             eccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC
Confidence            344455544444433  344999998642   2233567789999999999999999998765544      89999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                       +++|.+++..       ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus       103 -~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (343)
T cd07851         103 -GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE  171 (343)
T ss_pred             -CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence             5699998842       468999999999999999999999   99999999999999999999999999999876443


Q ss_pred             ccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHHHHHhhh
Q 039471          261 ISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWIYNRMRL  323 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~~~~~~~  323 (363)
                      .     ....++..|+|||.+         +|+||||+++|||++|+.||...........        .+++. ..+..
T Consensus       172 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~  245 (343)
T cd07851         172 M-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL-QKISS  245 (343)
T ss_pred             c-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH-hhccc
Confidence            1     334578889999975         7999999999999999999865432211000        00110 00000


Q ss_pred             cc------ccccccCCC---CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQ------ELCLDFEED---GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~------~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..      .........   .....+.++.+++.+||+.+|++|||++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e  294 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE  294 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence            00      000000000   01123678999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-32  Score=233.47  Aligned_cols=223  Identities=20%  Similarity=0.234  Sum_probs=179.0

Q ss_pred             ccccccCCcceeeccCC-----eeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLHSN-----EIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+|.|+.+.+.+..+     -+|+|++++.-    .....-+.|-++|+..+||.+..+--.|+.+.++++||||..|
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG  252 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG  252 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence            44556677777665433     29999997532    1223446789999999999999998899999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |.|.-++.      ..+.+++...+.+-..|+.||.|||+   .+|+.||+|.+|.|+|.+|.+||+|||+++..-....
T Consensus       253 GeLf~HLs------rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  253 GELFFHLS------RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             ceEeeehh------hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            99998883      34679999999999999999999999   9999999999999999999999999999987554433


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....||+.|+|||++        .|-|.+|+++|||++|+.||+..+...        +...+..+       +..
T Consensus       324 t--~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLIl~e-------d~k  386 (516)
T KOG0690|consen  324 T--TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELILME-------DLK  386 (516)
T ss_pred             e--eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHHHhh-------hcc
Confidence            2  3667899999999999        677999999999999999998765432        11111111       123


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      .+..++++...++...|..||.+|.-
T Consensus       387 FPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  387 FPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             CCccCCHHHHHHHHHHhhcChHhhcC
Confidence            45677788899999999999999953

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=210.61  Aligned_cols=239  Identities=21%  Similarity=0.259  Sum_probs=172.8

Q ss_pred             ccccccCCcceeeccCCe-----eEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          112 LISFNLTNSKFFFLHSNE-----IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~-----vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ...+|.|+.+.++...+.     ||+|.+.-.   ++--....+|+-+++.++|.|||++++....++.+.+|+|||. .
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence            344555566555543322     999988633   2333678999999999999999999999999999999999995 5


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+|..+.+     +.++.+.++.++.|+++||.|+|+   .++.|||+||.|.|++.+|..|++|||+++-+.-...-
T Consensus        86 dlkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   86 DLKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            9999986554     678999999999999999999999   99999999999999999999999999999877543321


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccc------
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL------  327 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  327 (363)
                        -.....|.+|++|.++         .|+||-||++.|+.. |++.|.+.+. ..+....-|......+.+-.      
T Consensus       158 --ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             --eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccCC
Confidence              1344578999999998         699999999999996 4554544332 22221111111111110000      


Q ss_pred             ----ccccC-CCCc----HHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          328 ----CLDFE-EDGD----EGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       328 ----~~~~~-~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                          -+... ....    +.+...=.+++.+.+.-+|..|.+++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae  278 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE  278 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence                00000 0011    22233457889999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=7.4e-31  Score=260.90  Aligned_cols=137  Identities=23%  Similarity=0.281  Sum_probs=115.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  +..||||++.....    ..+.+.+|+.+++.++|+||+++++++......++||||+.++
T Consensus        10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~   89 (669)
T cd05610          10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG   89 (669)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence            34455555555555444  44599999874322    1257888999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      +|.+++..      ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~L~~li~~------~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          90 DVKSLLHI------YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999943      2458899999999999999999999   999999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.1e-30  Score=228.29  Aligned_cols=213  Identities=23%  Similarity=0.365  Sum_probs=170.2

Q ss_pred             CeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHH
Q 039471          128 NEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK  205 (363)
Q Consensus       128 ~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~  205 (363)
                      +.+|+|++......  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++...      ..+++..
T Consensus        15 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~------~~~~~~~   88 (244)
T smart00220       15 KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR------GRLSEDE   88 (244)
T ss_pred             cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc------cCCCHHH
Confidence            55999999754332  578999999999999999999999999989999999999999999998432      2389999


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc----
Q 039471          206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----  281 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----  281 (363)
                      +..++.+++.++.+||+   .+++|+||+|+||++++++.++|+|||.+........   .....++..|++||..    
T Consensus        89 ~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pE~~~~~~  162 (244)
T smart00220       89 ARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTPEYMAPEVLLGKG  162 (244)
T ss_pred             HHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCcCCCCHHHHccCC
Confidence            99999999999999999   9999999999999999999999999999988765432   1344578899999976    


Q ss_pred             ----cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCC
Q 039471          282 ----SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE  357 (363)
Q Consensus       282 ----~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  357 (363)
                          +|+||||++++++++|..|+........       +.+.+..+...    .......++.++.+++.+|+..+|++
T Consensus       163 ~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-------~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~  231 (244)
T smart00220      163 YGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-------LFKKIGKPKPP----FPPPEWKISPEAKDLIRKLLVKDPEK  231 (244)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHhccCCC----CccccccCCHHHHHHHHHHccCCchh
Confidence                8999999999999999999865322111       22222211110    00011115678999999999999999


Q ss_pred             CCCCCC
Q 039471          358 RPSMPM  363 (363)
Q Consensus       358 RPs~~e  363 (363)
                      ||++.|
T Consensus       232 Rp~~~~  237 (244)
T smart00220      232 RLTAEE  237 (244)
T ss_pred             ccCHHH
Confidence            999864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=255.63  Aligned_cols=219  Identities=25%  Similarity=0.253  Sum_probs=167.1

Q ss_pred             eeccCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCC
Q 039471          123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL  201 (363)
Q Consensus       123 ~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l  201 (363)
                      ..+.++.||||++-..  ...-+.+|+..|+.- .|+|||++|+.-.+....||..|.|. .+|.+++.....  .....
T Consensus       529 G~ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~--d~~~~  603 (903)
T KOG1027|consen  529 GVYEGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGL--DVEMQ  603 (903)
T ss_pred             EeeCCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhcccc--chhhc
Confidence            4566778999988632  234556999999877 49999999999899999999999996 599999966311  11111


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---C--CCeeEeccccceeccCCccccc-cccccccccc
Q 039471          202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---N--FQPKISDFGLAKLCSKDISIVS-RTAARGTSGY  275 (363)
Q Consensus       202 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~--~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~y  275 (363)
                      ..-..+.+..|++.||++||+   .+|+|||+||.||||+.   +  ..++|+|||+++.+..+..... .....||.+|
T Consensus       604 ~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW  680 (903)
T KOG1027|consen  604 SDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGW  680 (903)
T ss_pred             ccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccc
Confidence            114457788999999999999   99999999999999975   3  4689999999999987654332 3566799999


Q ss_pred             cCCccc--------cCceehhHHHHHHhcC-CCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          276 IAPELF--------SRNFCYGMMLLEMVGC-RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       276 ~aPE~~--------~Di~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      +|||++        .||||+||++|+.++| ..||......+.          ++..+........+..+.    +..++
T Consensus       681 ~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~L~~L~~~~d~----eA~dL  746 (903)
T KOG1027|consen  681 QAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYTLVHLEPLPDC----EAKDL  746 (903)
T ss_pred             cCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCccceeeeccCchH----HHHHH
Confidence            999999        6999999999999976 788877655432          222233222222222211    68899


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      |.+|++++|..|||+.+
T Consensus       747 I~~ml~~dP~~RPsa~~  763 (903)
T KOG1027|consen  747 ISRMLNPDPQLRPSATD  763 (903)
T ss_pred             HHHhcCCCcccCCCHHH
Confidence            99999999999999863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.7e-31  Score=244.84  Aligned_cols=203  Identities=20%  Similarity=0.290  Sum_probs=164.3

Q ss_pred             CCCCcccccccccCCcceeeccCCe-----eEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeE
Q 039471          105 TACPFQSLISFNLTNSKFFFLHSNE-----IAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL  175 (363)
Q Consensus       105 ~~c~~~~~~~~~~~~~~~~~~~~~~-----vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  175 (363)
                      ...-|.++..+|.|..+.|.+..+-     +|+|.+.+.    +........|-.||..-.++-||+||-.|.++..+|+
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF  706 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF  706 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence            3456777888888888887764332     899998642    2233455678899999999999999999999999999


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ||+|++||++-.+|.      +-+.|.|...+.++.++..|+++.|+   .|+|||||||+|||||.+|.+||+|||++.
T Consensus       707 VMdYIPGGDmMSLLI------rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLI------RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             EEeccCCccHHHHHH------HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccc
Confidence            999999999999984      34679999999999999999999999   999999999999999999999999999986


Q ss_pred             eccCC--ccc--------------------------------------cccccccccccccCCccc--------cCceeh
Q 039471          256 LCSKD--ISI--------------------------------------VSRTAARGTSGYIAPELF--------SRNFCY  287 (363)
Q Consensus       256 ~~~~~--~~~--------------------------------------~~~~~~~gt~~y~aPE~~--------~Di~sl  287 (363)
                      -+...  ..+                                      ......+||..|+|||++        +|-||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            53210  000                                      001123699999999998        899999


Q ss_pred             hHHHHHHhcCCCCCCcchhcccccchHHH
Q 039471          288 GMMLLEMVGCRKNNDPAVEIQSQIYFPEW  316 (363)
Q Consensus       288 G~il~el~~g~~~~~~~~~~~~~~~~~~~  316 (363)
                      |+|||||+.|+.||-.......+.....|
T Consensus       858 gvil~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence            99999999999999776666555444444

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6e-31  Score=212.17  Aligned_cols=191  Identities=25%  Similarity=0.295  Sum_probs=154.2

Q ss_pred             CcccccccccCCcceeeccCCe--eEEEEcccCCcC--hhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNE--IAVKMLEHLKGN--GQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~--vAvK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ....++.+++|.+.......++  .|+|.+...-.+  ..+.++|+.+..+. .+|.+|++||........|+.||.|. 
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-  128 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-  128 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence            3445666666666665555444  999999754333  34677888887655 59999999999999999999999995 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .||..+-..--  ..+..++|..+-+|+..+.+||.|||+  +..++|||+||+|||++.+|.+|+||||.+-.+.+...
T Consensus       129 tSldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  129 TSLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             hhHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            58887764432  345789999999999999999999999  58999999999999999999999999999887755432


Q ss_pred             ccccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          263 IVSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      .   +...|...|+|||.+            |||||||+.+.||++++.|++....
T Consensus       205 k---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  205 K---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             H---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            2   334578899999998            8999999999999999999876543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-30  Score=229.69  Aligned_cols=237  Identities=22%  Similarity=0.300  Sum_probs=180.1

Q ss_pred             CcccccccccCCcceeec--cCCeeEEEEcccCCcCh--------hHHHHHHHHHhccCCCceeeeeeeee-eCCceeEE
Q 039471          108 PFQSLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNG--------QEFINEVATIGRIHHFHIVRLLGFCS-EGNRRTLI  176 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv  176 (363)
                      .+..++.+||+.++..+-  ..+-||||+-...+.+.        +...+|.++-+.|.|+.||++|++|. +.+.++-|
T Consensus       467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence            344467777777765543  33449999875333222        34568999999999999999999996 55678999


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEecccc
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGL  253 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~  253 (363)
                      +|||+|.+|+-|+      ..++.+++.+.+.|+.||+.||.||... ...|||.|+||.|||+.+   -|.+||+|||+
T Consensus       547 LEYceGNDLDFYL------KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  547 LEYCEGNDLDFYL------KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             eeecCCCchhHHH------HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            9999999999999      4457799999999999999999999862 368999999999999954   47799999999


Q ss_pred             ceeccCCccccc-----cccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH
Q 039471          254 AKLCSKDISIVS-----RTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW  316 (363)
Q Consensus       254 a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  316 (363)
                      ++++..+.....     .....||.+|++||.+            .||||.|+|+|.++.|+.||..........     
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL-----  694 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL-----  694 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH-----
Confidence            999876543211     2345699999999988            799999999999999999998765433210     


Q ss_pred             HHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          317 IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      -++-+.+..++.+..    .+-.+.+...+|++||++.-++|..
T Consensus       695 qeNTIlkAtEVqFP~----KPvVsseAkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  695 QENTILKATEVQFPP----KPVVSSEAKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             hhhchhcceeccCCC----CCccCHHHHHHHHHHHHhhhhhhhh
Confidence            111222223333322    3345667889999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=6.1e-31  Score=237.67  Aligned_cols=245  Identities=20%  Similarity=0.220  Sum_probs=187.7

Q ss_pred             CcccccccccCCcceeecc-----CCeeEEEEcccCCcChhHHHHHHHHHhccC------CCceeeeeeeeeeCCceeEE
Q 039471          108 PFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNGQEFINEVATIGRIH------HFHIVRLLGFCSEGNRRTLI  176 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~lv  176 (363)
                      .|...+..|.|-.+.|...     +..||||++.+.+...+.=+.|+++|++|+      -.|+++++..|...++++||
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV  512 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV  512 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence            4555555666666655543     345999999988777777789999999996      35899999999999999999


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccce
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAK  255 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~  255 (363)
                      +|.+ ..+|.+.+.....   +-.|....+..++.|+..||+.|-.   .+|+|.||||+|||+++. ..+||||||.|.
T Consensus       513 FE~L-slNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  513 FEPL-SLNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ehhh-hchHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCcccc
Confidence            9998 5799999976543   3678889999999999999999999   999999999999999865 457999999998


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH----HHHhhh
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI----YNRMRL  323 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~  323 (363)
                      ..+.+..    +....+.+|+|||++        .|+||.||+||||.||+..|.+...+...-++++..    ...+.+
T Consensus       586 ~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  586 FASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             ccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            8876653    344567899999999        799999999999999999998877666544332221    001111


Q ss_pred             cccccc--------------------------c---------------cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          324 GQELCL--------------------------D---------------FEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       324 ~~~~~~--------------------------~---------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ++....                          .               ..+........+|.+|+.+|+..||++|.|..
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence            110000                          0               01223345567799999999999999999865


Q ss_pred             C
Q 039471          363 M  363 (363)
Q Consensus       363 e  363 (363)
                      |
T Consensus       742 q  742 (752)
T KOG0670|consen  742 Q  742 (752)
T ss_pred             H
Confidence            3

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.5e-31  Score=220.50  Aligned_cols=241  Identities=21%  Similarity=0.318  Sum_probs=174.8

Q ss_pred             cccccccccCCcceeecc-----CCeeEEEEccc---CCcChhHHHHHHHHHhccCCCceeeeeeeeee--------CCc
Q 039471          109 FQSLISFNLTNSKFFFLH-----SNEIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSE--------GNR  172 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~  172 (363)
                      +.++...|.|..+-|+..     ++.||+|++-.   ..+.....++|+++|..++|+|++.++..|..        ...
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            344555666666644432     23388887632   33445678899999999999999999998842        235


Q ss_pred             eeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          173 RTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       173 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      +++||.+|+. +|..++.     +....++...+..++.+++.||.|+|.   ..|+|||+||.|+||+.++.+||+|||
T Consensus        99 ~ylVf~~ceh-DLaGlLs-----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLS-----NRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeHHHhhh-hHHHHhc-----CccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence            8999999986 8988883     333679999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCcccc-c-cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-----
Q 039471          253 LAKLCSKDISIV-S-RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-----  316 (363)
Q Consensus       253 ~a~~~~~~~~~~-~-~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-----  316 (363)
                      +++.++...... . -+..+.|..|++||.+         .|+|.-||++.||++|.+.+.+..+......+...     
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            997765432211 1 1233458999999998         79999999999999999998887665432221111     


Q ss_pred             -----------HHHHhhhccccccccCCCCc---HHH------HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          317 -----------IYNRMRLGQELCLDFEEDGD---EGI------ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       317 -----------~~~~~~~~~~~~~~~~~~~~---~~~------~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                 +++.++..     .......   .+.      .+..++++.+++..||.+|++++|
T Consensus       250 kevWP~~d~lpL~~sie~e-----Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELE-----PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             cccCCCcccchHHHhccCC-----CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence                       11111100     0000000   111      236789999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-30  Score=227.28  Aligned_cols=221  Identities=20%  Similarity=0.259  Sum_probs=175.1

Q ss_pred             ccccCCcceeeccCC---e--eEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          114 SFNLTNSKFFFLHSN---E--IAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       114 ~~~~~~~~~~~~~~~---~--vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .+|.|+.+.+.+..+   +  +|||++++.    ....+.-..|-++|.-. +-|.++++..+|+.-+++|+||||+.||
T Consensus       356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG  435 (683)
T KOG0696|consen  356 VLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG  435 (683)
T ss_pred             EeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence            345555566655433   2  999999753    22334445677777755 4678899999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|--.+      .+-+.+.+....-++.+|+-||-|||+   .+|+.||+|.+|+|+|.+|.+||+|||+++.---+.. 
T Consensus       436 DLMyhi------QQ~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~-  505 (683)
T KOG0696|consen  436 DLMYHI------QQVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV-  505 (683)
T ss_pred             hhhhHH------HHhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccCCc-
Confidence            999888      344678999999999999999999999   9999999999999999999999999999986433322 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                       +..+..||+.|+|||++        .|-||||++||||+.|.+||++.++..        +...+...       ....
T Consensus       506 -TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI~eh-------nvsy  569 (683)
T KOG0696|consen  506 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAIMEH-------NVSY  569 (683)
T ss_pred             -ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHHc-------cCcC
Confidence             23667899999999999        799999999999999999999877643        22222211       1235


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      +..++++...+....|...|.+|.-
T Consensus       570 PKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  570 PKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cccccHHHHHHHHHHhhcCCccccC
Confidence            6677888888899999999999853

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3.7e-30  Score=210.70  Aligned_cols=222  Identities=18%  Similarity=0.324  Sum_probs=169.8

Q ss_pred             ccCCeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeeeC--CceeEEEeccCCCCHHHHhhhcCCCCCCCCC
Q 039471          125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEG--NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL  201 (363)
Q Consensus       125 ~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l  201 (363)
                      ..++.++||+++..  ..+.+.+|+++|..|+ |+||+++++...+.  ....||+||..+.+...+.         ..+
T Consensus        61 ~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---------~tl  129 (338)
T KOG0668|consen   61 TNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---------PTL  129 (338)
T ss_pred             CCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---------hhh
Confidence            44556999999844  3467889999999998 99999999998654  4678999999998887776         678


Q ss_pred             CHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccCCccccccccccccccccCCcc
Q 039471          202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL  280 (363)
Q Consensus       202 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  280 (363)
                      +...+...+.++++||+|+|+   .||.|||+||+|+++|. .-.++|+|+|+|.++.++....   ..+.+..|--||+
T Consensus       130 ~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPEL  203 (338)
T KOG0668|consen  130 TDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPEL  203 (338)
T ss_pred             chhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCceee---eeeehhhcCCchh
Confidence            888999999999999999999   99999999999999995 4579999999999998876653   3346778899999


Q ss_pred             c---------cCceehhHHHHHHhcCCCCCCcchhcccccc-hHHHH-----HHHhh---------------hcccc-cc
Q 039471          281 F---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY-FPEWI-----YNRMR---------------LGQEL-CL  329 (363)
Q Consensus       281 ~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~-~~~~~-----~~~~~---------------~~~~~-~~  329 (363)
                      +         -|+|||||++..|+..+.||....++..+.. +...+     +..+.               ...+. ..
T Consensus       204 LVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~  283 (338)
T KOG0668|consen  204 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS  283 (338)
T ss_pred             eeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHH
Confidence            8         5899999999999999999876554443321 11110     00000               00000 00


Q ss_pred             cc-CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DF-EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+ ..+..+-.+++..+++.+.|..|-.+|||++|
T Consensus       284 ~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  284 RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             HhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence            11 12222334588999999999999999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.3e-29  Score=246.32  Aligned_cols=248  Identities=15%  Similarity=0.086  Sum_probs=151.8

Q ss_pred             CcccccccccCCcceeeccC------CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeee------eeeCCceeE
Q 039471          108 PFQSLISFNLTNSKFFFLHS------NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF------CSEGNRRTL  175 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~------~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~~~~l  175 (363)
                      ....++.+++|.++.+...+      ..||||++..... .+.+.+|  .+.+..+.++..++..      ...+...++
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L  212 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL  212 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence            34456667777766665544      3599998764321 2222222  1222222233222221      245568999


Q ss_pred             EEeccCCCCHHHHhhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc
Q 039471          176 IYEFMPNGSLQKFIFSKTNS--------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~  241 (363)
                      |+||+++++|.+++......              .......+..+..++.|++.||+|||+   .+|+||||||+|||++
T Consensus       213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~  289 (566)
T PLN03225        213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFS  289 (566)
T ss_pred             EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEe
Confidence            99999999999998643210              001122345577899999999999999   9999999999999998


Q ss_pred             C-CCCeeEeccccceeccCCccccccccccccccccCCccc------------------------------cCceehhHH
Q 039471          242 H-NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF------------------------------SRNFCYGMM  290 (363)
Q Consensus       242 ~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~------------------------------~Di~slG~i  290 (363)
                      . ++.+||+|||+|+........ ......+++.|+|||.+                              +|||||||+
T Consensus       290 ~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        290 EGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             CCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            5 578999999999866443222 12345688999999965                              299999999


Q ss_pred             HHHHhcCCCCCCcchhcc------cccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          291 LLEMVGCRKNNDPAVEIQ------SQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       291 l~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +|||+++..+.+......      .......|... .............+..........+|+.+||+.||++|||++|
T Consensus       369 L~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        369 FLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             HHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            999999776654321110      00111222111 0000000000000000011234568999999999999999864

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=220.50  Aligned_cols=223  Identities=22%  Similarity=0.265  Sum_probs=166.7

Q ss_pred             cCCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEeccCCCCHHHHhhhcCCCC
Q 039471          126 HSNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYEFMPNGSLQKFIFSKTNSS  196 (363)
Q Consensus       126 ~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~  196 (363)
                      .+..||+|++...   ....++..+|..++..++|+||++++.+|.-.      ...|+|||+|. .+|...+.      
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------  112 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------  112 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------
Confidence            4556999988633   33456888999999999999999999998532      46799999995 59998884      


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccccccccc
Q 039471          197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI  276 (363)
Q Consensus       197 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  276 (363)
                        ..++-..+..|+.|++.|++|||+   .+|+|||+||+||++..+..+||.|||+|+....+-   ..+..+.|..|+
T Consensus       113 --~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~---~mtpyVvtRyyr  184 (369)
T KOG0665|consen  113 --MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF---MMTPYVVTRYYR  184 (369)
T ss_pred             --HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCccc---ccCchhheeecc
Confidence              446778899999999999999999   999999999999999999999999999998765541   225567899999


Q ss_pred             CCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHHHH----------Hhhhccc----
Q 039471          277 APELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWIYN----------RMRLGQE----  326 (363)
Q Consensus       277 aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~~~----------~~~~~~~----  326 (363)
                      |||++        .||||+||++.||++|.-.|.+.+..++-...        +....+          ...+.+.    
T Consensus       185 apevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~  264 (369)
T KOG0665|consen  185 APEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFS  264 (369)
T ss_pred             CchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchh
Confidence            99999        89999999999999999888765443321110        000000          0000000    


Q ss_pred             -----cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 -----LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 -----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           ..+....+.++.-.....+++.+||..||++|.|+++
T Consensus       265 ~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d  306 (369)
T KOG0665|consen  265 ELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD  306 (369)
T ss_pred             hhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence                 0111112222233456788999999999999998753

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=225.26  Aligned_cols=157  Identities=20%  Similarity=0.329  Sum_probs=116.5

Q ss_pred             eeeecCC-CceeecCCCCceEEEeEEeeecceecccCCCCCCCcccccccccCCcceeecc-----CCeeEEEEcccCCc
Q 039471           67 ELSCLSD-KTILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKG  140 (363)
Q Consensus        67 ~l~c~~~-~~~l~~~~~g~y~v~~I~y~~~~~~v~~~~~~~c~~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~  140 (363)
                      .++|+++ +........|-|+...|.-.          ...-.|...+.+|.|....||+.     ++-||+|+.+....
T Consensus        47 ~~g~~~~eqE~~~dY~kGGYHpV~IGD~----------F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh  116 (590)
T KOG1290|consen   47 ILGSDDEEQEDPEDYRKGGYHPVRIGDV----------FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH  116 (590)
T ss_pred             cccCCcccccChhhhhcCCCceeecccc----------ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH
Confidence            4445442 33333345666765555421          11123444556666666666553     33399999987776


Q ss_pred             ChhHHHHHHHHHhccC-----C---Cceeeeeeeee----eCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHH
Q 039471          141 NGQEFINEVATIGRIH-----H---FHIVRLLGFCS----EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK  208 (363)
Q Consensus       141 ~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~  208 (363)
                      ..+..+.|+++|++++     |   ..||+|++.|.    .+.+.++|+|++ |.+|..+|....    .+.++...+++
T Consensus       117 YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~----YrGlpl~~VK~  191 (590)
T KOG1290|consen  117 YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN----YRGLPLSCVKE  191 (590)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC----CCCCcHHHHHH
Confidence            7788899999999984     2   47999999995    456999999999 679999996544    37899999999


Q ss_pred             HHHHHHHHHHHhhcCCCCCceecCCCCCceEE
Q 039471          209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILL  240 (363)
Q Consensus       209 i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill  240 (363)
                      |++|++.||+|||.  ..+|||.||||+|||+
T Consensus       192 I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  192 ICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             HHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            99999999999999  5899999999999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-31  Score=221.28  Aligned_cols=184  Identities=26%  Similarity=0.388  Sum_probs=151.6

Q ss_pred             cccccCCcceeec-----cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCC-----ceeEEEec
Q 039471          113 ISFNLTNSKFFFL-----HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN-----RRTLIYEF  179 (363)
Q Consensus       113 ~~~~~~~~~~~~~-----~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~  179 (363)
                      +.+|+|..+.+|-     .++.||+|++.+..   ...+++.+|++.|..++|.|+...++...-.+     .+|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            4567787777773     34449999887533   23468889999999999999999988765433     56889999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      |.. +|.++|      .....++.+.++-+..||++||+|||+   .+|+||||||.|.|+++|-.+||+|||+++....
T Consensus       139 mQS-DLHKII------VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  139 MQS-DLHKII------VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHh-hhhhee------ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            964 898888      445779999999999999999999999   9999999999999999999999999999998876


Q ss_pred             CccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhc
Q 039471          260 DISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEI  307 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~  307 (363)
                      +..... +..+.|..|+|||++         .||||.||++.|++.++..|......
T Consensus       209 d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi  264 (449)
T KOG0664|consen  209 RDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI  264 (449)
T ss_pred             hhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence            655432 334568899999998         79999999999999999888654443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.4e-28  Score=233.74  Aligned_cols=225  Identities=20%  Similarity=0.195  Sum_probs=153.5

Q ss_pred             CeeEEEEcccCCc-ChhH--------------HHHHHHHHhccCCCce-----eeeeeeeee--------CCceeEEEec
Q 039471          128 NEIAVKMLEHLKG-NGQE--------------FINEVATIGRIHHFHI-----VRLLGFCSE--------GNRRTLIYEF  179 (363)
Q Consensus       128 ~~vAvK~~~~~~~-~~~~--------------~~~E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~  179 (363)
                      ..||||.+..... ..++              +..|+..+.+++|.++     ++++++|..        .+..++||||
T Consensus       187 r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey  266 (507)
T PLN03224        187 RRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKF  266 (507)
T ss_pred             ceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEc
Confidence            3499999864321 1223              3446677777766544     677777643        3568999999


Q ss_pred             cCCCCHHHHhhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc
Q 039471          180 MPNGSLQKFIFSKTNS------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~  241 (363)
                      +++++|.++++.....                  .....+++..++.++.|++.+|.|||+   .+|+||||||+|||++
T Consensus       267 ~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~  343 (507)
T PLN03224        267 ESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVT  343 (507)
T ss_pred             CCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEEC
Confidence            9999999999653210                  011345778899999999999999999   9999999999999999


Q ss_pred             CCCCeeEeccccceeccCCccccccccccccccccCCccc------------------------------cCceehhHHH
Q 039471          242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF------------------------------SRNFCYGMML  291 (363)
Q Consensus       242 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~------------------------------~Di~slG~il  291 (363)
                      .++.+||+|||++.......... .....+++.|+|||.+                              .|+||+||++
T Consensus       344 ~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil  422 (507)
T PLN03224        344 VDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL  422 (507)
T ss_pred             CCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence            99999999999997654432211 1222347899999975                              3999999999


Q ss_pred             HHHhcCCC-CCCcchhcccc-----cchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCC---CCCCCCC
Q 039471          292 LEMVGCRK-NNDPAVEIQSQ-----IYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP---TERPSMP  362 (363)
Q Consensus       292 ~el~~g~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~  362 (363)
                      ++|++|.. |+.........     .....|.  .. .+....    .......+....+++.++|..+|   .+|+|++
T Consensus       423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~-~~~~~~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~  495 (507)
T PLN03224        423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY-KGQKYD----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVG  495 (507)
T ss_pred             HHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh-cccCCC----cccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence            99999875 55432111110     0011111  11 111111    11233456788999999999876   6899986


Q ss_pred             C
Q 039471          363 M  363 (363)
Q Consensus       363 e  363 (363)
                      |
T Consensus       496 e  496 (507)
T PLN03224        496 Q  496 (507)
T ss_pred             H
Confidence            4

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=211.70  Aligned_cols=230  Identities=20%  Similarity=0.254  Sum_probs=169.9

Q ss_pred             ccccccCCcceeeccCCe--eEEEEcccCC----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHSNE--IAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~--vAvK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++..+-.+.+.+..  +|+|++++.-    +...-...|-.+..+- +||.+|-+..+|..+..+++|.||.+||+
T Consensus       258 igrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggd  337 (593)
T KOG0695|consen  258 IGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGD  337 (593)
T ss_pred             ecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcc
Confidence            334433333334444443  9999987432    2223334555555544 59999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |--++      .+.+.++++..+.+...|+.||.|||+   .+|+.||+|.+|+|+|..|.+||+|+|.++.--..... 
T Consensus       338 lmfhm------qrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~-  407 (593)
T KOG0695|consen  338 LMFHM------QRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT-  407 (593)
T ss_pred             eeeeh------hhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCCcc-
Confidence            97777      344679999999999999999999999   99999999999999999999999999999865443332 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       ..+..||+.|+|||++        .|-|++|++++||+.|+.||+--........-.+++.+.+...+.       ..+
T Consensus       408 -tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-------rip  479 (593)
T KOG0695|consen  408 -TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-------RIP  479 (593)
T ss_pred             -cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-------ccc
Confidence             2567899999999999        789999999999999999997433222111222233332222221       223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      ..++-+...++..-|+.||.+|.
T Consensus       480 rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhc
Confidence            34555677788889999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=214.05  Aligned_cols=217  Identities=19%  Similarity=0.259  Sum_probs=173.7

Q ss_pred             eEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeC-CceeEEEeccCCCCHHHHhhhcCC--CCCCCCCCHH
Q 039471          130 IAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEG-NRRTLIYEFMPNGSLQKFIFSKTN--SSSHRQLSWE  204 (363)
Q Consensus       130 vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~l~~~  204 (363)
                      |-+|.+++....  ...++.|.-.+..++|+|+..+.+.+.+. ...++++.++.-|+|..++...+.  ....+.++..
T Consensus       317 v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~  396 (563)
T KOG1024|consen  317 VLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTI  396 (563)
T ss_pred             HHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHH
Confidence            888988765433  35788999999999999999999998654 567888999999999999974432  2233568888


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc---
Q 039471          205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF---  281 (363)
Q Consensus       205 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---  281 (363)
                      ++..++.|++.|++|||+   .+++|.||..+|++||+.-.+||+|=.+++.+-+....--......+..||+||.+   
T Consensus       397 qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~  473 (563)
T KOG1024|consen  397 QLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS  473 (563)
T ss_pred             HHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh
Confidence            999999999999999999   99999999999999999999999999998865443332222333457789999998   


Q ss_pred             -----cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCC
Q 039471          282 -----SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP  355 (363)
Q Consensus       282 -----~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p  355 (363)
                           +|+||||+++|||+| |+.|+...+..+        ++..+..|.+.      .++.+++.+|..++.-||...|
T Consensus       474 ~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------m~~ylkdGyRl------aQP~NCPDeLf~vMacCWallp  539 (563)
T KOG1024|consen  474 HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------MEHYLKDGYRL------AQPFNCPDELFTVMACCWALLP  539 (563)
T ss_pred             hhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------HHHHHhcccee------cCCCCCcHHHHHHHHHHHhcCc
Confidence                 899999999999996 667766554433        34445555544      4566788899999999999999


Q ss_pred             CCCCCCCC
Q 039471          356 TERPSMPM  363 (363)
Q Consensus       356 ~~RPs~~e  363 (363)
                      ++|||++|
T Consensus       540 eeRPsf~Q  547 (563)
T KOG1024|consen  540 EERPSFSQ  547 (563)
T ss_pred             ccCCCHHH
Confidence            99999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=224.70  Aligned_cols=182  Identities=24%  Similarity=0.294  Sum_probs=150.9

Q ss_pred             cccccccccCCcceeecc-----CCeeEEEEcccCCcCh---------hHHHHHHHHHhccC---CCceeeeeeeeeeCC
Q 039471          109 FQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNG---------QEFINEVATIGRIH---HFHIVRLLGFCSEGN  171 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~---------~~~~~E~~~l~~l~---h~niv~~~~~~~~~~  171 (363)
                      |..+...|.|+.|+|++.     ...|+||++.+.+--.         -..-.|+.+|..++   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            333445566666666542     2339999997543211         23457999999997   999999999999999


Q ss_pred             ceeEEEecc-CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEec
Q 039471          172 RRTLIYEFM-PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  250 (363)
Q Consensus       172 ~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D  250 (363)
                      .+||+||.- ++.+|.++|      ..+..++|.+...|++|++.|+++||+   .+|+|||||-+|+.++.+|-+||+|
T Consensus       643 ~yyl~te~hg~gIDLFd~I------E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFI------EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             eeEEEecCCCCCcchhhhh------hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence            999999985 677999999      445779999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCc
Q 039471          251 FGLAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDP  303 (363)
Q Consensus       251 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~  303 (363)
                      ||.|.....+..    ...+||..|.|||++         .|||++|+++|.++....|++.
T Consensus       714 fgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999887655433    567899999999999         7999999999999988888753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5e-28  Score=202.86  Aligned_cols=225  Identities=17%  Similarity=0.249  Sum_probs=167.3

Q ss_pred             ccccccCCcceeecc-----CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeee-eeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGF-CSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~~~~~s  184 (363)
                      ....|.|-.++..+.     +..+++|.+........+|.+|..---.| .|.||+.-|+. |+..+.+++++||++.|+
T Consensus        29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gd  108 (378)
T KOG1345|consen   29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGD  108 (378)
T ss_pred             HHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccch
Confidence            344455555554442     23399999987777788999998765556 49999998875 677778899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc--CCCCeeEeccccceeccCCcc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |.+-+.       ...+-|...+.++.|++.||+|||+   .+++|||||.+|||+-  +...+||+|||..+..+....
T Consensus       109 L~snv~-------~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  109 LRSNVE-------AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             hhhhcC-------cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            988772       2568899999999999999999999   9999999999999983  334799999999876543321


Q ss_pred             ccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          263 IVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                           ....+..|.+||..             +|+|.||++++.++||..||........  .+.+|  .++..+.... 
T Consensus       179 -----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~--~Y~~~--~~w~~rk~~~-  248 (378)
T KOG1345|consen  179 -----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK--PYWEW--EQWLKRKNPA-  248 (378)
T ss_pred             -----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--hHHHH--HHHhcccCcc-
Confidence                 22245679999987             8999999999999999999985433322  22333  2333222221 


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTER  358 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (363)
                        .+.....+++.+.++.++-+..+|++|
T Consensus       249 --~P~~F~~fs~~a~r~Fkk~lt~~~~dr  275 (378)
T KOG1345|consen  249 --LPKKFNPFSEKALRLFKKSLTPRFKDR  275 (378)
T ss_pred             --CchhhcccCHHHHHHHHHhcCCccccc
Confidence              122334566778888888999999988

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.3e-26  Score=197.76  Aligned_cols=194  Identities=30%  Similarity=0.505  Sum_probs=162.9

Q ss_pred             ccccCCcceeecc--CCeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          114 SFNLTNSKFFFLH--SNEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       114 ~~~~~~~~~~~~~--~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      .++++.++.+...  ++.+++|+.......  .+.+.+|+..++.++|++++++++++......++++|++++++|.+++
T Consensus         3 ~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~   82 (215)
T cd00180           3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL   82 (215)
T ss_pred             cCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHH
Confidence            4455555555555  566999999755442  478999999999999999999999999989999999999999999998


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccCCcccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      ....     ..+++..+..++.++++++++||+   .+++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        83 ~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          83 KENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             Hhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            4321     468999999999999999999999   99999999999999999 89999999999987655431  1133


Q ss_pred             ccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..+...|++||..         .|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4467789999875         7999999999998                                             


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+.+++.+|++.+|++||++.|
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~  210 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKE  210 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHH
Confidence             45889999999999999999753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=221.71  Aligned_cols=238  Identities=21%  Similarity=0.207  Sum_probs=186.4

Q ss_pred             CCCCCcccccccccCCcceeecc--CCeeEEEEcccCCcC-hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          104 ETACPFQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN-GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       104 ~~~c~~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      +.+.-+++++++.+|.++.....  ++..|+|+++-.... .....+|+-+++..+|+|||.++|.+......|++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            44455666676666666654433  333999999865443 456678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      .+|+|++.-+      -...+++.++...++..++|++|||+   .+-+|||||-.|||+++.|.+|++|||.+..+...
T Consensus        95 gggslQdiy~------~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   95 GGGSLQDIYH------VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             CCCcccceee------ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999773      23679999999999999999999999   99999999999999999999999999998776543


Q ss_pred             ccccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          261 ISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      .  ..+....||+.|||||+.           +|+|+.|+.-.|+.-..+|....-..+.        ...+.+..  ..
T Consensus       166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--------l~LmTkS~--~q  233 (829)
T KOG0576|consen  166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--------LFLMTKSG--FQ  233 (829)
T ss_pred             h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--------HHHhhccC--CC
Confidence            2  345678899999999987           8999999999999877776543322211        11111111  11


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ....+.....++.+.+|++.|+..+|++|||++
T Consensus       234 pp~lkDk~kws~~fh~fvK~altknpKkRptae  266 (829)
T KOG0576|consen  234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAE  266 (829)
T ss_pred             CCcccCCccchHHHHHHHHHHhcCCCccCCChh
Confidence            122234567788899999999999999999975

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.4e-27  Score=242.79  Aligned_cols=185  Identities=18%  Similarity=0.188  Sum_probs=128.7

Q ss_pred             ccCC-Cceeeeeeee-------eeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 039471          154 RIHH-FHIVRLLGFC-------SEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN  225 (363)
Q Consensus       154 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  225 (363)
                      .++| .||++++++|       .....++.++|++ +++|.+++...     ...+++..++.++.||++||+|||+   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHS---   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHh---
Confidence            3456 6888888887       2334577788988 56999999432     2569999999999999999999999   


Q ss_pred             CCceecCCCCCceEEcC-------------------CCCeeEeccccceeccCCcc--------------cccccccccc
Q 039471          226 QRILHFDIKPHNILLDH-------------------NFQPKISDFGLAKLCSKDIS--------------IVSRTAARGT  272 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt  272 (363)
                      ++|+||||||+|||++.                   ++.+|++|||+++.......              ........||
T Consensus        99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181         99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence            99999999999999954                   44566677776654221000              0001123578


Q ss_pred             ccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHH
Q 039471          273 SGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLA  344 (363)
Q Consensus       273 ~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  344 (363)
                      +.|+|||++        +|||||||++|||++|.+|+......          ...+... ..     +...........
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----------~~~~~~~-~~-----~~~~~~~~~~~~  242 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----------MSSLRHR-VL-----PPQILLNWPKEA  242 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----------HHHHHHh-hc-----ChhhhhcCHHHH
Confidence            889999997        79999999999999988876432111          0111100 00     000111233456


Q ss_pred             HHHHHhccCCCCCCCCCCC
Q 039471          345 IVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       345 ~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+||+.+|.+||||+|
T Consensus       243 ~~~~~~L~~~P~~Rps~~e  261 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSE  261 (793)
T ss_pred             HHHHHhCCCChhhCcChHH
Confidence            8889999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=4.9e-26  Score=189.86  Aligned_cols=151  Identities=21%  Similarity=0.247  Sum_probs=112.6

Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |||.+++...     +..+++..++.++.|++.||+|||+   .+      ||+|||++.++.+|+  ||.++...... 
T Consensus         1 GsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVR-----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-
Confidence            6899999532     2569999999999999999999999   66      999999999999999  99998765432 


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                            ..||..|+|||++        +|||||||++|||++|+.||........       ....+.............
T Consensus        64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~  130 (176)
T smart00750       64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-------ILEILLNGMPADDPRDRS  130 (176)
T ss_pred             ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-------HHHHHHHHhccCCccccc
Confidence                  2478999999988        8999999999999999999865433211       111111111111001111


Q ss_pred             CcHHHHH--HHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIAR--KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~--~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+.  .+.+++.+||+.+|++|||+.|
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~  161 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANH  161 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHH
Confidence            2333444  6999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=7.2e-25  Score=189.54  Aligned_cols=183  Identities=28%  Similarity=0.424  Sum_probs=152.3

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.++++.+..+...+  +.+|+|.......  ..+.+.+|++.+++++|+|++++++++......++++|++++++|.+
T Consensus         7 i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   86 (225)
T smart00221        7 LGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFD   86 (225)
T ss_pred             eecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHH
Confidence            3455556555555543  5599999975443  45788999999999999999999999998899999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..+..++.+++.++.+||+   .+++|+|++|.||+++.++.++|+|||.+......... ...
T Consensus        87 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~  157 (225)
T smart00221       87 YLRKKG-----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLK  157 (225)
T ss_pred             HHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-ccc
Confidence            995432     128899999999999999999999   89999999999999999999999999999887654310 113


Q ss_pred             cccccccccCCccc---------cCceehhHHHHHHhcCCCCCCc
Q 039471          268 AARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDP  303 (363)
Q Consensus       268 ~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~  303 (363)
                      ...++..|++||..         +|+|+||++++||++|+.||+.
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            34567789999986         8999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=2.1e-25  Score=197.89  Aligned_cols=183  Identities=21%  Similarity=0.316  Sum_probs=145.7

Q ss_pred             ccccccccCCcceeec-----cCCeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL-----HSNEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .+++.+.++.+.....     .+..||+|.+.... .-.++.+|++.|..+. +.||+++.+++..+++..+|+||+++.
T Consensus        42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~  120 (418)
T KOG1167|consen   42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD  120 (418)
T ss_pred             ccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence            3444555555543332     33449999987443 3456889999999996 899999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEeccccceeccCCc-
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDI-  261 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~-  261 (363)
                      ...++.         ..++...+...++.+++||+++|+   +||+||||||+|+|.+ ..+.-.|.|||+|....... 
T Consensus       121 ~f~~l~---------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  121 RFRDLY---------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             CHHHHH---------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            999998         567889999999999999999999   9999999999999998 45678999999998321100 


Q ss_pred             -----------------------------------------cccccccccccccccCCccc---------cCceehhHHH
Q 039471          262 -----------------------------------------SIVSRTAARGTSGYIAPELF---------SRNFCYGMML  291 (363)
Q Consensus       262 -----------------------------------------~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il  291 (363)
                                                               .....-...||++|+|||++         .||||.|+|+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                                                     00001112499999999999         8999999999


Q ss_pred             HHHhcCCCCCCcch
Q 039471          292 LEMVGCRKNNDPAV  305 (363)
Q Consensus       292 ~el~~g~~~~~~~~  305 (363)
                      +-+++++.||....
T Consensus       269 Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAK  282 (418)
T ss_pred             ehhhccccccccCc
Confidence            99999999986544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-23  Score=175.18  Aligned_cols=219  Identities=20%  Similarity=0.343  Sum_probs=171.1

Q ss_pred             cCCcceeeccCCeeEEEEccc---CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcC
Q 039471          117 LTNSKFFFLHSNEIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKT  193 (363)
Q Consensus       117 ~~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~  193 (363)
                      .|.......+++++++|+++.   +....++|..|...|+-+.||||..++|.|....++.++..||+.|||+..++...
T Consensus       203 sgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t  282 (448)
T KOG0195|consen  203 SGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT  282 (448)
T ss_pred             CcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc
Confidence            344445566788888898863   33455789999999999999999999999999999999999999999999997665


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEe--ccccceeccCCccccccccccc
Q 039471          194 NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS--DFGLAKLCSKDISIVSRTAARG  271 (363)
Q Consensus       194 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~g  271 (363)
                      .    -..+..+..+++.++++|++|||+- +.-|.-..+....+++|++.+.+|+  |--++...         ....-
T Consensus       283 ~----vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe---------~gr~y  348 (448)
T KOG0195|consen  283 S----VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---------VGRAY  348 (448)
T ss_pred             c----EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec---------ccccc
Confidence            4    4567788999999999999999982 1235566789999999999887775  32222211         22234


Q ss_pred             cccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc-cccccCCCCcHHH
Q 039471          272 TSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE-LCLDFEEDGDEGI  339 (363)
Q Consensus       272 t~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  339 (363)
                      .+.|++||.+           .|+|||.+++||+.|+.-||..-...+.              |.. ..+......++..
T Consensus       349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--------------gmkialeglrv~ippgi  414 (448)
T KOG0195|consen  349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--------------GMKIALEGLRVHIPPGI  414 (448)
T ss_pred             CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--------------hhhhhhccccccCCCCc
Confidence            6789999988           7999999999999999999976544332              111 1223445677888


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+.+++.-|++.||.+||.+++
T Consensus       415 s~hm~klm~icmnedpgkrpkfdm  438 (448)
T KOG0195|consen  415 SRHMNKLMNICMNEDPGKRPKFDM  438 (448)
T ss_pred             cHHHHHHHHHHhcCCCCcCCCcce
Confidence            999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=2.2e-23  Score=202.35  Aligned_cols=203  Identities=22%  Similarity=0.254  Sum_probs=157.6

Q ss_pred             HHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 039471          145 FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC  224 (363)
Q Consensus       145 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  224 (363)
                      +..|+-+-..++|+|++..+..+.+.....-.|||+++ +|...+.+      ...+....+..+++|++.|++|||+  
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~------~~~~~~~e~~c~fKqL~~Gv~y~h~--  438 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS------NGKLTPLEADCFFKQLLRGVKYLHS--  438 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc------ccccchhhhhHHHHHHHHHHHHHHh--
Confidence            45566677788999999888887776666666999999 99999832      2468888999999999999999999  


Q ss_pred             CCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc--cccccccccccccCCccc---------cCceehhHHHHH
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI--VSRTAARGTSGYIAPELF---------SRNFCYGMMLLE  293 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~---------~Di~slG~il~e  293 (363)
                       .++.|||+|++|++++.+|.+||+|||.+....-.-..  .......|+..|+|||.+         .|+||.|+++..
T Consensus       439 -~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~  517 (601)
T KOG0590|consen  439 -MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYIC  517 (601)
T ss_pred             -cCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEE
Confidence             99999999999999999999999999998766543322  334667799999999998         799999999999


Q ss_pred             HhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          294 MVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       294 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      |.+|+.||........+.+      ......+.....-.......++..-..++.+||+++|.+|.||++
T Consensus       518 m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~  581 (601)
T KOG0590|consen  518 MILGRFPWKVAKKSDNSFK------TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ  581 (601)
T ss_pred             EecCCCccccccccccchh------hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence            9999999987655443210      000001111111112244567778899999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.5e-21  Score=176.91  Aligned_cols=152  Identities=16%  Similarity=0.143  Sum_probs=112.6

Q ss_pred             ccccccccCCcceeecc---CCeeEEEEcccC------CcChhHHHHHHHHHhccCCCceee-eeeeeeeCCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH---SNEIAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVR-LLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~---~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~  179 (363)
                      ..++.+++|.++.....   +..||||++...      ....+.|.+|++++++++|+|++. ++++    +..++||||
T Consensus        24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~   99 (365)
T PRK09188         24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGW   99 (365)
T ss_pred             cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEc
Confidence            44566666666665443   233799986522      112356899999999999999985 5442    457999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCC-CCCceEEcCCCCeeEeccccceecc
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI-KPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~di-kp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ++|++|.. +.         ...   ...++.|++++|+|||+   .+|+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus       100 ~~G~~L~~-~~---------~~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188        100 TEGVPLHL-AR---------PHG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             cCCCCHHH-hC---------ccc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            99999963 20         011   14678899999999999   99999999 9999999999999999999999876


Q ss_pred             CCccccc------cccccccccccCCccc
Q 039471          259 KDISIVS------RTAARGTSGYIAPELF  281 (363)
Q Consensus       259 ~~~~~~~------~~~~~gt~~y~aPE~~  281 (363)
                      .......      .....++..|+|||.+
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            5432111      1344578889999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=1e-21  Score=182.68  Aligned_cols=200  Identities=21%  Similarity=0.362  Sum_probs=152.2

Q ss_pred             HhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc-ee
Q 039471          152 IGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRI-LH  230 (363)
Q Consensus       152 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H  230 (363)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..     ....+++.....++++|++||.|+|.   -.| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-----~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-----EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-----cccCccHHHHHHHHHHHHHHHHHHhc---Ccceee
Confidence            4568899999999999999999999999999999999954     33678999999999999999999998   444 99


Q ss_pred             cCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc---------------cCceehhHHHHHHh
Q 039471          231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF---------------SRNFCYGMMLLEMV  295 (363)
Q Consensus       231 ~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~  295 (363)
                      +.++..|+++|..+.+||+|||+.....................|.|||.+               .|+||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            999999999999999999999998776531111111222234568999987               69999999999999


Q ss_pred             cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          296 GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       296 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...||+........    +.+..++..+.....+.......+..+.+..++..||..+|++||++++
T Consensus       153 ~r~~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~  216 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ  216 (484)
T ss_pred             hccCccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence            999999876554432    1122223331221111111111155557999999999999999999863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=7.2e-20  Score=167.24  Aligned_cols=189  Identities=20%  Similarity=0.221  Sum_probs=147.2

Q ss_pred             ccccccccCCcceeeccCC---eeEEEEcccCCcC-hhHHHHHHHHHhccCC----Cceeeeeeee-eeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHSN---EIAVKMLEHLKGN-GQEFINEVATIGRIHH----FHIVRLLGFC-SEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~---~vAvK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+.....   .+|+|........ ...+..|+.++..+..    .++.++++.. ..+...++||+.+
T Consensus        24 ~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~  103 (322)
T KOG1164|consen   24 KKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL  103 (322)
T ss_pred             eeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc
Confidence            4556667777766665443   4888887654322 2378889999998863    5888899888 5777899999988


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-----CCeeEeccccce
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-----FQPKISDFGLAK  255 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-----~~~kl~Dfg~a~  255 (363)
                       |.+|.++.....    ...++..+...++.|++.+|++||+   .|++||||||.|+++...     ..+.|.|||+++
T Consensus       104 -G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  104 -GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             -CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence             789999874333    3789999999999999999999999   999999999999999854     469999999998


Q ss_pred             --eccCCcc---ccc---cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          256 --LCSKDIS---IVS---RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       256 --~~~~~~~---~~~---~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                        .......   ...   ....+||..|+++...        .|+||++.++.|+..|..||.....
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence              4322211   111   1345699999999876        7999999999999999999865443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=5e-19  Score=161.19  Aligned_cols=225  Identities=26%  Similarity=0.345  Sum_probs=165.9

Q ss_pred             CeeEEEEcccCCc----ChhHHHHHHHHHhccCCC-ceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCC
Q 039471          128 NEIAVKMLEHLKG----NGQEFINEVATIGRIHHF-HIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS  202 (363)
Q Consensus       128 ~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~  202 (363)
                      ..+++|.+.....    ....+.+|+..++.+.|+ +++++++.+......+++++++.++++.+++......   ..++
T Consensus        23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~~   99 (384)
T COG0515          23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK---GPLS   99 (384)
T ss_pred             cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc---cCCC
Confidence            5589998864332    356899999999999988 7999999997777789999999999999777432210   3689


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCcccc----ccccccccccccC
Q 039471          203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV----SRTAARGTSGYIA  277 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~----~~~~~~gt~~y~a  277 (363)
                      ......+..|++.+++|+|+   .+++|||+||+||+++..+ .++++|||.++.........    ......|+..|+|
T Consensus       100 ~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~  176 (384)
T COG0515         100 ESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA  176 (384)
T ss_pred             HHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCC
Confidence            99999999999999999999   9999999999999999988 69999999998665543221    2255679999999


Q ss_pred             Cccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc--ccccCCCCcHHHHHHHH
Q 039471          278 PELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL--CLDFEEDGDEGIARKLA  344 (363)
Q Consensus       278 PE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~  344 (363)
                      ||.+           .|+||+|++++++++|..|+........    .......+......  ...............+.
T Consensus       177 pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (384)
T COG0515         177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA----TSQTLKIILELPTPSLASPLSPSNPELISKAAS  252 (384)
T ss_pred             HHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc----HHHHHHHHHhcCCcccccccCccccchhhHHHH
Confidence            9944           6899999999999999999655432100    01111111111100  00000111122345788


Q ss_pred             HHHHHhccCCCCCCCCCC
Q 039471          345 IVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       345 ~l~~~cl~~~p~~RPs~~  362 (363)
                      +++..++..+|.+|.++.
T Consensus       253 ~~~~~~~~~~~~~r~~~~  270 (384)
T COG0515         253 DLLKKLLAKDPKNRLSSS  270 (384)
T ss_pred             HHHHHHHhcCchhcCCHH
Confidence            999999999999998764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=6.6e-20  Score=151.85  Aligned_cols=190  Identities=18%  Similarity=0.224  Sum_probs=147.3

Q ss_pred             cccccccCCccee--eccCCeeEEEEcccCCcChhHHHHHHHHHhccCC-CceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFF--FLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++++++||..+..  ...+.+||||+-.+.. .......|.++.+.|++ ..|.++..+..+.....+||+.+ |.||++
T Consensus        22 kiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEd   99 (341)
T KOG1163|consen   22 KIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLED   99 (341)
T ss_pred             eecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHH
Confidence            3445555544333  2345569999876433 44567889999999974 67888888888999999999999 889999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc---CCCCeeEeccccceeccCCcc--
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDIS--  262 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~--  262 (363)
                      ++.-+.     +.++..+++.++-|++.-++|+|.   .+++||||||+|.|+.   ....+.++|||+|+.+.+...  
T Consensus       100 LfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen  100 LFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             HHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            985443     679999999999999999999999   9999999999999985   335689999999998754321  


Q ss_pred             ---ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccc
Q 039471          263 ---IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ  310 (363)
Q Consensus       263 ---~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~  310 (363)
                         ........||..|.+--..        .|+-|+|.++.++.-|..||.+.....+.
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~  230 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK  230 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence               1122344588889876554        69999999999999999999987655543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=6.1e-20  Score=153.11  Aligned_cols=177  Identities=16%  Similarity=0.066  Sum_probs=132.3

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChh-----HHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQ-----EFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++..+||.+.++...+..++.+.+.......+     .|.+|+++|++|+ |+++++++++    +..+++|||+.|.
T Consensus         8 ~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~   83 (218)
T PRK12274          8 EPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGA   83 (218)
T ss_pred             eeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCc
Confidence            4567788888887666666688777765543222     5789999999995 5789999886    4468999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCC-CCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI-KPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~di-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      +|...+.            .. ...++.|++.+|+++|+   .+|+|||| ||+|||++.++.++|+|||+|....+...
T Consensus        84 ~L~~~~~------------~~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         84 AMYQRPP------------RG-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cHHhhhh------------hh-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            9875431            01 13577899999999999   99999999 79999999999999999999986654432


Q ss_pred             c-----------cccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          263 I-----------VSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       263 ~-----------~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      .           ........++.|++|+..          .+-++.|.-+|.++|++-+...+.+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            1           001122356777888755          2335889999999999987655443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=1.8e-19  Score=151.42  Aligned_cols=135  Identities=18%  Similarity=0.142  Sum_probs=99.5

Q ss_pred             cccccccCCcceeecc-CCeeEEEEcccCCc---C-------hhHH-----------------HHHHHHHhccCCCceee
Q 039471          111 SLISFNLTNSKFFFLH-SNEIAVKMLEHLKG---N-------GQEF-----------------INEVATIGRIHHFHIVR  162 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~---~-------~~~~-----------------~~E~~~l~~l~h~niv~  162 (363)
                      .++.+++|.++..... ++.||||+++....   .       ..+|                 .+|++.+.++.++++..
T Consensus         4 ~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~   83 (190)
T cd05147           4 CISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC   83 (190)
T ss_pred             ccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence            4566677766666553 45599999974321   1       1122                 34999999998777644


Q ss_pred             eeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCceecCCCCCceEEc
Q 039471          163 LLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYL-HQGCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       163 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dikp~Nill~  241 (363)
                      .......  ..++||||++++++.....      ....+++..+..++.|++.+|+++ |+   .+|+||||||+|||++
T Consensus        84 p~~~~~~--~~~iVmE~i~g~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~  152 (190)
T cd05147          84 PEPILLK--SHVLVMEFIGDDGWAAPRL------KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH  152 (190)
T ss_pred             CcEEEec--CCEEEEEEeCCCCCcchhh------hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence            3332222  2389999999877765431      124688999999999999999999 68   8999999999999998


Q ss_pred             CCCCeeEeccccceec
Q 039471          242 HNFQPKISDFGLAKLC  257 (363)
Q Consensus       242 ~~~~~kl~Dfg~a~~~  257 (363)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=6.8e-19  Score=155.63  Aligned_cols=183  Identities=20%  Similarity=0.256  Sum_probs=133.9

Q ss_pred             CCCceeeeeeeeee---------------------------CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHH
Q 039471          156 HHFHIVRLLGFCSE---------------------------GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK  208 (363)
Q Consensus       156 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~  208 (363)
                      +|||||++.++|.+                           +...|+||.-.+. +|..|+-.       ...+......
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-------~~~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-------RHRSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-------CCCchHHHHH
Confidence            49999999987632                           2357899988864 99999943       3466778888


Q ss_pred             HHHHHHHHHHHhhcCCCCCceecCCCCCceEEc--CCC--CeeEeccccceeccCCc---cccc-cccccccccccCCcc
Q 039471          209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNF--QPKISDFGLAKLCSKDI---SIVS-RTAARGTSGYIAPEL  280 (363)
Q Consensus       209 i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~--~~~--~~kl~Dfg~a~~~~~~~---~~~~-~~~~~gt~~y~aPE~  280 (363)
                      ++.|++.|+.|||+   +++.|||+|.+|||+.  +++  .+.++|||++--.....   .+.+ ....-|.-.-||||+
T Consensus       346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            99999999999999   9999999999999984  343  36889999875432211   1111 112236667899998


Q ss_pred             c--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          281 F--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       281 ~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      .              .|.|+.|.+-||+++...||+...+..-.    ...|+         +...+..+..+++.+.++
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~----~r~Yq---------e~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD----TRTYQ---------ESQLPALPSRVPPVARQL  489 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec----hhhhh---------hhhCCCCcccCChHHHHH
Confidence            8              79999999999999999999873322110    00111         112234566777889999


Q ss_pred             HHHhccCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMP  362 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~  362 (363)
                      +...|+.||++|+|..
T Consensus       490 V~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPN  505 (598)
T ss_pred             HHHHhcCCccccCCcc
Confidence            9999999999999863

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=3.8e-19  Score=151.50  Aligned_cols=162  Identities=14%  Similarity=0.137  Sum_probs=115.9

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhH----------HHHHHHHHhccCCCceeeeeeeeeeC--------C
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQE----------FINEVATIGRIHHFHIVRLLGFCSEG--------N  171 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~~~~~~~~~--------~  171 (363)
                      ..++.+|+|.+...-..++.+|||.+.......+.          +.+|+..+.++.|++|..+.+++...        +
T Consensus        37 ~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~  116 (232)
T PRK10359         37 KVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAH  116 (232)
T ss_pred             EEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccC
Confidence            33455566665554444556999999744333332          57899999999999999998886532        3


Q ss_pred             ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       172 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      ..+++|||++|.+|.++.          .+++    ....+++.+|..+|+   .+++|+|++|+||+++.++ ++|+||
T Consensus       117 ~~~lvmEyi~G~tL~~~~----------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        117 TYIMLIEYIEGVELNDMP----------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             CeEEEEEEECCccHHHhh----------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEEC
Confidence            588999999999998874          1233    245699999999999   9999999999999999988 999999


Q ss_pred             ccceeccCCccccccccccccccccCCccccCceehhHHHHHHh
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMV  295 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~Di~slG~il~el~  295 (363)
                      |.......+...   ....-...|-   .-.|+||||+.+....
T Consensus       179 g~~~~~~e~~a~---d~~vler~y~---~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK---DRIDLERHYG---IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH---HHHHHHhHhc---ccccccceeEeehHHH
Confidence            988766433221   0011111122   2379999999887543

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3.6e-18  Score=144.97  Aligned_cols=130  Identities=19%  Similarity=0.288  Sum_probs=96.8

Q ss_pred             cccccCCcceeeccCCe--eEEEEcccC-CcChhHHHHHHHHHhcc-----CCCceeeeeeeeeeCC---c-eeEEEec-
Q 039471          113 ISFNLTNSKFFFLHSNE--IAVKMLEHL-KGNGQEFINEVATIGRI-----HHFHIVRLLGFCSEGN---R-RTLIYEF-  179 (363)
Q Consensus       113 ~~~~~~~~~~~~~~~~~--vAvK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e~-  179 (363)
                      ..+|.|+.+.++...+.  .+||+.... ....+.+.+|+.+++++     .|+||++++|++.++.   . +.+|+|| 
T Consensus         8 ~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~   87 (210)
T PRK10345          8 SPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFD   87 (210)
T ss_pred             ceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCC
Confidence            34555666666543322  568877543 23456789999999999     5799999999998763   3 3478999 


Q ss_pred             -cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCceecCCCCCceEEcC----CCCeeEecccc
Q 039471          180 -MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGV-EYLHQGCNQRILHFDIKPHNILLDH----NFQPKISDFGL  253 (363)
Q Consensus       180 -~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dikp~Nill~~----~~~~kl~Dfg~  253 (363)
                       +.+++|.+++..       ..+++.  ..++.|++.++ +|||+   ++|+||||||+|||++.    ++.++|+||+.
T Consensus        88 G~~~~tL~~~l~~-------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         88 GKPSITLTEFAEQ-------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             CCcchhHHHHHHc-------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence             557999999932       235555  35678888887 99999   99999999999999974    34799999443


Q ss_pred             c
Q 039471          254 A  254 (363)
Q Consensus       254 a  254 (363)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=5e-18  Score=146.91  Aligned_cols=182  Identities=19%  Similarity=0.257  Sum_probs=145.3

Q ss_pred             ccccCCcceee-----ccCCeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          114 SFNLTNSKFFF-----LHSNEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       114 ~~~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .+|.|+.+..+     +.+..||||.-... ....+...|.+..+.|. .++|...|-+..++.+..||+|.+ |.||++
T Consensus        35 KIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLED  112 (449)
T KOG1165|consen   35 KIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLED  112 (449)
T ss_pred             ccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHH
Confidence            34445554444     34566999976532 24456778888888885 789999999989999999999999 789999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-----CCCeeEeccccceeccCCcc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----NFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++.-+.     +.|+..++..++.|++.-++|+|+   +.+|.|||||+|+||..     ...+.++|||+|+.+.+...
T Consensus       113 LFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  113 LFDLCG-----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             HHHHhc-----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            986443     789999999999999999999999   99999999999999963     33589999999998764322


Q ss_pred             -----ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcch
Q 039471          263 -----IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       263 -----~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                           ........||..||+--..        .|.-|+|-++++.+-|..||.+-.
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence                 1223445689999986544        789999999999999999998744

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=3.3e-18  Score=144.23  Aligned_cols=139  Identities=17%  Similarity=0.099  Sum_probs=102.1

Q ss_pred             cccccccCCcceeecc-CCeeEEEEcccCCcC---------------------------hhHHHHHHHHHhccCCCceee
Q 039471          111 SLISFNLTNSKFFFLH-SNEIAVKMLEHLKGN---------------------------GQEFINEVATIGRIHHFHIVR  162 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~niv~  162 (363)
                      .++.+++|.++..... ++.||||+++.....                           ...+.+|.+.+.++.|+++..
T Consensus         4 ~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (190)
T cd05145           4 CISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV   83 (190)
T ss_pred             eeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            3456666666665543 556999998753211                           112357889999999888754


Q ss_pred             eeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC
Q 039471          163 LLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  242 (363)
Q Consensus       163 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~  242 (363)
                      ...+...  ..++||||++++++.....      ....++......++.|++.++.++|+  ..+|+||||||+||+++ 
T Consensus        84 p~~~~~~--~~~lVmE~~~g~~~~~~~l------~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-  152 (190)
T cd05145          84 PEPILLK--KNVLVMEFIGDDGSPAPRL------KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             ceEEEec--CCEEEEEEecCCCchhhhh------hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence            4433333  2489999999876544321      11457788999999999999999997  37999999999999999 


Q ss_pred             CCCeeEeccccceeccCC
Q 039471          243 NFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       243 ~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++.++|+|||++...+..
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            789999999999877553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=1.5e-19  Score=177.05  Aligned_cols=207  Identities=20%  Similarity=0.221  Sum_probs=146.8

Q ss_pred             eEEEEcccCC--cChhHHHHHHHHHh--ccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHH
Q 039471          130 IAVKMLEHLK--GNGQEFINEVATIG--RIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK  205 (363)
Q Consensus       130 vAvK~~~~~~--~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~  205 (363)
                      |+||+.-+..  -.-+.|.++++-++  ..++||.+++--+...+...|+|-+|..+ +|++.+      ..+..+..-+
T Consensus        49 vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRl------STRPFL~~iE  121 (1431)
T KOG1240|consen   49 VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRL------STRPFLVLIE  121 (1431)
T ss_pred             EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhh------ccchHHHHHH
Confidence            8999885433  23355555444443  44799999998888888888899999976 999999      3345678888


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec--cCCccc---cccccccccccccCCcc
Q 039471          206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC--SKDISI---VSRTAARGTSGYIAPEL  280 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~--~~~~~~---~~~~~~~gt~~y~aPE~  280 (363)
                      .+-|+.|++.||+.+|+   .+|.|+|||.+|||+++=.=+.|+||..-+..  +++..-   ..-.+.+.-.-|+|||.
T Consensus       122 KkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPER  198 (1431)
T KOG1240|consen  122 KKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPER  198 (1431)
T ss_pred             HHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHh
Confidence            99999999999999999   99999999999999998777899999876532  222210   00011123345999998


Q ss_pred             c-------------------cCceehhHHHHHHhc-CCCCCCcchhc--c-cccchHHHHHHHhhhccccccccCCCCcH
Q 039471          281 F-------------------SRNFCYGMMLLEMVG-CRKNNDPAVEI--Q-SQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       281 ~-------------------~Di~slG~il~el~~-g~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      +                   .||||+||+++||++ |+++|.-.--.  . ...+.++.+.+.++               
T Consensus       199 Fv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ie---------------  263 (1431)
T KOG1240|consen  199 FVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIE---------------  263 (1431)
T ss_pred             hhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCc---------------
Confidence            7                   589999999999986 57776532100  0 00111222222211               


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...++.+++.|++.+|++|.|+++
T Consensus       264 --d~~~Rnlil~Mi~rdPs~RlSAed  287 (1431)
T KOG1240|consen  264 --DVSLRNLILSMIQRDPSKRLSAED  287 (1431)
T ss_pred             --CccHHHHHHHHHccCchhccCHHH
Confidence              235889999999999999999863

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.4e-19  Score=167.23  Aligned_cols=197  Identities=21%  Similarity=0.233  Sum_probs=159.2

Q ss_pred             eEEEEcccCC---cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHH
Q 039471          130 IAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK  205 (363)
Q Consensus       130 vAvK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~  205 (363)
                      +|+|++++..   +.......|-.++..++ |+.++++.-.++.++..++++++..+|.|...+.      ....+.+..
T Consensus        25 yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~------~~~~f~~~~   98 (612)
T KOG0603|consen   25 YAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS------KEVMFDELD   98 (612)
T ss_pred             hhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccc------cCCchHHHH
Confidence            7888775322   11124456777788787 9999999999999999999999999999988873      335678888


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc----
Q 039471          206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----  281 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----  281 (363)
                      .......++-+++++|+   .++++||+|++||+++.+|.+++.|||+++..-...      ...||..|||||++    
T Consensus        99 ~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~gh~  169 (612)
T KOG0603|consen   99 VAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIINGHL  169 (612)
T ss_pred             HHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhhccC
Confidence            88999999999999999   999999999999999999999999999998764432      22689999999998    


Q ss_pred             --cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          282 --SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       282 --~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                        .|-||||++.+||++|-.||...            +..++.+       .....+...+....+++..++..+|.+|-
T Consensus       170 ~a~D~ws~gvl~felltg~~pf~~~------------~~~~Il~-------~~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  170 SAADWWSFGVLAFELLTGTLPFGGD------------TMKRILK-------AELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             CcccchhhhhhHHHHhhCCCCCchH------------HHHHHhh-------hccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence              69999999999999999999871            1122221       12345677888888899999999998885


Q ss_pred             C
Q 039471          360 S  360 (363)
Q Consensus       360 s  360 (363)
                      -
T Consensus       231 g  231 (612)
T KOG0603|consen  231 G  231 (612)
T ss_pred             c
Confidence            3

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.70  E-value=3.1e-17  Score=144.01  Aligned_cols=158  Identities=22%  Similarity=0.302  Sum_probs=103.7

Q ss_pred             eeEEEeccCCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          173 RTLIYEFMPNGSLQKFIFSKTNS-SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       173 ~~lv~e~~~~~sL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      .+++|+-+. ++|.+++..-... ..+..+.......+..|+++.+++||+   .|++|+||+|+|++++.+|.++|+||
T Consensus       114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~~~nfll~~~G~v~Lg~F  189 (288)
T PF14531_consen  114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIKPENFLLDQDGGVFLGDF  189 (288)
T ss_dssp             EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEE-TTS-EEE--G
T ss_pred             hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccceeeEEEcCCCCEEEcCh
Confidence            366788774 5898886431110 112234444556677899999999999   99999999999999999999999999


Q ss_pred             ccceeccCCccccccccccccccccCCccc----------------cCceehhHHHHHHhcCCCCCCcchhcccccchHH
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELF----------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~  315 (363)
                      +.....+....    . ...+..|.+||..                .|.|++|+++|.|++++.||+.........    
T Consensus       190 ~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~----  260 (288)
T PF14531_consen  190 SSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE----  260 (288)
T ss_dssp             GGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG----
T ss_pred             HHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc----
Confidence            98776544221    1 2345678888765                589999999999999999998654432210    


Q ss_pred             HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCC
Q 039471          316 WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTER  358 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  358 (363)
                      |             .+ .... +.+..++.+|..+|++||++|
T Consensus       261 ~-------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  261 W-------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             G-------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             c-------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            0             11 1222 778889999999999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.7e-16  Score=136.24  Aligned_cols=132  Identities=16%  Similarity=0.144  Sum_probs=105.6

Q ss_pred             cccccccCCcceeeccCCeeEEEEcccCCcC---------hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLHSNEIAVKMLEHLKGN---------GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+...+..|++|+.......         ..++.+|++++..++|+++.....++......+++|||++
T Consensus         3 ~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   82 (211)
T PRK14879          3 LIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIE   82 (211)
T ss_pred             ccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeC
Confidence            3455556665555555677999986532211         1357789999999999988777777777778899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      |++|.+++..         ... ....++.+++.+|.+||+   .+++|+|++|.|||++ ++.++++|||.+..
T Consensus        83 G~~L~~~~~~---------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         83 GEPLKDLINS---------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CcCHHHHHHh---------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999832         122 788999999999999999   9999999999999999 78899999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=2.1e-17  Score=151.56  Aligned_cols=165  Identities=24%  Similarity=0.302  Sum_probs=120.2

Q ss_pred             ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       172 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      ++++.|++|.-.+|.+++.+...   ....++..++.++.|++.|++|      ++.+|+|+||.||+...+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence            57899999999999999964433   2456778899999999999999      48999999999999999999999999


Q ss_pred             ccceeccCCc----cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHH
Q 039471          252 GLAKLCSKDI----SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIY  318 (363)
Q Consensus       252 g~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      |+........    .........||..||+||++        +||||||.+++|++. -...++....           .
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-----------~  469 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-----------L  469 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-----------h
Confidence            9988776655    22233556799999999999        899999999999996 2222111100           0


Q ss_pred             HHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          319 NRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..+..+..     .+....+ -++=..+++|++.++|.+||++.
T Consensus       470 ~d~r~g~i-----p~~~~~d-~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  470 TDIRDGII-----PPEFLQD-YPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhhhcCCC-----ChHHhhc-CcHHHHHHHHhcCCCcccCchHH
Confidence            11111110     0011111 12335789999999999999653

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=4e-16  Score=135.63  Aligned_cols=134  Identities=16%  Similarity=0.110  Sum_probs=97.5

Q ss_pred             ccccccCCcceee---ccCCeeEEEEcccCCcC-------------------------hhHHHHHHHHHhccCCC--cee
Q 039471          112 LISFNLTNSKFFF---LHSNEIAVKMLEHLKGN-------------------------GQEFINEVATIGRIHHF--HIV  161 (363)
Q Consensus       112 ~~~~~~~~~~~~~---~~~~~vAvK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~--niv  161 (363)
                      ++.+++|.++...   ..+..||||++......                         ...+.+|+..+.++.+.  .+.
T Consensus        36 Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p  115 (237)
T smart00090       36 ISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVP  115 (237)
T ss_pred             eccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            4555666555554   23455999998643210                         02356899999999753  334


Q ss_pred             eeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-ceecCCCCCceEE
Q 039471          162 RLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR-ILHFDIKPHNILL  240 (363)
Q Consensus       162 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dikp~Nill  240 (363)
                      +++++    ...++||||+++.+|.....      ....+....+..++.|++.+|.+||+   .+ ++|+||||+||++
T Consensus       116 ~~~~~----~~~~lV~E~~~g~~L~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli  182 (237)
T smart00090      116 KPIAW----RRNVLVMEFIGGDGLPAPRL------KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILV  182 (237)
T ss_pred             eeeEe----cCceEEEEEecCCccccccc------ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEE
Confidence            44443    23589999999988876541      12345666788999999999999999   89 9999999999999


Q ss_pred             cCCCCeeEeccccceeccC
Q 039471          241 DHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       241 ~~~~~~kl~Dfg~a~~~~~  259 (363)
                      + ++.++|+|||.+.....
T Consensus       183 ~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      183 H-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             E-CCCEEEEEChhhhccCC
Confidence            9 88999999999876543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=6.6e-16  Score=131.35  Aligned_cols=128  Identities=17%  Similarity=0.187  Sum_probs=99.5

Q ss_pred             cccccCCcceeeccCCeeEEEEcccCC-c--------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          113 ISFNLTNSKFFFLHSNEIAVKMLEHLK-G--------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       113 ~~~~~~~~~~~~~~~~~vAvK~~~~~~-~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      +.+++|.++.+...+..|++|...... .        ...++.+|++++..++|+++.....++......+++|||++|+
T Consensus         3 g~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~   82 (199)
T TIGR03724         3 AKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGK   82 (199)
T ss_pred             CCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCc
Confidence            455666666666666679999864321 1        1245778999999998876655555555666779999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      +|.+.+...      .    .   .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++...
T Consensus        83 ~l~~~~~~~------~----~---~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        83 PLKDVIEEG------N----D---ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             cHHHHHhhc------H----H---HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999987321      1    0   789999999999999   9999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=2.6e-15  Score=130.84  Aligned_cols=130  Identities=16%  Similarity=0.149  Sum_probs=101.5

Q ss_pred             ccccCCcceeeccCCeeEEEEcccCC--------------cChhHHHHHHHHHhccCCCce--eeeeeeeeeC-C---ce
Q 039471          114 SFNLTNSKFFFLHSNEIAVKMLEHLK--------------GNGQEFINEVATIGRIHHFHI--VRLLGFCSEG-N---RR  173 (363)
Q Consensus       114 ~~~~~~~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~-~---~~  173 (363)
                      .+|.|+++++...+..++||......              ....++.+|++.+.+++|++|  ++.+++.... .   ..
T Consensus        42 ~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~  121 (239)
T PRK01723         42 AKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRA  121 (239)
T ss_pred             CCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceee
Confidence            67888888888888889998774211              122467889999999998774  6777765432 2   23


Q ss_pred             eEEEeccCC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          174 TLIYEFMPN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       174 ~lv~e~~~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      ++|+|+++| .+|.+++..       ..+++.    ...+++.+|.+||+   .+|+|+||||.|||++.++.++|+|||
T Consensus       122 ~lV~e~l~G~~~L~~~l~~-------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        122 DILIERIEGARDLVALLQE-------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             eEEEEecCCCCCHHHHHhc-------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEECC
Confidence            599999997 699988732       234544    35689999999999   999999999999999998899999999


Q ss_pred             cceec
Q 039471          253 LAKLC  257 (363)
Q Consensus       253 ~a~~~  257 (363)
                      .+...
T Consensus       188 ~~~~~  192 (239)
T PRK01723        188 RGELR  192 (239)
T ss_pred             CcccC
Confidence            98764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.5e-15  Score=147.99  Aligned_cols=130  Identities=15%  Similarity=0.137  Sum_probs=102.4

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccC--C-------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHL--K-------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~--~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.++++.++.....+..+++|+....  .       ...+++.+|++++++++|++++....++......++||||+
T Consensus       339 ~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~  418 (535)
T PRK09605        339 HLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYI  418 (535)
T ss_pred             ceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEec
Confidence            44556666665554445555666543211  1       01246889999999999999988887777777789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ++++|.+++.              ....++.+++.+|.+||+   .+++|||+||+|||+ .++.++|+|||+++..
T Consensus       419 ~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        419 GGKDLKDVLE--------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCcHHHHHH--------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999882              356789999999999999   999999999999999 5778999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=2e-16  Score=154.06  Aligned_cols=217  Identities=23%  Similarity=0.251  Sum_probs=167.0

Q ss_pred             eEEEEcccCCcC---hhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHH
Q 039471          130 IAVKMLEHLKGN---GQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK  205 (363)
Q Consensus       130 vAvK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~  205 (363)
                      +|+|.+......   .+....|..+-..+. |.|++++++...+....+++++|..++++.+-+..    ......+...
T Consensus        49 ~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~----~~~~~~~~~~  124 (601)
T KOG0590|consen   49 SATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH----PDSTGTSSSS  124 (601)
T ss_pred             eeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc----CCccCCCCcc
Confidence            666666543322   233445777777776 99999999999999999999999999999887731    1112567777


Q ss_pred             HHHHHHHHHHHHHHhh-cCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccC-Cccccccccccc-cccccCCccc
Q 039471          206 LRKIAFGVARGVEYLH-QGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSK-DISIVSRTAARG-TSGYIAPELF  281 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH-~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~  281 (363)
                      ....+.|+..++.|+| .   .++.|+||||+|.+++..+ ..+++|||+|..+.. +..........| +..|.|||..
T Consensus       125 ~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~  201 (601)
T KOG0590|consen  125 ASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL  201 (601)
T ss_pred             hhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence            8889999999999999 7   9999999999999999999 999999999998877 555445556667 9999999998


Q ss_pred             ---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhcc
Q 039471          282 ---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ  352 (363)
Q Consensus       282 ---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  352 (363)
                               .|+||.|+++.-+++|..|++.......  .+..|....        ................+++.+++.
T Consensus       202 ~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~k~l~  271 (601)
T KOG0590|consen  202 SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNK--------GRFTQLPWNSISDQAHDLLHKILK  271 (601)
T ss_pred             cchhhcCCCcccccccccccccccCCCCccccccccc--cceeecccc--------cccccCccccCChhhhhccccccc
Confidence                     6899999999999999999987665442  222332221        011122344556678888999999


Q ss_pred             CCCCCCCCCCC
Q 039471          353 WNPTERPSMPM  363 (363)
Q Consensus       353 ~~p~~RPs~~e  363 (363)
                      .+|+.|.+.++
T Consensus       272 ~~~~~r~s~~~  282 (601)
T KOG0590|consen  272 ENPSNRLSIEE  282 (601)
T ss_pred             CCchhcccccc
Confidence            99999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.58  E-value=9e-15  Score=124.23  Aligned_cols=131  Identities=15%  Similarity=0.154  Sum_probs=96.7

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCc-----------------------ChhHHHHHHHHHhccCCC--ceeee
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKG-----------------------NGQEFINEVATIGRIHHF--HIVRL  163 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~--niv~~  163 (363)
                      ..++.+++|.++..... +..||||+......                       ....+.+|...+.++.|.  .+...
T Consensus        21 ~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~  100 (198)
T cd05144          21 NQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKP  100 (198)
T ss_pred             CccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCce
Confidence            44556666666555443 45699998653221                       012356788889888777  44444


Q ss_pred             eeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC
Q 039471          164 LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  243 (363)
Q Consensus       164 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~  243 (363)
                      ++.    ...+++|||++|++|.+...            ......++.+++.++.++|+   .+++|+||||+||+++.+
T Consensus       101 ~~~----~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144         101 IDW----NRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             eec----CCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence            442    34589999999999976541            03456788999999999999   999999999999999999


Q ss_pred             CCeeEeccccceeccC
Q 039471          244 FQPKISDFGLAKLCSK  259 (363)
Q Consensus       244 ~~~kl~Dfg~a~~~~~  259 (363)
                      +.++|+|||.+.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999866544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=1.9e-14  Score=116.23  Aligned_cols=132  Identities=21%  Similarity=0.185  Sum_probs=105.8

Q ss_pred             ccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCC--CceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          112 LISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHH--FHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ++.++.+.+..+...+..+++|....... ...+.+|+..++.+++  .++++++++...++..++++||++++++..+ 
T Consensus         6 i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-   83 (155)
T cd05120           6 LKGGLTNRVYLLGTKDEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-   83 (155)
T ss_pred             cccccccceEEEEecCCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-
Confidence            44555555555555556799999865443 5678899999999976  5899999988888889999999988766432 


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                                  +......++.+++.+++.||.....+++|+|++|.||++++.+.++++|||.+...
T Consensus        84 ------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          84 ------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence                        45667788999999999999843347999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.6e-15  Score=147.92  Aligned_cols=175  Identities=20%  Similarity=0.158  Sum_probs=128.5

Q ss_pred             cccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccC---CCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          111 SLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .+|.+++|.++++...+ +.||+|+-+.....  +|.-...++.+|+   -+-|..+.....-.+.-+||+||.+.|||.
T Consensus       705 e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtll  782 (974)
T KOG1166|consen  705 EIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLL  782 (974)
T ss_pred             eeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHH
Confidence            34555555555554433 33999987643322  2333344444554   234555555555666778999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-------CCCCeeEeccccceec--
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-------HNFQPKISDFGLAKLC--  257 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-------~~~~~kl~Dfg~a~~~--  257 (363)
                      +++.      ..+.++|..+..++.|+++.++.||.   .+|||+||||+|.||.       .+..++|+|||.+--+  
T Consensus       783 d~~N------~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  783 DLIN------TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             Hhhc------cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            9993      44789999999999999999999999   9999999999999993       3456899999987544  


Q ss_pred             -cCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCC
Q 039471          258 -SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK  299 (363)
Q Consensus       258 -~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~  299 (363)
                       ++...+   ....+|-.+-.+|+.        .|-|.+..+++-|+.|+.
T Consensus       854 fp~~~~F---~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  854 FPDGTKF---KAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cCCCcEE---eeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence             333222   455678888888888        688999999999998874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.51  E-value=8.4e-15  Score=143.99  Aligned_cols=131  Identities=27%  Similarity=0.331  Sum_probs=99.1

Q ss_pred             HHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC-------------ccccccccccccccccCCcc
Q 039471          214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD-------------ISIVSRTAARGTSGYIAPEL  280 (363)
Q Consensus       214 ~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~-------------~~~~~~~~~~gt~~y~aPE~  280 (363)
                      +.+++|||+   .+|+|||+||+|.+|+.-|.+|+.|||+++.....             ..........||+.|+|||+
T Consensus       153 vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            788999999   99999999999999999999999999998753211             11112344579999999999


Q ss_pred             c--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhcc
Q 039471          281 F--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ  352 (363)
Q Consensus       281 ~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  352 (363)
                      +        .|-|++|+|+||.+-|..||.++....-   +...+.+.+.         -++.+....++.++++.+.|+
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg~visd~i~---------wpE~dea~p~Ea~dli~~LL~  297 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQVISDDIE---------WPEEDEALPPEAQDLIEQLLR  297 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hhhhhhhhcc---------ccccCcCCCHHHHHHHHHHHH
Confidence            9        7889999999999999999988743221   1111211111         122345566788999999999


Q ss_pred             CCCCCCC
Q 039471          353 WNPTERP  359 (363)
Q Consensus       353 ~~p~~RP  359 (363)
                      .+|.+|-
T Consensus       298 qnp~~Rl  304 (1205)
T KOG0606|consen  298 QNPLCRL  304 (1205)
T ss_pred             hChHhhc
Confidence            9999884

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.44  E-value=3e-13  Score=113.72  Aligned_cols=134  Identities=16%  Similarity=0.173  Sum_probs=88.8

Q ss_pred             ccccccCCcceeecc-CCeeEEEEcccCCcCh---hHH----------------------HHHHHHHhccCCC--ceeee
Q 039471          112 LISFNLTNSKFFFLH-SNEIAVKMLEHLKGNG---QEF----------------------INEVATIGRIHHF--HIVRL  163 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~--niv~~  163 (363)
                      ++.+++|.++..... +..||||+........   ..+                      ..|...+.++.+.  .+.+.
T Consensus         5 lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~   84 (187)
T cd05119           5 IGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKP   84 (187)
T ss_pred             cccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCce
Confidence            456666666655544 5559999886432211   111                      2455555555433  23444


Q ss_pred             eeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC
Q 039471          164 LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  243 (363)
Q Consensus       164 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~  243 (363)
                      ++.    ...+++|||++++++.......      .... .....++.+++.++.++|+  ..+++|+||||+||+++ +
T Consensus        85 ~~~----~~~~lv~e~~~g~~~~~~~l~~------~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          85 IDL----NRHVLVMEFIGGDGIPAPRLKD------VRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             Eec----CCCEEEEEEeCCCCccChhhhh------hhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-C
Confidence            433    2468999999985443211000      0011 5678899999999999997  37999999999999999 8


Q ss_pred             CCeeEeccccceeccC
Q 039471          244 FQPKISDFGLAKLCSK  259 (363)
Q Consensus       244 ~~~kl~Dfg~a~~~~~  259 (363)
                      +.++++|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=1.9e-13  Score=118.68  Aligned_cols=193  Identities=21%  Similarity=0.316  Sum_probs=130.6

Q ss_pred             HHhccCCCceeeeeeeeeeC-----CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 039471          151 TIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN  225 (363)
Q Consensus       151 ~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  225 (363)
                      .|-++.|.|+|+++.++.+.     .+..++.|||+.|+|..+++....  ....+......+|+-||+.||.|||+ |.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            34556799999999998543     457889999999999999976553  34678888999999999999999998 66


Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceeccCCcc--ccccccccccccccCCccc--------cCceehhHHHHHHh
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV  295 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~  295 (363)
                      ..|+|+++..+-|++..+|-+|+.--.-......-..  ........+-++|.|||.=        +|||+||+...||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            7899999999999999998888753221111110000  0111233466789999865        89999999999998


Q ss_pred             cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          296 GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       296 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      -+..-......    .+.++....+...+      ....       .-..++.+|++..|..||+|.+
T Consensus       277 ilEiq~tnseS----~~~~ee~ia~~i~~------len~-------lqr~~i~kcl~~eP~~rp~ar~  327 (458)
T KOG1266|consen  277 ILEIQSTNSES----KVEVEENIANVIIG------LENG-------LQRGSITKCLEGEPNGRPDARL  327 (458)
T ss_pred             HheeccCCCcc----eeehhhhhhhheee------ccCc-------cccCcCcccccCCCCCCcchhh
Confidence            77643221111    01111111111111      1000       1234688999999999999853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=3.4e-12  Score=120.95  Aligned_cols=158  Identities=14%  Similarity=0.200  Sum_probs=125.1

Q ss_pred             cCCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHH
Q 039471          126 HSNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE  204 (363)
Q Consensus       126 ~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~  204 (363)
                      .+..|.|+..+...+ ..+...+-++.|+.++||||+++++.++..+..|||+|.+  ..|..++         ..+...
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~l---------k~l~~~  104 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVL---------KELGKE  104 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHH---------HHhHHH
Confidence            344588887765444 2345678889999999999999999999999999999998  4788888         345577


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc---
Q 039471          205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF---  281 (363)
Q Consensus       205 ~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---  281 (363)
                      .+.-.+.||+.||.|||.  +.+++|++|.-+.++++..|..||++|.++...+....  ......-...|..|+.+   
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            788889999999999986  48999999999999999999999999998765443221  11122233456777765   


Q ss_pred             ---cCceehhHHHHHHhcCC
Q 039471          282 ---SRNFCYGMMLLEMVGCR  298 (363)
Q Consensus       282 ---~Di~slG~il~el~~g~  298 (363)
                         .|.|-||++++|++.|.
T Consensus       181 ~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  181 EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccchhhhhHHHHHHHHhCcc
Confidence               39999999999999993

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.30  E-value=1.1e-11  Score=102.48  Aligned_cols=119  Identities=19%  Similarity=0.103  Sum_probs=85.1

Q ss_pred             CCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCC
Q 039471          118 TNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS  196 (363)
Q Consensus       118 ~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~  196 (363)
                      +.++.+...+..+++|+..........+.+|+.+++.+.+.++ .+++.+..  ...++||||++|.++...-       
T Consensus        12 ~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~-------   82 (170)
T cd05151          12 NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED-------   82 (170)
T ss_pred             CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-------
Confidence            3334444455669999986544333456789999998865544 34555433  3457999999998775421       


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----ceecCCCCCceEEcCCCCeeEecccccee
Q 039471          197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQR-----ILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       197 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                             .....+..+++++|..||+   .+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        83 -------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          83 -------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             -------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                   0113456789999999998   66     59999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.21  E-value=8.4e-11  Score=111.33  Aligned_cols=80  Identities=21%  Similarity=0.283  Sum_probs=62.1

Q ss_pred             CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          170 GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR-GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       170 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                      .+..++||||++|++|.++.....     ....   ...++.+++. .+..+|.   .+++|+|++|.||+++.++.+++
T Consensus       230 ~~~~vLvmE~i~G~~L~~~~~~~~-----~~~~---~~~ia~~~~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~l  298 (437)
T TIGR01982       230 TSERVLTMEWIDGIPLSDIAALDE-----AGLD---RKALAENLARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIA  298 (437)
T ss_pred             cCCceEEEEeECCcccccHHHHHh-----cCCC---HHHHHHHHHHHHHHHHHh---CCceeCCCCcccEEECCCCcEEE
Confidence            345789999999999988764221     1122   3445666665 4678898   99999999999999999999999


Q ss_pred             eccccceeccCC
Q 039471          249 SDFGLAKLCSKD  260 (363)
Q Consensus       249 ~Dfg~a~~~~~~  260 (363)
                      +|||++..+++.
T Consensus       299 iDfG~~~~l~~~  310 (437)
T TIGR01982       299 LDFGIVGRLSEE  310 (437)
T ss_pred             EeCCCeeECCHH
Confidence            999999887643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=1.6e-11  Score=115.16  Aligned_cols=211  Identities=23%  Similarity=0.209  Sum_probs=152.8

Q ss_pred             eeEEEEcccC---CcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHH
Q 039471          129 EIAVKMLEHL---KGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE  204 (363)
Q Consensus       129 ~vAvK~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~  204 (363)
                      .+|+|.-+..   .....+=.+|+...++++ |+|.++.+..+..++..++-+|++. .+|..+.+...     ..++..
T Consensus       145 ~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~-----~~~p~~  218 (524)
T KOG0601|consen  145 KFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPC-----NFLPDN  218 (524)
T ss_pred             ccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhccc-----ccCCch
Confidence            3888874321   122233456777777775 9999999999999999999999995 68988885332     447888


Q ss_pred             HHHHHHHHHHH----HHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceeccCCcccc---cccccccccccc
Q 039471          205 KLRKIAFGVAR----GVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIV---SRTAARGTSGYI  276 (363)
Q Consensus       205 ~~~~i~~~i~~----~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~  276 (363)
                      .++....+...    ||..+|+   .+++|-|+||.||+...+ ...+++|||+...+.......   ......|...|+
T Consensus       219 ~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~  295 (524)
T KOG0601|consen  219 LLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYA  295 (524)
T ss_pred             hhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEe
Confidence            88888888888    9999999   999999999999999999 889999999998887654211   112225777899


Q ss_pred             CCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Q 039471          277 APELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIW  349 (363)
Q Consensus       277 aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  349 (363)
                      +||..       +|+|++|.++.+..++........       +..|.  ++....     ...+....-+.++..++..
T Consensus       296 ~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-------~~~W~--~~r~~~-----ip~e~~~~~s~~l~~~~~~  361 (524)
T KOG0601|consen  296 AKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK-------NSSWS--QLRQGY-----IPLEFCEGGSSSLRSVTSQ  361 (524)
T ss_pred             ChhhhccccchHhhhcchhhhhHhhHhhcccccCCC-------CCCcc--cccccc-----CchhhhcCcchhhhhHHHH
Confidence            99998       899999999999998876654321       11111  111111     1111222334556668999


Q ss_pred             hccCCCCCCCCCC
Q 039471          350 CIQWNPTERPSMP  362 (363)
Q Consensus       350 cl~~~p~~RPs~~  362 (363)
                      |++.+|..|++.+
T Consensus       362 ~~d~~~~~~~~~q  374 (524)
T KOG0601|consen  362 MLDEDPRLRLTAQ  374 (524)
T ss_pred             hcCcchhhhhHHH
Confidence            9999999998764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.12  E-value=5.2e-11  Score=114.24  Aligned_cols=81  Identities=16%  Similarity=0.206  Sum_probs=56.5

Q ss_pred             CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----C
Q 039471          170 GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----Q  245 (363)
Q Consensus       170 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----~  245 (363)
                      .+..+|||||++|+++.++-.-.........+.+..+..++.|+.       .   .|++|+|++|.||+++.++    .
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~---~GffHaDpHPGNIlv~~~g~~~~~  302 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------R---DGFFHADMHPGNIFVSYDPPENPR  302 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------h---CCeeeCCCChHHeEEecCCCCCCe
Confidence            345789999999999987531111101112244444444444443       4   7999999999999999887    9


Q ss_pred             eeEeccccceeccCC
Q 039471          246 PKISDFGLAKLCSKD  260 (363)
Q Consensus       246 ~kl~Dfg~a~~~~~~  260 (363)
                      +++.|||++..+++.
T Consensus       303 i~llDFGivg~l~~~  317 (537)
T PRK04750        303 YIALDFGIVGSLNKE  317 (537)
T ss_pred             EEEEecceEEECCHH
Confidence            999999999887653

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.11  E-value=9.3e-11  Score=88.74  Aligned_cols=66  Identities=39%  Similarity=0.765  Sum_probs=55.0

Q ss_pred             CCCCcccCCCCCCcccceeeCCCCCCCCC-CCeeeeecCC--CceeecCCCCceEEEeEEeeecceecccCCCCCC
Q 039471           35 FCQPTRCSNKSPRIRYPFRLKAQPTYCGL-EGFELSCLSD--KTILHFPSSGDYYVHKISYLDSSITITDVNETAC  107 (363)
Q Consensus        35 ~c~~~~c~~~~~~i~~pf~l~~~~~~cg~-~~~~l~c~~~--~~~l~~~~~g~y~v~~I~y~~~~~~v~~~~~~~c  107 (363)
                      .|+ .+||+.  +|+||||+..   .|+. |+|+|+|+++  ...+.. ..+.|.|.+|+|.++++++.+.....|
T Consensus         3 ~C~-~~CGnv--~IpYPFgi~~---~C~~~~~F~L~C~~~~~~~~l~l-~~~~~~V~~I~~~~~~i~v~~~~~~~~   71 (106)
T PF13947_consen    3 GCP-SSCGNV--SIPYPFGIGP---GCGRDPGFELTCNNNTSPPKLLL-SSGNYEVLSISYENGTIRVSDPISSNC   71 (106)
T ss_pred             CCC-CccCCE--eecCCCccCC---CCCCCCCcEEECCCCCCCceeEe-cCCcEEEEEEecCCCEEEEEeccccce
Confidence            494 899997  8999999976   5999 9999999987  444433 789999999999999999988764444

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.09  E-value=4.5e-10  Score=93.90  Aligned_cols=98  Identities=13%  Similarity=0.230  Sum_probs=75.2

Q ss_pred             HHHHHHHhccCC--CceeeeeeeeeeCCceeEEEeccCCCCHHH-HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHh-h
Q 039471          146 INEVATIGRIHH--FHIVRLLGFCSEGNRRTLIYEFMPNGSLQK-FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYL-H  221 (363)
Q Consensus       146 ~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H  221 (363)
                      .+|.+.|.++..  -++.+++++    ...+|||||+.+..+.. .+       ....++......+..+++.+|..| |
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-------kd~~~~~~~~~~i~~~i~~~l~~l~H  142 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-------KDAKLNDEEMKNAYYQVLSMMKQLYK  142 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-------hccccCHHHHHHHHHHHHHHHHHHHH
Confidence            379999999863  466777765    45689999997643321 12       112355566778889999999999 8


Q ss_pred             cCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          222 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       222 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      +   .+++|+|+++.|||++ ++.++|+|||.+....
T Consensus       143 ~---~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         143 E---CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             h---CCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            8   8999999999999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=2.7e-09  Score=94.19  Aligned_cols=106  Identities=20%  Similarity=0.161  Sum_probs=82.6

Q ss_pred             HHHHHHHHHhccCCC--ceeeeeeeeee-----CCceeEEEeccCCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 039471          144 EFINEVATIGRIHHF--HIVRLLGFCSE-----GNRRTLIYEFMPNG-SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR  215 (363)
Q Consensus       144 ~~~~E~~~l~~l~h~--niv~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~  215 (363)
                      .+.+|...+.++...  .+.+++++.+.     ...-++|+|++++. +|.+++....    ....+......++.+++.
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~  149 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVAT  149 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHH
Confidence            478999999888533  34455666543     23578999999875 8999874221    134566778899999999


Q ss_pred             HHHHhhcCCCCCceecCCCCCceEEcC-------CCCeeEecccccee
Q 039471          216 GVEYLHQGCNQRILHFDIKPHNILLDH-------NFQPKISDFGLAKL  256 (363)
Q Consensus       216 ~l~~LH~~~~~~i~H~dikp~Nill~~-------~~~~kl~Dfg~a~~  256 (363)
                      .+.-||.   .||+|+|+++.|||++.       +..+.++||+.+..
T Consensus       150 ~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        150 MVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            9999999   99999999999999975       46799999998864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.03  E-value=2.2e-09  Score=92.55  Aligned_cols=133  Identities=16%  Similarity=0.192  Sum_probs=96.7

Q ss_pred             cCCcceeeccC-CeeEEEEcccCCc--ChhHHHHHHHHHhccCC--CceeeeeeeeeeC---CceeEEEeccCCCCHHHH
Q 039471          117 LTNSKFFFLHS-NEIAVKMLEHLKG--NGQEFINEVATIGRIHH--FHIVRLLGFCSEG---NRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       117 ~~~~~~~~~~~-~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~~~sL~~~  188 (363)
                      .+.+..+...+ ..+++|.......  ....+.+|.++++.+++  .++.+++.+....   +..+++|||++|.++.+.
T Consensus        11 ~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~   90 (223)
T cd05154          11 SNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDR   90 (223)
T ss_pred             cceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCC
Confidence            33444444444 5699999865433  35678899999999975  3467777776654   256899999999888775


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC--------------------------------------------  224 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------  224 (363)
                      +..       ..+++.....++.+++++|..||+..                                            
T Consensus        91 ~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (223)
T cd05154          91 LLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW  163 (223)
T ss_pred             CCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence            510       24677777788888888888888521                                            


Q ss_pred             ---------CCCceecCCCCCceEEcC--CCCeeEecccccee
Q 039471          225 ---------NQRILHFDIKPHNILLDH--NFQPKISDFGLAKL  256 (363)
Q Consensus       225 ---------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~  256 (363)
                               ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                     245699999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.03  E-value=6.7e-09  Score=96.11  Aligned_cols=162  Identities=15%  Similarity=0.218  Sum_probs=122.0

Q ss_pred             ccCCeeEEEEcccCCcCh-hHHHHHHHHHhccCCCceeeeeeeee----eCCceeEEEeccCC-CCHHHHhhhcCCC---
Q 039471          125 LHSNEIAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCS----EGNRRTLIYEFMPN-GSLQKFIFSKTNS---  195 (363)
Q Consensus       125 ~~~~~vAvK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~sL~~~l~~~~~~---  195 (363)
                      .++..+.+|++...+... .....-++.++++.|.|+|++..++.    .+..+++||+|.++ ++|.++.+.....   
T Consensus       299 ~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~  378 (655)
T KOG3741|consen  299 VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR  378 (655)
T ss_pred             cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence            345558999884222111 12234577889999999999999875    34578999999875 7888887654332   


Q ss_pred             ------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc-cccccc
Q 039471          196 ------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-IVSRTA  268 (363)
Q Consensus       196 ------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~  268 (363)
                            ..+...+|..+|.++.|+..||.++|+   .|+.-+-+.|.+||++.+.+++|+..|.......+.. ... . 
T Consensus       379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~~le-~-  453 (655)
T KOG3741|consen  379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTEPLE-S-  453 (655)
T ss_pred             cccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCCCCcchh-H-
Confidence                  234678999999999999999999999   9999999999999999999999999988777655431 000 0 


Q ss_pred             ccccccccCCccccCceehhHHHHHHhcCCCCC
Q 039471          269 ARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNN  301 (363)
Q Consensus       269 ~~gt~~y~aPE~~~Di~slG~il~el~~g~~~~  301 (363)
                                .+-.|.=-||.+++.|.||...-
T Consensus       454 ----------~Qq~D~~~lG~ll~aLAt~~~ns  476 (655)
T KOG3741|consen  454 ----------QQQNDLRDLGLLLLALATGTENS  476 (655)
T ss_pred             ----------HhhhhHHHHHHHHHHHhhccccc
Confidence                      01146678999999999997663

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=1.1e-09  Score=88.64  Aligned_cols=98  Identities=18%  Similarity=0.251  Sum_probs=77.4

Q ss_pred             hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 039471          143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ  222 (363)
Q Consensus       143 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  222 (363)
                      ++-.+|.+++.+++-..|.-.+-+..+.....|+|||.+|..|.+++...             ...++..+-.-+.-||.
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~  110 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHK  110 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHh
Confidence            45678999999887554444444455666778999999999998888321             24567777778888999


Q ss_pred             CCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          223 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       223 ~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                         .+|+|+|+.++||++..+. +.++|||++..-
T Consensus       111 ---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642         111 ---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             ---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence               9999999999999998774 999999998753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=8.2e-10  Score=103.82  Aligned_cols=218  Identities=18%  Similarity=0.181  Sum_probs=142.8

Q ss_pred             cccccCCcceeecc---CCeeEEEEcccCCcCh---hHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          113 ISFNLTNSKFFFLH---SNEIAVKMLEHLKGNG---QEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       113 ~~~~~~~~~~~~~~---~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      +..+++.+..+..+   +..+++|.+.+.....   ..-..|+-+...+ .|.++++.+..+......++-.||++++++
T Consensus       274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~  353 (524)
T KOG0601|consen  274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSS  353 (524)
T ss_pred             cCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcch
Confidence            34444444443332   2238888876433221   1223455555544 488888888888777778899999999998


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceeccCCcccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ...+.      ....+.+...+++..|++.++.++|+   ..++|+|+||+||++..+ +.-++.|||.+..+.-..   
T Consensus       354 ~l~~~------~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---  421 (524)
T KOG0601|consen  354 SLRSV------TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---  421 (524)
T ss_pred             hhhhH------HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceec---
Confidence            87761      22568888999999999999999999   999999999999999886 778999999886422111   


Q ss_pred             cccccccccccc-CCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 SRTAARGTSGYI-APELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 ~~~~~~gt~~y~-aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        .......++. ..|++         .|++|||.-+.|.+++.........-..           +..+.  .    +.
T Consensus       422 --~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-----------i~~~~--~----p~  482 (524)
T KOG0601|consen  422 --GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-----------IRSGD--T----PN  482 (524)
T ss_pred             --ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee-----------eeccc--c----cC
Confidence              1111222333 23433         7899999999999988865433211110           00010  0    11


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+ .....+..+...++..++..||++.
T Consensus       483 ~~-~~~~~~q~~~kv~~~~~~~~~~l~~  509 (524)
T KOG0601|consen  483 LP-GLKLQLQVLLKVMINPDRKRRPSAV  509 (524)
T ss_pred             CC-chHHhhhhhhhhhcCCccccchhhh
Confidence            11 2225677778888888888888764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.91  E-value=7.8e-09  Score=83.54  Aligned_cols=107  Identities=22%  Similarity=0.326  Sum_probs=80.1

Q ss_pred             hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 039471          143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH  221 (363)
Q Consensus       143 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  221 (363)
                      ++-.+|.+.|.+++--.|.-..-++.+...-.|+|||++| .++.+++...-.    ..........++.+|-..+.-||
T Consensus        55 ~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH  130 (229)
T KOG3087|consen   55 KRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLH  130 (229)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhh
Confidence            5677899999988744443333345555666799999976 478888855432    22333444788999999999999


Q ss_pred             cCCCCCceecCCCCCceEEcCCCC---eeEecccccee
Q 039471          222 QGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKL  256 (363)
Q Consensus       222 ~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~  256 (363)
                      .   ++|+|+|+..+||++..++.   +.++|||++..
T Consensus       131 ~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  131 D---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             h---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9   99999999999999976543   58999999754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.87  E-value=1.1e-09  Score=108.67  Aligned_cols=185  Identities=20%  Similarity=0.237  Sum_probs=133.0

Q ss_pred             CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCC
Q 039471          157 HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH  236 (363)
Q Consensus       157 h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~  236 (363)
                      +|-+++..-.+......+|+++|..+++|...++..      ...+.+-.+..+..+..++++||.   ..+.|+|++|.
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~------~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~  933 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS------GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPD  933 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcC------CCcccccccchhHHHHhhhhcccc---chhhccccccc
Confidence            344444444444566789999999999999888533      345566667778888999999999   77999999999


Q ss_pred             ceEEcCCCCeeEeccccceeccC---------------------Ccc---c-----cccccccccccccCCccc------
Q 039471          237 NILLDHNFQPKISDFGLAKLCSK---------------------DIS---I-----VSRTAARGTSGYIAPELF------  281 (363)
Q Consensus       237 Nill~~~~~~kl~Dfg~a~~~~~---------------------~~~---~-----~~~~~~~gt~~y~aPE~~------  281 (363)
                      |++...++..+++|||......-                     ...   .     .......+|+.|.+||..      
T Consensus       934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen  934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred             chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence            99999999999999984332210                     000   0     112345689999999998      


Q ss_pred             --cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          282 --SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       282 --~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                        .|.|+.|++++|.++|.+||+......        +.+.+..+...    -+..+...+....+++...+..+|.+|-
T Consensus      1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~--------~f~ni~~~~~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQ--------IFENILNRDIP----WPEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             CcchhhhhhhhhhhhhcCCCCCCCcchhh--------hhhccccCCCC----CCCCccccChhhhhhhhhhhccCchhcc
Confidence              799999999999999999998765433        22333222221    1234445566788888889999999997


Q ss_pred             CCC
Q 039471          360 SMP  362 (363)
Q Consensus       360 s~~  362 (363)
                      .|.
T Consensus      1082 ~a~ 1084 (1205)
T KOG0606|consen 1082 GAK 1084 (1205)
T ss_pred             Ccc
Confidence            764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=1.7e-08  Score=84.06  Aligned_cols=100  Identities=24%  Similarity=0.306  Sum_probs=67.7

Q ss_pred             hHHHHHHHHHhccCCC--ceeeeeeeeeeCCceeEEEeccC--CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 039471          143 QEFINEVATIGRIHHF--HIVRLLGFCSEGNRRTLIYEFMP--NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVE  218 (363)
Q Consensus       143 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~  218 (363)
                      ....+|.+.|.++...  ++.+++++    ...+|||||++  |..+..+..        ..++......++.+++..+.
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~----~~~~ivME~I~~~G~~~~~l~~--------~~~~~~~~~~~~~~il~~~~  120 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDY----NRNVIVMEYIGEDGVPLPRLKD--------VDLSPEEPKELLEEILEEII  120 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEE----ETTEEEEE--EETTEEGGCHHH--------CGGGGSTHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEE----eCCEEEEEecCCCccchhhHHh--------ccccchhHHHHHHHHHHHHH
Confidence            3566899999999755  56777755    23479999998  655654431        11223455677778888555


Q ss_pred             H-hhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          219 Y-LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       219 ~-LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      . +|+   .+|+|+|+.+.|||++.+ .+.++|||.+....
T Consensus       121 ~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  121 KMLHK---AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHC---TTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             HHHHh---cCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            5 578   999999999999999988 99999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=3.7e-08  Score=84.03  Aligned_cols=108  Identities=22%  Similarity=0.287  Sum_probs=85.9

Q ss_pred             hhHHHHHHHHHhccC--CCceeeeeeeeeeCC----ceeEEEeccCC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHH
Q 039471          142 GQEFINEVATIGRIH--HFHIVRLLGFCSEGN----RRTLIYEFMPN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVA  214 (363)
Q Consensus       142 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~  214 (363)
                      ..++.+|...+..+.  .-.+.+.+++.....    ..++|+|++++ .+|.+++...      ...+......++.+++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~------~~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW------EQLDPSQRRELLRALA  128 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh------cccchhhHHHHHHHHH
Confidence            346788998888885  334566777765432    45899999987 4899988432      2266777889999999


Q ss_pred             HHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEeccccceecc
Q 039471          215 RGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCS  258 (363)
Q Consensus       215 ~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~  258 (363)
                      ..+.-||.   .+|+|+|+++.|||++.++   .+.++||+.++...
T Consensus       129 ~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  129 RLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999999   9999999999999999887   89999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.68  E-value=6.2e-09  Score=99.50  Aligned_cols=139  Identities=17%  Similarity=0.244  Sum_probs=94.3

Q ss_pred             HHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc----c---cccccccccccCCccc--
Q 039471          211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV----S---RTAARGTSGYIAPELF--  281 (363)
Q Consensus       211 ~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~----~---~~~~~gt~~y~aPE~~--  281 (363)
                      .+.+.|+.|+|.  ..+++|++|.|++|.++.++..||+.|+.+..........    +   .........|.|||.+  
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            344589999998  5899999999999999999999999999876654421110    0   0112245579999998  


Q ss_pred             ------cCceehhHHHHHHh-cCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCC
Q 039471          282 ------SRNFCYGMMLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN  354 (363)
Q Consensus       282 ------~Di~slG~il~el~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~  354 (363)
                            +|+||+|+++|.+. +|++.+........         ...+..  .......-....++.++.+=+.+++..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---------~~~~~~--~~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---------YSFSRN--LLNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcch---------hhhhhc--ccccccccccccCcHHHHHHHHHHhcCC
Confidence                  89999999999999 55554443321111         000000  0000011123567778888899999999


Q ss_pred             CCCCCCCC
Q 039471          355 PTERPSMP  362 (363)
Q Consensus       355 p~~RPs~~  362 (363)
                      +.-||++.
T Consensus       253 ~~~rp~~~  260 (700)
T KOG2137|consen  253 SAVRPTLD  260 (700)
T ss_pred             cccCcchh
Confidence            99999764

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=6.8e-07  Score=75.08  Aligned_cols=136  Identities=15%  Similarity=0.114  Sum_probs=100.4

Q ss_pred             cccccCCcceeeccCCeeEEEEcccC-------CcChhHHHHHHHHHhccCC--Cceeeeeeeee-e----CCceeEEEe
Q 039471          113 ISFNLTNSKFFFLHSNEIAVKMLEHL-------KGNGQEFINEVATIGRIHH--FHIVRLLGFCS-E----GNRRTLIYE  178 (363)
Q Consensus       113 ~~~~~~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~-~----~~~~~lv~e  178 (363)
                      +.+|.+++..+.+.+..+-+|.-.+.       +-....|.+|+..|.++..  -++.+.. ++. .    ...-+||+|
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence            45677777777777777888876521       2234689999999999963  3344555 332 1    124678999


Q ss_pred             ccCC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC--eeEeccccce
Q 039471          179 FMPN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--PKISDFGLAK  255 (363)
Q Consensus       179 ~~~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~  255 (363)
                      -++| .+|.+++....    ..+.+......+..++++.+.-||+   .++.|+|+.+.||+++.++.  ++++||--++
T Consensus       106 ~L~g~~~L~~~l~~~~----~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        106 DMAGFISIADWYAQHA----VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             eCCCCccHHHHHhcCC----cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            7753 68888873321    1356777888999999999999999   99999999999999986667  8999998765


Q ss_pred             e
Q 039471          256 L  256 (363)
Q Consensus       256 ~  256 (363)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.54  E-value=4.6e-07  Score=82.28  Aligned_cols=184  Identities=15%  Similarity=0.123  Sum_probs=119.8

Q ss_pred             eeEEEeccCCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          173 RTLIYEFMPNG-SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       173 ~~lv~e~~~~~-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      .-+.|..+++. .+..+.........-....|+.+++.++.++.+..-||.   .|..-+|++++|+|+++++.+.|.|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcc
Confidence            56777776653 233333222222333568899999999999999999999   99999999999999999999999986


Q ss_pred             ccceeccCCccccccccccccccccCCccc-------------cCceehhHHHHHHhcC-CCCCCcchhcccccchHH-H
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGC-RKNNDPAVEIQSQIYFPE-W  316 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g-~~~~~~~~~~~~~~~~~~-~  316 (363)
                      ..-.....+..+   ...+|...|.+||.-             .|.|.||+++++++.| +.||.+.........-.+ -
T Consensus       162 Dsfqi~~ng~~~---~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         162 DSFQINANGTLH---LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             cceeeccCCceE---ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            655444333322   445688899999976             7999999999999866 888876433222111000 0


Q ss_pred             HH-HH--hhhcccc--ccccCCCCcHHHHHHHHHHHHHhccCC--CCCCCCCC
Q 039471          317 IY-NR--MRLGQEL--CLDFEEDGDEGIARKLAIVAIWCIQWN--PTERPSMP  362 (363)
Q Consensus       317 ~~-~~--~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~--p~~RPs~~  362 (363)
                      +. ..  ....+..  ..........-+++.+.-+..+|+..-  +.-|||++
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            00 00  0000111  111111233456677888888888743  45788864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.49  E-value=7.5e-07  Score=76.79  Aligned_cols=96  Identities=19%  Similarity=0.233  Sum_probs=71.5

Q ss_pred             HHHHHHHHHhccCCC--ceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 039471          144 EFINEVATIGRIHHF--HIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH  221 (363)
Q Consensus       144 ~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  221 (363)
                      ...+|.+.|.+|...  .+.+.+++    +...+|||+++|-.|...-           +.......++..|+.-+.-+-
T Consensus       155 ~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~  219 (304)
T COG0478         155 AAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAY  219 (304)
T ss_pred             HHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHH
Confidence            456899999999754  77777776    6678999999986665432           123334444555555555555


Q ss_pred             cCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          222 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       222 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      .   .|++|+|+++-||+++++|.+.++||--+...
T Consensus       220 ~---~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         220 R---RGIVHGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             H---cCccccCCchheEEEecCCCEEEEeCcccccC
Confidence            5   89999999999999999999999999876544

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.34  E-value=2.7e-06  Score=71.85  Aligned_cols=123  Identities=13%  Similarity=0.172  Sum_probs=77.4

Q ss_pred             ccCCcceeeccCCeeEEEEcccCCcChhH----------HHHHHHHHhccCCC---ceeeeeeeeee-----CCceeEEE
Q 039471          116 NLTNSKFFFLHSNEIAVKMLEHLKGNGQE----------FINEVATIGRIHHF---HIVRLLGFCSE-----GNRRTLIY  177 (363)
Q Consensus       116 ~~~~~~~~~~~~~~vAvK~~~~~~~~~~~----------~~~E~~~l~~l~h~---niv~~~~~~~~-----~~~~~lv~  177 (363)
                      ....|...-..+..+.+|.........++          ..+++..+.+++..   ....++.+...     ....+++|
T Consensus        43 ~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~  122 (229)
T PF06176_consen   43 KRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLM  122 (229)
T ss_pred             CccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEE
Confidence            34444555556666788877543222222          22344444444332   22233333221     23457899


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ||++|..|.+..          .+++    .+...+..++.-||+   .|+.|+|..|.|++++++ .++++||+..+.
T Consensus       123 EYIeG~~l~d~~----------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  123 EYIEGVELNDIE----------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEecCeecccch----------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            999998886654          1333    244567788999999   999999999999999965 499999987543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.24  E-value=1.9e-05  Score=68.28  Aligned_cols=136  Identities=13%  Similarity=0.130  Sum_probs=76.9

Q ss_pred             ccCCcceeec-cCCeeEEEEcccCCcChhHHHHHHHHHhccCCC--ceeeeeeeeeeCCceeEEEeccCCCC-HHHHh--
Q 039471          116 NLTNSKFFFL-HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGFCSEGNRRTLIYEFMPNGS-LQKFI--  189 (363)
Q Consensus       116 ~~~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~s-L~~~l--  189 (363)
                      +.|....++. .++.+++|...... ...+..+|.++++.+...  .+.+.+++....+...++||+++|.+ +...+  
T Consensus        10 ~~G~t~~~y~~~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~   88 (226)
T TIGR02172        10 GEGGNGESYTHKTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISD   88 (226)
T ss_pred             cCCCCcceeEecCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcC
Confidence            3344433333 24457788876422 345678999999988643  35677888777777889999999863 22111  


Q ss_pred             -------------------hhcCCCCCCCCCCHHHHHHHHHH----------HHH-HHHHhhcC-CCCCceecCCCCCce
Q 039471          190 -------------------FSKTNSSSHRQLSWEKLRKIAFG----------VAR-GVEYLHQG-CNQRILHFDIKPHNI  238 (363)
Q Consensus       190 -------------------~~~~~~~~~~~l~~~~~~~i~~~----------i~~-~l~~LH~~-~~~~i~H~dikp~Ni  238 (363)
                                         +....  ....++. ....+..+          +.. ..++|... ....++|+|+.|.||
T Consensus        89 ~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Ni  165 (226)
T TIGR02172        89 NPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNL  165 (226)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcE
Confidence                               11000  0011110 00001000          000 11222211 124568999999999


Q ss_pred             EEcCCCCeeEecccccee
Q 039471          239 LLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       239 ll~~~~~~kl~Dfg~a~~  256 (363)
                      ++++++ +.++||+.+..
T Consensus       166 i~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       166 ITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             EEcCCC-cEEEechhcCc
Confidence            999887 99999998754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=6e-06  Score=69.05  Aligned_cols=106  Identities=25%  Similarity=0.283  Sum_probs=84.2

Q ss_pred             HHHHHHhccCC-CceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 039471          147 NEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN  225 (363)
Q Consensus       147 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  225 (363)
                      +|.-+++.+++ +++++++|+|-.    +++.||...+++.....   .-......+|..+.+|+.+++..+++|+.+..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~---~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR---PLSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc---ccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            57788888875 699999999844    57899998776643210   00112457899999999999999999998776


Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ..+.-.|++|+|+-+++++.+|++|...+.....
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence            6788999999999999999999999998766543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.21  E-value=1.8e-05  Score=69.42  Aligned_cols=127  Identities=13%  Similarity=0.097  Sum_probs=75.0

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhh----------------
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIF----------------  190 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~----------------  190 (363)
                      ..+.||+.....  ..+..+|+++++.+. +--+.+++++...++..++|||+++|.+|.....                
T Consensus        23 ~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~  100 (244)
T cd05150          23 PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALR  100 (244)
T ss_pred             CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHH
Confidence            358888876443  345678999988884 4456678887777677899999999987764421                


Q ss_pred             hcCCC-CCCCCCCHH---HHHHHHH-------------------HHHHHHHHhhc----CCCCCceecCCCCCceEEcCC
Q 039471          191 SKTNS-SSHRQLSWE---KLRKIAF-------------------GVARGVEYLHQ----GCNQRILHFDIKPHNILLDHN  243 (363)
Q Consensus       191 ~~~~~-~~~~~l~~~---~~~~i~~-------------------~i~~~l~~LH~----~~~~~i~H~dikp~Nill~~~  243 (363)
                      .-... .....+...   .+.....                   .+...++.|-.    .....++|+|+.|.|||++++
T Consensus       101 ~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~  180 (244)
T cd05150         101 RLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPG  180 (244)
T ss_pred             HHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCC
Confidence            00000 000111100   0000000                   01111222211    112568999999999999998


Q ss_pred             CCeeEecccccee
Q 039471          244 FQPKISDFGLAKL  256 (363)
Q Consensus       244 ~~~kl~Dfg~a~~  256 (363)
                      ..+.|+||+.+..
T Consensus       181 ~~~~iIDwe~a~~  193 (244)
T cd05150         181 KFSGFIDLGRLGV  193 (244)
T ss_pred             cEEEEEEcccccc
Confidence            7788999997754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=3.2e-05  Score=65.04  Aligned_cols=129  Identities=19%  Similarity=0.291  Sum_probs=89.6

Q ss_pred             cccccCCcceeeccCCe--eEEEEcccCC-----------------cChhHHHHHHHHHhccC------CCceeeeeeee
Q 039471          113 ISFNLTNSKFFFLHSNE--IAVKMLEHLK-----------------GNGQEFINEVATIGRIH------HFHIVRLLGFC  167 (363)
Q Consensus       113 ~~~~~~~~~~~~~~~~~--vAvK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~~~~~~  167 (363)
                      ..++.|+...++.+.+.  ..||+.....                 ....++.+|+.....+.      +.+|.+++|+.
T Consensus         7 ~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v   86 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFV   86 (199)
T ss_pred             cccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEE
Confidence            34566677777766555  8889886444                 23466778887777666      78999999999


Q ss_pred             eeCCceeEEEeccCC------CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc
Q 039471          168 SEGNRRTLIYEFMPN------GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       168 ~~~~~~~lv~e~~~~------~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~  241 (363)
                      +++.-.-+|+|.+.+      .+|.+++..       ..++. .+.+.+.   .-.+||-+   .+|+.+|++|+||++.
T Consensus        87 eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   87 ETNLGLGLVVELIRDADGNISPTLEDYLKE-------GGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             ecCCceEEEEEEEECCCCCcCccHHHHHHc-------CCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEE
Confidence            998888999998632      478888832       33555 3433333   33566677   8999999999999996


Q ss_pred             CC--C--CeeEec-cccce
Q 039471          242 HN--F--QPKISD-FGLAK  255 (363)
Q Consensus       242 ~~--~--~~kl~D-fg~a~  255 (363)
                      ..  +  .+.|+| ||...
T Consensus       153 ~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ecCCCceEEEEEeCCCCcc
Confidence            33  2  477777 55433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.00  E-value=4.5e-05  Score=65.30  Aligned_cols=100  Identities=20%  Similarity=0.246  Sum_probs=68.2

Q ss_pred             HHHHHHhccC--CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 039471          147 NEVATIGRIH--HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC  224 (363)
Q Consensus       147 ~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  224 (363)
                      .|+..|.++.  +-.+.+.+++    ....|||||+.....   -. .  .-+...+.......+..++++.+.-|-.  
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~---pA-P--~LkDv~~e~~e~~~~~~~~v~~~~~l~~--  184 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGL---PA-P--RLKDVPLELEEAEGLYEDVVEYMRRLYK--  184 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCC---CC-C--CcccCCcCchhHHHHHHHHHHHHHHHHH--
Confidence            5677777663  4445555554    234799999954311   00 0  0111233444677778888888888876  


Q ss_pred             CCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ..+++|+|++.-|||+. ++.+.|+|+|-|.....
T Consensus       185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            38999999999999999 78999999998876543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.88  E-value=0.00012  Score=63.78  Aligned_cols=59  Identities=14%  Similarity=0.240  Sum_probs=37.5

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhccCCC---ceeeeeeeeeeC---CceeEEEeccCCCCHH
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHF---HIVRLLGFCSEG---NRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.... ......+.+|.+.+..+...   .+.+.++.....   ...+++|++++|.++.
T Consensus        18 ~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~   82 (235)
T cd05155          18 GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT   82 (235)
T ss_pred             CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence            45577887553 22345788999999887532   344455443321   2458899999987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.87  E-value=8.5e-05  Score=64.25  Aligned_cols=136  Identities=17%  Similarity=0.180  Sum_probs=72.6

Q ss_pred             cceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCC--ceeeeeeeee---eCCceeEEEeccCCCCHHH-------
Q 039471          120 SKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGFCS---EGNRRTLIYEFMPNGSLQK-------  187 (363)
Q Consensus       120 ~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~~sL~~-------  187 (363)
                      +..+...+..+++|..... .....+.+|..+++.+...  .+.+++....   .....+++|++++|.++..       
T Consensus        13 ~~~v~~~~~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~   91 (239)
T PF01636_consen   13 VYRVTTDDGRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQR   91 (239)
T ss_dssp             EEEEEETTSEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHH
T ss_pred             EEEEEECCcEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccccccccccccc
Confidence            4444445556999997644 3446778899998888533  3566776442   3345789999999988877       


Q ss_pred             ---------HhhhcCCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc----CCCCCceec
Q 039471          188 ---------FIFSKTNS-SSHRQLSWEK---------LRKI------------AFGVAR-GVEYLHQ----GCNQRILHF  231 (363)
Q Consensus       188 ---------~l~~~~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~----~~~~~i~H~  231 (363)
                               .+..-... .....+....         ....            ...+.. .++.+++    .....++|+
T Consensus        92 ~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Hg  171 (239)
T PF01636_consen   92 PELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHG  171 (239)
T ss_dssp             HHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-S
T ss_pred             ccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEe
Confidence                     11110000 0001111100         0000            011122 2333332    123679999


Q ss_pred             CCCCCceEEc-CCCCeeEecccccee
Q 039471          232 DIKPHNILLD-HNFQPKISDFGLAKL  256 (363)
Q Consensus       232 dikp~Nill~-~~~~~kl~Dfg~a~~  256 (363)
                      |+.|.|||++ +++.+.|+||+.+..
T Consensus       172 D~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  172 DLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             S-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             ccccccceeeeccceeEEEecccceE
Confidence            9999999999 666667999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.80  E-value=3.3e-05  Score=74.16  Aligned_cols=83  Identities=19%  Similarity=0.277  Sum_probs=57.2

Q ss_pred             eeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCee
Q 039471          168 SEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK  247 (363)
Q Consensus       168 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~k  247 (363)
                      +-.+..+|+|||++|-.+.+...-..     ..++...+.....++.  +..+-.   .++.|.|..|.||+++.+|.+.
T Consensus       236 e~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~k~ia~~~~~~f--~~q~~~---dgffHaDpHpGNi~v~~~g~i~  305 (517)
T COG0661         236 EYTTRRVLTMEWIDGIKISDIAALKS-----AGIDRKELAELLVRAF--LRQLLR---DGFFHADPHPGNILVRSDGRIV  305 (517)
T ss_pred             hccCCcEEEEEeeCCEecccHHHHHh-----cCCCHHHHHHHHHHHH--HHHHHh---cCccccCCCccceEEecCCcEE
Confidence            33456789999999999988853222     2344333322222211  222222   7999999999999999999999


Q ss_pred             EeccccceeccCC
Q 039471          248 ISDFGLAKLCSKD  260 (363)
Q Consensus       248 l~Dfg~a~~~~~~  260 (363)
                      +.|||+...+++.
T Consensus       306 ~lDfGi~g~l~~~  318 (517)
T COG0661         306 LLDFGIVGRLDPK  318 (517)
T ss_pred             EEcCcceecCCHH
Confidence            9999998877654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.76  E-value=1.4e-05  Score=76.41  Aligned_cols=145  Identities=17%  Similarity=0.150  Sum_probs=108.1

Q ss_pred             hHHHHHHHHHhccCCCc-eeeeeeeeeeCCceeEEEeccCCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 039471          143 QEFINEVATIGRIHHFH-IVRLLGFCSEGNRRTLIYEFMPNG-SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYL  220 (363)
Q Consensus       143 ~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  220 (363)
                      ....-+++.|.+++||| .++.++-+..+...++.++++.++ +-..-.     ......+..-+...+.+.-+++++++
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~-----~~se~~~~~~~~~~~~r~et~~l~~l  352 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM-----TVSEIALEQYQFAYPLRKETRPLAEL  352 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC-----ChhhHhhhhhhhhhhhhhhccccccc
Confidence            34456888999999999 777777777788899999999776 222111     01123455556667778888999999


Q ss_pred             hcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHH
Q 039471          221 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLL  292 (363)
Q Consensus       221 H~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~  292 (363)
                      |+   ..-+|+|    ||+..+ +..+..||+....+++..   ......+++.++|||+.        -|+|++|.--.
T Consensus       353 ~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~  421 (829)
T KOG0576|consen  353 HS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAI  421 (829)
T ss_pred             cc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchh
Confidence            98   6668888    887766 578999999988777654   23667799999999977        68899998777


Q ss_pred             HHhcCCCCCCc
Q 039471          293 EMVGCRKNNDP  303 (363)
Q Consensus       293 el~~g~~~~~~  303 (363)
                      ++.-|-+|...
T Consensus       422 ~~ap~~pPr~~  432 (829)
T KOG0576|consen  422 QMAPGLPPRSS  432 (829)
T ss_pred             hcCCCCCCCCC
Confidence            77777766543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.63  E-value=0.00067  Score=70.00  Aligned_cols=57  Identities=11%  Similarity=0.237  Sum_probs=40.2

Q ss_pred             eeEEEEcccCC--cChhHHHHHHHHHhccC-CCc--eeeeeeeeeeC---CceeEEEeccCCCCH
Q 039471          129 EIAVKMLEHLK--GNGQEFINEVATIGRIH-HFH--IVRLLGFCSEG---NRRTLIYEFMPNGSL  185 (363)
Q Consensus       129 ~vAvK~~~~~~--~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~---~~~~lv~e~~~~~sL  185 (363)
                      .+++|+.....  .....+.+|.++++.+. |.+  +.+++.++.+.   +..++||||++|..+
T Consensus        67 ~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         67 RYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             eEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            46777664322  23356889999999995 555  47888887664   467899999988653

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.56  E-value=0.0001  Score=70.77  Aligned_cols=105  Identities=19%  Similarity=0.258  Sum_probs=65.5

Q ss_pred             HHHHHHHHHhcc----CCCc------eeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHH
Q 039471          144 EFINEVATIGRI----HHFH------IVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV  213 (363)
Q Consensus       144 ~~~~E~~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i  213 (363)
                      +|.+|.+...++    .|-+      |.++|-.+  ....+|+||||+|..+.+.-.-..     ..++...+..-+.+.
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~  312 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEA  312 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHH
Confidence            345555554444    3444      44444332  346789999999988876542222     345555443333332


Q ss_pred             HHHHHHhhcCCCCCceecCCCCCceEEcC----CCCeeEeccccceeccCC
Q 039471          214 ARGVEYLHQGCNQRILHFDIKPHNILLDH----NFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       214 ~~~l~~LH~~~~~~i~H~dikp~Nill~~----~~~~kl~Dfg~a~~~~~~  260 (363)
                      ..  +-+-.   .|++|+|-.|.||++..    ++.+.+-|||+....+..
T Consensus       313 ~~--~qIf~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  313 YL--EQIFK---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HH--HHHHh---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            22  12222   68999999999999984    667999999998876553

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.42  E-value=0.00084  Score=59.24  Aligned_cols=123  Identities=11%  Similarity=0.066  Sum_probs=66.8

Q ss_pred             CCeeEEEEcccCCcCh-hHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCHHHH----------------
Q 039471          127 SNEIAVKMLEHLKGNG-QEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSLQKF----------------  188 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~~~----------------  188 (363)
                      ++.+++|+........ -...+|.++++.+....+ .++++...    .++|+||++|.++...                
T Consensus        19 ~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~   94 (256)
T TIGR02721        19 GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALLH   94 (256)
T ss_pred             CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHHH
Confidence            3457888765332221 245689999988864333 34444432    3689999998665421                


Q ss_pred             -hhhcCCCCCCCCCCHH-HHHHHHHH---------HHHHHHHhhc-----CCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          189 -IFSKTNSSSHRQLSWE-KLRKIAFG---------VARGVEYLHQ-----GCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       189 -l~~~~~~~~~~~l~~~-~~~~i~~~---------i~~~l~~LH~-----~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                       +++...  ....++.. .+.....+         +...++.+-.     .....++|+|+.|.||++++++ ++++||.
T Consensus        95 ~lH~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE  171 (256)
T TIGR02721        95 QLHSQPR--FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWE  171 (256)
T ss_pred             HHhCCCC--CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEecc
Confidence             111111  11122211 11111111         1111222211     1124689999999999999876 7899999


Q ss_pred             ccee
Q 039471          253 LAKL  256 (363)
Q Consensus       253 ~a~~  256 (363)
                      .|..
T Consensus       172 ~a~~  175 (256)
T TIGR02721       172 YASD  175 (256)
T ss_pred             ccCc
Confidence            8764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.41  E-value=0.0014  Score=53.35  Aligned_cols=126  Identities=14%  Similarity=0.177  Sum_probs=81.6

Q ss_pred             ccccccccCCcceeec---cCCeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFL---HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      +....++.|+.+++++   .+..+|+|+-.... ....+..|.++|..+.-.++ .++|.+-.+    .+.|||+.|.+|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L   99 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence            3334455566666655   67789999876433 45778899999998876554 355555333    355999999899


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCC-CCCceEEcCCCCeeEecccccee
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI-KPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~di-kp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      .+.-.         ..+...+..++    ..---|-.   .+|-|..| .|...++.++..+.|+||..|+.
T Consensus       100 ~~~~~---------~~~rk~l~~vl----E~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEI---------GGDRKHLLRVL----EKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhh---------cccHHHHHHHH----HHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88762         11333333333    33222333   78888888 45555665566999999999874

>PRK10593 hypothetical protein; Provisional

Probab=97.39  E-value=0.0026  Score=57.45  Aligned_cols=73  Identities=8%  Similarity=0.034  Sum_probs=48.3

Q ss_pred             ccccccCCcceeec---cCCeeEEEEcccCCcChhHHHHHHHHHhccCC---Cceeeeeeeeee---CCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFL---HSNEIAVKMLEHLKGNGQEFINEVATIGRIHH---FHIVRLLGFCSE---GNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~~~  182 (363)
                      ...++.|....++.   .++.+.+|..+. ......|.+|.+.|+.+..   ..+.++++++..   .+..++|||++++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            33444455544443   334477787542 2234578899999998853   467888887754   3668999999998


Q ss_pred             CCH
Q 039471          183 GSL  185 (363)
Q Consensus       183 ~sL  185 (363)
                      .++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.36  E-value=0.0023  Score=55.63  Aligned_cols=30  Identities=23%  Similarity=0.278  Sum_probs=26.6

Q ss_pred             CCceecCCCCCceEEcC-CCCeeEeccccce
Q 039471          226 QRILHFDIKPHNILLDH-NFQPKISDFGLAK  255 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~  255 (363)
                      ..++|+|+.+.|||++. ++.+.++||..|.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            57999999999999998 5789999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.32  E-value=0.00044  Score=70.82  Aligned_cols=183  Identities=19%  Similarity=0.173  Sum_probs=120.2

Q ss_pred             HHHHHHHHhccCCCceeeeeeeeeeCC----ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 039471          145 FINEVATIGRIHHFHIVRLLGFCSEGN----RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYL  220 (363)
Q Consensus       145 ~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  220 (363)
                      -.-|...+.++.|+|++.++.|-.+..    ...+..|++..-++...+.+      ...++....+.+..++..|+.++
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~------v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS------VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh------ccccCHHHHHHHHHHHhhhHHHH
Confidence            345777788889999999999875432    22345577877788777732      25688899999999999999999


Q ss_pred             hcCCCCCceecCCCCC---ceEEcCCCCeeEe--ccccceeccCCccccccccccccccccCCccc----------cCce
Q 039471          221 HQGCNQRILHFDIKPH---NILLDHNFQPKIS--DFGLAKLCSKDISIVSRTAARGTSGYIAPELF----------SRNF  285 (363)
Q Consensus       221 H~~~~~~i~H~dikp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~  285 (363)
                      |+   ....|.-+..+   +-..+..+.+.++  ||+.++..+.....   ....-+..+.++|..          .|+|
T Consensus       303 h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence            99   65555555444   3444556666776  88887766543321   112233446666665          6999


Q ss_pred             ehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          286 CYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       286 slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+|.....+..|..+.........       .                 .+......+.+...+|+..++++|+++.|
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~~~-------~-----------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVPVS-------L-----------------LDVLSTSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccchhh-------h-----------------hccccchhhhhhhhhhcchhhhhccchhh
Confidence            999999988877765332211100       0                 00011115667788898888999887653

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.21  E-value=0.0036  Score=56.43  Aligned_cols=132  Identities=16%  Similarity=0.198  Sum_probs=74.0

Q ss_pred             eeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCC--ceeeeeee------eeeCCceeEEEeccCCCCHHH-------
Q 039471          123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGF------CSEGNRRTLIYEFMPNGSLQK-------  187 (363)
Q Consensus       123 ~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~~sL~~-------  187 (363)
                      +...+..+++|+...  ....+...|++++..+++.  .+.+++..      ...++..+++++|++|.++..       
T Consensus        33 v~~~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~  110 (296)
T cd05153          33 VTTDSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCR  110 (296)
T ss_pred             EEeCCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHH
Confidence            333445588898764  3445667788888888533  34454432      133456789999999876532       


Q ss_pred             ----H---hhhcCCC--C---CCCCCCHHHHH----------HHHHHHHHHHHHhhc----CCCCCceecCCCCCceEEc
Q 039471          188 ----F---IFSKTNS--S---SHRQLSWEKLR----------KIAFGVARGVEYLHQ----GCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       188 ----~---l~~~~~~--~---~~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~~~i~H~dikp~Nill~  241 (363)
                          .   ++.....  .   ......+....          .....+..++.++.+    ....+++|+|+.|.|++++
T Consensus       111 ~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~  190 (296)
T cd05153         111 QIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFD  190 (296)
T ss_pred             HHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEe
Confidence                0   1110000  0   00111111100          011112333444432    1235799999999999999


Q ss_pred             CCCCeeEecccccee
Q 039471          242 HNFQPKISDFGLAKL  256 (363)
Q Consensus       242 ~~~~~kl~Dfg~a~~  256 (363)
                      +++.+.|+||+.+..
T Consensus       191 ~~~~~~iIDfe~a~~  205 (296)
T cd05153         191 GDELSGVIDFYFACT  205 (296)
T ss_pred             CCceEEEeehhhhcC
Confidence            987778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=96.94  E-value=0.018  Score=52.58  Aligned_cols=31  Identities=23%  Similarity=0.326  Sum_probs=26.7

Q ss_pred             CCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      .+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            5899999999999999765568999998754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.94  E-value=0.0072  Score=50.70  Aligned_cols=115  Identities=20%  Similarity=0.253  Sum_probs=76.1

Q ss_pred             ccccc-CCcceeeccCCeeEEEEccc------------CC----------cChhHHHHHHHHHhccC---CCce--eeee
Q 039471          113 ISFNL-TNSKFFFLHSNEIAVKMLEH------------LK----------GNGQEFINEVATIGRIH---HFHI--VRLL  164 (363)
Q Consensus       113 ~~~~~-~~~~~~~~~~~~vAvK~~~~------------~~----------~~~~~~~~E~~~l~~l~---h~ni--v~~~  164 (363)
                      +.+.. |.+..+...+..+|+|+...            ..          .....|..|.+...+|+   +.++  |+.+
T Consensus        46 g~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~  125 (207)
T PF13095_consen   46 GHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCH  125 (207)
T ss_pred             CCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEee
Confidence            33334 55556666777799998321            00          12246888999988886   3455  8999


Q ss_pred             eeeeeC------------------CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 039471          165 GFCSEG------------------NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ  226 (363)
Q Consensus       165 ~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  226 (363)
                      ||..-.                  ....||.||.+...               .++..    -+.+|.+-|..+|+   .
T Consensus       126 Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~----~~~~~~~dl~~~~k---~  183 (207)
T PF13095_consen  126 GYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIR----DIPQMLRDLKILHK---L  183 (207)
T ss_pred             EEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchh----HHHHHHHHHHHHHH---C
Confidence            987211                  13456777765422               12222    34567777899999   9


Q ss_pred             CceecCCCCCceEEcCCCCeeEeccccc
Q 039471          227 RILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       227 ~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      +|+-+|+++.|..     .=||+|||.+
T Consensus       184 gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  184 GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CeeeccCcccccc-----CCEEEecccC
Confidence            9999999999997     3489999965

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.83  E-value=0.021  Score=51.80  Aligned_cols=129  Identities=16%  Similarity=0.249  Sum_probs=70.0

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhccCCC--ceeeeeeee------eeCCceeEEEeccCCCCHH-----------H
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGFC------SEGNRRTLIYEFMPNGSLQ-----------K  187 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~e~~~~~sL~-----------~  187 (363)
                      +..+++|+..... ..++...|.+++..|...  .+.+++...      ..++..++++||++|.++.           .
T Consensus        45 ~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~  123 (307)
T TIGR00938        45 VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGE  123 (307)
T ss_pred             CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHH
Confidence            3447788765322 234556777777777422  244444421      2245678999999885432           1


Q ss_pred             H---hhhcCCC--CC--C--CCCCHHHHH------------HHHHHHHHHHHHhhc----CCCCCceecCCCCCceEEcC
Q 039471          188 F---IFSKTNS--SS--H--RQLSWEKLR------------KIAFGVARGVEYLHQ----GCNQRILHFDIKPHNILLDH  242 (363)
Q Consensus       188 ~---l~~~~~~--~~--~--~~l~~~~~~------------~i~~~i~~~l~~LH~----~~~~~i~H~dikp~Nill~~  242 (363)
                      .   ++.....  ..  .  ..-.|....            .....+.+.++++..    ....+++|+|+.+.|++++.
T Consensus       124 ~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~  203 (307)
T TIGR00938       124 VLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDG  203 (307)
T ss_pred             HHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEEC
Confidence            1   1111000  00  0  001111100            011123334555532    12368999999999999998


Q ss_pred             CCCeeEecccccee
Q 039471          243 NFQPKISDFGLAKL  256 (363)
Q Consensus       243 ~~~~kl~Dfg~a~~  256 (363)
                      ++...|+||+.+..
T Consensus       204 ~~~~~vIDfd~~~~  217 (307)
T TIGR00938       204 DSVKGVIDFYFACT  217 (307)
T ss_pred             CceEEEeecccccC
Confidence            87678999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.75  E-value=0.015  Score=52.56  Aligned_cols=125  Identities=19%  Similarity=0.239  Sum_probs=70.8

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCCc-eeeeeeeeeeCCceeEEEeccCCCCHHHH-----------------h
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGNRRTLIYEFMPNGSLQKF-----------------I  189 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-----------------l  189 (363)
                      +.+++|+.........+..+|.+++..+.... ..++++.+..    .+|+||++|.++...                 +
T Consensus        30 ~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~l  105 (302)
T cd05156          30 RKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLTTEELRDPDISAEIARRMAKL  105 (302)
T ss_pred             CeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCCHhHcCCcHHHHHHHHHHHHh
Confidence            45888887654433345568888888886333 3455555542    358999988776432                 1


Q ss_pred             hhcCCCC-C----CCCCCHHHHHH--------------------------HHHHHHHHHHHhhc------CCCCCceecC
Q 039471          190 FSKTNSS-S----HRQLSWEKLRK--------------------------IAFGVARGVEYLHQ------GCNQRILHFD  232 (363)
Q Consensus       190 ~~~~~~~-~----~~~l~~~~~~~--------------------------i~~~i~~~l~~LH~------~~~~~i~H~d  232 (363)
                      +...... .    ....-+..+..                          +...+..-++.+-.      .....++|+|
T Consensus       106 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~D  185 (302)
T cd05156         106 HSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEAKYLRFLLESTSEESGSPVVFCHND  185 (302)
T ss_pred             hCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHHHHHHHHHhhccCCCCCCceEEecC
Confidence            1111000 0    00011111111                          11222233334431      2346789999


Q ss_pred             CCCCceEEcCC----CCeeEecccccee
Q 039471          233 IKPHNILLDHN----FQPKISDFGLAKL  256 (363)
Q Consensus       233 ikp~Nill~~~----~~~kl~Dfg~a~~  256 (363)
                      +.|.|||++++    +.++++||..|..
T Consensus       186 l~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         186 LQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            99999999974    7899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.73  E-value=0.016  Score=52.45  Aligned_cols=34  Identities=26%  Similarity=0.440  Sum_probs=29.3

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ..++|+|..+.|++++...-+-+.||+++..-.+
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            4689999999999999888899999999876443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.62  E-value=0.0033  Score=53.67  Aligned_cols=126  Identities=20%  Similarity=0.276  Sum_probs=62.0

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCHHHH-------h---------
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSLQKF-------I---------  189 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~~~-------l---------  189 (363)
                      ++.|+|++........-.-.+|..+++.+...++ .++++.+.++    .|.||+++.+|..-       +         
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            3558888887665555666789999888864443 4566655442    57799877654221       0         


Q ss_pred             -hhcCC-CCCCCCCCHHHHHHH----------------------HHHHHHHHHHhhc-----CCCCCceecCCCCCceEE
Q 039471          190 -FSKTN-SSSHRQLSWEKLRKI----------------------AFGVARGVEYLHQ-----GCNQRILHFDIKPHNILL  240 (363)
Q Consensus       190 -~~~~~-~~~~~~l~~~~~~~i----------------------~~~i~~~l~~LH~-----~~~~~i~H~dikp~Nill  240 (363)
                       +.... ......--+..+..+                      ...+..-+..+.+     +....+.|.|+.|.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence             10000 000111111222222                      0111111222211     112467899999999999


Q ss_pred             -cCCCCeeEecccccee
Q 039471          241 -DHNFQPKISDFGLAKL  256 (363)
Q Consensus       241 -~~~~~~kl~Dfg~a~~  256 (363)
                       +.++.++++||..|..
T Consensus       158 ~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             TSSSSCEEE--GTT-EE
T ss_pred             ccCCCeEEEecHHHHhh
Confidence             8889999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02236 choline kinase

Probab=96.44  E-value=0.036  Score=51.18  Aligned_cols=125  Identities=20%  Similarity=0.241  Sum_probs=69.1

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCHHHH-----------------h
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSLQKF-----------------I  189 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~~~-----------------l  189 (363)
                      +.|++|+........-+-.+|..+++.+...++ .++++.+..+    .|.||+++.+|..-                 +
T Consensus        66 ~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~l  141 (344)
T PLN02236         66 RKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREF  141 (344)
T ss_pred             CeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHH
Confidence            457888775433222233578888888864433 3556665433    57899987666421                 1


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHh----hc-CCCCCceecCCCCCceEEcC-CCCe
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGV-----------------ARGVEYL----HQ-GCNQRILHFDIKPHNILLDH-NFQP  246 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i-----------------~~~l~~L----H~-~~~~~i~H~dikp~Nill~~-~~~~  246 (363)
                      ++...........+..+..+..++                 ...++.|    .. .....++|+|+++.|||+++ ++.+
T Consensus       142 H~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~  221 (344)
T PLN02236        142 HSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAI  221 (344)
T ss_pred             hCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcE
Confidence            111111111112233333333221                 1112122    11 22357899999999999986 4679


Q ss_pred             eEecccccee
Q 039471          247 KISDFGLAKL  256 (363)
Q Consensus       247 kl~Dfg~a~~  256 (363)
                      +++||..+..
T Consensus       222 ~lID~Eya~~  231 (344)
T PLN02236        222 TIIDYEYASY  231 (344)
T ss_pred             EEEeehhccc
Confidence            9999988764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.18  E-value=0.027  Score=51.74  Aligned_cols=31  Identities=19%  Similarity=0.250  Sum_probs=26.1

Q ss_pred             CCceecCCCCCceEEcC-CCCeeEecccccee
Q 039471          226 QRILHFDIKPHNILLDH-NFQPKISDFGLAKL  256 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~  256 (363)
                      .-+.|.|+.+.|||+++ ++.++++||..|..
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            34789999999999974 57899999998754

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.13  E-value=0.079  Score=48.05  Aligned_cols=30  Identities=30%  Similarity=0.421  Sum_probs=26.3

Q ss_pred             CCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            68899999999999988 6789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.07  E-value=0.069  Score=50.05  Aligned_cols=31  Identities=23%  Similarity=0.353  Sum_probs=26.3

Q ss_pred             CCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ...++|+|+.+.||++..+ .++++|+-.+..
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~  252 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY  252 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence            3679999999999999876 599999987654

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.99  E-value=0.045  Score=49.03  Aligned_cols=57  Identities=14%  Similarity=0.264  Sum_probs=35.5

Q ss_pred             ccCCeeEEEEcccCCcChhHHHHHHHHHhccC---CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       125 ~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+.||+-.  ......|..|.+-|+.|.   .-.+.+++++...++..+|++||++.+
T Consensus        38 ~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   38 TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            344459999877  323456778888888774   456788999887777789999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.87  E-value=0.014  Score=52.31  Aligned_cols=96  Identities=18%  Similarity=0.229  Sum_probs=65.9

Q ss_pred             HHHHHHHHHhccCC--CceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 039471          144 EFINEVATIGRIHH--FHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH  221 (363)
Q Consensus       144 ~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  221 (363)
                      ...+|+..|+.|.-  .-+.+.+++    +..++|||++.+..|...-         ...+...+..-+..+   +--|-
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~---------~v~d~~~ly~~lm~~---Iv~la  219 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR---------HVEDPPTLYDDLMGL---IVRLA  219 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee---------ecCChHHHHHHHHHH---HHHHH
Confidence            44578888888752  345555554    5668999999998886643         222333333333222   33344


Q ss_pred             cCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          222 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       222 ~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      .   .|+||+|.+--||++++++.++++||--+...+
T Consensus       220 ~---~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  220 N---HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             H---cCceecccchheeEEecCCCEEEeechHhhccC
Confidence            4   899999999999999999999999998655433

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.84  E-value=0.14  Score=46.78  Aligned_cols=137  Identities=19%  Similarity=0.271  Sum_probs=77.5

Q ss_pred             CcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCc------eeeeeee----eeeCCceeEEEeccCCCCHHH-
Q 039471          119 NSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFH------IVRLLGF----CSEGNRRTLIYEFMPNGSLQK-  187 (363)
Q Consensus       119 ~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~----~~~~~~~~lv~e~~~~~sL~~-  187 (363)
                      .++.+...++..++|+.... ....+...|.+.+..|.-..      +..+=|-    ...+...+-+++|++|..+.. 
T Consensus        40 ~~f~~~~~~g~~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~  118 (331)
T COG2334          40 SNFRVQTEDGRYILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERD  118 (331)
T ss_pred             ceEEEEecCCCeEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCC
Confidence            34444555555899998766 56677778888888884221      2222221    112237788999999988772 


Q ss_pred             H--------------hhhcCC------CCCCCCCCHHH-------------HHHHHHHHHHHHHHhhc----CCC-CC--
Q 039471          188 F--------------IFSKTN------SSSHRQLSWEK-------------LRKIAFGVARGVEYLHQ----GCN-QR--  227 (363)
Q Consensus       188 ~--------------l~~~~~------~~~~~~l~~~~-------------~~~i~~~i~~~l~~LH~----~~~-~~--  227 (363)
                      .              ++....      ........|..             -.....++...++.+.+    ... .+  
T Consensus       119 ~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~  198 (331)
T COG2334         119 DNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQ  198 (331)
T ss_pred             CcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccce
Confidence            1              111000      00111222220             01122333344444443    111 23  


Q ss_pred             ceecCCCCCceEEcCCCC-eeEecccccee
Q 039471          228 ILHFDIKPHNILLDHNFQ-PKISDFGLAKL  256 (363)
Q Consensus       228 i~H~dikp~Nill~~~~~-~kl~Dfg~a~~  256 (363)
                      +||+|+.|.||+++.+.. ..++||+-+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            999999999999998874 89999997653

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.79  E-value=0.043  Score=46.56  Aligned_cols=100  Identities=22%  Similarity=0.187  Sum_probs=67.1

Q ss_pred             eEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHH
Q 039471          130 IAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR  207 (363)
Q Consensus       130 vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~  207 (363)
                      ..+|++...+-.  ..-|.++.+++++++  .|+++..=  ++..+-+|.|+|.-...               ...    
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------------~~~----  144 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------------NFS----  144 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------------chh----
Confidence            677777654433  456778899988765  56676632  44466789998843111               111    


Q ss_pred             HHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccc
Q 039471          208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       208 ~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      .++.-=+++|.-.|+. ..+.+|+|-.|+||+-|+.|.+||.|=+.
T Consensus       145 N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  145 NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence            1111224567778853 36899999999999999999999999764

The function of this family is unknown.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.73  E-value=0.001  Score=70.23  Aligned_cols=153  Identities=11%  Similarity=0.001  Sum_probs=107.4

Q ss_pred             HHHHHHHhccCCCceeeeeeeee--eCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 039471          146 INEVATIGRIHHFHIVRLLGFCS--EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG  223 (363)
Q Consensus       146 ~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  223 (363)
                      ..|...++...|.++...+.-..  ++...+..++|+.+|.+.+.|-+...  +...+...-+...-.+...+..-.|+.
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e--e~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE--ESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc--cCCcchhchHHHHHHHHHhccchhhhc
Confidence            44555566667888876665442  34567889999999999999865432  223344443433334436666666652


Q ss_pred             C--CCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHH
Q 039471          224 C--NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLE  293 (363)
Q Consensus       224 ~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~e  293 (363)
                      .  ..--+|+++|+.|-++..+..+|+.++|+.++..+....  .+...+++-|++|++.        +|+|..|+-+|+
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence            2  134689999999999999999999999999955544332  3556678888888877        899999999999


Q ss_pred             HhcCCCCCC
Q 039471          294 MVGCRKNND  302 (363)
Q Consensus       294 l~~g~~~~~  302 (363)
                      .-.|..++-
T Consensus      1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred             HhcccHHHH
Confidence            887776653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.44  E-value=0.11  Score=46.48  Aligned_cols=32  Identities=28%  Similarity=0.480  Sum_probs=26.5

Q ss_pred             CCceecCCCCCceEEcCCCC-eeEeccccceec
Q 039471          226 QRILHFDIKPHNILLDHNFQ-PKISDFGLAKLC  257 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~-~kl~Dfg~a~~~  257 (363)
                      ..++|+|+.|.|||++.++. .-|+||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 469999988654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.90  E-value=0.49  Score=44.44  Aligned_cols=30  Identities=17%  Similarity=0.279  Sum_probs=24.4

Q ss_pred             CCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ...++|+|+.|.||+++.++ .+++|.-.+.
T Consensus       229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~  258 (418)
T PLN02756        229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF  258 (418)
T ss_pred             ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence            46789999999999999875 8888865443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.88  E-value=0.085  Score=48.19  Aligned_cols=73  Identities=18%  Similarity=0.184  Sum_probs=57.4

Q ss_pred             ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       172 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      ..|++|++- |++|.. +         ....++++..++.+.+..+.-+.+  +...-|||+...||||+ +|++.|+||
T Consensus       300 y~yl~~kdh-gt~is~-i---------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         300 YLYLHFKDH-GTPISI-I---------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             EEEEEEecC-Cceeee-e---------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEe
Confidence            445666654 445432 2         345678899999999998888887  47889999999999999 999999999


Q ss_pred             ccceecc
Q 039471          252 GLAKLCS  258 (363)
Q Consensus       252 g~a~~~~  258 (363)
                      -+++.-.
T Consensus       366 klsRl~~  372 (488)
T COG5072         366 KLSRLSY  372 (488)
T ss_pred             eeeeccc
Confidence            9998543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.49  E-value=0.38  Score=41.28  Aligned_cols=59  Identities=15%  Similarity=0.333  Sum_probs=43.6

Q ss_pred             cCCeeEEEEcccCCcChhHHHHHHHHHhccC---CCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       126 ~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..+++.||+-.  .....-|..|+.-|..+.   .-.+.+++.+-....+-|+|+||++-+.+.
T Consensus        38 g~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          38 GTDPFFVKCNQ--REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCcceEEEecc--hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            34448888754  334466778887776664   456788888888999999999999876665

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.40  E-value=0.68  Score=42.39  Aligned_cols=29  Identities=34%  Similarity=0.460  Sum_probs=24.9

Q ss_pred             CCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      .+++|+|+.+.|||++ + .+.++||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            5789999999999995 3 688999998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.10  E-value=0.047  Score=51.99  Aligned_cols=162  Identities=20%  Similarity=0.226  Sum_probs=88.8

Q ss_pred             ChhHHHHHHHHHhccCCCceeeeeeeeeeCC-ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 039471          141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGN-RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEY  219 (363)
Q Consensus       141 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  219 (363)
                      +...+.-....++.+.|+|....+++-.... ...+|+|++ +.||++++....       +-.....        |   
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-------l~~~s~~--------~---   85 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-------LKDESLL--------A---   85 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-------cchhhhc--------c---
Confidence            3345566677888889999998888765433 467889998 679999984322       1111000        1   


Q ss_pred             hhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccccCceehhHHHHHHhcCCC
Q 039471          220 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRK  299 (363)
Q Consensus       220 LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~Di~slG~il~el~~g~~  299 (363)
                            +++.|-     |+       .+++| .++..   .      ....|      |  -+||||+|.++.|+.-|..
T Consensus        86 ------~~~~~~-----~~-------~~~td-~~~t~---~------~~~~~------p--KsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   86 ------HGVLHL-----NI-------IYITD-HFLTK---Y------PSPIG------P--KSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             ------ccccee-----hh-------hhccc-ccccc---C------CCCCC------c--chhhhhHHHHHHHHHHhhH
Confidence                  233222     11       23333 11000   0      11112      2  4899999999999998887


Q ss_pred             CCCcchhcccccchHHHHHHHhhhcccc-ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          300 NNDPAVEIQSQIYFPEWIYNRMRLGQEL-CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+...........    +.......+.. ....+....-++.+.++.+..+|+...|..||..
T Consensus       130 l~~~~~~s~~l~~----i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~  188 (725)
T KOG1093|consen  130 LEAELTESEYLEI----LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP  188 (725)
T ss_pred             HHHHHHHHHHHHH----HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence            6654433221111    11100000000 0000011223556778999999999999999964

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.07  E-value=0.064  Score=48.28  Aligned_cols=39  Identities=31%  Similarity=0.408  Sum_probs=28.1

Q ss_pred             HHHHHHHHHHHHHHHHHh-hcCCCCCceecCCCCCceEEc
Q 039471          203 WEKLRKIAFGVARGVEYL-HQGCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dikp~Nill~  241 (363)
                      .+.++.+..||+.-.-.+ .-.|..+.+|-||||+|||+-
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            455777888887655344 223346899999999999983

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.43  E-value=0.082  Score=47.83  Aligned_cols=55  Identities=25%  Similarity=0.394  Sum_probs=35.1

Q ss_pred             HHHHHHHHHHHHHHHHHhhc-CCCCCceecCCCCCceEEcC------------------CCCeeEeccccceec
Q 039471          203 WEKLRKIAFGVARGVEYLHQ-GCNQRILHFDIKPHNILLDH------------------NFQPKISDFGLAKLC  257 (363)
Q Consensus       203 ~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dikp~Nill~~------------------~~~~kl~Dfg~a~~~  257 (363)
                      .+.++.+..||+.-.--+.. .|....+|-||||+|||+-+                  .-..+|.||.+++.-
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            34566677777543211322 22468999999999999832                  223677788877654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=92.93  E-value=0.29  Score=44.96  Aligned_cols=103  Identities=19%  Similarity=0.172  Sum_probs=70.4

Q ss_pred             HHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 039471          146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN  225 (363)
Q Consensus       146 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  225 (363)
                      ..|++.|.+++...|.-.--...  ...+|||+|+....-..-      .-+...++...+..+-.|++.-|.-|.+  .
T Consensus       214 EKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aP------kLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~  283 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAP------KLKDASLSTSKARELYQQCVRIMRRLYQ--K  283 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCc------ccccccCChHHHHHHHHHHHHHHHHHHH--H
Confidence            46888888887555432111111  234799999853211110      1223567788888888999999999977  4


Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      .+++|.||.--|+|+.. |.+.|+|.+-+.....
T Consensus       284 c~LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  284 CRLVHADLSEFNLLYHD-GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             hceeccchhhhhheEEC-CEEEEEEccccccCCC
Confidence            79999999999999865 5899999987765443

>PTZ00384 choline kinase; Provisional

Probab=92.69  E-value=1.1  Score=42.12  Aligned_cols=29  Identities=28%  Similarity=0.147  Sum_probs=24.2

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ....|.|+-+.||+.+++ .++++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence            567899999999997654 69999998764

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.14  E-value=0.23  Score=44.13  Aligned_cols=54  Identities=26%  Similarity=0.239  Sum_probs=43.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCC-CCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          201 LSWEKLRKIAFGVARGVEYLHQGCN-QRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       201 l~~~~~~~i~~~i~~~l~~LH~~~~-~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      .....+...+..+-+++.-.+.  . .-++|.|+.|.|++.++.+.++|+||..|..
T Consensus       129 ~~~~~~~~~~~~l~~~l~~~~~--~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         129 RDNHLLRKKLKELRRALEEVPK--DDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             hhhHHHHHHHHHHHHHhhhcCC--CceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3445566677777777777776  2 3689999999999999999999999988764

>PRK10271 thiK thiamine kinase; Provisional

Probab=91.83  E-value=0.13  Score=42.74  Aligned_cols=31  Identities=19%  Similarity=0.219  Sum_probs=26.6

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ...+|+|+.|.|+++++++ ++++||+.|..-
T Consensus        77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            4668999999999998877 999999987653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	363
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-26
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-06
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		8e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		8e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		8e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		9e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-05
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 91/248 (36%), Positives = 131/248 (52%), Gaps = 21/248 (8%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK L  E  +G   +F  EV  I    H +++RL GFC     R L+Y +M NGS+  
Sbjct: 65  VAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 124
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +  +    S   L W K ++IA G ARG+ YLH  C+ +I+H D+K  NILLD  F+  
Sbjct: 125 CL--RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 248 ISDFGLAKLCS-KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
           + DFGLAKL   KD  +    A RGT G+IAPE  S          F YG+MLLE++  +
Sbjct: 183 VGDFGLAKLMDYKDXHVX--XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 299 KNNDPA-VEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDG---DEGIARKLAIVAIWCIQW 353
           +  D A +     +   +W+   ++  + E  +D +  G   DE +  +L  VA+ C Q 
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQS 299
Query: 354 NPTERPSM 361
           +P ERP M
Sbjct: 300 SPMERPKM 307

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 90/248 (36%), Positives = 130/248 (52%), Gaps = 21/248 (8%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK L  E  +G   +F  EV  I    H +++RL GFC     R L+Y +M NGS+  
Sbjct: 57  VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +  +    S   L W K ++IA G ARG+ YLH  C+ +I+H D+K  NILLD  F+  
Sbjct: 117 CL--RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 248 ISDFGLAKLCS-KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
           + DFGLAKL   KD  +    A RG  G+IAPE  S          F YG+MLLE++  +
Sbjct: 175 VGDFGLAKLMDYKDXHVX--XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 299 KNNDPA-VEIQSQIYFPEWIYNRMRLGQ-ELCLDFEEDG---DEGIARKLAIVAIWCIQW 353
           +  D A +     +   +W+   ++  + E  +D +  G   DE +  +L  VA+ C Q 
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQS 291
Query: 354 NPTERPSM 361
           +P ERP M
Sbjct: 292 SPMERPKM 299

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  114 bits (285), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 157 HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           H H+V L+GFC E N   LIY++M NG+L++ ++     +    +SWE+  +I  G ARG
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARG 151
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI 276
           + YLH    + I+H D+K  NILLD NF PKI+DFG++K  ++          +GT GYI
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 277 APELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC 328
            PE F        S  + +G++L E++ C ++       +  +   EW       GQ   
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVL-CARSAIVQSLPREMVNLAEWAVESHNNGQ--- 264
Query: 329 LDFEEDGDEGIA--------RKLAIVAIWCIQWNPTERPSM 361
              E+  D  +A        RK    A+ C+  +  +RPSM
Sbjct: 265 --LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 112/221 (50%), Gaps = 27/221 (12%)
Query: 157 HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           H H+V L+GFC E N   LIY++M NG+L++ ++     +    +SWE+  +I  G ARG
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARG 151
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI 276
           + YLH    + I+H D+K  NILLD NF PKI+DFG++K  ++          +GT GYI
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 277 APELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC 328
            PE F        S  + +G++L E++ C ++       +  +   EW       GQ   
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVL-CARSAIVQSLPREMVNLAEWAVESHNNGQ--- 264
Query: 329 LDFEEDGDEGIA--------RKLAIVAIWCIQWNPTERPSM 361
              E+  D  +A        RK    A+ C+  +  +RPSM
Sbjct: 265 --LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 121/253 (47%), Gaps = 24/253 (9%)
Query: 124 FLHSNEIAVKML--------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL 175
           ++++  +AVK L        E LK   Q+F  E+  + +  H ++V LLGF S+G+   L
Sbjct: 51  YVNNTTVAVKKLAAMVDITTEELK---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 107
Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           +Y +MPNGSL   +     +     LSW    KIA G A G+ +LH+  N  I H DIK 
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPP---LSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKS 161
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-------SRNFCYG 288
            NILLD  F  KISDFGLA+   K    V  +   GT+ Y+APE         S  + +G
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFG 221
Query: 289 MMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI 348
           ++LLE++      D   E Q  +   E I +  +  ++       D D      +  VA 
Sbjct: 222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS 281
Query: 349 WCIQWNPTERPSM 361
            C+     +RP +
Sbjct: 282 QCLHEKKNKRPDI 294

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 120/253 (47%), Gaps = 24/253 (9%)
Query: 124 FLHSNEIAVKML--------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL 175
           ++++  +AVK L        E LK   Q+F  E+  + +  H ++V LLGF S+G+   L
Sbjct: 51  YVNNTTVAVKKLAAMVDITTEELK---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 107
Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           +Y +MPNGSL   +     +     LSW    KIA G A G+ +LH+  N  I H DIK 
Sbjct: 108 VYVYMPNGSLLDRLSCLDGTPP---LSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKS 161
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-------SRNFCYG 288
            NILLD  F  KISDFGLA+   K    V      GT+ Y+APE         S  + +G
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFG 221
Query: 289 MMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI 348
           ++LLE++      D   E Q  +   E I +  +  ++       D D      +  VA 
Sbjct: 222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS 281
Query: 349 WCIQWNPTERPSM 361
            C+     +RP +
Sbjct: 282 QCLHEKKNKRPDI 294

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/253 (32%), Positives = 120/253 (47%), Gaps = 24/253 (9%)
Query: 124 FLHSNEIAVKML--------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL 175
           ++++  +AVK L        E LK   Q+F  E+  + +  H ++V LLGF S+G+   L
Sbjct: 45  YVNNTTVAVKKLAAMVDITTEELK---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 101
Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           +Y +MPNGSL   +     +     LSW    KIA G A G+ +LH+  N  I H DIK 
Sbjct: 102 VYVYMPNGSLLDRLSCLDGTPP---LSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKS 155
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-------SRNFCYG 288
            NILLD  F  KISDFGLA+   K    V      GT+ Y+APE         S  + +G
Sbjct: 156 ANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITPKSDIYSFG 215
Query: 289 MMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI 348
           ++LLE++      D   E Q  +   E I +  +  ++       D D      +  VA 
Sbjct: 216 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS 275
Query: 349 WCIQWNPTERPSM 361
            C+     +RP +
Sbjct: 276 QCLHEKKNKRPDI 288

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/187 (36%), Positives = 97/187 (51%), Gaps = 24/187 (12%)
Query: 124 FLHSNEIAVKML--------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL 175
           ++++  +AVK L        E LK   Q+F  E+    +  H ++V LLGF S+G+   L
Sbjct: 42  YVNNTTVAVKKLAAMVDITTEELK---QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCL 98
Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           +Y + PNGSL   +     +     LSW    KIA G A G+ +LH+  N  I H DIK 
Sbjct: 99  VYVYXPNGSLLDRLSCLDGTPP---LSWHXRCKIAQGAANGINFLHE--NHHI-HRDIKS 152
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-------SRNFCYG 288
            NILLD  F  KISDFGLA+   K    V  +   GT+ Y APE         S  + +G
Sbjct: 153 ANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFG 212
Query: 289 MMLLEMV 295
           ++LLE++
Sbjct: 213 VVLLEII 219

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 106/193 (54%), Gaps = 20/193 (10%)
Query: 126 HSNEIAVKMLEHLKGNGQ---EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           H +++AVK+L     + +   EF+ EVA + R+ H +IV  +G  ++    +++ E++  
Sbjct: 59  HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL + +     S +  QL   +   +A+ VA+G+ YLH   N  I+H ++K  N+L+D 
Sbjct: 119 GSLYRLLHK---SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDK 174
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
            +  K+ DFGL++L  K  + +S  +A GT  ++APE+         S  + +G++L E+
Sbjct: 175 KYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 295 VGCRK---NNDPA 304
              ++   N +PA
Sbjct: 233 ATLQQPWGNLNPA 245

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 42  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 102 LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 154
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 155 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 213
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 214 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 358 RPS 360
           RPS
Sbjct: 261 RPS 263

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 150 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 209 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 358 RPS 360
           RPS
Sbjct: 256 RPS 258

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 150 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 209 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 358 RPS 360
           RPS
Sbjct: 256 RPS 258

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 150 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 209 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 358 RPS 360
           RPS
Sbjct: 256 RPS 258

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 150 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 209 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 358 RPS 360
           RPS
Sbjct: 256 RPS 258

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 106/193 (54%), Gaps = 20/193 (10%)
Query: 126 HSNEIAVKMLEHLKGNGQ---EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           H +++AVK+L     + +   EF+ EVA + R+ H +IV  +G  ++    +++ E++  
Sbjct: 59  HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL + +     S +  QL   +   +A+ VA+G+ YLH   N  I+H D+K  N+L+D 
Sbjct: 119 GSLYRLLHK---SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDK 174
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
            +  K+ DFGL++L +    + S+ AA GT  ++APE+         S  + +G++L E+
Sbjct: 175 KYTVKVCDFGLSRLKASXF-LXSKXAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 295 VGCRK---NNDPA 304
              ++   N +PA
Sbjct: 233 ATLQQPWGNLNPA 245

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 42  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 101
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 102 LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 154
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 155 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 213
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 214 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 358 RPS 360
           RPS
Sbjct: 261 RPS 263

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 42  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 102 LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 154
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 155 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 213
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 214 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 358 RPS 360
           RPS
Sbjct: 261 RPS 263

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 150 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 209 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 358 RPS 360
           RPS
Sbjct: 256 RPS 258

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 150 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 209 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 255
Query: 358 RPS 360
           RPS
Sbjct: 256 RPS 258

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 41  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 101 LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 153
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 154 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 213 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 259
Query: 358 RPS 360
           RPS
Sbjct: 260 RPS 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 42  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 102 LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 154
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 155 VKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 213
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 214 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 358 RPS 360
           RPS
Sbjct: 261 RPS 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 35  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 94
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 95  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 147
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 148 VKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 206
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P ++  SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 207 GMSPYPGID-PSQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 253
Query: 358 RPS 360
           RPS
Sbjct: 254 RPS 256

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 50  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 109
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 110 LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 162
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 163 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 221
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 222 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 268
Query: 358 RPS 360
           RPS
Sbjct: 269 RPS 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 38  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL 97
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 98  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 150
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 151 VKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 209
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 210 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 358 RPS 360
           RPS
Sbjct: 257 RPS 259

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 35  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 95  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 147
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 148 VKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 206
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P ++  SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 207 GMSPYPGID-PSQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 253
Query: 358 RPS 360
           RPS
Sbjct: 254 RPS 256

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 42  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 102 LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 154
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 155 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 213
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 214 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 260
Query: 358 RPS 360
           RPS
Sbjct: 261 RPS 263

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 39  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 99  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 151
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 152 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 210
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 211 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 358 RPS 360
           RPS
Sbjct: 258 RPS 260

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 39  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 99  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 151
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 152 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 210
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 211 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 358 RPS 360
           RPS
Sbjct: 258 RPS 260

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 38  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 97
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 98  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 150
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 151 VKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 209
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 210 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 256
Query: 358 RPS 360
           RPS
Sbjct: 257 RPS 259

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 35  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 95  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 147
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 148 VKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 206
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P ++  SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 207 GMSPYPGID-PSQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 253
Query: 358 RPS 360
           RPS
Sbjct: 254 RPS 256

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 119/243 (48%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 39  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + ++++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 99  LDYL----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 151
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 152 VKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 210
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++
Sbjct: 211 GMSPYPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 257
Query: 358 RPS 360
           RPS
Sbjct: 258 RPS 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L  ++
Sbjct: 248 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
                  + +++S   L  +A  ++  +EYL +   +  +H ++   N L+  N   K++
Sbjct: 308 ----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVA 360
Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNN 301
           DFGL++L + D +  +   A+    + APE  + N        + +G++L E+     + 
Sbjct: 361 DFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
Query: 302 DPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
            P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++RPS
Sbjct: 420 YPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 465

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 117/239 (48%), Gaps = 29/239 (12%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L  ++
Sbjct: 287 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 346
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
                  + ++++   L  +A  ++  +EYL +   +  +H ++   N L+  N   K++
Sbjct: 347 ----RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVA 399
Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNN 301
           DFGL++L + D +  +   A+    + APE  + N        + +G++L E+     + 
Sbjct: 400 DFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458
Query: 302 DPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
            P +++ SQ+Y            + L  D+  +  EG   K+  +   C QWNP++RPS
Sbjct: 459 YPGIDL-SQVY------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 504

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 116/243 (47%), Gaps = 29/243 (11%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      ++ E+MP G+L
Sbjct: 56  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNL 115
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       +  +++   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 116 LDYL----RECNREEVTAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHV 168
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGL++L + D +  +   A+    + APE  + N        + +G++L E+   
Sbjct: 169 VKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY 227
Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
             +  P +++         +Y+ +  G      +  +  EG   K+  +   C +W+P +
Sbjct: 228 GMSPYPGIDLSQ-------VYDLLEKG------YRMEQPEGCPPKVYELMRACWKWSPAD 274
Query: 358 RPS 360
           RPS
Sbjct: 275 RPS 277

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 23/196 (11%)
Query: 127 SNEIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
             ++AVK ++  K   +E + NEV  +   HH ++V +      G+   ++ EF+  G+L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                  T+  +H +++ E++  +   V R + YLH   NQ ++H DIK  +ILL  + +
Sbjct: 130 -------TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGR 179
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMVGC 297
            K+SDFG     SK++    R    GT  ++APE+ SR         +  G+M++EM+  
Sbjct: 180 IKLSDFGFCAQVSKEVP--KRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237
Query: 298 RKN--NDPAVEIQSQI 311
                N+P ++   +I
Sbjct: 238 EPPYFNEPPLQAMRRI 253

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 22/180 (12%)
Query: 126 HSN-EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           HS  ++AVKM++  K   +E + NEV  +    HF++V +      G    ++ EF+  G
Sbjct: 68  HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           +L       T+  S  +L+ E++  +   V + + YLH    Q ++H DIK  +ILL  +
Sbjct: 128 AL-------TDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177
Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
            + K+SDFG     SKD+    R    GT  ++APE+ SR+        +  G+M++EMV
Sbjct: 178 GRVKLSDFGFCAQISKDVP--KRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 47/266 (17%)
Query: 127 SNEIAVKMLEHLKGNGQE---FINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S ++AVKML+  K +  E    ++E+  + ++  H +IV LLG C+      LI+E+   
Sbjct: 75  SIQVAVKMLKE-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 133
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKI-----------------AFGVARGVEYLH-QGC 224
           G L  ++ SK    S  ++ +E  +++                 A+ VA+G+E+L  + C
Sbjct: 134 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193
Query: 225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LF-- 281
               +H D+   N+L+ H    KI DFGLA+    D + V R  AR    ++APE LF  
Sbjct: 194 ----VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249
Query: 282 -----SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD 336
                S  + YG++L E+     N  P + + +  Y  + I N  ++ Q           
Sbjct: 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--KLIQNGFKMDQPFY-------- 299
Query: 337 EGIARKLAIVAIWCIQWNPTERPSMP 362
                ++ I+   C  ++  +RPS P
Sbjct: 300 --ATEEIYIIMQSCWAFDSRKRPSFP 323

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 186 QKFIFSKTNSSSHRQ------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
             ++ SK N     +      L+ E L   +F VA+G+E+L    +++ +H D+   NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMML 291
           L      KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L
Sbjct: 177 LSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 292 LEMVGCRKNNDPAVEIQSQ 310
            E+     +  P V+I  +
Sbjct: 237 WEIFSLGASPYPGVKIDEE 255

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEE 259

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 186 QKFIFSKTNSSSHRQ--------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
             ++ SK N     +        L+ E L   +F VA+G+E+L    +++ +H D+   N
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARN 178
Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGM 289
           ILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +G+
Sbjct: 179 ILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 290 MLLEMVGCRKNNDPAVEIQSQ 310
           +L E+     +  P V+I  +
Sbjct: 239 LLWEIFSLGASPYPGVKIDEE 259

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE 250

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEE 259

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 176
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEE 259

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 213
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 274 GVLLWEIFSLGASPYPGVKIDEE 296

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 120/258 (46%), Gaps = 44/258 (17%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVKML+      +  + ++E   + +++H H+++L G CS+     LI E+   GSL+ 
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 188 FI------------------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
           F+                   S  +    R L+   L   A+ +++G++YL      +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLV 172
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LF------- 281
           H D+   NIL+    + KISDFGL++   ++ S V R+  R    ++A E LF       
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 282 SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR 341
           S  + +G++L E+V    N  P +        PE ++N ++ G  +      +  +  + 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIP-------PERLFNLLKTGHRM------ERPDNCSE 279
Query: 342 KLAIVAIWCIQWNPTERP 359
           ++  + + C +  P +RP
Sbjct: 280 EMYRLMLQCWKQEPDKRP 297

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 120/258 (46%), Gaps = 44/258 (17%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVKML+      +  + ++E   + +++H H+++L G CS+     LI E+   GSL+ 
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 188 FI------------------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
           F+                   S  +    R L+   L   A+ +++G++YL      +++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLV 172
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LF------- 281
           H D+   NIL+    + KISDFGL++   ++ S V R+  R    ++A E LF       
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 282 SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR 341
           S  + +G++L E+V    N  P +        PE ++N ++ G  +      +  +  + 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIP-------PERLFNLLKTGHRM------ERPDNCSE 279
Query: 342 KLAIVAIWCIQWNPTERP 359
           ++  + + C +  P +RP
Sbjct: 280 EMYRLMLQCWKQEPDKRP 297

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 186 QKFIFSKTNSSSHRQ------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
             ++ SK N     +      L+ E L   +F VA+G+E+L    +++ +H D+   NIL
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNIL 176
Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMML 291
           L      KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L
Sbjct: 177 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236
Query: 292 LEMVGCRKNNDPAVEIQSQ 310
            E+     +  P V+I  +
Sbjct: 237 WEIFSLGASPYPGVKIDEE 255

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE 250

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     +++ E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 167
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 227
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 228 GVLLWEIFSLGASPYPGVKIDEE 250

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 186 QKFIFSKTNSSSHRQ---------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
             ++ SK N     +         L+ E L   +F VA+G+E+L    +++ +H D+   
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +G
Sbjct: 178 NILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 289 MMLLEMVGCRKNNDPAVEIQSQ 310
           ++L E+     +  P V+I  +
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEE 259

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L+ +++A+K +     + ++FI E   + ++ H  +V+L G C E     L++EFM +
Sbjct: 25  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         + E L  +   V  G+ YL + C   ++H D+   N L+  
Sbjct: 85  GCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGE 136
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 137 NQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 175

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L+ +++A+K +     + ++FI E   + ++ H  +V+L G C E     L++EFM +
Sbjct: 27  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 86
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         + E L  +   V  G+ YL + C   ++H D+   N L+  
Sbjct: 87  GCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGE 138
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 139 NQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 177

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 119/258 (46%), Gaps = 44/258 (17%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVKML+      +  + ++E   + +++H H+++L G CS+     LI E+   GSL+ 
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 188 FI------------------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
           F+                   S  +    R L+   L   A+ +++G++YL       ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLV 172
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LF------- 281
           H D+   NIL+    + KISDFGL++   ++ S V R+  R    ++A E LF       
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 282 SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR 341
           S  + +G++L E+V    N  P +        PE ++N ++ G  +      +  +  + 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIP-------PERLFNLLKTGHRM------ERPDNCSE 279
Query: 342 KLAIVAIWCIQWNPTERP 359
           ++  + + C +  P +RP
Sbjct: 280 EMYRLMLQCWKQEPDKRP 297

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L+ +++A+K +     + ++FI E   + ++ H  +V+L G C E     L++EFM +
Sbjct: 30  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         + E L  +   V  G+ YL + C   ++H D+   N L+  
Sbjct: 90  GCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGE 141
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 142 NQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 180

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 186 QKFIFSKTNSSSHRQLSWEKLRK----------IAFGVARGVEYLHQGCNQRILHFDIKP 235
             ++ SK N     + + E L K           +F VA+G+E+L    +++ +H D+  
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAA 178
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +        +
Sbjct: 179 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 238
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQ 310
           G++L E+     +  P V+I  +
Sbjct: 239 GVLLWEIFSLGASPYPGVKIDEE 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L+ +++A+K ++    +  +FI E   + ++ H  +V+L G C E     L++EFM +
Sbjct: 47  YWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 106
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         + E L  +   V  G+ YL + C   ++H D+   N L+  
Sbjct: 107 GCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGE 158
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 159 NQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 197

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 104
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 105 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 157
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R    GT  ++APEL SR         +  G+M++EMV
Sbjct: 158 SDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 87/170 (51%), Gaps = 15/170 (8%)
Query: 135 LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTN 194
           L+  +G     I E++ +  + H +IVRL       N+ TL++EFM N  L+K++ S+T 
Sbjct: 40  LDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTV 98
Query: 195 SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 254
            ++ R L    ++   + + +G+ + H+    +ILH D+KP N+L++   Q K+ DFGLA
Sbjct: 99  GNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLA 155
Query: 255 KLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMV 295
           +     ++  S      T  Y AP++   +  Y         G +L EM+
Sbjct: 156 RAFGIPVNTFSSEVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 113
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 114 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 166
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R    GT  ++APEL SR         +  G+M++EMV
Sbjct: 167 SDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 115
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 116 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 168
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R    GT  ++APEL SR         +  G+M++EMV
Sbjct: 169 SDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+      Q  +F+ E   +G+  H +I+RL G  S+     +I E+M NG+L K
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  K    S  QL       +  G+A G++YL    N   +H D+   NIL++ N   K
Sbjct: 136 FLREKDGEFSVLQLV-----GMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC 286
           +SDFGL+++   D       A   TSG      + APE  S R F 
Sbjct: 188 VSDFGLSRVLEDDPE-----ATYTTSGGKIPIRWTAPEAISYRKFT 228

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 108
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 109 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 161
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R    GT  ++APEL SR         +  G+M++EMV
Sbjct: 162 SDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 92/179 (51%), Gaps = 21/179 (11%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F++E + +G+  H +++ L G  ++     +I EFM NGSL  
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+       +  Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 124 FL-----RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCK 175
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTS---GYIAPELF--------SRNFCYGMMLLEMV 295
           +SDFGL++    D S  + T+A G      + APE          S  + YG+++ E++
Sbjct: 176 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 9/160 (5%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L+ +++A+K +     + ++FI E   + ++ H  +V+L G C E     L+ EFM +
Sbjct: 28  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         + E L  +   V  G+ YL + C   ++H D+   N L+  
Sbjct: 88  GCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGE 139
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 140 NQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 178

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 158
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 159 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 211
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R    GT  ++APEL SR         +  G+M++EMV
Sbjct: 212 SDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 21/175 (12%)
Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK ++  K   +E + NEV  +    H ++V +      G+   ++ EF+  G+L   
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL--- 235
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
               T+  +H +++ E++  +   V + +  LH    Q ++H DIK  +ILL H+ + K+
Sbjct: 236 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKL 288
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR--------NFCYGMMLLEMV 295
           SDFG     SK++    R    GT  ++APEL SR         +  G+M++EMV
Sbjct: 289 SDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 29/189 (15%)
Query: 129 EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           + A+K ++    K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L
Sbjct: 44  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 103
Query: 186 QKFI-----------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
             F+           F+  NS++   LS ++L   A  VARG++YL Q   ++ +H D+ 
Sbjct: 104 LDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 159
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-----LFSRN---FC 286
             NIL+  N+  KI+DFGL++   +++  V +T  R    ++A E     +++ N   + 
Sbjct: 160 ARNILVGENYVAKIADFGLSR--GQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 216
Query: 287 YGMMLLEMV 295
           YG++L E+V
Sbjct: 217 YGVLLWEIV 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F++E + +G+  H +I+RL G  + G    ++ E+M NGSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+ +        Q +  +L  +  GV  G+ YL    +   +H D+   N+L+D N   K
Sbjct: 140 FLRTHDG-----QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCK 191
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNF-------CYGMMLLE 293
           +SDFGL+++   D       AA  T+G      + APE  + R F        +G+++ E
Sbjct: 192 VSDFGLSRVLEDDPD-----AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 294 MV 295
           ++
Sbjct: 247 VL 248

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 29/189 (15%)
Query: 129 EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           + A+K ++    K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L
Sbjct: 54  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 113
Query: 186 QKFI-----------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
             F+           F+  NS++   LS ++L   A  VARG++YL Q   ++ +H D+ 
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 169
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-----LFSRN---FC 286
             NIL+  N+  KI+DFGL++   +++  V +T  R    ++A E     +++ N   + 
Sbjct: 170 ARNILVGENYVAKIADFGLSR--GQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226
Query: 287 YGMMLLEMV 295
           YG++L E+V
Sbjct: 227 YGVLLWEIV 235

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 25/192 (13%)
Query: 130 IAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H   + Q +F  E+  +  +H   IV+  G      R++L  + E++P+G L+
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 101
Query: 187 KFIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            F+        HR +L   +L   +  + +G+EYL    ++R +H D+   NIL++    
Sbjct: 102 DFL------QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAH 152
Query: 246 PKISDFGLAKL--CSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
            KI+DFGLAKL    KD  +V R   +    + APE  S N        + +G++L E+ 
Sbjct: 153 VKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 211
Query: 296 G-CRKNNDPAVE 306
             C K+  P+ E
Sbjct: 212 TYCDKSCSPSAE 223

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 25/192 (13%)
Query: 130 IAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H   + Q +F  E+  +  +H   IV+  G      R++L  + E++P+G L+
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 187 KFIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            F+        HR +L   +L   +  + +G+EYL    ++R +H D+   NIL++    
Sbjct: 115 DFL------QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAH 165
Query: 246 PKISDFGLAKL--CSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
            KI+DFGLAKL    KD  +V R   +    + APE  S N        + +G++L E+ 
Sbjct: 166 VKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
Query: 296 G-CRKNNDPAVE 306
             C K+  P+ E
Sbjct: 225 TYCDKSCSPSAE 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTH 238

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTH 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 25/192 (13%)
Query: 130 IAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H   + Q +F  E+  +  +H   IV+  G      R++L  + E++P+G L+
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 102
Query: 187 KFIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            F+        HR +L   +L   +  + +G+EYL    ++R +H D+   NIL++    
Sbjct: 103 DFL------QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAH 153
Query: 246 PKISDFGLAKL--CSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
            KI+DFGLAKL    KD  +V R   +    + APE  S N        + +G++L E+ 
Sbjct: 154 VKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 212
Query: 296 G-CRKNNDPAVE 306
             C K+  P+ E
Sbjct: 213 TYCDKSCSPSAE 224

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 9/160 (5%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++L+ +++A+K +     + ++FI E   + ++ H  +V+L G C E     L++EFM +
Sbjct: 27  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 86
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L  ++ ++         + E L  +   V  G+ YL +     ++H D+   N L+  
Sbjct: 87  GCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEAS---VIHRDLAARNCLVGE 138
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
           N   K+SDFG+ +    D    S T  +    + +PE+FS
Sbjct: 139 NQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 177

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F++E + +G+  H +I+RL G  + G    ++ E+M NGSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+ +        Q +  +L  +  GV  G+ YL    +   +H D+   N+L+D N   K
Sbjct: 140 FLRTHDG-----QFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCK 191
Query: 248 ISDFGLAKLCSKDISIV-SRTAARGTSGYIAPELFS-RNF-------CYGMMLLEMV 295
           +SDFGL+++   D     + T  +    + APE  + R F        +G+++ E++
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L
Sbjct: 70  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 186 QKFIFSKT----NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
             F+  K     +    R L    L   +  VA+G+ +L    ++  +H D+   N+LL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 186
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGMMLLE 293
           +    KI DFGLA+    D + + +  AR    ++APE        + S  + YG++L E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 294 MVGCRKNNDPAVEIQSQIY 312
           +     N  P + + S+ Y
Sbjct: 247 IFSLGLNPYPGILVNSKFY 265

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 93/179 (51%), Gaps = 21/179 (11%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   +EF++E + +G+  H +I+RL G  +      ++ EFM NG+L  
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  + N     Q +  +L  +  G+A G+ YL +      +H D+   NIL++ N   K
Sbjct: 107 FL--RLNDG---QFTVIQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCK 158
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTS---GYIAPELF--------SRNFCYGMMLLEMV 295
           +SDFGL++   ++ S  + T++ G      + APE          S  + YG+++ E++
Sbjct: 159 VSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K +  E L+G      NE+A + +I H +IV L      G    LI + +  G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNF 244
            I  K    + R  S     ++ F V   V+YLH   +  I+H D+KP N+L   LD + 
Sbjct: 106 RIVEK-GFYTERDAS-----RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           +  ISDFGL+K+  +D   V  TA  GT GY+APE+ ++ 
Sbjct: 157 KIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQK 193

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 91/179 (50%), Gaps = 21/179 (11%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F++E + +G+  H +++ L G  ++     +I EFM NGSL  
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+       +  Q +  +L  +  G+A G++YL    +   +H  +   NIL++ N   K
Sbjct: 98  FL-----RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCK 149
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTS---GYIAPELF--------SRNFCYGMMLLEMV 295
           +SDFGL++    D S  + T+A G      + APE          S  + YG+++ E++
Sbjct: 150 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 13/134 (9%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K+L    G     EF++E   +  + H H+VRLLG C     + L+ + MP+G L +
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 128
Query: 188 FIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           ++   K N  S   L+W         +A+G+ YL +   +R++H D+   N+L+      
Sbjct: 129 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHV 179
Query: 247 KISDFGLAKLCSKD 260
           KI+DFGLA+L   D
Sbjct: 180 KITDFGLARLLEGD 193

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 186 QKFIFSKT----NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
             F+  K     +    R L    L   +  VA+G+ +L    ++  +H D+   N+LL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGMMLLE 293
           +    KI DFGLA+    D + + +  AR    ++APE        + S  + YG++L E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 294 MVGCRKNNDPAVEIQSQIY 312
           +     N  P + + S+ Y
Sbjct: 255 IFSLGLNPYPGILVNSKFY 273

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 16/181 (8%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++ +S ++AVK L+    + Q F+ E   +  + H  +VRL    ++     +I EFM  
Sbjct: 32  YYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAK 91
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     S    ++   KL   +  +A G+ Y+ +   +  +H D++  N+L+  
Sbjct: 92  GSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSE 144
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
           +   KI+DFGLA++  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 145 SLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEI 203
Query: 295 V 295
           V
Sbjct: 204 V 204

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 178
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R +        +G
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 289 MMLLEMVGCRKNNDPAVEIQS 309
           +++ E+     +  P + ++ 
Sbjct: 239 VLMWEIFTLGGSPYPGIPVEE 259

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 13/134 (9%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K+L    G     EF++E   +  + H H+VRLLG C     + L+ + MP+G L +
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLE 105
Query: 188 FIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           ++   K N  S   L+W         +A+G+ YL +   +R++H D+   N+L+      
Sbjct: 106 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHV 156
Query: 247 KISDFGLAKLCSKD 260
           KI+DFGLA+L   D
Sbjct: 157 KITDFGLARLLEGD 170

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 90/172 (52%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +      + T  R    ++APE LF R + +
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTH 238

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 93/179 (51%), Gaps = 21/179 (11%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   +EF++E + +G+  H +I+RL G  +      ++ EFM NG+L  
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  + N     Q +  +L  +  G+A G+ YL +      +H D+   NIL++ N   K
Sbjct: 105 FL--RLNDG---QFTVIQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCK 156
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTS---GYIAPELF--------SRNFCYGMMLLEMV 295
           +SDFGL++   ++ S  + T++ G      + APE          S  + YG+++ E++
Sbjct: 157 VSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 175
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R +        +G
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 289 MMLLEMVGCRKNNDPAVEIQS 309
           +++ E+     +  P + ++ 
Sbjct: 236 VLMWEIFTLGGSPYPGIPVEE 256

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 232
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTAR 173
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R +        +G
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 289 MMLLEMVGCRKNNDPAVEIQS 309
           +++ E+     +  P + ++ 
Sbjct: 234 VLMWEIFTLGGSPYPGIPVEE 254

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K +  E L+G      NE+A + +I H +IV L      G    LI + +  G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNF 244
            I  K    + R  S     ++ F V   V+YLH   +  I+H D+KP N+L   LD + 
Sbjct: 106 RIVEK-GFYTERDAS-----RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           +  ISDFGL+K+  +D   V  TA  GT GY+APE+ ++ 
Sbjct: 157 KIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQK 193

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K +  E L+G      NE+A + +I H +IV L      G    LI + +  G L  
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFD 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNF 244
            I  K    + R  S     ++ F V   V+YLH   +  I+H D+KP N+L   LD + 
Sbjct: 106 RIVEK-GFYTERDAS-----RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           +  ISDFGL+K+  +D   V  TA  GT GY+APE+ ++ 
Sbjct: 157 KIMISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQK 193

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R +        +G
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 289 MMLLEMVGCRKNNDPAVEIQS 309
           +++ E+     +  P + ++ 
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE 267

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGLA++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLARVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R +        +G
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 289 MMLLEMVGCRKNNDPAVEIQS 309
           +++ E+     +  P + ++ 
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE 267

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 96/191 (50%), Gaps = 22/191 (11%)
Query: 127 SNEIAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPN 182
             ++AVK L+   G     +   E+  +  ++H +IV+  G C+E  GN   LI EF+P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL++++    N     +++ ++  K A  + +G++YL    +++ +H D+   N+L++ 
Sbjct: 110 GSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVES 161
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGY-IAPE--------LFSRNFCYGMMLLE 293
             Q KI DFGL K    D    +    R +  +  APE        + S  + +G+ L E
Sbjct: 162 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 294 MVG-CRKNNDP 303
           ++  C  ++ P
Sbjct: 222 LLTYCDSDSSP 232

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 25/192 (13%)
Query: 130 IAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H   + Q +F  E+  +  +H   IV+  G      R  L  + E++P+G L+
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 187 KFIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            F+        HR +L   +L   +  + +G+EYL    ++R +H D+   NIL++    
Sbjct: 99  DFL------QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAH 149
Query: 246 PKISDFGLAKL--CSKDISIVSRTAARGTSGYIAPE-----LFSRN---FCYGMMLLEMV 295
            KI+DFGLAKL    KD  +V R   +    + APE     +FSR    + +G++L E+ 
Sbjct: 150 VKIADFGLAKLLPLDKDXXVV-REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 208
Query: 296 G-CRKNNDPAVE 306
             C K+  P+ E
Sbjct: 209 TYCDKSCSPSAE 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 128 NEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 185 LQKFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L++++ ++           + +   QLS + L   A+ VARG+EYL    +++ +H D+ 
Sbjct: 121 LREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 177
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC------- 286
             N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 287 YGMMLLEMVGCRKNNDPAVEIQ 308
           +G++L E+     +  P V ++
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVE 259

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           IA K LE  +G+ +   NE+A + +I H +IV L      G    LI + +  G L   I
Sbjct: 51  IAKKALEGKEGSME---NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 107
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNFQP 246
             K    + R  S     ++ F V   V+YLH   +  I+H D+KP N+L   LD + + 
Sbjct: 108 VEK-GFYTERDAS-----RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI 158
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
            ISDFGL+K+  +D   V  TA  GT GY+APE+ ++ 
Sbjct: 159 MISDFGLSKM--EDPGSVLSTAC-GTPGYVAPEVLAQK 193

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 96/191 (50%), Gaps = 22/191 (11%)
Query: 127 SNEIAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPN 182
             ++AVK L+   G     +   E+  +  ++H +IV+  G C+E  GN   LI EF+P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL++++    N     +++ ++  K A  + +G++YL    +++ +H D+   N+L++ 
Sbjct: 98  GSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVES 149
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGY-IAPE--------LFSRNFCYGMMLLE 293
             Q KI DFGL K    D    +    R +  +  APE        + S  + +G+ L E
Sbjct: 150 EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHE 209
Query: 294 MVG-CRKNNDP 303
           ++  C  ++ P
Sbjct: 210 LLTYCDSDSSP 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 186 QKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
             F+  K       + + SH    QLS   L   +  VA+G+ +L    ++  +H D+  
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 194
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCY 287
            N+LL +    KI DFGLA+    D + + +  AR    ++APE        + S  + Y
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 254
Query: 288 GMMLLEMVGCRKNNDPAVEIQSQIY 312
           G++L E+     N  P + + S+ Y
Sbjct: 255 GILLWEIFSLGLNPYPGILVNSKFY 279

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 24/201 (11%)
Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L
Sbjct: 51  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 110
Query: 186 QKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           ++++ ++       + + SH    QLS + L   A+ VARG+EYL    +++ +H D+  
Sbjct: 111 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 167
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        +
Sbjct: 168 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 227
Query: 288 GMMLLEMVGCRKNNDPAVEIQ 308
           G++L E+     +  P V ++
Sbjct: 228 GVLLWEIFTLGGSPYPGVPVE 248

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 33  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 92  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 144
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 145 TLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 295 V 295
           V
Sbjct: 204 V 204

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 19/177 (10%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H ++V L G  + G    ++ EFM NG+L  
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDA 133
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G+ YL    +   +H D+   NIL++ N   K
Sbjct: 134 FLRKHDG-----QFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCK 185
Query: 248 ISDFGLAKLCSKDISIV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV 295
           +SDFGL+++   D   V + T  +    + APE          S  + YG+++ E++
Sbjct: 186 VSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 40/248 (16%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           + ++A+K +E  +   + FI E+  + R++H +IV+L G C   N   L+ E+   GSL 
Sbjct: 32  AKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 88
Query: 187 KFIFSKTN---SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
             +         ++   +SW          ++GV YLH    + ++H D+KP N+LL   
Sbjct: 89  NVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG 142
Query: 244 FQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
               KI DFG A  C  DI     T  +G++ ++APE+F  +        F +G++L E+
Sbjct: 143 GTVLKICDFGTA--C--DIQ-THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 197
Query: 295 VGCRKNNDPAVEIQSQIYFPEW-IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
           +  RK  D   EI    +   W ++N  R    L  +  +  +  + R        C   
Sbjct: 198 ITRRKPFD---EIGGPAFRIMWAVHNGTR--PPLIKNLPKPIESLMTR--------CWSK 244
Query: 354 NPTERPSM 361
           +P++RPSM
Sbjct: 245 DPSQRPSM 252

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 128 NEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 185 LQKFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L++++ ++           + +   QLS + L   A+ VARG+EYL    +++ +H D+ 
Sbjct: 121 LREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 177
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC------- 286
             N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 287 YGMMLLEMVGCRKNNDPAVEIQ 308
           +G++L E+     +  P V ++
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVE 259

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 128 NEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+
Sbjct: 54  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 113
Query: 185 LQKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L++++ ++       + + SH    QLS + L   A+ VARG+EYL    +++ +H D+ 
Sbjct: 114 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 170
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC------- 286
             N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        
Sbjct: 171 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 287 YGMMLLEMVGCRKNNDPAVEIQ 308
           +G++L E+     +  P V ++
Sbjct: 231 FGVLLWEIFTLGGSPYPGVPVE 252

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 128 NEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 185 LQKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L++++ ++       + + SH    QLS + L   A+ VARG+EYL    +++ +H D+ 
Sbjct: 121 LREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 177
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC------- 286
             N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 287 YGMMLLEMVGCRKNNDPAVEIQ 308
           +G++L E+     +  P V ++
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVE 259

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 106
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 107 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 158
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 159 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 213
Query: 294 MV 295
           ++
Sbjct: 214 VM 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 101/189 (53%), Gaps = 29/189 (15%)
Query: 129 EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           + A+K ++    K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L
Sbjct: 51  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 186 QKFI-----------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
             F+           F+  NS++   LS ++L   A  VARG++YL Q   ++ +H ++ 
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLA 166
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-----LFSRN---FC 286
             NIL+  N+  KI+DFGL++   +++  V +T  R    ++A E     +++ N   + 
Sbjct: 167 ARNILVGENYVAKIADFGLSR--GQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 223
Query: 287 YGMMLLEMV 295
           YG++L E+V
Sbjct: 224 YGVLLWEIV 232

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 24/201 (11%)
Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L
Sbjct: 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 186 QKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           ++++ ++       + + SH    QLS + L   A+ VARG+EYL    +++ +H D+  
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 219
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        +
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 288 GMMLLEMVGCRKNNDPAVEIQ 308
           G++L E+     +  P V ++
Sbjct: 280 GVLLWEIFTLGGSPYPGVPVE 300

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 24/201 (11%)
Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L
Sbjct: 54  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 113
Query: 186 QKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           ++++ ++       + + SH    QLS + L   A+ VARG+EYL    +++ +H D+  
Sbjct: 114 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 170
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        +
Sbjct: 171 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 230
Query: 288 GMMLLEMVGCRKNNDPAVEIQ 308
           G++L E+     +  P V ++
Sbjct: 231 GVLLWEIFTLGGSPYPGVPVE 251

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 128 NEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+
Sbjct: 61  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 120
Query: 185 LQKFIFSK-------TNSSSH---RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L++++ ++       + + SH    QLS + L   A+ VARG+EYL    +++ +H D+ 
Sbjct: 121 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLA 177
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC------- 286
             N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        
Sbjct: 178 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 287 YGMMLLEMVGCRKNNDPAVEIQ 308
           +G++L E+     +  P V ++
Sbjct: 238 FGVLLWEIFTLGGSPYPGVPVE 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 40/248 (16%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           + ++A+K +E  +   + FI E+  + R++H +IV+L G C   N   L+ E+   GSL 
Sbjct: 31  AKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87
Query: 187 KFIFSKTN---SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
             +         ++   +SW          ++GV YLH    + ++H D+KP N+LL   
Sbjct: 88  NVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG 141
Query: 244 FQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
               KI DFG A  C  DI     T  +G++ ++APE+F  +        F +G++L E+
Sbjct: 142 GTVLKICDFGTA--C--DIQ-THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196
Query: 295 VGCRKNNDPAVEIQSQIYFPEW-IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
           +  RK  D   EI    +   W ++N  R    L  +  +  +  + R        C   
Sbjct: 197 ITRRKPFD---EIGGPAFRIMWAVHNGTR--PPLIKNLPKPIESLMTR--------CWSK 243
Query: 354 NPTERPSM 361
           +P++RPSM
Sbjct: 244 DPSQRPSM 251

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L
Sbjct: 47  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106
Query: 186 QKFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           ++++ ++           + +   QLS + L   A+ VARG+EYL    +++ +H D+  
Sbjct: 107 REYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 163
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------Y 287
            N+L+  +   KI+DFGLA+           T  R    ++APE LF R +        +
Sbjct: 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
Query: 288 GMMLLEMVGCRKNNDPAVEIQS 309
           G++L E+     +  P V ++ 
Sbjct: 224 GVLLWEIFTLGGSPYPGVPVEE 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 123
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 124 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 175
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 176 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 230
Query: 294 MV 295
           ++
Sbjct: 231 VM 232

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   +I+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I EF+P GSL+
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           +++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 105 EYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 156
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 157 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 216 YIEKSKSPPAEFMRMI 231

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 134 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 185
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 186 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 240
Query: 294 MV 295
           ++
Sbjct: 241 VM 242

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++ +S ++AVK L+    + Q F+ E   +  + H  +VRL    +      +I E+M  
Sbjct: 33  YYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAK 92
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     S    ++   KL   +  +A G+ Y+ +   +  +H D++  N+L+  
Sbjct: 93  GSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSE 145
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
           +   KI+DFGLA++  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 146 SLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEI 204
Query: 295 V 295
           V
Sbjct: 205 V 205

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 186 QKFIFSKTN--------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
             F+  K+         + ++  LS   L   +  VA+G+ +L    ++  +H D+   N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGM 289
           +LL +    KI DFGLA+    D + + +  AR    ++APE        + S  + YG+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 290 MLLEMVGCRKNNDPAVEIQSQIY 312
           +L E+     N  P + + S+ Y
Sbjct: 255 LLWEIFSLGLNPYPGILVNSKFY 277

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 33  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 92  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 144
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 145 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 295 V 295
           V
Sbjct: 204 V 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 35  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 93
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 94  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 146
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 147 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 205
Query: 295 V 295
           V
Sbjct: 206 V 206

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 39  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 97
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 98  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 150
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 151 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 295 V 295
           V
Sbjct: 210 V 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 42  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 100
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 101 GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 153
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 154 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 212
Query: 295 V 295
           V
Sbjct: 213 V 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 33  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 92  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 144
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 145 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 295 V 295
           V
Sbjct: 204 V 204

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL ++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLGRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++ +      H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 105 DYLQAHAERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 156
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 157 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 216 YIEKSKSPPAEFMRMI 231

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 41  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 99
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 100 GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 152
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 153 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 211
Query: 295 V 295
           V
Sbjct: 212 V 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 34  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 92
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 93  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 145
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 146 TLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 204
Query: 295 V 295
           V
Sbjct: 205 V 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 33  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 92  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 144
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 145 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 295 V 295
           V
Sbjct: 204 V 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 38  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 96
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 97  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 149
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 150 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 208
Query: 295 V 295
           V
Sbjct: 209 V 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 39  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 97
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 98  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 150
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 151 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 295 V 295
           V
Sbjct: 210 V 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 43  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 101
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 102 GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 154
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 155 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 213
Query: 295 V 295
           V
Sbjct: 214 V 214

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 28  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 86
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+  
Sbjct: 87  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 139
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 140 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 198
Query: 295 V 295
           V
Sbjct: 199 V 199

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 88/172 (51%), Gaps = 17/172 (9%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I  +   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFCY 287
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R + +
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 101 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 152
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 153 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 212 YIEKSKSPPAEFMRMI 227

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 68/134 (50%), Gaps = 11/134 (8%)
Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    N  ++F  E   +  + H HIV+  G C EG+   +++E+M +G L KF
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
Query: 189 IFSK-------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           + +           +   +L+  ++  IA  +A G+ YL    +Q  +H D+   N L+ 
Sbjct: 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 162
Query: 242 HNFQPKISDFGLAK 255
            N   KI DFG+++
Sbjct: 163 ENLLVKIGDFGMSR 176

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+ L G  ++     ++ E+M NGSL  
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  K N     Q +  +L  +  G++ G++YL    +   +H D+   NIL++ N   K
Sbjct: 113 FL--KKNDG---QFTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCK 164
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + APE  + R F        YG+++ E
Sbjct: 165 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWE 219
Query: 294 MV 295
           +V
Sbjct: 220 VV 221

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 105 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 156
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 157 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 216 YIEKSKSPPAEFMRMI 231

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 100 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 151
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 152 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 211 YIEKSKSPPAEFMRMI 226

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 133 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 184
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 185 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 244 YIEKSKSPPAEFMRMI 259

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 106 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 157
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 158 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 217 YIEKSKSPPAEFMRMI 232

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E M NGSL  
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 106
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 107 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 158
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 159 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 213
Query: 294 MV 295
           ++
Sbjct: 214 VM 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 21/195 (10%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 102 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 247 KISDFGLAKLCSKDISIVS-RTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG- 296
           KI DFGL K+  +D      +        + APE  + +        + +G++L E+   
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213
Query: 297 CRKNNDPAVEIQSQI 311
             K+  P  E    I
Sbjct: 214 IEKSKSPPAEFMRMI 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 107 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 158
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 159 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 218 YIEKSKSPPAEFMRMI 233

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 102 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 154 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 213 YIEKSKSPPAEFMRMI 228

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 108 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 159
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 160 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 219 YIEKSKSPPAEFMRMI 234

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 102 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 154 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 213 YIEKSKSPPAEFMRMI 228

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I  +   G+L+
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 187 KFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +++ ++           N     Q++++ L    + +ARG+EYL    +Q+ +H D+   
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAAR 186
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YG 288
           N+L+  N   KI+DFGLA+  +        T  R    ++APE LF R +        +G
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 289 MMLLEMVGCRKNNDPAVEIQS 309
           +++ E+     +  P + ++ 
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE 267

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 109 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 160
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 161 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 220 YIEKSKSPPAEFMRMI 235

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 29/182 (15%)
Query: 130 IAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+  + +   ++F+ E + +G+  H +I+RL G  ++     ++ E M NGSL  
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL    +   +H D+   NIL++ N   K
Sbjct: 136 FL-----RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFGL+++   D       AA  T G      + +PE  + R F        YG++L E
Sbjct: 188 VSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 294 MV 295
           ++
Sbjct: 243 VM 244

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 130 IAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 79  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 186 --------QKFIFSKTNSS----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
                     FI SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+
Sbjct: 138 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 194
Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNF 285
              NILL H    KI DFGLA+    D + V +  AR    ++APE          S  +
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 286 CYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            YG+ L E+     +  P + + S+ Y
Sbjct: 255 SYGIFLWELFSLGSSPYPGMPVDSKFY 281

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 130 IAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 56  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 186 --------QKFIFSKTNSS----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
                     FI SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 171
Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNF 285
              NILL H    KI DFGLA+    D + V +  AR    ++APE          S  +
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 286 CYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            YG+ L E+     +  P + + S+ Y
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFY 258

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 120 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 171
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 172 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 231 YIEKSKSPPAEFMRMI 246

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 130 IAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 74  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 132
Query: 186 --------QKFIFSKTNSS----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
                     FI SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+
Sbjct: 133 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 189
Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNF 285
              NILL H    KI DFGLA+    D + V +  AR    ++APE          S  +
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 249
Query: 286 CYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            YG+ L E+     +  P + + S+ Y
Sbjct: 250 SYGIFLWELFSLGSSPYPGMPVDSKFY 276

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 130 IAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 79  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 186 --------QKFIFSKTNSS----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
                     FI SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+
Sbjct: 138 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 194
Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNF 285
              NILL H    KI DFGLA+    D + V +  AR    ++APE          S  +
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 254
Query: 286 CYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            YG+ L E+     +  P + + S+ Y
Sbjct: 255 SYGIFLWELFSLGSSPYPGMPVDSKFY 281

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++AVKM++    +  EF  E  T+ ++ H  +V+  G CS+     ++ E++ NG L  +
Sbjct: 34  DVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +      S  + L   +L ++ + V  G+ +L    + + +H D+   N L+D +   K+
Sbjct: 94  L-----RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKV 145
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK 299
           SDFG+ +    D   VS    +    + APE+F        S  + +G+++ E+    K
Sbjct: 146 SDFGMTRYVLDD-QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L
Sbjct: 78  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 186 QKFIFSKTN--------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
             F+  K+         + ++   S   L   +  VA+G+ +L    ++  +H D+   N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------LFSRNFCYGM 289
           +LL +    KI DFGLA+    D + + +  AR    ++APE        + S  + YG+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 290 MLLEMVGCRKNNDPAVEIQSQIY 312
           +L E+     N  P + + S+ Y
Sbjct: 255 LLWEIFSLGLNPYPGILVNSKFY 277

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 130 IAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +AVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 72  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 130
Query: 186 --------QKFIFSKTNSS----SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
                     FI SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+
Sbjct: 131 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDL 187
Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNF 285
              NILL H    KI DFGLA+    D + V +  AR    ++APE          S  +
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 247
Query: 286 CYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            YG+ L E+     +  P + + S+ Y
Sbjct: 248 SYGIFLWELFSLGSSPYPGMPVDSKFY 274

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 120 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 171
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSG--YIAPELFSRN--------FCYGMMLLEMVG 296
           KI DFGL K+  +D     +    G S   + APE  + +        + +G++L E+  
Sbjct: 172 KIGDFGLTKVLPQDKE-XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230
Query: 297 -CRKNNDPAVEIQSQI 311
              K+  P  E    I
Sbjct: 231 YIEKSKSPPAEFMRMI 246

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 32  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLL 90
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 91  DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 143
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 144 KVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 199

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 178
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 179 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 228
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 229 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPT 278

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 29/181 (16%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           + F+ EV  +  + H ++++ +G   +  R   I E++  G+L+  I      S   Q  
Sbjct: 52  RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-----KSMDSQYP 106
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS---- 258
           W +    A  +A G+ YLH   +  I+H D+  HN L+  N    ++DFGLA+L      
Sbjct: 107 WSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 259 --------KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNND 302
                   K      R    G   ++APE+ +          F +G++L E++G R N D
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNAD 222
Query: 303 P 303
           P
Sbjct: 223 P 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 178
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 179 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 228
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 229 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 278

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 35  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 93
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 94  DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 146
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 147 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 202

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 175
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 176 DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 225
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 226 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 275

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 178
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 179 DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 228
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 229 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 278

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 208 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 267 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 319
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 320 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 123 FFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           ++    ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M N
Sbjct: 29  YYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 87
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL  F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H +++  NIL+  
Sbjct: 88  GSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNLRAANILVSD 140
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
               KI+DFGLA+L  +D    +R  A+    + APE          S  + +G++L E+
Sbjct: 141 TLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 199
Query: 295 V 295
           V
Sbjct: 200 V 200

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 129 EIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML+        +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L
Sbjct: 63  KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 186 QKFIFSKT-----------------NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRI 228
             F+  K                  +    R L    L   +  VA+G+ +L    ++  
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNC 179
Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--------L 280
           +H D+   N+LL +    KI DFGLA+    D + + +  AR    ++APE        +
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 281 FSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY 312
            S  + YG++L E+     N  P + + S+ Y
Sbjct: 240 QSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 271

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 208 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 267 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 319
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 320 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 129 EIAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++A+K+L+    K + +E + E   + ++ + +IVRL+G C +     L+ E    G L 
Sbjct: 39  DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 97
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+  K       ++    + ++   V+ G++YL +   +  +H D+   N+LL +    
Sbjct: 98  KFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYA 149
Query: 247 KISDFGLAK-LCSKDISIVSRTAARGTSGYIAPE 279
           KISDFGL+K L + D    +R+A +    + APE
Sbjct: 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           + F  EV    ++ H +IV ++    E +   L+ E++   +L ++I       SH  LS
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI------ESHGPLS 109
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            +        +  G+++ H   + RI+H DIKP NIL+D N   KI DFG+AK  S + S
Sbjct: 110 VDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETS 165
Query: 263 IVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           +       GT  Y +PE             +  G++L EM+
Sbjct: 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 115 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 163
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +       A  GT+ Y++PEL +         L  +GC
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGC 220

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 208 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLL 266
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 267 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 319
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 320 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 178
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 179 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 228
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 229 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 278

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 65  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 124
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H D+   N ++ H+F  KI DFG+    ++
Sbjct: 125 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TR 177
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 227
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 228 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 277

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 291 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 350 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 402
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 403 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 21/195 (10%)
Query: 130 IAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQ 186
           +AVK L+H  + + ++F  E+  +  + H +IV+  G C    RR L  I E++P GSL+
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++        H      KL +    + +G+EYL     +R +H ++   NIL+++  + 
Sbjct: 103 DYLQKHKERIDHI-----KLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRV 154
Query: 247 KISDFGLAKLCSKDISIVS-RTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG- 296
           KI DFGL K+  +D      +        + APE  + +        + +G++L E+   
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 214
Query: 297 CRKNNDPAVEIQSQI 311
             K+  P  E    I
Sbjct: 215 IEKSKSPPAEFMRMI 229

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           + ++A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 33  NTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLL 91
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         R L    L  +A  VA G+ Y+ +      +H D++  NIL+ +    
Sbjct: 92  DFL----KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGNGLIC 144
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMVGCR 298
           KI+DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+V   
Sbjct: 145 KIADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 203
Query: 299 KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTER 358
           +   P +  +  +   E  Y RM   Q+  +   E            + I C + +P ER
Sbjct: 204 RVPYPGMNNREVLEQVERGY-RMPCPQDCPISLHE------------LMIHCWKKDPEER 250
Query: 359 PS 360
           P+
Sbjct: 251 PT 252

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 32/193 (16%)
Query: 124 FLHSNEIAVKMLEH-----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE 178
           F   +E+AVK   H     +    +    E      + H +I+ L G C +     L+ E
Sbjct: 27  FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86
Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
           F   G L + +       S +++  + L   A  +ARG+ YLH      I+H D+K  NI
Sbjct: 87  FARGGPLNRVL-------SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI 139
Query: 239 LLDHNFQP--------KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-----LFSRN- 284
           L+    +         KI+DFGLA+   +     ++ +A G   ++APE     +FS+  
Sbjct: 140 LILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAGAYAWMAPEVIRASMFSKGS 195
Query: 285 --FCYGMMLLEMV 295
             + YG++L E++
Sbjct: 196 DVWSYGVLLWELL 208

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 14/148 (9%)
Query: 139 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSS 196
           +G  ++   E+A + ++ H ++V+L+    + N   L  ++E +  G + +    K  S 
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
              +  ++ L K       G+EYLH    Q+I+H DIKP N+L+  +   KI+DFG++  
Sbjct: 137 DQARFYFQDLIK-------GIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
                +++S T   GT  ++APE  S  
Sbjct: 187 FKGSDALLSNTV--GTPAFMAPESLSET 212

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + +I H  +V+L    SE     ++ E+M  GSL 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 19/178 (10%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLI-YEFMP 181
           S E A+K+LE    +K N   ++  E   + R+ H   V+L  FC + + +      +  
Sbjct: 62  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAK 120
Query: 182 NGSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           NG L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NIL
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENIL 169
Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           L+ +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 170 LNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 227

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 80/184 (43%), Gaps = 32/184 (17%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRT----LIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           EV ++  + H +I++ +G    G        LI  F   GSL  F+ +         +SW
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------VSW 120
Query: 204 EKLRKIAFGVARGVEYLHQ-------GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
            +L  IA  +ARG+ YLH+       G    I H DIK  N+LL +N    I+DFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 257 CSKDISIVSRTAARGTSGYIAPEL------FSRN-------FCYGMMLLEMVG-CRKNND 302
                S        GT  Y+APE+      F R+       +  G++L E+   C   + 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 303 PAVE 306
           P  E
Sbjct: 241 PVDE 244

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 119
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 120 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 169
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 170 TVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 229
Query: 295 V 295
           +
Sbjct: 230 M 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 121 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 170
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 171 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 295 V 295
           +
Sbjct: 231 M 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 81  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 139
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 140 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 189
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 190 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249
Query: 295 V 295
           +
Sbjct: 250 M 250

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 39  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLL 97
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  ++  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 98  DFLKGETG----KYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 150
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 151 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 206

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 80  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 138
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 139 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 188
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 189 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 248
Query: 295 V 295
           +
Sbjct: 249 M 249

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 112
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 113 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 162
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 163 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 222
Query: 295 V 295
           +
Sbjct: 223 M 223

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 59  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 117
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 118 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 167
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 168 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227
Query: 295 V 295
           +
Sbjct: 228 M 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 54  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 113
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 114 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 162
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +       +  GT+ Y++PEL +         L  +GC
Sbjct: 163 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 219

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 39  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLL 97
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T     + L   +L  ++  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 98  DFLKGETG----KYLRLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 150
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 151 KVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 206

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL-- 201
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S   + ++  +  
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 202 --SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 58  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 117
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 118 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 166
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +       +  GT+ Y++PEL +         L  +GC
Sbjct: 167 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 223

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 57  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 115
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 116 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 165
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 166 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 295 V 295
           +
Sbjct: 226 M 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 121 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 170
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 171 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 295 V 295
           +
Sbjct: 231 M 231

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 35  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 94
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 95  GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 143
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 144 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 200

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 117 GCLLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 165
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +       +  GT+ Y++PEL +         L  +GC
Sbjct: 166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGC 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL-- 201
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S   + ++  +  
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 202 --SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 119
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 120 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 169
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 170 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 229
Query: 295 V 295
           +
Sbjct: 230 M 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 34  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 93
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 94  GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 142
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 143 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 33  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 91
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 92  DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 144
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 145 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 200

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 117 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 165
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 166 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGC 222

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 46/207 (22%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLI-------- 176
           L S   A+K + H +      ++EV  +  ++H ++VR      E  RR  +        
Sbjct: 29  LDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE--RRNFVKPMTAVKK 86
Query: 177 -------YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
                   E+  NG+L   I S+ N +  R   W   R+I       + Y+H   +Q I+
Sbjct: 87  KSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQIL----EALSYIH---SQGII 138
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV------------SRTAARGTSGYIA 277
           H D+KP NI +D +   KI DFGLAK   + + I+            + T+A GT+ Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 278 PELFSRN---------FCYGMMLLEMV 295
            E+             +  G++  EM+
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 118
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G++YL    +++ +H D+   N +LD  F
Sbjct: 119 NFIRNETHNPTVKDL-------IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 168
Query: 245 QPKISDFGLAK-LCSKD-ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 169 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 228
Query: 295 V 295
           +
Sbjct: 229 M 229

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 31  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 89
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 90  DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 142
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 143 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 198

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 12/154 (7%)
Query: 129 EIAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++A+K+L+    K + +E + E   + ++ + +IVRL+G C +     L+ E    G L 
Sbjct: 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 423
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+  K       ++    + ++   V+ G++YL +   +  +H ++   N+LL +    
Sbjct: 424 KFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYA 475
Query: 247 KISDFGLAK-LCSKDISIVSRTAARGTSGYIAPE 279
           KISDFGL+K L + D    +R+A +    + APE
Sbjct: 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 33  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 93  GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 141
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 198

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 39  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 98
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 99  GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 147
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 148 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 204

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 32  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 91
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 92  GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 140
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 141 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 197

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 138 LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKTNS 195
           +K    +F NE+  I  I + + +   G  +  +   +IYE+M N S+ KF   F   + 
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           +    +  + ++ I   V     Y+H   N  I H D+KP NIL+D N + K+SDFG ++
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 256 -LCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
            +  K I       +RGT  ++ PE FS    Y 
Sbjct: 201 YMVDKKIK-----GSRGTYEFMPPEFFSNESSYN 229

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H ++   N ++ H+F  KI DFG+    ++
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGM----TR 178
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 179 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 228
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 229 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPT 278

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 115 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 163
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 220

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 23/181 (12%)
Query: 129 EIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVK+L+ +       Q F NEVA + +  H +I+  +G+ ++ N   ++ ++    SL
Sbjct: 60  DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSL 118
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            K +  +       QL       IA   A+G++YLH    + I+H D+K +NI L     
Sbjct: 119 YKHLHVQETKFQMFQLI-----DIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLT 170
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEM 294
            KI DFGLA + S+           G+  ++APE+            S  + YG++L E+
Sbjct: 171 VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL 230
Query: 295 V 295
           +
Sbjct: 231 M 231

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 115 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 163
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 220

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 46/238 (19%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +      H+VRLLG  S+G    ++ E M +G L+ ++ S      N+    
Sbjct: 67  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 126
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             + +++ ++A  +A G+ YL+    ++ +H ++   N ++ H+F  KI DFG+    ++
Sbjct: 127 PPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGM----TR 179
Query: 260 DI--SIVSRTAARG--TSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI 307
           DI  +   R   +G     ++APE          S  + +G++L E+            +
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 229
Query: 308 QSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCIQWNPTERPS 360
             Q Y          L  E  L F  DG      +    ++  +   C Q+NP  RP+
Sbjct: 230 AEQPY--------QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPT 279

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 23/146 (15%)
Query: 130 IAVKML-EHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVKML E    + Q +F  E A +    + +IV+LLG C+ G    L++E+M  G L +
Sbjct: 80  VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 188 FIFS------------------KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
           F+ S                  + +S     LS  +   IA  VA G+ YL +   ++ +
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 196
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAK 255
           H D+   N L+  N   KI+DFGL++
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 115 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 163
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 220

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 58  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 117
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 118 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 166
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 167 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 223

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 117 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 165
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 166 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 222

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 54  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 113
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 114 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 162
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 163 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 219

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 117 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 165
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 166 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 222

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 117 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 165
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 166 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 57  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 117 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 165
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 166 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 222

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 59  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           S E A+K+LE    +K N   ++  E   + R+ H   V+L     +  +      +  N
Sbjct: 60  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 119
Query: 183 GSLQKFI--FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           G L K+I      + +  R  + E        +   +EYLH    + I+H D+KP NILL
Sbjct: 120 GELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLH---GKGIIHRDLKPENILL 168
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           + +   +I+DFG AK+ S +          GT+ Y++PEL +         L  +GC
Sbjct: 169 NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGC 225

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           L  +++AVK+L   K    + +     E+  +    H HI++L    S  +   ++ E++
Sbjct: 39  LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L  +I        + +L  ++ R++   +  GV+Y H+     ++H D+KP N+LL
Sbjct: 99  SGGELFDYI------CKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLL 149
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
           D +   KI+DFGL+ + S D   +  +   G+  Y APE+ S     G
Sbjct: 150 DAHMNAKIADFGLSNMMS-DGEFLRXSC--GSPNYAAPEVISGRLYAG 194

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 121
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 122 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 171
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 172 TVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 231
Query: 295 V 295
           +
Sbjct: 232 M 232

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+ +
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 118
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 119 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 168
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 169 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 228
Query: 295 V 295
           +
Sbjct: 229 M 229

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 121 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 170
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 171 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 295 V 295
           +
Sbjct: 231 M 231

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+    + Q  +F++E + +G+  H +I+ L G  ++     +I E+M NGSL  
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+       +  QL       +  G+  G++YL    +   +H D+   NIL++ N   K
Sbjct: 120 FLRKNDGRFTVIQLV-----GMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCK 171
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFG++++   D       AA  T G      + APE  + R F        YG+++ E
Sbjct: 172 VSDFGMSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 226
Query: 294 MV 295
           ++
Sbjct: 227 VM 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 18/152 (11%)
Query: 115 FNLTNSKFFFLHSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR 173
           +NL+ +K   L    +AVK L+       ++F  E   +  + H HIV+  G C +G+  
Sbjct: 37  YNLSPTKDKML----VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 92
Query: 174 TLIYEFMPNGSLQKFIFSKTNSS----------SHRQLSWEKLRKIAFGVARGVEYLHQG 223
            +++E+M +G L KF+ +    +          +  +L   ++  IA  +A G+ YL   
Sbjct: 93  IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL--- 149
Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
            +Q  +H D+   N L+  N   KI DFG+++
Sbjct: 150 ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 179
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 180 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 229
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 295 V 295
           +
Sbjct: 290 M 290

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 146 INEVATIGRIHHF---HIVRLLGFCS-----EGNRRTLIYEFMPNGSLQKFIFSKTNSSS 197
           I EVA +  +  F   ++VRL   C+        + TL++E + +  L  ++    +   
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVP 113
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              +  E ++ + F + RG+++LH   + R++H D+KP NIL+  + Q K++DFGLA++ 
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 258 SKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           S  +++ S      T  Y APE+  ++     + L  VGC
Sbjct: 171 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGC 207

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 146 INEVATIGRIHHF---HIVRLLGFCS-----EGNRRTLIYEFMPNGSLQKFIFSKTNSSS 197
           I EVA +  +  F   ++VRL   C+        + TL++E + +  L  ++    +   
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVP 113
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              +  E ++ + F + RG+++LH   + R++H D+KP NIL+  + Q K++DFGLA++ 
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 258 SKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           S  +++ S      T  Y APE+  ++     + L  VGC
Sbjct: 171 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGC 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 121
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 122 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 171
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 172 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 231
Query: 295 V 295
           +
Sbjct: 232 M 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E  NE++ +  + H +I++L     +     L+ EF   G L + I ++       +  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR------HKFD 144
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCSK 259
                 I   +  G+ YLH+     I+H DIKP NILL++       KI DFGL+   SK
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 260 DISIVSRTAARGTSGYIAPELFSRNF 285
           D  +  R    GT+ YIAPE+  + +
Sbjct: 202 DYKLRDRL---GTAYYIAPEVLKKKY 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 19/160 (11%)
Query: 146 INEVATIGRIHHF---HIVRLLGFCS-----EGNRRTLIYEFMPNGSLQKFIFSKTNSSS 197
           I EVA +  +  F   ++VRL   C+        + TL++E + +  L  ++    +   
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL----DKVP 113
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              +  E ++ + F + RG+++LH   + R++H D+KP NIL+  + Q K++DFGLA++ 
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 258 SKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           S  +++ S      T  Y APE+  ++     + L  VGC
Sbjct: 171 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGC 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 125
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 126 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 175
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 176 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 235
Query: 295 V 295
           +
Sbjct: 236 M 236

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +      + L   +L  +A  +A G+ Y+ +      +H D+   NIL+  N   
Sbjct: 101 DFLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 98/181 (54%), Gaps = 27/181 (14%)
Query: 131 AVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQ 186
           AVK L  +   G+  +F+ E   +    H +++ LLG C  SEG+   ++  +M +G L+
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
            FI ++T++ + + L       I FG  VA+G+++L    +++ +H D+   N +LD  F
Sbjct: 121 NFIRNETHNPTVKDL-------IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF 170
Query: 245 QPKISDFGLAK-LCSKDI-SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K++DFGLA+ +  K+  S+ ++T A+    ++A E          S  + +G++L E+
Sbjct: 171 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 230
Query: 295 V 295
           +
Sbjct: 231 M 231

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 89/176 (50%), Gaps = 17/176 (9%)
Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            ++AVK ++    + + F+ E   +  + H  +V+L    ++     +I EFM  GSL  
Sbjct: 40  TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD 98
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  K++  S + L   KL   +  +A G+ ++ Q   +  +H D++  NIL+  +   K
Sbjct: 99  FL--KSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCK 151
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV 295
           I+DFGLA++  +D    +R  A+    + APE          S  + +G++L+E+V
Sbjct: 152 IADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 206

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+    + Q  +F++E + +G+  H +I+ L G  ++     +I E+M NGSL  
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+       +  QL       +  G+  G++YL    +   +H D+   NIL++ N   K
Sbjct: 99  FLRKNDGRFTVIQLV-----GMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCK 150
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFG++++   D       AA  T G      + APE  + R F        YG+++ E
Sbjct: 151 VSDFGMSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 205
Query: 294 MV 295
           ++
Sbjct: 206 VM 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 35  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 93
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   + +     S  +   +KL  IA   ARG++YLH    + I+H D+K +NI L  + 
Sbjct: 94  LYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDN 145
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 146 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 205
Query: 294 MV 295
           ++
Sbjct: 206 LM 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 22/177 (12%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSL 185
            N++AVK +++     Q F+ E + + ++ H ++V+LLG    E     ++ E+M  GSL
Sbjct: 216 GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++ S+  S     L  + L K +  V   +EYL +G N   +H D+   N+L+  +  
Sbjct: 275 VDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGNN--FVHRDLAARNVLVSEDNV 327
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
            K+SDFGL K  S      ++   +    + APE          S  + +G++L E+
Sbjct: 328 AKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL 
Sbjct: 209 TTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 267
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +      + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 268 DFLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 320
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGL +L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 321 KVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 376

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 22/177 (12%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSL 185
            N++AVK +++     Q F+ E + + ++ H ++V+LLG    E     ++ E+M  GSL
Sbjct: 29  GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++ S+  S     L  + L K +  V   +EYL +G N   +H D+   N+L+  +  
Sbjct: 88  VDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGNN--FVHRDLAARNVLVSEDNV 140
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
            K+SDFGL K  S      ++   +    + APE          S  + +G++L E+
Sbjct: 141 AKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 130 IAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L+    + Q  +F++E + +G+  H +I+ L G  ++     +I E+M NGSL  
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+       +  QL       +  G+  G++YL    +   +H D+   NIL++ N   K
Sbjct: 105 FLRKNDGRFTVIQLV-----GMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCK 156
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSG------YIAPELFS-RNFC-------YGMMLLE 293
           +SDFG++++   D       AA  T G      + APE  + R F        YG+++ E
Sbjct: 157 VSDFGMSRVLEDDPE-----AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 211
Query: 294 MV 295
           ++
Sbjct: 212 VM 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 128 NEIAVKMLE----HLKGNGQEFINEVATIGRIH-------HFHIVRLLGFCSEGNRRTLI 176
           +E AVK++E     L     E + E AT    H       H HI+ L+      +   L+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVRE-ATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           ++ M  G L  ++  K        LS ++ R I   +   V +LH      I+H D+KP 
Sbjct: 179 FDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE 229
Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           NILLD N Q ++SDFG +  C  +     R    GT GY+APE+ 
Sbjct: 230 NILLDDNMQIRLSDFGFS--CHLEPGEKLRELC-GTPGYLAPEIL 271

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 31/266 (11%)
Query: 109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 168
           F S++  NL       L      +K+    +   +EF++E A +    H +++RLLG C 
Sbjct: 47  FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 169 EGN-----RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG 223
           E +     +  +I  FM  G L  ++      +  + +  + L K    +A G+EYL   
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--- 163
Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISIVSRTAARGTSGYIAPELFS 282
            N+  LH D+   N +L  +    ++DFGL+ K+ S D     R A           L  
Sbjct: 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223
Query: 283 RNF-------CYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-ELCLDFEED 334
           R +        +G+ + E+        P V+   ++Y  +++ +  RL Q E CLD    
Sbjct: 224 RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-NHEMY--DYLLHGHRLKQPEDCLD---- 276
Query: 335 GDEGIARKLAIVAIWCIQWNPTERPS 360
                  +L  +   C + +P +RP+
Sbjct: 277 -------ELYEIMYSCWRTDPLDRPT 295

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    +  Q+F  E   +  + H HIVR  G C+EG    +++E+M +G L +F
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 110
Query: 189 IFSKTNSS---------SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           + S    +         +   L   +L  +A  VA G+ YL        +H D+   N L
Sbjct: 111 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCL 167
Query: 240 LDHNFQPKISDFGLAK 255
           +      KI DFG+++
Sbjct: 168 VGQGLVVKIGDFGMSR 183

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 48  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLL 105
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 106 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 156
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 157 VKITDFGLAKLLGAE 171

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 22/177 (12%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGSL 185
            N++AVK +++     Q F+ E + + ++ H ++V+LLG    E     ++ E+M  GSL
Sbjct: 35  GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 93
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++ S+  S     L  + L K +  V   +EYL +G N   +H D+   N+L+  +  
Sbjct: 94  VDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGNN--FVHRDLAARNVLVSEDNV 146
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
            K+SDFGL K  S      ++   +    + APE          S  + +G++L E+
Sbjct: 147 AKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 12/144 (8%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 35  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 95  L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 146
Query: 249 SDFGLAKLCSKDISIVSRTAARGT 272
           SDFGL++    D      T++RG+
Sbjct: 147 SDFGLSRYVLDD----EYTSSRGS 166

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS----KTNSSSHR 199
           EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ ++ S      N+    
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             S  K+ ++A  +A G+ YL+     + +H D+   N  +  +F  KI DFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    +  Q+F  E   +  + H HIVR  G C+EG    +++E+M +G L +F
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 104
Query: 189 IFSKTNSS---------SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           + S    +         +   L   +L  +A  VA G+ YL        +H D+   N L
Sbjct: 105 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCL 161
Query: 240 LDHNFQPKISDFGLAK 255
           +      KI DFG+++
Sbjct: 162 VGQGLVVKIGDFGMSR 177

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           +AVK L+    +  Q+F  E   +  + H HIVR  G C+EG    +++E+M +G L +F
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
Query: 189 IFSKTNSS---------SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           + S    +         +   L   +L  +A  VA G+ YL        +H D+   N L
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCL 190
Query: 240 LDHNFQPKISDFGLAK 255
           +      KI DFG+++
Sbjct: 191 VGQGLVVKIGDFGMSR 206

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIYEFMPNGS 184
             N++AVK +++     Q F+ E + + ++ H ++V+LLG    E     ++ E+M  GS
Sbjct: 43  RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L  ++ S+  S     L  + L K +  V   +EYL +G N   +H D+   N+L+  + 
Sbjct: 102 LVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGNN--FVHRDLAARNVLVSEDN 154
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEM 294
             K+SDFGL K  S      ++   +    + APE          S  + +G++L E+
Sbjct: 155 VAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLL 104
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 156 VKITDFGLAKLLGAE 170

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 104
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 156 VKITDFGLAKLLGAE 170

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 89/176 (50%), Gaps = 17/176 (9%)
Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            ++AVK ++    + + F+ E   +  + H  +V+L    ++     +I EFM  GSL  
Sbjct: 213 TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD 271
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  K++  S + L   KL   +  +A G+ ++ Q   +  +H D++  NIL+  +   K
Sbjct: 272 FL--KSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCK 324
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV 295
           I+DFGLA++  +D    +R  A+    + APE          S  + +G++L+E+V
Sbjct: 325 IADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 50  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 107
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 159 VKITDFGLAKLLGAE 173

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 54  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 111
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 163 VKITDFGLAKLLGAE 177

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 48  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 105
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 106 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 156
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 157 VKITDFGLAKLLGAE 171

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 49  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 106
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 158 VKITDFGLAKLLGAE 172

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 85/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  G L 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 51  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 108
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 109 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 159
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 160 VKITDFGLAKLLGAE 174

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 27/155 (17%)
Query: 138 LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL------QKFIFS 191
           LKG      NE+A + +I H +IV L       N   L+ + +  G L      + F   
Sbjct: 60  LKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE 119
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKI 248
           K  S+  RQ            V   V YLH+     I+H D+KP N+L    D   +  I
Sbjct: 120 KDASTLIRQ------------VLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMI 164
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           SDFGL+K+  K   +   + A GT GY+APE+ ++
Sbjct: 165 SDFGLSKMEGKGDVM---STACGTPGYVAPEVLAQ 196

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+  + ++ H ++V LL  C +  R  L++EF+ +  L               L ++ 
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG------LDYQV 125
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           ++K  F +  G+ + H   +  I+H DIKP NIL+  +   K+ DFG A+  +    +  
Sbjct: 126 VQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
              A  T  Y APEL   +  YG  + +  +GC
Sbjct: 183 DEVA--TRWYRAPELLVGDVKYGKAVDVWAIGC 213

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 156 VKITDFGLAKLLGAE 170

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 11/119 (9%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS-KTNSSSHRQL 201
           +E ++E   +  + + H+ RLLG C     + LI + MP G L  ++   K N  S   L
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           +W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +
Sbjct: 121 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  +HH +IV L+         TL++EFM           K    +   L   +
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQ 120
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           ++   + + RGV + HQ    RILH D+KP N+L++ +   K++DFGLA+     I + S
Sbjct: 121 IKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRS 175
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T    T  Y AP++   +  Y   + +  +GC
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 11/119 (9%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS-KTNSSSHRQL 201
           +E ++E   +  + + H+ RLLG C     + LI + MP G L  ++   K N  S   L
Sbjct: 96  KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL 154
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           +W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +
Sbjct: 155 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 156 VKITDFGLAKLLGAE 170

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 21/177 (11%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           + +K++E   G    Q   + +  IG + H HIVRLLG C  G+   L+ +++P GSL  
Sbjct: 63  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 121
Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            +        HR  L  + L      +A+G+ YL +     ++H ++   N+LL    Q 
Sbjct: 122 HV------RQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQV 172
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV 295
           +++DFG+A L   D   +  + A+    ++A E          S  + YG+ + E++
Sbjct: 173 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 41  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 98
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 99  DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 149
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 150 VKITDFGLAKLLGAE 164

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 124 FLHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
            L   E+A+K+++  + N    Q+   EV  +  ++H +IV+L           LI E+ 
Sbjct: 37  ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G +  ++ +      H ++  ++ R     +   V+Y HQ   +RI+H D+K  N+LL
Sbjct: 97  SGGEVFDYLVA------HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLL 147
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
           D +   KI+DFG     S + ++  +  A  G   Y APELF 
Sbjct: 148 DADMNIKIADFGF----SNEFTVGGKLDAFCGAPPYAAPELFQ 186

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  +HH +IV L+         TL++EFM           K    +   L   +
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQ 120
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           ++   + + RGV + HQ    RILH D+KP N+L++ +   K++DFGLA+     I + S
Sbjct: 121 IKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRS 175
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T    T  Y AP++   +  Y   + +  +GC
Sbjct: 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC 208

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 49  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 106
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 158 VKITDFGLAKLLGAE 172

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 85/177 (48%), Gaps = 17/177 (9%)
Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  G L 
Sbjct: 42  TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLL 100
Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+         + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   
Sbjct: 101 DFL----KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVC 153
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE--LFSR------NFCYGMMLLEMV 295
           K++DFGLA+L  +D    +R  A+    + APE  L+ R       + +G++L E+ 
Sbjct: 154 KVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 209

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 50  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 107
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 159 VKITDFGLAKLLGAE 173

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 72  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 129
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 180
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 181 VKITDFGLAKLLGAE 195

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 50  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 107
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 159 VKITDFGLAKLLGAE 173

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 54  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 111
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 163 VKITDFGLAKLLGAE 177

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 54  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 111
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 163 VKITDFGLAKLLGAE 177

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 57  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 114
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 115 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 165
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 166 VKITDFGLAKLLGAE 180

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 50  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 107
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 108 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 158
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 159 VKITDFGLAKLLGAE 173

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 16/168 (9%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           L  +++AVK+L   K    + +     E+  +    H HI++L    S      ++ E++
Sbjct: 34  LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L  +I        H ++   + R++   +   V+Y H+     ++H D+KP N+LL
Sbjct: 94  SGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLL 144
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
           D +   KI+DFGL+ + S    +  RT+  G+  Y APE+ S     G
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFL--RTSC-GSPNYAAPEVISGRLYAG 189

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 53  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 110
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 111 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 161
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 162 VKITDFGLAKLLGAE 176

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLSFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 175

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 21/177 (11%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           + +K++E   G    Q   + +  IG + H HIVRLLG C  G+   L+ +++P GSL  
Sbjct: 45  VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 103
Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            +        HR  L  + L      +A+G+ YL +     ++H ++   N+LL    Q 
Sbjct: 104 HV------RQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQV 154
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMV 295
           +++DFG+A L   D   +  + A+    ++A E          S  + YG+ + E++
Sbjct: 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 93
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 94  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 148
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 149 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 176

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 175

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 92  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 174

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 19/160 (11%)
Query: 146 INEVATIGRIH---HFHIVRLLGFCSEGN-----RRTLIYEFMPNGSLQKFIFSKTNSSS 197
           + EVA + R+    H ++VRL+  C+        + TL++E + +  L+ ++    + + 
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAP 113
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
              L  E ++ +     RG+++LH  C   I+H D+KP NIL+      K++DFGLA++ 
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 258 SKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           S  +++   T    T  Y APE+  ++     + +  VGC
Sbjct: 171 SYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 207

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 24/170 (14%)
Query: 141 NGQE-----FINEVATIGRIH---HFHIVRLLGFCSEGN-----RRTLIYEFMPNGSLQK 187
           NG+E      + EVA + R+    H ++VRL+  C+        + TL++E + +  L+ 
Sbjct: 41  NGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRT 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++    + +    L  E ++ +     RG+++LH  C   I+H D+KP NIL+      K
Sbjct: 100 YL----DKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 152
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           ++DFGLA++ S  +++        T  Y APE+  ++     + +  VGC
Sbjct: 153 LADFGLARIYSYQMALAPVVV---TLWYRAPEVLLQSTYATPVDMWSVGC 199

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 175

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 175

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 43  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 99
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 100 --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 154
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 155 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 182

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 92  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 174

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 92  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 174

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 136 EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS 195
           E   G  +  + E+  +  + H +I+ LL      +  +L+++FM    L+  I  K NS
Sbjct: 50  EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVII--KDNS 106
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
                L+   ++       +G+EYLHQ     ILH D+KP+N+LLD N   K++DFGLAK
Sbjct: 107 LV---LTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160
Query: 256 -LCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
              S + +   +   R    Y APEL      YG+ + +  VGC
Sbjct: 161 SFGSPNRAYXHQVVTR---WYRAPELLFGARMYGVGVDMWAVGC 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 40  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 96
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 97  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 151
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 152 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 179

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 43  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 99
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 100 --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 154
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 155 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 182

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ S   +  ++ ++    S
Sbjct: 47  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSS 105
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   + +     S  +   +KL  IA   ARG++YLH    + I+H D+K +NI L  + 
Sbjct: 106 LYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDN 157
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA   S+           G+  ++APE+            S  + +G++L E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 294 MV 295
           ++
Sbjct: 218 LM 219

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 34  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 94  L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 145
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK 299
           SDFGL++    D    S   ++    +  PE+         S  + +G+++ E+    K
Sbjct: 146 SDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 203

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 79  FPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHL 138
           F   GD  V    YL     I D+ E      SL  ++ TN          +AVK L+  
Sbjct: 19  FQGPGDPTVFHKRYLKK---IRDLGEGHFGKVSLYCYDPTNDGT----GEMVAVKALKAD 71
Query: 139 KGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTN 194
            G      +  E+  +  ++H HI++  G C +    +L  + E++P GSL+ ++     
Sbjct: 72  AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----- 126
Query: 195 SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 254
                 +   +L   A  +  G+ YLH    Q  +H D+   N+LLD++   KI DFGLA
Sbjct: 127 --PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 255 K 255
           K
Sbjct: 182 K 182

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 80/150 (53%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 148 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 175

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 18/126 (14%)
Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           EF   G+L+++I  +      + L+ E   +I     +GV+Y+H   +++++H D+KP N
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLIHRDLKPSN 166
Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGM 289
           I L    Q KI DFGL      D     RT ++GT  Y++PE  S          +  G+
Sbjct: 167 IFLVDTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 223
Query: 290 MLLEMV 295
           +L E++
Sbjct: 224 ILAELL 229

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 44  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 101
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A G+ YL    ++R++H D+   N+L+     
Sbjct: 102 DYVREHKDNIGSQYLLNW------CVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQH 152
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLAKL   +
Sbjct: 153 VKITDFGLAKLLGAE 167

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 30  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 90  L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 141
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK 299
           SDFGL++    D    S   ++    +  PE+         S  + +G+++ E+    K
Sbjct: 142 SDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 46/207 (22%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLI-------- 176
           L S   A+K + H +      ++EV  +  ++H ++VR      E  RR  +        
Sbjct: 29  LDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE--RRNFVKPMTAVKK 86
Query: 177 -------YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
                   E+  N +L   I S+ N +  R   W   R+I       + Y+H   +Q I+
Sbjct: 87  KSTLFIQMEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQIL----EALSYIH---SQGII 138
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV------------SRTAARGTSGYIA 277
           H D+KP NI +D +   KI DFGLAK   + + I+            + T+A GT+ Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 278 PELFSRN---------FCYGMMLLEMV 295
            E+             +  G++  EM+
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 35  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 95  L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 146
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK 299
           SDFGL++    D    S   ++    +  PE+         S  + +G+++ E+    K
Sbjct: 147 SDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 47  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 105
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   + +     S  +   +KL  IA   ARG++YLH    + I+H D+K +NI L  + 
Sbjct: 106 LYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDN 157
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA   S+           G+  ++APE+            S  + +G++L E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 294 MV 295
           ++
Sbjct: 218 LM 219

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 41  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 101 L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 152
Query: 249 SDFGLAKLCSKD 260
           SDFGL++    D
Sbjct: 153 SDFGLSRYVLDD 164

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 24/170 (14%)
Query: 141 NGQE-----FINEVATIGRIH---HFHIVRLLGFCSEGN-----RRTLIYEFMPNGSLQK 187
           NG+E      + EVA + R+    H ++VRL+  C+        + TL++E + +  L+ 
Sbjct: 41  NGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRT 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++    + +    L  E ++ +     RG+++LH  C   I+H D+KP NIL+      K
Sbjct: 100 YL----DKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 152
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           ++DFGLA++ S  +++        T  Y APE+  ++     + +  VGC
Sbjct: 153 LADFGLARIYSYQMALFPVVV---TLWYRAPEVLLQSTYATPVDMWSVGC 199

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 50  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 110 L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 161
Query: 249 SDFGLAKLCSKD 260
           SDFGL++    D
Sbjct: 162 SDFGLSRYVLDD 173

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 50  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +        HR    ++L ++   V   +EYL    +++ LH D+   N L++     K+
Sbjct: 110 L----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKV 161
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK 299
           SDFGL++    D    S   ++    +  PE+         S  + +G+++ E+    K
Sbjct: 162 SDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 129 EIAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           E+A+KM++    +  G  Q   NEV    ++ H  I+ L  +  + N   L+ E   NG 
Sbjct: 38  EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGE 97
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           + +++ ++      +  S  + R     +  G+ YLH   +  ILH D+   N+LL  N 
Sbjct: 98  MNRYLKNRV-----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNM 149
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
             KI+DFGLA      +         GT  YI+PE+ +R+
Sbjct: 150 NIKIADFGLA--TQLKMPHEKHYTLCGTPNYISPEIATRS 187

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           L  +++AVK+L   K    + +     E+  +    H HI++L    S      ++ E++
Sbjct: 34  LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L  +I        H ++   + R++   +   V+Y H+     ++H D+KP N+LL
Sbjct: 94  SGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLL 144
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
           D +   KI+DFGL+ + S D   +  +   G+  Y APE+ S     G
Sbjct: 145 DAHMNAKIADFGLSNMMS-DGEFLRDSC--GSPNYAAPEVISGRLYAG 189

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 85/170 (50%), Gaps = 24/170 (14%)
Query: 141 NGQE-----FINEVATIGRIH---HFHIVRLLGFCSEGN-----RRTLIYEFMPNGSLQK 187
           NG+E      + EVA + R+    H ++VRL+  C+        + TL++E + +  L+ 
Sbjct: 41  NGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRT 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++    + +    L  E ++ +     RG+++LH  C   I+H D+KP NIL+      K
Sbjct: 100 YL----DKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 152
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGC 297
           ++DFGLA++ S  +++        T  Y APE+  ++     + +  VGC
Sbjct: 153 LADFGLARIYSYQMALDPVVV---TLWYRAPEVLLQSTYATPVDMWSVGC 199

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 124 FLHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
            L   E+A+K+++  + N    Q+   EV  +  ++H +IV+L           LI E+ 
Sbjct: 34  ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 93
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G +  ++ +      H ++  ++ R     +   V+Y HQ   +RI+H D+K  N+LL
Sbjct: 94  SGGEVFDYLVA------HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLL 144
Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
           D +   KI+DFG     S + ++  +     G+  Y APELF 
Sbjct: 145 DADMNIKIADFGF----SNEFTVGGKLDTFCGSPPYAAPELFQ 183

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 13/117 (11%)
Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           ++ + I + M  G L   +      S H   S   +R  A  +  G+E++H   N+ +++
Sbjct: 265 DKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMH---NRFVVY 315
Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
            D+KP NILLD +   +ISD GLA  C  D S     A+ GT GY+APE+  +   Y
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 13/117 (11%)
Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           ++ + I + M  G L   +      S H   S   +R  A  +  G+E++H   N+ +++
Sbjct: 265 DKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMH---NRFVVY 315
Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
            D+KP NILLD +   +ISD GLA  C  D S     A+ GT GY+APE+  +   Y
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 14/176 (7%)
Query: 125 LHSNEIAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           L  N +A+K   LEH +G     I EV+ +  + H +IV L          TL++E++ +
Sbjct: 25  LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-D 83
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
             L++++    N      ++   ++   F + RG+ Y H+   Q++LH D+KP N+L++ 
Sbjct: 84  KDLKQYLDDCGNI-----INMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINE 135
Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
             + K++DFGLA+  +K I   +      T  Y  P++   +  Y   + +  VGC
Sbjct: 136 RGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC 189

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 13/117 (11%)
Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           ++ + I + M  G L   +      S H   S   +R  A  +  G+E++H   N+ +++
Sbjct: 265 DKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMH---NRFVVY 315
Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
            D+KP NILLD +   +ISD GLA  C  D S     A+ GT GY+APE+  +   Y
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 13/117 (11%)
Query: 171 NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           ++ + I + M  G L   +      S H   S   +R  A  +  G+E++H   N+ +++
Sbjct: 264 DKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMH---NRFVVY 314
Query: 231 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
            D+KP NILLD +   +ISD GLA  C  D S     A+ GT GY+APE+  +   Y
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTHGYMAPEVLQKGVAY 367

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR 113
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL  N + KI+DFG     S 
Sbjct: 114 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSV 160
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 161 HAPSSRRTTLCGTLDYLPPEM 181

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG +  C  
Sbjct: 111 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHA 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
             S   RT   GT  Y+ PE+
Sbjct: 160 PSS--RRTTLSGTLDYLPPEM 178

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 95
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 96  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 151 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 94
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 95  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 149
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 150 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 177

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 51  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 108
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 109 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 159
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFG AKL   +
Sbjct: 160 VKITDFGRAKLLGAE 174

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 148 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 175

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 121 KFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           K   L  +E   +M+E      QEF  EV  +  ++H +IV+L G     N   ++ EF+
Sbjct: 50  KSLILGDSEGETEMIEKF----QEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL- 239
           P G L   +  K +      + W    ++   +A G+EY+ Q  N  I+H D++  NI  
Sbjct: 104 PCGDLYHRLLDKAHP-----IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFL 157
Query: 240 --LDHNFQ--PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
             LD N     K++DFGL++      S+ S +   G   ++APE
Sbjct: 158 QSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPE 196

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 148 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 175

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 148 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 175

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 92  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 147 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 174

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 148 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 175

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 49  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 106
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFG AKL   +
Sbjct: 158 VKITDFGRAKLLGAE 172

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 49  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLL 106
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFG AKL   +
Sbjct: 158 VKITDFGRAKLLGAE 172

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 92  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 147 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 174

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 93
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 94  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 148
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 149 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 176

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 94
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 95  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 149
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 150 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 177

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 95
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 96  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 151 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 178

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 47  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 104
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 105 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFG AKL   +
Sbjct: 156 VKITDFGRAKLLGAE 170

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 40  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 96
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 97  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 151
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 152 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 179

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 27/176 (15%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           EI V++ +    N +  +  + T     H  I+R+ G   +  +  +I +++  G L   
Sbjct: 42  EIVVRLKQVEHTNDERLMLSIVT-----HPFIIRMWGTFQDAQQIFMIMDYIEGGEL--- 93
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
            FS    S        K    A  V   +EYLH   ++ I++ D+KP NILLD N   KI
Sbjct: 94  -FSLLRKSQRFPNPVAKF--YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 147
Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
           +DFG AK    D++        GT  YIAPE+ S          + +G+++ EM+ 
Sbjct: 148 TDFGFAKYVP-DVTY----XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 93
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 94  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 148
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 149 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 176

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 94
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 95  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 149
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 150 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 177

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 54  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 111
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 112 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 162
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFG AKL   +
Sbjct: 163 VKITDFGRAKLLGAE 177

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-- 95
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 96  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 150
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 151 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 178

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 13/142 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G + K +   +     R
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQR 114
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 115 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 161
Query: 260 DISIVSRTAARGTSGYIAPELF 281
                 RT   GT  Y+ PE+ 
Sbjct: 162 HAPSSRRTTLCGTLDYLPPEMI 183

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K L      K N +E ++E   +  + + H+ RLLG C     + LI + MP G L 
Sbjct: 49  VAIKELREATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLL 106
Query: 187 KFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            ++   K N  S   L+W         +A+G+ YL    ++R++H D+   N+L+     
Sbjct: 107 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 157
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFG AKL   +
Sbjct: 158 VKITDFGRAKLLGAE 172

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 87/186 (46%), Gaps = 34/186 (18%)
Query: 134 MLEHLKGNGQEFINEVATIGRIHHFHIVRLLG----------FCSEGNRRT------LIY 177
           +++ +K N ++   EV  + ++ H +IV   G            S+ + R+      +  
Sbjct: 40  VIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99
Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           EF   G+L+++I  +      + L+ E   +I     +GV+Y+H   ++++++ D+KP N
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLINRDLKPSN 152
Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGM 289
           I L    Q KI DFGL      D     R  ++GT  Y++PE  S          +  G+
Sbjct: 153 IFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209
Query: 290 MLLEMV 295
           +L E++
Sbjct: 210 ILAELL 215

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 59/271 (21%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLI-------- 176
           L S   A+K + H +      ++EV  +  ++H ++VR      E  RR  +        
Sbjct: 29  LDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE--RRNFVKPXTAVKK 86
Query: 177 -------YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL 229
                   E+  N +L   I S+ N +  R   W   R+I       + Y+H   +Q I+
Sbjct: 87  KSTLFIQXEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQIL----EALSYIH---SQGII 138
Query: 230 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV------------SRTAARGTSGYIA 277
           H ++KP NI +D +   KI DFGLAK   + + I+            + T+A GT+ Y+A
Sbjct: 139 HRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVA 198
Query: 278 PELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY---------NRMRLGQELC 328
            E+               G    N+        I F E IY         N ++  + + 
Sbjct: 199 TEVLD-------------GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVS 245
Query: 329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
           ++F  D D+   +    +    I  +P +RP
Sbjct: 246 IEFPPDFDDNKXKVEKKIIRLLIDHDPNKRP 276

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-- 93
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 94  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 148
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 149 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 176

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+KF+  
Sbjct: 37  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-- 93
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 94  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 148
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 149 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 176

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 67/124 (54%), Gaps = 9/124 (7%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           V++ +  +G     + E+  +  + H +IVRL        + TL++EF  +  L+K+   
Sbjct: 35  VRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
               S +  L  E ++   F + +G+ + H   ++ +LH D+KP N+L++ N + K++DF
Sbjct: 92  ---DSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLADF 145
Query: 252 GLAK 255
           GLA+
Sbjct: 146 GLAR 149

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 13/141 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E++ +  + H HI++L       +   ++ E+  N  L  +I  +       ++S ++ R
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRD------KMSEQEAR 116
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           +    +   VEY H+    +I+H D+KP N+LLD +   KI+DFGL+ + + D + +  +
Sbjct: 117 RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS 172
Query: 268 AARGTSGYIAPELFSRNFCYG 288
              G+  Y APE+ S     G
Sbjct: 173 C--GSPNYAAPEVISGKLYAG 191

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 13/141 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E++ +  + H HI++L       +   ++ E+  N  L  +I  +       ++S ++ R
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRD------KMSEQEAR 115
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           +    +   VEY H+    +I+H D+KP N+LLD +   KI+DFGL+ + + D + +  +
Sbjct: 116 RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS 171
Query: 268 AARGTSGYIAPELFSRNFCYG 288
              G+  Y APE+ S     G
Sbjct: 172 C--GSPNYAAPEVISGKLYAG 190

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/67 (43%), Positives = 41/67 (61%), Gaps = 6/67 (8%)
Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
            ++YL    NQRI+H D+KP NILLD +    I+DF +A +  ++  I   T   GT  Y
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPY 180
Query: 276 IAPELFS 282
           +APE+FS
Sbjct: 181 MAPEMFS 187

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 13/141 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E++ +  + H HI++L       +   ++ E+  N  L  +I  +       ++S ++ R
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRD------KMSEQEAR 110
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           +    +   VEY H+    +I+H D+KP N+LLD +   KI+DFGL+ + + D + +  +
Sbjct: 111 RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS 166
Query: 268 AARGTSGYIAPELFSRNFCYG 288
              G+  Y APE+ S     G
Sbjct: 167 C--GSPNYAAPEVISGKLYAG 185

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 71/141 (50%), Gaps = 13/141 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E++ +  + H HI++L       +   ++ E+  N  L  +I  +       ++S ++ R
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRD------KMSEQEAR 106
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           +    +   VEY H+    +I+H D+KP N+LLD +   KI+DFGL+ + + D + +  +
Sbjct: 107 RFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS 162
Query: 268 AARGTSGYIAPELFSRNFCYG 288
              G+  Y APE+ S     G
Sbjct: 163 C--GSPNYAAPEVISGKLYAG 181

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E++ +  + H HI++L    +      ++ E+   G L  +I  K      ++++ ++ R
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK------KRMTEDEGR 111
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           +    +   +EY H+    +I+H D+KP N+LLD N   KI+DFGL+ + + D + +  +
Sbjct: 112 RFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS 167
Query: 268 AARGTSGYIAPELFSRNFCYG 288
              G+  Y APE+ +     G
Sbjct: 168 C--GSPNYAAPEVINGKLYAG 186

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AVK+++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H ++  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 97  GGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++  A  G   Y APELF 
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDAFCGAPPYAAPELFQ 185

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 63/141 (44%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G + K +   +     R
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQR 114
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 115 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 161
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 162 HAPSSRRXXLXGTLDYLPPEM 182

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 26/146 (17%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL-----QKFIFSKTNSSSHRQL 201
           NE+A + +I H +IV L           L+ + +  G L     ++ ++++ ++S   Q 
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ- 113
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS 258
                      V   V+YLH+     I+H D+KP N+L    + N +  I+DFGL+K+  
Sbjct: 114 ----------QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160
Query: 259 KDISIVSRTAARGTSGYIAPELFSRN 284
             I     + A GT GY+APE+ ++ 
Sbjct: 161 NGI----MSTACGTPGYVAPEVLAQK 182

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 22/180 (12%)
Query: 80  PSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLK 139
           P+S     HK  YL     I D+ E      SL  ++ TN          +AVK L+   
Sbjct: 4   PASDPTVFHK-RYLKK---IRDLGEGHFGKVSLYCYDPTNDGT----GEMVAVKALKADC 55
Query: 140 GNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNS 195
           G      +  E+  +  ++H HI++  G C +   ++L  + E++P GSL+ ++      
Sbjct: 56  GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL------ 109
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
                +   +L   A  +  G+ YLH   +Q  +H ++   N+LLD++   KI DFGLAK
Sbjct: 110 -PRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 113 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 160 HAPSSRRTTLCGTLDYLPPEM 180

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q  + E   + ++H   IV L           L+   M  G ++  I++    +      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP----G 285
Query: 203 WEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           +++ R I +   +  G+E+LHQ   + I++ D+KP N+LLD +   +ISD GLA      
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 261 ISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGCR 298
            +     A  GT G++APEL       FS + F  G+ L EM+  R
Sbjct: 343 QTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q  + E   + ++H   IV L           L+   M  G ++  I++    +      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP----G 285
Query: 203 WEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           +++ R I +   +  G+E+LHQ   + I++ D+KP N+LLD +   +ISD GLA      
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 261 ISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGCR 298
            +     A  GT G++APEL       FS + F  G+ L EM+  R
Sbjct: 343 QTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 95  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 49  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 108
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 109 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 155
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 156 HAPSSRRTTLCGTLDYLPPEM 176

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQR 113
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL  N + KI+DFG     S 
Sbjct: 114 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG----WSV 160
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 161 HAPSSRRDTLCGTLDYLPPEM 181

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q  + E   + ++H   IV L           L+   M  G ++  I++    +      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP----G 285
Query: 203 WEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           +++ R I +   +  G+E+LHQ   + I++ D+KP N+LLD +   +ISD GLA      
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 261 ISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGCR 298
            +     A  GT G++APEL       FS + F  G+ L EM+  R
Sbjct: 343 QTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 113 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 160 HAPSSRRTTLCGTLDYLPPEM 180

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q  + E   + ++H   IV L           L+   M  G ++  I++    +      
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP----G 285
Query: 203 WEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           +++ R I +   +  G+E+LHQ   + I++ D+KP N+LLD +   +ISD GLA      
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342
Query: 261 ISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGCR 298
            +     A  GT G++APEL       FS + F  G+ L EM+  R
Sbjct: 343 QTKTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 121 KFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           K   L  +E   +M+E      QEF  EV  +  ++H +IV+L G     N   ++ EF+
Sbjct: 50  KSLILGDSEGETEMIEKF----QEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL- 239
           P G L   +  K +      + W    ++   +A G+EY+ Q  N  I+H D++  NI  
Sbjct: 104 PCGDLYHRLLDKAHP-----IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFL 157
Query: 240 --LDHNFQ--PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
             LD N     K++DFG ++      S+ S +   G   ++APE
Sbjct: 158 QSLDENAPVCAKVADFGTSQQ-----SVHSVSGLLGNFQWMAPE 196

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AVK+++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 38  LTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYAS 97
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H ++  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 98  GGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---KYIVHRDLKAENLLLD 148
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + ++ ++     G+  Y APELF 
Sbjct: 149 GDMNIKIADFGF----SNEFTVGNKLDTFCGSPPYAAPELFQ 186

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 13/142 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 114
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 115 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 161
Query: 260 DISIVSRTAARGTSGYIAPELF 281
                 RT   GT  Y+ PE+ 
Sbjct: 162 HAPSSRRTTLCGTLDYLPPEMI 183

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 157 HAPSSRRTTLCGTLDYLPPEM 177

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +A+K +  ++ + QE I E++ + +    H+V+  G   +     ++ E+   GS+   I
Sbjct: 57  VAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII 115
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
             +     ++ L+ +++  I     +G+EYLH     R +H DIK  NILL+     K++
Sbjct: 116 RLR-----NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLA 167
Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           DFG+A   +  ++   R    GT  ++APE+ 
Sbjct: 168 DFGVAGQLTDXMA--KRNXVIGTPFWMAPEVI 197

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 13/142 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 135
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 136 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 182
Query: 260 DISIVSRTAARGTSGYIAPELF 281
                 RT   GT  Y+ PE+ 
Sbjct: 183 HAPSSRRTTLCGTLDYLPPEMI 204

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 13/142 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 67  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 126
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 127 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 173
Query: 260 DISIVSRTAARGTSGYIAPELF 281
                 RT   GT  Y+ PE+ 
Sbjct: 174 HAPSSRRTTLCGTLDYLPPEMI 195

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+ F+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-- 95
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 96  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 151 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 178

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R A  GT  Y+ PE+
Sbjct: 157 HAPSSRRAALCGTLDYLPPEM 177

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 47  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 106
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 107 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 153
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 154 HAPSSRRTTLCGTLDYLPPEM 174

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 13/169 (7%)
Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            ++AVK ++    + + F+ E   +  + H  +V+L    ++     +I EFM  GSL  
Sbjct: 207 TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD 265
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  K++  S + L   KL   +  +A G+ ++ Q   +  +H D++  NIL+  +   K
Sbjct: 266 FL--KSDEGSKQPLP--KLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCK 318
Query: 248 ISDFGLAKLCSK-DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMV 295
           I+DFGLA++ +K  I   +  A    S  I  +++S    +G++L+E+V
Sbjct: 319 IADFGLARVGAKFPIKWTAPEAINFGSFTIKSDVWS----FGILLMEIV 363

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+ F+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-- 95
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 96  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 151 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 178

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+ F+  
Sbjct: 36  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-- 92
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 93  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADF 147
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 148 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 175

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 80  PSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLK 139
           P+S     HK  YL     I D+ E      SL  ++ TN          +AVK L+   
Sbjct: 4   PASDPTVFHK-RYLKK---IRDLGEGHFGKVSLYCYDPTNDGT----GEMVAVKALKADC 55
Query: 140 GNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNS 195
           G      +  E+  +  ++H HI++  G C +   ++L  + E++P GSL+ ++      
Sbjct: 56  GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL------ 109
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
                +   +L   A  +  G+ YLH    Q  +H ++   N+LLD++   KI DFGLAK
Sbjct: 110 -PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 113
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 114 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 160
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 161 HAPSSRRTTLCGTLDYLPPEM 181

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 157 HAPSSRRTELCGTLDYLPPEM 177

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 113 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R A  GT  Y+ PE+
Sbjct: 160 HAPSSRRAALCGTLDYLPPEM 180

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 157 HAPSSRRTDLCGTLDYLPPEM 177

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 157 HAPSSRRTXLCGTLDYLPPEM 177

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++EF+ +  L+ F+  
Sbjct: 38  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-- 94
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 95  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 149
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 150 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 177

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AVK+++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H ++  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 97  GGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++     G+  Y APELF 
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQ 185

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AVK+++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H ++  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 97  GGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++     G+  Y APELF 
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQ 185

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 95  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 157 HAPSSRRTDLCGTLDYLPPEM 177

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 111 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 157
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 158 HAPSSRRTDLCGTLDYLPPEM 178

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ S   +  ++ ++    S
Sbjct: 31  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSS 89
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 90  LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 141
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 294 MV 295
           ++
Sbjct: 202 LM 203

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 121 KFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           K   L  +E   +M+E      QEF  EV  +  ++H +IV+L G     N   ++ EF+
Sbjct: 50  KSLILGDSEGETEMIEKF----QEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL- 239
           P G L   +  K +      + W    ++   +A G+EY+ Q  N  I+H D++  NI  
Sbjct: 104 PCGDLYHRLLDKAHP-----IKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFL 157
Query: 240 --LDHNFQ--PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
             LD N     K++DF L++      S+ S +   G   ++APE
Sbjct: 158 QSLDENAPVCAKVADFSLSQQ-----SVHSVSGLLGNFQWMAPE 196

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 125 LHSNEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           +   E AVK++       ++    + EV  + ++ H +I++L     + +   ++ E   
Sbjct: 45  ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G L   I  +   S H         +I   V  G+ Y+H+     I+H D+KP NILL+
Sbjct: 105 GGELFDEIIKRKRFSEHDAA------RIIKQVFSGITYMHK---HNIVHRDLKPENILLE 155
Query: 242 HNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
              +    KI DFGL+    ++  +  R    GT+ YIAPE+    +
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTY 199

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 75/253 (29%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 186 QKFIFS--------KTNSSSHRQ------------------------------------- 200
             ++ S        KT  +  RQ                                     
Sbjct: 120 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 179
Query: 201 ---------------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                          L+ E L   +F VA+G+E+L    +++ +H D+   NILL     
Sbjct: 180 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 236
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGC 297
            KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L E+   
Sbjct: 237 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 296
Query: 298 RKNNDPAVEIQSQ 310
             +  P V+I  +
Sbjct: 297 GASPYPGVKIDEE 309

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 75/253 (29%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 55  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
Query: 186 QKFIFS--------KTNSSSHRQ------------------------------------- 200
             ++ S        KT  +  RQ                                     
Sbjct: 115 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
Query: 201 ---------------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                          L+ E L   +F VA+G+E+L    +++ +H D+   NILL     
Sbjct: 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 231
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGC 297
            KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L E+   
Sbjct: 232 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291
Query: 298 RKNNDPAVEIQSQ 310
             +  P V+I  +
Sbjct: 292 GASPYPGVKIDEE 304

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 75/253 (29%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 186 QKFIFS--------KTNSSSHRQ------------------------------------- 200
             ++ S        KT  +  RQ                                     
Sbjct: 122 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 181
Query: 201 ---------------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                          L+ E L   +F VA+G+E+L    +++ +H D+   NILL     
Sbjct: 182 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 238
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGC 297
            KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L E+   
Sbjct: 239 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 298
Query: 298 RKNNDPAVEIQSQ 310
             +  P V+I  +
Sbjct: 299 GASPYPGVKIDEE 311

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 125 LHSNEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           +   E AVK++       ++    + EV  + ++ H +I++L     + +   ++ E   
Sbjct: 45  ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G L   I  +   S H         +I   V  G+ Y+H+     I+H D+KP NILL+
Sbjct: 105 GGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLE 155
Query: 242 HNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
              +    KI DFGL+    ++  +  R    GT+ YIAPE+ 
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPEVL 195

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 75/253 (29%)
Query: 130 IAVKMLEHLKGNGQE--FINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGSL 185
           +AVKML+    + +    ++E+  +  I HH ++V LLG C++ G    +I EF   G+L
Sbjct: 53  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 112
Query: 186 QKFIFS--------KTNSSSHRQ------------------------------------- 200
             ++ S        KT  +  RQ                                     
Sbjct: 113 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 172
Query: 201 ---------------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                          L+ E L   +F VA+G+E+L    +++ +H D+   NILL     
Sbjct: 173 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNV 229
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGC 297
            KI DFGLA+   KD   V +  AR    ++APE +F R +        +G++L E+   
Sbjct: 230 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 289
Query: 298 RKNNDPAVEIQSQ 310
             +  P V+I  +
Sbjct: 290 GASPYPGVKIDEE 302

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 99  ITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQE----FINEVATIGR 154
           I D+ E      SL  ++ TN          +AVK L+  +G G +    +  E+  +  
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGT----GEMVAVKALK--EGCGPQLRSGWQREIEILRT 67
Query: 155 IHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFG 212
           ++H HIV+  G C +   ++  L+ E++P GSL+ ++           +   +L   A  
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-------PRHCVGLAQLLLFAQQ 120
Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +  G+ YLH    Q  +H  +   N+LLD++   KI DFGLAK   +      R    G 
Sbjct: 121 ICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGD 176
Query: 273 SG--YIAPELF--------SRNFCYGMMLLEMVG-CRKNNDP 303
           S   + APE          S  + +G+ L E++  C  N  P
Sbjct: 177 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 125 LHSNEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           +   E AVK++       ++    + EV  + ++ H +I++L     + +   ++ E   
Sbjct: 45  ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G L   I  +   S H         +I   V  G+ Y+H+     I+H D+KP NILL+
Sbjct: 105 GGELFDEIIKRKRFSEHDAA------RIIKQVFSGITYMHK---HNIVHRDLKPENILLE 155
Query: 242 HNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
              +    KI DFGL+    ++  +  R    GT+ YIAPE+    +
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGTY 199

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 99  ITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQE----FINEVATIGR 154
           I D+ E      SL  ++ TN          +AVK L+  +G G +    +  E+  +  
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGT----GEMVAVKALK--EGCGPQLRSGWQREIEILRT 66
Query: 155 IHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFG 212
           ++H HIV+  G C +   ++  L+ E++P GSL+ ++           +   +L   A  
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-------PRHCVGLAQLLLFAQQ 119
Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +  G+ YLH    Q  +H  +   N+LLD++   KI DFGLAK   +      R    G 
Sbjct: 120 ICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGD 175
Query: 273 SG--YIAPELF--------SRNFCYGMMLLEMVG-CRKNNDP 303
           S   + APE          S  + +G+ L E++  C  N  P
Sbjct: 176 SPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 217

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 114
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 115 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 161
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 162 HAPSSRRTDLCGTLDYLPPEM 182

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 36  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 94
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 95  LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 146
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 147 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 206
Query: 294 MV 295
           ++
Sbjct: 207 LM 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQ 200
           Q  ++EV  +  + H +IVR      +    TL  + E+   G L   I   T  +  RQ
Sbjct: 50  QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQ 106
Query: 201 -LSWEKLRKIAFGVARGVEYLHQGCN--QRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
            L  E + ++   +   ++  H+  +    +LH D+KP N+ LD     K+ DFGLA++ 
Sbjct: 107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 258 SKDISIVSRTAARGTSGYIAPELFSR 283
           + D S     A  GT  Y++PE  +R
Sbjct: 167 NHDTSFAK--AFVGTPYYMSPEQMNR 190

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 31  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 89
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 90  LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 141
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 294 MV 295
           ++
Sbjct: 202 LM 203

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 67/124 (54%), Gaps = 9/124 (7%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           V++ +  +G     + E+  +  + H +IVRL        + TL++EF  +  L+K+   
Sbjct: 35  VRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
               S +  L  E ++   F + +G+ + H   ++ +LH D+KP N+L++ N + K+++F
Sbjct: 92  ---DSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANF 145
Query: 252 GLAK 255
           GLA+
Sbjct: 146 GLAR 149

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 33  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 91
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 92  LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 143
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 144 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 203
Query: 294 MV 295
           ++
Sbjct: 204 LM 205

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 36  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 94
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 95  LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 146
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 147 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 206
Query: 294 MV 295
           ++
Sbjct: 207 LM 208

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 29/166 (17%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL--- 185
           E AVK+++  K +  E I  +   G+  H +I+ L     +G    ++ E M  G L   
Sbjct: 49  EFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106
Query: 186 ---QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LD 241
              QKF FS+  +S+           + F + + VEYLH    Q ++H D+KP NIL +D
Sbjct: 107 ILRQKF-FSEREASA-----------VLFTITKTVEYLHA---QGVVHRDLKPSNILYVD 151
Query: 242 HNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
            +  P   +I DFG AK    +  ++       T+ ++APE+  R 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLERQ 195

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++E + +  L+KF+  
Sbjct: 39  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-- 95
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 96  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 150
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     +          T  Y APE+ 
Sbjct: 151 GLARAFGVPVRTYXHEVV--TLWYRAPEIL 178

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 119 NSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE 178
           NSKF    + ++  K      G   +   EV     + H +I+RL G+  +  R  LI E
Sbjct: 31  NSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILE 88
Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
           + P G++ + +   +     R  ++         +A  + Y H   +++++H DIKP N+
Sbjct: 89  YAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---SKKVIHRDIKPENL 139
Query: 239 LLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           LL    + KI+DFG     S       R A  GT  Y+ PE+
Sbjct: 140 LLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 95  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 95  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 13/140 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 55  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 114
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 115 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 161
Query: 260 DISIVSRTAARGTSGYIAPE 279
                 RT   GT  Y+ PE
Sbjct: 162 HAPSSRRTTLCGTLDYLPPE 181

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 33  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 92
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 93  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 143
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 59  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 117
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 118 LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 169
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 170 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 229
Query: 294 MV 295
           ++
Sbjct: 230 LM 231

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 58  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 116
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 117 LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 168
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA + S+           G+  ++APE+            S  + +G++L E
Sbjct: 169 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 228
Query: 294 MV 295
           ++
Sbjct: 229 LM 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I                 ++    +  GV YLH G    I H DIKP N+LLD     K
Sbjct: 94  RIEPDIGMPE------PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AV++++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 37  LTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H ++  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 97  GGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++     G+  Y APELF 
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQ 185

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AVK+++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 30  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 89
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H  +  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 90  GGEVFDYLVA------HGWMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 140
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++     G+  Y APELF 
Sbjct: 141 ADMNIKIADFGF----SNEFTFGNKLDTFCGSPPYAAPELFQ 178

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I           +     ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 95  RIEPDIG------MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I           +     ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 95  RIEPDIG------MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I           +     ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 95  RIEPDIG------MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +++    +G     I E++ +  ++H +IV+LL      N+  L++E + +  L+ F+  
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-- 91
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF 251
             ++S+   +    ++   F + +G+ + H   + R+LH D+KP N+L++     K++DF
Sbjct: 92  --DASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 252 GLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           GLA+     + + + T    T  Y APE+ 
Sbjct: 147 GLARAFG--VPVRTYTHEVVTLWYRAPEIL 174

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 94  DSSITITDVNETACPFQSLISFNLT---NSKFFFLHSNEIAVKM--LEHLKGNGQEFINE 148
           DSS     +N      Q +I    T    + +      ++A+K   LE  + +  E + E
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63
Query: 149 VATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ--LSWEKL 206
           +  + + HH +IV         +   L+ + +  GS+   I        H+   L    +
Sbjct: 64  IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             I   V  G+EYLH+      +H D+K  NILL  +   +I+DFG++   +    I +R
Sbjct: 124 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI-TR 179
Query: 267 TAAR----GTSGYIAPELFSRNFCY 287
              R    GT  ++APE+  +   Y
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGY 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AV++++  + N    Q+   EV  +  ++H +IV+L           L+ E+  
Sbjct: 37  LTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H ++  ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 97  GGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++     G+  Y APELF 
Sbjct: 148 ADMNIKIADFGF----SNEFTFGNKLDEFCGSPPYAAPELFQ 185

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 34/179 (18%)
Query: 125 LHSNEIAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRLL----GFCSEGNRR-TLIY 177
           L    +AVK+      N Q FINE  +  +  + H +I R +       ++G     L+ 
Sbjct: 34  LDERPVAVKVFSF--ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91
Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH----QGCNQR--ILHF 231
           E+ PNGSL K++   T+        W    ++A  V RG+ YLH    +G + +  I H 
Sbjct: 92  EYYPNGSLXKYLSLHTSD-------WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144
Query: 232 DIKPHNILLDHNFQPKISDFGLA---------KLCSKDISIVSRTAARGTSGYIAPELF 281
           D+   N+L+ ++    ISDFGL+         +   +D + +S     GT  Y+APE+ 
Sbjct: 145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV---GTIRYMAPEVL 200

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +++ L           LI E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 258
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
             +   +     GT  ++APE+
Sbjct: 171 DGVEFKN---IFGTPEFVAPEI 189

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           E AVK+++  K +  E I  +   G+  H +I+ L     +G    L+ E M  G L   
Sbjct: 54  EYAVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LDHNFQP- 246
           I  +    S R+ S+     +   + + VEYLH   +Q ++H D+KP NIL +D +  P 
Sbjct: 112 IL-RQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPE 162
Query: 247 --KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
             +I DFG AK    +  ++       T+ ++APE+  R 
Sbjct: 163 CLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQ 200

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           +NE   + +++   +V L       +   L+   M  G L+  I+         Q  + +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG------QAGFPE 285
Query: 206 LRKI--AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
            R +  A  +  G+E LH+   +RI++ D+KP NILLD +   +ISD GLA    +  +I
Sbjct: 286 ARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342
Query: 264 VSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             R    GT GY+APE+            +  G +L EM+ 
Sbjct: 343 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           +NE   + +++   +V L       +   L+   M  G L+  I+         Q  + +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG------QAGFPE 285
Query: 206 LRKI--AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
            R +  A  +  G+E LH+   +RI++ D+KP NILLD +   +ISD GLA    +  +I
Sbjct: 286 ARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342
Query: 264 VSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             R    GT GY+APE+            +  G +L EM+ 
Sbjct: 343 KGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 52  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 111
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI++FG     S 
Sbjct: 112 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSV 158
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 159 HAPSSRRTTLCGTLDYLPPEM 179

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI++FG     S 
Sbjct: 113 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG----WSV 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 RT   GT  Y+ PE+
Sbjct: 160 HAPSSRRTTLCGTLDYLPPEM 180

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 93
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I           +     ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 94  RIEPDIG------MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 144
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 145 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +++ L           LI E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 258
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
             +   +     GT  ++APE+
Sbjct: 171 DGVEFKN---IFGTPEFVAPEI 189

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 111 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 157
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 158 HAPSSRRDTLCGTLDYLPPEM 178

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +AVK+++  +     +    E+     ++H ++V+  G   EGN + L  E+   G L  
Sbjct: 35  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFD 94
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I           +     ++    +  GV YLH      I H DIKP N+LLD     K
Sbjct: 95  RIEPDIG------MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLK 145
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           ISDFGLA +   +          GT  Y+APEL  R
Sbjct: 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +++ L           LI E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 258
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
             +   +     GT  ++APE+
Sbjct: 171 DGVEFKN---IFGTPEFVAPEI 189

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           E AVK+++  K +  E I  +   G+  H +I+ L     +G    L+ E M  G L   
Sbjct: 54  EYAVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LDHNFQP- 246
           I  +    S R+ S+     +   + + VEYLH   +Q ++H D+KP NIL +D +  P 
Sbjct: 112 IL-RQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPE 162
Query: 247 --KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
             +I DFG AK    +  ++       T+ ++APE+  R 
Sbjct: 163 CLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQ 200

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQ 200
           Q  ++EV  +  + H +IVR      +    TL  + E+   G L   I   T  +  RQ
Sbjct: 50  QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQ 106
Query: 201 -LSWEKLRKIAFGVARGVEYLHQGCN--QRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
            L  E + ++   +   ++  H+  +    +LH D+KP N+ LD     K+ DFGLA++ 
Sbjct: 107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 258 SKDISIVSRTAARGTSGYIAPELFSR 283
           + D S        GT  Y++PE  +R
Sbjct: 167 NHDTSFAKTFV--GTPYYMSPEQMNR 190

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +++ L           LI E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 258
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
             +   +     GT  ++APE+
Sbjct: 171 DGVEFKN---IFGTPEFVAPEI 189

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +++ L           LI E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 258
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
             +   +     GT  ++APE+
Sbjct: 171 DGVEFKN---IFGTPEFVAPEI 189

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 52  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 111
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 112 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 158
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 159 HAPSSRRXXLCGTLDYLPPEM 179

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 64/117 (54%), Gaps = 15/117 (12%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ 200
           + F+ E   +  ++H +++ L+G     EG    L+  +M +G L +FI S   + + + 
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKD 125
Query: 201 LSWEKLRKIAFG--VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           L       I+FG  VARG+EYL     Q+ +H D+   N +LD +F  K++DFGLA+
Sbjct: 126 L-------ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 113 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 160 HAPSSRRXXLCGTLDYLPPEM 180

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 109
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 110 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 156
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 157 HAPSSRRXXLCGTLDYLPPEM 177

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  + H +I+++     + +   ++ E    G L + I S    +  + LS   + 
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA--QARGKALSEGYVA 127
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISI 263
           ++   +   + Y H   +Q ++H D+KP NIL   +  P    KI DFGLA+L   D   
Sbjct: 128 ELMKQMMNALAYFH---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD--- 180
Query: 264 VSRTAARGTSGYIAPELFSRNFCY 287
              T A GT+ Y+APE+F R+  +
Sbjct: 181 EHSTNAAGTALYMAPEVFKRDVTF 204

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 16/144 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +I+ L           LI E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 258
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 259 KDISIVSRTAARGTSGYIAPELFS 282
             +   +     GT  ++APE+ +
Sbjct: 171 DGVEFKN---IFGTPEFVAPEIVN 191

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 31  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 89
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 90  LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 141
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA   S+           G+  ++APE+            S  + +G++L E
Sbjct: 142 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 294 MV 295
           ++
Sbjct: 202 LM 203

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 23/167 (13%)
Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           ++ E L   +F VARG+E+L    +++ +H D+   NILL  N   KI DFGLA+   K+
Sbjct: 196 ITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY 312
              V +   R    ++APE          S  + YG++L E+     +  P V++     
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMD---- 308
Query: 313 FPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
             E   +R+R G  +         E    ++  + + C   +P ERP
Sbjct: 309 --EDFCSRLREGMRM------RAPEYSTPEIYQIMLDCWHRDPKERP 347

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 125 LHSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           L   E+AVK+++  + N    Q+   EV     ++H +IV+L           L+ E+  
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYAS 96
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G +  ++ +      H +   ++ R     +   V+Y HQ   + I+H D+K  N+LLD
Sbjct: 97  GGEVFDYLVA------HGRXKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLLD 147
Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            +   KI+DFG     S + +  ++  A  G   Y APELF 
Sbjct: 148 ADXNIKIADFGF----SNEFTFGNKLDAFCGAPPYAAPELFQ 185

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 13/142 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 76  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 135
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 136 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 182
Query: 260 DISIVSRTAARGTSGYIAPELF 281
                 R    GT  Y+ PE+ 
Sbjct: 183 HAPSSRRDDLCGTLDYLPPEMI 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 129 EIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR------TLIYEF 179
           ++AVKML+       + +EF+ E A +    H H+ +L+G       +       +I  F
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112
Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           M +G L  F+ +     +   L  + L +    +A G+EYL    ++  +H D+   N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCM 169
Query: 240 LDHNFQPKISDFGLAK 255
           L  +    ++DFGL++
Sbjct: 170 LAEDMTVCVADFGLSR 185

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 59  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 117
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 118 LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 169
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA   S+           G+  ++APE+            S  + +G++L E
Sbjct: 170 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 229
Query: 294 MV 295
           ++
Sbjct: 230 LM 231

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 85/189 (44%), Gaps = 30/189 (15%)
Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGN------RRTLIYEFMPNG 183
           A+K+++      +E   E+  + +  HH +I    G   + N      +  L+ EF   G
Sbjct: 53  AIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           S+   I +   ++    L  E +  I   + RG+ +LHQ    +++H DIK  N+LL  N
Sbjct: 113 SVTDLIKNTKGNT----LKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN 165
Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDP 303
            + K+ DFG++     D ++  R    GT  ++APE+              + C +N D 
Sbjct: 166 AEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEV--------------IACDENPDA 209
Query: 304 AVEIQSQIY 312
             + +S ++
Sbjct: 210 TYDFKSDLW 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 13/141 (9%)
Query: 140 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHR 199
           G   +   EV     + H +I+RL G+  +  R  LI E+ P G++ + +   +     R
Sbjct: 53  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 112
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
             ++         +A  + Y H   ++R++H DIKP N+LL    + KI+DFG     S 
Sbjct: 113 TATY------ITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG----WSV 159
Query: 260 DISIVSRTAARGTSGYIAPEL 280
                 R    GT  Y+ PE+
Sbjct: 160 HAPSSRRDDLCGTLDYLPPEM 180

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 104
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 105 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+
Sbjct: 157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 23/182 (12%)
Query: 128 NEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML       Q+   F NEV  + +  H +I+  +G+ ++  +  ++ ++    S
Sbjct: 51  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSS 109
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  + 
Sbjct: 110 LYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDL 161
Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             KI DFGLA   S+           G+  ++APE+            S  + +G++L E
Sbjct: 162 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 221
Query: 294 MV 295
           ++
Sbjct: 222 LM 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 125 LHSNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           L   E A+K+++        N    ++EVA + ++ H +I++L  F  +     L+ E  
Sbjct: 44  LTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVY 103
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L   I  +      ++ S      I   V  G  YLH+     I+H D+KP N+LL
Sbjct: 104 RGGELFDEIILR------QKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLL 154
Query: 241 DHNFQP---KISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRNF 285
           +   +    KI DFGL    S    +  +   R GT+ YIAPE+  + +
Sbjct: 155 ESKSRDALIKIVDFGL----SAHFEVGGKMKERLGTAYYIAPEVLRKKY 199

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 9/133 (6%)
Query: 129 EIAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++AVK L  +     E  F+ E   I +++H +IVR +G   +   R ++ E M  G L+
Sbjct: 77  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 136
Query: 187 KFIF-SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DH 242
            F+  ++   S    L+   L  +A  +A G +YL +      +H DI   N LL     
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGP 193
Query: 243 NFQPKISDFGLAK 255
               KI DFG+A+
Sbjct: 194 GRVAKIGDFGMAR 206

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 29/166 (17%)
Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL--- 185
           E AVK+++  K +  E I  +   G+  H +I+ L     +G    ++ E    G L   
Sbjct: 49  EFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 186 ---QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LD 241
              QKF FS+  +S+           + F + + VEYLH    Q ++H D+KP NIL +D
Sbjct: 107 ILRQKF-FSEREASA-----------VLFTITKTVEYLHA---QGVVHRDLKPSNILYVD 151
Query: 242 HNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
            +  P   +I DFG AK    +  ++       T+ ++APE+  R 
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQ 195

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 22/175 (12%)
Query: 139 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSH 198
           +G   +   E+     + H +I+R+  +  +  R  L+ EF P G L K +        H
Sbjct: 55  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL------QKH 108
Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
            +   ++       +A  + Y H+   ++++H DIKP N+L+ +  + KI+DFG     S
Sbjct: 109 GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFG----WS 161
Query: 259 KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLE-MVGCRKNNDPA 304
                + R    GT  Y+ PE+            +C G++  E +VG    + P+
Sbjct: 162 VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 43/217 (19%)
Query: 133 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC----SEGNRRTLIYEFMPNGSLQKF 188
           ++L H + + +E   E       +H +I+RL+ +C       +   L+  F   G+L   
Sbjct: 61  RILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE 120
Query: 189 I---FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           I     K N  +  Q+ W     +  G+ RG+E +H    +   H D+KP NILL    Q
Sbjct: 121 IERLKDKGNFLTEDQILW-----LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQ 172
Query: 246 PKISDFG-LAKLC------SKDISIVSRTAARGTSGYIAPELFS-RNFC----------- 286
           P + D G + + C       + +++    A R T  Y APELFS ++ C           
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 287 ----YGMMLLE----MVGCRKNNDPAVEIQSQIYFPE 315
               Y MM  E    MV  +K +  A+ +Q+Q+  P+
Sbjct: 233 GCVLYAMMFGEGPYDMV-FQKGDSVALAVQNQLSIPQ 268

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 48  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 106 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 157
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+
Sbjct: 158 LTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 63/133 (47%), Gaps = 9/133 (6%)
Query: 129 EIAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++AVK L  +     E  F+ E   I +++H +IVR +G   +   R ++ E M  G L+
Sbjct: 63  QVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 122
Query: 187 KFIF-SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DH 242
            F+  ++   S    L+   L  +A  +A G +YL +      +H DI   N LL     
Sbjct: 123 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGP 179
Query: 243 NFQPKISDFGLAK 255
               KI DFG+A+
Sbjct: 180 GRVAKIGDFGMAR 192

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 104
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 105 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+
Sbjct: 157 LTDFGFCAQITPEQS--KRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 12/168 (7%)
Query: 128 NEIAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            ++A+K   LE  + +  E + E+  + + HH +IV         +   L+ + +  GS+
Sbjct: 36  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 186 QKFIFSKTNSSSHRQ--LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
              I        H+   L    +  I   V  G+EYLH+      +H D+K  NILL  +
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 152
Query: 244 FQPKISDFGLAKLCSKDISIVSRTAAR----GTSGYIAPELFSRNFCY 287
              +I+DFG++   +    I +R   R    GT  ++APE+  +   Y
Sbjct: 153 GSVQIADFGVSAFLATGGDI-TRNKVRKTFVGTPCWMAPEVMEQVRGY 199

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 104
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 105 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+
Sbjct: 157 LTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 16/180 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +F+ E   + +  H +IVRL+G C++     ++ E +  G    F+ ++       +L  
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRV 212
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L ++    A G+EYL   C    +H D+   N L+      KISDFG+++  +  +  
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXA 269
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE 315
            S    +    + APE          S  + +G++L E      +  P +  Q    F E
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/139 (23%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +++I E+  +    H +IV+LLG      +  ++ EF P G++   +         R L+
Sbjct: 53  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML-----ELDRGLT 107
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             +++ +   +   + +LH   ++RI+H D+K  N+L+      +++DFG++    K  +
Sbjct: 108 EPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 162
Query: 263 IVSRTAARGTSGYIAPELF 281
           +  R +  GT  ++APE+ 
Sbjct: 163 LQKRDSFIGTPYWMAPEVV 181

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 70/154 (45%), Gaps = 27/154 (17%)
Query: 141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI-----FSKTNS 195
           N    ++EVA + ++ H +I++L  F  +     L+ E    G L   I     FS+ ++
Sbjct: 47  NSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA 106
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFG 252
           +            I   V  G  YLH+     I+H D+KP N+LL+   +    KI DFG
Sbjct: 107 AV-----------IMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFG 152
Query: 253 LAKLCSKDISIVSRTAAR-GTSGYIAPELFSRNF 285
           L    S    +  +   R GT+ YIAPE+  + +
Sbjct: 153 L----SAHFEVGGKMKERLGTAYYIAPEVLRKKY 182

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 22/175 (12%)
Query: 139 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSH 198
           +G   +   E+     + H +I+R+  +  +  R  L+ EF P G L K +        H
Sbjct: 56  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL------QKH 109
Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
            +   ++       +A  + Y H+   ++++H DIKP N+L+ +  + KI+DFG     S
Sbjct: 110 GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFG----WS 162
Query: 259 KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLE-MVGCRKNNDPA 304
                + R    GT  Y+ PE+            +C G++  E +VG    + P+
Sbjct: 163 VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 217

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 126
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 184 YKAQTHGKWPVKWYAPE 200

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 126
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 184 YKAQTHGKWPVKWYAPE 200

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 15/135 (11%)
Query: 130 IAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +A+K+L      K N +E ++E   +  +   ++ RLLG C     + L+ + MP G L 
Sbjct: 49  VAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLL 106
Query: 187 KFIF-SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             +  ++    S   L+W         +A+G+ YL    + R++H D+   N+L+     
Sbjct: 107 DHVRENRGRLGSQDLLNW------CMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNH 157
Query: 246 PKISDFGLAKLCSKD 260
            KI+DFGLA+L   D
Sbjct: 158 VKITDFGLARLLDID 172

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 25/150 (16%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL-----QKFIFSKTNSSSH 198
           + + EVA +  + H +I++L  F  +     L+ E    G L      +  F++ +++  
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV- 140
Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAK 255
                     I   V  GV YLH+     I+H D+KP N+LL+   +    KI DFGL+ 
Sbjct: 141 ----------IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRNF 285
           +      +  R    GT+ YIAPE+  + +
Sbjct: 188 VFENQKKMKERL---GTAYYIAPEVLRKKY 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/139 (23%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +++I E+  +    H +IV+LLG      +  ++ EF P G++   +         R L+
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML-----ELDRGLT 115
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             +++ +   +   + +LH   ++RI+H D+K  N+L+      +++DFG++    K  +
Sbjct: 116 EPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170
Query: 263 IVSRTAARGTSGYIAPELF 281
           +  R +  GT  ++APE+ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVV 189

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 106
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 107 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 164 YKAQTHGKWPVKWYAPE 180

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 110
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 111 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 168 YKAQTHGKWPVKWYAPE 184

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 116
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 117 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 174 YKAQTHGKWPVKWYAPE 190

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 13/139 (9%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
           NE++ + ++HH  ++ L     +     LI EF+  G L    F +  +  ++    E +
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVI 152
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--KISDFGLAKLCSKDISIV 264
             +      G++++H+     I+H DIKP NI+ +       KI DFGLA   + D  IV
Sbjct: 153 NYMR-QACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIV 207
Query: 265 SRTAARGTSGYIAPELFSR 283
             T A  T+ + APE+  R
Sbjct: 208 KVTTA--TAEFAAPEIVDR 224

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 110
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 111 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 168 YKAQTHGKWPVKWYAPE 184

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 124
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 125 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 182 YKAQTHGKWPVKWYAPE 198

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQ 200
           Q  ++EV  +  + H +IVR      +    TL  + E+   G L   I   T  +  RQ
Sbjct: 50  QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQ 106
Query: 201 -LSWEKLRKIAFGVARGVEYLHQGCN--QRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
            L  E + ++   +   ++  H+  +    +LH D+KP N+ LD     K+ DFGLA++ 
Sbjct: 107 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 258 SKDISIVSRTAARGTSGYIAPELFSR 283
           + D          GT  Y++PE  +R
Sbjct: 167 NHDEDFAKEFV--GTPYYMSPEQMNR 190

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 104
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 105 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 162 YKAQTHGKWPVKWYAPE 178

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q    E+A    + H +IV+ LG  SE     +  E +P GSL   + SK          
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK---------- 113
Query: 203 WEKLRK----IAF---GVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLA 254
           W  L+     I F    +  G++YLH   + +I+H DIK  N+L++ ++   KISDFG +
Sbjct: 114 WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170
Query: 255 KLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           K  +  I+  + T   GT  Y+APE+  + 
Sbjct: 171 KRLA-GINPCTETFT-GTLQYMAPEIIDKG 198

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 16/180 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +F+ E   + +  H +IVRL+G C++     ++ E +  G    F+ ++       +L  
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRV 212
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L ++    A G+EYL   C    +H D+   N L+      KISDFG+++  +  +  
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE 315
            S    +    + APE          S  + +G++L E      +  P +  Q    F E
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K  ++   +   ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  +  S     L    L   A+ ++  + YL    ++R +H DI   N+L+  N   K
Sbjct: 100 FLQVRKYS-----LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 151
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           + DFGL++   +D +    +  +    ++APE
Sbjct: 152 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 182

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 29/154 (18%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ--------GCNQ 226
           LI  F   GSL  ++           ++W +L  +A  ++RG+ YLH+        G   
Sbjct: 90  LITAFHDKGSLTDYLKGNI-------ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKP 142
Query: 227 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL------ 280
            I H D K  N+LL  +    ++DFGLA                GT  Y+APE+      
Sbjct: 143 SIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAIN 202
Query: 281 FSRN-------FCYGMMLLEMVG-CRKNNDPAVE 306
           F R+       +  G++L E+V  C+  + P  E
Sbjct: 203 FQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F+  +  S     L 
Sbjct: 84  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-----LD 137
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              L   A+ ++  + YL    ++R +H DI   N+L+  N   K+ DFGL++   +D +
Sbjct: 138 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDST 193
Query: 263 IVSRTAARGTSGYIAPE 279
               +  +    ++APE
Sbjct: 194 YYKASKGKLPIKWMAPE 210

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K  ++   +   ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  +  S     L    L   A+ ++  + YL    ++R +H DI   N+L+  N   K
Sbjct: 100 FLQVRKYS-----LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 151
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           + DFGL++   +D +    +  +    ++APE
Sbjct: 152 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 182

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 27/160 (16%)
Query: 148 EVATIGRIHHFHIVRL-LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
           E   +  ++H  +V+L   F +EG +  LI +F+  G L       T  S     + E +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEG-KLYLILDFLRGGDLF------TRLSKEVMFTEEDV 132
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
           +     +A G+++LH   +  I++ D+KP NILLD     K++DFGL+K       I   
Sbjct: 133 KFYLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEA-----IDHE 184
Query: 267 TAAR---GTSGYIAPELFSRN--------FCYGMMLLEMV 295
             A    GT  Y+APE+ +R         + YG+++ EM+
Sbjct: 185 KKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEML 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K  ++   +   ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ 
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 96
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  +  S     L    L   A+ ++  + YL    ++R +H DI   N+L+  N   K
Sbjct: 97  FLQVRKYS-----LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 148
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           + DFGL++   +D +    +  +    ++APE
Sbjct: 149 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 179

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 128 NEIAVKMLEHLKGNGQEFINEV-----ATIGRIH-------HFHIVRLLGFCSEGNRRTL 175
            E AVK+++ + G G     EV     AT+  +        H +I++L           L
Sbjct: 43  KEYAVKIID-VTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           +++ M  G L  ++  K        LS ++ RKI   +   +  LH+     I+H D+KP
Sbjct: 102 VFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHK---LNIVHRDLKP 152
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
            NILLD +   K++DFG +  C  D     R+   GT  Y+APE+
Sbjct: 153 ENILLDDDMNIKLTDFGFS--CQLDPGEKLRSVC-GTPSYLAPEI 194

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +         +++  
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------KEAKRIPE 113
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           E L K++  V RG+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 114 EILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 170
Query: 264 VSRTAARGTSGYIAPE 279
               +  GT  Y+APE
Sbjct: 171 ---NSFVGTRSYMAPE 183

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F+  +  S     L 
Sbjct: 58  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-----LD 111
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              L   A+ ++  + YL    ++R +H DI   N+L+  N   K+ DFGL++   +D +
Sbjct: 112 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDST 167
Query: 263 IVSRTAARGTSGYIAPE 279
               +  +    ++APE
Sbjct: 168 YYKASKGKLPIKWMAPE 184

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F+  +  S     L 
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-----LD 114
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              L   A+ ++  + YL    ++R +H DI   N+L+  N   K+ DFGL++   +D +
Sbjct: 115 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDST 170
Query: 263 IVSRTAARGTSGYIAPE 279
               +  +    ++APE
Sbjct: 171 YYKASKGKLPIKWMAPE 187

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K  ++   +   ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  +  S     L    L   A+ ++  + YL    ++R +H DI   N+L+  N   K
Sbjct: 100 FLQVRKFS-----LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVK 151
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           + DFGL++   +D +    +  +    ++APE
Sbjct: 152 LGDFGLSRYM-EDSTXXKASKGKLPIKWMAPE 182

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F+  +  S     L 
Sbjct: 59  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-----LD 112
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              L   A+ ++  + YL    ++R +H DI   N+L+  N   K+ DFGL++   +D +
Sbjct: 113 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDST 168
Query: 263 IVSRTAARGTSGYIAPE 279
               +  +    ++APE
Sbjct: 169 YYKASKGKLPIKWMAPE 185

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 138 LKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS 196
           LK + +E ++   +I R + H H+V   GF  + +   ++ E     SL +         
Sbjct: 54  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL------HK 107
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + + KI DFGLA  
Sbjct: 108 RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
              D     +    GT  YIAPE+ S+ 
Sbjct: 165 VEYDGE--RKKVLCGTPNYIAPEVLSKK 190

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           Q    E+A    + H +IV+ LG  SE     +  E +P GSL   + SK          
Sbjct: 50  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK---------- 99
Query: 203 WEKLRK----IAF---GVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLA 254
           W  L+     I F    +  G++YLH   + +I+H DIK  N+L++ ++   KISDFG +
Sbjct: 100 WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTS 156
Query: 255 KLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           K  +  I+  + T   GT  Y+APE+  + 
Sbjct: 157 KRLA-GINPCTETFT-GTLQYMAPEIIDKG 184

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 128 NEIAVKMLEHLKGNGQEFINEV-----ATIGRIH-------HFHIVRLLGFCSEGNRRTL 175
            E AVK+++ + G G     EV     AT+  +        H +I++L           L
Sbjct: 30  KEYAVKIID-VTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 88
Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           +++ M  G L  ++  K        LS ++ RKI   +   +  LH+     I+H D+KP
Sbjct: 89  VFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHK---LNIVHRDLKP 139
Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFS 282
            NILLD +   K++DFG +  C  D     R    GT  Y+APE+  
Sbjct: 140 ENILLDDDMNIKLTDFGFS--CQLDPGEKLREVC-GTPSYLAPEIIE 183

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 26/224 (11%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E+  + +++H ++++      E N   ++ E    G L + I  K      R +    
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERT 137
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           + K    +   +E++H   ++R++H DIKP N+ +      K+ D GL +  S   +   
Sbjct: 138 VWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 266 RTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI 317
                GT  Y++PE    N        +  G +L EM            +QS  Y  +  
Sbjct: 195 SLV--GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA----------LQSPFYGDKMN 242
Query: 318 YNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM 361
              +    E C D+     +  + +L  +   CI  +P +RP +
Sbjct: 243 LYSLCKKIEQC-DYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 138 LKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS 196
           LK + +E ++   +I R + H H+V   GF  + +   ++ E     SL +         
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL------HK 109
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + + KI DFGLA  
Sbjct: 110 RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 166
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
              D     +    GT  YIAPE+ S+ 
Sbjct: 167 VEYDGE--RKKTLCGTPNYIAPEVLSKK 192

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 138 LKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS 196
           LK + +E ++   +I R + H H+V   GF  + +   ++ E     SL +         
Sbjct: 78  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL------HK 131
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + + KI DFGLA  
Sbjct: 132 RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 188
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
              D     +    GT  YIAPE+ S+ 
Sbjct: 189 VEYDGE--RKKVLCGTPNYIAPEVLSKK 214

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  + H +IV+L        R  L++E + +  L+K +           L    
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVT 101
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
            +     +  G+ Y H   ++R+LH D+KP N+L++   + KI+DFGLA+     I +  
Sbjct: 102 AKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRK 156
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T    T  Y AP++   +  Y   + +  VGC
Sbjct: 157 YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 138 LKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS 196
           LK + +E ++   +I R + H H+V   GF  + +   ++ E     SL +         
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL------HK 109
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + + KI DFGLA  
Sbjct: 110 RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 166
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
              D     +    GT  YIAPE+ S+ 
Sbjct: 167 VEYDGE--RKKTLCGTPNYIAPEVLSKK 192

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  + H +IV+L        R  L++E + +  L+K +           L    
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVT 101
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
            +     +  G+ Y H   ++R+LH D+KP N+L++   + KI+DFGLA+     I +  
Sbjct: 102 AKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRK 156
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T    T  Y AP++   +  Y   + +  VGC
Sbjct: 157 YTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 138 LKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS 196
           LK + +E ++   +I R + H H+V   GF  + +   ++ E     SL +         
Sbjct: 60  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL------HK 113
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + + KI DFGLA  
Sbjct: 114 RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 170
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
              D     +    GT  YIAPE+ S+ 
Sbjct: 171 VEYDGE--RKKTLCGTPNYIAPEVLSKK 196

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 138 LKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSS 196
           LK + +E ++   +I R + H H+V   GF  + +   ++ E     SL +         
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL------HK 133
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
             + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + + KI DFGLA  
Sbjct: 134 RRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRN 284
              D     +    GT  YIAPE+ S+ 
Sbjct: 191 VEYDGE--RKKVLCGTPNYIAPEVLSKK 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  + H +IV+L        R  L++E + +  L+K +           L    
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVT 101
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
            +     +  G+ Y H   ++R+LH D+KP N+L++   + KI+DFGLA+     I +  
Sbjct: 102 AKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRK 156
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T    T  Y AP++   +  Y   + +  VGC
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 12/106 (11%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+++ M  G L  ++  K        LS ++ RKI   +   +  LH+     I+H D+K
Sbjct: 101 LVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHK---LNIVHRDLK 151
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P NILLD +   K++DFG +  C  D     R    GT  Y+APE+
Sbjct: 152 PENILLDDDMNIKLTDFGFS--CQLDPGEKLREVC-GTPSYLAPEI 194

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 114 SFNLTNSKFFFLHSNEIAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCS--- 168
           ++ + +S +  +    +A+K +   +     Q  + E+  + R  H +++ +        
Sbjct: 55  AYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAST 114
Query: 169 -EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR 227
            E  R   I + +    L K + S+       QLS + +    + + RG++Y+H      
Sbjct: 115 LEAMRDVYIVQDLMETDLYKLLKSQ-------QLSNDHICYFLYQILRGLKYIHSA---N 164
Query: 228 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAARGTSGYIAPELFSRNFC 286
           +LH D+KP N+L++     KI DFGLA++   +       T    T  Y APE+   +  
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 287 Y---------GMMLLEMVGCR 298
           Y         G +L EM+  R
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 16/145 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + R+ H +I++L          +L+ E +  G L   I  K   S     + + +
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD--AADAV 154
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISI 263
           ++I   VA    YLH+     I+H D+KP N+L      +   KI+DFGL+K+      +
Sbjct: 155 KQILEAVA----YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QV 205
Query: 264 VSRTAARGTSGYIAPELFSRNFCYG 288
           + +T   GT GY APE+  R   YG
Sbjct: 206 LMKTVC-GTPGYCAPEIL-RGCAYG 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 101 LRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 160
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 161 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 212
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y M + +  VGC
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGC 240

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 84/176 (47%), Gaps = 21/176 (11%)
Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 48  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
                T+  +   +   ++  +     + +E+LH   + +++H +IK  NILL  +   K
Sbjct: 106 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRNIKSDNILLGMDGSVK 157
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+
Sbjct: 158 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 27/152 (17%)
Query: 139 KGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSS 197
           +G  +E I  EV+ +  I H +++ L           LI E +  G L  F+  K +   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGL 253
              L+ E+  +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 254 AKLCS-----KDISIVSRTAARGTSGYIAPEL 280
           A         K+I         GT  ++APE+
Sbjct: 165 AHKIDFGNEFKNIF--------GTPAFVAPEI 188

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F+  +  S     L 
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LD 489
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              L   A+ ++  + YL    ++R +H DI   N+L+  N   K+ DFGL++   +D +
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDST 545
Query: 263 IVSRTAARGTSGYIAPE 279
               +  +    ++APE
Sbjct: 546 YYKASKGKLPIKWMAPE 562

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+ T+  + H  +V L     + N   +IYEFM  G L    F K  +  H ++S ++  
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL----FEKV-ADEHNKMSEDEAV 258
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQPKISDFGLAKLCSKDISIVS 265
           +    V +G+ ++H+      +H D+KP NI+     + + K+ DFGL        S+  
Sbjct: 259 EYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315
Query: 266 RTAARGTSGYIAPEL 280
            T   GT+ + APE+
Sbjct: 316 TT---GTAEFAAPEV 327

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 13/135 (9%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+ T+  + H  +V L     + N   +IYEFM  G L    F K  +  H ++S ++  
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL----FEKV-ADEHNKMSEDEAV 152
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQPKISDFGLAKLCSKDISIVS 265
           +    V +G+ ++H+      +H D+KP NI+     + + K+ DFGL        S+  
Sbjct: 153 EYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 209
Query: 266 RTAARGTSGYIAPEL 280
            T   GT+ + APE+
Sbjct: 210 TT---GTAEFAAPEV 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 17/150 (11%)
Query: 141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ 200
           + +E  NE++ + ++ H ++++L       N   L+ E++  G L   I  ++ + +   
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT--- 185
Query: 201 LSWEKLRKIAF--GVARGVEYLHQGCNQRILHFDIKPHNILLDHN--FQPKISDFGLAKL 256
               +L  I F   +  G+ ++HQ     ILH D+KP NIL  +    Q KI DFGLA+ 
Sbjct: 186 ----ELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 257 CSKDISIVSRTAARGTSGYIAPELFSRNFC 286
                 +       GT  ++APE+ + +F 
Sbjct: 239 YKPREKL---KVNFGTPEFLAPEVVNYDFV 265

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 468
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 469 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 526 YKAQTHGKWPVKWYAPE 542

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 128 NEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
            E AVK++       K + +  + EV  + ++ H +I++L  F  +     L+ E    G
Sbjct: 52  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 111
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            L   I S+      ++ S     +I   V  G+ Y+H+    +I+H D+KP N+LL+  
Sbjct: 112 ELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESK 162
Query: 244 FQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
            +    +I DFGL+        +  +    GT+ YIAPE+ 
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL 200

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV  +  I H +I+ L           LI E +  G L  F+  K +      L+
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LT 113
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QPKIS--DFGLAKLCS 258
            ++  +    +  GV YLH   ++RI HFD+KP NI LLD N   P+I   DFG+A    
Sbjct: 114 EDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
                 +     GT  ++APE+
Sbjct: 171 AGNEFKN---IFGTPEFVAPEI 189

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 11/137 (8%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           E + E   + ++ + +IVR++G C E     L+ E    G L K++        +R +  
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKD 469
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + + ++   V+ G++YL +      +H D+   N+LL      KISDFGL+K    D + 
Sbjct: 470 KNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 526
Query: 264 V-SRTAARGTSGYIAPE 279
             ++T  +    + APE
Sbjct: 527 YKAQTHGKWPVKWYAPE 543

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 16/144 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV  +  I H +I+ L           LI E +  G L  F+  K +      L+
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LT 106
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QPKIS--DFGLAKLCS 258
            ++  +    +  GV YLH   ++RI HFD+KP NI LLD N   P+I   DFG+A    
Sbjct: 107 EDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 259 KDISIVSRTAARGTSGYIAPELFS 282
                 +     GT  ++APE+ +
Sbjct: 164 AGNEFKN---IFGTPEFVAPEIVN 184

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 16/144 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV  +  I H +I+ L           LI E +  G L  F+  K +      L+
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LT 127
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QPKIS--DFGLAKLCS 258
            ++  +    +  GV YLH   ++RI HFD+KP NI LLD N   P+I   DFG+A    
Sbjct: 128 EDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 259 KDISIVSRTAARGTSGYIAPELFS 282
                 +     GT  ++APE+ +
Sbjct: 185 AGNEFKN---IFGTPEFVAPEIVN 205

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 6/104 (5%)
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK- 255
           S + L+ E +R   + + RG++Y+H   + +++H D+KP N+L++ N + KI DFG+A+ 
Sbjct: 152 SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG 208
Query: 256 LCSKDIS-IVSRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
           LC+         T    T  Y APEL      Y   + L  VGC
Sbjct: 209 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 125 LHSNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           +   E AVK++       K + +  + EV  + ++ H +I++L  F  +     L+ E  
Sbjct: 55  ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 114
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L   I S+      ++ S     +I   V  G+ Y+H+    +I+H D+KP N+LL
Sbjct: 115 TGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLL 165
Query: 241 DHNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +   +    +I DFGL+        +  +    GT+ YIAPE+ 
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL 206

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  S++ F  ++  T        N    + LS E ++ + 
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLV 137
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   +++     T   
Sbjct: 138 YQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYV 189
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK- 255
           S + L+ E +R   + + RG++Y+H     +++H D+KP N+L++ N + KI DFG+A+ 
Sbjct: 151 SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207
Query: 256 LCSKDIS-IVSRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
           LC+         T    T  Y APEL      Y   + L  VGC
Sbjct: 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 41/251 (16%)
Query: 125 LHSNEIAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           LH  E+ +K+L+    N  E F    + + ++ H H+V   G C  G+   L+ EF+  G
Sbjct: 38  LHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFG 97
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL  ++    N  +   + W+   ++A  +A  + +L +     ++H ++   NILL   
Sbjct: 98  SLDTYLKKNKNCIN---ILWK--LEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIRE 149
Query: 244 FQPKISDFGLAKLCSKDISI--VSRTAARGTSGYIAPE---------LFSRNFCYGMMLL 292
              K  +    KL    ISI  + +   +    ++ PE         L +  + +G  L 
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209
Query: 293 EMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIW--- 349
           E+  C   + P   + SQ                  L F ED  +  A K A +A     
Sbjct: 210 EI--CSGGDKPLSALDSQRK----------------LQFYEDRHQLPAPKAAELANLINN 251
Query: 350 CIQWNPTERPS 360
           C+ + P  RPS
Sbjct: 252 CMDYEPDHRPS 262

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 46/234 (19%)
Query: 126 HSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
            +  +A+K L+  K  G   +EF +E     R+ H ++V LLG  ++    ++I+ +  +
Sbjct: 38  QTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH 96
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAF----------GVARGVEYLHQGCNQRILHFD 232
           G L +F+  ++  S       ++  K A            +A G+EYL    +  ++H D
Sbjct: 97  GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKD 153
Query: 233 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS----GYIAPELF------- 281
           +   N+L+      KISD GL     +++         G S     ++APE         
Sbjct: 154 LATRNVLVYDKLNVKISDLGLF----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI 209
Query: 282 -SRNFCYGMMLLEMVG------CRKNNDPAVEI--QSQIY-----FPEWIYNRM 321
            S  + YG++L E+        C  +N   VE+    Q+       P W+Y  M
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALM 263

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 46/234 (19%)
Query: 126 HSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
            +  +A+K L+  K  G   +EF +E     R+ H ++V LLG  ++    ++I+ +  +
Sbjct: 55  QTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSH 113
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAF----------GVARGVEYLHQGCNQRILHFD 232
           G L +F+  ++  S       ++  K A            +A G+EYL    +  ++H D
Sbjct: 114 GDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKD 170
Query: 233 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS----GYIAPELF------- 281
           +   N+L+      KISD GL     +++         G S     ++APE         
Sbjct: 171 LATRNVLVYDKLNVKISDLGLF----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI 226
Query: 282 -SRNFCYGMMLLEMVG------CRKNNDPAVEI--QSQIY-----FPEWIYNRM 321
            S  + YG++L E+        C  +N   VE+    Q+       P W+Y  M
Sbjct: 227 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALM 280

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 149 VATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK 208
           + ++ R H F + +L       +R   + EF+  G L   I         R+    + R 
Sbjct: 76  ILSLARNHPF-LTQLFCCFQTPDRLFFVMEFVNGGDLMFHI------QKSRRFDEARARF 128
Query: 209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSR 266
            A  +   + +LH   ++ I++ D+K  N+LLDH    K++DFG+ K  +C+     V+ 
Sbjct: 129 YAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTT 181
Query: 267 TAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR-----KNNDPAVE--IQSQI 311
               GT  YIAPE+            +  G++L EM+        +N D   E  +  ++
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241
Query: 312 YFPEWIY 318
            +P W++
Sbjct: 242 VYPTWLH 248

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 125 LHSNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           +   E AVK++       K + +  + EV  + ++ H +I++L  F  +     L+ E  
Sbjct: 72  ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 131
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L   I S+      ++ S     +I   V  G+ Y+H+    +I+H D+KP N+LL
Sbjct: 132 TGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLL 182
Query: 241 DHNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +   +    +I DFGL+        +  +    GT+ YIAPE+ 
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL 223

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 17/135 (12%)
Query: 157 HFHIVRLLGFCSEGNRR-TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR 215
           H +++R   FC+E +R+   I   +   +LQ+++  K  +     L  E +  +      
Sbjct: 77  HPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFA----HLGLEPITLLQ-QTTS 129
Query: 216 GVEYLHQGCNQRILHFDIKPHNILLD-----HNFQPKISDFGL-AKLCSKDISIVSRTAA 269
           G+ +LH   +  I+H D+KPHNIL+         +  ISDFGL  KL     S   R+  
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 270 RGTSGYIAPELFSRN 284
            GT G+IAPE+ S +
Sbjct: 187 PGTEGWIAPEMLSED 201

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 125 LHSNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
           +   E AVK++       K + +  + EV  + ++ H +I++L  F  +     L+ E  
Sbjct: 73  ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 132
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L   I S+      ++ S     +I   V  G+ Y+H+    +I+H D+KP N+LL
Sbjct: 133 TGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLL 183
Query: 241 DHNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +   +    +I DFGL+        +  +    GT+ YIAPE+ 
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL 224

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 27/152 (17%)
Query: 139 KGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSS 197
           +G  +E I  EV+ +  I H +++ L           LI E +  G L  F+  K +   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGL 253
              L+ E+  +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 254 AKLCS-----KDISIVSRTAARGTSGYIAPEL 280
           A         K+I         GT  ++APE+
Sbjct: 165 AHKIDFGNEFKNIF--------GTPEFVAPEI 188

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 5/76 (6%)
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           E L KI     + + +L +  N +I+H DIKP NILLD +   K+ DFG++    + +  
Sbjct: 125 EILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDS 179
Query: 264 VSRTAARGTSGYIAPE 279
           +++T   G   Y+APE
Sbjct: 180 IAKTRDAGCRPYMAPE 195

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 137 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TGYV 188
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 137 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TGYV 188
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGC 211

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 116
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 174 KNIF--------GTPEFVAPEI 187

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 27/152 (17%)
Query: 139 KGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSS 197
           +G  +E I  EV+ +  I H +++ L           LI E +  G L  F+  K +   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGL 253
              L+ E+  +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 254 AKLCS-----KDISIVSRTAARGTSGYIAPEL 280
           A         K+I         GT  ++APE+
Sbjct: 165 AHKIDFGNEFKNIF--------GTPEFVAPEI 188

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 116
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 174 KNIF--------GTPEFVAPEI 187

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K  ++   +   ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ 
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  +  S     L    L   A+ ++  + YL    ++R +H DI   N+L+      K
Sbjct: 100 FLQVRKFS-----LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVK 151
Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           + DFGL++   +D +    +  +    ++APE
Sbjct: 152 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 182

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 137
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 194 --PELLVDLQDYDYSLDMWSL-GC 214

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 137
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 194 --PELLVDLQDYDYSLDMWSL-GC 214

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 137
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 194 --PELLVDLQDYDYSLDMWSL-GC 214

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 11/142 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++   E+A    + + H+V   GF  + +   ++ E     SL +           + ++
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL------HKRRKAVT 140
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             + R       +GV+YLH   N R++H D+K  N+ L+ +   KI DFGLA     D  
Sbjct: 141 EPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 197
Query: 263 IVSRTAARGTSGYIAPELFSRN 284
              +    GT  YIAPE+  + 
Sbjct: 198 --RKKTLCGTPNYIAPEVLCKK 217

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 138
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 194
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 195 --PELLVDLQDYDYSLDMWSL-GC 215

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 137
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 194 --PELLVDLQDYDYSLDMWSL-GC 214

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 137
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 194 --PELLVDLQDYDYSLDMWSL-GC 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 27/153 (17%)
Query: 155 IHHFHIVRL-LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
           ++H  IV+L   F +EG +  LI +F+  G L       T  S     + E ++     +
Sbjct: 83  VNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLF------TRLSKEVMFTEEDVKFYLAEL 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR--- 270
           A  +++LH   +  I++ D+KP NILLD     K++DFGL+K      SI     A    
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-----SIDHEKKAYSFC 187
Query: 271 GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           GT  Y+APE+ +R         + +G+++ EM+
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 70/146 (47%), Gaps = 30/146 (20%)
Query: 157 HFHIVRLLGFCSEGNRRTLIYEF-MPNGSLQKFIFSKTNSSSHRQLSWEK-----LRKIA 210
           H +++R   +CSE   R L     + N +LQ  + SK  S  + +L  E      LR+IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKL 256
            GVA    +LH   + +I+H D+KP NIL+               N +  ISDFGL  KL
Sbjct: 126 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 257 CSKDISIVSR-TAARGTSGYIAPELF 281
            S   S  +      GTSG+ APEL 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELL 204

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 137
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 194 --PELLVDLQDYDYSLDMWSL-GC 214

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 138
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 194
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 195 --PELLVDLQDYDYSLDMWSL-GC 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGXV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 83  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 143 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TGYV 194
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 222

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+  + ++     T   
Sbjct: 139 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYV 190
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 218

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 106
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++     +++ 
Sbjct: 107 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA- 163
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDP 303
                  GT  Y++PE          S  +  G+ L+EM   R    P
Sbjct: 164 ---NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+  + ++     T   
Sbjct: 139 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYV 190
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 11/142 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++   E+A    + + H+V   GF  + +   ++ E     SL +           + ++
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL------HKRRKAVT 140
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             + R       +GV+YLH   N R++H D+K  N+ L+ +   KI DFGLA     D  
Sbjct: 141 EPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 197
Query: 263 IVSRTAARGTSGYIAPELFSRN 284
              +    GT  YIAPE+  + 
Sbjct: 198 --RKKXLCGTPNYIAPEVLCKK 217

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 21/144 (14%)
Query: 159 HIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARG 216
           +IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + 
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKA 139
Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGY 275
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G 
Sbjct: 140 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 195
Query: 276 IAPELFS--RNFCYGMMLLEMVGC 297
             PEL    +++ Y + +  + GC
Sbjct: 196 --PELLVDLQDYDYSLDMWSL-GC 216

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+  + ++     T   
Sbjct: 139 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYV 190
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 218

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 41/251 (16%)
Query: 125 LHSNEIAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           LH  E+ +K+L+    N  E F    + + ++ H H+V   G C  G+   L+ EF+  G
Sbjct: 38  LHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFG 97
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL  ++    N  +   + W+   ++A  +A  + +L +     ++H ++   NILL   
Sbjct: 98  SLDTYLKKNKNCIN---ILWK--LEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIRE 149
Query: 244 FQPKISDFGLAKLCSKDISI--VSRTAARGTSGYIAPE---------LFSRNFCYGMMLL 292
              K  +    KL    ISI  + +   +    ++ PE         L +  + +G  L 
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209
Query: 293 EMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIW--- 349
           E+  C   + P   + SQ                  L F ED  +  A K A +A     
Sbjct: 210 EI--CSGGDKPLSALDSQRK----------------LQFYEDRHQLPAPKAAELANLINN 251
Query: 350 CIQWNPTERPS 360
           C+ + P  RPS
Sbjct: 252 CMDYEPDHRPS 262

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 11/142 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++   E+A    + + H+V   GF  + +   ++ E     SL +           + ++
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL------HKRRKAVT 124
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             + R       +GV+YLH   N R++H D+K  N+ L+ +   KI DFGLA     D  
Sbjct: 125 EPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 181
Query: 263 IVSRTAARGTSGYIAPELFSRN 284
              +    GT  YIAPE+  + 
Sbjct: 182 --RKKDLCGTPNYIAPEVLCKK 201

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 67/144 (46%), Gaps = 26/144 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPELFS 282
           K+I         GT  ++APE+ +
Sbjct: 175 KNIF--------GTPEFVAPEIVN 190

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 43/74 (58%), Gaps = 5/74 (6%)
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           L KIA  + + +E+LH   +  ++H D+KP N+L++   Q K+ DFG++      +  V+
Sbjct: 155 LGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVA 209
Query: 266 RTAARGTSGYIAPE 279
           +T   G   Y+APE
Sbjct: 210 KTIDAGCKPYMAPE 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  S++ F  ++  T        N    + LS E ++ + 
Sbjct: 78  LRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLV 137
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   +++     T   
Sbjct: 138 YQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYV 189
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 217

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 25/167 (14%)
Query: 143 QEFINEVATIGRIHHFHIVRLL-GFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
           ++++ E+  +    H +IV+LL  F  E N   LI EF   G++   +         R L
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLE-----LERPL 132
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +  +++ +       + YLH   + +I+H D+K  NIL   +   K++DFG++   ++  
Sbjct: 133 TESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-- 187
Query: 262 SIVSRTAARGTSGYIAPELF------SRNFCY-------GMMLLEMV 295
           +I  R +  GT  ++APE+        R + Y       G+ L+EM 
Sbjct: 188 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 138 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM-----TGYV 189
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 134 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM-----TGYV 185
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 213

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 137 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 188
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 216

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 103
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 160
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 161 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 27/153 (17%)
Query: 155 IHHFHIVRL-LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
           ++H  IV+L   F +EG +  LI +F+  G L       T  S     + E ++     +
Sbjct: 83  VNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLF------TRLSKEVMFTEEDVKFYLAEL 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR--- 270
           A  +++LH   +  I++ D+KP NILLD     K++DFGL+K      SI     A    
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-----SIDHEKKAYSFC 187
Query: 271 GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           GT  Y+APE+ +R         + +G+++ EM+
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 103
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 160
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 161 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 103
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 160
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 161 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 103
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 160
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 161 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 82  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 141
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 142 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 193
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 194 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 221

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 11/142 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++   E+A    + + H+V   GF  + +   ++ E     SL +           + ++
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL------HKRRKAVT 140
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
             + R       +GV+YLH   N R++H D+K  N+ L+ +   KI DFGLA     D  
Sbjct: 141 EPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE 197
Query: 263 IVSRTAARGTSGYIAPELFSRN 284
              +    GT  YIAPE+  + 
Sbjct: 198 --RKKDLCGTPNYIAPEVLCKK 217

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 71/143 (49%), Gaps = 21/143 (14%)
Query: 160 IVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGV 217
           IV+LL    + + +T  LI+E++ N   +    + T+           +R   + + + +
Sbjct: 109 IVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYD---------IRYYIYELLKAL 159
Query: 218 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYI 276
           +Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+          R A+R   G  
Sbjct: 160 DYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 214
Query: 277 APELFS--RNFCYGMMLLEMVGC 297
            PEL    +++ Y + +  + GC
Sbjct: 215 -PELLVDLQDYDYSLDMWSL-GC 235

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 139 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 190
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 158 FHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLR 207
           +  +RLL      N   L+  F P  S++ F  ++  T        N    + LS E ++
Sbjct: 67  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ 126
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            + + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   +++     T
Sbjct: 127 FLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEM-----T 178
Query: 268 AARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
               T  Y APE+      Y   + +  VGC
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 19/138 (13%)
Query: 127 SNE-IAVKM--LEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           +NE +A+K   LEH + G     I EV+ +  + H +I+ L       +R  LI+E+  N
Sbjct: 58  TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-- 240
             L+K++        +  +S   ++   + +  GV + H   ++R LH D+KP N+LL  
Sbjct: 118 -DLKKYM------DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSV 167
Query: 241 -DHNFQP--KISDFGLAK 255
            D +  P  KI DFGLA+
Sbjct: 168 SDASETPVLKIGDFGLAR 185

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 77  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 137 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 188
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 27/153 (17%)
Query: 155 IHHFHIVRL-LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGV 213
           ++H  IV+L   F +EG +  LI +F+  G L       T  S     + E ++     +
Sbjct: 84  VNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLF------TRLSKEVMFTEEDVKFYLAEL 136
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR--- 270
           A  +++LH   +  I++ D+KP NILLD     K++DFGL+K      SI     A    
Sbjct: 137 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-----SIDHEKKAYSFC 188
Query: 271 GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           GT  Y+APE+ +R         + +G+++ EM+
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 221

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 71  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 130
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 131 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 182
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 210

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 165
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 166 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 222
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 223 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 30/155 (19%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL---------QKFIFSKT 193
           ++   E +    + H HIV LL   S      +++EFM    L           F++S+ 
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 194 NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQP-KISD 250
            +S + +   E LR           Y H   +  I+H D+KP N+LL    N  P K+ D
Sbjct: 131 VASHYMRQILEALR-----------YCH---DNNIIHRDVKPENVLLASKENSAPVKLGD 176
Query: 251 FGLA-KLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           FG+A +L    +    R    GT  ++APE+  R 
Sbjct: 177 FGVAIQLGESGLVAGGRV---GTPHFMAPEVVKRE 208

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 138 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 189
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 103
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 104 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 160
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 161 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 138 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 189
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 69  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 129 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 180
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 208

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 128 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 179
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 70  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 129
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 130 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 181
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 209

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 69  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 129 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 180
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 208

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 78  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 138 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 189
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 134 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 185
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 213

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 128 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 179
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 131 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 66/142 (46%), Gaps = 26/142 (18%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           EV+ +  I H +++ L           LI E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES------LTEEEAT 117
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCS----- 258
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 259 KDISIVSRTAARGTSGYIAPEL 280
           K+I         GT  ++APE+
Sbjct: 175 KNIF--------GTPEFVAPEI 188

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 134 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 185
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 213

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 144 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 195
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 74  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 134 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 185
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 213

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 83  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 143 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 194
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 10/137 (7%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F+  +  S     L 
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LD 489
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              L   A+ ++  + YL    ++R +H DI   N+L+      K+ DFGL++   +D +
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDST 545
Query: 263 IVSRTAARGTSGYIAPE 279
               +  +    ++APE
Sbjct: 546 YYKASKGKLPIKWMAPE 562

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 25/167 (14%)
Query: 143 QEFINEVATIGRIHHFHIVRLL-GFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
           ++++ E+  +    H +IV+LL  F  E N   LI EF   G++   +         R L
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLE-----LERPL 132
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +  +++ +       + YLH   + +I+H D+K  NIL   +   K++DFG++   ++ I
Sbjct: 133 TESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 262 SIVSRTAARGTSGYIAPELF------SRNFCY-------GMMLLEMV 295
               R +  GT  ++APE+        R + Y       G+ L+EM 
Sbjct: 190 Q--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 21/168 (12%)
Query: 124 FLHSNEIAVKMLEHLKGNGQEFI-NEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMP 181
            + S E AVK++E   G+ +  +  EV  + +   H +++ L+ F  E +R  L++E M 
Sbjct: 35  LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            GS+   I  +      R  +  +   +   VA  +++LH   N+ I H D+KP NIL +
Sbjct: 95  GGSILSHIHKR------RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCE 145
Query: 242 HNFQ---PKISDFGLA---KL---CSKDISIVSRTAARGTSGYIAPEL 280
           H  Q    KI DFGL    KL   CS  IS        G++ Y+APE+
Sbjct: 146 HPNQVSPVKICDFGLGSGIKLNGDCSP-ISTPELLTPCGSAEYMAPEV 192

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 144 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 195
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 223

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 152 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 203
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 84  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 144 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 195
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 223

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 130
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 131 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 187
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 188 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 139 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSH 198
           +G   +   E+     +HH +I+RL  +  +  R  LI E+ P G L K +         
Sbjct: 64  EGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQ 123
Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
           R  +      I   +A  + Y H    ++++H DIKP N+LL    + KI+DFG     S
Sbjct: 124 RTAT------IMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFG----WS 170
Query: 259 KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
                + R    GT  Y+ PE+            +C G++  E++
Sbjct: 171 VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 95  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 154
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 155 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 206
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 234

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 21/135 (15%)
Query: 155 IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL-----QKFIFSKTNSSSHRQLSWEKLRKI 209
           + H  IV L+     G +  LI E++  G L     ++ IF +  +  +       L +I
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-------LAEI 130
Query: 210 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA 269
           +  +     +LHQ   + I++ D+KP NI+L+H    K++DFGL K    D ++      
Sbjct: 131 SMALG----HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC- 182
Query: 270 RGTSGYIAPELFSRN 284
            GT  Y+APE+  R+
Sbjct: 183 -GTIEYMAPEILMRS 196

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 21/135 (15%)
Query: 155 IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL-----QKFIFSKTNSSSHRQLSWEKLRKI 209
           + H  IV L+     G +  LI E++  G L     ++ IF +  +  +       L +I
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-------LAEI 130
Query: 210 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA 269
           +  +     +LHQ   + I++ D+KP NI+L+H    K++DFGL K    D ++      
Sbjct: 131 SMALG----HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC- 182
Query: 270 RGTSGYIAPELFSRN 284
            GT  Y+APE+  R+
Sbjct: 183 -GTIEYMAPEILMRS 196

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 91  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 151 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 202
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 230

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + I E+  +   +  +IV   G        ++  E M  GSL + +  K       ++  
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAG-----RIPE 122
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 263
           + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++ 
Sbjct: 123 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA- 179
Query: 264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR 298
               +  GT  Y++PE          S  +  G+ L+EM   R
Sbjct: 180 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           L KIA  + + +E+LH   +  ++H D+KP N+L++   Q K+ DFG++     D   V+
Sbjct: 111 LGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VA 165
Query: 266 RTAARGTSGYIAPE 279
           +    G   Y+APE
Sbjct: 166 KDIDAGCKPYMAPE 179

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 91  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 151 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 202
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 230

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 15/100 (15%)
Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
           + R  A  +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC ++I   
Sbjct: 140 RARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHN 193
Query: 265 SRTAAR-GTSGYIAPELFSRN--------FCYGMMLLEMV 295
           S T+   GT  Y+APE+  +         +C G +L EM+
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 243 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 300
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
              KD + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 301 EGIKDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 152 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 203
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 231

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 101 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 158
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
              KD + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 159 EGIKDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSH--RQLSW 203
           + E+  + ++ H ++V LL       R  L++E+  +  L +    +     H  + ++W
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 204 EKLRKIAFGVARGVEYLHQGCNQR-ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
           + L+ + F            C++   +H D+KP NIL+  +   K+ DFG A+L +    
Sbjct: 110 QTLQAVNF------------CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157
Query: 263 IVSRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
                 A  T  Y +PEL   +  YG  + +  +GC
Sbjct: 158 YYDDEVA--TRWYRSPELLVGDTQYGPPVDVWAIGC 191

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 102 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 159
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
              KD + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 160 EGIKDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 131 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 100 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 157
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
              KD + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 158 EGIKDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 135 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 131 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  S ++ R     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 297
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
              KD + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 298 EGIKDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 13/101 (12%)
Query: 157 HFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVA 214
           H +IV LL      N R   L++++M    L   I +      H+Q        + + + 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY-------VVYQLI 119
Query: 215 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           + ++YLH G    +LH D+KP NILL+     K++DFGL++
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 135 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGL +    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 154 EGISDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 15/146 (10%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+     +    IV L G   EG    +  E +  GSL + I         R L +  
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY-- 171
Query: 206 LRKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD--- 260
                 G A  G+EYLH    +RILH D+K  N+LL  +  +  + DFG A     D   
Sbjct: 172 -----LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 223
Query: 261 ISIVSRTAARGTSGYIAPELFSRNFC 286
            S+++     GT  ++APE+     C
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPC 249

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 66/138 (47%), Gaps = 9/138 (6%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EVA +  + H +IV+      E     ++ ++   G L    F + N+       
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQ 123
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            +++      +   ++++H   +++ILH DIK  NI L  +   ++ DFG+A++ +  + 
Sbjct: 124 EDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 263 IVSRTAARGTSGYIAPEL 280
           +    A  GT  Y++PE+
Sbjct: 181 LA--RACIGTPYYLSPEI 196

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 25/167 (14%)
Query: 143 QEFINEVATIGRIHHFHIVRLL-GFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
           ++++ E+  +    H +IV+LL  F  E N   LI EF   G++   +         R L
Sbjct: 79  EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLE-----LERPL 132
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +  +++ +       + YLH   + +I+H D+K  NIL   +   K++DFG++   ++ I
Sbjct: 133 TESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXI 189
Query: 262 SIVSRTAARGTSGYIAPELF------SRNFCY-------GMMLLEMV 295
               R    GT  ++APE+        R + Y       G+ L+EM 
Sbjct: 190 Q--RRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 102 SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 158
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 159 EGISDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N     +L+ + ++ + 
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI 127
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++     T   
Sbjct: 128 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYV 179
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 151 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI D+GLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 69/146 (47%), Gaps = 30/146 (20%)
Query: 157 HFHIVRLLGFCSEGNRRTLIYEF-MPNGSLQKFIFSKTNSSSHRQLSWEK-----LRKIA 210
           H +++R   +CSE   R L     + N +LQ  + SK  S  + +L  E      LR+IA
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKL 256
            GVA    +LH   + +I+H D+KP NIL+               N +  ISDFGL  KL
Sbjct: 126 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 257 CSKDISI-VSRTAARGTSGYIAPELF 281
            S       +     GTSG+ APEL 
Sbjct: 179 DSGQXXFRXNLNNPSGTSGWRAPELL 204

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 150 ATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK---L 206
           A +G+  H H+VR     +E +   +  E+   GSL   I     S ++R +S+ K   L
Sbjct: 63  AVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAEL 115
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGLAKLCSK 259
           + +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+   K+  K
Sbjct: 116 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172
Query: 260 --DISIVSRTAA----RGTSGYIAPELFSRNFCY 287
             D+  V+R ++     G S ++A E+   N+ +
Sbjct: 173 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTH 206

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 15/146 (10%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+     +    IV L G   EG    +  E +  GSL + I         R L +  
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY-- 155
Query: 206 LRKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD--- 260
                 G A  G+EYLH    +RILH D+K  N+LL  +  +  + DFG A     D   
Sbjct: 156 -----LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207
Query: 261 ISIVSRTAARGTSGYIAPELFSRNFC 286
            S+++     GT  ++APE+     C
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPC 233

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 154 EGISDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 154 EGISDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 15/146 (10%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+     +    IV L G   EG    +  E +  GSL + I         R L +  
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY-- 169
Query: 206 LRKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD--- 260
                 G A  G+EYLH    +RILH D+K  N+LL  +  +  + DFG A     D   
Sbjct: 170 -----LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 261 ISIVSRTAARGTSGYIAPELFSRNFC 286
            S+++     GT  ++APE+     C
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPC 247

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 150 ATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK---L 206
           A +G+  H H+VR     +E +   +  E+   GSL   I     S ++R +S+ K   L
Sbjct: 63  AVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAEL 115
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGLAKLCSK 259
           + +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+   K+  K
Sbjct: 116 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172
Query: 260 --DISIVSRTAA----RGTSGYIAPELFSRNFCY 287
             D+  V+R ++     G S ++A E+   N+ +
Sbjct: 173 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTH 206

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 100 SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 156
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 157 EGISDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 154 EGISDGATMKTFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 15/144 (10%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRR--TLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + E   + +++H +IV+L     E   R   LI EF P GSL   +   +N+     L  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPE 111
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSK 259
            +   +   V  G+ +L +     I+H +IKP NI+     D     K++DFG A+    
Sbjct: 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 260 DISIVSRTAARGTSGYIAPELFSR 283
           D   VS     GT  Y+ P+++ R
Sbjct: 169 DEQFVS---LYGTEEYLHPDMYER 189

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           S  R  + E+ R     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFGL K
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 256 LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
               D + +      GT  Y+APE+   N        +  G+++ EM+  R
Sbjct: 154 EGISDGATMKXFC--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 133 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 22/156 (14%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF---MP--NGSLQKFIFSKTNSSSHRQLS 202
           E+  +  + H +++ LL   +  +     Y+F   MP     LQK +  K         S
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--------FS 124
Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            EK++ + + + +G++Y+H      ++H D+KP N+ ++ + + KI DFGLA+    ++ 
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM- 180
Query: 263 IVSRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
               T    T  Y APE+      Y   + +  VGC
Sbjct: 181 ----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 150 ATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK---L 206
           A +G+  H H+VR     +E +   +  E+   GSL   I     S ++R +S+ K   L
Sbjct: 61  AVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAEL 113
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGLAKLCSK 259
           + +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+   K+  K
Sbjct: 114 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170
Query: 260 --DISIVSRTAA----RGTSGYIAPELFSRNFCY 287
             D+  V+R ++     G S ++A E+   N+ +
Sbjct: 171 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTH 204

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 150 ATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK---L 206
           A +G+  H H+VR     +E +   +  E+   GSL   I     S ++R +S+ K   L
Sbjct: 65  AVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAEL 117
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGLAKLCSK 259
           + +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+   K+  K
Sbjct: 118 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 260 --DISIVSRTAA----RGTSGYIAPELFSRNFCY 287
             D+  V+R ++     G S ++A E+   N+ +
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTH 208

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 131 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 69/146 (47%), Gaps = 30/146 (20%)
Query: 157 HFHIVRLLGFCSEGNRRTLIYEF-MPNGSLQKFIFSKTNSSSHRQLSWEK-----LRKIA 210
           H +++R   +CSE   R L     + N +LQ  + SK  S  + +L  E      LR+IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKL 256
            GVA    +LH   + +I+H D+KP NIL+               N +  ISDFGL  KL
Sbjct: 144 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 257 CSKDISI-VSRTAARGTSGYIAPELF 281
            S       +     GTSG+ APEL 
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELL 222

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 69/146 (47%), Gaps = 30/146 (20%)
Query: 157 HFHIVRLLGFCSEGNRRTLIYEF-MPNGSLQKFIFSKTNSSSHRQLSWEK-----LRKIA 210
           H +++R   +CSE   R L     + N +LQ  + SK  S  + +L  E      LR+IA
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKL 256
            GVA    +LH   + +I+H D+KP NIL+               N +  ISDFGL  KL
Sbjct: 144 SGVA----HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 257 CSKDISI-VSRTAARGTSGYIAPELF 281
            S       +     GTSG+ APEL 
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELL 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 129 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 21/166 (12%)
Query: 126 HSNEIAVKMLEHLKGNGQEFI-NEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           +  E AVK++E   G+ +  +  EV T+ +   + +I+ L+ F  +  R  L++E +  G
Sbjct: 37  NGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGG 96
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-- 241
           S+   I  K    + R+ S     ++   VA  +++LH    + I H D+KP NIL +  
Sbjct: 97  SILAHI-QKQKHFNEREAS-----RVVRDVAAALDFLH---TKGIAHRDLKPENILCESP 147
Query: 242 HNFQP-KISDFGLA---KL---CSKDISIVSRTAARGTSGYIAPEL 280
               P KI DF L    KL   C+  I+    T   G++ Y+APE+
Sbjct: 148 EKVSPVKICDFDLGSGMKLNNSCTP-ITTPELTTPCGSAEYMAPEV 192

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
           + LS + +    + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++  
Sbjct: 123 QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179
Query: 259 KDISIVS-RTAARGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
            D       T    T  Y APE+   +  Y         G +L EM+  R
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 136 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 192
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 129 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 186 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 137 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 193
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 194 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 128 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 184
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 185 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 135 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 19/161 (11%)
Query: 128 NEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
            E AVK++       K + +  + EV  + ++ H +I +L  F  +     L+ E    G
Sbjct: 52  QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGG 111
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            L   I S+      ++ S     +I   V  G+ Y H+    +I+H D+KP N+LL+  
Sbjct: 112 ELFDEIISR------KRFSEVDAARIIRQVLSGITYXHK---NKIVHRDLKPENLLLESK 162
Query: 244 FQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
            +    +I DFGL+           +    GT+ YIAPE+ 
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKXKDKI---GTAYYIAPEVL 200

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 139 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 131 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 135 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 133 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 115
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 116 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 133 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 111
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 112 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 168 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 111
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 112 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF---MPNGSLQKFIFSKTNSSSHRQLSWE 204
           E+  +  + H +++ LL   +  +     Y+F   MP      F+ +        + S E
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP------FMQTDLQKIMGMEFSEE 144
Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
           K++ + + + +G++Y+H      ++H D+KP N+ ++ + + KI DFGLA+    ++   
Sbjct: 145 KIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--- 198
Query: 265 SRTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
             T    T  Y APE+      Y   + +  VGC
Sbjct: 199 --TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 230

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-RTAA 269
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D       T  
Sbjct: 151 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 270 RGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
             T  Y APE+   +  Y         G +L EM+  R
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 121
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 122 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 178 XVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +++        
Sbjct: 128 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----GFV 179
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 207

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +++        
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----GFV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 111
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 112 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +++        
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----GFV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 65/152 (42%), Gaps = 24/152 (15%)
Query: 160 IVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVA-RGVE 218
           IV L G   EG    +  E +  GSL + +  +      R L +        G A  G+E
Sbjct: 147 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYY-------LGQALEGLE 199
Query: 219 YLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD---ISIVSRTAARGTSG 274
           YLH   ++RILH D+K  N+LL  +     + DFG A     D    S+++     GT  
Sbjct: 200 YLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 275 YIAPELFSRNFCYG---------MMLLEMVGC 297
           ++APE+     C           MML  + GC
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGC 288

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 20/155 (12%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  ++H +I+ LL   +   ++TL  EF     + + + +        +L  E++ 
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTP--QKTL-EEFQDVYLVMELMDANLXQVIQMELDHERMS 129
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA           RT
Sbjct: 130 YLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA-----------RT 175
Query: 268 AARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
           A  GTS  + P + +R +    ++L M G ++N D
Sbjct: 176 A--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 115
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 116 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 171
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 18/160 (11%)
Query: 144 EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           +FI EV  +  + H +++RL G       + ++ E  P GSL   +        H  L  
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG- 121
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS 262
             L + A  VA G+ YL    ++R +H D+   N+LL      KI DFGL + L   D  
Sbjct: 122 -TLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
Query: 263 IVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEM 294
            V +   +    + APE L +R F        +G+ L EM
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 158 FHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI-------FSKTNSSS---HRQLSWEKLR 207
           +  +RLL      N   L+  F P+ +L  F        F  T+      H +L  ++++
Sbjct: 72  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 131
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI--SIVS 265
            + + + +G+ Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++   +V+
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVT 188
Query: 266 RTAARGTSGYIAPELFSRNFCYGMML-LEMVGC 297
           R        Y APE+      Y   + +  VGC
Sbjct: 189 R-------WYRAPEVILNWMRYTQTVDIWSVGC 214

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +AVK +E      +    E+     + H +IVR            +I E+   G L + I
Sbjct: 48  VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--K 247
            +        + S ++ R     +  GV Y H   + +I H D+K  N LLD +  P  K
Sbjct: 108 CNAG------RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLK 158
Query: 248 ISDFGLAK---LCSKDISIVSRTAARGTSGYIAPELFSRN 284
           I DFG +K   L S+  S V      GT  YIAPE+  R 
Sbjct: 159 ICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRQ 192

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 92  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++         
Sbjct: 152 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----XGXV 203
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 231

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           L+   +  N   L+  F P  SL++F         + +  +     +L  E++  + + +
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA           RTA  GTS
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA-----------RTA--GTS 179
Query: 274 GYIAPELFSRNFCYGMMLLEMVGCRKNND 302
             + P + +R +    ++L M G ++N D
Sbjct: 180 FMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           L+   +  N   L+  F P  SL++F         + +  +     +L  E++  + + +
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA           RTA  GTS
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA-----------RTA--GTS 179
Query: 274 GYIAPELFSRNFCYGMMLLEMVGCRKNND 302
             + P + +R +    ++L M G ++N D
Sbjct: 180 FMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           L+   +  N   L+  F P  SL++F         + +  +     +L  E++  + + +
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA           RTA  GTS
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA-----------RTA--GTS 179
Query: 274 GYIAPELFSRNFCYGMMLLEMVGCRKNND 302
             + P + +R +    ++L M G ++N D
Sbjct: 180 FMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 95  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 154
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    ++         
Sbjct: 155 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----XGYV 206
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 5/74 (6%)
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           L K+   + + + YL +     ++H D+KP NILLD   Q K+ DFG++     D    +
Sbjct: 126 LGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KA 180
Query: 266 RTAARGTSGYIAPE 279
           +  + G + Y+APE
Sbjct: 181 KDRSAGCAAYMAPE 194

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 64/138 (46%), Gaps = 12/138 (8%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +    +I R  G   +  +  +I E++  GS    +       ++       +
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETY-------I 118
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             I   + +G++YLH   ++R +H DIK  N+LL      K++DFG+A   +   + + R
Sbjct: 119 ATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKR 173
Query: 267 TAARGTSGYIAPELFSRN 284
               GT  ++APE+  ++
Sbjct: 174 NXFVGTPFWMAPEVIKQS 191

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 17/120 (14%)
Query: 166 FCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG 223
           FC+  + + L  + E+MP G L   +     S+      W K     F  A  V  L   
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDVPEKWAK-----FYTAEVVLALDAI 190
Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSRTAARGTSGYIAPELF 281
            +  ++H D+KP N+LLD +   K++DFG    C K  +  +V    A GT  YI+PE+ 
Sbjct: 191 HSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVHCDTAVGTPDYISPEVL 247

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 5/74 (6%)
Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
           L KIA  + + +E+LH   +  ++H D+KP N+L++   Q K  DFG++     D   V+
Sbjct: 138 LGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VA 192
Query: 266 RTAARGTSGYIAPE 279
           +    G   Y APE
Sbjct: 193 KDIDAGCKPYXAPE 206

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 15/144 (10%)
Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRR--TLIYEFMPNGSLQKFIFSKTNSSSHRQLSW 203
           + E   + +++H +IV+L     E   R   LI EF P GSL   +   +N+     L  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPE 111
Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSK 259
            +   +   V  G+ +L +     I+H +IKP NI+     D     K++DFG A+    
Sbjct: 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 260 DISIVSRTAARGTSGYIAPELFSR 283
           D   V      GT  Y+ P+++ R
Sbjct: 169 DEQFV---XLYGTEEYLHPDMYER 189

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +H DIKP N+LLD N   +++DFG + L   D   V  + A GT  YI+PE+ 
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEIL 264

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 124 FLHSNEIAVKMLEHLKGNGQEFI-NEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMP 181
            + S E AVK++E   G+ +  +  EV  + +   H +++ L+ F  E +R  L++E M 
Sbjct: 35  LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            GS+   I  +      R  +  +   +   VA  +++LH   N+ I H D+KP NIL +
Sbjct: 95  GGSILSHIHKR------RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCE 145
Query: 242 HNFQ---PKISDFGLA---KL---CSKDISIVSRTAARGTSGYIAPEL 280
           H  Q    KI DF L    KL   CS  IS        G++ Y+APE+
Sbjct: 146 HPNQVSPVKICDFDLGSGIKLNGDCSP-ISTPELLTPCGSAEYMAPEV 192

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 15/128 (11%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           LL   +  N  +L+  F P  +L++F         + +      H +L  E++  + + +
Sbjct: 74  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 133
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA+  S +  +      R   
Sbjct: 134 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTR--- 187
Query: 274 GYIAPELF 281
            Y APE+ 
Sbjct: 188 YYRAPEVI 195

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +H DIKP N+LLD N   +++DFG + L   D   V  + A GT  YI+PE+ 
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEIL 248

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 8/73 (10%)
Query: 215 RGVEYLHQGCN-------QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           R +E +   C          I+H D+KP NI++      K+ DFG+A+  +   + V++T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 268 AAR-GTSGYIAPE 279
           AA  GT+ Y++PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 8/73 (10%)
Query: 215 RGVEYLHQGCN-------QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           R +E +   C          I+H D+KP NI++      K+ DFG+A+  +   + V++T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 268 AAR-GTSGYIAPE 279
           AA  GT+ Y++PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ 200
           N ++F++E   +  + H HIV+L+G   E     +I E  P G L  ++  + N +S + 
Sbjct: 52  NKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKV 108
Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           L+   L   +  + + + YL    +   +H DI   NIL+      K+ DFGL++   +D
Sbjct: 109 LT---LVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-ED 161
Query: 261 ISIVSRTAARGTSGYIAPELFSRNF 285
                 +  R    +++PE  S NF
Sbjct: 162 EDYYKASVTRLPIKWMSPE--SINF 184

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 215 RGVEYLHQGCN-------QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           R +E +   C          I+H D+KP NIL+      K+ DFG+A+  +   + V +T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 268 AAR-GTSGYIAPE 279
           AA  GT+ Y++PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD---ISIVSRT 267
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D      +   
Sbjct: 135 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 268 AARGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
            A  T  Y APE+   +  Y         G +L EM+  R
Sbjct: 192 VA--TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 8/73 (10%)
Query: 215 RGVEYLHQGCN-------QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           R +E +   C          I+H D+KP NI++      K+ DFG+A+  +   + V++T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 268 AAR-GTSGYIAPE 279
           AA  GT+ Y++PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD---ISIVSRT 267
           + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D      +   
Sbjct: 136 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 268 AARGTSGYIAPELFSRNFCY---------GMMLLEMVGCR 298
            A  T  Y APE+   +  Y         G +L EM+  R
Sbjct: 193 VA--TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI D GLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI  FGLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           L+   +  N  +L+  F P  +L++F         + +        +L  E++  + + +
Sbjct: 76  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA           RTA  GTS
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA-----------RTA--GTS 179
Query: 274 GYIAPELFSRNFCYGMMLLEMVGCRKNND 302
             + P + +R +    ++L M G ++N D
Sbjct: 180 FMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 8/73 (10%)
Query: 215 RGVEYLHQGCN-------QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           R +E +   C          I+H D+KP NI++      K+ DFG+A+  +   + V++T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 268 AAR-GTSGYIAPE 279
           AA  GT+ Y++PE
Sbjct: 177 AAVIGTAQYLSPE 189

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ E+MP G L        N  S+  +  +  R     V   ++ +H   +   +H D+K
Sbjct: 151 MVMEYMPGGDL-------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVK 200
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           P N+LLD +   K++DFG     +K+  +   TA  GT  YI+PE+ 
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 246

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 8/73 (10%)
Query: 215 RGVEYLHQGCN-------QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
           R +E +   C          I+H D+KP NI++      K+ DFG+A+  +   + V++T
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 268 AAR-GTSGYIAPE 279
           AA  GT+ Y++PE
Sbjct: 194 AAVIGTAQYLSPE 206

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + PE+ +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMTPEVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ E+MP G L        N  S+  +  +  R     V   ++ +H   +   +H D+K
Sbjct: 146 MVMEYMPGGDL-------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVK 195
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           P N+LLD +   K++DFG     +K+  +   TA  GT  YI+PE+ 
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 64/152 (42%), Gaps = 24/152 (15%)
Query: 160 IVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVA-RGVE 218
           IV L G   EG    +  E +  GSL + +  +      R L +        G A  G+E
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYY-------LGQALEGLE 180
Query: 219 YLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD---ISIVSRTAARGTSG 274
           YLH   ++RILH D+K  N+LL  +     + DFG A     D     +++     GT  
Sbjct: 181 YLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 275 YIAPELFSRNFCYG---------MMLLEMVGC 297
           ++APE+     C           MML  + GC
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGC 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 11/107 (10%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ E+MP G L        N  S+  +  +  R     V   ++ +H   +   +H D+K
Sbjct: 151 MVMEYMPGGDL-------VNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVK 200
Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           P N+LLD +   K++DFG     +K+  +   TA  GT  YI+PE+ 
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 246

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ 200
           N ++F++E   +  + H HIV+L+G   E     +I E  P G L  ++  + N +S + 
Sbjct: 56  NKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKV 112
Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           L+   L   +  + + + YL    +   +H DI   NIL+      K+ DFGL++   +D
Sbjct: 113 LT---LVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-ED 165
Query: 261 ISIVSRTAARGTSGYIAPELFSRNF 285
                 +  R    +++PE  S NF
Sbjct: 166 EDYYKASVTRLPIKWMSPE--SINF 188

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 37/217 (17%)
Query: 87  VHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKMLEHLK-----GN 141
           V + S  D  +   DV E  C       F++           + AVK+++  K     G 
Sbjct: 12  VPRGSMADDDVLFEDVYEL-CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL 70
Query: 142 GQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL---------QKFIFS 191
             E +   A+I   + H HIV LL   S      +++EFM    L           F++S
Sbjct: 71  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 130
Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQP-KI 248
           +  +S + +   E LR           Y H   +  I+H D+KPH +LL    N  P K+
Sbjct: 131 EAVASHYMRQILEALR-----------YCH---DNNIIHRDVKPHCVLLASKENSAPVKL 176
Query: 249 SDFGLA-KLCSKDISIVSRTAARGTSGYIAPELFSRN 284
             FG+A +L    +    R    GT  ++APE+  R 
Sbjct: 177 GGFGVAIQLGESGLVAGGRV---GTPHFMAPEVVKRE 210

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           L+   +  N  +L+  F P  +L++F         + +        +L  E++  + + +
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 128
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA           RTA  GTS
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA-----------RTA--GTS 172
Query: 274 GYIAPELFSRNFCYGMMLLEMVGCRKNND 302
             + P + +R +    ++L M G ++N D
Sbjct: 173 FMMTPYVVTRYYRAPEVILGM-GYKENVD 200

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 141 NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ 200
           N ++F++E   +  + H HIV+L+G   E     +I E  P G L  ++  + N +S + 
Sbjct: 68  NKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKV 124
Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 260
           L+   L   +  + + + YL    +   +H DI   NIL+      K+ DFGL++   +D
Sbjct: 125 LT---LVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-ED 177
Query: 261 ISIVSRTAARGTSGYIAPELFSRNF 285
                 +  R    +++PE  S NF
Sbjct: 178 EDYYKASVTRLPIKWMSPE--SINF 200

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 20/155 (12%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  ++H +I+ LL   +   ++TL  EF     + + + +        +L  E++ 
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTP--QKTL-EEFQDVYLVMELMDANLXQVIQMELDHERMS 129
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA           RT
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA-----------RT 175
Query: 268 AARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
           A  GTS  + P + +R +    ++L M G ++N D
Sbjct: 176 A--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI D GLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + PE+ +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMEPEVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           L+   +  N   L+  F P  SL++F         + +  +     +L  E++  + + +
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA           RTA  GTS
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA-----------RTA--GTS 179
Query: 274 GYIAPELFSRNFCYGMMLLEMVGCRKNND 302
             + P + +R +    ++L M G ++N D
Sbjct: 180 FMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/138 (21%), Positives = 66/138 (47%), Gaps = 12/138 (8%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +    ++ +  G   +  +  +I E++  GS    +           L   ++
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQI 126
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             I   + +G++YLH   +++ +H DIK  N+LL  + + K++DFG+A   +   + + R
Sbjct: 127 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKR 181
Query: 267 TAARGTSGYIAPELFSRN 284
               GT  ++APE+  ++
Sbjct: 182 NTFVGTPFWMAPEVIKQS 199

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + PE+ +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMEPEVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI DF LA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +    ++ +  G   +G++  +I E++  GS    +  +       Q++   L
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL--RAGPFDEFQIA-TML 126
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
           ++I     +G++YLH   +++ +H DIK  N+LL      K++DFG+A   +   + + R
Sbjct: 127 KEIL----KGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKR 177
Query: 267 TAARGTSGYIAPELFSRN 284
               GT  ++APE+  ++
Sbjct: 178 NTFVGTPFWMAPEVIQQS 195

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 30/155 (19%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL---------QKFIFSKT 193
           ++   E +    + H HIV LL   S      +++EFM    L           F++S+ 
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 194 NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQP-KISD 250
            +S + +   E LR           Y H   +  I+H D+KPH +LL    N  P K+  
Sbjct: 131 VASHYMRQILEALR-----------YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGG 176
Query: 251 FGLA-KLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           FG+A +L    +    R    GT  ++APE+  R 
Sbjct: 177 FGVAIQLGESGLVAGGRV---GTPHFMAPEVVKRE 208

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 116
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 117 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 171
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 172 LMRTLC-GTPTYLAPEVL 188

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 203 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 255
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 256 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 310
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 311 LMRTLC-GTPTYLAPEVL 327

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)
Query: 161 VRLLGFCSEGNRRTLIYEFMPNGSLQKF--IFSKT--------NSSSHRQLSWEKLRKIA 210
           +RLL      N   L+  F P  SL++F  ++  T        N    ++L+ + ++ + 
Sbjct: 72  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR 270
           + + RG++Y+H      I+H D+KP N+ ++ + + KI D GLA+    ++     T   
Sbjct: 132 YQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM-----TGYV 183
Query: 271 GTSGYIAPELFSRNFCYGMML-LEMVGC 297
            T  Y APE+      Y   + +  VGC
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGC 211

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 241
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 242 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 296
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 297 LMRTLC-GTPTYLAPEVL 313

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 37/187 (19%)
Query: 114 SFNLTNSKFFFLHSNEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG 170
           +F++       L   E A K++  + L     + +   A I R+  H +IVRL    SE 
Sbjct: 34  AFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE 93
Query: 171 NRRTLIYEFMPNGSLQKFI-----FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN 225
               LI++ +  G L + I     +S+ ++S   Q   E +             LH  C+
Sbjct: 94  GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-------------LH--CH 138
Query: 226 QR-ILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSRTAA----RGTSGYIA 277
           Q  ++H D+KP N+LL    +    K++DFGLA      I +     A     GT GY++
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA------IEVEGEQQAWFGFAGTPGYLS 192
Query: 278 PELFSRN 284
           PE+  ++
Sbjct: 193 PEVLRKD 199

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 116
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 117 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 171
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 172 LMRTLC-GTPTYLAPEVL 188

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 115
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 116 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 170
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 171 LMRTLC-GTPTYLAPEVL 187

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 116
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 117 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 171
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 172 LMRTLC-GTPTYLAPEVL 188

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 78/201 (38%), Gaps = 41/201 (20%)
Query: 109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHL-----KGNGQEFINEVATIGR--------- 154
           FQS+ +FN     F+ L S E+       +     K  GQE+  +     R         
Sbjct: 20  FQSMENFN----NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75
Query: 155 IHHFHIVRLLGFC----------SEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWE 204
           +H   ++ L   C             +   LI E+   G     IFS         +S  
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSEN 131
Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCSKDI 261
            + ++   +  GV YLHQ     I+H D+KP NILL   +     KI DFG+++      
Sbjct: 132 DVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 262 SIVSRTAARGTSGYIAPELFS 282
            +       GT  Y+APE+ +
Sbjct: 189 EL---REIMGTPEYLAPEILN 206

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 31/176 (17%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH        +NE   +  ++   +V+L     + +   ++ E+MP G +    
Sbjct: 80  VKLKQIEHT-------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---- 128
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS        + S    R  A  +    EYLH   +  +++ D+KP N+L+D     K++
Sbjct: 129 FSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 250 DFGLAKLCSKDISIVSRTAAR-GTSGYIAPE-LFSRNF-------CYGMMLLEMVG 296
           DFG AK       +  RT    GT  Y+APE + S+ +         G+++ EM  
Sbjct: 184 DFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 31/176 (17%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH        +NE   +  ++   +V+L     + +   ++ E+MP G +    
Sbjct: 80  VKLKQIEHT-------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM---- 128
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS        + S    R  A  +    EYLH   +  +++ D+KP N+L+D     K++
Sbjct: 129 FSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 250 DFGLAKLCSKDISIVSRTAAR-GTSGYIAPE-LFSRNF-------CYGMMLLEMVG 296
           DFG AK       +  RT    GT  Y+APE + S+ +         G+++ EM  
Sbjct: 184 DFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/138 (21%), Positives = 66/138 (47%), Gaps = 12/138 (8%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +    ++ +  G   +  +  +I E++  GS    +           L   ++
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQI 106
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             I   + +G++YLH   +++ +H DIK  N+LL  + + K++DFG+A   +   + + R
Sbjct: 107 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKR 161
Query: 267 TAARGTSGYIAPELFSRN 284
               GT  ++APE+  ++
Sbjct: 162 NTFVGTPFWMAPEVIKQS 179

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +++H  I+++  F  +     ++ E M  G L    F K     +++L     
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 122
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 263
           +   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +  + 
Sbjct: 123 KLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TS 177
Query: 264 VSRTAARGTSGYIAPELF 281
           + RT   GT  Y+APE+ 
Sbjct: 178 LMRTLC-GTPTYLAPEVL 194

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+L+DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 127 SNEIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           + E A K++  + L     + +   A I R+  H +IVRL    SE     L+++ +  G
Sbjct: 56  TQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            L + I ++   S                +   V ++HQ     I+H D+KP N+LL   
Sbjct: 116 ELFEDIVAREYYSE------ADASHCIHQILESVNHIHQ---HDIVHRDLKPENLLLASK 166
Query: 244 FQP---KISDFGLAKLCSKDISIVSRTAA----RGTSGYIAPELFSRN 284
            +    K++DFGLA      I +     A     GT GY++PE+  ++
Sbjct: 167 CKGAAVKLADFGLA------IEVQGEQQAWFGFAGTPGYLSPEVLRKD 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 1/53 (1%)
Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           +H DIKP NIL+D N   +++DFG      +D ++ S  A  GT  YI+PE+ 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 248

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/138 (21%), Positives = 66/138 (47%), Gaps = 12/138 (8%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +    ++ +  G   +  +  +I E++  GS    +           L   ++
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQI 106
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             I   + +G++YLH   +++ +H DIK  N+LL  + + K++DFG+A   +   + + R
Sbjct: 107 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKR 161
Query: 267 TAARGTSGYIAPELFSRN 284
               GT  ++APE+  ++
Sbjct: 162 NXFVGTPFWMAPEVIKQS 179

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/138 (21%), Positives = 66/138 (47%), Gaps = 12/138 (8%)
Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            E+  + +    ++ +  G   +  +  +I E++  GS    +           L   ++
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQI 121
Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR 266
             I   + +G++YLH   +++ +H DIK  N+LL  + + K++DFG+A   +   + + R
Sbjct: 122 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKR 176
Query: 267 TAARGTSGYIAPELFSRN 284
               GT  ++APE+  ++
Sbjct: 177 NXFVGTPFWMAPEVIKQS 194

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 26/137 (18%)
Query: 175 LIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN 225
           L+  F P  SL++F         + +  +     +L  E++  + + +  G+++LH    
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
             I+H D+KP NI++  +   KI DFGLA           RTA  GTS  + P + +R +
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLA-----------RTA--GTSFMMTPYVVTRYY 191
Query: 286 CYGMMLLEMVGCRKNND 302
               ++L M G ++N D
Sbjct: 192 RAPEVILGM-GYKENVD 207

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 30/159 (18%)
Query: 141 NGQEFINEVATIGRIHHFHIVRL------LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTN 194
           N + +  E+  + +++H ++V        L   +  +   L  E+   G L+K++    N
Sbjct: 55  NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 195 SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDF 251
                 L    +R +   ++  + YLH+    RI+H D+KP NI+L    Q    KI D 
Sbjct: 115 CCG---LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 252 GLAK------LCSKDISIVSRTAARGTSGYIAPELFSRN 284
           G AK      LC++ +         GT  Y+APEL  + 
Sbjct: 169 GYAKELDQGELCTEFV---------GTLQYLAPELLEQK 198

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 54/119 (45%), Gaps = 24/119 (20%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L  E+   G L+K++    N      L    +R +   ++  + YLH+    RI+H D+K
Sbjct: 96  LAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSALRYLHEN---RIIHRDLK 149
Query: 235 PHNILLDHNFQP---KISDFGLAK------LCSKDISIVSRTAARGTSGYIAPELFSRN 284
           P NI+L    Q    KI D G AK      LC++ +         GT  Y+APEL  + 
Sbjct: 150 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---------GTLQYLAPELLEQK 199

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 20/155 (12%)
Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
           E+  +  ++H +I+ LL   +   ++TL  EF     + + + +        +L  E++ 
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTP--QKTL-EEFQDVYLVMELMDANLCQVIQMELDHERMS 129
Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA           RT
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA-----------RT 175
Query: 268 AARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
           A  GTS  + P + +R +    ++L M G ++N D
Sbjct: 176 A--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQLSWE----KLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL        +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 158
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 215
Query: 295 VGC 297
           +GC
Sbjct: 216 LGC 218

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 103 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 159
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 216
Query: 295 VGC 297
           +GC
Sbjct: 217 LGC 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 15/128 (11%)
Query: 163 LLGFCSEGNRRTLIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGV 213
           LL   +  N  +L+  F P  +L++F         + +      H +L  E++  + + +
Sbjct: 76  LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 135
Query: 214 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTS 273
             G+++LH      I+H D+KP NI++  +   KI DFGLA+    +  +      R   
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR--- 189
Query: 274 GYIAPELF 281
            Y APE+ 
Sbjct: 190 YYRAPEVI 197

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 126 HSNE-IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            +NE +AVK +E  +   +    E+     + H +IVR            ++ E+   G 
Sbjct: 42  QANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L    F +  ++   + S ++ R     +  GV Y H     ++ H D+K  N LLD + 
Sbjct: 102 L----FERICNAG--RFSEDEARFFFQQLISGVSYAHA---MQVAHRDLKLENTLLDGSP 152
Query: 245 QP--KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
            P  KI+DFG +K     +      +A GT  YIAPE+ 
Sbjct: 153 APRLKIADFGYSKAS---VLHSQPKSAVGTPAYIAPEVL 188

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
           S + LS + ++   +   R V+ LH G N  ++H D+KP N+L++ N   K+ DFGLA++
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 257 CSKDISIVSRTAAR--GTSGYIA 277
             +  +  S    +  G + Y+A
Sbjct: 162 IDESAADNSEPTGQQSGMTEYVA 184

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 135 LEHLKGNG--QEFINEVATIGRIHHFHIVRLLG-FCSEGNRRT-LIYEFMPNGSLQKFIF 190
           L+ ++G G       E+A +  + H +++ L   F S  +R+  L++++  +       F
Sbjct: 53  LKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF 112
Query: 191 SKTNSSSHR--QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNF 244
            + + ++ +  QL    ++ + + +  G+ YLH      +LH D+KP NIL+        
Sbjct: 113 HRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169
Query: 245 QPKISDFGLAKLCSKDIS-IVSRTAARGTSGYIAPELF--SRNFCYGMMLLEMVGC 297
           + KI+D G A+L +  +  +        T  Y APEL   +R++   + +   +GC
Sbjct: 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW-AIGC 224

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 26/137 (18%)
Query: 175 LIYEFMPNGSLQKF---------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCN 225
           L+  F P  SL++F         + +  +     +L  E++  + + +  G+++LH    
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
             I+H D+KP NI++  +   KI DFGLA           RTA  GTS  + P + +R +
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLA-----------RTA--GTSFMMTPYVVTRYY 191
Query: 286 CYGMMLLEMVGCRKNND 302
               ++L M G ++N D
Sbjct: 192 RAPEVILGM-GYKENVD 207

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 103 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 159
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 160 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 216
Query: 295 VGC 297
           +GC
Sbjct: 217 LGC 219

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 15/110 (13%)
Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
            R+L  E  R  +  ++  + YLH+   + I++ D+K  N+LLD     K++D+G   +C
Sbjct: 147 QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG---MC 200
Query: 258 SKDISIVSRTAAR-GTSGYIAPEL-------FSRN-FCYGMMLLEMVGCR 298
            + +     T+   GT  YIAPE+       FS + +  G+++ EM+  R
Sbjct: 201 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 104 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 160
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 217
Query: 295 VGC 297
           +GC
Sbjct: 218 LGC 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 24/181 (13%)
Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           A+K+++    N  E I+ V T   +     +H  +V L       +R   + E++  G L
Sbjct: 34  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 93
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                   +    R+L  E  R  +  ++  + YLH+   + I++ D+K  N+LLD    
Sbjct: 94  M------FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGH 144
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGC 297
            K++D+G+ K   +     S     GT  YIAPE+       FS + +  G+++ EM+  
Sbjct: 145 IKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 202
Query: 298 R 298
           R
Sbjct: 203 R 203

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 40/78 (51%), Gaps = 8/78 (10%)
Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHN--FQPKISDFGLAKLCSK--DISIVSRTAARG 271
            + YLH   NQ I H DIKP N L   N  F+ K+ DFGL+K   K  +      T   G
Sbjct: 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 272 TSGYIAPELF-SRNFCYG 288
           T  ++APE+  + N  YG
Sbjct: 237 TPYFVAPEVLNTTNESYG 254

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 181 PNGSLQKFIFSKTNSSSHRQL----SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           P       +F   N++  +QL    +   +R   + + + ++Y H   +  I+H D+KPH
Sbjct: 109 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPH 165
Query: 237 NILLDHNFQP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYGMML-LEM 294
           N+++DH  +  ++ D+GLA+          R A+R   G   PEL      Y   L +  
Sbjct: 166 NVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWS 222
Query: 295 VGC 297
           +GC
Sbjct: 223 LGC 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 24/181 (13%)
Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           A+K+++    N  E I+ V T   +     +H  +V L       +R   + E++  G L
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                   +    R+L  E  R  +  ++  + YLH+   + I++ D+K  N+LLD    
Sbjct: 98  M------FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGH 148
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGC 297
            K++D+G+ K   +     S     GT  YIAPE+       FS + +  G+++ EM+  
Sbjct: 149 IKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206
Query: 298 R 298
           R
Sbjct: 207 R 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 24/181 (13%)
Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           A+K+++    N  E I+ V T   +     +H  +V L       +R   + E++  G L
Sbjct: 49  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 108
Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                   +    R+L  E  R  +  ++  + YLH+   + I++ D+K  N+LLD    
Sbjct: 109 M------FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGH 159
Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL-------FSRN-FCYGMMLLEMVGC 297
            K++D+G+ K   +     S     GT  YIAPE+       FS + +  G+++ EM+  
Sbjct: 160 IKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 217
Query: 298 R 298
           R
Sbjct: 218 R 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 210 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA 269
           A  ++ G+ +LH+   + I++ D+K  N++LD     KI+DFG+ K    D  + +R   
Sbjct: 126 AAEISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD-GVTTREFC 181
Query: 270 RGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
            GT  YIAPE+ +          + YG++L EM+ 
Sbjct: 182 -GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 215

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
           S + LS + ++   +   R V+ LH G N  ++H D+KP N+L++ N   K+ DFGLA++
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 257 CSKDISIVSR--------TAARGTSGYIAPELF 281
             +  +  S         T    T  Y APE+ 
Sbjct: 162 IDESAADNSEPTGQQSGMTEXVATRWYRAPEVM 194

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 126 HSNE-IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            SNE +AVK +E  +   +    E+     + H +IVR            ++ E+   G 
Sbjct: 41  QSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 100
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L    F +  ++   + S ++ R     +  GV Y H     ++ H D+K  N LLD + 
Sbjct: 101 L----FERICNAG--RFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSP 151
Query: 245 QP--KISDFGLAK---LCSKDISIVSRTAARGTSGYIAPELF 281
            P  KI DFG +K   L S+  S V      GT  YIAPE+ 
Sbjct: 152 APRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVL 187

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 256
           S + LS + ++   +   R V+ LH G N  ++H D+KP N+L++ N   K+ DFGLA++
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 257 CSKDISIVSRTAAR--------GTSGYIAPELF 281
             +  +  S    +         T  Y APE+ 
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 30/180 (16%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL--QKFIFSKTNSS---S 197
           ++ + EV  + ++ H  IVR      E N    +    P   L  Q  +  K N     +
Sbjct: 48  EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 198 HRQLSWEKLRKIAF----GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 253
            R    E+ R +       +A  VE+LH   ++ ++H D+KP NI    +   K+ DFGL
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164
Query: 254 AKLCSKD----------ISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
                +D           +    T   GT  Y++PE    N        F  G++L E++
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 208 KIAFGVARGVEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +I   +A G+ +LH      QG    I H D+K  NIL+  N Q  I+D GLA + S+  
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 262 SI--VSRTAARGTSGYIAPELFSRNF 285
           +   V      GT  Y+APE+     
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETI 193

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 56/124 (45%), Gaps = 19/124 (15%)
Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH------QGCNQRI 228
           LI  +  +GSL  F+  +T    H  L      ++A   A G+ +LH      QG    I
Sbjct: 83  LITHYHEHGSLYDFLQRQT-LEPHLAL------RLAVSAACGLAHLHVEIFGTQG-KPAI 134
Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSRTAARGTSGYIAPELFS---R 283
            H D K  N+L+  N Q  I+D GLA + S+  D   +      GT  Y+APE+     R
Sbjct: 135 AHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIR 194
Query: 284 NFCY 287
             C+
Sbjct: 195 TDCF 198

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 208 KIAFGVARGVEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +I   +A G+ +LH      QG    I H D+K  NIL+  N Q  I+D GLA + S+  
Sbjct: 138 RIVLSIASGLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 196
Query: 262 S--IVSRTAARGTSGYIAPELFSRNF 285
           +   V      GT  Y+APE+     
Sbjct: 197 NQLDVGNNPRVGTKRYMAPEVLDETI 222

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/117 (23%), Positives = 56/117 (47%), Gaps = 13/117 (11%)
Query: 143 QEFINEVATIGRIHHFHIVRLLGFC----SEGNRRTLIYEFMPNGSLQKFIFSKTNSSSH 198
           +  + E+A + R++H H+V++L        E      +   + +   +K   +       
Sbjct: 97  KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV----- 151
Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
             L+   ++ + + +  GV+Y+H      ILH D+KP N L++ +   K+ DFGLA+
Sbjct: 152 -YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 9/86 (10%)
Query: 208 KIAFGVARGVEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
           +I   +A G+ +LH      QG    I H D+K  NIL+  N Q  I+D GLA + S+  
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 262 S--IVSRTAARGTSGYIAPELFSRNF 285
           +   V      GT  Y+APE+     
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETI 193

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 31/176 (17%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH        +NE   +  ++   +V+L     + +   ++ E++P G +    
Sbjct: 80  VKLKQIEHT-------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---- 128
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS        + S    R  A  +    EYLH   +  +++ D+KP N+L+D     K++
Sbjct: 129 FSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 250 DFGLAKLCSKDISIVSRTAAR-GTSGYIAPE-LFSRNF-------CYGMMLLEMVG 296
           DFG AK       +  RT    GT  Y+APE + S+ +         G+++ EM  
Sbjct: 184 DFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 23/141 (16%)
Query: 166 FCSEGNRRTLIY--EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG 223
           FC+   +  L +  E++  G L   I      S H+     +    A  +  G+++LH  
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHK-FDLSRATFYAAEIILGLQFLH-- 136
Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            ++ I++ D+K  NILLD +   KI+DFG   +C +++   ++T    GT  YIAPE+  
Sbjct: 137 -SKGIVYRDLKLDNILLDKDGHIKIADFG---MCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 283 RN--------FCYGMMLLEMV 295
                     + +G++L EM+
Sbjct: 193 GQKYNHSVDWWSFGVLLYEML 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 167
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 168 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 201

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 121 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 172
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 173 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 206

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 211
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 212 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 245

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 174
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 175 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 208

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 174
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 175 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 208

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 23/141 (16%)
Query: 166 FCSEGNRRTLIY--EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQG 223
           FC+   +  L +  E++  G L   I      S H+     +    A  +  G+++LH  
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHK-FDLSRATFYAAEIILGLQFLH-- 135
Query: 224 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFS 282
            ++ I++ D+K  NILLD +   KI+DFG   +C +++   ++T    GT  YIAPE+  
Sbjct: 136 -SKGIVYRDLKLDNILLDKDGHIKIADFG---MCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 283 RN--------FCYGMMLLEMV 295
                     + +G++L EM+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEML 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 21/162 (12%)
Query: 126 HSNE-IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            SNE +AVK +E  +        E+     + H +IVR            ++ E+   G 
Sbjct: 42  QSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L    F +  ++   + S ++ R     +  GV Y H     ++ H D+K  N LLD + 
Sbjct: 102 L----FERICNAG--RFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSP 152
Query: 245 QP--KISDFGLAK---LCSKDISIVSRTAARGTSGYIAPELF 281
            P  KI DFG +K   L S+  S V      GT  YIAPE+ 
Sbjct: 153 APRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVL 188

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 166
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 167 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 200

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 167
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 168 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 201

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 211
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 212 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 245

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 173
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 174 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 207

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 116 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 167
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 168 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 201

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 127 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 178
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 179 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 212

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 75  TILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKM 134
           T++  P  G     ++SY D+ +                SF +            +A+K 
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTKVIGNG------------SFGVVYQAKLCDSGELVAIKK 52
Query: 135 LEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFCSEGNRRTLIY-----EFMPNGSLQK 187
           +      G+ F N E+  + ++ H +IVRL   F S G ++  +Y     +++P      
Sbjct: 53  VLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV--- 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP- 246
           +  ++  S + + L    ++   + + R + Y+H   +  I H DIKP N+LLD +    
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVL 162
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 163 KLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 194

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 200 QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 259
           +L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA     
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA----- 174
Query: 260 DISIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNND 302
                 RTA  GTS  + P + +R +    ++L M G ++N D
Sbjct: 175 ------RTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVD 208

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 75  TILHFPSSGDYYVHKISYLDSSITITDVNETACPFQSLISFNLTNSKFFFLHSNEIAVKM 134
           T++  P  G     ++SY D+ +                SF +            +A+K 
Sbjct: 5   TVVATPGQGPDRPQEVSYTDTKVIGNG------------SFGVVYQAKLCDSGELVAIKK 52
Query: 135 LEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFCSEGNRRTLIY-----EFMPNGSLQK 187
           +      G+ F N E+  + ++ H +IVRL   F S G ++  +Y     +++P      
Sbjct: 53  VLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV--- 105
Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP- 246
           +  ++  S + + L    ++   + + R + Y+H   +  I H DIKP N+LLD +    
Sbjct: 106 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVL 162
Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF 281
           K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 163 KLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 194

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 31/176 (17%)
Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH        +NE   +  ++   +V+L     + +   ++ E+ P G +    
Sbjct: 80  VKLKEIEHT-------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM---- 128
Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
           FS        + S    R  A  +    EYLH   +  +++ D+KP N+++D     K++
Sbjct: 129 FSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVT 183
Query: 250 DFGLAKLCSKDISIVSRTAAR-GTSGYIAPE-LFSRNF-------CYGMMLLEMVG 296
           DFGLAK       +  RT    GT  Y+APE + S+ +         G+++ EM  
Sbjct: 184 DFGLAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 16/141 (11%)
Query: 148 EVATIGRIHHFHIVRL-LGFCSEGNRRTLIY-----EFMPNGSLQKFIFSKTNSSSHRQL 201
           E+  + ++ H +IVRL   F S G ++ ++Y     +++P      +  ++  S + + L
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETV---YRVARHYSRAKQTL 119
Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKD 260
               ++   + + R + Y+H      I H DIKP N+LLD +    K+ DFG AK   + 
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 261 ISIVSRTAARGTSGYIAPELF 281
              VS   +R    Y APEL 
Sbjct: 177 EPNVSXICSR---YYRAPELI 194

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	363
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-84
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-71
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-69
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-38
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-26
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-23
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-22
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-21
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-21
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-20
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-20
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-15
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-09
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  257 bits (658), Expect = 5e-84
 Identities = 88/247 (35%), Positives = 129/247 (52%), Gaps = 17/247 (6%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +AVK L  E  +G   +F  EV  I    H +++RL GFC     R L+Y +M NGS+ 
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             +  +  S     L W K ++IA G ARG+ YLH  C+ +I+H D+K  NILLD  F+ 
Sbjct: 116 SCLRERPESQPP--LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
            + DFGLAKL     + V+ TA RGT G+IAPE  S          F YG+MLLE++  +
Sbjct: 174 VVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232

Query: 299 KNNDPA-VEIQSQIYFPEWIYNRMRLGQELCL---DFEEDGDEGIARKLAIVAIWCIQWN 354
           +  D A +     +   +W+   ++  +   L   D + +  +    +L  VA+ C Q +
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292

Query: 355 PTERPSM 361
           P ERP M
Sbjct: 293 PMERPKM 299

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  224 bits (574), Expect = 1e-71
 Identities = 73/260 (28%), Positives = 119/260 (45%), Gaps = 38/260 (14%)

Query: 124 FLHSNEIAVKMLEHLKGNG-----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE 178
           ++++  +AVK L  +         Q+F  E+  + +  H ++V LLGF S+G+   L+Y 
Sbjct: 51  YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110

Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
           +MPNGSL   +     +     LSW    KIA G A G+ +LH+      +H DIK  NI
Sbjct: 111 YMPNGSLLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164

Query: 239 LLDHNFQPKISDFGLAKLC-SKDISIVSRTAARGTSGYIAPE-----------LFSRNFC 286
           LLD  F  KISDFGLA+       ++++ +   GT+ Y+APE           ++S    
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMT-SRIVGTTAYMAPEALRGEITPKSDIYS---- 219

Query: 287 YGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY----NRMRLGQELCLDFE-EDGDEGIAR 341
           +G++LLE++      D     +      +           +  E  +D +  D D     
Sbjct: 220 FGVVLLEIITGLPAVDEH---REPQLLLDIKEEIEDEEKTI--EDYIDKKMNDADSTSVE 274

Query: 342 KLAIVAIWCIQWNPTERPSM 361
            +  VA  C+     +RP +
Sbjct: 275 AMYSVASQCLHEKKNKRPDI 294

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  220 bits (562), Expect = 1e-69
 Identities = 80/250 (32%), Positives = 124/250 (49%), Gaps = 28/250 (11%)

Query: 129 EIAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           ++A+K        G +EF  E+ T+    H H+V L+GFC E N   LIY++M NG+L++
Sbjct: 65  KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            ++     +    +SWE+  +I  G ARG+ YLH      I+H D+K  NILLD NF PK
Sbjct: 125 HLYGSDLPTMS--MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 248 ISDFGLAKLC-SKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
           I+DFG++K     D + +S T  +GT GYI PE F +         + +G++L E++  R
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 299 KNNDPAVEIQSQIYFPEWIYNRMRLGQ-------ELCLDFEEDGDEGIARKLAIVAIWCI 351
                ++  +  +   EW       GQ        L      +      RK    A+ C+
Sbjct: 239 SAIVQSLP-REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES----LRKFGDTAVKCL 293

Query: 352 QWNPTERPSM 361
             +  +RPSM
Sbjct: 294 ALSSEDRPSM 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  176 bits (448), Expect = 1e-52
 Identities = 64/270 (23%), Positives = 97/270 (35%), Gaps = 41/270 (15%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT----LIYEFM 180
           L +  +AVK+         +   EV ++  + H +I++ +G    G        LI  F 
Sbjct: 45  LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ-------GCNQRILHFDI 233
             GSL  F+           +SW +L  IA  +ARG+ YLH+       G    I H DI
Sbjct: 105 EKGSLSDFL-------KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157

Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------- 284
           K  N+LL +N    I+DFGLA       S        GT  Y+APE+             
Sbjct: 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217

Query: 285 ----FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI- 339
               +  G++L E+       D  V+ +  + F E I     L     +   +     + 
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVD-EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLR 276

Query: 340 --------ARKLAIVAIWCIQWNPTERPSM 361
                      L      C   +   R S 
Sbjct: 277 DYWQKHAGMAMLCETIEECWDHDAEARLSA 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  163 bits (414), Expect = 7e-48
 Identities = 65/251 (25%), Positives = 120/251 (47%), Gaps = 36/251 (14%)

Query: 126 HSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           H +++AVK+L     +     EF+ EVA + R+ H +IV  +G  ++    +++ E++  
Sbjct: 59  HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL + +     S +  QL   +   +A+ VA+G+ YLH   N  I+H ++K  N+L+D 
Sbjct: 119 GSLYRLL---HKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK 174

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
            +  K+ DFGL++L  K  + +S  +A GT  ++APE+            + +G++L E+
Sbjct: 175 KYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

Query: 295 VGCR---KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI 351
              +    N +PA     Q+      +   R      L+   + +  +A  +      C 
Sbjct: 233 ATLQQPWGNLNPA-----QVVA-AVGFKCKR------LEIPRNLNPQVAAIIE----GCW 276

Query: 352 QWNPTERPSMP 362
              P +RPS  
Sbjct: 277 TNEPWKRPSFA 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  150 bits (380), Expect = 8e-43
 Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 34/246 (13%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            + ++A+K +E  +   + FI E+  + R++H +IV+L G C   N   L+ E+   GSL
Sbjct: 30  RAKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
              +            +           ++GV YLH    + ++H D+KP N+LL     
Sbjct: 87  YNVLHGAEPLP---YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143

Query: 246 -PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             KI DFG A            T  +G++ ++APE+F  +        F +G++L E++ 
Sbjct: 144 VLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198

Query: 297 CRKNNDPAVEIQSQIYFPEW-IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP 355
            RK   P  EI    +   W ++N  R          ++  + I      +   C   +P
Sbjct: 199 RRK---PFDEIGGPAFRIMWAVHNGTR------PPLIKNLPKPIES----LMTRCWSKDP 245

Query: 356 TERPSM 361
           ++RPSM
Sbjct: 246 SQRPSM 251

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (372), Expect = 6e-42
 Identities = 55/260 (21%), Positives = 93/260 (35%), Gaps = 55/260 (21%)

Query: 129 EIAVKMLEHLKGNG--------QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
            +A+K L      G        QEF  EV  +  ++H +IV+L G      R  ++ EF+
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFV 103

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           P G L   +  K        + W    ++   +A G+EY+    N  I+H D++  NI L
Sbjct: 104 PCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFL 157

Query: 241 D-----HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN----------F 285
                      K++DFGL++     +     +   G   ++APE               +
Sbjct: 158 QSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTY 212

Query: 286 CYGMMLLEMVGCR---KNNDPAVEIQSQIYFPEWI-YNRMRLGQELCLDFEEDGDEGIAR 341
            + M+L  ++                 +I F   I    +R          ED    +  
Sbjct: 213 SFAMILYTILTGEGPFDEYSYG-----KIKFINMIREEGLR------PTIPEDCPPRLRN 261

Query: 342 KLAIVAIWCIQWNPTERPSM 361
               V   C   +P +RP  
Sbjct: 262 ----VIELCWSGDPKKRPHF 277

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  147 bits (372), Expect = 7e-42
 Identities = 55/252 (21%), Positives = 101/252 (40%), Gaps = 38/252 (15%)

Query: 128 NEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            ++AVKML          Q F NEV  + +  H +I+  +G+ +      ++ ++    S
Sbjct: 47  GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSS 105

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   + +        +   +KL  IA   ARG++YLH    + I+H D+K +NI L  + 
Sbjct: 106 LYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDN 157

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-----------FCYGMMLLE 293
             KI DFGLA   S+           G+  ++APE+               + +G++L E
Sbjct: 158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217

Query: 294 MVGCR---KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWC 350
           ++  +    N +   +I   +         +                   +++  +   C
Sbjct: 218 LMTGQLPYSNINNRDQIIEMVGR-----GSLSPDLSKV-------RSNCPKRMKRLMAEC 265

Query: 351 IQWNPTERPSMP 362
           ++    ERPS P
Sbjct: 266 LKKKRDERPSFP 277

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  147 bits (373), Expect = 1e-41
 Identities = 61/282 (21%), Positives = 99/282 (35%), Gaps = 54/282 (19%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRLLGFCSEGNRRT-----LIY 177
           L    +AVK+      N Q FINE  +  +  + H +I R +               L+ 
Sbjct: 34  LDERPVAVKVFS--FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91

Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ------GCNQRILHF 231
           E+ PNGSL K++   T         W    ++A  V RG+ YLH            I H 
Sbjct: 92  EYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144

Query: 232 DIKPHNILLDHNFQPKISDFGLAK------LCSKDISIVSRTAARGTSGYIAPELFSRN- 284
           D+   N+L+ ++    ISDFGL+       L        +  +  GT  Y+APE+     
Sbjct: 145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204

Query: 285 --------------FCYGMMLLEMVGCRKNNDPAVEIQS-QIYFPEWIYNR-----MR-- 322
                         +  G++  E+     +  P   +   Q+ F   + N      M+  
Sbjct: 205 NLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL 264

Query: 323 -LGQELCLDFEED--GDEGIARKLAIVAIWCIQWNPTERPSM 361
              ++    F E    +    R L      C   +   R + 
Sbjct: 265 VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  142 bits (360), Expect = 3e-40
 Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 47/257 (18%)

Query: 126 HSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFM 180
             N+I VK+L+    +    ++F  E   +    H +++ +LG C          I  +M
Sbjct: 32  QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
           P GSL   +   TN      +   +  K A  +ARG+ +LH      I    +   ++++
Sbjct: 92  PYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMI 146

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-----------FCYGM 289
           D +   +IS   +                     ++APE   +            + + +
Sbjct: 147 DEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199

Query: 290 MLLEMVGCR---KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV 346
           +L E+V       +     EI  ++         +R                +++ + I 
Sbjct: 200 LLWELVTREVPFADLSNM-EIGMKV-----ALEGLR------PTIPPGISPHVSKLMKI- 246

Query: 347 AIWCIQWNPTERPSMPM 363
              C+  +P +RP   M
Sbjct: 247 ---CMNEDPAKRPKFDM 260

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  141 bits (357), Expect = 6e-40
 Identities = 56/256 (21%), Positives = 98/256 (38%), Gaps = 49/256 (19%)

Query: 129 EIAVKML-----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           E+AVK       E +    +    E      + H +I+ L G C +     L+ EF   G
Sbjct: 32  EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            L + +       S +++  + L   A  +ARG+ YLH      I+H D+K  NIL+   
Sbjct: 92  PLNRVL-------SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144

Query: 244 FQP--------KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCY 287
            +         KI+DFGLA+   +     ++ +A G   ++APE+   +        + Y
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSY 200

Query: 288 GMMLLEMVGCRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAI 345
           G++L E++           + +   +       N++ L                    A 
Sbjct: 201 GVLLWELLTGEVPFRGIDGLAVAYGV-----AMNKLAL----------PIPSTCPEPFAK 245

Query: 346 VAIWCIQWNPTERPSM 361
           +   C   +P  RPS 
Sbjct: 246 LMEDCWNPDPHSRPSF 261

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  139 bits (351), Expect = 1e-38
 Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 41/254 (16%)

Query: 129 EIAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            + +K L       Q  F+ EV  +  + H ++++ +G   +  R   I E++  G+L+ 
Sbjct: 37  VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            I S        Q  W +    A  +A G+ YLH      I+H D+  HN L+  N    
Sbjct: 97  IIKSM-----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVV 148

Query: 248 ISDFGLAKL------------CSKDISIVSRTAARGTSGYIAPELFSRN--------FCY 287
           ++DFGLA+L              K      R    G   ++APE+ +          F +
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208

Query: 288 GMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA 347
           G++L E++G                 P+++   M  G  +    +             + 
Sbjct: 209 GIVLCEIIGR------------VNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPIT 256

Query: 348 IWCIQWNPTERPSM 361
           + C   +P +RPS 
Sbjct: 257 VRCCDLDPEKRPSF 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  137 bits (347), Expect = 5e-38
 Identities = 48/261 (18%), Positives = 93/261 (35%), Gaps = 51/261 (19%)

Query: 128 NEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            E+A+++++  + N    + F  EV    +  H ++V  +G C       +I       +
Sbjct: 56  GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +           L   K R+IA  + +G+ YLH    + ILH D+K  N+  D+  
Sbjct: 116 LYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG- 166

Query: 245 QPKISDFGLAKL---CSKDISIVSRTAARGTSGYIAPELFSRN----------------- 284
           +  I+DFGL  +                 G   ++APE+  +                  
Sbjct: 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226

Query: 285 FCYGMMLLEMVGCR---KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR 341
           F  G +  E+       K           I +   +   M+               G+ +
Sbjct: 227 FALGTIWYELHAREWPFKTQPAE-----AIIWQ--MGTGMKP---------NLSQIGMGK 270

Query: 342 KLAIVAIWCIQWNPTERPSMP 362
           +++ + ++C  +   ERP+  
Sbjct: 271 EISDILLFCWAFEQEERPTFT 291

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 1e-34
 Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 45/272 (16%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRLLGFCSEGNRRT----LIYE 178
               ++AVK+          +  E  +     + H +I+  +    +G        LI +
Sbjct: 58  WRGEKVAVKVF--FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115

Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH-----QGCNQRILHFDI 233
           +  NGSL  ++           L  + + K+A+    G+ +LH           I H D+
Sbjct: 116 YHENGSLYDYL-------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168

Query: 234 KPHNILLDHNFQPKISDFGLAKLC--SKDISIVSRTAARGTSGYIAPELFSRN------- 284
           K  NIL+  N    I+D GLA       +   +      GT  Y+ PE+   +       
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228

Query: 285 -------FCYGMMLLEMVGCRKNNDPAVEIQ--------SQIYFPEWIYNRMRLGQELCL 329
                  + +G++L E+     +     E Q        S   + +              
Sbjct: 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288

Query: 330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSM 361
                 DE + R++  +   C   NP  R + 
Sbjct: 289 PNRWSSDECL-RQMGKLMTECWAHNPASRLTA 319

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  122 bits (309), Expect = 1e-32
 Identities = 52/276 (18%), Positives = 94/276 (34%), Gaps = 53/276 (19%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRLLGFCSEGNRRT----LIYE 178
                +AVK+      + + +  E  +     + H +I+  +         +    LI  
Sbjct: 29  WQGENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86

Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH-----QGCNQRILHFDI 233
           +   GSL  ++           L      +I   +A G+ +LH           I H D+
Sbjct: 87  YHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139

Query: 234 KPHNILLDHNFQPKISDFGLAKLCS--KDISIVSRTAARGTSGYIAPELFSRN------- 284
           K  NIL+  N Q  I+D GLA + S   +   V      GT  Y+APE+           
Sbjct: 140 KSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD 199

Query: 285 -------FCYGMMLLEMVGCRKNNDPAVEIQ--------SQIYFPEWI----YNRMRLGQ 325
                  + +G++L E+     +N    + +        +   F +       ++ R   
Sbjct: 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-- 257

Query: 326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM 361
            +   +  D        LA +   C   NP+ R + 
Sbjct: 258 NIPNRWFSDP---TLTSLAKLMKECWYQNPSARLTA 290

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  123 bits (310), Expect = 2e-32
 Identities = 50/273 (18%), Positives = 99/273 (36%), Gaps = 47/273 (17%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRLLGFCSEGNRRT----LIYE 178
               E+AVK+        + +  E  +     + H +I+  +   ++ N       L+ +
Sbjct: 63  WRGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120

Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ-----GCNQRILHFDI 233
           +  +GSL  ++       +   ++ E + K+A   A G+ +LH           I H D+
Sbjct: 121 YHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173

Query: 234 KPHNILLDHNFQPKISDFGLAKLCS--KDISIVSRTAARGTSGYIAPELFSRN------- 284
           K  NIL+  N    I+D GLA       D   ++     GT  Y+APE+   +       
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233

Query: 285 -------FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED--- 334
                  +  G++  E+   R +     E   Q+ + + + +   + +   +  E+    
Sbjct: 234 SFKRADIYAMGLVFWEIA-RRCSIGGIHE-DYQLPYYDLVPSDPSVEEMRKVVCEQKLRP 291

Query: 335 ------GDEGIARKLAIVAIWCIQWNPTERPSM 361
                       R +A +   C   N   R + 
Sbjct: 292 NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  106 bits (267), Expect = 1e-26
 Identities = 59/266 (22%), Positives = 102/266 (38%), Gaps = 59/266 (22%)

Query: 131 AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNR----------RTLIY--- 177
           A+K + H +      ++EV  +  ++H ++VR      E             ++ ++   
Sbjct: 35  AIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQM 94

Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           E+  NG+L   I    N +  R   W   R+I       + Y+H    Q I+H D+KP N
Sbjct: 95  EYCENGTLYDLI-HSENLNQQRDEYWRLFRQIL----EALSYIHS---QGIIHRDLKPMN 146

Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVS------------RTAARGTSGYIAPELFSRNF 285
           I +D +   KI DFGLAK   + + I+              T+A GT+ Y+A E+     
Sbjct: 147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206

Query: 286 CY---------GMMLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG 335
            Y         G++  EM+       +              I  ++R          +D 
Sbjct: 207 HYNEKIDMYSLGIIFFEMIYPFSTGMERVN-----------ILKKLRSVSIEFPPDFDDN 255

Query: 336 DEGIARKLAIVAI-WCIQWNPTERPS 360
              + +K+    I   I  +P +RP 
Sbjct: 256 KMKVEKKI----IRLLIDHDPNKRPG 277

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  104 bits (261), Expect = 1e-25
 Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 34/249 (13%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQ 186
           AVK L  +    +   +  E+  +  ++H HI++  G C +    +  L+ E++P GSL+
Sbjct: 64  AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++           +   +L   A  +  G+ YLH    Q  +H D+   N+LLD++   
Sbjct: 124 DYL-------PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLV 173

Query: 247 KISDFGLAKLCSKDISI-VSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMV-G 296
           KI DFGLAK   +       R        + APE L    F        +G+ L E++  
Sbjct: 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCI 351
           C  +  P  +    I        +M     L  +  E G+     +    ++  +   C 
Sbjct: 234 CDSSQSPPTKFLELIGIA---QGQMT-VLRL-TELLERGERLPRPDKCPAEVYHLMKNCW 288

Query: 352 QWNPTERPS 360
           +   + RP+
Sbjct: 289 ETEASFRPT 297

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  106 bits (266), Expect = 1e-25
 Identities = 63/257 (24%), Positives = 109/257 (42%), Gaps = 55/257 (21%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 244 YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H ++   N L+  N  
Sbjct: 304 LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHL 356

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGC 297
            K++DFGL++L + D    +   A+    + APE L    F        +G++L E+   
Sbjct: 357 VKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415

Query: 298 RK------NNDPAVEIQSQIY-------FPEWIYNRMRLGQELCLDFEEDGDEGIARKLA 344
                   +     E+  + Y        PE +Y  MR                      
Sbjct: 416 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR---------------------- 453

Query: 345 IVAIWCIQWNPTERPSM 361
                C QWNP++RPS 
Sbjct: 454 ----ACWQWNPSDRPSF 466

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  103 bits (259), Expect = 2e-25
 Identities = 56/249 (22%), Positives = 108/249 (43%), Gaps = 32/249 (12%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQ 186
           AVK L  E    +  +   E+  +  ++H +IV+  G C+E       LI EF+P+GSL+
Sbjct: 54  AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           +++       +  +++ ++  K A  + +G++YL     ++ +H D+   N+L++   Q 
Sbjct: 114 EYL-----PKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQV 165

Query: 247 KISDFGLAKLCSKDISI-VSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVG- 296
           KI DFGL K    D      +        + APE L    F        +G+ L E++  
Sbjct: 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD-----EGIARKLAIVAIWCI 351
           C  ++ P       I      + +M     L ++  ++G           ++  +   C 
Sbjct: 226 CDSDSSPMALFLKMIGPT---HGQMT-VTRL-VNTLKEGKRLPCPPNCPDEVYQLMRKCW 280

Query: 352 QWNPTERPS 360
           ++ P+ R S
Sbjct: 281 EFQPSNRTS 289

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  103 bits (258), Expect = 7e-25
 Identities = 50/261 (19%), Positives = 91/261 (34%), Gaps = 67/261 (25%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +AVK            +F+ E   + +  H +IVRL+G C++     ++ E +  G   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+  +T      +L  + L ++    A G+EYL     +  +H D+   N L+      
Sbjct: 201 TFL--RTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVL 252

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYI-----APELFSRN--------FCYGMMLLE 293
           KISDFG+++  +  +       A G    +     APE  +          + +G++L E
Sbjct: 253 KISDFGMSREEADGVYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

Query: 294 MVG------CRKNNDPAVEIQSQIY-------FPEWIYNRMRLGQELCLDFEEDGDEGIA 340
                       +N    E   +          P+ ++  M                   
Sbjct: 308 TFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME------------------ 349

Query: 341 RKLAIVAIWCIQWNPTERPSM 361
                    C  + P +RPS 
Sbjct: 350 --------QCWAYEPGQRPSF 362

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  100 bits (251), Expect = 2e-24
 Identities = 58/249 (23%), Positives = 90/249 (36%), Gaps = 42/249 (16%)

Query: 129 EIAVK---MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT----LIYEFMP 181
           E+A       +  K   Q F  E   +  + H +IVR         +      L+ E M 
Sbjct: 53  EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           +G+L+ ++         + +  + LR     + +G+++LH      I+H D+K  NI + 
Sbjct: 113 SGTLKTYL------KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFIT 165

Query: 242 H-NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY-------GMMLLE 293
                 KI D GLA L           A  GT  ++APE++   +         GM +LE
Sbjct: 166 GPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLE 221

Query: 294 MVGCRKNNDPAVEIQS--QIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI 351
           M        P  E Q+  QIY                     +  E I          CI
Sbjct: 222 MATSEY---PYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIEG--------CI 267

Query: 352 QWNPTERPS 360
           + N  ER S
Sbjct: 268 RQNKDERYS 276

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (251), Expect = 2e-24
 Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 13/134 (9%)

Query: 131 AVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQK 187
           AVK L    + + ++F  E+  +  + H +IV+  G C    RR   LI E++P GSL+ 
Sbjct: 43  AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102

Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           ++        H+ ++   KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 103 YL------QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRV 153

Query: 247 KISDFGLAKLCSKD 260
           KI DFGL K+  +D
Sbjct: 154 KIGDFGLTKVLPQD 167

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (252), Expect = 2e-24
 Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 9/131 (6%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K +          EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+ +
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118

Query: 189 IFSK----TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           + S      N+      S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175

Query: 245 QPKISDFGLAK 255
             KI DFG+ +
Sbjct: 176 TVKIGDFGMTR 186

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 3e-24
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 13/134 (9%)

Query: 131 AVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF- 188
           AVK L E  +   Q+F  E   +  + H HIVR  G C+EG    +++E+M +G L +F 
Sbjct: 75  AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134

Query: 189 --------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
                   + +     +   L   +L  +A  VA G+ YL        +H D+   N L+
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLV 191

Query: 241 DHNFQPKISDFGLA 254
                 KI DFG++
Sbjct: 192 GQGLVVKIGDFGMS 205

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  100 bits (250), Expect = 4e-24
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 17/164 (10%)

Query: 129 EIAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGS 184
             A+K+             + E   + +++H +IV+L     E   R   LI EF P GS
Sbjct: 36  LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---- 240
           L   +   +N+     L   +   +   V  G+ +L +     I+H +IKP NI+     
Sbjct: 96  LYTVLEEPSNAYG---LPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGE 149

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           D     K++DFG A+    D   VS     GT  Y+ P+++ R 
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMYERA 190

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  100 bits (250), Expect = 4e-24
 Identities = 42/175 (24%), Positives = 76/175 (43%), Gaps = 19/175 (10%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K L         +E ++E   +  + + H+ RLLG C   +   LI + MP G L  +
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +           +  + L      +A+G+ YL     +R++H D+   N+L+      KI
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKI 158

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNF-------CYGMMLLEMV 295
           +DFGLAKL   +         +    ++A E +  R +        YG+ + E++
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (250), Expect = 4e-24
 Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 16/151 (10%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRT----LIYEFMPNGSLQKFIFSKTNSSSH 198
           +E   E       +H +I+RL+ +C           L+  F   G+L   I  +      
Sbjct: 71  EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKG 128

Query: 199 RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
             L+ +++  +  G+ RG+E +H    +   H D+KP NILL    QP + D G      
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185

Query: 259 KDISIVSRTAA-------RGTSGYIAPELFS 282
             +    +          R T  Y APELFS
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFS 216

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (250), Expect = 4e-24
 Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 13/134 (9%)

Query: 131 AVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQK 187
           AVK L    + + ++F  E+  +  + H +IV+  G C    RR   LI E++P GSL+ 
Sbjct: 74  AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133

Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           ++        H+ ++   KL +    + +G+EYL     +R +H D+   NIL+++  + 
Sbjct: 134 YL------QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRV 184

Query: 247 KISDFGLAKLCSKD 260
           KI DFGL K+  +D
Sbjct: 185 KIGDFGLTKVLPQD 198

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  100 bits (250), Expect = 5e-24
 Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 13/130 (10%)

Query: 131 AVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQK 187
           AVK L+H   + Q +F  E+  +  +H   IV+  G      R++  L+ E++P+G L+ 
Sbjct: 56  AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115

Query: 188 FIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           F+        HR +L   +L   +  + +G+EYL     +R +H D+   NIL++     
Sbjct: 116 FL------QRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHV 166

Query: 247 KISDFGLAKL 256
           KI+DFGLAKL
Sbjct: 167 KIADFGLAKL 176

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 36/135 (26%), Positives = 65/135 (48%), Gaps = 11/135 (8%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT-----LIYEFM 180
           ++AVK +      +   +EF++E A +    H +++RLLG C E + +      +I  FM
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L  ++      +  + +  + L K    +A G+EYL     +  LH D+   N +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCML 180

Query: 241 DHNFQPKISDFGLAK 255
             +    ++DFGL+K
Sbjct: 181 RDDMTVCVADFGLSK 195

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 14/135 (10%)

Query: 131 AVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF- 188
           AVK L +      ++F  E   +  + H HIV+  G C +G+   +++E+M +G L KF 
Sbjct: 49  AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108

Query: 189 ---------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
                    +       +  +L   ++  IA  +A G+ YL     Q  +H D+   N L
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCL 165

Query: 240 LDHNFQPKISDFGLA 254
           +  N   KI DFG++
Sbjct: 166 VGANLLVKIGDFGMS 180

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 12/136 (8%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT------LIYEF 179
           ++AVKML        + +EF+ E A +    H H+ +L+G       +       +I  F
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           M +G L  F+ +     +   L  + L +    +A G+EYL     +  +H D+   N +
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCM 169

Query: 240 LDHNFQPKISDFGLAK 255
           L  +    ++DFGL++
Sbjct: 170 LAEDMTVCVADFGLSR 185

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 97.3 bits (243), Expect = 2e-23
 Identities = 34/132 (25%), Positives = 66/132 (50%), Gaps = 8/132 (6%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++AVKM++    +  EF  E  T+ ++ H  +V+  G CS+     ++ E++ NG L  +
Sbjct: 34  DVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +      S  + L   +L ++ + V  G+ +L      + +H D+   N L+D +   K+
Sbjct: 94  L-----RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKV 145

Query: 249 SDFGLAKLCSKD 260
           SDFG+ +    D
Sbjct: 146 SDFGMTRYVLDD 157

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 40/136 (29%), Positives = 72/136 (52%), Gaps = 7/136 (5%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +S  +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L
Sbjct: 37  YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N  
Sbjct: 97  LDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHL 149

Query: 246 PKISDFGLAKLCSKDI 261
            K++DFGL++L + D 
Sbjct: 150 VKVADFGLSRLMTGDT 165

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 97.8 bits (244), Expect = 2e-23
 Identities = 49/266 (18%), Positives = 91/266 (34%), Gaps = 67/266 (25%)

Query: 131 AVKM--LEHLKGNGQE-FINEVATIGRI--HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           A+K   LE       + + NE+A + ++  H   I+RL  +        ++ E   N  L
Sbjct: 56  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL 114

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++         + +   + +     +   V  +HQ     I+H D+KP N L+     
Sbjct: 115 NSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-M 164

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY------------------ 287
            K+ DFG+A     D + V + +  GT  Y+ PE                          
Sbjct: 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224

Query: 288 -GMMLLEMVGCR------KNNDPA----VEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD 336
            G +L  M   +       N        ++   +I FP+         ++   D      
Sbjct: 225 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-------EKDLQDV----- 272

Query: 337 EGIARKLAIVAIWCIQWNPTERPSMP 362
             +          C++ +P +R S+P
Sbjct: 273 --LKC--------CLKRDPKQRISIP 288

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 8/133 (6%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 50  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +          +   ++L ++   V   +EYL     ++ LH D+   N L++     K+
Sbjct: 110 L-----REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKV 161

Query: 249 SDFGLAKLCSKDI 261
           SDFGL++    D 
Sbjct: 162 SDFGLSRYVLDDE 174

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 11/132 (8%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K L         +E ++E   +  + + H+ RLLG C   +   LI + MP G L  +
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +           +  + L      +A+G+ YL     +R++H D+   N+L+      KI
Sbjct: 107 V-----REHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKI 158

Query: 249 SDFGLAKLCSKD 260
           +DFGLAKL   +
Sbjct: 159 TDFGLAKLLGAE 170

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.5 bits (241), Expect = 4e-23
 Identities = 32/136 (23%), Positives = 58/136 (42%), Gaps = 15/136 (11%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K L  +      +EF +E     R+ H ++V LLG  ++    ++I+ +  +G L +F
Sbjct: 43  AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102

Query: 189 ----------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
                       +  + +    L       +   +A G+EYL       ++H D+   N+
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNV 159

Query: 239 LLDHNFQPKISDFGLA 254
           L+      KISD GL 
Sbjct: 160 LVYDKLNVKISDLGLF 175

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 37/135 (27%), Positives = 59/135 (43%), Gaps = 14/135 (10%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVKML         +  ++E+  +  +  H +IV LLG C+ G    +I E+   G L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139

Query: 188 F--------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           F              + ++   S   L   +  VA+G+ +L     +  +H D+   N+L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196

Query: 240 LDHNFQPKISDFGLA 254
           L +    KI DFGLA
Sbjct: 197 LTNGHVAKIGDFGLA 211

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 96.1 bits (240), Expect = 4e-23
 Identities = 34/135 (25%), Positives = 63/135 (46%), Gaps = 8/135 (5%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +++A+K +     + ++FI E   + ++ H  +V+L G C E     L+ EFM +G L 
Sbjct: 32  KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            ++      +     + E L  +   V  G+ YL +     ++H D+   N L+  N   
Sbjct: 92  DYL-----RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVI 143

Query: 247 KISDFGLAKLCSKDI 261
           K+SDFG+ +    D 
Sbjct: 144 KVSDFGMTRFVLDDQ 158

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 97.5 bits (243), Expect = 5e-23
 Identities = 49/266 (18%), Positives = 91/266 (34%), Gaps = 67/266 (25%)

Query: 131 AVKM--LEHLKGNGQE-FINEVATIGRI--HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           A+K   LE       + + NE+A + ++  H   I+RL  +        ++ E   N  L
Sbjct: 37  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDL 95

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++         + +   + +     +   V  +HQ     I+H D+KP N L+     
Sbjct: 96  NSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-M 145

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY------------------ 287
            K+ DFG+A     D + V + +  GT  Y+ PE                          
Sbjct: 146 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 205

Query: 288 -GMMLLEMVGCR------KNNDPA----VEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD 336
            G +L  M   +       N        ++   +I FP+         ++   D      
Sbjct: 206 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-------EKDLQDV----- 253

Query: 337 EGIARKLAIVAIWCIQWNPTERPSMP 362
             +          C++ +P +R S+P
Sbjct: 254 --LKC--------CLKRDPKQRISIP 269

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 11/142 (7%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
            +K++  +  + + Q   + +  IG + H HIVRLLG C   +   L+ +++P GSL   
Sbjct: 46  CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +           L  + L      +A+G+ YL +     ++H ++   N+LL    Q ++
Sbjct: 105 V-----RQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQV 156

Query: 249 SDFGLAKLCSKDISIVSRTAAR 270
           +DFG+A L   D   +  + A+
Sbjct: 157 ADFGVADLLPPDDKQLLYSEAK 178

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.0 bits (244), Expect = 5e-23
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 17/164 (10%)

Query: 129 EIAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGS 184
             A+K+             + E   + +++H +IV+L     E   R   LI EF P GS
Sbjct: 36  LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---- 240
           L   +   +N+     L   +   +   V  G+ +L +     I+H +IKP NI+     
Sbjct: 96  LYTVLEEPSNAYG---LPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGE 149

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           D     K++DFG A+    D   VS     GT  Y+ P+++ R 
Sbjct: 150 DGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDMYERA 190

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 39/132 (29%), Positives = 69/132 (52%), Gaps = 10/132 (7%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K L   + +   ++F++E + +G+  H +I+RL G  + G    ++ E+M NGSL  F
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +      +   Q +  +L  +  GV  G+ YL        +H D+   N+L+D N   K+
Sbjct: 141 L-----RTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKV 192

Query: 249 SDFGLAKLCSKD 260
           SDFGL+++   D
Sbjct: 193 SDFGLSRVLEDD 204

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 15/160 (9%)

Query: 129 EIAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
             A K++    L    Q      E++    + H H+V   GF  + +   ++ E     S
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L +           + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + 
Sbjct: 128 LLELH------KRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDL 178

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           + KI DFGLA     D     +    GT  YIAPE+ S+ 
Sbjct: 179 EVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKK 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++AVK ++    + + F+ E   +  + H  +V+L    ++     +I EFM  GSL  F
Sbjct: 214 KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 272

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +     S    +    KL   +  +A G+ ++ Q   +  +H D++  NIL+  +   KI
Sbjct: 273 L----KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKI 325

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYI---APE 279
           +DFGLA++   +      TA  G    I   APE
Sbjct: 326 ADFGLARVIEDNE----YTAREGAKFPIKWTAPE 355

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 42/143 (29%), Positives = 67/143 (46%), Gaps = 8/143 (5%)

Query: 147 NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI--FSKTNSSSHRQLSWE 204
           NE+  I  I + + +   G  +  +   +IYE+M N S+ KF   F   + +    +  +
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 264
            ++ I   V     Y+H   N  I H D+KP NIL+D N + K+SDFG ++         
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--- 206

Query: 265 SRTAARGTSGYIAPELFSRNFCY 287
               +RGT  ++ PE FS    Y
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSY 228

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 18/164 (10%)

Query: 125 LHSNEI-AVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
             S  I A+K+L    L+  G E     EV     + H +I+RL G+  +  R  LI E+
Sbjct: 31  KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
            P G++ + +          +   ++       +A  + Y H    +R++H DIKP N+L
Sbjct: 91  APLGTVYREL------QKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLL 141

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           L    + KI+DFG +           RT   GT  Y+ PE+   
Sbjct: 142 LGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEG 181

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 17/136 (12%)

Query: 125 LHSNEIAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIY---EF 179
              N++AVK +   K +   Q F+ E + + ++ H ++V+LLG   E   +  +Y   E+
Sbjct: 214 YRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLYIVTEY 268

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           M  GSL  ++     S     L  + L K +  V   +EYL        +H D+   N+L
Sbjct: 269 MAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 321

Query: 240 LDHNFQPKISDFGLAK 255
           +  +   K+SDFGL K
Sbjct: 322 VSEDNVAKVSDFGLTK 337

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 13/134 (9%)

Query: 125 LHSNEIAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLI-YEFMP 181
              N++AVK +   K +   Q F+ E + + ++ H ++V+LLG   E      I  E+M 
Sbjct: 42  YRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            GSL  ++     S     L  + L K +  V   +EYL        +H D+   N+L+ 
Sbjct: 99  KGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVS 151

Query: 242 HNFQPKISDFGLAK 255
            +   K+SDFGL K
Sbjct: 152 EDNVAKVSDFGLTK 165

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 52/255 (20%), Positives = 100/255 (39%), Gaps = 56/255 (21%)

Query: 131 AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF-------------CSEGNRRTLIY 177
            +K +++   N ++   EV  + ++ H +IV   G               S  ++   ++
Sbjct: 40  VIKRVKY---NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLF 96

Query: 178 ---EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
              EF   G+L+++I          +L      ++   + +GV+Y+H    +++++ D+K
Sbjct: 97  IQMEFCDKGTLEQWI----EKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLK 149

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FC 286
           P NI L    Q KI DFGL      D     RT ++GT  Y++PE  S          + 
Sbjct: 150 PSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYA 206

Query: 287 YGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV 346
            G++L E++        A E           +  +R G            +   +K   +
Sbjct: 207 LGLILAELLHVCD---TAFETSK-------FFTDLRDGII---------SDIFDKKEKTL 247

Query: 347 AIWCIQWNPTERPSM 361
               +   P +RP+ 
Sbjct: 248 LQKLLSKKPEDRPNT 262

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 41/160 (25%), Positives = 68/160 (42%), Gaps = 15/160 (9%)

Query: 129 EIAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
             A K++    L    Q      E++    + H H+V   GF  + +   ++ E     S
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L +           + L+  + R     +  G +YLH+    R++H D+K  N+ L+ + 
Sbjct: 102 LLELH------KRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDL 152

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           + KI DFGLA     D     +    GT  YIAPE+ S+ 
Sbjct: 153 EVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKK 190

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 16/138 (11%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           A+K +     K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L  
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115

Query: 188 F----------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           F                +S+   LS ++L   A  VARG++YL Q   ++ +H D+   N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 172

Query: 238 ILLDHNFQPKISDFGLAK 255
           IL+  N+  KI+DFGL++
Sbjct: 173 ILVGENYVAKIADFGLSR 190

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 10/132 (7%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K L   + +    +F+ E   +G+  H +I+RL G  S+     +I E+M NG+L KF
Sbjct: 77  AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +          + S  +L  +  G+A G++YL        +H D+   NIL++ N   K+
Sbjct: 137 L-----REKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKV 188

Query: 249 SDFGLAKLCSKD 260
           SDFGL+++   D
Sbjct: 189 SDFGLSRVLEDD 200

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 15/165 (9%)

Query: 125 LHSNEI-AVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
           +H+    A+KM+  + +   G      NEV    ++ H  I+ L  +  + N   L+ E 
Sbjct: 33  IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
             NG + +++ ++      +  S  + R     +  G+ YLH      ILH D+   N+L
Sbjct: 93  CHNGEMNRYLKNR-----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLL 144

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           L  N   KI+DFGLA                GT  YI+PE+ +R+
Sbjct: 145 LTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRS 187

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 11/132 (8%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K+L     K + +E + E   + ++ + +IVRL+G C       L+ E    G L KF
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKF 99

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +          ++    + ++   V+ G++YL +   +  +H D+   N+LL +    KI
Sbjct: 100 L-----VGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKI 151

Query: 249 SDFGLAKLCSKD 260
           SDFGL+K    D
Sbjct: 152 SDFGLSKALGAD 163

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 8/135 (5%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
             ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M NGSL 
Sbjct: 37  HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
            F+     + S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+      
Sbjct: 96  DFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSC 148

Query: 247 KISDFGLAKLCSKDI 261
           KI+DFGLA+L   + 
Sbjct: 149 KIADFGLARLIEDNE 163

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 36/130 (27%), Positives = 60/130 (46%), Gaps = 11/130 (8%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL-IYEFMPNGSL 185
             AVK L      G   +F+ E   +    H +++ LLG C       L +  +M +G L
Sbjct: 55  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           + FI      +     + + L      VA+G++YL     ++ +H D+   N +LD  F 
Sbjct: 115 RNFI-----RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFT 166

Query: 246 PKISDFGLAK 255
            K++DFGLA+
Sbjct: 167 VKVADFGLAR 176

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 3e-22
 Identities = 36/131 (27%), Positives = 63/131 (48%), Gaps = 11/131 (8%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL-IYEFMPNGSL 185
           + A+K L         + F+ E   +  ++H +++ L+G           +  +M +G L
Sbjct: 51  QCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL 110

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            +FI      S  R  + + L      VARG+EYL +   Q+ +H D+   N +LD +F 
Sbjct: 111 LQFI-----RSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFT 162

Query: 246 PKISDFGLAKL 256
            K++DFGLA+ 
Sbjct: 163 VKVADFGLARD 173

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 54/253 (21%), Positives = 101/253 (39%), Gaps = 56/253 (22%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
            +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL  F
Sbjct: 210 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 268

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +       + + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   K+
Sbjct: 269 L----KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 321

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGCRK- 299
           +DFGLA+L   +    +R  A+    + APE      F        +G++L E+    + 
Sbjct: 322 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

Query: 300 -----NNDPAVEIQSQIY-------FPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA 347
                 N   ++   + Y        PE +++ M                          
Sbjct: 381 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC------------------------- 415

Query: 348 IWCIQWNPTERPS 360
             C +  P ERP+
Sbjct: 416 -QCWRKEPEERPT 427

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.5 bits (240), Expect = 4e-22
 Identities = 54/253 (21%), Positives = 101/253 (39%), Gaps = 56/253 (22%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
            +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL  F
Sbjct: 293 RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 351

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +       + + L   +L  +A  +A G+ Y+ +      +H D++  NIL+  N   K+
Sbjct: 352 L----KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV 404

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC-------YGMMLLEMVGCRK- 299
           +DFGLA+L   +    +R  A+    + APE      F        +G++L E+    + 
Sbjct: 405 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 463

Query: 300 -----NNDPAVEIQSQIY-------FPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA 347
                 N   ++   + Y        PE +++ M                          
Sbjct: 464 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC------------------------- 498

Query: 348 IWCIQWNPTERPS 360
             C +  P ERP+
Sbjct: 499 -QCWRKEPEERPT 510

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 22/167 (13%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL-IYEFMPNGSL 185
             AVK L      G   +F+ E   +    H +++ LLG C       L +  +M +G L
Sbjct: 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           + FI      +     + + L      VA+G+++L     ++ +H D+   N +LD  F 
Sbjct: 179 RNFI-----RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFT 230

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSG------YIAPE-LFSRNF 285
            K++DFGL    ++D+      +    +G      ++A E L ++ F
Sbjct: 231 VKVADFGL----ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 18/139 (12%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVKML         +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L  
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116

Query: 188 F------------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           F                        L  E L   ++ VA+G+ +L     +  +H D+  
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA 173

Query: 236 HNILLDHNFQPKISDFGLA 254
            NILL H    KI DFGLA
Sbjct: 174 RNILLTHGRITKICDFGLA 192

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 23/145 (15%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           AVKML         ++ ++E   + +++H H+++L G CS+     LI E+   GSL+ F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116

Query: 189 ------------------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
                               S  +    R L+   L   A+ +++G++YL +    +++H
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVH 173

Query: 231 FDIKPHNILLDHNFQPKISDFGLAK 255
            D+   NIL+    + KISDFGL++
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSR 198

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 43/145 (29%), Positives = 67/145 (46%), Gaps = 23/145 (15%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           AVKML  E       +F  E A +    + +IV+LLG C+ G    L++E+M  G L +F
Sbjct: 81  AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140

Query: 189 ------------------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
                               ++ +S     LS  +   IA  VA G+ YL +   ++ +H
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197

Query: 231 FDIKPHNILLDHNFQPKISDFGLAK 255
            D+   N L+  N   KI+DFGL++
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSR 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 93.2 bits (232), Expect = 7e-22
 Identities = 55/250 (22%), Positives = 85/250 (34%), Gaps = 63/250 (25%)

Query: 143 QEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
           Q  + EV     +  H H+VR     +E +   +  E+   GSL   I    N       
Sbjct: 55  QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYF 112

Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--------------- 246
              +L+ +   V RG+ Y+H      ++H DIKP NI +     P               
Sbjct: 113 KEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169

Query: 247 ----KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLE 293
               KI D G     S            G S ++A E+   N+ +          + ++ 
Sbjct: 170 KVMFKIGDLGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVC 223

Query: 294 MVGCR---KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWC 350
             G     +N D   EI+ Q   P       R+ Q L  +F E           ++    
Sbjct: 224 AAGAEPLPRNGDQWHEIR-QGRLP-------RIPQVLSQEFTE-----------LLK-VM 263

Query: 351 IQWNPTERPS 360
           I  +P  RPS
Sbjct: 264 IHPDPERRPS 273

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 16/138 (11%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L++
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130

Query: 188 F----------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           +               N     Q++++ L    + +ARG+EYL     Q+ +H D+   N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN 187

Query: 238 ILLDHNFQPKISDFGLAK 255
           +L+  N   KI+DFGLA+
Sbjct: 188 VLVTENNVMKIADFGLAR 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 94.4 bits (235), Expect = 8e-22
 Identities = 38/132 (28%), Positives = 68/132 (51%), Gaps = 10/132 (7%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K L   + +   ++F+ E + +G+  H +I+RL G  ++     ++ E+M NGSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +          Q +  +L  +  G+A G++YL        +H D+   NIL++ N   K+
Sbjct: 137 L-----RKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKV 188

Query: 249 SDFGLAKLCSKD 260
           SDFGL ++   D
Sbjct: 189 SDFGLGRVLEDD 200

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 46/266 (17%), Positives = 90/266 (33%), Gaps = 67/266 (25%)

Query: 131 AVKMLEHLKGNGQE---FINEVATIGRIHH--FHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           A+K +   + + Q    + NE+A + ++      I+RL  +        ++ E   N  L
Sbjct: 84  AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDL 142

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++         + +   + +     +   V  +HQ     I+H D+KP N L+     
Sbjct: 143 NSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-M 192

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY------------------ 287
            K+ DFG+A     D + V + +  G   Y+ PE                          
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252

Query: 288 -GMMLLEMVGCR------KNNDPA----VEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD 336
            G +L  M   +       N        ++   +I FP+         ++   D      
Sbjct: 253 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-------EKDLQDV----- 300

Query: 337 EGIARKLAIVAIWCIQWNPTERPSMP 362
             +          C++ +P +R S+P
Sbjct: 301 --LKC--------CLKRDPKQRISIP 316

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 9/131 (6%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           AVK L     + +  +F+ E   I + +H +IVR +G   +   R ++ E M  G L+ F
Sbjct: 64  AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123

Query: 189 IFSKTNSSSH-RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNF 244
           +       S    L+   L  +A  +A G +YL +      +H DI   N LL       
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGR 180

Query: 245 QPKISDFGLAK 255
             KI DFG+A+
Sbjct: 181 VAKIGDFGMAR 191

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 31/198 (15%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            +AVK +  L       + E+  +     H +++R     +      +  E   N +LQ 
Sbjct: 41  PVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQD 97

Query: 188 FIFSKTNSSSHRQLSWEK-LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---- 242
            + SK  S  + +L  E     +   +A GV +LH     +I+H D+KP NIL+      
Sbjct: 98  LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRF 154

Query: 243 ---------NFQPKISDFGLAKLCSKDISIVSRTA--ARGTSGYIAPELFSRNFCYGMML 291
                    N +  ISDFGL K      S          GTSG+ APEL   +       
Sbjct: 155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEES------- 207

Query: 292 LEMVGCRKNNDPAVEIQS 309
              +  ++    +++I S
Sbjct: 208 -NNLQTKRRLTRSIDIFS 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 11/128 (8%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 105

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +           L    L   A+ ++  + YL     +R +H DI   N+L+  N   K+
Sbjct: 106 L-----QVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKL 157

Query: 249 SDFGLAKL 256
            DFGL++ 
Sbjct: 158 GDFGLSRY 165

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 9/131 (6%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           AVK L     + +  +F+ E   I + +H +IVR +G   +   R ++ E M  G L+ F
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164

Query: 189 I-FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNF 244
           +  ++   S    L+   L  +A  +A G +YL +      +H DI   N LL       
Sbjct: 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGR 221

Query: 245 QPKISDFGLAK 255
             KI DFG+A+
Sbjct: 222 VAKIGDFGMAR 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 16/138 (11%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVKML  +  + +  + ++E+  +  I  H +I+ LLG C++     +I E+   G+L++
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176

Query: 188 F----------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           +               N     Q++++ L    + +ARG+EYL     Q+ +H D+   N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN 233

Query: 238 ILLDHNFQPKISDFGLAK 255
           +L+  N   KI+DFGLA+
Sbjct: 234 VLVTENNVMKIADFGLAR 251

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 13/133 (9%)

Query: 131 AVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVK+L++         E + E   + ++ + +IVR++G C       L+ E    G L K
Sbjct: 48  AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNK 106

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++        +R +  + + ++   V+ G++YL +      +H D+   N+LL      K
Sbjct: 107 YL------QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAK 157

Query: 248 ISDFGLAKLCSKD 260
           ISDFGL+K    D
Sbjct: 158 ISDFGLSKALRAD 170

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 90.8 bits (226), Expect = 4e-21
 Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 8/144 (5%)

Query: 143 QEFINEVATIGRIHHFHIVRLLG-FCSEGNRRTLIY-EFMPNGSLQKFIFSKTNSSSHRQ 200
           Q  ++EV  +  + H +IVR         N    I  E+   G L   I     +   + 
Sbjct: 50  QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQY 107

Query: 201 LSWEKLRKIAFGVARGVEYLHQ--GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 258
           L  E + ++   +   ++  H+       +LH D+KP N+ LD     K+ DFGLA++ +
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167

Query: 259 KDISIVSRTAARGTSGYIAPELFS 282
            D S  ++T   GT  Y++PE  +
Sbjct: 168 HDTS-FAKTFV-GTPYYMSPEQMN 189

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 33/138 (23%), Positives = 66/138 (47%), Gaps = 9/138 (6%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EVA +  + H +IV+      E     ++ ++   G L K I    N+       
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQ 123

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
            +++      +   ++++H    ++ILH DIK  NI L  +   ++ DFG+A++ +  + 
Sbjct: 124 EDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180

Query: 263 IVSRTAARGTSGYIAPEL 280
            ++R    GT  Y++PE+
Sbjct: 181 -LARACI-GTPYYLSPEI 196

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.5 bits (232), Expect = 5e-21
 Identities = 35/134 (26%), Positives = 66/134 (49%), Gaps = 11/134 (8%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++A+K+L     K + +E + E   + ++ + +IVRL+G C       L+ E    G L 
Sbjct: 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLH 423

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+          ++    + ++   V+ G++YL +   +  +H ++   N+LL +    
Sbjct: 424 KFL-----VGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYA 475

Query: 247 KISDFGLAKLCSKD 260
           KISDFGL+K    D
Sbjct: 476 KISDFGLSKALGAD 489

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 90.7 bits (226), Expect = 5e-21
 Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 11/128 (8%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           AVK    +    N ++F++E   +  + H HIV+L+G   E     +I E  P G L  +
Sbjct: 44  AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHY 102

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +       +   L    L   +  + + + YL        +H DI   NIL+      K+
Sbjct: 103 L-----ERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKL 154

Query: 249 SDFGLAKL 256
            DFGL++ 
Sbjct: 155 GDFGLSRY 162

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 90.3 bits (225), Expect = 6e-21
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 18/164 (10%)

Query: 125 LHSNEI-AVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
             +  I A+K+L    L+  G E     E+     + H +I+R+  +  +  R  L+ EF
Sbjct: 36  KQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
            P G L K +        H +   ++       +A  + Y H+   ++++H DIKP N+L
Sbjct: 96  APRGELYKEL------QKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLL 146

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           + +  + KI+DFG +       S+  RT   GT  Y+ PE+   
Sbjct: 147 MGYKGELKIADFGWSVHAP---SLRRRTMC-GTLDYLPPEMIEG 186

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 41/138 (29%), Positives = 72/138 (52%), Gaps = 16/138 (11%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L++
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164

Query: 188 F----------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           +               + +   QLS + L   A+ VARG+EYL     ++ +H D+   N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221

Query: 238 ILLDHNFQPKISDFGLAK 255
           +L+  +   KI+DFGLA+
Sbjct: 222 VLVTEDNVMKIADFGLAR 239

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 23/144 (15%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVKML  +      +  ++E+  + ++  H +IV LLG C+      LI+E+   G L  
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138

Query: 188 F-----------------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
           +                             L++E L   A+ VA+G+E+L     +  +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH 195

Query: 231 FDIKPHNILLDHNFQPKISDFGLA 254
            D+   N+L+ H    KI DFGLA
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLA 219

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 90.1 bits (224), Expect = 8e-21
 Identities = 47/267 (17%), Positives = 90/267 (33%), Gaps = 65/267 (24%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN---------RRTLIY-- 177
            I +   E  +   ++ + EV  + ++ H  IVR      E N          +  +Y  
Sbjct: 37  RIRLPNRELAR---EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ 93

Query: 178 -EFMPNGSLQKFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
            +     +L+ ++    T     R +      +IA      VE+LH   ++ ++H D+KP
Sbjct: 94  MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA----EAVEFLH---SKGLMHRDLKP 146

Query: 236 HNILLDHNFQPKISDFGLAKL----------CSKDISIVSRTAARGTSGYIAPELFSRN- 284
            NI    +   K+ DFGL              +   +    T   GT  Y++PE    N 
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206

Query: 285 -------FCYGMMLLEM-VGCRKNNDPAV---EIQSQIYFPEWIYNRMRLGQELCLDFEE 333
                  F  G++L E+        +      ++++  + P +                 
Sbjct: 207 YSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLF----------------- 249

Query: 334 DGDEGIARKLAIVAIWCIQWNPTERPS 360
                      ++    +  +P ERP 
Sbjct: 250 ---TQKYPCEYVMVQDMLSPSPMERPE 273

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 91.0 bits (226), Expect = 9e-21
 Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           + AVK +  L+    E   E+     +    IV L G   EG    +  E +  GSL + 
Sbjct: 85  QCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPK 247
           I           L  ++          G+EYLH    +RILH D+K  N+LL  +  +  
Sbjct: 141 I------KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAA 191

Query: 248 ISDFGLAKLCSKDI---SIVSRTAARGTSGYIAPE 279
           + DFG A     D    S+++     GT  ++APE
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 36/136 (26%), Positives = 57/136 (41%), Gaps = 13/136 (9%)

Query: 129 EIAVKML----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            +AVK L            +FI EV  +  + H +++RL G         ++ E  P GS
Sbjct: 48  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGS 106

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +  + +           L + A  VA G+ YL     +R +H D+   N+LL    
Sbjct: 107 LLDRL--RKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRD 158

Query: 245 QPKISDFGLAKLCSKD 260
             KI DFGL +   ++
Sbjct: 159 LVKIGDFGLMRALPQN 174

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 31/138 (22%), Positives = 62/138 (44%), Gaps = 7/138 (5%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
            + I E+  + +++H ++++      E N   ++ E    G L + I  K      R + 
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIP 134

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
              + K    +   +E++H    +R++H DIKP N+ +      K+ D GL +  S   +
Sbjct: 135 ERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191

Query: 263 IVSRTAARGTSGYIAPEL 280
             + +   GT  Y++PE 
Sbjct: 192 -AAHSLV-GTPYYMSPER 207

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 41/139 (29%), Positives = 63/139 (45%), Gaps = 17/139 (12%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRT-LIYEFMPNGSLQ 186
           AVKML         +  ++E+  +  I HH ++V LLG C++      +I EF   G+L 
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120

Query: 187 KF----------IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
            +                      L+ E L   +F VA+G+E+L     ++ +H D+   
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR 177

Query: 237 NILLDHNFQPKISDFGLAK 255
           NILL      KI DFGLA+
Sbjct: 178 NILLSEKNVVKICDFGLAR 196

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 44/229 (19%), Positives = 79/229 (34%), Gaps = 42/229 (18%)

Query: 143 QEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
              + EV +  ++  H   VRL     EG    L  E     SLQ+        +    L
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-----EAWGASL 154

Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 261
              ++          + +LH   +Q ++H D+KP NI L    + K+ DFGL        
Sbjct: 155 PEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211

Query: 262 SIVSRTAARGTSGYIAPELFSRNFCY-------GMMLLEMVGCRK---NNDPAVEIQSQI 311
           +   +    G   Y+APEL   ++         G+ +LE+    +     +   +++   
Sbjct: 212 AGEVQE---GDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY 268

Query: 312 YFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
             PE           L  +               V +  ++ +P  R +
Sbjct: 269 LPPE-------FTAGLSSELRS------------VLVMMLEPDPKLRAT 298

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 30/188 (15%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           ++AVK +  L         EV  +     H +++R      +   + +  E     +LQ+
Sbjct: 50  DVAVKRI--LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE 106

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-----DH 242
           ++  K  +    +        +      G+ +LH      I+H D+KPHNIL+       
Sbjct: 107 YVEQKDFAHLGLEP-----ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHG 158

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRNFCYGMMLLEMVGCRKNN 301
             +  ISDFGL K  +      SR +   GT G+IAPE+ S +            C++N 
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED------------CKENP 206

Query: 302 DPAVEIQS 309
              V+I S
Sbjct: 207 TYTVDIFS 214

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 43/175 (24%), Positives = 78/175 (44%), Gaps = 20/175 (11%)

Query: 131 AVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           A+K           ++F+ E  T+ +  H HIV+L+G  +E N   +I E    G L+ F
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 480

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +           L    L   A+ ++  + YL     +R +H DI   N+L+  N   K+
Sbjct: 481 L-----QVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKL 532

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNF-------CYGMMLLEMV 295
            DFGL++   +D +    +  +    ++APE +  R F        +G+ + E++
Sbjct: 533 GDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 21/171 (12%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLL------GFCSEGNRRTLIYEFM 180
           ++A+K    E    N + +  E+  + +++H ++V            +  +   L  E+ 
Sbjct: 41  QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L+K++    N      L    +R +   ++  + YLH+    RI+H D+KP NI+L
Sbjct: 101 EGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVL 154

Query: 241 DHNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
               Q    KI D G AK   +           GT  Y+APEL  +   Y 
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLAPELLEQK-KYT 201

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 22/179 (12%)

Query: 129 EIAVKML-EHLKGNGQ---EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           ++A+K +    +   +    F  EV    ++ H +IV ++    E +   L+ E++   +
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L ++I       SH  LS +        +  G+++ H     RI+H DIKP NIL+D N 
Sbjct: 98  LSEYI------ESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNK 148

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFC------Y--GMMLLEMV 295
             KI DFG+AK  S + S+       GT  Y +PE             Y  G++L EM+
Sbjct: 149 TLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 87.7 bits (218), Expect = 6e-20
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 12/153 (7%)

Query: 130 IAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           IA+K +        Q    E+A    + H +IV+ LG  SE     +  E +P GSL   
Sbjct: 50  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109

Query: 189 IFSKTNSSSHRQLSWEKL-RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQP 246
           + SK           E+        +  G++YLH     +I+H DIK  N+L++ ++   
Sbjct: 110 LRSKWGPLKDN----EQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVL 162

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           KISDFG +K  +            GT  Y+APE
Sbjct: 163 KISDFGTSKRLAGINP--CTETFTGTLQYMAPE 193

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 12/163 (7%)

Query: 130 IAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           + V       G   E +  E +    + H HIV LL   S      +++EFM    L   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQ 245
           I  +  + +    S          +   + Y H      I+H D+KPH +LL   +++  
Sbjct: 117 IVKR--ADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAP 171

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
            K+  FG+A    +   +       GT  ++APE+  R   YG
Sbjct: 172 VKLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEVVKRE-PYG 211

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 30/141 (21%), Positives = 62/141 (43%), Gaps = 17/141 (12%)

Query: 129 EIAVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+ +K+L +  +   + F    + + ++ H H+V   G C  G+   L+ EF+  GSL  
Sbjct: 42  EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP- 246
           ++  K N +    ++     ++A  +A  + +L +     ++H ++   NILL       
Sbjct: 102 YL--KKNKN---CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRK 153

Query: 247 -------KISDFGLAKLCSKD 260
                  K+SD G++      
Sbjct: 154 TGNPPFIKLSDPGISITVLPK 174

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 42/180 (23%), Positives = 67/180 (37%), Gaps = 28/180 (15%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRT-------LIYEFM 180
            +     E      +  I EV  + ++  H +IV+     S G   +       L+   +
Sbjct: 60  RLLSNEEEKN----RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL 115

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
             G L +F+       S   LS + + KI +   R V+++H+     I+H D+K  N+LL
Sbjct: 116 CKGQLVEFL---KKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLL 171

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAAR----------GTSGYIAPELFS--RNFCYG 288
            +    K+ DFG A   S           R           T  Y  PE+     NF  G
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 15/165 (9%)

Query: 129 EIAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           E  +K +     +   ++   E+  +  + H +I+++     + +   ++ E    G L 
Sbjct: 49  ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL 108

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHN 243
           + I S         LS   + ++   +   + Y H    Q ++H D+KP NIL      +
Sbjct: 109 ERIVSAQARGKA--LSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPH 163

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
              KI DFGLA+L   D       AA GT+ Y+APE+F R+    
Sbjct: 164 SPIKIIDFGLAELFKSDEHS--TNAA-GTALYMAPEVFKRD--VT 203

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 85.0 bits (211), Expect = 8e-19
 Identities = 39/184 (21%), Positives = 80/184 (43%), Gaps = 26/184 (14%)

Query: 129 EIAVKML-EHLKGNGQ---EFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIY----EFM 180
           ++AVK+L   L  +      F  E      ++H  IV +            +     E++
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
              +L+  +       +   ++ ++  ++     + + + HQ     I+H D+KP NI++
Sbjct: 99  DGVTLRDIV------HTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMI 149

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRNFC------Y--GMML 291
                 K+ DFG+A+  +   + V++TAA  GT+ Y++PE    +        Y  G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209

Query: 292 LEMV 295
            E++
Sbjct: 210 YEVL 213

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 86.8 bits (215), Expect = 8e-19
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 14/152 (9%)

Query: 131 AVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           A K +     + +E +  E+ T+  + H  +V L     + N   +IYEFM  G L + +
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--K 247
             + N  S  +   E +R++     +G+ ++H+      +H D+KP NI+         K
Sbjct: 246 ADEHNKMSEDEAV-EYMRQVC----KGLCHMHE---NNYVHLDLKPENIMFTTKRSNELK 297

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           + DFGL        S+       GT+ + APE
Sbjct: 298 LIDFGLTAHLDPKQSV---KVTTGTAEFAAPE 326

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 35/163 (21%), Positives = 64/163 (39%), Gaps = 27/163 (16%)

Query: 125 LHSNEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNR--RTLIY-- 177
           ++   + +K L    G+ +     + E   +  + H  IV++  F    +R    + Y  
Sbjct: 104 VNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162

Query: 178 -EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
            E++   SL++           ++L   +       +   + YLH      +++ D+KP 
Sbjct: 163 MEYVGGQSLKRSK--------GQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPE 211

Query: 237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           NI+L    Q K+ D G          I S     GT G+ APE
Sbjct: 212 NIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPE 247

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 19/166 (11%)

Query: 129 EIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           E A K++   K + ++      E     ++ H +IVRL     E +   L+++ +  G L
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DH 242
            + I ++         S          +   + Y H      I+H ++KP N+LL     
Sbjct: 93  FEDIVAREF------YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 143

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
               K++DFGLA   +   +      A GT GY++PE+  ++  Y 
Sbjct: 144 GAAVKLADFGLAIEVNDSEAW--HGFA-GTPGYLSPEVLKKD-PYS 185

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 34/188 (18%), Positives = 59/188 (31%), Gaps = 28/188 (14%)

Query: 129 EIAVKMLEHLKGNGQEF---INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +  +K+ +    N  EF      +  +        ++        N   L+ E    G+L
Sbjct: 97  KFVLKVQK--PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
              I    N+     +    +   A  +   +E +H   +  I+H DIKP N +L + F 
Sbjct: 155 LNAINLYKNTPEKV-MPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFL 210

Query: 246 P-----------KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FC 286
                        + D G +            TA   TSG+   E+ S          F 
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270

Query: 287 YGMMLLEM 294
               +  M
Sbjct: 271 VAATVYCM 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 17/150 (11%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +++ L           LI E +  G L  F+  K +      LS
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LS 113

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCS 258
            E+       +  GV YLH    ++I HFD+KP NI+L     P    K+ DFGLA    
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 259 KDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             +    +    GT  ++APE+ +     G
Sbjct: 171 DGVEF--KNIF-GTPEFVAPEIVNYEP-LG 196

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 23/167 (13%)

Query: 129 EIAVKML----------EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIY 177
           E AVK++          E ++   +  + EV  + ++  H +I++L           L++
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103

Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           + M  G L  ++  K        LS ++ RKI   +   +  LH      I+H D+KP N
Sbjct: 104 DLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALH---KLNIVHRDLKPEN 154

Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           ILLD +   K++DFG +        +  R    GT  Y+APE+   +
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKL--REVC-GTPSYLAPEIIECS 198

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 17/150 (11%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV+ + ++ H +I+ L           LI E +  G L  F+  K +      LS
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LS 113

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCS 258
            E+       +  GV YLH    ++I HFD+KP NI+L     P    K+ DFGLA    
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 259 KDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             +    +    GT  ++APE+ +     G
Sbjct: 171 DGVEF--KNIF-GTPEFVAPEIVNYEP-LG 196

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 82.2 bits (204), Expect = 5e-18
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +E   EV  +  I H +I+ L           LI E +  G L  F+  K +      L+
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LT 106

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCS 258
            ++  +    +  GV YLH    +RI HFD+KP NI+L     P    K+ DFG+A    
Sbjct: 107 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163

Query: 259 KDISIVSRTAARGTSGYIAPELFSRNFCYG 288
                  +    GT  ++APE+ +     G
Sbjct: 164 AGNEF--KNIF-GTPEFVAPEIVNYEP-LG 189

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 39/137 (28%), Positives = 73/137 (53%), Gaps = 14/137 (10%)

Query: 148 EVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           E+A + ++ H ++V+L+    + N   L  ++E +  G + +         + + LS ++
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------TLKPLSEDQ 138

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 265
            R     + +G+EYLH    Q+I+H DIKP N+L+  +   KI+DFG++       +++S
Sbjct: 139 ARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195

Query: 266 RTAARGTSGYIAPELFS 282
            T   GT  ++APE  S
Sbjct: 196 NTV--GTPAFMAPESLS 210

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 82.6 bits (204), Expect = 7e-18
 Identities = 40/203 (19%), Positives = 76/203 (37%), Gaps = 44/203 (21%)

Query: 178 EFMPNGSLQKFIFSKTNSSSHR-QLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           +     +L+ ++  + +       +      +IA      VE+LH    + ++H D+KP 
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA----EAVEFLHS---KGLMHRDLKPS 193

Query: 237 NILLDHNFQPKISDFGLAK----------LCSKDISIVSRTAARGTSGYIAPELFSRN-- 284
           NI    +   K+ DFGL            + +   +  + T   GT  Y++PE    N  
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253

Query: 285 ------FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC-LDFEEDGDE 337
                 F  G++L E+                +Y       R+R+  ++  L F     +
Sbjct: 254 SHKVDIFSLGLILFEL----------------LYSFSTQMERVRIITDVRNLKFPLLFTQ 297

Query: 338 GIARKLAIVAIWCIQWNPTERPS 360
              ++  +V    +  +PTERP 
Sbjct: 298 KYPQEHMMVQ-DMLSPSPTERPE 319

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 35/239 (14%), Positives = 74/239 (30%), Gaps = 49/239 (20%)

Query: 145 FINEVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           FI     +       ++R+     +    +   +Y  M +          ++SS+H+ L 
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 262
                ++   V R +  LH      ++H  ++P +I+LD      ++ F           
Sbjct: 205 HHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--- 258

Query: 263 IVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-----I 317
              R  +  + G+  PEL +R              R     + +         W     I
Sbjct: 259 ---RVVSSVSRGFEPPELEARRATISYHRDR----RTLMTFSFDA--------WALGLVI 303

Query: 318 YNRMRLGQELCLD--FEEDGDEGIARKL------------AIVAIWCIQWNPTERPSMP 362
           Y  +      C D    +D   G +  +            A++    +++   +R    
Sbjct: 304 Y-WI-----WCADLPITKDAALGGSEWIFRSCKNIPQPVRALLE-GFLRYPKEDRLLPL 355

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 37/109 (33%), Positives = 65/109 (59%), Gaps = 4/109 (3%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  + H +IVRL       N+ TL++EFM N  L+K++ S+T  ++ R L    
Sbjct: 51  IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 254
           ++   + + +G+ + H+    +ILH D+KP N+L++   Q K+ DFGLA
Sbjct: 110 VKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 19/166 (11%)

Query: 129 EIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           E A K++   K + ++      E     ++ H +IVRL     E +   L+++ +  G L
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DH 242
            + I ++         S          +   + Y H      I+H ++KP N+LL     
Sbjct: 116 FEDIVAREF------YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 166

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
               K++DFGLA   +   +      A GT GY++PE+  ++  Y 
Sbjct: 167 GAAVKLADFGLAIEVNDSEAW--HGFA-GTPGYLSPEVLKKD-PYS 208

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 20/163 (12%)

Query: 131 AVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           A+K ++           NE+A + +I H +IV L           L+ + +  G L   I
Sbjct: 38  ALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI 97

Query: 190 FSKTNSSSHRQLSWEKL-RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQ 245
             +   +       EK    +   V   V+YLH+     I+H D+KP N+L    + N +
Sbjct: 98  LERGVYT-------EKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSK 147

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             I+DFGL+K+       +  TA  GT GY+APE+ ++   Y 
Sbjct: 148 IMITDFGLSKMEQNG---IMSTAC-GTPGYVAPEVLAQK-PYS 185

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 42/162 (25%), Positives = 72/162 (44%), Gaps = 19/162 (11%)

Query: 131 AVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           AVK++       K + +  + EV  + ++ H +I++L  F  +     L+ E    G L 
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHN 243
             I S+         S     +I   V  G+ Y+H+    +I+H D+KP N+LL     +
Sbjct: 115 DEIISRKR------FSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKD 165

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
              +I DFGL+        +  +    GT+ YIAPE+    +
Sbjct: 166 ANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVLHGTY 204

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 17/165 (10%)

Query: 127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
                    ++++   +E  NE++ +  + H +I++L     +     L+ EF   G L 
Sbjct: 75  DKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL- 133

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHN 243
              F +  +             I   +  G+ YLH+     I+H DIKP NILL   +  
Sbjct: 134 ---FEQIINRHK--FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
              KI DFGL+   SKD  +  R    GT+ YIAPE+  +   Y 
Sbjct: 186 LNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEVLKKK--YN 225

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 40/184 (21%)

Query: 130 IAVKMLEHLKGNGQEF---INEVATIGRIHHFHIVRLLG-FCSEGNRRTLIY---EFMPN 182
           +A K++ HL+         I E+  +   +  +IV   G F S+G     I    E M  
Sbjct: 61  MARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDG 115

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GSL + +          ++  + L K++  V +G+ YL +    +I+H D+KP NIL++ 
Sbjct: 116 GSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNS 167

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAAR---GTSGYIAPELFSRNFCY---------GMM 290
             + K+ DFG++         +  + A    GT  Y++PE       Y         G+ 
Sbjct: 168 RGEIKLCDFGVS-------GQLIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLS 219

Query: 291 LLEM 294
           L+EM
Sbjct: 220 LVEM 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 29/163 (17%), Positives = 60/163 (36%), Gaps = 14/163 (8%)

Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
                K ++    +      E++ +    H +I+ L           +I+EF+    + +
Sbjct: 31  KTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQ 245
            I +     + R++    + ++       +++LH      I HFDI+P NI+     +  
Sbjct: 91  RINTSAFELNEREIV-SYVHQV----CEALQFLHS---HNIGHFDIRPENIIYQTRRSST 142

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
            KI +FG A+      +            Y APE+   +    
Sbjct: 143 IKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDV-VS 181

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E AVK+++  K +  E   E+  + R   H +I+ L     +G    ++ E M  G L  
Sbjct: 49  EFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLD 105

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNF 244
            I  +      +  S  +   + F + + VEYLH    Q ++H D+KP NIL      N 
Sbjct: 106 KILRQ------KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNP 156

Query: 245 QP-KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
           +  +I DFG AK    +  ++  T    T+ ++APE+  R   Y 
Sbjct: 157 ESIRICDFGFAKQLRAENGLLM-TPC-YTANFVAPEVLERQ-GYD 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 39/164 (23%), Positives = 70/164 (42%), Gaps = 15/164 (9%)

Query: 128 NEIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
                K +       +  + NE++ + ++HH  ++ L     +     LI EF+  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NF 244
             I ++    S  ++    +R+       G++++H+     I+H DIKP NI+ +     
Sbjct: 137 DRIAAEDYKMSEAEVI-NYMRQAC----EGLKHMHE---HSIVHLDIKPENIMCETKKAS 188

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             KI DFGLA   + D  +        T+ + APE+  R    G
Sbjct: 189 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREP-VG 228

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 38/179 (21%), Positives = 66/179 (36%), Gaps = 22/179 (12%)

Query: 129 EIAVKML-EHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            +A+K++ E L  +         E  T GR+   H+V +  F     +  +    +    
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +           L+  +   I   +   ++  H        H D+KP NIL+  + 
Sbjct: 121 LAAML------RRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADD 171

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFC------Y--GMMLLEMV 295
              + DFG+A   + D  +       GT  Y+APE FS +        Y    +L E +
Sbjct: 172 FAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 14/161 (8%)

Query: 128 NEIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            ++A K+++      +E + NE++ + ++ H ++++L       N   L+ E++  G L 
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL- 173

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NF 244
              F +    S+  L+          +  G+ ++HQ     ILH D+KP NIL  +    
Sbjct: 174 ---FDRIIDESYN-LTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAK 226

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
           Q KI DFGLA+       +  +    GT  ++APE+ + +F
Sbjct: 227 QIKIIDFGLARRYKPREKL--KVNF-GTPEFLAPEVVNYDF 264

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 32/110 (29%), Positives = 63/110 (57%), Gaps = 8/110 (7%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  ++H +IV+LL      N+  L++EF+    L+KF+    ++S+   +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM----DASALTGIPLPL 104

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++   F + +G+ + H     R+LH D+KP N+L++     K++DFGLA+
Sbjct: 105 IKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 22/159 (13%)

Query: 130 IAVKMLEHLKGNGQEF---INEVATIGR-IHHFHIVRLLG-FCSEGNRRTLIY---EFMP 181
           +AVK +     + +E    + ++  + R     +IV+  G    EG+     +   E M 
Sbjct: 50  MAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD----CWICMELM- 103

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           + S  KF      S     +  E L KI     + + +L +  N +I+H DIKP NILLD
Sbjct: 104 STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLD 160

Query: 242 HNFQPKISDFGL-AKLCSKDISIVSRTAARGTSGYIAPE 279
            +   K+ DFG+  +L    +  +++T   G   Y+APE
Sbjct: 161 RSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPE 195

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 15/158 (9%)

Query: 129 EIAVKMLEHLKGNGQEFIN---EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           E+A+K+++  + N         EV  +  ++H +IV+L           LI E+   G +
Sbjct: 42  EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 101

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             ++       +H ++  ++ R     +   V+Y HQ   +RI+H D+K  N+LLD +  
Sbjct: 102 FDYL------VAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMN 152

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
            KI+DFG +   +    +       G   Y APELF  
Sbjct: 153 IKIADFGFSNEFTVGGKL--DAFC-GAPPYAAPELFQG 187

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 38/164 (23%), Positives = 60/164 (36%), Gaps = 18/164 (10%)

Query: 129 EIAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
             A K +        + F  E+  +  + H +I+RL     +     L+ E    G L +
Sbjct: 36  RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE 95

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNF 244
            +  K               +I   V   V Y H+     + H D+KP N L      + 
Sbjct: 96  RVVHKRV------FRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDS 146

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             K+ DFGLA        +  RT   GT  Y++P++      YG
Sbjct: 147 PLKLIDFGLAARFKPGKMM--RTKV-GTPYYVSPQVLEGL--YG 185

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 18/161 (11%)

Query: 131 AVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           A+K++     +       + EVA +  + H +I++L  F  +     L+ E    G L  
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNF 244
            I  +         +      I   V  GV YLH+     I+H D+KP N+LL   + + 
Sbjct: 126 EIIHRMK------FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDA 176

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNF 285
             KI DFGL+ +      +  R    GT+ YIAPE+  + +
Sbjct: 177 LIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVLRKKY 214

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 22/166 (13%)

Query: 129 EIAVKML---------EHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYE 178
           E AVK++         E L+   +    E   + ++  H HI+ L+      +   L+++
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
            M  G L  ++  K        LS ++ R I   +   V +LH      I+H D+KP NI
Sbjct: 181 LMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENI 231

Query: 239 LLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           LLD N Q ++SDFG +        +  R    GT GY+APE+   +
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPEILKCS 274

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 78.8 bits (195), Expect = 8e-17
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 24/170 (14%)

Query: 120 SKFFFLHSNEI-AVKMLEHLKGNGQEF---INEVATIGR-IHHFHIVRLLG-FCSEGNRR 173
            K   + S +I AVK +     N QE    + ++    R +     V   G    EG+  
Sbjct: 24  EKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-- 80

Query: 174 TLIY---EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
             ++   E M + SL KF   K      + +  + L KIA  + + +E+LH      ++H
Sbjct: 81  --VWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIH 133

Query: 231 FDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSRTAARGTSGYIAPE 279
            D+KP N+L++   Q K+ DFG+   L      +     A G   Y+APE
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDA-GCKPYMAPE 179

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 25/170 (14%)

Query: 131 AVKMLEHLKGNGQE---------FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           A++++   K                 E+  + +++H  I+++  F  +     ++ E M 
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELME 222

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL- 240
            G L   +           L     +   + +   V+YLH+     I+H D+KP N+LL 
Sbjct: 223 GGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLS 273

Query: 241 --DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             + +   KI+DFG +K+  +   +  RT   GT  Y+APE+       G
Sbjct: 274 SQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPEVLVSVGTAG 320

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 15/150 (10%)

Query: 143 QEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQL 201
            E ++E+A +        ++ L       +   LI E+   G +      +        +
Sbjct: 73  AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM----V 128

Query: 202 SWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS 258
           S   + ++   +  GV YLHQ     I+H D+KP NILL         KI DFG+++   
Sbjct: 129 SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 259 KDISIVSRTAARGTSGYIAPELFSRNFCYG 288
               +  R    GT  Y+APE+ + +    
Sbjct: 186 HACEL--REIM-GTPEYLAPEILNYDP-IT 211

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 21/162 (12%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +AVK++  +      +    E+     ++H ++V+  G   EGN + L  E+   G L 
Sbjct: 34  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93

Query: 187 KFIFSKTNSSSHRQLSWEKLRK-----IAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
             I           +     ++     +A     GV YLH      I H DIKP N+LLD
Sbjct: 94  DRI------EPDIGMPEPDAQRFFHQLMA-----GVVYLHG---IGITHRDIKPENLLLD 139

Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
                KISDFGLA +   +          GT  Y+APEL  R
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 31/169 (18%)

Query: 125 LHSNEIAVK-MLEHLKGNGQEFIN-EVATIGRIHHFHIVRLLG-FCSEGNRRT-----LI 176
           + S+E+A+K +L+      + F N E+  +  + H ++V L   F S G+++      L+
Sbjct: 62  VESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
            E++P  ++ +    +  +   + +    ++   + + R + Y+H      I H DIKP 
Sbjct: 117 LEYVPE-TVYRAS--RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQ 170

Query: 237 NILLD-HNFQPKISDFGLAKLCSKDIS----IVSRTAARGTSGYIAPEL 280
           N+LLD  +   K+ DFG AK+          I SR        Y APEL
Sbjct: 171 NLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-------YRAPEL 212

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 20/164 (12%)

Query: 131 AVKMLE--HLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVK++     K       + EV  + ++ H +I++L     + +   ++ E    G L  
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNF 244
            I  +         S     +I   V  G+ Y+H+     I+H D+KP NILL   + + 
Sbjct: 111 EIIKRKR------FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDC 161

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             KI DFGL+    ++  +  R    GT+ YIAPE+      Y 
Sbjct: 162 DIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPEVLRGT--YD 200

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 18/164 (10%)

Query: 131 AVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           A  ++   K + ++      E      + H +IVRL    SE     LI++ +  G L +
Sbjct: 40  AAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE 99

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNF 244
            I ++         S          +   V + HQ     ++H ++KP N+LL       
Sbjct: 100 DIVAREY------YSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGA 150

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             K++DFGLA     +       A  GT GY++PE+  ++  YG
Sbjct: 151 AVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKD-PYG 191

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           ++   EV+ +  I H +++ L           LI E +  G L  F+  K +      L+
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LT 112

Query: 203 WEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCS 258
            E+  +    +  GV YLH     +I HFD+KP NI+L     P    KI DFGLA    
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169

Query: 259 KDISIVSRTAARGTSGYIAPELFSRNFCYG 288
                  +    GT  ++APE+ +     G
Sbjct: 170 FGNEF--KNIF-GTPEFVAPEIVNYEP-LG 195

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 19/161 (11%)

Query: 129 EIAVKMLEHLKGNGQE-FINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           E AVK++E   G+ +     EV  + +   H +++ L+ F  E +R  L++E M  GS+ 
Sbjct: 40  EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI- 98

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
               S  +   H   +  +   +   VA  +++LH   N+ I H D+KP NIL +H  Q 
Sbjct: 99  ---LSHIHKRRH--FNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQV 150

Query: 247 ---KISDFGLAKLCSKDISIVSRTAAR-----GTSGYIAPE 279
              KI DF L      +      +        G++ Y+APE
Sbjct: 151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 24/109 (22%), Positives = 50/109 (45%), Gaps = 9/109 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+  + ++ H ++V LL       R  L++E+  + ++   +         R +    
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-----DRYQRGVPEHL 103

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 254
           ++ I +   + V + H+      +H D+KP NIL+  +   K+ DFG A
Sbjct: 104 VKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFA 149

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 22/165 (13%)

Query: 131 AVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           AVK++       ++    + EV  + ++ H +I++L     + +   ++ E    G L  
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 188 FIFSKTNSSSHRQLSWEKL-RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHN 243
            I  +   S       E    +I   V  G+ Y+H+     I+H D+KP NILL   + +
Sbjct: 111 EIIKRKRFS-------EHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKD 160

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
              KI DFGL+    ++  +  +    GT+ YIAPE+      Y 
Sbjct: 161 CDIKIIDFGLSTCFQQNTKM--KDRI-GTAYYIAPEVLRGT--YD 200

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 15/159 (9%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +AVK++  +      +    E+     ++H ++V+  G   EGN + L  E+   G L 
Sbjct: 34  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             I           +     ++    +  GV YLH      I H DIKP N+LLD     
Sbjct: 94  DRI------EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 144

Query: 247 KISDFGLAKLCSKDISIVS--RTAARGTSGYIAPELFSR 283
           KISDFGLA +  +  +          GT  Y+APEL  R
Sbjct: 145 KISDFGLATV-FRYNNRERLLNKMC-GTLPYVAPELLKR 181

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 43/196 (21%), Positives = 68/196 (34%), Gaps = 42/196 (21%)

Query: 133 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSK 192
           K+ +    + +    EV  + ++HH +I RL     +     L+ E    G L   +   
Sbjct: 63  KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122

Query: 193 TNSSSHRQLSWEKLRKIAFGVAR----------------------------------GVE 218
            + S+ +        +I                                         + 
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182

Query: 219 YLHQGCNQRILHFDIKPHNILL--DHNFQPKISDFGLAKLCSKDISIVSRTAAR--GTSG 274
           YLH    Q I H DIKP N L   + +F+ K+ DFGL+K   K  +          GT  
Sbjct: 183 YLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239

Query: 275 YIAPE-LFSRNFCYGM 289
           ++APE L + N  YG 
Sbjct: 240 FVAPEVLNTTNESYGP 255

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 24/166 (14%)

Query: 125 LHSNEI-AVK-MLEHLKGNGQEFIN-EVATIGRIHHFHIVRLLG-FCSEGNRRT-----L 175
             S E+ A+K +L+      + F N E+  + ++ H +IVRL   F S G ++      L
Sbjct: 76  CDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130

Query: 176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           + +++P  ++ +    +  S + + L    ++   + + R + Y+H   +  I H DIKP
Sbjct: 131 VLDYVPE-TVYRVA--RHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKP 184

Query: 236 HNILLDHN-FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
            N+LLD +    K+ DFG AK   +    VS   +R    Y APEL
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPEL 227

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 76.8 bits (190), Expect = 5e-16
 Identities = 35/110 (31%), Positives = 60/110 (54%), Gaps = 9/110 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  +HH +IV L+         TL++EFM    L+K +       +   L   +
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-----DENKTGLQDSQ 120

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++   + + RGV + HQ    RILH D+KP N+L++ +   K++DFGLA+
Sbjct: 121 IKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 21/163 (12%), Positives = 56/163 (34%), Gaps = 11/163 (6%)

Query: 125 LHSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM-- 180
           +    + +++L  +K     +  +  +     +      +++    +     ++  F   
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 181 --PNGSLQKFIFS-KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
                +LQ F     ++SS+H+ L      ++   V R +  LH      ++H  ++P +
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVD 241

Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           I+LD      ++ F          ++             A  +
Sbjct: 242 IVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPETTAERM 283

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.4 bits (189), Expect = 5e-16
 Identities = 31/110 (28%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+  +  + H +IVRL        + TL++EF     L+K+       S +  L  E 
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-----DSCNGDLDPEI 102

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++   F + +G+ + H    + +LH D+KP N+L++ N + K+++FGLA+
Sbjct: 103 VKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 44/166 (26%), Positives = 67/166 (40%), Gaps = 22/166 (13%)

Query: 129 EIAVKMLEHLKGNGQEFIN---------EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
           E+ VK ++  K     +I          E+A + R+ H +I+++L          L+ E 
Sbjct: 51  EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110

Query: 180 MPNGS-LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
             +G  L  FI        H +L       I   +   V YL     + I+H DIK  NI
Sbjct: 111 HGSGLDLFAFI------DRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENI 161

Query: 239 LLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN 284
           ++  +F  K+ DFG A    +       T   GT  Y APE+   N
Sbjct: 162 VIAEDFTIKLIDFGSAAYLERGKLF--YTFC-GTIEYCAPEVLMGN 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.4 bits (189), Expect = 6e-16
 Identities = 30/110 (27%), Positives = 53/110 (48%), Gaps = 9/110 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I E++ +  + H +IV+L        R  L++E +    L+K +           L    
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL-----DVCEGGLESVT 101

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
            +     +  G+ Y H    +R+LH D+KP N+L++   + KI+DFGLA+
Sbjct: 102 AKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 23/222 (10%), Positives = 50/222 (22%), Gaps = 27/222 (12%)

Query: 152 IGRIHHFHIVRLLGFCSEGNRRTLIYEFMP--NGSLQKFI-FSKTNSSSHRQLSWEKLRK 208
              +        L    +          MP  +  L+                    L  
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198

Query: 209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA 268
           +   + R    L     + ++H    P N+ +  + +  + D                 A
Sbjct: 199 LTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPA 250

Query: 269 ARGTSGYIAPELFSRNFCY----------GMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY 318
           +     Y   E  + +             G+ +  +  C         + +      W  
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW-CLF---LPFGLVTPGIKGSWKR 306

Query: 319 NRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
             +R+     L F          K  I     + ++   R  
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGR--FLNFDRRRRLL 346

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 25/172 (14%)

Query: 129 EIAVKMLEHLKGNGQE---------FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF 179
           ++A+K++   K                 E+  + +++H  I+++  F  +     ++ E 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLEL 95

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           M  G L   +           L     +   + +   V+YLH+     I+H D+KP N+L
Sbjct: 96  MEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVL 146

Query: 240 LDHNFQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
           L    +    KI+DFG +K+  +   +  RT   GT  Y+APE+       G
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPEVLVSVGTAG 195

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 9/109 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+  + ++ H ++V LL  C +  R  L++EF+ + ++   +           L ++ 
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-----ELFPNGLDYQV 125

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 254
           ++K  F +  G+ + H      I+H DIKP NIL+  +   K+ DFG A
Sbjct: 126 VQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 9/110 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           + E+  +  + H +I+ LL      +  +L+++FM    L+  I       +   L+   
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-----KDNSLVLTPSH 113

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++       +G+EYLHQ     ILH D+KP+N+LLD N   K++DFGLAK
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 23/177 (12%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           ++AVKM++  K   +E + NEV  +    HF++V +      G    ++ EF+  G+L  
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +       S  +L+ E++  +   V + + YLH    Q ++H DIK  +ILL  + + K
Sbjct: 132 IV-------SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVK 181

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMV 295
           +SDFG     SKD+    R +  GT  ++APE+ SR+  Y         G+M++EMV
Sbjct: 182 LSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMV 235

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 37/166 (22%), Positives = 74/166 (44%), Gaps = 15/166 (9%)

Query: 129 EIAVKMLEHLK----GNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRT--LIYEFMP 181
             AVK+L+  K     NG+  +  E+  + R+ H ++++L+       ++   ++ E+  
Sbjct: 32  RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV 91

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G  +       +S   ++    +       +  G+EYLH    Q I+H DIKP N+LL 
Sbjct: 92  CGMQEML-----DSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLT 143

Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY 287
                KIS  G+A+      +  +   ++G+  +  PE+ +    +
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.9 bits (185), Expect = 3e-15
 Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I EV+ +  + H +IV L          TL++E++    L++++           ++   
Sbjct: 48  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-----DDCGNIINMHN 101

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           ++   F + RG+ Y H+   Q++LH D+KP N+L++   + K++DFGLA+
Sbjct: 102 VKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR 148

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 41/150 (27%), Positives = 65/150 (43%), Gaps = 18/150 (12%)

Query: 143 QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLS 202
           +    E+  + R+ H +I++L          +L+ E +  G L   I  K   S      
Sbjct: 93  KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS------ 146

Query: 203 WEKL-RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS 258
            E+        +   V YLH+     I+H D+KP N+L      +   KI+DFGL+K+  
Sbjct: 147 -ERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

Query: 259 KDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             + +  +T   GT GY APE+      YG
Sbjct: 203 HQVLM--KTVC-GTPGYCAPEILRGC-AYG 228

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 15/115 (13%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK 205
           I EV+ +  + H +I+ L       +R  LI+E+  N  L+K++        +  +S   
Sbjct: 81  IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM------DKNPDVSMRV 133

Query: 206 LRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-----KISDFGLAK 255
           ++   + +  GV + H    +R LH D+KP N+LL  +        KI DFGLA+
Sbjct: 134 IKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 24/187 (12%)

Query: 127 SNEI-AVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
             E  A+K   LE  + +  E + E+  + + HH +IV         +   L+ + +  G
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAF---GVARGVEYLHQGCNQRILHFDIKPHNILL 240
           S+   I        H+    ++   IA     V  G+EYLH       +H D+K  NILL
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDE-STIATILREVLEGLEYLH---KNGQIHRDVKAGNILL 154

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAAR----GTSGYIAPELFSRNFCY--------- 287
             +   +I+DFG++         ++R   R    GT  ++APE+  +   Y         
Sbjct: 155 GEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSF 213

Query: 288 GMMLLEM 294
           G+  +E+
Sbjct: 214 GITAIEL 220

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 14/157 (8%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
            +AVK +E      +    E+     + H +IVR            +I E+   G L + 
Sbjct: 47  LVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYER 106

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-- 246
           I       +  + S ++ R     +  GV Y H     +I H D+K  N LLD +  P  
Sbjct: 107 I------CNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRL 157

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           KI DFG +K          ++   GT  YIAPE+  R
Sbjct: 158 KICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLR 191

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 23/177 (12%)

Query: 129 EIAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E I NE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +       +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 107 VV-------TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMV 295
           ++DFG     + + S   R+   GT  ++APE+ +R   Y         G+M +EM+
Sbjct: 157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMI 210

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 27/170 (15%)

Query: 120 SKFFFLHSNEI-AVKMLEHLKGNGQEF---INEVATIGR-IHHFHIVRLLG-FCSEGNRR 173
            K  F  +  + AVK +    GN +E    + ++  + +     +IV+  G F +  +  
Sbjct: 42  WKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD-- 98

Query: 174 TLIY---EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILH 230
             ++   E M     +K             +    L K+   + + + YL +     ++H
Sbjct: 99  --VFIAMELM-GTCAEKLK-----KRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIH 148

Query: 231 FDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSRTAARGTSGYIAPE 279
            D+KP NILLD   Q K+ DFG+  +L    +   ++  + G + Y+APE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAGCAAYMAPE 194

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 21/175 (12%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           +A+K +  ++ + QE I E++ + +    H+V+  G   +     ++ E+   GS+   I
Sbjct: 57  VAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII 115

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
                   ++ L+ +++  I     +G+EYLH     R +H DIK  NILL+     K++
Sbjct: 116 -----RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLA 167

Query: 250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMV 295
           DFG+A   +  ++   R    GT  ++APE+      Y         G+  +EM 
Sbjct: 168 DFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMA 219

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 24/131 (18%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
            I + M  G L   +      S H   S   +R  A  +  G+E++H    + +++ D+K
Sbjct: 269 FILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLK 319

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRN--------- 284
           P NILLD +   +ISD GLA   SK      +  A  GT GY+APE+  +          
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADW 374

Query: 285 FCYGMMLLEMV 295
           F  G ML +++
Sbjct: 375 FSLGCMLFKLL 385

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 20/165 (12%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
             AVK++   K        E+  +     H +IV+L     +     L+ E +  G L +
Sbjct: 38  AFAVKIIS--KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95

Query: 188 FIFSKTNSSSHRQLSWEKL-RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHN 243
            I  K + S       E     I   +   V ++H      ++H D+KP N+L    + N
Sbjct: 96  RIKKKKHFS-------ETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDN 145

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
            + KI DFG A+L   D   +  T    T  Y APEL ++N  Y 
Sbjct: 146 LEIKIIDFGFARLKPPDNQPLK-TPC-FTLHYAAPELLNQN-GYD 187

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 23/139 (16%)

Query: 154 RIHHFHIVRLL-GFCSEGNRR------TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL 206
            +HH +IV+L   F + G R        ++ E++P+ +L +    +             +
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPILI 131

Query: 207 RKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKD---IS 262
           +   F + R +  LH      + H DIKPHN+L++  +   K+ DFG AK  S     ++
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

Query: 263 -IVSRTAARGTSGYIAPEL 280
            I SR        Y APEL
Sbjct: 191 YICSRY-------YRAPEL 202

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 16/159 (10%)

Query: 129 EIAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           ++AVK+L   K    + +     E+  +    H HI++L    S      ++ E++  G 
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L  +I        H ++   + R++   +   V+Y H+     ++H D+KP N+LLD + 
Sbjct: 98  LFDYI------CKHGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHM 148

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
             KI+DFGL+ + S    +  RT+  G+  Y APE+ S 
Sbjct: 149 NAKIADFGLSNMMSDGEFL--RTSC-GSPNYAAPEVISG 184

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 23/163 (14%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG-FCSEGNRRTLIY---EFMPNG 183
           + A+K+L       QE    V    +     HIV +L  + +  + +  +    E M  G
Sbjct: 56  KCALKLLYDSPKARQE----VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--- 240
            L    FS+      +  +  +  +I   +   +++LH      I H D+KP N+L    
Sbjct: 112 EL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSK 164

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           + +   K++DFG AK  +++     +T    T  Y+APE+   
Sbjct: 165 EKDAVLKLTDFGFAKETTQN---ALQTPC-YTPYYVAPEVLGP 203

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 34/126 (26%), Positives = 56/126 (44%), Gaps = 27/126 (21%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT 272
           +   ++YL     QRI+H D+KP NILLD +    I+DF +A +  ++  I +     GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177

Query: 273 SGYIAPELFSRN-----------FCYGMMLLEM-VGCR----KNNDPAVEIQSQI----- 311
             Y+APE+FS             +  G+   E+  G R    +++  + EI         
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237

Query: 312 YFPEWI 317
            +P   
Sbjct: 238 TYPSAW 243

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 37/167 (22%), Positives = 64/167 (38%), Gaps = 25/167 (14%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT-------LIYE 178
           H N I +    +  G+ +    +              +                  +I E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
           ++P+ +L K +  K+   S R +    +    + + R V ++H   +  I H DIKP N+
Sbjct: 119 YVPD-TLHKVL--KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNL 172

Query: 239 LLD-HNFQPKISDFGLAKLCSKD---IS-IVSRTAARGTSGYIAPEL 280
           L++  +   K+ DFG AK        ++ I SR        Y APEL
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-------YRAPEL 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 39/140 (27%), Positives = 53/140 (37%), Gaps = 17/140 (12%)

Query: 148 EVATIGRIHHF--HIVRLLGFCSEGNRRTLIYEF-MPNGSLQKFIFSKTNSSSHRQLSWE 204
           EV  + ++      ++RLL +    +   LI E   P   L  FI      +    L  E
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI------TERGALQEE 149

Query: 205 KLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISI 263
             R   + V   V + H      +LH DIK  NIL+D N  + K+ DFG   L       
Sbjct: 150 LARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--- 203

Query: 264 VSRTAARGTSGYIAPELFSR 283
           V      GT  Y  PE    
Sbjct: 204 VYTDFD-GTRVYSPPEWIRY 222

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 15/89 (16%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSG 274
           G+E+LHQ   + I++ D+KP N+LLD +   +ISD GLA    +  +  ++T    GT G
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPG 354

Query: 275 YIAPELFSRN--------FCYGMMLLEMV 295
           ++APEL            F  G+ L EM+
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 34/158 (21%), Positives = 73/158 (46%), Gaps = 15/158 (9%)

Query: 125 LHSNEI-AVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
             + ++ A+K+  LE  +   ++   E+  + +    ++ +  G   +  +  +I E++ 
Sbjct: 44  NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            GS    +           L   ++  I   + +G++YLH   +++ +H DIK  N+LL 
Sbjct: 104 GGSALDLLEPGP-------LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLS 153

Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
            + + K++DFG+A   +       R    GT  ++APE
Sbjct: 154 EHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPE 189

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 13/105 (12%)

Query: 156 HHFHIVRLL-----GFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIA 210
            H ++VRL             + TL++E +    L  ++    +      +  E ++ + 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTETIKDMM 126

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
           F + RG+++LH     R++H D+KP NIL+  + Q K++DFGLA+
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 16/159 (10%)

Query: 129 EIAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           ++AVK+L   K    + +     E+  +    H HI++L    S  +   ++ E++  G 
Sbjct: 43  KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L  +I        + +L  ++ R++   +  GV+Y H+     ++H D+KP N+LLD + 
Sbjct: 103 LFDYI------CKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHM 153

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
             KI+DFGL+ + S    +  RT+  G+  Y APE+ S 
Sbjct: 154 NAKIADFGLSNMMSDGEFL--RTSC-GSPNYAAPEVISG 189

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 13/105 (12%)

Query: 156 HHFHIVRLLGFCSEGNRR-----TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIA 210
            H ++VRL+  C+          TL++E +    L+ ++    + +    L  E ++ + 
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKDLM 126

Query: 211 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 255
               RG+++LH      I+H D+KP NIL+      K++DFGLA+
Sbjct: 127 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 37/168 (22%), Positives = 62/168 (36%), Gaps = 26/168 (15%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGR-----------IHHFHIVRLLGFCSEGNRRTLIY 177
           ++A+K++   +  G   +++  T                H  ++RLL +        L+ 
Sbjct: 58  QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117

Query: 178 EF-MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           E  +P   L  +I      +    L     R     V   +++ H    + ++H DIK  
Sbjct: 118 ERPLPAQDLFDYI------TEKGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDE 168

Query: 237 NILLD-HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
           NIL+D      K+ DFG   L   +          GT  Y  PE  SR
Sbjct: 169 NILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTRVYSPPEWISR 212

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 42/168 (25%), Positives = 68/168 (40%), Gaps = 23/168 (13%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRT----LIYEFMPNG 183
           + A+KML+    +  +   EV    R     HIVR++              ++ E +  G
Sbjct: 89  KFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--- 240
            L    FS+      +  +  +  +I   +   ++YLH      I H D+KP N+L    
Sbjct: 145 EL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK 197

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG 288
             N   K++DFG AK  +   S+   T    T  Y+APE+      Y 
Sbjct: 198 RPNAILKLTDFGFAKETTSHNSL--TTPC-YTPYYVAPEVLGPE-KYD 241

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 16/89 (17%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSG 274
           G+E LH+   +RI++ D+KP NILLD +   +ISD GLA      +        R GT G
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVG 350

Query: 275 YIAPELFSRN--------FCYGMMLLEMV 295
           Y+APE+            +  G +L EM+
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 11/151 (7%)

Query: 130 IAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
            A K++E       +++I E+  +    H +IV+LLG      +  ++ EF P G++   
Sbjct: 47  AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI 106

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +       +  Q+       +   +   + +LH    +RI+H D+K  N+L+      ++
Sbjct: 107 MLELDRGLTEPQIQV-----VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRL 158

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           +DFG++    K +    R +  GT  ++APE
Sbjct: 159 ADFGVSAKNLKTLQ--KRDSFIGTPYWMAPE 187

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 37/159 (23%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 129 EIAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           ++A+K +        +       E++ +  + H HI++L    +      ++ E+   G 
Sbjct: 36  KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGE 94

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L  +I         ++++ ++ R+    +   +EY H+    +I+H D+KP N+LLD N 
Sbjct: 95  LFDYI------VEKKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNL 145

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSR 283
             KI+DFGL+ + +    +  +T+  G+  Y APE+ + 
Sbjct: 146 NVKIADFGLSNIMTDGNFL--KTSC-GSPNYAAPEVING 181

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 11/132 (8%)

Query: 127 SNEI-AVKM--LEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           + E   V+   LE        F+  E+      +H +IV         N   ++  FM  
Sbjct: 51  TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GS +  I     +     ++   +  I  GV + ++Y+H       +H  +K  +IL+  
Sbjct: 111 GSAKDLI----CTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISV 163

Query: 243 NFQPKISDFGLA 254
           + +  +S     
Sbjct: 164 DGKVYLSGLRSN 175

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 19/154 (12%)

Query: 130 IAVKML----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           +A+K +    +      Q+ I EV  + ++ H + ++  G     +   L+ E+   GS 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
              +          +++      +  G  +G+ YLH   +  ++H D+K  NILL     
Sbjct: 141 SDLLEVHKKPLQEVEIAA-----VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
            K+ DFG A + +   S V      GT  ++APE
Sbjct: 193 VKLGDFGSASIMAPANSFV------GTPYWMAPE 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 13/161 (8%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR--TLIYEFMPN--GS 184
           + A+K +E   G       E+A +  + H +++ L         R   L++++  +    
Sbjct: 50  DYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWH 108

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           + KF  +   +    QL    ++ + + +  G+ YLH      +LH D+KP NIL+    
Sbjct: 109 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEG 165

Query: 245 QP----KISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPEL 280
                 KI+D G A+L +  +  ++       T  Y APEL
Sbjct: 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 64.9 bits (159), Expect = 5e-12
 Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 40/192 (20%)

Query: 126 HSNEI-AVKML--EH-LKGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM 180
            ++   A+K+L   H +K N   ++  E   + R+ H   V+L     +  +      + 
Sbjct: 53  ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 112

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVAR--------GVEYLHQGCNQRILHFD 232
            NG L               +   K+        R         +EYLH    + I+H D
Sbjct: 113 KNGEL----LK--------YIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRD 155

Query: 233 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRN------- 284
           +KP NILL+ +   +I+DFG AK+ S   S  +R  +  GT+ Y++PEL +         
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELLTEKSACKSSD 214

Query: 285 -FCYGMMLLEMV 295
            +  G ++ ++V
Sbjct: 215 LWALGCIIYQLV 226

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 64.9 bits (159), Expect = 7e-12
 Identities = 26/121 (21%), Positives = 58/121 (47%), Gaps = 17/121 (14%)

Query: 146 INEVATIGRIHHFHIVRLLGFCSEGNRRT--------LIYEFMPNGSLQKFIFSKTNSSS 197
           + E+  +  + H ++V L+  C               L+++F  +  L   +     S+ 
Sbjct: 64  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-----SNV 117

Query: 198 HRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 257
             + +  +++++   +  G+ Y+H+    +ILH D+K  N+L+  +   K++DFGLA+  
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 174

Query: 258 S 258
           S
Sbjct: 175 S 175

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 16/157 (10%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG------FCSEGNRRTLIYEFMPN 182
            A+K+++      +E   E+  + +  HH +I    G           ++  L+ EF   
Sbjct: 52  AAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA 111

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           GS+   I     ++    L  E +  I   + RG+ +LH     +++H DIK  N+LL  
Sbjct: 112 GSVTDLI----KNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTE 164

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE 279
           N + K+ DFG++    + +    R    GT  ++APE
Sbjct: 165 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPE 199

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 43/177 (24%)

Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRR-TLIYEFMPNGSLQKFI 189
           +K+LE+L+G                  +I+ L        +R   L++E + N   ++  
Sbjct: 81  IKILENLRG----------------GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKI 248
                    + L+   +R   + + + ++Y H      I+H D+KPHN+++DH + + ++
Sbjct: 125 ---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRL 172

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMVG 296
            D+GLA+          R A+R    +  PEL      Y         G ML  M+ 
Sbjct: 173 IDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 17/92 (18%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
            ++ +HQ      +H DIKP NIL+D N   +++DFG      +D ++ S  A  GT  Y
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242

Query: 276 IAPELFSRNF-------------CYGMMLLEM 294
           I+PE+                    G+ + EM
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 16/130 (12%), Positives = 41/130 (31%), Gaps = 15/130 (11%)

Query: 129 EIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           ++A+  ++          QE ++    + RI    + R+L          ++ E++  GS
Sbjct: 58  QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           LQ+              S     +    +A   +  H+     +      P  + +  + 
Sbjct: 118 LQEVA--------DTSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDG 166

Query: 245 QPKISDFGLA 254
              ++     
Sbjct: 167 DVVLAYPATM 176

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 22/67 (32%), Positives = 36/67 (53%), Gaps = 4/67 (5%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI 276
           ++ +H       +H D+KP N+LLD +   K++DFG     +K+  +   TA  GT  YI
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 236

Query: 277 APELFSR 283
           +PE+   
Sbjct: 237 SPEVLKS 243

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 22/68 (32%), Positives = 35/68 (51%), Gaps = 4/68 (5%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
            ++ +H+      +H DIKP NILLD     +++DFG       D ++ S  A  GT  Y
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDY 229

Query: 276 IAPELFSR 283
           ++PE+   
Sbjct: 230 LSPEILQA 237

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 47/214 (21%), Positives = 80/214 (37%), Gaps = 52/214 (24%)

Query: 170 GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ-LSWEKLRKIAFGVARGVEYLHQGCNQRI 228
            ++ +    F+   SL      +     ++  L+ E L   +F VA+G+E+L     ++ 
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKC 214

Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE-LFSRNFC- 286
           +H D+   NILL      KI DFGLA+   KD   V +  AR    ++APE +F R +  
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274

Query: 287 ------YGMMLLEMVGCRKNNDPAVEIQSQIYF--------------PEWIYNRMRLGQE 326
                 +G++L E+     +  P V+I  +                    +Y  M     
Sbjct: 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD--- 331

Query: 327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
                                  C    P++RP+
Sbjct: 332 -----------------------CWHGEPSQRPT 342

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 4/70 (5%)

Query: 130 IAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRT-LIYEFMPNGSL 185
           +AVKML         +  ++E+  +  I HH ++V LLG C++      +I EF   G+L
Sbjct: 55  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114

Query: 186 QKFIFSKTNS 195
             ++ SK N 
Sbjct: 115 STYLRSKRNE 124

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 29/91 (31%), Positives = 44/91 (48%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +   + +LH    + I++ D+K  N+LLDH    K++DFG+ K     I     TA   G
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCG 186

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  YIAPE+            +  G++L EM
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 15/88 (17%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSG 274
            + YLH+   + I++ D+K  N+LLD     K++D+G+ K     +     T+   GT  
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPN 175

Query: 275 YIAPELFSRN--------FCYGMMLLEM 294
           YIAPE+            +  G+++ EM
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEM 203

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +A  + YLH      I++ D+KP NILLD      ++DFGL K    +I   S T+   G
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCG 201

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  Y+APE+  +         +C G +L EM
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 32/121 (26%), Positives = 58/121 (47%), Gaps = 21/121 (17%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K     I   +      G
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCG 311

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEMVGCR-----KNNDPAVE--IQSQIYFPEW 316
           T  Y+APE+   N        +  G+++ EM+  R     ++++   E  +  +I FP  
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 371

Query: 317 I 317
           +
Sbjct: 372 L 372

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 25/91 (27%), Positives = 45/91 (49%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           ++  + YLH+   + I++ D+K  N+LLD     K++D+G+ K     +     T+   G
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCG 215

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  YIAPE+            +  G+++ EM
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +  G+++LH    + I++ D+K  NILLD +   KI+DFG+ K    ++   ++T    G
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCG 180

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  YIAPE+            + +G++L EM
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +   +EYLH    + +++ DIK  N++LD +   KI+DFGL K     IS  +      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG 167

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  Y+APE+   N        +  G+++ EM
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.4 bits (137), Expect = 3e-09
 Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 61/189 (32%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH         +E   +  + H  I+R+ G   +  +  +I +++  G L    
Sbjct: 45  VRLKQVEHTN-------DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL---- 93

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVAR--------GVEYLHQGCNQRILHFDIKPHNILLD 241
           FS         L   K ++    VA+         +EYLH    + I++ D+KP NILLD
Sbjct: 94  FS--------LLR--KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLD 140

Query: 242 HNFQPKISDFGLAK--------LCSKDISIVSRTAARGTSGYIAPELFSRN--------F 285
            N   KI+DFG AK        LC             GT  YIAPE+ S          +
Sbjct: 141 KNGHIKITDFGFAKYVPDVTYTLC-------------GTPDYIAPEVVSTKPYNKSIDWW 187

Query: 286 CYGMMLLEM 294
            +G+++ EM
Sbjct: 188 SFGILIYEM 196

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +A G+ +L     + I++ D+K  N++LD     KI+DFG+ K    +I     T    G
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCG 183

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  YIAPE+ +          + +G++L EM
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 39/190 (20%), Positives = 75/190 (39%), Gaps = 61/190 (32%)

Query: 130 IAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI 189
           + +K +EH         NE   +  ++   +V+L     + +   ++ E++  G +    
Sbjct: 80  VKLKQIEHTL-------NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---- 128

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVAR--------GVEYLHQGCNQRILHFDIKPHNILLD 241
           FS      H +    ++ + +   AR          EYLH   +  +++ D+KP N+L+D
Sbjct: 129 FS------HLR----RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLID 175

Query: 242 HNFQPKISDFGLAK--------LCSKDISIVSRTAARGTSGYIAPELFSRN--------F 285
                +++DFG AK        LC             GT   +APE+            +
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIILSKGYNKAVDWW 222

Query: 286 CYGMMLLEMV 295
             G+++ EM 
Sbjct: 223 ALGVLIYEMA 232

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 16/106 (15%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+  FM    L K +  +       Q        + + + +G+ Y+H      I+H D+K
Sbjct: 107 LVMPFMGT-DLGKLMKHEKLGEDRIQF-------LVYQMLKGLRYIHAA---GIIHRDLK 155

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P N+ ++ + + KI DFGLA+    ++     T    T  Y APE+
Sbjct: 156 PGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEV 196

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +A G+ +L     + I++ D+K  N++LD     KI+DFG+ K    +I     T    G
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCG 504

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  YIAPE+ +          + +G++L EM
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 32/160 (20%)

Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRT---LIYEFMPNGSLQK 187
           +K+L+ +        +       +   HI++LL  F  +G       +++E +   +L  
Sbjct: 66  IKLLQRVNDADNTKED------SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENL-- 116

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP- 246
               K     HR +    +++I+  +  G++Y+H+ C   I+H DIKP N+L++    P 
Sbjct: 117 LALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 172

Query: 247 -----KISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPE 279
                KI+D G A    +  +  I +R        Y +PE
Sbjct: 173 NLIQIKIADLGNACWYDEHYTNSIQTRE-------YRSPE 205

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 34/133 (25%), Positives = 61/133 (45%), Gaps = 21/133 (15%)

Query: 154 RIHHFHIVRLLG-FCSEGNRRT-----LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR 207
            ++H +I+ LL  F  + +        ++ E M   +L + I          +L  E++ 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--------QMELDHERMS 130

Query: 208 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT 267
            + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+       +   T
Sbjct: 131 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---T 184

Query: 268 AARGTSGYIAPEL 280
               T  Y APE+
Sbjct: 185 PYVVTRYYRAPEV 197

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 16/106 (15%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+   M    L   +  +  +  H Q        + + + RG++Y+H      I+H D+K
Sbjct: 111 LVTHLMGA-DLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLK 159

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P N+ ++ + + KI DFGLA+  + ++     T    T  Y APE+
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRAPEI 200

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 30/147 (20%), Positives = 58/147 (39%), Gaps = 15/147 (10%)

Query: 154 RIHHFHIVRLLGFCSEGNRRT-----LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK 208
           R++H H+V++L      +        ++ E   +   +K         +   L+   ++ 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF------RTPVYLTELHIKT 160

Query: 209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA 268
           + + +  GV+Y+H      ILH D+KP N L++ +   K+ DFGLA+      +  S+  
Sbjct: 161 LLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 269 ARGTSGYIAPELFSRNFCYGMMLLEMV 295
                  +    F         L   V
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHV 244

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 34/133 (25%), Positives = 55/133 (41%), Gaps = 19/133 (14%)

Query: 131 AVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRT----LIYEFMPNGSL 185
           A+KML+    +  +   EV    R     HIVR++              ++ E +  G L
Sbjct: 47  ALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 102

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DH 242
               FS+      +  +  +  +I   +   ++YLH      I H D+KP N+L      
Sbjct: 103 ----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRP 155

Query: 243 NFQPKISDFGLAK 255
           N   K++DFG AK
Sbjct: 156 NAILKLTDFGFAK 168

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 14/89 (15%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY 275
            +E+LH+     I++ DIK  NILLD N    ++DFGL+K    D +  +     GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226

Query: 276 IAPELFSRNF----------CYGMMLLEM 294
           +AP++                 G+++ E+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 55.6 bits (135), Expect = 7e-09
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 15/91 (16%)

Query: 213 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-G 271
           +A  +++LH      I++ D+KP NILLD     K++DFGL+K     I    +  +  G
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCG 188

Query: 272 TSGYIAPELFSRN--------FCYGMMLLEM 294
           T  Y+APE+ +R         + +G+++ EM
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 12/107 (11%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           ++ + M    L K + ++  S+ H            + + RG++Y+H      +LH D+K
Sbjct: 107 IVQDLMET-DLYKLLKTQHLSNDHICY-------FLYQILRGLKYIHSA---NVLHRDLK 155

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSR-TAARGTSGYIAPEL 280
           P N+LL+     KI DFGLA++   D       T    T  Y APE+
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 12/106 (11%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ E M    L + I           +S + ++   + +  G+  LH+     ++H D+ 
Sbjct: 111 LVTELMRT-DLAQVI-----HDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH 161

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P NILL  N    I DF LA+  + D +    T       Y APEL
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPEL 204

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 15/88 (17%)

Query: 216 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSG 274
            + +LHQ   + I++ D+KP NI+L+H    K++DFGL K     I   + T    GT  
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVTHTFCGTIE 186

Query: 275 YIAPELFSRN--------FCYGMMLLEM 294
           Y+APE+  R+        +  G ++ +M
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDM 214

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 15/106 (14%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+ E M   +L + I          +L  E++  + + +  G+++LH      I+H D+K
Sbjct: 144 LVMELMDA-NLCQVI--------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 191

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL 280
           P NI++  +   KI DFGLA+       +   T    T  Y APE+
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV 234

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 34/133 (25%), Positives = 62/133 (46%), Gaps = 26/133 (19%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L+  FM    LQK +          + S EK++ + + + +G++Y+H      ++H D+K
Sbjct: 106 LVMPFMQT-DLQKIM--------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLK 153

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY------- 287
           P N+ ++ + + KI DFGLA+    ++     T    T  Y APE+      Y       
Sbjct: 154 PGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIW 208

Query: 288 --GMMLLEMVGCR 298
             G ++ EM+  +
Sbjct: 209 SVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 29/114 (25%), Positives = 51/114 (44%), Gaps = 19/114 (16%)

Query: 175 LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           +I E M    L + I ++  S  H Q          +   R V+ LH      ++H D+K
Sbjct: 91  IIQELMQT-DLHRVISTQMLSDDHIQY-------FIYQTLRAVKVLHGS---NVIHRDLK 139

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGT--SGYI------APEL 280
           P N+L++ N   K+ DFGLA++  +  +  S    + +    ++      APE+
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 29/125 (23%)

Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGNRRT-LIYEFMPNGSLQKFI 189
           + +L  L G                H +IV LL    ++ +R   L++++M    L   I
Sbjct: 59  IMILTELSG----------------HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI 101

Query: 190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 249
            +      H+Q        + + + + ++YLH G    +LH D+KP NILL+     K++
Sbjct: 102 RANILEPVHKQY-------VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151

Query: 250 DFGLA 254
           DFGL+
Sbjct: 152 DFGLS 156

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 26/137 (18%), Positives = 52/137 (37%), Gaps = 15/137 (10%)

Query: 154 RIHHFHIVRLLGFCSEGNRRT-----LIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK 208
           R+   +I+RL       +        ++ E   +  L+K         +   L+ E ++ 
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF------KTPIFLTEEHIKT 133

Query: 209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA 268
           I + +  G  ++H+     I+H D+KP N LL+ +   K+ DFGLA+  + +        
Sbjct: 134 ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 269 ARGTSGYIAPELFSRNF 285
                         +  
Sbjct: 191 LEENEEPGPHNKNLKKQ 207

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 45/172 (26%)

Query: 119 NSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF-------CSEGN 171
           N K F   +    +++LEHL+   ++           +  +++ +L         C    
Sbjct: 132 NEKRFHRQA-AEEIRILEHLRKQDKD-----------NTMNVIHMLENFTFRNHIC---- 175

Query: 172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHF 231
              + +E +   S+  +   K N    +  S   +RK A  + + ++ LH+    RI+H 
Sbjct: 176 ---MTFELL---SMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK---NRIIHC 224

Query: 232 DIKPHNILLDHNFQP--KISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPE 279
           D+KP NILL    +   K+ DFG +    + +   I SR        Y APE
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-------YRAPE 269

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 35/151 (23%), Positives = 63/151 (41%), Gaps = 16/151 (10%)

Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           +K++  L     + I +V  I       +   +G  +E N   ++ E+M    L   +  
Sbjct: 59  IKIIRRLD---HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ 114

Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISD 250
                 H +L         + + RG++Y+H      +LH D+KP N+ ++  +   KI D
Sbjct: 115 GPLLEEHARL-------FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164

Query: 251 FGLAKLCSKDISIVSR-TAARGTSGYIAPEL 280
           FGLA++     S     +    T  Y +P L
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 28/152 (18%)

Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS 191
           V++LE +  +  E             ++IV L       N   L++E +   S   +   
Sbjct: 101 VRLLELMNKHDTE-----------MKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLL 146

Query: 192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--KIS 249
           +  +   R +S    RK A  +   + +L       I+H D+KP NILL +  +   KI 
Sbjct: 147 RNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203

Query: 250 DFGLAKLCSKDIS--IVSRTAARGTSGYIAPE 279
           DFG +    + I   I SR        Y +PE
Sbjct: 204 DFGSSCQLGQRIYQYIQSRF-------YRSPE 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.4 bits (110), Expect = 7e-06
 Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 14/113 (12%)

Query: 132 VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG-SLQKFIF 190
           +++L+ ++ +     N    +  +  F I         G    +++E +  G  L K+I 
Sbjct: 84  IRLLKSVRNSDPNDPNREMVVQLLDDFKISG-----VNGTHICMVFEVL--GHHLLKWI- 135

Query: 191 SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
                S+++ L    ++KI   V +G++YLH  C   I+H DIKP NILL  N
Sbjct: 136 ---IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 19/139 (13%)

Query: 125 LHSNEI-AVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPN 182
           L++NE  A+K LE +K    +   E     ++     I ++  F   G    ++ E +  
Sbjct: 31  LYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-- 87

Query: 183 G-SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
           G SL+  +F   +    R  S + +  IA  +   +EY+H   ++ +++ D+KP N L+ 
Sbjct: 88  GPSLED-LFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIG 139

Query: 242 HNFQPK-----ISDFGLAK 255
                      I DF LAK
Sbjct: 140 RPGNKTQQVIHIIDFALAK 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.9 bits (100), Expect = 9e-05
 Identities = 21/132 (15%), Positives = 42/132 (31%), Gaps = 22/132 (16%)

Query: 169 EGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRI 228
           + ++  ++ EF   G   + + +K         S    + I   +   +           
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL-------SSLATAKSILHQLTASLAVAEASLR--F 183

Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAK-----LCSKDISIVSRTAARGTSG--------Y 275
            H D+   N+LL      K+      K      C   +SI+  T +R             
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

Query: 276 IAPELFSRNFCY 287
           +  +LF+ +  Y
Sbjct: 244 MDEDLFTGDGDY 255

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.8 bits (101), Expect = 9e-05
 Identities = 24/114 (21%), Positives = 47/114 (41%), Gaps = 13/114 (11%)

Query: 146 INEVATIGRIHHFHIVRLLGF-CSEGNRRTLIYEFMPNG-SLQKFIFSKTNSSSHRQLSW 203
           +N+   +       I   +GF   +   R L+   +  G SLQ  +    + S    LS 
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL----DVSPKHVLSE 158

Query: 204 EKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI--SDFGLAK 255
             + ++A  +   +E+LH       +H ++   NI +D   Q ++  + +G A 
Sbjct: 159 RSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 29/177 (16%), Positives = 65/177 (36%), Gaps = 47/177 (26%)

Query: 124 FLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           +  +  + + +L+ +K   +E           + F  V +  + +      + +E +   
Sbjct: 59  YREAARLEINVLKKIKEKDKE-----------NKFLCVLMSDWFNFHGHMCIAFELL--- 104

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
               F F K N+   +      +R +A+ +   + +LH+    ++ H D+KP NIL  ++
Sbjct: 105 GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNS 159

Query: 244 FQP-------------------KISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPE 279
                                 +++DFG A    +  +  + +R        Y  PE
Sbjct: 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-------YRPPE 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 13/41 (31%), Positives = 23/41 (56%), Gaps = 5/41 (12%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKI--SDFGLAK 255
           +EY+H       +H DIK  N+LL +    ++  +D+GL+ 
Sbjct: 164 LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 40/174 (22%), Positives = 61/174 (35%), Gaps = 57/174 (32%)

Query: 132 VKMLEHLKGNGQEFINEVATIGR--IHHFH--IV-RLLGFCSEGNRRTLIYEFMPNGSLQ 186
           +++LEHL             +     HH H  IV  LLG           Y+F+      
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLS--------TYDFI------ 107

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
                K N         + +RK+A+ + + V +LH     ++ H D+KP NIL   +   
Sbjct: 108 -----KENG--FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYT 157

Query: 247 -------------------KISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPE 279
                              K+ DFG A    +  S  + +R        Y APE
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-------YRAPE 204

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 27/137 (19%), Positives = 53/137 (38%), Gaps = 15/137 (10%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPNG 183
           L +N+      E  + +  +  +E  T   +     I  +  F  EG    L+ + +   
Sbjct: 32  LLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP- 90

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL+  +         R+ S + +   A  +   V+ +H    + +++ DIKP N L+   
Sbjct: 91  SLED-LLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRP 142

Query: 244 FQPK-----ISDFGLAK 255
                    + DFG+ K
Sbjct: 143 NSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 17/67 (25%), Positives = 29/67 (43%), Gaps = 10/67 (14%)

Query: 217 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKI--SDFGLAKL-----CSKDISIVSRTAA 269
           +EY+H       +H DIK  N+LL++    ++   D+GLA         K  +   +   
Sbjct: 165 LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221

Query: 270 RGTSGYI 276
            GT  + 
Sbjct: 222 DGTIEFT 228

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 24/106 (22%), Positives = 35/106 (33%), Gaps = 37/106 (34%)

Query: 201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-------------- 246
              E ++     + + + YL +     + H D+KP NILLD  +                
Sbjct: 134 FHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190

Query: 247 -----------KISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPE 279
                      K+ DFG A   S      I +R        Y APE
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQ-------YRAPE 229

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	363
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.5
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.94
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.63
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.47
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.33
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.09
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.05
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.46
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.32
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.31
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.82
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.79
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.71
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.47
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.36
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.58
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.43
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.91
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.22
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.72

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-52  Score=376.75  Aligned_cols=237  Identities=22%  Similarity=0.328  Sum_probs=189.6

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..+|.|++|.++.....       +..||||+++.... ..++|.+|++++++++|||||+++|+|.+++..+||||||+
T Consensus        19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~   98 (299)
T 4asz_A           19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK   98 (299)
T ss_dssp             EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCC
Confidence            44677777777665432       23499999975432 34689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          182 NGSLQKFIFSKTN-------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       182 ~~sL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      +|+|.+++.....       ......+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|
T Consensus        99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGla  175 (299)
T 4asz_A           99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMS  175 (299)
T ss_dssp             TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred             CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcccc
Confidence            9999999975421       1234679999999999999999999999   99999999999999999999999999999


Q ss_pred             eeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          255 KLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       255 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      +...............||+.|+|||++        +|||||||++|||+| |+.||.......        +...+..+.
T Consensus       176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------~~~~i~~~~  247 (299)
T 4asz_A          176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIECITQGR  247 (299)
T ss_dssp             HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHHTC
T ss_pred             eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCC
Confidence            877655443333445689999999998        899999999999998 899997643321        333444333


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..      ..+..+++++.+++.+||+.||++||||+|
T Consensus       248 ~~------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~  279 (299)
T 4asz_A          248 VL------QRPRTCPQEVYELMLGCWQREPHMRKNIKG  279 (299)
T ss_dssp             CC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CC------CCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            22      233456778999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.5e-52  Score=375.30  Aligned_cols=237  Identities=21%  Similarity=0.295  Sum_probs=191.1

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++|.|+||.++...+.       +..||||+++...  ...++|.+|+.++++++|||||+++|+|.+++..+||||||
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~  111 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC  111 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence            45777788877766542       2349999997433  33478999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEec
Q 039471          181 PNGSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  250 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D  250 (363)
                      ++|+|.+++......          .....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEECC
Confidence            999999999654321          123569999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHh
Q 039471          251 FGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRM  321 (363)
Q Consensus       251 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ||+|+...............||+.|+|||++        +|||||||++|||+| |+.||.......        +...+
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--------~~~~i  260 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--------VVEMI  260 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--------HHHHH
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHH
Confidence            9999877654433333556799999999998        899999999999998 889987643321        33333


Q ss_pred             hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...      +.+..++..+.+++.+||+.||++||||+|
T Consensus       261 ~~~~~~------~~p~~~~~~~~~li~~C~~~dP~~RPs~~e  296 (308)
T 4gt4_A          261 RNRQVL------PCPDDCPAWVYALMIECWNEFPSRRPRFKD  296 (308)
T ss_dssp             HTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HcCCCC------CCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            333322      233456778999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=370.73  Aligned_cols=235  Identities=24%  Similarity=0.345  Sum_probs=180.4

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      .++|.|++|.++...+. +.||||+++....   ..++|.+|+.++++++|||||+++|++.+ +..+||||||++|+|.
T Consensus        42 ~~iG~G~fG~Vy~~~~~-~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~  119 (307)
T 3omv_A           42 TRIGSGSFGTVYKGKWH-GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLY  119 (307)
T ss_dssp             EECCCCSSSEEEEEESS-SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHH
T ss_pred             eEEeeCCCcEEEEEEEC-CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHH
Confidence            45677777777666544 4699999974432   23679999999999999999999998865 5689999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..+..|+.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+|+...........
T Consensus       120 ~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~  191 (307)
T 3omv_A          120 KHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV  191 (307)
T ss_dssp             HHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred             HHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence            9996432     569999999999999999999999   99999999999999999999999999999877654333333


Q ss_pred             ccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          267 TAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ....||+.|+|||++           +|||||||++|||+||+.||.......       .+...+..+..  .......
T Consensus       192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-------~~~~~~~~~~~--~p~~~~~  262 (307)
T 3omv_A          192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-------QIIFMVGRGYA--SPDLSKL  262 (307)
T ss_dssp             --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHHHHHTTCC--CCCSTTS
T ss_pred             cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcCCC--CCCcccc
Confidence            556799999999986           799999999999999999997543221       12222222211  1111223


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+++.+.+++.+||+.||++||||+|
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~e  290 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQ  290 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            4456788999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-52  Score=377.89  Aligned_cols=237  Identities=23%  Similarity=0.343  Sum_probs=181.6

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .++|.+++|.++.....       +..||||+++... ...++|.+|++++++++|||||+++|+|.++...+||||||+
T Consensus        47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~  126 (329)
T 4aoj_A           47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR  126 (329)
T ss_dssp             EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            34677777777665432       2349999997543 234689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          182 NGSLQKFIFSKTNS---------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       182 ~~sL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      +|+|.++++.....         .....+++..+..|+.||+.||+|||+   .+|+||||||+|||+++++.+||+|||
T Consensus       127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DFG  203 (329)
T 4aoj_A          127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG  203 (329)
T ss_dssp             TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcccc
Confidence            99999999764321         123569999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      +|+...............||+.|+|||++        +|||||||++|||+| |+.||.......        +...+..
T Consensus       204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--------~~~~i~~  275 (329)
T 4aoj_A          204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------AIDCITQ  275 (329)
T ss_dssp             ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--------HHHHHHH
T ss_pred             cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHc
Confidence            99977654433333456799999999988        899999999999998 899997643321        3333433


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...      +.+..+++++.+++.+||+.||++||||+|
T Consensus       276 g~~~------~~p~~~~~~~~~li~~cl~~dP~~RPs~~e  309 (329)
T 4aoj_A          276 GREL------ERPRACPPEVYAIMRGCWQREPQQRHSIKD  309 (329)
T ss_dssp             TCCC------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             CCCC------CCcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence            3322      233456778999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.3e-52  Score=371.50  Aligned_cols=229  Identities=24%  Similarity=0.277  Sum_probs=188.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .+|.|++|.++.+...  ++.||||++..    .....+.+.+|++++++++|||||++++++.+++..|+||||++||+
T Consensus        39 ~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~  118 (311)
T 4aw0_A           39 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE  118 (311)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred             EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence            3566666666655443  44599999963    23455789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus       119 L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          119 LLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            99999543      569999999999999999999999   999999999999999999999999999999886554333


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||+.|+|||++        +|+||+||++|||++|+.||.......        +..++..+..       ..+
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~-------~~p  254 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--------IFAKIIKLEY-------DFP  254 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC-------CCC
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCC-------CCC
Confidence            34566799999999999        899999999999999999997654321        3333332221       123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++++.+|+.+||+.||++|||++|
T Consensus       255 ~~~s~~~~dli~~lL~~dp~~R~t~~e  281 (311)
T 4aw0_A          255 EKFFPKARDLVEKLLVLDATKRLGCEE  281 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred             cccCHHHHHHHHHHccCCHhHCcChHH
Confidence            345678999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-51  Score=373.90  Aligned_cols=232  Identities=22%  Similarity=0.306  Sum_probs=188.2

Q ss_pred             CcccccccccCCcceeecc--CCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          108 PFQSLISFNLTNSKFFFLH--SNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .+.++|.|++|.++.+...  ++.||||++... ....+.+.+|+.++++++|||||++++++.+++..|||||||+||+
T Consensus        78 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~  157 (346)
T 4fih_A           78 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  157 (346)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEE
T ss_pred             EeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence            3445666666666665544  344999999643 3445678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..       ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+........ 
T Consensus       158 L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  226 (346)
T 4fih_A          158 LTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  226 (346)
T ss_dssp             HHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred             HHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence            9999843       459999999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||+.|+|||++        +|||||||++|||++|+.||.......        +...+....    .......
T Consensus       227 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~----~~~~~~~  293 (346)
T 4fih_A          227 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNL----PPRLKNL  293 (346)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSS----CCCCSCG
T ss_pred             -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCC----CCCCCcc
Confidence             2456799999999998        899999999999999999997643321        222222211    1112234


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++++.+|+.+||+.||++|||++|
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e  320 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAE  320 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            566788999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-51  Score=375.66  Aligned_cols=232  Identities=19%  Similarity=0.282  Sum_probs=183.5

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ...+|.|++|.++.+...  ++.||||++.....   ..+.|.+|++++++++|||||++++++.+++..|||||||+||
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            344566666666665433  44599999975432   2367899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....    ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+........
T Consensus       109 ~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          109 DLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             BHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             cHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            9999996543    2568999999999999999999999   99999999999999999999999999999877543221


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        .....||+.|+|||++        +|||||||++|||++|+.||.......        +..++..+..      +..
T Consensus       182 --~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~------~~~  245 (350)
T 4b9d_A          182 --ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSF------PPV  245 (350)
T ss_dssp             --HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCC------CCC
T ss_pred             --ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCC------CCC
Confidence              2345699999999998        899999999999999999997654321        2233332221      122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+++++.+|+.+||+.||++|||++|
T Consensus       246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e  273 (350)
T 4b9d_A          246 SLHYSYDLRSLVSQLFKRNPRDRPSVNS  273 (350)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            3456778999999999999999999764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-51  Score=363.74  Aligned_cols=228  Identities=25%  Similarity=0.338  Sum_probs=180.2

Q ss_pred             cccccccCCcceeeccC--CeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeee----CCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLHS--NEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE----GNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~  181 (363)
                      .+|.|++|.++......  ..||||++....   ...++|.+|++++++++|||||++++++.+    +...+||||||+
T Consensus        33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~  112 (290)
T 3fpq_A           33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT  112 (290)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCC
Confidence            36777777777665443  349999986433   233679999999999999999999999865    346899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEcC-CCCeeEeccccceecc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDH-NFQPKISDFGLAKLCS  258 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~  258 (363)
                      ||+|.+++...      ..+++..+..++.||+.||+|||+   ++  |+||||||+|||++. ++.+||+|||+|+...
T Consensus       113 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          113 SGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999543      569999999999999999999999   77  999999999999984 7899999999998654


Q ss_pred             CCccccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ...    .....||+.|+|||++       +|||||||++|||+||+.||.......       .+...+..+...    
T Consensus       184 ~~~----~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~~----  248 (290)
T 3fpq_A          184 ASF----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP----  248 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC----
T ss_pred             CCc----cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCCC----
Confidence            332    2446799999999998       899999999999999999996543221       133333322211    


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...+...++++.+++.+||+.||++|||++|
T Consensus       249 -~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e  279 (290)
T 3fpq_A          249 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             -CCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence             1122234567999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=371.99  Aligned_cols=232  Identities=22%  Similarity=0.306  Sum_probs=186.4

Q ss_pred             CcccccccccCCcceeecc--CCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          108 PFQSLISFNLTNSKFFFLH--SNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .+.++|.|++|.++.+...  ++.||||++... ....+.+.+|+.+|++++|||||++++++.+++.+|||||||+||+
T Consensus       155 ~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~  234 (423)
T 4fie_A          155 NFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  234 (423)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             eeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence            3444555555555554443  344999999743 3345678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..       ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+.+...... 
T Consensus       235 L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  303 (423)
T 4fie_A          235 LTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  303 (423)
T ss_dssp             HHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred             HHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence            9999842       459999999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||+.|||||++        +|||||||++|||++|+.||.......        +...+.....    ......
T Consensus       304 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~----~~~~~~  370 (423)
T 4fie_A          304 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLP----PRLKNL  370 (423)
T ss_dssp             -BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCC----CCCSCT
T ss_pred             -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCC----CCCccc
Confidence             2456799999999998        899999999999999999997643321        2222222211    111233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++++.+|+.+||+.||++|||++|
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~e  397 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAE  397 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            456778999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-50  Score=356.87  Aligned_cols=226  Identities=22%  Similarity=0.353  Sum_probs=172.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.|++|.+..+...  ++.||||++...    ....+.+.+|++++++++|||||++++++.+++..++||||+ +|
T Consensus        19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g   97 (275)
T 3hyh_A           19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN   97 (275)
T ss_dssp             EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence            44567777777666543  445999999643    233467899999999999999999999999999999999999 67


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+........
T Consensus        98 ~L~~~l~~------~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           98 ELFDYIVQ------RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EHHHHHHH------SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             CHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            99999953      2569999999999999999999999   99999999999999999999999999999876554322


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                         ....||+.|+|||++         +||||+||++|||++|+.||......        .+.+.+..+..       .
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--------~~~~~i~~~~~-------~  230 (275)
T 3hyh_A          169 ---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--------VLFKNISNGVY-------T  230 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCC-------C
T ss_pred             ---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCC-------C
Confidence               446799999999998         79999999999999999999764321        12333332221       1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+++++.+++.+||+.||++|||++|
T Consensus       231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~e  259 (275)
T 3hyh_A          231 LPKFLSPGAAGLIKRMLIVNPLNRISIHE  259 (275)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            23345678999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-50  Score=362.74  Aligned_cols=229  Identities=21%  Similarity=0.165  Sum_probs=180.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++|.+++|.++.+...  ++.||||+++....    +.+|+.++++++|||||++++++.+++..||||||++||+|.+
T Consensus        64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~  139 (336)
T 4g3f_A           64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ  139 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred             cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence            45677777777666544  44599999974332    2479999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCccc---
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISI---  263 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~---  263 (363)
                      ++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+....+...   
T Consensus       140 ~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          140 LIKQM------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             HHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             HHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            99543      569999999999999999999999   9999999999999999987 5999999999987654321   


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      .......||+.|+|||++        +|||||||++|||++|+.||........        ..++..+....    ...
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--------~~~i~~~~~~~----~~~  278 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--------CLKIASEPPPI----REI  278 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--------HHHHHHSCCGG----GGS
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHHcCCCCc----hhc
Confidence            122345699999999998        8999999999999999999976543221        11222111111    123


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+++.+.+++.+||+.||++|||++|
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~e  306 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAME  306 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            3456788999999999999999999754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-49  Score=359.13  Aligned_cols=246  Identities=20%  Similarity=0.198  Sum_probs=181.8

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC----ceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN----RRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL  185 (363)
                      ..+|.|++|.++.....++.||||+++........+..|+..+.+++|||||+++|++.+++    ..+||||||++|+|
T Consensus         9 ~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL   88 (303)
T 3hmm_A            9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL   88 (303)
T ss_dssp             EEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             EEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcH
Confidence            45788899998888888888999999754333233445666677889999999999997654    57999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC-----NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      .++++.       ..++++.+.+++.|++.||+|||+.+     ..+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 ~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           89 FDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            999953       45899999999999999999999821     139999999999999999999999999999987654


Q ss_pred             cccc--ccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccc-------cchHHHH
Q 039471          261 ISIV--SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ-------IYFPEWI  317 (363)
Q Consensus       261 ~~~~--~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~-------~~~~~~~  317 (363)
                      ....  ......||+.|+|||++              +|||||||++|||+||++|+.........       ....+.+
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~  241 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence            3321  12345699999999975              69999999999999999877543322110       0011112


Q ss_pred             HHHhhhccccccccCCC-CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 YNRMRLGQELCLDFEED-GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+. .+...+..... ...+.++.+.+++.+||+.||++||||+|
T Consensus       242 ~~~~~-~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  287 (303)
T 3hmm_A          242 RKVVC-EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             HHHHT-TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             HHHHh-cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence            22211 11111111111 23456788999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.1e-50  Score=358.12  Aligned_cols=226  Identities=20%  Similarity=0.211  Sum_probs=173.8

Q ss_pred             cccccccCCcceeec-----cCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFL-----HSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .+|.|++|.++.+..     .++.||||+++...   ....++.+|++++++++|||||++++++.+++..++||||++|
T Consensus        31 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g  110 (304)
T 3ubd_A           31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG  110 (304)
T ss_dssp             EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTT
T ss_pred             EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCC
Confidence            344555554444322     12349999996432   2335788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus       111 g~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          111 GDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             CEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred             CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence            9999999543      569999999999999999999999   9999999999999999999999999999987544322


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....||+.|+|||++        +|+||+||++|||++|+.||.......        +...+..+..       .
T Consensus       182 ~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~-------~  244 (304)
T 3ubd_A          182 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTMILKAKL-------G  244 (304)
T ss_dssp             C--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------C
T ss_pred             c--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHHHHcCCC-------C
Confidence            1  2456799999999998        899999999999999999997654322        2233322211       2


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+..+++++.+++.+||+.||++|||+.
T Consensus       245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          245 MPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             CCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence            2344677899999999999999999963

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.2e-49  Score=363.08  Aligned_cols=237  Identities=26%  Similarity=0.369  Sum_probs=185.6

Q ss_pred             cccccccCCcceeeccC-------CeeEEEEcccCCc--ChhHHHHHHHHHhccCC-CceeeeeeeeeeC-CceeEEEec
Q 039471          111 SLISFNLTNSKFFFLHS-------NEIAVKMLEHLKG--NGQEFINEVATIGRIHH-FHIVRLLGFCSEG-NRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~-~~~~lv~e~  179 (363)
                      .+|.++||.++.....+       +.||||++.....  ..++|.+|++++.+++| +|||+++|+|.+. +..+|||||
T Consensus        71 ~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey  150 (353)
T 4ase_A           71 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF  150 (353)
T ss_dssp             EEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEEC
T ss_pred             EEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEc
Confidence            35556666555543322       2499999975432  23579999999999965 8999999999764 578999999


Q ss_pred             cCCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEe
Q 039471          180 MPNGSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  249 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~  249 (363)
                      |++|+|.++++.....          .....+++..+..++.||++||+|||+   ++|+||||||+|||+++++.+||+
T Consensus       151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~vKi~  227 (353)
T 4ase_A          151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKIC  227 (353)
T ss_dssp             CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCEEEC
Confidence            9999999999764321          123568999999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHH
Q 039471          250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      |||+|+....+..........||+.|+|||++        +|||||||++|||+| |+.||.......       .+...
T Consensus       228 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-------~~~~~  300 (353)
T 4ase_A          228 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRR  300 (353)
T ss_dssp             CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHH
T ss_pred             cchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            99999987665544444566799999999998        899999999999998 899987543221       13333


Q ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+...      ..+..+++++.+++.+||+.||++||||+|
T Consensus       301 i~~g~~~------~~p~~~~~~~~~li~~c~~~dP~~RPt~~e  337 (353)
T 4ase_A          301 LKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  337 (353)
T ss_dssp             HHHTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHcCCCC------CCCccCCHHHHHHHHHHcCcChhHCcCHHH
Confidence            4333322      233445678999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.8e-47  Score=341.46  Aligned_cols=232  Identities=20%  Similarity=0.216  Sum_probs=166.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCC------------ce
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGN------------RR  173 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------------~~  173 (363)
                      ..+|.|++|.++.+...  ++.||||+++....  ..+.+.+|+.++++++|||||++++++.+.+            ..
T Consensus        11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l   90 (299)
T 4g31_A           11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL   90 (299)
T ss_dssp             EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEE
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEE
Confidence            44566667666665433  44599999864332  2367899999999999999999999986544            36


Q ss_pred             eEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccc
Q 039471          174 TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       174 ~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      |+||||+++|+|.+++.....   ....++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        91 ~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           91 YIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             EEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCcc
Confidence            899999999999999964432   1345677889999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCcccc----------ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHH
Q 039471          254 AKLCSKDISIV----------SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       254 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~  315 (363)
                      |+....+....          ......||+.|+|||++        +|||||||++|||++   ||....+...      
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~------  235 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR------  235 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH------
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH------
Confidence            99876543211          11335699999999998        799999999999996   6654322110      


Q ss_pred             HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ....+....      .+......++.+.+++.+||+.||++|||++|
T Consensus       236 -~~~~~~~~~------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  276 (299)
T 4g31_A          236 -TLTDVRNLK------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN  276 (299)
T ss_dssp             -HHHHHHTTC------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -HHHHHhcCC------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence             111111111      01123345567789999999999999999753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=345.04  Aligned_cols=244  Identities=19%  Similarity=0.247  Sum_probs=177.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeee------CCceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSE------GNRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e  178 (363)
                      ..+|.|++|.++.+...  ++.||||+++.....   .+.+.+|+++|++++|||||++++++..      .+..|||||
T Consensus        60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE  139 (398)
T 4b99_A           60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD  139 (398)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred             EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence            44566666665555433  445999999754332   3578899999999999999999998753      367899999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ||+ |+|.+++.      ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       140 ~~~-g~L~~~i~------~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          140 LME-SDLHQIIH------SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             CCS-EEHHHHHT------SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             CCC-CCHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            996 68999993      34679999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCcc--ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHH--------
Q 039471          259 KDIS--IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYN--------  319 (363)
Q Consensus       259 ~~~~--~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~--------  319 (363)
                      ....  ........||+.|+|||++         +||||+||++|||++|++||.+.........+......        
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            4321  1122456799999999986         79999999999999999999875443221100000000        


Q ss_pred             ----HhhhccccccccCCCC----cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 ----RMRLGQELCLDFEEDG----DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ----~~~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ................    ....++++.+|+.+||+.||++|||++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  341 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA  341 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                0000000000000000    1123567899999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.3e-45  Score=336.62  Aligned_cols=183  Identities=18%  Similarity=0.274  Sum_probs=149.5

Q ss_pred             ccccccccCCcceeecc-----CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..+|.|++|.++....+     ++.||||++.... ...++.+|+++++++ +|+||+++++++.++++.++||||+++|
T Consensus        27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~  105 (361)
T 4f9c_A           27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE  105 (361)
T ss_dssp             EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCC
T ss_pred             EEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcc
Confidence            34455555555444321     2349999886443 456788999999988 6999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceeccCCcc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~  262 (363)
                      +|.+++         ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus       106 ~L~~~~---------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A          106 SFLDIL---------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             CHHHHH---------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             cHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            999999         458999999999999999999999   999999999999999876 7999999999987543221


Q ss_pred             c--------------------------cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcch
Q 039471          263 I--------------------------VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       263 ~--------------------------~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                      .                          .......||+.|+|||++         +|+||+||++|||++|+.||....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            0                          011234699999999987         699999999999999999996543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4e-44  Score=348.19  Aligned_cols=228  Identities=22%  Similarity=0.215  Sum_probs=179.1

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHH---HHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINE---VATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ...+|.|++|.|..+...  ++.||||++...    ......+.+|   +.+++.++|||||+++++|.+.+.+|+||||
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy  273 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL  273 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence            344566666666555443  334999999632    2223333444   5667788999999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++||+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+....
T Consensus       274 ~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          274 MNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999543      569999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      ...    ....||+.|+|||++         +|+||+||++|||++|+.||........     ..+...+...      
T Consensus       345 ~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~------  409 (689)
T 3v5w_A          345 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTM------  409 (689)
T ss_dssp             CCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHC------
T ss_pred             CCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCC------
Confidence            432    446799999999988         7999999999999999999976543221     0122222111      


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                       ....+..+++++.+|+.+||+.||++|++.
T Consensus       410 -~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          410 -AVELPDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             -CCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence             112344567889999999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.4e-44  Score=350.66  Aligned_cols=231  Identities=19%  Similarity=0.284  Sum_probs=183.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .+|.|++|.+..+...  ++.||||++..... ..+.+.+|+.+|++++|||||++++++.+++..++|||||+||+|.+
T Consensus       164 ~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~  243 (573)
T 3uto_A          164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE  243 (573)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred             EEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHH
Confidence            3444445444444333  34499999875432 34678899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC--CCeeEeccccceeccCCccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN--FQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ++..     ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+......  
T Consensus       244 ~i~~-----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~--  313 (573)
T 3uto_A          244 KVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--  313 (573)
T ss_dssp             HHTC-----TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE--
T ss_pred             HHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce--
Confidence            9943     23579999999999999999999999   999999999999999854  88999999999988665433  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                       ....||+.|+|||++        +||||+||++|||++|+.||.......        ....+....   .........
T Consensus       314 -~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--------~~~~i~~~~---~~~~~~~~~  381 (573)
T 3uto_A          314 -KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCD---WNMDDSAFS  381 (573)
T ss_dssp             -EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTC---CCCCSGGGT
T ss_pred             -eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHhCC---CCCCccccc
Confidence             345699999999998        899999999999999999997654322        222332221   112222334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+++++.+|+.+||+.||++|||++|
T Consensus       382 ~~s~~~~dli~~~L~~dp~~R~t~~e  407 (573)
T 3uto_A          382 GISEDGKDFIRKLLLADPNTRMTIHQ  407 (573)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHH
Confidence            56778999999999999999999753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-42  Score=315.80  Aligned_cols=243  Identities=25%  Similarity=0.279  Sum_probs=186.8

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC----ceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN----RRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...++.||||++.........+.+|+.++++++|+||+++++++....    ..++||||+++|+|
T Consensus        30 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L  109 (322)
T 3soc_A           30 EVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL  109 (322)
T ss_dssp             EEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             heecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCH
Confidence            33566777777777666777999999765555566778999999999999999999997754    46999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC----------CceecCCCCCceEEcCCCCeeEeccccce
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ----------RILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      .+++..       ..+++..++.++.|++.||+|||+   .          +|+||||||+|||++.++.+||+|||+++
T Consensus       110 ~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          110 SDFLKA-------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             HHHHHH-------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence            999943       348999999999999999999999   8          99999999999999999999999999998


Q ss_pred             eccCCccccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hH
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FP  314 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~  314 (363)
                      ...............||..|+|||++             +||||||+++|||++|+.||...........        ..
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            87655443333446799999999986             4999999999999999999976543322111        01


Q ss_pred             HHHHHHhhhccccccccCC-CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          315 EWIYNRMRLGQELCLDFEE-DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+........ ....... ......+..+.+++.+||+.||++|||++|
T Consensus       260 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (322)
T 3soc_A          260 EDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC  308 (322)
T ss_dssp             HHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHH
Confidence            11111111111 1111111 123356677999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.6e-42  Score=307.51  Aligned_cols=236  Identities=19%  Similarity=0.281  Sum_probs=186.8

Q ss_pred             CCCCCcccccccccCCcceeec--cCCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          104 ETACPFQSLISFNLTNSKFFFL--HSNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       104 ~~~c~~~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..+.....++.+++|.++.+..  .++.||||++... ....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            3344455566666666655542  3445999998643 344577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       100 ~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A          100 AGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             TTCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999943       358999999999999999999999   99999999999999999999999999999877654


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...  .....||+.|+|||++        +|+||||+++|||++|+.||........       ...... ...    ..
T Consensus       170 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~-~~~----~~  235 (297)
T 3fxz_A          170 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIAT-NGT----PE  235 (297)
T ss_dssp             TCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHH-HCS----CC
T ss_pred             ccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-CCC----CC
Confidence            332  2445699999999987        7999999999999999999976433221       111111 111    11


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..++..+.+++.+||+.||++|||++|
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  266 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE  266 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHH
Confidence            1234456778999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.4e-42  Score=312.67  Aligned_cols=225  Identities=23%  Similarity=0.334  Sum_probs=181.6

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ++.+++|.+..+..  .++.||||++.....   ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus        23 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~  102 (328)
T 3fe3_A           23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVF  102 (328)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHH
T ss_pred             EeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHH
Confidence            44555555544442  355599999975432   2357889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.........   
T Consensus       103 ~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~---  170 (328)
T 3fe3_A          103 DYLVAH------GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---  170 (328)
T ss_dssp             HHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG---
T ss_pred             HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc---
Confidence            999543      469999999999999999999999   99999999999999999999999999999876654332   


Q ss_pred             ccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          267 TAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      ....||+.|+|||++         +|+||+|+++|||++|+.||.......        +...+..+..       ..+.
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~-------~~p~  235 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRERVLRGKY-------RIPF  235 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------CCCT
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC-------CCCC
Confidence            455699999999987         799999999999999999997654321        2222222211       1223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++.+.+++.+||+.||++|||++|
T Consensus       236 ~~s~~~~~li~~~L~~dP~~R~t~~e  261 (328)
T 3fe3_A          236 YMSTDCENLLKRFLVLNPIKRGTLEQ  261 (328)
T ss_dssp             TSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            35677899999999999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.2e-41  Score=305.08  Aligned_cols=250  Identities=31%  Similarity=0.506  Sum_probs=193.4

Q ss_pred             CcccccccccCCcceeecc-CCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          108 PFQSLISFNLTNSKFFFLH-SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ....++.+++|.++.+... +..||||++..... ..+.+.+|+.++++++|+||+++++++.+++..++||||+++++|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            3344566666666555443 45599999875433 346889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....  .....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..........
T Consensus       123 ~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          123 KRHLYGSD--LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             GGGSSSSC--CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             HHHHhccC--CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99995433  223469999999999999999999999   9999999999999999999999999999987654332222


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc---ccccccCCC
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ---ELCLDFEED  334 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  334 (363)
                      .....||..|+|||++        +|+||||+++|||++|+.||....... ......|.......+.   .........
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLADK  276 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred             ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhhccc
Confidence            2445589999999987        899999999999999999997654332 2223333322222111   112223334


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+..+.+++.+||+.||++|||++|
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~e  305 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGD  305 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            56788999999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-41  Score=313.59  Aligned_cols=231  Identities=22%  Similarity=0.282  Sum_probs=182.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc-------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...  +..||+|++.....       ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus        18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~   97 (361)
T 2yab_A           18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV   97 (361)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcC
Confidence            44556666665555443  44599999974332       2367899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----CeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~  256 (363)
                      ++|+|.+++.      ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++    .+||+|||+++.
T Consensus        98 ~gg~L~~~l~------~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           98 SGGELFDFLA------QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             CSCBHHHHHT------TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             CCCcHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            9999999993      33579999999999999999999999   9999999999999998776    799999999988


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .......   ....||+.|+|||++        +|+||||+++|+|++|..||.......        ....+..+..  
T Consensus       169 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~--  235 (361)
T 2yab_A          169 IEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANITAVSY--  235 (361)
T ss_dssp             CCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCC--
T ss_pred             cCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCC--
Confidence            7654332   445699999999987        799999999999999999997654322        2222221111  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..........+..+.+++.+||+.||++|||++|
T Consensus       236 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  269 (361)
T 2yab_A          236 -DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE  269 (361)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             -CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence             1111112234677999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.4e-41  Score=308.44  Aligned_cols=233  Identities=24%  Similarity=0.317  Sum_probs=181.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  ++.||||++....  ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++|
T Consensus        13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L   92 (323)
T 3tki_A           13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL   92 (323)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence            34555666665555433  4459999986432  2346788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.      ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus        93 ~~~l~------~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           93 FDRIE------PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             GGGSB------TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            99983      33569999999999999999999999   9999999999999999999999999999987654433323


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      .....||..|+|||++         +|+||||+++|||++|+.||........  .+..+     .....     .....
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~-----~~~~~-----~~~~~  231 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW-----KEKKT-----YLNPW  231 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHH-----HTTCT-----TSTTG
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHH-----hcccc-----cCCcc
Confidence            3456799999999987         7999999999999999999976543321  11111     11110     11122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++..+.+++.+||+.||++|||++|
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~e  258 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPD  258 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            345677899999999999999999854

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-40  Score=300.74  Aligned_cols=244  Identities=31%  Similarity=0.456  Sum_probs=192.4

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCC-----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLK-----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...++.||||++....     ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        37 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  116 (307)
T 2nru_A           37 NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS  116 (307)
T ss_dssp             CEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             CccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCc
Confidence            456777777777777777779999986432     224678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....   ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........
T Consensus       117 L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          117 LLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             HHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             HHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            999996432   22569999999999999999999999   999999999999999999999999999998766543332


Q ss_pred             ccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc----cccccCC
Q 039471          265 SRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE----LCLDFEE  333 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  333 (363)
                      ......||..|+|||++       +|+||||+++|||++|..||..........   .+ ...+.....    .......
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL---DI-KEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT---HH-HHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH---HH-HHHhhhhhhhhhhhcccccc
Confidence            23445689999999987       899999999999999999997654332211   11 111111110    0111123


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......+..+.+++.+||+.+|++|||++|
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~  296 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKK  296 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            356778889999999999999999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-40  Score=303.89  Aligned_cols=255  Identities=34%  Similarity=0.540  Sum_probs=194.4

Q ss_pred             CCCcccccccccCCcceeecc-CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          106 ACPFQSLISFNLTNSKFFFLH-SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       106 ~c~~~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      +.....++.+++|.++.+... ++.||||++....  .....+.+|++++++++|+||+++++++.+....++||||+++
T Consensus        32 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  111 (326)
T 3uim_A           32 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN  111 (326)
T ss_dssp             SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTT
T ss_pred             cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccC
Confidence            334455666666666655443 3449999997543  2334789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++.....  ....+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+|||+++.......
T Consensus       112 ~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  189 (326)
T 3uim_A          112 GSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT  189 (326)
T ss_dssp             CBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred             CCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence            999999965432  335699999999999999999999991111999999999999999999999999999988754433


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhc-ccccchHHHHHHHhhhcc---ccccc
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEI-QSQIYFPEWIYNRMRLGQ---ELCLD  330 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~  330 (363)
                      . ......||..|+|||++        +||||||+++|||++|+.||...... ........|+........   .....
T Consensus       190 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (326)
T 3uim_A          190 H-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD  268 (326)
T ss_dssp             C-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTT
T ss_pred             c-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChh
Confidence            2 12445589999999988        89999999999999999999754322 223334444433222211   11222


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .........++.+.+++.+||+.||++|||++|
T Consensus       269 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  301 (326)
T 3uim_A          269 LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE  301 (326)
T ss_dssp             CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred             hccccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence            334466788899999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.8e-41  Score=307.39  Aligned_cols=232  Identities=25%  Similarity=0.426  Sum_probs=174.1

Q ss_pred             cccccccCCcceeeccCCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLHSNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+...++.||||++......   .+++.+|++++++++|+||+++++++.+....++||||+++++|.+
T Consensus        44 ~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  123 (309)
T 3p86_A           44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR  123 (309)
T ss_dssp             EEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHH
T ss_pred             EeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHH
Confidence            3455666666555556667999999754432   2478899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ++.....   ...+++..++.++.|++.||+|||+   .+  |+||||||+|||++.++.+||+|||+++.......  .
T Consensus       124 ~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~  195 (309)
T 3p86_A          124 LLHKSGA---REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--S  195 (309)
T ss_dssp             HHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             HHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--c
Confidence            9954221   1348999999999999999999999   88  99999999999999999999999999986544322  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||..|+|||++        +|+||||+++|||++|+.||.......        ....+....     .....+.
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~-----~~~~~~~  262 (309)
T 3p86_A          196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKC-----KRLEIPR  262 (309)
T ss_dssp             ------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHHSC-----CCCCCCT
T ss_pred             cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcC-----CCCCCCc
Confidence            2445689999999987        799999999999999999997653321        111111010     1112334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+++.+.+++.+||+.+|++|||++|
T Consensus       263 ~~~~~l~~li~~~l~~dP~~Rps~~~  288 (309)
T 3p86_A          263 NLNPQVAAIIEGCWTNEPWKRPSFAT  288 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            56678999999999999999999853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=309.46  Aligned_cols=232  Identities=16%  Similarity=0.186  Sum_probs=183.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.++.+...  +..||+|.+.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus        11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~   90 (321)
T 1tki_A           11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE   90 (321)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred             eEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHH
Confidence            33455555555554433  3449999997665555678899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC--CCCeeEeccccceeccCCccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++........  
T Consensus        91 ~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~--  160 (321)
T 1tki_A           91 RINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--  160 (321)
T ss_dssp             HHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE--
T ss_pred             HHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc--
Confidence            99432     2469999999999999999999999   99999999999999987  789999999999887654432  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                       ....||+.|+|||++        +|+||||+++|||++|..||.......        ....+..+...   .......
T Consensus       161 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~---~~~~~~~  228 (321)
T 1tki_A          161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAEYT---FDEEAFK  228 (321)
T ss_dssp             -EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCC---CCHHHHT
T ss_pred             -ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--------HHHHHHcCCCC---CChhhhc
Confidence             345689999999987        899999999999999999997654321        12222211110   1111112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.++.+++.+||+.||++|||++|
T Consensus       229 ~~s~~~~~li~~~L~~dp~~Rpt~~e  254 (321)
T 1tki_A          229 EISIEAMDFVDRLLVKERKSRMTASE  254 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            34678999999999999999999854

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.6e-41  Score=310.75  Aligned_cols=217  Identities=24%  Similarity=0.435  Sum_probs=174.9

Q ss_pred             eEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC----------C
Q 039471          130 IAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS----------S  196 (363)
Q Consensus       130 vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------~  196 (363)
                      ||||+++....  ..+++.+|+.+++++ +|+||+++++++.+.+..++||||+++|+|.+++......          .
T Consensus       116 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  195 (370)
T 2psq_A          116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV  195 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------
T ss_pred             EEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccccccc
Confidence            99999975432  235789999999999 8999999999999999999999999999999999764321          1


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccccccccc
Q 039471          197 SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYI  276 (363)
Q Consensus       197 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  276 (363)
                      ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...............+|+.|+
T Consensus       196 ~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~  272 (370)
T 2psq_A          196 PEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM  272 (370)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGC
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceE
Confidence            23468999999999999999999999   999999999999999999999999999998776544332334455788999


Q ss_pred             CCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHH
Q 039471          277 APELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA  347 (363)
Q Consensus       277 aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~  347 (363)
                      |||++        +|+||||+++|||++ |+.||.......        +...+..+..      ...+..++..+.+++
T Consensus       273 aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~~l~~li  338 (370)
T 2psq_A          273 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKLLKEGHR------MDKPANCTNELYMMM  338 (370)
T ss_dssp             CHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCC------CCCCTTSCHHHHHHH
T ss_pred             CHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHhcCCC------CCCCCCCCHHHHHHH
Confidence            99987        899999999999999 999987643221        2222222211      123345567899999


Q ss_pred             HHhccCCCCCCCCCCC
Q 039471          348 IWCIQWNPTERPSMPM  363 (363)
Q Consensus       348 ~~cl~~~p~~RPs~~e  363 (363)
                      .+||+.||++|||++|
T Consensus       339 ~~~l~~dP~~Rpt~~e  354 (370)
T 2psq_A          339 RDCWHAVPSQRPTFKQ  354 (370)
T ss_dssp             HHHTCSSGGGSCCHHH
T ss_pred             HHHcCCChhhCcCHHH
Confidence            9999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.1e-41  Score=310.88  Aligned_cols=233  Identities=24%  Similarity=0.286  Sum_probs=173.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.++.+...  ++.||||++.......+.+.+|+.++++++|+||+++++++.++...++||||+++++|.+
T Consensus        26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~  105 (361)
T 3uc3_A           26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE  105 (361)
T ss_dssp             EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             EEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHH
Confidence            34456666655555443  4449999998766667889999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC--eeEeccccceeccCCccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--PKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||+++.......   
T Consensus       106 ~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~---  173 (361)
T 3uc3_A          106 RICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  173 (361)
T ss_dssp             HHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             HHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---
Confidence            99543      459999999999999999999999   99999999999999987765  99999999975433222   


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      .....||+.|+|||++         +|+||||+++|||++|+.||........   +...+ ..+....     ......
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~-~~~~~~~-----~~~~~~  244 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTI-QRILSVK-----YSIPDD  244 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHH-HHHHTTC-----CCCCTT
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHH-HHHhcCC-----CCCCCc
Confidence            1345699999999987         7999999999999999999976544322   11111 1111111     111112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...++.+.+++.+||+.||++|||++|
T Consensus       245 ~~~s~~~~~li~~~L~~dP~~Rps~~e  271 (361)
T 3uc3_A          245 IRISPECCHLISRIFVADPATRISIPE  271 (361)
T ss_dssp             SCCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            234677899999999999999999854

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-40  Score=302.80  Aligned_cols=230  Identities=24%  Similarity=0.341  Sum_probs=184.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+...  ++.||||++.... ...+.+.+|+.++++++|+||+++++++..+...++||||+++++|.
T Consensus        51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  130 (321)
T 2c30_A           51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT  130 (321)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence            34666667666655543  4559999997543 34567899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.........  .
T Consensus       131 ~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~  198 (321)
T 2c30_A          131 DIVSQ-------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--R  198 (321)
T ss_dssp             HHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--B
T ss_pred             HHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--c
Confidence            99832       458999999999999999999999   99999999999999999999999999999877654322  2


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....||..|+|||++        +|+||||+++|||++|+.||.......        ....+......    .......
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~----~~~~~~~  266 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPP----KLKNSHK  266 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSSCC----CCTTGGG
T ss_pred             ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCC----CcCcccc
Confidence            445699999999988        899999999999999999997643321        12222211111    1112334


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++.+.+++.+||+.||++|||++|
T Consensus       267 ~~~~l~~li~~~l~~dp~~Rps~~e  291 (321)
T 2c30_A          267 VSPVLRDFLERMLVRDPQERATAQE  291 (321)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHH
Confidence            5677999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4e-41  Score=298.96  Aligned_cols=231  Identities=21%  Similarity=0.392  Sum_probs=185.5

Q ss_pred             ccccccccCCcceeec-cCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFL-HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+.. .++.||+|++.......+++.+|++++++++|+||+++++++.+++..++||||+++++|.++
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (269)
T 4hcu_A           16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY   95 (269)
T ss_dssp             EEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             heecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHH
Confidence            4456666666665554 344599999987777778999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++........ ....
T Consensus        96 l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  166 (269)
T 4hcu_A           96 LRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG  166 (269)
T ss_dssp             HHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTS
T ss_pred             HHhcC-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc-cccC
Confidence            95432     568999999999999999999999   99999999999999999999999999999876543221 2234


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..+|..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+..      ...+...
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  232 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFR------LYKPRLA  232 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCC------CCCCTTS
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCcc------CCCCCcC
Confidence            4577889999988        799999999999999 899987643321        2222222211      1223334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~  256 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSR  256 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHH
Confidence            677999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.3e-41  Score=322.22  Aligned_cols=230  Identities=27%  Similarity=0.391  Sum_probs=186.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ++.+++|.++.+...  +..||||+++......++|.+|+.++++++|+||+++++++.+....++||||+++|+|.+++
T Consensus       228 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l  307 (495)
T 1opk_A          228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL  307 (495)
T ss_dssp             SGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred             ecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHH
Confidence            455566666555444  345999999877767789999999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAA  269 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  269 (363)
                      .....    ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       308 ~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~  379 (495)
T 1opk_A          308 RECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGA  379 (495)
T ss_dssp             HHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTC
T ss_pred             HhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCC
Confidence            65432    568999999999999999999999   99999999999999999999999999999887544322 22344


Q ss_pred             cccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          270 RGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       270 ~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      .++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      ...+..++
T Consensus       380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~  445 (495)
T 1opk_A          380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYR------MERPEGCP  445 (495)
T ss_dssp             CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCC------CCCCTTCC
T ss_pred             cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCCCC
Confidence            567899999988        899999999999999 888887543221        2222322211      12334566


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.||++|||++|
T Consensus       446 ~~l~~li~~cl~~dP~~RPs~~e  468 (495)
T 1opk_A          446 EKVYELMRACWQWNPSDRPSFAE  468 (495)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHcCcChhHCcCHHH
Confidence            78999999999999999999863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.6e-41  Score=296.96  Aligned_cols=231  Identities=22%  Similarity=0.393  Sum_probs=185.2

Q ss_pred             ccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+...+. .||+|++.......+++.+|+.++++++|+||+++++++.++...++||||+++++|.++
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (268)
T 3sxs_A           14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY   93 (268)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             eeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHH
Confidence            3445566665555544444 499999987777778899999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++......... ....
T Consensus        94 l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~  164 (268)
T 3sxs_A           94 LRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVG  164 (268)
T ss_dssp             HHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCS
T ss_pred             HHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccC
Confidence            96432     458999999999999999999999   99999999999999999999999999999877654432 2234


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..+|..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+..      ...+...
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  230 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHR------LYRPHLA  230 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCC------CCCCTTS
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHHcCCC------CCCCCcC
Confidence            4567789999987        899999999999998 999987544321        1122221211      1122334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+.+++.+||+.||++|||++|
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~  254 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQ  254 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHH
Confidence            567999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-41  Score=314.73  Aligned_cols=232  Identities=22%  Similarity=0.305  Sum_probs=181.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  +..||||+++....  ..++|.+|++++++++|+||+++++++.++...++||||+++|+|
T Consensus       120 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  199 (377)
T 3cbl_A          120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF  199 (377)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCH
Confidence            33555566655555543  44599999874422  235788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..........
T Consensus       200 ~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          200 LTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             HHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            99996432     458999999999999999999999   9999999999999999999999999999987554332222


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      .....++..|+|||++        +||||||+++|||++ |..||.......        +...+..+...      ..+
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~  337 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--------TREFVEKGGRL------PCP  337 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--------HHHHHHTTCCC------CCC
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CCC
Confidence            2223457789999987        899999999999998 888887643221        22223222211      223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++..+.+++.+||+.||++|||++|
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~  364 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFST  364 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            345677999999999999999999863

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-40  Score=304.95  Aligned_cols=224  Identities=20%  Similarity=0.245  Sum_probs=179.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.+..+...  ++.||||+++.    .....+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg   90 (337)
T 1o6l_A           11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   90 (337)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            33455555555544433  44599999964    2345568899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        91 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-  160 (337)
T 1o6l_A           91 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence            999999533      568999999999999999999999   9999999999999999999999999999986433222 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                       ......||+.|+|||++        +|+||||+++|||++|+.||.......        +...+..+.       ...
T Consensus       161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~-------~~~  224 (337)
T 1o6l_A          161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-------IRF  224 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-------CCC
T ss_pred             -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--------HHHHHHcCC-------CCC
Confidence             12445689999999998        799999999999999999997643221        222222211       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +..+++.+.+++.+||+.||++||
T Consensus       225 p~~~s~~~~~li~~lL~~dP~~R~  248 (337)
T 1o6l_A          225 PRTLSPEAKSLLAGLLKKDPKQRL  248 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTST
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhc
Confidence            334567899999999999999999

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=305.91  Aligned_cols=231  Identities=21%  Similarity=0.274  Sum_probs=180.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc-------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...  +..||+|++.....       ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   96 (326)
T 2y0a_A           17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV   96 (326)
T ss_dssp             EEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcC
Confidence            33455555555554443  44599999864322       3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----CeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~  256 (363)
                      ++++|.+++.      ....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++    .+||+|||+++.
T Consensus        97 ~~~~L~~~l~------~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           97 AGGELFDFLA------EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             CSCBHHHHHT------TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCCCHHHHHH------hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999993      23569999999999999999999999   9999999999999999877    799999999988


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .......   ....||+.|+|||++        +|+||||+++|||++|..||.......        ....+.....  
T Consensus       168 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~--  234 (326)
T 2y0a_A          168 IDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNY--  234 (326)
T ss_dssp             CCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHTCC--
T ss_pred             CCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHhcCC--
Confidence            7644322   345689999999987        799999999999999999997643321        1111111110  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..........+..+.+++.+||+.||++|||++|
T Consensus       235 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  268 (326)
T 2y0a_A          235 -EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD  268 (326)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             -CcCccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence             0111111234567899999999999999999854

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=298.90  Aligned_cols=240  Identities=20%  Similarity=0.247  Sum_probs=185.3

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--ceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--RRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++....  ...+.+.+|++++++++|+||+++++++....  ..++||||+++++
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~   95 (319)
T 4euu_A           16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS   95 (319)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCB
T ss_pred             EecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCC
Confidence            3455666666555444  4459999997432  34577889999999999999999999987655  7899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE----cCCCCeeEeccccceeccCC
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      |.+++.....   ...+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.....
T Consensus        96 L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A           96 LYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             HHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             HHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            9999965432   2349999999999999999999999   999999999999999    77888999999999887655


Q ss_pred             ccccccccccccccccCCccc----------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          261 ISIVSRTAARGTSGYIAPELF----------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~----------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ...   ....||..|+|||++                +||||||+++|||++|+.||............   +...+. +
T Consensus       170 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~-~  242 (319)
T 4euu_A          170 EQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV---MYKIIT-G  242 (319)
T ss_dssp             CCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH---HHHHHH-H
T ss_pred             Cce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH---HHHHhc-C
Confidence            432   345689999999974                69999999999999999999754332222111   111111 1


Q ss_pred             cc----------------c--ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QE----------------L--CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~----------------~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..                .  ...........++..+.+++.+||++||++|||++|
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence            10                0  111223456788999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-40  Score=302.95  Aligned_cols=236  Identities=21%  Similarity=0.248  Sum_probs=166.6

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+...  ++.||||++...  ....+.+|+.+++++. |+||+++++++.++...++||||+++++|.+
T Consensus        18 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (325)
T 3kn6_A           18 PLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE   95 (325)
T ss_dssp             CSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence            3566666666655543  445999998643  3467789999999997 9999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEeccccceeccCCcccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++   .+||+|||+++........ 
T Consensus        96 ~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-  165 (325)
T 3kn6_A           96 RIKKK------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-  165 (325)
T ss_dssp             HHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence            99542      569999999999999999999999   9999999999999998665   7999999999876544322 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||..|+|||++        +|+||||+++|||++|+.||............ ..+...+..+..   .......
T Consensus       166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~i~~~~~---~~~~~~~  240 (325)
T 3kn6_A          166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA-VEIMKKIKKGDF---SFEGEAW  240 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH-HHHHHHHTTTCC---CCCSHHH
T ss_pred             -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH-HHHHHHHHcCCC---CCCcccc
Confidence             2345689999999998        79999999999999999999865443221111 122233332211   1111222


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++++.+++.+||+.||++|||++|
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~e  267 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSG  267 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHH
Confidence            346788999999999999999999976

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.7e-41  Score=305.07  Aligned_cols=231  Identities=23%  Similarity=0.383  Sum_probs=179.1

Q ss_pred             cccccccCCcceeecc-----CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH-----SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+...     +..||||++....  ...+.|.+|+.++++++|+||+++++++.+++..++||||++++
T Consensus        56 ~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  135 (325)
T 3kul_A           56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG  135 (325)
T ss_dssp             EEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTC
T ss_pred             EEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCC
Confidence            3456666666554442     1229999997532  23457899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       136 ~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          136 SLDTFLRTH-----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             BHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred             cHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence            999999533     2569999999999999999999999   99999999999999999999999999999887654321


Q ss_pred             -cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          264 -VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       264 -~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                       .......+|..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      .
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~------~  273 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--------VISSVEEGYR------L  273 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCC------C
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCC------C
Confidence             112334467789999988        799999999999998 999986643321        2222222211      1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..++..+.+++.+||+.||++|||++|
T Consensus       274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  303 (325)
T 3kul_A          274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQ  303 (325)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence            233455678999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-40  Score=309.13  Aligned_cols=234  Identities=20%  Similarity=0.260  Sum_probs=180.3

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccCC----cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.+..+....  +.||||+++...    ...+.+.+|..++.++ +||||+++++++.++...++||||+++
T Consensus        58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~g  137 (396)
T 4dc2_A           58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG  137 (396)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCC
Confidence            345666666665554443  349999997432    2335688999999887 799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|..++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       138 g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          138 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            9999999543      469999999999999999999999   9999999999999999999999999999986332221


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccc-cchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ-IYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ......||+.|+|||++        +|+||||+++|||++|+.||......... ....+.+...+....       .
T Consensus       209 --~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------~  279 (396)
T 4dc2_A          209 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------I  279 (396)
T ss_dssp             --CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-------C
T ss_pred             --ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-------c
Confidence              12456799999999998        79999999999999999999653321111 111122333332221       1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ..+..++.++.+++.+||+.||++||++
T Consensus       280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            2233467789999999999999999996

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8e-41  Score=303.23  Aligned_cols=234  Identities=22%  Similarity=0.385  Sum_probs=179.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+...  +..||+|++... ....+.|.+|++++++++|+||+++++++.++...++||||+++++|.
T Consensus        16 ~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~   95 (310)
T 3s95_A           16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR   95 (310)
T ss_dssp             EEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             ceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHH
Confidence            34566666666555543  444999988543 234468999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc-
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-  265 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  265 (363)
                      +++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......... 
T Consensus        96 ~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           96 GIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             HHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            9996532     569999999999999999999999   9999999999999999999999999999987654332110 


Q ss_pred             -----------cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          266 -----------RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       266 -----------~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                                 .....||+.|+|||++        +||||||+++|||++|..|+.............  ......    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--~~~~~~----  241 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--VRGFLD----  241 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--HHHHHH----
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--hhcccc----
Confidence                       1145689999999987        799999999999999999886544332211100  000000    


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ...+..+++.+.+++.+||+.||++|||++|
T Consensus       242 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  272 (310)
T 3s95_A          242 ------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVK  272 (310)
T ss_dssp             ------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------ccCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence                  0112234466899999999999999999853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.6e-40  Score=306.21  Aligned_cols=231  Identities=20%  Similarity=0.276  Sum_probs=181.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  +..||+|++......   .+.+.+|+.++++++||||+++++++.+++..++||||+++++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~  114 (362)
T 2bdw_A           35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE  114 (362)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence            33455566655554433  445999999754322   3578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC---CCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++.      ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.+   +.+||+|||++.......
T Consensus       115 L~~~l~------~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          115 LFEDIV------AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             HHHHHT------TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             HHHHHH------HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            999983      33569999999999999999999999   999999999999999865   459999999998776443


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..   ....||+.|+|||++        +|+||||+++|||++|..||.......        +...+..+..   ....
T Consensus       186 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~---~~~~  251 (362)
T 2bdw_A          186 AW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAY---DYPS  251 (362)
T ss_dssp             SC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC---CCCT
T ss_pred             cc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCC---CCCc
Confidence            22   345699999999987        899999999999999999997643321        2223322211   1111


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+++.+.+++.+||+.||++|||++|
T Consensus       252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  281 (362)
T 2bdw_A          252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQ  281 (362)
T ss_dssp             TGGGGSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            223345678999999999999999999753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-40  Score=315.35  Aligned_cols=225  Identities=24%  Similarity=0.377  Sum_probs=180.3

Q ss_pred             ccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC-ceeEEEeccCCCCHHHHhh
Q 039471          112 LISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN-RRTLIYEFMPNGSLQKFIF  190 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~  190 (363)
                      ++.+++|.++.....++.||||+++... ..+.|.+|+.++++++|+||+++++++.+.. ..++||||+++|+|.+++.
T Consensus       201 lG~G~fg~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~  279 (450)
T 1k9a_A          201 IGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR  279 (450)
T ss_dssp             EEECSSEEEEEEEETTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHH
T ss_pred             ecCcCCeeEEEEEecCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHH
Confidence            4555666666555667779999997544 5678999999999999999999999987655 7899999999999999996


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccc
Q 039471          191 SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR  270 (363)
Q Consensus       191 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  270 (363)
                      ....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......     ....
T Consensus       280 ~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~  347 (450)
T 1k9a_A          280 SRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGK  347 (450)
T ss_dssp             HHCT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------C
T ss_pred             hcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCC
Confidence            5432    457999999999999999999999   999999999999999999999999999998654322     2235


Q ss_pred             ccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          271 GTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       271 gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      ++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      ...+..+++
T Consensus       348 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~------~~~p~~~~~  413 (450)
T 1k9a_A          348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYK------MDAPDGCPP  413 (450)
T ss_dssp             CCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCC------CCCCTTCCH
T ss_pred             CCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCcCCH
Confidence            78899999988        899999999999998 999987543221        2223332222      223345678


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++.+||+.||++|||++|
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~  435 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQ  435 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHH
Confidence            8999999999999999999853

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.5e-41  Score=305.94  Aligned_cols=226  Identities=21%  Similarity=0.333  Sum_probs=180.2

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+..  .++.||||++...    ....+.+.+|+.+++.++||||+++++++.+....++||||+ +|
T Consensus        15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g   93 (336)
T 3h4j_B           15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG   93 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence            3345566666555543  3445999998632    334568899999999999999999999999999999999999 68


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.........
T Consensus        94 ~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           94 ELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             EHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence            999988543      469999999999999999999999   99999999999999999999999999999876554332


Q ss_pred             cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                         ....||+.|+|||++         +|+||||+++|||++|+.||.........        ..+.       .....
T Consensus       165 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------~~i~-------~~~~~  226 (336)
T 3h4j_B          165 ---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------KKVN-------SCVYV  226 (336)
T ss_dssp             ---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------CCCC-------SSCCC
T ss_pred             ---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------HHHH-------cCCCC
Confidence               445699999999987         79999999999999999999754322110        0010       01112


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...++.+.+++.+||+.||.+|||++|
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~e  255 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQE  255 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            23345678999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=306.90  Aligned_cols=227  Identities=20%  Similarity=0.304  Sum_probs=182.8

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+....  +.||+|++..    .....+.+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus        21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg  100 (384)
T 4fr4_A           21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG  100 (384)
T ss_dssp             EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence            445666666666555443  3399999863    2345578899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..      ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       101 ~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A          101 DLRYHLQQ------NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             EHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            99999943      3569999999999999999999999   99999999999999999999999999999987654332


Q ss_pred             cccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                         ....||+.|+|||++           +|+|||||++|||++|+.||........     ..+...+....       
T Consensus       172 ---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~-------  236 (384)
T 4fr4_A          172 ---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFETTV-------  236 (384)
T ss_dssp             ---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHHCC-------
T ss_pred             ---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhhcc-------
Confidence               456699999999987           6999999999999999999975433221     11122221111       


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ...+..++..+.+++.+||+.||++||+
T Consensus       237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          237 VTYPSAWSQEMVSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             cCCCCcCCHHHHHHHHHHhcCCHhHhcc
Confidence            1223445678999999999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.9e-41  Score=318.56  Aligned_cols=229  Identities=24%  Similarity=0.370  Sum_probs=181.1

Q ss_pred             ccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhh
Q 039471          112 LISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIF  190 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  190 (363)
                      ++.+++|.++..... +..||||+++......+.|.+|+.++++++|+||+++++++. ....++||||+++|+|.+++.
T Consensus       196 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~  274 (454)
T 1qcf_A          196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLK  274 (454)
T ss_dssp             EECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHH
T ss_pred             cccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHH
Confidence            444555555444443 344999999876667789999999999999999999999987 567899999999999999995


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccc
Q 039471          191 SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR  270 (363)
Q Consensus       191 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  270 (363)
                      ...    ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       275 ~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~  346 (454)
T 1qcf_A          275 SDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAK  346 (454)
T ss_dssp             SHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSS
T ss_pred             hcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCc
Confidence            432    1368899999999999999999999   9999999999999999999999999999987654322 1223445


Q ss_pred             ccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          271 GTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       271 gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      ++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      ...+..+++
T Consensus       347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~------~~~~~~~~~  412 (454)
T 1qcf_A          347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYR------MPRPENCPE  412 (454)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHHTCC------CCCCTTSCH
T ss_pred             ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCCCCH
Confidence            67889999988        799999999999999 999987543221        2223332221      122345667


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++.+||+.||++|||++|
T Consensus       413 ~l~~li~~cl~~dp~~RPt~~~  434 (454)
T 1qcf_A          413 ELYNIMMRCWKNRPEERPTFEY  434 (454)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHH
Confidence            8999999999999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=305.57  Aligned_cols=226  Identities=21%  Similarity=0.252  Sum_probs=177.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.+..+...  ++.||||+++..    ....+.+.+|..+++.+ +|+||+++++++.+....++||||+++
T Consensus        29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g  108 (353)
T 3txo_A           29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG  108 (353)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence            34556666666555443  344999999642    23456788999999988 699999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       109 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          109 GDLMFHIQKS------RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            9999999543      469999999999999999999999   9999999999999999999999999999986433222


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ......||+.|+|||++        +|+||||+++|||++|+.||.......        +...+..+..       .
T Consensus       180 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~-------~  242 (353)
T 3txo_A          180 --TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEV-------V  242 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------C
T ss_pred             --cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCC-------C
Confidence              12445699999999988        899999999999999999997654322        2333332221       1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+...+..+.+++.+||+.||++||++
T Consensus       243 ~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          243 YPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            223356779999999999999999997

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-40  Score=297.63  Aligned_cols=229  Identities=21%  Similarity=0.358  Sum_probs=181.1

Q ss_pred             ccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhh
Q 039471          112 LISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIF  190 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  190 (363)
                      ++.+++|.++.....+. .||||++.......+++.+|++++++++|+||+++++++.+++..++||||+++++|.+++.
T Consensus        32 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  111 (283)
T 3gen_A           32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR  111 (283)
T ss_dssp             CC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHH
T ss_pred             cCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHH
Confidence            44555555544444433 49999998777777899999999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccc
Q 039471          191 SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR  270 (363)
Q Consensus       191 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  270 (363)
                      ..     ...+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++........ ......
T Consensus       112 ~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  182 (283)
T 3gen_A          112 EM-----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSK  182 (283)
T ss_dssp             CG-----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTT
T ss_pred             Hh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCc
Confidence            43     2569999999999999999999999   99999999999999999999999999999876543221 223445


Q ss_pred             ccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          271 GTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       271 gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      +|..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+..      ...+...++
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~~~  248 (283)
T 3gen_A          183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLR------LYRPHLASE  248 (283)
T ss_dssp             SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCC------CCCCTTCCH
T ss_pred             cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--------HHHHHhcccC------CCCCCcCCH
Confidence            67889999987        799999999999998 999987644321        2222222211      112233456


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++.+||+.+|++|||++|
T Consensus       249 ~l~~li~~~l~~~p~~Rps~~~  270 (283)
T 3gen_A          249 KVYTIMYSCWHEKADERPTFKI  270 (283)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHH
Confidence            7999999999999999999854

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=298.71  Aligned_cols=229  Identities=22%  Similarity=0.314  Sum_probs=175.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc---------------------------ChhHHHHHHHHHhccCCCce
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---------------------------NGQEFINEVATIGRIHHFHI  160 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---------------------------~~~~~~~E~~~l~~l~h~ni  160 (363)
                      ..++.+++|.++.+...  ++.||||++.....                           ..+.+.+|++++++++|+||
T Consensus        19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   98 (298)
T 2zv2_A           19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV   98 (298)
T ss_dssp             EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred             eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence            33455666665555432  34499999864321                           13578899999999999999


Q ss_pred             eeeeeeeee--CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCce
Q 039471          161 VRLLGFCSE--GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI  238 (363)
Q Consensus       161 v~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Ni  238 (363)
                      +++++++.+  ....++||||+++++|.+++       ....+++..+..++.|++.||+|||+   .+|+||||||+||
T Consensus        99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNL  168 (298)
T ss_dssp             CCEEEEEECSSSSEEEEEEECCTTCBSCCSS-------CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred             CeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence            999999976  56899999999999998865       22569999999999999999999999   9999999999999


Q ss_pred             EEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhc
Q 039471          239 LLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEI  307 (363)
Q Consensus       239 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~  307 (363)
                      |++.++.+||+|||+++........  .....||+.|+|||++           +|+||||+++|||++|+.||......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            9999999999999999877654322  2345689999999987           59999999999999999999754321


Q ss_pred             ccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          308 QSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .        +...+.... ..    .......++.+.+++.+||+.||++|||++|
T Consensus       247 ~--------~~~~~~~~~-~~----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e  289 (298)
T 2zv2_A          247 C--------LHSKIKSQA-LE----FPDQPDIAEDLKDLITRMLDKNPESRIVVPE  289 (298)
T ss_dssp             H--------HHHHHHHCC-CC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             H--------HHHHHhccc-CC----CCCccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence            1        122222111 11    1112245677999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-40  Score=300.05  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=178.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  +..||||+++...  ...+.+.+|+.++++++|+||+++++++.+++..++||||++ ++|
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L   89 (317)
T 2pmi_A           11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDL   89 (317)
T ss_dssp             --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBH
T ss_pred             eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCH
Confidence            44555555555554433  4449999986432  334688999999999999999999999999999999999998 599


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...........+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--  164 (317)
T 2pmi_A           90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--  164 (317)
T ss_dssp             HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--
T ss_pred             HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--
Confidence            9999765433334569999999999999999999999   99999999999999999999999999999876543221  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc-----------
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-----------  325 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  325 (363)
                      .....||..|+|||++         +|+|||||++|||++|+.||.........    ..+.+......           
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL----KLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHhCCCChhHhhhhhhhh
Confidence            2345689999999986         79999999999999999999765433211    11111100000           


Q ss_pred             cccccc------------CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDF------------EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......            ........+..+.+++.+||+.||++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  290 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ  290 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence            000000            00011134567999999999999999999854

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.1e-40  Score=303.32  Aligned_cols=227  Identities=19%  Similarity=0.252  Sum_probs=182.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.+..+...  ++.||||+++..    ....+.+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus        23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g  102 (345)
T 1xjd_A           23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG  102 (345)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence            34566666666655543  334999999743    34556788999999877 899999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       103 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A          103 GDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence            9999999543      468999999999999999999999   9999999999999999999999999999986433221


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ......||+.|+|||++        +|+||||+++|||++|+.||.......        +...+..+..       .
T Consensus       174 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~-------~  236 (345)
T 1xjd_A          174 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNP-------F  236 (345)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------C
T ss_pred             --cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCC-------C
Confidence              12455699999999987        799999999999999999997654321        2233322211       1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+..+++.+.+++.+||+.||++|||+.
T Consensus       237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          237 YPRWLEKEAKDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred             CCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence            2234567899999999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=313.20  Aligned_cols=232  Identities=21%  Similarity=0.266  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+..  .++.+|+|++.....   ..+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus        17 ~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~   96 (444)
T 3soa_A           17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE   96 (444)
T ss_dssp             EEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCB
T ss_pred             EEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCC
Confidence            4455666666555433  344599999875432   23578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc---CCCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++   .++.+||+|||++.......
T Consensus        97 L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           97 LFEDIVAR------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             HHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            99999543      569999999999999999999999   9999999999999998   46789999999998765543


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..  .....||+.|+|||++        +||||+|+++|+|++|..||.......        +...+..+..   ....
T Consensus       168 ~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~---~~~~  234 (444)
T 3soa_A          168 QA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQQIKAGAY---DFPS  234 (444)
T ss_dssp             CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCC---CCCT
T ss_pred             ce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhCCC---CCCc
Confidence            22  2345699999999988        799999999999999999997654321        2233332221   1112


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......++.+.+++.+||+.||++|||++|
T Consensus       235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  264 (444)
T 3soa_A          235 PEWDTVTPEAKDLINKMLTINPSKRITAAE  264 (444)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            222355678999999999999999999854

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-41  Score=309.73  Aligned_cols=237  Identities=22%  Similarity=0.332  Sum_probs=182.3

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...       +..||||++....  ....++.+|+.++++++|+||+++++++.++...++||||+
T Consensus        77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  156 (367)
T 3l9p_A           77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM  156 (367)
T ss_dssp             EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeC
Confidence            34555566655554432       2249999996432  23357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNS-SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~  256 (363)
                      ++|+|.+++...... .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++   .+||+|||+++.
T Consensus       157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~  233 (367)
T 3l9p_A          157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  233 (367)
T ss_dssp             TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence            999999999765431 223569999999999999999999999   9999999999999999554   599999999986


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ..............+|+.|+|||++        +|||||||++|||++ |..||.......        +...+..+...
T Consensus       234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------~~~~i~~~~~~  305 (367)
T 3l9p_A          234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VLEFVTSGGRM  305 (367)
T ss_dssp             HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCC
T ss_pred             cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            6443332233445678999999987        899999999999998 999987653321        22223222211


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ..+..++..+.+++.+||+.||++|||++|
T Consensus       306 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  335 (367)
T 3l9p_A          306 ------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAI  335 (367)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------CCCccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence                  223345667999999999999999999854

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=308.91  Aligned_cols=230  Identities=20%  Similarity=0.259  Sum_probs=179.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ++.+++|.++.+...  +..||+|++.... ...+++.+|+.++++++|+||+++++++.+.+..++||||+++++|.++
T Consensus        97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~  176 (373)
T 2x4f_A           97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR  176 (373)
T ss_dssp             CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHH
T ss_pred             EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence            566666666655433  4459999997543 3456899999999999999999999999999999999999999999998


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE--cCCCCeeEeccccceeccCCcccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +....     ..+++..+..++.||+.||+|||+   .+|+||||||+|||+  +.++.+||+|||+++........   
T Consensus       177 l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---  245 (373)
T 2x4f_A          177 IIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---  245 (373)
T ss_dssp             HHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred             HHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence            85432     468999999999999999999999   999999999999999  56778999999999987654432   


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ....||+.|+|||++        +|+||||+++|||++|+.||.......        ....+....   ..........
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~~---~~~~~~~~~~  314 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--------TLNNILACR---WDLEDEEFQD  314 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTC---CCSCSGGGTT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcc---CCCChhhhcc
Confidence            344689999999987        899999999999999999997654322        111221111   1111122234


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.+.+++.+||+.||++|||++|
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e  339 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASE  339 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHH
Confidence            5678999999999999999999754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-40  Score=302.42  Aligned_cols=236  Identities=22%  Similarity=0.352  Sum_probs=169.2

Q ss_pred             ccccccccCCcceeeccCC-----eeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCce------eE
Q 039471          110 QSLISFNLTNSKFFFLHSN-----EIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR------TL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~l  175 (363)
                      ..++.+++|.++.+.....     .||||++...   ....+++.+|++++++++|+||+++++++......      ++
T Consensus        29 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~  108 (323)
T 3qup_A           29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV  108 (323)
T ss_dssp             EEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEE
T ss_pred             ceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEE
Confidence            3445555655555544332     5999999753   23346899999999999999999999999776654      99


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ||||+++++|.+++...........+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~  185 (323)
T 3qup_A          109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSR  185 (323)
T ss_dssp             EEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             EEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeeccccc
Confidence            99999999999999665433333469999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      ...............++..|+|||.+        +|+||||+++|||++ |+.||.......        ....+..+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  257 (323)
T 3qup_A          186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------IYNYLIGGNR  257 (323)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             cccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--------HHHHHhcCCC
Confidence            77554433333445578889999987        899999999999999 899887644322        2222222211


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                            ...+...+..+.+++.+||+.||++|||++
T Consensus       258 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  287 (323)
T 3qup_A          258 ------LKQPPECMEEVYDLMYQCWSADPKQRPSFT  287 (323)
T ss_dssp             ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             ------CCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence                  122334567899999999999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.6e-40  Score=304.14  Aligned_cols=234  Identities=19%  Similarity=0.232  Sum_probs=180.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC------CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+...  ++.||||++...      ....+.+.+|+.++++++|+||+++++++.+++..++||||+++
T Consensus        31 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g  110 (351)
T 3c0i_A           31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG  110 (351)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSS
T ss_pred             EEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence            3455566655555433  445999998521      22457899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC---eeEeccccceeccC
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSK  259 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~~~~  259 (363)
                      ++|.+++.....  ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||++.....
T Consensus       111 ~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~  185 (351)
T 3c0i_A          111 ADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE  185 (351)
T ss_dssp             CBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred             CCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence            999988854321  22468999999999999999999999   99999999999999986654   99999999988765


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ....  .....||+.|+|||++        +|+||||+++|||++|+.||......         ....+..+...   .
T Consensus       186 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~i~~~~~~---~  251 (351)
T 3c0i_A          186 SGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---------LFEGIIKGKYK---M  251 (351)
T ss_dssp             TSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---------HHHHHHHTCCC---C
T ss_pred             CCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---------HHHHHHcCCCC---C
Confidence            4321  2345699999999988        79999999999999999999764321         22222222111   0


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......++..+.+++.+||+.||++|||++|
T Consensus       252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  283 (351)
T 3c0i_A          252 NPRQWSHISESAKDLVRRMLMLDPAERITVYE  283 (351)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            00111234678999999999999999999753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.6e-40  Score=302.17  Aligned_cols=231  Identities=22%  Similarity=0.346  Sum_probs=175.8

Q ss_pred             ccccccccCCcceeeccCC--e----eEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHSN--E----IAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~--~----vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+....+  .    ||+|.+...  ....++|.+|+.++++++|+||+++++++.++. .++++||++
T Consensus        21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~   99 (327)
T 3poz_A           21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP   99 (327)
T ss_dssp             EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCT
T ss_pred             eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecC
Confidence            3445666666655543222  2    688887533  345578999999999999999999999998754 788999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A          100 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             TCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            999999996543     569999999999999999999999   999999999999999999999999999998876554


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........+|..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~------  237 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER------  237 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC------
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCCC------
Confidence            43333445578899999987        899999999999999 999997643322        2222222211      


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...+..+.+++.+||+.+|++|||++|
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  268 (327)
T 3poz_A          238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRE  268 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            1223345667999999999999999999854

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.4e-40  Score=303.12  Aligned_cols=221  Identities=21%  Similarity=0.248  Sum_probs=180.5

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++...    ....+.+.+|+.++++++|+||+++++++.++...++||||+++|+
T Consensus        48 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~  127 (350)
T 1rdq_E           48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE  127 (350)
T ss_dssp             EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCc
Confidence            3455556655555443  445999998632    3455788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......   
T Consensus       128 L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~---  195 (350)
T 1rdq_E          128 MFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---  195 (350)
T ss_dssp             HHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred             HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc---
Confidence            99999543      458999999999999999999999   999999999999999999999999999998765432   


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....||+.|+|||++        +|+||||+++|||++|+.||.......        ++..+..+..       ..+
T Consensus       196 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~-------~~p  258 (350)
T 1rdq_E          196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKV-------RFP  258 (350)
T ss_dssp             --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------CCC
T ss_pred             --ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--------HHHHHHcCCC-------CCC
Confidence              345689999999987        899999999999999999997653321        2333332221       123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ..++..+.+++.+||+.||++||+
T Consensus       259 ~~~~~~~~~li~~lL~~dp~~R~~  282 (350)
T 1rdq_E          259 SHFSSDLKDLLRNLLQVDLTKRFG  282 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred             CCCCHHHHHHHHHHhhcCHHhccC
Confidence            345678999999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-40  Score=297.66  Aligned_cols=221  Identities=22%  Similarity=0.297  Sum_probs=178.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.+..+...  ++.||+|+++..    ....+.+.+|..+++.++|+||+++++++.+....++||||+++|
T Consensus        12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg   91 (318)
T 1fot_A           12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG   91 (318)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence            33455555555554433  445999998642    245567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  
T Consensus        92 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~--  160 (318)
T 1fot_A           92 ELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  160 (318)
T ss_dssp             BHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence            999999542      468999999999999999999999   999999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||+.|+|||++        +|+||||+++|||++|+.||.......        .+..+..+.       ...
T Consensus       161 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~-------~~~  222 (318)
T 1fot_A          161 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAE-------LRF  222 (318)
T ss_dssp             ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCC-------CCC
T ss_pred             ---ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC-------CCC
Confidence               345689999999987        799999999999999999997643321        222222221       112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +...+.++.+++.+||+.||++||
T Consensus       223 p~~~~~~~~~li~~lL~~dp~~R~  246 (318)
T 1fot_A          223 PPFFNEDVKDLLSRLITRDLSQRL  246 (318)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcC
Confidence            234567899999999999999999

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.1e-40  Score=297.23  Aligned_cols=239  Identities=22%  Similarity=0.256  Sum_probs=176.3

Q ss_pred             ccccccccCCcceeec-cCCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFL-HSNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+.. .++.||+|++......   .+.+.+|++++++++|+||+++++++.++...++||||+++ +|
T Consensus        27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l  105 (311)
T 3niz_A           27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL  105 (311)
T ss_dssp             EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EH
T ss_pred             hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CH
Confidence            3445555655555443 2344999998743322   36788999999999999999999999999999999999975 88


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...     ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus       106 ~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--  175 (311)
T 3niz_A          106 KKVLDEN-----KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--  175 (311)
T ss_dssp             HHHHHTC-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             HHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--
Confidence            8888533     2569999999999999999999999   99999999999999999999999999999876543221  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc----------
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE----------  326 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------  326 (363)
                      .....||..|+|||++         +|+||||+++|||++|+.||..........    .+...+.....          
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP----KIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH----HHHHHHCCCCTTTSGGGTTSH
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHHHHCCCChHHhhhhhccc
Confidence            2345689999999986         799999999999999999997654433211    11111100000          


Q ss_pred             -----cccccCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 -----LCLDFEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 -----~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           ........    ....+++++.+++.+||++||++|||++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  297 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD  297 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence                 00000000    11224567899999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-40  Score=315.44  Aligned_cols=229  Identities=24%  Similarity=0.365  Sum_probs=176.6

Q ss_pred             ccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhh
Q 039471          112 LISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIF  190 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  190 (363)
                      ++.+++|.++.....+. .||||+++......++|.+|+.++++++|+||+++++++.+ ...++||||+++|+|.+++.
T Consensus       192 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~  270 (452)
T 1fmk_A          192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK  270 (452)
T ss_dssp             EEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHS
T ss_pred             ecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHH
Confidence            45555555555544443 49999998766667899999999999999999999999876 67899999999999999995


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccc
Q 039471          191 SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR  270 (363)
Q Consensus       191 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  270 (363)
                      ...    ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus       271 ~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~  342 (452)
T 1fmk_A          271 GET----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAK  342 (452)
T ss_dssp             HHH----HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred             hcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCc
Confidence            432    2458999999999999999999999   99999999999999999999999999999876543221 223345


Q ss_pred             ccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          271 GTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       271 gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      ++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      ...+..+++
T Consensus       343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~------~~~~~~~~~  408 (452)
T 1fmk_A          343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYR------MPCPPECPE  408 (452)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCC------CCCCTTSCH
T ss_pred             ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCCCCH
Confidence            77899999987        899999999999999 899986543221        2233332221      122345667


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++.+||+.||++|||++|
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~  430 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEY  430 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHH
Confidence            8999999999999999999853

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=306.88  Aligned_cols=218  Identities=26%  Similarity=0.442  Sum_probs=175.6

Q ss_pred             eeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCC----------
Q 039471          129 EIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNS----------  195 (363)
Q Consensus       129 ~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------  195 (363)
                      .||||++.....  ..+++.+|+++++++ +|+||+++++++.+++..++||||+++++|.+++......          
T Consensus       103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~  182 (382)
T 3tt0_A          103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH  182 (382)
T ss_dssp             EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCS
T ss_pred             EEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccccccc
Confidence            499999975432  236788999999999 8999999999999999999999999999999999765321          


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccc
Q 039471          196 SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGY  275 (363)
Q Consensus       196 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  275 (363)
                      .....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...............+|..|
T Consensus       183 ~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y  259 (382)
T 3tt0_A          183 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW  259 (382)
T ss_dssp             SCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGG
T ss_pred             ccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcce
Confidence            123469999999999999999999999   99999999999999999999999999999877654333333445678899


Q ss_pred             cCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHH
Q 039471          276 IAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV  346 (363)
Q Consensus       276 ~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  346 (363)
                      +|||++        +||||||+++|||++ |..||.......        +...+..+...      ..+..+++++.++
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~l~~l  325 (382)
T 3tt0_A          260 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------LFKLLKEGHRM------DKPSNCTNELYMM  325 (382)
T ss_dssp             SCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCC------CCCSSCCHHHHHH
T ss_pred             eCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CCCccCCHHHHHH
Confidence            999987        899999999999999 999986543221        22223222211      1223456779999


Q ss_pred             HHHhccCCCCCCCCCCC
Q 039471          347 AIWCIQWNPTERPSMPM  363 (363)
Q Consensus       347 ~~~cl~~~p~~RPs~~e  363 (363)
                      +.+||+.||++|||++|
T Consensus       326 i~~~l~~dP~~Rps~~e  342 (382)
T 3tt0_A          326 MRDCWHAVPSQRPTFKQ  342 (382)
T ss_dssp             HHHHTCSSGGGSCCHHH
T ss_pred             HHHHcCCChhhCcCHHH
Confidence            99999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-40  Score=307.74  Aligned_cols=232  Identities=19%  Similarity=0.275  Sum_probs=181.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+...  ++.||+|++.... .....+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus        57 ~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~  136 (387)
T 1kob_A           57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF  136 (387)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred             EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHH
Confidence            33455555555554433  3449999987443 23457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC--CCCeeEeccccceeccCCcccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      +++...     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++........ 
T Consensus       137 ~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~-  207 (387)
T 1kob_A          137 DRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-  207 (387)
T ss_dssp             HHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE-
T ss_pred             HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcce-
Confidence            998432     2469999999999999999999999   99999999999999974  467999999999987654332 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....||..|+|||++        +|+||||+++|||++|..||.......        ....+....   ........
T Consensus       208 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~i~~~~---~~~~~~~~  274 (387)
T 1kob_A          208 --KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCD---WEFDEDAF  274 (387)
T ss_dssp             --EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCC---CCCCSSTT
T ss_pred             --eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC---CCCCcccc
Confidence              334689999999988        899999999999999999997654321        112222111   11122233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++.+.+++.+||+.||++|||++|
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~e  301 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHD  301 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            456778999999999999999999853

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.2e-40  Score=295.42  Aligned_cols=240  Identities=20%  Similarity=0.239  Sum_probs=179.0

Q ss_pred             cccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhc--cCCCceeeeeeeeee----CCceeEEEeccCC
Q 039471          109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGR--IHHFHIVRLLGFCSE----GNRRTLIYEFMPN  182 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~lv~e~~~~  182 (363)
                      ...++.+++|.++.....++.||||++...  ....+.+|.+++..  ++|+||+++++++..    ....++||||+++
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~   90 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSWQGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEM   90 (301)
T ss_dssp             EEEEEECSSEEEEEEEETTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTT
T ss_pred             EEeeccCCCcEEEEEEECCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccC
Confidence            345667777777666666777999998643  34556667776665  789999999998654    3468999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCceecCCCCCceEEcCCCCeeEeccccc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH--------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  254 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a  254 (363)
                      |+|.+++.       ...+++..+..++.|++.||+|||        +   .+|+||||||+|||++.++.+||+|||++
T Consensus        91 g~L~~~l~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           91 GSLYDYLQ-------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             CBHHHHHT-------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCHHHHHh-------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            99999993       246999999999999999999999        7   99999999999999999999999999999


Q ss_pred             eeccCCcccc--ccccccccccccCCccc--------------cCceehhHHHHHHhcC----------CCCCCcchhcc
Q 039471          255 KLCSKDISIV--SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGC----------RKNNDPAVEIQ  308 (363)
Q Consensus       255 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g----------~~~~~~~~~~~  308 (363)
                      +.........  ......||+.|+|||++              +||||||+++|||++|          ..||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8766543321  12334689999999975              6999999999999999          77775543322


Q ss_pred             cccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          309 SQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...  .. .......................++.+.+++.+||+.||++|||++|
T Consensus       241 ~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  292 (301)
T 3q4u_A          241 PSF--ED-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR  292 (301)
T ss_dssp             CCH--HH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cch--hh-hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence            211  11 11111111111111111133467889999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1e-39  Score=311.52  Aligned_cols=226  Identities=22%  Similarity=0.343  Sum_probs=183.0

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++...    ....+.+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus        23 ~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~  102 (476)
T 2y94_A           23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE  102 (476)
T ss_dssp             EEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence            3566666666555443  455999999642    2344678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++.      ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus       103 L~~~l~------~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~-  172 (476)
T 2y94_A          103 LFDYIC------KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-  172 (476)
T ss_dssp             HHHHTT------SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB-
T ss_pred             HHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccccc-
Confidence            999993      33569999999999999999999999   99999999999999999999999999999887654322 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        ....||+.|+|||++         +|+||||+++|||++|+.||.......        +...+..+..       ..
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~-------~~  235 (476)
T 2y94_A          173 --RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--------LFKKICDGIF-------YT  235 (476)
T ss_dssp             --CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--------HHHHHHTTCC-------CC
T ss_pred             --cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCc-------CC
Confidence              345699999999987         799999999999999999997643211        2223322211       12


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...++.+.+++.+||+.||++|||++|
T Consensus       236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~e  263 (476)
T 2y94_A          236 PQYLNPSVISLLKHMLQVDPMKRATIKD  263 (476)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            2334567999999999999999999854

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.3e-40  Score=305.32  Aligned_cols=233  Identities=22%  Similarity=0.340  Sum_probs=170.2

Q ss_pred             cccccccccCCcceeecc-----CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          109 FQSLISFNLTNSKFFFLH-----SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ...++.+++|.++.+...     +..||||+++...  ...++|.+|+.++++++|+||+++++++.++...++||||++
T Consensus        50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (373)
T 2qol_A           50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME  129 (373)
T ss_dssp             CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence            344566666666555443     3349999997532  234579999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       130 ~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          130 NGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             TCBHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            99999999533     2569999999999999999999999   999999999999999999999999999998775543


Q ss_pred             ccc-ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          262 SIV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       262 ~~~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ... ......++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..     
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------~~~~i~~~~~-----  268 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYR-----  268 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------HHHHHHTTEE-----
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC-----
Confidence            211 11223457789999988        899999999999997 999986543221        2222222211     


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...+..++..+.+++.+||+.||++|||++|
T Consensus       269 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~  299 (373)
T 2qol_A          269 -LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ  299 (373)
T ss_dssp             -CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCCccccHHHHHHHHHHhCcChhhCcCHHH
Confidence             1122345677999999999999999999853

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-40  Score=302.61  Aligned_cols=237  Identities=25%  Similarity=0.331  Sum_probs=183.1

Q ss_pred             ccccccccCCcceeeccC-------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHS-------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...+       ..||||+++....  ..+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus        53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  132 (343)
T 1luf_A           53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM  132 (343)
T ss_dssp             EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence            345566666665555432       4599999975432  2357899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC
Q 039471          181 PNGSLQKFIFSKTNS------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  242 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~  242 (363)
                      ++++|.+++......                  .....+++..++.++.||+.||.|||+   .+|+||||||+|||++.
T Consensus       133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~  209 (343)
T 1luf_A          133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE  209 (343)
T ss_dssp             TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred             CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEECC
Confidence            999999999764311                  012579999999999999999999999   99999999999999999


Q ss_pred             CCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccch
Q 039471          243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYF  313 (363)
Q Consensus       243 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~  313 (363)
                      ++.+||+|||+++...............+|..|+|||++        +|+||||+++|||++ |+.||.......     
T Consensus       210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----  284 (343)
T 1luf_A          210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-----  284 (343)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----
T ss_pred             CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-----
Confidence            999999999999876544332223445678999999987        899999999999999 999987543221     


Q ss_pred             HHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 PEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         +...+..+...      ..+..++..+.+++.+||+.||++|||++|
T Consensus       285 ---~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  325 (343)
T 1luf_A          285 ---VIYYVRDGNIL------ACPENCPLELYNLMRLCWSKLPADRPSFCS  325 (343)
T ss_dssp             ---HHHHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---HHHHHhCCCcC------CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence               22222222211      123345678999999999999999999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-39  Score=300.15  Aligned_cols=226  Identities=19%  Similarity=0.212  Sum_probs=181.0

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEcccC----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.+..+....  +.||||+++..    ....+.+.+|..++..+ +|+||+++++++.+....++||||+++
T Consensus        26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g  105 (353)
T 2i0e_A           26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG  105 (353)
T ss_dssp             EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence            345566666655555443  33999999742    34556788999999988 799999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       106 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          106 GDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence            9999999543      459999999999999999999999   9999999999999999999999999999986433221


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ......||+.|+|||++        +|+||||+++|||++|+.||.......        +...+..+..       .
T Consensus       177 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~-------~  239 (353)
T 2i0e_A          177 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHNV-------A  239 (353)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------C
T ss_pred             --ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhCCC-------C
Confidence              12455699999999988        799999999999999999997643321        2333322211       1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      .+...++++.+++.+||+.||++||++
T Consensus       240 ~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          240 YPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            233466789999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.4e-40  Score=296.23  Aligned_cols=230  Identities=23%  Similarity=0.293  Sum_probs=172.9

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++....  .+..||+|++......    .+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~   97 (294)
T 4eqm_A           18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT   97 (294)
T ss_dssp             EEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCC
Confidence            345555555544432  2445999998543322    2578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        98 L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  167 (294)
T 4eqm_A           98 LSEYIESH------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-  167 (294)
T ss_dssp             HHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-
Confidence            99999543      468999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||+.|+|||++        +|+||||+++|||++|+.||........       ....+...   .........
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~---~~~~~~~~~  237 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-------AIKHIQDS---VPNVTTDVR  237 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-------HHHHHSSC---CCCHHHHSC
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhhcc---CCCcchhcc
Confidence            12345689999999987        7999999999999999999976543221       11111111   011111122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                      ..+++.+.+++.+||+.||++||+
T Consensus       238 ~~~~~~l~~li~~~l~~dp~~R~~  261 (294)
T 4eqm_A          238 KDIPQSLSNVILRATEKDKANRYK  261 (294)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred             cCCCHHHHHHHHHHhcCCHhHccc
Confidence            345678999999999999999994

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.7e-40  Score=293.85  Aligned_cols=227  Identities=25%  Similarity=0.352  Sum_probs=171.7

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCC-----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLK-----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...++.||||++....     ...+.+.+|++++++++|+||+++++++.+++..++||||+++++
T Consensus        13 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   92 (271)
T 3dtc_A           13 EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP   92 (271)
T ss_dssp             EEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEE
T ss_pred             eeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCC
Confidence            445667777777766667779999986432     234678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---ceecCCCCCceEEcC--------CCCeeEecccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR---ILHFDIKPHNILLDH--------NFQPKISDFGL  253 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---i~H~dikp~Nill~~--------~~~~kl~Dfg~  253 (363)
                      |.+++.       ...+++..++.++.|++.||+|||+   .+   ++||||||+||+++.        ++.+||+|||+
T Consensus        93 L~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           93 LNRVLS-------GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             HHHHHT-------SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             HHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999983       2568999999999999999999999   77   999999999999986        67899999999


Q ss_pred             ceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          254 AKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       254 a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      +........    ....||..|+|||++        +|+||||+++|||++|+.||........        ........
T Consensus       163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~  230 (271)
T 3dtc_A          163 AREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------AYGVAMNK  230 (271)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--------HHHHHTSC
T ss_pred             ccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHhhhcCC
Confidence            987654432    234689999999987        7999999999999999999976443211        11111111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           .....+...++.+.+++.+||+.||++|||++|
T Consensus       231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  263 (271)
T 3dtc_A          231 -----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTN  263 (271)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence                 111223445678999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-39  Score=299.12  Aligned_cols=234  Identities=21%  Similarity=0.258  Sum_probs=179.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.+..+...  ++.||||++.....    ..+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus        15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g   94 (345)
T 3a8x_A           15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   94 (345)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence            34455556555555443  34499999975432    224578899999987 899999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        95 g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           95 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            9999999543      469999999999999999999999   9999999999999999999999999999986433221


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccc-cchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ-IYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ......||+.|+|||++        +|+|||||++|||++|+.||......... ......+...+....       .
T Consensus       166 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-------~  236 (345)
T 3a8x_A          166 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------I  236 (345)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------C
T ss_pred             --cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------C
Confidence              12445699999999987        79999999999999999999653221110 011122333332221       1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ..+...+..+.+++.+||+.||++|||+
T Consensus       237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1233456789999999999999999996

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-39  Score=305.22  Aligned_cols=245  Identities=14%  Similarity=0.110  Sum_probs=176.6

Q ss_pred             cccc--ccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISF--NLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~--~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+  ++|.++.+...  +..||||++......   .+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        33 lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  112 (389)
T 3gni_B           33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS  112 (389)
T ss_dssp             EEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             ccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCC
Confidence            3444  55555555443  445999999754322   3567889999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc-
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  263 (363)
                      |.+++.....    ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.+......... 
T Consensus       113 L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~  185 (389)
T 3gni_B          113 AKDLICTHFM----DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ  185 (389)
T ss_dssp             HHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEEC
T ss_pred             HHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccc
Confidence            9999965432    569999999999999999999999   99999999999999999999999999998765332111 


Q ss_pred             ----cccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHh--------
Q 039471          264 ----VSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRM--------  321 (363)
Q Consensus       264 ----~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--------  321 (363)
                          .......||..|+|||++          +|||||||++|||++|+.||...................+        
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (389)
T 3gni_B          186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA  265 (389)
T ss_dssp             SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------
T ss_pred             cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccc
Confidence                111234688999999987          6999999999999999999976433221100000000000        


Q ss_pred             --------------------hhcc---ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 --------------------RLGQ---ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 --------------------~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                          ....   .............+++.+.+++.+||++||++|||++|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             ----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             ccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence                                0000   00000011123445678999999999999999999754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.1e-40  Score=293.76  Aligned_cols=240  Identities=20%  Similarity=0.262  Sum_probs=177.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  ++.||||++......   .+.+.+|+.++++++|+||+++++++.+++..++||||+++ +
T Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   86 (292)
T 3o0g_A            8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D   86 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred             eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence            34556666666555443  344999999743322   36788999999999999999999999999999999999975 6


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...     ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        87 l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  157 (292)
T 3o0g_A           87 LKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             HHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred             HHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence            66666432     2569999999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc--------
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL--------  327 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  327 (363)
                       .....||..|+|||++         +|+||||+++|||++|..|+.........   ...+.+........        
T Consensus       158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ---LKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH---HHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhhhhhccc
Confidence             2445689999999987         79999999999999988886543322211   01111111000000        


Q ss_pred             ----------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 ----------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ----------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                ............+..+.+++.+||+.||++|||++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  279 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE  279 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence                      000011122345678899999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.8e-40  Score=296.96  Aligned_cols=235  Identities=24%  Similarity=0.404  Sum_probs=183.0

Q ss_pred             ccccccCCcceeec-------cCCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFL-------HSNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+..       .+..||||++.....  ..+.+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  110 (314)
T 2ivs_A           31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY  110 (314)
T ss_dssp             EEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             ecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCC
Confidence            45555555544432       114499999974332  236788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC
Q 039471          183 GSLQKFIFSKTNS------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF  244 (363)
Q Consensus       183 ~sL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~  244 (363)
                      ++|.+++......                  .....+++..++.++.|++.||+|||+   .+|+||||||+||+++.++
T Consensus       111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~~~~  187 (314)
T 2ivs_A          111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGR  187 (314)
T ss_dssp             CBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTT
T ss_pred             CCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEcCCC
Confidence            9999999764321                  012458999999999999999999999   9999999999999999999


Q ss_pred             CeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHH
Q 039471          245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       245 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~  315 (363)
                      .+||+|||+++...............++..|+|||++        +|+||||+++|||++ |+.||.......       
T Consensus       188 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------  260 (314)
T 2ivs_A          188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-------  260 (314)
T ss_dssp             EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------
T ss_pred             CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            9999999999887655443333455678899999987        899999999999999 999987644321       


Q ss_pred             HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       +...+..+..      ...+..+++.+.+++.+||+.||++|||++|
T Consensus       261 -~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  301 (314)
T 2ivs_A          261 -LFNLLKTGHR------MERPDNCSEEMYRLMLQCWKQEPDKRPVFAD  301 (314)
T ss_dssp             -HHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -HHHHhhcCCc------CCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence             2222222211      1223455678999999999999999999854

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=303.51  Aligned_cols=230  Identities=20%  Similarity=0.255  Sum_probs=165.9

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      .++.+++|.++.+...  ++.||||++.... ..+.+.+|+.++++++|+||+++++++.++...++||||+++++|.++
T Consensus        60 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~  138 (349)
T 2w4o_A           60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR  138 (349)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             EEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHH
Confidence            3455666665555544  3349999997543 446788999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      +..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++........  
T Consensus       139 l~~------~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--  207 (349)
T 2w4o_A          139 IVE------KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--  207 (349)
T ss_dssp             HTT------CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             HHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc--
Confidence            942      3568999999999999999999999   99999999999999975   889999999999876543221  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                       ....||+.|+|||++        +|+||||+++|||++|+.||.......       .....+.....   ........
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~---~~~~~~~~  276 (349)
T 2w4o_A          208 -KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEY---YFISPWWD  276 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCC---CCCTTTTT
T ss_pred             -ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCC---ccCCchhh
Confidence             345689999999987        899999999999999999997543321       12222222211   11112233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.||++|||++|
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (349)
T 2w4o_A          277 EVSLNAKDLVRKLIVLDPKKRLTTFQ  302 (349)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             hCCHHHHHHHHHHccCChhhCcCHHH
Confidence            45678999999999999999999753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.7e-40  Score=305.81  Aligned_cols=236  Identities=27%  Similarity=0.378  Sum_probs=179.3

Q ss_pred             ccccccCCcceeecc-------CCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCC-ceeEEEecc
Q 039471          112 LISFNLTNSKFFFLH-------SNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGN-RRTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~  180 (363)
                      ++.+++|.++.+...       ++.||||+++....  ..+.+.+|++++.++ +|+||+++++++.+.+ ..++||||+
T Consensus        30 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~  109 (359)
T 3vhe_A           30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  109 (359)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECC
T ss_pred             ecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEec
Confidence            445555555444311       13499999975432  235789999999999 7999999999987754 489999999


Q ss_pred             CCCCHHHHhhhcCCCC------------------------------------------------------------CCCC
Q 039471          181 PNGSLQKFIFSKTNSS------------------------------------------------------------SHRQ  200 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~------------------------------------------------------------~~~~  200 (363)
                      ++|+|.+++.......                                                            ....
T Consensus       110 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3vhe_A          110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF  189 (359)
T ss_dssp             TTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTC
T ss_pred             CCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccc
Confidence            9999999997543210                                                            0123


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCcc
Q 039471          201 LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPEL  280 (363)
Q Consensus       201 l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  280 (363)
                      +++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...............||..|+|||+
T Consensus       190 l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          190 LTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhh
Confidence            8999999999999999999999   9999999999999999999999999999987755444333455668899999998


Q ss_pred             c--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhc
Q 039471          281 F--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI  351 (363)
Q Consensus       281 ~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (363)
                      +        +||||||+++|||++ |+.||........       ....+..+..      ...+...++.+.+++.+||
T Consensus       267 ~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~~~l~~li~~~l  333 (359)
T 3vhe_A          267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRLKEGTR------MRAPDYTTPEMYQTMLDCW  333 (359)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-------HHHHHHHTCC------CCCCTTCCHHHHHHHHHHT
T ss_pred             hcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-------HHHHHHcCCC------CCCCCCCCHHHHHHHHHHc
Confidence            7        899999999999998 9999876432211       2222222211      1223345677999999999


Q ss_pred             cCCCCCCCCCCC
Q 039471          352 QWNPTERPSMPM  363 (363)
Q Consensus       352 ~~~p~~RPs~~e  363 (363)
                      +.||++|||++|
T Consensus       334 ~~dP~~Rps~~e  345 (359)
T 3vhe_A          334 HGEPSQRPTFSE  345 (359)
T ss_dssp             CSSGGGSCCHHH
T ss_pred             cCChhhCCCHHH
Confidence            999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.2e-40  Score=295.16  Aligned_cols=232  Identities=27%  Similarity=0.393  Sum_probs=186.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.++.+...  +..||+|++.......+.+.+|+.++++++|+||+++++++.++...++||||+++++|.+
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   98 (288)
T 3kfa_A           19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD   98 (288)
T ss_dssp             EESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred             eecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence            34566666666665544  3449999998766667889999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++.....    ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......... ...
T Consensus        99 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~  170 (288)
T 3kfa_A           99 YLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA  170 (288)
T ss_dssp             HHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EET
T ss_pred             HHHhccc----CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-ccc
Confidence            9965432    569999999999999999999999   99999999999999999999999999999876654322 223


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEG  338 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (363)
                      ...+|..|+|||++        +|+||||+++|+|++ |..||.......        +...+....      ....+..
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~  236 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDY------RMERPEG  236 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTC------CCCCCTT
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhccC------CCCCCCC
Confidence            44578889999987        799999999999999 888887643322        122222111      1122344


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          339 IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       339 ~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.+.+++.+||+.||++|||++|
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~  261 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAE  261 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHH
Confidence            5678999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-39  Score=313.51  Aligned_cols=235  Identities=22%  Similarity=0.244  Sum_probs=186.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||||++...    ....+.+.+|+.++++++|+||+++++++.+....++||||++||
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            34566666666655543  445999999632    234567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++.....  ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       271 ~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          271 DIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             BHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            99999865431  23579999999999999999999999   99999999999999999999999999999887654322


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        .....||+.|+|||++        +|+|||||++|||++|+.||.........    ..+...+....       ...
T Consensus       346 --~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~-------~~~  412 (543)
T 3c4z_A          346 --TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQA-------VTY  412 (543)
T ss_dssp             --BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCC-------CCC
T ss_pred             --cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcc-------cCC
Confidence              1345799999999988        79999999999999999999865432211    11222222111       122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      +..+++.+.+++.+||+.||++||++.
T Consensus       413 p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          413 PDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             CcccCHHHHHHHHHhccCCHhHCCCCc
Confidence            345677899999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-40  Score=293.39  Aligned_cols=234  Identities=20%  Similarity=0.258  Sum_probs=176.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  +..||+|++....  ...+.+.+|++++++++|+||+++++++.+....++||||+++++|
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  107 (285)
T 3is5_A           28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL  107 (285)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBH
T ss_pred             ceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcH
Confidence            34455666655554433  4459999986543  3457899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCcc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .+++.....  ....+++..++.++.|++.||+|||+   .+|+||||||+||++   +.++.+||+|||++........
T Consensus       108 ~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~  182 (285)
T 3is5_A          108 LERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH  182 (285)
T ss_dssp             HHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             HHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence            999855321  22569999999999999999999999   999999999999999   4567899999999987654432


Q ss_pred             ccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          263 IVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      .   ....||..|+|||++       +|+||||+++|||++|+.||.......        ............    ...
T Consensus       183 ~---~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~----~~~  247 (285)
T 3is5_A          183 S---TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--------VQQKATYKEPNY----AVE  247 (285)
T ss_dssp             -------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCC----CC-
T ss_pred             C---cCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--------HHhhhccCCccc----ccc
Confidence            2   345689999999987       899999999999999999997643221        111111111110    011


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....++.+.+++.+||+.||++|||++|
T Consensus       248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e  275 (285)
T 3is5_A          248 CRPLTPQAVDLLKQMLTKDPERRPSAAQ  275 (285)
T ss_dssp             -CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence            1124567889999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-39  Score=287.44  Aligned_cols=233  Identities=24%  Similarity=0.296  Sum_probs=182.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  ++.||||++....  ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++|
T Consensus        13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (276)
T 2yex_A           13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL   92 (276)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred             EEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcH
Confidence            34555666665555433  4559999986433  2346889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.      ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||.+...........
T Consensus        93 ~~~l~------~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           93 FDRIE------PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             GGGSB------TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHh------hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99983      23568999999999999999999999   9999999999999999999999999999987654432222


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      .....|+..|+|||++         +|+||||+++|||++|+.||........       ....+.....     .....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-----~~~~~  231 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKT-----YLNPW  231 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-------HHHHHHTTCT-----TSTTG
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHhhhccc-----ccCch
Confidence            3455689999999987         7999999999999999999976543221       1111111111     01122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+.+++.+||+.||++|||++|
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~  258 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPD  258 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence            345678999999999999999999853

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-39  Score=296.90  Aligned_cols=232  Identities=20%  Similarity=0.214  Sum_probs=175.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--------------
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--------------  171 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------------  171 (363)
                      ..++.+++|.++.+...  +..||||++....  ...+.+.+|++++++++||||+++++++.+..              
T Consensus        12 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~   91 (332)
T 3qd2_B           12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLK   91 (332)
T ss_dssp             EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----
T ss_pred             eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhc
Confidence            34566666666655543  4459999987433  23468999999999999999999999986543              


Q ss_pred             -------------------------------------------ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHH
Q 039471          172 -------------------------------------------RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRK  208 (363)
Q Consensus       172 -------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~  208 (363)
                                                                 ..++||||+++++|.+++.....   ....++..++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~  168 (332)
T 3qd2_B           92 DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDREHGVCLH  168 (332)
T ss_dssp             ----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGGSCHHHHHH
T ss_pred             cccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccchhhHHHHH
Confidence                                                       37999999999999999965432   24567788999


Q ss_pred             HHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc----------cccccccccccccCC
Q 039471          209 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI----------VSRTAARGTSGYIAP  278 (363)
Q Consensus       209 i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aP  278 (363)
                      ++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........          .......||+.|+||
T Consensus       169 i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            99999999999999   99999999999999999999999999999887654321          112345699999999


Q ss_pred             ccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHh
Q 039471          279 ELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWC  350 (363)
Q Consensus       279 E~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  350 (363)
                      |++        +|+||||+++|||++|..|+.....          ........      ..+......++.+.+++.+|
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----------~~~~~~~~------~~~~~~~~~~~~~~~li~~~  309 (332)
T 3qd2_B          246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----------IITDVRNL------KFPLLFTQKYPQEHMMVQDM  309 (332)
T ss_dssp             HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----------HHHHHHTT------CCCHHHHHHCHHHHHHHHHH
T ss_pred             HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----------HHHHhhcc------CCCcccccCChhHHHHHHHH
Confidence            987        7999999999999998766432211          11111111      11112345567789999999


Q ss_pred             ccCCCCCCCCCCC
Q 039471          351 IQWNPTERPSMPM  363 (363)
Q Consensus       351 l~~~p~~RPs~~e  363 (363)
                      |+.||++|||++|
T Consensus       310 l~~~p~~Rps~~~  322 (332)
T 3qd2_B          310 LSPSPTERPEATD  322 (332)
T ss_dssp             HCSSGGGSCCHHH
T ss_pred             ccCCCCcCCCHHH
Confidence            9999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.4e-40  Score=290.69  Aligned_cols=228  Identities=20%  Similarity=0.312  Sum_probs=181.9

Q ss_pred             cccccccccCCcceeeccCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccCCC
Q 039471          109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMPNG  183 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~~  183 (363)
                      ...++.+++|.++.+...++.||||++.....   ..+.|.+|+.++++++|+||+++++++.+.  ...++||||++++
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   94 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG   94 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred             HHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence            34566777777777777777799999975432   235789999999999999999999999876  7889999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|.+++....    ...+++..++.++.|++.||+|||+   .+  ++||||||+||+++.++.++|.|||++.....  
T Consensus        95 ~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--  165 (271)
T 3kmu_A           95 SLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--  165 (271)
T ss_dssp             BHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred             cHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence            9999996432    2469999999999999999999999   88  99999999999999999999999988654322  


Q ss_pred             cccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          262 SIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                           ....||+.|+|||++           +|+||||+++|||++|+.||........       .......+      
T Consensus       166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~------  227 (271)
T 3kmu_A          166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------GMKVALEG------  227 (271)
T ss_dssp             -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------HHHHHHSC------
T ss_pred             -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------HHHHHhcC------
Confidence                 234589999999987           7999999999999999999976433221       11111111      


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+...++.+.+++.+||+.||++|||++|
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  260 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDM  260 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            111233455678999999999999999999853

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-40  Score=301.03  Aligned_cols=237  Identities=28%  Similarity=0.398  Sum_probs=180.5

Q ss_pred             cccccccCCcceeec-------cCCeeEEEEcccC--CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFL-------HSNEIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-------~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++.+++|.++.+..       .+..||||++...  ....+.+.+|+.+++++ +|+||+++++++..++..++||||+
T Consensus        52 ~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  131 (344)
T 1rjb_A           52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC  131 (344)
T ss_dssp             EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecC
Confidence            345555555544432       1224999999743  23457899999999999 8999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC
Q 039471          181 PNGSLQKFIFSKTNS-----------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  243 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~  243 (363)
                      ++|+|.+++......                 .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.+
T Consensus       132 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~  208 (344)
T 1rjb_A          132 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHG  208 (344)
T ss_dssp             TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEETT
T ss_pred             CCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEEcCC
Confidence            999999999654321                 011348999999999999999999999   999999999999999999


Q ss_pred             CCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchH
Q 039471          244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFP  314 (363)
Q Consensus       244 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~  314 (363)
                      +.+||+|||++................+|..|+|||++        +|+||||+++|||++ |..||........     
T Consensus       209 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----  283 (344)
T 1rjb_A          209 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-----  283 (344)
T ss_dssp             TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----
T ss_pred             CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH-----
Confidence            99999999999877655443333455678899999987        899999999999998 9999876532211     


Q ss_pred             HHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          315 EWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ....+..+.      ....+...++.+.+++.+||+.||++|||++|
T Consensus       284 --~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  324 (344)
T 1rjb_A          284 --FYKLIQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN  324 (344)
T ss_dssp             --HHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --HHHHHhcCC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence              222222111      11223345678999999999999999999853

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-39  Score=289.32  Aligned_cols=231  Identities=21%  Similarity=0.378  Sum_probs=183.7

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+... ++.||+|++.......+.+.+|++++++++|+||+++++++.+++..++||||+++++|.++
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (267)
T 3t9t_A           14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY   93 (267)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHH
T ss_pred             eEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHH
Confidence            34455566655555443 34599999987776778999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........ .....
T Consensus        94 ~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~  164 (267)
T 3t9t_A           94 LRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG  164 (267)
T ss_dssp             HHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred             HhhCc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-ccccc
Confidence            96432     468999999999999999999999   9999999999999999999999999999987644321 12234


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+..      ...+...
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~------~~~~~~~  230 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFR------LYKPRLA  230 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCC------CCCCTTS
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCc------CCCCccC
Confidence            4577889999987        899999999999999 898887543221        2222222211      1122334


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.||++|||++|
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~  254 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSR  254 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHH
Confidence            677999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.7e-40  Score=293.03  Aligned_cols=239  Identities=21%  Similarity=0.260  Sum_probs=176.5

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+... ++.||+|++....   ...+.+.+|+.++++++|+||+++++++.+++..++||||+++ +|
T Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l   86 (288)
T 1ob3_A            8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL   86 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred             hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence            34556666666555443 4459999986432   2346788999999999999999999999999999999999975 99


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        87 ~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  156 (288)
T 1ob3_A           87 KKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--  156 (288)
T ss_dssp             HHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             HHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence            9998543     2568999999999999999999999   99999999999999999999999999999876533221  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc-----------
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-----------  325 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  325 (363)
                      .....||..|+|||++         +|+||||+++|||++|+.||.........    ..+........           
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL----MRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHHCCCChhhchhhhccc
Confidence            1344689999999986         79999999999999999999765432211    00111100000           


Q ss_pred             cccccc-------CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDF-------EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......       ........++.+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  277 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ  277 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence            000000       00111235678899999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.9e-40  Score=308.33  Aligned_cols=232  Identities=19%  Similarity=0.252  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||+|++..    .....+.+.+|+.+++.++|+||+++++++.++...++||||++||
T Consensus        75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  154 (410)
T 3v8s_A           75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG  154 (410)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34556666665555444  33499999864    2334456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++..       ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       155 ~L~~~l~~-------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          155 DLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             cHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999843       358999999999999999999999   99999999999999999999999999999887654322


Q ss_pred             cccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          264 VSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                       ......||+.|+|||++            +|+||||+++|||++|+.||.......        .+..+..+...   .
T Consensus       225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~---~  292 (410)
T 3v8s_A          225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHKNS---L  292 (410)
T ss_dssp             -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHH---C
T ss_pred             -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------HHHHHHhcccc---c
Confidence             22456799999999976            699999999999999999997654322        22222221110   0


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCC--CCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTE--RPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~e  363 (363)
                      .......+++.+.+++.+||+.+|++  ||+++|
T Consensus       293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~e  326 (410)
T 3v8s_A          293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEE  326 (410)
T ss_dssp             CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred             cCCCcccccHHHHHHHHHHccChhhhCCCCCHHH
Confidence            11112245678999999999999988  998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.6e-40  Score=307.87  Aligned_cols=232  Identities=22%  Similarity=0.287  Sum_probs=171.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhc-cCCCceeeeeeeeee----CCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSE----GNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+...  ++.||||++.    ....+.+|+.++.+ .+|+||+++++++..    ....++||||+++|
T Consensus        69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~----~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg  144 (400)
T 1nxk_A           69 VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG  144 (400)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEE----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSE
T ss_pred             eeeeccCeEEEEEEECCCCCEEEEEEeC----cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCC
Confidence            3566666666655543  3449999996    33567789988754 479999999999865    56789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCC
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~  260 (363)
                      +|.+++....    ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       145 ~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          145 ELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             cHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            9999995432    2469999999999999999999999   99999999999999997   788999999999876543


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...   ....||..|+|||++        +|||||||++|||++|+.||...........    ....+..+..   ...
T Consensus       218 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~i~~~~~---~~~  287 (400)
T 1nxk_A          218 NSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMGQY---EFP  287 (400)
T ss_dssp             ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS----HHHHHHHTCC---CCC
T ss_pred             Ccc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH----HHHHHHcCcc---cCC
Confidence            322   445689999999998        7999999999999999999976543321111    1112221211   111


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......++.++.+++.+||+.||++|||++|
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  318 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITE  318 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1122346678999999999999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-40  Score=309.62  Aligned_cols=230  Identities=20%  Similarity=0.314  Sum_probs=168.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC---------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK---------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .++.+++|.++.+...  ++.||||++....         .....+.+|+.++++++|+||+++++++.. ...++||||
T Consensus       142 ~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~  220 (419)
T 3i6u_A          142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLEL  220 (419)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEEC
T ss_pred             EEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEc
Confidence            3555555555554433  3459999986422         122358899999999999999999999754 557899999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEecccccee
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKL  256 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~Dfg~a~~  256 (363)
                      +++++|.+++.      ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++   .+||+|||+++.
T Consensus       221 ~~~g~L~~~l~------~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          221 MEGGELFDKVV------GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             CTTCBGGGGTS------SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             CCCCcHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            99999999883      33679999999999999999999999   9999999999999997544   599999999987


Q ss_pred             ccCCccccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      .......   ....||+.|+|||++           +|+||||+++|||++|+.||........       +...+..+.
T Consensus       292 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~~i~~~~  361 (419)
T 3i6u_A          292 LGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQITSGK  361 (419)
T ss_dssp             CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------HHHHHHTTC
T ss_pred             cCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------HHHHHhcCC
Confidence            7544322   345689999999986           6999999999999999999976433222       112222111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..   .........+..+.+++.+||+.||++|||++|
T Consensus       362 ~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  396 (419)
T 3i6u_A          362 YN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE  396 (419)
T ss_dssp             CC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CC---CCchhhcccCHHHHHHHHHHccCChhHCcCHHH
Confidence            10   001111234678999999999999999999854

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-40  Score=295.07  Aligned_cols=239  Identities=23%  Similarity=0.363  Sum_probs=175.1

Q ss_pred             cccccccCCcceeec------cCCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFL------HSNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+.+      .+..||||++..... ..+.+.+|+.++++++|+||+++++++..  ....++||||++
T Consensus        17 ~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   96 (295)
T 3ugc_A           17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLP   96 (295)
T ss_dssp             EEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCT
T ss_pred             eeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCC
Confidence            345555555554432      233499999875432 33678999999999999999999999854  356899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        97 ~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           97 YGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             TCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             CCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            999999996432     458999999999999999999999   999999999999999999999999999998876543


Q ss_pred             cc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc----ccc----hHHHHHHHhhhc
Q 039471          262 SI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS----QIY----FPEWIYNRMRLG  324 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~----~~~----~~~~~~~~~~~~  324 (363)
                      .. .......++..|+|||++        +||||||+++|||++|..|+........    ...    ........+..+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence            22 112334577889999987        7999999999999999999876432210    000    011111111111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            .....+..+++.+.+++.+||+.||++|||++|
T Consensus       249 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  281 (295)
T 3ugc_A          249 ------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD  281 (295)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence                  112234456778999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-40  Score=291.28  Aligned_cols=230  Identities=19%  Similarity=0.263  Sum_probs=182.0

Q ss_pred             cccccccCCcceeeccCC--eeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLHSN--EIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+.....  .||+|++... ....+.+.+|++++++++|+||+++++++.++...++||||+++++|.+
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   95 (277)
T 3f3z_A           16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE   95 (277)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             EEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHH
Confidence            345556665555544333  4899998643 4456789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCcccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||++   +.++.+||+|||++......... 
T Consensus        96 ~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~-  165 (277)
T 3f3z_A           96 RVVHK------RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-  165 (277)
T ss_dssp             HHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB-
T ss_pred             HHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch-
Confidence            98543      458999999999999999999999   999999999999999   78899999999999877654332 


Q ss_pred             ccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          265 SRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                        ....||..|+|||++       +|+||||+++|||++|+.||.......        ....+..+....   ......
T Consensus       166 --~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~---~~~~~~  232 (277)
T 3f3z_A          166 --RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------VMLKIREGTFTF---PEKDWL  232 (277)
T ss_dssp             --CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCC---CHHHHT
T ss_pred             --hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCCC---Cchhhh
Confidence              445689999999987       899999999999999999997654322        222222221110   000111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++.+.+++.+||+.||++|||+.|
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~  258 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQ  258 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            34678999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-39  Score=296.82  Aligned_cols=232  Identities=22%  Similarity=0.324  Sum_probs=177.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.+..+...  ++.||||++.....   .+.+|++++.++ +|+||+++++++.++...++||||+++|+|.
T Consensus        28 ~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~  104 (342)
T 2qr7_A           28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL  104 (342)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHH
Confidence            34455555555554433  34499999975443   345788888888 7999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC----CCeeEeccccceeccCCcc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN----FQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~~~~~~~  262 (363)
                      +++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||+..+    +.+||+|||+++.......
T Consensus       105 ~~i~~------~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A          105 DKILR------QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             HHHHT------CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             HHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            99943      3569999999999999999999999   999999999999998543    3499999999987655432


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....||+.|+|||++        +|+||||+++|||++|..||.......     ...+...+..+..   .....
T Consensus       176 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~---~~~~~  245 (342)
T 2qr7_A          176 L--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGKF---SLSGG  245 (342)
T ss_dssp             C--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCCC---CCCST
T ss_pred             c--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCCc---ccCcc
Confidence            2  2345689999999988        799999999999999999997543211     1223333332221   11122


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+..+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~  274 (342)
T 2qr7_A          246 YWNSVSDTAKDLVSKMLHVDPHQRLTAAL  274 (342)
T ss_dssp             TTTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            23456778999999999999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=299.16  Aligned_cols=221  Identities=23%  Similarity=0.237  Sum_probs=178.3

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCc---------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEe
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKG---------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      ..++.+++|.++.+..  .++.||||++.....         ..+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus        30 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  109 (335)
T 3dls_A           30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME  109 (335)
T ss_dssp             EECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEE
Confidence            3455666666665532  344499999975431         33467889999999999999999999999999999999


Q ss_pred             ccCCC-CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          179 FMPNG-SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       179 ~~~~~-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      |+.+| +|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~~~~g~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          110 KHGSGLDLFAFIDR------HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             CCTTSCBHHHHHHT------CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eCCCCccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99766 99999943      3569999999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ......   ....||+.|+|||++         +|+||||+++|||++|+.||.........               .  
T Consensus       181 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---------------~--  240 (335)
T 3dls_A          181 ERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA---------------A--  240 (335)
T ss_dssp             CTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT---------------C--
T ss_pred             CCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh---------------c--
Confidence            654432   345689999999987         69999999999999999999753321110               0  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ...+...++.+.+++.+||+.||++|||++|
T Consensus       241 ----~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  271 (335)
T 3dls_A          241 ----IHPPYLVSKELMSLVSGLLQPVPERRTTLEK  271 (335)
T ss_dssp             ----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----cCCCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence                0111224567999999999999999999853

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.1e-40  Score=300.00  Aligned_cols=231  Identities=22%  Similarity=0.343  Sum_probs=175.6

Q ss_pred             ccccccccCCcceeeccCC--e----eEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHSN--E----IAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~--~----vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+....+  .    ||+|.+...  ....+.+.+|+.++++++|+||+++++++.+ ...++||||++
T Consensus        19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   97 (325)
T 3kex_A           19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLP   97 (325)
T ss_dssp             EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCT
T ss_pred             eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCC
Confidence            3445555655555443322  2    788877533  2334678899999999999999999999864 56889999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|+|.+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           98 LGSLLDHVRQH-----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             TCBSHHHHHSS-----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             CCCHHHHHHHc-----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            99999999543     2568999999999999999999999   999999999999999999999999999999876554


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........+|..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+...     
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----  236 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGERL-----  236 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTCBC-----
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCC-----
Confidence            43333455678899999988        799999999999999 999997643221        22222222211     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+...+..+.+++.+||+.||++|||++|
T Consensus       237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  266 (325)
T 3kex_A          237 -AQPQICTIDVYMVMVKCWMIDENIRPTFKE  266 (325)
T ss_dssp             -CCCTTBCTTTTHHHHHHTCSCTTTSCCHHH
T ss_pred             -CCCCcCcHHHHHHHHHHcCCChhhCcCHHH
Confidence             112234556889999999999999999853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.4e-40  Score=308.70  Aligned_cols=234  Identities=18%  Similarity=0.219  Sum_probs=183.0

Q ss_pred             ccccccccCCcceeeccC--CeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHS--NEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~--~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.+..+....  +.||||++..    .....+.+.+|..++..++|+||+++++++.++...++||||+++|
T Consensus        80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg  159 (437)
T 4aw2_A           80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG  159 (437)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCC
Confidence            345666666666655543  3499999964    2233456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...     ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+....+...
T Consensus       160 ~L~~~l~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          160 DLLTLLSKF-----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             BHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             cHHHHHHHc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence            999999542     2569999999999999999999999   99999999999999999999999999999877554332


Q ss_pred             cccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc-cccc
Q 039471          264 VSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-ELCL  329 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  329 (363)
                       ......||+.|+|||++             +|+|||||++|||++|+.||.......        .+..+.... ....
T Consensus       232 -~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~  302 (437)
T 4aw2_A          232 -QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERFQF  302 (437)
T ss_dssp             -ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHCCC
T ss_pred             -ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--------HHHhhhhccccccC
Confidence             22345799999999985             699999999999999999998654322        222221111 1111


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCC--CCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTE--RPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~e  363 (363)
                         +.....+++++.+++.+||+.+|++  ||+++|
T Consensus       303 ---p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e  335 (437)
T 4aw2_A          303 ---PTQVTDVSENAKDLIRRLICSREHRLGQNGIED  335 (437)
T ss_dssp             ---CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred             ---CcccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence               1112235678999999999988888  898753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.5e-40  Score=299.16  Aligned_cols=235  Identities=17%  Similarity=0.160  Sum_probs=179.2

Q ss_pred             ccccccccCCcceee--ccCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFF--LHSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+.  ..++.||||++.... ..+.+.+|+.+++++ +|+||+++++++..+...++||||+ +++|.
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   92 (330)
T 2izr_A           15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLE   92 (330)
T ss_dssp             EECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHH
Confidence            445666666666655  234459999987443 345788999999999 8999999999999999999999999 89999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC-----eeEeccccceeccCCc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-----PKISDFGLAKLCSKDI  261 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~-----~kl~Dfg~a~~~~~~~  261 (363)
                      +++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++......
T Consensus        93 ~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           93 DLFDLC-----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             HHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             HHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            999643     2579999999999999999999999   99999999999999998877     9999999999765433


Q ss_pred             ccc-----ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          262 SIV-----SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       262 ~~~-----~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ...     ......||..|+|||++        +|+||||+++|||++|+.||.........     .....+.......
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-----~~~~~i~~~~~~~  239 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-----ERYQKIGDTKRAT  239 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-----HHHHHHHHHHHHS
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-----HHHHHHHhhhccC
Confidence            211     12355699999999988        79999999999999999999765322211     1111111111100


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ..  .......+ ++.+++.+||+.+|.+|||++
T Consensus       240 ~~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~  270 (330)
T 2izr_A          240 PI--EVLCENFP-EMATYLRYVRRLDFFEKPDYD  270 (330)
T ss_dssp             CH--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHH
T ss_pred             CH--HHHhccCh-HHHHHHHHHHhCCCCCCCCHH
Confidence            00  00001123 899999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-39  Score=297.10  Aligned_cols=231  Identities=22%  Similarity=0.288  Sum_probs=181.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc-------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...  +..||||++.....       ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus        18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   97 (321)
T 2a2a_A           18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV   97 (321)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcC
Confidence            34555666665555443  44599999864322       2467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----CeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~  256 (363)
                      ++++|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++    .+||+|||++..
T Consensus        98 ~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           98 SGGELFDFLAQ------KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             CSCBHHHHHHT------CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             CCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            99999999943      3568999999999999999999999   9999999999999999887    799999999988


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .......   ....||..|+|||++        +|+||||+++|||++|+.||.......        ....+.....  
T Consensus       169 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~--  235 (321)
T 2a2a_A          169 IEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANITSVSY--  235 (321)
T ss_dssp             CCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHTTCC--
T ss_pred             cCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhccc--
Confidence            7654322   345689999999987        799999999999999999997643321        1111211110  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..........+..+.+++.+||+.||++|||++|
T Consensus       236 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  269 (321)
T 2a2a_A          236 -DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE  269 (321)
T ss_dssp             -CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred             -ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence             0111111234567999999999999999999753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=291.31  Aligned_cols=239  Identities=23%  Similarity=0.284  Sum_probs=176.3

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCC------cChhHHHHHHHHHhccC---CCceeeeeeeeeeCC-----ce
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLK------GNGQEFINEVATIGRIH---HFHIVRLLGFCSEGN-----RR  173 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-----~~  173 (363)
                      ..++.+++|.++.+..  .++.||||++....      .....+.+|+.++++++   |+||+++++++....     ..
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~   94 (308)
T 3g33_A           15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV   94 (308)
T ss_dssp             EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence            3455666666655542  34459999986322      22357778888887775   999999999997655     57


Q ss_pred             eEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccc
Q 039471          174 TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       174 ~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      +++|||+. ++|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        95 ~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           95 TLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             EEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             EEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            99999997 599999964332    459999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          254 AKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       254 a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ++........   ....||..|+|||++        +|+||||+++|||++|+.||.........    ..+.+.+....
T Consensus       167 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~  239 (308)
T 3g33_A          167 ARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL----GKIFDLIGLPP  239 (308)
T ss_dssp             TTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH----HHHHHHHCCCC
T ss_pred             ccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHhCCCC
Confidence            9876543322   445689999999988        89999999999999999999765443221    11111110000


Q ss_pred             cccc-----------c-cCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCL-----------D-FEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~-----------~-~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....           . ...    ....+.+..+.+++.+||++||++|||++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  293 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR  293 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence            0000           0 000    011234577899999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.6e-39  Score=288.31  Aligned_cols=227  Identities=23%  Similarity=0.369  Sum_probs=175.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcC--------hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN--------GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++.+++|.++.+...  ++.||||++......        .+++.+|+.++++++|+||+++++++.+..  ++||||+
T Consensus        26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~  103 (287)
T 4f0f_A           26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFV  103 (287)
T ss_dssp             ECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECC
T ss_pred             ccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEec
Confidence            3456666666555443  445999998643221        167899999999999999999999987654  6999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEcCCCC-----eeEecccc
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQ-----PKISDFGL  253 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~~~~~-----~kl~Dfg~  253 (363)
                      ++++|.+++...     ...+++..++.++.|++.||+|||+   .+  |+||||||+|||++.++.     +||+|||+
T Consensus       104 ~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A          104 PCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             TTCBHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             CCCCHHHHHhcc-----cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence            999999988533     2579999999999999999999999   89  999999999999988776     99999999


Q ss_pred             ceeccCCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          254 AKLCSKDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       254 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ++.....     .....||..|+|||++          +|+||||+++|||++|+.||........     .. ......
T Consensus       176 ~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~-~~~~~~  244 (287)
T 4f0f_A          176 SQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KF-INMIRE  244 (287)
T ss_dssp             CBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HH-HHHHHH
T ss_pred             ccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HH-HHHHhc
Confidence            9754432     2345689999999987          7999999999999999999975432211     00 111111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .     ......+..+++.+.+++.+||+.||++|||++|
T Consensus       245 ~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          245 E-----GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             S-----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             c-----CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            1     1112233455678999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.2e-39  Score=296.03  Aligned_cols=226  Identities=19%  Similarity=0.203  Sum_probs=170.0

Q ss_pred             cccccccCCcceeec-----cCCeeEEEEcccCC-----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFL-----HSNEIAVKMLEHLK-----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++.+++|.++.+..     .++.||+|+++...     .....+.+|+.++++++|+||+++++++..++..++||||+
T Consensus        24 ~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3a62_A           24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL  103 (327)
T ss_dssp             EEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             EEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCC
Confidence            345555555554433     34459999997432     23456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A          104 SGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             CCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            999999999543      468999999999999999999999   99999999999999999999999999999765433


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...  .....||+.|+|||++        +|+||||+++|||++|+.||.......        ....+....       
T Consensus       175 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~-------  237 (327)
T 3a62_A          175 GTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--------TIDKILKCK-------  237 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTC-------
T ss_pred             Ccc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCC-------
Confidence            221  2345689999999987        799999999999999999997654321        122222111       


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ...+...+..+.+++.+||+.||++||++.
T Consensus       238 ~~~p~~~~~~~~~li~~~L~~dp~~R~~~~  267 (327)
T 3a62_A          238 LNLPPYLTQEARDLLKKLLKRNAASRLGAG  267 (327)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred             CCCCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence            112234567899999999999999999653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=297.76  Aligned_cols=242  Identities=23%  Similarity=0.262  Sum_probs=173.1

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHH--HhccCCCceeeeeeeee-----eCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVAT--IGRIHHFHIVRLLGFCS-----EGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.....++.||||++....  .+.+..|.++  +..++|+||+++++.+.     .....++||||+++
T Consensus        19 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~   96 (336)
T 3g2f_A           19 ELIGRGRYGAVYKGSLDERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN   96 (336)
T ss_dssp             EEEEECSSEEEEEEEETTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred             eecccCCCeEEEEEEECCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence            445666666666665666679999997433  3445555555  44589999999998653     23367899999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---------CceecCCCCCceEEcCCCCeeEecccc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ---------RILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      |+|.+++..       ...++..+..++.|++.||+|||+   .         +|+||||||+|||++.++.+||+|||+
T Consensus        97 g~L~~~l~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           97 GSLXKYLSL-------HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             CBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             CcHHHHHhh-------cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            999999943       335889999999999999999999   7         999999999999999999999999999


Q ss_pred             ceeccCCcc------ccccccccccccccCCccc---------------cCceehhHHHHHHhcCCCCCCcchhccccc-
Q 039471          254 AKLCSKDIS------IVSRTAARGTSGYIAPELF---------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI-  311 (363)
Q Consensus       254 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~~g~~~~~~~~~~~~~~-  311 (363)
                      ++.......      ........||..|+|||++               +||||||+++|||++|..|+.......... 
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            987754321      1112344689999999986               599999999999999987765433221110 


Q ss_pred             ----------chHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          312 ----------YFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       312 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                .+..+.......................++.+.+++.+||+.||++|||++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  308 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX  308 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence                      0111111111111111111112233457888999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-39  Score=289.50  Aligned_cols=231  Identities=20%  Similarity=0.282  Sum_probs=180.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  +..||+|++......   .+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   91 (284)
T 3kk8_A           12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   91 (284)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence            33455555555544333  445999998654322   3578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC---eeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||.+.......
T Consensus        92 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           92 LFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            99988543      468999999999999999999999   99999999999999986655   9999999998776543


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..   ....||..|+|||++        +|+||||+++|+|++|+.||.......        ....+..+..   ....
T Consensus       163 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~---~~~~  228 (284)
T 3kk8_A          163 AW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAY---DYPS  228 (284)
T ss_dssp             BC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC---CCCT
T ss_pred             cc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------HHHHHHhccc---cCCc
Confidence            32   345689999999987        899999999999999999997644322        2222222211   1111


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ......++.+.+++.+||+.||++|||++|
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  258 (284)
T 3kk8_A          229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQ  258 (284)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhhcccCHHHHHHHHHHcccChhhCCCHHH
Confidence            222345677999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-39  Score=289.98  Aligned_cols=229  Identities=21%  Similarity=0.337  Sum_probs=167.0

Q ss_pred             cccccccCCcceeeccC-----CeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHS-----NEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+....     ..||+|+.....  ...+.+.+|+.++++++|+||+++++++. ++..++||||++++
T Consensus        22 ~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~  100 (281)
T 1mp8_A           22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG  100 (281)
T ss_dssp             EEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTE
T ss_pred             EeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCC
Confidence            34556666655544432     139999987532  22457899999999999999999999985 45788999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........
T Consensus       101 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A          101 ELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             EHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            9999995432     468999999999999999999999   99999999999999999999999999999876544322


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......+++.|+|||++        +|+||||+++|||++ |..||.......        ....+..+..      ..
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~~------~~  237 (281)
T 1mp8_A          173 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGER------LP  237 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC------CC
T ss_pred             -ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCCC------CC
Confidence             12334467889999987        799999999999996 899987644322        1222222211      12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+++.+.+++.+||+.||++|||++|
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~  266 (281)
T 1mp8_A          238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTE  266 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            23445678999999999999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-39  Score=301.36  Aligned_cols=226  Identities=21%  Similarity=0.246  Sum_probs=171.4

Q ss_pred             cccccccCCcceeeccC--CeeEEEEcccCC----cChhHHHHHHHH-HhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHS--NEIAVKMLEHLK----GNGQEFINEVAT-IGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.+..+....  ..||||++....    ...+.+.+|..+ ++.++|+||+++++++.+.+..++||||+++|
T Consensus        45 ~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg  124 (373)
T 2r5t_A           45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG  124 (373)
T ss_dssp             EEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCC
Confidence            34566666665555443  349999996432    233456677776 46789999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       125 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~-  194 (373)
T 2r5t_A          125 ELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-  194 (373)
T ss_dssp             BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC-
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCCC-
Confidence            999999543      468999999999999999999999   9999999999999999999999999999986433222 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                       ......||+.|+|||++        +|+||||+++|||++|..||.......        ++..+.....       ..
T Consensus       195 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~-------~~  258 (373)
T 2r5t_A          195 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKPL-------QL  258 (373)
T ss_dssp             -CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--------HHHHHHHSCC-------CC
T ss_pred             -ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhccc-------CC
Confidence             12455699999999987        899999999999999999997653321        2233322211       11


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      +..++..+.+++.+||+.||++||++.
T Consensus       259 ~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          259 KPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             CSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             CCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence            234567799999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=296.43  Aligned_cols=238  Identities=21%  Similarity=0.317  Sum_probs=175.2

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhcc--CCCceeeeeeeeeeC----CceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRI--HHFHIVRLLGFCSEG----NRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.....++.||||++....  ...+.+|.+++..+  +|+||+++++++...    ...++||||++++
T Consensus        43 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g  120 (337)
T 3mdy_A           43 KQIGKGRYGEVWMGKWRGEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG  120 (337)
T ss_dssp             EEEEEETTEEEEEEEETTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTC
T ss_pred             eEeecCCCeEEEEEEECCceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCC
Confidence            445667777777666667779999986433  34555666666554  899999999999877    6889999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--------CceecCCCCCceEEcCCCCeeEeccccce
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ--------RILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      +|.+++..       ..+++..++.++.|++.||+|||+   .        +|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          121 SLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             BHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            99999943       358999999999999999999998   7        99999999999999999999999999998


Q ss_pred             eccCCcccc--ccccccccccccCCccc--------------cCceehhHHHHHHhcC----------CCCCCcchhccc
Q 039471          256 LCSKDISIV--SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGC----------RKNNDPAVEIQS  309 (363)
Q Consensus       256 ~~~~~~~~~--~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g----------~~~~~~~~~~~~  309 (363)
                      .........  ......||..|+|||++              +||||||+++|||++|          ..||........
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            765443221  11345689999999987              6999999999999999          445443222111


Q ss_pred             ccchHHHHHHHhhhccccccccCC-CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          310 QIYFPEWIYNRMRLGQELCLDFEE-DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .  +.. ....... ......... .....+++.+.+++.+||+.||++|||++|
T Consensus       271 ~--~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          271 S--YED-MREIVCI-KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             C--HHH-HHHHHTT-SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             c--hhh-hHHHHhh-hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            1  111 1111111 111111111 123478889999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-39  Score=288.77  Aligned_cols=231  Identities=24%  Similarity=0.395  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+...+. .||||++.......+.+.+|++++++++|+||+++++++.+ +..++||||+++++|.++
T Consensus        19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~   97 (279)
T 1qpc_A           19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF   97 (279)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred             eeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHH
Confidence            3455666666655544443 49999998766677899999999999999999999999874 468999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......... ....
T Consensus        98 l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~  169 (279)
T 1qpc_A           98 LKTPS----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREG  169 (279)
T ss_dssp             TTSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTT
T ss_pred             HhcCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccC
Confidence            94321    1369999999999999999999999   99999999999999999999999999999887654322 2234


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+..      ...+...
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~~~  235 (279)
T 1qpc_A          170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYR------MVRPDNC  235 (279)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCC------CCCCTTC
T ss_pred             CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--------HHHHHhcccC------CCCcccc
Confidence            4567889999987        799999999999999 888886543221        2222222211      1223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.||++|||++|
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~  259 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDY  259 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHH
Confidence            678999999999999999999753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=294.17  Aligned_cols=225  Identities=22%  Similarity=0.209  Sum_probs=171.9

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcCh---hHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNG---QEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++.......   .++..|+..+.++ +|+||+++++++.+++..++||||+ +++
T Consensus        64 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~  142 (311)
T 3p1a_A           64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS  142 (311)
T ss_dssp             EEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             eeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCC
Confidence            4556666666655443  4459999986543332   3455666666655 8999999999999999999999999 679


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus       143 L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~-  213 (311)
T 3p1a_A          143 LQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG-  213 (311)
T ss_dssp             HHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC-
Confidence            999986543     469999999999999999999999   99999999999999999999999999999877544322 


Q ss_pred             ccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          265 SRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                        ....||+.|+|||++       +||||||+++|||++|..++......           ..+..+..     ......
T Consensus       214 --~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~-----~~~~~~  275 (311)
T 3p1a_A          214 --EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYL-----PPEFTA  275 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----------HHHTTTCC-----CHHHHT
T ss_pred             --cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHhccCC-----Cccccc
Confidence              345589999999988       79999999999999998776543221           11111110     011122


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++.+.+++.+||++||++|||++|
T Consensus       276 ~~~~~l~~li~~~L~~dP~~Rpt~~e  301 (311)
T 3p1a_A          276 GLSSELRSVLVMMLEPDPKLRATAEA  301 (311)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            34678999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.9e-39  Score=291.27  Aligned_cols=236  Identities=22%  Similarity=0.350  Sum_probs=171.6

Q ss_pred             cccccccCCcceeeccC-----CeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCC-----ceeEEE
Q 039471          111 SLISFNLTNSKFFFLHS-----NEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGN-----RRTLIY  177 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~  177 (363)
                      .++.+++|.++.+....     ..||||++......   .+.+.+|+.++++++|+||+++++++.+..     ..++||
T Consensus        41 ~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~  120 (313)
T 3brb_A           41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL  120 (313)
T ss_dssp             EEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEE
T ss_pred             ceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEE
Confidence            34566666665544432     14999999754322   357889999999999999999999987654     359999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||+++++|.+++...........+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus       121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~  197 (313)
T 3brb_A          121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKI  197 (313)
T ss_dssp             ECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred             ecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence            999999999999655433445679999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .............++..|+|||.+        +|+||||+++|||++ |..||.......        ....+..+..  
T Consensus       198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~--  267 (313)
T 3brb_A          198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------MYDYLLHGHR--  267 (313)
T ss_dssp             -------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCC--
T ss_pred             ccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHHcCCC--
Confidence            554332223445578899999987        799999999999999 888886543322        1222222211  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ...+..+++.+.+++.+||+.||++|||++|
T Consensus       268 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  298 (313)
T 3brb_A          268 ----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSV  298 (313)
T ss_dssp             ----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             ----CCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence                1223445678999999999999999999853

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.2e-40  Score=318.10  Aligned_cols=229  Identities=24%  Similarity=0.366  Sum_probs=181.2

Q ss_pred             ccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhh
Q 039471          112 LISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIF  190 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~  190 (363)
                      ++.+++|.++.+...+ ..||||+++......++|.+|++++++++|+||+++++++.+ ...++||||+++|+|.+++.
T Consensus       275 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~  353 (535)
T 2h8h_A          275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK  353 (535)
T ss_dssp             EEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHS
T ss_pred             cccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHh
Confidence            4445555555544444 349999998766667899999999999999999999999876 67899999999999999995


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccccc
Q 039471          191 SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAAR  270 (363)
Q Consensus       191 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  270 (363)
                      ...    ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       354 ~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~  425 (535)
T 2h8h_A          354 GET----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAK  425 (535)
T ss_dssp             HHH----HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTT
T ss_pred             hcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCc
Confidence            432    1458999999999999999999999   9999999999999999999999999999987654321 1223345


Q ss_pred             ccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          271 GTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       271 gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      ++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      ...+..++.
T Consensus       426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~------~~~~~~~~~  491 (535)
T 2h8h_A          426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYR------MPCPPECPE  491 (535)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------HHHHHHTTCC------CCCCTTCCH
T ss_pred             CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCCCCCH
Confidence            67899999987        899999999999999 898887543221        2233332221      122335567


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+.+++.+||+.||++|||++|
T Consensus       492 ~l~~li~~cl~~dP~~RPt~~~  513 (535)
T 2h8h_A          492 SLHDLMCQCWRKEPEERPTFEY  513 (535)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHH
Confidence            8999999999999999999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-39  Score=314.02  Aligned_cols=231  Identities=23%  Similarity=0.273  Sum_probs=183.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||||++...    ....+.+.+|+.++++++|+||+++++++.+....++||||++||
T Consensus       190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg  269 (576)
T 2acx_A          190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG  269 (576)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence            34555556555554443  445999998632    334567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....    ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       270 ~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~  342 (576)
T 2acx_A          270 DLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  342 (576)
T ss_dssp             BHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred             cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence            9999995432    2459999999999999999999999   99999999999999999999999999999887654432


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||+.|+|||++        +|+|||||++|||++|+.||.........    ..+...+...       ....
T Consensus       343 ---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~~-------~~~~  408 (576)
T 2acx_A          343 ---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEV-------PEEY  408 (576)
T ss_dssp             ---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHHC-------CCCC
T ss_pred             ---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhcc-------cccC
Confidence               345699999999988        79999999999999999999865432211    1122222211       1122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +..+++.+.+++.+||+.||++||++
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~  434 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGC  434 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCC
Confidence            34567789999999999999999954

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-39  Score=295.81  Aligned_cols=236  Identities=26%  Similarity=0.386  Sum_probs=182.5

Q ss_pred             ccccccCCcceeec-------cCCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccC
Q 039471          112 LISFNLTNSKFFFL-------HSNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ++.+++|.++.+..       .+..||||++.....  ..+.+.+|+.+++++ +|+||+++++++.+++..++||||++
T Consensus        31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~  110 (313)
T 1t46_A           31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC  110 (313)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             hCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCC
Confidence            45555555544432       123499999975432  346789999999999 89999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEe
Q 039471          182 NGSLQKFIFSKTNS------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  249 (363)
Q Consensus       182 ~~sL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~  249 (363)
                      +++|.+++......            .....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus       111 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~  187 (313)
T 1t46_A          111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKIC  187 (313)
T ss_dssp             TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEEEC
T ss_pred             CCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCCEEEc
Confidence            99999999765321            112359999999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHH
Q 039471          250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      |||++................+|..|+|||++        +|+||||+++|||++ |+.||........       ....
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~  260 (313)
T 1t46_A          188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------FYKM  260 (313)
T ss_dssp             CCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-------HHHH
T ss_pred             cccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-------HHHH
Confidence            99999887665443333445678899999987        899999999999998 9999876432211       1222


Q ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+..      ...+...+..+.+++.+||+.||++|||++|
T Consensus       261 ~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  297 (313)
T 1t46_A          261 IKEGFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (313)
T ss_dssp             HHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hccCCC------CCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            221111      1123345678999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.8e-39  Score=311.46  Aligned_cols=230  Identities=23%  Similarity=0.332  Sum_probs=179.6

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+...  +..||||++...   ....+.+.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus        44 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L  123 (494)
T 3lij_A           44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL  123 (494)
T ss_dssp             EEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             EEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcH
Confidence            3455555555544433  344999998743   33457889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC---CCeeEeccccceeccCCcc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .+++...      ..+++..+..++.||+.||.|||+   .+|+||||||+|||++..   +.+||+|||++........
T Consensus       124 ~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          124 FDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            9988543      468999999999999999999999   999999999999999764   4599999999988765433


Q ss_pred             ccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          263 IVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      .   ....||+.|+|||++       +||||+|+++|+|++|..||.......        +...+..+...   .....
T Consensus       195 ~---~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~---~~~~~  260 (494)
T 3lij_A          195 M---KERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRKVEKGKYT---FDSPE  260 (494)
T ss_dssp             B---CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCC---CCSGG
T ss_pred             c---cccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC---CCchh
Confidence            2   445699999999988       899999999999999999997654321        22233222211   11122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....++.+.+++.+||+.||++|||++|
T Consensus       261 ~~~~s~~~~~li~~~L~~dp~~R~s~~e  288 (494)
T 3lij_A          261 WKNVSEGAKDLIKQMLQFDSQRRISAQQ  288 (494)
T ss_dssp             GTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cccCCHHHHHHHHHHCCCChhhCccHHH
Confidence            2345678999999999999999999754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=294.80  Aligned_cols=230  Identities=22%  Similarity=0.336  Sum_probs=170.4

Q ss_pred             cccccccCCcceeeccC--Ce----eEEEEccc--CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHS--NE----IAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~--~~----vAvK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+....  +.    ||+|.+..  .....+++.+|+.++++++|+||+++++++..+. .++++||+++
T Consensus        22 ~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~  100 (327)
T 3lzb_A           22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPF  100 (327)
T ss_dssp             EEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSS
T ss_pred             EeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCC
Confidence            34555555555544322  22    57777753  2345578999999999999999999999998755 7899999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       101 g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A          101 GCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            99999996543     569999999999999999999999   9999999999999999999999999999988765443


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ........+|..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+..      .
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~------~  238 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER------L  238 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC------C
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC------C
Confidence            3333445578899999987        899999999999999 999997654322        1222222211      1


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...+..+.+++.+||+.||++|||++|
T Consensus       239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  268 (327)
T 3lzb_A          239 PQPPICTIDVYMIMRKCWMIDADSRPKFRE  268 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            223345667999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-39  Score=298.57  Aligned_cols=226  Identities=20%  Similarity=0.293  Sum_probs=177.4

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+..  .++.||||++......    .+++.+|++++++++|+||+++++++.+++..++||||+. |
T Consensus        60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g  138 (348)
T 1u5q_A           60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G  138 (348)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence            3455556655555442  3444999999744322    2578899999999999999999999999999999999997 6


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       139 ~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          139 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            8888885432     568999999999999999999999   99999999999999999999999999999876432   


Q ss_pred             cccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          264 VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                         ....||+.|+|||++           +||||||+++|||++|+.||.......       .+.. +......     
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------~~~~-~~~~~~~-----  271 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNESP-----  271 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHH-HHHSCCC-----
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-------HHHH-HHhcCCC-----
Confidence               334689999999975           799999999999999999987643321       1111 1111111     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .......+..+.+++.+||+.||++|||++|
T Consensus       272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~  302 (348)
T 1u5q_A          272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  302 (348)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            1122345677899999999999999999753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=317.49  Aligned_cols=230  Identities=23%  Similarity=0.381  Sum_probs=177.9

Q ss_pred             cccccccCCcceeecc----CCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH----SNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~----~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...    +..||||+++..  ....++|.+|++++++++|+||+++++++.. ...++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            3566666666655442    223999999753  2345789999999999999999999999976 56899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...     ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....+....
T Consensus       422 L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          422 LHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             HHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             HHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            99999532     3569999999999999999999999   999999999999999999999999999998765433221


Q ss_pred             -ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 -SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 -~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......++..|+|||++        +||||||+++|||++ |+.||.......        +...+..+..      ..
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~------~~  559 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKR------ME  559 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTTCC------CC
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC------CC
Confidence             12233467899999988        899999999999998 999997643321        2333333322      12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+++.+.+++.+||+.+|++|||++|
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~  588 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLT  588 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            33456788999999999999999999853

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-39  Score=306.20  Aligned_cols=183  Identities=21%  Similarity=0.341  Sum_probs=144.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~  179 (363)
                      ..++.+++|.+..+...  ++.||||++......   .+++.+|++++++++|+||+++++++...     ...++||||
T Consensus        32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~  111 (432)
T 3n9x_A           32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI  111 (432)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred             EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence            34455555555554433  334999999754322   36788999999999999999999998765     578999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++ ++|.+++..      ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       112 ~~-~~L~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          112 AD-SDLKKLFKT------PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CS-EEHHHHHHS------SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CC-cCHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            96 599999942      3569999999999999999999999   9999999999999999999999999999998754


Q ss_pred             Cccc--------------------cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCC
Q 039471          260 DISI--------------------VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNND  302 (363)
Q Consensus       260 ~~~~--------------------~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~  302 (363)
                      ....                    .......||..|+|||++         +|||||||++|||++|..|+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            3221                    112456789999999985         799999999999998655443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.1e-39  Score=290.83  Aligned_cols=237  Identities=15%  Similarity=0.167  Sum_probs=180.7

Q ss_pred             ccccccccCCcceee--ccCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFF--LHSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+.  ..++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.++...++||||+ +++|.
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   93 (298)
T 1csn_A           16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE   93 (298)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHH
Confidence            345566666665555  334559999986433 446788999999999 7999999999999999999999999 89999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC-----eeEeccccceeccCCc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-----PKISDFGLAKLCSKDI  261 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~-----~kl~Dfg~a~~~~~~~  261 (363)
                      +++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++......
T Consensus        94 ~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           94 DLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             HHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             HHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            9996432     469999999999999999999999   99999999999999987766     9999999998876543


Q ss_pred             cc-----cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          262 SI-----VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       262 ~~-----~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ..     .......||..|+|||++        +|+||||+++|||++|+.||..........     ....+.......
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~  240 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYERIGEKKQST  240 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHHHHHHHHHS
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-----HHHHHHhhccCc
Confidence            21     112445689999999987        799999999999999999997743322111     111111111000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .  .......+++.+.+++.+||+.||++|||++|
T Consensus       241 ~--~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~  273 (298)
T 1csn_A          241 P--LRELCAGFPEEFYKYMHYARNLAFDATPDYDY  273 (298)
T ss_dssp             C--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred             c--HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHH
Confidence            0  00011234678999999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-39  Score=309.94  Aligned_cols=231  Identities=23%  Similarity=0.328  Sum_probs=181.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc---CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  +..||||++..   .....+.+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus        28 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~  107 (486)
T 3mwu_A           28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE  107 (486)
T ss_dssp             EEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCc
Confidence            33456666666555443  44599999853   23456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc---CCCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++...      ..+++..+..++.||+.||.|||+   .+|+||||||+|||++   .++.+||+|||+++......
T Consensus       108 L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          108 LFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            99998543      468999999999999999999999   9999999999999995   45679999999998765543


Q ss_pred             cccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          262 SIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ..   ....||+.|+|||++       +||||+|+++|+|++|+.||.......        +...+..+..   .....
T Consensus       179 ~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~---~~~~~  244 (486)
T 3mwu_A          179 KM---KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKY---AFDLP  244 (486)
T ss_dssp             ------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC---CSCSG
T ss_pred             cc---CCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC---CCCCc
Confidence            22   345699999999998       799999999999999999997654322        2222222211   11122


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+++.+.+++.+||+.||++|||++|
T Consensus       245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~  273 (486)
T 3mwu_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQ  273 (486)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            23456778999999999999999999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.9e-39  Score=294.06  Aligned_cols=235  Identities=23%  Similarity=0.383  Sum_probs=181.1

Q ss_pred             ccccccCCcceeec---------cCCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEec
Q 039471          112 LISFNLTNSKFFFL---------HSNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       112 ~~~~~~~~~~~~~~---------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ++.+++|.++.+..         .+..||||++.....  ..+++.+|+++++++ +|+||+++++++.+.+..++||||
T Consensus        43 lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~  122 (334)
T 2pvf_A           43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY  122 (334)
T ss_dssp             EEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEEC
T ss_pred             EeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEEC
Confidence            45555555554432         123499999975432  235788999999999 899999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEe
Q 039471          180 MPNGSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  249 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~  249 (363)
                      +++++|.+++......          .....+++..++.++.||+.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus       123 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~  199 (334)
T 2pvf_A          123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIA  199 (334)
T ss_dssp             CTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             CCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCCEEEc
Confidence            9999999999654321          112458999999999999999999999   999999999999999999999999


Q ss_pred             ccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHH
Q 039471          250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      |||+++...............+|..|+|||++        +|+||||+++|||++ |+.||.......        +...
T Consensus       200 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~  271 (334)
T 2pvf_A          200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------LFKL  271 (334)
T ss_dssp             CCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHH
T ss_pred             cccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--------HHHH
Confidence            99999887654433333445578899999987        899999999999999 999986543211        2222


Q ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+..      ...+..++..+.+++.+||+.+|++|||++|
T Consensus       272 ~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  308 (334)
T 2pvf_A          272 LKEGHR------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQ  308 (334)
T ss_dssp             HHHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HhcCCC------CCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            222211      1223345677999999999999999999854

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-39  Score=313.54  Aligned_cols=231  Identities=23%  Similarity=0.345  Sum_probs=180.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--------------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCce
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--------------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR  173 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  173 (363)
                      ..++.+++|.++.+...  +..||||++....              ...+.+.+|+.++++++||||+++++++.++...
T Consensus        42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  121 (504)
T 3q5i_A           42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF  121 (504)
T ss_dssp             EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            34455555555554433  3459999986432              2346789999999999999999999999999999


Q ss_pred             eEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC---CeeEec
Q 039471          174 TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISD  250 (363)
Q Consensus       174 ~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~---~~kl~D  250 (363)
                      ++||||+++|+|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++   .+||+|
T Consensus       122 ~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          122 YLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            9999999999999998543      569999999999999999999999   9999999999999998775   699999


Q ss_pred             cccceeccCCccccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          251 FGLAKLCSKDISIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       251 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ||+++........   ....||+.|+|||++       +|+||+|+++|+|++|..||.......        +...+..
T Consensus       193 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~  261 (504)
T 3q5i_A          193 FGLSSFFSKDYKL---RDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--------IIKKVEK  261 (504)
T ss_dssp             CTTCEECCTTSCB---CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHH
T ss_pred             CCCCEEcCCCCcc---ccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHc
Confidence            9999887655332   445699999999988       799999999999999999997654322        2233332


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...   ........+++++.+++.+||+.||.+|||++|
T Consensus       262 ~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e  298 (504)
T 3q5i_A          262 GKYY---FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEE  298 (504)
T ss_dssp             CCCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCC---CCccccCCCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            2211   001111235678999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9e-39  Score=299.56  Aligned_cols=241  Identities=20%  Similarity=0.250  Sum_probs=184.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--ceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--RRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||||++....  ...+.+.+|++++++++|+||+++++++.+..  ..++||||++++
T Consensus        15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g   94 (396)
T 4eut_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (396)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred             EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence            33456666666555444  4459999997432  34577889999999999999999999997655  789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE----cCCCCeeEeccccceeccC
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +|.+++.....   ...+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++....
T Consensus        95 ~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           95 SLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             EHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             CHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            99999954321   2349999999999999999999999   999999999999999    7778899999999988765


Q ss_pred             CccccccccccccccccCCccc----------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          260 DISIVSRTAARGTSGYIAPELF----------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~----------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ....   ....||..|+|||++                +|+||||+++|||++|+.||..........   +.+...+. 
T Consensus       169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~~~~~-  241 (396)
T 4eut_A          169 DEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKIIT-  241 (396)
T ss_dssp             GGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH---HHHHHHHH-
T ss_pred             CCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH---HHHHHHhc-
Confidence            4332   345689999999975                699999999999999999997543322211   11221111 


Q ss_pred             cccc------------------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQEL------------------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...                  ...........++..+.+++.+||++||++|||++|
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence            1100                  111222345788999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=299.11  Aligned_cols=230  Identities=20%  Similarity=0.272  Sum_probs=170.2

Q ss_pred             cccccccCCcceeecc-CCeeEEEEcccCCcCh---hHHHHHHHHHhccCC--CceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH-SNEIAVKMLEHLKGNG---QEFINEVATIGRIHH--FHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+... +..||||++.......   +.+.+|+.++++++|  +||+++++++.++...++|||+ .+++
T Consensus        16 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~   94 (343)
T 3dbq_A           16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID   94 (343)
T ss_dssp             EESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEE
T ss_pred             EEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCC
Confidence            3455555555444332 3349999987543332   578899999999976  9999999999999999999994 5789


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++ ++.+||+|||+++.........
T Consensus        95 L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           95 LNSWLKK------KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             HHHHHHH------SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence            9999954      2568999999999999999999999   9999999999999997 5789999999998776544332


Q ss_pred             ccccccccccccCCccc-------------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc
Q 039471          265 SRTAARGTSGYIAPELF-------------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-------------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (363)
                      ......||+.|+|||++                   +||||||+++|||++|+.||........      .....+..  
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~--  236 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDP--  236 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH------HHHHHHCT--
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH------HHHHHhcC--
Confidence            33456799999999985                   6999999999999999999975432111      11111111  


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ......+...+..+.+++.+||+.||++|||++|
T Consensus       237 ----~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e  270 (343)
T 3dbq_A          237 ----NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE  270 (343)
T ss_dssp             ----TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ----CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence                1111122223467899999999999999999854

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=294.43  Aligned_cols=243  Identities=18%  Similarity=0.231  Sum_probs=174.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  ++.||||++......   .+.+.+|++++++++|+||+++++++.+++..++||||+++++
T Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (311)
T 4agu_A            9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV   88 (311)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence            34455555555554443  445999998654433   3567899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++......... 
T Consensus        89 l~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  158 (311)
T 4agu_A           89 LHELDRY------QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-  158 (311)
T ss_dssp             HHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             HHHHHhh------hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence            9988742      3569999999999999999999999   99999999999999999999999999999876543322 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH-------HHHhhhccc--
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI-------YNRMRLGQE--  326 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~--  326 (363)
                       .....||..|+|||++         +|+||||+++|||++|+.||................       .........  
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence             1345689999999976         799999999999999999997654432211100000       000000000  


Q ss_pred             -cccc-cCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 -LCLD-FEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 -~~~~-~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .... ....     .....+..+.+++.+||++||++|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  281 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ  281 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence             0000 0000     01235667999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-39  Score=290.00  Aligned_cols=235  Identities=25%  Similarity=0.349  Sum_probs=169.2

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.... .+.||||+++.....   .+.|.+|+.++++++|+||+++++++ .....++||||+++++|.
T Consensus        30 ~~lG~G~~g~Vy~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~  107 (289)
T 3og7_A           30 QRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLY  107 (289)
T ss_dssp             EEEEECSSEEEEEEES-SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHH
T ss_pred             eEecCCCCeEEEEEEE-cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHH
Confidence            3345555555554443 345999999754433   35789999999999999999999965 456689999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++...     ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++............
T Consensus       108 ~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          108 HHLHAS-----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             HHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             HHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            999433     3569999999999999999999999   99999999999999999999999999999876543322223


Q ss_pred             ccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          267 TAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ....||..|+|||++           +|+||||+++|||++|+.||........       +......+...  ......
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~--~~~~~~  250 (289)
T 3og7_A          180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIEMVGRGSLS--PDLSKV  250 (289)
T ss_dssp             ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-------HHHHHHHTSCC--CCTTSS
T ss_pred             cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-------HHHHhcccccC--cchhhc
Confidence            445689999999976           6999999999999999999976433221       22222211111  111122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+++.+.+++.+||+.||++|||++|
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~~Rps~~e  278 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRDERPSFPR  278 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHH
Confidence            3355678999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-39  Score=312.06  Aligned_cols=230  Identities=24%  Similarity=0.332  Sum_probs=183.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++...    ....+.+.+|+.++++++||||+++++++.+.+..++||||+.+++
T Consensus        33 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~  112 (484)
T 3nyv_A           33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE  112 (484)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC
Confidence            3455555555544433  445999998643    3345789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++..      ...+++..+..++.||+.||.|||+   .+|+||||||+|||+   +.++.+||+|||+++......
T Consensus       113 L~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          113 LFDEIIS------RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             HHHHHHT------CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             HHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            9999843      3569999999999999999999999   999999999999999   467889999999998776543


Q ss_pred             cccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          262 SIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ..   ....||+.|+|||++       +||||+|+++|+|++|+.||.......        +...+..+..   .....
T Consensus       184 ~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~---~~~~~  249 (484)
T 3nyv_A          184 KM---KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEKGKY---TFELP  249 (484)
T ss_dssp             SH---HHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC---CCCSG
T ss_pred             cc---ccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCC---CCCCc
Confidence            32   345689999999987       799999999999999999997654322        2222322211   11122


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+++.+.+++.+||+.+|++|||++|
T Consensus       250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e  278 (484)
T 3nyv_A          250 QWKKVSESAKDLIRKMLTYVPSMRISARD  278 (484)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            33456778999999999999999999753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-39  Score=298.99  Aligned_cols=183  Identities=23%  Similarity=0.284  Sum_probs=153.9

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhccC-----CCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRIH-----HFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+..  .++.||||++.......+.+..|+.++++++     |+||+++++++...+..++||||+ +
T Consensus        41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~  119 (360)
T 3llt_A           41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-G  119 (360)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-C
T ss_pred             EEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-C
Confidence            3345555555555444  3444999999865555677888999999986     999999999999999999999999 8


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC--------------------
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--------------------  242 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~--------------------  242 (363)
                      ++|.+++.....    ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.                    
T Consensus       120 ~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          120 PSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             CCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence            999999965432    459999999999999999999999   99999999999999975                    


Q ss_pred             -----CCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcch
Q 039471          243 -----NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       243 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                           ++.+||+|||+++......     ....||..|+|||++        +|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                 7889999999998755432     345689999999987        799999999999999999997654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.8e-39  Score=308.52  Aligned_cols=239  Identities=21%  Similarity=0.242  Sum_probs=169.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  178 (363)
                      ..++.+++|.+..+...  ++.||||++....   ...+++.+|+.++++++|+||+++++++...      ...++|||
T Consensus        68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E  147 (464)
T 3ttj_A           68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME  147 (464)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred             EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence            34555555555444332  4449999997532   2346788999999999999999999998654      35799999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+++ +|.+.+.        ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       148 ~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          148 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            9975 5767662        348999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHH-----
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWI-----  317 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~-----  317 (363)
                      ....   .....||+.|+|||++        +|||||||++|||++|+.||.+.........+        +++.     
T Consensus       216 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          216 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             -CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            5432   2445689999999997        79999999999999999999765432211000        0000     


Q ss_pred             --HHHhhhccc-c-----------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 --YNRMRLGQE-L-----------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 --~~~~~~~~~-~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...+..... .           ............++++.+|+.+||++||++|||++|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  352 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD  352 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence              000000000 0           000001112234678999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.2e-39  Score=291.96  Aligned_cols=240  Identities=22%  Similarity=0.265  Sum_probs=174.4

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ++.+++|.++.+..  .++.||||++.... ...+.+.+|++++.++ +|+||+++++++.+++..++||||+++++|.+
T Consensus        21 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  100 (316)
T 2ac3_A           21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS  100 (316)
T ss_dssp             CCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred             ecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHH
Confidence            45555555544432  34459999997543 3457899999999985 79999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC---eeEeccccceeccCCcc--
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDIS--  262 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~~~~~~~~--  262 (363)
                      ++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.   +||+|||++........  
T Consensus       101 ~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A          101 HIHKR------RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             HHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             HHhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            99543      468999999999999999999999   99999999999999998766   99999999876543211  


Q ss_pred             ---ccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccc-------hHHHHHH
Q 039471          263 ---IVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY-------FPEWIYN  319 (363)
Q Consensus       263 ---~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~-------~~~~~~~  319 (363)
                         ........||..|+|||++             +||||||+++|||++|+.||...........       ....+..
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  251 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE  251 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence               0111234589999999986             6999999999999999999976543221100       0111222


Q ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+...   .........+..+.+++.+||+.||++|||++|
T Consensus       252 ~i~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (316)
T 2ac3_A          252 SIQEGKYE---FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ  292 (316)
T ss_dssp             HHHHCCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHhccCcc---cCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence            22222110   000011234678999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-39  Score=294.60  Aligned_cols=233  Identities=19%  Similarity=0.284  Sum_probs=169.6

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCCc----eeEEEec
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGNR----RTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~  179 (363)
                      ..++.+++|.++.+..  .++.||||++......    .+.+.+|+.++++++|+||+++++++.....    .++||||
T Consensus        18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~   97 (311)
T 3ork_A           18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY   97 (311)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence            3345555555554442  3445999999754322    2468899999999999999999999876543    4999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           98 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            9999999999543      468999999999999999999999   9999999999999999999999999999987654


Q ss_pred             Cccc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          260 DISI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       260 ~~~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .... .......||..|+|||++        +|+||||+++|||++|+.||........       ............  
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~--  239 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPIPP--  239 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCCCH--
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCCCc--
Confidence            3221 122345689999999987        7999999999999999999976543221       111111111100  


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                        ......++..+.+++.+||+.||++||+..
T Consensus       240 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~  269 (311)
T 3ork_A          240 --SARHEGLSADLDAVVLKALAKNPENRYQTA  269 (311)
T ss_dssp             --HHHSTTCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             --ccccCCCCHHHHHHHHHHHhcCHhhChhhH
Confidence              001123567799999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=300.89  Aligned_cols=230  Identities=20%  Similarity=0.202  Sum_probs=179.6

Q ss_pred             ccccccccCCcceeec-----cCCeeEEEEcccC-----CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEe
Q 039471          110 QSLISFNLTNSKFFFL-----HSNEIAVKMLEHL-----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      ..++.+++|.++.+..     .++.||||+++..     ....+.+.+|+.+++++ +|+||+++++++......++|||
T Consensus        60 ~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  139 (355)
T 1vzo_A           60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD  139 (355)
T ss_dssp             EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred             EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEee
Confidence            3345556665555443     3455999998642     23446778899999999 69999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+++++|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       140 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          140 YINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             CCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             cCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999543      468999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ..... ......||..|+|||++          +||||||+++|||++|+.||..........    .+...+...    
T Consensus       211 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~~~~~----  281 (355)
T 1vzo_A          211 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA----EISRRILKS----  281 (355)
T ss_dssp             GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH----HHHHHHHHC----
T ss_pred             cCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH----HHHHHHhcc----
Confidence            43322 12345689999999986          699999999999999999997654332211    111111111    


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPS  360 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  360 (363)
                         ....+..++..+.+++.+||+.||++||+
T Consensus       282 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~~  310 (355)
T 1vzo_A          282 ---EPPYPQEMSALAKDLIQRLLMKDPKKRLG  310 (355)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             ---CCCCCcccCHHHHHHHHHHhhhCHHHhcC
Confidence               11223445677999999999999999993

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-39  Score=298.59  Aligned_cols=240  Identities=20%  Similarity=0.204  Sum_probs=176.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC------CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+...  +..||+|++...      ....+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus        32 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  111 (345)
T 3hko_A           32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCH  111 (345)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCC
Confidence            34455566555554433  334999998632      2344689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCC----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 039471          182 NGSLQKFIFSKTNS----------------------------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR  227 (363)
Q Consensus       182 ~~sL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  227 (363)
                      +++|.+++......                                  .....+++..++.++.|++.||+|||+   .+
T Consensus       112 gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~  188 (345)
T 3hko_A          112 GGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QG  188 (345)
T ss_dssp             SCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             CCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CC
Confidence            99999998421100                                  001235678899999999999999999   99


Q ss_pred             ceecCCCCCceEEcCCC--CeeEeccccceeccCCcc--ccccccccccccccCCccc----------cCceehhHHHHH
Q 039471          228 ILHFDIKPHNILLDHNF--QPKISDFGLAKLCSKDIS--IVSRTAARGTSGYIAPELF----------SRNFCYGMMLLE  293 (363)
Q Consensus       228 i~H~dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~e  293 (363)
                      |+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||++          +||||||+++||
T Consensus       189 ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e  268 (345)
T 3hko_A          189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL  268 (345)
T ss_dssp             EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHH
T ss_pred             ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHH
Confidence            99999999999998766  899999999987644221  1112445689999999976          799999999999


Q ss_pred             HhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          294 MVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       294 l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      |++|+.||........       . ..+.....   ..........++.+.+++.+||+.||++|||++|
T Consensus       269 l~~g~~pf~~~~~~~~-------~-~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  327 (345)
T 3hko_A          269 LLMGAVPFPGVNDADT-------I-SQVLNKKL---CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR  327 (345)
T ss_dssp             HHHSSCSSCCSSHHHH-------H-HHHHHCCC---CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             HHHCCCCCCCCChHHH-------H-HHHHhccc---ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            9999999976543221       1 11111111   1111222345678999999999999999999753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.3e-39  Score=285.71  Aligned_cols=227  Identities=25%  Similarity=0.335  Sum_probs=165.3

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+..  .++.||||++...    ....+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus        19 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (278)
T 3cok_A           19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM   98 (278)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred             ecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcH
Confidence            45555555554443  3445999998632    23347889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...     ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.........  
T Consensus        99 ~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--  168 (278)
T 3cok_A           99 NRYLKNR-----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--  168 (278)
T ss_dssp             HHHHHTC-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             HHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--
Confidence            9999533     2568999999999999999999999   99999999999999999999999999999876533221  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||..|+|||++        +|+||||+++|||++|+.||........        .......       ....+.
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~-------~~~~~~  233 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVVLA-------DYEMPS  233 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSS-------CCCCCT
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHhhc-------ccCCcc
Confidence            1334589999999987        8999999999999999999976432211        0111100       111233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.||++|||++|
T Consensus       234 ~~~~~~~~li~~~l~~dp~~Rps~~~  259 (278)
T 3cok_A          234 FLSIEAKDLIHQLLRRNPADRLSLSS  259 (278)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccCHHHHHHHHHHcccCHhhCCCHHH
Confidence            45678999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=303.29  Aligned_cols=229  Identities=20%  Similarity=0.247  Sum_probs=178.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.+..+...  ++.||||++...    ....+.+.+|..++.+++|+||+++++++.+.+..++||||+++|
T Consensus        67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg  146 (412)
T 2vd5_A           67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG  146 (412)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence            34566666666655543  445999999642    223356889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       147 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          147 DLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             BHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence            9999996432     469999999999999999999999   99999999999999999999999999999887654332


Q ss_pred             cccccccccccccCCccc---------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc-cc
Q 039471          264 VSRTAARGTSGYIAPELF---------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-EL  327 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  327 (363)
                       ......||+.|+|||++               +|+|||||++|||++|+.||.......        .+..+.... ..
T Consensus       219 -~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~~  289 (412)
T 2vd5_A          219 -RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--------TYGKIVHYKEHL  289 (412)
T ss_dssp             -ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHHC
T ss_pred             -ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcccCc
Confidence             12345799999999975               699999999999999999997654322        222222111 11


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      ..   +.....+++++.+++.+||+ +|++|+
T Consensus       290 ~~---p~~~~~~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          290 SL---PLVDEGVPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             CC---C----CCCHHHHHHHHTTSS-CGGGCT
T ss_pred             CC---CccccCCCHHHHHHHHHHcC-ChhhcC
Confidence            10   11223467789999999999 999995

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-39  Score=288.80  Aligned_cols=229  Identities=24%  Similarity=0.385  Sum_probs=179.5

Q ss_pred             ccccccCCcceeec----cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL----HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~----~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+..    .+..||||++....  ...+++.+|++++++++|+||+++++++ .....++||||+++++|
T Consensus        18 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L   96 (287)
T 1u59_A           18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL   96 (287)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEH
T ss_pred             ccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCH
Confidence            45556665555432    23349999997543  2346789999999999999999999999 45678999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc-
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-  264 (363)
                      .+++...     ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......... 
T Consensus        97 ~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  168 (287)
T 1u59_A           97 HKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  168 (287)
T ss_dssp             HHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             HHHHHhC-----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence            9999532     2569999999999999999999999   999999999999999999999999999998876443321 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ......+|..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+..      ...
T Consensus       169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~i~~~~~------~~~  234 (287)
T 1u59_A          169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKR------MEC  234 (287)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCC------CCC
T ss_pred             ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHhcCCc------CCC
Confidence            12334568899999987        899999999999998 999987543221        2222222221      122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+++.+.+++.+||+.||++|||++|
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~  262 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLT  262 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHH
Confidence            3456678999999999999999999853

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.6e-39  Score=288.59  Aligned_cols=238  Identities=22%  Similarity=0.383  Sum_probs=178.5

Q ss_pred             ccccccCCcceeec------cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEeccC
Q 039471          112 LISFNLTNSKFFFL------HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~------~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  181 (363)
                      ++.+++|.++.+.+      .++.||||++....  ...+.+.+|+.++++++|+||+++++++...  ...++||||++
T Consensus        29 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~  108 (302)
T 4e5w_A           29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP  108 (302)
T ss_dssp             EEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCT
T ss_pred             cCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCC
Confidence            44455555444432      23449999987432  3447899999999999999999999999776  67899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++....     ..+++..++.++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++.......
T Consensus       109 ~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  180 (302)
T 4e5w_A          109 SGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  180 (302)
T ss_dssp             TCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence            999999995443     458999999999999999999999   999999999999999999999999999998876543


Q ss_pred             cc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc-------ccchHHHHHHHhhhcc
Q 039471          262 SI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS-------QIYFPEWIYNRMRLGQ  325 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~  325 (363)
                      .. .......+|..|+|||++        +|+||||+++|||++|..|+........       .......+...+..+.
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (302)
T 4e5w_A          181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK  260 (302)
T ss_dssp             CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC
T ss_pred             cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC
Confidence            32 122445688889999987        8999999999999999988654322110       0001111112222111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ....+..+++.+.+++.+||+.||++|||++|
T Consensus       261 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  292 (302)
T 4e5w_A          261 ------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN  292 (302)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHH
Confidence                  12233456678999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=292.43  Aligned_cols=231  Identities=25%  Similarity=0.375  Sum_probs=174.1

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ..++.+++|.++.+...++.||||++... ...+.|.+|+.++++++|+||+++++++.+  ..++||||+++++|.+++
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l   90 (307)
T 2eva_A           14 EVVGRGAFGVVCKAKWRAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL   90 (307)
T ss_dssp             EEEECCSSSEEEEEEETTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHH
T ss_pred             eEeecCCCceEEEEEECCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHH
Confidence            44567777777776667777999999643 345789999999999999999999998874  478999999999999999


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC-eeEeccccceeccCCcccccccc
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-PKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      ....   ....+++..+..++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.......     ..
T Consensus        91 ~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~  162 (307)
T 2eva_A           91 HGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TN  162 (307)
T ss_dssp             HCSS---SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------
T ss_pred             hccC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----cc
Confidence            6432   1245889999999999999999999843358999999999999998887 7999999997654322     23


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..||..|+|||++        +||||||+++|||++|+.||........     . +......+.      .......++
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~-~~~~~~~~~------~~~~~~~~~  230 (307)
T 2eva_A          163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-----R-IMWAVHNGT------RPPLIKNLP  230 (307)
T ss_dssp             --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-----H-HHHHHHTTC------CCCCBTTCC
T ss_pred             CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-----H-HHHHHhcCC------CCCcccccC
Confidence            4589999999987        8999999999999999999975432211     0 111111111      112233456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+.+++.+||+.||++|||++|
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~e  253 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEE  253 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHH
Confidence            77999999999999999999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.3e-39  Score=288.16  Aligned_cols=225  Identities=22%  Similarity=0.326  Sum_probs=176.1

Q ss_pred             cccccccCCcceeeccCC--eeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLHSN--EIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~--~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+....+  .||||++...    ....+.+.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (279)
T 3fdn_A           16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT   95 (279)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred             EEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCc
Confidence            345555555555544333  4999998532    2344678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++........  
T Consensus        96 l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~--  164 (279)
T 3fdn_A           96 VYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--  164 (279)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcccc--
Confidence            99999543      458999999999999999999999   9999999999999999999999999999866543322  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....|+..|+|||++        +|+||||+++|||++|+.||.......        ....+....       ...+
T Consensus       165 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~-------~~~~  227 (279)
T 3fdn_A          165 --TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVE-------FTFP  227 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTC-------CCCC
T ss_pred             --cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--------HHHHHHhCC-------CCCC
Confidence              345689999999987        799999999999999999997543221        122222111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+.+++.+||+.||++|||++|
T Consensus       228 ~~~~~~~~~li~~~l~~~p~~Rps~~e  254 (279)
T 3fdn_A          228 DFVTEGARDLISRLLKHNPSQRPMLRE  254 (279)
T ss_dssp             TTSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CcCCHHHHHHHHHHhccChhhCCCHHH
Confidence            335677899999999999999999864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.6e-39  Score=287.42  Aligned_cols=227  Identities=25%  Similarity=0.339  Sum_probs=175.9

Q ss_pred             ccccccCCcceeeccC--CeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeee----CCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSE----GNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+....  ..||+|++.....   ..+.+.+|+.++++++|+||+++++++..    +...++||||+++
T Consensus        34 lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~  113 (290)
T 1t4h_A           34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS  113 (290)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCS
T ss_pred             ccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCC
Confidence            5566666665554433  3399999864332   33578899999999999999999999865    3568999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEc-CCCCeeEeccccceeccC
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLD-HNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++|.+++...      ..+++..++.++.|++.||.|||+   .+  ++|+||||+|||++ .++.+||+|||++.....
T Consensus       114 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          114 GTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            9999999543      468999999999999999999999   88  99999999999998 789999999999976544


Q ss_pred             CccccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          260 DISIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...    ....||..|+|||++       +|+||||+++|+|++|+.||........       ....+..+...     
T Consensus       185 ~~~----~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~-----  248 (290)
T 1t4h_A          185 SFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKP-----  248 (290)
T ss_dssp             TSB----EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-------HHHHHTTTCCC-----
T ss_pred             ccc----ccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-------HHHHHhccCCc-----
Confidence            322    344689999999987       7999999999999999999975433211       22222222111     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...++.+.+++.+||+.||++|||++|
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  279 (290)
T 1t4h_A          249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  279 (290)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cccCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            1112223467999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.3e-39  Score=292.96  Aligned_cols=237  Identities=22%  Similarity=0.333  Sum_probs=178.3

Q ss_pred             cccccccCCcceeec------cCCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeC--CceeEEEecc
Q 039471          111 SLISFNLTNSKFFFL------HSNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--NRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~------~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  180 (363)
                      .++.+++|.++.+.+      .++.||||++....  ...+.+.+|++++++++|+||+++++++.+.  ...++||||+
T Consensus        38 ~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~  117 (318)
T 3lxp_A           38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV  117 (318)
T ss_dssp             EEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCC
T ss_pred             eecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecc
Confidence            345555555543322      23449999997543  2245789999999999999999999999874  5789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++..       ..+++..++.++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus       118 ~~~~L~~~l~~-------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          118 PLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             TTCBHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             cCCcHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999999942       348999999999999999999999   99999999999999999999999999999987654


Q ss_pred             ccc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccc---cchH----HHHHHHhhhc
Q 039471          261 ISI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ---IYFP----EWIYNRMRLG  324 (363)
Q Consensus       261 ~~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~---~~~~----~~~~~~~~~~  324 (363)
                      ... .......+|..|+|||++        +|+||||+++|||++|+.||.........   ....    ..+...+..+
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            332 122345578889999988        79999999999999999998754322100   0000    0011111111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            .....+..++..+.+++.+||+.||++|||++|
T Consensus       268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  300 (318)
T 3lxp_A          268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN  300 (318)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHH
Confidence                  122234456678999999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=292.39  Aligned_cols=232  Identities=23%  Similarity=0.358  Sum_probs=174.4

Q ss_pred             ccccccccCCcceeeccCC------eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHSN------EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~------~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+.....      .||||++.....  ...++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus        50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  129 (333)
T 1mqb_A           50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME  129 (333)
T ss_dssp             EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence            3456666666665544322      299999974332  23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++......
T Consensus       130 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          130 NGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             TEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            999999996432     569999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cc-cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          262 SI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       262 ~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      .. .......+|..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+..     
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~-----  268 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------VMKAINDGFR-----  268 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCC-----
T ss_pred             ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHCCCc-----
Confidence            21 111233467889999987        799999999999998 999986543221        2222222211     


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...+..++..+.+++.+||+.+|++|||++|
T Consensus       269 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  299 (333)
T 1mqb_A          269 -LPTPMDCPSAIYQLMMQCWQQERARRPKFAD  299 (333)
T ss_dssp             -CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             -CCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence             1223345677999999999999999999753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-39  Score=305.77  Aligned_cols=178  Identities=22%  Similarity=0.334  Sum_probs=136.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeee-----CCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSE-----GNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~  179 (363)
                      ..++.+++|.+..+...  ++.||||++......   .+++.+|++++++++|+||+++++++..     ....++||||
T Consensus        59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  138 (458)
T 3rp9_A           59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI  138 (458)
T ss_dssp             CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred             eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence            44556666665555333  445999998653322   3578899999999999999999999843     3578999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +. ++|.+++..      ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       139 ~~-~~L~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          139 AD-SDFKKLFRT------PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CS-EEHHHHHHS------SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             cc-cchhhhccc------CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            84 699999842      3569999999999999999999999   9999999999999999999999999999987653


Q ss_pred             Cccc-------------------------cccccccccccccCCccc---------cCceehhHHHHHHhcC
Q 039471          260 DISI-------------------------VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGC  297 (363)
Q Consensus       260 ~~~~-------------------------~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g  297 (363)
                      ....                         .......||+.|+|||++         +|||||||++|||++|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            2110                         112345689999999975         7999999999999993

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-39  Score=319.01  Aligned_cols=228  Identities=23%  Similarity=0.394  Sum_probs=176.2

Q ss_pred             ccccccCCcceeecc----CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH----SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~----~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.....    +..||||+++....   ..+++.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus       377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~  455 (635)
T 4fl3_A          377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGP  455 (635)
T ss_dssp             EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCC
Confidence            556666666554332    23499999975432   24689999999999999999999999865 45889999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc-
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  263 (363)
                      |.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++....+... 
T Consensus       456 L~~~l~~------~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          456 LNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             HHHHHHH------CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             HHHHHhh------CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999953      2568999999999999999999999   99999999999999999999999999999877554322 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .......+|..|+|||++        +||||||+++|||++ |+.||.......        +...+..+...      .
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~------~  592 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERM------G  592 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCC------C
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------C
Confidence            112334567889999988        899999999999998 999997654322        23333333221      2


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+++++.+++.+||+.||++|||++|
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~  621 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAA  621 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            23456678999999999999999999853

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.8e-39  Score=287.21  Aligned_cols=228  Identities=24%  Similarity=0.400  Sum_probs=175.9

Q ss_pred             ccccccCCcceeecc----CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH----SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~----~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...    ++.||||++......   .+++.+|+.++++++|+||+++++++ .....++||||+++++
T Consensus        25 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~  103 (291)
T 1xbb_A           25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGP  103 (291)
T ss_dssp             EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCC
Confidence            455556555554322    234999999754322   46789999999999999999999999 5677899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........
T Consensus       104 L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A          104 LNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             HHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             HHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence            99999542      458999999999999999999999   999999999999999999999999999998876543321


Q ss_pred             c-cccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          265 S-RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       265 ~-~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . .....++..|+|||.+        +|+||||+++|||++ |+.||.......        +...+..+..      ..
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~------~~  240 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGER------MG  240 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCC------CC
T ss_pred             cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC------CC
Confidence            1 2234467889999987        899999999999999 999987643321        2222222221      12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+++.+.+++.+||+.||++|||++|
T Consensus       241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~  269 (291)
T 1xbb_A          241 CPAGCPREMYDLMNLCWTYDVENRPGFAA  269 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            23456678999999999999999999853

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.2e-39  Score=293.56  Aligned_cols=231  Identities=21%  Similarity=0.321  Sum_probs=178.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  ++.||||++....   ....++.+|+.++.++. |+||+++++++.+....++||||+++++|
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L  116 (327)
T 3lm5_A           37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI  116 (327)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred             eCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcH
Confidence            556666665555443  4559999987432   33468899999999995 69999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCcc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .+++....    ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++.......
T Consensus       117 ~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  189 (327)
T 3lm5_A          117 FSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE  189 (327)
T ss_dssp             GGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred             HHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc
Confidence            99984322    2679999999999999999999999   99999999999999997   78999999999988765433


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .   ....||+.|+|||++        +|+||||+++|||++|+.||........        ...+...   .......
T Consensus       190 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------~~~i~~~---~~~~~~~  255 (327)
T 3lm5_A          190 L---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--------YLNISQV---NVDYSEE  255 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHT---CCCCCTT
T ss_pred             c---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--------HHHHHhc---ccccCch
Confidence            2   345689999999987        7999999999999999999976543221        1111111   1112222


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....++.+.+++.+||+.||++|||++|
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~  284 (327)
T 3lm5_A          256 TFSSVSQLATDFIQSLLVKNPEKRPTAEI  284 (327)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            33456678999999999999999999753

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.4e-39  Score=292.91  Aligned_cols=233  Identities=26%  Similarity=0.416  Sum_probs=177.1

Q ss_pred             cccccccCCcceeeccCC----eeEEEEcccC--CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHSN----EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~----~vAvK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+....+    .||+|.+...  ....+.+.+|+++++++ +|+||+++++++.+.+..++||||++++
T Consensus        32 ~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~  111 (327)
T 1fvr_A           32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG  111 (327)
T ss_dssp             EEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             eeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCC
Confidence            345556665555544333    2599988642  33456799999999999 8999999999999999999999999999


Q ss_pred             CHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccc
Q 039471          184 SLQKFIFSKTN----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       184 sL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      +|.+++.....          ......+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       112 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~Dfg~  188 (327)
T 1fvr_A          112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL  188 (327)
T ss_dssp             BHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             CHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcccCc
Confidence            99999964420          0122579999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          254 AKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       254 a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ++.......   .....++..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+
T Consensus       189 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~  257 (327)
T 1fvr_A          189 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQG  257 (327)
T ss_dssp             EESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHGGGT
T ss_pred             Ccccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------HHHHhhcC
Confidence            875432211   1334568899999987        899999999999998 999987643321        22233222


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..      ...+...++.+.+++.+||+.||++|||++|
T Consensus       258 ~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  290 (327)
T 1fvr_A          258 YR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  290 (327)
T ss_dssp             CC------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CC------CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence            11      1223345678999999999999999999753

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-39  Score=307.45  Aligned_cols=224  Identities=20%  Similarity=0.236  Sum_probs=166.5

Q ss_pred             cccccccCCcceeec--cCCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+..  .+..||||++..    .......+.+|+.++++++|+||+++++++.+.+..++||||+++++
T Consensus       155 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~  234 (446)
T 4ejn_A          155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE  234 (446)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCB
T ss_pred             EEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCc
Confidence            344444544443332  244599999964    23334677899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.+||+|||+++........ 
T Consensus       235 L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-  305 (446)
T 4ejn_A          235 LFFHLSRE------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-  305 (446)
T ss_dssp             HHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc-
Confidence            99999543      568999999999999999999995  268999999999999999999999999999864433221 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||+.|+|||++        +|+||||+++|||++|+.||.......        +...+....       ...+
T Consensus       306 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~-------~~~p  369 (446)
T 4ejn_A          306 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEE-------IRFP  369 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-------CCCC
T ss_pred             -cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHHhCC-------CCCC
Confidence             2446799999999998        799999999999999999997654321        222222111       1123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      ..+++.+.+++.+||+.||++||
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~R~  392 (446)
T 4ejn_A          370 RTLGPEAKSLLSGLLKKDPKQRL  392 (446)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTST
T ss_pred             ccCCHHHHHHHHHHcccCHHHhC
Confidence            34567899999999999999999

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.8e-39  Score=291.59  Aligned_cols=235  Identities=23%  Similarity=0.337  Sum_probs=180.7

Q ss_pred             ccccccCCcceeecc-------CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH-------SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.....       +..||||++.....  ...++.+|+.++++++|+||+++++++.+++..++||||+++
T Consensus        33 lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  112 (322)
T 1p4o_A           33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR  112 (322)
T ss_dssp             EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCC
Confidence            445555555443322       33499999974432  234688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          183 GSLQKFIFSKTN----SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       183 ~sL~~~l~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ++|.+++.....    ......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus       113 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~  189 (322)
T 1p4o_A          113 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY  189 (322)
T ss_dssp             CBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGG
T ss_pred             CcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCccccccc
Confidence            999999965321    1112457999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ............+|..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+..   
T Consensus       190 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~---  258 (322)
T 1p4o_A          190 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRFVMEGGL---  258 (322)
T ss_dssp             GGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------HHHHHHTTCC---
T ss_pred             cccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--------HHHHHHcCCc---
Confidence            54333233445578899999987        899999999999999 888886543221        2222222211   


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ...+...+..+.+++.+||+.||++|||++|
T Consensus       259 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  289 (322)
T 1p4o_A          259 ---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE  289 (322)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence               1123345677999999999999999999854

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-38  Score=297.68  Aligned_cols=231  Identities=20%  Similarity=0.261  Sum_probs=172.4

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcC---hhHHHHHHHHHhccC--CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGN---GQEFINEVATIGRIH--HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+... +..||||++......   .+.+.+|+.++++++  |+||+++++++..+...++||| +.++
T Consensus        62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~  140 (390)
T 2zmd_A           62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI  140 (390)
T ss_dssp             EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred             EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence            34556666665554433 344999998654322   357899999999996  5999999999999999999999 5678


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++........
T Consensus       141 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          141 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            999999543      468999999999999999999999   9999999999999996 578999999999877654432


Q ss_pred             cccccccccccccCCccc-------------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          264 VSRTAARGTSGYIAPELF-------------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .......||+.|+|||++                   +|||||||++|||++|+.||........      .+...+. .
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~~~~~-~  283 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIID-P  283 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHC-T
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH------HHHHHhC-c
Confidence            223455799999999975                   6999999999999999999975432111      1111111 1


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      . .    ....+...+..+.+++.+||+.||++|||++|
T Consensus       284 ~-~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  317 (390)
T 2zmd_A          284 N-H----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE  317 (390)
T ss_dssp             T-S----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             c-c----cCCCCccchHHHHHHHHHHcccChhhCCCHHH
Confidence            1 0    11111222567899999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.2e-39  Score=289.56  Aligned_cols=230  Identities=23%  Similarity=0.341  Sum_probs=179.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+...  ++.||+|++..... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   94 (304)
T 2jam_A           15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF   94 (304)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             eeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHH
Confidence            34555666655554433  45599999975432 3467889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||++   +.++.+||+|||++........ 
T Consensus        95 ~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~-  164 (304)
T 2jam_A           95 DRILER------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM-  164 (304)
T ss_dssp             HHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT-
T ss_pred             HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc-
Confidence            998543      468999999999999999999999   999999999999999   7888999999999876543321 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||..|+|||++        +|+||||+++|||++|+.||.......        ....+..+..   ......
T Consensus       165 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~---~~~~~~  230 (304)
T 2jam_A          165 ---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------LFEKIKEGYY---EFESPF  230 (304)
T ss_dssp             ---HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHCCC---CCCTTT
T ss_pred             ---ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCC---CCCccc
Confidence               334589999999987        899999999999999999997643321        2222222211   111122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+..+.+++.+||+.||++|||++|
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~  258 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEK  258 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            3345678999999999999999999753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.7e-39  Score=287.02  Aligned_cols=227  Identities=25%  Similarity=0.379  Sum_probs=173.8

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeC-CceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-NRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.+++|.++.+...++.||||++.... ..+.+.+|+.++++++|+||+++++++.+. +..++||||+++++|.++
T Consensus        27 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (278)
T 1byg_A           27 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY  105 (278)
T ss_dssp             EEEEECSSCEEEEEEETTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred             eEEecCCCceEEEEEEcCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence            445666777776666667779999997543 567899999999999999999999987544 578999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +.....    ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.......     ..
T Consensus       106 l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~  173 (278)
T 1byg_A          106 LRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  173 (278)
T ss_dssp             HHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHhccc----ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-----cC
Confidence            954321    348899999999999999999999   999999999999999999999999999988654432     23


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..++..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+.      ....+...
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~------~~~~~~~~  239 (278)
T 1byg_A          174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGY------KMDAPDGC  239 (278)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTC------CCCCCTTC
T ss_pred             CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCC------CCCCcccC
Confidence            3478899999987        899999999999998 999987543221        122222221      12233455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+.+++.+||+.||++|||++|
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~  263 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQ  263 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHH
Confidence            678999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.2e-39  Score=294.04  Aligned_cols=243  Identities=20%  Similarity=0.267  Sum_probs=176.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  ++.||||++......   .+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  110 (331)
T 4aaa_A           31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI  110 (331)
T ss_dssp             EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence            44566666666665544  445999998654433   2457899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......... 
T Consensus       111 l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  180 (331)
T 4aaa_A          111 LDDLELF------PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-  180 (331)
T ss_dssp             HHHHHHS------TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             HHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence            9887632      2569999999999999999999999   99999999999999999999999999999876543321 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH-------HHHHHhhhc----
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE-------WIYNRMRLG----  324 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----  324 (363)
                       .....||..|+|||++         +|+||||+++|||++|+.||..............       .........    
T Consensus       181 -~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          181 -YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             -cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence             2345689999999976         7999999999999999999976544322110000       000000000    


Q ss_pred             cccccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..........     ....+++.+.+++.+||+.||++|||++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  303 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE  303 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence            0000000000     11234678999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-38  Score=298.35  Aligned_cols=186  Identities=23%  Similarity=0.275  Sum_probs=143.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccC-CCceeeeeeeeeeCC--ceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGN--RRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~e~~~  181 (363)
                      ..++.+++|.+..+...  ++.||||++....   ...+++.+|+.+++++. |+||+++++++...+  ..++||||++
T Consensus        15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~   94 (388)
T 3oz6_A           15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME   94 (388)
T ss_dssp             EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred             EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence            34555566655554332  4459999986432   23357789999999997 999999999997543  7899999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ++|.+++..       ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+......
T Consensus        95 -~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           95 -TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             -EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             -cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence             599999843       358999999999999999999999   999999999999999999999999999998764311


Q ss_pred             c-------------------ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          262 S-------------------IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       262 ~-------------------~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      .                   ........||+.|+|||++         +|||||||++|||++|++||.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            0                   0112345699999999987         7999999999999999999976543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-39  Score=297.72  Aligned_cols=231  Identities=23%  Similarity=0.329  Sum_probs=167.1

Q ss_pred             cccccccCCcceeeccCC-----eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeee-eCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHSN-----EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCS-EGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++......+     .||||.++....  ..++|.+|+.++++++|+||+++++++. .++..++||||+++
T Consensus        96 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~  175 (373)
T 3c1x_A           96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  175 (373)
T ss_dssp             EEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTT
T ss_pred             EeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCC
Confidence            456666666665544221     389999874332  3468999999999999999999999875 45688999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       176 g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          176 GDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             CBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            9999999533     2568899999999999999999999   9999999999999999999999999999987644321


Q ss_pred             c--cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          263 I--VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       263 ~--~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      .  .......+|..|+|||++        +|+||||+++|||++ |.+||.......        +...+..+...    
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~~----  315 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRRL----  315 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCCC----
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCCC----
Confidence            1  112334577889999987        899999999999999 566665433221        11122222211    


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ..+..++..+.+++.+||+.||++|||++|
T Consensus       316 --~~p~~~~~~l~~li~~cl~~dp~~RPs~~e  345 (373)
T 3c1x_A          316 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  345 (373)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence              123345677999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-38  Score=294.01  Aligned_cols=238  Identities=16%  Similarity=0.147  Sum_probs=172.4

Q ss_pred             cccccccCCcceeecc-------CCeeEEEEcccCCc------------ChhHHHHHHHHHhccCCCceeeeeeeeeeC-
Q 039471          111 SLISFNLTNSKFFFLH-------SNEIAVKMLEHLKG------------NGQEFINEVATIGRIHHFHIVRLLGFCSEG-  170 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  170 (363)
                      .++.+++|.++.+...       +..||||++.....            ....+.+|+..++.++|+||+++++++... 
T Consensus        42 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~  121 (364)
T 3op5_A           42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK  121 (364)
T ss_dssp             ECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEE
T ss_pred             EEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeecc
Confidence            3456666666555443       24599999864331            112345566677788899999999998764 


Q ss_pred             ---CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc--CCCC
Q 039471          171 ---NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQ  245 (363)
Q Consensus       171 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~--~~~~  245 (363)
                         ...++||||+ +++|.+++....     ..+++..++.++.||+.||+|||+   .+|+||||||+|||++  .++.
T Consensus       122 ~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          122 NGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             TTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTTC
T ss_pred             CCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCCe
Confidence               4589999999 999999996432     569999999999999999999999   9999999999999999  8899


Q ss_pred             eeEeccccceeccCCccccc-----cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc
Q 039471          246 PKISDFGLAKLCSKDISIVS-----RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY  312 (363)
Q Consensus       246 ~kl~Dfg~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~  312 (363)
                      +||+|||+++..........     .....||..|+|||++        +||||||+++|||++|+.||.......... 
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~-  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV-  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH-
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH-
Confidence            99999999988754432111     1334599999999988        799999999999999999998643322111 


Q ss_pred             hHHHHHHHhhhc--cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          313 FPEWIYNRMRLG--QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       313 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ..........  .......   .....+.++.+++.+||+.+|++|||+++
T Consensus       272 --~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~  319 (364)
T 3op5_A          272 --RDSKIRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYEN  319 (364)
T ss_dssp             --HHHHHHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             --HHHHHHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHH
Confidence              1111111000  0000000   01223567999999999999999999753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.6e-39  Score=290.16  Aligned_cols=230  Identities=17%  Similarity=0.170  Sum_probs=172.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||||++......    .+.+.+|+.++++++|+||+++++++..++..++||||+++++
T Consensus        41 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 2h34_A           41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD  120 (309)
T ss_dssp             EEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEE
T ss_pred             EEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCC
Confidence            3455566655555432  444999999754322    3678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++......... 
T Consensus       121 L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-  190 (309)
T 2h34_A          121 LAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-  190 (309)
T ss_dssp             HHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-
Confidence            99999543      458999999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......|+..|+|||++        +|+||||+++|||++|+.||.......        ....+.....    ......
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~----~~~~~~  258 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--------MGAHINQAIP----RPSTVR  258 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--------HHHHHHSCCC----CGGGTS
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--------HHHHhccCCC----CccccC
Confidence            12345689999999988        899999999999999999997654321        1111211111    111223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC-CCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERP-SMP  362 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RP-s~~  362 (363)
                      ..++..+.+++.+||+.||++|| |++
T Consensus       259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~  285 (309)
T 2h34_A          259 PGIPVAFDAVIARGMAKNPEDRYVTCG  285 (309)
T ss_dssp             TTCCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CCCCHHHHHHHHHhccCCHHHHHHhHH
Confidence            34567799999999999999999 654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-38  Score=314.11  Aligned_cols=224  Identities=19%  Similarity=0.221  Sum_probs=180.1

Q ss_pred             ccccccCCcceeeccC--CeeEEEEccc----CCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLHS--NEIAVKMLEH----LKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~--~~vAvK~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+....  +.||||+++.    .....+.+.+|..++..+ +|+||+++++++.+....++||||+++|+
T Consensus       349 LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~  428 (674)
T 3pfq_A          349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD  428 (674)
T ss_dssp             SSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCB
T ss_pred             EccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCc
Confidence            4444454444444333  3399999864    234556788999999988 69999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       429 L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--  497 (674)
T 3pfq_A          429 LMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--  497 (674)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--
Confidence            99999543      469999999999999999999999   9999999999999999999999999999986443322  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ......||+.|+|||++        +|+||||+++|||++|+.||.......        ++..+....       ...+
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~-------~~~p  562 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHN-------VAYP  562 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHSSC-------CCCC
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhCC-------CCCC
Confidence            12456799999999998        799999999999999999998654322        233333221       1223


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ..+++++.+++.+||+.||++||++
T Consensus       563 ~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          563 KSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ccCCHHHHHHHHHHccCCHHHCCCC
Confidence            4567789999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.7e-39  Score=297.14  Aligned_cols=231  Identities=23%  Similarity=0.320  Sum_probs=180.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---------hhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEE
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---------GQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIY  177 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  177 (363)
                      ..++.+++|.++.+...  ++.||||++......         .+.+.+|+.+++++ +|+||+++++++......++||
T Consensus       100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  179 (365)
T 2y7j_A          100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF  179 (365)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence            34556666666555543  456999998644321         34678999999999 7999999999999999999999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||+++++|.+++...      ..+++..+..++.||+.||.|||+   .+++|+||||+|||++.++.+||+|||++...
T Consensus       180 e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          180 DLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             CCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            999999999999532      468999999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCccccccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ......   ....||+.|+|||++              +|+||||+++|||++|+.||.......        ....+..
T Consensus       251 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--------~~~~i~~  319 (365)
T 2y7j_A          251 EPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--------MLRMIME  319 (365)
T ss_dssp             CTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHH
T ss_pred             CCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHh
Confidence            654332   345689999999975              799999999999999999997643221        1122221


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +....   ........+..+.+++.+||+.||++|||++|
T Consensus       320 ~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  356 (365)
T 2y7j_A          320 GQYQF---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ  356 (365)
T ss_dssp             TCCCC---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCC---CCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            11100   00001123567999999999999999999754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-39  Score=287.50  Aligned_cols=231  Identities=22%  Similarity=0.309  Sum_probs=177.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...  ++.||+|++....       ...+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus        11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   90 (283)
T 3bhy_A           11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV   90 (283)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             HhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeec
Confidence            34455566655555443  4559999986432       13568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----CeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~  256 (363)
                      ++++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++    .+||+|||.+..
T Consensus        91 ~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           91 SGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            999999999542      468999999999999999999999   9999999999999998877    799999999987


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .......   ....|+..|+|||++        +|+||||+++|||++|+.||.......        ....+.....  
T Consensus       162 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~--  228 (283)
T 3bhy_A          162 IEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTNISAVNY--  228 (283)
T ss_dssp             CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCC--
T ss_pred             ccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHHhHhccc--
Confidence            6544322   344589999999987        899999999999999999997654321        1111111110  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..........+..+.+++.+||+.||++|||++|
T Consensus       229 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  262 (283)
T 3bhy_A          229 -DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ  262 (283)
T ss_dssp             -CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             -CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence             0001111234567999999999999999999753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.4e-39  Score=289.38  Aligned_cols=224  Identities=21%  Similarity=0.302  Sum_probs=172.2

Q ss_pred             cccccccCCcceeeccC---------CeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFLHS---------NEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~---------~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .++.+++|.++.+....         ..||+|++.... ...+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus        15 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   94 (289)
T 4fvq_A           15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFV   94 (289)
T ss_dssp             EEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             eeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECC
Confidence            34555555555443332         349999986443 34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC--------eeEeccc
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--------PKISDFG  252 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~--------~kl~Dfg  252 (363)
                      ++++|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.        +||+|||
T Consensus        95 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           95 KFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             TTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             CCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            9999999996432     448999999999999999999999   99999999999999998887        9999999


Q ss_pred             cceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      ++......      ....+|..|+|||++         +|+||||+++|||++|..|+........       .......
T Consensus       167 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------~~~~~~~  233 (289)
T 4fvq_A          167 ISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQFYED  233 (289)
T ss_dssp             SCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHT
T ss_pred             ccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-------HHHHhhc
Confidence            98755332      223478899999987         7999999999999996655543322211       1111111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...        .+...+..+.+++.+||+.||++|||++|
T Consensus       234 ~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~  265 (289)
T 4fvq_A          234 RHQ--------LPAPKAAELANLINNCMDYEPDHRPSFRA  265 (289)
T ss_dssp             TCC--------CCCCSSCTTHHHHHHHSCSSGGGSCCHHH
T ss_pred             cCC--------CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            111        11122456889999999999999999854

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-38  Score=291.50  Aligned_cols=226  Identities=22%  Similarity=0.299  Sum_probs=180.3

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  ++.||+|++....    ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++|
T Consensus        49 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  128 (335)
T 2owb_A           49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL  128 (335)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCH
Confidence            455666665555443  3349999986432    2346788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...      ..+++..++.++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||++.........  
T Consensus       129 ~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--  197 (335)
T 2owb_A          129 LELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--  197 (335)
T ss_dssp             HHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc--
Confidence            9998532      468999999999999999999999   99999999999999999999999999999876543221  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....||..|+|||++        +|+||||+++|||++|+.||.......        ....+.....       ..+.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~-------~~~~  262 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEY-------SIPK  262 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCC-------CCCT
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCCC-------CCCc
Confidence            2345689999999987        899999999999999999997643221        1111211111       1223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++..+.+++.+||+.||++|||++|
T Consensus       263 ~~~~~~~~li~~~l~~dp~~Rps~~e  288 (335)
T 2owb_A          263 HINPVAASLIQKMLQTDPTARPTINE  288 (335)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHH
Confidence            44567899999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=284.55  Aligned_cols=233  Identities=23%  Similarity=0.255  Sum_probs=179.6

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+...  +..||||++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA  108 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence            4566666666655533  3449999987543 345789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceeccCCcccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      ++.....   ...+++..+..++.|++.||+|||+   .+++|+||||+||+++. ++.+||+|||++.........  .
T Consensus       109 ~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~  180 (295)
T 2clq_A          109 LLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--T  180 (295)
T ss_dssp             HHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             HHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--c
Confidence            9965432   2457899999999999999999999   99999999999999987 899999999999876543221  2


Q ss_pred             ccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          267 TAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      ....|+..|+|||++          +|+||||+++|||++|+.||.........      ......      .......+
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~------~~~~~~~~  248 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA------MFKVGM------FKVHPEIP  248 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH------HHHHHH------HCCCCCCC
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH------HHhhcc------cccccccc
Confidence            345689999999986          79999999999999999998654322110      111000      01112233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+.+++.+||+.||++|||++|
T Consensus       249 ~~~~~~~~~li~~~l~~dp~~Rps~~~  275 (295)
T 2clq_A          249 ESMSAEAKAFILKCFEPDPDKRACAND  275 (295)
T ss_dssp             TTSCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHH
Confidence            455678999999999999999999753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.1e-39  Score=286.74  Aligned_cols=225  Identities=20%  Similarity=0.280  Sum_probs=179.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  +..||||++...    ....+.+.+|++++++++|+||+++++++.+++..++||||+++++
T Consensus        21 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  100 (284)
T 2vgo_A           21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE  100 (284)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred             eecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCc
Confidence            3455555555554433  234999998532    2345678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........  
T Consensus       101 L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  169 (284)
T 2vgo_A          101 LYKELQKH------GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--  169 (284)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB--
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccccc--
Confidence            99999543      458999999999999999999999   9999999999999999999999999999876654322  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....|+..|+|||++        +|+||||+++|||++|+.||.......        ....+....       ...+
T Consensus       170 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~-------~~~~  232 (284)
T 2vgo_A          170 --RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVD-------LKFP  232 (284)
T ss_dssp             --CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-------CCCC
T ss_pred             --ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccc-------cCCC
Confidence              345689999999987        899999999999999999997643321        111221111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~~~~li~~~l~~~p~~Rps~~~  259 (284)
T 2vgo_A          233 PFLSDGSKDLISKLLRYHPPQRLPLKG  259 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CcCCHHHHHHHHHHhhcCHhhCCCHHH
Confidence            345677999999999999999999753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.6e-39  Score=285.45  Aligned_cols=229  Identities=20%  Similarity=0.301  Sum_probs=174.4

Q ss_pred             cccccccCCcceeeccCC-----eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHSN-----EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .++.+++|.++.+.....     .||+|++....  ...+.+.+|+.++++++|+||+++++++.++ ..++||||++++
T Consensus        19 ~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~   97 (281)
T 3cc6_A           19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYG   97 (281)
T ss_dssp             EEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTC
T ss_pred             EEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCC
Confidence            345556665555443222     29999987542  2346789999999999999999999998754 568999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus        98 ~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           98 ELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             BHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             CHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            9999996432     458999999999999999999999   99999999999999999999999999999876543321


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......++..|+|||++        +|+||||+++|||++ |+.||.......        ....+..+...      .
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~------~  234 (281)
T 3cc6_A          170 -KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL------P  234 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC------C
T ss_pred             -ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC------C
Confidence             12344578899999987        799999999999998 999987543322        11222222111      1


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+...++.+.+++.+||+.||++|||++|
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~e  263 (281)
T 3cc6_A          235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTE  263 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence            22335677999999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.5e-39  Score=291.79  Aligned_cols=237  Identities=22%  Similarity=0.340  Sum_probs=178.2

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...       +..||||++....  ....++.+|+.++++++|+||+++++++.+....++||||+
T Consensus        36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (327)
T 2yfx_A           36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM  115 (327)
T ss_dssp             EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence            34455666665554422       2349999996432  23357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNS-SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~  256 (363)
                      ++++|.+++...... .....+++..++.++.|++.||.|||+   .+|+||||||+|||++.   +..+||+|||++..
T Consensus       116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~  192 (327)
T 2yfx_A          116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD  192 (327)
T ss_dssp             TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred             CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence            999999999765431 122458999999999999999999999   99999999999999984   44699999999986


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ..............+|..|+|||++        +|+||||+++|||++ |+.||.......        +...+..+...
T Consensus       193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~  264 (327)
T 2yfx_A          193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VLEFVTSGGRM  264 (327)
T ss_dssp             HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHTTCCC
T ss_pred             cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------HHHHHhcCCCC
Confidence            6544332223445678899999987        899999999999998 888886543221        22222222111


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ..+..++..+.+++.+||+.||++|||++|
T Consensus       265 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  294 (327)
T 2yfx_A          265 ------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAI  294 (327)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence                  123345677999999999999999999853

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-38  Score=285.14  Aligned_cols=227  Identities=22%  Similarity=0.294  Sum_probs=180.6

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      .++.+++|.++.+...  ++.||+|++....    ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++
T Consensus        22 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  101 (294)
T 2rku_A           22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS  101 (294)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             EEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCC
Confidence            3455666665555444  3349999986432    233578899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......... 
T Consensus       102 L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-  171 (294)
T 2rku_A          102 LLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-  171 (294)
T ss_dssp             HHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred             HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCccc-
Confidence            99988432      468999999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       .....||..|+|||++        +|+||||+++|||++|+.||.......        ....+....       ...+
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~-------~~~~  235 (294)
T 2rku_A          172 -KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE-------YSIP  235 (294)
T ss_dssp             -BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-------CCCC
T ss_pred             -cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhcc-------CCCc
Confidence             2345689999999987        899999999999999999997654321        111221111       1122


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+.+++.+||+.||++|||++|
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rps~~~  262 (294)
T 2rku_A          236 KHINPVAASLIQKMLQTDPTARPTINE  262 (294)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             cccCHHHHHHHHHHcccChhhCcCHHH
Confidence            345567999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.6e-39  Score=294.52  Aligned_cols=236  Identities=24%  Similarity=0.363  Sum_probs=180.3

Q ss_pred             ccccccCCcceeeccC-------CeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccC
Q 039471          112 LISFNLTNSKFFFLHS-------NEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ++.+++|.++.+....       ..||+|++.....  ..+.+.+|+.+++++ +|+||+++++++.+++..++||||++
T Consensus        54 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (333)
T 2i1m_A           54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCC  133 (333)
T ss_dssp             EEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCC
Confidence            4555555554443221       2499999975432  335788999999999 89999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccc
Q 039471          182 NGSLQKFIFSKTNS--------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  253 (363)
Q Consensus       182 ~~sL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~  253 (363)
                      +|+|.+++......        .....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       134 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  210 (333)
T 2i1m_A          134 YGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGL  210 (333)
T ss_dssp             TEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCCCGG
T ss_pred             CCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECcccc
Confidence            99999999653210        012468999999999999999999999   9999999999999999999999999999


Q ss_pred             ceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          254 AKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       254 a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      +................+|..|+|||++        +|+||||+++|||++ |..||........       .......+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~  283 (333)
T 2i1m_A          211 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-------FYKLVKDG  283 (333)
T ss_dssp             GCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-------HHHHHHHT
T ss_pred             ccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-------HHHHHhcC
Confidence            9876554433333445678899999987        899999999999998 8888875432221       11112111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..      ...+...+..+.+++.+||+.||.+|||++|
T Consensus       284 ~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  316 (333)
T 2i1m_A          284 YQ------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQ  316 (333)
T ss_dssp             CC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CC------CCCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            11      1122334567999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-38  Score=290.42  Aligned_cols=236  Identities=16%  Similarity=0.251  Sum_probs=177.3

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeee--CCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSE--GNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+..  .++.||||++..  ...+.+.+|+.++++++ |+||+++++++.+  ....++||||+++++|
T Consensus        43 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l  120 (330)
T 3nsz_A           43 KLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF  120 (330)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCH
T ss_pred             EecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhH
Confidence            345555555555432  344599999873  34578999999999997 9999999999987  6678999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCcccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      .+++         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||+++........ 
T Consensus       121 ~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-  187 (330)
T 3nsz_A          121 KQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-  187 (330)
T ss_dssp             HHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC-
T ss_pred             HHHH---------HhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc-
Confidence            9998         458999999999999999999999   9999999999999999776 8999999999877654432 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch------HHHHHHHhhhcc----
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF------PEWIYNRMRLGQ----  325 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~------~~~~~~~~~~~~----  325 (363)
                        ....++..|+|||++         +|+||||+++|||++|+.||............      .......+....    
T Consensus       188 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          188 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             --CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             --ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence              345689999999986         79999999999999999999543322111100      000000000000    


Q ss_pred             -------------ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 -------------ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 -------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                   .............+++.+.+++.+||++||++|||++|
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e  316 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE  316 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence                         00001111223336788999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=293.95  Aligned_cols=239  Identities=20%  Similarity=0.252  Sum_probs=171.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  ++.||||++.....  ....+.+|+.++++++|+||+++++++.+++..++||||++ ++|
T Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l   86 (324)
T 3mtl_A            8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL   86 (324)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred             EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence            34555566555555443  44499999864332  22356689999999999999999999999999999999997 599


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--  156 (324)
T 3mtl_A           87 KQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--  156 (324)
T ss_dssp             HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc--
Confidence            99986432     568999999999999999999999   99999999999999999999999999999865533221  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc---------
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL---------  327 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  327 (363)
                      .....||..|+|||++         +|+||||+++|||++|+.||.........    ..+...+......         
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL----HFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCCCCTTTSTTGGGCH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHhCCCChHhchhhhcch
Confidence            2344689999999986         79999999999999999999765433211    1111111000000         


Q ss_pred             ------ccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 ------CLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ------~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ......    .....+++.+.+++.+||++||++|||++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  278 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED  278 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHH
Confidence                  000000    011234567899999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=286.01  Aligned_cols=232  Identities=22%  Similarity=0.314  Sum_probs=176.5

Q ss_pred             cccccccCCcceeecc--CC---eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCce-eEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SN---EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRR-TLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~---~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~  182 (363)
                      .++.+++|.++.+...  ..   .||+|++.....  ..+.+.+|+.++++++|+||+++++++.+.... +++|||+.+
T Consensus        28 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~  107 (298)
T 3pls_A           28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH  107 (298)
T ss_dssp             EEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTT
T ss_pred             eeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccC
Confidence            3556666665554432  11   399999875332  336788999999999999999999999766554 999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++...     ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus       108 ~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          108 GDLLQFIRSP-----QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             CCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            9999999542     3568999999999999999999999   9999999999999999999999999999986644321


Q ss_pred             c--cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          263 I--VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       263 ~--~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .  .......++..|+|||.+        +|+||||+++|||++|..|+........       ....+..+..      
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~------  246 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRR------  246 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTTCC------
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcCCC------
Confidence            1  122345678899999987        7999999999999996666544332221       1222222211      


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+...+..+.+++.+||+.||++|||++|
T Consensus       247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccchHHHHHHHHHHccCChhhCcCHHH
Confidence            1223345677999999999999999999753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-38  Score=285.96  Aligned_cols=231  Identities=23%  Similarity=0.331  Sum_probs=172.2

Q ss_pred             cccccccCCcceeeccCC-----eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeee-eeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHSN-----EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFC-SEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+....+     .||+|.+.....  ..+.+.+|+.++++++|+||+++++++ ..++..++||||+++
T Consensus        32 ~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~  111 (298)
T 3f66_A           32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  111 (298)
T ss_dssp             EEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTT
T ss_pred             eeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCC
Confidence            345556665555443222     289999875332  336789999999999999999999986 455688999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++...     ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus       112 ~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          112 GDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             CBHHHHHHCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            9999999532     2568999999999999999999999   9999999999999999999999999999987654332


Q ss_pred             c--cccccccccccccCCccc--------cCceehhHHHHHHhcCCC-CCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          263 I--VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK-NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       263 ~--~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      .  .......+|..|+|||.+        +|+||||+++|||++|.. |+.......        ....+..+..     
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~-----  250 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR-----  250 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTTCC-----
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcCCC-----
Confidence            1  122345578899999987        799999999999999554 444332211        1111211111     


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...+...+..+.+++.+||+.||++|||++|
T Consensus       251 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  281 (298)
T 3f66_A          251 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  281 (298)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence             1122334567999999999999999999854

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-38  Score=289.76  Aligned_cols=238  Identities=21%  Similarity=0.252  Sum_probs=181.2

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhc--cCCCceeeeeeeeeeCC----ceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGR--IHHFHIVRLLGFCSEGN----RRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.....++.||||++...  ..+.+.+|.+++..  ++|+||+++++++....    ..++||||++++
T Consensus        48 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g  125 (342)
T 1b6c_B           48 ESIGKGRFGEVWRGKWRGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG  125 (342)
T ss_dssp             EEEEEETTEEEEEEEETTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTC
T ss_pred             eeecCCCCcEEEEEEEcCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCC
Confidence            44566677777666666777999998633  34677889888887  78999999999998765    789999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH--------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      +|.+++..       ..+++..++.++.|++.||.|||        +   .+|+||||||+|||++.++.+||+|||++.
T Consensus       126 ~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          126 SLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             BHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999943       35899999999999999999999        7   899999999999999999999999999998


Q ss_pred             eccCCcccc--ccccccccccccCCccc--------------cCceehhHHHHHHhcC----------CCCCCcchhccc
Q 039471          256 LCSKDISIV--SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGC----------RKNNDPAVEIQS  309 (363)
Q Consensus       256 ~~~~~~~~~--~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g----------~~~~~~~~~~~~  309 (363)
                      .........  ......||..|+|||++              +|+||||+++|||++|          ..||........
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            776543221  12445689999999975              6999999999999999          566654322111


Q ss_pred             ccchHHHHHHHhhhccccccccCCC-CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          310 QIYFPEWIYNRMRLGQELCLDFEED-GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        .... +...+... ......... .....+..+.+++.+||+.||++|||++|
T Consensus       276 --~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          276 --SVEE-MRKVVCEQ-KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             --CHHH-HHHHHTTS-CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             --cHHH-HHHHHHHH-HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence              1111 11221111 111111111 23467788999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-38  Score=293.84  Aligned_cols=238  Identities=18%  Similarity=0.212  Sum_probs=172.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  178 (363)
                      ..++.+++|.+..+...  ++.||||++......   .+++.+|+.++++++|+||+++++++...      ...++|||
T Consensus        31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e  110 (367)
T 1cm8_A           31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP  110 (367)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence            34455566655554432  445999999643322   35788999999999999999999998765      34699999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+ +++|.+++..       ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       111 ~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          111 FM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            99 7899999853       358999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchH-------HHHHHHh-
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFP-------EWIYNRM-  321 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~-------~~~~~~~-  321 (363)
                      ...     ....+|..|+|||++         +|+||+||+++||++|+.||...........+.       ......+ 
T Consensus       180 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          180 SEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             SSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            432     345689999999986         799999999999999999998654322110000       0000000 


Q ss_pred             --------hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 --------RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 --------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                              ..-...............++.+.+++.+||+.||++|||++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e  304 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE  304 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence                    000000000001112344678999999999999999999753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=285.23  Aligned_cols=232  Identities=19%  Similarity=0.243  Sum_probs=178.6

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccC-----CcChhHHHHHHHHHhccCCCceeeeeeee--eeCCceeEEEec
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHL-----KGNGQEFINEVATIGRIHHFHIVRLLGFC--SEGNRRTLIYEF  179 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~e~  179 (363)
                      ...++.+++|.++.+...  +..||+|++...     ....+.+.+|+.++++++|+||+++++++  .+....++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (305)
T 2wtk_C           10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY   89 (305)
T ss_dssp             CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence            345566667666655543  334999998643     23346889999999999999999999998  455688999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++++ |.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           90 CVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             CSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             ccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            9875 777775433    2569999999999999999999999   9999999999999999999999999999987754


Q ss_pred             CccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          260 DISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ...........||..|+|||++          +|+||||+++|||++|+.||.......        ....+..+..   
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~---  230 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------LFENIGKGSY---  230 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC---
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--------HHHHHhcCCC---
Confidence            3322223455689999999976          799999999999999999997643211        2222222211   


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ..+...+..+.+++.+||+.||++|||++|
T Consensus       231 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  260 (305)
T 2wtk_C          231 ----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQ  260 (305)
T ss_dssp             ----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ----CCCCccCHHHHHHHHHHccCChhhCCCHHH
Confidence                122234567899999999999999999854

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=292.93  Aligned_cols=239  Identities=23%  Similarity=0.257  Sum_probs=176.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+...  ++.||||++....      ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   95 (346)
T 1ua2_A           16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   95 (346)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC
Confidence            44555566655555443  4459999996422      123578899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      + +|.+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        96 ~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           96 T-DLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             E-EHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             C-CHHHHHHhc-----CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            6 899888432     2568899999999999999999999   999999999999999999999999999998765432


Q ss_pred             cccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc-----
Q 039471          262 SIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL-----  327 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  327 (363)
                      ..  .....||+.|+|||++         +|+||||+++|||++|.+||.........    ..+..........     
T Consensus       167 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~----~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          167 RA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL----TRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             CC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHHHCCCCTTTSSST
T ss_pred             cc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHHcCCCChhhhhhh
Confidence            21  2345689999999987         79999999999999999998765432211    0111111000000     


Q ss_pred             -------ccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 -------CLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 -------~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                             .......     .....+..+.+++.+||+.||++|||++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  288 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  288 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence                   0000000     01234578999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.2e-38  Score=286.21  Aligned_cols=228  Identities=17%  Similarity=0.277  Sum_probs=181.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  +..||||++...  ....+.+.+|+.++++++|+||+++++++.++...++||||+++++|
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  107 (303)
T 3a7i_A           28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA  107 (303)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence            33455556555554332  445999998644  33457899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.       ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........  .
T Consensus       108 ~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  175 (303)
T 3a7i_A          108 LDLLE-------PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  175 (303)
T ss_dssp             HHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--C
T ss_pred             HHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc--c
Confidence            99983       2468999999999999999999999   9999999999999999999999999999987655432  1


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....|+..|+|||++        +|+||||+++|||++|+.||.......        ....+.....      .....
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~~  241 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--------VLFLIPKNNP------PTLEG  241 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCC------CCCCS
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--------HHHHhhcCCC------CCCcc
Confidence            2445689999999987        799999999999999999987543221        1111111111      11223


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .++..+.+++.+||+.||++|||++|
T Consensus       242 ~~~~~l~~li~~~l~~dp~~Rps~~~  267 (303)
T 3a7i_A          242 NYSKPLKEFVEACLNKEPSFRPTAKE  267 (303)
T ss_dssp             SCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHH
Confidence            44567999999999999999999854

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.8e-39  Score=291.03  Aligned_cols=236  Identities=27%  Similarity=0.378  Sum_probs=179.1

Q ss_pred             ccccccCCcceeec-------cCCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCC-ceeEEEecc
Q 039471          112 LISFNLTNSKFFFL-------HSNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGN-RRTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~  180 (363)
                      ++.+++|.++.+..       .++.||||++.....  ..+.+.+|+.++.++ +|+||+++++++...+ ..++||||+
T Consensus        35 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~  114 (316)
T 2xir_A           35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC  114 (316)
T ss_dssp             EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECC
T ss_pred             EcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcC
Confidence            44555555544432       123499999975432  235788999999999 6999999999987654 589999999


Q ss_pred             CCCCHHHHhhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEec
Q 039471          181 PNGSLQKFIFSKTNSS----------SHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  250 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~D  250 (363)
                      ++++|.+++.......          ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus       115 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~D  191 (316)
T 2xir_A          115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD  191 (316)
T ss_dssp             TTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEECC
Confidence            9999999996543210          02238999999999999999999999   9999999999999999999999999


Q ss_pred             cccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHh
Q 039471          251 FGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRM  321 (363)
Q Consensus       251 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~  321 (363)
                      ||+++...............+|..|+|||++        +|+||||+++|||++ |+.||........       ....+
T Consensus       192 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~  264 (316)
T 2xir_A          192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRL  264 (316)
T ss_dssp             CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-------HHHHH
T ss_pred             CccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-------HHHHh
Confidence            9999877654433333455678899999987        799999999999998 9999865432211       22222


Q ss_pred             hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..      ...+...++.+.+++.+||+.||++|||++|
T Consensus       265 ~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  300 (316)
T 2xir_A          265 KEGTR------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  300 (316)
T ss_dssp             HHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCcc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            22211      1122335677999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-38  Score=289.99  Aligned_cols=240  Identities=23%  Similarity=0.345  Sum_probs=181.5

Q ss_pred             ccccccccCCcceeec------cCCeeEEEEcccCCc-ChhHHHHHHHHHhccCCCceeeeeeeee--eCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFL------HSNEIAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCS--EGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+..      .+..||||++..... ..+.+.+|++++++++|+||+++++++.  +....++||||+
T Consensus        29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~  108 (327)
T 3lxl_A           29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL  108 (327)
T ss_dssp             EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECC
T ss_pred             hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeec
Confidence            3345555555554432      233499999975432 3356899999999999999999999886  456789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++....     ..+++..++.++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||++......
T Consensus       109 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          109 PSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            9999999996432     458999999999999999999999   99999999999999999999999999999887654


Q ss_pred             cccc-ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc-------ccchHHHHHHHhhhc
Q 039471          261 ISIV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS-------QIYFPEWIYNRMRLG  324 (363)
Q Consensus       261 ~~~~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  324 (363)
                      .... ......+|..|+|||++        +|+||||+++|||++|+.||........       .......+...+..+
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            3321 22345578889999987        8999999999999999999865443210       001111112222211


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            .....+..+++.+.+++.+||+.||++|||++|
T Consensus       261 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  293 (327)
T 3lxl_A          261 ------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSA  293 (327)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence                  112234456778999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.9e-38  Score=282.61  Aligned_cols=225  Identities=23%  Similarity=0.357  Sum_probs=172.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+...  ++.||||++...    ....+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (276)
T 2h6d_A           19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL   98 (276)
T ss_dssp             EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             ecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcH
Confidence            455555555544433  455999998632    33456889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.........  
T Consensus        99 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--  167 (276)
T 2h6d_A           99 FDYICKH------GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--  167 (276)
T ss_dssp             HHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCcce--
Confidence            9999543      458999999999999999999999   99999999999999999999999999999876544321  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                       ....++..|+|||.+         +|+||||+++|||++|+.||.......        ....+..+..       ..+
T Consensus       168 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~-------~~~  231 (276)
T 2h6d_A          168 -RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------LFKKIRGGVF-------YIP  231 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------CCC
T ss_pred             -ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcCcc-------cCc
Confidence             344589999999987         799999999999999999997543211        2222222211       112


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+.+++.+||+.||++|||++|
T Consensus       232 ~~~~~~l~~li~~~l~~~p~~Rps~~~  258 (276)
T 2h6d_A          232 EYLNRSVATLLMHMLQVDPLKRATIKD  258 (276)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhcCHHHHHHHHHHccCChhhCCCHHH
Confidence            334567999999999999999999854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.8e-39  Score=292.67  Aligned_cols=237  Identities=22%  Similarity=0.258  Sum_probs=168.2

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+..  .++.||||++.....   ..+.+.+|+.++++++|+||+++++++.++...++||||++ ++|
T Consensus        41 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L  119 (329)
T 3gbz_A           41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDL  119 (329)
T ss_dssp             EEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred             EEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCH
Confidence            345556665555532  344599999964332   23567899999999999999999999999999999999997 499


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-----CCCCeeEeccccceeccCC
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-----HNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-----~~~~~kl~Dfg~a~~~~~~  260 (363)
                      .+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++     .++.+||+|||+++.....
T Consensus       120 ~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          120 KKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             HHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            9999543      458999999999999999999999   9999999999999994     4555999999999876543


Q ss_pred             ccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc----
Q 039471          261 ISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL----  327 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  327 (363)
                      ...  .....||..|+|||++         +||||||+++|||++|+.||...........    +..........    
T Consensus       191 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          191 IRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK----IFEVLGLPDDTTWPG  264 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHHHCCCCTTTSTT
T ss_pred             ccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH----HHHHhCCCchhhhhh
Confidence            221  2344579999999987         7999999999999999999976544321100    11100000000    


Q ss_pred             ----------ccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          328 ----------CLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       328 ----------~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                .......     .....+.++.+++.+||+.||++|||++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  315 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN  315 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence                      0000000     01114577899999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=290.23  Aligned_cols=240  Identities=15%  Similarity=0.122  Sum_probs=172.8

Q ss_pred             ccccccccCCcceeecc-----CCeeEEEEcccCCc------------ChhHHHHHHHHHhccCCCceeeeeeeeee---
Q 039471          110 QSLISFNLTNSKFFFLH-----SNEIAVKMLEHLKG------------NGQEFINEVATIGRIHHFHIVRLLGFCSE---  169 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-----~~~vAvK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  169 (363)
                      ..++.+++|.++.+...     ...||||+......            ..+.+.+|+..++.++|+||+++++++..   
T Consensus        43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~  122 (345)
T 2v62_A           43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK  122 (345)
T ss_dssp             EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred             eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence            34566667766666553     33499999875432            22357788889999999999999999977   


Q ss_pred             -CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC--Ce
Q 039471          170 -GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF--QP  246 (363)
Q Consensus       170 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~--~~  246 (363)
                       +...++||||+ +++|.+++..      ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++  .+
T Consensus       123 ~~~~~~lv~e~~-~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          123 GRSYRFMVMERL-GIDLQKISGQ------NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             SCEEEEEEEECE-EEEHHHHCBG------GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSE
T ss_pred             CCcEEEEEEecc-CCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcE
Confidence             67899999999 8999999943      2479999999999999999999999   9999999999999999877  99


Q ss_pred             eEeccccceeccCCccc-----cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccch
Q 039471          247 KISDFGLAKLCSKDISI-----VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF  313 (363)
Q Consensus       247 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~  313 (363)
                      ||+|||+++........     .......||..|+|||++        +||||||+++|||++|+.||..........  
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--  270 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV--  270 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH--
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH--
Confidence            99999999877543221     111345689999999987        899999999999999999996533222110  


Q ss_pred             HHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 PEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .......... ..............+..+.+++.+||+.||++|||++|
T Consensus       271 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  318 (345)
T 2v62_A          271 -QTAKTNLLDE-LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQA  318 (345)
T ss_dssp             -HHHHHHHHHT-TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             -HHHHHhhccc-ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence             0011111000 00000000001135568999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-38  Score=285.16  Aligned_cols=226  Identities=21%  Similarity=0.293  Sum_probs=176.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+...  ++.||||++....   ....++.+|+..+.++ +|+||+++++++.+++..++||||++++
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   96 (289)
T 1x8b_A           17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG   96 (289)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             hhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCC
Confidence            34455566655555443  4559999987532   2345788999999999 8999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-------------------C
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-------------------F  244 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-------------------~  244 (363)
                      +|.+++.....  ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.+                   .
T Consensus        97 ~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           97 SLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             BHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------CC
T ss_pred             cHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            99999965421  12568999999999999999999999   999999999999999844                   4


Q ss_pred             CeeEeccccceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH
Q 039471          245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE  315 (363)
Q Consensus       245 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~  315 (363)
                      .+||+|||.+.......      ...||..|+|||++         +||||||+++|||++|.+++.....         
T Consensus       172 ~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------  236 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---------  236 (289)
T ss_dssp             CEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---------
T ss_pred             EEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---------
Confidence            79999999998765432      23489999999987         7999999999999999987654321         


Q ss_pred             HHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 WIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...+..+..      ...+..+++.+.+++.+||+.||++|||++|
T Consensus       237 --~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  276 (289)
T 1x8b_A          237 --WHEIRQGRL------PRIPQVLSQEFTELLKVMIHPDPERRPSAMA  276 (289)
T ss_dssp             --HHHHHTTCC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --HHHHHcCCC------CCCCcccCHHHHHHHHHHhCCCcccCCCHHH
Confidence              111211111      1222345677999999999999999999854

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-38  Score=290.53  Aligned_cols=231  Identities=21%  Similarity=0.321  Sum_probs=174.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      ..++.+++|.++.+...  ++.||||++....         .....+.+|+.++++++|+||+++++++..+. .++|||
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e   94 (322)
T 2ycf_A           16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLE   94 (322)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEE
T ss_pred             eEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEe
Confidence            34455666655555433  3449999986432         12246889999999999999999999987655 899999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC---eeEeccccce
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAK  255 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a~  255 (363)
                      |+++++|.+++.      ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.   +||+|||+++
T Consensus        95 ~~~~~~L~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           95 LMEGGELFDKVV------GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             CCTTEETHHHHS------TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            999999999983      33579999999999999999999999   99999999999999987654   9999999998


Q ss_pred             eccCCccccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      ........   ....||..|+|||++           +|+||||+++|||++|+.||........       +...+..+
T Consensus       166 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~  235 (322)
T 2ycf_A          166 ILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQITSG  235 (322)
T ss_dssp             ECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------HHHHHHHT
T ss_pred             eccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------HHHHHHhC
Confidence            87544321   334589999999984           7999999999999999999976543222       11122211


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...   .........+..+.+++.+||+.||++|||++|
T Consensus       236 ~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~  271 (322)
T 2ycf_A          236 KYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE  271 (322)
T ss_dssp             CCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccc---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHH
Confidence            110   000111234678999999999999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8e-39  Score=285.53  Aligned_cols=233  Identities=21%  Similarity=0.273  Sum_probs=178.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeee--eCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCS--EGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+...  ++.||+|++.....   ..+.+.+|+.++++++|+||+++++++.  .+...++||||+++
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   91 (279)
T 2w5a_A           12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   91 (279)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred             hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence            34455666665555443  44499999975432   3357889999999999999999999874  46789999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----ceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR-----ILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ++|.+++.....  ....+++..++.++.|++.||+|||+   .+     ++|+||||+||+++.++.+||+|||.+...
T Consensus        92 ~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           92 GDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             CCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            999999965432  23559999999999999999999999   78     999999999999999999999999999876


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ......  .....|+..|+|||++        +|+||||+++|||++|+.||.......        +...+..+..   
T Consensus       167 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~---  233 (279)
T 2w5a_A          167 NHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKF---  233 (279)
T ss_dssp             ---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC---
T ss_pred             cccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------HHHHHhhccc---
Confidence            543321  1234589999999987        899999999999999999987653221        2222222221   


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ...+..++..+.+++.+||+.||++|||++|
T Consensus       234 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  264 (279)
T 2w5a_A          234 ---RRIPYRYSDELNEIITRMLNLKDYHRPSVEE  264 (279)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---ccCCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence               1223345678999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=284.66  Aligned_cols=231  Identities=21%  Similarity=0.298  Sum_probs=180.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.++.+...  ++.||||++.... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.+
T Consensus        35 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  113 (314)
T 3com_A           35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD  113 (314)
T ss_dssp             EECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred             eeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHH
Confidence            33455555555555443  4459999997543 45789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+........  ...
T Consensus       114 ~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~  183 (314)
T 3com_A          114 IIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRN  183 (314)
T ss_dssp             HHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBC
T ss_pred             HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccC
Confidence            985332     568999999999999999999999   9999999999999999999999999999987654322  123


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...|+..|+|||++        +|+||||+++|||++|+.||........       . ..+.....    .....+..+
T Consensus       184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~-~~~~~~~~----~~~~~~~~~  251 (314)
T 3com_A          184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------I-FMIPTNPP----PTFRKPELW  251 (314)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------H-HHHHHSCC----CCCSSGGGS
T ss_pred             ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------H-HHHhcCCC----cccCCcccC
Confidence            45689999999987        7999999999999999999975433211       1 11111111    111223345


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+.+++.+||+.||++|||++|
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~  275 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQ  275 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHH
Confidence            678999999999999999999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-38  Score=299.61  Aligned_cols=183  Identities=21%  Similarity=0.297  Sum_probs=151.5

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc------CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI------HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .++.+++|.++.+...  +..||||++.......+.+.+|+++++.+      +|+||+++++++......++||||+. 
T Consensus       104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-  182 (429)
T 3kvw_A          104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-  182 (429)
T ss_dssp             EEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-
T ss_pred             EcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-
Confidence            3455555555544333  34499999986555556788899888887      46799999999999999999999996 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC--eeEeccccceeccCC
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--PKISDFGLAKLCSKD  260 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~~~~~  260 (363)
                      ++|.+++.....    ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.  +||+|||++......
T Consensus       183 ~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~  255 (429)
T 3kvw_A          183 MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR  255 (429)
T ss_dssp             CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence            699999965432    459999999999999999999999   99999999999999999887  999999999765433


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      .     ....||+.|+|||++        +|||||||++|||++|++||.....
T Consensus       256 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          256 V-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             C-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             c-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            2     345689999999987        8999999999999999999976544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=289.95  Aligned_cols=231  Identities=21%  Similarity=0.276  Sum_probs=175.6

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeee------CCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE------GNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+..  .++.||||++.......+.+.+|+.+++++ +|+||+++++++..      ....++||||++
T Consensus        31 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~  110 (326)
T 2x7f_A           31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG  110 (326)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCT
T ss_pred             EeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCC
Confidence            345555555555444  344599999987666778999999999999 79999999999976      468899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++....    ...+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus       111 ~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  183 (326)
T 2x7f_A          111 AGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  183 (326)
T ss_dssp             TEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred             CCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence            999999996542    2568999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cccccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          262 SIVSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .  ......||..|+|||++             +|+||||+++|||++|+.||........        ...+.....  
T Consensus       184 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~--  251 (326)
T 2x7f_A          184 G--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--------LFLIPRNPA--  251 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHSCC--
T ss_pred             c--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--------HHHhhcCcc--
Confidence            1  12345689999999986             6999999999999999999965433211        111111111  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .   ......++..+.+++.+||+.||++|||++|
T Consensus       252 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  283 (326)
T 2x7f_A          252 P---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQ  283 (326)
T ss_dssp             C---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             c---cCCccccCHHHHHHHHHHhccChhhCCCHHH
Confidence            0   1112334677999999999999999999753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=287.73  Aligned_cols=227  Identities=15%  Similarity=0.056  Sum_probs=176.7

Q ss_pred             ccccccccCCcceee-------ccCCeeEEEEcccCCcChhHHHHHHHHHhccC---CCceeeeeeeeeeCCceeEEEec
Q 039471          110 QSLISFNLTNSKFFF-------LHSNEIAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ..++.+++|.++.+.       ..++.||||++..  ....++.+|+.++++++   |+||+++++++..++..++||||
T Consensus        71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~  148 (365)
T 3e7e_A           71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL  148 (365)
T ss_dssp             EEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred             EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence            345666666666552       2234499999864  34567888888888887   99999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-----------CCCeeE
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----------NFQPKI  248 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-----------~~~~kl  248 (363)
                      +++|+|.+++..... .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.           ++.+||
T Consensus       149 ~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl  224 (365)
T 3e7e_A          149 YSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL  224 (365)
T ss_dssp             CCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred             cCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence            999999999965332 123679999999999999999999999   99999999999999998           899999


Q ss_pred             eccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHH
Q 039471          249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      +|||+|+...............||..|+|||++        +|||||||++|||++|+.||.........          
T Consensus       225 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------  294 (365)
T 3e7e_A          225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----------  294 (365)
T ss_dssp             CCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----------
T ss_pred             eeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----------
Confidence            999999876533222233556799999999988        79999999999999999998654332110          


Q ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                            ........   .....+.+++..|++.+|.+|++.
T Consensus       295 ------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          295 ------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             ------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             ------echhcccc---CcHHHHHHHHHHHcCCCCCCcchH
Confidence                  00000000   125568889999999999999653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.3e-38  Score=289.15  Aligned_cols=241  Identities=18%  Similarity=0.195  Sum_probs=174.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeee--------CCceeEE
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--------GNRRTLI  176 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv  176 (363)
                      ..++.+++|.++.+...  ++.||||++....   .....+.+|+.++++++|+||+++++++..        .+..++|
T Consensus        23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv  102 (351)
T 3mi9_A           23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV  102 (351)
T ss_dssp             EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred             EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence            33455555555555443  4459999986432   234578899999999999999999999876        4568999


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      |||+++ +|.+.+...     ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A          103 FDFCEH-DLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             EECCSE-EHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeccCC-CHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence            999975 888777432     2569999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccc--cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc-
Q 039471          257 CSKDISI--VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG-  324 (363)
Q Consensus       257 ~~~~~~~--~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-  324 (363)
                      .......  .......||+.|+|||++         +||||||+++|||++|+.||...........    +....... 
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~  249 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL----ISQLCGSIT  249 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHHHCCCC
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHHHhCCCC
Confidence            6532211  112345689999999976         7999999999999999999987543321110    10000000 


Q ss_pred             cc-------------ccc--ccCCCCcHH-----HHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QE-------------LCL--DFEEDGDEG-----IARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~-------------~~~--~~~~~~~~~-----~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..             ...  .........     .++.+.+++.+||+.||++|||++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  308 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD  308 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence            00             000  000000011     1456889999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-38  Score=285.28  Aligned_cols=229  Identities=21%  Similarity=0.289  Sum_probs=179.5

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCC----------cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEe
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLK----------GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      ++.+++|.++.+...  ++.||||++....          ...+.+.+|+++++++. |+||+++++++..+...++|||
T Consensus        25 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  104 (298)
T 1phk_A           25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD  104 (298)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEe
Confidence            445555555444433  3449999986432          11356789999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus       105 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A          105 LMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            99999999999543      468999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCccccccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .....   ....++..|+|||++              +|+||||+++|||++|+.||.......        ....+..+
T Consensus       176 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~  244 (298)
T 1phk_A          176 PGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMIMSG  244 (298)
T ss_dssp             TTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred             CCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HHHHHhcC
Confidence            54332   345689999999975              699999999999999999997543221        11222211


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..   .........++..+.+++.+||+.||++|||++|
T Consensus       245 ~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  280 (298)
T 1phk_A          245 NY---QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  280 (298)
T ss_dssp             CC---CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             Cc---ccCcccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            11   1111223456778999999999999999999753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.7e-38  Score=282.63  Aligned_cols=222  Identities=21%  Similarity=0.313  Sum_probs=176.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeee----------------CC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE----------------GN  171 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~  171 (363)
                      ..++.+++|.++.+...  ++.||+|++....   +.+.+|++++++++|+||+++++++..                ..
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (284)
T 2a19_B           17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK   93 (284)
T ss_dssp             EEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEE
T ss_pred             eeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcc
Confidence            34566666666665544  4559999997443   567899999999999999999998854                44


Q ss_pred             ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       172 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      ..++||||+++++|.+++....    ...+++..++.++.|++.||.|||+   .+|+|+||||+||+++.++.+||+||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           94 CLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECcc
Confidence            6899999999999999996543    2569999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      |++.........   ....|+..|+|||++        +|+||||+++|||++|..|+.....          ....+..
T Consensus       167 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~~~  233 (284)
T 2a19_B          167 GLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------FFTDLRD  233 (284)
T ss_dssp             TTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------HHHHHHT
T ss_pred             hhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----------HHHHhhc
Confidence            999887654322   345689999999987        8999999999999999988643211          1111111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +.         .+..++..+.+++.+||+.||++|||++|
T Consensus       234 ~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e  264 (284)
T 2a19_B          234 GI---------ISDIFDKKEKTLLQKLLSKKPEDRPNTSE  264 (284)
T ss_dssp             TC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cc---------ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            11         12234567899999999999999999854

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.4e-38  Score=285.61  Aligned_cols=232  Identities=20%  Similarity=0.296  Sum_probs=177.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+...  +..||+|++... ....+.+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~  104 (302)
T 2j7t_A           25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD  104 (302)
T ss_dssp             EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred             ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence            44566666666665554  444999998643 345578999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      +++....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........  ..
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  174 (302)
T 2j7t_A          105 AIMLELD-----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KR  174 (302)
T ss_dssp             HHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C-
T ss_pred             HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--cc
Confidence            9985432     569999999999999999999999   9999999999999999999999999998764322111  11


Q ss_pred             ccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          267 TAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ....||..|+|||++             +|+||||+++|||++|+.|+.......        ....+......    ..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~----~~  242 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDPP----TL  242 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCC----CC
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCCc----cc
Confidence            334689999999975             799999999999999999987643321        11111111111    11


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..++..+.+++.+||+.||++|||++|
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  272 (302)
T 2j7t_A          243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQ  272 (302)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             CCccccCHHHHHHHHHHcccChhhCCCHHH
Confidence            223455678999999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-38  Score=290.05  Aligned_cols=242  Identities=21%  Similarity=0.239  Sum_probs=184.6

Q ss_pred             cccccccccCCcceeeccCCeeEEEEcccCCcC----h--------------hHHHHHHHHHhccCCCceeeeeeeeeeC
Q 039471          109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLKGN----G--------------QEFINEVATIGRIHHFHIVRLLGFCSEG  170 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~----~--------------~~~~~E~~~l~~l~h~niv~~~~~~~~~  170 (363)
                      ...++.+++|.++.+...++.||||++......    .              +.+.+|+.++++++|+||+++++++.+.
T Consensus        36 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  115 (348)
T 2pml_X           36 IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY  115 (348)
T ss_dssp             EEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred             EEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            344567777777766665666999998632211    1              7899999999999999999999999999


Q ss_pred             CceeEEEeccCCCCHHHHhhhcC--CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          171 NRRTLIYEFMPNGSLQKFIFSKT--NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       171 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                      +..++||||+++++|.+++....  .......+++..++.++.|++.||+|||+  ..+++|+||||+||+++.++.+||
T Consensus       116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~kl  193 (348)
T 2pml_X          116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKL  193 (348)
T ss_dssp             SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSCEEE
T ss_pred             CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCcEEE
Confidence            99999999999999999832110  01114679999999999999999999996  379999999999999999999999


Q ss_pred             eccccceeccCCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHH
Q 039471          249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIY  318 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  318 (363)
                      +|||.+.......    .....|+..|+|||++          +|+||||+++|||++|+.||........       ..
T Consensus       194 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~  262 (348)
T 2pml_X          194 SDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-------LF  262 (348)
T ss_dssp             CCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-------HH
T ss_pred             ecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------HH
Confidence            9999998765442    2445689999999987          7999999999999999999976543211       22


Q ss_pred             HHhhhcccccccc------------CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          319 NRMRLGQELCLDF------------EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       319 ~~~~~~~~~~~~~------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.......            ........+..+.+++.+||+.||++|||++|
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  319 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED  319 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence            2222221110000            00011445678999999999999999999854

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-38  Score=287.62  Aligned_cols=244  Identities=19%  Similarity=0.282  Sum_probs=166.6

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+..  .++.||||++...  ....+++.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus        21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  100 (303)
T 2vwi_A           21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV  100 (303)
T ss_dssp             EECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred             heeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence            3455566665555544  3455999998643  23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          186 QKFIFSKTN--SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       186 ~~~l~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      .+++.....  ......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus       101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  177 (303)
T 2vwi_A          101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI  177 (303)
T ss_dssp             HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred             HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence            999864211  1123569999999999999999999999   99999999999999999999999999998766543211


Q ss_pred             ---cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc--
Q 039471          264 ---VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL--  329 (363)
Q Consensus       264 ---~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  329 (363)
                         .......||..|+|||++         +|+||||+++|||++|+.||........       .............  
T Consensus       178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~  250 (303)
T 2vwi_A          178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-------LMLTLQNDPPSLETG  250 (303)
T ss_dssp             ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-------HHHHHTSSCCCTTC-
T ss_pred             cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-------HHHHhccCCCccccc
Confidence               112345689999999986         7999999999999999999976543221       1111110000000  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..........+..+.+++.+||+.||++|||++|
T Consensus       251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  284 (303)
T 2vwi_A          251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE  284 (303)
T ss_dssp             ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cccchhhhhhhHHHHHHHHHHccCChhhCcCHHH
Confidence            0011122334567999999999999999999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6e-39  Score=297.00  Aligned_cols=235  Identities=22%  Similarity=0.280  Sum_probs=177.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..++.+++|.++.+...  +..||+|++....  ...+.+.+|+.++++++|+||+++++++.+++..++||||+++++|
T Consensus        39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  118 (360)
T 3eqc_A           39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL  118 (360)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence            34455566655555444  4449999987542  2236789999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      .+++...      ..+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||++.......   
T Consensus       119 ~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  186 (360)
T 3eqc_A          119 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  186 (360)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence            9999543      458999999999999999999998   6 89999999999999999999999999987654322   


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccch-----------------------
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF-----------------------  313 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~-----------------------  313 (363)
                       .....||..|+|||++        +|+||||+++|||++|+.||...........+                       
T Consensus       187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence             1345689999999987        79999999999999999999764332110000                       


Q ss_pred             ------------HHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 ------------PEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                  .+ ..+.+....     ........++..+.+++.+||++||++|||++|
T Consensus       266 ~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  321 (360)
T 3eqc_A          266 KFGMDSRPPMAIFE-LLDYIVNEP-----PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ  321 (360)
T ss_dssp             --------CCCHHH-HHHHHHHSC-----CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             ccccCCCCcccchh-hhhHHhccC-----CCCCCcccccHHHHHHHHHHhhcChhhCCCHHH
Confidence                        00 000000000     001112234667999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.8e-38  Score=281.30  Aligned_cols=237  Identities=17%  Similarity=0.199  Sum_probs=176.7

Q ss_pred             ccccccccCCcceee--ccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeee-eeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFF--LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC-SEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+.  ..++.||||+..... ..+++.+|+.++++++|++++..++.+ ..+...++||||+ +++|.
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   92 (296)
T 4hgt_A           15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE   92 (296)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             eeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHH
Confidence            445566666665554  334459999876433 335688999999999988777666655 6677889999999 89999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++........
T Consensus        93 ~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           93 DLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             HHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            9995432     469999999999999999999999   999999999999999   78899999999999887654321


Q ss_pred             -----cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 -----VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 -----~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                           .......||..|+|||++        +||||||+++|||++|+.||...........+............     
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  239 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----  239 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----
Confidence                 112345689999999987        79999999999999999999865443322222221111111000     


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ......+++.+.+++.+||+.||++|||++|
T Consensus       240 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  270 (296)
T 4hgt_A          240 --EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             --HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             --hhhhccCCHHHHHHHHHHHhcCCCCCCCHHH
Confidence              0011223578999999999999999999753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=287.25  Aligned_cols=240  Identities=23%  Similarity=0.380  Sum_probs=178.5

Q ss_pred             ccccccccCCcceeec------cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCC--ceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFL------HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGN--RRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  180 (363)
                      ..++.+++|.++.+..      .+..||||++.... ...+.+.+|+.++++++|+||+++++++....  ..++||||+
T Consensus        47 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~  126 (326)
T 2w1i_A           47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL  126 (326)
T ss_dssp             EEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCC
T ss_pred             eeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECC
Confidence            3345555555554432      23349999987543 23467899999999999999999999986543  789999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++....     ..+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++......
T Consensus       127 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          127 PYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             TTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            9999999996432     458999999999999999999999   99999999999999999999999999999887654


Q ss_pred             cccc-ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccc-------c-cchHHHHHHHhhh
Q 039471          261 ISIV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQS-------Q-IYFPEWIYNRMRL  323 (363)
Q Consensus       261 ~~~~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~-------~-~~~~~~~~~~~~~  323 (363)
                      .... ......++..|+|||++        +|+||||+++|||++|..|+........       . ......+...+..
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence            3321 12334577889999987        8999999999999999988764321100       0 0000111111111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +.      ....+..++..+.+++.+||+.||++|||++|
T Consensus       279 ~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  312 (326)
T 2w1i_A          279 NG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD  312 (326)
T ss_dssp             TC------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CC------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHH
Confidence            11      11223445678999999999999999999854

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6e-38  Score=293.68  Aligned_cols=241  Identities=21%  Similarity=0.252  Sum_probs=177.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccC--------CCceeeeeeeee----eCCceeE
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIH--------HFHIVRLLGFCS----EGNRRTL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~----~~~~~~l  175 (363)
                      ..++.+++|.++.+...  ++.||||++.......+.+.+|+.++++++        |+||+++++++.    .+...++
T Consensus        43 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~l  122 (397)
T 1wak_A           43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM  122 (397)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEE
Confidence            33455555555555332  344999999865555678899999999985        788999999987    5568999


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEcCCC----------
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNF----------  244 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~~~~----------  244 (363)
                      ||||+ +++|.+++....    ...+++..++.++.||+.||+|||+   . +|+||||||+|||++.++          
T Consensus       123 v~e~~-~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          123 VFEVL-GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EECCC-CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             EEecc-CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            99999 567777765432    2569999999999999999999999   8 999999999999999775          


Q ss_pred             ---------------------------------------CeeEeccccceeccCCccccccccccccccccCCccc----
Q 039471          245 ---------------------------------------QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----  281 (363)
Q Consensus       245 ---------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----  281 (363)
                                                             .+||+|||++.......     ....||..|+|||++    
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHHHHTSC
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChhhcCCC
Confidence                                                   79999999998765432     344689999999988    


Q ss_pred             ----cCceehhHHHHHHhcCCCCCCcchhccccc--chHHHHHHHhh--------hcccc----c---------------
Q 039471          282 ----SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--YFPEWIYNRMR--------LGQEL----C---------------  328 (363)
Q Consensus       282 ----~Di~slG~il~el~~g~~~~~~~~~~~~~~--~~~~~~~~~~~--------~~~~~----~---------------  328 (363)
                          +|||||||++|||++|+.||..........  .....+.....        .+...    .               
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence                899999999999999999997644321100  00000000000        00000    0               


Q ss_pred             ----cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 ----LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ----~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ...........+..+.+++.+||+.||++|||++|
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  388 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE  388 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence                00011235677889999999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.6e-38  Score=285.73  Aligned_cols=234  Identities=18%  Similarity=0.288  Sum_probs=168.6

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.+..  .+..||||++....    ...+++.+|+.++++++|+||+++++++.+++..++||||+++++|
T Consensus        40 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  119 (310)
T 2wqm_A           40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL  119 (310)
T ss_dssp             EECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBH
T ss_pred             ecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCH
Confidence            45555665555443  35559999987432    2235788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.....  ....+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.........  
T Consensus       120 ~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--  192 (310)
T 2wqm_A          120 SRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--  192 (310)
T ss_dssp             HHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------------
T ss_pred             HHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--
Confidence            999864321  23568999999999999999999999   99999999999999999999999999999876543221  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      .....|+..|+|||++        +|+||||+++|||++|+.||........     . ....+.....     ......
T Consensus       193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~~~-----~~~~~~  261 (310)
T 2wqm_A          193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----S-LCKKIEQCDY-----PPLPSD  261 (310)
T ss_dssp             ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-----H-HHHHHHTTCS-----CCCCTT
T ss_pred             ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-----H-HHHHhhcccC-----CCCccc
Confidence            1334589999999987        7999999999999999999875432111     1 1122221111     111123


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+.+++.+||+.||++|||++|
T Consensus       262 ~~~~~l~~li~~~l~~dp~~Rps~~~  287 (310)
T 2wqm_A          262 HYSEELRQLVNMCINPDPEKRPDVTY  287 (310)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCCCHHH
Confidence            45678999999999999999999853

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.8e-38  Score=290.22  Aligned_cols=245  Identities=18%  Similarity=0.168  Sum_probs=172.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCc-------eeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNR-------RTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~~lv~e~~  180 (363)
                      ..++.+++|.++.+...  +..||||++.........+.+|+..++.++|+||+++++++.....       .++||||+
T Consensus        29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~  108 (360)
T 3e3p_A           29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV  108 (360)
T ss_dssp             ----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence            44566666666655543  4459999997766666788899999999999999999999865433       78999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCceecCCCCCceEEcC-CCCeeEeccccceec
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH--QGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLC  257 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~  257 (363)
                      ++ +|...+....  .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|||+++..
T Consensus       109 ~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~  182 (360)
T 3e3p_A          109 PD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL  182 (360)
T ss_dssp             SC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             cc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence            86 6655543321  23367899999999999999999999  8   99999999999999996 899999999999877


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH-------HHHHHh
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE-------WIYNRM  321 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~-------~~~~~~  321 (363)
                      ......   ....||..|+|||++         +||||||+++|||++|+.||..............       .....+
T Consensus       183 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          183 SPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            654332   345689999999986         7999999999999999999987543322111000       000000


Q ss_pred             hhc-ccccc---------ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 RLG-QELCL---------DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ~~~-~~~~~---------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ... .....         ..........+..+.+++.+||+.||++|||++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  311 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE  311 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence            000 00000         0001111225678999999999999999999754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-37  Score=279.54  Aligned_cols=236  Identities=17%  Similarity=0.199  Sum_probs=176.5

Q ss_pred             cccccccCCcceee--ccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeee-eeCCceeEEEeccCCCCHHH
Q 039471          111 SLISFNLTNSKFFF--LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC-SEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       111 ~~~~~~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~~sL~~  187 (363)
                      .++.+++|.++.+.  ..++.||||++.... ..+++.+|+.++++++|++++..++.+ .++...++||||+ +++|.+
T Consensus        16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~   93 (296)
T 3uzp_A           16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLED   93 (296)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHH
T ss_pred             EEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHH
Confidence            34555555555554  234459999987543 346789999999999988766666655 6677889999999 899999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCcccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|||++..........
T Consensus        94 ~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (296)
T 3uzp_A           94 LFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  165 (296)
T ss_dssp             HHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred             HHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence            995332     469999999999999999999999   999999999999999   488899999999998876543211


Q ss_pred             -----ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          265 -----SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       265 -----~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                           ......||..|+|||++        +||||||+++|||++|+.||...........+............      
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  239 (296)
T 3uzp_A          166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI------  239 (296)
T ss_dssp             BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH------
T ss_pred             ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch------
Confidence                 12345689999999987        79999999999999999999865433222222111111111000      


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ......+++.+.+++.+||+.||++|||++|
T Consensus       240 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  270 (296)
T 3uzp_A          240 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             -HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             -HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHH
Confidence             0011234577999999999999999999753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.7e-39  Score=296.83  Aligned_cols=234  Identities=9%  Similarity=-0.020  Sum_probs=158.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc----ChhHHHHHHHHHhcc--CCCceeeee-------eeeeeC----
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG----NGQEFINEVATIGRI--HHFHIVRLL-------GFCSEG----  170 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~~----  170 (363)
                      ..++.+++|.++.+...  ++.||||++.....    ..+.+.+|+.+++.+  +||||++++       +++...    
T Consensus        68 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~  147 (371)
T 3q60_A           68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPP  147 (371)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCS
T ss_pred             eeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCC
Confidence            34556666665555433  34499999986442    234667785444444  699988755       444332    


Q ss_pred             -------------CceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCCceec
Q 039471          171 -------------NRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKL------RKIAFGVARGVEYLHQGCNQRILHF  231 (363)
Q Consensus       171 -------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i~H~  231 (363)
                                   ...++||||++ ++|.+++....     ..+++..+      ..++.||+.||+|||+   .+|+||
T Consensus       148 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHr  218 (371)
T 3q60_A          148 FAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHG  218 (371)
T ss_dssp             SSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             eeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccC
Confidence                         33799999998 89999996542     23445555      6778999999999999   999999


Q ss_pred             CCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCC
Q 039471          232 DIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNN  301 (363)
Q Consensus       232 dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~  301 (363)
                      ||||+|||++.++.+||+|||+++......     ....+|+.|+|||++          +||||||+++|||++|+.||
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998765322     134467999999987          79999999999999999999


Q ss_pred             CcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          302 DPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...........      ....................+++.+.+++.+||+.||++|||++|
T Consensus       294 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  349 (371)
T 3q60_A          294 GLVTPGIKGSW------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE  349 (371)
T ss_dssp             TBCCTTCTTCC------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred             CCcCcccccch------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            87643321100      000000000111111222355778999999999999999999853

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.9e-38  Score=284.51  Aligned_cols=233  Identities=20%  Similarity=0.251  Sum_probs=164.3

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCcCh---hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+..  .++.||||++.......   +.+.++...++.++|+||+++++++.+++..++||||++ ++
T Consensus        13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   91 (290)
T 3fme_A           13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS   91 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred             HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence            3455555655555443  34449999997543222   233445555788899999999999999999999999997 59


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      |.+++....  .....+++..++.++.|++.||+|||+   . +++||||||+||+++.++.+||+|||+++........
T Consensus        92 l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  166 (290)
T 3fme_A           92 LDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK  166 (290)
T ss_dssp             HHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred             hHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence            988875432  123679999999999999999999999   7 9999999999999999999999999999876554332


Q ss_pred             cccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          264 VSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                         ....||..|+|||++            +|+||||+++|||++|+.||........      .+....... .     
T Consensus       167 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~-~-----  231 (290)
T 3fme_A          167 ---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ------QLKQVVEEP-S-----  231 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH------HHHHHHHSC-C-----
T ss_pred             ---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH------HHHHHhccC-C-----
Confidence               334689999999994            7999999999999999999975322111      111111111 1     


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ........++.+.+++.+||+.||++|||++|
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e  263 (290)
T 3fme_A          232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE  263 (290)
T ss_dssp             CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhcChhhCcCHHH
Confidence            11112345677999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=287.93  Aligned_cols=237  Identities=22%  Similarity=0.283  Sum_probs=177.0

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeee----eCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCS----EGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+..  .++.||||++.... ...+.+.+|+.++++++|+||+++++++.    .....++||||+++
T Consensus        35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~  114 (317)
T 2buj_A           35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR  114 (317)
T ss_dssp             EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTT
T ss_pred             EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCC
Confidence            3345556665555442  34559999886432 34467899999999999999999999986    33478999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++.....  ....+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus       115 ~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  189 (317)
T 2buj_A          115 GTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE  189 (317)
T ss_dssp             CBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred             CcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence            999999965421  23679999999999999999999999   9999999999999999999999999999876542211


Q ss_pred             c-------cccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          263 I-------VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       263 ~-------~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .       .......||..|+|||++           +|+||||+++|||++|+.||..........      ...... 
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~-  262 (317)
T 2buj_A          190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV------ALAVQN-  262 (317)
T ss_dssp             SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH------HHHHHC-
T ss_pred             cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh------hHHhhc-
Confidence            0       001234579999999976           699999999999999999986543322211      111111 


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .    .........+..+.+++.+||+.||++|||++|
T Consensus       263 -~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  296 (317)
T 2buj_A          263 -Q----LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL  296 (317)
T ss_dssp             -C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -c----CCCCccccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence             0    111122345678999999999999999999853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.8e-38  Score=282.90  Aligned_cols=232  Identities=24%  Similarity=0.347  Sum_probs=170.8

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeee-------------CCceeE
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE-------------GNRRTL  175 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------------~~~~~l  175 (363)
                      .++.+++|.++.+..  .+..||||++.......+.+.+|+.++++++|+||+++++++.+             ....++
T Consensus        13 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~l   92 (303)
T 1zy4_A           13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFI   92 (303)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEE
T ss_pred             eeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEE
Confidence            345555655555543  34459999997655556788999999999999999999998854             357899


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ||||+++++|.+++....     ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.
T Consensus        93 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  164 (303)
T 1zy4_A           93 QMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAK  164 (303)
T ss_dssp             EEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred             EEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence            999999999999996432     468899999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCcc------------ccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchH
Q 039471          256 LCSKDIS------------IVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFP  314 (363)
Q Consensus       256 ~~~~~~~------------~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~  314 (363)
                      .......            ........||..|+|||++         +|+||||+++|||++   |+........     
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~-----  236 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN-----  236 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-----
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH-----
Confidence            7643211            0112345689999999986         799999999999998   4433221111     


Q ss_pred             HHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          315 EWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ....+...   ............+..+.+++.+||+.||++|||++|
T Consensus       237 --~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  280 (303)
T 1zy4_A          237 --ILKKLRSV---SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART  280 (303)
T ss_dssp             --HHHHHHST---TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --HHHhcccc---ccccCccccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence              11222211   111222334455677899999999999999999753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-38  Score=295.54  Aligned_cols=242  Identities=19%  Similarity=0.213  Sum_probs=173.0

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeee------------------
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE------------------  169 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------------------  169 (363)
                      ..++.+++|.++.+..  .++.||||++......   ..+|+.+++.++|+||+++++++..                  
T Consensus        13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~   89 (383)
T 3eb0_A           13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKL   89 (383)
T ss_dssp             EEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-----------------
T ss_pred             EEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccc
Confidence            3345555555554433  2445999998754332   2379999999999999999999843                  


Q ss_pred             --------------------CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 039471          170 --------------------GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRIL  229 (363)
Q Consensus       170 --------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~  229 (363)
                                          +...++||||++ ++|.+.+....  .....+++..++.++.||+.||+|||+   .+|+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi~  163 (383)
T 3eb0_A           90 GGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHS---LGIC  163 (383)
T ss_dssp             --------------------CCEEEEEECCCS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEE
T ss_pred             cccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH---CcCc
Confidence                                334889999998 58888775432  123679999999999999999999999   9999


Q ss_pred             ecCCCCCceEEc-CCCCeeEeccccceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCC
Q 039471          230 HFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRK  299 (363)
Q Consensus       230 H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~  299 (363)
                      ||||||+|||++ .++.+||+|||+++........   ....+|..|+|||++         +|+||+||++|||++|+.
T Consensus       164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            999999999998 6889999999999977554432   345689999999976         799999999999999999


Q ss_pred             CCCcchhcccccchHH--------HHHHHhhhcccccc-c-----cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          300 NNDPAVEIQSQIYFPE--------WIYNRMRLGQELCL-D-----FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       300 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ||...........+..        .+............ .     .....+...+..+.+++.+||+.||++|||++|
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            9987544332111100        00000000000000 0     000122235667999999999999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-37  Score=285.25  Aligned_cols=239  Identities=18%  Similarity=0.255  Sum_probs=178.3

Q ss_pred             ccccccCCcceeec---cCCeeEEEEcccCCcChhHHHHHHHHHhccCCCc------eeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFL---HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFH------IVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+..   .+..||||+++......+.+.+|+.++++++|++      ++++++++...+..++||||+ +
T Consensus        22 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  100 (339)
T 1z57_A           22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-G  100 (339)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-C
T ss_pred             EecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-C
Confidence            45555555554432   2344999999865555678889999999987664      999999999999999999999 7


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-------------------C
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-------------------N  243 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-------------------~  243 (363)
                      ++|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.                   +
T Consensus       101 ~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~  173 (339)
T 1z57_A          101 LSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN  173 (339)
T ss_dssp             CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESC
T ss_pred             CCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccccccccC
Confidence            899999965432    468999999999999999999999   99999999999999987                   6


Q ss_pred             CCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc---
Q 039471          244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY---  312 (363)
Q Consensus       244 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~---  312 (363)
                      +.+||+|||+++......     ....||..|+|||++        +|+||||+++|||++|+.||...........   
T Consensus       174 ~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  248 (339)
T 1z57_A          174 PDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER  248 (339)
T ss_dssp             CCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred             CCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            689999999998754432     345689999999987        8999999999999999999976543221100   


Q ss_pred             ----hHHHHHHHhhhccc----------------------cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          313 ----FPEWIYNRMRLGQE----------------------LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       313 ----~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .+............                      .............++.+.+++.+||+.||++|||++|
T Consensus       249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  325 (339)
T 1z57_A          249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE  325 (339)
T ss_dssp             HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence                01111010000000                      0000011123456788999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.3e-38  Score=290.63  Aligned_cols=241  Identities=20%  Similarity=0.255  Sum_probs=174.0

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+...  +..||||++.....  ..+.+.+|++++++++|+||+++++++...     ...++||||++ 
T Consensus        35 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-  113 (364)
T 3qyz_A           35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-  113 (364)
T ss_dssp             EEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-
T ss_pred             eecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-
Confidence            444555544444322  33499999974332  236788999999999999999999998654     46899999997 


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       114 ~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          114 TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            599999843       458999999999999999999999   9999999999999999999999999999987764432


Q ss_pred             cc-ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH-------HHHhhh--
Q 039471          263 IV-SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI-------YNRMRL--  323 (363)
Q Consensus       263 ~~-~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~-------~~~~~~--  323 (363)
                      .. ......||+.|+|||++         +|+||||+++|||++|+.||................       ......  
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  263 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  263 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence            21 12345689999999976         699999999999999999997654332211000000       000000  


Q ss_pred             cccc--ccccCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQEL--CLDFEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~--~~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....  .......     .....+.++.+++.+||++||++|||++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  310 (364)
T 3qyz_A          264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ  310 (364)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            0000  0000000     11234567999999999999999999754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-37  Score=295.17  Aligned_cols=236  Identities=22%  Similarity=0.219  Sum_probs=168.1

Q ss_pred             ccccccCCccee-eccCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHh
Q 039471          112 LISFNLTNSKFF-FLHSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       112 ~~~~~~~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l  189 (363)
                      ++.+++|.+.+. ...++.||||++...  ..+.+.+|+.+++++ +||||+++++++.++...++||||+. |+|.+++
T Consensus        23 LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l   99 (434)
T 2rio_A           23 LGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLV   99 (434)
T ss_dssp             EEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHH
T ss_pred             EeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHH
Confidence            566666665332 234556999998643  345678999999876 89999999999999999999999996 6999999


Q ss_pred             hhcCCCCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-------------CCeeEeccccce
Q 039471          190 FSKTNSSSH-RQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-------------FQPKISDFGLAK  255 (363)
Q Consensus       190 ~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-------------~~~kl~Dfg~a~  255 (363)
                      ......... ...++..++.++.||+.||+|||+   .+|+||||||+|||++.+             +.+||+|||+++
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~  176 (434)
T 2rio_A          100 ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK  176 (434)
T ss_dssp             HTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCE
T ss_pred             hccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccce
Confidence            654321111 112344567899999999999999   999999999999999754             479999999999


Q ss_pred             eccCCcccc--ccccccccccccCCccc---------------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHH
Q 039471          256 LCSKDISIV--SRTAARGTSGYIAPELF---------------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWI  317 (363)
Q Consensus       256 ~~~~~~~~~--~~~~~~gt~~y~aPE~~---------------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~  317 (363)
                      .........  ......||+.|+|||++               +|||||||++|||++ |+.||........        
T Consensus       177 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------  248 (434)
T 2rio_A          177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--------  248 (434)
T ss_dssp             ECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--------
T ss_pred             ecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--------
Confidence            876543211  12345699999999976               799999999999998 8999865432211        


Q ss_pred             HHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 YNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        .+..+..............++.++.+++.+||+.||++|||++|
T Consensus       249 --~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          249 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             --HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             --HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence              11111111111222345678899999999999999999999853

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-37  Score=289.47  Aligned_cols=239  Identities=20%  Similarity=0.229  Sum_probs=166.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCC------ceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGN------RRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e  178 (363)
                      ..++.+++|.+..+...  ++.||||++.....   ..+.+.+|+.+++.++|+||+++++++....      ..++|||
T Consensus        31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e  110 (371)
T 2xrw_A           31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME  110 (371)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred             eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence            33455555555444332  44599999975332   2357889999999999999999999987654      7899999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+++ +|.+++.        ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       111 ~~~~-~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          111 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCSE-EHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             cCCC-CHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            9974 8888883        358999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHH-----
Q 039471          259 KDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWI-----  317 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~-----  317 (363)
                      ....   .....||..|+|||++        +|+||||+++|||++|+.||..........        ..+++.     
T Consensus       179 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          179 TSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             cccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            4322   1345689999999987        899999999999999999997654322100        000000     


Q ss_pred             --HHHhhhccc------------cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 --YNRMRLGQE------------LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 --~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        .........            .............+..+.+++.+||+.||++|||++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e  315 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE  315 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH
Confidence              000000000            0000001112344778999999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=291.46  Aligned_cols=236  Identities=17%  Similarity=0.097  Sum_probs=175.3

Q ss_pred             ccccccCCcceeecc----------CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceee---------------eeee
Q 039471          112 LISFNLTNSKFFFLH----------SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVR---------------LLGF  166 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~----------~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------~~~~  166 (363)
                      ++.+++|.++.+...          +..||||++...    +.+.+|++++++++|+||++               ++++
T Consensus        50 lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~  125 (352)
T 2jii_A           50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF  125 (352)
T ss_dssp             EEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEE
T ss_pred             ecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhc
Confidence            355566665555443          345999998743    57889999999999999988               5667


Q ss_pred             eee-CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-
Q 039471          167 CSE-GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-  244 (363)
Q Consensus       167 ~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-  244 (363)
                      +.. +...++||||+ +++|.+++....    ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++ 
T Consensus       126 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          126 GVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             EEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEETTEE
T ss_pred             cccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcCCCC
Confidence            665 67889999999 999999996442    2579999999999999999999999   9999999999999999998 


Q ss_pred             -CeeEeccccceeccCCcccc-----ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccc
Q 039471          245 -QPKISDFGLAKLCSKDISIV-----SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ  310 (363)
Q Consensus       245 -~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~  310 (363)
                       .+||+|||+++.........     ......||..|+|||++        +|+||||+++|||++|+.||.........
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  277 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED  277 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence             89999999998765432211     11334689999999987        89999999999999999999865422211


Q ss_pred             cchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          311 IYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...... ..... ..............++.+.+++.+||+.||++|||++|
T Consensus       278 --~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  326 (352)
T 2jii_A          278 --IMKQKQ-KFVDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM  326 (352)
T ss_dssp             --HHHHHH-HHHHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             --HHHHHH-hccCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence              111111 11100 00000011111234678999999999999999999853

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.4e-38  Score=281.27  Aligned_cols=232  Identities=23%  Similarity=0.312  Sum_probs=172.0

Q ss_pred             ccccccccCCcceeecc---CC--eeEEEEcccCC----cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH---SN--EIAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~---~~--~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.+...   ++  .||||++....    ...+.+.+|+.++++++|+||+++++++..+. .++|+||+
T Consensus        24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~  102 (291)
T 1u46_A           24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA  102 (291)
T ss_dssp             EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred             eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence            33456666666555432   12  38999986432    23468899999999999999999999998765 88999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++....     ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus       103 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A          103 PLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             TTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             cCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            9999999996432     458999999999999999999999   99999999999999999999999999999887654


Q ss_pred             cccc-ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          261 ISIV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       261 ~~~~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .... ......+|..|+|||++        +|+||||+++|||++ |+.||.......        ....+.....    
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~----  242 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGE----  242 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCC----
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHccCC----
Confidence            3221 12334577889999988        899999999999999 999987653321        1222221111    


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ....+..++..+.+++.+||+.||++|||++|
T Consensus       243 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  274 (291)
T 1u46_A          243 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA  274 (291)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCCCcCcCHHHHHHHHHHccCCcccCcCHHH
Confidence             11223345678999999999999999999853

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=292.12  Aligned_cols=190  Identities=20%  Similarity=0.261  Sum_probs=141.1

Q ss_pred             cccccccCCcceeecc----CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeee--eCCceeEEEeccCCCC
Q 039471          111 SLISFNLTNSKFFFLH----SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS--EGNRRTLIYEFMPNGS  184 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~----~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~s  184 (363)
                      +++.+++|.++.+...    +..||||++.... ..+.+.+|+.++++++|+||+++++++.  .+...++||||++ ++
T Consensus        28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~  105 (405)
T 3rgf_A           28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HD  105 (405)
T ss_dssp             CCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EE
T ss_pred             EeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CC
Confidence            3566666666665533    3349999997443 4467889999999999999999999995  4678999999996 58


Q ss_pred             HHHHhhhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE----cCCCCeeEeccccceec
Q 039471          185 LQKFIFSKTN---SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLC  257 (363)
Q Consensus       185 L~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill----~~~~~~kl~Dfg~a~~~  257 (363)
                      |.+++.....   ......+++..++.++.||+.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++..
T Consensus       106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  182 (405)
T 3rgf_A          106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  182 (405)
T ss_dssp             HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred             HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence            8888753221   1122359999999999999999999999   999999999999999    67889999999999876


Q ss_pred             cCCccc-cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcch
Q 039471          258 SKDISI-VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       258 ~~~~~~-~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                      ...... .......||..|+|||++         +|||||||++|||++|+.||....
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            543211 122445689999999987         799999999999999999997543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.5e-38  Score=280.56  Aligned_cols=230  Identities=23%  Similarity=0.330  Sum_probs=179.5

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .++.+++|.++.+...  ++.||||++...   ....+.+.+|++++++++|+||+++++++.+.+..++||||+++++|
T Consensus        29 ~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  108 (287)
T 2wei_A           29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL  108 (287)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCH
Confidence            3455555555554432  445999998643   33557899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC---CCeeEeccccceeccCCcc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .+++...      ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.+   +.+||+|||++........
T Consensus       109 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          109 FDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            9988543      458999999999999999999999   999999999999999754   4699999999987654432


Q ss_pred             ccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          263 IVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      .   ....++..|+|||++       +|+||||+++|+|++|+.||.......        +...+..+...   .....
T Consensus       180 ~---~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~---~~~~~  245 (287)
T 2wei_A          180 M---KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYA---FDLPQ  245 (287)
T ss_dssp             C---SCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC---CCSGG
T ss_pred             c---ccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCC---CCchh
Confidence            2   334588999999987       799999999999999999997653321        22222222111   11112


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+++.+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~~~~~~li~~~l~~dp~~Rps~~e  273 (287)
T 2wei_A          246 WRTISDDAKDLIRKMLTFHPSLRITATQ  273 (287)
T ss_dssp             GTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhcCHHHHHHHHHHcccChhhCcCHHH
Confidence            2345678999999999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-38  Score=295.11  Aligned_cols=242  Identities=18%  Similarity=0.159  Sum_probs=172.0

Q ss_pred             ccccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC------ceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN------RRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+.... +.||+|++......   ..+|+.+++.++|+||+++++++....      ..++||||+++
T Consensus        46 ~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~  122 (394)
T 4e7w_A           46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE  122 (394)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE
T ss_pred             EEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc
Confidence            445666666666555433 34999988644322   237999999999999999999985543      37899999986


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEeccccceeccCCc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ++.+.+....  .....+++..++.++.||+.||+|||+   .+|+||||||+|||++ .++.+||+|||+++......
T Consensus       123 -~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~  196 (394)
T 4e7w_A          123 -TVYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE  196 (394)
T ss_dssp             -EHHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             -cHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence             4444443211  123679999999999999999999999   9999999999999999 79999999999998875544


Q ss_pred             cccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH--------HHHHhhhc
Q 039471          262 SIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW--------IYNRMRLG  324 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~--------~~~~~~~~  324 (363)
                      ..   ....+|..|+|||++         +|||||||++|||++|+.||...........+...        +.......
T Consensus       197 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          197 PN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             CC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             CC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            32   345689999999986         79999999999999999999875543221111100        00000000


Q ss_pred             cccc-cccCC-----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELC-LDFEE-----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~-~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .... .....     ......++++.+++.+||+.||++|||+.|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (394)
T 4e7w_A          274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE  318 (394)
T ss_dssp             SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHH
Confidence            0000 00000     011235678999999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-38  Score=296.96  Aligned_cols=225  Identities=14%  Similarity=0.133  Sum_probs=164.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHHHH---HHHhccCCCceeeee-------eeeeeCC--
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFINEV---ATIGRIHHFHIVRLL-------GFCSEGN--  171 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~~~--  171 (363)
                      ..++.+++|.++.+...  ++.||||++...    ....+.+.+|+   +.+++++||||++++       +++.+.+  
T Consensus        79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  158 (377)
T 3byv_A           79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK  158 (377)
T ss_dssp             EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred             ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence            44566666666555533  455999999632    22346788999   555566799999998       5555443  


Q ss_pred             ---------------ceeEEEeccCCCCHHHHhhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCC
Q 039471          172 ---------------RRTLIYEFMPNGSLQKFIFSKTN-SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP  235 (363)
Q Consensus       172 ---------------~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp  235 (363)
                                     ..+++|||+ +|+|.+++..... ......+++..+..++.||+.||+|||+   .+|+||||||
T Consensus       159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDikp  234 (377)
T 3byv_A          159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP  234 (377)
T ss_dssp             SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred             cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence                           378999999 5799999965321 1112345568899999999999999999   9999999999


Q ss_pred             CceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc-------------------cCceehhHHHHHHhc
Q 039471          236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-------------------SRNFCYGMMLLEMVG  296 (363)
Q Consensus       236 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-------------------~Di~slG~il~el~~  296 (363)
                      +|||++.++.+||+|||+++.....     .....| ..|+|||++                   +||||||+++|||++
T Consensus       235 ~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          235 VDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            9999999999999999999864431     134457 899999985                   599999999999999


Q ss_pred             CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       297 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      |+.||.........        ..+.           .....+++.+.+++.+||+.||++|||++|
T Consensus       309 g~~Pf~~~~~~~~~--------~~~~-----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          309 ADLPITKDAALGGS--------EWIF-----------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             SSCCC------CCS--------GGGG-----------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             CCCCCcccccccch--------hhhh-----------hhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            99999764432211        0000           011234567999999999999999999854

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.1e-38  Score=290.74  Aligned_cols=238  Identities=18%  Similarity=0.263  Sum_probs=159.0

Q ss_pred             ccccccccCCcceeec--cCCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEe
Q 039471          110 QSLISFNLTNSKFFFL--HSNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  178 (363)
                      ..++.+++|.++.+..  .+..||||++.....   ..+++.+|++++++++|+||+++++++...      ...++++|
T Consensus        35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e  114 (367)
T 2fst_X           35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  114 (367)
T ss_dssp             EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred             eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence            4455556665555432  244599999964332   235788999999999999999999998653      56799999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ++ +++|.+++..       ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       115 ~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          115 LM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             cc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            99 6899998832       469999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH-------HHHhh
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI-------YNRMR  322 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~-------~~~~~  322 (363)
                      ...     ....||..|+|||++         +|+|||||++|||++|+.||...........+...+       ...+.
T Consensus       184 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          184 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             ccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            321     345689999999976         799999999999999999997654322110000000       00000


Q ss_pred             hc--c---ccccccCCCC----cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 LG--Q---ELCLDFEEDG----DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~~--~---~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..  .   ..........    ....++.+.+++.+||+.||++|||++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e  308 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ  308 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence            00  0   0000000000    1123567899999999999999999753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-37  Score=284.31  Aligned_cols=230  Identities=21%  Similarity=0.243  Sum_probs=151.7

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHH-HHhccCCCceeeeeeeeee----CCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVA-TIGRIHHFHIVRLLGFCSE----GNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  ++.||||++....    ...+|+. .++.++|+||+++++++..    +...++||||+++|+
T Consensus        37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~  112 (336)
T 3fhr_A           37 LGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE  112 (336)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEE
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCC
Confidence            456666666555444  4559999986432    2233333 3556689999999999875    456899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++....    ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++......
T Consensus       113 L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~  185 (336)
T 3fhr_A          113 LFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA  185 (336)
T ss_dssp             HHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence            999996432    2569999999999999999999999   99999999999999986   4559999999998765432


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .    ....+|+.|+|||++        +|+||||+++|||++|+.||...........    ....+..+   ......
T Consensus       186 ~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~---~~~~~~  254 (336)
T 3fhr_A          186 L----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRLG---QYGFPN  254 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCT
T ss_pred             c----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhcc---ccccCc
Confidence            2    345589999999998        7999999999999999999976543221100    01111111   111112


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....++..+.+++.+||+.||++|||++|
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  284 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQ  284 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            222356778999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.1e-38  Score=296.49  Aligned_cols=242  Identities=19%  Similarity=0.211  Sum_probs=172.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeC------CceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------NRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+...  ++.||||++.....   .+.+|++++++++|+||+++++++...      ...++||||++
T Consensus        60 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~  136 (420)
T 1j1b_A           60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  136 (420)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC
T ss_pred             eEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc
Confidence            34566666666665553  44599999864432   234799999999999999999998532      23679999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC-CCeeEeccccceeccCC
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD  260 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~-~~~kl~Dfg~a~~~~~~  260 (363)
                      + +|.+.+....  .....+++..++.++.||+.||+|||+   .+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus       137 ~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          137 E-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             E-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             c-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            5 7777664321  123679999999999999999999999   999999999999999965 56899999999976554


Q ss_pred             ccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHH----HHHhhhc---
Q 039471          261 ISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWI----YNRMRLG---  324 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~---  324 (363)
                      ...   ....||..|+|||++         +|||||||++|||++|+.||...........+...+    .+.+...   
T Consensus       211 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~  287 (420)
T 1j1b_A          211 EPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  287 (420)
T ss_dssp             CCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred             CCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            332   345689999999987         699999999999999999998754332211110000    0000000   


Q ss_pred             -cccccc-cCCC-----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 -QELCLD-FEED-----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 -~~~~~~-~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...... ....     .....+.++.+|+.+||+.||++|||+.|
T Consensus       288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e  333 (420)
T 1j1b_A          288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE  333 (420)
T ss_dssp             CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHH
Confidence             000000 0000     11234678999999999999999999753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.6e-38  Score=289.10  Aligned_cols=239  Identities=19%  Similarity=0.197  Sum_probs=166.1

Q ss_pred             ccccccccCCcceeec-cCCeeEEEEcccCCcC------------hhHHHHHHHHHhccCCCceeeeeeeeee-----CC
Q 039471          110 QSLISFNLTNSKFFFL-HSNEIAVKMLEHLKGN------------GQEFINEVATIGRIHHFHIVRLLGFCSE-----GN  171 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-~~~~vAvK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~  171 (363)
                      ..++.+++|.++.+.. .+..||||++......            .+.+.+|++++++++|+||+++++++..     ..
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (362)
T 3pg1_A           28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH  107 (362)
T ss_dssp             EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred             EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence            3445555555554432 2445999998643221            1678999999999999999999999843     34


Q ss_pred             ceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecc
Q 039471          172 RRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  251 (363)
Q Consensus       172 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Df  251 (363)
                      ..++||||++ ++|.+++...     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       108 ~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          108 KLYLVTELMR-TDLAQVIHDQ-----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             EEEEEEECCS-EEHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eEEEEEccCC-CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEec
Confidence            6899999997 5888888532     2579999999999999999999999   99999999999999999999999999


Q ss_pred             ccceeccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH-------
Q 039471          252 GLAKLCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE-------  315 (363)
Q Consensus       252 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~-------  315 (363)
                      |+++........   ....||..|+|||++         +|+||||+++|||++|+.||.............+       
T Consensus       179 g~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          179 NLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             TC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             Cccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            999865443322   345689999999976         7999999999999999999976543221100000       


Q ss_pred             --HH-------HHHhhhccccccccCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 --WI-------YNRMRLGQELCLDFEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 --~~-------~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        +.       ...+.   .........    .....++.+.+++.+||+.||++|||++|
T Consensus       256 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  313 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLR---NSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ  313 (362)
T ss_dssp             HHHHHTSCHHHHHHTT---TCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHhhhccchhhhHHHH---hhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence              00       00000   000000000    11233567999999999999999999754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-37  Score=305.91  Aligned_cols=230  Identities=22%  Similarity=0.353  Sum_probs=175.4

Q ss_pred             ccccccccCCcceeeccC-----CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHS-----NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-----~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..++.+++|.++.+....     ..||||++.....  ..+.|.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus       396 ~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~  474 (656)
T 2j0j_A          396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTL  474 (656)
T ss_dssp             EEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             eEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCC
Confidence            335666666665554422     1299999874332  23678999999999999999999999854 568999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       475 g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          475 GELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             CBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            99999996432     468999999999999999999999   9999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      . ......+|+.|+|||++        +|+||||+++|||++ |..||.......        ....+..+...      
T Consensus       547 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~------  611 (656)
T 2j0j_A          547 Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERL------  611 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHHTCCC------
T ss_pred             e-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCCC------
Confidence            2 12334567899999987        899999999999997 889987643321        22222222211      


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+++.+.+++.+||+.||++|||++|
T Consensus       612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~e  641 (656)
T 2j0j_A          612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  641 (656)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            223345678999999999999999999854

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.5e-37  Score=282.28  Aligned_cols=239  Identities=17%  Similarity=0.254  Sum_probs=176.3

Q ss_pred             ccccccCCcceeecc--C-CeeEEEEcccCCcChhHHHHHHHHHhccCCCc------eeeeeeeeeeCCceeEEEeccCC
Q 039471          112 LISFNLTNSKFFFLH--S-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFH------IVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ++.+++|.++.+...  + ..||||++.......+.+.+|+.++++++|++      ++.+++++...+..++||||+ +
T Consensus        27 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~  105 (355)
T 2eu9_A           27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-G  105 (355)
T ss_dssp             EEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-C
Confidence            445555555444322  2 35999999765555678889999999998766      899999999999999999999 5


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE-------------------cCC
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-------------------DHN  243 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill-------------------~~~  243 (363)
                      ++|.+++....    ...+++..++.++.||+.||+|||+   .+|+||||||+|||+                   +.+
T Consensus       106 ~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  178 (355)
T 2eu9_A          106 KNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN  178 (355)
T ss_dssp             CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC
T ss_pred             CChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccccCC
Confidence            67777775432    2469999999999999999999999   999999999999999                   667


Q ss_pred             CCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc---
Q 039471          244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY---  312 (363)
Q Consensus       244 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~---  312 (363)
                      +.+||+|||+++......     ....||..|+|||++        +|+||||+++|||++|+.||...........   
T Consensus       179 ~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          179 TSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             CCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            899999999998754432     345689999999987        8999999999999999999976543221100   


Q ss_pred             ----hHHHHHHHhhhccc----------------------cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          313 ----FPEWIYNRMRLGQE----------------------LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       313 ----~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .+............                      .............+..+.+++.+||+.||++|||++|
T Consensus       254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  330 (355)
T 2eu9_A          254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE  330 (355)
T ss_dssp             HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence                11111111000000                      0000011223355678999999999999999999854

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.6e-37  Score=285.53  Aligned_cols=237  Identities=19%  Similarity=0.236  Sum_probs=170.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCce------eEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNRR------TLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e  178 (363)
                      ..++.+++|.++.+...  ++.||||++......   .+++.+|+.++++++|+||+++++++......      ++|||
T Consensus        48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e  127 (371)
T 4exu_A           48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP  127 (371)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence            34556666655555433  445999999754332   35788999999999999999999999876654      99999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+. ++|.+++.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       128 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          128 FMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             ccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            997 68988872        459999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHhh
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRMR  322 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~  322 (363)
                      ...     ....||..|+|||++         +|+||||+++|||++|+.||...............       ....+.
T Consensus       196 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          196 AEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            332     345689999999976         79999999999999999999765432211000000       000000


Q ss_pred             hc------cccccccCC---CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 LG------QELCLDFEE---DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~~------~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..      +........   ......++.+.+++.+||++||++|||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  320 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ  320 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH
Confidence            00      000000000   011234678999999999999999999854

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.5e-37  Score=285.60  Aligned_cols=186  Identities=23%  Similarity=0.232  Sum_probs=149.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccC-CC-----ceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIH-HF-----HIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..++.+++|.++.+...  ++.||||+++......+++.+|+.+++.++ |+     +|+++++++...+..++||||++
T Consensus        60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~  139 (382)
T 2vx3_A           60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS  139 (382)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC
Confidence            33455566555555433  344999999855444567788999888875 44     59999999999999999999996


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc--CCCCeeEeccccceeccC
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~~  259 (363)
                       ++|.+++.....    ..+++..+..++.|++.||.|||+. +.+|+||||||+|||++  .++.+||+|||+++....
T Consensus       140 -~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          140 -YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             -CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             -CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence             599999965432    4589999999999999999999941 17899999999999995  477899999999988754


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchh
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~  306 (363)
                      ..     ....||+.|+|||++        +|||||||++|||++|+.||.....
T Consensus       214 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          214 RI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            32     345689999999987        8999999999999999999986543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.8e-37  Score=279.13  Aligned_cols=239  Identities=24%  Similarity=0.323  Sum_probs=176.6

Q ss_pred             ccccccccCCcceeecc---CCeeEEEEcccCC---cChhHHHHHHHHHhcc---CCCceeeeeeeee-----eCCceeE
Q 039471          110 QSLISFNLTNSKFFFLH---SNEIAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCS-----EGNRRTL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~---~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~~~l  175 (363)
                      ..++.+++|.++.+...   ++.||||++....   .....+.+|+.+++++   +|+||+++++++.     .....++
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   96 (326)
T 1blx_A           17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   96 (326)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence            34455566665555432   3349999986432   2335677888888777   7999999999987     5568899


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      ||||++ ++|.+++.....    ..+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||+++
T Consensus        97 v~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           97 VFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            999997 699999965432    458999999999999999999999   999999999999999999999999999998


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc-
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE-  326 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  326 (363)
                      .......   .....||..|+|||++        +|+||||+++|||++|+.||.........    ..+......... 
T Consensus       169 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~  241 (326)
T 1blx_A          169 IYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL----GKILDVIGLPGEE  241 (326)
T ss_dssp             CCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCCCCGG
T ss_pred             cccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHHHcCCCCcc
Confidence            7654322   2445689999999987        79999999999999999999865443211    111111100000 


Q ss_pred             -c--------------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 -L--------------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 -~--------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .              ...........++..+.+++.+||+.||++|||++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  293 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  293 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence             0              000001122345678999999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-37  Score=286.62  Aligned_cols=242  Identities=19%  Similarity=0.191  Sum_probs=172.8

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~  181 (363)
                      .++.+++|.++.+...  ++.||||++.....  ...++.+|+.++++++|+||+++++++...     ...++||||+.
T Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~   97 (353)
T 2b9h_A           18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ   97 (353)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS
T ss_pred             EEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC
Confidence            3455555555555443  44499999964332  235788999999999999999999987654     67899999997


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                       ++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 -~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           98 -TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             -EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             -ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence             599999843       458999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccc--------ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH--------
Q 039471          262 SIV--------SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW--------  316 (363)
Q Consensus       262 ~~~--------~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~--------  316 (363)
                      ...        ......||..|+|||++         +|+||||+++|||++|+.||...............        
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence            211        11234689999999976         79999999999999999999765432210000000        


Q ss_pred             ---------HHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          317 ---------IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       317 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                               .......-...............++.+.+++.+||+.||++|||++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE  302 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence                     00000000000000000011245677899999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-37  Score=290.86  Aligned_cols=231  Identities=21%  Similarity=0.209  Sum_probs=167.7

Q ss_pred             ccccccccCCcc-eeeccCCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSK-FFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~-~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..++.+++|.+. .....++.||||++...  ....+.+|+.+++++ +|+||+++++++.+....++||||++ |+|.+
T Consensus        30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~  106 (432)
T 3p23_A           30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPE--CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE  106 (432)
T ss_dssp             EEEEECGGGCEEEEEESSSSEEEEEEECTT--TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred             CeeecCcCEEEEEEEEeCCeEEEEEEECHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHH
Confidence            345677777642 23345666999998643  234567899999999 79999999999999999999999996 59999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-----CCCeeEeccccceeccCCcc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----NFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      ++....     ..+.+..+..++.||+.||+|||+   .+|+||||||+|||++.     ...+||+|||+++.......
T Consensus       107 ~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          107 YVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             HHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             HHHhcC-----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            996433     334455677899999999999999   99999999999999953     33578999999987764422


Q ss_pred             c-cccccccccccccCCccc-----------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          263 I-VSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       263 ~-~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      . .......||+.|+|||++           +|||||||++|||++ |..||........         .... +.....
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~---------~~~~-~~~~~~  248 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA---------NILL-GACSLD  248 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH---------HHHT-TCCCCT
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH---------HHHh-ccCCcc
Confidence            1 122445699999999987           699999999999999 8888854322111         1111 111000


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ........+..+.+++.+||+.||++|||++|
T Consensus       249 --~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  280 (432)
T 3p23_A          249 --CLHPEKHEDVIARELIEKMIAMDPQKRPSAKH  280 (432)
T ss_dssp             --TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             --ccCccccccHHHHHHHHHHHhCCHhhCCCHHH
Confidence              11122345677899999999999999999853

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-37  Score=283.98  Aligned_cols=218  Identities=26%  Similarity=0.329  Sum_probs=173.7

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCCc-------ChhHHHHHHHHHhccC--CCceeeeeeeeeeCCceeEEEecc
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLKG-------NGQEFINEVATIGRIH--HFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ++.+++|.++.+..  .+..||||++.....       ..+.+.+|+.++++++  |+||+++++++..++..++|+|++
T Consensus        51 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~  130 (320)
T 3a99_A           51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP  130 (320)
T ss_dssp             CSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcC
Confidence            44555555554432  234499999964321       2356778999999996  599999999999999999999999


Q ss_pred             CC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEeccccceecc
Q 039471          181 PN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCS  258 (363)
Q Consensus       181 ~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~  258 (363)
                      .+ ++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++ +++.+||+|||+++...
T Consensus       131 ~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          131 EPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             SSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             CCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            76 8999999542      568999999999999999999999   9999999999999999 78899999999998876


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ....    ....||..|+|||++         +|+||||+++|||++|+.||.......              .+..   
T Consensus       202 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~~~---  260 (320)
T 3a99_A          202 DTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV---  260 (320)
T ss_dssp             SSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC---
T ss_pred             cccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------cccc---
Confidence            4322    345689999999977         699999999999999999997543211              0110   


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          .....+++.+.+++.+||+.||++|||++|
T Consensus       261 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  290 (320)
T 3a99_A          261 ----FFRQRVSSECQHLIRWCLALRPSDRPTFEE  290 (320)
T ss_dssp             ----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----cccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence                111234567999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.6e-37  Score=291.81  Aligned_cols=238  Identities=19%  Similarity=0.202  Sum_probs=178.3

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCC-CceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ...++.+++|.++.+...  +..||||++.... ..+++.+|+++++.++| +++..+..++.+....++||||+ +++|
T Consensus        12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL   89 (483)
T 3sv0_A           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL   89 (483)
T ss_dssp             CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence            344566666666665533  4559999876443 34568899999999986 55666666677888999999999 8999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEE---cCCCCeeEeccccceeccCCcc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .+++....     ..+++..++.++.||+.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++.......
T Consensus        90 ~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           90 EDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            99995432     569999999999999999999999   999999999999999   6889999999999998765432


Q ss_pred             cc-----ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          263 IV-----SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       263 ~~-----~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ..     ......||..|+|||++        +||||||+++|||++|+.||...........+............    
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----  237 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI----  237 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH----
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH----
Confidence            11     12356699999999998        79999999999999999999765433221111111111111000    


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         ......++.++.+++.+||+.+|++||++++
T Consensus       238 ---~~l~~~~p~~l~~li~~cl~~dP~~RPs~~e  268 (483)
T 3sv0_A          238 ---EALCRGYPTEFASYFHYCRSLRFDDKPDYSY  268 (483)
T ss_dssp             ---HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred             ---HHHhcCCcHHHHHHHHHHhcCChhhCcCHHH
Confidence               0011233568999999999999999999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.7e-37  Score=285.44  Aligned_cols=240  Identities=19%  Similarity=0.273  Sum_probs=174.2

Q ss_pred             cccccccCCcceeec--cCCeeEEEEcccCCcChhHHHHHHHHHhccC-----------CCceeeeeeeeeeCC----ce
Q 039471          111 SLISFNLTNSKFFFL--HSNEIAVKMLEHLKGNGQEFINEVATIGRIH-----------HFHIVRLLGFCSEGN----RR  173 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~----~~  173 (363)
                      .++.+++|.++.+..  .++.||||++.......+.+.+|+.++++++           |+||+++++++...+    ..
T Consensus        26 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  105 (373)
T 1q8y_A           26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV  105 (373)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEE
T ss_pred             eeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceE
Confidence            345555555555442  3445999999765555577889999999886           789999999987644    78


Q ss_pred             eEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEc------CCCCe
Q 039471          174 TLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLD------HNFQP  246 (363)
Q Consensus       174 ~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~------~~~~~  246 (363)
                      +++||++ +++|.+++.....    ..+++..+..++.||+.||+|||+   . +|+||||||+|||++      ..+.+
T Consensus       106 ~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A          106 VMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             EEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             EEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcceE
Confidence            9999999 8899999965432    559999999999999999999999   8 999999999999995      34479


Q ss_pred             eEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc------
Q 039471          247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY------  312 (363)
Q Consensus       247 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~------  312 (363)
                      ||+|||++.......     ....||..|+|||++        +|+||||+++|||++|+.||...........      
T Consensus       178 kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          178 KIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             EEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            999999998765432     334689999999988        8999999999999999999976542211000      


Q ss_pred             -------hHHHHHHHhhhc-------ccc-------------ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          313 -------FPEWIYNRMRLG-------QEL-------------CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       313 -------~~~~~~~~~~~~-------~~~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                             .+..........       ...             ........+...+..+.+++.+||+.||++|||++|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence                   000000000000       000             000112345678899999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.1e-37  Score=281.72  Aligned_cols=238  Identities=20%  Similarity=0.272  Sum_probs=160.7

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHH-HHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVA-TIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ...++.+++|.++.+...  ++.||||++.....  ...++..|+. +++.++|+||+++++++.+++..++||||+++ 
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence            344566666666555544  44599999975432  2245666666 67778999999999999999999999999975 


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      +|.+++..... .....+++..+..++.|++.||.|||+   . +++||||||+||+++.++.+||+|||+++.......
T Consensus       106 ~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          106 SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence            88888753211 123679999999999999999999999   8 999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCCccc------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          263 IVSRTAARGTSGYIAPELF------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .   ....||..|+|||++            +|+||||+++|||++|+.||.........       ......+..  ..
T Consensus       182 ~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~--~~  249 (327)
T 3aln_A          182 K---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGDP--PQ  249 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC--CC
T ss_pred             c---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCCC--CC
Confidence            2   334689999999986            69999999999999999999754321110       011111111  11


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .........++.+.+++.+||+.||++|||++|
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  282 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKE  282 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence            111122345678999999999999999999853

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=282.11  Aligned_cols=219  Identities=23%  Similarity=0.264  Sum_probs=170.7

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc-------ChhHHHHHHHHHhcc----CCCceeeeeeeeeeCCceeEEE
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG-------NGQEFINEVATIGRI----HHFHIVRLLGFCSEGNRRTLIY  177 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~lv~  177 (363)
                      .++.+++|.++.+...  +..||||++.....       ....+.+|+.++.++    +|+||+++++++...+..++|+
T Consensus        38 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~  117 (312)
T 2iwi_A           38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL  117 (312)
T ss_dssp             EEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEE
T ss_pred             EEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEE
Confidence            3456666666555442  34599999964432       224566899999988    8999999999999989999999


Q ss_pred             ec-cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEeccccce
Q 039471          178 EF-MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAK  255 (363)
Q Consensus       178 e~-~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Dfg~a~  255 (363)
                      |+ +.+++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+||+++ .++.+||+|||++.
T Consensus       118 e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          118 ERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             ECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            99 7899999999543      458999999999999999999999   9999999999999999 88999999999998


Q ss_pred             eccCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .......    ....|+..|+|||++         +|+||||+++|||++|+.||.......          .    . .
T Consensus       189 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------~----~-~  249 (312)
T 2iwi_A          189 LLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL----------E----A-E  249 (312)
T ss_dssp             ECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------H----T-C
T ss_pred             hcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----------h----h-c
Confidence            8765432    345589999999976         799999999999999999997542210          0    0 0


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                            ...+...+..+.+++.+||+.||++|||++|
T Consensus       250 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  280 (312)
T 2iwi_A          250 ------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEE  280 (312)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ------cCCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence                  1122345667899999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=283.61  Aligned_cols=228  Identities=22%  Similarity=0.262  Sum_probs=157.0

Q ss_pred             ccccccCCcceeec--cCCeeEEEEcccCC-cChhHHHHHHHHHhccC-CCceeeeeeeee--------eCCceeEEEec
Q 039471          112 LISFNLTNSKFFFL--HSNEIAVKMLEHLK-GNGQEFINEVATIGRIH-HFHIVRLLGFCS--------EGNRRTLIYEF  179 (363)
Q Consensus       112 ~~~~~~~~~~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~~~~lv~e~  179 (363)
                      ++.+++|.++.+..  .++.||||++.... ...+.+.+|+.+++++. |+||+++++++.        .....+++|||
T Consensus        36 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~  115 (337)
T 3ll6_A           36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL  115 (337)
T ss_dssp             EECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEEC
T ss_pred             EccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEe
Confidence            45556665555544  34459999885433 33467889999999996 999999999984        34458999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      +. |+|.+++.....   ...+++..++.++.||+.||+|||+   .+  |+||||||+|||++.++.+||+|||+++..
T Consensus       116 ~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  188 (337)
T 3ll6_A          116 CK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI  188 (337)
T ss_dssp             CS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred             cC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCccceec
Confidence            96 699998865321   2569999999999999999999999   88  999999999999999999999999999876


Q ss_pred             cCCcccc----------ccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH
Q 039471          258 SKDISIV----------SRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW  316 (363)
Q Consensus       258 ~~~~~~~----------~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  316 (363)
                      .......          ......||..|+|||++           +||||||+++|||++|+.||........       
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------  261 (337)
T 3ll6_A          189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-------  261 (337)
T ss_dssp             SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-------
Confidence            5432211          11134589999999986           6999999999999999999965432210       


Q ss_pred             HHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          317 IYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....      ...    ......+..+.+++.+||+.||++|||++|
T Consensus       262 ~~~~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  298 (337)
T 3ll6_A          262 VNGK------YSI----PPHDTQYTVFHSLIRAMLQVNPEERLSIAE  298 (337)
T ss_dssp             ----------CCC----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHH
T ss_pred             hcCc------ccC----CcccccchHHHHHHHHHccCChhhCcCHHH
Confidence            0000      000    111122345889999999999999999754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=281.19  Aligned_cols=231  Identities=22%  Similarity=0.318  Sum_probs=171.9

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.+++|.++.+.. .+.||+|++....   ...+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus        39 ~~lg~G~~g~V~~~~~-~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~  117 (319)
T 2y4i_B           39 ELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY  117 (319)
T ss_dssp             CBCCCSSSSEEEEEEE-SSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHH
T ss_pred             eEeccCCceEEEEEEE-cCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHH
Confidence            3344555555444433 3459999997432   33457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc---c
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS---I  263 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~  263 (363)
                      +++...     ...+++..+..++.|++.||+|||+   .+++||||||+||+++ ++.+||+|||++........   .
T Consensus       118 ~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          118 SVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             HHTTSS-----CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            999432     2468999999999999999999999   9999999999999998 67999999999876532211   1


Q ss_pred             cccccccccccccCCccc-----------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc
Q 039471          264 VSRTAARGTSGYIAPELF-----------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE  326 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-----------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (363)
                      .......|+..|+|||++                 +||||||+++|||++|+.||.......        ....+..+..
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~  260 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQMGTGMK  260 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--------HHHHHHTTCC
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHhccCCC
Confidence            112334588999999975                 699999999999999999997643321        1222222211


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...     .....+..+.+++.+||+.||++|||++|
T Consensus       261 ~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  292 (319)
T 2y4i_B          261 PNL-----SQIGMGKEISDILLFCWAFEQEERPTFTK  292 (319)
T ss_dssp             CCC-----CCSSCCTTHHHHHHHHHCSSTTTSCCHHH
T ss_pred             CCC-----CcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            111     11134566999999999999999999853

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.4e-37  Score=279.00  Aligned_cols=231  Identities=21%  Similarity=0.264  Sum_probs=169.3

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcC---hhHHHHHHHHHhccC--CCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGN---GQEFINEVATIGRIH--HFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.+++|.++.+... +..||||++......   .+.+.+|+.++++++  |+||+++++++.++...++||| +.++
T Consensus        34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~  112 (313)
T 3cek_A           34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI  112 (313)
T ss_dssp             EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred             EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence            34455566655554433 344999999644322   357889999999997  5999999999999999999999 5578


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.|++.||.|||+   .+|+||||||+|||+++ +.+||+|||+++........
T Consensus       113 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          113 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            999999543      468999999999999999999999   99999999999999975 78999999999877654332


Q ss_pred             cccccccccccccCCccc-------------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhc
Q 039471          264 VSRTAARGTSGYIAPELF-------------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG  324 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (363)
                      .......||..|+|||++                   +|+||||+++|||++|+.||........      .........
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~  256 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN  256 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH------HHHHHHCTT
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH------HHHHHHhcc
Confidence            223445689999999984                   6999999999999999999975432211      111111111


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .      ....+...+..+.+++.+||+.||++|||++|
T Consensus       257 ~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  289 (313)
T 3cek_A          257 H------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE  289 (313)
T ss_dssp             S------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             c------ccCCcccchHHHHHHHHHHccCCcccCcCHHH
Confidence            1      11112223567999999999999999999854

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=280.48  Aligned_cols=237  Identities=19%  Similarity=0.226  Sum_probs=170.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCCc------eeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGNR------RTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e  178 (363)
                      ..++.+++|.++.+...  ++.||||++......   .+++.+|+.++++++|+||+++++++.....      .++|||
T Consensus        30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  109 (353)
T 3coi_A           30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP  109 (353)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred             eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence            34556666655555433  445999999754322   3578899999999999999999999977653      499999


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |++ ++|.+++.        ..+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus       110 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          110 FMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             ccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            997 58888772        358999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch--------HHHHH---
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF--------PEWIY---  318 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~--------~~~~~---  318 (363)
                      ...     ....+|..|+|||++         +|+||||+++|||++|+.||............        .++..   
T Consensus       178 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          178 AEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            321     344689999999976         79999999999999999999765432110000        00000   


Q ss_pred             -----HHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          319 -----NRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       319 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           ..+..-...............++.+.+++.+||+.||++|||++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  302 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ  302 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence                 000000000000011122355778999999999999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=279.59  Aligned_cols=243  Identities=21%  Similarity=0.240  Sum_probs=169.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeee--------------eCCc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCS--------------EGNR  172 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------------~~~~  172 (363)
                      ..++.+++|.++.+...  ++.||||++.... ...+++.+|++++++++|+||+++++++.              +...
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~   96 (320)
T 2i6l_A           17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS   96 (320)
T ss_dssp             EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence            34555666665555444  4459999986443 23467899999999999999999999873              4467


Q ss_pred             eeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc-CCCCeeEecc
Q 039471          173 RTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDF  251 (363)
Q Consensus       173 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~-~~~~~kl~Df  251 (363)
                      .++||||++ ++|.+++.       ...+++..++.++.|++.||+|||+   .+|+||||||+||+++ +++.+||+||
T Consensus        97 ~~lv~e~~~-~~L~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           97 VYIVQEYME-TDLANVLE-------QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             EEEEEECCS-EEHHHHHT-------TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeeccC-CCHHHHhh-------cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence            899999997 59999983       2468999999999999999999999   9999999999999997 5678999999


Q ss_pred             ccceeccCCccc-cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHH------
Q 039471          252 GLAKLCSKDISI-VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPE------  315 (363)
Q Consensus       252 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~------  315 (363)
                      |+++........ .......+|..|+|||++         +|+||||+++|||++|+.||..............      
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            999876533211 112334578899999976         7999999999999999999976543221000000      


Q ss_pred             -HHHHHhhhcc----ccccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          316 -WIYNRMRLGQ----ELCLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       316 -~~~~~~~~~~----~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       .....+....    ........    .....++..+.+++.+||+.||++|||++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE  302 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence             0000000000    00000000    011234678999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.7e-36  Score=291.56  Aligned_cols=247  Identities=22%  Similarity=0.269  Sum_probs=179.1

Q ss_pred             CcccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeee------CCceeEEE
Q 039471          108 PFQSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSE------GNRRTLIY  177 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~  177 (363)
                      ....++.+++|.++.+...  ++.||||++....  ...+.+.+|++++++++|+||+++++++..      ++..++||
T Consensus        18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm   97 (676)
T 3qa8_A           18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM   97 (676)
T ss_dssp             CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence            3344566666666554432  4459999987432  234578899999999999999999998755      67889999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC---eeEeccccc
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLA  254 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~---~kl~Dfg~a  254 (363)
                      ||+++++|.+++.....   ...+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.   +||+|||.+
T Consensus        98 Ey~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           98 EYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             ECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            99999999999965332   2468999999999999999999999   99999999999999997665   899999999


Q ss_pred             eeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc-hHHHHHHHhh---
Q 039471          255 KLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY-FPEWIYNRMR---  322 (363)
Q Consensus       255 ~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~~---  322 (363)
                      .........   ....||..|+|||++        +|+||||+++|||++|+.||........... ..........   
T Consensus       172 ~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          172 KELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            887654332   445689999999998        7999999999999999999976422110000 0000000000   


Q ss_pred             --hccc-c--ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 --LGQE-L--CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 --~~~~-~--~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        .+.. .  ...........+++.+.+++.+||++||++|||++|
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence              0000 0  001112244567889999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=270.14  Aligned_cols=231  Identities=19%  Similarity=0.253  Sum_probs=161.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcCh---hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..++.+++|.++.+...  ++.||||++.......   +.+.++..+++.++|+||+++++++.++...++||||+ ++.
T Consensus        31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~  109 (318)
T 2dyl_A           31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC  109 (318)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred             ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence            34566666666665543  4559999997543222   23344455677889999999999999999999999999 456


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +..+....     ...+++..+..++.|++.||.|||+   . +++|+||||+||+++.++.+||+|||++.........
T Consensus       110 ~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (318)
T 2dyl_A          110 AEKLKKRM-----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK  181 (318)
T ss_dssp             HHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             HHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence            65555322     2568999999999999999999998   6 9999999999999999999999999999776543322


Q ss_pred             cccccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 VSRTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                         ....+|..|+|||++             +|+||||+++|||++|+.||........       .......+..... 
T Consensus       182 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~-  250 (318)
T 2dyl_A          182 ---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-------VLTKVLQEEPPLL-  250 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-------HHHHHHHSCCCCC-
T ss_pred             ---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-------HHHHHhccCCCCC-
Confidence               344589999999986             6999999999999999999975322111       1112221111111 


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         .....++..+.+++.+||+.||++|||++|
T Consensus       251 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  280 (318)
T 2dyl_A          251 ---PGHMGFSGDFQSFVKDCLTKDHRKRPKYNK  280 (318)
T ss_dssp             ---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             ---CccCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence               111235677999999999999999999753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-35  Score=268.03  Aligned_cols=218  Identities=19%  Similarity=0.250  Sum_probs=160.8

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHH-hccCCCceeeeeeeeee----CCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATI-GRIHHFHIVRLLGFCSE----GNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~~s  184 (363)
                      ++.+++|.++.+...  +..||||++..    ...+.+|+.++ +.++|+||+++++++..    +...++||||+++++
T Consensus        26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~  101 (299)
T 3m2w_A           26 LGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE  101 (299)
T ss_dssp             EEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCB
T ss_pred             cccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCc
Confidence            456666666555442  44599999863    45678899988 55589999999999876    678899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||++.......
T Consensus       102 L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (299)
T 3m2w_A          102 LFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK  174 (299)
T ss_dssp             HHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCG
T ss_pred             HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccccc
Confidence            9999965432    469999999999999999999999   99999999999999998   7889999999997654321


Q ss_pred             cccccccccccccccCCccccCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHH
Q 039471          262 SIVSRTAARGTSGYIAPELFSRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIAR  341 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (363)
                      .                ..-+|+||||+++|||++|+.||............    ...+..+   ...........+++
T Consensus       175 ~----------------~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~  231 (299)
T 3m2w_A          175 Y----------------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMG---QYEFPNPEWSEVSE  231 (299)
T ss_dssp             G----------------GGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----CCSSCTT---CCSSCHHHHTTSCH
T ss_pred             C----------------CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----HHHHhhc---cccCCchhcccCCH
Confidence            1                01279999999999999999999765432210000    0000000   00000001123567


Q ss_pred             HHHHHHHHhccCCCCCCCCCCC
Q 039471          342 KLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       342 ~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+++.+||+.||++|||++|
T Consensus       232 ~~~~li~~~l~~dP~~Rps~~e  253 (299)
T 3m2w_A          232 EVKMLIRNLLKTEPTQRMTITE  253 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHHHHHcccChhhCCCHHH
Confidence            8999999999999999999854

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-35  Score=292.91  Aligned_cols=213  Identities=19%  Similarity=0.212  Sum_probs=168.1

Q ss_pred             cccccccCCcceeecc---CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCc-----eeEEEecc
Q 039471          111 SLISFNLTNSKFFFLH---SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNR-----RTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~---~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv~e~~  180 (363)
                      .++.+++|.++.....   ++.||||++....  ...+.+.+|+.++++++|+||+++++++...+.     .++||||+
T Consensus        87 ~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~  166 (681)
T 2pzi_A           87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV  166 (681)
T ss_dssp             EEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECC
T ss_pred             EEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeC
Confidence            3456666666655443   3459999986432  223578899999999999999999999987665     79999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++.        ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.+ .+||+|||+++.....
T Consensus       167 ~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          167 GGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             CCEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             CCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            9999998772        368999999999999999999999   999999999999999986 8999999999876543


Q ss_pred             ccccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          261 ISIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                            ....||+.|+|||++       +||||||+++|||++|.+|+.........                     ..
T Consensus       235 ------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------------------~~  287 (681)
T 2pzi_A          235 ------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------------------ED  287 (681)
T ss_dssp             ------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---------------------TT
T ss_pred             ------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccccc---------------------cc
Confidence                  334589999999987       89999999999999998887653211100                     00


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      ......++.+.+++.+||+.||++||+..
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~  316 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTA  316 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHH
Confidence            11123456799999999999999999753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.6e-35  Score=260.85  Aligned_cols=210  Identities=14%  Similarity=0.015  Sum_probs=158.2

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcCh----hHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+++|.++.....  ++.||||++.......    +.+.+|+..+.+++|+||+++++++.+++..++||||+++++|
T Consensus        39 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L  118 (286)
T 3uqc_A           39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL  118 (286)
T ss_dssp             EEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEH
T ss_pred             EcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCH
Confidence            456666666655544  4459999997554332    6789999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++..        ......+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+++|..           
T Consensus       119 ~~~l~~--------~~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~~~-----------  176 (286)
T 3uqc_A          119 QEVADT--------SPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPATM-----------  176 (286)
T ss_dssp             HHHHTT--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCCCC-----------
T ss_pred             HHHHhc--------CCChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecccc-----------
Confidence            999931        23566788999999999999999   99999999999999999999999865432           


Q ss_pred             cccccccccccCCccc-cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHH
Q 039471          266 RTAARGTSGYIAPELF-SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLA  344 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~-~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  344 (363)
                                 +|.-. +|+||||+++|||++|+.||............    ..... +..   .........+++.+.
T Consensus       177 -----------~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~-~~~---~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          177 -----------PDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ERDTA-GQP---IEPADIDRDIPFQIS  237 (286)
T ss_dssp             -----------TTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----CBCTT-SCB---CCHHHHCTTSCHHHH
T ss_pred             -----------CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----HHHhc-cCC---CChhhcccCCCHHHH
Confidence                       22222 79999999999999999999875442210000    00000 000   000011124567799


Q ss_pred             HHHHHhccCCCCCCCCCCC
Q 039471          345 IVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       345 ~l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.+||+.||++| |++|
T Consensus       238 ~li~~~l~~dP~~R-s~~e  255 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SAST  255 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHH
T ss_pred             HHHHHHcccCCccC-CHHH
Confidence            99999999999999 8753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2e-35  Score=270.78  Aligned_cols=222  Identities=12%  Similarity=0.085  Sum_probs=163.3

Q ss_pred             cccccccccCCcceeeccCCeeEEEEcccCC---------cChhHHHHHHHHHhccC---------CCceee--------
Q 039471          109 FQSLISFNLTNSKFFFLHSNEIAVKMLEHLK---------GNGQEFINEVATIGRIH---------HFHIVR--------  162 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~---------h~niv~--------  162 (363)
                      ...++.+++|.++.+...++.||||++....         ...+.+.+|+.++++++         |+||++        
T Consensus        25 ~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~  104 (336)
T 2vuw_A           25 CEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ  104 (336)
T ss_dssp             CEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred             eeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence            3456667777776666666679999997432         12378899999999886         555554        


Q ss_pred             ---------eeeeeee-------------CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 039471          163 ---------LLGFCSE-------------GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYL  220 (363)
Q Consensus       163 ---------~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  220 (363)
                               +++++.+             +...++||||+++|++.+.+..       ..+++..++.++.||+.||+||
T Consensus       105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A          105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHHHHHHHH
Confidence                     4444443             6789999999999977776621       4589999999999999999999


Q ss_pred             h-cCCCCCceecCCCCCceEEcCCC--------------------CeeEeccccceeccCCccccccccccccccccCCc
Q 039471          221 H-QGCNQRILHFDIKPHNILLDHNF--------------------QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPE  279 (363)
Q Consensus       221 H-~~~~~~i~H~dikp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  279 (363)
                      | +   .+|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|||
T Consensus       178 H~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE  247 (336)
T 2vuw_A          178 EAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED  247 (336)
T ss_dssp             HHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred             HHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence            9 8   9999999999999999887                    8999999999877542       235899999999


Q ss_pred             cc-------cCceehhHH-HHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhc
Q 039471          280 LF-------SRNFCYGMM-LLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI  351 (363)
Q Consensus       280 ~~-------~Di~slG~i-l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  351 (363)
                      ++       +||||+|++ .+++++|..||......       ....+.+.................+++++.+++.+||
T Consensus       248 ~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          248 LFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWL-------HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             GGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-------HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             hhcCCCccceehhhhhCCCCcccccccCCCcchhhh-------hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            98       799998776 77788898887432100       0011111111111111122234578899999999999


Q ss_pred             cCC
Q 039471          352 QWN  354 (363)
Q Consensus       352 ~~~  354 (363)
                      +.|
T Consensus       321 ~~d  323 (336)
T 2vuw_A          321 NFS  323 (336)
T ss_dssp             GSS
T ss_pred             ccC
Confidence            976

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-34  Score=268.36  Aligned_cols=223  Identities=14%  Similarity=0.124  Sum_probs=160.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC----cChhHHHHHHHHHhccCC-Ccee---------------ee-----
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK----GNGQEFINEVATIGRIHH-FHIV---------------RL-----  163 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~h-~niv---------------~~-----  163 (363)
                      .++.+++|.++.+...  ++.||||++....    ...+.+.+|+.+++.++| +|..               .+     
T Consensus        85 ~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (413)
T 3dzo_A           85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK  164 (413)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---
T ss_pred             ccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCc
Confidence            4566667666666544  4559999987322    235789999999999976 2211               11     


Q ss_pred             -eeeeee-----CCceeEEEeccCCCCHHHHhhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCC
Q 039471          164 -LGFCSE-----GNRRTLIYEFMPNGSLQKFIFSKTN-SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH  236 (363)
Q Consensus       164 -~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~  236 (363)
                       ..++..     ....+++|+++ +++|.+++..... ......+++..+..++.|++.||+|||+   .+|+||||||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp~  240 (413)
T 3dzo_A          165 MIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPV  240 (413)
T ss_dssp             ------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred             cccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcccc
Confidence             111111     22456777766 6799998843211 1123568889999999999999999999   99999999999


Q ss_pred             ceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccc------------------cCceehhHHHHHHhcCC
Q 039471          237 NILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF------------------SRNFCYGMMLLEMVGCR  298 (363)
Q Consensus       237 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~------------------~Di~slG~il~el~~g~  298 (363)
                      |||++.++.+||+|||+++.....     .....| ..|+|||++                  +|||||||++|||++|+
T Consensus       241 NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~  314 (413)
T 3dzo_A          241 DIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD  314 (413)
T ss_dssp             GEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred             eEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence            999999999999999999876543     134457 999999976                  59999999999999999


Q ss_pred             CCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          299 KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .||..........        .+       ..    ....+++.+.+++.+||+.||++|||+.
T Consensus       315 ~Pf~~~~~~~~~~--------~~-------~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          315 LPNTDDAALGGSE--------WI-------FR----SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             CCCCTTGGGSCSG--------GG-------GS----SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCcchhhhHH--------HH-------Hh----hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            9997654322110        00       00    0112347799999999999999999964

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.4e-32  Score=263.64  Aligned_cols=163  Identities=20%  Similarity=0.230  Sum_probs=127.0

Q ss_pred             eccCCeeEEEEcccCC-----------cChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhh
Q 039471          124 FLHSNEIAVKMLEHLK-----------GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFS  191 (363)
Q Consensus       124 ~~~~~~vAvK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~  191 (363)
                      ++-++.+|+|.+....           .+.++|.+|+++|+++ +|+||+++++++++++..||||||++|++|.++|..
T Consensus       256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~  335 (569)
T 4azs_A          256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA  335 (569)
T ss_dssp             EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred             ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence            4456779999996432           2335799999999999 699999999999999999999999999999999953


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccc
Q 039471          192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARG  271 (363)
Q Consensus       192 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  271 (363)
                            ...+++.   +|+.||+.||+|+|+   +||+||||||+|||++.++.+||+|||+|+....+...  .....|
T Consensus       336 ------~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~--~~t~vG  401 (569)
T 4azs_A          336 ------GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW--PTNLVQ  401 (569)
T ss_dssp             ------TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC--SHHHHH
T ss_pred             ------CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc--ccCcee
Confidence                  2456664   478999999999999   99999999999999999999999999999877654332  244679


Q ss_pred             cccccCCccc-------cCceehhHHHHHHhcCCCC
Q 039471          272 TSGYIAPELF-------SRNFCYGMMLLEMVGCRKN  300 (363)
Q Consensus       272 t~~y~aPE~~-------~Di~slG~il~el~~g~~~  300 (363)
                      |+.|+|||++       +|+||+|++++++.++..+
T Consensus       402 Tp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          402 SFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             chhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            9999999998       7999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.2e-25  Score=217.72  Aligned_cols=173  Identities=17%  Similarity=0.156  Sum_probs=133.7

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcC---------hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGN---------GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..++.+++|.++.....+..+++|+.......         .+++.+|++++++++|+||+++..++......++||||+
T Consensus       342 ~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~  421 (540)
T 3en9_A          342 HLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYI  421 (540)
T ss_dssp             ------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECC
T ss_pred             CEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECC
Confidence            35667777776666566777999986532211         245789999999999999997666666777889999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++++|.+++..              +..++.|++.||+|||+   ++|+||||||+|||++.  .+||+|||+++.....
T Consensus       422 ~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          422 NGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999932              56899999999999999   99999999999999999  9999999999987654


Q ss_pred             cccc-----ccccccccccccCCccc----------cCceehhHHHHHHhcCCCCC
Q 039471          261 ISIV-----SRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNN  301 (363)
Q Consensus       261 ~~~~-----~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~  301 (363)
                      ....     ......||+.|+|||++          +|+||...-..+.+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3211     11345689999999998          67888877777766555543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.81  E-value=1.5e-20  Score=167.43  Aligned_cols=136  Identities=13%  Similarity=0.072  Sum_probs=104.2

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCc-------------------ChhHHHHHHHHHhccCCCceeeeeeeeee
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKG-------------------NGQEFINEVATIGRIHHFHIVRLLGFCSE  169 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~  169 (363)
                      ..++.+++|.++.+... +..||||++.....                   ....+.+|+.++++++  | +++.+++..
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~  172 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW  172 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence            44566666666655542 44599999963221                   1346889999999999  5 677776544


Q ss_pred             CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEe
Q 039471          170 GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  249 (363)
Q Consensus       170 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~  249 (363)
                       +..++||||++|++|.+ +.          .  .....++.|++.||.|||+   .+|+||||||+|||++ ++.+||+
T Consensus       173 -~~~~lvmE~~~g~~L~~-l~----------~--~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          173 -EGNAVLMELIDAKELYR-VR----------V--ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             -ETTEEEEECCCCEEGGG-CC----------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred             -cceEEEEEecCCCcHHH-cc----------h--hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence             56699999999999988 51          0  1245799999999999999   9999999999999999 9999999


Q ss_pred             ccccceeccCCccccccccccccccccCCccc
Q 039471          250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF  281 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  281 (363)
                      |||+|+.               +..+.|||.+
T Consensus       235 DFG~a~~---------------~~~~~a~e~l  251 (282)
T 1zar_A          235 DFPQSVE---------------VGEEGWREIL  251 (282)
T ss_dssp             CCTTCEE---------------TTSTTHHHHH
T ss_pred             ECCCCeE---------------CCCCCHHHHH
Confidence            9999863               3346778876

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=4e-18  Score=149.77  Aligned_cols=131  Identities=17%  Similarity=0.128  Sum_probs=97.0

Q ss_pred             ccccccccCCcceeec--cCCe--eEEEEcccCCcC-------------------------hhHHHHHHHHHhccCCCce
Q 039471          110 QSLISFNLTNSKFFFL--HSNE--IAVKMLEHLKGN-------------------------GQEFINEVATIGRIHHFHI  160 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~--~~~~--vAvK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~ni  160 (363)
                      ..++.+++|.++.+..  .+..  ||||+.+.....                         ...+.+|+..+.+++|+++
T Consensus        53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i  132 (258)
T 1zth_A           53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV  132 (258)
T ss_dssp             EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3456666666666655  4567  999987532111                         1267899999999988754


Q ss_pred             --eeeeeeeeeCCceeEEEeccCC-C----CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCceecC
Q 039471          161 --VRLLGFCSEGNRRTLIYEFMPN-G----SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLH-QGCNQRILHFD  232 (363)
Q Consensus       161 --v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~d  232 (363)
                        ..+++.    ...++||||+.+ |    +|.++..         ..++..+..++.|++.||.||| +   .+|+|||
T Consensus       133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~---~givHrD  196 (258)
T 1zth_A          133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR---------ELKELDVEGIFNDVVENVKRLYQE---AELVHAD  196 (258)
T ss_dssp             CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG---------GGGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred             CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh---------ccChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence              344432    356899999942 3    7776652         1234567889999999999999 8   9999999


Q ss_pred             CCCCceEEcCCCCeeEeccccceecc
Q 039471          233 IKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       233 ikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |||+|||++.  .++|+|||+|....
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCHHHEEEcC--cEEEEECcccccCC
Confidence            9999999998  89999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.50  E-value=7.9e-15  Score=134.33  Aligned_cols=130  Identities=12%  Similarity=0.088  Sum_probs=85.2

Q ss_pred             ccccccccCCcceeec-cCCeeEEEEcccCCc---------------ChhHH--------HHHHHHHhccCCCcee--ee
Q 039471          110 QSLISFNLTNSKFFFL-HSNEIAVKMLEHLKG---------------NGQEF--------INEVATIGRIHHFHIV--RL  163 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~-~~~~vAvK~~~~~~~---------------~~~~~--------~~E~~~l~~l~h~niv--~~  163 (363)
                      ..++.|+++.++.+.. .++.||||+++....               .....        .+|...|.++.+.++.  ..
T Consensus       101 ~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p  180 (397)
T 4gyi_A          101 SRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEP  180 (397)
T ss_dssp             EEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCE
T ss_pred             CEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCee
Confidence            3455555555555443 344599998753210               01112        2455555555443332  22


Q ss_pred             eeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCC
Q 039471          164 LGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  243 (363)
Q Consensus       164 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~  243 (363)
                      ++.    ...+|||||++|++|.++..          .  +....++.|++.+|.+||+   .+|+||||||.|||++++
T Consensus       181 ~~~----~~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          181 IAQ----SRHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREE  241 (397)
T ss_dssp             EEE----ETTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEE
T ss_pred             eec----cCceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCC
Confidence            221    23479999999988866541          1  1245678999999999999   999999999999999877


Q ss_pred             C----------CeeEeccccceecc
Q 039471          244 F----------QPKISDFGLAKLCS  258 (363)
Q Consensus       244 ~----------~~kl~Dfg~a~~~~  258 (363)
                      +          .+.|+||+-+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=3.3e-11  Score=105.58  Aligned_cols=120  Identities=14%  Similarity=0.092  Sum_probs=93.0

Q ss_pred             cCCeeEEEEcccCC-cChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCH
Q 039471          126 HSNEIAVKMLEHLK-GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSW  203 (363)
Q Consensus       126 ~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~  203 (363)
                      .+..+++|+..... .....+.+|+++++.+. +.++.++++++...+..++||||++|.+|.+.+.           +.
T Consensus        36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----------~~  104 (263)
T 3tm0_A           36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----------DE  104 (263)
T ss_dssp             SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----------TT
T ss_pred             CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----------Cc
Confidence            45569999986421 23456889999999885 6778899999998889999999999999987641           11


Q ss_pred             HHHHHHHHHHHHHHHHhhcCC--------------------------------------------------------CCC
Q 039471          204 EKLRKIAFGVARGVEYLHQGC--------------------------------------------------------NQR  227 (363)
Q Consensus       204 ~~~~~i~~~i~~~l~~LH~~~--------------------------------------------------------~~~  227 (363)
                      .....++.+++.+|..||+-.                                                        ...
T Consensus       105 ~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~  184 (263)
T 3tm0_A          105 QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV  184 (263)
T ss_dssp             TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEE
T ss_pred             ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCce
Confidence            223467889999999999711                                                        145


Q ss_pred             ceecCCCCCceEEcCCCCeeEecccccee
Q 039471          228 ILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       228 i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ++|+|++|.||+++.+..+.|+||+.+..
T Consensus       185 l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            89999999999998765567999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=2.2e-10  Score=99.98  Aligned_cols=114  Identities=18%  Similarity=0.116  Sum_probs=84.3

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCCc--eeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHH
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEK  205 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~  205 (363)
                      ..+++|+....  ....+.+|+++++.+++.+  +.+++++...++..++||||++|.+|.  ..         ..+   
T Consensus        45 ~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---------~~~---  108 (264)
T 1nd4_A           45 PVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---------HLA---  108 (264)
T ss_dssp             CCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---------CCC---
T ss_pred             CeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---------cCC---
Confidence            34999997643  3356789999999886444  566888888878899999999998884  31         111   


Q ss_pred             HHHHHHHHHHHHHHhhcCC-------------------------------------------------------CCCcee
Q 039471          206 LRKIAFGVARGVEYLHQGC-------------------------------------------------------NQRILH  230 (363)
Q Consensus       206 ~~~i~~~i~~~l~~LH~~~-------------------------------------------------------~~~i~H  230 (363)
                      ...++.+++..|..||+..                                                       ...++|
T Consensus       109 ~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H  188 (264)
T 1nd4_A          109 PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH  188 (264)
T ss_dssp             HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred             HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEEC
Confidence            1256677777788888621                                                       112999


Q ss_pred             cCCCCCceEEcCCCCeeEeccccceec
Q 039471          231 FDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       231 ~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      +|++|.||+++.++.+.|+||+.+...
T Consensus       189 gDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          189 GDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             SSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             CCCCCCcEEEECCcEEEEEcchhcccC
Confidence            999999999987766779999987643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=8.6e-10  Score=101.21  Aligned_cols=130  Identities=15%  Similarity=0.170  Sum_probs=95.8

Q ss_pred             ceeeccCCeeEEEEcc--cCC--cChhHHHHHHHHHhccC--CCceeeeeeeeeeC---CceeEEEeccCCCCHHHHhhh
Q 039471          121 KFFFLHSNEIAVKMLE--HLK--GNGQEFINEVATIGRIH--HFHIVRLLGFCSEG---NRRTLIYEFMPNGSLQKFIFS  191 (363)
Q Consensus       121 ~~~~~~~~~vAvK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~  191 (363)
                      +.+...+..+++|+..  ...  .....+.+|.++++.++  +.++.++++++.+.   +..++||||++|.++.+..  
T Consensus        55 y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--  132 (359)
T 3dxp_A           55 FKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--  132 (359)
T ss_dssp             EEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--
T ss_pred             EEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--
Confidence            3344445568888876  332  22357789999999987  45688899988776   4589999999998775422  


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------------
Q 039471          192 KTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC-----------------------------------------------  224 (363)
Q Consensus       192 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------------  224 (363)
                            ...++......++.++++.|..||+..                                               
T Consensus       133 ------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  206 (359)
T 3dxp_A          133 ------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQ  206 (359)
T ss_dssp             ------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGG
T ss_pred             ------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHh
Confidence                  134778888999999999999999721                                               


Q ss_pred             --------CCCceecCCCCCceEEcCCCC--eeEeccccceecc
Q 039471          225 --------NQRILHFDIKPHNILLDHNFQ--PKISDFGLAKLCS  258 (363)
Q Consensus       225 --------~~~i~H~dikp~Nill~~~~~--~kl~Dfg~a~~~~  258 (363)
                              ...++|+|++|.|||++.++.  +.|+||+.+..-.
T Consensus       207 ~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          207 HIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             CCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             cCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                    257999999999999997653  6899999887643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.94  E-value=5.8e-10  Score=99.94  Aligned_cols=177  Identities=18%  Similarity=0.183  Sum_probs=115.1

Q ss_pred             ccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccC-CC--ceeeeeeeeeeCC---ceeEEEeccCCCCHHHHh
Q 039471          116 NLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIH-HF--HIVRLLGFCSEGN---RRTLIYEFMPNGSLQKFI  189 (363)
Q Consensus       116 ~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~--niv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l  189 (363)
                      +.|....++.-++.+++|+.... .....+.+|.++++.+. +.  .+.+++.......   ..|+|||+++|.+|....
T Consensus        29 ~~G~~n~v~~v~~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~  107 (304)
T 3sg8_A           29 GEGNDCIAYEINRDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLL  107 (304)
T ss_dssp             EECSSEEEEESTTSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHH
T ss_pred             CCCCcceEEEECCEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccc
Confidence            34444455555567999986532 23467889999998874 32  2445555543332   458899999998887543


Q ss_pred             hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------------
Q 039471          190 FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC---------------------------------------------  224 (363)
Q Consensus       190 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  224 (363)
                      .        ..++..+...++.+++..+..||+..                                             
T Consensus       108 ~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          108 L--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             H--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             c--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            1        34677777888888888888888511                                             


Q ss_pred             ----------CCCceecCCCCCceEEcC--CCCeeEeccccceeccCCcccccccc------------ccccccccC-Cc
Q 039471          225 ----------NQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIVSRTA------------ARGTSGYIA-PE  279 (363)
Q Consensus       225 ----------~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~------------~~gt~~y~a-PE  279 (363)
                                ...++|+|++|.||+++.  ...+.|+||+.+..-...........            .....+... |+
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~  259 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT  259 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence                      135799999999999998  45678999998876543211100000            001112233 44


Q ss_pred             cc------cCceehhHHHHHHhcCCCCC
Q 039471          280 LF------SRNFCYGMMLLEMVGCRKNN  301 (363)
Q Consensus       280 ~~------~Di~slG~il~el~~g~~~~  301 (363)
                      ..      .+.|++|.+++.+.+|..++
T Consensus       260 ~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          260 VLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            33      57799999999999998664

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.47  E-value=8e-07  Score=79.47  Aligned_cols=128  Identities=16%  Similarity=0.178  Sum_probs=85.4

Q ss_pred             eeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCC---ceeeeeeeee-eCCceeEEEeccCCCCHHHHhhhcCCCCC
Q 039471          122 FFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHF---HIVRLLGFCS-EGNRRTLIYEFMPNGSLQKFIFSKTNSSS  197 (363)
Q Consensus       122 ~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~  197 (363)
                      .++.-+..+++|+.. .......+.+|.++|+.+.+.   .+.+.+.+.. ..+..+++||+++|.+|.+...       
T Consensus        34 ~v~~vg~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~-------  105 (306)
T 3tdw_A           34 YAILVNGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM-------  105 (306)
T ss_dssp             EEEEETTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH-------
T ss_pred             eEEEECCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh-------
Confidence            333336678999853 222345788999999998742   3566666664 4456789999999988876321       


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------------------
Q 039471          198 HRQLSWEKLRKIAFGVARGVEYLHQG------------------------------------------------------  223 (363)
Q Consensus       198 ~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------------------  223 (363)
                       ..++......++.++.+.|..||+-                                                      
T Consensus       106 -~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~  184 (306)
T 3tdw_A          106 -AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPV  184 (306)
T ss_dssp             -TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHH
T ss_pred             -hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcc
Confidence             2234455555555555555555541                                                      


Q ss_pred             ---CCCCceecCCCCCceEEcC---CCCe-eEeccccceecc
Q 039471          224 ---CNQRILHFDIKPHNILLDH---NFQP-KISDFGLAKLCS  258 (363)
Q Consensus       224 ---~~~~i~H~dikp~Nill~~---~~~~-kl~Dfg~a~~~~  258 (363)
                         ....++|+|++|.||+++.   ++.+ .|+||+.+..-.
T Consensus       185 ~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          185 YTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence               1235699999999999987   4554 899999887643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.33  E-value=2e-06  Score=75.19  Aligned_cols=117  Identities=14%  Similarity=0.124  Sum_probs=84.7

Q ss_pred             eeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHH
Q 039471          129 EIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLR  207 (363)
Q Consensus       129 ~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~  207 (363)
                      .+.+|+-...  ....+.+|...|+.+. +-.+.++++++.+.+..++|||+++|.++.+.....          .....
T Consensus        52 ~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----------~~~~~  119 (272)
T 4gkh_A           52 ELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----------PDSGE  119 (272)
T ss_dssp             CEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----------GGGHH
T ss_pred             EEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----------HHHHH
Confidence            4888986522  3456788999998885 445778899999989999999999998887765211          11223


Q ss_pred             HHHHHHHHHHHHhhcCC-------------------------------------------------------CCCceecC
Q 039471          208 KIAFGVARGVEYLHQGC-------------------------------------------------------NQRILHFD  232 (363)
Q Consensus       208 ~i~~~i~~~l~~LH~~~-------------------------------------------------------~~~i~H~d  232 (363)
                      .+..+++..|.-||+..                                                       ...++|+|
T Consensus       120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD  199 (272)
T 4gkh_A          120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD  199 (272)
T ss_dssp             HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred             HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence            45556666666666410                                                       12368999


Q ss_pred             CCCCceEEcCCCCeeEeccccceec
Q 039471          233 IKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       233 ikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      +.+.|||++.++.+-|+||+.+..-
T Consensus       200 l~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          200 FSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             CCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             CCCCeEEEECCeEEEEEECcccccC
Confidence            9999999998777789999987653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.05  E-value=1.1e-05  Score=73.45  Aligned_cols=59  Identities=5%  Similarity=0.087  Sum_probs=41.3

Q ss_pred             CeeEEEEcccCC---c-ChhHHHHHHHHHhccCC---CceeeeeeeeeeC---CceeEEEeccCCCCHH
Q 039471          128 NEIAVKMLEHLK---G-NGQEFINEVATIGRIHH---FHIVRLLGFCSEG---NRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       128 ~~vAvK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~~~~sL~  186 (363)
                      ..+++|+.....   . ....+.+|+++++.+..   ..+.++++++.+.   +..++|||+++|.++.
T Consensus        53 ~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           53 QKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             EEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             ceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            458888765332   1 23567889999988853   3577888887655   3568999999987664

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=0.00022  Score=64.20  Aligned_cols=32  Identities=25%  Similarity=0.257  Sum_probs=28.6

Q ss_pred             CCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            37899999999999998888899999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.46  E-value=0.00045  Score=61.17  Aligned_cols=32  Identities=22%  Similarity=0.161  Sum_probs=26.6

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ..++|+|+.+.||+ ..++.+.++||..+..-+
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            56899999999999 556678999999876543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.32  E-value=0.0012  Score=58.86  Aligned_cols=62  Identities=13%  Similarity=0.147  Sum_probs=46.7

Q ss_pred             eeeccCCeeEEEEcccCCcChhHHHHHHHHHhccC---CCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          122 FFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       122 ~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .+...+..+++|+....  ....+..|.+.|+.+.   ...+.+++++....+..++||||+++.++
T Consensus        54 ~v~~~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           54 LINDEVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEESSSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEEECCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            33344556899987633  3467889999998884   35688899888877889999999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.31  E-value=0.00092  Score=61.20  Aligned_cols=124  Identities=15%  Similarity=0.191  Sum_probs=75.0

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCC-ceeeeeeeeeeCCceeEEEeccCCCCHHHH-----------------h
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHF-HIVRLLGFCSEGNRRTLIYEFMPNGSLQKF-----------------I  189 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~-----------------l  189 (363)
                      ..+.+|+............+|.++++.+... -..++++.+.++    +||||++|.+|..-                 +
T Consensus        83 ~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~L  158 (379)
T 3feg_A           83 REVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQF  158 (379)
T ss_dssp             SEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHH
T ss_pred             CeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHH
Confidence            4588888643333456677999999888522 235667666542    89999998665311                 1


Q ss_pred             hhcCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHhh----c-CCCCCceecCCCCCceEEcCC
Q 039471          190 FSKTNSSSHRQL--SWEKLRKIAFGVAR-------------------GVEYLH----Q-GCNQRILHFDIKPHNILLDHN  243 (363)
Q Consensus       190 ~~~~~~~~~~~l--~~~~~~~i~~~i~~-------------------~l~~LH----~-~~~~~i~H~dikp~Nill~~~  243 (363)
                      +...... .+..  -+.++.++..++..                   .++.|.    . .....++|+|+.+.||+++.+
T Consensus       159 H~~~~~~-~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~  237 (379)
T 3feg_A          159 HGMEMPF-TKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSE  237 (379)
T ss_dssp             HTCCCSS-CCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESC
T ss_pred             hCCCCCC-CCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCC
Confidence            1111101 1112  24566666654422                   123332    1 223578999999999999876


Q ss_pred             ----CCeeEecccccee
Q 039471          244 ----FQPKISDFGLAKL  256 (363)
Q Consensus       244 ----~~~kl~Dfg~a~~  256 (363)
                          +.+.++||..+..
T Consensus       238 ~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          238 PENADSLMLVDFEYSSY  254 (379)
T ss_dssp             C---CCEEECCCTTCEE
T ss_pred             CCccCcEEEEecccCCc
Confidence                6899999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.26  E-value=0.00044  Score=63.80  Aligned_cols=32  Identities=19%  Similarity=0.297  Sum_probs=27.1

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ..++|+|+.|.||+++.+ .++++||..+..-+
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G~  258 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGP  258 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEEEC
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCcccccCC
Confidence            689999999999999876 48999998776543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.82  E-value=0.0074  Score=56.01  Aligned_cols=32  Identities=13%  Similarity=0.269  Sum_probs=28.5

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ..++|+|++|.|||++.++ ++++||+.+..-+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            7899999999999999876 9999999887644

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.79  E-value=0.012  Score=52.74  Aligned_cols=34  Identities=26%  Similarity=0.301  Sum_probs=29.1

Q ss_pred             CCceecCCCCCceEEcCC----CCeeEeccccceeccC
Q 039471          226 QRILHFDIKPHNILLDHN----FQPKISDFGLAKLCSK  259 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~----~~~kl~Dfg~a~~~~~  259 (363)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..-+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            689999999999999874    6789999998876544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.76  E-value=0.0023  Score=53.19  Aligned_cols=96  Identities=9%  Similarity=0.052  Sum_probs=61.3

Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      -||.+++....     .+++++++|.++.|.+.+|.-+-.+  ..-..+=+.|..|++..+|++-+.+ +.+.       
T Consensus        33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence            48999996544     7899999999999999998776210  1111333467899999999887764 1111       


Q ss_pred             ccccccccccccccCCccc-------cCceehhHHHHHHhcCCCC
Q 039471          263 IVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKN  300 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~  300 (363)
                             .....+.+||..       .=|||+|+++|..+.-..+
T Consensus        98 -------~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -------AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -------ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence                   011234566653       2479999999998854444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.71  E-value=0.0035  Score=55.79  Aligned_cols=129  Identities=13%  Similarity=0.159  Sum_probs=69.7

Q ss_pred             CCeeEEEEcccCCcChhHHHHHHHHHhccCCCc--eeeeeee------eeeCCceeEEEeccCCCCHHH-----------
Q 039471          127 SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGF------CSEGNRRTLIYEFMPNGSLQK-----------  187 (363)
Q Consensus       127 ~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~~~~sL~~-----------  187 (363)
                      +..+++|+.... ...+++..|+.++..+...+  +.+++..      ....+..+++++|++|.++..           
T Consensus        45 ~g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~  123 (322)
T 2ppq_A           45 KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGK  123 (322)
T ss_dssp             SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHH
T ss_pred             CccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHH
Confidence            345888987642 23346667888888775322  3444422      123456789999998865321           


Q ss_pred             ---HhhhcCCCCCCC---CC---CHHHHHH------------HHHHHHHHHHHhhc----CCCCCceecCCCCCceEEcC
Q 039471          188 ---FIFSKTNSSSHR---QL---SWEKLRK------------IAFGVARGVEYLHQ----GCNQRILHFDIKPHNILLDH  242 (363)
Q Consensus       188 ---~l~~~~~~~~~~---~l---~~~~~~~------------i~~~i~~~l~~LH~----~~~~~i~H~dikp~Nill~~  242 (363)
                         .++.....-...   ..   .|.....            +...+...++.+.+    .....++|+|+.+.|||++.
T Consensus       124 ~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~  203 (322)
T 2ppq_A          124 ALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLG  203 (322)
T ss_dssp             HHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEET
T ss_pred             HHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeC
Confidence               112111000000   01   1111000            00113344455542    11357999999999999998


Q ss_pred             CCCeeEecccccee
Q 039471          243 NFQPKISDFGLAKL  256 (363)
Q Consensus       243 ~~~~kl~Dfg~a~~  256 (363)
                      +..+.++||+.+..
T Consensus       204 ~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          204 DELSGLIDFYFACN  217 (322)
T ss_dssp             TEEEEECCCTTCEE
T ss_pred             CceEEEecchhccC
Confidence            76568999998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.63  E-value=0.028  Score=49.93  Aligned_cols=128  Identities=12%  Similarity=0.114  Sum_probs=70.6

Q ss_pred             eeEEEEcccCCcChhHHHHHHHHHhccCCC--ceeeeeee-----eeeCCceeEEEeccCCCCHH-----H------H--
Q 039471          129 EIAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGF-----CSEGNRRTLIYEFMPNGSLQ-----K------F--  188 (363)
Q Consensus       129 ~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~~~sL~-----~------~--  188 (363)
                      .+++|...........+..|..+++.+...  .+++++..     ...++..+++|++++|.++.     .      .  
T Consensus        51 ~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La  130 (328)
T 1zyl_A           51 RFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLG  130 (328)
T ss_dssp             CEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHH
T ss_pred             EEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHH
Confidence            589999864433456777888888887522  24455543     12245667899999875432     1      1  


Q ss_pred             -hhhcCC---CCCCCCCCHHH----------------------HHHHHHHHHHHHHHhhc-CCCCCceecCCCCCceEEc
Q 039471          189 -IFSKTN---SSSHRQLSWEK----------------------LRKIAFGVARGVEYLHQ-GCNQRILHFDIKPHNILLD  241 (363)
Q Consensus       189 -l~~~~~---~~~~~~l~~~~----------------------~~~i~~~i~~~l~~LH~-~~~~~i~H~dikp~Nill~  241 (363)
                       ++....   .......+...                      ....+.+++..++-+-. .....++|+|+++.|||++
T Consensus       131 ~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~  210 (328)
T 1zyl_A          131 RMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR  210 (328)
T ss_dssp             HHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES
T ss_pred             HHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc
Confidence             111100   00001112111                      11122222222222211 1136789999999999999


Q ss_pred             CCCCeeEeccccceecc
Q 039471          242 HNFQPKISDFGLAKLCS  258 (363)
Q Consensus       242 ~~~~~kl~Dfg~a~~~~  258 (363)
                       + .+.++||+.+..-.
T Consensus       211 -~-~~~lIDfe~a~~g~  225 (328)
T 1zyl_A          211 -D-GPMFVDLDDARNGP  225 (328)
T ss_dssp             -S-SEEECCCTTCCEEC
T ss_pred             -C-CCEEEECCCCCcCc
Confidence             4 89999998876543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.47  E-value=0.011  Score=55.13  Aligned_cols=53  Identities=17%  Similarity=0.339  Sum_probs=34.8

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCH
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..+++|+.... ...+.+.+|..+++.+...++ .++++.+.+    .+|+||++|.+|
T Consensus       106 ~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          106 NKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             SEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             ceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence            45888887432 122667789999988863333 567766543    289999987444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.36  E-value=0.009  Score=56.09  Aligned_cols=54  Identities=15%  Similarity=0.094  Sum_probs=33.7

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCH
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..+++|+........-+-.+|..+++.+...++ .++++.+..    .+|+||++|.+|
T Consensus       134 ~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          134 AKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             ceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            458888874322221122589999988864444 567776632    259999987554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.25  E-value=0.0058  Score=55.63  Aligned_cols=30  Identities=20%  Similarity=0.349  Sum_probs=25.2

Q ss_pred             CCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ..++|+|+.+.|||++.+. +.++||..+..
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            5789999999999998654 89999987764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.43  E-value=0.072  Score=46.39  Aligned_cols=62  Identities=18%  Similarity=0.132  Sum_probs=38.2

Q ss_pred             cceeecc-CCeeEEEEcccCCcC-hhHHHHHHHHHhccCC---CceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          120 SKFFFLH-SNEIAVKMLEHLKGN-GQEFINEVATIGRIHH---FHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       120 ~~~~~~~-~~~vAvK~~~~~~~~-~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ++.+.+. ++.|.+|+....... ...|..|.+.|+.+..   -.+.+++++.    ..+++|||++++..
T Consensus        31 vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           31 LYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred             EEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence            3334333 456999987643322 3457889999888842   2345555542    24789999876543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.91  E-value=0.086  Score=48.80  Aligned_cols=31  Identities=16%  Similarity=0.322  Sum_probs=26.9

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ..++|+|+.+.||+ +.++.+.++||..|..-
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            56899999999999 77888999999987653

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.91  E-value=0.31  Score=43.57  Aligned_cols=33  Identities=24%  Similarity=0.275  Sum_probs=29.0

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ..++|+|+.+.||+++.++.+.++||+.+..-.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            679999999999999988889999998876544

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.22  E-value=1.6  Score=36.16  Aligned_cols=117  Identities=15%  Similarity=0.114  Sum_probs=76.5

Q ss_pred             CCCceeeeeeeeeeCCceeEEEeccCC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCceecCC
Q 039471          156 HHFHIVRLLGFCSEGNRRTLIYEFMPN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVE-YLHQGCNQRILHFDI  233 (363)
Q Consensus       156 ~h~niv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~di  233 (363)
                      .|++.  -..+-.+++.+.+.++.-++ -++. .+         ..++....++++.+|+...+ +++     .-+|.-+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l  110 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIV  110 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEE
Confidence            57776  33333566667676765533 3443 34         45788899999999887665 444     4678889


Q ss_pred             CCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccccCc-eehhHHHHHHhcCCCCCCcchh
Q 039471          234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-FCYGMMLLEMVGCRKNNDPAVE  306 (363)
Q Consensus       234 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~Di-~slG~il~el~~g~~~~~~~~~  306 (363)
                      .|+||+++.++.+++.-.|+-..+++...              .+|   |. -++=+++..++.++..|+.-..
T Consensus       111 ~P~NL~f~~~~~p~i~hRGi~~~lpP~e~--------------~ee---~fl~qyKali~all~~K~~Fe~l~~  167 (219)
T 4ano_A          111 CPENLMFNRALEPFFLHVGVKESLPPDEW--------------DDE---RLLREVKATVLALTEGEYRFDEYLK  167 (219)
T ss_dssp             CGGGEEECTTCCEEESCCEETTTBSSCSC--------------CHH---HHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred             eCceEEEeCCCcEEEEEcCCcccCCCCCC--------------CHH---HHHHHHHHHHHHHHcCCCCHHHHHh
Confidence            99999999999999998887443332211              111   22 2567778888888777655433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.72  E-value=1.5  Score=36.18  Aligned_cols=125  Identities=10%  Similarity=0.129  Sum_probs=81.9

Q ss_pred             HHHHHhccCCCceeeeeeeeeeCCceeEEEeccC-CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 039471          148 EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP-NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQ  226 (363)
Q Consensus       148 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  226 (363)
                      |+..|. ..|++.+.. .+-.+.+...+.++.-+ +-++.. +         +.++....++++.+|+....++++    
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~~----   99 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNRT----   99 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGGS----
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhcC----
Confidence            444443 357777755 34455566666666543 233333 3         567889999999999988765553    


Q ss_pred             CceecCCCCCceEEcCCCCeeEeccccceeccCCccccccccccccccccCCccccCc-eehhHHHHHHhcCCCCCCcch
Q 039471          227 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-FCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       227 ~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~Di-~slG~il~el~~g~~~~~~~~  305 (363)
                       -+|.-+.|+||+++.++.+++.-.|+-..+++...              .+|   |. -.+=+++..+++++..|+.-.
T Consensus       100 -r~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P~~~--------------~ee---~fL~qyKAliiall~~K~~Fe~l~  161 (215)
T 4ann_A          100 -RYTFVLAPDELFFTRDGLPIAKTRGLQNVVDPLPV--------------SEA---EFLTRYKALVICAFNEKQSFDALV  161 (215)
T ss_dssp             -SEECCCSGGGEEECTTSCEEESCCEETTTBSCCCC--------------CHH---HHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred             -ceEEEEecceEEEcCCCCEEEEEccCccCCCCCCC--------------CHH---HHHHHHHHHHHHHHcCCCCHHHHH
Confidence             57888999999999999999998887443332210              011   22 256778888888888776543


Q ss_pred             h
Q 039471          306 E  306 (363)
Q Consensus       306 ~  306 (363)
                      .
T Consensus       162 ~  162 (215)
T 4ann_A          162 E  162 (215)
T ss_dssp             H
T ss_pred             c
Confidence            3

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	363
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-43
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-43
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-40
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-40
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-35
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-33
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-28
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-21
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-20
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-20
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-10

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 4e-48
 Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 32/250 (12%)

Query: 126 HSNEIAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
              ++AVKML       Q+   F NEV  + +  H +I+  +G+ +      ++ ++   
Sbjct: 29  WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEG 87

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
            SL   +          +    KL  IA   A+G++YLH    + I+H D+K +NI L  
Sbjct: 88  SSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHE 139

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-----------FCYGMML 291
           +   KI DFGLA + S+           G+  ++APE+               + +G++L
Sbjct: 140 DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199

Query: 292 LEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI 351
            E++   +     +  + QI F         +G+               + +  +   C+
Sbjct: 200 YELM-TGQLPYSNINNRDQIIF--------MVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250

Query: 352 QWNPTERPSM 361
           +    ERP  
Sbjct: 251 KKKRDERPLF 260

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 4e-44
 Identities = 47/245 (19%), Positives = 100/245 (40%), Gaps = 30/245 (12%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           L+ +++A+K +     + ++FI E   + ++ H  +V+L G C E     L++EFM +G 
Sbjct: 27  LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L  ++ ++         + E L  +   V  G   +       ++H D+   N L+  N 
Sbjct: 87  LSDYLRTQ-----RGLFAAETLLGMCLDVCEG---MAYLEEACVIHRDLAARNCLVGENQ 138

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             K+SDFG+ +    D    S    +    + +PE+FS +        + +G+++ E+  
Sbjct: 139 VIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
             K              P    +   + +++   F        +  +  +   C +  P 
Sbjct: 198 EGK-------------IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPE 244

Query: 357 ERPSM 361
           +RP+ 
Sbjct: 245 DRPAF 249

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 1e-43
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 43/262 (16%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML  +      +  ++E+  + ++  H +IV LLG C+      LI+E+   G L
Sbjct: 69  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128

Query: 186 QKFIFSKTNSSSHRQ-----------------LSWEKLRKIAFGVARGVEYLHQGCNQRI 228
             ++ SK    S  +                 L++E L   A+ VA+G+E+L     +  
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSC 185

Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF------- 281
           +H D+   N+L+ H    KI DFGLA+    D + V R  AR    ++APE         
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245

Query: 282 -SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA 340
            S  + YG++L E+     N  P + + +  Y  + I N  ++          D      
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--KLIQNGFKM----------DQPFYAT 293

Query: 341 RKLAIVAIWCIQWNPTERPSMP 362
            ++ I+   C  ++  +RPS P
Sbjct: 294 EEIYIIMQSCWAFDSRKRPSFP 315

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-43
 Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 38/256 (14%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            +AVKML         +  ++E+  +  + +H +IV LLG C+ G    +I E+   G L
Sbjct: 55  TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114

Query: 186 QKFIFSKTNS------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDI 233
             F+  K +S                 L  E L   ++ VA+G+ +L     +  +H D+
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDL 171

Query: 234 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNF 285
              NILL H    KI DFGLA+    D + V +  AR    ++APE          S  +
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231

Query: 286 CYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAI 345
            YG+ L E+     +  P + + S+ Y  + I    R+             E    ++  
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFY--KMIKEGFRM----------LSPEHAPAEMYD 279

Query: 346 VAIWCIQWNPTERPSM 361
           +   C   +P +RP+ 
Sbjct: 280 IMKTCWDADPLKRPTF 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-43
 Identities = 47/241 (19%), Positives = 95/241 (39%), Gaps = 30/241 (12%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
           ++A+KM++    +  EFI E   +  + H  +V+L G C++     +I E+M NG L  +
Sbjct: 30  DVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +          +   ++L ++   V   +EYL     ++ LH D+   N L++     K+
Sbjct: 90  LREM-----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKV 141

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKN 300
           SDFGL++    D    S   ++    +  PE+   +        + +G+++ E+    K 
Sbjct: 142 SDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK- 199

Query: 301 NDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
                        P   +      + +            + K+  +   C      ERP+
Sbjct: 200 ------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247

Query: 361 M 361
            
Sbjct: 248 F 248

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 6e-43
 Identities = 48/269 (17%), Positives = 95/269 (35%), Gaps = 39/269 (14%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT----LIYEFM 180
               E+AVK+    +        E+     + H +I+  +   ++ N       L+ ++ 
Sbjct: 24  WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC-----NQRILHFDIKP 235
            +GSL  ++       +   ++ E + K+A   A G+ +LH           I H D+K 
Sbjct: 84  EHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136

Query: 236 HNILLDHNFQPKISDFGLAKLC--SKDISIVSRTAARGTSGYIAPELF------------ 281
            NIL+  N    I+D GLA     + D   ++     GT  Y+APE+             
Sbjct: 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196

Query: 282 --SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD--- 336
             +  +  G++  E+           + Q   Y        +   +++  + +   +   
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256

Query: 337 ----EGIARKLAIVAIWCIQWNPTERPSM 361
                   R +A +   C   N   R + 
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTA 285

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (374), Expect = 7e-43
 Identities = 61/241 (25%), Positives = 114/241 (47%), Gaps = 29/241 (12%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
            +AVK L+      +EF+ E A +  I H ++V+LLG C+      +I EFM  G+L  +
Sbjct: 44  TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 248
           +       + +++S   L  +A  ++  +EYL +   +  +H D+   N L+  N   K+
Sbjct: 104 LREC----NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKV 156

Query: 249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRKN 300
           +DFGL++L + D +  +   A+    + APE  + N        + +G++L E+     +
Sbjct: 157 ADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215

Query: 301 NDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPS 360
             P +             +  ++ + L  D+  +  EG   K+  +   C QWNP++RPS
Sbjct: 216 PYPGI-------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262

Query: 361 M 361
            
Sbjct: 263 F 263

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 9e-43
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 30/242 (12%)

Query: 128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
            ++AVK L+    +   F+ E   + ++ H  +VRL    ++     +I E+M NGSL  
Sbjct: 38  TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVD 96

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+ +     S  +L+  KL  +A  +A G+ ++ +   +  +H D++  NIL+      K
Sbjct: 97  FLKTP----SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCK 149

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRK 299
           I+DFGLA+L   +    +R  A+    + APE  +          + +G++L E+V   +
Sbjct: 150 IADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
                         P        + Q L   +     +    +L  +   C +  P +RP
Sbjct: 209 -------------IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255

Query: 360 SM 361
           + 
Sbjct: 256 TF 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 34/245 (13%)

Query: 130 IAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L   + +   ++F++E + +G+  H +++ L G  ++     +I EFM NGSL  
Sbjct: 57  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+          Q +  +L  +  G+A G++YL        +H D+   NIL++ N   K
Sbjct: 117 FLRQN-----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCK 168

Query: 248 ISDFGLAKLCSKDISIVSRTAA---RGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
           +SDFGL++    D S  + T+A   +    + APE             + YG+++ E++ 
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
             +              P W      +   +  D+           L  + + C Q +  
Sbjct: 229 YGE-------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRN 275

Query: 357 ERPSM 361
            RP  
Sbjct: 276 HRPKF 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 2e-41
 Identities = 54/246 (21%), Positives = 100/246 (40%), Gaps = 35/246 (14%)

Query: 125 LHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-NRRTLIYEFMPNG 183
              N++AVK +++     Q F+ E + + ++ H ++V+LLG   E      ++ E+M  G
Sbjct: 28  YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
           SL  ++ S+        L  + L K +  V   +EYL        +H D+   N+L+  +
Sbjct: 87  SLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSED 139

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
              K+SDFGL K  S       +   +    + APE             + +G++L E+ 
Sbjct: 140 NVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194

Query: 296 GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP 355
              +   P +         + +  R+  G ++      D  +G    +  V   C   + 
Sbjct: 195 SFGRVPYPRIP-------LKDVVPRVEKGYKM------DAPDGCPPAVYEVMKNCWHLDA 241

Query: 356 TERPSM 361
             RPS 
Sbjct: 242 AMRPSF 247

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-41
 Identities = 51/244 (20%), Positives = 100/244 (40%), Gaps = 33/244 (13%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           ++A+K+L     K + +E + E   + ++ + +IVRL+G C +     L+ E    G L 
Sbjct: 38  DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 96

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+  K       ++    + ++   V+ G++YL +   +  +H D+   N+LL +    
Sbjct: 97  KFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYA 148

Query: 247 KISDFGLAK-LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
           KISDFGL+K L + D    +R+A +    + APE  +          + YG+ + E +  
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 208

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
            +              P        +   +      +       +L  +   C  +   +
Sbjct: 209 GQ-------------KPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 255

Query: 358 RPSM 361
           RP  
Sbjct: 256 RPDF 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (363), Expect = 6e-41
 Identities = 47/248 (18%), Positives = 88/248 (35%), Gaps = 43/248 (17%)

Query: 129 EIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            +A+K + +         Q+ I EV  + ++ H + ++  G     +   L+ E+    +
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
                  K      + L   ++  +  G  +G+ YLH      ++H D+K  NILL    
Sbjct: 102 SDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPG 152

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLE 293
             K+ DFG A + +   S V      GT  ++APE+               +  G+  +E
Sbjct: 153 LVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206

Query: 294 MVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
           +   RK     +   S +Y                 +         +         C+Q 
Sbjct: 207 LA-ERKPPLFNMNAMSALY------------HIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 354 NPTERPSM 361
            P +RP+ 
Sbjct: 254 IPQDRPTS 261

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-40
 Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 38/248 (15%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT----LIYEFMP 181
           E+A   L   +  K   Q F  E   +  + H +IVR         +      L+ E M 
Sbjct: 36  EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL- 240
           +G+L+ ++         + +  + LR     + +G+++LH      I+H D+K  NI + 
Sbjct: 96  SGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFIT 148

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-------FCYGMMLLE 293
                 KI D GLA L     +     A  GT  ++APE++          + +GM +LE
Sbjct: 149 GPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLE 204

Query: 294 MVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
           M                  + E         +          D+    ++  +   CI+ 
Sbjct: 205 MATSEYP------------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252

Query: 354 NPTERPSM 361
           N  ER S+
Sbjct: 253 NKDERYSI 260

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-40
 Identities = 51/244 (20%), Positives = 100/244 (40%), Gaps = 30/244 (12%)

Query: 126 HSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            +  +A+K L+    + + F+ E   + ++ H  +V+L    SE     ++ E+M  GSL
Sbjct: 40  GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSL 98

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
             F+  +T           +L  +A  +A G+ Y+ +      +H D++  NIL+  N  
Sbjct: 99  LDFLKGETGKYLR----LPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLV 151

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            K++DFGLA+L   +    +R  A+    + APE             + +G++L E+   
Sbjct: 152 CKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
            +   P +           + +++  G  +               L  +   C +  P E
Sbjct: 211 GRVPYPGMV-------NREVLDQVERGYRMPC------PPECPESLHDLMCQCWRKEPEE 257

Query: 358 RPSM 361
           RP+ 
Sbjct: 258 RPTF 261

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (352), Expect = 2e-39
 Identities = 62/261 (23%), Positives = 100/261 (38%), Gaps = 44/261 (16%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +AVKML  E       +F  E A +    + +IV+LLG C+ G    L++E+M  G L 
Sbjct: 45  MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104

Query: 187 KFIFSKT------------------NSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRI 228
           +F+ S +                  +S     LS  +   IA  VA G+ YL +   ++ 
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 161

Query: 229 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---- 284
           +H D+   N L+  N   KI+DFGL++         +         ++ PE    N    
Sbjct: 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221

Query: 285 ----FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA 340
               + YG++L E+          +         E +   +R G  L         E   
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMA-------HEEVIYYVRDGNILAC------PENCP 268

Query: 341 RKLAIVAIWCIQWNPTERPSM 361
            +L  +   C    P +RPS 
Sbjct: 269 LELYNLMRLCWSKLPADRPSF 289

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 2e-39
 Identities = 50/248 (20%), Positives = 94/248 (37%), Gaps = 33/248 (13%)

Query: 129 EIAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTL--IYEFMPNG 183
            +  K L++    +   Q  ++EV  +  + H +IVR      +    TL  + E+   G
Sbjct: 31  ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQ--GCNQRILHFDIKPHNILLD 241
            L   I     +   + L  E + ++   +   ++  H+       +LH D+KP N+ LD
Sbjct: 91  DLASVITK--GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 148

Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLE 293
                K+ DFGLA++ + D S     A  GT  Y++PE  +R         +  G +L E
Sbjct: 149 GKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 206

Query: 294 MVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
           +                   P   +++  L  ++            + +L  +    +  
Sbjct: 207 LCALM--------------PPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 252

Query: 354 NPTERPSM 361
               RPS+
Sbjct: 253 KDYHRPSV 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-39
 Identities = 50/272 (18%), Positives = 93/272 (34%), Gaps = 51/272 (18%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A K++  E       + I E+  +   +  +IV   G        ++  E M  GSL 
Sbjct: 33  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           + +          ++  + L K++  V +G+ YL +    +I+H D+KP NIL++   + 
Sbjct: 93  QVLK------KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 144

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV--- 295
           K+ DFG++      ++     +  GT  Y++PE             +  G+ L+EM    
Sbjct: 145 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

Query: 296 ----GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI--- 348
                        +              R R        +  D    +A    +  I   
Sbjct: 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 260

Query: 349 -------------------WCIQWNPTERPSM 361
                               C+  NP ER  +
Sbjct: 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-39
 Identities = 55/244 (22%), Positives = 103/244 (42%), Gaps = 32/244 (13%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A+K L   + +    +F+ E   +G+  H +I+RL G  S+     +I E+M NG+L 
Sbjct: 38  PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALD 97

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
           KF+  K       + S  +L  +  G+A G++YL    N   +H D+   NIL++ N   
Sbjct: 98  KFLREK-----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149

Query: 247 KISDFGLAKLCSKDIS-IVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
           K+SDFGL+++   D     + +  +    + APE  S          + +G+++ E++  
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
            +              P W  +   + + +   F           +  + + C Q     
Sbjct: 210 GER-------------PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERAR 256

Query: 358 RPSM 361
           RP  
Sbjct: 257 RPKF 260

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 49/245 (20%), Positives = 97/245 (39%), Gaps = 35/245 (14%)

Query: 129 EIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            +AVK+L++   +     E + E   + ++ + +IVR++G C E     L+ E    G L
Sbjct: 36  TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPL 94

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
            K++        +R +  + + ++   V+ G++YL +      +H D+   N+LL     
Sbjct: 95  NKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHY 145

Query: 246 PKISDFGLAKLCSKDIS-IVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
            KISDFGL+K    D +   ++T  +    + APE  +          + +G+++ E   
Sbjct: 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
             +              P        +   L          G  R++  +   C  ++  
Sbjct: 206 YGQ-------------KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE 252

Query: 357 ERPSM 361
            RP  
Sbjct: 253 NRPGF 257

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 32/244 (13%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +AVK++  +      +    E+     ++H ++V+  G   EGN + L  E+   G L 
Sbjct: 32  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             I           +     ++    +  GV YLH      I H DIKP N+LLD     
Sbjct: 92  DRIEP------DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNL 142

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---------FCYGMMLLEMVGC 297
           KISDFGLA +   +          GT  Y+APEL  R          +  G++L  M+  
Sbjct: 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
               D   +           Y+  +  +     +++     +A     +    +  NP+ 
Sbjct: 203 ELPWDQPSDS-------CQEYSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSA 250

Query: 358 RPSM 361
           R ++
Sbjct: 251 RITI 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 44/247 (17%), Positives = 93/247 (37%), Gaps = 36/247 (14%)

Query: 129 EIAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
             A K+++       ++++ E+  +    H +IV+LL      N   ++ EF   G++  
Sbjct: 39  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +         R L+  +++ +       + YLH     +I+H D+K  NIL   +   K
Sbjct: 99  VMLEL-----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIK 150

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN-------------FCYGMMLLEM 294
           ++DFG++   ++ I    R +  GT  ++APE+                 +  G+ L+EM
Sbjct: 151 LADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208

Query: 295 VGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
                 +     ++        +  ++   +   L             L      C++ N
Sbjct: 209 AEIEPPHHELNPMR--------VLLKIAKSEPPTLAQPSRWSSNFKDFLK----KCLEKN 256

Query: 355 PTERPSM 361
              R + 
Sbjct: 257 VDARWTT 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-38
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 37/255 (14%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE-GNRRTLIYEFMPNGS 184
            +AVKML         +  ++E+  +  I HH ++V LLG C++ G    +I EF   G+
Sbjct: 45  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104

Query: 185 LQKFIFSKTNSSSHRQ----------LSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIK 234
           L  ++ SK N     +          L+ E L   +F VA+G+E+L     ++ +H D+ 
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 161

Query: 235 PHNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFC 286
             NILL      KI DFGLA+   KD   V +  AR    ++APE          S  + 
Sbjct: 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221

Query: 287 YGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV 346
           +G++L E+     +  P V+I       E    R++ G  +         +    ++   
Sbjct: 222 FGVLLWEIFSLGASPYPGVKI------DEEFCRRLKEGTRMRA------PDYTTPEMYQT 269

Query: 347 AIWCIQWNPTERPSM 361
            + C    P++RP+ 
Sbjct: 270 MLDCWHGEPSQRPTF 284

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 6e-38
 Identities = 49/247 (19%), Positives = 95/247 (38%), Gaps = 44/247 (17%)

Query: 129 EIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            +A+K+L   +        +   EV     + H +I+RL G+  +  R  LI E+ P G+
Sbjct: 33  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           + + +          +   ++       +A  + Y H    +R++H DIKP N+LL    
Sbjct: 93  VYRELQK------LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAG 143

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
           + KI+DFG +           RT   GT  Y+ PE+            +  G++  E + 
Sbjct: 144 ELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199

Query: 297 CRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
            +     +   E   +I   E+ +                  + +      +    ++ N
Sbjct: 200 GKPPFEANTYQETYKRISRVEFTF-----------------PDFVTEGARDLISRLLKHN 242

Query: 355 PTERPSM 361
           P++RP +
Sbjct: 243 PSQRPML 249

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-37
 Identities = 46/242 (19%), Positives = 87/242 (35%), Gaps = 32/242 (13%)

Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K L         +E ++E   +  + + H+ RLLG C     + LI + MP G L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 99

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           ++           +  + L      +A+G+ YL    ++R++H D+   N+L+      K
Sbjct: 100 YVREH-----KDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVK 151

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRK 299
           I+DFGLAKL   +         +    ++A E             + YG+ + E++    
Sbjct: 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
                         P        +   L               + ++ + C   +   RP
Sbjct: 212 -------------KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP 258

Query: 360 SM 361
             
Sbjct: 259 KF 260

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-37
 Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 40/254 (15%)

Query: 129 EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           + A+K ++    K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L
Sbjct: 39  DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 98

Query: 186 QKFIFSKTN----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
             F+               +S+   LS ++L   A  VARG++YL Q   ++ +H D+  
Sbjct: 99  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAA 155

Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCY 287
            NIL+  N+  KI+DFGL++        V +T  R    ++A E  + +        + Y
Sbjct: 156 RNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212

Query: 288 GMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA 347
           G++L E+V                  P        L ++L   +  +       ++  + 
Sbjct: 213 GVLLWEIVSLGGT-------------PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLM 259

Query: 348 IWCIQWNPTERPSM 361
             C +  P ERPS 
Sbjct: 260 RQCWREKPYERPSF 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 4e-37
 Identities = 54/246 (21%), Positives = 92/246 (37%), Gaps = 34/246 (13%)

Query: 129 EIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
            +AVK L+    +      +FI EV  +  + H +++RL G       + ++ E  P GS
Sbjct: 38  SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGS 96

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +                L + A  VA G+ YL     +R +H D+   N+LL    
Sbjct: 97  LLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRD 148

Query: 245 QPKISDFGLAK-LCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
             KI DFGL + L   D   V +   +    + APE             + +G+ L EM 
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208

Query: 296 GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP 355
              +     +         + ++   + G+ L         E   + +  V + C    P
Sbjct: 209 TYGQEPWIGLNGS------QILHKIDKEGERL------PRPEDCPQDIYNVMVQCWAHKP 256

Query: 356 TERPSM 361
            +RP+ 
Sbjct: 257 EDRPTF 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 5e-36
 Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 34/246 (13%)

Query: 129 EIAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEG-NRRTLIYEFMPNGSL 185
             AVK L  +   G+  +F+ E   +    H +++ LLG C        ++  +M +G L
Sbjct: 57  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           + FI ++         + + L      VA+G   +    +++ +H D+   N +LD  F 
Sbjct: 117 RNFIRNE-----THNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFT 168

Query: 246 PKISDFGLAKLCSKD--ISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
            K++DFGLA+        S+ ++T A+    ++A E             + +G++L E++
Sbjct: 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228

Query: 296 GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNP 355
                  P V          ++    RL Q           E     L  V + C     
Sbjct: 229 TRGAPPYPDVNTFDIT---VYLLQGRRLLQ----------PEYCPDPLYEVMLKCWHPKA 275

Query: 356 TERPSM 361
             RPS 
Sbjct: 276 EMRPSF 281

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-36
 Identities = 53/247 (21%), Positives = 97/247 (39%), Gaps = 30/247 (12%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A+K +          EF+NE + +   +  H+VRLLG  S+G    +I E M  G L+
Sbjct: 52  RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111

Query: 187 KFIF----SKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
            ++     +  N+      S  K+ ++A  +A G+ YL      + +H D+   N ++  
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAE 168

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
           +F  KI DFG+ +   +               +++PE             + +G++L E+
Sbjct: 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228

Query: 295 VGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
               +     +         E +   +  G  L      D  +     L  +   C Q+N
Sbjct: 229 ATLAEQPYQGLS-------NEQVLRFVMEGGLL------DKPDNCPDMLFELMRMCWQYN 275

Query: 355 PTERPSM 361
           P  RPS 
Sbjct: 276 PKMRPSF 282

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-35
 Identities = 48/242 (19%), Positives = 97/242 (40%), Gaps = 33/242 (13%)

Query: 130 IAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           +A+K  ++   +   ++F+ E  T+ +  H HIV+L+G  +E     +I E    G L+ 
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRS 96

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
           F+  +        L    L   A+ ++  + YL     +R +H DI   N+L+  N   K
Sbjct: 97  FLQVR-----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVK 148

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRK 299
           + DFGL++         + +  +    ++APE  +          + +G+ + E++    
Sbjct: 149 LGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
                V+          +  R+  G+ L +             L  +   C  ++P+ RP
Sbjct: 208 KPFQGVK-------NNDVIGRIENGERLPM------PPNCPPTLYSLMTKCWAYDPSRRP 254

Query: 360 SM 361
             
Sbjct: 255 RF 256

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 7e-35
 Identities = 59/254 (23%), Positives = 115/254 (45%), Gaps = 37/254 (14%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++AVKML  +  + +  + I+E+  +  I  H +I+ LLG C++     +I E+   G+L
Sbjct: 47  KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106

Query: 186 QKFIFSK----------TNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKP 235
           ++++ ++           + +   QLS + L   A+ VARG+EYL     ++ +H D+  
Sbjct: 107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 163

Query: 236 HNILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCY 287
            N+L+  +   KI+DFGLA+           T  R    ++APE             + +
Sbjct: 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223

Query: 288 GMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVA 347
           G++L E+     +  P V +       E ++  ++ G  +      D       +L ++ 
Sbjct: 224 GVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRM------DKPSNCTNELYMMM 270

Query: 348 IWCIQWNPTERPSM 361
             C    P++RP+ 
Sbjct: 271 RDCWHAVPSQRPTF 284

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 47/242 (19%), Positives = 93/242 (38%), Gaps = 33/242 (13%)

Query: 129 EIAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A++ +   +   +E  INE+  +    + +IV  L     G+   ++ E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 247
            +           +   ++  +     + +E+LH     +++H DIK  NILL  +   K
Sbjct: 107 VVT-------ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVK 156

Query: 248 ISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCRK 299
           ++DFG     + + S   R+   GT  ++APE+ +R         +  G+M +EM+    
Sbjct: 157 LTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

Query: 300 NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERP 359
                        +      R           E    E ++         C+  +  +R 
Sbjct: 215 P------------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262

Query: 360 SM 361
           S 
Sbjct: 263 SA 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  124 bits (313), Expect = 2e-33
 Identities = 47/245 (19%), Positives = 95/245 (38%), Gaps = 33/245 (13%)

Query: 128 NEIAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
           N  A K +     + +E    E+ T+  + H  +V L     + N   +IYEFM  G L 
Sbjct: 52  NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 111

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNF 244
           + +  +     H ++S ++  +    V +G+ ++H+      +H D+KP NI+     + 
Sbjct: 112 EKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSN 163

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
           + K+ DFGL        S+   T   GT+ + APE+            +  G++   ++ 
Sbjct: 164 ELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
                          +  E     +R  +    + ++    GI+          +  +P 
Sbjct: 221 GL-----------SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 269

Query: 357 ERPSM 361
            R ++
Sbjct: 270 TRMTI 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 9e-32
 Identities = 53/245 (21%), Positives = 92/245 (37%), Gaps = 36/245 (14%)

Query: 129 EIAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
           E A+K+LE      +        E   + R+ H   V+L     +  +      +  NG 
Sbjct: 35  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L K+I                 R     +   +EYLH    + I+H D+KP NILL+ + 
Sbjct: 95  LLKYIRK------IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDM 145

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             +I+DFG AK+ S +       +  GT+ Y++PEL +          +  G ++ ++V 
Sbjct: 146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205

Query: 297 CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
                            P    N   + Q++ +  E D  E    K   +    +  + T
Sbjct: 206 GL--------------PPFRAGNEYLIFQKI-IKLEYDFPEKFFPKARDLVEKLLVLDAT 250

Query: 357 ERPSM 361
           +R   
Sbjct: 251 KRLGC 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  118 bits (297), Expect = 5e-31
 Identities = 46/244 (18%), Positives = 94/244 (38%), Gaps = 33/244 (13%)

Query: 129 EIAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
               K +      +     NE++ + ++HH  ++ L     +     LI EF+  G L  
Sbjct: 56  VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP- 246
            I ++       ++S  ++         G++++H+     I+H DIKP NI+ +      
Sbjct: 116 RIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASS 167

Query: 247 -KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGC 297
            KI DFGLA   + D  +   T    T+ + APE+  R         +  G++   ++  
Sbjct: 168 VKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224

Query: 298 RKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTE 357
                         +  E     ++  +    +F+ED    ++ +        +Q  P +
Sbjct: 225 L-----------SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRK 273

Query: 358 RPSM 361
           R ++
Sbjct: 274 RLTV 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 38/245 (15%), Positives = 82/245 (33%), Gaps = 36/245 (14%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF 188
               K ++    +      E++ +    H +I+ L           +I+EF+    + + 
Sbjct: 32  TYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFER 91

Query: 189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQP 246
           I +        +L+  ++      V   +++LH      I HFDI+P NI+     +   
Sbjct: 92  INTS-----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTI 143

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
           KI +FG A+         +         Y APE+   +        +  G ++  ++   
Sbjct: 144 KIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200

Query: 299 K--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPT 356
                +   +I   I   E+              F+E+  + I+ +        +     
Sbjct: 201 NPFLAETNQQIIENIMNAEY-------------TFDEEAFKEISIEAMDFVDRLLVKERK 247

Query: 357 ERPSM 361
            R + 
Sbjct: 248 SRMTA 252

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (282), Expect = 2e-29
 Identities = 47/243 (19%), Positives = 88/243 (36%), Gaps = 30/243 (12%)

Query: 129 EIAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A+K +  + L+G      NE+A + +I H +IV L      G    LI + +  G L 
Sbjct: 36  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             I            +     ++ F V   V+YLH                  LD + + 
Sbjct: 96  DRI------VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 149

Query: 247 KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVGCR 298
            ISDFGL+K+          + A GT GY+APE+ ++         +  G++   ++   
Sbjct: 150 MISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206

Query: 299 KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTER 358
                        ++ E          +   +F+    + I+          ++ +P +R
Sbjct: 207 P-----------PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 255

Query: 359 PSM 361
            + 
Sbjct: 256 FTC 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  112 bits (280), Expect = 3e-29
 Identities = 46/258 (17%), Positives = 95/258 (36%), Gaps = 48/258 (18%)

Query: 129 EIAVKML----------EHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIY 177
           E AVK++          E ++   +  + EV  + ++  H +I++L           L++
Sbjct: 30  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89

Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           + M  G L  ++      +    LS ++ RKI   +   +  LH+     I+H D+KP N
Sbjct: 90  DLMKKGELFDYL------TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPEN 140

Query: 238 ILLDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN------------- 284
           ILLD +   K++DFG +                GT  Y+APE+   +             
Sbjct: 141 ILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 197

Query: 285 -FCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKL 343
            +  G+++  ++                ++       +R+       F     +  +  +
Sbjct: 198 MWSTGVIMYTLLAGSP-----------PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246

Query: 344 AIVAIWCIQWNPTERPSM 361
             +    +   P +R + 
Sbjct: 247 KDLVSRFLVVQPQKRYTA 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  113 bits (283), Expect = 5e-29
 Identities = 50/250 (20%), Positives = 91/250 (36%), Gaps = 41/250 (16%)

Query: 129 EIAVKML-------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
             A+K L       +  +         ++ +       IV +       ++ + I + M 
Sbjct: 31  MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G L   +      S H   S   +R  A  +  G+E++H    + +++ D+KP NILLD
Sbjct: 91  GGDLHYHL------SQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLD 141

Query: 242 HNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLL 292
            +   +ISD GLA   SK        A+ GT GY+APE+  +   Y         G ML 
Sbjct: 142 EHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197

Query: 293 EMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ 352
           ++            ++    F +           + L    +  +  + +L  +    +Q
Sbjct: 198 KL------------LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 245

Query: 353 WNPTERPSMP 362
            +   R    
Sbjct: 246 RDVNRRLGCL 255

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 4e-28
 Identities = 48/249 (19%), Positives = 99/249 (39%), Gaps = 37/249 (14%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFC----SEGNRRTLIYEFMPNG 183
           + A+KML+    +  +   EV    R     HIVR++       +      ++ E +  G
Sbjct: 39  KFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 94

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            L   I  + +    +  +  +  +I   +   ++YLH      I H D+KP N+L    
Sbjct: 95  ELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK 147

Query: 244 FQP---KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLL 292
                 K++DFG AK  +   S+ +      T  Y+APE+            +  G+++ 
Sbjct: 148 RPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204

Query: 293 EMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ 352
            ++       P       +     +  R+R+GQ    +F       ++ ++ ++    ++
Sbjct: 205 ILLCGY----PPFYSNHGLAISPGMKTRIRMGQ---YEFPNPEWSEVSEEVKMLIRNLLK 257

Query: 353 WNPTERPSM 361
             PT+R ++
Sbjct: 258 TEPTQRMTI 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-28
 Identities = 47/261 (18%), Positives = 91/261 (34%), Gaps = 34/261 (13%)

Query: 129 EIAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ 186
            +A+K +   +     Q  + E+  + R  H +I+ +           +   ++    + 
Sbjct: 35  RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94

Query: 187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 246
             ++        + LS + +    + + RG++Y+H      +LH D+KP N+LL+     
Sbjct: 95  ADLYKLLK---TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDL 148

Query: 247 KISDFGLAKLCSKD-ISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMV- 295
           KI DFGLA++   D       T    T  Y APE+   +  Y         G +L EM+ 
Sbjct: 149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208

Query: 296 -----GCRKNNDPAVEIQSQIYFP-EWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI- 348
                  +   D    I   +  P +   N +   +             +          
Sbjct: 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 268

Query: 349 --------WCIQWNPTERPSM 361
                     + +NP +R  +
Sbjct: 269 SKALDLLDKMLTFNPHKRIEV 289

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (265), Expect = 3e-27
 Identities = 49/251 (19%), Positives = 97/251 (38%), Gaps = 41/251 (16%)

Query: 129 EIAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLLGFC----SEGNRRTLIYEFM 180
           ++AVK+L             F  E      ++H  IV +          G    ++ E++
Sbjct: 34  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
              +L+  + +         ++ ++  ++     + + + HQ     I+H D+KP NI++
Sbjct: 94  DGVTLRDIVHT------EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMI 144

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAAR-GTSGYIAPELFSRN--------FCYGMML 291
                 K+ DFG+A+  +   + V++TAA  GT+ Y++PE    +        +  G +L
Sbjct: 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 204

Query: 292 LEMVGCRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIW 349
            E++        D  V +  Q    + I                   EG++  L  V + 
Sbjct: 205 YEVLTGEPPFTGDSPVSVAYQHVREDPI-------------PPSARHEGLSADLDAVVLK 251

Query: 350 CIQWNPTERPS 360
            +  NP  R  
Sbjct: 252 ALAKNPENRYQ 262

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 3e-26
 Identities = 54/253 (21%), Positives = 88/253 (34%), Gaps = 54/253 (21%)

Query: 129 EIAVKMLEHLK-------GNGQEFINEVATIGRIHHFH--IVRLLGFCSEGNRRTLIYEF 179
            +A+K +E  +        NG     EV  + ++      ++RLL +    +   LI E 
Sbjct: 31  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
                      ++        L  E  R   + V   V +     N  +LH DIK  NIL
Sbjct: 91  PEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENIL 142

Query: 240 LDHN-FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---------FCYGM 289
           +D N  + K+ DFG   L    +     T   GT  Y  PE    +         +  G+
Sbjct: 143 IDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198

Query: 290 MLLEMV-GCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI 348
           +L +MV G          I+ Q++F + +          C                    
Sbjct: 199 LLYDMVCGDIPFEHDEEIIRGQVFFRQRV-------SSECQHLIR--------------- 236

Query: 349 WCIQWNPTERPSM 361
           WC+   P++RP+ 
Sbjct: 237 WCLALRPSDRPTF 249

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 3e-26
 Identities = 57/261 (21%), Positives = 93/261 (35%), Gaps = 39/261 (14%)

Query: 129 EIAVKML------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
            +A+K +      E   G  +  + E+  +  + H +I+ LL      +  +L+++FM  
Sbjct: 25  IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
                         +   L+   ++       +G+EYLHQ     ILH D+KP+N+LLD 
Sbjct: 85  DLEVIIK------DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDE 135

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLE 293
           N   K++DFGLAK         + T    T  Y APEL      Y         G +L E
Sbjct: 136 NGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 193

Query: 294 MVG------CRKNNDPAVEIQSQIYFP---EWIYNRMRLGQELCLDFEEDGDEGIARKLA 344
           ++          + D    I   +  P   +W              F       I     
Sbjct: 194 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 253

Query: 345 IVAI----WCIQWNPTERPSM 361
              +        +NP  R + 
Sbjct: 254 DDLLDLIQGLFLFNPCARITA 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 5e-26
 Identities = 55/259 (21%), Positives = 104/259 (40%), Gaps = 32/259 (12%)

Query: 129 EIAVKMLEHLKGNG---QEFINEVA---TIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
            +A+K +    G        I EVA    +    H ++VRL   C+           +  
Sbjct: 35  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
             + + + +  +      +  E ++ + F + RG+++LH     R++H D+KP NIL+  
Sbjct: 95  EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTS 151

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEM 294
           + Q K++DFGLA++ S  +++ S      T  Y APE+  ++        +  G +  EM
Sbjct: 152 SGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208

Query: 295 VGCR------KNNDPAVEIQSQIYFP--EWIYNRMRLGQELCLDFEEDGDEGIARKLAIV 346
              +       + D   +I   I  P  E     + L ++          E     +  +
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268

Query: 347 AI----WCIQWNPTERPSM 361
                  C+ +NP +R S 
Sbjct: 269 GKDLLLKCLTFNPAKRISA 287

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (254), Expect = 2e-25
 Identities = 42/250 (16%), Positives = 77/250 (30%), Gaps = 34/250 (13%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           E+A+K+   +K    +   E      +     I  +    +EG+   ++ E +       
Sbjct: 34  EVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDL 92

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNF 244
           F F        R+ S + +  +A  +   +EY+H    +  +H D+KP N L        
Sbjct: 93  FNFCS------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGN 143

Query: 245 QPKISDFGLAKLCS-----KDISIVSRTAARGTSGYIAPELFSRN--------FCYGMML 291
              I DFGLAK        + I         GT+ Y +                  G +L
Sbjct: 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203

Query: 292 LEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCI 351
           +                 +  +      +M           E   +G   + A    +C 
Sbjct: 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMS-------TPIEVLCKGYPSEFATYLNFCR 256

Query: 352 QWNPTERPSM 361
                ++P  
Sbjct: 257 SLRFDDKPDY 266

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 46/248 (18%), Positives = 88/248 (35%), Gaps = 43/248 (17%)

Query: 129 EIAVKMLE----HLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
             A+K L+     +  + +  + E   +     H  +  +            + E++  G
Sbjct: 29  FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            L   I S        +    +    A  +  G+++LH    + I++ D+K  NILLD +
Sbjct: 89  DLMYHIQS------CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKD 139

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
              KI+DFG+ K      +        GT  YIAPE+            + +G++L EM+
Sbjct: 140 GHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197

Query: 296 GCRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
             +   +     E+   I      Y R           E++  + + +            
Sbjct: 198 IGQSPFHGQDEEELFHSIRMDNPFYPR---------WLEKEAKDLLVK--------LFVR 240

Query: 354 NPTERPSM 361
            P +R  +
Sbjct: 241 EPEKRLGV 248

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  100 bits (249), Expect = 8e-25
 Identities = 35/256 (13%), Positives = 78/256 (30%), Gaps = 40/256 (15%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK 187
           ++A+K     + +  +  +E  T   +     I  +  F  EG    L+ + +       
Sbjct: 32  QVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDL 90

Query: 188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP- 246
                      R+ S + +   A  +   V+ +H+   + +++ DIKP N L+       
Sbjct: 91  LD------LCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKN 141

Query: 247 ----KISDFGLAKLCSKDIS-----IVSRTAARGTSGYIAPELFSRN--------FCYGM 289
                + DFG+ K     ++        +    GT+ Y++                  G 
Sbjct: 142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201

Query: 290 MLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLG--QELCLDFEEDGDEGIARKLAIVA 347
           + +  +         ++  +     E I  + +    +ELC         G   +     
Sbjct: 202 VFMYFL-RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC--------AGFPEEFYKYM 252

Query: 348 IWCIQWNPTERPSMPM 363
            +         P    
Sbjct: 253 HYARNLAFDATPDYDY 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 55/263 (20%), Positives = 99/263 (37%), Gaps = 42/263 (15%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT------LIYEFMPN 182
            +A+K +   K   +    E+  + ++ H +IVRL  F      +       L+ +++P 
Sbjct: 47  LVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE 103

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
              +     +  S + + L    ++   + + R + Y+H      I H DIKP N+LLD 
Sbjct: 104 TVYRVA---RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDP 157

Query: 243 N-FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLL 292
           +    K+ DFG AK   +    VS   +R    Y APEL      Y         G +L 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAGCVLA 214

Query: 293 EMVGCRK--NNDPAVEIQSQIY------FPEWI------YNRMRLGQELCLDFEEDGDEG 338
           E++  +     D  V+   +I         E I      Y   +  Q     + +     
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274

Query: 339 IARKLAIVAIWCIQWNPTERPSM 361
              +   +    +++ PT R + 
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTP 297

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 3e-24
 Identities = 49/259 (18%), Positives = 106/259 (40%), Gaps = 36/259 (13%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            +A+K +      +G     I E++ +  ++H +IV+LL      N+  L++EF+     
Sbjct: 29  VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           +       ++S+   +    ++   F + +G+ + H     R+LH D+KP N+L++    
Sbjct: 89  KFM-----DASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGA 140

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---------FCYGMMLLEMVG 296
            K++DFGLA+     +   +      T  Y APE+             +  G +  EMV 
Sbjct: 141 IKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

Query: 297 CRK--NNDPAVEIQSQIY-----FPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAI- 348
            R     D  ++   +I+       E ++  +    +    F +   +  ++ +  +   
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED 258

Query: 349 ------WCIQWNPTERPSM 361
                   + ++P +R S 
Sbjct: 259 GRSLLSQMLHYDPNKRISA 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 4e-24
 Identities = 44/252 (17%), Positives = 89/252 (35%), Gaps = 42/252 (16%)

Query: 129 EIAVKMLEHLKGNG-------QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP 181
           + A K ++  +          ++   EV+ +  I H +++ L           LI E + 
Sbjct: 37  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96

Query: 182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 241
            G L  F+  K        L+ E+  +    +  G   ++   + +I HFD+KP NI+L 
Sbjct: 97  GGELFDFLAEK------ESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLL 147

Query: 242 HNFQP----KISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGM 289
               P    KI DFGLA                GT  ++APE+ +          +  G+
Sbjct: 148 DRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 204

Query: 290 MLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIW 349
           +   ++                +  +     +     +  +FE++     +         
Sbjct: 205 ITYILLSGA-----------SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253

Query: 350 CIQWNPTERPSM 361
            +  +P +R ++
Sbjct: 254 LLVKDPKKRMTI 265

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 96.1 bits (238), Expect = 2e-23
 Identities = 49/262 (18%), Positives = 92/262 (35%), Gaps = 37/262 (14%)

Query: 126 HSNEIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN 182
           +    A+K +   K +       I E++ +  + H +IV+L        R  L++E +  
Sbjct: 25  YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
              +     +        L     +     +  G+ Y H    +R+LH D+KP N+L++ 
Sbjct: 85  DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINR 135

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---------FCYGMMLLE 293
             + KI+DFGLA+     +     T    T  Y AP++   +         +  G +  E
Sbjct: 136 EGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193

Query: 294 MVGCR------KNNDPAVEIQSQIYFPEWIY----NRMRLGQELCLDFEEDGDEGIARKL 343
           MV            D  + I   +  P          +         +E    E   + L
Sbjct: 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253

Query: 344 AIVAI----WCIQWNPTERPSM 361
               I      ++ +P +R + 
Sbjct: 254 DESGIDLLSKMLKLDPNQRITA 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.9 bits (238), Expect = 4e-23
 Identities = 53/246 (21%), Positives = 96/246 (39%), Gaps = 45/246 (18%)

Query: 129 EIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
             A+K+L+          +   +E   +  + H  I+R+ G   +  +  +I +++  G 
Sbjct: 31  YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +         ++      +  A  V   +EYLH    + I++ D+KP NILLD N 
Sbjct: 91  LFSLLRK------SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNG 141

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             KI+DFG AK               GT  YIAPE+ S          + +G+++ EM+ 
Sbjct: 142 HIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196

Query: 297 CRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
                 +   ++   +I   E  +            F ED  + ++R         I  +
Sbjct: 197 GYTPFYDSNTMKTYEKILNAELRFPP---------FFNEDVKDLLSR--------LITRD 239

Query: 355 PTERPS 360
            ++R  
Sbjct: 240 LSQRLG 245

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 1e-21
 Identities = 47/247 (19%), Positives = 87/247 (35%), Gaps = 42/247 (17%)

Query: 129 EIAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS 184
             A+K+L       ++     + E   +    H  +  L       +R   + E+   G 
Sbjct: 32  YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91

Query: 185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 244
           L   +      S  R  + E+ R     +      L    ++ +++ DIK  N++LD + 
Sbjct: 92  LFFHL------SRERVFTEERARFYGAEIVSA---LEYLHSRDVVYRDIKLENLMLDKDG 142

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMVG 296
             KI+DFGL K    D +  +     GT  Y+APE+   N        +  G+++ EM+ 
Sbjct: 143 HIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

Query: 297 CRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWN 354
            R    N     +   I   E  + R             +    +A          ++ +
Sbjct: 201 GRLPFYNQDHERLFELILMEEIRFPR---------TLSPEAKSLLAG--------LLKKD 243

Query: 355 PTERPSM 361
           P +R   
Sbjct: 244 PKQRLGG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.9 bits (219), Expect = 9e-21
 Identities = 48/260 (18%), Positives = 99/260 (38%), Gaps = 38/260 (14%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
            +A+K +   +  +G     + E+  +  + H +IVRL        + TL++EF      
Sbjct: 29  IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
           + F         +  L  E ++   F + +G+ + H    + +LH D+KP N+L++ N +
Sbjct: 89  KYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGE 139

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMMLLEMVG 296
            K+++FGLA+     +     +A   T  Y  P++      Y         G +  E+  
Sbjct: 140 LKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197

Query: 297 CRKNNDPAVEIQSQIY--------FPEWIY---NRMRLGQELCLDFEEDGDEGIARKLAI 345
             +   P  ++  Q+           E  +    ++   +   +         +  KL  
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257

Query: 346 VAI----WCIQWNPTERPSM 361
                    ++ NP +R S 
Sbjct: 258 TGRDLLQNLLKCNPVQRISA 277

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 88.7 bits (219), Expect = 1e-20
 Identities = 43/269 (15%), Positives = 101/269 (37%), Gaps = 53/269 (19%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRT--LIYEFMPNGSL 185
           ++ VK+L+      ++   E+  +  +    +I+ L     +   RT  L++E + N   
Sbjct: 62  KVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NF 244
           ++           + L+   +R   + + + ++Y H      I+H D+KPHN+++DH + 
Sbjct: 120 KQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHR 167

Query: 245 QPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCYG---------MMLLEMV 295
           + ++ D+GLA+                +  +  PEL      Y           ML  M+
Sbjct: 168 KLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

Query: 296 GCR------KNNDPAVEIQSQIYFPEWIYNRMR-------------LGQELCLDFEEDGD 336
             +       +N   +   +++   E +Y+ +              LG+     +E    
Sbjct: 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH 284

Query: 337 EGIARKLAIVAI----WCIQWNPTERPSM 361
                 ++  A+      ++++   R + 
Sbjct: 285 SENQHLVSPEALDFLDKLLRYDHQSRLTA 313

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 4e-20
 Identities = 44/272 (16%), Positives = 94/272 (34%), Gaps = 48/272 (17%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRT--------LIY 177
           ++A+K +      +G     + E+  +  + H ++V L+  C               L++
Sbjct: 37  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96

Query: 178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHN 237
           +F  +             +   + +  +++++   +  G   L+     +ILH D+K  N
Sbjct: 97  DFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLLNG---LYYIHRNKILHRDMKAAN 147

Query: 238 ILLDHNFQPKISDFGLAKLCS--KDISIVSRTAARGTSGYIAPELFSRNFCY-------- 287
           +L+  +   K++DFGLA+  S  K+      T    T  Y  PEL      Y        
Sbjct: 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207

Query: 288 -GMMLLEMVGCRK--NNDPAVEIQSQIY-----FPEWI---------YNRMRLGQELCLD 330
            G ++ EM         +      + I          +         Y ++ L +     
Sbjct: 208 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRK 267

Query: 331 FEEDGDEGIARKLAIVAI-WCIQWNPTERPSM 361
            ++     +    A+  I   +  +P +R   
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 84.9 bits (209), Expect = 5e-19
 Identities = 44/246 (17%), Positives = 90/246 (36%), Gaps = 45/246 (18%)

Query: 128 NEIAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG 183
           N  A+K+L+  K       +  +NE   +  ++   +V+L     + +   ++ E++  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 243
            +   +          + S    R  A  +    EYLH      +++ D+KP N+L+D  
Sbjct: 127 EMFSHLRR------IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQ 177

Query: 244 FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGMMLLEMV 295
              +++DFG AK        +      GT   +APE+            +  G+++ EM 
Sbjct: 178 GYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 296 GCRK--NNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQW 353
                   D  ++I  +I   +  +                     +  L  +    +Q 
Sbjct: 233 AGYPPFFADQPIQIYEKIVSGKVRF-----------------PSHFSSDLKDLLRNLLQV 275

Query: 354 NPTERP 359
           + T+R 
Sbjct: 276 DLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 7e-19
 Identities = 43/261 (16%), Positives = 97/261 (37%), Gaps = 38/261 (14%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL 185
           ++A+K L      +   +    E+  +  + H +++ LL   +         +F      
Sbjct: 45  KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104

Query: 186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 245
                 K     H +L  ++++ + + + +G+ Y+H      I+H D+KP N+ ++ + +
Sbjct: 105 MGTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCE 159

Query: 246 PKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN---------FCYGMMLLEMVG 296
            KI DFGLA+    +      T    T  Y APE+             +  G ++ EM+ 
Sbjct: 160 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214

Query: 297 CRK--NNDPAVEIQSQIY-----FPEWIYNRMRLGQELCL-----DFEEDGDEGIARKLA 344
            +        ++   +I       P     R++  +         + E+     I    +
Sbjct: 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274

Query: 345 IVAI----WCIQWNPTERPSM 361
            +A+      +  +  +R + 
Sbjct: 275 PLAVNLLEKMLVLDAEQRVTA 295

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (189), Expect = 2e-16
 Identities = 44/249 (17%), Positives = 84/249 (33%), Gaps = 37/249 (14%)

Query: 129 EIAVKMLEHLKGNG-----QEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN 182
             A+K+L+           +    E   +  I     +V L        +  LI +++  
Sbjct: 54  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113

Query: 183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 242
           G L   +  +   + H    +         V   V  L       I++ DIK  NILLD 
Sbjct: 114 GELFTHLSQRERFTEHEVQIY---------VGEIVLALEHLHKLGIIYRDIKLENILLDS 164

Query: 243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN----------FCYGMMLL 292
           N    ++DFGL+K    D +  +     GT  Y+AP++              +  G+++ 
Sbjct: 165 NGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 223

Query: 293 EMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQ 352
           E++           +  +      I  R+       L  E    + ++     +    + 
Sbjct: 224 ELLTGA----SPFTVDGEKNSQAEISRRI-------LKSEPPYPQEMSALAKDLIQRLLM 272

Query: 353 WNPTERPSM 361
            +P +R   
Sbjct: 273 KDPKKRLGC 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 3e-16
 Identities = 55/277 (19%), Positives = 97/277 (35%), Gaps = 59/277 (21%)

Query: 129 EIAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS------EGNRRTLIYEF 179
            +A+K L      + + +    E+  +  ++H +I+ LL   +      E     L+ E 
Sbjct: 44  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103

Query: 180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 239
           M     Q             +L  E++  + + +  G+++LH        H D+KP NI+
Sbjct: 104 MDANLCQVI---------QMELDHERMSYLLYQMLCGIKHLHSAGII---HRDLKPSNIV 151

Query: 240 LDHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY--------GMML 291
           +  +   KI DFGLA+           T    T  Y APE+               G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208

Query: 292 LEMV------GCRKNNDPAVEIQSQIYFP-------------EWIYNRMRLGQ----ELC 328
            EMV        R   D   ++  Q+  P              ++ NR +       +L 
Sbjct: 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 268

Query: 329 LDFEEDGDEGIARKLAIVAI----WCIQWNPTERPSM 361
            D     D    +  A  A       +  +P +R S+
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 72.4 bits (176), Expect = 1e-14
 Identities = 32/186 (17%), Positives = 73/186 (39%), Gaps = 21/186 (11%)

Query: 129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIY--EFMPNGSLQ 186
            +A+K++   K   +   +E+  + R++     +     +    + L +     PNG   
Sbjct: 40  HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 99

Query: 187 KFI--------FSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 238
             +         +      HR +    +++I+  +  G++Y+H+ C   I+H DIKP N+
Sbjct: 100 VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENV 157

Query: 239 LLDHN-FQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRN--------FCYGM 289
           L++       +    +A L +        T +  T  Y +PE+            +    
Sbjct: 158 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 217

Query: 290 MLLEMV 295
           ++ E++
Sbjct: 218 LIFELI 223

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 1e-12
 Identities = 42/266 (15%), Positives = 98/266 (36%), Gaps = 48/266 (18%)

Query: 129 EIAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGNRRT-----LIYEFM 180
            +AVK L     +    +    E+  +  + H +++ LL   +            +   +
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104

Query: 181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 240
               L   +         ++L+ + ++ + + + RG++Y+H      I+H D+KP N+ +
Sbjct: 105 MGADLNNIV-------KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAV 154

Query: 241 DHNFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELFSRNFCY---------GMML 291
           + + + KI DFGLA+    +      T    T  Y APE+      Y         G ++
Sbjct: 155 NEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209

Query: 292 LEMVGCR-----KNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIARKLAIV 346
            E++  R      ++   +++  ++          ++  E   ++ +   +      A V
Sbjct: 210 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 269

Query: 347 AIW-----------CIQWNPTERPSM 361
            I             +  +  +R + 
Sbjct: 270 FIGANPLAVDLLEKMLVLDSDKRITA 295

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 55.2 bits (132), Expect = 9e-10
 Identities = 22/139 (15%), Positives = 41/139 (29%), Gaps = 24/139 (17%)

Query: 128 NEIAVKMLE-----------HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLI 176
            E  VK  +                   F        R     + +L G           
Sbjct: 25  GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV----- 79

Query: 177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPH 236
           Y +  N  L + I +K       ++  E   ++   +   V   +    + I+H D+  +
Sbjct: 80  YAWEGNAVLMELIDAKE----LYRVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQY 132

Query: 237 NILLDHNFQPKISDFGLAK 255
           N+L+       I DF  + 
Sbjct: 133 NVLV-SEEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	363
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.78
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.89
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.57
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.35
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.79
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.35

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=358.82  Aligned_cols=233  Identities=24%  Similarity=0.296  Sum_probs=185.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..+|.|++|.++.+...  ++.||||++....  ...+++.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L   90 (271)
T d1nvra_          11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL   90 (271)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcH
Confidence            44566667666665543  4459999986432  3346789999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++.      ....+++..++.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+|+....+.....
T Consensus        91 ~~~l~------~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          91 FDRIE------PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             GGGSB------TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99993      33579999999999999999999999   9999999999999999999999999999998765544333


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                      .....||+.|+|||++         +||||+||++|||++|+.||........       ..........     .....
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~~~~~~~~-----~~~~~  229 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKT-----YLNPW  229 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------HHHHHHTTCT-----TSTTG
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCCC-----CCCcc
Confidence            4556799999999988         7999999999999999999976543321       1111111111     11123


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++++.+++.+||+.||++|||++|
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~e  256 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPD  256 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            345678899999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=352.91  Aligned_cols=235  Identities=20%  Similarity=0.277  Sum_probs=188.6

Q ss_pred             CCCCcccccccccCCcceeecc--CCeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          105 TACPFQSLISFNLTNSKFFFLH--SNEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       105 ~~c~~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .+..+..+|.|++|.++.+...  ++.||||++... ....+.+.+|+.++++++|||||++++++.+++..++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            3445555666666666665433  445999998643 3455789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|+|.+++..       ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....+.
T Consensus       101 gg~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         101 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999998742       458999999999999999999999   999999999999999999999999999999876543


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..  .....||+.|+|||++        +|||||||++|||++|+.||........       +..... ...    ...
T Consensus       171 ~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~~~~-~~~----~~~  236 (293)
T d1yhwa1         171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIAT-NGT----PEL  236 (293)
T ss_dssp             CC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHH-HCS----CCC
T ss_pred             cc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-------HHHHHh-CCC----CCC
Confidence            22  2455699999999998        8999999999999999999976443221       122111 111    112


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+++.+.+++.+||+.||++|||++|
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  266 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKE  266 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            234556788999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-50  Score=351.37  Aligned_cols=232  Identities=22%  Similarity=0.380  Sum_probs=178.1

Q ss_pred             ccccccccCCcceeeccC-CeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHS-NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..+|.|++|.++.....+ +.||||+++......++|.+|++++++++|||||+++|++.+++..++||||+++|+|.++
T Consensus        11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~   90 (263)
T d1sm2a_          11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY   90 (263)
T ss_dssp             EEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHH
Confidence            456778888877766654 3499999987777788999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......... ...
T Consensus        91 l~~~-----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~  161 (263)
T d1sm2a_          91 LRTQ-----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STG  161 (263)
T ss_dssp             HHTT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             hhcc-----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee-ecc
Confidence            8543     2568999999999999999999999   999999999999999999999999999998776543322 234


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..||..|+|||++        +|||||||++|||+|+..|+........       +...+..+...      ..+...+
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~~------~~p~~~~  228 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL------YKPRLAS  228 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-------HHHHHHHTCCC------CCCTTSC
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHhcCCC------CCccccC
Confidence            5689999999998        7999999999999996555443322111       22333332221      2233456


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.+++.+||+.||++||||+|
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~  251 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSR  251 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHH
Confidence            78999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-50  Score=354.08  Aligned_cols=237  Identities=24%  Similarity=0.326  Sum_probs=180.5

Q ss_pred             CcccccccccCCcceeeccCCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          108 PFQSLISFNLTNSKFFFLHSNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ....+|.|++|.++..... ..||||+++...   ...++|.+|+.++++++|||||++++++.+ +..++||||+++|+
T Consensus        12 ~~~~lG~G~fg~Vy~~~~~-~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          12 VGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS   89 (276)
T ss_dssp             CCSEEEECSSCEEEEEESS-SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred             EEEEEeeCCCcEEEEEEEC-CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence            3455777777777766543 459999996432   334689999999999999999999998765 56899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++....     ..+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+|+.........
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          90 LYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             HHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            999995432     569999999999999999999999   999999999999999999999999999998876544333


Q ss_pred             ccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          265 SRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ......||+.|+|||++           +|||||||++|||+||+.||........       +...+..+...  ....
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-------~~~~~~~~~~~--p~~~  232 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------IIFMVGRGYLS--PDLS  232 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------HHHHHHHTSCC--CCGG
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-------HHHHHhcCCCC--Ccch
Confidence            33556799999999986           6999999999999999999975432211       22222222111  0111


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+++.+.+++.+||+.||++||||+|
T Consensus       233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~  262 (276)
T d1uwha_         233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQ  262 (276)
T ss_dssp             GSCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            233445678999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.4e-50  Score=355.31  Aligned_cols=233  Identities=27%  Similarity=0.428  Sum_probs=191.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..+|.|++|.++.+...  +..||||+++......++|.+|++++++++|||||+++|++.+++..++||||+++|+|.+
T Consensus        23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~  102 (287)
T d1opja_          23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD  102 (287)
T ss_dssp             EETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred             eEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHH
Confidence            45677888887776654  3349999998777778899999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRT  267 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  267 (363)
                      ++.....    ..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+....+... ...
T Consensus       103 ~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~  174 (287)
T d1opja_         103 YLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA  174 (287)
T ss_dssp             HHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EET
T ss_pred             Hhhhccc----cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce-eec
Confidence            9965432    679999999999999999999999   99999999999999999999999999999987655433 224


Q ss_pred             cccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          268 AARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       268 ~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ...|+..|+|||++        +|||||||++|||++|..|+........       +.+.+..+.      ....+..+
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-------~~~~i~~~~------~~~~~~~~  241 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDY------RMERPEGC  241 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTC------CCCCCTTC
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-------HHHHHhcCC------CCCCCccc
Confidence            45588999999988        8999999999999998777654333221       223332221      12334456


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++.+.+++.+||+.||++||||+|
T Consensus       242 ~~~l~~li~~cl~~dP~~Rps~~e  265 (287)
T d1opja_         242 PEKVYELMRACWQWNPSDRPSFAE  265 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHH
Confidence            778999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=349.78  Aligned_cols=226  Identities=22%  Similarity=0.321  Sum_probs=184.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..++.|++|.++.+...  ++.||||++..    .....+.+.+|+.++++++|||||++++++.+++..++||||+++|
T Consensus        12 ~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g   91 (263)
T d2j4za1          12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG   91 (263)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence            34566666666555543  33499999853    2345578899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        92 ~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~-  161 (263)
T d2j4za1          92 TVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-  161 (263)
T ss_dssp             BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred             cHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence            999999543      569999999999999999999999   9999999999999999999999999999987654432 


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||+.|+|||++        +|||||||++|||++|+.||.......        +...+....       ...
T Consensus       162 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~-------~~~  223 (263)
T d2j4za1         162 ---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVE-------FTF  223 (263)
T ss_dssp             ---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-------CCC
T ss_pred             ---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCC-------CCC
Confidence               345699999999998        899999999999999999997643321        233333222       122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +...++++.+++.+||+.||++|||++|
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~e  251 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLRE  251 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            3345678999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=351.06  Aligned_cols=232  Identities=24%  Similarity=0.401  Sum_probs=187.3

Q ss_pred             ccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..+|.|++|.++.....++ .||||+++......++|.+|++++++++|||||+++|++.+ +..++||||+++|+|.++
T Consensus        19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~   97 (272)
T d1qpca_          19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF   97 (272)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred             EEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHH
Confidence            4467788888777776544 49999998777777899999999999999999999998865 567899999999999998


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +....    ...+++..+..++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+|+........ ....
T Consensus        98 ~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~  169 (272)
T d1qpca_          98 LKTPS----GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREG  169 (272)
T ss_dssp             TTSHH----HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTT
T ss_pred             HhhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc-cccc
Confidence            84332    2469999999999999999999999   99999999999999999999999999999987654332 2345


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..||+.|+|||++        +|||||||++|||+||..|+........       +...+..+..      ...+..++
T Consensus       170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-------~~~~i~~~~~------~~~p~~~~  236 (272)
T d1qpca_         170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYR------MVRPDNCP  236 (272)
T ss_dssp             CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC------CCCCTTCC
T ss_pred             cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCC------CCCcccCh
Confidence            5689999999988        8999999999999997666544332211       2333333222      12234556


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.+++.+||+.||++||||+|
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~e  259 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDY  259 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHH
Confidence            78999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=353.24  Aligned_cols=233  Identities=18%  Similarity=0.270  Sum_probs=187.0

Q ss_pred             cccccccccCCcceeeccC--CeeEEEEcccC-CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          109 FQSLISFNLTNSKFFFLHS--NEIAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~--~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ...+|.|++|.++.+....  ..||||++... ....+.|.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L   96 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence            3456666666666655433  34999999643 34457899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      .+++....     ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......  .
T Consensus        97 ~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~  166 (288)
T d2jfla1          97 DAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R  166 (288)
T ss_dssp             HHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--H
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--c
Confidence            99985432     569999999999999999999999   9999999999999999999999999999987654322  1


Q ss_pred             cccccccccccCCccc-------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          266 RTAARGTSGYIAPELF-------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~-------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .....||+.|+|||++             +|||||||++|||++|+.||.......        +..++..+...    .
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~----~  234 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPP----T  234 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCC----C
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCC----C
Confidence            2456799999999986             699999999999999999997654322        12222222211    1


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...+..+++++.+++.+||+.||++|||++|
T Consensus       235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e  265 (288)
T d2jfla1         235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ  265 (288)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            2234456788999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=352.50  Aligned_cols=230  Identities=23%  Similarity=0.285  Sum_probs=183.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..+|.|++|.++.+...  ++.||||++..    .....+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus        14 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg   93 (288)
T d1uu3a_          14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG   93 (288)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCC
Confidence            34566666666555443  44599999863    2345578999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+|+........
T Consensus        94 ~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          94 ELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            999998543      569999999999999999999999   99999999999999999999999999999987654433


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      .......||+.|+|||++        +||||+||++|||++|+.||.......        +..++..+.       ...
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~-------~~~  229 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLE-------YDF  229 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTC-------CCC
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--------HHHHHHcCC-------CCC
Confidence            333456799999999998        899999999999999999997653321        333333221       122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+++++.+++.+||+.||++|||++|
T Consensus       230 p~~~s~~~~~li~~~L~~dP~~R~t~~e  257 (288)
T d1uu3a_         230 PEKFFPKARDLVEKLLVLDATKRLGCEE  257 (288)
T ss_dssp             CTTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            3345678999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-49  Score=346.41  Aligned_cols=228  Identities=25%  Similarity=0.334  Sum_probs=180.0

Q ss_pred             cccccccCCcceeeccC--CeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeee----CCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLHS--NEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSE----GNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~--~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~  181 (363)
                      .+|.|++|.++.+....  ..||+|++.....   ..+.|.+|++++++++|||||++++++.+    +...++||||++
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~   95 (270)
T d1t4ha_          16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT   95 (270)
T ss_dssp             EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred             EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence            36777777777665543  3499999864332   23578999999999999999999999864    346899999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceecCCCCCceEEc-CCCCeeEeccccceecc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLD-HNFQPKISDFGLAKLCS  258 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dikp~Nill~-~~~~~kl~Dfg~a~~~~  258 (363)
                      +|+|.+++...      ..+++..++.++.||+.||+|||+   ++  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        96 ~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          96 SGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             CCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999543      569999999999999999999999   77  99999999999997 57899999999998654


Q ss_pred             CCccccccccccccccccCCccc-------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          259 KDISIVSRTAARGTSGYIAPELF-------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~-------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ....    ....||+.|+|||++       +|||||||++|||++|+.||.......       .+.+.+..+...    
T Consensus       167 ~~~~----~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~----  231 (270)
T d1t4ha_         167 ASFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP----  231 (270)
T ss_dssp             TTSB----EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC----
T ss_pred             CCcc----CCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCCC----
Confidence            4322    345699999999998       899999999999999999996543221       133333322211    


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...+...++++.+++.+||+.||++|||++|
T Consensus       232 -~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e  262 (270)
T d1t4ha_         232 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD  262 (270)
T ss_dssp             -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             -cccCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence             1122334567899999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=349.18  Aligned_cols=236  Identities=21%  Similarity=0.271  Sum_probs=173.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeee--CCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSE--GNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  182 (363)
                      ..+|.|++|.++.+...  ++.||||++......   .+.+.+|++++++++|||||++++++.+  ++..++||||+++
T Consensus        10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~   89 (269)
T d2java1          10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   89 (269)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence            45667777776666544  344999998754322   3568899999999999999999999864  4578999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC--NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      |+|.+++.....  ....+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+....+
T Consensus        90 g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  167 (269)
T d2java1          90 GDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD  167 (269)
T ss_dssp             EEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred             CcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence            999999864321  2367999999999999999999999810  124999999999999999999999999999987654


Q ss_pred             ccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          261 ISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ...  .....||+.|+|||++        +|||||||++|||++|+.||.......        +...+..+...     
T Consensus       168 ~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--------~~~~i~~~~~~-----  232 (269)
T d2java1         168 TSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFR-----  232 (269)
T ss_dssp             ----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCC-----
T ss_pred             CCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCC-----
Confidence            332  2446799999999998        899999999999999999997643321        33333332221     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+..+++++.+++.+||+.||++|||++|
T Consensus       233 -~~~~~~s~~l~~li~~~L~~dp~~Rps~~e  262 (269)
T d2java1         233 -RIPYRYSDELNEIITRMLNLKDYHRPSVEE  262 (269)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence             223456678999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=340.71  Aligned_cols=233  Identities=21%  Similarity=0.360  Sum_probs=193.3

Q ss_pred             CcccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          108 PFQSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       108 ~~~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..+.++.|++|.++....+++ .||||+++......++|.+|+.++++++||||++++|++.+++..++||||+++|+|.
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~   87 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL   87 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence            345677888888877776544 5999999987778889999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSR  266 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  266 (363)
                      .++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++........ ..
T Consensus        88 ~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~  158 (258)
T d1k2pa_          88 NYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SS  158 (258)
T ss_dssp             HHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CC
T ss_pred             Hhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-ee
Confidence            9975433     578999999999999999999999   99999999999999999999999999999876654332 23


Q ss_pred             ccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          267 TAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       267 ~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                      ....||..|+|||.+        +|||||||++|||+| |+.||.......        +...+..+...      ..+.
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~------~~p~  224 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRL------YRPH  224 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCC------CCCT
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--------HHHHHHhCCCC------CCcc
Confidence            446689999999998        899999999999998 788887654321        33334333221      2334


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..++++.+++.+||+.||++||||+|
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~e  250 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKI  250 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHH
Confidence            55678999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-48  Score=349.69  Aligned_cols=232  Identities=23%  Similarity=0.346  Sum_probs=174.1

Q ss_pred             ccccccccCCcceeeccCC-----eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHSN-----EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..+|.|++|.++.+....+     .||||.+....  ...++|.+|++++++++|||||+++|++.+++..++||||+++
T Consensus        32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~  111 (299)
T d1jpaa_          32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN  111 (299)
T ss_dssp             EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence            3467777777776655322     28899886432  2346899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...     ...+++..+..++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+|+.......
T Consensus       112 g~L~~~~~~~-----~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         112 GSLDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EEHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             Ccceeeeccc-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            9999988533     2569999999999999999999999   9999999999999999999999999999988765433


Q ss_pred             ccc---cccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          263 IVS---RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       263 ~~~---~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      ...   .....||+.|+|||.+        +|||||||++|||+| |+.||.......        +...+..+..    
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~----  251 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQDYR----  251 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCC----
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC----
Confidence            211   1234578999999988        899999999999998 899987543321        2233332222    


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...+...++.+.+++.+||+.||++||||+|
T Consensus       252 --~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e  282 (299)
T d1jpaa_         252 --LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ  282 (299)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             --CCCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence              1233456678999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=346.36  Aligned_cols=229  Identities=23%  Similarity=0.393  Sum_probs=180.4

Q ss_pred             cccccccCCcceeeccC----CeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          111 SLISFNLTNSKFFFLHS----NEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~----~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      .+|.|++|.++......    +.||||+++....   ..++|.+|++++++++|||||+++|+|.. ...++||||+++|
T Consensus        14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g   92 (277)
T d1xbba_          14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG   92 (277)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCC
Confidence            36777777776665432    2399999964332   23579999999999999999999999865 4578999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        93 ~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          93 PLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999533      569999999999999999999999   99999999999999999999999999999987654332


Q ss_pred             c-ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          264 V-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       264 ~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      . ......||+.|+|||++        +|||||||++|||++ |+.||.......        +...+..+...      
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~------  229 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERM------  229 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCC------
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------HHHHHHcCCCC------
Confidence            2 22345689999999988        899999999999997 899987643221        33333333322      


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+++++.+++.+||+.||++||||+|
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~  259 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAA  259 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            233456678999999999999999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=346.31  Aligned_cols=229  Identities=24%  Similarity=0.394  Sum_probs=183.0

Q ss_pred             ccccccCCcceeecc--CC--eeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          112 LISFNLTNSKFFFLH--SN--EIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~--~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      +|.|++|.++.....  ++  .||||+++...  ...++|.+|++++++++|||||+++|++.+ +..++||||+++|+|
T Consensus        17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L   95 (285)
T d1u59a_          17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPL   95 (285)
T ss_dssp             EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEH
T ss_pred             EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcH
Confidence            677777777665432  22  39999997443  234689999999999999999999999865 468899999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc-
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-  264 (363)
                      .+++...     ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+......... 
T Consensus        96 ~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  167 (285)
T d1u59a_          96 HKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  167 (285)
T ss_dssp             HHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             HHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence            9998432     2579999999999999999999999   999999999999999999999999999999876543322 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                      ......||+.|+|||++        +|||||||++|||+| |+.||.......        +...+..+...      +.
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~------~~  233 (285)
T d1u59a_         168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRM------EC  233 (285)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCC------CC
T ss_pred             cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC------CC
Confidence            22345689999999998        899999999999998 899987543221        23334433322      23


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+++++.+++.+||+.||++||||.+
T Consensus       234 p~~~~~~l~~li~~cl~~~p~~RPs~~~  261 (285)
T d1u59a_         234 PPECPPELYALMSDCWIYKWEDRPDFLT  261 (285)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            3456678999999999999999999853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-48  Score=349.96  Aligned_cols=227  Identities=19%  Similarity=0.261  Sum_probs=180.5

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      +..+|.|++|.++.+...  ++.||||++......    .+.+.+|+.++++++|||||++++++.+++..++||||+++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   99 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence            344566666666555433  334999998754332    24688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|..++..      ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus       100 g~l~~~~~~------~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_         100 SASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             EHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             CchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            999876632      2569999999999999999999999   99999999999999999999999999999876443  


Q ss_pred             ccccccccccccccCCccc-----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          263 IVSRTAARGTSGYIAPELF-----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~-----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                          ....||+.|+|||++           +|||||||++|||++|+.||.......        ....+..+...    
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------~~~~i~~~~~~----  232 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESP----  232 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCC----
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCC----
Confidence                345699999999986           799999999999999999997543321        11122212111    


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ......+++.+.+++.+||+.||++|||++|
T Consensus       233 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  263 (309)
T d1u5ra_         233 -ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV  263 (309)
T ss_dssp             -CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence             1122345678999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=355.79  Aligned_cols=185  Identities=24%  Similarity=0.325  Sum_probs=156.1

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ...+|.|++|.++.+...  +..||+|+++...  ...+++.+|+.++++++|||||+++++|.++++.++||||+++|+
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~   90 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   90 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence            345667777777666544  3349999987432  234678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      |.+++...      ..+++..++.++.|++.||+|||+  .++|+||||||+|||+++++.+||+|||+|+.......  
T Consensus        91 L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~--  160 (322)
T d1s9ja_          91 LDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  160 (322)
T ss_dssp             HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred             HHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc--
Confidence            99999543      469999999999999999999996  14899999999999999999999999999987654322  


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcch
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAV  305 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~  305 (363)
                        ....||+.|+|||++        +||||+||++|||++|+.||....
T Consensus       161 --~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         161 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             -----CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             --ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence              445799999999998        899999999999999999997643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=351.23  Aligned_cols=238  Identities=27%  Similarity=0.396  Sum_probs=184.6

Q ss_pred             ccccccccCCcceeeccCC-------eeEEEEcccC--CcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLHSN-------EIAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-------~vAvK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ..+|.|++|.++.+...+.       .||+|++...  ....+.+.+|+.++.++ +|||||++++++.+.+..++||||
T Consensus        43 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey  122 (325)
T d1rjba_          43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY  122 (325)
T ss_dssp             EEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEc
Confidence            3456666666655543321       3999988643  33456899999999998 899999999999999999999999


Q ss_pred             cCCCCHHHHhhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC
Q 039471          180 MPNGSLQKFIFSKTNS-----------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  242 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~  242 (363)
                      +++|+|.+++......                 .....+++..++.++.|++.||+|||+   ++|+||||||+|||++.
T Consensus       123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill~~  199 (325)
T d1rjba_         123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTH  199 (325)
T ss_dssp             CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEET
T ss_pred             CCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcccccc
Confidence            9999999999754321                 112458999999999999999999999   99999999999999999


Q ss_pred             CCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccch
Q 039471          243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYF  313 (363)
Q Consensus       243 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~  313 (363)
                      ++.+||+|||+|+...............||+.|+|||++        +|||||||++|||+| |+.||........    
T Consensus       200 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~----  275 (325)
T d1rjba_         200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----  275 (325)
T ss_dssp             TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----
T ss_pred             CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH----
Confidence            999999999999987665544344556689999999988        899999999999997 8999875433221    


Q ss_pred             HHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 PEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         +...+..+..      ...+...++++.+++.+||+.||++||||+|
T Consensus       276 ---~~~~~~~~~~------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e  316 (325)
T d1rjba_         276 ---FYKLIQNGFK------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN  316 (325)
T ss_dssp             ---HHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---HHHHHhcCCC------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence               2222222211      2233455678999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-48  Score=348.14  Aligned_cols=231  Identities=22%  Similarity=0.320  Sum_probs=169.4

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC--cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..+|.|++|.++.+...  ++.||||++....  ...+.+.+|++++++++|||||++++++.+++..++||||++||+|
T Consensus        15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L   94 (307)
T d1a06a_          15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL   94 (307)
T ss_dssp             EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            44566666666665543  3449999986432  2345788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc---CCCCeeEeccccceeccCCcc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      .+++..      ...+++..+..++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|+.......
T Consensus        95 ~~~l~~------~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          95 FDRIVE------KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             HHHHHT------CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             HHhhhc------ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999943      3579999999999999999999999   9999999999999995   578999999999987765433


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .   ....||+.|+|||++        +|||||||++|||++|+.||.......        +...+..+..   .....
T Consensus       166 ~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~---~~~~~  231 (307)
T d1a06a_         166 L---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEY---EFDSP  231 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHTTCC---CCCTT
T ss_pred             e---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCC---CCCCc
Confidence            2   345699999999998        899999999999999999997643322        2222222211   11222


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....+++++.+++.+||+.||++|||++|
T Consensus       232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e  260 (307)
T d1a06a_         232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQ  260 (307)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            33456778999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=341.80  Aligned_cols=232  Identities=23%  Similarity=0.362  Sum_probs=180.6

Q ss_pred             ccccccccCCcceeeccCC-eeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSN-EIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..+|.|++|.++.+...+. .||||+++......++|.+|+.++++++|+|||+++|++.+ +..++||||+++|+|..+
T Consensus        23 ~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~  101 (285)
T d1fmka3          23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF  101 (285)
T ss_dssp             EEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHH
T ss_pred             eEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhh
Confidence            3467777777777766554 49999998777777899999999999999999999999865 567899999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +.....    ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+........ ....
T Consensus       102 ~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~  173 (285)
T d1fmka3         102 LKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQG  173 (285)
T ss_dssp             HSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             hhhccc----ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-eecc
Confidence            865432    569999999999999999999999   99999999999999999999999999999877544322 2244


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGIA  340 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (363)
                      ..||+.|+|||.+        +||||||+++|||++|..|+.......+       +...+..+..      .+.+..++
T Consensus       174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-------~~~~i~~~~~------~~~~~~~~  240 (285)
T d1fmka3         174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR------MPCPPECP  240 (285)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC------CCCCTTSC
T ss_pred             ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhcCC------CCCCcccC
Confidence            5689999999998        8999999999999997766655433221       2222322221      12334556


Q ss_pred             HHHHHHHHHhccCCCCCCCCCCC
Q 039471          341 RKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       341 ~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +++.+++.+||+.||++||||+|
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~  263 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEY  263 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHH
Confidence            78999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=339.56  Aligned_cols=232  Identities=23%  Similarity=0.356  Sum_probs=175.6

Q ss_pred             cccccccCCcceeeccCC------eeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHSN------EIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~------~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      .+|.|++|.++...+...      .||||++.....  ...+|.+|++++++++|||||+++|++.+....++||||+.+
T Consensus        14 ~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~   93 (283)
T d1mqba_          14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN   93 (283)
T ss_dssp             EEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             EEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEeccc
Confidence            356777777766554432      399999864332  235789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      +++.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        94 ~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          94 GALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             Ccchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            99999885433     569999999999999999999999   9999999999999999999999999999988755432


Q ss_pred             c-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 I-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      . .......||+.|+|||++        +|||||||++|||++|..|+........       +...+..+..      .
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~------~  232 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFR------L  232 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC------C
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-------HHHHHhccCC------C
Confidence            1 122445689999999988        8999999999999997766554332211       2333333222      2


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+...+..+.+++.+||+.||++||||+|
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  262 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFAD  262 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCchhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence            233446678999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-47  Score=347.73  Aligned_cols=232  Identities=19%  Similarity=0.275  Sum_probs=184.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..+|.|++|.++.+...  ++.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||+++|+|.
T Consensus        35 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~  114 (352)
T d1koba_          35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF  114 (352)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHH
Confidence            34555555555554433  4449999987543 23457889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc--CCCCeeEeccccceeccCCcccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      +++..     ....+++..++.++.||+.||+|||+   ++|+||||||+|||++  .++.+||+|||+|+....+... 
T Consensus       115 ~~~~~-----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~-  185 (352)
T d1koba_         115 DRIAA-----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-  185 (352)
T ss_dssp             HHTTC-----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE-
T ss_pred             HHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCce-
Confidence            88742     23569999999999999999999999   9999999999999998  6789999999999988765432 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....||+.|+|||++        +|||||||++|||++|+.||.......        ....+..+.   ........
T Consensus       186 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~---~~~~~~~~  252 (352)
T d1koba_         186 --KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCD---WEFDEDAF  252 (352)
T ss_dssp             --EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCC---CCCCSSTT
T ss_pred             --eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC---CCCCcccc
Confidence              445689999999998        899999999999999999997654322        222222221   11222334


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++++.+|+.+||+.||++|||++|
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~e  279 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHD  279 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            456788999999999999999999754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=341.41  Aligned_cols=231  Identities=22%  Similarity=0.275  Sum_probs=183.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-------cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..+|.|++|.++.+...  ++.||||+++...       ...+.|.+|+.++++++|||||++++++.+++..++||||+
T Consensus        16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (293)
T d1jksa_          16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV   95 (293)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            44566666666655543  4459999986321       23467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC----CeeEecccccee
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDFGLAKL  256 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~----~~kl~Dfg~a~~  256 (363)
                      ++|+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++    .+|++|||+|+.
T Consensus        96 ~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          96 AGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCccccchhccc------cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            999999999543      469999999999999999999999   9999999999999998776    499999999998


Q ss_pred             ccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .......   ....||+.|+|||++        +||||+||++|||++|+.||.......        ....+.....  
T Consensus       167 ~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~--  233 (293)
T d1jksa_         167 IDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TLANVSAVNY--  233 (293)
T ss_dssp             CTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTCC--
T ss_pred             cCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--------HHHHHHhcCC--
Confidence            7654432   445689999999998        899999999999999999997654322        2222222211  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..........++.+.+++.+||+.||++|||++|
T Consensus       234 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  267 (293)
T d1jksa_         234 -EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD  267 (293)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             -CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence             1111112235677999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.1e-47  Score=347.27  Aligned_cols=232  Identities=19%  Similarity=0.284  Sum_probs=184.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC-cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..+|.|++|.++.+...  ++.||||++.... ...+.+.+|+.++++++|||||++++++.+++..++||||++||+|.
T Consensus        32 ~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~  111 (350)
T d1koaa2          32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF  111 (350)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHH
Confidence            34566666666655443  4459999986543 23467889999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC--CCCeeEeccccceeccCCcccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      +++...     ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.  ++.+||+|||+|+........ 
T Consensus       112 ~~l~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~-  182 (350)
T d1koaa2         112 EKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-  182 (350)
T ss_dssp             HHHTCT-----TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE-
T ss_pred             HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc-
Confidence            998432     3569999999999999999999999   99999999999999964  578999999999987655432 


Q ss_pred             ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCc
Q 039471          265 SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGD  336 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (363)
                        ....||+.|+|||++        +|||||||++|||++|+.||.......        ....+.....   .......
T Consensus       183 --~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~---~~~~~~~  249 (350)
T d1koaa2         183 --KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDW---NMDDSAF  249 (350)
T ss_dssp             --EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC---CSCCGGG
T ss_pred             --ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC---CCCcccc
Confidence              445689999999998        899999999999999999997653321        2222222211   1112233


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          337 EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       337 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+++.+.+++.+||+.||++|||++|
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~e  276 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQ  276 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            456778999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=332.96  Aligned_cols=227  Identities=25%  Similarity=0.380  Sum_probs=177.7

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeee-CCceeEEEeccCCCCHHHH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE-GNRRTLIYEFMPNGSLQKF  188 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~  188 (363)
                      ..++.|++|.++.+...++.||||+++.. ...++|.+|++++++++||||++++|++.+ ++..++||||+++|+|.++
T Consensus        13 ~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~   91 (262)
T d1byga_          13 QTIGKGEFGDVMLGDYRGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY   91 (262)
T ss_dssp             EEEEECSSCEEEEEEETTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred             EEEecCCCeEEEEEEECCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHH
Confidence            45788888888888888888999999754 355789999999999999999999999854 4678999999999999999


Q ss_pred             hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccccccc
Q 039471          189 IFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSRTA  268 (363)
Q Consensus       189 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  268 (363)
                      +.....    ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+|++|||+++......     ..
T Consensus        92 l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~  159 (262)
T d1byga_          92 LRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  159 (262)
T ss_dssp             HHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred             HHhcCC----CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-----cc
Confidence            965321    458999999999999999999999   999999999999999999999999999998765432     33


Q ss_pred             ccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcHHH
Q 039471          269 ARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDEGI  339 (363)
Q Consensus       269 ~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (363)
                      ..+|..|+|||.+        +||||||+++|||+| |+.|+.......        +...+..+..      .+.+...
T Consensus       160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------~~~~i~~~~~------~~~~~~~  225 (262)
T d1byga_         160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYK------MDAPDGC  225 (262)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCC------CCCCTTC
T ss_pred             ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC------CCCCccC
Confidence            4578999999988        899999999999998 677765543221        2333332222      2334455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCCC
Q 039471          340 ARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       340 ~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ++++.+++.+||+.||++||||+|
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~  249 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQ  249 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHH
Confidence            678999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=338.35  Aligned_cols=226  Identities=20%  Similarity=0.235  Sum_probs=184.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..+|.|++|.+..+...  ++.||||+++.    .....+.+.+|+.+|++++||||+++++++.++...++||||+++|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg   90 (337)
T d1o6la_          11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   90 (337)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCC
Confidence            34566666666555533  44599999863    2345578899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+........
T Consensus        91 ~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          91 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             chhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            999999543      568999999999999999999999   99999999999999999999999999999876543321


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                        .....||+.|+|||++        +|+||+||++|||++|+.||.......        +...+..+.       ...
T Consensus       162 --~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~~i~~~~-------~~~  224 (337)
T d1o6la_         162 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-------IRF  224 (337)
T ss_dssp             --BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-------CCC
T ss_pred             --cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHHHHhcCC-------CCC
Confidence              2456799999999998        899999999999999999998754322        233333222       122


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      +..+++++.+++.+||+.||++||+.
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~  250 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGG  250 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CccCCHHHHHHHHhhccCCchhhccc
Confidence            34567789999999999999999973

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-46  Score=329.71  Aligned_cols=231  Identities=21%  Similarity=0.302  Sum_probs=185.1

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC----------hhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEE
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN----------GQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLI  176 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  176 (363)
                      ..++.|++|.++.+...  ++.||||++......          .+.+.+|+.++++++ ||||+++++++.+++..++|
T Consensus         9 ~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~iv   88 (277)
T d1phka_           9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV   88 (277)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEE
Confidence            34455556555555432  334999998643321          136889999999997 99999999999999999999


Q ss_pred             EeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          177 YEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       177 ~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      |||+++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        89 mE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          89 FDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeE
Confidence            9999999999999543      569999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCccccccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhh
Q 039471          257 CSKDISIVSRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMR  322 (363)
Q Consensus       257 ~~~~~~~~~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  322 (363)
                      ...+...   ....||..|+|||.+              +||||+||++|||++|+.||.......        ....+.
T Consensus       160 ~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--------~~~~i~  228 (277)
T d1phka_         160 LDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMIM  228 (277)
T ss_dssp             CCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHH
T ss_pred             ccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------HHHHHH
Confidence            7665432   445699999999987              699999999999999999998654322        223332


Q ss_pred             hccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 LGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..   .........+++++.+++.+||+.||++|||++|
T Consensus       229 ~~~~---~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e  266 (277)
T d1phka_         229 SGNY---QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE  266 (277)
T ss_dssp             HTCC---CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             hCCC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            2221   1122234467788999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=337.84  Aligned_cols=231  Identities=22%  Similarity=0.291  Sum_probs=179.0

Q ss_pred             ccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhcc-CCCceeeeeeeeee----CCceeEEEeccCCCC
Q 039471          112 LISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE----GNRRTLIYEFMPNGS  184 (363)
Q Consensus       112 ~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~~s  184 (363)
                      +|.|++|.++.+...  ++.||||+++    ....+.+|+.++.++ +|||||++++++.+    +...++|||||+||+
T Consensus        20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~----~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~   95 (335)
T d2ozaa1          20 LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE   95 (335)
T ss_dssp             EEECSSCEEEEEEETTTCCEEEEEEEE----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEE
T ss_pred             eeeccCeEEEEEEECCCCCEEEEEEEC----CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCc
Confidence            567777777666543  3459999986    345678999987655 79999999999865    467899999999999


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC---CCCeeEeccccceeccCCc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~---~~~~kl~Dfg~a~~~~~~~  261 (363)
                      |.+++....    ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+|+......
T Consensus        96 L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          96 LFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             HHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             HHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCC
Confidence            999995432    2579999999999999999999999   99999999999999985   5679999999999876554


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..   ....||+.|+|||++        +|||||||++|||++|+.||.........    ..+...+..+   ......
T Consensus       169 ~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~~~---~~~~~~  238 (335)
T d2ozaa1         169 SL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMG---QYEFPN  238 (335)
T ss_dssp             CC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSC---SSSCCT
T ss_pred             cc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHhcC---CCCCCC
Confidence            32   455699999999998        79999999999999999999765432211    1111111111   111122


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....+++++.+++.+||+.||++|||++|
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  268 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITE  268 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            233467788999999999999999999854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.1e-46  Score=333.99  Aligned_cols=221  Identities=22%  Similarity=0.298  Sum_probs=182.0

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..+|.|++|.++.+...  ++.||||+++.    .....+.+.+|+.++++++|||||++++++.+++..++||||++||
T Consensus        10 ~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg   89 (316)
T d1fota_          10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG   89 (316)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCc
Confidence            44566666666666543  44599999863    2345678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+......  
T Consensus        90 ~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          90 ELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             BHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             ccccccccc------ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            999998533      568899999999999999999999   999999999999999999999999999999875432  


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||+.|+|||++        +|||||||++|||++|+.||.......        +..++..+..       ..
T Consensus       159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~-------~~  220 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAEL-------RF  220 (316)
T ss_dssp             ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCC-------CC
T ss_pred             ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--------HHHHHHcCCC-------CC
Confidence               345699999999998        899999999999999999997653321        2333332221       22


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +..+++++.+++.+||+.||++||
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~  244 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRL  244 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCT
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhcc
Confidence            334567799999999999999997

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=337.25  Aligned_cols=231  Identities=23%  Similarity=0.352  Sum_probs=178.3

Q ss_pred             ccccccccCCcceeeccCC------eeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLHSN------EIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~------~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..+|.|++|.++.+....+      .||+|+++..  ....++|.+|++++++++|||||+++|+|.++ ..++++||+.
T Consensus        15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~   93 (317)
T d1xkka_          15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP   93 (317)
T ss_dssp             EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEecc
Confidence            4456666666655544322      3899988633  34557899999999999999999999999875 5678889999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++|.+++....     ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        94 ~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          94 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             TCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             CCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            999999886443     579999999999999999999999   999999999999999999999999999999876654


Q ss_pred             cccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          262 SIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........||..|+|||++        +|||||||++|||+| |.+||.......        +...+..+...     
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~-----  232 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL-----  232 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCC-----
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCC-----
Confidence            44333455689999999987        899999999999998 777776543221        22333333222     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+..+++.+.+++.+||+.||++|||++|
T Consensus       233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~e  262 (317)
T d1xkka_         233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRE  262 (317)
T ss_dssp             -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCcccCHHHHHHHHHhCCCChhhCcCHHH
Confidence             223455678999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=330.07  Aligned_cols=230  Identities=22%  Similarity=0.363  Sum_probs=170.8

Q ss_pred             ccccccccCCcceeeccCC-----eeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHSN-----EIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..+|.|++|.++......+     .||||+++.....  .+.|.+|+.++++++|||||+++|++.+ +..++||||+++
T Consensus        13 ~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~   91 (273)
T d1mp8a_          13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTL   91 (273)
T ss_dssp             EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             EEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccC
Confidence            3456666766665544322     2888988643322  3579999999999999999999999864 678999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++....     ..+++..++.++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+|+.......
T Consensus        92 g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          92 GELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             CcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            99999875432     568999999999999999999999   9999999999999999999999999999987665433


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhccccccccCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEE  333 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (363)
                      . ......||+.|+|||++        +|||||||++|||++ |.+||.......        +...+..+...      
T Consensus       164 ~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~------  228 (273)
T d1mp8a_         164 Y-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERL------  228 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCC------
T ss_pred             e-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC------
Confidence            2 22445689999999998        899999999999997 788887654322        23333333222      


Q ss_pred             CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          334 DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       334 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..+..+++++.+++.+||+.||++|||++|
T Consensus       229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~e  258 (273)
T d1mp8a_         229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  258 (273)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            234456778999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-46  Score=334.63  Aligned_cols=237  Identities=25%  Similarity=0.323  Sum_probs=183.6

Q ss_pred             ccccccccCCcceeeccC-------CeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLHS-------NEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~-------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..+|.|++|.++.....+       ..||||+++....  ..++|.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus        19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~   98 (301)
T d1lufa_          19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM   98 (301)
T ss_dssp             EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEec
Confidence            445666666666654432       3499999974332  2357999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCC------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC
Q 039471          181 PNGSLQKFIFSKTN------------------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  242 (363)
Q Consensus       181 ~~~sL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~  242 (363)
                      ++|+|.+++.....                  ......+++..+..++.|++.||+|||+   .+++||||||+|||++.
T Consensus        99 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld~  175 (301)
T d1lufa_          99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE  175 (301)
T ss_dssp             TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred             CCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEECC
Confidence            99999999965432                  1122458999999999999999999999   99999999999999999


Q ss_pred             CCCeeEeccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCC-CCCcchhcccccch
Q 039471          243 NFQPKISDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK-NNDPAVEIQSQIYF  313 (363)
Q Consensus       243 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~-~~~~~~~~~~~~~~  313 (363)
                      ++.+||+|||+|+...............||+.|+|||.+        +|||||||++|||++|.. ||.......     
T Consensus       176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e-----  250 (301)
T d1lufa_         176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-----  250 (301)
T ss_dssp             GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----
T ss_pred             CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH-----
Confidence            999999999999877655443333456688999999988        899999999999999864 555433221     


Q ss_pred             HHHHHHHhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 PEWIYNRMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                         +...+..+..      ...+..+++++.+|+.+||+.+|++||||+|
T Consensus       251 ---~~~~v~~~~~------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         251 ---VIYYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             ---HHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ---HHHHHHcCCC------CCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence               2333333332      1233455678999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=337.13  Aligned_cols=232  Identities=16%  Similarity=0.186  Sum_probs=184.6

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCHHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSLQK  187 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~  187 (363)
                      ..+|.|++|.++.+...  ++.||||+++........+.+|+++|++++|||||++++++.+++..|+||||++||+|.+
T Consensus        11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~   90 (321)
T d1tkia_          11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE   90 (321)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHH
Confidence            44566666666655543  3349999998666555678899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC--CCCeeEeccccceeccCCccccc
Q 039471          188 FIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       188 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ++...     ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.  ...+||+|||+++........  
T Consensus        91 ~i~~~-----~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~--  160 (321)
T d1tkia_          91 RINTS-----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--  160 (321)
T ss_dssp             HHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE--
T ss_pred             HHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCcc--
Confidence            99432     2469999999999999999999999   99999999999999985  457999999999887654432  


Q ss_pred             cccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCCcH
Q 039471          266 RTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDGDE  337 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (363)
                       ....+|+.|+|||.+        +||||+||++|||++|+.||.......        +...+..+...   .......
T Consensus       161 -~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--------~~~~i~~~~~~---~~~~~~~  228 (321)
T d1tkia_         161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIENIMNAEYT---FDEEAFK  228 (321)
T ss_dssp             -EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCCC---CCHHHHT
T ss_pred             -cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC---CChhhcc
Confidence             345689999999987        799999999999999999997654322        22333222111   1111112


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          338 GIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       338 ~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+++++.+++.+||+.||++|||++|
T Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e  254 (321)
T d1tkia_         229 EISIEAMDFVDRLLVKERKSRMTASE  254 (321)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHH
Confidence            35677999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=333.41  Aligned_cols=239  Identities=21%  Similarity=0.223  Sum_probs=178.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc------ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG------NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      ..+|.|++|.++.+...  ++.||||+++....      ..+.+.+|+.++++++|||||++++++.+++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            44566666666655543  34499999864321      13578999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      ++++..+.      .....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+......
T Consensus        84 ~~~~~~~~------~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          84 TDLEVIIK------DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEHHHHHT------TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             chHHhhhh------hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            87776665      233679999999999999999999999   999999999999999999999999999998765543


Q ss_pred             cccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc-------
Q 039471          262 SIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ-------  325 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  325 (363)
                      ..  .....||+.|+|||++         +|||||||++|||++|..||.........    ..+.+.+....       
T Consensus       155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l----~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         155 RA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL----TRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             CC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHHHCCCCTTTSSST
T ss_pred             cc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH----HHHHHhcCCCChhhccch
Confidence            32  2345689999999987         79999999999999999999765443211    00111100000       


Q ss_pred             -----ccccccCCCC-----cHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 -----ELCLDFEEDG-----DEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 -----~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           ..........     ....++++.+|+.+||+.||++|||++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e  276 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ  276 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence                 0000000000     1134568999999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=331.35  Aligned_cols=246  Identities=20%  Similarity=0.188  Sum_probs=181.9

Q ss_pred             ccccccccCCcceeeccCCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeeeCC----ceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLHSNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGN----RRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL  185 (363)
                      ..+|.|++|.++.+...++.||||+++........+..|+..+.+++|||||++++++.+.+    ..++||||+++|+|
T Consensus         9 ~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L   88 (303)
T d1vjya_           9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL   88 (303)
T ss_dssp             EEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred             EEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCH
Confidence            45788888888888877778999999754332223344555666789999999999997653    57999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGC-----NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      .+++..       ..+++..+..++.|++.||.|||+..     +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          89 FDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            999953       35899999999999999999999621     269999999999999999999999999999987654


Q ss_pred             cccc--ccccccccccccCCccc--------------cCceehhHHHHHHhcCCCCCCcchhcccc-------cchHHHH
Q 039471          261 ISIV--SRTAARGTSGYIAPELF--------------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQ-------IYFPEWI  317 (363)
Q Consensus       261 ~~~~--~~~~~~gt~~y~aPE~~--------------~Di~slG~il~el~~g~~~~~~~~~~~~~-------~~~~~~~  317 (363)
                      ....  ......||+.|+|||++              +|||||||++|||+||..|+.........       ....+.+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence            3321  22446799999999986              59999999999999999887543322111       0111222


Q ss_pred             HHHhhhccccccccC-CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 YNRMRLGQELCLDFE-EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...... +...+... .....+....+.+++.+||+.||++||||.|
T Consensus       242 ~~~~~~-~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  287 (303)
T d1vjya_         242 RKVVCE-QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             HHHHTT-SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             HHHHhc-cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence            222211 11111111 1123456678999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-45  Score=335.29  Aligned_cols=221  Identities=20%  Similarity=0.241  Sum_probs=181.2

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNG  183 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  183 (363)
                      ..+|.|++|.++.+...  ++.||||++..    .....+.+.+|+.++++++|||||++++++.+....++||||+.+|
T Consensus        47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g  126 (350)
T d1rdqe_          47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG  126 (350)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence            34566666666655443  44599999863    2345578999999999999999999999999999999999999999


Q ss_pred             CHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccc
Q 039471          184 SLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       184 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +|..++...      ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+......  
T Consensus       127 ~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--  195 (350)
T d1rdqe_         127 EMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--  195 (350)
T ss_dssp             BHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred             chhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence            999999543      469999999999999999999999   999999999999999999999999999999875432  


Q ss_pred             cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCCC
Q 039471          264 VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEEDG  335 (363)
Q Consensus       264 ~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (363)
                         ....||+.|+|||++        +|||||||++|||++|+.||......        .+..++..+..       ..
T Consensus       196 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~-------~~  257 (350)
T d1rdqe_         196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSGKV-------RF  257 (350)
T ss_dssp             ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-------CC
T ss_pred             ---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--------HHHHHHhcCCC-------CC
Confidence               345699999999998        79999999999999999999764322        13333332221       22


Q ss_pred             cHHHHHHHHHHHHHhccCCCCCCC
Q 039471          336 DEGIARKLAIVAIWCIQWNPTERP  359 (363)
Q Consensus       336 ~~~~~~~l~~l~~~cl~~~p~~RP  359 (363)
                      +..+++++.+++.+||+.||.+|+
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~  281 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRF  281 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred             CccCCHHHHHHHHHHhhhCHHhcc
Confidence            335677899999999999999995

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=328.37  Aligned_cols=233  Identities=23%  Similarity=0.304  Sum_probs=175.7

Q ss_pred             cccccccccCCcceeeccCC-----eeEEEEcccC----CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEec
Q 039471          109 FQSLISFNLTNSKFFFLHSN-----EIAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      ...+|.|++|.++...+...     .||||+++..    ....++|.+|+.++++++||||++++|++.+ ...++||||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~   91 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL   91 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence            34567778888777654322     3899998643    2233689999999999999999999999976 467899999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +++|+|.+++....     ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          92 APLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             CTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             ecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999886443     569999999999999999999999   9999999999999999999999999999998765


Q ss_pred             Ccccc-ccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHHHhhhcccccc
Q 039471          260 DISIV-SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCL  329 (363)
Q Consensus       260 ~~~~~-~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (363)
                      ..... ......|+..|+|||++        +||||||+++|||+| |+.||.......        +...+....    
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~----  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEG----  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSC----
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHHHHhCC----
Confidence            54322 22344578899999988        899999999999998 899987543322        122222111    


Q ss_pred             ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          330 DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       330 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ...+.+..+++.+.+++.+||+.||++||||+|
T Consensus       232 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e  264 (273)
T d1u46a_         232 -ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA  264 (273)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence             112233455678999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=331.70  Aligned_cols=234  Identities=26%  Similarity=0.398  Sum_probs=182.6

Q ss_pred             ccccccccCCcceeeccCC----eeEEEEccc--CCcChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLHSN----EIAVKMLEH--LKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~~~----~vAvK~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..+|.|++|.++.+...++    .||||++..  .....++|.+|++++.++ +|||||+++|++.+++..++||||+++
T Consensus        16 ~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~   95 (309)
T d1fvra_          16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   95 (309)
T ss_dssp             EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCC
Confidence            4577888888777665443    288888753  233456899999999999 799999999999999999999999999


Q ss_pred             CCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccc
Q 039471          183 GSLQKFIFSKTN----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  252 (363)
Q Consensus       183 ~sL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg  252 (363)
                      |+|.+++.....          ......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        96 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~DfG  172 (309)
T d1fvra_          96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  172 (309)
T ss_dssp             CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             CcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEcccc
Confidence            999999965421          1234679999999999999999999999   999999999999999999999999999


Q ss_pred             cceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCC-CCCcchhcccccchHHHHHHHhhh
Q 039471          253 LAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK-NNDPAVEIQSQIYFPEWIYNRMRL  323 (363)
Q Consensus       253 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~  323 (363)
                      +++........   ....||..|+|||.+        +|||||||++|||++|.. ||.....        ..+...+..
T Consensus       173 ~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~~~~~i~~  241 (309)
T d1fvra_         173 LSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQ  241 (309)
T ss_dssp             CEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHGGG
T ss_pred             ccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHh
Confidence            99865543322   345689999999999        899999999999999775 4543321        113444443


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          324 GQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..      .+.+..+++++.+++.+||+.||++||||+|
T Consensus       242 ~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         242 GYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             TCC------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCC------CCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            322      2233456678999999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=330.37  Aligned_cols=227  Identities=19%  Similarity=0.259  Sum_probs=184.5

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEccc----CCcChhHHHHHHHHHh-ccCCCceeeeeeeeeeCCceeEEEeccCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEH----LKGNGQEFINEVATIG-RIHHFHIVRLLGFCSEGNRRTLIYEFMPN  182 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~----~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~  182 (363)
                      ..+|.|++|.++.+...  ++.||||++..    .....+.+.+|..++. .++|||||++++++.+++..++||||+++
T Consensus         8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~   87 (320)
T d1xjda_           8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG   87 (320)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCC
Confidence            45667777777666553  34499999963    2344567788888776 68999999999999999999999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.......
T Consensus        88 g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          88 GDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            9999999543      568999999999999999999999   9999999999999999999999999999987654432


Q ss_pred             ccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccCCC
Q 039471          263 IVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFEED  334 (363)
Q Consensus       263 ~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....||+.|+|||++        +||||+||++|||++|+.||.......        +...+..+.       ..
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~-------~~  221 (320)
T d1xjda_         159 K--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDN-------PF  221 (320)
T ss_dssp             C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-------CC
T ss_pred             c--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC-------CC
Confidence            2  2445799999999998        899999999999999999997654322        333333222       12


Q ss_pred             CcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          335 GDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       335 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .+..+++++.+|+.+||+.||++|||+.
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~  249 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVR  249 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHH
Confidence            2344577899999999999999999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.2e-45  Score=335.88  Aligned_cols=227  Identities=22%  Similarity=0.217  Sum_probs=178.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccC----CcChhHHHH---HHHHHhccCCCceeeeeeeeeeCCceeEEEecc
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHL----KGNGQEFIN---EVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~----~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      ..+|.|++|.++.+...  ++.||||++...    ......+.+   |+.+++.++|||||++++++.+++..++||||+
T Consensus        10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~   89 (364)
T d1omwa3          10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   89 (364)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence            34567777776666544  445999998532    122233444   467777888999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCC
Q 039471          181 PNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  260 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~  260 (363)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        90 ~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          90 NGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             CCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            999999999543      568999999999999999999999   99999999999999999999999999999987654


Q ss_pred             ccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccccccc
Q 039471          261 ISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDF  331 (363)
Q Consensus       261 ~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (363)
                      ..    ....||+.|+|||++         +|||||||++|||++|+.||........     ..+.....       ..
T Consensus       161 ~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~-------~~  224 (364)
T d1omwa3         161 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTL-------TM  224 (364)
T ss_dssp             CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHSS-------SC
T ss_pred             cc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcc-------cC
Confidence            32    445699999999988         7999999999999999999976433221     11111111       11


Q ss_pred             CCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          332 EEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       332 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                      ....+..+++++.+++.+||+.||++|||.
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         225 AVELPDSFSPELRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             CCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence            112233467789999999999999999995

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=329.60  Aligned_cols=232  Identities=24%  Similarity=0.347  Sum_probs=181.4

Q ss_pred             cccccccCCcceeeccCC-----eeEEEEcccC--CcChhHHHHHHHHHhccCCCceeeeeeeeee-CCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLHSN-----EIAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSE-GNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~-----~vAvK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~  182 (363)
                      .+|.|++|.++.+.+..+     .||||+++..  ....++|.+|++++++++||||++++|++.+ ++..++||||+++
T Consensus        34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~  113 (311)
T d1r0pa_          34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  113 (311)
T ss_dssp             EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTT
T ss_pred             EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeec
Confidence            467888888777655332     2899998643  2234689999999999999999999999875 4688999999999


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  262 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~  262 (363)
                      |+|.+++...     ...+++..+..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus       114 g~l~~~~~~~-----~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         114 GDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             CBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             Cchhhhhccc-----cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999998543     3567889999999999999999999   9999999999999999999999999999998765433


Q ss_pred             cc--ccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccccC
Q 039471          263 IV--SRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLDFE  332 (363)
Q Consensus       263 ~~--~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  ......||..|+|||.+        +||||||+++|||++|+.||........       +...+..+...     
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-------~~~~i~~g~~~-----  253 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRL-----  253 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC-----
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC-----
Confidence            21  22345689999999988        8999999999999998888765443222       12222223222     


Q ss_pred             CCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          333 EDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       333 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ..+...++++.+++.+||+.||++||||+|
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~e  283 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  283 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -CCcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence             223345678999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=325.85  Aligned_cols=236  Identities=25%  Similarity=0.380  Sum_probs=182.9

Q ss_pred             cccccccCCcceeeccC---------CeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEe
Q 039471          111 SLISFNLTNSKFFFLHS---------NEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYE  178 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~~---------~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  178 (363)
                      .+|.|++|.++.+...+         ..||||+++....  ...++.+|+..+.++ +|+|||+++++|.+++..++|||
T Consensus        20 ~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e   99 (299)
T d1fgka_          20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE   99 (299)
T ss_dssp             ECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             EEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEE
Confidence            35666666665554321         1399999975443  336888999999988 79999999999999999999999


Q ss_pred             ccCCCCHHHHhhhcCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          179 FMPNGSLQKFIFSKTN----------SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                      |+++|+|.+++.....          ......+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       100 ~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~kl  176 (299)
T d1fgka_         100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKI  176 (299)
T ss_dssp             CCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEE
T ss_pred             ccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCCeEe
Confidence            9999999999965432          1223569999999999999999999999   99999999999999999999999


Q ss_pred             eccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhc-CCCCCCcchhcccccchHHHHHH
Q 039471          249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVG-CRKNNDPAVEIQSQIYFPEWIYN  319 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~-g~~~~~~~~~~~~~~~~~~~~~~  319 (363)
                      +|||+++...............+|+.|+|||.+        +||||||+++|||++ |.+||......        .+.+
T Consensus       177 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--------~~~~  248 (299)
T d1fgka_         177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--------ELFK  248 (299)
T ss_dssp             CSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHH
T ss_pred             ccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--------HHHH
Confidence            999999988765544444556789999999988        899999999999998 67777543322        1333


Q ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+...      ..+...++.+.+++.+||+.||++||||+|
T Consensus       249 ~i~~~~~~------~~p~~~~~~l~~li~~cl~~dP~~Rps~~e  286 (299)
T d1fgka_         249 LLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  286 (299)
T ss_dssp             HHHTTCCC------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHcCCCC------CCCccchHHHHHHHHHHccCCHhHCcCHHH
Confidence            44333222      223345678999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=327.45  Aligned_cols=238  Identities=26%  Similarity=0.380  Sum_probs=172.7

Q ss_pred             ccccccccCCcceeecc-------CCeeEEEEcccCC--cChhHHHHHHHHHhcc-CCCceeeeeeeeeeC-CceeEEEe
Q 039471          110 QSLISFNLTNSKFFFLH-------SNEIAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEG-NRRTLIYE  178 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e  178 (363)
                      ..+|.|++|.++.....       .+.||||+++...  ...+.+.+|...+.++ +|+||+.+++++.+. ...++|||
T Consensus        19 ~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E   98 (299)
T d1ywna1          19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE   98 (299)
T ss_dssp             EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEE
T ss_pred             eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEE
Confidence            34566666665554322       1349999997433  2345788888888887 689999999987654 57899999


Q ss_pred             ccCCCCHHHHhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          179 FMPNGSLQKFIFSKTNS----------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                      |+++|+|.+++......          .....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||
T Consensus        99 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~Kl  175 (299)
T d1ywna1          99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI  175 (299)
T ss_dssp             CCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEE
T ss_pred             ecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcEEE
Confidence            99999999999754321          123468999999999999999999999   99999999999999999999999


Q ss_pred             eccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCC-CCCcchhcccccchHHHHHH
Q 039471          249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRK-NNDPAVEIQSQIYFPEWIYN  319 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~-~~~~~~~~~~~~~~~~~~~~  319 (363)
                      +|||+|+...............||+.|+|||++        +|||||||++|||++|.. ||.......       .+..
T Consensus       176 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-------~~~~  248 (299)
T d1ywna1         176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCR  248 (299)
T ss_dssp             CC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-------HHHH
T ss_pred             ccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            999999877655444344556799999999988        899999999999998754 554432211       1233


Q ss_pred             HhhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .+..+...      ..+...++++.+++.+||+.||++||||+|
T Consensus       249 ~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e  286 (299)
T d1ywna1         249 RLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSE  286 (299)
T ss_dssp             HHHHTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHhcCCCC------CCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            33333222      233445678999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-45  Score=325.09  Aligned_cols=240  Identities=22%  Similarity=0.308  Sum_probs=178.8

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCC---cChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGS  184 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s  184 (363)
                      ..+|.|++|.++.+...  ++.||||+++...   ...+++.+|++++++++|||||++++++.+++..++||||+.+ +
T Consensus         8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~   86 (298)
T d1gz8a_           8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D   86 (298)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred             cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence            45566667666666543  4459999996432   2357899999999999999999999999999999999999975 5


Q ss_pred             HHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCcccc
Q 039471          185 LQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       185 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      +..++....    ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.|+........ 
T Consensus        87 ~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-  158 (298)
T d1gz8a_          87 LKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  158 (298)
T ss_dssp             HHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred             hhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence            555553332    2569999999999999999999999   99999999999999999999999999999877654332 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccc---------
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQE---------  326 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  326 (363)
                       .....||+.|+|||++         +|+||+||++|||++|+.||..........   . +.........         
T Consensus       159 -~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~---~-i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF---R-IFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             -TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---H-HHHHHCCCCTTTSTTGGGS
T ss_pred             -ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH---H-HHHhcCCCchhhccccccc
Confidence             2445799999999986         899999999999999999997654322100   0 0000000000         


Q ss_pred             --ccc---ccCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          327 --LCL---DFEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       327 --~~~---~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                        ...   .....    ....+++++.+++.+||+.||++|||++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e  279 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA  279 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence              000   00000    11234577899999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-45  Score=326.15  Aligned_cols=236  Identities=22%  Similarity=0.330  Sum_probs=184.3

Q ss_pred             cccccccCCcceeecc-------CCeeEEEEcccCCcC--hhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccC
Q 039471          111 SLISFNLTNSKFFFLH-------SNEIAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMP  181 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  181 (363)
                      .+|.|++|.++.....       +..||||+++.....  ...|.+|+.++++++|+||++++|++..+...++||||++
T Consensus        27 ~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~  106 (308)
T d1p4oa_          27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMT  106 (308)
T ss_dssp             EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             EEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecC
Confidence            3566666666554432       234999999754322  2468999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          182 NGSLQKFIFSKTN----SSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       182 ~~sL~~~l~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      +|+|.+++.....    ......+++..+..++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+|+..
T Consensus       107 ~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~  183 (308)
T d1p4oa_         107 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI  183 (308)
T ss_dssp             TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred             CCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccceec
Confidence            9999999865321    1122457999999999999999999999   99999999999999999999999999999887


Q ss_pred             cCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCC-CCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCR-KNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .............||+.|+|||.+        +|+||||+++|||+||+ +|+..... ..       +...+..+..  
T Consensus       184 ~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~~-------~~~~i~~~~~--  253 (308)
T d1p4oa_         184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQ-------VLRFVMEGGL--  253 (308)
T ss_dssp             GGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HH-------HHHHHHTTCC--
T ss_pred             cCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-HH-------HHHHHHhCCC--
Confidence            665444444555689999999987        79999999999999986 45543322 11       2333333322  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ...+..+++.+.+++.+||+.+|++||||+|
T Consensus       254 ----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~  284 (308)
T d1p4oa_         254 ----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE  284 (308)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ----CCCcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence                1223445678999999999999999999854

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-44  Score=320.63  Aligned_cols=233  Identities=19%  Similarity=0.282  Sum_probs=172.9

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcC----hhHHHHHHHHHhccCCCceeeeeeeeeeCC----ceeEEEec
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGN----RRTLIYEF  179 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~  179 (363)
                      ..++.|++|.++.+...  ++.||||+++.....    .++|.+|+.++++++||||+++++++....    ..++||||
T Consensus        13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~   92 (277)
T d1o6ya_          13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY   92 (277)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence            34566666666655433  445999999754322    247889999999999999999999987644    47899999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      ++|++|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++..+++|||.+.....
T Consensus        93 ~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          93 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             CCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            9999999988543      569999999999999999999999   9999999999999999999999999999876544


Q ss_pred             Cccc-cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          260 DISI-VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       260 ~~~~-~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                      .... .......||+.|+|||++        +|||||||++|||+||+.||.......       .....+......   
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~~~~~~~~~---  233 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIP---  233 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCC---
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHHHHHhcCCCC---
Confidence            3221 123455699999999998        899999999999999999997643321       122222211111   


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCC-CCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERP-SMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~  362 (363)
                       .......+++++.+++.+||+.||++|| |++
T Consensus       234 -~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~  265 (277)
T d1o6ya_         234 -PSARHEGLSADLDAVVLKALAKNPENRYQTAA  265 (277)
T ss_dssp             -GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             -CchhccCCCHHHHHHHHHHccCCHhHCHhHHH
Confidence             1112234567899999999999999999 553

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=323.27  Aligned_cols=219  Identities=26%  Similarity=0.320  Sum_probs=175.1

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCC-------cChhHHHHHHHHHhccC--CCceeeeeeeeeeCCceeEEEec
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLK-------GNGQEFINEVATIGRIH--HFHIVRLLGFCSEGNRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~  179 (363)
                      .+|.|++|.++.....  +..||||++....       ....++.+|+.++++++  |+|||++++++.+++..++||||
T Consensus        11 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~   90 (273)
T d1xwsa_          11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER   90 (273)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence            3566666666655443  4459999986422       12345779999999997  89999999999999999999999


Q ss_pred             cCC-CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-CCCeeEeccccceec
Q 039471          180 MPN-GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLC  257 (363)
Q Consensus       180 ~~~-~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-~~~~kl~Dfg~a~~~  257 (363)
                      +.+ +++.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++. ++.+||+|||+|+..
T Consensus        91 ~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          91 PEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             CSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceec
Confidence            975 6788887432      569999999999999999999999   99999999999999985 478999999999876


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      .....    ....||+.|+|||++         +||||+||++|||++|+.||......              ..+..  
T Consensus       162 ~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------------~~~~~--  221 (273)
T d1xwsa_         162 KDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------IRGQV--  221 (273)
T ss_dssp             CSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------HHCCC--
T ss_pred             ccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------------hhccc--
Confidence            54332    445699999999987         79999999999999999999764321              11111  


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           ..+..+++++.+++.+||+.||++|||++|
T Consensus       222 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  251 (273)
T d1xwsa_         222 -----FFRQRVSSECQHLIRWCLALRPSDRPTFEE  251 (273)
T ss_dssp             -----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence                 112234677999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=322.85  Aligned_cols=238  Identities=27%  Similarity=0.420  Sum_probs=183.3

Q ss_pred             cccccccCCcceeecc-------CCeeEEEEcccCCc--ChhHHHHHHHHHhcc-CCCceeeeeeeeeeCCceeEEEecc
Q 039471          111 SLISFNLTNSKFFFLH-------SNEIAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGNRRTLIYEFM  180 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  180 (363)
                      .+|.|++|.++.+...       ...||||+++....  ...+|.+|+.+++++ +|||||+++|++.++...++||||+
T Consensus        30 ~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~  109 (311)
T d1t46a_          30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC  109 (311)
T ss_dssp             EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcC
Confidence            3555666555554321       12399999975432  335789999999999 6999999999999999999999999


Q ss_pred             CCCCHHHHhhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeE
Q 039471          181 PNGSLQKFIFSKTNS------------SSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  248 (363)
Q Consensus       181 ~~~sL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl  248 (363)
                      ++|+|.+++......            .....+++..+..++.||++||+|||+   ++++||||||+|||++.++.+|+
T Consensus       110 ~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~ki  186 (311)
T d1t46a_         110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKI  186 (311)
T ss_dssp             TTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEEE
T ss_pred             CCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCcccc
Confidence            999999999764321            123469999999999999999999999   99999999999999999999999


Q ss_pred             eccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHH
Q 039471          249 SDFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNR  320 (363)
Q Consensus       249 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  320 (363)
                      +|||.++...............||+.|+|||.+        +|||||||++|||+|+..|+.........      +.+.
T Consensus       187 ~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~------~~~~  260 (311)
T d1t46a_         187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------FYKM  260 (311)
T ss_dssp             CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH------HHHH
T ss_pred             cccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH------HHHH
Confidence            999999987765544444567799999999988        89999999999999855554433222111      2222


Q ss_pred             hhhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          321 MRLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      +..+..      ...+...+..+.+++.+||+.||++||||+|
T Consensus       261 i~~~~~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         261 IKEGFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             HHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HhcCCC------CCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            222211      2223345678999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.8e-44  Score=318.62  Aligned_cols=239  Identities=19%  Similarity=0.216  Sum_probs=177.1

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      ..+|.|++|.++.+... ++.||||++...   ....+++.+|+.++++++||||+++++++..++..++++|++.++.+
T Consensus         8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~   87 (286)
T d1ob3a_           8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK   87 (286)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred             cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence            44566666666655433 344999999643   23357899999999999999999999999999999999999987766


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..+.      .....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||.|.........  
T Consensus        88 ~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--  156 (286)
T d1ob3a_          88 KLLD------VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--  156 (286)
T ss_dssp             HHHH------TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             HHHH------hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence            6665      233679999999999999999999999   99999999999999999999999999999876543321  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHh-----------hhcc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRM-----------RLGQ  325 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~  325 (363)
                      .....+++.|+|||.+         +|+||+||++|||++|+.||..........    .+....           ....
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM----RIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHHHCCCCTTTSTTGGGST
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH----HHHHhhCCCChhhccchhhhh
Confidence            2344589999999987         799999999999999999997654322100    000000           0000


Q ss_pred             cccc-------ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELCL-------DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ....       ..........++.+.+++.+||+.||++|||++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e  277 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ  277 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            0000       0001122345678999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=315.92  Aligned_cols=239  Identities=23%  Similarity=0.291  Sum_probs=173.7

Q ss_pred             ccccccccCCcceeecc--CC-eeEEEEcccC---CcChhHHHHHHHHHhcc---CCCceeeeeeeeee-----CCceeE
Q 039471          110 QSLISFNLTNSKFFFLH--SN-EIAVKMLEHL---KGNGQEFINEVATIGRI---HHFHIVRLLGFCSE-----GNRRTL  175 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~-~vAvK~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~l  175 (363)
                      ..+|.|++|.++.+...  ++ .||||+++..   ......+.+|+.+++.+   +||||++++++|..     ....++
T Consensus        13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~   92 (305)
T d1blxa_          13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   92 (305)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence            34555556655554432  22 3999998632   23345677888887776   79999999999853     347899


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccce
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  255 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~  255 (363)
                      +|||++++++.....     .....+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~e~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          93 VFEHVDQDLTTYLDK-----VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEECCSCBHHHHHHH-----SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEeccCCchhhhhh-----ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            999998877655442     223679999999999999999999999   999999999999999999999999999988


Q ss_pred             eccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcc--
Q 039471          256 LCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQ--  325 (363)
Q Consensus       256 ~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  325 (363)
                      .......   .....||+.|+|||++        +||||+||++|||++|+.||...........    +........  
T Consensus       165 ~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~~~  237 (305)
T d1blxa_         165 IYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK----ILDVIGLPGEE  237 (305)
T ss_dssp             CCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHHHCCCCGG
T ss_pred             hhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH----HHHhhCCCchh
Confidence            7654432   2556799999999988        8999999999999999999976543221100    111000000  


Q ss_pred             ----------c----cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ----------E----LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ----------~----~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                                .    .............++.+.+|+.+||++||++|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e  289 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS  289 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                      0    0000011122345677899999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=317.07  Aligned_cols=241  Identities=20%  Similarity=0.187  Sum_probs=173.2

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCceeeeeeeeee------CCceeEEEeccCC
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE------GNRRTLIYEFMPN  182 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~  182 (363)
                      .+|.|++|.++.+...  ++.||||++......   +.+|++++++++|+||+++++++..      ..+.++||||+++
T Consensus        27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~  103 (350)
T d1q5ka_          27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE  103 (350)
T ss_dssp             EEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSE
T ss_pred             EEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCC
Confidence            3566677766665544  344999999754433   3479999999999999999999853      2357899999986


Q ss_pred             CCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCc
Q 039471          183 GSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDI  261 (363)
Q Consensus       183 ~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~  261 (363)
                      +.+ +.+....  .....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++......
T Consensus       104 ~~~-~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         104 TVY-RVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EHH-HHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             ccH-HHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            543 3332211  123679999999999999999999999   9999999999999999775 89999999998876544


Q ss_pred             cccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccc--------hHHHHHHHhhhc
Q 039471          262 SIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY--------FPEWIYNRMRLG  324 (363)
Q Consensus       262 ~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~--------~~~~~~~~~~~~  324 (363)
                      ..   ....||..|+|||.+         +||||+||++|||++|+.||...........        ..+++.......
T Consensus       178 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         178 PN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             CC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             cc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            32   445689999999986         7999999999999999999976543321110        011111110000


Q ss_pred             ccccc------ccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          325 QELCL------DFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       325 ~~~~~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .....      ..........++++.+|+.+||++||++|||++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e  299 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE  299 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            00000      0011122345678999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-42  Score=315.07  Aligned_cols=239  Identities=19%  Similarity=0.228  Sum_probs=172.9

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeCC------ceeEEE
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGN------RRTLIY  177 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~  177 (363)
                      ...+|.|++|.+..+...  ++.||||+++.....   .+.+.+|+.+|++++|+|||+++++|...+      ..++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            344555666655555433  444999999754322   357889999999999999999999997654      579999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||+ +.+|..++..       ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||+|+..
T Consensus       103 e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_         103 PFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             ECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence            999 5688877732       469999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch-------HHHHHHHh
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF-------PEWIYNRM  321 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~-------~~~~~~~~  321 (363)
                      ....     ....||+.|+|||++         +||||+||++|||++|+.||............       +.......
T Consensus       172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            5432     445689999999987         89999999999999999999765432211000       00000000


Q ss_pred             ---------hhccccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          322 ---------RLGQELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       322 ---------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                               ..................++.+.+|+.+||++||++|||++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  297 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE  297 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence                     000000000011122345667899999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=314.16  Aligned_cols=244  Identities=20%  Similarity=0.216  Sum_probs=173.3

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCc--ChhHHHHHHHHHhccCCCceeeeeeeeeeCC----ceeEEEeccC
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGN----RRTLIYEFMP  181 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~  181 (363)
                      ..+|.|++|.++.+...  ++.||||++.....  ..+++.+|+.+|++++|+||+++++++....    ..+++++++.
T Consensus        14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~   93 (345)
T d1pmea_          14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM   93 (345)
T ss_dssp             EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred             EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence            44566666666555433  44599999974332  2357889999999999999999999986543    2345556677


Q ss_pred             CCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCc
Q 039471          182 NGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       182 ~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +|+|.+++..       ..+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        94 ~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          94 GADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             CEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             CCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            9999999942       358999999999999999999999   999999999999999999999999999998765543


Q ss_pred             ccc-ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHH-----
Q 039471          262 SIV-SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYN-----  319 (363)
Q Consensus       262 ~~~-~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~-----  319 (363)
                      ... ......||+.|+|||++         +|+||+||++|||++|+.||...............       ...     
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            221 12456689999999987         79999999999999999999765432211000000       000     


Q ss_pred             HhhhccccccccCC----CCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          320 RMRLGQELCLDFEE----DGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       320 ~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..............    ......++++.+++.+||+.||++|||++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e  291 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ  291 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            00000000000000    011233567899999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.6e-42  Score=309.86  Aligned_cols=235  Identities=16%  Similarity=0.253  Sum_probs=175.6

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccC-CCceeeeeeeeee--CCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSE--GNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~~sL  185 (363)
                      .+|.|++|.++.+...  ++.||||+++.  ...+++.+|+.+|++++ |+||+++++++..  ....++||||+++++|
T Consensus        42 ~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L  119 (328)
T d3bqca1          42 KLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF  119 (328)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBG
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcH
Confidence            3455555555544432  34499999864  34678899999999996 9999999999874  4578999999999999


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCC-CeeEeccccceeccCCcccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV  264 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~  264 (363)
                      ..+.         +.+++..++.++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+........ 
T Consensus       120 ~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~-  186 (328)
T d3bqca1         120 KQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-  186 (328)
T ss_dssp             GGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC-
T ss_pred             HHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCcc-
Confidence            8765         569999999999999999999999   9999999999999998655 5899999999887655432 


Q ss_pred             ccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccch----------HHHHHHHhhhcc
Q 039471          265 SRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYF----------PEWIYNRMRLGQ  325 (363)
Q Consensus       265 ~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~  325 (363)
                        ....+|..|+|||.+         +|+||+||+++||++|+.||........+...          ..+.. ......
T Consensus       187 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~-~~~~~~  263 (328)
T d3bqca1         187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID-KYNIEL  263 (328)
T ss_dssp             --CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH-HTTCCC
T ss_pred             --cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh-hccccc
Confidence              455689999999987         69999999999999999998764432211100          00000 000000


Q ss_pred             c--------------cccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 E--------------LCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~--------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      .              ............+++++.+|+.+||++||++|||++|
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  315 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE  315 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            0              0000111233446678999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=304.48  Aligned_cols=242  Identities=18%  Similarity=0.195  Sum_probs=179.1

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCc---ChhHHHHHHHHHhccCCCceeeeeeeeeeCCceeEEEeccCCCCH
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .+|.|++|.++.+...  ++.||||+++....   ..+++.+|+.++++++|+||+++++++.+....++++|++.+++|
T Consensus         9 ~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l   88 (292)
T d1unla_           9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK   88 (292)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHH
T ss_pred             EEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccc
Confidence            4455555555554433  33399999864332   236889999999999999999999999999999999999999988


Q ss_pred             HHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccCCccccc
Q 039471          186 QKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  265 (363)
Q Consensus       186 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  265 (363)
                      ..++.      ..+.+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.|+........  
T Consensus        89 ~~~~~------~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--  157 (292)
T d1unla_          89 KYFDS------CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--  157 (292)
T ss_dssp             HHHHH------TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--
T ss_pred             ccccc------cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc--
Confidence            88773      23678999999999999999999999   99999999999999999999999999999987654332  


Q ss_pred             cccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHh-----------hhcc
Q 039471          266 RTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRM-----------RLGQ  325 (363)
Q Consensus       266 ~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~  325 (363)
                      .....++..|+|||++         +||||+||++|||++|+.||....................           ....
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            2344577889999987         7999999999999999999754332221110000000000           0000


Q ss_pred             ----ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ----ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                          ..............++.+.+|+.+||++||++|||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e  279 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE  279 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence                00001111233445678899999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-42  Score=308.34  Aligned_cols=240  Identities=17%  Similarity=0.169  Sum_probs=171.0

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccC---CcChhHHHHHHHHHhccCCCceeeeeeeeee--------CCceeEEE
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSE--------GNRRTLIY  177 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~  177 (363)
                      .+|.|++|.++.+...  ++.||||++...   ....+++.+|+.+|++++|+||+++++++..        ++..++||
T Consensus        17 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~   96 (318)
T d3blha1          17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF   96 (318)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEE
T ss_pred             EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEE
Confidence            3556666665555433  344999998533   2344678999999999999999999998854        35689999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||++++.+..+.      .....+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        97 e~~~~~~~~~~~------~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          97 DFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ECCCEEHHHHHT------CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eccCCCccchhh------hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            999877665544      233678999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCccc--cccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhh-cc
Q 039471          258 SKDISI--VSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRL-GQ  325 (363)
Q Consensus       258 ~~~~~~--~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  325 (363)
                      ......  .......||+.|+|||++         +||||+||++|||++|+.||...........    +...... ..
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~----i~~~~~~~~~  243 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL----ISQLCGSITP  243 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHHHCCCCT
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH----HHHhcCCCCh
Confidence            643321  112345689999999987         7999999999999999999976543322111    1010000 00


Q ss_pred             ccc--------------cccCCCCc------HHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          326 ELC--------------LDFEEDGD------EGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       326 ~~~--------------~~~~~~~~------~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ...              ........      ...++.+.+|+.+||++||++|||++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e  301 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD  301 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence            000              00000000      112456789999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-42  Score=309.84  Aligned_cols=232  Identities=20%  Similarity=0.202  Sum_probs=182.8

Q ss_pred             cccccccccCCcceeec-----cCCeeEEEEcccC-----CcChhHHHHHHHHHhccCC-CceeeeeeeeeeCCceeEEE
Q 039471          109 FQSLISFNLTNSKFFFL-----HSNEIAVKMLEHL-----KGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIY  177 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~-----~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  177 (363)
                      ...+|.|++|.++.+..     .++.||||+++..     ....+.+.+|++++++++| +||+++++++.+....+++|
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~  108 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  108 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence            34566666666655432     2345999998532     2345678899999999976 89999999999999999999


Q ss_pred             eccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceec
Q 039471          178 EFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  257 (363)
Q Consensus       178 e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~  257 (363)
                      ||+.+|+|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       109 e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         109 DYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             CCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             ecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999544      457899999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCccccccccccccccccCCccc----------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhcccc
Q 039471          258 SKDISIVSRTAARGTSGYIAPELF----------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQEL  327 (363)
Q Consensus       258 ~~~~~~~~~~~~~gt~~y~aPE~~----------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (363)
                      ....... .....|++.|+|||.+          +|||||||++|||++|+.||.........    ..+.......   
T Consensus       180 ~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~---  251 (322)
T d1vzoa_         180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS---  251 (322)
T ss_dssp             CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHC---
T ss_pred             ccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHhcccC---
Confidence            5443322 2456689999999987          79999999999999999999766443321    1111111111   


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCC
Q 039471          328 CLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSM  361 (363)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  361 (363)
                          ....+...++++.+++.+||+.||++|||+
T Consensus       252 ----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         252 ----EPPYPQEMSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ----CCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence                112334567889999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=304.84  Aligned_cols=238  Identities=21%  Similarity=0.235  Sum_probs=165.0

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeee------CCceeEEEec
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSE------GNRRTLIYEF  179 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~  179 (363)
                      .+|.|++|.+..+...  +..||||++......   .+++.+|+.++++++||||+++++++..      ..+.++||||
T Consensus        24 ~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey  103 (355)
T d2b1pa1          24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL  103 (355)
T ss_dssp             ECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred             EeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEec
Confidence            4455555555554433  444999999754332   2468899999999999999999999853      4688999999


Q ss_pred             cCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceeccC
Q 039471          180 MPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  259 (363)
Q Consensus       180 ~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~~  259 (363)
                      +.++.+ +.+.        ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||+++....
T Consensus       104 ~~~~l~-~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         104 MDANLC-QVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CSEEHH-HHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             cchHHH-Hhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcccc
Confidence            976544 4441        568999999999999999999999   9999999999999999999999999999887665


Q ss_pred             CccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhccccc--------chHHHH------
Q 039471          260 DISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQI--------YFPEWI------  317 (363)
Q Consensus       260 ~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~--------~~~~~~------  317 (363)
                      ....   ....+|+.|+|||++        +||||+||+++||++|+.||..........        ..+++.      
T Consensus       172 ~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         172 SFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            4432   445689999999998        899999999999999999996543221100        000000      


Q ss_pred             -HHHhhhcc------------ccccccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          318 -YNRMRLGQ------------ELCLDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       318 -~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                       ........            ..............++.+.+|+.+||++||++|||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e  307 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD  307 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence             00000000            00001111123456788999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-40  Score=296.22  Aligned_cols=236  Identities=17%  Similarity=0.154  Sum_probs=171.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..+|.|++|.++.+...  ++.||||++.... ..+++.+|++++++++|+|+ +.+.++..++...++||||+ +++|.
T Consensus        13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~   90 (299)
T d1ckia_          13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLE   90 (299)
T ss_dssp             EEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchh
Confidence            44566666666665433  4459999987543 34568899999999987664 55555667888899999999 45777


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEc---CCCCeeEeccccceeccCCccc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISI  263 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~  263 (363)
                      +.+...     ...+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+........
T Consensus        91 ~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          91 DLFNFC-----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             HHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             hhhhhc-----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            766433     2579999999999999999999999   9999999999999986   4557999999999987653321


Q ss_pred             -----cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccccc
Q 039471          264 -----VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELCLD  330 (363)
Q Consensus       264 -----~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (363)
                           .......||+.|+|||++        +|||||||++|||++|+.||..............+........      
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~------  236 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------  236 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC------
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC------
Confidence                 122445799999999988        8999999999999999999976544333221111111111100      


Q ss_pred             cCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          331 FEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       331 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                       .......+++++.+++.+||+.+|++||+++
T Consensus       237 -~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~  267 (299)
T d1ckia_         237 -IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS  267 (299)
T ss_dssp             -HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred             -hhHhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence             0011223457799999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.7e-40  Score=293.29  Aligned_cols=236  Identities=14%  Similarity=0.153  Sum_probs=177.7

Q ss_pred             ccccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccCC-CceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          110 QSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      ..++.|++|.++.+...  ++.||||++.... ..+.+.+|+++++.++| +|++.+++++.++...++||||+ +++|.
T Consensus        11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~   88 (293)
T d1csna_          11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE   88 (293)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHH
Confidence            34567777777666533  4459999886433 34567889999999975 89999999999999999999999 68999


Q ss_pred             HHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcC-----CCCeeEeccccceeccCCc
Q 039471          187 KFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----NFQPKISDFGLAKLCSKDI  261 (363)
Q Consensus       187 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~-----~~~~kl~Dfg~a~~~~~~~  261 (363)
                      +++....     ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||+|+......
T Consensus        89 ~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          89 DLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             HHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             HHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            9885433     569999999999999999999999   99999999999999974     5679999999999875432


Q ss_pred             cc-----cccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccchHHHHHHHhhhccccc
Q 039471          262 SI-----VSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEWIYNRMRLGQELC  328 (363)
Q Consensus       262 ~~-----~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (363)
                      ..     .......||+.|+|||++        +|+||||+++|||++|+.||..........     .+..+.......
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-----~~~~i~~~~~~~  235 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYERIGEKKQST  235 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHHHHHHHHHS
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-----HHHHHHhccCCC
Confidence            21     122445799999999988        799999999999999999997544332211     111111111000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCC
Q 039471          329 LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMP  362 (363)
Q Consensus       329 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  362 (363)
                      .  ..+....+++++.+++..|++.+|++||+++
T Consensus       236 ~--~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         236 P--LRELCAGFPEEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             C--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             C--hHHhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence            0  0001123456799999999999999999753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=303.77  Aligned_cols=240  Identities=17%  Similarity=0.233  Sum_probs=171.4

Q ss_pred             cccccccccCCcceeecc--CCeeEEEEcccCCcC---hhHHHHHHHHHhccCCCceeeeeeeeeeC-----CceeEEEe
Q 039471          109 FQSLISFNLTNSKFFFLH--SNEIAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEG-----NRRTLIYE  178 (363)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e  178 (363)
                      ...+|.|++|.++.+...  ++.||||++......   .+++.+|+.+|++++|+|||++++++...     ...+++++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            345566666666665433  444999999754433   34788999999999999999999998532     34466777


Q ss_pred             ccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          179 FMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       179 ~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      |+.+|+|.+++..       ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||.+....
T Consensus       103 ~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         103 HLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             ECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence            8889999999832       469999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccccccccccccccccCCccc---------cCceehhHHHHHHhcCCCCCCcchhcccccchHHH-------HHHHhh
Q 039471          259 KDISIVSRTAARGTSGYIAPELF---------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIYFPEW-------IYNRMR  322 (363)
Q Consensus       259 ~~~~~~~~~~~~gt~~y~aPE~~---------~Di~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~~~~~  322 (363)
                      ..     .....|+..|+|||.+         +|+||+||++|+|++|+.||...............       ......
T Consensus       173 ~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         173 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             GG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             cc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            32     2445689999999986         79999999999999999999765433211000000       000000


Q ss_pred             hc--c---ccccccCCC----CcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          323 LG--Q---ELCLDFEED----GDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       323 ~~--~---~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                      ..  .   .........    .....++.+.+|+.+||+.||++|||++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e  297 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ  297 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence            00  0   000000000    01134567899999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.7e-35  Score=268.33  Aligned_cols=243  Identities=19%  Similarity=0.237  Sum_probs=164.4

Q ss_pred             cccccccCCcceeecc--CCeeEEEEcccCCcChhHHHHHHHHHhccC-----------CCceeeeeeeeee--CCceeE
Q 039471          111 SLISFNLTNSKFFFLH--SNEIAVKMLEHLKGNGQEFINEVATIGRIH-----------HFHIVRLLGFCSE--GNRRTL  175 (363)
Q Consensus       111 ~~~~~~~~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~--~~~~~l  175 (363)
                      .+|.|++|.++.+...  ++.||||+++......+.+.+|+.++++++           |+||+++++++..  ....++
T Consensus        20 ~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~   99 (362)
T d1q8ya_          20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV   99 (362)
T ss_dssp             EEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEE
T ss_pred             EEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceee
Confidence            3444455554444332  344999999866555577889999998875           4789999998854  345666


Q ss_pred             EEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCC------eeEe
Q 039471          176 IYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ------PKIS  249 (363)
Q Consensus       176 v~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~------~kl~  249 (363)
                      +++++..+.........   .....+++..++.++.||+.||+|||+  ..+|+||||||+|||++.++.      ++++
T Consensus       100 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~  174 (362)
T d1q8ya_         100 VMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIA  174 (362)
T ss_dssp             EEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             eeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEe
Confidence            66665444332222211   223678999999999999999999996  378999999999999986654      8999


Q ss_pred             ccccceeccCCccccccccccccccccCCccc--------cCceehhHHHHHHhcCCCCCCcchhcccccc---h-----
Q 039471          250 DFGLAKLCSKDISIVSRTAARGTSGYIAPELF--------SRNFCYGMMLLEMVGCRKNNDPAVEIQSQIY---F-----  313 (363)
Q Consensus       250 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--------~Di~slG~il~el~~g~~~~~~~~~~~~~~~---~-----  313 (363)
                      |||.+.......     ....||+.|+|||++        +|+||+||+++||++|+.||...........   .     
T Consensus       175 dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         175 DLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             CCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             eccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            999998654332     345689999999988        8999999999999999999875433211100   0     


Q ss_pred             -----HHHHHHHhhh-c-----ccc--c------------cccCCCCcHHHHHHHHHHHHHhccCCCCCCCCCCC
Q 039471          314 -----PEWIYNRMRL-G-----QEL--C------------LDFEEDGDEGIARKLAIVAIWCIQWNPTERPSMPM  363 (363)
Q Consensus       314 -----~~~~~~~~~~-~-----~~~--~------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  363 (363)
                           +......... .     ...  .            ...........++.+.+|+.+||++||++|||++|
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence                 0000000000 0     000  0            00122345677889999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.78  E-value=1.5e-19  Score=149.48  Aligned_cols=129  Identities=13%  Similarity=0.126  Sum_probs=96.5

Q ss_pred             ccccccccCCcceeecc-CCeeEEEEcccCCcC-------------------hhHHHHHHHHHhccCCCceeeeeeeeee
Q 039471          110 QSLISFNLTNSKFFFLH-SNEIAVKMLEHLKGN-------------------GQEFINEVATIGRIHHFHIVRLLGFCSE  169 (363)
Q Consensus       110 ~~~~~~~~~~~~~~~~~-~~~vAvK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~~~~~~~~  169 (363)
                      ..++.|++|.++..... ++.||||+++.....                   ...+.+|...+.++.|.+++..+++.  
T Consensus         6 ~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~--   83 (191)
T d1zara2           6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--   83 (191)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--
T ss_pred             CEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--
Confidence            34677777777776543 445999987521110                   12345688889999999999888653  


Q ss_pred             CCceeEEEeccCCCCHHHHhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceecCCCCCceEEcCCCCeeEe
Q 039471          170 GNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQLSWEKLRKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  249 (363)
Q Consensus       170 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dikp~Nill~~~~~~kl~  249 (363)
                        ..+++|||+++..+.+             ++......++.|++.+|.|||+   .+|+||||||+|||++++ .++|+
T Consensus        84 --~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 --GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             --TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred             --CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence              2379999998765432             3344467889999999999999   999999999999999965 48999


Q ss_pred             ccccceeccC
Q 039471          250 DFGLAKLCSK  259 (363)
Q Consensus       250 Dfg~a~~~~~  259 (363)
                      |||.|.....
T Consensus       145 DFG~a~~~~~  154 (191)
T d1zara2         145 DFPQSVEVGE  154 (191)
T ss_dssp             CCTTCEETTS
T ss_pred             ECCCcccCCC
Confidence            9999987653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=7.6e-07  Score=75.40  Aligned_cols=123  Identities=15%  Similarity=0.113  Sum_probs=84.1

Q ss_pred             eeccCCeeEEEEcccC-CcChhHHHHHHHHHhccC-CCceeeeeeeeeeCCceeEEEeccCCCCHHHHhhhcCCCCCCCC
Q 039471          123 FFLHSNEIAVKMLEHL-KGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGNRRTLIYEFMPNGSLQKFIFSKTNSSSHRQ  200 (363)
Q Consensus       123 ~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~  200 (363)
                      +..++..+.+|+.... ......+.+|...+..++ +-.+.+++.+..+++..++||++++|.++.+.....        
T Consensus        33 v~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--------  104 (263)
T d1j7la_          33 LVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------  104 (263)
T ss_dssp             EECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--------
T ss_pred             EEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--------
Confidence            3344555888887533 334456778998888775 445678888888888999999999998886654110        


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------------------
Q 039471          201 LSWEKLRKIAFGVARGVEYLHQGC--------------------------------------------------------  224 (363)
Q Consensus       201 l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------------------  224 (363)
                         .....++.++++.+..||+..                                                        
T Consensus       105 ---~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (263)
T d1j7la_         105 ---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE  181 (263)
T ss_dssp             ---SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred             ---ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence               112233445555555555410                                                        


Q ss_pred             CCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ...++|+|+.|.|||+++++...|+||+.+..
T Consensus       182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcEEEEeeccCcceeecCCceEEEeechhccc
Confidence            12368999999999999876677999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.89  E-value=1.6e-05  Score=66.48  Aligned_cols=55  Identities=20%  Similarity=0.184  Sum_probs=40.5

Q ss_pred             eEEEEcccCCcChhHHHHHHHHHhccCC--CceeeeeeeeeeCCceeEEEeccCCCCHH
Q 039471          130 IAVKMLEHLKGNGQEFINEVATIGRIHH--FHIVRLLGFCSEGNRRTLIYEFMPNGSLQ  186 (363)
Q Consensus       130 vAvK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~  186 (363)
                      +.+|.....  ....+..|.+.++.+..  -.+.+++++..+++..+++|++++|.++.
T Consensus        38 ~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          38 LFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             EEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             EEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            788876533  33457788888887753  34677888888888899999999986653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.57  E-value=0.0045  Score=54.76  Aligned_cols=32  Identities=19%  Similarity=0.297  Sum_probs=27.0

Q ss_pred             CCceecCCCCCceEEcCCCCeeEeccccceecc
Q 039471          226 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  258 (363)
Q Consensus       226 ~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~~~  258 (363)
                      ..++|+|+.|.|||++.+ .++|+||..|..-+
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G~  254 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGP  254 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEEEC
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhcccCC
Confidence            468999999999999876 48999998876543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.35  E-value=0.014  Score=49.91  Aligned_cols=128  Identities=11%  Similarity=0.091  Sum_probs=71.6

Q ss_pred             CeeEEEEcccCCcChhHHHHHHHHHhccCCCce--eeeee-----eeeeCCceeEEEeccCCCCHHH-----------H-
Q 039471          128 NEIAVKMLEHLKGNGQEFINEVATIGRIHHFHI--VRLLG-----FCSEGNRRTLIYEFMPNGSLQK-----------F-  188 (363)
Q Consensus       128 ~~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~~sL~~-----------~-  188 (363)
                      ..+++|+........+++..|.+.+..|...++  +..+.     .+..++..+.++++++|..+..           . 
T Consensus        47 ~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~L  126 (325)
T d1zyla1          47 RRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYL  126 (325)
T ss_dssp             CCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHH
T ss_pred             CEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHH
Confidence            349999987655566788899998888753222  22211     2244567788999997643311           0 


Q ss_pred             --hhhc---CCCCCCCCCCH----------------------HHHHHHHHHHHHHHHHh-hcCCCCCceecCCCCCceEE
Q 039471          189 --IFSK---TNSSSHRQLSW----------------------EKLRKIAFGVARGVEYL-HQGCNQRILHFDIKPHNILL  240 (363)
Q Consensus       189 --l~~~---~~~~~~~~l~~----------------------~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dikp~Nill  240 (363)
                        ++..   .........+.                      ......+.++...+.-. .+.-..+++|+|+.+.|||+
T Consensus       127 A~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~  206 (325)
T d1zyla1         127 GRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILW  206 (325)
T ss_dssp             HHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEE
T ss_pred             HHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEE
Confidence              1110   00000011111                      12233333333333322 12224678999999999999


Q ss_pred             cCCCCeeEeccccceec
Q 039471          241 DHNFQPKISDFGLAKLC  257 (363)
Q Consensus       241 ~~~~~~kl~Dfg~a~~~  257 (363)
                      +++  ..++||+-+..-
T Consensus       207 ~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         207 RDG--PMFVDLDDARNG  221 (325)
T ss_dssp             SSS--EEECCCTTCCEE
T ss_pred             eCC--ceEEechhcccC
Confidence            753  568999988753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.79  E-value=0.0089  Score=52.77  Aligned_cols=52  Identities=15%  Similarity=0.332  Sum_probs=33.6

Q ss_pred             eeEEEEcccCCcChhHHHHHHHHHhccCCCce-eeeeeeeeeCCceeEEEeccCCCCH
Q 039471          129 EIAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGNRRTLIYEFMPNGSL  185 (363)
Q Consensus       129 ~vAvK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL  185 (363)
                      .|.+++... ........+|..+++.+.-.++ .++++++.+    .+|+||++|.+|
T Consensus        76 ~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          76 KVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             cEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            366666542 2233455689999888863343 477777653    589999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.35  E-value=0.012  Score=50.14  Aligned_cols=32  Identities=19%  Similarity=0.217  Sum_probs=28.3

Q ss_pred             CCCceecCCCCCceEEcCCCCeeEecccccee
Q 039471          225 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  256 (363)
Q Consensus       225 ~~~i~H~dikp~Nill~~~~~~kl~Dfg~a~~  256 (363)
                      ..+++|+|+.++|++++.+...-|+||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            46899999999999999887778999998764